2011”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ€‹†‹ÆÑW(HTML”Å)

i’FŒŽ–{‚ÅŒäŠm”F‰º‚³‚¢j


‰ð–UŠw (ûŒŽ’PˆÊ)

[Šwp˜_•¶]

110001. [ŒŽ’˜] An Aboriginal Australian genome reveals separate human disperslas into Asia. Rasmussen M, Guo X, Wang Y, Lohmueller KE, Rasmussen S, Albrechtsen A, Skotte L, Lindgreen S, Metspalu M, Jombart T, Kivisild T, Zhai W, Eriksson A, Manica A, Orlando L, De La Vega FM, Tridico S, Metspalu E, Nielsen K, çvila-Arcos MC, Moreno-Mayar JV, Muller C, Dortch J, Gilbert MT, Lund O, Wesolowska A, Karmin M, Weinert LA, Wang B, Li J, Tai S, Xiao F, Hanihara T1, van Driem G, Jha AR, Ricaut FX, de Knijff P, Migliano AB, Gallego Romero I, Kristiansen K, Lambert DM, Brunak S, Forster P, Brinkmann B, Nehlich O, Bunce M, Richards M, Gupta R, Bustamante CD, Krogh A, Foley RA, Lahr MM, Balloux F, Sicheritz-PontŽn T, Villems R, Nielsen R, Wang J, Willerslev E: Science 2011/10; 334 (6052): 94-8. (ûŒŽP•F1: 1‰ð–U)

110002. [ŒŽ’˜] Gene conversion and purifying selection shape nucleotide variation in gibbon L/M opsin genes. Hiwatashi T, Mikami A, Katsumura T, Suryobroto B, Perwitasari-Farajallah D, Malaivijitnond S, Siriaroonrat B, Oota H1, Goto S, Kawamura S: BMC Evol Biol 2011/10; 11: 312. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

110003. [ŒŽ’˜] A population genetic study on the relationship between medaka fish and wet-rice-cultivation spreads over the Japanese archipelago. Katsumura T, Oda S, Tsukamoto K, Sekiya Y, Yamashita T, Aso M, Hata M, Nonaka M, Mano S, Ishida H, Mitani H, Kawamura S, Oota H1: Anthropological Science 2012; 120 (1): 81-9. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

522001. [uÀ]y“ÁW: ŒÃl—ÞŠwEÅVŒ€‹†‚Ì“®ŒüzŒ»¶l—ޏW’c‚Ì“ªŠWŒ`‘Ԃ̕ψفE‘œ—l«‚Æ‚»‚̐i‰». ûŒŽP•F (‰ð–U): ‹GŠ§lŒÃŠw 2012/3; 118: 48-53.

530001. [‚»EȆŒ (’Z•ñ)] Autosomal and Y-chromosomal STR markers reveal a close relationship between Hokkaido Ainu and Ryukyu islanders. Koganebuchi K, Katsumura T, Nakagome S, Ishida H, Kawamura S, Oota H1 (The Asian Archival DNA Repository Consortium). Anthropological Science 2012/3; DOI: 10.1537/ase.120322. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

[’˜@‘]

610001. [Šwp‘] (•ª’SŽ·•M)yRacial Representations in AsiazEffects of Human Migration on Genome Diversity in East Asia, p.173-87. Oota H1, Stoneking M, Eds. Yasuko Takezawa, Trans Pacific Pr, 2011/4”­s. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

610002. [Šwp‘] (•ª’SŽ·•M)yMedaka: Model for Organogenesis, Human Disease and EvolutionzHuman Population Genetics Meets Medaka, p.339-50. Oota H1, Mitani H, Edited by Takeda H, Naruse K, Tanaka M, Springer-Verlag, 2011/6”­s. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

610003. [Šwp‘] (•ª’SŽ·•M)yUlcerative Colitis from Genetics to ComplicationszChapter 1 @Evolutionary Insights into the gPopulation-Specificityh of the Genetic Factors Associated with Inflammatory Bowel Diseases, p.1-20. Nakagome S, Oota H1, Edited by Shennak MM, InTech, 2012/1”­s. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

610004. [Šwp‘] (•ª’SŽ·•M)yPost-Genome Biology of PrimateszDuplicated Gene Evolution of the Primate Alcohol Dehydrogenase Family, p.149-61. Oota H1, Kidd KK, Edited by Hirai H, Imai H, Go Y, Springer-Verlag, 2012/3”­s. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

620001. [Šwp‘] (•ª’SŽ·•M)yƒTƒCƒGƒ“ƒXŽ‚ɍڂÁ‚œ“ú–{lŒ€‹†ŽÒ2011zƒI[ƒXƒgƒ‰ƒŠƒAæZ–¯‚̃Qƒmƒ€‚ªŽŠ‚·•¡”‰ñ‚̃AƒWƒA‚ւ̐l‚̈ړ®, p.61. ûŒŽP•F (‰ð–U), ƒTƒCƒGƒ“ƒX“ú–{Ž––±‹Ç, 2012/2”­s.

620002. [Šwp‘] (–|–ó)yƒqƒg‚Í‚Ç‚Ì‚æ‚€‚ɐi‰»‚µ‚Ä‚«‚œ‚©z‘æ2Í ˆâ“`Šw, p.51-94. ‘æ4Í Ží•ª‰»‚ÆŒn“”­¶, p.143-88. ‘Ÿ“c”ŽŽ÷ (‰ð–U), ’˜: ƒƒo[ƒgEƒ{ƒCƒh, ƒWƒF[ƒ“EBEƒVƒ‹ƒN, ŠÄ–ó: Œ–{»Žq, ¬“c@—º, ƒ~ƒlƒ‹ƒ”ƒ@‘–[, ‹ž“s, 2011/7”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712001. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) An evolutionary study of human complex diseases. Workshop on Evolutionary Analyses and Applications. Nakagome S, Mano S, Kozlowski L, Bujnicki JM, Kidd JR, Kidd KK, Kawamura S, Oota H1: Workshop on Evolutionary Analyses and Applications (2011/6/7), Xi'an & Lhasa, China. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

712002. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) How do physical anthropologists have committed themselves on genome medicine? Oota H1: IUAES/AAS/ASAANZ Conference 2011 (2011/7/5), Perth, Australia. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Allelic Variations of Cytochrome P450 Genes in Wild Medaka Populations: a Parallelism to Human Alleles. Katsumura T, Oda S, Mitani H, Kawamura S, Oota H1: SMBE 2011 - Annual Meeting of the Society for Molecular Biology and Evolution (2011/7/26), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Finding a Polymorphism of the L-M Opsin Gene in Howler Monkeys Which Have Been Supposed to Have Uniform Trichromacy in New World Monkeys. Matsushita Y, Oota H1, Welker B, Pavelka M, Kawamura S: SMBE 2011 - Annual Meeting of the Society for Molecular Biology and Evolution (2011/7/26), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Genetic Variation in Wild Capuchins and Spider Monkeys in Costa Rica: Implications for Dispersal Patterns. Sato A, Campos F, Oota H1, Jack K, Fiore AD, Aureli F, Fedigan L, Kawamura S: SMBE 2011 - Annual Meeting of the Society for Molecular Biology and Evolution (2011/7/26), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713004. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Population specific distribution of Crohn's disease risk alleles on the NOD2 locus and natural selection on standing variation. Nakagome T, Mano S, Kozlowski L, Bujnicki JM, Shibata H, Fukumaki Y, Kidd JR, Kidd KK, Kawamura S, Oota H1: SMBE 2011 - Annual Meeting of the Society for Molecular Biology and Evolution (2011/7/26), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713005. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Toward Understanding Evolutionary Force behind Color Vision Polymorphism in Humans. Ishizaki N, Shirai Y, Fukuyo Y, Ishida H, Kidd KK, Oota H1, Kawamura S: SMBE 2011 - Annual Meeting of the Society for Molecular Biology and Evolution (2011/7/26), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713006. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Toward Understanding Importance of Chemical Sense in Primates: a Study of Natural Populations of Color-Vision Polymorphic New World Monkeys. Sakurai K, Bergstrom M, Shirasu M, Imai H, Touhara K, Oota H1, Aureli F, Fedigan L, Kawamura S: SMBE 2011 - Annual Meeting of the Society for Molecular Biology and Evolution (2011/7/26), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713007. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Allelic Variations of Cytochrome P450 Genes in Wild Medaka Populations: Curious Similarities to Humans' Polymorphisms and Their Functions. Katsumura T, Oda S, Mitani H, Kawamura S, Oota H1: Isogenic Medaka Workshop (2011/9/26), EBI, Hinxton, UK. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713008. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Population specific susceptibility to Crohn's disease and signals of natural selection on standing variation. Nakagome S, Mano S, Kozlowski L, Bujnicki JM, Shibat Ha, Fukumaki Y, Kidd JR, Kidd KK, Kawamura S, Oota H1: The 12th ICHG/The 61th Annual Meeting of The American Society of Human Genetics (2011/10/11), Montreal, Canada. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713009. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Allelic Variations of Cytochrome P450 1B1 in Wild Medaka Populations: Curious Similarities to Humansf Polymorphisms and Their Functions. Katsumura T Oda, S, Mitani H, Kawamura S, Oota H1: The 1st Strategic Meeting for Medaka Research (2011/11/23), Okazaki. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713010. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Comparative Analysis of Salivary Microbiota of IBD Patients and Healthy Individuals using Barcoded Pyrosequencing. Said HS, Wataru S, Shigeki N, Oota H1, Chinen H, Morita H, Hattori M: International Human Microbiome Congress (2012/3/19-21), Paris, France. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

722001. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŠÂ‹«—vˆö‚ƈâ“`“I‘œŒ^‚Æ‘œ—l‚È•\E»Œ^‚Æ‚ÌŠÖŒW^Environmental factors and relationship between genetic polymorphisms and various phenotypes. ‘Ÿ“c”ŽŽ÷ (‰ð–U): ‘æ64‰ñ“ú–{¶—l—ÞŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€IwŠÂ‹«‹y‚шâ“`‚Ì—vˆö‚Ɛ¶—“I‘œŒ^«‚Æ‚ÌŠÖŒWx(2011/6/11), •Ÿ‰ª.

722002. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰«“êl‚ª‘å˜al‚æ‚èŽð‚É‹­‚¢——R|ˆâ“`Žq‚𒲂ׂĂ킩‚Á‚œ‚±‚Ɓ|. ‘Ÿ“c”ŽŽ÷ (‰ð–U): ‘æ65‰ñ“ú–{l—ÞŠw‰ïŒöŠJƒVƒ“ƒ|ƒWƒEƒ€Iw—®‹…ŒÊ‚ƃqƒg‚Ì“K‰ží—ªx(2011/11/6), “ß”e.

723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pí“I3FŒ^FŠo‚Æ‚³‚ê‚Ä‚«‚œƒzƒGƒUƒ‹‘®‚É‚š‚¯‚éŽí“àL-MƒIƒvƒVƒ“‘œŒ^‚Ì”­Œ©. Œ‰º—T, ‘Ÿ“c”ŽŽ÷1, Barbara Welker, Mary Pavelka, ‰Í‘º³“ñ (1‰ð–U): “ú–{—ì’·—ÞŠw‰ï27‰ñŠwp‘å‰ï (2011/7/10), Œ¢ŽR.

723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FŠoŽí“à‘œŒ^‚ðŽŠ‚·V¢ŠEƒUƒ‹–쐶W’c‚É‚š‚¯‚鉻Šw•šŽ¿ŠŽŠoƒZƒ“ƒT[‚Ì‘œŒ^‰ðÍ (Œo‰ß•ñ). ŸNˆäŽ™‘Ÿ–€, ¡ˆäŒ[—Y, “ŒŒŽ˜a¬, ‘Ÿ“c”ŽŽ÷1, Aureli F, Fedigan L, ‰Í‘º³“ñ (1‰ð–U): “ú–{—ì’·—ÞŠw‰ï27‰ñŠwp‘å‰ï (2011/7/10), Œ¢ŽR.

723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Allelic variations of cytochrome P450 genes in wild medaka populations: a parallelism to human alleles. Ÿ‘ºŒ[Žj, ”ö“c³“ñ, ŽO’JŒ[Žu, ‰Í‘º³“ñ, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): “ú–{i‰»Šw‰ï‘æ13‰ñ”N‰ï (2011/7/29), ‹ž“s.

723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Finding a polymorphism of the L-M opsin gene in howler monkeys which have been supposed to have uniform trichromacy in New World monkeys. Œ‰º—T, ‘Ÿ“c”ŽŽ÷1, Welker B, Pavelka M, ‰Í‘º³“ñ (1‰ð–U): “ú–{i‰»Šw‰ï‘æ13‰ñ”N‰ï (2011/7/29), ‹ž“s.

723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Toward understanding evolutionary force behind color vision polymorphism in humans. Îè’Œ–ç, ”’ˆä—T‰î, •Ÿ¢—T‹MŽq, Î“c@”£, Kidd KK, ‘Ÿ“c”ŽŽ÷1, ‰Í‘º³“ñ (1‰ð–U): “ú–{i‰»Šw‰ï‘æ13‰ñ”N‰ï (2011/7/29), ‹ž“s.

723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Toward understanding importance of chemical sense in primates: a study of natural populations of color-vision polymorphic New World monkeys. ŸNˆäŽ™‘Ÿ–€, Bergstrom M, ”’{–¢, ¡ˆäŒ[—Y, “ŒŒŽ˜a¬, ‘Ÿ“c”ŽŽ÷1, Aureli F, Fedigan L, ‰Í‘º³“ñ (1‰ð–U): “ú–{i‰»Šw‰ï‘æ13‰ñ”N‰ï (2011/7/29), ‹ž“s.

723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¢ŠEƒzƒGƒUƒ‹–쐶ŒQ‚ɑ΂·‚é‹Œ¢ŠE—ì’·—ÞŒ^3FŒ^FŠo‚Ì‘œŒ^«’²ž. Œ‰º—T, ‘Ÿ“c”ŽŽ÷1, Welker B, Pavelka M, ‰Í‘º³“ñ (1‰ð–U): “ú–{ˆâ“`Šw‰ï‘æ83‰ñ‘å‰ï (2011/9/20), ‹ž“s.

723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ›z—‘ŠúƒjƒƒgƒŠéҌã‘Ì‚É”­Œ»‚·‚éƒCƒ“ƒXƒŠƒ“ŽY¶×–E‚̃ƒJƒjƒYƒ€‚̉ðÍ. ŽO‰Y³–Ÿ1, Œê r”V (1‰ð–U): ‘æ117‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï (2012/3/28), ŽR—œ.

733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒ_ƒJW’c‚ð—p‚¢‚œƒqƒg‘œŒ^‚̐¶‘Ì‹@”\‰ðÍŽÀŒ±Œn‚ÌŒŸ“¢|cytochrome P450‚É’…–Ú‚µ‚Ä. Ÿ‘ºŒ[Žj, ”ö“c³“ñ, ŽO’JGŽu, ‰Í‘º³“ñ, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): ‘æ11‰ñ“Œ‹ž‘åŠw¶–œ‰ÈŠwƒVƒ“ƒ|ƒWƒEƒ€ (2011/6/4), “Œ‹ž.

733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¢ŠE—ì’·—Þ‚Ì’†‚Å—BˆêPí“I3FŒ^FŠo‚Æ‚³‚ê‚éƒzƒGƒUƒ‹‘®‚É‚š‚¯‚éŽí“àL-MƒIƒvƒVƒ“‘œŒ^‚Ì”­Œ©. Œ‰º—T, ‘Ÿ“c”ŽŽ÷1, Barbara Welker, Mary Pavelka, ‰Í‘º³“ñ (1‰ð–U): ‘æ11‰ñ“Œ‹ž‘åŠw¶–œ‰ÈŠwƒVƒ“ƒ|ƒWƒEƒ€ (2011/6/4), “Œ‹ž.


733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) l—Þ‚ÌŒ`‘Ô, ¶—E‘ãŽÓ, ŽŸŠ³‚̐i‰»‚ÉŠÖ‚·‚éƒQƒmƒ€‘œ—l«Œ€‹†. ‘Ÿ“c”ŽŽ÷ (‰ð–U): ‹€“¯—˜—pd“_Œ^Œ€‹†‚É‚æ‚錀‹†W‰ï|ƒQƒmƒ€‚Ì‘œ—l«, i‰», ŽŸŠ³‚ÉŠÖ‚í‚é˜b‘è‚ɂ‚¢‚Ă̍u‰‰| (2011/12/19), —§ì (“Œv”—ŠwŒ€‹†Š)

733004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒjƒzƒ“ƒƒ_ƒJ (Oryzias latipes) ‘Sg‘gDØ•Ð‚ÉŠÏŽ@‚³‚ê‚œ•ÏˆÙ2—á‚Ì•ñ. Œê r”V, Ÿ‘ºŒ[Žj, ”ö“c³“ñ, ŒÃ‰êŒú“¿, ûŒŽP•F1, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): ‘æ23‰ñ¶•šŠw‹ZpŒ€‹†‰ï (2012/2/16-17), ‰ªè.

H22”N“xˆÈ‘O•ª

[’˜@‘]

H17-620001. [Šwp‘] (•ª’SŽ·•M)yƒqƒg‚Ì‹³ˆçzûŒŽ˜a˜Y‚Ì•à‚Ý‚ðŽÃ‚ñ‚Å, p.74-5. ûŒŽP•F (‰ð–U), •Ò: ˆäŒû@Œ‰, ¬ŠwŠÙ, “Œ‹ž, 2005/12”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H22-712001. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) How should we think of "population" in population genetics? Oota H1: A Japan-based Global Study of Racial Representation International Workshop. The Interface of Humanities and Genomics (2011/1/22), Kyoto. (‘Ÿ“cEŽŽE: 1‰ð–U)

H22-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Molecular genetic reevaluation of the uniform-trichromacy hypothesis for howler monkeys. Matsushita Y, Oota H1, Welker B, Pavelka M, Kawamura S: The 4th International Symposium of the Biodiversity and Evolution, Kyoto University Global COE project "Evolution of Sensor," Communication and Society (2010/9/11), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

H22-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A population genetic test of balancing selection for color vision variation in New World monkeys. Kawamura S, Hiwatashi T, Okabe Y, Tsutsui T, Hiramatsu C, Melin AD, Oota H1, Schaffner CM, Aureli F, Fedigan LM, Innan H: The 23rd International Primatological Society Congress Kyoto 2010: Symposium ""Variation and Evolution of Primate Color Vision Revealed by Cross-disciplinary Studies"" organized by S. Kawamura and A. D. Melin (2010/9/12), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

H22-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Analysis of expression mechanism of insulin-producing cells in ultimobranchical gland of chick embryo. ŽO‰Y³–Ÿ (‰ð–U): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï^‘æ116‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï ‡“¯‘å‰ï (2011/3/29), ŽãŠJÃ.


‰ð–UŠw (ãã’PˆÊ)

[Šwp˜_•¶]

110004. [ŒŽ’˜] Prickle2 is localized in the postsynaptic density and interacts with PSD-95 and NMDA receptors in the brain. Hida Y, Fukaya M1, Hagiwara A, Deguchi-Tawarada M, Yoshioka T, Kitajima I, Inoue E, Watanabe M, Ohtsuka T: J Biochem 2011/6; 149 (6): 693-700. ([’J¹O1: 1‰ð–U)

110005. [ŒŽ’˜] NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. DeBiase LM, Kang SH, Potter E, Fukaya M1, Pucak M, Rowich D, Mishina M, Calabresi P, Bergles DE: J Neurosci 2011/8; 31 (35): 12650-62. ([’J¹O1: 1‰ð–U)

510001. [‘à] Ubiquitin-mediated proteasomal degradation of ABC transporters: a new aspect of genetic polymorphisms and clinical impacts. Nakagawa H, Toyoda Y, Wakabayashi-Nakao K, Tamaki H1, Osumi M, Ishikawa T: J Pharm Sci 2011/9; 100 (9): 3602-19. (‹Ê–؉p–Ÿ1: 1‰ð–U)

[Šw‰ïEŒ€‹†‰ï“™]

723009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒXV¶Ž™Ò‘• ‘€‚É‚š‚¢‚Ä“¯‘€‚É“ŠŽË‚·‚é—}§«ƒjƒ…[ƒƒ“‚Ì‹@\“IEŒ`‘ÔŠw“I‰ðÍ. ŒŠÛLŽj, ãã—ms1, Š`è”ü‘ã, –öì‰Eç•v (1‰ð–U): ‘æ34‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2011/9/16), ‰¡•l.

723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Postsynaptic and endosomal localization of BRAG2/GEP100 in the adult mouse brain. [’J¹O1, ŒŽ@–FL1, ãã—ms1 (1‰ð–U): ‘æ34‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2011/9/17), ‰¡•l.

723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒNƒ`ƒ“Œ‹‡«“]ŽÊŠˆ«ˆöŽqMKL‚ªŠÖ—^‚·‚éƒAƒNƒ`ƒrƒ“—U“±«‚̃‰ƒbƒg‘å”]”玿ƒjƒ…[ƒƒ“Ž÷ó“Ë‹NŒ`‘Ԑ§Œä‚É‚š‚¯‚éV‹KƒVƒOƒiƒ‹“`’BŒo˜H‚̉ðÍ. Îì@[, Œ“ˆ’Œ‹I, ãã—ms1, “y“c–M”Ž, …‰z”ü”¿, ‰–“c@“Õ, •Ÿ’n@Žç, ’Óc³–Ÿ, “cŸº–ŸŽq (1‰ð–U): ‘æ34‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2011/9/17), ‰¡•l.

723012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX¬”]ƒvƒ‹ƒLƒ“ƒG×–E‚̐¶Œã”­¶‰ß’ö‚É‚š‚¯‚éƒSƒ‹ƒW‘•’u‚Ì“®‘Ô. ‹Ê–؉p–Ÿ1, ãã—ms1 (1‰ð–U): ‘æ117‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï (2012/3/27), b•{.

723013. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬‘̃}ƒEƒX”]‚É‚š‚¯‚éARF6Šˆ«‰»ˆöŽqBRAG2/IQSEC1‚̍זE“à‹ÇÝ‰ðÍ. [’J¹O1, ŒŽ@–FL1, ãã—ms1 (1‰ð–U): ‘æ117‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï (2012/3/28), b•{.


¶—Šw (ìã’PˆÊ)

[Šwp˜_•¶]

110006. [ŒŽ’˜] Inhibition of axonal transport caused by tert-butyl hydroperoxide in cultured mouse dorsal root ganglion neurons. Isonaka R1, Hiruma H1, Kawakami T1: J Mol Neurosci 2011/10; 45 (2): 194-201. (ˆé’†—¹1, ”ä—¯ŠÔO”ü1, ìã@—Ï1: 1¶—)

110007. [ŒŽ’˜] Inhibition of superoxide dismutase selectively suppresses growth of rat spinal motor neurons: Comparison with phosphorylated neurofilament-containing spinal neurons. Isonaka R1, Hiruma H1, Katakura T1, Kawakami T1: Brain Res 2011/11; 1425: 13-9. (ˆé’†—¹1, ”ä—¯ŠÔO”ü1, •Ð‘q@—²1, ìã@—Ï1: 1¶—)

120001. [ŒŽ’˜] ’áŽ_‘f–\˜I“®•š‚š‚æ‚э‚ŒŒˆ³“®•š‚É‚š‚¯‚é‹C“¹”S–Œ‚Ì“®‘Ô. ˆé’†—¹1, ìã@—Ï1, Œ“cGŽ÷, —Ñ“c‰Ã˜N, “ú‰º•”’CŽO (1¶—): ‘ŽmŠÚ‘åŠw‘̈猀‹†Š•ñ 2012/3; 30: 57-9.

[Šw‰ïEŒ€‹†‰ï“™]

713011. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tert-Butyl hydroperoxide induced-inhibition of axonal transport and its reversal by ƒ¿-tocopherol. Isonaka R1, Hiruma H1, Takenami T2, Kawakami T1: Neuroscience 2011 (2011/11/13), Washington DC, USA. (ˆé’†—¹1, ”ä—¯ŠÔO”ü1, ’|˜Q–¯]2, ìã@—Ï1: 1¶—, 2–ƒŒ)

723014. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”|—{_Œo×–E‚É‚š‚¯‚éƒyƒ“ƒgƒoƒ‹ƒrƒ^[ƒ‹‚̓Ő«•]‰¿. ™]G–Ÿ1, ”ä—¯ŠÔO”ü1, ìã@—Ï1 (1¶—): “ú–{–@’†“ÅŠw‰ï‘æ30”N‰ï (2011/6/11), ’·è.

723015. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Motor neurons are more vulnerable to superoxide dismutase inhibition than other spinal neurons: rescue by antioxidants. ˆé’†—¹1, ”ä—¯ŠÔO”ü1, •Ð‘q@—²1, ìã@—Ï1 (1¶—): ‘æ34‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2011/9/15), ‰¡•l.

723016. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Influence of Neurotropin® on axonal transport in cultured mouse dorsal root ganglion neurons. ˆé’†—¹1, ’|˜Q–¯]2, •Ð‘q@—²1, ìã@—Ï1 (1¶—, 2–ƒŒ): ‘æ89‰ñ“ú–{¶—Šw‰ï‘å‰ï (2012/3/30), Œ–{.


¶—Šw (‰ÍŒŽ’PˆÊ)

[Šwp˜_•¶]

110008. [ŒŽ’˜] Aldosterone requires vasopressin V1a receptors on intercalated cells to mediate acid-base homeostasis. Izumi Y, Hori K, Nakayama Y, Kimura M, Hasuike Y, Nanami M, Kohda Y, Otaki Y, Kuragano T, Obinata M, Kawahara K1, Tanoue A, Tomita K, Nakanishi T, Nonoguchi H: J Am Soc Nephrol 2011/4; 22 (4): 673-80. (‰ÍŒŽŽ‰ë1: 1¶—)

110009. [ŒŽ’˜] Different localization of ATP sensitive K+ channel subunits in rat testis. Zhou M, He HJ, Tanaka O, Sekiguchi M, Kawahara K1, Abe H: Anat Rec (Hoboken). 2011/4; 294 (4): 729-37. (‰ÍŒŽŽ‰ë1: 1¶—)

110010. [ŒŽ’˜] The atypical Guanine-nucleotide exchange factor, dock7, negatively regulates schwann cell differentiation and myelination. Yamauchi J, Miyamoto Y, Hamasaki H, Sanbe A, Kusakawa S, Nakamura A, Tsumura H, Maeda M, Nemoto N, Kawahara K1, Torii T, Tanoue A: J Neurosci 2011/8; 31 (35): 12579-92. (‰ÍŒŽŽ‰ë1: 1¶—)

110011. [ŒŽ’˜] Long-term maintenance and eventual extinction of preference for a mate's call in the female budgerigar. Eda-Fujiwara H, Kanesada A, Okamoto Y, Satoh R1, Watanabe A, Miyamoto T: Animal Behaviour 2011/11; 82 (5): 971-9. (²“¡—º•œ1: 1¶—)

120002. [ŒŽ’˜] –¢¬nƒ}ƒEƒX‚Ì–¡ŠoŒ™ˆ«ŠwKŒã‚̏Á‹Ž‹L‰¯ŠÖ˜A”]•”ˆÊ‚Å‚Ý‚ç‚ê‚éƒAƒ“ƒhƒƒQƒ“Žó—e‘̈â“`Žq”­Œ»—ʂ̐«·. —é–Øœš‰ë, ìç²‚Æ‚à‚±, “¡ŒŽGŽq, âV“¡—‰À, ²“¡—º•œ1, ‹{–{•“T (1¶—): –¡‚Æ“õŽ 2011/12; 18 (3): 311-4.

522002. [uÀ]y“ÁW: t‘ã‘֗Ö@‚Ì–â‘è“_‚ðÄl‚·‚éz…“d‰ðŽ¿Coffee Break@‰–‚ÆŒŒˆ³‚Ì‚¢‚¢ŠÖŒW. ‰ÍŒŽŽ‰ë1, ˆÀ‰ª—L‹IŽq1 (1¶—): t‚Æ“§Í 2011/9; 71 (3): 408.

522003. [uÀ]y…“d‰ðŽ¿Et‹@”\‚ÉŠÖ‚·‚éÅ‹ß‚̘b‘èzƒL[ƒ[ƒh‚©‚çŠw‚ԁE: Ca sensing receptor. ‰ÍŒŽŽ‰ë1, ˆÀ‰ª—L‹IŽq1 (1¶—): t‚Æ“§Í 2011/10; 71 (4): 453-6.

522004. [uÀ]yt‘Ÿƒgƒ‰ƒ“ƒXƒ|[ƒ^[ˆÙí‚É‚æ‚鎟Š³zŠª“ªŒŸ: “’–è‹q‚Ì•úŽËü”픚. ‰ÍŒŽŽ‰ë (¶—): BIO Clinica 2011/11; 2011”N11ŒŽ†: 13.

522005. [uÀ]yKlotho‚Ɛt‘Ÿ•azKlotho‚ÌŠî‘b@Klotho‚ƃJƒŠƒEƒ€ƒ`ƒƒƒlƒ‹. ‰ÍŒŽŽ‰ë (¶—): t‚Æ“§Í 2012/3; 72 (3): 335-40.

540001. [‚»‚Ì‘Œ (PREFACE)] The kidney and hypertension. Kawahara K1, Kamata K2: Clin Exp Nephrol 2012; 16 (1): 3-7. (‰ÍŒŽŽ‰ë1, Š™“cvšæ2: 1¶—, 2t‘Ÿ“à)

[’˜@‘]

622001. [Šwp‘] (–|–ó)yƒJƒ‰[”Ł@ƒ{ƒƒ“@ƒu[ƒ‹ƒy[ƒv@¶—Šwz40Í Á‰»ŠíŒn‚̍\¬, 41Í ˆÝ‚Ì‹@”\, 42Í äX‘B‚Æ‘Á‰t‘B, 43Í Á‰»ŠÇ‚Ì—n‰tE“d‰ðŽ¿ˆÚ“®, 44Í ‰h—{•ª‚̏Á‰»‚Æ‹zŽû, 45Í ŠÌ, ’_ùN‚Ì‹@”\, p.913-1035. ‰ÍŒŽŽ‰ë (¶—), ‘ŠÄ–ó: òˆä@—º, ŠÄ–ó: ‰Í“ì@—m, ‹v•ÛìŠw, Œ‘º‘“X, VŠƒ, 2011/9”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713012. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of androgen on maturation of retention mechanism of extinction memory after conditioned taste aversion learning in mice. Suzuki E, Kawabe T, Nishiyama M, Eda-Fujiwara H, Saito R1, Satoh R, Miyamoto T: 8th International Brain Research Organization (IBRO) World Congress of Neuroscience (2011/7/14-18), Florence, Italy. (²“¡—º•œ1: 1¶—)

713013. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Decreased ability of urine concentration in vasopressin V1a receptor (V1aR) knockout mice. Yasuoka Y1, Sato Y, Nonoguchi H, Tagami A, Kawahara K1: International Joint Meeting of Cellular and Molecular Physiology in Epithelia (2011/7/31), Tokyo. (ˆÀ‰ª—L‹IŽq1, ²“¡—Yˆê, –ìXŒû”ŽŽj, “cãºl, ‰ÍŒŽŽ‰ë1: 1¶—)

713014. [Šw‰ï (‘Û)[ (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prostaglandin E2 maintains the expression of COX-2 in mouse macula densa cell line (NE-MD). Fukuda H1, Kawahara K1: International Joint Meeting of Cellular and Molecular Physiology in Epithelia (2011/7/31), Tokyo. (•Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1: 1¶—)

713015. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Sex difference of gene expression of androgen receptor in brain regions related to extinction of conditioned taste aversion memory in mice. Suzuki E, Kawabe T, Eda-Fujiwara H, Saito R, Satoh R1, Miyamoto T: The 9th International Symposium on Molecular and Neural Mechanisms of Taste and Olfactory Perception (2011/11/4-6), Fukuoka. (²“¡—º•œ1: 1¶—)

713016. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Acid decreased the expression of Ca-sensing receptor in type-B of mouse kidney collecting duct intercalated cells. Yasuoka Y1, Sato Y, Izumi Y, Nonoguchi H, Kawahara K1: Kidney week 2011 (ƒAƒƒŠƒJt‘ŸŠw‰ï) (2011/11/10), Philadelphia, USA. (ˆÀ‰ª—L‹IŽq1, ²“¡—Yˆê, ò—Sˆê˜Y, –ìXŒû”ŽŽj, ‰ÍŒŽŽ‰ë1: 1¶—)

722003. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) A role of vasopressin V1aR in the urine concentration. ˆÀ‰ª—L‹IŽq1, ²“¡—Yˆê, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ89‰ñ“ú–{¶—Šw‰ï‘å‰ï (2012/3/30), Œ–{.

722004. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Regulatory mechanisms of water and electrolyte transport in kidney and intestinal epithelia. ‰ÍŒŽŽ‰ë1, ‹v•ÛìŠw (1¶—): ‘æ89‰ñ“ú–{¶—Šw‰ï‘å‰ï (2012/3/30), Œ–{.

723017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒoƒ\ƒvƒŒƒVƒ“V1aŽó—e‘Ì (V1aR) KOƒ}ƒEƒX‚É‚š‚¯‚étW‡ŠÇV2R-AQP2E². ˆÀ‰ª—L‹IŽq1, ¬—ѐ‰À2, ²“¡—Yˆê, –ìXŒû”ŽŽj, “cãºl, ‰ÍŒŽŽ‰ë1 (1¶—, 2–ƒŒ): ‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2011/6/15), ‰¡•l.

723018. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒ“ƒhƒƒQƒ“‚É‚æ‚Á‚Ä—U”­‚³‚ê‚éƒ}ƒEƒX‚Ì–¡ŠoŒ™ˆ«ŠwK‚̏Á‹Ž‹L‰¯•ÛŽ‚̐¬n‰ß’ö‚̐«•ª‰». —é–Øœš‰ë, ìç²‚Æ‚à‚±, “¡ŒŽGŽq, âV“¡—‰À, ²“¡—º•œ1, ‹{–{•“T (1¶—): ‘æ34‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2011/9/14-17), ‰¡•l.

723019. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –¡ŠoŒ™ˆ«ŠwKŒã‚̃}ƒEƒX‚É‚š‚¯‚éÁ‹Ž‹L‰¯ŠÖ˜A”]•”ˆÊ‚̐¬n‚ɑ΂·‚éƒAƒ“ƒhƒƒQƒ“‚ÌŠÖ—^. —é–Øœš‰ë, ìç²‚Æ‚à‚±, “¡ŒŽGŽq, âV“¡—‰À, ²“¡—º•œ1, ‹{–{•“T (1¶—): “ú–{“®•šŠw‰ï‘æ82‰ñ‘å‰ï (2011/9/21-23), ˆ®ì.

723020. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –¢¬nƒ}ƒEƒX‚Ì–¡ŠoŒ™ˆ«ŠwKŒã‚̏Á‹Ž‹L‰¯ŠÖ˜A”]•”ˆÊ‚Å‚Ý‚ç‚ê‚éƒAƒ“ƒhƒƒQƒ“Žó—e‘̈â“`Žq”­Œ»—ʂ̐«·. —é–Øœš‰ë, ìç²‚Æ‚à‚±, “¡ŒŽGŽq, âV“¡—‰À, ²“¡—º•œ1, ‹{–{•“T (1¶—): “ú–{–¡‚Æ“õŠw‰ï‘æ45‰ñ‘å‰ï (2011/10/5-7), ‹à‘ò.

733005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX‚Ì–¡ŠoŒ™ˆ«ŠwKŒã‚̏Á‹Ž‹L‰¯‚ÌŠl“Ÿ‚Æ•ÛŽ‚ɑ΂·‚éƒAƒ“ƒhƒƒQƒ“‚̍ì—p. —é–Øœš‰ë, ìç²‚Æ‚à‚±, “¡ŒŽGŽq, ²“¡—º•œ1, âV“¡—‰À, ‹{–{•“T (1¶—): ‘æ15‰ñ“ú–{s“®_Œo“à•ª”匀‹†‰ï(“ú–{s“®_Œo“à•ª”匀‹†‰ï›•@Œ€‹†‰ï‡“¯W‰ï) (2011/7/2), “Œ‹ž.

733006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t”A×ŠÇ‚ÌK+•ª”å‚ÆK+ƒ`ƒƒƒlƒ‹. ‰ÍŒŽŽ‰ë (¶—): ƒ\ƒ‹ƒgEƒTƒCƒGƒ“ƒXŒ€‹†à’c‘æ23‰ñ•¬Œ€‹†”­•\‰ï (2011/7/19), “Œ‹ž.

733007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒoƒ\ƒvƒŒƒVƒ“V1aŽó—e‘Ì (V1aR) KOƒ}ƒEƒX‚̏W‡ŠÇ…—A‘—’²ß. ˆÀ‰ª—L‹IŽq1, ²“¡—Yˆê, –ìXŒû”ŽŽj, “cãºl, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ100‰ñ“Œ‹žt¶—W’k‰ï (2011/9/10), “Œ‹ž.

733008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tW‡ŠÇ…—A‘—’²ß‚É‚š‚¯‚éƒoƒ\ƒvƒŒƒVƒ“V2R/V1aRƒVƒOƒiƒ‹. ˆÀ‰ª—L‹IŽq1, ‰ÍŒŽŽ‰ë1 (1¶—): 2011”N“x¶—ŠwŒ€‹†ŠŒ€‹†‰ïu’ŽŠK‘wƒVƒOƒiƒ‹“`’BŒ€‹†‚̐V“WŠJv(2011/9/29), ‰ªè.

733009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“E2-EP4ƒVƒOƒiƒ‹‚̓}ƒEƒXƒ}ƒNƒ‰ƒfƒ“ƒT×–EŠ” (NE-MD) ‚ÌCOX-2”­Œ»‚ðˆÛŽ‚·‚é. •Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ41‰ñ“ú–{EtEŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/15), “Œ‹ž.

733010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) …“d‰ðŽ¿‘ãŽÓ‚É‚š‚¯‚éƒ}ƒNƒ‰ƒfƒ“ƒT×–E‚̃vƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“Žó—e‘Ì‚Ì–ðŠ„. •Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1 (1¶—): 2011”N“x¶—ŠwŒ€‹†ŠŒ€‹†‰ï [ã”ç×–E‚̍Pí«ˆÛŽ‹@\‚É‚š‚¯‚éƒCƒIƒ“E•šŽ¿—A‘—‚̐V‚µ‚¢•ªŽq¶—v(2011/11/21), –ŒŒÃ‰® (“Œ‰ªè).

H22”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H22-722001. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Molecular machineries maintaining the acid-base homeostasis in the kidney nephron. ˆÀ‰ª—L‹IŽq1, ²“¡—Yˆê, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï^‘æ116‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï ‡“¯‘å‰ï (2011/3/30), ŽãŠJÃ.

H22-722002. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) The mechanisms of urine acidification by aldosterone. –ìXŒû”ŽŽj, –x‰Á•ä—, ò—Tˆê˜Y, ‰iˆäFŒ›, ˆÀ‰ª—L‹IŽq1, “cãºl, ‰ÍŒŽŽ‰ë1, ’†Œ@Œ’ (1¶—): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï^‘æ116‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï ‡“¯‘å‰ï (2011/3/30), ŽãŠJÃ.

H22-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neural control mechanism of sugar-preference suppression caused by body weight increase under chronic food restriction in mice. Ohkubo L, Kitazawa M, Matsukawa T, Eda-Fujiwara H, ²“¡—º•œ1, Yasoshima Y, Miyamoto T (1¶—): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï^‘æ116‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï ‡“¯‘å‰ï (2011/3/28), ŽãŠJÃ.

H22-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prostaglandin E2 stimulates the expression of COX-2 in mouse macula densa cell line. •Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï^‘æ116‰ñ“ú–{‰ð–UŠw‰ï‘‰ï¥‘S‘ŠwpW‰ï ‡“¯‘å‰ï (2011/3/28), ŽãŠJÃ.


¶‰»Šw

[Šwp˜_•¶]

110012. [ŒŽ’˜] Differential expression of SNAP-25 family proteins in the mouse brain. Yamamori S1, Itakura M1, Sugaya D, Katsumata O, Sakagami H2, Takahashi M1: J Comp Neurol 2011/4; 19 (5): 916-32. (ŽRX‘D1, ”‘q@œ1, ›’J‘å’n, Ÿ–”@C, ãã—ms2, ‚‹Ž³g1: 1¶‰», 2‰ð–U)

110013. [ŒŽ’˜] Functional expression of a two-transmembrane HtrII protein using cell-free synthesis. Sudo Y, Tanaka R, Kobayashi T, Kamo N, Kohno T1. Kojima C: BIOPHYSICS 2011/6; 7: 51-8. (‰Í–ìr”V1: 1¶‰»)

110014. [ŒŽ’˜] Structure and function of a membrane component SecDF that enhances protein export. Tsukazaki T, Mori H, Echizen Y, Ishitani R, Fukai S, Tanaka T, Perederina A, Vassylyev DG, Kohno T1, Maturana AD, Ito K, Nureki O: Nature 2011/6; 474 (7350): 235-8. (‰Í–ìr”V1: 1¶‰»)

110015. [ŒŽ’˜] A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouse. Kataoka M, Yamamori S1, Suzuki E, Watanabe S, Sato T, Miyaoka H2, Azuma S3, Ikegami S, Kuwahara R, Suzuki-Migishima R, Nakahara Y, Nihonmatsu I, Inokuchi K, Katoh-Fukui Y, Yokoyama M, Takahashi M1: PLoS One 2011/9; 6 (9): e25158. (ŽRX‘D1, ‹{‰ª@“™2, “Œ@’åG3, ‚‹Ž³g1: 1¶‰», 2ž_, 3ŽÀ“®)

110016. [ŒŽ’˜] Calcium-dependent activator protein for secretion 2 interacts with the class II ARF small GTPases and regulates dense-core vesicle trafficking. Sadakata T, Sekine Y, Oka M, Itakura M1, Takahashi M1, Furuichi T: FEBS J 2012/2; 279 (3): 384-94. (”‘q@œ1, ‚‹Ž³g1: 1¶‰»)

110017. [ŒŽ’˜] Essential role of gastric gland mucin in preventing gastric cancer in mice. Karasawa F, Shiota A, Goso Y1, Kobayashi M, Sato Y, Masumoto J, Fujiwara M, Yokosawa S, Muraki T, Miyagawa S, Ueda M, Fukuda MN, Fukuda M, Ishihara K2, Nakayama J: J Clin Invest 2012/3; 122 (3): 923-34. (ŒÜäzsM1, ÎŒŽ˜a•F2: 1¶‰», 2ˆã—Éq¶Šw•”)

110018. [ŒŽ’˜] Hippocampal CA3 and CA2 have distinct bilateral innervation patterns to CA1 in rodents. Shinohara Y, Hosoya A, Yahagi K, FerecskEAS, Yaguchi K, S’k A, Itakura M1, Takahashi M1, Hirase H: Eur J Neurosci 2012/3; 35 (5): 702-10. (”‘q@œ1, ‚‹Ž³g1: 1¶‰»)

110019. [ŒŽ’˜] Rapid and specific alterations of goblet cell mucin in rat airway and small intestine associated with resistance against Nippostrongylus brasiliensis reinfection. Tsubokawa D1, Goso Y2, Nakamura T3, Maruyama H, Yatabe F, Kurihara M, Ichikawa T4, Ishihara K4: Exp Parasitol 2012/3; 130 (3): 209-17. (’ؐì‘åŒå1, ŒÜäzsM2, ’†‘º@Œ’3, Žsì‘ž•¶4, ÎŒŽ˜a•F4: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶‰», 3Šñ¶’Ž, 4ˆã—Éq¶Šw•”)

110020. [ŒŽ’˜] Solution structure of Kurtoxin: a gating modifier selective for Cav3 voltage-gated Ca2+ channels. Lee CW, Bae C, Lee J, Ryu JH, Kim HH, Kohno T1, Swartz KJ, Kim JI: Biochemistry 2012/3; 51 (9): 1862-73. (‰Í–ìr”V1: 1¶‰»)

520001. [‘à] ƒVƒiƒvƒXƒ^ƒO‰Œà‚ÌŽÀØ. ‰ª“c‘叕1, ˆäƒmŒûŠ] (1¶‰»): ¶‰»Šw 2011/5; 83 (5): 395-9.

522006. [uÀ]y“ÁW: ‹L‰¯‚𕪎qE×–E‚ÌŒŸ—t‚Å—‰ð‚·‚é@î•ñ‚Ì•Û‘¶ + XV + ˆÚsƒƒJƒjƒYƒ€zŠe˜_: “ü—Í“ÁˆÙ“I‚È‹L‰¯ŒÅ’艻‚ƃVƒiƒvƒXƒ^ƒO‹@\. ‰ª“c‘叕 (¶‰»): ×–EHŠw 2011/4; 30 (5): 515-20.

[Šw‰ïEŒ€‹†‰ï“™]

713017. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) O-glycan profiling for rat gastric mucins by MALDI-TOF/MS and HPLC. Goso Y1, Tsubokawa D2, Ishihara K3: 21th International Symposium on Glycoconjugates (2011/8/25), Vienna, Austria. (ŒÜäzsM1, ’ؐì‘åŒå2, ÎŒŽ˜a•F3: 1¶‰», 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”)

723021. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ“x‚̈قȂéƒuƒ^ƒ€ƒ`ƒ“‚ւ̃rƒtƒBƒYƒX‹Û‚Ì•t’…«. ŒŽRŒ[‘Ÿ1, ŽR–{—TŽi1, Žsì‘ž•¶2, ÎŒŽ˜a•F2, ŒÜäzsM3, ‹{“à_•¶, ”ªd“‡’qŽq, ˆ¢•”•¶–Ÿ, ŒüˆäF•v1 (1bˆãŠw•”, 2ˆã—Éq¶Šw•”, 3¶‰»): “ú–{“ûŽ_‹ÛŠw‰ï2011”N“x‘å‰ï (2011/7/12), “c.

723022. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SNAP-25‚̃Šƒ“Ž_‰»‚͐¶Œã”­’BŠú‚Ì‚Ä‚ñ‚©‚ñ‚Æ•sˆÀ—ls“®‚Ì”­Ç‚Ì—}§‚ÉŠÖ—^‚·‚é. ‘å’ːM‘Ÿ˜N, ŽRX‘D1, “n•Ó@Ž , —é–؉f“ñ, âV“¡³”Í2, ‹{‰ª@“™2, ‚‹Ž³g1 (1¶‰», 2ž_): ‘æ34‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2011/9/16), ‰¡•l.

723023. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Rƒ€ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚ð—p‚¢‚œÁ‰»ŠÇŠñ¶’ŽŠŽõƒ‰ƒbƒg¬’°ƒ€ƒ`ƒ“‚̐«óŒŸ“¢. Žë–ìˆÀ—˜, ŒŽ“c@˜Ð, ”Ñ“c‘׍L, ’ؐì‘åŒå1, ŒÜäzsM2, ’†‘º@Œ’3, ÎŒŽ˜a•F4, àVŒû’qÆ, •ŽR_”V, çŽº’q”V, ŒIŒŽ@œ (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶‰», 3Šñ¶’Ž, 4ˆã—Éq¶Šw•”): ‘æ84‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (2011/9/22), ‹ž“s.

723024. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V‹KRƒ€ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚ð—p‚¢‚œƒqƒg‘Á‰tƒ€ƒ`ƒ“‚Ì‘ªEE “c’†GŽ÷, ŒÜäzsM1, ÎŒŽ˜a•F2, ŒIŒŽ@œ (1¶‰», 2ˆã—Éq¶Šw•”): ‘æ84‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (2011/9/22), ‹ž“s.

723025. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Á‰»ŠÇŠñ¶ü’Ž‚ÌŠŽõ‚É‚æ‚郉ƒbƒg•³•Ö’†‚̃€ƒ`ƒ“•Ï‰»‚ÌŒŸ“¢. ’ؐì‘åŒå1, ŒÜäzsM2, ’†‘º@Œ’3, Žsì‘ž•¶4, ŒIŒŽ@œ, ÎŒŽ˜a•F4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶‰», 3Šñ¶’Ž, 4ˆã—Éq¶Šw•”): ‘æ84‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (2011/9/23), ‹ž“s.

723026. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •sˆÀ—ls“®‚Ì”­Œ»‚É‚š‚¯‚é, BDNF‚ÌŠÖ—^‚̉”\«. ‘åéŒË‘Ÿ˜N, ”ђˁ@Œ’, ”‘q@œ1, ‘å’ːM‘Ÿ˜N, “n粐’Žk, ŽRX‘D1, “n•Ó@Ž , ‹{‰ª@“™2, ‚‹Ž³g1 (1¶‰», 2ž_): ‘æ54‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï (2011/9/26), ‹à‘ò.

723027. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 8-ƒjƒgƒ-cGMP‚̃Vƒiƒvƒgƒ\[ƒ€“àƒ^ƒ“ƒpƒNŽ¿‚É‹y‚Ú‚·‰e‹¿. “à–ì’B–ç, àV@’q—T, Ô’rFÍ, ”‘q@œ1, ‚‹Ž³g1, ‹ŒŽ@G (1¶‰»): ‘æ54‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï (2011/9/27), ‹à‘ò.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-522001. [uÀ]y‹L‰¯‚̃ƒJƒjƒYƒ€‚Æ‚»‚̏áŠQz‹L‰¯‚̃ƒJƒjƒYƒ€|ƒXƒpƒCƒ“‚Ì“®‘Ô‚Æ•ªŽqƒƒJƒjƒYƒ€|. ‰ª“c‘叕 (¶‰»): Clinical Neuroscience 2011/2; 29 (2): 157-61.


•ªŽqˆâ“`Šw

[Šwp˜_•¶]

110021. [ŒŽ’˜] Nationwide survey of nevoid basal cell carcinoma syndrome in Japan revealing the low frequency of basal cell carcinoma. Endo M, Fujii K, Sugita K, Saito K, Kohno Y, Miyashita T1: Am J Med Genet A 2012/2; 158A (2): 351-7. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

110022. [ŒŽ’˜] Selective haploinsufficiency of longer isoforms of PTCH1 protein can cause nevoid basal cell carcinoma syndrome. Suzuki M, Hatsuse H, Nagao K1, Takayama Y, Kameyama K1, Kabasawa Y, Omura K, Yoshida M, Fujii K, Miyashita T1: J Hum Genet 2012/7; 57 (7): 422-6. (’·”ö˜a‰E1, ‹TŽRFŽO1, ‹{‰ºr”V1: 1•ªŽqˆâ“`)

521001. [‰ðà]yCurrent Knowledgezê–åˆã‚É‹‚ß‚ç‚ê‚éÅV‚Ì’mŽ¯: ”]Žîᇁ|ƒwƒbƒWƒzƒbƒOƒVƒOƒiƒ‹“`’B‚Æ”]Žîᇁ|. ‰–•l@’Œ, “àì‰p‹I, …—ŽO”ü, ‹{‰ºr”V1, “¡ˆäŽ‘¥ (1•ªŽqˆâ“`): ”]_ŒoŠO‰È‘¬•ñ 2012/1; 22 (1): 66-73.

[Šw‰ïEŒ€‹†‰ï“™]

712003. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •ê”ÁŠî’ê×–EŠàÇŒóŒQ‚Ì•ªŽqˆâ“`Šw. ‹{‰ºr”V (•ªŽqˆâ“`): “ú–{l—Þˆâ“`Šw‰ï‘æ56‰ï‘å‰ï E‘æ11‰ñ“ŒƒAƒWƒAl—Þˆâ“`Šw‰ï ‹€“¯‘å‰ï (2011/11/10), ç—t.

722005. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) GorlinÇŒóŒQ‚̈â“`Žq‰ðÍ. ‹{‰ºr”V (•ªŽqˆâ“`): ‘æ2‰ñGorlinÇŒóŒQƒVƒ“ƒ|ƒWƒEƒ€ (2012/1/21), _ŒË.

723028. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{‚É‚š‚¯‚é•ê”Á«Šî’ê×–EŠàÇŒóŒQ‚É‚š‚¯‚éŠî’ê×–EŠà”­Ç—Š. “¡ˆäŽ‘¥, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ70‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2011/10/4), –ŒŒÃ‰®.

723029. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Disrupting the RCAN1 alleles resulted in poor response to glucocorticoid-induced apoptosis in the leukemic cell line. ’·”ö˜a‰E1, Maiko Kiryu, ‚ŽR‹g‰i1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ70‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2011/10/5), –ŒŒÃ‰®.

723030. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Molecular pathogenesis of keratocystic odontogenic tumor developed in nevoid basal cell carcinoma syndrome. Maiko Suzuki, ’·”ö˜a‰E1, ‚ŽR‹g‰i1, Katsunori Fujii, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ70‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2011/10/5), –ŒŒÃ‰®.

723031. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A small fraction of keratocystic odontogenic tumors developed in Gorlin syndrome is caused by the second hit in the PTCH1 gene. Maiko Suzuki, ’·”ö˜a‰E1, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ34‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï (2011/12/14), ‰¡•l.

723032. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RCAN1 is involved in glucocorticoid-induced apoptosis in the leukemic cell line, Nalm-6. ’·”ö˜a‰E1, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ34‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï (2011/12/14), ‰¡•l.


–ò—Šw

[Šwp˜_•¶]

110023. [ŒŽ’˜] Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice. Isono M1, Suzuki T2, Hosono K2, Hayashi I, Sakagami H3, Uematsu S, Akira S, DeClerck YA, Okamoto H4, Majima M2: Life Sci 2011/4; 88 (15-16): 693-700. (ˆé–ì‰ëŽq1, —é–Ø—§‹I2, ×–ì‰Á“ÞŽq2, ãã—ms3, ‰ª–{_Žk4, ”n“ˆ³—²2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3‰ð–U, 4–ƒŒ)

110024. [ŒŽ’˜] Application of a heat- and steam-generating sheet increases peripheral blood flow and induces parasympathetic predominance. Nagashima Y, Igaki M, Suzuki A, Tsuchiya S, Yamazaki Y, Hishinuma M, Oh-Ishi S, Majima M1: Evid Based Complement Alternat Med 2011/5; 2011: 965095. (”n“ˆ³—²1: 1–ò—)

110025. [ŒŽ’˜] Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation. Hosono K1, Suzuki T1, Tamaki H2, Sakagami H2, Hayashi I, Narumiya S, Alitalo K, Majima M1: Arterioscler Thromb Vasc Biol 2011/5; 31 (5): 1049-58. (×–ì‰Á“ÞŽq1, —é–Ø—§‹I1, ‹Ê–؉p–Ÿ2, ãã—ms2, ”n“ˆ³—²1: 1–ò—, 2‰ð–U)

110026. [ŒŽ’˜] Nonlinear pharmacokinetics of oral quinidine and verapamil in healthy subjects: a clinical microdosing study. Maeda K, Takano J, Ikeda Y, Fujita T1, Oyama Y, Nozawa K, Kumagai Y2, Sugiyama Y: Clin Pharmacol Ther 2011/8; 90 (2): 263-70. (“¡“c•üŒb1, ŒF’J—YŽ¡2: 1–ò—, 2—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

110027. [ŒŽ’˜] Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema. Kashiwagi S1,2, Hosono K1, Suzuki T1, Takeda A2, Uchinuma E2, Majima M1: Lab Invest 2011/9; 91 (9): 1314-25. (”–ؐT–ç1,2, ×–ì‰Á“ÞŽq1, —é–Ø—§‹I1, •“c@Œ[2, “àÀ‰hŽ÷2, ”n“ˆ³—²1: 1–ò—, 2Œ`¬E”üŠO)

110028. [ŒŽ’˜] Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study. Maeda K, Ikeda Y, Fujita T1, Yoshida K, Azuma Y, Haruyama Y, Yamane N, Kumagai Y2, Sugiyama Y: Clin Pharmacol Ther 2011/10; 90 (4): 575-81. (“¡“c•üŒb1, ŒF’J—YŽ¡2: 1–ò—, 2—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

110029. [ŒŽ’˜] Thromboxane A(2) receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells. Matsui Y1, Amano H2, Ito Y3, Eshima K4, Suzuki T5, Ogawa F1, Iyoda A6, Satoh Y6, Kato S3, Nakamura M, Kitasato H, Narumiya S, Majima M5: Cancer Sci 2012/4; 103 (4): 700-7. (ŒˆäŒ[•v1, “V–ì‰pŽ÷2, ˆÉ“¡‹`–ç3, ]“‡k“ñ4, —é–Ø—§‹I5, ¬ìŽj—m1, ˆÉ˜¬“c–Ÿ6, ²“¡”Vr6, ‰Á“¡L‘Ÿ˜Y3, ”n“ˆ³—²5: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2—Տ°Œ€‹†E‘n–òƒV[ƒY, 3ŠO‰È, 4–Ɖu, 5–ò—, 6ŒÄ‹zŠíŠO)

110030. [ŒŽ’˜] In vivo kinetics of indoxyl sulfate in humans and its renal interaction with Angiotensin-converting enzyme inhibitor quinapril in rats. Fujita T1, Ishihara K, Yasuda S, Nakamura T, Maeda M, Kobayashi M, Sahashi K, Ikeda Y, Kumagai Y, Majima M1: J Pharmacol Exp Ther 2012/6; 341 (3): 626-33. (“¡“c•üŒb1, ”n“ˆ³—²1: 1–ò—)

510002. [‘à] EP3/EP4 signaling regulates tumor microenvironment formation by bone marrow-derived fibroblasts. Katoh H1,2, Hosono K1, Suzuki T1, Watanabe M2, Majima M1: Inflammation and Regeneration 2011/4; 31 (3): 316-24. (‰Á“¡@O1,2, ×–ì‰Á“ÞŽq1, —é–Ø—§‹I1, “n粏¹•F2, ”n“ˆ³—²1: 1–ò—, 2ŠO‰È)

510003. [‘à] Roles of calcitonin gene-related peptide in ehancement of angiogenesis. Majima M1, Toda M2, Ito Y, Ohno T, Mishima T, Suzuki T1, Hosono K1, Hayashi I: Inflammation and Regeneration 2011/7; 31 (2): 146-50. (”n“ˆ³—²1, ŒË“c‰ë–ç2, —é–Ø—§‹I1, ×–ì‰Á“ÞŽq1: 1–ò—, 2–ƒŒ)

[Šw‰ïEŒ€‹†‰ï“™]

711001. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Calcitonin Gene-related Peptide; A neuronal cue for angiogenesis. Majima M1: The Second Pacific Symposium on Vascular Biology (2011/11/1), Jeju, Korea. (”n“ˆ³—²1: 1–ò—)

712004. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)yTumor Microenvironment and InflammationzRoles of prostaglandins in enhancement of angiogenesis and lymphangiogenesis during tumor development. Majima M1: 32nd Annual Meeting of the Japanese Society of Inflammation and Regeneration (2011/6/2), Kyoto. (”n“ˆ³—²1: 1–ò—, 2ŠO‰È)

712005. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Heterogeniety of endothelial cells: Thromboxane-dependent platelet adhesion and angiogenesis. Majima M1: Gordon Research Conferences 2012: Angiogenesis (2011/8/21), New Port, USA. (”n“ˆ³—²1: 1–ò—)

712006. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of prostaglandins in enhancement of angiogenesis and lymphangiogenesis in pathological conditions. Majima M1: Keystone Symposia: Angiogenesis: Advances in Basic Science and Therapeutic Applications (2012/1/16), Snowbird, USA. (”n“ˆ³—²1: 1–ò—)

712007. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Prostanoids; Regulators of Pathological Lymphangiogenesis. Majima M1: Gordon Research Conferences 2012: Molecular Mechanisms in Lymphatic Functions & Disease (2012/3/4), Ventura, USA. (”n“ˆ³—²1: 1–ò—)

712008. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)ySymposium; Recent Advances in Lymphangiogenesis: Therapeutic TargetszRoles of prostaglandins in enhancement of lymphangiogenesis in pathological states. Majima M1: The 85th Annual Meeting of The Japanese Pharmacological Society (2012/3/14), Kyoto. (”n“ˆ³—²1: 1–ò—)

722006. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“—U”­«ŠÌáŠQŒã‚̊̏C•œ‚š‚æ‚Ñ—Þ“Ž•ÇÄ\’z‚É‚š‚¯‚錌ŠÇ“à”瑝BˆöŽq1Œ^Žó—e‘Ì‚Ì–ðŠ„. ‰Á“¡“NŠó1, ˆÉ“¡‹`–ç1, ×–ì‰Á“ÞŽq1, —é–Ø—§‹I1, “ì–ì@•×2, ”n“ˆ³—²1 (1–ò—, 2Á‰»Ší“à): ‘æ38‰ñ “ú–{ƒgƒLƒVƒRƒƒW[Šw‰ï (2011/7/12), ‰¡•l, The Journal of Toxicological Sciences 2011/6; 36 (Suppl): S135.

723033. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ŠÇ‘ƒ‹ßÚƒŠƒ“ƒpß‚É‚š‚¢‚ÄCOX-2‚ð”­Œ»‚·‚é×–E‚Ì“¯’è. ì‘º“¹Žq1, ‘œ“c”üm, ”š’†@Œö1, ŒŽ“c–FÆ (1–ò—): ‘æ32‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï (2011/6/3), ‹ž“s.

723034. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{l‚Å‚Ì”A’†ƒiƒgƒŠƒEƒ€”rŸ•—ʂ̌‘̍·—vˆö‚Æ‚µ‚ẴJƒŠƒNƒŒƒCƒ“ˆâ“`Žq‘œŒ^ŒŸõ. “¡“c•üŒb1, ˆÀ“cCˆê, –쑺¡“úŽq, ”‹ŒŽ‹v”üŽq, “üŒË–ì˜a‘ã, ‚‘º‰ë”ü, ²‹Ž–M•F, ¬—ѐ^”ü, ŠÛ‰ª“Þ•ä, ’†ŒŽ‚¢‚¿‚Ý, ŒF’J—YŽ¡2, ”n“ˆ³—²1 (1–ò—, 2—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/3), •lŒ —Տ°–ò— 2011; 42 (suppl): 352.

723035. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ŠÇ‘ƒ‹ßÚƒŠƒ“ƒpß‚É‚š‚¯‚écyclooxygenase-2”­Œ»×–E‚Ì“¯’è. ì‘º“¹Žq1, ‘œ“c”üm, ”š’†@Œö1, ŒŽ“c–FÆ (1–ò—): ‘æ85‰ñ“ú–{–ò—Šw‰ï”N‰ï (2012/3/14), ‹ž“s.

H22”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H22-722003. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of Prostanoids in Enhancement of Angiogenesis and Lymphangiogenesis in Pathological Conditions. ”n“ˆ³—² (–ò—): ‘æ36‰ñ“ú–{”÷¬zŠÂŠw‰ï‘‰ï (2011/2/11), –ŒŒÃ‰®.

H22-722004. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of prostaglandins in enhancement of angiogenesis and lymphangiogenesis in pathological conditions. ”n“ˆ³—² (–ò—): ‘æ89‰ñ“ú–{¶—Šw‰ï‘å‰ï (2011/3/30), Œ–{.


”÷¶•šŠw

[Šwp˜_•¶]

110031. [ŒŽ’˜] Monthly administration of a novel PTH-collagen binding domain fusion protein is anabolic in mice. Ponnapakkam T, Katikaneni R, Miller E, Ponnapakkam A, Suda H, Miyata S, Suva LJ, Sakon J, Matsushita O1, Gensure RC: Calcif Tissue Int 2011/6; 88 (6): 511-20. (Œ‰º@Ž¡1: 1”÷¶•š)

110032. [ŒŽ’˜] In vitro activity of BAL30072 against Burkholderia pseudomallei. Mima T1, Kvitko BH, Rholl DA, Page MG, Desarbre E, Schweizer HP: Int J Antimicrob Agents 2011/8; 38 (2): 157-9. (”üŠÔŒ’•F1: 1”÷¶•š)

110033. [ŒŽ’˜] Characterization of d-boroAla as a novel broad-spectrum antibacterial agent targeting d-Ala-d-Ala ligase. Putty S, Rai A, Jamindar D, Pagano P, Quinn CL, Mima T1, Schweizer HP, Gutheil WG: Chem Biol Drug Des 2011/11; 78 (5): 757-63. (”üŠÔŒ’•F1: 1”÷¶•š)

522007. [uÀ]y“ÁW: ‘œÜ‘ϐ«ƒOƒ‰ƒ€‰A«ž…‹Ûz‘œÜ‘ϐ«ƒAƒVƒlƒgƒoƒNƒ^[‚Ƃ́@1. –òÜ‘ϐ«‚ɂ‚¢‚Ä. ‰ª–{—¹ˆê (”÷¶•š): ŠŽõ‚ƍR‹Û–ò 2011/6; 14 (2): 139-44.

522008. [uÀ]y“ÁW: ¡“ú“I˜b‘è‚Ì‘œÜ‘ϐ«‹Û‚Ì“®Œü‚Ƒ΍ôz3. ‘œÜ‘ϐ«‹ÛoŒ»‚̈â“`“I”wŒi‚Æ‚»‚Ì–â‘è“_. ‰ª–{—¹ˆê (”÷¶•š): ‰»Šw—Ö@‚̗̈æ 2011/7; 27 (7): 1656-62.

522009. [uÀ]y“ÁW: ‚±‚±‚Ü‚Å‚Í’m‚Á‚Ä‚š‚«‚œ‚¢! ŠŽõÇ‚ÌŠî‘b’mŽ¯z‘ϐ«‹ÛŠŽõÇ‚ð‹É‚ß‚é!|R‹Û–ò‚ªŒø‚©‚È‚­‚Ȃ闝—R‚Æ‚»‚̑ϐ«‚Ì‚µ‚­‚݁|. ‰ª–{—¹ˆê (”÷¶•š): ŒŽŠ§ƒi[ƒVƒ“ƒO 2011/7; 31 (8): 30-4.

522010. [uÀ]y“ÁW: ¡’m‚é‚ׂ«¬Ž™ŠŽõÇ—̈æ‚̐V‚µ‚¢’mŒ©2011zII ‘ϐ«‹Û@AmpCŽY¶ƒOƒ‰ƒ€‰A«ž…‹Û. ‰ª–{—¹ˆê (”÷¶•š): ¬Ž™‰Èf—à 2011/9; 74 (9): 1307-13.

522011. [uÀ]y“ÁW: ‘œÜ‘ϐ«ƒAƒVƒlƒgƒoƒNƒ^[ vs ICTzBasic 1) ‘œÜ‘ϐ«ƒAƒVƒlƒgƒoƒNƒ^[‚Ƃ́|‘ϐ«‹@\EƒoƒCƒIƒtƒBƒ‹ƒ€Œ`¬‚ðŠÜ‚߂ā|. ùŒŽ•Žu1, “¡–Ø‚­‚ÉŽq2 (1”÷¶•š, 2ŠŽõŠÇ—Žº): ŠŽõ‘΍ôICTƒWƒƒ[ƒiƒ‹ 2012/1; 7 (1): 15-9.

[’˜@‘]

620003. [Šwp‘] (•ª’SŽ·•M)yƒVƒ“ƒvƒ‹”÷¶•šŠw ‰ü’ù‘æ‚T”Łz‘æ2•Ò ×‹ÛŠw‘˜_@5. ŠŽõ‚Æ”­Ç, p.43-55. ‘æ4•Ò×‹ÛŠwŠe˜_@6. •Î«Œ™‹C«‹Û, p.175-81. Œ‰º@Ž¡ (”÷¶•š), •Ò: “Œ@‹§L, ¬ŒFŒb“ñ, –x“c@”Ž, “ì]“°, “Œ‹ž, 2011/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712009. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) The Potential Application of Copper and its Alloys for Infection Prevention and Control in Hospitals and Outdoors in Africa. Sasahara T1: 3rd Conference Infection Prevention and Control Africa Network 2011 (2011/10/31), Windhoek, Namibia. (ùŒŽ•Žu1: 1”÷¶•š)

713018. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Sustained Reduction of Environmental MRSA Contamination by Copper and Its alloys: Possible Application for Infection Prevention and Control in Hospital. Sasahara T1, Niiyama N2, Abe M, Fujiki K3: 1st Annual World Congress of Microbes-2011 (2011/7/31), Beijing, China. (ùŒŽ•Žu1, VŽR“ށXŽq2, “¡–Ø‚­‚ÉŽq3: 1”÷¶•š, 2”畆, 3ŠŽõŠÇ—Žº)

723036. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “º‚š‚æ‚Ñ“º‡‹à‚É‚æ‚é•a‰@“à×‹Û‰˜õ‚̒ጞ‰»|ˆã—Ê֘AMRSAŠŽõ‘΍ô‚Ö‚Ì“WŠJ|. ùŒŽ•Žu1, ‹e–엝—¥Žq2 “¡–Ø‚­‚ÉŽq3, ‚ŽR—zŽq3, »ìŒc‰î3 (1”÷¶•š, 2à’c–@l–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[, 3ŠŽõŠÇ—Žº): ‘æ85‰ñ“ú–{ŠŽõÇŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/4/21), “Œ‹ž, ŠŽõÇŠwŽGŽ 2011/3; 85: 230.

723037. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’°‹…‹Û‚ɑ΂·‚é‹à‘®“º‚ÌŽE‹ÛŒø‰Ê. ùŒŽ•Žu1, ‰ª–{—¹ˆê1 (1”÷¶•š): ‘æ59‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2011/6/24), ŽD–y.

723038. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”òŽU”÷—±Žq‚̉Ž‹‰»‚ª‘š‚Š‚œ•a“ŠÂ‹«|ˆã—Ê֘AŠŽõ‘΍ô‚É‚Ç‚€—˜—p‚·‚é‚©|. ùŒŽ•Žu1, VŽR“ށXŽq2, “¡–Ø‚­‚ÉŽq3 (1”÷¶•š, 2”畆, 3ŠŽõŠÇ—Žº): ‘æ27‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2012/2/4), •Ÿ‰ª, ŠÂ‹«ŠŽõŽ 2012/1; 27: 162.

723039. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a‰@“à‰q¶ŠÂ‹«‚̉ü‘P‚ÉŒü‚¯‚œ“º‡‹àŠˆ—p‚ÌŽŽ‚݁|‰q¶“I‚ňÀ‘S‚Ȑf—Ã¥ŒŸžŠÂ‹«‚ð–ÚŽw‚µ‚ā|. ùŒŽ•Žu1, Ø’Ê”ŽŒÈ, VŽR“ށXŽq2, ç‘㔜“cW (1”÷¶•š, 2”畆): ‘æ27‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2012/2/4), •Ÿ‰ª.

733011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒvƒ‰ƒXƒ~ƒh«AmpCƒÀ-lactamase CFE-1‚̍‚”­Œ»‹@\‚̉ðÍ. ’†–ì—³ˆê, ‰ª–{—¹ˆê1 (1”÷¶•š): ‘æ58‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï^‘æ60‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{’n•ûŠwp W‰ï‡“¯Šw‰ï (2011/10/28), ŽRŒ`.

733012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŠƒvƒgƒXƒ|ƒŠƒWƒEƒ€ŠŽõ‚ɑ΂·‚éƒ}ƒNƒƒ‰ƒCƒhŒnR‹Û–ò‚ÌŒø‰Ê. ùŒŽ•Žu1, ’†–ì—³ˆê, ‰ª–{—¹ˆê1 (1”÷¶•š): ‘æ58‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï^‘æ60‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{’n•ûŠwp W‰ï‡“¯Šw‰ï (2011/10/28), ŽRŒ`.


Šñ¶’ŽŠw

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110001. [ŒŽ’˜] Paragonimus westermani possesses aerobic and anaerobic mitochondria in different tissues, adapting to fluctuating oxygen tension in microaerobic habitats. Takamiya S, Fukuda K, Nakamura T1, Aoki T, Sugiyama H: IInt J Parasitol 2010/12; 40 (14): 1651-8. (‚‹{MŽO˜Y, •Ÿ“cFˆê, ’†‘º Œ’1, ™ŽR@L: 1Šñ¶’Ž)


•a—Šw

[Šwp˜_•¶]

110034. [ŒŽ’˜] Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma. Mikami T1, Yoshida T1, Numata Y, Kikuchi M, Araki K, Nakada N1, Okayasu I: Diagn Pathol 2011/4; 6: 30. (ŽOã“N•v1, ‹g“c@Œ÷1, ’‡“c“TL1: 1•a—)

110035. [ŒŽ’˜] High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Ichinoe M1, Mikami T1, Yoshida T1, Igawa I, Tsuruta T, Nakada N1, Anzai N, Suzuki Y, Endou H, Okayasu I: Pathol Int 2011/5; 61 (5): 281-9. (ˆêŒË¹–Ÿ1, ŽOã“N•v1, ‹g“c@Œ÷1, ’‡“c“TL1: 1•a—)

110036. [ŒŽ’˜] Cytoglobin expression of rectal subepithelial myofibroblasts: significant alterations of cytoglobin+ stromal cells in long-standing ulcerative colitis. Okayasu I1, Mikami T1, Yoshida T1, Hana K, Yokozawa M, Sada M2, Fujiwara M, Kawada N: Histol Histopathol 2011/6; 26 (6): 679-88. (‰ªˆÀ@ŒM1, ŽOã“N•v1, ‹g“c@Œ÷1, ²“c”ü˜a2: 1•a—, 2Á‰»Ší“à)

110037. [ŒŽ’˜] HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer. Kageyama T1, Nagashio R, Ryuge S2, Matsumoto T, Iyoda A3, Satoh Y3, Masuda N2, Jiang SX1, Saegusa M1, Sato Y: Asian Pac J Cancer Prev 2011/12; 12 (12): 3457-63. (‰eŽR‘וœ1, —Ž‰ØTˆê˜Y2, ˆÉ˜¬“c–Ÿ3, ²“¡”Vr3, ‰v“c“TK2, Ó@¢ˆ®1, ŽOŽ}@M1: 1•a—, 2ŒÄ‹zŠí“à, 3ŒÄ‹zŠíŠO)

110038. [ŒŽ’˜] Progesterone receptor expression correlates with estrogen receptor ƒ¿ but not ƒÀ and pS2 status in ovarian carcinomas: relation to apoptosis, cell proliferation, p27kip1 expression, and survival. Kajit1a S1, Suzuki E, Saegusa M1: Kitasato Med J 2012/3; 42 (1): 22-32. (Š“cç”ü”T1, —é–؃GƒŠ“Þ, ŽOŽ}@M1: 1•a—)

110039. [ŒŽ’˜] Sox4 functions as a positive regulator of ƒÀ-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas. Saegusa M1, Hashimura M, Kuwata T: Lab Invest 2012/4; 92 (4): 511-21. (ŽOŽ}@M1: 1•a—)

110040. [ŒŽ’˜] Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy. Chaopotong P, Kajita S1, Hashimura M, Saegusa M1: J Clin Pathol 2012/5; 65 (5): 424-30. (Š“cç”ü”T1, ŽOŽ}@M1: 1•a—)

210001. [€ŒŽ’˜] Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma. Mikami T1, Yoshida T1, Numata Y2, Kikuchi M3, Araki K, Nakada N, Okayasu I1: Diagn Pathol 2011/4; 6: 30. (ŽOã“N•v1, ‹g“c@Œ÷1, À“c‰êŽq2, ‹e’n³b3, ‰ªˆÀ@ŒM1: 1•a—, 2Œ`‘ÔŒn, 3Á‰»Ší“à)

[’˜@‘]

610005. [Šwp‘] (•ª’SŽ·•M)yUlcerative Colitis - Epidemiology, Pathogenesis and ComplicationszChapter 14 Mucosal Remodeling and Alteration of Stromal Microenvironment in Ulcerative Colitis as Related to Colorectal Tumorigenesis, p.241-56. Okayasu I, Yoshida T1, Mikami T1, Mitsuhashi J, Ichinoe M1, Yanagisawa N1, Tokuyama W1, Hana K, Ishibashi Y, Edited by O'Connor MB, InTech, 2011/12”­s. (‹g“c@Œ÷1, ŽOã“N•v1, ˆêŒË¹–Ÿ1, –öàVM”V1, “¿ŽR@é1: 1•a—)

[Šw‰ïEŒ€‹†‰ï“™]

713019. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HIGH EXPRESSION OF L-TYPE AMINO-ACID TRANSPORTER 1 (LAT1) IN GASTRIC CARCINOMA: INDEPENDENT PROGNOSTIC FACTOR IN NON-SCIRRHOUS CARCINOMAS. Ichinoe M1, Mikami T1, Yoshida T1, Igawa I, Tsuruta T, Nakada N1, Anzai N, Y Suzuki, Koizumi W2, Endou H, Okayasu I: 9th International Gastric Cancer Congress (2011/4/20-23), Seoul, Korea. (ˆêŒË¹–Ÿ1, ŽOã“N•v1, ‹g“c@Œ÷1, ’‡“c“TL1, ¬ò˜aŽO˜Y2: 1•a—, 2Á‰»Ší“à)

713020. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Statistical method to improve the accuracy of retrieving similar images in histopathological information database system. Hara A1, Ishibashi Y: ‘Û“Œv‹Š‰ï (ISI) ‘æ58‰ñ¢ŠE“Œv‘å‰ï (2011/8/22), ƒ_ƒuƒŠƒ“, ƒAƒCƒ‹ƒ‰ƒ“ƒh (ŒŽ@“ÖŽq1, Î‹Ž—Yˆê: 1•a—)

723040. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒ“ƒ_ƒ€–Ɖu–@‚É‚æ‚èì»‚µ‚œNo.1044R‘Ì‚Ì”xŠàŒŒŽf’fƒ}[ƒJ[‚Æ‚µ‚Ä‚Ì—L—p«. ¬—с@M, Œ–{r‰p, “ì@@®, –ö“cŒ›Œá, Ó@¢ˆ®1, ŽOŽ}@M1, ²“¡—Yˆê (1•a—): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/28), ‰¡•l.

723041. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ¬×–E”xŠà‚É‚š‚¯‚éEGFRˆâ“`Žq•ÏˆÙ‚Ìheterogeneity. Ó@¢ˆ®1, ‹–@“`ž^, –p@t•P, ”~‘ò“ÖŽq, ‘ì˜ad2, ˆÉ˜¬“c–Ÿ3, ²“¡”Vr3, ²“¡—Yˆê, ŽR‰º˜a–ç4, ‰ªˆÀ@ŒM1, ŽOã“N•v1, ŽOŽ}@M1 (1•a—, 2•úŽËü (Žîá‡), 3ŒÄ‹zŠíŠO, 4•a‰@•a—•”): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/28), ‰¡•l.

723042. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«’_ùN‰Š”S–Œ‚É‚š‚¯‚éŽU”­«TP53ˆâ“`Žqƒgƒ‰ƒ“ƒWƒVƒ‡ƒ“Œ^“_“Ë‘R•ÏˆÙ‚ÌŒŸo. –öàVM”V1, ŽR‰º˜a–ç2, ‹vê@Ž÷, ‰ªˆÀ@ŒM1 (1•a—, 2•a‰@•a—•”): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/28), ‰¡•l.

723043. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) bó‘B“û“ª‚ª‚ñ‚ÌŒŒs«Ä”­EŽ€–S‚ÌŒŸ“¢`—\Œã•s—LjöŽq‚ÌŒŸ“¢`. Š“cç”ü”T1, ŽOŽ}@M1 (1•a—): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/29), ‰¡•l.

723044. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‰ŠÇŠÖ˜A’`”’Ž¿OLFM4 ‚̉ŠÇ‚É‚š‚¯‚é–ðŠ„. ŽOã“N•v1, À“c‰êŽq2, ŽOŽ}@M1, ‰ªˆÀ@ŒM1 (1•a—, 2Œ`‘ÔŒn): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/30), ‰¡•l.

723045. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “û‘BŽŸŠ³•a—f’f•ñ‘‚©‚ç‚̃eƒLƒXƒgî•ñ‚ð—p‚¢‚œ‹qŠÏ“I•a—f’f‰ß’ö‚̃‚ƒfƒ‹‰»‚ÌŽŽ‚Ý. ŒŽ@“ÖŽq1, ŽOŽ}@M1, Î‹Ž—Yˆê (1•a—): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/30), ‰¡•l.

723046. [Šw‰ï(‘S‘)] (ƒ|ƒXƒ^[) H“¹Šà‚É‚š‚¯‚é•\”瑝BˆöŽqEGFR”­Œ»‚š‚æ‚їՏ°•a—Šw“IŒŸ“¢. ŠÖ’JŒ³Š²1, •Ð“c‰Ä–ç2, “c糁@‘3, ‘å•”@œ4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3Á‰»Ší“à, 4•a—): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/30), ‰¡•l, “ú–{•a—Šw‰ï‰ïŽ 2011/3; 100 (1): 448.

723047. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pin1‚ÍNF-ƒÈBƒVƒOƒiƒ‹“`’BŒn‚ð‰î‚µ‚ÄŽq‹{“à–ŒŠà×–E‚Ì‘B‚𐧌䂷‚é. ‹Ž‘º”ü‹I, ŒK“c@Œ’, ’ß“c’qŽq, Ó@¢ˆ®1, Š“cç”ü”T1, ŠâŸºŒ[ˆê1, ŒŽ@“ÖŽq1, ‹g“c@Œ÷1, ŽOŽ}@M1 (1•a—): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/28-30), ‰¡•l.

723048. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —\ŒãˆöŽq‚Æ‚µ‚Ä‚ÌŽîᇌ^ƒAƒ~ƒmŽ_ƒgƒ‰ƒ“ƒXƒ|[ƒ^[ LAT1‚Ì”­Œ» (ƒXƒLƒ‹ƒXˆÝŠà‚Æ”ñƒXƒLƒ‹ƒXˆÝŠà‚Ì”äŠr). ˆêŒË¹–Ÿ1, ŽOã“N•v1, ‹g“c@Œ÷1 (1•a—): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/28-30), ‰¡•l.

723049. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ¬×–E”xŠà‚É‚š‚¯‚éTKI‘ϐ«Šl“ŸƒƒJƒjƒYƒ€‘œ—l«‚ÌŒŸ“¢. Ó@¢ˆ®1, ŽOã“N•v1, ”~‘ò“ÖŽq, ŽR‰º˜a–ç2, ‘ì˜ad3, ˆÉ˜¬“c–Ÿ4, ²“¡”Vr4, ²“¡—Yˆê, ‰ªˆÀ@ŒM1, ŽOŽ}@M1 (1•a—, 2•a‰@•a—•”, 3•úŽËü (Žîá‡), 4ŒÄ‹zŠíŠO): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/3-4), ‘åã.

733013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a—f’f•ñ‘‚̃eƒLƒXƒgî•ñ‚ð—p‚¢‚œ‹qŠÏ“I•a—f’f‰ß’öƒ‚ƒfƒ‹‰»‚ÌŽŽ‚Ý. ŒŽ@“ÖŽq1, Î‹Ž—Yˆê (1•a—): ‹ž“s‘åŠwƒAƒJƒfƒ~ƒbƒNƒ‰ƒCƒeƒBƒ“ƒOŒ€‹†‰ïE“ú–{ŒvŽZ‹@“ŒvŠw‰ï (‹€Ã), 2011/9/24), ‹ž“s.

733014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ªŠWœ‚š‚æ‚ÑŽ‹°‰º•”‚É•a•Ï‚ðŽ‚ÂHistiocytic disorder‚̈ê—á. ŒŽ@“ÖŽq (•a—): ‘æ99‰ñ“Œ‹ž”]Žîᇌ€‹†‰ï (2011/10/9), “Œ‹ž.

733015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žîᇐ«•a•Ï‚ð‹^‚í‚ê‚œ“«GE’ׁE‡‚̈ê—á. –öàVM”V1, Š“cç”ü”T1, ŽOŽ}@M1 (1•a—): ‘æ92‰ñ_“ސ쌧•a—ˆã‰ï (2012/1/7), _“ސì.


‰q¶Šw

[Šwp˜_•¶]

110041. [ŒŽ’˜] Safety evaluation of rock wool after nasal inhalation in rats. Kudo Y1, Aizawa Y1: Ind Health 2011; 49 (1): 47-55. (H“¡—Yˆê˜N1, ‘ŠàVDŽ¡1: 1‰q¶)

110042. [ŒŽ’˜] The alterations in neurotransmitters and their metabolites in discrete brain regions in the rats after inhalation of disinfectant, glutaraldehyde or ortho-phthalaldehyde for 4 weeks. Katagiri H1, Yamamoto T, Uchimura A, Tsunoda M2, Aizawa Y2, Yamauchi H1: Ind Health 2011; 49 (3): 328-37. (•Ð‹Ë—TŽj1, Šp“c³Žj2, ‘ŠàVDŽ¡2, ŽR“à@”Ž1: 1ˆã—Éq¶Šw•”, 2‰q¶)

110043. [ŒŽ’˜] Cytotoxicity and solubility evaluation of two types of whiskers by cell magnetometry. Kudo Y1, Aizawa Y1: Environ Health Prev Med 2011/9; 16 (5): 327-34. (H“¡—Yˆê˜N1, ‘ŠàVDŽ¡1: 1‰q¶)

110044. [ŒŽ’˜] Fluoride in drinking water exacerbates glomerulonephriris and induces liver damage in ICR-derived glomerulonephriris mice. Hosokawa M1, Asakawa H, Kaido T, Sugaya C1, Tsunoda M1, Itai K, Kodama Y, Sugita-Konishi Y, Takata A, Yokoyama K, Aizawa Y1: Toxicological & Environmental Chemistry 2011/12; 93 (10): 2072-84. (×ì‚Ü‚äŽq1, ›’J‚¿‚Š”ü1, Šp“c³Žj1, ‘ŠàVDŽ¡1: 1‰q¶)

110045. [ŒŽ’˜] Exposure to tributyltin (TBT) via food during developmental stages after weaning, or the exposure via the placenta and their dams' milk, inhibits body weight gain and behaviors in rats. Ikeuchi R1, Kido T1, Sugaya C2, Katagiri H3, Akita H, Saji M3, Tsunoda M2, Aizawa Y2: Kitasato Med J 2012/3; 42 (1): 57-66. (’r“à—Ž‘Ÿ˜Y1, –،ˑž›’1, ›’J‚¿‚Š”ü2, •Ð‹Ë—TŽj3, ²Ž¡^—3, Šp“c³Žj2, ‘ŠàVDŽ¡2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶, 3ˆã—Éq¶Šw•”)

110046. [ŒŽ’˜] Evaluation of neurotoxicity of artificial dura mater and dura mater containing a high concentration of dibutyltin in rats after intracranial implantation. Tsunoda M1, Ikeuchi R2, Tsuji M1, Inoue Y2, Ito K, Katagiri H3, Akita H, Saji M3, Yuba T, Yamada T, Tsuchiya T, Aizawa Y1: Kitasato Med J 2012/3; 42 (1): 67-75. (Šp“c³Žj1, ’r“à—Ž‘Ÿ˜Y2, ’ҁ@‰ë‘P1, ˆäã—tŽq2, •Ð‹Ë—TŽj3, ²Ž¡^—3, ‘ŠàVDŽ¡1: 1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”)

120003. [ŒŽ’˜] ‹·‹`ƒVƒbƒNƒnƒEƒXÇŒóŒQf’fŠî€‚ÌŒŸ“¢. ‹{“‡]—¢Žq1, ¬‘ò@Šw, ¯@‰À–F1, Šp“c³Žj1, â•”@v, ‹{“cŠ²•v, ‘ŠàVDŽ¡1 (1‰q¶): —Տ°ŠÂ‹«ˆãŠw 2011/7; 20 (1): 32-9.

120004. [ŒŽ’˜] –k—¢‘åŠwˆãŠw•”•‘®—Տ°Œ€‹†ƒZƒ“ƒ^[‚É‚š‚¯‚é—Տ°Œ€‹†Žx‰‡‹³ˆçƒvƒƒOƒ‰ƒ€ŽQ‰ÁŽÒ‚Ì—v–]’²ž. ¯@‰À–F1, ‰€@‘‹Õ2, â–{‘×—2, ˆíŒ©@Ž¡2, “V–ì‰pŽ÷3, “c”šŒ’ˆê2, ²“¡•q•F2, ŒF’J—YŽ¡2, ‘ŠàVDŽ¡1 (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ, 3—Տ°Œ€‹†E‘n‘¢ƒV[ƒY): ƒwƒ‹ƒXƒTƒCƒGƒ“ƒXEƒwƒ‹ƒXƒPƒA 2011/12; 11 (2): 91-5.

520002. [‘à] ˆãŠw’†‰›ŽGŽ‚ðŠî–{ƒf[ƒ^ƒx[ƒX‚Æ‚µ‚œ“ú–{‚É‚š‚¯‚éHˆç‚ÌŒ»ó‚Ì•¶Œ£“IŒŸ“¢. ’ҁ@‰ë‘P1, Šp“c³Žj1, —é–Ø—çŽq, ’r“à—Ž‘Ÿ˜Y2, •Ÿ“‡“Nm (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): •Ÿ“‡ˆãŠwŽGŽ 2011; 61 (2): 79-87.

522012. [uÀ]y‘æ19‰ñ ŒÄ‹zŠíŽŸŠ³ƒtƒH[ƒ‰ƒ€EzEê‚̊‹«ŠÇ—|ì‹ÆŠÂ‹«‘ª’è‚ÌŽ‹“_‚©‚ç|. ‘å“c‰xŽq1, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶): Œ’NŠÇ— 2011/12; 58 (12) : 31-7.

540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚ª‹^‚í‚ê‚銳ŽÒ‚Ì’²ž•[‚É‚æ‚éƒNƒŠ[ƒjƒ“ƒO“X“à‚š‚æ‚ѐ»•i‚Ɖƒë—pôÜ‚È‚Ç‚ÉŠÖ‚·‚é’²ž. ‘ŠàVDŽ¡1, ‹{“‡]—¢Žq1 (1‰q¶): ƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錀‹†•ñ‘ •œ¬22”N“x 2011/4; p.26-32.

540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ƒNƒŠ[ƒjƒ“ƒO—p—nÜ‚É‚æ‚éƒ}ƒNƒƒtƒ@[ƒWŒn×–E‚̉ŠÇŒnƒTƒCƒgƒJƒCƒ“”­Œ»‚ÉŠÖ‚·‚郊ƒAƒ‹ƒ^ƒCƒ€PCR–@‚É‚æ‚錟“¢. Šp“c³Žj (‰q¶): ƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錀‹†•ñ‘ •œ¬22”N“x 2011/4; p.33-41.

540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u1p36Œ‡ŽžÇŒóŒQ‚ÌŽÀ‘Ô”cˆ¬‚ƍ‡•¹f—ÃKƒCƒhƒ‰ƒCƒ“ì¬ (Œ€‹†‘ã•\ŽÒ: ŽR–{rŽŠ)vz1p36Œ‡ŽžÇŒóŒQ‚ÌŽÀ‘Ô”cˆ¬‚ƍ‡•¹Çf—ÃKƒCƒhƒ‰ƒCƒ“ì¬. ŽR–{rŽŠ, •œàV‹±Žq, ‘OŠ_‹`O, Œ”ö^—, ²“¡Nm, ¯@‰À–F1 (1‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u1p36Œ‡ŽžÇŒóŒQ‚ÌŽÀ‘Ô”cˆ¬‚ƍ‡•¹f—ÃKƒCƒhƒ‰ƒCƒ“ì¬v‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.1-12.

540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]Ey•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u1p36Œ‡ŽžÇŒóŒQ‚ÌŽÀ‘Ô”cˆ¬‚ƍ‡•¹f—ÃKƒCƒhƒ‰ƒCƒ“ì¬ (Œ€‹†‘ã•\ŽÒ: ŽR–{rŽŠ)vz1p36Œ‡ŽžÇŒóŒQ‚ÉŠÖ‚·‚éWebî•ñ‚ÌŽûW. ¯@‰À–F1, ²“¡Nm, ŽO‹{”ÍŽq2, â–{‘×—2, ‰€@‘‹Õ2, ŽR–{rŽŠ (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u1p36Œ‡ŽžÇŒóŒQ‚ÌŽÀ‘Ô”cˆ¬‚ƍ‡•¹f—ÃKƒCƒhƒ‰ƒCƒ“ì¬v‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.35-54.

540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz–k—¢‘åŠwˆãŠw•”•‘®—Տ°Œ€‹†ƒZƒ“ƒ^[Eƒ‰ƒ“ƒ_ƒ€‰»Š„•tŽ––±‹Ç‚ÌŒ»‹µ. ¯@‰À–F1, ‰€@‘‹Õ2, â–{‘×—2, ˆíŒ©@Ž¡2, ŽO‹{”ÍŽq2, ²“¡•q•F2, ‘ŠàVDŽ¡1 (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†vŒ€‹†•ñ‘ 2012/3; p.43-9.

540007. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†Žx‰‡‚ÉŠÖ‚·‚錟“¢ (—Տ°Œ€‹†‚ÉŠÖ‚·‚鋳ˆçƒvƒƒOƒ‰ƒ€‚Ì‚ ‚è•û‚ɂ‚¢‚Ä). ¯@‰À–F1, ‰€@‘‹Õ2, â–{‘×—2, ˆíŒ©@Ž¡2, ²“¡•q•F2, ‘ŠàVDŽ¡1 (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†vŒ€‹†•ñ‘ 2012/3; p.111-77.

540008. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰»ŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)u’nˆæŒ’NˆÀ‘SEŠë‹@ŠÇ—ƒVƒXƒeƒ€‚Ì‹@”\•]‰¿‹y‚ÑŽ¿‚̉ü‘P‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘œ“c—…_ŽO)vzž_•ÛŒ’•ª–ì. ‚‰ª“¹—Y, ‰F“c‰p“T, ˆÉ’n’mº_, ŽR“c‘SŒ[, ‰Á”[g‘ã, –{‰®•~”ü“Þ, Žðˆäƒ‹ƒ~, Šp“c³Žj1, ’|“‡@³, H“¡ˆêŒb (1‰q¶): •œ¬23”N“xŒú¶˜J“­‰»ŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)u’nˆæŒ’NˆÀ‘SEŠë‹@ŠÇ—ƒVƒXƒeƒ€‚Ì‹@”\•]‰¿‹y‚ÑŽ¿‚̉ü‘P‚ÉŠÖ‚·‚錀‹†vŒ€‹†•ñ‘ 2012/3; p.131-58.

540009. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰»ŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)u’nˆæŒ’NˆÀ‘SEŠë‹@ŠÇ—ƒVƒXƒeƒ€‚Ì‹@”\•]‰¿‹y‚ÑŽ¿‚̉ü‘P‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘œ“c—…_ŽO)vzž_•ÛŒ’•ª–ì. ‚‰ª“¹—Y, ‰F“c‰p“T, ˆÉ’n’mº_, ŽR“c‘SŒ[, ‰Á”[g‘ã, –{‰®•~”ü“Þ, Žðˆäƒ‹ƒ~, Šp“c³Žj1, ’|“‡@³, H“¡ˆêŒb (1‰q¶): •œ¬23”N“xŒú¶˜J“­‰»ŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)u’nˆæŒ’NˆÀ‘SEŠë‹@ŠÇ—ƒVƒXƒeƒ€‚Ì‹@”\•]‰¿‹y‚ÑŽ¿‚̉ü‘P‚ÉŠÖ‚·‚錀‹†vŒ€‹†•ñ‘ 2012/3; p.195-220.

[’˜@‘]

610006. [Šwp‘] (•ª’SŽ·•M)yOccupational Toxicology, 3rdzEnvironmental Toxicoology; Biological and Health Effects of Pollutants, p.265-80. Tsunoda M1, Tsunoda H, Edited by Yu Ming-Ho, Tsunoda H, Tsunoda M1, Taylor & Francis, USA, 2011/11”­s. (Šp“c³Žj1: 1‰q¶)

610007. [Šwp‘] (ŠÄCE•ÒWE‚»‚Ì‘Œ)yEnvironmental ToxicologyzEdited by Ming-Ho Yu, Tsunoda H, Tsunoda M1, CRC Press, 2011/2”­s. (Šp“c³Žj1: 1‰q¶)

620004. [Šwp‘] (•ÒW)yƒXƒgƒŒƒX‰ÈŠwŽ–“Tz‘ŠàVDŽ¡ (‰q¶), Îìr’j, ìãŒ›l, ‰ºŒõ‹Pˆê, ‘ºã³l, ˆŸ¶CŽi, “àŽR–Ÿ•F, Ž™‹Ê¹‹v, “c’†³•q, ”ª–؍F•F, Â–ؘa•v, ‘å–ì@Œ‹, “‡@@Œå, ’†‘º@Œ«, “n•Ó’Œ“o, ”ѐXáÁŠì—Y, ŠÄC: “ú–{ƒXƒgƒŒƒXŠw‰ï, ƒpƒuƒŠƒbƒNƒwƒ‹ƒXƒŠƒT[ƒ`ƒZƒ“ƒ^[, ŽÀ–±‹³ˆço”Å, “Œ‹ž, 2011/6”­s.

620005. [Šwp‘] (•ª’SŽ·•M)yZ‹ˆãŠw (E)z‘æ2Í@g‚̉ñ‚è‚̉»Šw•šŽ¿‚ÆŒ’NáŠQ, p.11-26. â•”@v, –Ø‘º@õ, Šp“c³Žj1, ŒF–ìGº, ’†‘º—zˆê, X@ç—¢, –ö‘òK—Y, ‘ŠàVDŽ¡1 (1‰q¶), •ÒW: ”³@‹`l, ‹g“c@C, •Ä“co”Å, ç—t, 2011/8”­s.

620006. [Šwp‘] (•ª’SŽ·•M)yŽY‹Æˆã‚ÌŽèˆø‚« ‘æ8”ŁzVÍ ŽY‹Æ•ÛŒ’Šˆ“®‚Å‘˜‹ö‚·‚錒N‰Û‘è@‹i‰Œ‘΍ô, p.114-32. ‘ŠàVDŽ¡ (‰q¶), ŒŽ“c@‹v, •ÒW: “Œ‹ž“sˆãŽt‰ïŽY‹Æ•ÛŒ’ˆÏˆõ‰ïE•ÒWˆÏˆõ‰ï, “Œ‹ž“sˆãŽt‰ï, “Œ‹ž, 2011/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713021. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The effects of fluoride on the neurotransmitters in discrete brain regions of ICR-derived glomerulonephritis mice by exposure via their drinking water. Tsunoda M1, Kido T2, Ikeuchi R2, Sugaya C1, Kodama Y, Sugita-Konishi Y, Aizawa Y1: 51st Annual Meeting and ToxExpo (2012/3/11), San Francisco, USA, Abstracts 2012; p.221-2. (Šp“c³Žj1, –،ˑž›’2, ’r“à—Ž‘Ÿ˜Y2, ›EJ‚¿‚Š”ü1, ‘ŠàVDŽ¡1: 1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713022. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The body weight and fluoride concentrations in the urine of ICGN mice and ICR mice after subacute administration via drinking water. Kido T1, Tsunoda M2, Sugaya C2, Ikeuchi R1, Itai K, Kodama Y, Sugita-Konishi Y, Takata A, Yokoyama K, Aizawa Y2: 51st Annual Meeting and ToxExpo (2012/3/11), San Francisco, USA, Abstracts 2012; p.259. (–،ˑž›’1, Šp“c³Žj2, ›’J‚¿‚Š”ü2, ’r“à—Ž‘Ÿ˜Y1, ‘ŠàVDŽ¡2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶)

713023. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The effects of tributyltin on the bones of F1 rats by exposure VIA the placenta and their dams' milk and/or their food. Hosokawa M1, Tsunoda M1, Asakawa H, Kaido T1, Sugaya C1, Inoue Y, Tashiro T, Yokoyama K, Aizawa Y1: 51st Annual Meeting and ToxExpo (2012/3/11), San Francisco, USA, Abstracts 2012; p.411. (×ì‚Ü‚äŽq1, Šp“c³Žj1, ‹¬ŒËF–ç1, ›’J‚¿‚Š”ü1, ‘ŠàVDŽ¡1: 1‰q¶)

713024. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The immunotoxic effects of tributyltin on splenocytes in female F1 rats by continuous exposure from the fetus stage through their developing stages. Ikeuchi R1, Kido T1, Sugaya C2, Tsunoda M2, Katagiri H, Hayashi K, Kosaka T, Aizawa Y2: 51st Annual Meeting and ToxExpo (2012/3/11), San Francisco, USA, Abstracts 2012; p.537. (’r“à—Ž‘Ÿ˜Y1, –،ˑž›’1, ›’J‚¿‚Š”ü2, Šp“c³Žj2, ‘ŠàVDŽ¡2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶)

722007. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒbƒNƒnƒEƒXÇŒóŒQŒ€‹†Å‹ß‚Ì“®ŒüzƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì•a‘ԉ𖟂Ɋւ·‚鐬‰Ê (‘Š‡). â•”@v, ‹{“‡]—¢Žq1, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ82‰ñ“ú–{‰q¶Šw‰ïŠwp‘‰ï (2012/3/25), ‹ž“s, “ú‰qŽ 2012; 67 (2): 231.

723050. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒNƒŠ[ƒjƒ“ƒO—p—nÜ”˜˜I‚É‚æ‚éƒ}ƒNƒƒtƒ@[ƒWŒn×–E‚ÌIL-12p40”­Œ»‚ɑ΂·‚é‰e‹¿. –،ˑž›’1, Šp“c³Žj2, ›’J‚¿‚Š”ü2, H“¡—Yˆê˜N2, ‘ŠàVDŽ¡2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/18), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 399.

723051. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒgƒŠƒuƒ`ƒ‹ƒXƒY‚É‘ÙŽ™Šú|”­’BŠú”˜˜I‚³‚ê‚œF1ƒ‰ƒbƒgE̐¬’·—}§‹y‚эs“®—}§|. ’r“à—Ž‘Ÿ˜Y1, –،ˑž›’1, ›’J‚¿‚Š”ü2, Šp“c³Žj2, •Ð‹Ë—TŽj, “à‘ºÊŽq, ‘ŠàVDŽ¡2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/18), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 408.

723052. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒb‘f“Š—^‚É‚æ‚莓ICGNƒ}ƒEƒX‚̍œ‚ւ̉e‹¿. ×ì‚Ü‚äŽq1, ›’J‚¿‚Š”ü1, ˆäã—tŽq, •œ–ìKŽq, ’£@@•ó1, ’ҁ@‰ë‘P1, ”ˆäˆêD, Šp“c³Žj1, Šp“c•¶’j, Ž™‹ÊK•v, ¬Œ—ÇŽq, ‘Ÿ“c‹v‹g, ‰¡ŽR˜am, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/18), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 411.

723053. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆù—¿…’†ƒtƒb‘f‚É”˜˜I‚³‚ê‚œICR-derives glomerulonephrtis (ICGN) ƒ}ƒEƒX‚ÌBUN’l. Šp“c³Žj1, –،ˑž›’2, ›’J‚¿‚Š”ü1, H“¡—Yˆê˜N1, ×ì‚Ü‚äŽq1, Ž™‹ÊK•v, ¬Œ—ÇŽq, ‘ŠàVDŽ¡1 (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/18), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 411.

723054. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒgƒŒƒX”œ‰ž‚ð‰ü‘P‚·‚éAdapt-ability‚Ì—v‘f‚Æ, “K‰ž/•s“K‰žW’c‚ňقȂéƒXƒgƒŒƒX‰ü‘P‚ð‚à‚œ‚ç‚·Eê‚̃XƒgƒŒƒX—vˆö. ‹TŽR»Žq, ‹àŽq‘œŽq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/20), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 579.

723055. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)uS‚ÌŒ’N‘΍ôv‚ŎЈõ‚Ì•a‹C”­¶‚ð–hŽ~‚µ“Ÿ‚œƒvƒƒOƒ‰ƒ€‚ÌŒø‰Ê•ªÍ|ƒXƒgƒŒƒXƒAƒ“ƒP[ƒgE‘SŽÐˆõƒtƒB[ƒhƒoƒbƒNEŠÇ—EŒ€CEŽÐˆõŒ€C‚𓝍‡‚µ‚ā|. ‹àŽq‘œŽq, ‹TŽR»Žq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/20), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 582.

723056. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 1p36Œ‡ŽžÇŒóŒQ‚ÌŽÀ‘Ô”cˆ¬‚ƍ‡•¹Çf—ÃKƒCƒhƒ‰ƒCƒ“ì¬. ŽR–{rŽŠ, •œàV‹±Žq, ‘OŠ_‹`O, Œ”ö^—, ²“¡Nm, ¯@‰À–F1 (1‰q¶): ‘æ53‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï(2011/5/27), ‰¡•l, ”]‚Æ”­’B 2011; 43 (suppl): S132.

723057. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒtƒb‘f…“Š—^Œã‚É‚æ‚ét•s‘Sƒ}ƒEƒX (ICGN) ‚Ì‘ŸŠí’†ƒtƒb‘f”Z“x. –،ˑž›’1, Šp“c³Žj2, ›’J‚¿‚Š”ü2, ’r“à—Ž‘Ÿ˜Y1, Ž…rG, ”ˆäˆêD, ‘ŠàVDŽ¡2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶): ‘æ22‰ñ“ú–{”÷—ÊŒ³‘fŠw‰ï(2011/7/1), ‹ž“s, Biomed Res Trace Elements 2011; 22 (2): 115.

723058. [Šw‰ï (ES‘)] (ˆê”ʍu‰‰) ‡¬‹zŽû«lHd–Œ‚̈À‘S«•]‰¿; “®•šƒ‚ƒfƒ‹‚Ì1ƒ–ŒŽŠÏŽ@Œã‚Ì”]Še•”ˆÊ_Œo“`’B•šŽ¿‘ª’è. ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç2, ×ì‚Ü‚äŽq2, ›’J‚¿‚Š”ü2, ˆäã—tŽq, Šp“c³Žj2, •Ð‹Ë—TŽj, “y‰®—˜], ‘ŠàVDŽ¡2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶): ‘æ22‰ñ“ú–{”÷—ÊŒ³‘fŠw‰ï(2011/7/1), ‹ž“s, Biomed Res Trace Elements 2011; 22 (2): 119.

723059. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒ“ƒ^ƒ‹ŽŸŠ³ŽÐˆõW’c‚Ì“Á’¥‚Ì•ªÍ(1)|ƒXƒgƒŒƒXƒ`ƒFƒbƒNƒAƒ“ƒP[ƒg‚ð—˜—p‚µ‚Ä”­Œ©‚Å‚«‚È‚¢ƒXƒgƒŒƒX‚ª‚‚­‚È‚¢W’c‚ª‚ ‚é. ‹TŽR»Žq, ‹àŽq‘œŽq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ18‰ñ“ú–{ŽY‹Æž_•ÛŒ’Šw‰ï (2011/7/2), “Œ‹ž, ŽY‹Æž_•ÛŒ’ 2011; 19 (‘Š§): 63.

723060. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒ“ƒ^ƒ‹ŽŸŠ³ŽÐˆõW’c‚Ì“Á’¥‚Ì•ªÍ (2)|ŠOŽ‘ŒnŠé‹Æ (¬‰ÊŽå‹`ŒXŒü‚Ì‹­‚¢Šé‹Æ) ‚É‘¶Ý‚·‚é‘æ3‚̃ƒ“ƒ^ƒ‹ŽŸŠ³œëŠ³ƒNƒ‰ƒXƒ^[‚Ì“Á’¥. ‹àŽq‘œŽq, ‹TŽR»Žq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ18‰ñ“ú–{ŽY‹Æž_•ÛŒ’Šw‰ï(2011/7/2), “Œ‹ž, ŽY‹Æž_•ÛŒ’ 2011; 19 (‘Š§): 64.

723061. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒb‘f…“Š—^Œã‚É‚æ‚éICGNƒ}ƒEƒX‚É‚š‚¯‚éƒTƒCƒgƒJƒCƒ“‚Ì”­Œ»‚ɑ΂·‚錟“¢. –،ˑž›’1, Šp“c³Žj2, ›’J‚¿‚Š”ü2, ’r“à—Ž‘Ÿ˜Y1, Ž™‹ÊK•v, ¬Œ—ÇŽq, ”ˆäˆêD, ‘ŠàVDŽ¡2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶): ‘æ18‰ñ“ú–{–Ɖu“Ő«Šw‰ïŠwp‘å‰ï (2011/9/8), ç—t, ‘æ18‰ñ“ú–{–Ɖu“Ő«Šw‰ïŠwp‘å‰ïu‰‰—vŽ|W 2011; p.96.

723062. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒgƒŠƒuƒ`ƒ‹ƒXƒY‚É‘ÙŽ™Šú-”­’B‰Šú”˜˜I‚³‚ê‚œƒIƒXF1ƒ‰ƒbƒg‚ÌäB×–EƒTƒCƒgƒJƒCƒ“ŽY¶‚ÉŠÖ‚·‚錟“¢. Šp“c³Žj1, –،ˑž›’2, ’r“à—Ž‘Ÿ˜Y2, ›’J‚¿‚Š”ü1, •Ð‹Ë—TŽj, ‘ŠàVDŽ¡1 (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ18‰ñ“ú–{–Ɖu“Ő«Šw‰ïŠwp‘å‰ï (2011/9/8), ç—t, ‘æ18‰ñ“ú–{–Ɖu“Ő«Šw‰ïŠwp‘å‰ïu‰‰—vŽ|W 2011; p.99.

723063. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰uŠwE—Տ°Œ€‹†‚ÉŠÖ‚·‚鏉ŠwŽÒ‚Ì‚œ‚ß‚Ì‹³ˆçƒvƒƒOƒ‰ƒ€‚Ì‚ ‚è•û‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¯@‰À–F1, ‰€@‘‹Õ2, â–{‘×—2, ˆíŒ©@Ž¡2, ²“¡•q•F2, ‘ŠàVDŽ¡1 (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ): ‘æ70‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2011/10/20), H“c, “ú–{ŒöO‰q¶ŽGŽ 2011; 58 (10): 150.

723064. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒOƒ‰ƒXƒE[ƒ‹‹y‚уKƒ‰ƒX’·‘@ˆÛ‚̔畆ŽhŒƒ«‚ÉŠÖ‚·‚éƒpƒbƒ`ƒeƒXƒg‚ð—p‚¢‚œŒŸ“¢. Šp“c³Žj1, –،ˑž›’2, –Ζ؍¹ç‘ã1, ™‰Y—R”üŽq3, ‹{“‡]—¢Žq1, H“¡—Yˆê˜N1, ŒFàV—§’Œ, ‘ŠàVDŽ¡1 (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3—\–hˆãŠwŒn): ‘æ20‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï^‘æ59‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ïƒAƒŒƒ‹ƒM[–Ɖu“Ő«Œ€‹†‰ï(2011/11/12), ç—t, ƒvƒƒOƒ‰ƒ€Ž˜^W 2011; p.45.

723065. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒVƒbƒNƒnƒEƒXÇŒóŒQŠ³ŽÒ‚É‚š‚¯‚錚•š“àŠÂ‹«‘ª’茋‰Ê: f’f‚ւ̍vŒ£“x‚ɂ‚¢‚Ä. ‹{“‡]—¢Žq1, ¬‘ò@Šw, ¯@‰À–F1, Šp“c³Žj1, …é‚Ü‚³‚Ý, ’†‘º—zˆê, â•”@v, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ20‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï^‘æ59‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ïƒAƒŒƒ‹ƒM[–Ɖu“Ő«Œ€‹†‰ï(2011/11/12), ç—t, ƒvƒƒOƒ‰ƒ€Ž˜^W 2011; p.47.

723066. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ~ƒNƒƒOƒŠƒA‚ɑ΂·‚éŠÂ‹«ƒGƒXƒgƒƒQƒ“‚̍ì—p‹@\|GPR-30‚ÆŠÖ˜A‚³‚¹‚ā|. â•”@v, ‹÷ŽRD, ¬‘ò@Šw, “c’†@—, ŠÖŒû‰ëŽ÷, Šp“c³Žj1, –Ø‘º@õ, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ20‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï^‘æ59‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ïƒAƒŒƒ‹ƒM[–Ɖu“Ő«Œ€‹†‰ï(2011/11/12), ç—t, ƒvƒƒOƒ‰ƒ€Ž˜^W 2011; p.48.

723067. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V’zZŽÉ‚É‚š‚¯‚éƒVƒbƒNƒXƒN[ƒ‹‚ÉŠÖ‚·‚鎩ŠoÇó’²ž‚ÆVOC‚ÌŽº“à”Z“x‘ª’è. –،ˑž›’1, ‹{“‡]—¢Žq2, ¯@‰À–F2, Šp“c³Žj2, ™‰Y—R”üŽq3, ¬Œ—T”ü1, Šâé‹`Œ[, ˆÉ“¡r—m, â•”@v, ‘ŠàVDŽ¡2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶, 3—\–hˆãŠwŒn): ‘æ20‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï^‘æ59‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ïƒAƒŒƒ‹ƒM[–Ɖu“Ő«Œ€‹†‰ï(2011/11/13), ç—t, ƒvƒƒOƒ‰ƒ€Ž˜^W 2011; p.67.

723068. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒAƒXƒxƒXƒgˆ—–@‚ÌŒŸ“¢. •Ð‹Ë—TŽj, ‰ª–ì“N˜Y, ™‰Y—R”üŽq1, Šp“c³Žj2, H“¡—Yˆê˜N2, —é–؍kˆê˜Y, ‹TˆäŒªŒc (1—\–hˆãŠwŒn, 2‰q¶): ‘æ51‰ñ“ú–{˜J“­‰q¶HŠw‰ïE‘æ32‰ñì‹ÆŠÂ‹«‘ª’茀‹†”­•\‰ï (2011/11/16), ‰F“s‹{, Ž˜^W 2011; p.30-1.

723069. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒVƒbƒNƒnƒEƒXÇŒóŒQŠ³ŽÒ‚̉»Šw•šŽ¿•s‘ϐ«‚ƃNƒŠ[ƒjƒ“ƒOŠÖ˜A—vˆö‚ÉŠÖ‚·‚é’²ž. ‹{“‡]—¢Žq1, –،ˑž›’2, ™‰Y—R”üŽq3, ¬Œ—T”ü1, ¬‘ò@Šw, ¯@‰À–F1, Šp“c³Žj1, â•”@v, ‘ŠàVDŽ¡1 (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3—\–hˆãŠwŒn): ‘æ82‰ñ“ú–{‰q¶Šw‰ïŠwp‘‰ï(2012/3/24), ‹ž“s, “ú–{‰q¶ŠwŽGŽ 2012; 67 (2): 306.

723070. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆù—¿…‚ð‰î‚µ‚œ2ƒ–ŒŽŠÔ‚̃tƒb‘f“Š—^‚É‚æ‚郉ƒbƒg‚Ì”]Še•”ˆÊ_Œo“`’B•šŽ¿‚ւ̉e‹¿. Šp“c³Žj1, –،ˑž›’2, ’r“à—Ž‘Ÿ˜Y2, ›’J‚¿‚Š”ü1, ’ҁ@‰ë‘P1, ’£@@àð1, ˆäã—tŽq, •Ð‹Ë—TŽj, ”ˆäˆêD, ‘ŠàVDŽ¡1 (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ82‰ñ“ú–{‰q¶Šw‰ïŠwp‘‰ï (2012/3/25), ‹ž“s, “ú‰qŽ 2012; 67 (2): 266.

723071. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒb‘f…“Š—^Œã‚Ì‚æ‚éICGNƒ}ƒEƒX‹y‚ÑICRƒ}ƒEƒX‚Ì”A’†CRE‚ÆCCr‚ÌŒŸ“¢. –،ˑž›’1, Šp“c³Žj2, ›’J‚¿‚Š”ü2, ’r“à—Ž‘Ÿ˜Y1, ™‰Y—R”üŽq3, Ž™‹ÊK•v, ¬Œ—ÇŽq, ”ˆäˆêD, ‘ŠàVDŽ¡2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶, 3—\–hˆãŠwŒn): ‘æ82‰ñ“ú–{‰q¶Šw‰ïŠwp‘‰ï (2012/3/25), ‹ž“s, “ú‰qŽ 2012; 67 (2): 315.

723072. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒAƒXƒxƒXƒgˆ—–@‚ÌŒŸ“¢. •Ð‹Ë—TŽj, ‰ª–ì“N˜Y, ™‰Y—R”üŽq1, Šp“c³Žj2, H“¡—Yˆê˜N2, —é–؍kˆê˜Y, ‹TˆäŒªŒc (1—\–hˆãŠwŒn, 2‰q¶): ‘æ82‰ñ“ú–{‰q¶Šw‰ïŠwp‘‰ï (2012/3/25), ‹ž“s, “ú‰qŽ 2012; 67 (2): 332.

731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒIƒ“ƒ‰ƒCƒ“ƒŠƒ\[ƒX‚Ì‚ä‚­‚ŠuƒIƒ“ƒ‰ƒCƒ“ƒŠƒ\[ƒX‚ð—˜—p‚·‚é—§ê‚©‚çv. ¯@‰À–F (‰q¶): “ú–{ˆãŠw}‘ŠÙ‹Š‰ï•ª‰È‰ï(2011/9/10), “Œ‹ž.

732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘«”ö“ºŽR‚Ì—ðŽj. ‘ŠàVDŽ¡ (‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï‘æ60‰ñ˜J“­‰q¶ŽjŒ€‹†‰ï (2011/5/18), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 284.

732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)yŽ{ô—§ˆÄŽx‰‡zƒAƒ“ƒP[ƒg’²žE‰‰K. ¯@‰À–F (‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬23”N“x’nˆæ•ÛŒ’Žx‰‡‚Ì‚œ‚ß‚Ì•ÛŒ’î•ñˆ—‹ZpŒ€C (2011/11/30), ˜aŒõ.

732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)yŽ{ô—§ˆÄŽx‰‡zŽ{ô‚ւ̃KƒCƒhƒ‰ƒCƒ“Šˆ—p. ¯@‰À–F (‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬23”N“x’nˆæ•ÛŒ’Žx‰‡‚Ì‚œ‚ß‚Ì•ÛŒ’î•ñˆ—‹ZpŒ€C (2011/11/30), ˜aŒõ.

732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)y•ÛŒ’î•ñ—˜—pŠT˜_z‰ÈŠw“Iª‹’‚ÉŠî‚­•ÛŒ’î•ñ‚ÌŽûW. ¯@‰À–F (‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬23”N“xê–å‰Û’öE•ÛŒ’î•ñ—˜—pŠT˜_Œ€C (2011/12/12), ˜aŒõ.

732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)Web‚ð—p‚¢‚œî•ñ”­MEî•ñ—˜—p. ¯@‰À–F (‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬23”N“xê–å‰Û’öE•ÛŒ’î•ñ—˜—pŠT˜_Œ€C (2011/12/16), ˜aŒõ.

H22EN“xˆÈ‘OEª

[Šwp˜_•¶]

H22-540001. [‚»‚Ì‘Œ (‰ï‹c˜^)] ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̗Տ°•ª—Þ‚É‚š‚¯‚鉻Šw•šŽ¿‹NˆöƒVƒbƒNƒnƒEƒXÇŒóŒQŠ³ŽÒ (2Œ^) ‚Ì”­Ç‘OŒã‚̉»Šw•šŽ¿•s‘ϐ«‚̕ω». ‹{“‡]—¢Žq1, ¬‘ò@Šw, ‰€@‘‹Õ2, ¯@‰À–F1, Šp“c³Žj1, ‹{“cŠ²•v, â•”@v, ™‰Y—R”üŽq3, ‘ŠàVDŽ¡1 (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ, 3—\–hˆãŠwŒn): ‘æ19‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/7; p.54.

H22-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ƒgƒi[‚ÌŽæ‚舵‚¢‚ÉŠÖ‚í‚錒N‰e‹¿’²ž. ‘ŠàVDŽ¡1, ²“¡•q•F2, Šp“c³Žj1, H“¡—Yˆê˜N1, ˜a“ckŽ¡3, ‘Ÿ“c@Š°3, ì“‡³•q3 (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ, ŒöO‰q¶3): ƒgƒi[‚ÌŽæ‚舵‚¢‚ÉŠÖ‚í‚錒N‰e‹¿’²ž2009”N“x•ñ‘ 2011/2; p.1-63.

H22-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬21`22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘ŠàVDŽ¡)vzƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†. ‘ŠàVDŽ¡ (‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†v•œ¬21`22”N“x‘‡Œ€‹†•ñ‘ 2011/3; p.1-5.

H22-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬21`22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†vz‘S‘‰uŠw’²ž‚É‚æ‚éƒVƒbƒNƒnƒEƒXÇŒóŒQf’fŠî€‘Ó–«‚ÌŒŸ“¢. ‘ŠàVDŽ¡1, ‹{“‡]—¢Žq1, ¬‘q‰p˜Y, –Ø‘ºŒÜ˜Y, ŒF–ìGº, ’†‘º—zˆê, â•”@v, ’·’JìáÁ‹I, X@ç—¢, ‹g–ì@”Ž, HŽRˆê’j, Šp“c˜a•F, Ž›‘ò­•F, –kžŠËŽq, …–Ø‚Ü‚³‚Ý, ‹{“cŠ²•v, Šp“c³Žj1, ¯@‰À–F1, ‰€@‘‹Õ2, Šâé‹`Œ[, ™‰Y—R”üŽq3, ¬Œ—T”ü1, ¬‘ò@Šw, –،ˑž›’1, ˆÉ“¡r—m (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ, 3—\–hˆãŠwŒn): •œ¬21`22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†v•œ¬21`22”N“x‘‡Œ€‹†•ñ‘ 2011/3; p.9-24.

H22-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬21`22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘ŠàVDŽ¡)vzƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì”íŠQŒW”‚ÉŠÖ‚·‚錀‹†. â•”@v, ‘ºãŽüŽO, ˆÉ‰êrŽ¡, Eɒؓ¿G, ¬“cØÌ, ‹÷ŽRD, –Ø‘º@÷, ‘ŠàVDŽ¡1 (1‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†v•œ¬21`22”N“x‘‡Œ€‹†•ñ‘ 2011/3; p.51-63.

H22-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)u‚¶‚ñ”xŒ’Nf’f‚É‚š‚¯‚éƒfƒWƒ^ƒ‹‰æ‘œ‚Ì•W€‰»‚È‚ç‚тɃ‚ƒjƒ^[f’f‚š‚æ‚Ñ”äŠr“lje•û–@‚ÌŠm—§‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘º“cŠì‘ãŽj)vzƒfƒWƒ^ƒ‹‚¶‚ñ”x•W€ŽÊ^‚̍쐬‚ÉŠÖ‚·‚錟“¢. ‘ŠàVDŽ¡1, H“¡—Yˆê˜N1, ‘º“cŠì‘ãŽj, ‚‹Ž‰ëŽm, Žu“cŽõ•v, R—ǐ³‘¥, â’JŒõ‘¥, ŠÝ–{‘ì–€, ‰Á“¡Ÿ–ç, “ú‰ºK‘¥, “c‘º‘Ÿ˜N, ›À¬•¶, “c’†—˜•F (1‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)u‚¶‚ñ”xŒ’Nf’f‚É‚š‚¯‚éƒfƒWƒ^ƒ‹‰æ‘œ‚Ì•W€‰»‚È‚ç‚тɃ‚ƒjƒ^[f’f‚š‚æ‚Ñ”äŠr“lje•û–@‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡Œ€‹†•ñ‘ 2011/3; p.1-74.

H22-540007. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘ŠàVDŽ¡)vzŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ. ‘ŠàVDŽ¡ (‰q¶): •œ¬22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†vŒ€‹†•ñ‘ 2011/3; p.1-5.

H22-540008. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†Žx‰‡‚ÉŠÖ‚·‚錀‹†. ¯@‰À–F1, ‰€@‘‹Õ2, â–{‘×—2, ˆíŒ©@Ž¡2, ²“¡•q•F2, ‘ŠàVDŽ¡1 (1‰q¶, 2—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.159-84.

[Šw‰ïEŒ€‹†‰ï“™]

H22-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽÐˆõ‚̃XƒgƒŒƒXEƒR[ƒsƒ“ƒO•û–@‚Ì‘I‘ð‚ƐEêƒXƒgƒŒƒbƒT[‚ÌŠÖ˜A|‹ÆŽíEŠé‹Æ‚É‚æ‚é‘Šˆá|. ‹TŽR»Žq, ‹àŽq‘œŽq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ18‰ñ“ú–{ŽY‹ÆƒXƒgƒŒƒXŠw‰ï (2011/1/21), _ŒË, ŽY‹ÆƒXƒgƒŒƒXŒ€‹† 2011; 18 (1): 68.

H22-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EEƒ|ƒXƒ^[) ŽdŽ–‚Ö‚ÌŽpš (ƒ`ƒƒƒŒƒ“ƒWETd/ŒÂlEW’c) ‚ƎЈõ‚̐«Ši“Á«, “K‰ž”\—Í, ƒXƒgƒŒƒX‚Æ‚ÌŠÖ˜A. ‹TŽR»Žq, ‹àŽq‘œŽq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶): ‘æ18‰ñ“ú–{ŽY‹ÆƒXƒgƒŒƒXŠw‰ï (2011/1/21), _ŒË, ŽY‹ÆƒXƒgƒŒƒXŒ€‹† 2010; 18 (1): 69.


ŒöO‰q¶Šw

[Šwp˜_•¶]

110047. [ŒŽ’˜] Factors of working conditions and prolonged fatigue among teachers at public elementary and junior high schools. Shimizu M1, Wada K1, Wang G2, Kawashima M3, Yoshino Y3, Sakaguchi Y3, Ohta H1, Miyaoka H4, Aizawa Y5: Ind Health 2011; 49 (4): 434-42. (Ž…‚Ý‚Ç‚è1, ˜a“ckŽ¡1, ‰€@‘‹Õ2, ì“‡³•q3, ‹g–씪d3, ãŒû—mŽq3, ‘Ÿ“c@Š°1, ‹{‰ª@“™4, ‘ŠàVDŽ¡5: 1ŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ž_, 5‰q¶)

110048. [ŒŽ’˜] Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanease male workers; a long-term retrospective cohort study. Kawashima M1, Wada K2, Ohta H2, Terawaki H, Aizawa Y3: BMC Nephrology 2011/7; 12: 31-7. (ì“‡³•q1, ˜a“ckŽ¡2, ‘Ÿ“c@Š°2, ‘ŠàVDŽ¡3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŒöO‰q¶, 3‰q¶)

110049. [ŒŽ’˜] Factors associated with preferences for health system goals in Japan. Wada K1, Kakuma R, Hoshi K2, Sato Y, Hasegawa T, Sato T3: Asia Pac J Public Health 2011/9; 23 (5): 721-9. (˜a“ckŽ¡1, ¯@‰À–F2, ²“¡•q•F3: 1ŒöO‰q¶, 2‰q¶, 3—Տ°Œ€‹†EŠé‰æ)

110050. [ŒŽ’˜] Association of depression and suicidal ideation with unreasonable patient demands and complaints among Japanese physicians: a national cross-sectional survey. Wada K1, Yoshikawa T, Goto T, Hirai A, Matsushima E, Nakashima Y, Akaho R, Kido M, Hosaka T: Int J Behav Med 2011/12; 18 (4): 384-90. (˜a“ckŽ¡1: 1ŒöO‰q¶)

110051. [ŒŽ’˜] Work-family conflict and prolonged fatigue among Japanese married male physicians. Ohta H1, Wada K1, Kawashima M2, Arimatsu M, Higashi T, Yoshikawa T, Aizawa Y3: Int Arch Occup Environ Health 2011/12; 84 (8): 937-42. (‘Ÿ“c@Š°1, ˜a“ckŽ¡1,ì“‡³•q2, ‘ŠàVDŽ¡3: 1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‰q¶)

110052. [EŽ’˜] Correlation of "Google Flu Trends" with sentinel surveillance data for influennza in 2009 in Japan. Wada K1, Ohta H1, Aizawa Y2: The Open Public Health Journal 2011; 4; 17-20. (˜a“ckŽ¡1, ‘Ÿ“c@Š°1, ‘ŠàVDŽ¡2: 1ŒöO‰q¶, 2‰q¶)

110053. [ŒŽ’˜] Lifestyle Habits among Physicians Working at Hospitals in Japan. Wada K1, Yoshikawa T, Goto T, Hirai A, Matsushima E, Nakashima Y, Akaho R, Kido M, Hosoka T: JMAJ 2011; 54 (5): 318-24. (˜a“ckŽ¡1: 1ŒöO‰q¶)

110054. [ŒŽ’˜] Assessment of border control measures and community containment measures used in Japan during the early stages of pandemic (H1N1) 2009. Sakaguchi H1, Tsunoda M2, Wada K3, Ohta H3, Kawashima M1, Yoshino Y1, Aizawa Y2: PloS ONE 2012/2; 7 (2): e31289. (ãŒû—mŽq1, Šp“c³Žj2, ˜a“ckŽ¡3, ‘Ÿ“c@Š°3, ì“‡³•q1, ‹g–씪d1, ‘ŠàVDŽ¡2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶, 3ŒöO‰q¶)

110055. [ŒŽ’˜] Risk factors of household transmission of pandemic (H1N1) 2009 among patients treated with antivirals: a prospective study at a primary clinic in Japan. Hirotsu N, Wada K1, Oshitani H: PLoS One 2012; 7 (2): e31519 (Epub 2012 Feb 16). (˜a“ckŽ¡1: 1ŒöO‰q¶)

110056. [ŒŽ’˜] Trends in cause specific mortality across occupations in Japanese men of working age during period of economic stagnation, 1980-2005: retrospective cohort study. Wada K1, Kondo N, Gilmour S, Ichida Y, Fujino Y, Sato T2, Shibuya K: BMJ 2012/3; 344: e1191. (˜a“ckŽ¡1, ²“¡•q•F2: 1ŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ)

110057. [ŒŽ’˜] The Knowledge of cervical cancer and screening adherence among nurses at university-affiliated hospital in Japan. Yoshino Y1, Ohta H2, Kawashima M1, Wada K2, Shimizu M2, Sakaguchi H1, Okada J3, Aizawa Y4: Kitasato Med J 2012/3; 42 (1): 6-14. (‹g–씪d1, ‘Ÿ“c@Š°2, ì“‡³•q1, ˜a“ckŽ¡2, Ž…‚Ý‚Ç‚è2, ãŒû—mŽq1, ‰ª“c@ƒ3, ‘ŠàVDŽ¡4: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŒöO‰q¶, 3Œ’NŠÇ—ƒZ, 4‰q¶)

110058. [ŒŽ’˜] Evaluation of validity of urine dipstick test for identification of reduced glomerular filtration rate in Japanese male workers aged 40 years and over. Kawashima M1, Wada K2, Ohta H2, Moriya R3, Aizawa Y4: J Occup Health 2012; 54 (3):176-80. (ì“‡³•q1, ˜a“ckŽ¡2, ‘Ÿ“c@Š°2, Žç‰®—˜‰À3, ‘ŠàVDŽ¡4: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŒöO‰q¶, 3ˆãŠw‹³ˆç, 4‰q¶)

120005. [ŒŽ’˜] “Œ‹ž“s‚̈ã—Ë@ŠÖ‚É‚š‚¯‚é–\—Í‚ÌŒ»ó (‚»‚Ì2)|EˆõŠÔ‚Å‚Ì–\ŒŸ, –\—Í, ƒZƒNƒnƒ‰sˆ×|. ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, •“c—œŠG, ŽO–Ø–ŸŽq (1ŒöO‰q¶): ˆÀ‘SˆãŠw 2011/4; 7 (1): 33-40.

120006. [ŒŽ’˜] VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬s‰Šú‚É‚š‚¯‚é’â—¯‘[’u‚̈ӎvŒˆ’è‚Ì‚ ‚è•û‚ÌŒŸ“¢. ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, ãŒû—mŽq2 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{ŒöO‰q¶ŽGŽ 2011/4; 58 (4): 259-65.

310001. [Ç—á•ñ] Occult schistosomiasis haematobia in a traveller returned from Africa. Brabury R S, Wada K1: ANNALS of the ACTM 2011; 12 (1): 28-31. (˜a“ckŽ¡1: 1ŒöO‰q¶)

310002. [Ç—á•ñ] Trends in cause specific mortality across occupations in Japanese men of working age during period of economic stagnation, 1980-2005. Wada K1, Kondo N, Gilmour S, Ichida Y, Fujino Y, Satoh T2, Shibuya K: BMJ 2012/3; 344: e1191. (˜a“ckŽ¡1, ²“¡•q•F2: 1ŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ)

510004. [‘à] Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanease male workers; a long-term retrospective cohort study. Kawashima M1, Wada K2, Ohta H2, Terawaki H, Aizawa Y3: BMC Nephrology 2011; 12: 31-7. (ì“‡³•q1, ˜a“ckŽ¡2, ‘Ÿ“c@Š°2, ‘ŠàVDŽ¡3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŒöO‰q¶, 3‰q¶)

520003. [‘à] ‚킪‘‚̋Ζ±ˆã‚̘J“­ŽžŠÔ§ŒÀ‚ÌŒŸ“¢‚É‚š‚¢‚čl—¶‚·‚ׂ«“_‚ƈã—Ë@ŠÖ‚É‹‚ß‚ç‚ê‚é‘Ήž. ˜a“ckŽ¡1, ‹gì@“O, “ޗLj䗝Œb, X–{‹M‘ã (1ŒöO‰q¶): ŽY‹Æ‰q¶ŠwŽGŽ 2011/7; 53 (4): 147-51.

520004. [‘à] VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU”­¶Žž‚ÉŠé‹Æ‚É•K—v‚ÈŠŽõ‘΍ô‚ÉŠÖ‚·‚éˆÓŽvŒˆ’è‚Æ‚»‚Ì‚œ‚߂̏î•ñ. ˜a“ckŽ¡1, —é–؉pF, ¡ˆä“S•œ, ‘ŠàVDŽ¡2 (1ŒöO‰q¶, 2‰q¶): ŽY‹Æ‰q¶ŠwŽGŽ 2012/3; 54 (2): 77-81.

521002. [‰ðà]y’ñŒŸz“Œ“ú–{‘åkÐ‚Ì1ƒ–ŒŽŒãˆÈ~‚É’nˆæ‚Å‹N‚±‚è‚€‚邱‚Æ‚Æ—\–h“IŽæ‚è‘g‚Ý. ˜a“ckŽ¡1, ––œA—LŠóŽq, ãŒû—mŽq2 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ƒAƒCƒ† 2011; 4; 239: 11-5.

521003. [‰ðà] ŠŽõ‘΍ô‚ÌŠî–{’†‚ÌŠî–{, Žèô‚¢`‚Ç‚€‚µ‚ÄŽèô‚¢‚Í•K—v‚©`. ˜a“ckŽ¡1, ãŒû—mŽq2 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ’†Šw•ÛŒ’ƒjƒ…[ƒX 2011; 1484: 1.

521004. [‰ðà] ’ÔgE’nk‚É‚š‚¢‚ÄŽ©•ª, ‰Æ‘°, “¯—», ’nˆæ‚ÌŒ’N‚ðŽç‚éƒqƒ“ƒg. ˜a“ckŽ¡ (ŒöO‰q¶): Œ’NŠJ”­ 2011; 15 (3): 47-55.

521005. [‰ðà] “Œ“ú–{‘åkÐ‚Å”íÐ‚³‚ê‚œ•ûX‚ðŽx‰‡‚·‚é‚œ‚߂̏d—v‚ȃ|ƒCƒ“ƒg. ˜a“ckŽ¡ (ŒöO‰q¶): Œ’N‚©‚È‚ª‚í 2011; 517: 1.

521006. [‰ðà]yî•ñ’ñ‹ŸzHŽ–•œ‹Œ]Ž–ŽÒ‚̈À‘S‰q¶‚š‚æ‚Ñ•úŽËü‚ÌŠî‘b’mŽ¯. ˜a“ckŽ¡ (ŒöO‰q¶): ˆÀ‘S‚ÆŒ’N 2011; 12 (5): 478-9.

521007. [‰ðà] “Œ“ú–{‘åkÐ‚Ì”íÐ’n‚É‚š‚¯‚éŽY‹Æ•ÛŒ’Šˆ“®. ˜a“ckŽ¡ (ŒöO‰q¶): Œ’N‚©‚È‚ª‚í 2011; 520: 2.

521008. [‰ðà] A˜JŽx‰‡‚Ì“y‘ä‚Æ‚È‚é‚݂̂͌¢‚ɏ•‚¯‡‚Š‚éEê‚­‚è‚Ÿ. ˜a“ckŽ¡ (ŒöO‰q¶): ˜A‡ 2011; 276: 18-20.

521009. [‰ðà] ‚킪‘‚Ì’j«‚É‚š‚¯‚é“­‚«¢‘ã‚̐E‹Æ‚ÆŽ€–S|ê–åE‹ZpE‚ÆŠÇ—E‚ÌŒ’N‚ðŽç‚ê|. ˜a“ckŽ¡1, ‹ß“¡’Œ®ŒÈ (1ŒöO‰q¶): ˆÀ‘S‚ÆŒ’N 2012/3; 13 (4): 372-6.

522013. [uÀ]y˜AÚ: ¡, ’–Ú‚Ì•a‹C-4zƒCƒ“ƒtƒ‹ƒGƒ“ƒU. ˜a“ckŽ¡ (ŒöO‰q¶): ’n•ûŒö–±ˆõ@ˆÀ‘S‚ÆŒ’NƒtƒH[ƒ‰ƒ€ 2011/4; 79: 42.

522014. [uÀ]y‘æ2“ÁW: Eê‚Å‚Ì‚€‚•a‘΍ôzˆã—Ë@ŠÖ‚É‚š‚¯‚郁ƒ“ƒ^ƒ‹ƒwƒ‹ƒX•s‘S‚̈ꎟE“ñŽŸ—\–h‚Ö‚ÌŽæ‚è‘g‚Ý. ˜a“ckŽ¡ (ŒöO‰q¶): ƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO 2011/5; 27 (5): 513-5.

522015. [uÀ] ˆã—Ë@ŠÖ‚É‚š‚¯‚郁ƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô. ˜a“ckŽ¡ (ŒöO‰q¶): Square 2011/6; 584: 6-11.

522016. [uÀ]yŽ‘—¿z‚킪‘‚̋Ζ±ˆã‚̘J“­ŽžŠÔ§ŒÀ‚ÌŒŸ“¢‚É‚š‚¢‚čl—¶‚·‚ׂ«“_‚ƈã—Ë@ŠÖ‚É‹‚ß‚ç‚ê‚é‘Ήž. ˜a“ckŽ¡1, ‹gì@“O, “ޗLj䗝Œb, X–{‹M‘ã (1ŒöO‰q¶): ŽY‹Æ‰q¶ŠwŽGŽ 2011/7; 53 (4): 147-51.

522017. [uÀ]y“ÁW: ƒCƒ“ƒtƒ‹ƒGƒ“ƒU|l—ނƃEƒCƒ‹ƒX‚Ƃ̍U–h‚Ì—ðŽj‚©‚çŠw‚ԁ|z¡ƒEƒCƒ‹ƒX«ã‹C“¹ŠŽõÇ‚ɑ΂·‚é—\–hŒø‰Ê‚̃Gƒrƒfƒ“ƒX@ƒ}ƒXƒN^ƒŒƒXƒsƒŒ[ƒ^|ˆã—Ï]Ž–ŽÒ‚ªÅ’áŒÀ’m‚Á‚Ä‚š‚­‚ׂ«ŒÄ‹z—p–hŒì‹ï‚Ì’mŽ¯|. ‘Ÿ“c@Š°1, ì“‡³•q2, ˜a“ckŽ¡1, ‘ŠàVDŽ¡3 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‰q¶): –ò‹Ç 2011/11; 62 (12): 3736-440.

522018. [uÀ]y“úí¶Šˆ‚É‚š‚¯‚銎õÇ‚Ì—\–hEŽ¡—ÂƃŠƒXƒNŠÇ—‘΍ôz“úí¶Šˆ‚É‚š‚¯‚銎õŠÇ—‚Æ‚»‚ÌŽÀ‘H‚ÉŠÖ‚í‚é—\–hŠˆ“®‚̐„i|ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚ð—á‚Ɂ|. ˜a“ckŽ¡1, ãŒû—mŽq2 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ŒŽŠ§ò‰»‘… 2011; 423: 19-22.

522019. [uÀ] ˆã—Ë@ŠÖ‚Å‚Ì–\—͑΍ô (‘æ4‰ñ)|ˆã—Ë@ŠÖ‚ł̐EˆõŠÔ‚Ì–\ŒŸE–\—͑΍ô|. ˜a“ckŽ¡ (ŒöO‰q¶): Medical forumn CHUGAI 2011; 15 (4): 2-6.

540010. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (‚ª‚ñ—Տ°Œ€‹†Ž–‹Æ)u“­‚­‚ª‚ñŠ³ŽÒ‚ƉƑ°‚ÉŒü‚¯‚œ•ïŠ‡“IA‹ÆŽx‰‡ƒVƒXƒeƒ€‚̍\’z‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‚‹Ž@“s)vzŽÀ—á‚ÉŠw‚Ô‚ª‚ñŠ³ŽÒ‚̏A˜JŽx‰‡‚ɖ𗧂Â5‚‚̃|ƒCƒ“ƒg (‚ª‚ñŽ¡—ÂɊւí‚éˆãŽtŒü‚¯). ‘å’Ð^‹|, ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, “c’†@Š®, “ޗLj䗝Œb, ì“‡³•q2 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ƒŠ[ƒtƒŒƒbƒg 2011/10; p.1-4.
(http://www.cancer-work.jp/2011/10/%e5%ae%9f%e4%be%8b%e3%81%ab%e5%ad%a6%e3%
81%b6%e2%80%95%e3%81%8c%e3%82%93%e6%82%
a3%e8%80%85%e3%81%ae%e5%b0%b1%e5%8a%b4%
e6%94%af%e6%8f%b4%e3%81%ab%e5%bd%b9%e7%
ab%8b%e3%81%a4%ef%bc%95%e3%81%a4%e3%81%ae/)

540011. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)uEˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‚‹Ž@Œª)vzVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU”­¶Žž‚ÉŠé‹Æ‚É•K—v‚ÈŠŽõ‘΍ô‚ÉŠÖ‚·‚éˆÓŽvŒˆ’è‚Æ‚»‚Ì‚œ‚߂̏î•ñ. ˜a“ckŽ¡1, —é–؉pF, ¡ˆä“S•œ, ‘ŠàVDŽ¡2 (1ŒöO‰q¶, 2‰q¶): •œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)uEˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡Œ€‹†•ñ‘ 2012/3; p.63-75.

[’˜@‘]

620007. [Šwp‘] (•ÒW)yˆã—Ë@ŠÖ‚É‚š‚¯‚é–\—͑΍ôƒnƒ“ƒhƒuƒbƒNz˜a“ckŽ¡1, ŽO–Ø–ŸŽq, ‹gì@“O (1ŒöO‰q¶), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

620008. [Šwp‘] (•ª’SŽ·•M)yˆã—Ë@ŠÖ‚É‚š‚¯‚é–\—͑΍ôƒnƒ“ƒhƒuƒbƒNz3Í Š³ŽÒ‚©‚犳ŽÒ‚Ö‚Ì–\—́@Œ»ó‚Ƒ΍ô, p.93-7. ˜a“ckŽ¡1 (1ŒöO‰q¶), •Ò’˜: ˜a“ckŽ¡1, ŽO–Ø–ŸŽq, ‹gì@“O, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

620009. [Šwp‘] (•ª’SŽ·•M)yˆã—Ë@ŠÖ‚É‚š‚¯‚é–\—͑΍ôƒnƒ“ƒhƒuƒbƒNz4Í Eˆõ‚©‚犳ŽÒ‚Ö‚Ì–\—́@Œ»ó‚Ƒ΍ô, p.121-5. ˜a“ckŽ¡1 (1ŒöO‰q¶), •Ò’˜: ˜a“ckŽ¡1, ŽO–Ø–ŸŽq, ‹gì@“O, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

620010. [Šwp‘] (•ª’SŽ·•M)yˆã—Ë@ŠÖ‚É‚š‚¯‚é–\—͑΍ôƒnƒ“ƒhƒuƒbƒNz5Í ˆã—Ë@ŠÖ‚ł̑̐§ì‚è@1. ˆã—Ë@ŠÖ‚Å”­¶‚·‚é–\—Í‚Í‘gD“I‚ÈŽæ‚è‘g‚݂ōŽ•ž‚·‚é|ŽÀ‘ԂƑ΍ô|, p.153-62. ˜a“ckŽ¡1 (1ŒöO‰q¶), •Ò’˜: ˜a“ckŽ¡1, ŽO–Ø–ŸŽq, ‹gì@“O, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

620011. [Šwp‘] (•ª’SŽ·•M)yˆã—Ë@ŠÖ‚É‚š‚¯‚é–\—͑΍ôƒnƒ“ƒhƒuƒbƒNz5Í ˆã—Ë@ŠÖ‚ł̑̐§ì‚è@2. ˆã—Ë@ŠÖ‚É‚š‚¯‚é‘gD“I‚ÈŽæ‚è‘g‚Ý‚Ì‚œ‚ß‚ÌŽQ‰ÁŒ^ƒvƒƒOƒ‰ƒ€‚ÌŽÀŽ{|ƒAƒNƒVƒ‡ƒ“ƒ`ƒFƒbƒNƒŠƒXƒg‚ÌŠˆ—p|, p.163-9. ˜a“ckŽ¡1 (1ŒöO‰q¶), •Ò’˜: ˜a“ckŽ¡1, ŽO–Ø–ŸŽq, ‹gì@“O, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

620012. [Šwp‘] (ŠÄC)y‚—îŽÒ‚Ì‚Ý‚È‚³‚ñ‚ց@”M’†Ç‚É‹C‚ð‚‚¯‚Ü‚µ‚å‚€ (ƒpƒ“ƒtƒŒƒbƒg)z˜a“ckŽ¡ (ŒöO‰q¶), “Œ‹ž–@‹Ko”Å, “Œ‹ž, 2011/6”­s.

620013. [Šwp‘] (DVD)yƒtƒBƒbƒgƒeƒXƒgƒCƒ“ƒXƒgƒ‰ƒNƒ^[—{¬uÀz˜a“ckŽ¡1, ‘Ÿ“c@Š°1, žÄ—¯•x”üŽq, ’·£@m, ‹gì@“O, •{ˆêŒ©, –Ø‘º‹e“ñ (1ŒöO‰q¶), ƒtƒBƒbƒgƒeƒXƒgŒ€‹†‰ï, 2011/7”­s.

620014. [Šwp‘] (•ÒW)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèzŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1 (1ŒöO‰q¶), ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620015. [Šwp‘] (•ª’SŽ·•M)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèz‘æ3Í@‰uŠw“I“Á’¥, p.58-81. ³—ѓÍ, ˜a“ckŽ¡1 (1ŒöO‰q¶), ŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1, ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620016. [Šwp‘] (•ª’SŽ·•M)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèz‘æ4Í@“ü‘ŽÒŠÇ— (…Û‘΍ô), p.82-113. ˜a“ckŽ¡1 (1ŒöO‰q¶), ŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1, ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620017. [Šwp‘] (•ª’SŽ·•M)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèz‘æ5Í@’nˆæ‚Å‚ÌŠŽõŠg‘å–hŽ~ô, p.114-57. ˜a“ckŽ¡1 (1ŒöO‰q¶), ŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1, ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620018. [Šwp‘] (•ª’SŽ·•M)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèz‘æ6Í@ˆã—Ñ̐§, p.158-227. ˜a“ckŽ¡ (ŒöO‰q¶), ŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1, ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620019. [Šwp‘] (•ª’SŽ·•M)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèz‘æ7Í@ƒT[ƒxƒCƒ‰ƒ“ƒX, p.228-59. ˜a“ckŽ¡1 (1ŒöO‰q¶), ŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1, ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620020. [Šwp‘] (•ª’SŽ·•M)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèz‘æ8Í@î•ñ’ñ‹ŸEƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“, p.260-95. ˜a“ckŽ¡1 (1ŒöO‰q¶), ŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1, ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620021. [Šwp‘] (•ª’SŽ·•M)yVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1)@‚킪‘‚É‚š‚¯‚é‘Ήž‚ƍ¡Œã‚̉ۑèz‘æ9Í@ƒƒNƒ`ƒ“, p.296-343. ˜a“ckŽ¡1 (1ŒöO‰q¶), ŠÄC: ‹{‘º’B’j, •Ò: ˜a“ckŽ¡1, ’†‰›–@‹Ko”Å, “Œ‹ž, 2011/8”­s.

620022. [Šwp‘] (DVD)y”íÐ’n‚Å“­‚­l‚ªƒzƒRƒŠ‚âƒAƒXƒxƒXƒg‚©‚玩•ª‚ÌŒ’N‚ðŽç‚é‚œ‚߂̃}ƒXƒN‚ÌŠî‘b’mŽ¯z˜a“ckŽ¡1, ‘Ÿ“c@Š°1, žÄ—¯•x”üŽq, ’·£@m, ‹gì@“O (1ŒöO‰q¶), 2011/9”­s.

620023. [’˜‘] (•ª’SŽ·•M)ywƒ‰ƒ“ƒZƒbƒgx“ú–{“ÁW†u‘–¯ŠF•ÛŒ¯’B¬‚©‚ç50”Nv(The Lancet, Volume 378)z“ÁW†1@‚È‚º“ú–{‘–¯‚ÍŒ’N‚È‚Ì‚©, p.29-43. ’r“c“Þ—R, âV“¡‰pŽq, ‹ß“¡®ŒÈ, ˆäã^“Þ”ü, ²“¡•q•F, ˜a“ckŽ¡1, ƒAƒ“ƒhƒŠƒ…[EƒXƒeƒBƒbƒNƒŠ[, •Ð–ì“ck‘Ÿ, aã“N–ç, –ì“cŒõ•F, ˆé@”ŽN, “¡–ì‘P‹v, ‘c•ƒ]—FF, ’Ã‹à¹ˆê˜Y, ƒ‚[ƒZƒ“EƒiƒKƒ”ƒB, ƒ}ƒWƒbƒhEƒGƒUƒfƒB, a’JŒ’Ži (1ŒöO‰q¶), •ÒE’˜:wƒ‰ƒ“ƒZƒbƒgx“ú–{“ÁW†ƒvƒƒWƒFƒNƒgŒ€‹†ƒ`[ƒ€ (ŠÄC: a’JŒ’Ži), (Œöà) “ú–{‘ÛŒð—¬ƒZƒ“ƒ^[, “Œ‹ž, 2011/9”­s.

620024. [’˜‘] (ŠÄC)yƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚©‚ç‰Æ‘°‚Æ’nˆæ‚ðŽç5‚‚̑΍ô (ƒpƒ“ƒtƒŒƒbƒg)z˜a“ckŽ¡ (ŒöO‰q¶), “Œ‹ž–@‹Ko”Å, “Œ‹ž, 2011/10”­s.

620025. [’˜‘] (ŠÄC)yƒEƒCƒ‹ƒX‚ðŒ‚‘Þ‚µ‚ăCƒ“ƒtƒ‹ƒGƒ“ƒU‚ð—\–h‚µ‚Ü‚µ‚å‚€ (ƒpƒ“ƒtƒŒƒbƒg)z˜a“ckŽ¡ (ŒöO‰q¶), “Œ‹ž–@‹Ko”Å, “Œ‹ž, 2012/1”­s.

620026. [’˜‘] (ŠÄC)y‚—îŽÒ‚Ì•û‚ց@‚ ‚È‚Ç‚é‚ȁ@ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Í–œ•a‚ÌŒ³ (ƒpƒ“ƒtƒŒƒbƒg)z˜a“ckŽ¡ (ŒöO‰q¶), “Œ‹ž–@‹Ko”Å, “Œ‹ž, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722008. [Šw‰ï (‘S‘)] (Žs–¯ŒöŠJuÀ) “Œ“ú–{‘åkÐ‚Ì•œ‹ŒE•œ‹»‚É‹‚ß‚ç‚ê‚éŽY‹Æ•ÛŒ’Šˆ“®. ˜a“ckŽ¡ (ŒöO‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/19), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§-•Êü‚è): 2.

723073. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆã—Ë@ŠÖ‚̉^‰c‚ðŽx‚Š‚éŽü•ÓŽY‹Æ‚É‚š‚¯‚é˜J“­ŽÒ‚̐VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’mŽ¯, ”FŽ¯, ŽÀ‘H. ˜a“ckŽ¡1, ì“‡³•q2, ‘Ÿ“c@Š°1, ¬X—F‹M, “ޗLj䗝Œb, D“c@i, ‘ŠàVDŽ¡3 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/20), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 543.

723074. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Eˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (‘æ4•ñ)|Ž¿–â•[‚É‚æ‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU—¬sI‘§Œã‚̒ǐՒ²ž|. ÎŠÛ’mG, ŠÛŽR@’, ¡ˆä“S•œ, “Œ@•qº, ‹{‘º‰ÀF, Œ”WA‹KG, ãŒŽ³“¹, ˜a“ckŽ¡1, XŒ“Œ[‘Ÿ, ‚‹Ž@Œª, X@WŽ¢ (1ŒöO‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/20), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53(—ÕŽž‘Š§): 545.

723075. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Eˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (‘æ5•ñ)|’†¬‹K–Í‚ÌŠé‹Æ‚ɑ΂·‚éƒCƒ“ƒ^ƒrƒ…[’²ž|. ŠÛŽR@’, ÎŠÛ’mG, ¬“cãŒö–@, ¡ˆä“S•œ, ‹{‘º‰ÀF, Œ”WA‹KG, ãŒŽ³“¹, “Œ@•qº, ˜a“ckŽ¡1, XŒ“Œ[‘Ÿ, ‚‹Ž@Œª, X@WŽ¢ (1ŒöO‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/20), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53(—ÕŽž‘Š§): 545.

723076. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Eˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (‘æ6•ñ)|ƒTƒvƒ‰ƒCƒ`ƒF[ƒ“Šé‹Æ‚Æ‘åŠé‹Æ‚̘AŒg‚ÉŠÖ‚·‚éƒCƒ“ƒ^ƒrƒ…[’²ž|. ¡ˆä“S•œ, ‚‹Ž@Œª, X@WŽ¢, ãŒŽ³“¹, ˜a“ckŽ¡1, XŒ“Œ[‘Ÿ, ŠÛŽR@’, Œ”WA‹KG, ‹{‘º‰ÀF, “Œ@•qº (1ŒöO‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/20), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53(—ÕŽž‘Š§): 544.

723077. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ^ƒNƒV[ƒhƒ‰ƒCƒo[‚É‚š‚¯‚éƒvƒŒƒ[ƒ“ƒeƒB[ƒYƒ€‚ÌŽÀ‘Ô. r–Ø“c”üŽq, ªŠÝ–Γo”ü, ˜a“ckŽ¡1, “n•Ó—¢, X“c—] (1ŒöO‰q¶): ‘æ84‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2011/5/20), “Œ‹ž, ŽY‹Æ‰q¶ŠwŽGŽ 2011; 53 (—ÕŽž‘Š§): 571.

731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “Œ“ú–{‘åkÐ‚Ì”íÐ’n‚É‚š‚¯‚éŽY‹Æ•ÛŒ’Šˆ“®. ˜a“ckŽ¡ (ŒöO‰q¶): Œ’N‚©‚È‚ª‚íŽx‰‡ƒZƒ~ƒi[ (2011/6/10), _“ސì, Œ’N‚©‚È‚ª‚í 2011; 520: 2.

731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ˆã—Ë@ŠÖ‚Å‚ÌŽY‹Æ•ÛŒ’Šˆ“®. ˜a“ckŽ¡ (ŒöO‰q¶): ‘æ60‰ñL“‡ŽsˆãŽt‰ïŽY‹ÆˆãŒ€C‰ï (2011/6/27), L“‡.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H20-520001. [‘à] ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì’nˆæ‚Å‚ÌŠŽõ‘΍ô. ˜a“ckŽ¡1, ãŒû—mŽq2 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ŽÀŒ±Ž¡—à 2010; 699: 55-8.

H20-520002. [‘à] Žq‹{èò‚ª‚ñŒŸfŽóf‚ÌŒ»ó‚ÆŽóf—ŠŒüã‚Ì‚œ‚ß‚Ì•ûô‚ÌŒŸ“¢. ‹g–씪d1, ì“‡³•q1, ‘Ÿ“c@Š°2, ˜a“ckŽ¡2, ‘ŠàVDŽ¡3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŒöO‰q¶, 3‰q¶): ŽY‹ÆˆãŠwƒWƒƒ[ƒiƒ‹ 2011/1; 34 (1): 61-5.

H22-521001. [‰ðà]yŽž˜_zˆã—Ë@ŠÖ‚É‚š‚¯‚éEˆõ‚Ì•œEŽx‰‡‘̐§‚ÌŒ»ó‚Ƒ΍ô. ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, ì“‡³•q2, “c’†Žr2, ‘ŠàVDŽ¡3 (1ŒöO‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‰q¶): “ú–{ˆãŽ–V•ñ 2010/7; 4500: 105-8.

H22-521002. [‰ðà] Ž©‚ç‚ÌŒ’N‚ƈÀ‘S‚ðŽç‚é‚œ‚ß‚Ì—¯ˆÓ“_. ˜a“ckŽ¡ (ŒöO‰q¶): Œú¶•ŸŽƒ 2011/3; 5800: 8-9.

H22-522002. [uÀ]yŽY‹Æˆã‚É’®‚­! Œ»ê‚ÌŠˆ“® ƒRƒ‰ƒ{‚ÆŽÀ‘Hzˆã—ÃŒ»ê‚É‚š‚¯‚éŽY‹Æˆã‚ÆŽY‹ÆŠÅŒìE‚̘AŒg. ¬X—F‹M, ˜a“ckŽ¡1 (1ŒöO‰q¶): ŽY‹ÆŠÅŒì 2011/1; 3 (1): 44-6.

[Šw‰ïEŒ€‹†‰ï“™]

H22-713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) National survey of the association of depressive symptoms with the number of off duty, on call and sleep hours among physicians in Japan. Wada K1, Yoshikawa T, Goto T, Hosaka T: 20th Asian Conference on Occupational Health (2011/3/9), Bangkok, Thailand, Program and Abstract Book p.117. (˜a“ckŽ¡1: 1ŒöO‰q¶)

H22-721001. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ŠŽõ‘΍ô‚É‚š‚¯‚éŒÄ‹z—p–hŒì‹ï‚Ì“KØ‚ÈŽg—p‚Æ‚»‚̈Ӌ`. ˜a“ckŽ¡ (ŒöO‰q¶): ‘æ28‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/18), ‰¡•l.

H22-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 2009”N‚É‚š‚¯‚é“ú–{‚ÌGoogle Flu Trends‚̑Ó–«‚ÌŒŸØ. ˜a“ckŽ¡1, ì“‡³•q, ‘Ÿ“c@Š°1, ‘ŠàVDŽ¡2 (1ŒöO‰q¶, 2‰q¶): ‘æ28‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/18), ‰¡•l.

H22-723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œö‹€‹óŠÔ‚É‚š‚¯‚銎õ—\–h‚Ì‚œ‚߂̑̉·ƒXƒNƒŠ[ƒjƒ“ƒOŽè–@‚ÌŒŸ“¢. —é–Ø’B•F, ˜a“c—DŽq, ˜a“ckŽ¡1 (1ŒöO‰q¶): ‘æ28‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/18), ‰¡•l.

H22-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Žx‰‡‚ÉŒü‚¯‚œŒ»ê‚̉ۑ聃ŽY‹Æˆã‚Ì—§ê‚©‚灄. ˜a“ckŽ¡ (EöO‰q¶): ‚ª‚ñ‚ƏA˜J@‘æ3‰ñ•×‹­‰ï (2011/1/31), “Œ‹ž.


–@ˆãŠw

[Šwp˜_•¶]

110059. [ŒŽ’˜] Analysis of ventricular myosin light chain genes in cardiomyopathy. Irie W1, Murakami C1, Nakamura S1, Maeda K, Sasaki C2, Furukawa M1, Kurihara K1: Forensic Science International 2011/12; Genetics Supplement Series 3: e143-4. (“ü]@Â1, ‘ºãçŽq1, ’†‘º–Ίî1, ‘O“cˆê•ã, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

110060. [ŒŽ’˜] New rapid ABO genotyping using direct extraction kit. Maeda K, Nakamura S1, Murakami C1, Irie W1, Sasaki C2, Furukawa M1, Kurihara K1: Forensic Science International 2011/12; Genetics Supplement Series 3: e359-60. (‘O“cˆê•ã, ’†‘º–Ίî1, ‘ºãçŽq1, “ü]@Â1, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

110061. [ŒŽ’˜] Mutational analysis of the mitochondrial DNA detected in sudden death cases with cardiac hypertrophy. Nakamura S1, Kobayashi M, Murakami C1, Irie W1, Maeda K, Sasaki C2, Furukawa M1, Kurihara K1: Forensic Science International 2011/12; Genetics Supplement Series 3: e361-2. (’†‘º–Ίî1, ¬—ѐ³@, ‘ºãçŽq1, “ü]@Â1, ‘O“cˆê•ã, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

110062. [ŒŽ’˜] Analysis of the sarcomere protein gene mutation on cardiomyopathy –Mutations in the troponin complex genes. Murakami C1, Nakamura S1, Irie W1, Sasaki C2, Furukawa M1, Kurihara K1: Forensic Science International 2011/12; Genetics Supplement Series 3: e526-e7. (‘ºãçŽq1, ’†‘º–Ίî1, “ü]@Â1, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

220001. [€ŒŽ’˜] Real-Time PCR‚ð—p‚¢‚œTaqMan Probe ABO genotyping II. ‘O“cˆê•ã, ‘ºãçŽq1, “ü]@Â1, ¬—ѐ³@, —Ñ‚Ü‚¢Žq, ²X–ؐçŽõŽq2, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒÃì—F1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): DNA‘œŒ^ 2011/5; 19: 210-3.

220002. [€ŒŽ’˜] S‹ØÇ‚ÉŠî‚­“Ë‘RŽ€Ç—á‚É‚š‚¯‚émtDNAˆâ“`Žq‰ðÍ. ¬—ѐ³@, ’†‘º–Ίî1, ‘ºãçŽq1, ‘O“cˆê•ã, “ü]@Â1, —Ñ‚Ü‚¢Žq, ²X–ؐçŽõŽq2, ’†ŠÛ®”ü2, ŒÃì—F1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): DNA‘œŒ^ 2011/5; 19: 250-4.

[Šw‰ïEŒ€‹†‰ï“™]

713025. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Analysis of the sarcomere protein gene mutation on cardiomyopathy - Mutations in the troponin complex genes. Murakami C1, Nakamura S1, Irie W1, Sasaki C2, Furukawa M1, Kurihara K1: 24th World Congress of the. International Society for Forensic Genetics (2011/8/29-9/3), Vienna, Austria. (‘ºãçŽq1, ’†‘º–Ίî1, “ü]@Â1, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

713026. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Analysis of ventricular myosin light chain genes in cardiomyopathy. Irie W1, Murakami C1, Nakamura S1, Maeda K, Sasaki C2, Furukawa M1, Kurihara K1: 24th World Congress of the. International Society for Forensic Genetics (2011/8/29-9/3), Vienna, Austria. (“ü]@Â1, ‘ºãçŽq1, ’†‘º–Ίî1, ‘O“cˆê•ã, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

713027. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Mutational analysis of the mitochondrial DNA detected in sudden death cases with cardiac hypertrophy. Nakamura S1, Kobayashi M, Murakami C1, Irie W1, Maeda K, Sasaki C2, Furukawa M1, Kurihara K1: 24th World Congress of the. International Society for Forensic Genetics (2011/8/29-9/3), Vienna, Austria. (’†‘º–Ίî1, ¬—ѐ³@, ‘ºãçŽq1, “ü]@Â1, ‘O“cˆê•ã, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

713028. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) New rapid ABO genotyping using direct extraction kit. Maeda K, Nakamura S1, Murakami C1, Irie W1, Sasaki C2, Furukawa M1, Kurihara K1: 24th World Congress of the. International Society for Forensic Genetics (2011/8/29-9/3), Vienna, Austria. (‘O“cˆê•ã, ’†‘º–Ίî1, ‘ºãçŽq1, “ü]@Â1, ²X–ؐçŽõŽq2, ŒÃì—F1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

723078. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Real-Time PCR‚ð—p‚¢‚œTaqMan Probe ABO genotyping III. ‘O“cˆê•ã, ‘ºãçŽq1, “ü]@Â1, ¬—ѐ³@, —Ñ‚Ü‚¢Žq, ²X–ؐçŽõŽq2, ’†ŠÛ®”ü2, ŒÃì—F1, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): ‘æ95ŽŸ“ú–{–@ˆãŠw‰ïŠwp‘S‘W‰ï (2011/6/15-17), •Ÿ“‡.

723079. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÙŠ«‰Eœœ‰º“®–¬‚ð—L‚·‚é‹}«‘å“®–¬‰ð—£‚̈ê–UŒŸ—á. “ü]@Â1, ‘ºãçŽq1, ¬—ѐ³@, ‘O“cˆê•ã, —Ñ‚Ü‚¢Žq, ’†ŠÛ®”ü2, ²X–ؐçŽõŽq2, ’†‘º–Ίî1, ŒÃì—F1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): ‘æ95ŽŸ“ú–{–@ˆãŠw‰ïŠwp‘S‘W‰ï (2011/6/15-17), •Ÿ“‡.

723080. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Real-Time PCR‚ð—p‚¢‚œTaqMan Probe ABO genotyping IV. ‘O“cˆê•ã, ‘ºãçŽq1, “ü]@Â1, “n糗˜^, ²X–ؐçŽõŽq2, ’†ŠÛ®”ü2, ŒÃì—F1, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): “ú–{DNA‘œŒ^Šw‰ï‘æ20‰ñŠwpW‰ï (2011/8/30), ‰¡•l.

733016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©ì’²—Ší‹ï‚É‚æ‚éŒãèò•”žZ‘n‚ÅŽ€–S‚µ‚œˆê–UŒŸ—á. ‘O“cˆê•ã, “ü]@Â1, ‘ºãçŽq1, “n糗˜^, ²X–ؐçŽõŽq2, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒÃì—F1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): “ú–{–@ˆãŠw‰ï‘æ80‰ñŠwpŠÖ“Œ’n•ûW‰ï (2011/10/29), ‰F“s‹{.

733017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆÙ‚ÈŒ`‘Ô‚ð’悵‚œ‹¹•”‘å“®–¬áŽH“¹ú”j. “ü]@Â1, ‘ºãçŽq1, ‘O“cˆê•ã, “n糗˜^, ²X–ؐçŽõŽq2, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒÃì—F1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): “ú–{–@ˆãŠw‰ï‘æ80‰ñŠwpŠÖ“Œ’n•ûW‰ï (2011/10/29), ‰F“s‹{.


ˆã—ÎЉïŠw


ˆã—pî•ñŠw


ŽÀŒ±“®•šŠw

[Šwp˜_•¶]

110063. [ŒŽ’˜] Methyl CpG-binding protein isoform MeCP2_e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development. Itoh M, Tahimic CG, Ide S, Otsuki A, Sasaoka T1, Noguchi S, Oshimura M, Goto Y, Kurimasa A: J Biol Chem 2012/4; 287 (17): 13859-67. (ù‰ªr–M1: 1ŽÀ“®)

522020. [uÀ] ×–EŒn•ˆ‰ðÍ‚©‚ç‚Ý‚œã‚š‚æ‚Ñ“îŒûŠWã”ç‚ÌŠ²×–EƒVƒXƒeƒ€. ‘å‹v•Û’Œ (ŽÀ“®): “ú–{–¡‚Æ“õŠw‰ïŽ 2011/4; 18 (1): 29-35

[Šw‰ïEŒ€‹†‰ï“™]

712010. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Development of Animal Models for Human Disease Using Genetically Modified Mice. Sasaoka T1: Japan-China International Forum of Advanced Research on Biotechnology 2011 (2011/8/10), Tokyo. (ù‰ªr–M1: 1ŽÀ“®)

723081. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒh[ƒpƒ~ƒ“D1‚š‚æ‚ÑD2Žó—e‘̃mƒbƒNƒAƒEƒgƒ}ƒEƒX‚É‚š‚¯‚és“®‚š‚æ‚ѐüð‘ÌGABA«ƒVƒiƒvƒX“`’B‚̉ðÍ. –àŽRr•F, ²“¡’©Žq1, Ÿ–ØŒ³–ç, ù‰ªr–M1 (1ŽÀ“®): ‘æ34‰ñ“ú–{_Œo‰ÈŠwŠw‰ï (2011/9/17), ‰¡•l.

723082. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒh[ƒpƒ~ƒ“Žó—e‘̃mƒbƒNƒAƒEƒgƒ}ƒEƒX‚É‚š‚¯‚és“®‚š‚æ‚ѐüð‘Ì—}§«ƒVƒiƒvƒX“`’B‚̉ðÍ. –àŽRr•F, ²“¡’©Žq1, Ÿ–ØŒ³–ç, ù‰ªr–M1 (1ŽÀ“®): ‘æ89‰ñ“ú–{¶—Šw‰ï‘å‰ï (2012/3/29), Œ–{.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H19-110001. [ŒŽ’˜] Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Alvarez-Medina R, Cayuso J, Okubo T1, Takada S, Mart E: Development 2008/1; 135 (2): 237-47. (‘å‹v•Û’Œ1: 1ŽÀ“®)

H20-110001. [ŒŽ’˜] Epithelial Progenitor Cells of the Embryonic Lung and the Role of MicroRNAs in Their Proliferation. Lu Y, Okubo T1, Rawlins E, Hogan BL: Proc Am Thorac Soc 2008/4; 5 (3): 300-4. (‘å‹v•Û’Œ1: 1ŽÀ“®)

H20-110002. [ŒŽ’˜] Epithelial Stem/Progenitor Cells in Lung Postnatal Growth, Maintenance, and Repair. Rawlins EL, Okubo T1, Que J, Xue Y, Clark C, Luo X, Hogan BL: Cold Spring Harb Symp Quant Biol 2008; 73: 291-5. (‘å‹v•Û’Œ1: 1ŽÀ“®)

H20-110003. [ŒŽ’˜] Cell lineage mapping of taste bud cells and keratinocytes in the mouse tongue and soft palate. Okubo T1, Clark C, Hogan BL: Stem Cells 2009/2; 27 (2): 442-50. (‘å‹v•Û’Œ1: 1ŽÀ“®)

H21-110001. [ŒŽ’˜] The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Rawlins EL, Okubo T1, Xue Y, Brass DM, Auten RL, Hasegawa H, Wang F, Hogan BL: Cell Stem Cell 2009/6; 4 (6): 525-34. (‘å‹v•Û’Œ1: 1ŽÀ“®)

H22-110002. [ŒŽ’˜] Ripply3, a Tbx1 repressor, is required for development of the pharyngeal apparatus and its derivatives in mice. Okubo T1, Kawamura A, Takahashi J, Yagi H, Morishima M, Matsuoka R, Takada S: Development 2011/1; 138 (2): 339-48. (‘å‹v•Û’Œ1: 1ŽÀ“®)

[’˜@‘]

H22-620001. [Šwp‘] (•ª’SŽ·•M)yAnnual Review ŒÄ‹zŠí 2011zI. ŒÄ‹zŠíŒn‚̐¶•šŠw@1. ‹CŠÇE”xã”ç×–E‚Ì”­¶•ª‰»§Œä‹@\, p.1-6. ‘å‹v•Û’Œ (ŽÀ“®), •Ò: ‰iˆäŒúŽu, ’F_ˆê˜Y, X–ì˜a‘P, ‚‹Ž˜a‹v, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H22-722005. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹CŠÇE”xã”ç×–E“ÁˆÙ“I‚Ȉâ“`Žq‘€ìƒVƒXƒeƒ€‚̍\’z‚ƍזEŒn•ˆ‰ðÍ‚ւ̉ž—p. ‘å‹v•Û’Œ (ŽÀ“®): ‘æ50‰ñ“ú–{ŒÄ‹zŠíŠw‰ï (2010/4/23), ‹ž“s.

H22-722006. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™ Ripply3, a Tbx1 repressor is required for the development of pharyngeal arch. ‘å‹v•Û’Œ1, Kawamura A, Takahashi J, Takada S (1ŽÀ“®): ‘æ43‰ñ“ú–{”­¶¶•šŠw‰ï‘å‰ï (2010/6/23), ‹ž“s.

H22-722007. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ×–EŒn•ˆ‰ðÍ‚©‚ç‚Ý‚œƒ}ƒEƒXãE“îŒûŠWã”ç‚ÌŠ²×–EƒVƒXƒeƒ€. ‘å‹v•Û’Œ (ŽÀ“®): ‘æ44‰ñ“ú–{–¡‚Æ“õŠw‰ï‘å‰ï (2010/9/9), –k‹ãB.


–ƉuŠw

[Šwp˜_•¶]

110064. [ŒŽ’˜] Cognate interaction plays a key role in the surveillance of autoreactive B cells in induced mixed bone marrow chimerism in BXSB lupus mice. Takeuchi E1, Shinohara N1, Takeuchi Y2: Autoimmunity 2011/8; 44 (5): 363-72. (’|“àŒb”üŽq1, ŽÂŒŽMŒ«1, ’|“àN—Y2: 1–Ɖu, 2t‘Ÿ“à)

110065. [ŒŽ’˜] Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo. Ale MT, Maruyama H, Tamauchi H1, Mikkelsen JD, Meyer AS: Int J Biol Macromol 2011/10; 49 (3): 331-6. (‹Ê“àGˆê1: 1–Ɖu)

110066. [ŒŽ’˜] Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds Inhibit Proliferation of Melanoma Cells and Induce Apoptosis by Activation of Caspase-3 in Vitro. Ale MT, Maruyama H, Tamauchi H1, Mikkelsen JD, Meyer AS: Mar Drugs 2011/12; 9 (12): 2605-21. (‹Ê“àGˆê1: 1–Ɖu)

110067. [ŒŽ’˜] Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. Satoh M1, Andoh Y, Clingan CS, Ogura H, Fujii S, Eshima K1, Nakayama T, Taniguchi M, Hirata N, Ishimori N, Tsutsui H, OnoEK, Iwabuchi K1: PLoS One 2012/2; 7 (2): e30568. (²“¡@‰ë1, ]“‡k“ñ1, ŠâŸº˜a–ç1: 1–Ɖu)

120007. [ŒŽ’˜] Ni-Ti Œ`ó‹L‰¯‡‹à‚̍זE“K‡«‚É‹y‚Ú‚·‚‰·Ž_‰»ˆ—‚ÌŒø‰Ê–. …’J³‹`, Œ‘º—LŠóŽq, ¬–Î’¹, ‹Ê“àGˆê1 (1–Ɖu): “ú–{‹@ŠBŠw‰ï˜_•¶W (A•Ò) 2011; 77 (784): 99-107.

520005. [‘à] ƒiƒ`ƒ…ƒ‰ƒ‹ƒLƒ‰[T (natural killer T: NKT) ×–E‚Ì•ª‰»‚Æ‹@”\|‘O•Ò|. ŠâŸº˜a–ç (–Ɖu): –k—¢ˆãŠw 2011/12; 41 (2): 99-109.

[’˜@‘]

610008. [Šwp‘] (•ª’SŽ·•M)yAn Update GlomerulopathieszChapter 16@Mixed Hematopoietic Chimerism Allows Cure of Autoimmune Glomerulonephritis: Its Potential and Risks, p.277-90. Takeuchi E1, Edited by Prabhakar S, InTech, 2011/10”­s. (’|“àŒb”üŽq1: 1–Ɖu)

[Šw‰ïEŒ€‹†‰ï“™]

713029. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Type II NKT cells operate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. Sato M1: 6th international symposium on CD1 and NKT cells (2011/9/23-27), Chicago, USA. (²“¡@‰ë1: 1–Ɖu)

723083. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) On the role of T-box family molecules in the activation of two cytolytic pathways. ]“‡k“ñ1, ç—tŽÑ—R—˜, ²“¡@‰ë1, ŽÂŒŽMŒ«, ŠâŸº˜a–ç1 (1–Ɖu): ‘æ40‰ñ“ú–{–ƉuŠw‰ïŠwpW‰ï (2011/11/27), ç—t.

723084. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Type II NKT cells operate diet-induced obesity by mediating adipose tissue inflammation and steatohepatitis. ²“¡@‰ë (–Ɖu): ‘æ40‰ñ“ú–{–ƉuŠw‰ïŠwpW‰ï (2011/11/27-29), ç—t.

733018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HŽ–—U“±«”ì–ž‚É‚š‚¯‚étypeII NKT×–E‚Ì–ðŠ„. ²“¡@‰ë1, ]“‡k“ñ1, ŠâŸº˜a–ç1 (1–Ɖu): ‘æ21‰ñ Kyoto T Cell Conference (2011/6/11), ‹ž“s.


•š—Šw

[’˜@‘]

620027. [Šwp‘] (•ª’SŽ·•M)yƒvƒ‰ƒYƒ}ŒŽŽq•ªŽq‰ß’öƒnƒ“ƒhƒuƒbƒNz‘æ1•” Šî‘b•Ò@‘æ2Í ŒŽŽq‚̍\‘¢‚ƃXƒyƒNƒgƒ‹. ¬’r•¶”Ž (•š—), •Ò: ƒvƒ‰ƒYƒ}EŠj—Z‡Šw‰ï, ‘åã‘åŠwo”ʼnï, ‘åã, 2011/4”­s.


—Տ°‚€‚•aŠw


’nˆæŽüŽYŠúE‹~‹}ˆã—ØAŒg‹³ˆç

[Šwp˜_•¶]

530002. [‚»‚Ì‘Œ]yAuthor's ReplyzPotential role of recombinant erythropoietin and intravenous iron preparations in target vessel re-stenosis following coronary stint insertions in hemodialysis patients. Takeuchi I1, Imaki R2, Shimohama T2, Tojo T2, Inomata T2, Soma K3, Izumi T2: Int Med 2011; 50: 1447. (’|“àˆê˜Y1, ¡–Ø—²‘Ÿ2, ‰º•lF˜Y2, “ŒžŠ‘å‹P2, ’––”FŒ³2, ‘Š”nˆêˆå3, ˜aò@“O2: 1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2zŠÂŠí“à, 3‹~–œ)

[’˜@‘]

620028. [Šwp‘] (•ª’SŽ·•M)yf—ÃKƒCƒhƒ_ƒCƒWƒFƒXƒg2011 (Ž¡—Ã2011”N5ŒŽ—ÕŽž‘Š§†)zzŠÂŠí@S•s‘S, p.40-42. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã), •ÒW: ‘O‘ò­ŽŸ, ”“Œ@_, “ìŽR“°, “Œ‹ž, 2011/5”­s.

620029. [Šwp‘] (•ª’SŽ·•M)yƒhƒLƒ…ƒƒ“ƒg“Œ“ú–{‘åkÐ@‹~•‚̍őOü‚Łz‹‚ß‚ç‚ê‚Ä‚¢‚œ‚͈̂ã—Â̒·ŠúŽx‰‡‚Ÿ‚Á‚œ, p.291-301. ’|“àˆê˜Y1, ‰–’J–Αã (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã), •ÒW: JƒŒƒXƒLƒ…[•ÒW•”, ƒCƒJƒƒXo”Å, “Œ‹ž, 2011/9”­s.

620030. [Šwp‘] (•ª’SŽ·•M)yƒrƒWƒ…ƒAƒ‹‹~‹}•K{Žè‹Zƒ|ƒPƒbƒgƒ}ƒjƒ…ƒAƒ‹@‰ü’ù”Łz‘æ1Í ‹~‹}ˆã—ÑS”ʁ@3. •a‰@‘O‹~‹}ˆã—Á`ƒhƒNƒ^[ƒJ[‰^—p, p.26-32. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã), •Ò: –¥—֗Ǎs, Ž™‹Ê‹MŒõ, —r“yŽÐ, “Œ‹ž, 2012/2”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722009. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)u‹s‘Ò‚ÌŒ»ó‚Æ•a‰@‚Ì–ðŠ„v. ŽsìŒõ‘Ÿ˜Y1, Š}ŒŽ–ƒ—¢2, “¡ˆä”ü]3, ‘â—R”üŽq4, ×’J—º‘Ÿ5 (1–k‹ãBŽs—§”ª”Š•a‰@‰@’·¬Ž™‹~‹}ƒZƒ“ƒ^[’·, 2‘—§¬ˆçˆã—ÃŒ€‹†ƒZƒ“ƒ^[‚±‚±‚ë‚̐f—Õ”@ˆçŽ™S—‰Èˆã’·, 3•œŒI–@—¥Ž––±Š (•ÙŒìŽm), 4’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 5(À’·) ¹˜H‰Á‘Û•a‰@•›‰@’·): ‘æ61‰ñ“ú–{•a‰@Šw‰ï (2011/7/14), ‹ž‰€ƒvƒ‰ƒUƒzƒeƒ‹, “Œ‹ž, “ú–{•a‰@‰ïŽGŽ 2012; 59 (3): 26 (278)-61 (313).

722010. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‚±‚ê‚©‚ç‚Ì‹~‹}‰“Šuˆã—Á|ƒvƒŒƒzƒXƒsƒ^ƒ‹‚©‚çƒCƒ“ƒ^[ƒzƒXƒsƒ^ƒ‹‚܂Ł|z–k—¢‘åŠwƒhƒNƒ^[ƒJ[‚ÌŒ»êf—ÂðŽx‚Š‚éƒRƒ~ƒ…ƒjƒ…ƒP[ƒVƒ‡ƒ“ƒeƒNƒmƒƒW[. ’|“àˆê˜Y1, ¡–Ø—²‘Ÿ2, ˆîŠ_‘דl2, ŽR’J—§‘å2, ’©ŒG’õ—²2, ‰Ô“‡@Ž‘2, _œä’m“¹2, •ž•”@2, “‡“c@Œª2, ‘Š”nˆêˆå2, “¡“c‰p—Y3 (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2‹~–œ, 3“Œ‹ž‘åŠwˆãŠw•”•t‘®•a‰@zŠÂŠí“à‰È): ‘æ39‰ñ‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/18), “Œ‹ž.

722011. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹~‹}E‰“Šuˆã—ÂɌü‚¯‚œƒNƒ‰ƒEƒhŒ^12—U“±S“d}‚ÌŠJ”­‚ÆŽÀØŽŽŒ±. “¡“c‰p—Y1, ‰iˆä—ÇŽO2, ‘å]˜a•F3, ’|“àˆê˜Y4, ˜aò@“O5, ‘Š”nˆêˆå6 (1“Œ‹ž‘åŠwŒ’N‹óŠÔî•ñŠwuÀ, 2“Œ‹ž‘åŠwzŠÂŠí“à‰È, 3“Œ‹ž‘åŠwˆã—Ïî•ñŒoÏŠw, 4’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 5zŠÂŠí“à, 6‹~–œ): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/18), “Œ‹ž.

723085. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”D•w‚ƐV¶Ž™‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1pdm2009) ƒƒNƒ`ƒ“Œã–Ɖu‰ž“š‚ÌŒŸØ. –ì“n³•F1, â“Œ—R‹I2, ‘剪–ƒ—2, ŒÏè‰ëŽq2, ˆÉ“¡®Žu2, Îˆä³_2, –]ŒŽƒŽq3, ¯“c@—²3, “V–ì@Š®3, ŠC–ìM–ç1,3 (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2¬Ž™, 3ŽY‰È): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 397.

723086. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _“ސ쌧‚É‚š‚¯‚éV¶Ž™‘h¶–@ (NCPR) •‹y‘£i‚ÌŒ»ó. ¯–ì—€•v1, ’–’J‘׎j1, ŠâèŽu•ä1, Šì‘œ–ƒˆßŽq1, ù–{—D‰À1, “‡‘ܗяG1, ŠÖ@˜a’j1, ŒàV‘PŽ÷1, ŒŠª@Ž 1, –ì“n³•F2, ³–؁@G1, é@—T”V1 (1V¶Ž™‘h¶–@•‹yŽ–‹Æ_“ސ쐄iˆÏˆõ‰ï (_“ސìNCPRˆÏˆõ‰ï), 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 414.

723087. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹~‹}‰“Šuˆã—ÂɌü‚¯‚œƒNƒ‰ƒEƒhŒ^12—U“±S“d}‚ÌŠJ”­‚ÆŽÀØŽŽŒ±. “¡“cG—Y1, ’|“àˆê˜Y2, ‰iˆä—ÇŽO3 (1“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰ÈŒ’N‹óŠÔî•ñŠwuÀ, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3“Œ‹ž‘å•a‰@zŠÂŠí“à‰È): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (2011/10/18-20), “Œ‹ž.

723088. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) S‘ŸˆÚA‚ɑΉž‚·‚é|PCPS IABPŠ³ŽÒ‚Ì”À‘—‚̓wƒŠ‚©? —€˜H‚©?|. ’|“àˆê˜Y1, ¡–Ø—²‘Ÿ3, ‘Š”nˆêˆå2 (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2‹~–œ, 3zŠÂŠí“à): ‘æ18‰ñ“ú–{q‹óˆã—Êw‰ï‘‰ï (2011/11/12), ’·è.

723089. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹}«ŠúDMAT‚©‚爟‹}«Šú‚Ì‘åŠw•a‰@ˆã—ÃŽx‰‡ƒ`[ƒ€‚ց|‚»‚µ‚Ä’nŒ³ˆã—Ñ̐§•œ‹»‚Ö‚¢‚©‚ɂ‚Ȃ°‚é‚©|. ’|“àˆê˜Y1, ¡–Ø—²‘Ÿ2, •ž•”@3, ‘Š”nˆêˆå3 (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2zŠÂŠí“à, 3‹~–œ): ‘æ17‰ñW’cÐŠQˆãŠw‰ïŠwpW‰ï (2012/2/21-22), ‹à‘ò.

731004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒvƒŒƒzƒXƒsƒ^ƒ‹‚ւ̏Á–h, ‹~•, ƒhƒNƒ^[ƒJ[‚ÌŽæ‚è‘g‚Ý. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘å˜aŽsÁ–h–{•”u‰‰‰ï (2011/8/1), ‘å˜a.

731005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yê–å‰Æ‚É’®‚­ÅV‚̈ã—Ã, ³‚µ‚¢’mŽ¯|ÐŠQˆã—ÂƕúŽË”\‰˜õ|z‘Š–ÍŒŽŽs‚Å‘å‹K–͍ЊQ‚ª‹N‚«‚œ‚çc|“Œ“ú–{‘åkÐ‚©‚çl‚Š‚é|. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ10‰ñ–k—¢‘åŠwˆãŠw•”Žs–¯ŒöŠJuÀ (2011/10/22), ‘Š–ÍŒŽ.

731006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘Š–ÍŒŽŽs‚É–hÐƒwƒŠ“±“ü‚ÉŒü‚¯‚Ä. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘Š–ÍŒŽƒVƒeƒBƒ‰ƒCƒIƒ“ƒYƒNƒ‰ƒuŠg‘å10ŒŽ‘‰ï (2011/10/20), ‘Š–ÍŒŽ.

731007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹}«S‹Ø[Ç‚ɑ΂·‚éƒhƒNƒ^[ƒJ[‚Ì—L—p«. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ3‰ñ‚³‚ª‚Ý‚Í‚çzŠÂŠí‹~‹}ˆã—ØAŒg‚̉ï (2012/2/10), ‘Š–ÍŒŽ.

731008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _“ސ쌧‚Å‚Ì‘å‹K–͍ЊQ‘Ήž‚ðl‚Š‚é`“Œ“ú–{‘åkÐ‚ð‹³ŒP‚Ɂ`. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ¬“cŒŽ¶ŠˆKŠµ•aƒZƒ~ƒi[ (2012/2/24), ¬“cŒŽ.

731009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _“ސ쌧Œ§–kŒ§‰›ƒhƒNƒ^[ƒJ[‚ɂ‚¢‚ā|ƒhƒNƒ^[ƒJ[‚͉œ‚É—L—p‚ʼnœ‚ª‰Û‘è‚©|. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ53‰ñ_“ސ쌧ˆã‰ï‹~–œî•ñƒVƒXƒeƒ€ŒŸ“¢‰ï (2012/3/7), ‰¡•l.

732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ƒhƒNƒ^[ƒJ[‚Í‚Ç‚ñ‚ȏǗá‚É‚Ç‚ñ‚ÈŽž‚É—LŒø‚©. ’|“àˆê˜Y1, •ž•”@2, ‘Š”nˆêˆå2 (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2‹~–œ): ‘æ51‰ñ_“ސ쌧‹~–œî•ñƒVƒXƒeƒ€ŒŸ“¢‰ï (2011/10/21), ‰¡•l.

732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€)yIT‚ð—˜—p‚µ‚œƒvƒŒƒzƒXƒsƒ^ƒ‹S“d}“d‘—zACS‚ɑ΂·‚éƒhƒNƒ^[ƒJ[‚Ì—L—p«|S“d}“d‘—‚ð‰î‚µ‚œÁ–h‚Æ–k—¢ƒhƒNƒ^[ƒJ[‚ÌŽæ‚è‘g‚݁|. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ31‰ñ“Œ‹žCCUŒ€‹†‰ï (2011/12/3), “Œ‹ž.

732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚±‚ê‚©‚ç‚̃hƒNƒ^[ƒJ[‚̉^—p‚ðl‚Š‚é. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æˆê‰ñŠÖ“ŒƒhƒNƒ^[ƒJ[‹Š‹c‰ï (2011/12/4), “Œ‹ž.

733019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œ§–kŒ§‰›MC‚ÅŽæ‚è‘g‚ށ|ŠOÇ—á‚ɑ΂·‚éƒhƒNƒ^[ƒJ[‚Ì—L—p«|. ’|“àˆê˜Y (’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ52‰ñ_“ސ쌧‹~–œî•ñƒVƒXƒeƒ€ŒŸ“¢‰ï (2011/6/15), ‰¡•l.

733020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@NICU‚©‚ç“]‰@‚µ‚œV¶Ž™Ç—á‚ÌŒã•ûŽ‹“IŒŸ“¢. ‰Á“¡Ê”ü1, –ì“n³•F2, ˆÉ“¡®Žu3, –]ŒŽƒŽq4, ŠC–ìM–ç4 (1ˆãŠw•”5”N¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3¬Ž™, 4ŽY‰È): ‘æ397_“ސìŽY•wl‰ÈŠw‰ï (2012/3/10), –ŸŽ¡ˆÀ“c¶–œƒrƒ‹1FEƒ‰ƒWƒAƒ“ƒgƒz[ƒ‹.


S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“E—\–hˆãŠw


ˆã—ÃŒo‰cŠw

[Šwp˜_•¶]

110068. [ŒŽ’˜] A lifestyle to prevent or combat the metabolic syndrome among Japanese workers: analyses using the health belief model and the multidimensional health locus of control. Kudo Y1, Okada M2, Tsunoda M2 , Satoh T3, Aizawa Y2: Ind Health 2011/6; 49 (3): 365-73. Erratum in: Ind Health 2011; 49 (4): 543. (H“¡ˆÀŽj1, ‰ª“c[Žj2, Šp“c³Žj2, ²“¡•q•F3, ‘ŠàVDŽ¡2: 1ˆã—ÃŒo‰c, 2‰q¶, 3—Տ°Œ€‹†EŠé‰æ)

110069. [ŒŽ’˜] Work Motivation for Japanese Nursing Assistants in Small- to Medium-Sized Hospitals. Kudo Y1, Kido S2, Shahzad MT3,Yoshimura E, Shibuya A1,4, Aizawa Y5: Tohoku J Exp Med 2011/11; 225 (4): 293-300. (H“¡ˆÀŽj1, éŒËŽ —¢2, ƒVƒFƒU[ƒh’M’Ë‚Ü‚¿Žq3, a’J–Ÿ—²1,4, ‘ŠàVDŽ¡5: 1ˆã—ÃŒo‰c, 2ŠÅŒìŠw•”EŠî‘bŠÅŒìŠw, 3ŠÅŒìŠw•”E¶ŠU”­’BŠÅŒìŠw, 4ˆã—ÈÀ‘SEŠÇ—, 5‰q¶)


Á‰»Ší“à‰ÈŠw

[Šwp˜_•¶]

110070. [ŒŽ’˜] Mid-term prognosis after endoscopic resection for submucosal colorectal carcinoma: summary of a multicenter questionnaire survey conducted by the colorectal endoscopic resection standardization implementation working group in Japanese Society for Cancer of the Colon and Rectum. Oka S, Tanaka S, Kanao H, Ishikawa H, Watanabe T, Igarashi M1, Saito Y, Ikematsu H, Kobayashi K2, Inoue Y, Yahagi N, Tsuda S, Simizu S, Iishi H, Yamano H, Kudo SE, Tsuruta O, Tamura S, Saito Y, Cho E, Fujii T, Sano Y, Nakamura H, Sugihara K, Muto T (Colorectal Endoscopic Resection Standardization Implementation Working Group in Japanese Society for Cancer of the Colon and Rectum): Dig Endosc 2011/4; 23 (2): 190-4. (ŒÜ\—’³L1,2, ¬—ѐŽ“T2: 1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

110071. [ŒŽ’˜] Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib. Morimoto M, Numata K, Kondo M, Hidaka H1, Takada J1, Shibuya A1,2, Kobayashi S, Ohkawa S, Okuse C, Morita S, Taguri M, Tanaka K: Hepatol Res 2011/4; 41 (4): 296-302. (“ú‚@‰›1, ‚“cŽ÷ˆê1, a’J–Ÿ—²1,2: 1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—)

110072. [ŒŽ’˜] Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer. Pohl A, Azuma M1, Zhang W, Yang D, Ning Y, Winder T, Danenberg K, Lenz HJ: Pharmacogenomics J 2011/4; 11: 93-9. (“Œ@’q1: 1Á‰»Ší“à)

110073. [ŒŽ’˜] Comparison of diagnostic accuracy of endscopic ultrasound-guided fine-needle aspiration with 22- and 25-gauge needles in the same patients. Kida M1, Araki M1, Miyazawa S1, Ikeda H1, Takezawa M1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: J Interv Gastroenterol 2011/7; 1 (3): 102-7. (–Ø“cŒõL1, r–ؐ³—Y1, ‹{àVŽu˜N1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110074. [ŒŽ’˜] An open-label, single-arm study assessing the efficacy and safety of L: -menthol sprayed onto the gastric mucosa during upper gastrointestinal endoscopy. Hiki N, Kaminishi M, Tanabe S1, Fujisaki J, Yoshino J, Iguchi M, Kobayashi H, Ashida K, Kawabe T, Kawano T, Nomura S, Yahagi N, Tajiri H, Suzuki H: J Gastroenterol 2011/7; 46 (7): 873-82. (“c糁@‘1: 1Á‰»Ší“à)

110075. [ŒŽ’˜] Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels. Nakazawa T1,2, Shibuya A1,3, Takeuchi A1, Shibata Y1, Hidaka H1, Okuwaki Y1, Takada J1, Tanaka Y1, Watanabe M1, Minamino T1, Sakurai K, Koizumi W1: J Viral Hepat 2011/7; 18: (7): e191-9. (’†àV‹MG1,2, a’J–Ÿ—²1,3, ’|“à“ÖŽq1, ŽÄ“c—zŽq1, “ú‚@‰›1, ‰œ˜e—T‰î1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, “n粐^²1, “ì–ì@•×1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2’†‘ò“à‰È, 3ˆã—ÈÀ‘SEŠÇ—)

110076. [ŒŽ’˜] A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial). Hamaguchi T, Shirao K, Ohtsu A, Hyodo I, Arai Y, Takiuchi H, Fujii H, Yoshida M, Saito H, Denda T, Koizumi W1, Iwase H, Boku N (Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group): Gastric Cancer 2011/8; 14: (3): 226-33. (¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110077. [ŒŽ’˜] Fine needle aspiration using forward-viewing endoscopic ultrasonography. Kida M1, Araki M1, Miyazawa S1, Ikeda H1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: Endoscopy 2011/9; 43 (9): 796-801. (–Ø“cŒõL1, r–ؐ³—Y1, ‹{àVŽu˜N1, ’r“cOŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110078. [ŒŽ’˜] Biweekly gemcitabine with S-1 combination chemotherapy in locally advanced or metastatic pancreatic cancer. Kikuchi H1, Kida M1, Iwai T1, Miyazawa S1, Takezawa M1, Imaizumi H1, Koizumi W1: Kitasato Med J 2011/9; 41 (2): 154-9. (‹e’nG•F1, –Ø“cŒõL1, Šâˆä’m‹v1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110079. [ŒŽ’˜] Studies of endoscopic ultrasound-guided drainage for pancreatic pseudocysts and abscesses: a university hospital-based experience. Kida M1, Miyazawa S1, Iwai T1, Ikeda H1, Takezawa M1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: Kitasato Med J 2011/9; 41 (2): 170-7. (–Ø“cŒõL1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110080. [ŒŽ’˜] Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms. Satoh T, Ura T, Yamada Y, Yamazaki K, Tsujinaka T, Munakata M, Nishina T, Okamura S, Esaki T, Sasaki Y, Koizumi W1, Kakeji Y, Ishizuka N, Hyodo I, Sakata Y: Cancer Sci 2011/10; 102 (10): 1868-73. (¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110081. [ŒŽ’˜] Endoscopic management of malignant biliary obstruction by means of covered metallic stents:primary stent placement vs.re-intervention. Kida M1, Miyazawa S1, Iwai T1, Ikeda H1, Takezawa M1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: Endoscopy 2011/10; 43 (12): 1039-44. (–Ø“cŒõL1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110082. [ŒŽ’˜] Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-TEST): covered wallstent versus doublelayer stent. Isayama H, Yasuda I, Ryozawa S, Maguchi H, Igarashi Y, Matsuyama Y, Katanuma A, Hasebe O, Irisawa A, Itoi T, Mukai H, Arisaka Y, Okushima K, Uno K, Kida M1, Tamada K: Dig Endosc 2011/10; 23 (4): 310-5. (–Ø“cŒõL1: 1Á‰»Ší“à)

110083. [ŒŽ’˜] Role for p16 (INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16 (INK4a) network members. Mitomi H, Fukui N, Kishimoto I, Tanabe S1, Kikuchi S, Saito T, Hayashi T, Yao T: Hum Pathol 2011/10; 42 (10): 1505-13. (“c糁@‘1: 1Á‰»Ší“à)

110084. [ŒŽ’˜] Gender-related survival differences associated with polymorphic variants of estrogen receptor-beta (ERbeta) in patients with metastatic colon cancer. Press OA, Zhang W, Gordon MA, Yang D, Haiman CA, Azuma M1, Iqbal S, Lenz HJ: Pharmacogenomics J 2011/10; 11 (5): 375-82. (“Œ@’q1: 1Á‰»Ší“à)

110085. [ŒŽ’˜] Clinical and histopathological characteristics of patients with duodenal papillary tumors treated at Kitasato University East Hospital. Ikeda H1, Kida M1, Miyazawa S1, Iwai T1, Takezawa M1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: J Interv Gastroenterol 2011/10; 1 (4): 149-52. (’r“cOŽq1, –Ø“cŒõL1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110086. [ŒŽ’˜] Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial. Hidaka H1, Nakazawa T1, Shibuya A1,2, Minamino T1, Takada J1, Tanaka Y1, Okuwaki Y1, Watanabe M1, Koizumi W1: J Gastroenterol 2011/11; 46 (11): 1316-23. (“ú‚@‰›1, ’†àV‹MG1, a’J–Ÿ—²1,2, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n粐^²1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—)

110087. [ŒŽ’˜] Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancer. Matsubara J, Shimada Y, Kato K, Nagai Y, Iwasa S, Nakajima TE, Hamaguchi T, Yamada Y, Takagi S, Kobayashi K, Yoshioka A, Nakayama N1,2, Tsuji A: Oncology 2011/11; 81 (5-6): 291-7. (’†ŽRž“T1,2: 1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à)

110088. [ŒŽ’˜] Two-point fixed endoscopic submucosal dissection in rectal tumor (with video). Motohashi O1,2: Gastrointest Endosc 2011/11; 74 (5): 1132-6. (–{‹Ž@C1,2: 1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à)

110089. [ŒŽ’˜] Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older. Abe N, Gotoda T, Hirasawa T, Hoteya S, Ishido K1, Ida Y, Imaeda H, Ishii E, Kokawa A, Kusano C, Maehata T, Ono S, Takeuchi H, Sugiyama M, Takahashi S: Gastric Cancer 2012/1; 15 (1): 70-5. (ÎŒËŒªŽŸ1: 1Á‰»Ší“à)

110090. [ŒŽ’˜] A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601). Koizumi W1, Nakayama N1,2, Tanabe S1, Sasaki T1, Higuchi K1, Nishimura K1,2, Takagi S2, Azuma M1, Ae T1, Ishido K1, Nakatani K1, Naruke A1, Katada C1: Cancer Chemother Pharmacol 2012/2; 69 (2): 407-13. (¬ò˜aŽO˜Y1, ’†ŽRž“T1,2, “c糁@‘1, ²X–Ø“O1, ”óŒûŸ•F1, Œ‘º@Œ«1,2, ‚–ؐžˆê2, “Œ@’q1, ˆ¢]‘Ÿ‰ÀŽq1, ÎŒËŒªŽŸ1, ’†’JŒ€“l1, ¬–с@“N1, Œ˜“ce—˜1: 1Á‰»Ší“à, 2_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[)

110091. [ŒŽ’˜] Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial. Hidaka H1, Nakazawa T1, Wang G2, Kokubu S1,3, Minamino T1, Takada J1, Tanaka Y1, Okuwaki Y1, Watanabe M1, Tanabe S1, Shibuya A1,4, Koizumi W1: J Gastroenterol 2012/2; 47 (2): 118-26. (“ú‚@‰›1, ’†àV‹MG1, ‰€@‘‹Õ2, š •ª–ΔŽ1,3, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n粐^²1, “c糁@‘1, a’J–Ÿ—²1,4, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2—Տ°Œ€‹†EŠé‰æ, 3‡‘å—û”n•a‰@, 4ˆã—ÈÀ‘SEŠÇ—)

110092. [ŒŽ’˜] Thromboxane A(2) receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment. Minamino T1, Ito Y2, Ohkubo H2, Hosono K3, Suzuki T3, Sato T1, Ae T1, Shibuya A1,4, Sakagami H5, Narumiya S, Koizumi W1, Majima M3: Toxicol Appl Pharmacol 2012/2; 259 (1): 104-14. (“ì–ì@•×1, ˆÉ“¡‹`–ç2, ‘å‹v•Û”Ž¢2, ×–ì‰Á“ÞŽq3, —é–Ø—§‹I3, ²“Œäm1, ˆ¢]‘Ÿ‰ÀŽq1, a’J–Ÿ—²1,4, ãã—ms5, ¬ò˜aŽO˜Y1, ”n“ˆ³—²3: 1Á‰»Ší“à, 2ŠO‰È, 3–ò—, 4ˆã—ÈÀ‘SEŠÇ—, 5‰ð–U)

110093. [ŒŽ’˜] Different effects of two types of H2-receptor antagonists, famotidine and roxatidine, on the mucus barrier of rat gastric mucosa. Shikama N1, Ichikawa T2, Iwai T1, Yamamoto H1, Kida M1, Koizumi W1, Ishihara K2: Biomed Res 2012; 33 (1): 45-51. (Ž­ŠÔL–Ÿ1, Žsì‘ž•¶2, Šâˆä’m‹v1, ŽR–{@‘n1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1, ÎŒŽ˜a•F2: 1Á‰»Ší“à, 2ˆã—Éq¶Šw•”)

120008. [ŒŽ’˜] ˆÝᑊ³ŽÒ‚Ì”ŒŒÅŒ`‰»‰h—{‚É‚š‚¯‚é˜ZŒNŽq“’‚ðŠÜ‚ވ݉^“®‰ü‘PÜ‚̈ݔro”\‚̉ü‘P‚ɑ΂·‚é—L—p«‚ÌŒŸ“¢. Œ–ìŒ\ˆê˜Y1, ‘ºã‹§l1,2, ‘ºãdl1, ‚‰ª—mŽq1, Šâ­Šì‹vŒb1, X@Œö‰î1, ‘ºã–}•œ1 (1‘ºã‹L”O•a‰@, 2Á‰»Ší“à): Ý‘îˆã—Ã‚Æ“àŽ‹‹ŸŽ¡—à 2011/9; 15 (1): 12-8.

120009. [ŒŽ’˜] ‘Šú‘å’°Šà‚̐[’B“xf’f‚É‚š‚¯‚éNBI•¹—pŠg‘å“àŽ‹‹ŸŠÏŽ@‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, ŽOã“N•v2, ŽOŽ}@M2 (1Á‰»Ší“à, 2•a—): “ú–{‘å’°ŒŸžŠw‰ïŽGŽ 2012/1; 28 (2): 93-7.

210002. [€ŒŽ’˜] EUS 2010 in Shanghai - Highlights and Scientific Abstracts. Leong Ang T, De Angelis CG, Alvarez-Sanchez M, Chak A, Chang KJ, Chen R, Eloubeidi M, Herth FJ, Hirooka K, Irisawa A, Jin Z, Kida M1, Kitano M, Levy MJ, Maguchi H, Napoleon BV, Penman I, Seewald S, Wang G, Wallace M, Yamao K, Yasuda I, Yasuda K, Yasufuku K: Endoscopy 2011/11; 43 (Suppl 3): S1-20. (–؁EcŒõL1: 1EÁ‰»Ší“à)

210003. [€ŒŽ’˜] Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Watanabe T1, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M2,3, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K (Japanese Society for Cancer of the Colon and Rectum): Int J Clin Oncol 2012/2; 17 (1): 1-29. (ŒÜ\—’³L2,3: 1’é‹ž‘å, 2ŠàŒ€—L–Ÿ, 3Á‰»Ší“à)

220003. [€ŒŽ’˜] (—Տ°ŒoŒ±) Œo”ç“àŽ‹‹Ÿ“IˆÝᑑ¢Ýp (PEG) ‚š‚æ‚уJƒe[ƒeƒ‹ŒðŠ·Žž‚É”­Œ©‚³‚ê‚œã•”Á‰»ŠÇˆ««Žîᇂ̌Ÿ“¢. ‘ºã‹§l1,2, Œ–ìŒ\ˆê˜Y, ‚‰ª—mŽq, Šâ­Šì‹vŒb, ‘ºãdl, X@Œö‰î, ‘ºã–}•œ (1‘ºã‹L”O•a‰@, 2Á‰»Ší“à): Ý‘îˆã—Ã‚Æ“àŽ‹‹ŸŽ¡—à 2011/9; 15 (1): 82-8.

310003. [Ç—á•ñ] Undifferentiated hepatocellular carcinoma difficult to distinguish from liver abscess. Shimizu Y1, Kaneko F, Motoori T, Yokomori H: Intern Med 2011/; 50 (5): 519-20. (Ž…—T‹M1: 1Á‰»Ší“à)

310004. [Ç—á•ñ] Late-onset benefit in progressive advanced hepatocellular carcinoma with continued sorafenib therapy: a case report. Okuwaki Y1, Nakazawa T1, Hidaka H1, Shibuya A1,2, Koizumi W1: J Med Case Reports 2012/1; 6: 38. (‰œ˜e—T‰î1, ’†àV‹MG1, “ú‚@‰›1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—)

320001. [Ç—á•ñ]yŠÌŽŸŠ³‚É‚š‚¯‚éÅV‚Ì’Ž‰¹”gf’fzˆê”ʉ‰‘è2 ’_“¹EÁ‰»ŠÇE–¬ŠÇ@‘¢‰e’Ž‰¹”g‚ª—L—p‚Å‚ ‚Á‚œ’_ùN•a•Ï‚Ì“ñ—á. ’|“c@“w1, ‘å‹v•Û—T’Œ, š •ª–ΔŽ1,2, ˆÉ“¡’qN, ŽRŒ`Žõ•¶, ’†‘º—L, ‹{èµ‹v (1‡‘å—û”n•a‰@, 2Á‰»Ší“à): Rad Fan 2011/5; 9 (6): 42-3.

320002. [Ç—á•ñ] RFAŒã‹ÇŠÄ”­‚ɑ΂µAngio-CTƒKƒCƒh‰ºrepeat RFA‚ª—LŒø‚Å‚ ‚Á‚œ1—á. “c’†Œ«–Ÿ1, ’†àV‹MG1, ‹àŽq@‹œ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “ú‚@‰›1, “n粐^²1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1, Œ‰iŒh“ñ3, ¬Š}ŒŽ‹3 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3•úŽËü(‰æ‘œ)): ˆãŠw‚Æ–òŠw 2011/8; 66 (2): 194-8.

320003. [Ç—á•ñ] ’_ùNŠÇŠà‚Ì1—á. ‘åX’qŽq1, ‘ëì­˜a, ¬Š}ŒŽ‹, –x“cˆ»Žq, âV“¡¶˜N, ›–ì@‘1,2, ‹à“cŒå˜Y, ²X–ؐ^‹| (1‘—§‘Š–ÍŒŽ, 2Á‰»Ší“à): —Տ°•úŽËü 2011/9; 56 (9): 1138-42.

320004. [Ç—á•ñ] ‘ŠúˆÝŠàŒ€‹†‰ïÇ—á ‰º’°ŠÔ–ŒÃ–¬‚̕ǂ𔺂Á‚œ’°ŠÔ–ŒŽ‰–bD‰Š‚Ì1Øœ—á. Œ}@”üK1, ¬—ѐŽ“T1, Ÿ–””º‰h1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, “¡ˆä@Š]2, Œ‰iŒh“ñ2, ŽOã“N•v3, ‹ã“ˆ—ºŽ¡3 (1Á‰»Ší“à, 2•úŽËü (‰æ‘œ), 3•a—): ˆÝ‚Æ’° 2011/10; 46 (11): 1701-7.

320005. [Ç—á•ñ] ’˜–Ÿ‚Ȕ얞‚ɍ‡•¹‚µ‚œŒ€Ç1Œ^“œ”A•a‚̈ê—á. ˆÉ“¡@r1, ‰¡“c²˜a, ‰¬ŒŽr, “à“¡ƒs, ¬–ì‰Ã•¶, ‚²Œ°”V, ‘å’ˏr˜a1,2, ’†ìˆê (1’ËvˆäÔ\Žš, 2Á‰»Ší“à): “œ”A•a 2011/11; 54 (11): 860-4.

320006. [Ç—á•ñ] “àŽ‹‹Ÿ“I‚ɏœ‹Ž‚µ“Ÿ‚œ‘åŒ^ˆÝÎ‚Ì1—á. ‚‹ŽW•F1, “c糁@‘1, ÎŒËŒªŽŸ1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, ’†’JŒ€“l1, “Œ@’q1, ¬–с@“N1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Progress of Digestive Endoscopy 2011/12; 79 (2): 62-3.

320007. [Ç—á•ñ] Neoadjuvant chemotherapy‚ª—LŒø‚Å‚ ‚Á‚œ’Œ’°GIST‚Ì1—á. Œ”öN³1, ç–쏻Žq, –x“à—T‰î, ‹gàV“Þ’ÃŽq1,2, ¡ˆä, —Ñ—TŽq, ŠÝŒŽ‹Pm, •œàVr–Ÿ, ŽR–{—Š³, “y“c’mG, “¡è‡Žq, ¯–윚’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2011/12; 79 (2): 94-6.

320008. [Ç—á•ñ] ”rÎ‘O‚̏󋵂ª“àŽ‹‹Ÿ“I‚ÉŠm”F‚³‚ê‚œ’_ÎƒCƒŒƒEƒX‚Ì1—á. ’r“c@”™1,2, ‹e’n³b1,2, “n•ÓWŽ¯1,2, ‰ÍŒèû‘Ÿ˜Y1, •ìŒ«ˆê˜Y1, ‹e’nG•F1,2, —¢“¹“N•F1,2, ŽRèDŠì1,2, –ì“o@œ1,2 (1•œ’Ë‹€Ï, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2011/12; 79 (2): 108-9,10.

320009. [Ç—á•ñ] ’_ŠÇ‘¹—\–h‚É’_ŠÇ’…Ÿó—¬‚ðs‚Á‚œŠJ• ‰ºƒ‰ƒWƒI”gŽ¡—×á. ‰œ˜e—T‰î1, ’†àV‹MG1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, “ú‚@‰›1, “n粐^²1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1, “c“‡@O3, •Ð‹ËŠ°”V3 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3ŠO‰È): ˆãŠw‚Æ–òŠw 2012/1; 67 (1): 70-3.

510005. [‘à] Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status. Higuchi K1, Tanabe S1, Azuma M1, Sasaki T1, Ishido K1, Koizumi W1: Pathobiology 2011/; 78 (6): 334-42. (”óŒûŸ•F1, “c糁@‘1, “Œ@’q1, ²X–Ø“O1, ÎŒËŒªŽŸ1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à)

520006. [‘à]y‘“à‘æI/II‘Š—Տ°ŽŽŒ± (JO19380)zXELOX + BEV•¹—p—Ö@‚̐¬Ñ‚Æ’·ŠúŽ¡—×á‚ÌŒŸ“¢. ²“¡@‰·1, “yˆär•F, –p@¬˜a, ‰Á“¡@Œ’, ¬Œ‰Ãl, ŽRŒûŒ€¬, Žº@@Œ\, •l–{N•v, ¬ò˜aŽO˜Y2, …ÀM”V, ‘ë“à”ä˜C–ç (1º˜a‘åŠwˆãŠw•”•‘®–LF•a‰@, 2Á‰»Ší“à): Šà‚Ɖ»Šw—Ö@ 2011/4; 38 (4): 561-9.

520007. [‘à]ys‚±‚€‚·‚ê‚΂ł«‚ét‰æ‘œ‹­’²“àŽ‹‹Ÿ‚É‚æ‚éŽîᇐf’fz‰ºˆô“ª: Šà‚̏E‚¢ã‚°f’f|‰ºˆô“ªŠÏŽ@‚ÌŠî–{‚ƃRƒc. Œ˜“ce—˜1, “c糁@‘1, ³˜Ò@—²2, ’†ŽR–Ÿm2, Œ—tG‹N2, ÎŒËŒªŽŸ1, “Œ@’q1, ’†’JŒ€“l1, ²X–Ø“O1, ”óŒûŸ•F1, ‰ª–{–ql2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2Žš•@): Á‰»Ší“àŽ‹‹Ÿ 2011/4; 23 (4): 651-8.

520008. [‘à]ys‚±‚€‚·‚ê‚΂ł«‚ét‰æ‘œ‹­’²“àŽ‹‹Ÿ‚É‚æ‚éŽîᇐf’fz\“ñŽw’°E¬’°: Žîᇂ̏E‚¢ã‚°f’f|NBI‚É‚æ‚éŽîᇂ̐f’f. ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2011/4; 23 (4): 766-72.

520009. [‘à]yŽå‘è: ’°ŠÇBehet•a‚Æ’Pƒ«’×ᇁ|f’f‚ÆŽ¡—Â̐i•àz’°ŠÇBehet•aE’Pƒ«’×ᇂƑŒ‚̉ŠÇ«’°ŽŸŠ³‚Ƃ̊ӕʐf’f|—Տ°‚Ì—§ê‚©‚ç. ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ˆÝ‚Æ’° 2011/6; 46 (7): 1023-31.

520010. [‘à]y’×ᇐ«‘å’°‰Š|’·ŠúŒo‰ßŠÏŽ@—á‚̏”–â‘èz2. ‘S‘å’°‰ŠŒ^E¶‘€‘å’°‰ŠŒ^‚Ì’·ŠúŒo‰ßŠÏŽ@—á‚̐„ˆÚ. ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬—ѐŽ“T1, Ÿ–””º‰h1 (1Á‰»Ší“à): —Տ°Á‰»Ší“à‰È 2011/6; 26 (8): 1085-91.

520011. [‘à]y×ŒaƒXƒR[ƒv‚ðŽg‚¢‚±‚È‚·-2011z×ŒaƒXƒR[ƒv‚̈Ӌ`‚ƍ¡Œã‚Ì“W–]F‰º•”Á‰»ŠÇ@[‰º•”Á‰»ŠÇ:f’f]@‘}“ü‚ÆŠÏŽ@‚É‚š‚¯‚é×Œa“àŽ‹‹Ÿ‚Ì—˜“_EŒ‡“_. ¬—ѐŽ“T1, ‰Á“¡@Ê1, Œ}@”üK1, ¬ì‘åŽu1, t–Ø‘”ü1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2011/6; 23 (6): 1103-8.

520012. [‘à] ’†‰ºˆô“ª‚̃‹[ƒ`ƒ“ŠÏŽ@–@. Œ˜“ce—˜1, “c糁@‘1, ³˜Ò@—²2, ’†ŽR–Ÿm2, ‰ª–{–ql2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2Žš•@): Gastroenterological Endoscopy 2011/8; 53 (8): 2038-48.

520013. [‘à]yEUS-FNA Nowz‘å’°•a•Ï‚ɑ΂·‚éEUS-FNA‚ÌŽÀÛ. Œ}@”üK1, ¬—ѐŽ“T1, –؁EcŒõL1, ¬EEåŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, ŒŽ@“ÖŽq2 (1Á‰»Ší“à, 2•a—): Á‰»Ší“àŽ‹‹Ÿ 2011/8; 23 (8): 1358-63.

520014. [‘à] Š`ˆÝÎ‚̍ӐΏp‚ɂ‚¢‚Ä. ”nêGŽq1, ŽO‰Y”ü•Û1, ŒÃàV–ŸŽq1, ì‘º–ƒ‹MŽq1, ‚ŽR’q‘ã1, “cŒŽŒb—Žq1, Œ”nê‹P˜a1, “c糁@‘1,2, –Ø“cŒõL1,2, ¬ò˜aŽO˜Y1,2 (1“Œ•a‰@“àŽ‹‹Ÿ‰È, 2Á‰»Ší“à): ŠÖ“ŒÁ‰»Ší“àŽ‹‹Ÿ‹ZŽt‰ïŽ 2011/9; 18: 21-3.

520015. [‘à]y‘å’°“àŽ‹‹Ÿ‚ðƒ}ƒXƒ^[‚·‚éz[Ž¡—Ã]@‘å’°oŒŒ«•a•Ï‚Ö‚Ì‹Ù‹}‘Ήž‚ðƒ}ƒXƒ^[‚·‚é. ²“c”ü˜a1, Ÿ–””º‰h1, Œ}@”üK1, ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2011/9; 23 (9): 1614-9.

520016. [‘à]y‘å’°“àŽ‹‹Ÿ‚ðƒ}ƒXƒ^[‚·‚éz[“W–]] V‚µ‚¢ƒRƒƒ“ƒ‚ƒfƒ‹‚ð—p‚¢‚œ‘å’°“àŽ‹‹ŸƒgƒŒ[ƒjƒ“ƒOƒVƒXƒeƒ€‚Ì’ñŒŸ. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à‰È): Á‰»Ší“àŽ‹‹Ÿ 2011/9; 23 (9): 1648-52.

520017. [‘à] Chapter.1 PEG@Step 1 ƒeƒLƒXƒg@3.ˆÝᑑ¢Ý@3-1. ‘¢ÝŽè‹Z@EPullEpush–@. ‘ºã‹§l1,2 (1‘ºã‹L”O•a‰@, 2Á‰»Ší“à): PDN (PEGƒhƒNƒ^[ƒYƒlƒbƒgƒ[ƒN) PDNƒŒƒNƒ`ƒƒ[ 2011/9; http://www.peg.or.jp/lecture/peg/03-01-02.html.

520018. [‘à]yŽå‘è: \“ñŽw’°‚ÌŽîᇐ«•a•Ïz\“ñŽw’°‚É‚š‚¯‚é”ñ“û“ª•”Žîᇂɑ΂·‚éEMR, ESD‚ÌŒ»ó‚Æ–â‘è“_. ¬–ì—T”V1, –ì’†@“N, ã“°•¶–ç, ŠL£@–ž, ¬ŽRP’j, “yŽRŽõŽu, •²ì“ÖŽj, ‹àŽq˜aO, ¬“c“‡T–ç, “c糁@‘2, –L‰i‚Žj, •œàVr–Ÿ, “¹“c’mŽ÷ (1Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ˆÝ‚Æ’° 2011/10; 46 (11): 1669-77.

520019. [‘à]y“à‰È ŽŸŠ³ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒKƒCƒh@‰œ‚ð‚Ç‚€à–Ÿ‚·‚é‚©zÁ‰»ŠíŽŸŠ³ ‹•ŒŒ«‘å’°‰Š. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1 (1Á‰»Ší“à): Medicina 2011/11; 48 (11‘Š§): 234-6.

520020. [‘à]y–å–¬ˆ³˜ŽiÇ‚ÌŽ¡—Ãupdatez–å–¬ˆ³˜ŽiÇ‚ɑ΂·‚é–ò•š—Ö@@Ã–¬áŽoŒŒ—\–h‚É‚š‚¯‚é–ò•š—Ö@. “ú‚@‰› (Á‰»Ší“à): —Տ°Á‰»Ší“à‰È 2012/1; 27 (2): 225-31.

520021. [‘à]y‚¢‚‚à‚ÌŽ¡—Ã‚ðŒ©’Œ‚·! ‚©‚ºf—Ãp[ƒtƒFƒNƒg@Ž©M‚ð‚à‚Á‚Đf’fEˆ•û, d‘原Š³‚ðŒ©“Š‚³‚È‚¢, ¡“ú‚©‚çŽg‚Š‚é‚©‚º‚̋ɈÓ!!z‘æ5Í Šeê–å‰È‚©‚ç‚Ý‚œ‚©‚ºf—Á@3. Á‰»Ší“à‰È‚©‚ç‚Ý‚œ, ‚©‚º. ŽR“à_Žj1, ²X–Ø“O1 (1Á‰»Ší“à): ƒŒƒWƒfƒ“ƒgƒm[ƒg 2012/1; 13 (14): 2670-6.

520022. [‘à]yESD up-to-datez[Še˜_] V‚µ‚¢ˆ’u‹ï@VŒ^¬Œ^ITƒiƒCƒt‚Ì“Á’¥‚ÆŽ¡—ÃŽè‹Z‚ÌŽÀÛ. ŽRŒû—Tˆê˜Y1, Ö“¡@–L, –x“c‹Óˆê, ‘剪³•œ1,2, ¡ˆäŒ’ˆê˜Y, ‘é”ör’B, ¬–ì—T”V (1Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2012/1; 24 (1): 48-52.

520023. [‘à]y“àŽ‹‹Ÿ‚ª•Ï‚Š‚œ, Crohn•af—Áz[Še˜_] ŠÓ•Êf’f: ’°ŠÇƒx[ƒ`ƒFƒbƒg•a/’Pƒ«’×á‡. ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2012/2; 24 (2): 205-11.

521010. [‰ðà]y˜AÚ: ESD‚ÌŽÀÛzˆÝESD|Ž„‚̍H•v@p’†Ž~ŒŒ¢“ï—á‚ւ̑΍ô. ŽR–{—Š³1, “¡è‡Žq, –x“à—S‰î, Œ”öN³, ‹gàV“Þ’ÃŽq1,2, ›ÀF‹I, ‘å‘O³ŽÀ, ‰ª“c˜a‹v, ŒE“c@Šw, •œàVr–Ÿ, ÎŽRW¢Žu, “y“c’mG, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): Á‰»Ší‚̗Տ° 2011/8; 14 (4): 419-24.

521011. [‰ðà]y“à‰È ŽŸŠ³ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒKƒCƒh@‰œ‚ð‚Ç‚€à–Ÿ‚·‚é‚©zÁ‰»ŠíŽŸŠ³@‘å’°ƒ|ƒŠ[ƒv. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): Medicina 2011/11; 48 (11): 244-6.

521012. [‰ðà]yŽå‘è: BarrettH“¹Šà‚̐f’fzBarrettH“¹Šà‚Ì“àŽ‹‹Ÿf’f|Šg‘å“àŽ‹‹Ÿ‚𕹗p‚µ‚œ[’B“xf’f|. “¡è‡Žq1, ‘å‘O‰ëŽÀ, ‰ª“c˜a‹v, ŽR–{’q—Žq, –x“à—T‰î, ‹g‘ò“Þ’ÃŽq1,2, —é–؁@ãÄ, ’J“à’q, Œ”öN³, •œàVr–Ÿ, ›ÀF‹I, ŽR–{—Š³, “y“c’mG, ÎŽRW¢Žu, ¯–윚’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ˆÝ‚Æ’° 2011/11; 46 (12): 1843-51.

521013. [‰ðà]yŠCŠO˜_•¶‰ðà|World Wide Topics|‘æ32‰ñz‚ª‚ñŠ³ŽÒ‚©‚ç‚̃}ƒCƒNƒƒ`ƒbƒv‹Zp‚ð—p‚¢‚œzŠÂŽîᇍזE•ª—£–@Duke's B‚à‚µ‚­‚ÍC‚Ì‘å’°ŠàŠ³ŽÒ‚É‚š‚¯‚é, ––œŒŒ’†‚ÌŠàŠ²×–E—l×–E‚ðŠÜ‚ޏzŠÂŽîᇍזE‚̍Ĕ­‚â—\Œã‚ɑ΂·‚é—Տ°“IˆÓ‹`. “Œ@’q1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): •ªŽqÁ‰»Ší•a 2011/12; 8 (4): 375-7.

521014. [‰ðà]yŽå‘è: ‰ü’ù‚³‚ê‚œˆÝ¶ŒŸGroup•ª—Þ‚ÌŒ»ózV‹Œ•ª—Þ‚Å‚ÌGroup 2•a•Ï‚Ì“àŽ‹‹ŸÄŒŸ, ’ǐՌ‹‰Ê‚ÌŒŸ“¢. “¡è‡Žq1, ‹gàV“Þ’ÃŽq1,2, ŽR–{’q—Žq, ‰Á“¡@—m, —é–؁@ãÄ, ŒE“c@Šw, ’JŒû’q, ‘å‘O‰ëŽÀ, ‰ª“c˜a‹v, Œ”öN³, –x“à—T‰î, ›ÀF‹I, ŽR–{—Š³, •œàVr–Ÿ, ÎŽRW¢Žu, “y“c’mG, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à‰È): ˆÝ‚Æ’° 2012/2; 47 (2): 174-85.

522021. [uÀ]y“ÁW: ‚ª‚ñ‡•¹Ç‚ÌŠÇ—z’°•ÂÇ‚ÆŠà«• –Œ‰Š‚ÌŽ¡—Ã. ÎŒËŒªŽŸ1, ¬Eò˜aŽO˜Y1, “c糁@‘1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬–с@“N1 (1Á‰»Ší“à): Šà‚Ɖ»Šw—Ö@ 2011/4; 38 (4): 509-14.

522022. [uÀ]y“ÁW: ’×ᇐ«‘å’°‰Š‚ÌTherapeutic Strategy|Standard‚ÈŽ¡—Ö@‚©‚çÅVî•ñ‚܂Łz2-8. [Še˜_] V‹KŽ¡—Ö@ (clinical trial) ‚ÌŒ»ó. ‰¡ŽR@ŒO (Á‰»Ší“à): Intestine 2011/5; 15 (3): 262-6.

522023. [uÀ]yForum: ˆÝŠàBoard MeetingzisˆÝŠà‚ɑ΂·‚éŠO—ˆ‰»Šw—Ö@ƒŒƒWƒƒ“|ƒhƒZƒ^ƒLƒZƒ‹‚Ì–ðŠ„‚É‚Â‚¢‚čl‚Š‚é|. ‘å’Á@“Ö1, Š|’n‹gO, ¬ò˜aŽO˜Y2, ¬Ž›‘׍O, ¬Œ‰Ãl, ùŽqŽO’ׯ, ‘ë“à”ä˜C–ç, ’|“à³O, “¡ˆä‰ëŽu, “¡’J˜a³, ‹g“c˜aO (1‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[“Œ•a‰@, 2Á‰»Ší“à): ŠO—ˆŠà‰»Šw—Ö@ 2011/6; 2 (2): 134-41.

522024. [uÀ]y˜AÚ: ‰æ‘œ‚ðf‚é|ŠÓ•Êf’f‚̃|ƒCƒ“ƒgz’_ùN‘B‹ØŽîÇ. ¡ò@O1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší‚̗Տ° 2011/6; 14 (3): 312-4.

522025. [uÀ]y“ÁW: Á‰»ŠÇŠŽõÇ‚ÌŒ»‹µ|Å‹ß‚Ì’mŒ©, f’f‚̃|ƒCƒ“ƒgz2-1. f’f (1)@Á‰»ŠÇŠŽõÇ‚̐f’f. ŒÜ\—’³L1,2, ç–쏻Žq, ŠÝŒŽ‹Pm (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2011/6; 26 (7): 757-65.

522026. [uÀ]yH“¹Šà‚ÌŽ¡—Ð헪z7. isH“¹Šà‚ɑ΂·‚鉻Šw•úŽËü—Ö@‚ÌŒ»ó. ”óŒûŸ•F1, Œ˜“ce—˜1, ²X–Ø“O1, “Œ@’q1, ÎŒËŒªŽŸ1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): —Տ°Á‰»Ší“à‰È 2011/8; 26 (10): 1397-403.

522027. [uÀ]y“ÁW: BarrettH“¹, BarrettH“¹Šà; Å‹ß‚̘b‘èz5. BarrettH“¹Šà‚Ì“àŽ‹‹Ÿ“IŽ¡—Ã. ‘å‘O‰ëŽÀ1, “¡è‡Žq, ’JŒû’q, —é–؁@ãÄ, –x“à—T‰î, Œ”öN³, ‹gàV“Þ’ÃŽq1,2, ŒE“c@Šw, ›ÀF‹I, ÎŽRW¢Žu, •œàVr–Ÿ, ŽR–{—Š³, “y“c’mG, ¯–ìŒb’Õv, ŒÜ\—’³L1,2, ŽR–{’q—Žq (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): Á‰»ŠíŠO‰È 2011/8; 34 (9): 1341-8.

522028. [uÀ]y‚±‚ê‚Å‚í‚©‚Á‚œ! IBDŽ¡—Ẫ|ƒCƒ“ƒgzIBDŽ¡—ÃŽwj‚̓ljðuÀ (‘æ3‰ñ)@ƒyƒ“ƒ^ƒT (5-ASA) ‚ðŽg‚Á‚œIBDŽ¡—Ẫ|ƒCƒ“ƒg. ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): IBD Research 2011/9; 5 (3): 202-8.

522029. [uÀ]y“ÁW: “àŽ‹‹Ÿ‚Å‘˜‹ö‚·‚é‘å’°—²‹NŒ^‚š‚æ‚Ñ•\–ÊŒ^•a•Ï‚ðŒ©’Œ‚·z5-1. ”S–Œ‰ºŽîᇠ(SMT)@(1) ƒJƒ‹ƒ`ƒmƒCƒh. ¬—ѐŽ“T1, ²“c”ü˜a1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1 (1EÁ‰»Ší“à): —Տ°Á‰»Ší“à‰È 2011/10; 26 (12): 1639-45.

522030. [uÀ]yForum: Tokyo Gastric Cancer ConferencezisEÄ”­ˆÝŠà‚ɑ΂·‚鉻Šw—Ö@‚ÌŒ»ó‚Æ“W–]|“à‰Èˆã‚Ì—§ê‚©‚ç|. ¬ò˜aŽO˜Y1, ‘Š‰HŒb‰î2 (1Á‰»Ší“à, 2ŽœŒbˆã‘å): ŠO—ˆŠà‰»Šw—Ö@ 2011/10; 2 (3): 210-3.

522031. [uÀ]y“ÁW: “à‰Èˆã‚̘r‚ÌŒ©‚¹‚Ç‚±‚ë@‰º—ŸE•Ö”é‚̐f—ÁzI. ‰º—ŸE•Ö”é‚ւ̃Aƒvƒ[ƒ`@4. “–’Œ‚ÅŒ©“Š‚µ‚Ä‚Í‚¢‚¯‚È‚¢‰º—ŸE•Ö”é. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ŒŽŠ§ƒŒƒWƒfƒ“ƒg 2011/11; 4 (11): 30-6.

522032. [uÀ]yIBD‚̍ŋ߂̎¡—Áz8-4. ‚»‚Ì‘Œ‚ÌŽ¡—Ö@@(4) ƒNƒ[ƒ“•a‚É‚š‚¯‚é“àŽ‹‹Ÿ“IŽ¡—Á|“àŽ‹‹Ÿ“IŠg’£p. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ‰Á“¡@Ê1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1 (1Á‰»Ší“à): —Տ°Á‰»Ší“à‰È 2011/12; 27 (1): 93-7.

522033. [uÀ]y“ÁW: “àŽ‹‹Ÿ‚Å‘˜‹ö‚·‚é‘å’°—²‹NŒ^‚š‚æ‚Ñ•\–ÊŒ^•a•Ï‚ðŒ©’Œ‚·zŠª“ªŒŸ. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2011/12; 26 (12): 1577-8.

522034. [uÀ]y“ÁW: ˆÝŠàf—ẪgƒsƒbƒNƒXz9. ˆÝŠà‚É‚š‚¯‚镪Žq•W“IŽ¡—ÂƃoƒCƒIƒ}[ƒJ[‚Ì“WŠJ. “Œ@’q1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»ŠíŠO‰È 2012/2; 35 (2): 209-14.

522035. [uÀ]y“ÁW: ’_“¹EäX‚̃hƒŒƒi[ƒW‚ƃXƒeƒ“ƒgz11. EUS‰ºäX‰Œ«ùN–EE”^ᇃhƒŒƒi[ƒW. –Ø“c ŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä˜a‹v1, ’r“cOŽq1, ’|àV”ü‘ãŽq1, r–ؐ³—Y1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2012/3; 27 (4): 473-82.

522036. [uÀ]y“ÁW: ‘å’°SMŠà@Z‹——£1,000ƒÊm‚ÌŒ»ó‚Ɖۑèz4-3uZ‹——£1,000ƒÊmv‚Ì‚à‚œ‚炵‚œ—˜‰v (3)@—Տ°‘€ [2] |–â‘è“_‚àŠÜ‚ß‚Ä. ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): INTESTINE 2012/3; 16 (2): 130-5.

[’˜@‘]

620031. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNz‘æVÍ Á‰»Ší@äBŒ‹’°‹ÈÇŒóŒQ, p.259. ¬—ѐŽ“T (Á‰»Ší“à), ‘•ÒW: ˆä‘º—T•v, •ÒW: •ŸˆäŽŸ–î, ’ҁ@ÈŽŸ, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

620032. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNz‘æVÍ Á‰»Ší@ƒQƒC’°ÇŒóŒQ, p.299. ¬—ѐŽ“T (Á‰»Ší“à), ‘•ÒW: ˆä‘º—T•v, •ÒW: •ŸˆäŽŸ–î, ’ҁ@ÈŽŸ, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

620033. [Šwp‘] (•ªESŽ·•M)yEUS‰ºúŽhp@Interventional EUS‚ÌŠî‘b‚ÆŽÀ‘HƒeƒNƒjƒbƒNz‘æIIÍ Še˜_@4. f’f“IúŽhp@D. ã•”Á‰»ŠÇ”S–Œ‰ºŽîᇐ«•a•Ï‚ւ̃Aƒvƒ[ƒ`, p87-92. –Ø“cŒõL1, ¡ò@O1 (1Á‰»Ší“à), •ÒW: ŽR—YŒ’ŽŸ, “üàV“ÄŽu, “ì]“°, “Œ‹ž, 2011/5”­s.

620034. [Šwp‘](•ª’SŽ·•M)yEUS‰ºúŽhp@Interventional EUS‚ÌŠî‘b‚ÆŽÀ‘HƒeƒNƒjƒbƒNz‘æIIÍ Še˜_@4. f’f“IúŽhp@K. —L—p‚Å‚ ‚Á‚œÇ—áW|EUS-FNA‚ª—L—p‚Å‚ ‚Á‚œÇ—á|@2. ã•”Á‰»ŠÇ”S–Œ‰ºŽîá‡, p.130-3. –Ø“cŒõL1, ‹e’nG•F1 (1Á‰»Ší“à), •ÒW: ŽR—YŒ’ŽŸ, “üàV“ÄŽu, “ì]“°, “Œ‹ž, 2011/5”­s.

620035. [Šwp‘](•ª’SŽ·•M)yEUS‰ºúŽhp@Interventional EUS‚ÌŠî‘b‚ÆŽÀ‘HƒeƒNƒjƒbƒNz‘æIIÍ Še˜_@6. ƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOW@B. Á‰»ŠÇ”S–Œ‰ºŽîᇂɑ΂·‚éEUS-FNA, p.191-2. ‹{àVŽu˜N (Á‰»Ší“à), •ÒW: ŽR—YŒ’ŽŸ, “üàV“ÄŽu, “ì]“°, “Œ‹ž, 2011/5”­s.

620036. [Šwp‘] (•ª’SŽ·•M)yNBI“àŽ‹‹ŸƒAƒgƒ‰ƒXz‘æ2•” NBIƒAƒgƒ‰ƒX@IÍ ˆô“ª|H“¹ƒAƒgƒ‰ƒX@EŽŸŠ³•ÊŠe˜_qŽîᇐ«•a•Ïr@N. ˆô“ª‚Ì•\ÝŠà, p.88-91. Œ˜“ce—˜ (Á‰»Ší“à), •ÒW: •“¡@Šw, ”ª”öŒ’Žj, ²–ì@”J, “ì]“°, “Œ‹ž, 2011/5”­s.

620037. [Šwp‘] (•ª’SŽ·•M)yŠÌ‰ŠEŠÌŠà‚̐V‚µ‚¢f’f‚ÆŽ¡—Á|‘æ28‰ñŒ¢ŽRƒVƒ“ƒ|ƒWƒEƒ€z(Session 4) ŠÌŠà|isŠÌ×–EŠà‚ɑ΂·‚ésorafenib‚ÌŽg—pŽÀ‘Ԃƍ¡Œã‚̉ۑè: Kanagawa Liver Study Group‘œŽ{Ý‹€“¯Œ€‹†, p.197-204. “c’†Ž–Ÿ1, X–{@Šw, À“c˜aŽi, ‹ß“¡³W, “ú‚@‰›2, ‚“cŽ÷ˆê2, a’J–Ÿ—²2,3, ‹{ì@ŒO, ‘åìLˆê, ‰œ£çW, —é–Ø’Ê”Ž (1‰¡•lŽs—§‘åŠw•‘®Žs–¯‘‡ˆã—ÃZƒ“ƒ^[, 2Á‰»Ší“à, 3ˆã—ÈÀ‘SEŠÇ—), •ÒW: Œ¢ŽRƒVƒ“ƒ|ƒWƒEƒ€‹L˜^Š§s‰ï, ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“, “Œ‹ž, 2011/6”­s.

620038. [Šwp‘] (•ª’SŽ·•M)yJCNƒZƒŒƒNƒg5: Evidence-Based NutritionƒGƒrƒfƒ“ƒX‚É‚à‚Ƃ­‰h—{ƒPƒA (—Տ°‰h—{•Êû)zPart-2. ŽŸŠ³•ÊƒKƒCƒhƒ‰ƒCƒ“‚É‚š‚¯‚é‰h—{ŠÇ—‚̈ʒu‚¯‚Ɖh—{ƒPƒA‚ÌŽÀ‘H|‰ŠÇ«’°ŽŸŠ³, p.98-103. ¬—ѐŽ“T (Á‰»Ší“à), Ó”C•ÒW: ²X–؉ë–ç, ˆãŽ•–òo”Å, “Œ‹ž, 2011/7”­s.

620039. [Šwp‘] (•ª’SŽ·•M)yH“¹Šà|Šî‘bE—Տ°Œ€‹†‚̐i•à|(“ú–{—Õ଑Š§ 69 (6)zXI. H“¹Šà‚Ì‘œŽ{Ý‹€“¯ŽŽŒ±@1. ‰ä‚ª‘‚É‚š‚¯‚éH“¹Šà‚Ì‘œŽ{Ý‹€“¯ŽŽŒ±@2) H“¹•\ÝŠà‚ÉŠÖ‚·‚é‘œŽ{Ý‹€“¯Œ€‹†, p.458-63. ŽO—œŒjŽq1, Œ˜“ce—˜2, •“¡@Šw (1ç—tŒ§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à), “ú–{—Õ଎Ð, ‘åã, 2011/8”­s.

620040. [Šwp‘] (•ª’SŽ·•M)yŠà‰»Šw—Ö@‚Ɛ§“f–òŽg—pƒ}ƒjƒ…ƒAƒ‹@Á‰»ŠíŠà•Òz[H“¹ŠàEˆÝŠà] S-1 + CDDP—Ö@, p.14-5. ¬ò˜aŽO˜Y (Á‰»Ší“à), •ÒW: ‘Š‰HŒb‰î, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[, ‘åã, 2011/9”­s.

620041. [Šwp‘] (•ª’SŽ·•M)yƒNƒ[ƒ“•a‚̐f—ÃKƒCƒhz‘æ11Í ŽÐ‰ïŽx‰‡, p.112-7. ¬—ѐŽ“T (Á‰»Ší“à), •ÒW: NPO–@l“ú–{‰ŠÇ«’°ŽŸŠ³‹Š‰ï (CCFJ), •¶Œõ“°, “Œ‹ž, 2011/10”­s.

620042. [Šwp‘] (•ª’SŽ·•M)yÁ‰»ŠÇ“àŽ‹‹ŸƒGƒLƒXƒp[ƒg@3. ‘å’°Šàz4. ‘Šú‘å’°Šà‚Ì“àŽ‹‹Ÿ“IŽ¡—Ã: ƒ|ƒŠƒyƒNƒgƒ~[, EMR‚𒆐S‚É, p.30-7. ¬—ѐŽ“T (Á‰»Ší“à), •ÒW: ŒÜ\—’³L, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/10”­s.

620043. [Šwp‘] (•ª’SŽ·•M)y’×ᇐ«‘å’°‰Š‚̐f—ÃKƒCƒh ‘æ2”Łz‘æ3Í“àŽ‹‹Ÿ, p.23-6. ‰¡ŽR@ŒO1, Ÿ–””º‰h1 (1Á‰»Ší“à), •ÒW: NPO–@l“ú–{‰ŠÇ«’°ŽŸŠ³‹Š‰ï (CCFJ), •¶Œõ“°, “Œ‹ž, 2011/10”­s.

620044. [Šwp‘] (•ª’SŽ·•M)y’×ᇐ«‘å’°‰Š‚̐f—ÃKƒCƒh ‘æ2”Łz‘æ7ÍHŽ–‚š‚æ‚ѐ¶ŠˆŽw“±, p.68-73. ¬—ѐŽ“T (Á‰»Ší“à), •ÒW: NPO–@l“ú–{‰ŠÇ«’°ŽŸŠ³‹Š‰ï (CCFJ), •¶Œõ“°, “Œ‹ž, 2011/10”­s.

620045. [Šwp‘] (•ÒW)yÁ‰»ŠÇ“àŽ‹‹ŸƒGƒLƒXƒp[ƒg@E‘å’°Šàz‘æ3Šª•ÒW. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/10”­s.

620046. [Šwp‘] (•ª’SŽ·•M)y“àŽ‹‹Ÿf’f‚̃vƒƒZƒX‚ÆŽŸŠ³•Ê“àŽ‹‹Ÿ‘œzf’f‚̃vƒƒZƒX@ƒAƒtƒ^E‚Ñ‚ç‚ñ, p.198-205. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à‰È), ŠÄC: “cK‹v•v3 (3“Œ‹žŽœŒb‰ïˆã‰È‘åŠw), •ÒW: “c’†MŽ¡4, ’·“ì–Ÿ“¹5, •“¡@Šw6 (4L“‡‘åŠw, 5å‘äŒú¶•a‰@, 6‹ž“s‘åŠw), “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2011/10”­s.’ljÁ•ª

620047. [Šwp‘] (•ª’SŽ·•M)y“àŽ‹‹Ÿf’f‚̃vƒƒZƒX‚ÆŽŸŠ³•Ê“àŽ‹‹Ÿ‘œz’×ᇐ«‘å’°‰Š‚ÌMatts“àŽ‹‹Ÿ•ª—Þ, p.318-21. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à‰È), ŠÄC: “cK‹v•v3 (3“Œ‹žŽœŒb‰ïˆã‰È‘åŠw), •ÒW: “c’†MŽ¡4, ’·“ì–Ÿ“¹5, •“¡@Šw6 (4L“‡‘åŠw, 5å‘äŒú¶•a‰@, 6‹ž“s‘åŠw), “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2011/10”­s.’ljÁ•ª

620048. [Šwp‘] (•ª’SŽ·•M)y“àŽ‹‹Ÿf’f‚̃vƒƒZƒX‚ÆŽŸŠ³•Ê“àŽ‹‹Ÿ‘œzŠŽõ«’°‰Š‚Ì•ª—Þ‚ÆŠÓ•Ê, p.330-2. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à‰È), ŠÄC: “cK‹v•v3 (3“Œ‹žŽœŒb‰ïEã‰È‘åŠw), •ÒEW: “c’†MŽ¡4, ’·“ì–Ÿ“¹5, •“¡@Šw6 (4L“‡‘åŠw, 5å‘äŒú¶•a‰@, 6‹ž“s‘åŠw), “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2011/10”­s.’ljÁ•ª

620049. [Šwp‘] (•ª’SŽ·•M)yÁ‰»ŠíŠà‰»Šw—Ö@zÁ‰»ŠíŠà‚ɑ΂·‚é‘œÜ•¹—p—Ö@-1@S-1/CDDP, p.51-5. ¬ò˜aŽO˜Y (Á‰»Ší“à), •ÒW: ‘呺Œ’“ñ, ‘ë“à”ä˜C–ç, “ìŽR“°, “Œ‹ž, 2011/11”­s.

620050. [Šwp‘] (•ª’SŽ·•M)y‰ŠÇ«’°ŽŸŠ³|•aˆö‰ð–Ÿ‚Ɛf’fEŽ¡—Â̍ŐV’mŒ©| (“ú–{—Õଠ70 (1))z‰ŠÇ«’°ŽŸŠ³‚ÌŒŸžEf’f@‰ŠÇ«’°ŽŸŠ³‚̐f’fŽè‡, p.179-84. Ÿ–””º‰h (Á‰»Ší“à), “ú–{—Õ଎Р2012/2”­s.

620051. [Šwp‘] (•ª’SŽ·•M)y‰ŠÇ«’°ŽŸŠ³|•aˆö‰ð–Ÿ‚Ɛf’fEŽ¡—Â̍ŐV’mŒ©|(“ú–{—Õଠ70 (1))zV. ‰ŠÇ«’°ŽŸŠ³‚ÌŒŸžEf’f@5. ‰ŠÇ«’°ŽŸŠ³‚̉摜f’f@2) XüŒŸž, p.204-8. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1 (1Á‰»Ší“à), “ú–{—Õ଎Ð, ‘åã, 2012/2”­s.

620052. [Šwp‘] (•ª’SŽ·•M)y‰ŠÇ«’°ŽŸŠ³|•aˆö‰ð–Ÿ‚Ɛf’fEŽ¡—Â̍ŐV’mŒ©|(“ú–{—Õଠ70 (1))zV. ‰ŠÇ«’°ŽŸŠ³‚ÌŒŸžEf’f@5. ‰ŠÇ«’°ŽŸŠ³‚̉摜f’f@5) CTEMRIf’f, p.225-8. ¬—ѐŽ“T1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à), “ú–{—Õ଎Ð, ‘åã, 2012/2”­s.

620053. [Šwp‘] (•ª’SŽ·•M)y‰ŠÇ«’°ŽŸŠ³|•aˆö‰ð–Ÿ‚Ɛf’fEŽ¡—Â̍ŐV’mŒ©| (“ú–{—Õଠ70 (1))z‰ŠÇ«’°ŽŸŠ³‚ÆŠÓ•Ê‚·‚ׂ«Žå‚ÈŽŸŠ³‚Æ‚»‚̊ӕʐf’f@ƒAƒ[ƒo«‘å’°‰Š, p.591-5. ŒÜ\—’³L1,2, ŠÝŒŽ‹Pm, ç–쏻Žq (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à), “ú–{—Õ଎Р2012/2”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711002. [Šw‰ï (‘Û)] (“Á•Êu‰‰) ’Ž‰¹”g“àŽ‹‹Ÿ‚̗Տ°“I—L—p«. –Ø“cŒõL (Á‰»Ší“à): ’†‘“àŽ‹‹ŸŠwp‘å‰ï (2011/9/3), dŒc.

711003. [Šw‰ï (‘Û)] (“Á•Êu‰‰) EUS-guided therapy as a novel modality for pancreatic diseases. Kida M1: The 5th Meeting of the Society of Gastrointestinal Intervention (2011/10/14-15), Seoul. (–Ø“cŒõL1: 1Á‰»Ší“à)

711004. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Endoscopic treatment for early gastric cancer. “c糁@‘ (Á‰»Ší“à): ’†‘ŽR“ŒÈÁ‰»ŠíŠw‰ï (2011/11/15), ŽR“Œ.

711005. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Role of EUS-FNA for Pancreatic Diseases. Kida M1: 14th National Academic EUS Conference 4th Shanghai International Pancreatology Forum (2011/11/24-27), Shanghai. (–Ø“cŒõL1: 1Á‰»Ší“à)
íœšH23”N“xŒfÚÏ‚Ý (p.44: 712038)

712011. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Nutritional Therapy Combination with Nutrition and Medication In Inflammatoty Bowel Disease. Kobayashi K1: ‘æ17‰ñSpring meeting of the Korean society of digestive endoscopy (2011/4/3), Seoul. (¬—ѐŽ“T1: 1Á‰»Ší“à)

712012. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Techniques in EUS-FNA and Trucut Biopsy. Kida M1: 1st practical Workshop in Diagnostic and Therapeutic Endoscopic Ultrasound (2011/4/7-8), Hong Kong. (–Ø“cŒõL1: 1Á‰»Ší“à)

712013. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Future in EUS Development. Kida M1: 1st practical Workshop in Diagnostic and Therapeutic Endoscopic Ultrasound (2011/4/7-8), Hong Kong. (–Ø“cŒõL1: 1Á‰»Ší“à)

712014. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) The role of EUS & EUS-FNA in the diagnosis of pancreatic cancer. Kida M1: Asian Pacific Digestive Week 2011 (2011/10/1-4), Singapore. (–Ø“cŒõL1: 1Á‰»Ší“à)

712015. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Prevention of post ERCP pancreatitis. Kida M1: The 5th Meeting of the Society of Gastrointestinal Intervention (2011/10/14-15), Seoul. (–Ø“cŒõL1: 1Á‰»Ší“à)

712016. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) EUS Anatomy of Bilio-pancreatic System (Linear). Kida M1: The Digestive Endoscopy Society of Taiwan. EUS Phantom Workshop (2012/3/18), Taiwan. (–Ø“cŒõL1: 1Á‰»Ší“à)

713030. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Endoscopic Surveillance for Colorectal Tumors Associated with Ulcerative Colitis. Kobayashi K1, Sada M1, Mukae M1, Ogawa T1, Yokoyama K1, Koizum W1: Digestive Disease Weak 2011 (2011/5/8), Chicago. (¬—ѐŽ“T1, ²“c”ü˜a1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713031. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Inhibitory effect of lansoprazole on bleeding from artificial ulcers after endoscopic submucosal dissection for gastric tumors: A prospective randomized study. Tanabe S1, Higuchi K1, Ishido K1, Sasaki T1, Azuma M1, Katada C1, Ae T1, Naruke A1, Koizumi W1: Digestive Disease Week 2011 (2011/5/9), Chicago. (“c糁@‘1, ”óŒûŸ•F1, ÎŒËŒªŽŸ1, ²X–Ø“O1, “Œ@’q1, Œ˜“ce—˜1, ˆ¢]‘Ÿ‰ÀŽq1, ¬–с@“N1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713032. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Clinical Usefulness of Balloon Endoscopy for the Diagnosis and Treatment of Small Intestinal Diseases. Mukae M1, Kobayashi K1, Ogawa T1, Yokoyama K1, Sada M1, Koizumi W1: Digestive Disease Week 2011 (2011/5/10), Chicago. (Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713033. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Endoscopic assistance as the safety technique of Percutaneous Trans-Esophageal Gastrotubing (PTEG) for the patients who had difficulty with the Percutaneous Endoscopic Gastrostomy (PEG) insertion. Murakami M1,2, Nishino K1, Takaoka Y1, Murakami S1, Murakami B1, Tanabe S2, Kida M2, Koizumi W2: ‘æ19‰ñ‰¢BÁ‰»Ší•aŠw‰ï (19th UEGW) (2011/10/25), ƒXƒgƒbƒNƒzƒ‹ƒ€. (‘ºã‹§l1,2, “c糁@‘2, –Ø“cŒõL2, ¬ò˜aŽO˜Y2: 1‘ºã‹L”O•a‰@, 2Á‰»Ší“à)

713034. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effectiveness and Limitations of Granulocyte and Monocyte/Macrophage Adsorption Apheresis and Leukocytapheresis in Patients Hospitalized for Ulcerative Colitis. Yokoyama K1, Kobayashi K1, Mukae M1, Ogawa T1, Sada M1, Koizumi W1: 19th United European Gastroenterology Week (2011/10/25), ƒXƒgƒbƒNƒzƒ‹ƒ€. (‰¡ŽR@ŒO1, ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713035. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Surgical indications and limitations of medical therapy in patients with intestinal complications due to Crohn's disease. Yokoyama K1, Kobayashi K1, Mukae M1, Sada M1, Koizumi W1: 2011 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference (2011/12/1), ƒtƒƒŠƒ_. (‰¡ŽR@ŒO1, ¬—ѐŽ“T1, Œ}@”üK1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713036. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Treatment Outcomes of Tacrolimus in Patients with Ulcerative Colitis. Mukae M1, Kobayashi K1, Ogawa T1, Yokoyama K1, Sada M1, Koizumi W1: Korea Japan IBD symposium (2012/1/28), “Œ‹ž. (Œ}@”üK1, ¬—сEŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

722012. [Šw‰ï (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€) isŠÌ×–EŠà‚ɑ΂·‚ésorafenib‚ÌŽg—pŽÀ‘Ԃƍ¡Œã‚̉ۑè: Kanagawa Liver Study Group‘œŽ{Ý‹€“¯Œ€‹†. Œ‰iŒõ‘Ÿ˜Y1, ‰œ£çW, —é–Ø“¹”Ž, “ú‚@‰›2, ‚“cŽ÷ˆê2, ‰œ˜e—T‰î2, a’J–Ÿ—²3, ¬—с@’q, ‘åìLˆê, ‹ß“¡³W, X–{@Šw, À“c˜aŽi, “c’†Ž–Ÿ (1¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw, 2Á‰»Ší“à, 3ˆã—ÈÀ‘SEŠÇ—): ‘æ97‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2011/5/13), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/3; 108 (—Õ‘): A196.

722013. [Šw‰ï (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€) Ž©ŒÈ–ƉuŽŸŠ³ Churg-StraussÇŒóŒQ (CSS) ‚̓«DŽ_‹…«‘å’°‰Š‚ɑ΂·‚éIVIG—Ö@‚̉”\«. ’Þ–ØàV®ŽÀ1, ‰Ÿ•û’q–çŽq, âV“¡”ŽŽm, —±—ˆ’”Ž, ’J–{‰p‘¥, ŠÖ’JŒ‰Žj, ’JŒû³ŽÀ, ‘å—FŽç, ‘O“c—T“ñ, ›–ì@‘1,2, ‹Ê^r•œ1,2, ‰º“c‘ñ–ç1,2, ²“¡@•¶1,2, –x“cˆ»Žq, âV“¡¶˜N, HŽRˆê’j (1‘—§‘Š–ÍŒŽ, 2Á‰»Ší“à): ‘æ23‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï (2011/5/14), ç—t, ƒAƒŒƒ‹ƒM[ 2011/4; 60 (3-4 ): 420.

722014. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠÌŠà‰æ‘œf’f‚̐i•àzGd-EOB-DTPA‘¢‰eMRIŠÌ×–E‘Š‚Å’áM†‚ð’æ‚·‚é–RŒŒ«ŠÌŽîᇂ̑œŒŒ‰»‚ւ̐i“W. “c’†Œ«–Ÿ1, ’†àV‹MG1, š •ª–ΔŽ1,2 (1Á‰»Ší“à, 2‡‘å—û”n): ‘æ47‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2011/6/3), “Œ‹ž, ŠÌ‘Ÿ 2011/4; 52 (Suppl 1): A78.

722015. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y‚ª‚ñŽ¡—ʳŽÒ‚ɑ΂·‚é‰h—{—Ö@zŽ¡—Ê®‹‚ð‚ß‚Ž‚µ‚œV‚µ‚¢‰h—{—Ö@ Á‰»ŠíŠà‰»Šw—Ö@Ž{sŽž‚ÌŒû“à‰Š‚ɑ΂·‚鐬•ª‰h—{Ü (ƒGƒŒƒ“ƒ^[ƒ‹) —L—p«‚ɂ‚¢‚Ä. ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ‚–ؐžˆê, óŒ©¹Ž÷, {]‘ˆê˜Y, –{‹Ž@C1,2, ‹T“c@—º (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): “ú–{ŠO‰È‘ãŽÓ‰h—{Šw‰ï‘æ48‰ñŠwpW‰ï (2011/7/7), –ŒŒÃ‰®, ŠO‰È‚Æ‘ãŽÓE‰h—{ 2011/6; 45 (3): 87.

722016. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yV‹Kf’f‹Zp‚Ì—LŒø«•]‰¿: “Ÿ‚ç‚ê‚œƒGƒrƒfƒ“ƒX‚ƍ¡Œã‚Ì“W–]z¬’°“àŽ‹‹Ÿ: ¬’°ŽŸŠ³‚̐f’f‚ÆŽ¡—Âɂš‚¯‚éƒoƒ‹[ƒ““àŽ‹‹Ÿ‚̗Տ°“I—L—p«. ¬—ѐŽ“T1, ²“c”ü˜a1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 637.

722017. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŽ¡—Ã“àŽ‹‹Ÿ‚Ì—LŒø«•]‰¿: “Ÿ‚ç‚ê‚œƒGƒrƒfƒ“ƒX‚ƍ¡Œã‚Ì“W–]zH“¹EEˆÝÃ–¬áŽd‰»—Ö@ VP3/VP4ŠÌ×–EŠàÇ—á‚̐H“¹Ã–¬áŽ‚ɑ΂·‚錟“¢: H“¹Ã–¬áŽŽ¡—ª•K—v‚ȏǗá‚Æ‚Í. ‹àŽq@‹œ1, “ì–ì@•×1, “ú‚@‰›1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/18), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 655.

722018. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y“àŽ‹‹Ÿ‚É‚æ‚éIBD‚Ì•a‘Ô’Ç‹z’×ᇐ«‘å’°‰Š‚̏‰Šú•a•Ï‚ɂ‚¢‚Ä‚Ì“àŽ‹‹Ÿ“IŒ€‹†. Œ}@”üK1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/18), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 730.

722019. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yColitic Cancer‚̐f’f‚ÆŽ¡—Ã: Å‹ß‚̐i•àz’×ᇐ«‘å’°‰ŠŠÖ˜A: colitic cancerEdysplasia‚̃T[ƒxƒCƒ‰ƒ“ƒX–@‚â“àŽ‹‹Ÿf’f‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ²“c”ü˜a1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/18), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 735.

722020. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€) Current status of EUS-guided drainage of pancreatic cysts and efforts to prevent complications. Iwai T, Kida K1, Koizumi W1: ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/18), –ŒŒÃ‰®. (Šâˆä’m‹v1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

722021. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰»Ší“àŽ‹‹Ÿ—̈æ‚É‚š‚¯‚é—Տ°ŽŽŒ±‚ÌŽÀÛzH“¹ŠàEMR/ESDÇ—á‚̃ˆ[ƒh•sõ‘Ñ‚ðƒoƒCƒIƒ}[ƒJ[‚É‚µ‚œ‘œ”­Šà”­¶‚ÉŠÖ‚·‚éƒRƒz[ƒgŒ€‹†. Œ˜“ce—˜1, •“¡@Šw (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/19), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 710.

722022. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y–å–¬ˆ³˜ŽiÇ‚É‚š‚¯‚é‘ŸŠí‘ŠŠÖzŠÌE”xEtEäB is«ŠÌ×–EŠàŠ³ŽÒ‚É‚š‚¯‚éƒ\ƒ‰ƒtƒFƒjƒu“Š—^‚Í–å–¬ˆ³˜ŽiÇ‚ð‰ü‘P‚·‚é‚©: ‘OŒü‚«ƒRƒz[ƒgŒ€‹†‚©‚ç. “ú‚@‰›1, ‹àŽq@‹œ1, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ18‰ñ“ú–{–å–¬˜ŽiÇŠw‰ï‘‰ï (2011/9/15), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 47.

722023. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y–«ŠÌŽŸŠ³Ž¡—ẪuƒŒ[ƒNƒXƒ‹[‚ð–ÚŽw‚µ‚āzäB“E vs PSE Partial Splenic Embolization (PSE) ‚Ì’·Šú—\Œã‚É‹y‚Ú‚·ˆöŽq‚ÌŒŸ“¢. “ú‚@‰›1, EE݉Á“Þ1, “ì–ìE@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ18‰ñ“ú–{–å–¬˜ŽiÇŠw‰ï‘‰ï (2011/9/15), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 49.

722024. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv)yŽ„‚ª‘E‚ß‚é’_“¹“àŽ‹‹ŸŽ¡—ẪeƒNƒjƒbƒN (“û“ª•”Øœ‚àŠÜ‚ß)zƒRƒc‚ƃsƒbƒgƒtƒH[ƒ‹: “–‰@‚É‚š‚¯‚é“àŽ‹‹Ÿ“I“û“ª•”Øœp‚̏p‘Of’f‚ÆŽ¡—ẪeƒNƒjƒbƒN. ’r“cOŽq1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ47‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2011/9/16), ‹{è, ’_“¹ 2011/8; 25 (3): 402.

722025. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–å–¬ˆ³˜ŽiÇ‚É‚š‚¯‚é–ò•š—Ö@zŽ„‚̏ˆ•û—á: ƒ‰ƒxƒvƒ‰ƒ][ƒ‹10 mg“Š—^‚ÍEVLŒã‚̐H“¹Ã–¬áŽoŒŒ‚ð—}§‚·‚é. “ú‚@‰›1, š •ª–ΔŽ1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‡‘å—û”n): ‘æ18‰ñ“ú–{–å–¬˜ŽiÇŠw‰ï‘‰ï (2011/9/16), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 71.

722026. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’×ᇐ«‘å’°‰Š‚É‚š‚¯‚é”S–ŒŽ¡–ü‚ƍĔR‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ29‰ñ“ú–{‘å’°ŒŸžŠw‰ï‘‰ï (2011/9/18), “Œ‹ž.

722027. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yT4H“¹Šà‚ɑ΂·‚éf’f‚ÆŽ¡—ÁzcT4H“¹Šà‚ɑ΂·‚éDCF•¹—p‰»Šw•úŽËü—Ö@ (DCF-R) ‚ÌŽ¡—ЬÑ. ”óŒûŸ•F1, ¬ò˜aŽO˜Y1, “c糁@‘1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬’J³Žq2, ª–{¹”V3, ŽÄ“c’q—²3, •Ð“c‰Ä–ç3 (1Á‰»Ší“à, 2•úŽËü (Žîá‡), 3ŠO‰È): ‘æ65‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2011/9/26), å‘ä, ‘æ65‰ñ“ú–{H“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/9; p.76.

722028. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yisŠÌŠà‚ɑ΂·‚鎡—Ð헪zŽîᇃ}[ƒJ[‚Ì‘Šú•Ï‰»‚Æ‘tŒ÷«‚Æ‚ÌŠÖ˜A‚©‚ç‚Ý‚œisŠÌ×–EŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒu‚ÌŽ¡—Ð헪. ’†àV‹MG1, “ú‚@‰›1, a’J–Ÿ—²1,2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ15‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2011/10/20), •Ÿ‰ª, ŠÌ‘Ÿ 2011/9; 52 (Suppl 2): A482.

722029. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŽ©ŒÈ–Ɖu«ŠÌáŠQE–ò•š«ŠÌáŠQ‚Ìup-to-datezRƒ~ƒgƒRƒ“ƒhƒŠƒAM2R‘Ì (M2R‘Ì) ‚Í–ò•š«ŠÌáŠQ (DILI) ‚É‚š‚¢‚Ĉê‰ß«‚É—z«‚ðŽŠ‚·‚±‚Æ‚ª‚ ‚é. “n粐^²1, a’J–Ÿ—²1,2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ15‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2011/10/20), •Ÿ‰ª, ŠÌ‘Ÿ 2011/9; 52 (Suppl 2): A542.

722030. [ŠwEE(‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yÁ‰»ŠíŽŸŠ³‚É‚š‚¯‚镪Žq•W“IŽ¡—ÁzisŠÌ×–EŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒuŽ¡—Ã: —LŠQŽ–Û‚©‚ç‚Ý‚œŽ¡—ÃŒp‘±ˆöŽq‚ÌŒŸ“¢. ‚“cŽ÷ˆê1, ’†àV‹MG1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ15‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2011/10/21), •Ÿ‰ª, ŠÌ‘Ÿ 2011/9; 52 (Suppl 2): A527.

722031. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÁ‰»Ší‚ª‚ñ‚Ì”­ˆç‘¬“x‚Æ—LŒø‚ÈŒŸfŠÔŠuz‘å’°Šà—}§‚Ì‚œ‚ß‚Ì“KØ‚È‘å’°“àŽ‹‹ŸŒŸžŠÔŠu‚ÉŠÖ‚·‚é‘œŽ{Ý‹€“¯Œ€‹† (‘æˆê•ñ). ‰Í‘º‘ì“ñ1, ¬—ѐŽ“T2, ”ö“c@‹± (1‹ž“s‘æ“ñÔ\Žš•a‰@, 2Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/21), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2405.

722032. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yEUS-FNAŠÖ˜A‚ÌŽè‹Z‚ƍH•vzEUS-FNA‚̐úŽhjŒa‚É‚æ‚éf’f”\‚ÌŒŸ“¢. r–ؐ³—Y1,2, –Ø“cŒõL2, ¬ò˜aŽO˜Y2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/21), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2470.

722033. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y“àŽ‹‹Ÿ‰º“EœŒã‚Ì‘å’°SMŠà‚ɑ΂·‚é‘Ήžz‘å’°SMŠà‚Ì“àŽ‹‹Ÿ“I“Eœ—á‚©‚ç‚Ý‚œŽ¡—Ð헪. ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/22), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2502.

722034. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y¬’°ŽŸŠ³‚̐f’f‚ÆŽ¡—ÁzŒŽˆö•s–ŸÁ‰»ŠÇoŒŒ‚̐f’f‚ÆŽ¡—Ã. Œ}@”üK1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/22), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2570.

722035. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y‘å’°“àŽ‹‹Ÿ‘}“ü–@‚ÌŠî–{‚ƍH•vz‘å’°“àŽ‹‹Ÿ‰SŽÒ‚ɑ΂·‚éƒRƒƒ“ƒ‚ƒfƒ‹‚ðŽg‚Á‚œ‘}“ü–@Žw“±‚ÌŽÀÛ. ‰¡ŽR@ŒO (Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/22), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2577.

722036. [Šw‰ï (‘S‘)] (ƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€)y’×ᇐ«‘å’°‰Š‚ÌŽ¡—Ð헪z‚±‚ê‚Ü‚Å‚Ì10”N‚Æ‚±‚ê‚©‚ç‚Ì10”N. ‰¡ŽR@ŒO (Á‰»Ší“à): JDDW 2011 Fukuoka (2011/10/22), •Ÿ‰ª.

722037. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yØœ•s”\isÁ‰»Ší‚ª‚ñ‚ɑ΂·‚鎡—ÑI‘ðzØœ•s”\isˆÝŠàŽ¡—ÂɁEš‚¯‚éS-1‚ð—p‚¢‚œE•ʉ»ˆã—Âւ̓W–]: 5FU‘ãŽÓŠÖ˜Ay‘f‚𒆐S‚É. “Œ@’q1, ¬–с@“N1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): JDDW 2011 (2011/10/22), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A600.

722038. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yH“¹Šà‚ɑ΂·‚é“à‰È“IŽ¡—ÂƊO‰È“IŽ¡—Â̐ړ_zClinical T4/M1LYMH“¹Šà‚ɑ΂·‚éDocetaxel/CDDP/5-FU/•úŽËü“¯Žž•¹—p—Ö@ (DCF-R) ‚̐¬Ñ. ”óŒûŸ•F1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): JDDW 2011 (2011/10/22), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A613.

722039. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÁ‰»Ší“àŽ‹‹ŸŒŸžEŽ¡—ÃŽž‚Ì–ƒŒ–ò/’ÁÃ–òŽg—p‚̃Gƒrƒfƒ“ƒX: f—ÃKƒCƒhƒ‰ƒCƒ“ì¬‚ð–ÚŽw‚µ‚āzBISƒ‚ƒjƒ^[‚𕹗p‚µ‚œpropofol‚É‚æ‚ésedation: –³ìˆ×‰»—Տ°‘æII‘ŠŽŽŒ± (KDOG0801) ‚ÌŒ‹‰Ê‚ÉŠî‚¢‚œ‚—îŽÒ‚É‚š‚¯‚é—LŒø«‚ƈÀ‘S«‚ÌŒŸ“¢. ²X–Ø“O1, “c糁@‘1, “Œ@’q1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/23), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2434.

722040. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yˆô“ªŠà‚ƐH“¹Šà‚ÌŒø—Š“I‚ÈŠÏŽ@–@zŒ©—Ž‚Æ‚µ‚ª­‚È‚¢“ªèò•”—̈æ‚ÌŠÏŽ@•û–@. Œ˜“ce—˜1, “c糁@‘1, ³˜Ò@—²2 (1Á‰»Ší“à, 2Žš•@): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/23), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2583.

722041. [Šw‰ï (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€)y–ò•š—Ö@zØœ•s”\EÄ”­ˆÝŠà‚ɑ΂·‚é2ŽŸŽ¡—ÂƂµ‚Ä‚ÌABI-007 (3T–ˆ“Š—^–@) ‘æII‘ŠŽŽŒ±. ˆÀˆä”ŽŽj1, ²X–؍Nj, m‰È’q—T, ‘ë“à”ä˜C–ç, ’ҁ@Wm, Žº@@Œ\, “¡–琡Žu, ¬ò˜aŽO˜Y2, ŒŽ@‘ñ‰›, ‹{“c‰À“T (1Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽ 2011/9; 46 (2): 411.

722042. [Šw‰ï (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€)y–ò•š—Ö@zØœ•s”\‘å’°Šà‚ɑ΂·‚éƒxƒoƒVƒYƒ}ƒu‚ÆmOPTIMOX1—Ö@‚Ì•¹—p‘æII‘Š—Տ°ŽŽŒ±. “ˆ“c@Œ°, ’†ŽRž“T1,2, “c’†‘‘ˆê, ²“¡@‰·, ²X–؉hì, ¬Œˆê’j, “ú”䌒Žu, Žsì‰¢Žq, ‹e’r—Ré, òŽR”N˜a, ŠÖì‚Žu, —с@˜a•F, ŒÃ“cˆê—T, m‰È°O, ŒIŒŽ@–« (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽ 2011/9; 46 (2): 413.

722043. [Šw‰ï (‘S‘)] (ƒŒƒNƒ`ƒƒ[) ã•”EÁ‰»ŠÇoŒŒ‚ɑ΂·‚éE~ŒŒ–@ (”ñÃ–¬áŽoŒŒ). “c糁@‘ (Á‰»Ší“à): ‘æ73‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2011/11/19), “Œ‹ž.

722044. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yØœ•s”\isˆÝŠàŽ¡—Âɂš‚¯‚éS-1‚ð—p‚¢‚œŒÂ•Ê‰»ˆã—Âւ̓W–]z5FU‘ãŽÓŠÖ˜Ay‘f‚𒆐S‚É. “Œ@’q1, ¬–с@“N1, ÎŒËŒªŽŸ1, Œ˜“ce—˜1, ”óŒûŸ•F1, ²X–Ø“O1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ84‰ñˆÝŠàŠw‰ï‘‰ï (2012/2/9), ‘åã.

722045. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) isˆÝŠà‚ɑ΂·‚鉻Šw•úŽËü—Ö@‚Ì—L—p«. ÎŒËŒªŽŸ1, ”óŒûŸ•F1, “c糁@‘1, “Œ@’q1, ²X–Ø“O1, Œ˜“ce—˜1, ¬–с@“N1, ¬ò˜aŽO˜Y1, ¬’J³Žq2, ‘ì˜ad2 (1Á‰»Ší“à, 2•úŽËü (Žîá‡)): ‘æ84‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2012/2/10), ‘åã.

722046. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y‰»Šw—Ö@’˜Œø—á‚ɑ΂·‚éŠO‰ÈØœ‚̈Ӌ` (Žèp‚Í•K—v‚©E‚¢‚ÂŽèp‚·‚é‚©E‚Ç‚±‚܂Ő؏œ‚·‚é‚©) zØœ•s”\ˆÝ‘BŠà‚ɑ΂·‚鉻Šw—Ö@Ž{sŒã, —Տ°“I‚ɍªŽ¡Øœ‚̑ΏۂƂȂÁ‚œÇ—á‚ÌŒŸ“¢. Œ‘º@Œ«1,2, ’†ŽRž“T1,2, ‚–ؐžˆê, ÂŽR@“O, —с@@•×, ’·@°•F, ‹gì‹MŒÈ, ‰~’J@² (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ84‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2012/2/10), ‘åã, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ–84‰ñ 2012/2; p.153.

723090. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ý‘î’†SÃ–¬‰h—{—Ö@‚ðŒp‘±‚µ‚Ä‚¢‚鉊Ç«’°ŽŸŠ³Š³ŽÒ‚É‚š‚¯‚錌’†ƒrƒ^ƒ~ƒ“”Z“x‚̐„ˆÚ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‰Á“¡@Ê1, ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, Ÿ–””º‰h1 (1Á‰»Ší“à): ‘æ97‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2011/5/13), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/3; 108 (—Õ‘): A311.

723091. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Sitagliptin‚ÆŽv‚í‚ê‚é–ò•š«ŠÌáŠQ‚̈ê—á|’Ž”÷Œ`‘ÔŠw“IŠÏŽ@‚©‚ç|. –L“c‚ß‚®‚Ý1, ‰¡XOº, D“c³–ç, Ž…—T‹M1,2, ’|“à@ˆê1,2, “cŒŽ‹v”üŽq1,2, ‹àŽq•¶•F, “ú”ä‹I•¶ (1–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ97‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2011/5/14), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/3; 108 (—Õ‘‘‰ï): A345.

723092. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÌd•ÏŠ³ŽÒ‚ɑ΂µ‚ÄSF-8‚ðQOLŽw•W‚Æ‚µ‚œ•ªŠòœƒAƒ~ƒmŽ_è÷—±»Ü‚Ì—LŒø«‚ÌŒŸ“¢: ‘œŽ{Ý‹Š“¯–³ìˆ×‰»”äŠrŽŽŒ±. “ú‚@‰›1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1, ŒBŠ|L“ñ3, ŽRèDŠì4, ”üŒŽÃ5, Â–Ø‚¢‚ÂÝ6, ‘å’ˏr˜a7, “y‹Ž@Œ’8, ’†–ìŽj˜Y9, ²“¡‘ˆê˜Y10, ó—té”V11, ‘å–ì@—²12 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3ŒBŠ|ˆã‰@, 4•œ’Ë‹€Ï•a‰@, 5‘Š–Í–ì•a‰@, 6“ŒŽÅ—ÑŠÔ•a‰@, 7’ËvˆäÔ\Žš•a‰@, 8‚‚¿‚Í‚µƒNƒŠƒjƒbƒN, 9Šp’†ƒNƒŠƒjƒbƒN, 10²“¡ˆã‰@, 11‚ ‚³‚Γà‰ÈEÁ‰»ŠíƒNƒŠƒjƒbƒN, 12ˆÉšŒŽ‹Š“¯•a‰@): ‘æ47‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2011/6/2), “Œ‹ž, ŠÌ‘Ÿ 2011/4; 52 (Suppl 1): A245.

723093. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) HBVÄŠˆ«‰»–hŽ~–Ú“I‚É“Š—^‚µ‚œƒGƒ“ƒeƒJƒrƒ‹‚Ì’†Ž~‚ɂ‚¢‚Ä. “n粐^²1, a’J–Ÿ—²1,2, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, “ì–ì@•×1, ‰œ˜e—T‰î1, “ú‚@‰›1, ’†àV‹MG1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ47‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2011/6/3), “Œ‹ž, ŠÌ‘Ÿ 2011/4; 52 (Suppl 1): A241.

723094. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) BCAAè÷—±»Ü‚ð—p‚¢‚œŠÌd•Ï‚ÌQOL‰ü‘P‚ɂ‚¢‚ā`‘œŽ{Ý‹Š“¯Œ€‹†‚É‚æ‚éŽæ‚è‘g‚݁`. “ú‚@‰›1, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n•Ó^²1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1, ŒBŠ|L“ñ3, ŽRèDŠì4, ”üŒŽÃ5, Â–Ø‚¢‚ÂÝ6, ‘å’ˏr˜a7, “y‹Ž@Œ’8, ’†–ìŽj˜Y9, ²“¡‘ˆê˜Y10, ó—té”V11, ‘å–ì@—²12 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3ŒBŠ|ˆã‰@, 4•œ’Ë‹€Ï•a‰@, 5‘Š–Í–ì•a‰@, 6“ŒŽÅ—ÑŠÔ•a‰@, 7’ËvˆäÔ\Žš•a‰@, 8‚‚¿‚Í‚µƒNƒŠƒjƒbƒN, 9Šp’†ƒNƒŠƒjƒbƒN, 10²“¡ˆã‰@, 11‚ ‚³‚Γà‰ÈEÁ‰»ŠíƒNƒŠƒjƒbƒN, 12ˆÉšŒŽ‹Š“¯•a‰@): ‘æ47‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2011/6/3), “Œ‹ž.

723095. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) isEÄ”­‘å’°Šà‚É‚š‚¯‚éƒIƒLƒTƒŠƒvƒ‰ƒ`ƒ“‹y‚Ñ ƒCƒŠƒmƒeƒJƒ“ŠùŽ¡—×á‚ɑ΂·‚é ƒIƒLƒTƒŠƒvƒ‰ƒ`ƒ“Ä“±“ü‚ÌŒã•ûŽ‹Šw“IŒŸ“¢. ²X–Ø“O1, “Œ@’q1, ¬ò˜aŽO˜Y1, ]ì’q‹v2, ’·“‡@“Ö2, ŒšŽŠxŽj2, ŽRŽº@“n2, “ˆ“c@Œ°3, ˆÉ“Œ—FO3, ‘ꐌˆÀ—²3, Ô’Ë‘s‘Ÿ˜Y4, —L‰ª@m4, ’†ŽRž“T5, Œ‘º@Œ«5, ‚–ؐžˆê5, ‘]“c@‹Ï6, “ú”䌒Žu6 (1Á‰»Ší“à, 2Ï¶‰ï‰¡•lŽs“Œ•”•a‰@, 3º˜a‘åŠw‰¡•lŽs–k•”•a‰@, 4‰¡•l˜JÐ•a‰@, 5_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 6º˜a‘åŠw“¡‚ª‹u•a‰@): ‘æ9‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2011/7/22), ‰¡•l.

723096. [Šw‰ï (‘S‘)] (—v–]‰‰‘è) dÇ‹}«äX‰Š‚ɑ΂·‚éBiapenem‚ð—p‚¢‚œäX‹ÇŠ“®’—Ö@‚ÌŽ¡—ЬÑ. ‹{àVŽu˜N1, ¡ò@O1, •Ð‰ª—Sˆê2, Š~Œ©•¶Ž}2, _œä’m“¹2, ’†’JŒ€“l2, ŒŠª@”Ž, ‘Š”nˆêˆå2 (1Á‰»Ší“à, 2‹~–œ): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/11), •Ÿ‰ª.

723097. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –¢•ª‰»Œ^¬‡‘ŠúˆÝŠà‚ɑ΂·‚éESD“K‰žŠg‘å. “Œ@’q1, “c糁@‘1, •@‰ª@ž1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 792.

723098. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆ««’†‰º•”’_ŠÇ‹·ó‚ɑ΂·‚éCovered Metallic Stent (CMS) —¯’up‚ƃgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. ‹e’nG•F1, –Ø“cŒõL1, ‘剪³•œ1, ŽR–{@‘n1, Šâˆä’m‹v1, ‹{àVŽu˜N1, ˆÀ“¡@‹1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1, ‰F’Ö؋±Žq1, ŽRèDŠì1, Ž­ŠÔL–Ÿ1, “n•Ó–€–ç1, –Ø“c–FŽ÷1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 822.

723099. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘å’°“àŽ‹‹Ÿ‘}“ü¢“ï—á‚ɑ΂·‚éƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ““àŽ‹‹Ÿ‚̗Տ°“I—L—p«. ¬ì‘åŽu1, ¬—ѐŽ“T1, Œ}@”üK1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/18), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 858.

723100. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) H“¹•\ÝŠà‚ɑ΂·‚éESD‚ÌŽ¡—ЬÑ: Žg—pdevice•Ê‚ÌŒŸ“¢. ”óŒûŸ•F1, “c糁@‘1, “Œ@’q1 (1Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/18), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 873.

723101. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘Šú’Œ’°ãè–å•”ˆ««•FŽî‚̈ê—á. ‹gàV“Þ’ÃŽq1,2, ŠÝŒŽ‹Pm, ¡ˆä, —с@—TŽq, ‰Yã®”V, ç–쏻Žq, ŒÜ\—’³L1,2, “¡–{‰À–ç, ã–ì‰ëŽ‘ (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17-19), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 831.

723102. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Crohn•aŠ³ŽÒ‚̉º•”Á‰»ŠÇ‹·ó•a•Ï‚ɑ΂·‚é“àŽ‹‹Ÿ“IŠg’£p‚Ì—L—p«‚ɂ‚¢‚Ä. ‰Á“¡@Ê1,2, ‰¡ŽR@ŒO2, ¬—ѐŽ“T2, ’†–Ú“N•œ2, Œ}@”üK2, ¬ì‘åŽu2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1“ŒŽÅ—ÑŠÔ, 2Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17-19), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 868.

723103. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ¬Œ^‚Ì‘å’°SMŠà‚ɂ‚¢‚Ä‚ÌŒŸ“¢. —с@—TŽq1, ç–쏻Žq, ‹gàV“Þ’ÃŽq1,2, ¡ˆä, ‰Á“¡@ŒO, ŠÝŒŽ‹Pm, ‰Yã®”V, •œàVr–Ÿ, ŽR–{—Š³, “y“c’mG, “¡E菇Žq, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17-19), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 892.

723104. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚é‚Ñ‚Ü‚ñZŒ^ (4Œ^) ‘å’°Šà (’ᕪ‰»Œ^‘BŠàEˆóŠÂ×–EŠà) 8—á‚ÌŒŸ“¢. ¡ˆä1, ç–쏻Žq, ‹gàV“Þ’ÃŽq1,2, ŒE“c@Šw, ŠÝŒŽ‹Pm, ŽR–{—Š³, “y“c’mG, “¡è‡Žq, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17-19), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 893.

723105. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Multiple lymphomatous polyposis (MLP) ‚ÌŒ`‘Ô‚ð’悵‚œ‘SÁ‰»ŠÇŒ^ƒ}ƒ“ƒgƒ‹×–EƒŠƒ“ƒpŽî‚Ì1—á. óŒ©¹Ž÷1, –{‹Ž@C1,2, ‚–ؐžˆê, ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ‹gˆä‹MŽq, –ö“c’Œ‹B, ‚èŒ[F, –{‘º–ÎŽ÷ (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ81‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/8/17-19), –ŒŒÃ‰®, Gastroenterological Endoscopy 2011/3; 53 (Suppl 1): 900.

723106. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) \“ñŽw’°Ã–¬áŽ”j—ô‚ɑ΂µB-RTO‚É‚æ‚èŽ~ŒŒ‚ª“Ÿ‚ç‚ê‚œ1—á. Ž…—T‹M1, “ú‚@‰›1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—S‰î1, “n粐^²1, “ì–ì@•×1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1, “¡ˆä@Š]3, Œ‰iŒh“ñ3 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3•úŽËü (‰æ‘œ)): ‘æ18‰ñ“ú–{–å–¬˜ŽiÇŠw‰ï‘‰ï (2011/9/16), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 126.

723107. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÌ–å•”ˆ««’_“¹‹·ó‚ɑ΂·‚éMetallic stent‚É‚æ‚é“àŽ‹‹Ÿ“I—Œ—tƒhƒŒƒi[ƒWp‚̐¬Ñ‚Æ“K‰ž. ‹{àVŽu˜N1, –Ø“cŒõL1, “¿‰iŽüŽq1, Œ–{—Y‘Ÿ1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ˆÀ“¡@‹1, ’r“cOŽq1, ‹e’nG•F1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ47‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2011/9/17), ‹{è, ’_“¹ 2011/8; 25 (3): 478.

723108. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”ñØœ’†‰º•”ˆ««’_“¹‹·ó‚ɑ΂·‚éself-expandable metal stents‚É‚æ‚é“àŽ‹‹Ÿ“I’_“¹ƒhƒŒƒi[ƒW‚ÌŒŸ“¢: ‰‰ñ—¯’uƒXƒeƒ“ƒg‚ƍė¯’uƒXƒeƒ“ƒg‚Æ‚Ì”äŠr. ¡ò@O1, –Ø“cŒõL1, ‰œ˜e‹»‰î1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ47‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2011/9/17), ‹{è, ’_“¹ 2011/8; 25 (3): 484.

723109. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éˆÝpŒãŠ³ŽÒ‚ɑ΂·‚éERCP‚ÌŒŸ“¢. ŽR“à_Žj1, –Ø“cŒõL1, ŽR–{@‘n1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, ‰¡ŽR@ŒO1, ‹v•Û“c”ü˜a1, ¡ò@O1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ47‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2011/9/17), ‹{è, ’_“¹ 2011/8; 25 (3): 544.

723110. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œ’_ùNŒŽ”­_Œo“à•ª”åŽîᇂÌ2—á. ‰œ˜e‹»‰î1, –Ø“cŒõL1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ47‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2011/9/17), ‹{è, ’_“¹ 2011/8; 25 (3): 562.

723111. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tŽŸŠ³‹y‚Ñåñጂð—L‚·‚鍂—ŽÒ‚ɑ΂·‚éNST‰î“ü‚̈ê—á. ˆîŒŽ²Žq1, rˆä–õ‘ã, –Ø’Ã’J—º, ¬ìƒZƒcƒR, ˆÉ“¡”Ž, ••”‚³‚â‚©, ›ŒŽ—¥Žq, ‹àX—R”ü, –ì–ؐ^ˆê, ŠÛ’J—ŽŽv, ‰º“c‘ñ–ç1,2, X’JGŒõ, –؉º@L (1‘—§‘Š–ÍŒŽ, 2Á‰»Ší“à): ‘æ65‰ñ‘—§•a‰@‘‡ˆãŠw‰ï (2011/10/7), ‰ªŽR, ‘æ65‰ñ‘—§•a‰@‘‡ˆãŠw‰ïu‰‰Ž˜^W 2011/10; p.523.

723112. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “«CŒ^–«ŠÌ‰Š‚ɑ΂·‚éPEG-IFNƒ¿2a/Ribavirin + Calcitriol•¹—p—Ö@‚Ì—LŒø«‹y‚шÀ‘S«‚ÉŠÖ‚·‚錟“¢. ’†àV‹MG1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “ú‚@‰›1, “n粐^²1, “ì–ì@•×1, Ž…—T‹M1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ15‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2011/10/20), •Ÿ‰ª, ŠÌ‘Ÿ 2011/9; 52 (Suppl 2): A595.

723113. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) isŠÌ×–EŠà‚É‚š‚¯‚éSorafenibŽ¡—Á|Ž¡—ЬÑ‚Ì‘ÌŠi‚É‚æ‚é‰e‹¿‚ÌŒŸ“¢|. ¬—с@’q1, ‘åìLˆê, ‚“cŽ÷ˆê2, ‰œ˜e—T‰î2, “ú‚@‰›2, a’J–Ÿ—²2,3, Œ‰iŒõ‘Ÿ˜Y, ‰œ£çW, —é–Ø’Ê”Ž, ‹ß“¡³W, X–{@Šw, À“c˜aŽi, “c’†Ž–Ÿ (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à, 3ˆã—ÈÀ‘SEŠÇ—): ‘æ15‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2011/10/20), •Ÿ‰ª, ŠÌ‘Ÿ 2011/9; 52 (Suppl 2): A627.

723114. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Crohn•a‚ÌUC—ÞŽ—•a•Ï‡•¹—á‚̗Տ°“IŒŸ“¢. Œ–{—Y‘Ÿ1, ‰¡ŽR@ŒO1, ‰Á“¡@Ê1, ’†–Ú“N•œ1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): JDDW2011 (2011/10/20), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A838.

723115. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Crohn•a‚Ì’°ŠÇ‡•¹Ç‚ɑ΂·‚éŽèp“K‰ž‚Æ“à‰È“IŽ¡—Â̌ÀŠE. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ‰Á“¡@Ê1, ’†–Ú“N•œ1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): JDDW2011 (2011/10/20), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A844.

723116. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚Ì’°ŠÇ‹·ó‚É‚š‚¯‚é”S–Œ‰º‘wüˆÛ‰»‚Æbasic-fibroblast growth factor—z«D’†‹…‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ŽRãp@m1, Œ}@”üK1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬—ѐŽ“T1, ŽOã“N•v2, Ÿ–””º‰h1, ¬ò˜aŽO˜Y1, ŒŒ³Ž›ŽâX1, ‰ªˆÀ@ŒM2 (1Á‰»Ší“à, 2•a—): JDDW2011 (2011/10/20), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A851.

723117. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñØœ’_“¹Šà‚ɑ΂·‚éBiweekly GEM/S1•¹—p‰»Šw—Ö@‚ÌŽ¡—ЬÑ. ‹{àVŽu˜N1, –Ø“cŒõL1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ’r“cOŽq1, ‹e’nG•F1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1, “n粖€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): JDDW2011 (2011/10/21), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A898.

723118. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Å‹ß5”N‚Ì’²ž‚©‚ç‚Ý‚œ“–‰@‚É‚š‚¯‚éBŒ^‹}«ŠÌ‰Š‚Ì“®Œü. ˜a“c‘ñ–ç1, ’†àV‹MG1, ‚“cŽ÷ˆê1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, ¬–ìO“ñ1, “n粐^²1, “ú‚@‰›1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): JDDW2011 (2011/10/21), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A929.

723119. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚—îŽÒ‚Ì‘ŠúˆÝŠà‚ɑ΂·‚éESD‚Ì—L—p«‚ƑÓ–«. ÎŒËŒªŽŸ1, “c糁@‘1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬–с@“N1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/21), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2633.

723120. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰º•”’Œ’°isŠà‚̏p‘O‰»Šw•úŽËü—Ö@‚ɑ΂·‚é“àŽ‹‹Ÿ“IŒø‰Ê”»’è. ¬ì‘åŽu1, ‘å–î‰ë•q, ç–쏻Žq, “¡–{‰À–ç, ã–ì‰ëŽ‘, ŒÜ\—’³L (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/21), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2671.

723121. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “àŽ‹‹Ÿ“IŽ~ŒŒ‚ª¢“ï‚Å‚ ‚Á‚œ‘å’°ŒeŽºoŒŒ‚ɑ΂µ‚Ä“®–¬Çðp‚É‚æ‚èŽ~ŒŒ‚ª“Ÿ‚ç‚ê‚œ3Ç—á. Ž…—T‹M1, Œ}@”üK1, “cŒŽ‹v”üŽq2, ’|“à@ˆê2, ˆäŒû”Ž‘P2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/21), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2653.

723122. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹‘åᰕǂð’悵‚œ‚Ñ‚Ü‚ñ«ˆÝ”S–Œ‰ºˆÙŠ‘B‚É‘ŠúˆÝŠà‚ð‡•¹‚µ‚œˆê—á. óŒ©¹Ž÷1, –{‹Ž@C1,2, ’†ŽRž“T1,2, ‚–ؐžˆê, Œ‘º@Œ«1,2, ‰~’J@², ‹T“c—zˆê (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/21), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2643.

723123. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) is«ŠÌ×–EŠàŠ³ŽÒ‚É‚š‚¯‚éƒ\ƒ‰ƒtƒFƒjƒu“Š—^‚É‚æ‚éŠÌ“àzŠÂ“®‘Ô‚É‹y‚Ú‚·‰e‹¿: ‘OŒü‚«ƒRƒz[ƒgŒ€‹†‚©‚ç. ‹àŽq@‹œ1, “ú‚@‰›1, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1, X@D, “¡ˆä@Ž , –öŒŽ”ü’qŽq, ‰““¡@—m, ŒFâ@L (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): JDDW2011 (2011/10/22), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A948.

723124. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Partial Splenic Embolization (PSE) ‚Ì’·Šú—\Œã‚É‹y‚Ú‚·ˆöŽq‚ÌŒŸ“¢. ìŠÝ‰Á“Þ1, “ú‚@‰›1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): JDDW2011 (2011/10/22), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A953.

723125. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) H“¹ƒXƒeƒ“ƒgŠ³ŽÒ‚̐H“¹ˆÙ•šœ‹Ž‚ւ̃EƒH[ƒ^[ƒvƒŠ[ƒYŽg—p‚É‚æ‚é—L—p«‚ɂ‚¢‚Ä. ŽO‰Y”ü•Û, ŒÃàV–ŸŽq, ì‘º–ƒ‹MŽq, ‚ŽR’q‘ã, “cŒŽŒb—Žq, ”nêGŽq, Œ”nê‹P˜a, “Œ@’q1, –Ø“cŒõL1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ66E67‰ñ“ú–{Á‰»Ší“àŽ‹‹Ÿ‹ZŽtŠw‰ï (2011/10/22), ŒF–{, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2870.

723126. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚—îŽÒ‚Ì‘’_ŠÇŒ‹ÎÇ‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Ã. ’r“cOŽq1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‘剪³•œ1, ²“Œäm1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ˆÀ“¡@‹1, ‹e’nG•F1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1, ‰F’Ö؋±Žq1, ŽRèDŠì1, Ž­ŠÔM–Ÿ1, “n•Ó–€–ç1, –Ø“c–FŽ÷1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/22), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2724.

723127. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ESDŒã‚É’x”­«úE‚𗈂µ‚œ3—á. •Êác•üL1, “c糁@‘1, –î–ì‹MŽj1, ”óŒûŸ•F1, ÎŒËŒªŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, ¬ò˜aŽO˜Y1, ŽOã“N•v2 (1Á‰»Ší“à, 2•a—): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/23), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2746.

723128. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÌ×–EŠà‚É‚æ‚é’_ŠÇ•ÂÇ‚ɑ΂·‚é“àŽ‹‹Ÿ“I’_ŠÇƒhƒŒƒi[ƒW (EBD) ‚Ì—L—p«. “c’†Œ«–Ÿ1, “ú‚@‰›1, ’†àV‹MG1, –Ø“cŒõL1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n粐^²1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/23), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2754.

723129. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éˆÝpŒãŠ³ŽÒ‚ɑ΂·‚éERCP‚ÌŒŸ“¢. ŽR“à_Žj1, –Ø“cŒõL1, ŽR–{@‘n1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¡ò@O1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/23), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2760.

723130. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éäX“à•ª”åŽîᇂ̌Ÿ“¢. ‰œ˜e‹»‰î1, –Ø“cŒõL1, ˆÀ“¡@‹1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/23), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2764.

723131. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠŽõ«äX‰óŽ€‚ɑ΂·‚éEndoscopic Necrosectomy‚Ì—LŒø«‚ƍ‡•¹Ç—\–h‚Ì‚œ‚߂̍H•v. Šâˆä’m‹v1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ82‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2011/10/23), •Ÿ‰ª, Gastroenterological Endoscopy 2011/9; 53 (Suppl 2): 2769.

723132. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) isÄ”­‘å’°Šà‚ÌL-OHPÄ“±“ü—á‚É‚š‚¯‚éOxaliplatin-free interval•Ê‚ÌŽ¡—ЬÑ. ŒšŽŠxŽj1, ]ì’q‹v1, “ˆ“c@Œ°1, ˆÉ“Œ—FO, ‘ꐌˆÀ—², ²X–Ø“O2, “Œ@’q2, ¬ò˜aŽO˜Y2, ’†ŽRž“T2, Œ‘º@Œ«2, ‚–ؐžˆê, ‘]“c@‹Ï, “ú”䌒Žu, Ô’Ë‘s‘Ÿ˜Y, —L‰ª@m (1Ï¶‰ï‰¡•lŽs“Œ•”•a‰@, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2011/10/27), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽ 2011/9; 46 (2): 523.

723133. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) isÄ”­ˆÝŠà‚̃hƒZƒ^ƒLƒZƒ‹‚ðŠÜ‚ÞƒŒƒWƒƒ“•s‰ž—á‚ɑ΂·‚éƒpƒNƒŠƒ^ƒLƒZƒ‹‚Ì—LŒø«. ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ‚–ؐžˆê, {]‘ˆê˜Y, óŒ©¹Ž÷, ‹T“c@—º, –{‹Ž@C1,2 (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽ 2011/9; 46 (2): 564.

723134. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰): • –Œ”dŽí‚ð—L‚·‚éˆÝŠà‚ɑ΂·‚éƒtƒb‰»ƒsƒŠƒ~ƒWƒ“ŒnRŠàÜ•s‰žŒã‚ÌCPT-11‚ÌŽ¡—ЬÑ. Œ‘º@Œ«1,2, ’†ŽRž“T1,2, ‚–ؐžˆê, {]‘ˆê˜Y, óŒ©¹Ž÷, ‹T“c@—º, –{‹Ž@C1,2 (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽ 2011/9; 46 (2): 602.

723135. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰): is‘å’°Šà‚ɑ΂·‚éTri-weekly XELIRI + BV—Ö@‚Ì‘æI/II‘Š—Տ°ŽŽŒ±BIX Study: ‰ŠúˆÀ‘S«‰ðÍ. •l–{N•v1, m‰È’q—T, ŽRŒû’B˜Y, ŽRèŒ’‘Ÿ˜Y, ‰F—ǁ@Œh, ’†“‡‹MŽq, Œã“¡@•à, “ˆ“c@Œ°, ’†ŽRž“T2,3, â–{ƒˆê, X“c’qŽ‹, ŽR“cNG (1Œcœä‘å, 2_“ސ삪‚ñƒZƒ“ƒ^[, 3Á‰»Ší“à): ‘æ49‰ñŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®.

723136. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰): Á‰»ŠíŠà‰»Šw—Ö@Ž{sŽž‚ÌŒû“à‰Š‚ɑ΂·‚鐬•ª‰h—{Ü (ƒGƒŒƒ“ƒ^[ƒ‹) ‚Ì—L—p«‚ÌŒŸ“¢. ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ‚–ؐžˆê, {]‘ˆê˜Y, óŒ©¹Ž÷, ‹T“c@—º, –{‹Ž@C1,2 (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï 82011/10/29), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽ 2011/9; 46 (2): 694.

723137. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) p‘OS-1+Docetaxel—Ö@‚É‚æ‚èPathological CR‚ª“Ÿ‚ç‚ê‚œˆÝŠà‚Ì1—á. ÂŽR@“O1, ‹gì‹MŒÈ, ŒKŒŽ@Š°, ŽO‰ÓŽR—m, —с@@•×, Œ‘º@Œ«1,2, ”öŒ`‚Žm, ’·@°•F, ’†ŽRž“T1,2, ‰~’J@² (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ73‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2011/11/19), “Œ‹ž, “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2011/10; 72 (‘Š§ ): 1015.

723138. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ×ŒaƒXƒR[ƒv (PCF-PQ260) ‚̗Տ°“I—L—p«. ¬ì‘åŽu1, ¬—ѐŽ“T1, Œ}@”üK1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ66‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2011/11/25), “Œ‹ž, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2011/9; 64 (9): 702.

723139. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’_Î”­ì‚ðŒ_‹@‚ɐf’f‚³‚ê‚œƒ~ƒNƒŠƒbƒc•a. ”üŒŽÃ1,2, ’|‰º’mEe1,2, ŽOŽ}—zˆê1,2, EŸ“c¬•S‡, ‹g“c@‹I, ŠøŽè˜a•F, ‰HœAŒ’m, ‘åˆä“c³l1,2, ŒŒ³Ž›ŽâX1,2 (1‘Š–Í–ì•a‰@, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŽÐ‰ï•ÛŒ¯ˆãŠw‰ï‘‰ï (2011/12/13), •Ÿ‰ª.

723140. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äX’_ŠÇ‡—¬ˆÙí‚ÉäX‘Ì•””ö•”Œ`¬•s‘S‚𔺂Á‚œˆê—á. ‰Ÿ“c¬•S‡1, ‹g“c@‹I, ŠøŽè˜a•F, ‰HœAŒ’m, ”üŒŽÃ1,2, ’|‰º’me1,2, ŽOŽ}—zˆê1,2, ‘åˆä“c³l1,2, ŒŒ³Ž›ŽâX1,2 (1‘Š–Í–ì•a‰@, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{ŽÐ‰ï•ÛŒ¯ˆãŠw‰ï‘‰ï (2011/12/13), •Ÿ‰ª.

723141. [Šw‰ï (‘S‘)] (—v–]‰‰‘è) ˆÝŠÇŠà‚ÌŽ¡—à “–‰@‚ɂĐf’f‚µ‚œH“¹ŠàpŒãÄŒšˆÝŠÇŠà21Ç—á32•a•Ï‚ÌŒŸ“¢. óŒ©¹Ž÷, –{‹Ž@C1,2, ‚–ؐžˆê, ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ˆäŒû–õO, {]‘ˆê˜Y, “ìoƒ“ñ, ÂŽR@–@ (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ84‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2012/2/9), ‘åã, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ–84‰ñ 2012/2; p.174.

723142. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “K‰žŠO•a•Ï‚ɑ΂·‚éESDÇ—á‚ÌŒŸ“¢. ˆäŒû–õO1, –{‹Ž@C1,2, {]‘ˆê˜Y, óŒ©¹Ž÷, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, ‚–ؐžˆê (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ84‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2012/2/10), ‘åã, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ–84‰ñ 2012/2; p.227.

723143. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‚“x• …‚ð‚Æ‚à‚È‚€• –Œ“]ˆÚˆÝŠà‚ɑ΂·‚éƒhƒZƒ^ƒLƒZƒ‹ + TS-1•¹—p—Ö@ (DS—Ö@). ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ‚–ؐžˆê, óŒ©¹Ž÷, {]‘ˆê˜Y, ˆäŒû–õO, –{‹Ž@C1,2 (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ84‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2012/2/10), ‘åã, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ–84‰ñ 2012/2; p.229.

723144. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”S–Œ”cŽççŽq—pƒ`ƒƒƒlƒ‹•t‚«“§–Ÿƒt[ƒh—p‚¢‚œ“ñ“_ŒÅ’è–@ESD‚ðŽ{s‚µ‚œH“¹ŠàpŒãˆÝŠÇŠà‚Ì1—á. {]‘ˆê˜Y, –{‹Ž@C1,2, ‚–ؐžˆê, ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ˆäŒû–õO, óŒ©¹Ž÷ (1_“ސ삪‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ84‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2012/2/10), ‘åã, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ–84‰ñ 2012/2; p.367.

723145. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ““àŽ‹‹Ÿ‚Őf’f‚³‚ê‚œNSAIDs‹Nˆö«¬’°’×ᇂ̗Տ°“IŒŸ“¢. ŒE“cK‰î1, ‰¡ŽR@ŒO1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ8‰ñ“ú–{Á‰»ŠÇŠw‰ï‘‰ïŠwpW‰ï (2012/2/10), å‘ä.

723146. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) OGIB‚ɑ΂·‚éƒJƒvƒZƒ‹“àŽ‹‹ŸŒŸž‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Œ}@”üK1, ¬—ѐŽET1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ8‰ñ“ú–{Á‰»ŠÇŠw‰ï‘‰ï (2012/2/10), å‘ä.

723147. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) NSTŠˆ“®•ñ‚ƍ¡Œã‚̉ۑè|“–‰@ƒIƒŠƒWƒiƒ‹‚ÌNSTƒvƒƒOƒ‰ƒ€‚̍쐬E‰^—p•]‰¿|. •ŽRMˆê1, ¬“‡Žu•Û, Œõè–Ÿ“ú, ˆÀ’B@Ž 1,2 (1•£–ì•Ó‘‡, 2Á‰»Ší“à): ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2012/2/17), –ŒŒÃ‰®, Ã–¬Œo’°‰h—{ 2012/1; 27 (1): 305.

723148. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) NSTŠˆ“®•ñ‚ƍ¡Œã‚̉ۑè|‰ÁŽZŠJŽnŒã3ƒ•ŒŽ‚ð’Ê‚µ‚ÄŒ©‚Š‚Ä‚«‚œ‚à‚́|. •ŽRMˆê1, Œõè–Ÿ“ú, ¬“‡Žu•Û, ˆÀ’B@Ž 1,2 (1•£–ì•Ó‘‡, 2Á‰»Ší“à): ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2012/2/18), –ŒŒÃ‰®, Ã–¬Œo’°‰h—{ 2012/1; 27 (1): 337.

723149. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘å’°“àŽ‹‹Ÿ“I‚ɐ®•œ‚µ“Ÿ‚œˆÝ‘S“EpŒã‰¡sŒ‹’°Ž²”P“]Ç‚Ì1—á. åb“c@—Ç1, â“Œ‰x˜Y, ‹ß“¡–ç, “¿‰i³‘¥, ’JàV@–L, ì‘º‘׈ê, ‘剪³•œ1,2, ‘é”ör’B, ŽRŒû—Tˆê˜Y, ŒŠŠ}—S‰î, ‹à–{Gs, ãâŽ•F, Ž›“‡‰ë“T (1Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ48‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2012/3/15), ‹à‘ò, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2012/2; 32 (2): 485.

723150. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Role of thromboxaneA2 receptor signaling in liver tissue repair after hepatotoxicity. “ì–ì@•×1, ˆÉ“¡‹`–ç2, ‘å‹v•Û”Ž¢2, ×–ì‰Á“ÞŽq2, ¬ò˜aŽO˜Y1, ¬‹{@Žü3, ”n“ˆ³—²2 (1Á‰»Ší“à, 2–ò—, 3‹ž“s‘åŠw–ò—): ‘æ85‰ñ“ú–{–ò—Šw‰ï”N‰ï (2012/3/16), ‹ž“s.

723151. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒgƒƒ“ƒ{ƒLƒTƒ“A2Žó—e‘̃VƒOƒiƒ‹‚̓}ƒEƒXŽl‰–‰»’Y‘f—U”­‹}«ŠÌáŠQ‚É‚š‚¯‚éŠÌÄ¶‚𑣐i‚·‚é. “ì–ì@•×1, ˆÉ“¡‹`–ç2, ‘å‹v•Û”Ž¢2, ×–ì‰Á“ÞŽq2, ²“Œäm1, ¬ò˜aŽO˜Y1, ”n“ˆ³—²2 (1Á‰»Ší“à, 2–ò—): ‘æ37‰ñ“ú–{”÷¬zŠÂŠw‰ï‘‰ï (2012/3/17), ŠâŽè.

723152. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÌ‹•ŒŒÄŠÁ—¬áŠQŒãŠÌC•œ‚É‚š‚¯‚éVEGFŽó—e‘Ì-1‚Ì–ðŠ„. ‘å‹v•Û”Ž¢1, ˆÉ“¡‹`–ç1, “ì–ì@•×2, ×–ì‰Á“ÞŽq1, “n粏¹•F3, ”n“ˆ³—²1 (1–ò—, 2Á‰»Ší“à, 3ŠO‰È): ‘æ37‰ñ“ú–{”÷¬zŠÂŠw‰ï‘‰ï (2012/3/17), ŠâŽè.

731010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éŠÌŠàŽ¡—Ã. ‚“cŽ÷ˆê (Á‰»Ší“à): ‘æ73‰ñ‘Š–̓Šƒo[ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/5/16), _“ސ쌧‘Š–ÍŒŽŽs.

731011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŠÌ‘Ÿ‚Ɗ̍זE‚ª‚ñ. ’†àV‹MG (Á‰»Ší“à): (ŽÐ) “ú–{ŠÌ‘ŸŠw‰ï^_“ސ쌧^‘Š–ÍŒŽŽs‹€ÃuŽs–¯ŒöŠJuÀ‚₳‚µ‚¢ŠÌ‘Ÿ•a‚Ì‚Í‚È‚µv(2011/5/26), ‘Š–ÍŒŽ.

731012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ŠÇ«’°ŽŸŠ³‚Ì“àŽ‹‹Ÿf’f. ¬—ѐŽ“T (Á‰»Ší“à): ‘æ6‰ñTokai-KitasatoÁ‰»Ší•aŒ€‹†‰ï (2011/6/15), Œú–Ø.

731013. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ŠÇ«’°ŽŸŠ³‚̉摜f’f|IBD‚𒆐S‚Ɂ|. ¬—ѐŽ“T (Á‰»Ší“à): ‘æ34‰ñL“‡‰ŠÇ«’°ŽŸŠ³Œ€‹†‰ï (2011/6/23), L“‡.

731014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬’°ŽŸŠ³‚ɑ΂·‚é“àŽ‹‹Ÿf’f‚̐i•à. ¬—ѐŽ“T (Á‰»Ší“à): Á‰»ŠÇƒtƒH[ƒ‰ƒ€ in Yokohama 2011 (2011/7/28), ‰¡•l.

731015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’×ᇎ¡—Â̗¬‚ê‚ÆŽc‚³‚ê‚œ‰Û‘è|H. pylori‚©‚çNSAID‚ÌŽž‘ã‚ց|. “c糁@‘ (Á‰»Ší“à): º–ò“¯‘‹‰ï•œ¬m‘æ5‰ñƒXƒN[ƒŠƒ“ƒO (2011/8/28), “Œ‹ž.

731016. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’×ᇐ«‘å’°‰Š‚É‚š‚¯‚éÅ‹ß‚Ì’mŒ©. ‰¡ŽR@ŒO (Á‰»Ší“à): ‘æ31‰ñ“ú–{¬Ž™•a—Œ€‹†‰ï (2011/9/3), ‰¡•l.

731017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “àŽ‹‹ŸŽ¡—ÃŽ{sÇ—á‚©‚ç‚Ý‚œˆÝŠàf—Â̌»ó‚ƍ¡Œã‚̉ۑè. “c糁@‘ (Á‰»Ší“à): •œ’Ë‹€Ï•a‰@E‚ª‚ñ‘Šú”­Œ©Ž¡—ÃŒ€C‰ï (2011/9/14), •œ’Ë.

731018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŠÌ×–E‚ª‚ñŽ¡—Á`‹ÇŠŽ¡—©‚番Žq•W“I–òŽ¡—Â܂Ł`. ’†àV‹MG (Á‰»Ší“à): ‘æ15‰ñŠÌ‘Ÿ•a‚ðl‚Š‚é•af˜AŒg‚̉ï`ŠÌŠà–o–Å‚ð–ÚŽw‚µ‚ā`_“ސìˆãŠw‰ï (2011/11/26), ‘Š–ÍŒŽ.

731019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) IBD‚ɑ΂·‚éÅ‹ß‚Ì“à‰ÈŽ¡—Â̐i•à. ¬—ѐŽ“T (Á‰»Ší“à): ‘æ49‰ñ_“ސì‘å’°ŽŸŠ³Œ€‹†‰ï (2012/2/29), ‰¡•l.

731020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’×ᇐ«‘å’°‰Š‚ÌŽ¡—Ð헪|ŽÀ’nˆã‰Æ‚É‘¥‚µ‚œ–òÜ‘I‘ð|. ¬—ѐŽ“T (Á‰»Ší“à): ‘æ3‰ñŠò•ŒIBDƒZƒ~ƒi[ (2012/3/1), Šò•Œ.

731021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) IBDŽ¡—Âɂš‚¯‚鐶•šŠw“I»Ü‚Ì–â‘è“_|RTNFƒ¿R‘̐»Ü‚Ì•›ì—p‚𒆐S‚Ɂ|. ¬—ѐŽ“T (Á‰»Ší“à): ‘æ3‰ñIBD Centre's Conference (2012/3/22), “Œ‹ž.

731022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) CŒ^–«ŠÌ‰Š‚̍ŐVŽ¡—Ã. ’†àV‹MG (Á‰»Ší“à): ‘æ78‰ñ‘Š–̓Šƒo[ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX (2012/3/16), ‘Š–ÍŒŽ.

732009. [Šw‰ï (’nEû‰EEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‚³‚ ¢‚Á‚œ@‚Ç‚€Ž¡—µ‚æ‚€’×ᇐ«‘å’°‰Š. ‰¡ŽR@ŒO (Á‰»Ší“à): _“ސìƒAƒTƒR[ƒ‹ƒ[ƒNƒVƒ‡ƒbƒv (2011/5/19), ‰¡•l.

732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒŒƒNƒ`ƒƒ[) äXùN–E«•a•Ï‚̊ӕʂƐf—Õûj. Šâˆä’m‹v (Á‰»Ší“à): ‘Š–ÍŒŽˆÝ‚Æ’° (2011/5/25), _“ސì.

732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€)y’_äXŽŸŠ³‚ɑ΂·‚é“àŽ‹‹Ÿ“IƒhƒŒƒi[ƒWzŠÌ–å•”ˆ««’_“¹‹·ó‚ɑ΂·‚éuncovered-MS‚ð—p‚¢‚œmulti-stenting‚ÌŒ»ó. ‹{àVŽu˜N1, –Ø“cŒõL1, Œ–{—Y‘Ÿ1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ˆÀ“¡@‹1, ’r“cOŽq1, ‹e’nG•F1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 60.

732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “«’×ᇐ«‘å’°‰Š‚̐V‚µ‚¢Ž¡—Ð헪. ‰¡ŽR@ŒO (Á‰»Ší“à): ‘æ36‰ñIBD Club Jr.Œ€‹†‰ï (2011/6/18), “Œ‹ž.

732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ŠÌŠà‚̍Ĕ­‚Æ•ªŽq•W“I–ò‚ðŠÜ‚ß‚œWŠw“IŽ¡—Ã. ’†àV‹MG (Á‰»Ší“à): ‘æ19‰ñŒÃŠÌ‘ŸƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX (2011/6/28), Œú–Ø.

732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€)ygƒqƒ„ƒbh‚Æ‚µ‚œÇ—á‚©‚çŠw‚ÔIBDŽ¡—ÁzƒXƒeƒƒCƒh»Ü. ‰¡ŽR@ŒO (Á‰»Ší“à): ˆÇ—ÑIBD Symposium in Tokyo (2011/7/2), “Œ‹ž.

732015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒŒƒNƒ`ƒƒ[) ‚±‚±‚܂Ői‚ñ‚Ÿ“àŽ‹‹ŸŽ¡—Á|‘ŠúˆÝ‚ª‚ñ‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̍őOü|. “c糁@‘ (Á‰»Ší“à): Žs–¯‘åŠwuÀ (2011/9/14), ‘Š–ÍŒŽ.

732016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‰h—{—Ö@‚ðŒp‘±‚·‚éƒNƒ[ƒ“•a‚ɑ΂·‚éˆã—ÃŽx‰‡‘̐§. ¬—ѐŽ“T1, –Ñ’Ë—R”üŽq2, –ìŒû‹…Žq3 (1Á‰»Ší“à, 2ŠÅŒì•”, 3‰h—{•”): ‘æ8‰ñ“ú–{Ý‘îÃ–¬Œo’°‰h—{Œ€‹†‰ïŠwpW‰ï (2011/10/8), “Œ‹ž.

732017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ’°Œ^ƒx[ƒ`ƒFƒbƒg•a‚Æ’Pƒ«’×ᇁ|ŽŸŠ³ŠT”O‚ƈٓ¯|. ¬—ѐŽ“T (Á‰»Ší“à): ‘æ24‰ñIBD•ƒx[ƒ`ƒFƒbƒg•aŒ€‹†‰ï (2011/12/9), “Œ‹ž.

732018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y¬’°Žîᇐf’fEŽ¡—Â̌»‹µ‚Æ–â‘è“_z¬’°Žîᇂɑ΂·‚é“àŽ‹‹Ÿf’f‚̈Ӌ`. Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, ²“¡•˜Y2, ŽOŽ}@M3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 73.

732019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yEUS-FNA‚ð—p‚¢‚œf’f‚ÆŽ¡—Â̐i•àzŠŽõ«äX‰óŽ€‚ɑ΂·‚é“àŽ‹‹Ÿ‘}“ü‰º‰óŽ€‘ƒœ‹Žp‚ÌŽÀÛ. Šâˆä’m‹v1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 86.

732020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ’_“¹ŽŸŠ³‚̐f’f‚ÆŽ¡—Ã. –Ø“cŒõL (Á‰»Ší“à): ‘æ23‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒƒZƒ~ƒi[ (2012/1/21-22), “Œ‹ž.

732021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) FNA‚Ì“K‰žŽŸŠ³‚Ɛf’fEŽ¡—Â̌ÀŠE. –Ø“cŒõL (Á‰»Ší“à): ‘æ20‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï–k—€Žx•”ƒZƒ~ƒi[ (2012/1/29), ‹à‘ò.

733021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) PEIT•¹—p‚ɂĈÀ‘S‚ÉRFA‚ðŽÀŽ{‚Å‚«‚œ’°ŠÇ‹ß–T|ŠÌ×–EŠà‚̈ê—á|. ¬–ìO“ñ1,2 (1ˆÉšŒŽ‹Š“¯, 2Á‰»Ší“à): ‘æ14‰ñuŠÌ‘Ÿ•a‚ðl‚Š‚é•af˜AŒg‚̉ïv`ŠÌ‚ª‚ñ–o–Å‚ð–ÚŽw‚µ‚ā` (2011/5/21), •œ’Ë.

733022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ž¡—Âɓïa‚µ‚œ“«‰º—ŸÇ‚Ì1—á. ‰œ˜e‹»‰î1, ‰¡ŽR@ŒO1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1, ŽOã“N•v2, ˆêŒË¹–Ÿ2, ŽOŽ}@M2 (1Á‰»Ší“à, 2•a—): ‘æ119‰ñ‘Š–ÍŒŽˆÝ‚Æ’°Œ€‹†‰ï (2011/5/25), ‘Š–ÍŒŽ.

733023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) äXùN–EŒo‰ßŠÏŽ@’†‚ÉäXŠà‚ª”­Ç‚µ‚œ1—á. ŽR“à_Žj1, –Ø“cŒõL1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’rG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1, ŽOã“N•v2, ŽOŽ}@M2 (1Á‰»Ší“à, 2•a—): ‘æ119‰ñ‘Š–ÍŒŽˆÝ‚Æ’°Œ€‹†‰ï (2011/5/25), ‘Š–ÍŒŽ.

733024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠÌŽîᇂ̈ê—á. ¬–ìO“ñ1,2, ˜a“c‘ñ–ç1,2, ˆ¢]‘Ÿ‰ÀŽq1,2, ‘OàV@”J1,2,‘å–ì@—²1,2, ‹Êì‰pŽj, ŠÖŒËN—F (1ˆÉšŒŽ‹Š“¯, 2Á‰»Ší“à): ‘æ17‰ñÃ“쐌•”ŠÌŽŸŠ³Œ€‹†‰ï (2011/6/9), ˆÉšŒŽ.

733025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “àŽ‹‹Ÿ“I‚ɏœ‹Ž‚µ“Ÿ‚œˆÝÎ‚Ì1—á. ‚‹ŽW•F1, ÎŒËŒªŽŸ1, “c糁@‘1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ceEE, ’†’JŒ€“l1, “Œ@’q1, ¬–с@“N1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/10), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 89.

733026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’Œ’°‚É•¡”‚̗ǐ«ƒŠƒ“ƒpàh–E«ƒ|ƒŠ[ƒv‚ð”F‚ß‚œ1—á. Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, ŒŽ@“ÖŽq2, ŽOŽ}@M2 (1Á‰»Ší“à, 2•a—): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/10), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 92.

733027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’°ŠÇùNŽî—l‹CŽîÇ14—á‚̗Տ°Šw“IŒŸ“¢. ’†–Ú“N•œ1, ‰¡ŽR@ŒO1, Œ}@”üK1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/10), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 95.

733028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éˆÝpŒãŠ³ŽÒ‚ɑ΂·‚éERCP‚ÌŒŸ“¢. ŽR“à_Žj1, –Ø“cŒõL1, ‰œ˜e‹»‰î1, ŽR–{@‘n1, Šâˆä’m‹v1, ‹{àVŽu˜N1, ‹e’rG•F1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 98.

733029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) äX“à•ª”åŽîᇂ̐f’f‚É‚š‚¯‚éEUS-FNA‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ‰œ˜e‹»‰î1, –Ø“cŒõL1, ŽR“à_Žj1, ŽR–{@‘n1, ²“Œäm1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1, ŽOã“N•v2, ŽOŽ}@M2 (1Á‰»Ší“à, 2•a—): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 101.

733030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰): ’Œ’°Žîᇂɂš‚¯‚鎡—ÃXƒgƒ‰ƒeƒW[|‰º•”’Œ’°Žîᇂɑ΂·‚鎡—Õû–@•Ê‚Ì”äŠrŒŸ“¢|. –x“à—T‰î1, ç–쏻Žq, Œ”öN³, ‹gàV“Þ’ÃŽq1,2, ¡ˆä, —с@—TŽq, ŠÝŒŽ‹Pm, ‰Á“¡@ŒO, •œàV•q–Ÿ, ŽR–{—Š³, “y“c’mG, ‰Yã®”V, “¡è‡Žq, ŒÜ\—’³L1,2, “¡–{‰À–ç, ã–ì‰ëŽ‘ (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 67.

733031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) EUS-FNA‚ÅŠm’èf’fŒã, p‘OE⏕‰»Šw—Ö@‚ðŽ{s‚µ‚œ’Œ’°GIST‚Ì1—á. Œ”öN³1, ç–쏻Žq, –x“à—T‰î, ‹gàV“Þ’ÃŽq1,2, ¡ˆä, ŠÝŒŽ‹Pm, •œàVr–Ÿ, ŽR–{—Š³, “y“c’mG, “¡è‡Žq, ŒÜ\—’³L1,2, ”öã«l, ŽÂè‰pŽi, ––‰iŒõ–M, …ÀM”V (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 97.

733032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ”rÎ‘O‚̏󋵂ª“àŽ‹‹Ÿ“I‚ÉŠm”F‚³‚ê‚œ’_ÎƒCƒŒƒEƒX‚Ì1—á. ‹e’n³b1,2, ŽRèDŠì1,2, ’r“c@”™1,2, “n•ÓWŽ¯1,2, ‰ÍŒèû‘Ÿ˜Y, ¬–с@“N1,2, •ìŒ«ˆê˜Y, ‹e’nG•F1,2, —¢“¹“N•F1,2, –ì“o@œ1,2 (1•œ’Ë‹€Ï 2Á‰»Ší“à): ‘æ92‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2011/6; 79 (1): 100.

733033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŒŒð«ŒŒ¬”ÂŒž­«Ž‡”Á•a‚É‚æ‚è”­Ç‚µ‚œ‚ÆŽv‚í‚ê‚é‹•ŒŒ«äX‰Š‚Ì1—á. ŽO“‡Fm1, ‹{àVŽu˜N1, ŽR’J—§‘å2, _œä’m“¹2, ’†’JŒ€“l1,2, ¡ò@O1, –Ø“cŒõL1, ‘Š”nˆêˆå2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‹~–œ): ‘æ581‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/11), “Œ‹ž, ‘æ581‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/9; p.22.

733034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘å’°Šà‚̈ê—á. ŽR“à_Žj1, ²“c”ü˜a1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ6‰ñTokai-KitasatoÁ‰»Ší•aŒ€‹†‰ï (2011/6/15), Œú–Ø.

733035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) pŒã‚Ì–ü’…‚Ì‚œ‚ߎ©‘R”rÎ‚ª¢“ï‚Å‚ ‚Á‚œ’_ÎƒCƒŒƒEƒX‚Ì1—á. “n•ÓWŽ¯1,2, ŽRèDŠì1,2, ’r“c@”™1,2, ‰ÍŒèû‘Ÿ˜Y, ‹e’n³b1,2, •ìŒ«ˆê˜Y, —¢“¹“N•F1,2, ‹e’nG•F1,2, à_–Œr–ç, –ì“o@œ1,2 (1•œ’Ë‹€Ï, 2Á‰»Ší“à): _“ސ쌧Á‰»Ší•aˆãŠw‰ï‘æ56‰ñŒ€‹†‰ï (2011/6/18), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2012/1; 39 (1): 88-9.

733036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Rƒ~ƒgƒRƒ“ƒhƒŠƒAM2R‘Ì (M2R‘Ì) ‚ª—z«‚ðŽŠ‚µ‚œ–ò•š«ŠÌáŠQ (DILI) ‚Ì4Ç—á. “n粐^²1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, “ú‚@‰›1, ’†àV‹MG1, ¬ò˜aŽO˜Y1, a’J–Ÿ—²1,2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ56‰ñ_“ސ쌧Á‰»Ší•aŒ€‹†‰ïƒvƒƒOƒ‰ƒ€ (2011/6/18), ‰¡•l.

733037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ž©‘RŽ¡–ü‚µ‚œCŒ^–«ŠÌ‰ŠÇ—á‚É‚š‚¯‚éIL28BˆâE`Žq‚ÌŒŸ“¢. ŽRªŒhŽq1, ’†àV‹MG1, Ž…—T‹M1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—S‰î1, “ú‚@‰›1, “n粐^²1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ75‰ñ‘Š–̓Šƒo[ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX (2011/6/20), ‘Š–ÍŒŽ.

733038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “ÁŽê‘gDŒ^isH“¹Šà‚É“¯Žž«’†ˆô“ª•\ÝŠà‚ªd•¡‚µ‚œ1—á. Ž…—T‹M1, Œ˜“ce—˜1, “c糁@‘1, ¬ò˜aŽO˜Y1, ³˜Ò@—²2, Œ—tG‹N2, ‰ª–{—·l2, ’†ŽR–Ÿm2, ‰ª–{–ql2, ¬’J³Žq3, ‘ì˜ad3 (1Á‰»Ší“à, 2Žš•@, 3•úŽËü (Žîá‡)): ‘æ9‰ñ“ªèò•”•\ÝŠàŒ€‹†‰ï (2011/6/25), “Œ‹ž.

733039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ºˆô“ª•\ÝŠà‚ª“¯Žž«‚ɏd•¡‚·‚éisH“¹Šà‚ɑ΂µ‚ĉ»Šw•úŽËü—Ö@‚ðŽ{s‚µ‚œ3—á. Œ˜“ce—˜1, ’†ŽR–Ÿm2, ³˜Ò@—²2, Œ—tG‹N2, ‰ª–{—·l2, ¬’J³Žq3, “c糁@‘1, ¬ò˜aŽO˜Y1, ‘ì˜ad3, ‰ª–{–ql2 (1Á‰»Ší“à, 2Žš•@, 3•úŽËü (Žîá‡)): ‘æ9‰ñ“ªèò•”•\ÝŠàŒ€‹†‰ï (2011/6/25), “Œ‹ž.

733040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ”ñØœäXŠà‚ɑ΂·‚é’·Šú‰»Šw—Ö@Ž{s—á‚ÌŒŸ“¢. Šâˆä’m‹v1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): _“ސ쌧äXŠàŒ€‹†‰ï (2011/7/6), _“ސì.

733041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‚Ì‚€–E«’Ž‚Žîᇂ̈ê—á. ˜a“c‘ñ–ç1,2, ˆ¢]‘Ÿ‰ÀŽq1,2, ‘OàV@”J1,2, ¬–ìO“ñ1,2, ‘å–ì@—²1,2, ‹ß“¡’”V, ‹Êì‰pŽj, ŠÖŒËN—F (1ˆÉšŒŽ‹Š“¯, 2Á‰»Ší“à): ‘æ11‰ñŒ_“ސìÁ‰»ŠíƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/7/7), ˆÉšŒŽ.

733042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠÌ‰ßŒ`¬Œ‹ß‚ÌEOB‰æ‘œŠŒ©‚ÌŒŸ“¢. ’†àV‹MG (Á‰»Ší“à): ‘æ4‰ñEOB/ƒvƒŠƒ‚ƒrƒXƒgƒZƒ~ƒi[ (2011/7/15), ‰¡•l.

733043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ä”R‚µ‚œ‹}«dÇŠÌ‰Š‚̈ê—á. Œ–{‚–Ÿ1, ’†àV‹MG1, “c’†Œ«–Ÿ1, Ž…—T‹M1, ‚“cŽ÷ˆê1, ‰œ˜e—S‰î1, “ú‚@‰›1, “n粐^²1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ74‰ñ‘Š–̓Šƒo[ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX (2011/7/25), ‘Š–ÍŒŽ.

733044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠÌŠàŒ€‹†‰ïƒ‰ƒWƒI”gŽ¡—Ãnƒ“ƒYƒIƒ“ƒZƒbƒVƒ‡ƒ“. ¬–ìO“ñ1,2 (1ˆÉšŒŽ‹Š“¯, 2Á‰»Ší“à): ‘æ47‰ñ“ú–{ŠÌŠàŒ€‹†‰ï (2011/7/28), Ã‰ª.

733045. [Šw‰ï (’nEû‰EEŒ€‹†‰ï)] (ˆê”ʍu‰‰) EUS-FNA‚É‚æ‚èp‘Of’f‚ª‰Â”\‚Æ‚È‚Á‚œˆÝƒOƒ[ƒ€ƒXŽîᇂ̈ê—á. ‰œ˜e‹»‰î1, –Ø“cŒõL1, ’·’Jì—Í–ç1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): FNA Club JAPAN (2011/8/10), “Œ‹ž.

733046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒŒƒ~ƒP[ƒhŽ¡—ªƒNƒ[ƒ“•a (‘å’°Œ^) ‚Ì‹·ó‚ɑ΂·‚éŽèp‚É—LŒø‚Å‚ ‚Á‚œ‚ƍl‚Š‚ç‚ê‚é1—á. ‘å–ì@—²1,2, ˜a“c‘ñ–ç1,2, ˆ¢]‘Ÿ‰ÀŽq1,2, ‘OàV@”J1,2, ¬–ìO“ñ1,2, Œ‰ª“¹l,ŠÖŒËN—F (1ˆÉšŒŽ‹Š“¯, 2Á‰»Ší“à): Ã“ìInfliximab Seminar (2011/9/7), Œú–Ø.

733047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Olmesartan‚̈ê”NŠÔ“Š—^‚͊̐üˆÛ‰»‚ð‰ü‘P‚³‚¹‚é‚©. “ú‚@‰›1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ13‰ñ ŠÌ•s‘SŽ¡—ÃŒ€‹†‰ï (2011/9/16), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 168.

733048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Øœ•s”\isˆÝŠàŽ¡—Âɑ΂·‚éPharmacogenomics‚ð—p‚¢‚œŒÂ•Ê‰»ˆã—ÂɌü‚¯‚Ä‚ÌŽæ‚è‘g‚Ý. “Œ@’q1, ÎŒËŒªŽŸ1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, ¬–с@“N1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ1‰ñˆÝŠàTVƒlƒbƒgƒ[ƒNƒZƒ~ƒi[ (2011/9/16), Œú–Ø.

733049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’_ŠÇ‘¹—\–h‚É’_ŠÇ’…ŠÁ—¬‚ðs‚Á‚œŠJ• ‰ºƒ‰ƒWƒI”gŽ¡—×á. ‰œ˜e—S‰î1, ’†àV‹MG1, •Ð‹ËŠ°”V2 (1Á‰»Ší“à, 2ŠO‰È): ‘æ28‰ñ“Œ‹žŠÌŠà‹ÇŠŽ¡—ÃŒ€‹†‰ï (2011/9/17), “Œ‹ž.

733050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Sorafenib“Š—^Œã‘ˆ«‚·‚é‚àÄ’·Šú“Š—^‚É‚æ‚è‘tŒ÷‚ðŽŠ‚µ‚œŠÌ×–EŠà‘œ”­”x“]ˆÚ‚̈ê—á. ‰œ˜e—T‰î1, ’†àV‹MG1, Ž…—T‹M1, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, “n粐^²1, “ú‚@‰›1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ316‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (2011/9/17), “Œ‹ž.

733051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Infliximab“Š—^’†‚É’°ŠÇ‹·ó‚𗈂œ‚µ‚œCrohn•a‚Ì1—á. ˆäã’qm1, ‰¡ŽR@ŒO1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ316‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (2011/9/17), “Œ‹ž.

733052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŒŽˆö•s–ŸÁ‰»ŠÇoŒŒ‚̐f’f‰ßEö‚ÆŽ¡—Ã. Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ11‰ñ_“ސ쏬’°‰æ‘œŒ€‹†‰ï (2011/9/22), ‰¡•l.

733053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘å’°”S–Œ‰º•a•Ï‚̈ê—á. Ž…—T‹M1, ¬—ѐŽ“T1, Œ}@”üK1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, ŽOã“N•v2, ŽOŽ}@M2 (1Á‰»Ší“à, 2•a—): ‘Š–ÍŒŽˆÝ‚Æ’° (2011/9/28), _“ސì.

733054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) pŒã‚Ì‘å—Ê—AŒŒŒã‚É”­¶‚µ‚œˆÙDR‘Ì‚ªŒŽˆö‚ÆŽv‚í‚ê‚éHCV‹[—z«‚Ì1—á. “n•ÓWŽ¯1,2, ŽRèDŠì1,2, ’r“c@”™1,2, ‰ÍŒŒ°‘Ÿ˜Y, ‹e’n³b1,2, •ìŒ«ˆê˜Y, ‹e’nG•F1,2, —¢“¹“N•F1,2, à_–Œr–ç, –ì“o@œ1,2 (1•œ’Ë‹€Ï, 2Á‰»Ší“à): ‘æ580‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2011/10/9), “Œ‹ž, ‘æ580‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/10; p.31.

733055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) H“¹ˆ««•FŽî‚Ì1—á. ’r“c”™1,2, ŽRèDŠì1,2, —é–Ø—z•F, ³–ØŽkl, ‰ÍŒèû‘Ÿ˜Y1, “n•ÓWŽ¯1,2, ‹e’n³b1,2, •ìŒ«ˆê˜Y, ‹e’nG•F1,2, —¢“¹“N•F1,2, à_–Œr–ç, –ì“o@œ1,2 (1•œ’Ë‹€Ï, 2Á‰»Ší“à): _“ސ쌧Á‰»Ší•aˆãŠw‰ï‘æ44‰ñ‘‰ï (2011/10/15), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2012/1; 39 (1): 78-9.

733056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) •úŽËü‚š‚æ‚у\ƒ‰ƒtƒFƒjƒu•¹—p—Ö@‚Å2”NˆÈã‚Ì’·Šú¶‘¶‚ª“Ÿ‚ç‚ê‚Ä‚¢‚鍂“x–¬ŠÇŽîᇐZ (Vp2 + Vv3) ‡•¹‹‘åŠÌ×–EŠà‚Ì1—á. —é–ؐl1, ’†àV‹MG1, Ž…—T‹M1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “ú‚@‰›1, “ì–ì@•×1, “n粐^²1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ15‰ñŠÌ‘Ÿ•a‚ðl‚Š‚é•af˜AŒg‚̉ï`ŠÌŠà–o–Å‚ð–ÚŽw‚µ‚ā`_“ސìˆãŠw‰ï (2011/11/26), ‘Š–ÍŒŽ.

733057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ŠàÇ—á‚É‚š‚¯‚铪èò•”•\ÝŠà”­¶‚̊댯ˆöŽq. Œ˜“ce—˜1, “c糁@‘1, ³˜Ò@—²2, Œ—tG‹N2, ‰ª–{—·l2, Ž–ì—R”y2, ’†ŽR–Ÿm2, ¬ò˜aŽO˜Y1, ‰ª–{–ql2 (1Á‰»Ší“à, 2Žš•@): ‘æ10‰ñ“ªèò•”•\ÝŠàŒ€‹†‰ï (2011/11/26), “Œ‹ž.

733058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) •úŽËü‚š‚æ‚у\ƒ‰ƒtƒFƒjƒu•¹—p—Ö@‚Å2”NˆÈã‚Ì’·Šú¶‘¶‚ª“Ÿ‚ç‚ê‚Ä‚¢‚鍂“x–¬ŠÇŽîᇐZ (Vp2 + Vv3) ‡•¹‹‘åŠÌ×–EŠà‚Ì1—á. —é–ؐl1, ’†àV‹MG1, Ž…—T‹M1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “ú‚@‰›1, “ì–ì@•×1, “n粐^²1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ317‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/3), “Œ‹ž.

733059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’_äX“àŽ‹‹ŸŽ¡—Âɂš‚¯‚éƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO: Covered metallic stent•ÂÇŽž‚Ì”²‹Ž¢“ï—á‚ɑ΂·‚é‘Ήž. ‹{àVŽu˜N1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ’r“cOŽq1, ‹e’nG•F1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 68.

733060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒƒ‰ƒjƒ“Œ‡–R«¬•ª‚ðŽå•a•Ï‚Æ‚·‚éH“¹ŒŽ”­ˆ««•FŽî‚̈ê—á. ŽRª‘‹IŽq1, “Œ@’q1, “c糁@‘1, ¬ò˜aŽO˜Y1, ŽR“c˜a•F, ŽOŽ}@M2, ŽOã“N•v2 (1Á‰»Ší“à, 2•a—): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 101.

733061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘œ”­¬’°‹·ó‚ð‚«‚œ‚µ‚œNSAID‹Nˆö«¬’°’×ᇂÌ1—á. ŒE“cK‰î1, ‰¡ŽR@ŒO1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 102.

733062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘å’°“àŽ‹‹Ÿ‚É‚æ‚鐶ŒŸ‘gDf’f‚ª‰Â”\‚Å‚ ‚Á‚œ’°ŠÇŽq‹{“à–ŒÇ‚Ì1—á. Ž…—T‹M1, ¬—ѐŽ“T1, Œ}@”üK1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, ŽOã“N•v2 (1Á‰»Ší“à‰È, 2•a—): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 112.

733063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Á‰»ŠÇ”S–Œ‰ºŽîᇎèpÇ—á‚É‚š‚¯‚ép‘OEUS-FNA‚̐f’f”\‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “¿‰iŽüŽq1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ‹e’rG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 118.

733064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Á‰»ŠÇESD: ‘œ—l‚ȃfƒoƒCƒX‚ð‚Ç‚€Žg‚€‚© ã•”Á‰»ŠÇ•a•Ï‚Ì“àŽ‹‹Ÿ“I”S–Œ‰º‘w”—£p (ESD) ‚É‚š‚¯‚郀ƒRƒ[ƒNƒg[ƒ€2‚Ì—L—p«. –x“à—T‰î1, ŽR–{—ŠE³, —é–؁@ãÄ, ’JŒû’q, Œ”öN³, ‹gàV“Þ’ÃŽq1,2, ›ÀF‹I, ‘å‘O‰ëŽÀ, ÎŽRW¢Žu, •œàVr–Ÿ, ç–쏻Žq, “y“c’mG, ˆ×‰äˆä–F˜Y, “¡è‡Žq, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 77.

733065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “–‰@‚ňݐ¶ŒŸ‚É‚Äatypical epithelium (VGroup•ª—Þ; Group 2‘Š“–) ‚Ɛf’f‚³‚ê‚œ•a•Ï‚ÉŠÖ‚·‚錟“¢. ‹gàV“Þ’ÃŽq1,2, “¡è‡Žq, —é–؁@ãÄ, ’JŒû’q, –x“à—T‰î, Œ”öN³, ›ÀF‹I, ŒE“c@Šw, ‘å‘O‰ëŽÀ, ÎŽRW¢Žu, •œàVr–Ÿ, ç–쏻Žq, ŽR–{—Š³, “y“c’mG, ˆ×‰äˆä–F˜Y, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 119.

733066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) p‘O¶ŒŸf’ftub2-por‚Ì‘ŠúˆÝŠà‚ɑ΂·‚éNBIŠg‘åŠÏŽ@‚Ì—L—p«|NBIŠg‘åŠÏŽ@‚Æ•a—•W–{‚Ƃ̑Δä|. Œ”öN³1, “¡è‡Žq, ’JŒû’q, —é–؁@ãÄ, –x“à—T‰î, ‹gàV“Þ’ÃŽq1,2, ›ÀF‹I, ŒE“c@Šw, ‘å‘O‰ëŽÀ, ÎŽRW¢Žu, •œàVr–Ÿ, ç–쏻Žq, ŽR–{—Š³, “y“c’mG, ˆ×‰äˆä–F˜Y, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 119.•ª

733067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “àŽ‹‹Ÿ“I”S–Œ‰º‘w”—£p‚ðŽ{s‚µ‚œ–¢•ª‰»Œ^ˆÝŠà‚É“ûŠàˆÝ“]ˆÚ‚ð”F‚ß‚œ1—á. ’JŒû’q1, ŽR–{—Š³, —é–؁@ãÄ, –x“à—T‰î, Œ”öN³, ‹gàV“Þ’ÃŽq1,2, ŒE“c@Šw, ›ÀF‹I, ‘å‘O‰ëŽÀ, ÎŽRW¢Žu, •œàVr–Ÿ, “y“c’mG, “¡è‡Žq, ¯–ìŒb’Õv, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 120.

733068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰): ‰»Šw—Ö@‚Ì‘tŒø‚É‚æ‚èÁ‰»ŠÇƒXƒeƒ“ƒg‚ª’E—Ž‚µ, ãè–å‚©‚玩‘R”rŸ•‚³‚ê‚œ‚ÆŽv‚í‚ê‚éisˆÝŠà‚Ì1—á. “n•ÓWŽ¯1,2, ŽRèDŠì1,2, ’r“c@”™1,2, ‰ÍŒèû‘Ÿ˜Y, •ìŒ«ˆê˜Y, ‹e’r³b1,2, —¢“¹“N•F1,2, ‹e’rG•F1,2, à_–Œr–ç, –ì“o@œ1,2 (1•œ’Ë‹€Ï, 2Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 121.

733069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) H. pylori‰A«‘œ”­ˆÝŠà‚̈ê—á. —é–؁@ãÄ1, “¡è‡Žq, ’JŒû’q, –x“à—T‰î, ‹gàV“Þ’ÃŽq1,2, Œ”öN³, ›ÀF‹I, ŒE“c@Šw, ‘å‘O‰ëŽÀ, ÎŽRW¢Žu, •œàVr–Ÿ, ç–쏻Žq, ŽR–{—Š³, “y“c’mG, ˆ×‰äˆä–F˜Y, ¯–ìŒb’Õv, ŒÜ\—’³L1,2, ”äŠé’ŒŽ÷ (1ŠàŒ€—L–Ÿ, 2Á‰»Ší“à): ‘æ93‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/9-10), “Œ‹ž, Progress of Digestive Endoscopy 2011/12; 80 (1): 121.

733070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) oŒŒ«ˆÝ’×ᇂðŒ_‹@‚É”­Œ©‚³‚ê‚œŒã“V«ŒŒ—F•a‚Ì1—á. —é–Ø—z•F1, à_–Œr–ç, ’r“c@”™1,2, “n•ÓWŽ¯1,2, ‰ÍŒŒ°‘Ÿ˜Y, •ìŒ«ˆê˜Y, ‹e’n³b1,2, —¢“¹“N•F1,2, ‹e’nG•F1,2, ŽRèDŠì1,2 (1•œ’Ë‹€Ï, 2Á‰»Ší“à): ‘æ584‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2011/12/10), ìè, ‘æ584‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/12; p.51.

733071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) áŠQŠÌ‘gDC•œ‚É‚š‚¯‚éƒgƒƒ“ƒ{ƒLƒTƒ“Žó—e‘̃VƒOƒiƒ‹‚Ì–ðŠ„. “ì–ì@•×1, ˆÉ“¡‹`–ç2, ‘å‹v•Û”Ž¢2, ×–ì‰Á“ÞŽq2, ¬ò˜aŽO˜Y1, ”n“ˆ³—²2 (1Á‰»Ší“à, 2–ò—): ‘æ25‰ñŠÌ—Þ“Ž•Ç×–EŒ€‹†‰ïŠwpW‰ï (2011/12/18), “Œ‹ž.

733072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Double-scope ESD‚ª—LŒø‚Å‚ ‚Á‚œ ESDŒã‹ß–TˆÙŽž‘œ”­•a•Ï‚̏Ǘá. ÎŒËŒªŽŸ1, “c糁@‘1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬–с@“N1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): EGMRŒ€‹†‰ï (2012/1/20), “Œ‹ž.

733073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘å’°”ñã”琫Žîᇂ̐f’f‰ß’ö‚Æ’Ž‰¹”g“àŽ‹‹Ÿf’f‚̈Ӌ`. Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1, ²“¡•˜Y2, ŽOã“N•v3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—): ‘æ74‰ñ‘å’°ŠàŒ€‹†‰ï (2011/1/21), •Ÿ‰ª, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2011/8; 64 (8): 532.

733074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Crohn•a‚ɑ΂·‚éƒAƒ_ƒŠƒ€ƒ}ƒu‚ÌŽ¡—ЬÑ. ¬—ѐŽ“T (Á‰»Ší“à): _“ސìƒqƒ…ƒ~ƒ‰ŠwpƒVƒ“ƒ|ƒWƒEƒ€ (2012/2/12), ‰¡•l.

733075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “]ˆÚÄ”­‚ð‚«‚œ‚µ‚œ ˆÝè÷—±×–EŽî‚Ì1—á. “¿‰iŽüŽq1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‚“cŽ÷ˆê1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’rG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1, ŽRŒû‚éEŽq2, “n粏¹•F2, ŒŽ@“ÖŽq3, ŽOã“N•v3, ŽOŽ}@M3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—): Shinyokohama Digestive Disease Meeting (2012/2/22), ‰¡•l.

733076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ž©‘RŽ¡–ü‚µ‚œCŒ^–«ŠÌ‰ŠÇ—á‚ÌIL28Bˆâ“`Žq‚ðŠÜ‚ß‚œ—Տ°“IŒŸ“¢. ŽRªŒhŽq1, ’†àV‹MG1, Ž…—T‹M1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—S‰î1, “ú‚@‰›1, “n粐^²1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ23‰ñ_“ސìŠÌ‰ŠƒEƒCƒ‹ƒXƒZƒ~ƒi[ (2012/2/23), ‰¡•l.

733077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) 5-ASA‚ÌŽg‚¢•û‚̃Rƒc. ‰¡ŽR@ŒO (Á‰»Ší“à): ‘Š–ÍŒŽUCƒZƒ~ƒi[ (2012/2/29), ‘Š–ÍŒŽ.

733078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éBŒ^‹}«ŠÌ‰Š‚̍ŋ߂̓®Œü. ˆäã’qm1, ’†àV‹MG1, ˜a“c‘ñ–ç1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “ú‚@‰›1, “n粐^²1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ78‰ñ‘Š–̓Šƒo[ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX (2012/3/16), ‘Š–ÍŒŽ.

733079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’_ŠÇ“à”S‰tŽY¶«•a•Ï‚Ì2—á. “¿‰iŽüŽq1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1, •Ð‹ËŠ°”V2, ÎˆäŒ’ˆê˜Y2, ŒGŒ³—Y‰î2, “n粏¹•F2, ŽOã“N•v3, ‹g“c@Œ÷3, ‘å•”@œ4, ŽOŽ}@M3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—, 4ˆã—Éq¶Šw•”): ‘Š–ÍŒŽˆÝ‚Æ’° (2012/3/28), ‘Š–ÍŒŽ.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-522003. [uÀ]y“ÁW:u’Bl‚Ì‹Zv|’_EäXz [‚±‚ꂪŽ„‚ÌŠÏŽ@–@EŽB‰e–@]@’Ž‰¹”g“àŽ‹‹Ÿ: ƒ‰ƒWƒAƒ‹Œ^|EUS‰ð–U—‰ð‚Ì‚œ‚߂̃gƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. –Ø“cŒõL (Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2011/3; 23 (3): 542-7.

[Šw‰ïEŒ€‹†‰ï“™]

H22-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘å’°”S–Œ‰º‘wZ (pSM) Šà‚Ì”­ŠàŒo˜H‚É‚æ‚é•a—Šw“I·ˆÙ|—²‹NŒ^‚Æ•œ’RŒ^‚Ì”äŠr|. ¬ì‘åŽu1, ‹g“c@Œ÷2, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1, ‰ªˆÀ@ŒM2 (1Á‰»Ší“à, 2•a—): ‘æ74‰ñ‘å’°ŠàŒ€‹†‰ï (2011/1/21), •Ÿ‰ª, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2011/8; 64 (8): 535.

H22-733002. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Crohn•a‚ɑ΂·‚é“àŽ‹‹Ÿ“Iƒoƒ‹[ƒ“Šg’£pŽ{sŒã‚ÉŠO‰ÈŽèp‚Æ‚È‚Á‚œ1—á. ‰Á“¡@Ê1, ‰¡ŽR@ŒO1, ’†–Ú“N•œ1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, E¬—ѐŽ“T1, ¬ò˜aŽO˜Y1, ’r“c@“Ä2, ¬àV•œ‘Ÿ2 (1Á‰»Ší“à, 2ŠO‰È): _“ސìIBDƒ~ƒjƒJƒ“ƒtƒ@Šg‘åu‰‰‰ï (2011/3/4), ‰¡•l.


zŠÂŠí“à‰ÈŠw

[Šwp˜_•¶]

110094. [ŒŽ’˜] Clinical significance of corticosteroid therapy for eosinophilic myocarditis. Yanagisawa T1, Inomata T1, Watanabe I, Maekawa E, Mizutani T, Shinagawa H1, Koitabashi T1, Takeuchi I2, Izumi T1: Int Heart J 2011/4; 52 (2): 110-3. (–öàV’q‹`1, ’––”FŒ³1, “n•Óˆê˜Y, ‘OìŒb”ü, …’J’m‘×, •iì–íl1, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ˜aò@“O1: 1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã)

110095. [ŒŽ’˜] Comparison of nitrite compounds and carperitide for initial treatment of acute decompensated heart failure. Mizutani T, Inomata T1, Watanabe I, Maekawa E, Yanagisawa T1, Shinagawa H1, Koitabashi T1, Takeuchi I2, Izumi T1: Int Heart J 2011/4; 52 (2): 114-8. (…’J’m‘×, ’––”FŒ³1, “n•Óˆê˜Y, ‘OìŒb”ü, –öàV’q‹`1, •iì–íl1, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ˜aò@“O1: 1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã)

110096. [ŒŽ’˜] Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS LibertEstents in de novo native coronary artery lesions. Otake H, Honda Y, Courtney BK, Shimohama T1, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ: Circ Cardiovasc Interv 2011/4; 4 (2): 146-54. (‰º•lF˜Y1: 1zŠÂŠí“à)

110097. [ŒŽ’˜] Prognostic significance of right ventricular dimension on acute decompensation in chronic left-sided heart failure. Maekawa E1, Inomata T1, Watanabe I1, Yanagisawa T1, Mizutani T1, Shinagawa H1, Koitabashi T1, Takeuchi I2, Tokita N1, Inoue Y3, Izumi T1: Int Heart J 2011/4; 52 (2): 119-26. (‘OìŒb”ü1, ’––”FŒ³1, “n•Óˆê˜Y1, –öàV’q‹`1, …’J’m‘×1, •iì–íl1, ¬”‹Žr”ü1, ’|“àˆê˜Y2, “Œ“c®Ž÷1, ˆäã—D‰î3, ˜aò@“O1: 1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3•úŽËü (‰æ‘œ))

110098. [ŒŽ’˜] The T wave inversion score is useful for evaluating the time-course of acute pulmonary embolism. Kunishima T, Akashi YJ, Miyake F, Aoyama N1, Kohshoh H, Yoshino H, Seki K, Matsumoto K, Furukawa T, Yoshioka K, Amano H, Taguchi I, Sugimura H, Murakawa Y: Circ J 2011/4; 75 (5): 1222-6. (ÂŽR’Œ‘P1: 1zŠÂŠí“à)

110099. [ŒŽ’˜] Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan. - Subanalysis of the J-RHYTHM Registry-. Niwano S1 (J-RHYTHM Registry Investigators): Circ J 2011/9; 75 (10): 2357-62. (’ë–ìTˆê1: 1zŠÂŠí“à)

110100. [ŒŽ’˜] Progression of ventricular remodeling and arrhythmia in the primary hyperoxidative state of glutathione-depleted rats. Kurokawa S1, Niwano S1, Niwano H1, Ishikawa S, Kishihara J, Aoyama Y1, Kosukegawa T, Masaki Y, Izumi T1: Circ J 2011/5; 75 (6): 1386-93. (•ì‘–1, ’ë–ìTˆê1, ’ë–ì—TŒb1, ÂŽR’Œ‘P1, ˜aò@“O1: 1zŠÂŠí“à)

110101. [ŒŽ’˜] Phase III clinical pharmacology study of tolvaptan. Inomata T1, Izumi T1, Matsuzaki M, Hori M, Hirayama A; Tolvaptan Investigators: Cardiovasc Drugs Ther 2011/12; 25 (Suppl 1): S57-65. (’––”FŒ³1, ˜aò@“O1: 1zŠÂŠí“à)

110102. [ŒŽ’˜] Intravascular ultrasound assessment of postprocedural incomplete stent apposition. Kume T, Waseda K, Ako J, Sakata K, Yamasaki M, Shimohama T1, Tsujino I, Hasegawa T, Fitzgerald PJ, Honda Y: J Invasive Cardiol 2012/1; 24 (1): 13-6. (‰º•lF˜Y1: 1zŠÂŠí“à)

110103. [ŒŽ’˜] Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents. Tsujino I, Koizumi T, Shimohama T1, Ako J, Waseda K, Krucoff M, Honda Y, Fitzgerald PJ: Cardiovasc Revasc Med 2012/3; 13 (2): 111-8. (‰º•lF˜Y1: 1zŠÂŠí“à)

120010. [ŒŽ’˜] “–‰@‚Ö”À‘—‚³‚ê‚œ‰@ŠOS”x’âŽ~Š³ŽÒ‚ÌŒ»ó‚Æ—\Œã—\‘ªˆöŽq‚ÌŒŸ“¢. Îì®Žq, ’ë–ìTˆê1, ¡–Ø—²‘Ÿ2, ’|“àˆê˜Y3, ‹Ë¶“T˜Y, “ü]@Â4, –L‰ªÆ•F, ŒIŒŽŽ—R4, ‘Š”nˆêˆå2, ˜aò@“O1 (1zŠÂŠí“à, 2‹~–œ, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 4–@ˆã): S‘Ÿ 2011/8; 43: 97-104.

120011. [ŒŽ’˜] dÇ‹•EŒŽEɂš‚¯‚鎩‰Æ––œŒŒ’PŠj‹…×–EˆÚAŽ¡—ÑtŒø—á‚̗Տ°‘œ. Œ¬^‹Õ, ÂŽR’Œ‘P1, ‘å’JTˆê2, ‹àˆäº•¶3, ‰Á“¡L‘Ÿ˜N4, “n•Ó¹•¶, •œ“cŒõ”Ž4, ˜aò “O1 (1zŠÂŠí“à, 2—AŒŒE×–EˆÚA, 3–ƒŒ, 4ŠO‰È): “ú–{‰ºŽˆ‹~Ï‘«•aŠw‰ïŽ 2011/9; 3 (3): 121-8.

310005. [Ç—á•ñ] Acute myocardial infarction involving double vessel total occlusion of the left anterior descending and left circumflex arteries: A case report. Fukaya H1, Oikawa J1, Hirasawa S1, Shimohama T1, Tojo T1, Niwano S1, Izumi T1: Journal of Cardiology Cases 2011/8; 4 (1): e1-4. ([’J‰p•œ1, ‹yì@~1, •œàV³ŽŸ1, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, ’ë–ìTˆê1, ˜aò@“O1: 1zŠÂŠí“à)

320010. [Ç—á•ñ] ƒgƒ‹ƒoƒvƒ^ƒ“‚̒ljÁ“Š—^‚É‚æ‚èˆÀ’肵‚œŒŒs“®‘Ô‚Ì‚à‚Æ‚É‚€‚ÁŒŒ‚Ì‰ðœ‚ª‰Â”\‚Å‚ ‚Á‚œdÇ”x«S‚Æ‘å“®–¬•Ù‹·óÇ‚̍‡•¹S•s‘S‚Ì1—á. •iì–íl1, ’––”FŒ³1, ‰Í–ì@Œ’1, Îˆär•ã, “n•Óˆê˜Y, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ŒˆäŠîŒp3, ˜aò@“O1 (1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3‹~–œ): Fluid Management Renaissance 2011/7; 1 (1): 93-5.

320011. [Ç—á•ñ] S‘ŸÄ“¯Šú—Ö@‚É‚æ‚èˆê‰ß«¶‹rƒuƒƒbƒN‚É”º‚€S•s‘S‘ˆ«ƒCƒxƒ“ƒg‚Ì”œ•œ‚ª‰ñ”ð‚Å‚«‚œ1—á. “n•Óˆê˜Y, ’––”FŒ³1, Œ¬^‹Õ, •iì–íl1, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ÂŽR’Œ‘P1, ˜aò@“O1 (1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ŒÄ‹z‚ƏzŠÂ 2011/8; 59 (8): 833-8.

320012. [Ç—á•ñ] –«ŒŒðÇð«”x‚ŒŒˆ³Ç‚Ì‹}«Šú—\‘ªˆöŽq‚ÌŒŸ“¢|‘¢‰eCTE”xŒŒ—¬ƒVƒ“ƒ`ŠŒ©‚̃~ƒXƒ}ƒbƒ`|. •iì–íl1, ’––”FŒ³1, ¬™—Œb1, ŠâŒ³ŽO˜a, Îˆär•ã, “n•Óˆê˜Y, ¬”‹Žr”ü1, ŒˆäŠîŒp2, ’|“àˆê˜Y3, ˜aò@“O1 (1zŠÂŠí“à, 2‹~–œ, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Ther Res 2011/10; 32 (10): 1237-40.

320013. [Ç—á•ñ] …—˜”A–òCƒgƒ‹ƒoƒvƒ^ƒ“‚̒ljÁ“Š—^‚Å’áNaŒŒÇ‚Æ’áS”o—ʏó‘Ô‚©‚ç’E‚µ, “Æ•à‘Þ‰@‚ƍݑî—Ö@‚ª‰Â”\‚Æ‚È‚Á‚œ“«S•s‘S‚Ì1—á. •iì–íl1, ’––”FŒ³1, ‰Í–ì@Œ’1, ŠâŒ³ŽO˜a, b”ã“c–L“ñ, Îˆär•ã, “n•Óˆê˜Y, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ŒˆäŠîŒp3, ˜aò@“O1 (1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3‹~–œ): ŒÄ‹z‚ƏzŠÂ 2011/11; 59 (11): 1145-52.

320014. [Ç—á•ñ] ƒxƒvƒŠƒWƒ‹“à•ž’†‚ɐSŽº×“®‚ð’悵“ÁˆÙ‚ÈŒŒ’†”Z“x„ˆÚ‚ðŽŠ‚µ‚œ1Ç—á. •ì‘–1, ’ë–ìTˆê1, ²“¡F“T, ÂŽR—T–ç, ‘ºãEEE ’|“àˆê˜Y2, “’–{‰ÀG, ã–ì˜as, ˜aò@“O1 (1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): S‘Ÿ 2011/12; 43: 89-94.

520024. [‘à] SŒŽ«”]ÇðÇ—\–h‚É‚š‚¯‚éR‹ÃŒÅ—Ö@‚̏d—v«. ’ë–ìTˆê (zŠÂŠí“à): ‰¡{‰êˆãŽt‰ï•ñ 2011; 299: 33.

520025. [‘à] S•s‘S‚É”º‚€S–[×“®. ’†—¢—S“ñ, ’ë–ìTˆê1, “¡–؁@–Ÿ, ‰L–ì‹N‹v–ç (1zŠÂŠí“à): V–ò‚ƗՏ° 2011; 60: 824-32.

521015. [‰ðà] “àŽ‹‹ŸŒŸž‚Ì‚œ‚߂ɍR‹ÃŒÅ—Ö@ƒ[ƒtƒ@ƒŠƒ“‚Ì‹x–ò‚ðŽwŽŠ‚µ‚œ‚±‚Æ‚É‚æ‚è, Š³ŽÒ‚ª”][Ç‚É‚æ‚莀–S‚µ‚œ‚Æ‚µ‚Ä‘¹ŠQ”…ž‚ð‹‚ß‚œŽ–—á. ÂŽR’Œ‘P (zŠÂŠí“à): ˆã—Ô»—á‰ðà 2011/12; 35: 71-3.

522037. [uÀ]y‘æ57‰ñ“ú–{S‘Ÿ•aŠw‰ï‚ÉŠw‚ԁz–«S•s‘S‚ÌŽ¡—Á|EACE‘jŠQ–ò‚ÆARB–ò‚ÌŒø‰Ê. ’––”FŒ³ (zŠÂŠí“à): S‘Ÿ 2011/4; 43 (4).

522038. [uÀ] S•s‘S‚Ì•]‰¿. ’––”FŒ³ (zŠÂŠí“à): ƒhƒNƒ^[ƒTƒƒ“ 2011/4; 55 (4): 246-54.

522039. [uÀ]ySelected Papersz¡, ‰ü‚ß‚ÄEVEREST‚ð“Ç‚Ý’Œ‚·. ’––”FŒ³ (zŠÂŠí“à): Fluid Management Renaissance 2011/7; 1 (1): 79-80.

522040. [uÀ]yzŠÂŠíŽŸŠ³@‚»‚Ì–{Ž¿‚ð‚‚©‚ñ‚Ÿf’fEŽ¡—Áz‹}«S•s‘SŽ¡—Â̖{Ž¿‚Æ‚Í? ’––”FŒ³ (zŠÂŠí“à): ƒŒƒWƒfƒ“ƒgƒm[ƒg 2011/8; 13 (8): 1366-71.

522041. [uÀ]y“ÁW: S–[×“®|Ž¡—Â̍l‚Š•û‚ƃ|ƒCƒ“ƒgz6. S–[×“®‚ª’·ˆø‚­‚Æ‚È‚º–ò‚ªŒø‚©‚È‚­‚È‚é‚Ì‚©. ’ë–ìTˆê (zŠÂŠí“à): Heart View 2011/9; 15 (10): 39-46.

522042. [uÀ]yŽ¿‹^‰ž“šzS–[×“®‚̃AƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Â̗L—p«. ’ë–ìTˆê (zŠÂŠí“à): “ú–{ˆãŽ–V•ñ 2011/9; 4558: 51-2.

522043. [uÀ] Œ»‹µ‚̐S•s‘SŠÇ—ŽÀ‘H–@`ƒAƒEƒgƒJƒ€‚ð‚¢‚©‚ÉŒ©˜‚Š‚é‚©? ’––”FŒ³ (zŠÂŠí“à): “ú–{—Տ°–ƒŒ‰ÈŠw‰ïŽ 2011/9; 31 (5): 846-53.

522044. [uÀ]yzŠÂŠíƒtƒH[ƒ‰ƒ€2010@•s®–¬–ò•šŽ¡—ÃtƒH[ƒ‰ƒ€zS•s‘SƒCƒxƒ“ƒg—}§‚ÌŠÏ“_‚©‚ç‚Ý‚œS–[×“®ƒRƒ“ƒgƒ[ƒ‹‚̈Ӌ`. ’ë–ìTˆê (zŠÂŠí“à): S“d} 2011; 31 (2): 202-4.

522045. [uÀ]y‘æ27‰ñ“ú–{S“dŠw‰ïŠwpW‰ï@ŠwpŽ–âˆÏˆõ‰ï’ñŒŸƒVƒ“ƒ|ƒWƒEƒ€zS•s‘S‚É”º‚€•s®–¬‚ÌŽ¡—Ð헪@6. S•s‘S‚É”º‚€•s®–¬‚̃AƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Ã. ’ë–ìTˆê (zŠÂŠí“à): S“d} 2011; 31 (4): 387-93.

522046. [uÀ]y“ÁW: ‚—îŽÒ‚̐S•s‘SzSeminar 2. ‚—îŽÒS•s‘S‚É‚š‚¯‚鎡—Öò‚Æ‚»‚ÌŽg‚¢•û. ’––”FŒ³ (zŠÂŠí“à): Geriatric Medicine 2012/1; 50 (1): 23-6.

522047. [uÀ]y“ÁW2: S•s‘S‚É‚š‚¯‚é‘̉t’™—¯‚̐V‚µ‚¢Ž¡—Ð헪`…—˜”AÜ‚Æ‚¢‚€V‚µ‚¢ƒAƒvƒ[ƒ``z1. ‘˜_`…—˜”A‚̓iƒgƒŠƒEƒ€—˜”A‚ð‚¢‚©‚É•â‚€‚±‚Æ‚ª‚Å‚«‚é‚©`. ˜aò@“O (zŠÂŠí“à): ˆã–òƒWƒƒ[ƒiƒ‹ 2012/2; 48 (2): 117-8.

522048. [uÀ]y“ÁW2: S•s‘S‚É‚š‚¯‚é‘̉t’™—¯‚̐V‚µ‚¢Ž¡—Ð헪`…—˜”AÜ‚Æ‚¢‚€V‚µ‚¢ƒAƒvƒ[ƒ``z(5) S–[’†ŠuŒ‡‘¹•ÂœpŒã‚ÉŽc‘¶‚µ‚œd“xŽOë•Ù‹t—¬‚É‚æ‚é”x‚ŒŒˆ³Ç‚ƉES•s‘S‚ɑ΂µ, ƒgƒ‹ƒoƒvƒ^ƒ“‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. •iì–íl1, ’––”FŒ³1, ‰Í–ì@Œ’1, Îˆär•ã1, “n•Óˆê˜Y1, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ŒˆäŠîŒp1, ˜aò@“O1 (1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ˆã–òƒWƒƒ[ƒiƒ‹ 2012/2; 48 (2): 135-9.

522049. [uÀ]y“ÁW2: S•s‘S‚É‚š‚¯‚é‘̉t’™—¯‚̐V‚µ‚¢Ž¡—Ð헪`…—˜”AÜ‚Æ‚¢‚€V‚µ‚¢ƒAƒvƒ[ƒ``z3. Ç—á‚Ì•ªÍ`S•s‘S‚ɍ‡•¹‚·‚é’áƒiƒgƒŠƒEƒ€ŒŒÇ‚Ì•a‘Ô‚ÆŽ¡—Âðl‚Š‚é`. ’––”FŒ³ (zŠÂŠí“à): ˆã–òƒWƒƒ[ƒiƒ‹, 2012/2; 48 (2): 140-4.

522050. [uÀ]ySymposium: ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ïƒCƒuƒjƒ“ƒO‹³ˆçƒZƒ~ƒi[zS•s‘S‚ðƒA[ƒg‚·‚é|•ïŠ‡ŠÇ—‚̃XƒXƒ |. ’––”FŒ³ (zŠÂŠí“à): THERAPEUTIC RESEARCH 2012/2; 33 (2): 141-51.

522051. [uÀ]y“ÁW: S•s‘S|ŽÀ’nˆã‰Æ‚Í‘‰Á‚·‚鍂—îŽÒS•s‘S‚É‚Ç‚€‘Ώˆ‚·‚é‚©zŒŸžŠŒ©‚ƑΏˆ‚Ì‚µ‚©‚œ@S•s‘SŠ³ŽÒ‚Ì‹¹•”Xü, S“d}. ’––”FŒ³ (zŠÂŠí“à): Medical Practice 2012/2; 29 (2): 238-44.

522052. [uÀ]y“ÁW: –«S•s‘Szf’f‚ÆŽ¡—Â̐i•à@ III. —\–hEŠÇ—EŽ¡—Â̐i•à@2. ˆê”ʗÖ@ (Šî‘b—Ö@). ’––”FŒ³ (zŠÂŠí“à): “ú–{“à‰ÈŠw‰ïŽGŽ, 2012/3; 101 (2).

[’˜@‘]

620054. [Šwp‘] (•ª’SŽ·•M)yV”Å ŠŽõÇf—ÃŽÀ‘HƒKƒCƒh@—LŒø‚ȍR‹Û–ò‚ÌŽg‚¢‚©‚œ‚Ì‚·‚×‚Ä (Medical Practice—ÕŽž‘Š§†)zVI. Žå‚ÈŠŽõÇ‚ɑ΂·‚éŽÀ’nˆã‰Æ‚̍R‹Û–òŽg—p‚ÌŽÀÛ@A. Žå—vŠŽõÇ‚©‚ç‚Ý‚œR‹Û–ò‚Ì‘I‘ð‚ÆŽg—p‚ÌŽÀÛ@17. ŠŽõÇS“à–Œ‰Š p.719-24. ‘OìŒb”ü1, ˜aò@“O1 (1zŠÂŠí“à), •Ò: Medical Practice•ÒWˆÏˆõ‰ï, •¶Œõ“°, “Œ‹ž, 2011/4”­s.

620055. [Šwp‘] (•ª’SŽ·•M)y‚©‚©‚è‚‚¯ˆãE”ñê–åˆã‚́@S•s‘S “úíf—à Q&Az9. Key DrugˆÈŠO‚Ì–ò•š—Ö@‚Ì—¯ˆÓ“_@Q68 CahR–ò‚ÌŽg‚¢•û‚̃|ƒCƒ“ƒg‚ð‹³EŠ‚ĉº‚³‚¢, p.210-2. ’––”FŒ³ (zŠÂŠí“à), Žå•ÒW: –ìoFˆê, “ìŽR“°, “Œ‹ž, 2011/4”­s.

620056. [Šwp‘] (•ª’SŽ·•M)y‚©‚©‚è‚‚¯ˆãE”ñê–åˆã‚́@S•s‘S “úíf—à Q&Az9. Key DrugˆÈŠO‚Ì–ò•š—Ö@‚Ì—¯ˆÓ“_@Q69 S•s‘SŠ³ŽÒ‚Ö‚Ì“Š—^‚ð“Á‚É’ˆÓ‚·‚ׂ«–ò, ‚Ü‚œ‚͍T‚Š‚é‚ׂ«–ò‚Í‚ ‚è‚Ü‚·‚©? p.213-5. ’––”FŒ³ (zŠÂŠí“à), Žå•ÒW: –ìoFˆê, “ìŽR“°, “Œ‹ž, 2011/4”­s.

620057. [Šwp‘] (•ª’SŽ·•M)y‚©‚©‚è‚‚¯ˆãE”ñê–åˆã‚́@S•s‘S “úíf—à Q&Az12. ‡•¹Ç‚Ì‚ ‚éS•s‘SŠ³ŽÒ‚ÌŽ¡—Á@Q77 ‚ŒŒˆ³‡•¹—á‚ÌŽ¡—Õû–@‚ɂ‚¢‚Ä‹³‚Š‚ĉº‚³‚¢, p.241-2. ’––”FŒ³ (zŠÂŠí“à), Žå•ÒW: –ìoFˆê, “ìŽR“°, “Œ‹ž, 2011/4”­s.

620058. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNzƒAƒ_ƒ€ƒXƒg[ƒNƒXÇŒóŒQ, p.150. ’ë–ìTˆê (zŠÂŠí“à), •Ò: •ŸˆäŽŸ–î, ‘•ÒW: ˆä‘º—T•v, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

620059. [Šwp‘] (•ª’SŽ·•M)yƒoƒ]ƒvƒŒƒVƒ“‚ÆŽó—e‘̝hR|‚»‚ÌŠî‘b‚ƗՏ°|z‘æ3Í —Տ°@4. ƒoƒ]ƒvƒŒƒVƒ“hR–ò‚Ì’·Šú“Š—^|S•s‘SŽ¡—Âł̉”\«‚ð’T‚é, p.201-8. ’––”FŒ³1 (1zŠÂŠí“à), ŠÄC: Ü“c‹`³, •Ò: ˜aò@“O1, ÎìŽO‰q, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2011/7”­s.

620060. [Šwp‘] (•ª’SŽ·•M)yƒtƒ@[ƒ}ƒiƒrƒQ[ƒ^[E11@ƒÀŽÕ’f–ò•Ò [‰ü’ù”Å]zChapter 6 Ç—á‚ÌŽÀÛ@1. ‘æˆê‘I‘ð–ò‚Æ‚µ‚ÄŽg‚€Ç—á‚Í‚Ç‚ñ‚È•a‘Ô‚Å‚µ‚å‚€‚©? P.182-5. ’––”FŒ³ (zŠÂŠí“à), •ÒWŽåŠ²: ¬Žºˆê¬, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2011/10”­s.

620061. [Šwp‘] (•ª’SŽ·•M)yJRC‘h¶ƒKƒCƒhƒ‰ƒCƒ“2010zœ×“®‚ÉŠÖ‚·‚éƒgƒsƒbƒNƒX, p.69-71. ’ë–ìTˆê (zŠÂŠí“à), ŠÄC: “ú–{‘h¶‹Š‹c‰ïE“ú–{‹~‹}ˆã—Íà’c, ‚Ö‚é‚·o”Å, “Œ‹ž, 2011/10”­s.

620062. [Šwp‘] (•ª’SŽ·•M)yJRC‘h¶ƒKƒCƒhƒ‰ƒCƒ“2010z•p–¬‚ÌŽ¡—Ã, p.73-8. ’ë–ìTˆê (zŠÂŠí“à), ŠÄC: “ú–{‘h¶‹Š‹c‰ïE“ú–{‹~‹}ˆã—Íà’c, ‚Ö‚é‚·o”Å, “Œ‹ž, 2011/10”­s.

620063. [Šwp‘] (•ª’SŽ·•M)yŠ¥“®–¬ŽŸŠ³ ‰º|f’f‚ÆŽ¡—Â̐i•à| (“ú–{—Õଠ‘Š§†)zXII. ‹•ŒŒ«S‹ØÇ‚̗Տ°@5. ‹•ŒŒ«S‹ØÇ‚ÌŽ¡—Ð헪@e. ƒgƒ‹ƒoƒvƒ^ƒ“ (ƒoƒ\ƒvƒŒƒVƒ“hR–ò) p.408-11. ’––”FŒ³ (zŠÂŠí“à), •Ò: ˆêF‚–Ÿ, “ú–{—Õ଎Ð, ‘åã, 2011/11”­s.

620064. [Šwp‘] (•ª’SŽ·•M)yŠ¥“®–¬ŽŸŠ³ ‰º|f’f‚ÆŽ¡—Â̐i•à| (“ú–{—Õଠ‘Š§†)zXVII. Žå‚ÈŠ¥“®–¬ŽŸŠ³‚̃KƒCƒhƒ‰ƒCƒ“‚̃|ƒCƒ“ƒg@5. ‹}«S•s‘SŽ¡—ÃKƒCƒhƒ‰ƒCƒ“, p.589-94. ‰––ì•û–Ÿ1, ˜aò@“O1 (1zŠÂŠí“à), •Ò: ˆêF‚–Ÿ, “ú–{—Õ଎Ð, ‘åã, 2011/11”­s.

620065. [Šwp‘] (•ª’SŽ·•M)yS•s‘S‚É”º‚€•s®–¬‚ÌŽ¡—Ð헪zS•s‘S‚É”º‚€•s®–¬‚̃AƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Ã, p.85-95. ’ë–ìTˆê (zŠÂŠí“à), ƒ‰ƒCƒtƒƒfƒBƒRƒ€, ˆ€’m, 2011/12”­s.

620066. [Šwp‘] (•ª’SŽ·•M)yƒGƒrƒfƒ“ƒX‚ÉŠî‚­zŠÂŠí•a—\–hˆãŠw@–«S•s‘S‚ð–h‚®—\–hí—ª‚Æ‚Í?z‘æIIIÍzŠÂŠí•a—\–hˆãŠwŠe˜_@B –ò•š—Ö@‚ƏzŠÂŠí•a—\–hˆãŠw@4 —˜”A–ò, p.291-5. ’––”FŒ³1 (1zŠÂŠí“à), ŠÄC: ˜aò@“O1, •Ò: “ŒžŠ”ü“ÞŽq2, ’––”FŒ³1 (2ˆã—Éq¶Šw•”), “ì]“°, “Œ‹ž, 2012/3”­s.

620067. [Šwp‘] (•ª’SŽ·•M)yS•s‘SƒPƒA‹³–{z5 S•s‘S‚̐f’f@E”]«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh (BNP) ‚Ì–ðŠ„, p.101-6. ’––”FŒ³ (zŠÂŠí“à), •Ò: ^Š‚Ý‚ä‚«, ’r‹Tr”ü, ‰Á“¡®Žq, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2012/3”­s.

620068. [Šwp‘] (•ª’SŽ·•M)yS•s‘SƒPƒA‹³–{z9 –«S•s‘S‚Ì–ò•šŽ¡—Á@EƒÀŽÕ’f–ò, p.143-8. ’––”FŒ³ (zŠÂŠí“à), •Ò: ^Š‚Ý‚ä‚«, ’r‹Tr”ü, ‰Á“¡®Žq, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712017. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Reconsideration of the Role of the Up-stream Therapy in Atrial Fibrillation. Niwano S1: 26th JHRS & 4th APHRS joint meeting (2011/9/19), Fukuoka. (’ë–ìTˆê1: 1zŠÂŠí“à)

712018. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Pharmacological Therapy for Atrial Fbrillation with Congestive Heart Failure. Niwano S1: 26th JHRS & 4th APHRS joint meeting (2011/9/21), Fukuoka. (’ë–ìTˆê1: 1zŠÂŠí“à)

712019. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) International Guidelines for CRT in Heart Failure Patients. Niwano S1: New Horizons in Heart Failure Symposium 2011 (2011/12/3), Osaka. (’ë–ìTˆê1: 1zŠÂŠí“à)

713037. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stent implantation for rat aorta. Shiono T, Izumi T1, Tojo T1: TCTAP2011 (2011/4/27), Seoul, Korea. (‰––ì•û–Ÿ, ˜aò@“O1, “Œð‘å‹P1: 1zŠÂŠí“à)

713038. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neointimal Coverage of Zotarolimus-Eluting Stent at 2, 4, 6, 8 and 10 Weeks Follow-up: Evaluation by Optical Coherence Tomography. Nishinari M, Shimohama T1, Tojo T1, Shiono T, Kameda R, Aoyama N1, Izumi T1: European Society of Cardiology 2011 (2011/8/30), Paris, France. (‰º•lF˜Y1, “ŒžŠ‘å‹P1, ÂŽR’Œ‘P1, ˜aò@“O1: 1zŠÂŠí“à)

713039. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neointimal Coverage of Everolimus-Eluting Stent at 1, 2 and 3 Months Follow-up: Evaluation by Optical Coherence Tomography. Shimohama T1, Nishinari M, Tojo T1, Shiono T, Shinagawa H1, Kameda R, Izumi T1: Transcatheter Cardiovascular Therapeutics 2011 (2011/11/8), San Francisco, USA. (‰º•lF˜Y1, “ŒžŠ‘å‹P1, •iì–íl1, ˜aò@“O1: 1zŠÂŠí“à)

713040. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Comparison of Neointimal Coverage of Zotarolimus-Eluting Stent and Everolimus-Eluting Stent at 1, 2 and 3-Month Follow-up: Evaluation by Optical Coherence Tomography. Nishinari M, Shimohama T1, Tojo T1, Shiono T, Shinagawa H1, Kameda R, Aoyama N1, Izumi T1: American Heart Association 2011 (2011/11/16), Orlando, USA. (‰º•lF˜Y1, “ŒžŠ‘å‹P1, •iì–íl1, ÂŽR’Œ‘P1, ˜aò@“O1: 1zŠÂŠí“à)

722047. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S•s‘Sf—ÑS‘Ì‚ðŒ©˜‚Š‚œS‘ŸÄ“¯Šú—Ö@‚̈ʒu•t‚¯‚ƐSƒGƒR[}‚Ì–ðŠ„. ’––”FŒ³ (zŠÂŠí“à): “ú–{’Ž‰¹”gˆãŠw‰ï‘æ84‰ñŠwpW‰ï (2011/5/28), “Œ‹ž.

722048. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒfƒoƒCƒXŽ¡—Âɕt‚·‚éS•s‘S‰“Šuƒ‚ƒjƒ^ƒŠƒ“ƒO. ’––”FŒ³ (zŠÂŠí“à): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/23), _ŒË.

722049. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S‹Ø‰Š‚É‚š‚¯‚éS‘ŸMRI. ’––”FŒ³ (zŠÂŠí“à): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/23), _ŒË.

722050. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Šg’£«S•s‘S‚Ì‹}«ŠúŽ¡—Ã. ÂŽR’Œ‘P (zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/13), Ž­Ž™“‡.

722051. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S•s‘S‚ðƒA[ƒg‚·‚é: •ïŠ‡“IŠÇ—‚̃XƒXƒ. ’––”FŒ³ (zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/13), Ž­Ž™“‡.

722052. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEE€Eµ‘ҍu‰‰“™) ‹}«S‹Ø‰Š‚É‚š‚¯‚éS•s‘SŠÇ—. ’––”FŒ³ (zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/14), Ž­Ž™“‡.

722053. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒgƒ‹ƒoƒvƒ^ƒ“. ’––”FŒ³ (zŠÂŠí“à): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/3), •lŒ.

722054. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Clinical and Economical Contribution of the Clinical Pathway approach in the Management of Acute Decompensated Heart Failure. “n•Óˆê˜Y, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/17), •Ÿ‰ª.

722055. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Novel Treatment Strategy to Bail Out Low Cardiac Output by Using Tolvaptan in End-Stage Heart Failure. •iì–íl1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/18), •Ÿ‰ª.

722056. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S•s‘S‚̓ƒ‹ƒNƒ}[ƒ‹‚ŏŸ•‰‚·‚é`ˆê•àãs‚­ŠÇ—‚ð–ÚŽw‚µ‚ā`. ’––”FŒ³ (zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/16), •Ÿ‰ª.

722057. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒbƒVƒ‡ƒ“)ydÇS•s‘SŽ¡—Â̐V‚µ‚¢“WŠJz1. dÇS•s‘S‚Ö‚Ì‘œ–Ê“I‰î“ü. ’––”FŒ³ (zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/17), •Ÿ‰ª.

722058. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Short- and Long-term Prognosis of Fulminant Myocarditis. ’––”FŒ³ (zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/18), •Ÿ‰ª.

722059. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) uŠg’£Œ^S‹ØÇ‚È‚ç‚Ñ‚ÉŠÖ˜A‚·‚é“ñŽŸ«S‹ØÇ‚̐f—ÂɊւ·‚éƒKƒCƒhƒ‰ƒCƒ“v–«ŠúŽ¡—Ã. ’––”FŒ³ (zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/18), •Ÿ‰ª.

723153. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A case of expanding incomplete stent apposition after Zotarolimus-eluting stent implantation observed by OCT and IVUS. Makoto Nishinari, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, Masahiko Moriguchi, Naoto Fukuda, Toshiro Kurosawa, Takaaki Shiono, Ryo Kameda, ˜aò@“O1 (1zŠÂŠí“à): ‘æ20‰ñ“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ï”NŽŸŠwpW‰ï (2011/7/21), ‘åã.

723154. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neointimal Coverage of Zotarolimus-Eluting Stent within 10-Week after Implantation: Evaluation Using Optical Coherence Tomography. Makoto Nishinari, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, Takaaki Shiono, Ryo Kameda, ˜aò@“O1 (1zŠÂŠí“à): ‘æ75‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2011/8/3), ‰¡•l.

723155. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S•s‘S‘ˆ«ƒCƒxƒ“ƒgŽž‚̐S””‚ª—\‘ª‚·‚鍶Žº‹tƒŠƒ‚ƒfƒŠƒ“ƒO‚ÌŒŸ“¢. Îˆär•ã, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/23), _ŒË.

723156. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒoƒ]ƒvƒŒƒVƒ“Žó—e‘̝hR–ò (ƒgƒ‹ƒoƒvƒ^ƒ“) ‚ð—p‚¢‚œ–«S•s‘SŽ¡—Á|—£’EŽž‚É‚š‚¯‚é—˜”A–ò’ljÁ“Š—^‚̏d—v«|. ‰Í–ì@Œ’1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/24), _ŒË.

723157. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«t‘Ÿ•aŠ³ŽÒ‚É‚š‚¯‚é, TAXUS-Liberte‚ÆTAXUS Express2‚Ì”äŠrŒŸ“¢. ‹T“c@—Ç, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, Œ¬^‹Õ, ’|“àˆê˜Y2, ‰––ì•û–Ÿ, ˜aò “O1 (1zŠÂŠí“à, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/24), _ŒË.

723158. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶Žºãk–§‰»áŠQ‚ƏdÇ‘m–X•Ù‹t—¬‚ð’悵‚œChurg-StraussÇŒóŒQ‚̗Տ°“I“Á’¥. ¬”‹Žr”ü1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/24), _ŒË.

723159. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S•s‘SƒNƒŠƒjƒJƒ‹ƒpƒX‚̍\’z‚Æ‚»‚Ì“±“üˆÓ‹`‚ÌŒŸ“¢. “n•Óˆê˜Y, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/25), _ŒË.

723160. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÙ‚È‚éŒo‰ß‚ð’H‚Á‚œƒ‹[ƒvƒXS‹Ø‰Š‚É‚æ‚édÇS•s‘S‚Ì2—á. ¬”‹Žr”ü1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/13), Ž­Ž™“‡.

723161. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SMRI‚É‚š‚¯‚éS“à–Œ‘€‚Ìfirst-pass‘¢‰eŒ‡‘¹‚Í, ”÷­ŒŒŠÇ‚Ì‹•ŒŒ‚𔜉f‚·‚é. •iì–íl1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/14), Ž­Ž™“‡.

723162. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S‘ŸÄ“¯Šú—Ö@‚ÆHisƒAƒuƒŒ[ƒVƒ‡ƒ“‚ªˆê‰ß«S‘Ÿ×“®‚É”º‚€S•s‘S‘ˆ«‚Ì”œ•œ‚ð‰ñ”ð‚³‚¹‚œˆê—á. “n•Óˆê˜Y, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/15), Ž­Ž™“‡.

723163. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶Žº‹tƒŠƒ‚ƒfƒŠƒ“ƒO‚ð—\‘ª‚·‚éS•s‘S‘ˆ«Žž‚É‚š‚¯‚éS””‚̗Տ°“Id—v«. Îˆär•ã1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/15), Ž­Ž™“‡.

723164. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒKƒCƒhƒ‰ƒCƒ“‚ÉŠî‚¢‚œŽ¡—Âł悢‚Ì‚©H`ŠŽõ«S“à–Œ‰Š‚É‚š‚¯‚éƒyƒjƒVƒŠƒ“GŒŒ’†”Z“x‘ª’è‚̗Տ°“IˆÓ‹``. ’––”FŒ³1, “n•Óˆê˜Y, ¬Œ•q², “ñ–{–öL2, ˜aò@“O1 (1zŠÂŠí“à, 2—ÕŒŸ•”): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/16), •Ÿ‰ª.

723165. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical Significance of Recurrence of Intrathoracic lymph node Ga-67 Uptake in Cardiac Sarcoidosis During Steroid Therapy. ’––”FŒ³1, Îˆär•ã, ˜aò@“O1 (1zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/18), •Ÿ‰ª.

731023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): ‘æ3‰ñ‹›ÀzŠÂŠíƒ~[ƒeƒBƒ“ƒO (2011/8/1), VŠƒ.

731024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): ƒoƒ]ƒvƒŒƒVƒ“Žó—e‘̝hR–ò‚ÌŠî‘b‚ƗՏ°ŒŸ“¢‰ï (2011/8/2), VŠƒ.

731025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚Æ“œ”A•a. ’ë–ìTˆê (zŠÂŠí“à): ‘æ4‰ñS–[×“®Œ€‹†‰ï (2011/8/4), “Œ‹ž.

731026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): —˜”A–ò‚ƐS•s‘SŽ¡—Âðl‚Š‚é‰ï (2011/8/4), H“c.

731027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, ‚¢‚©‚ɐS•s‘S‚Ɛ킀‚©`ƒÀŽÕ’f–ò‚ð‚Í‚¶‚ß‚Æ‚µ‚œŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹`. ’––”FŒ³ (zŠÂŠí“à): ‘æ14‰ñ‹–žzŠÂŠíƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/8/5), ‹ž“s.

731028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): ŽR—œƒƒCƒ“ƒe[ƒgŒø”\’ljÁ‹L”Ou‰‰‰ï (2011/8/6), b•{.

731029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): ‘æ2‰ñS•s‘S‚Ì•a‘Ô‚ÆŽ¡—Âðl‚Š‚é‰ï (2011/8/7), ‘åEE

731030. [ŠwEE(’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, ‚¢‚©‚ɐS•s‘S‚Ɛ킀‚©`ŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹`. ’––”FŒ³ (zŠÂŠí“à): “ȖؐS•s‘SƒZƒ~ƒi[ (2011/8/8), ‰F“s‹{.

731031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œn“—§‚Ä‚œS•s‘Sf—Ã‚ð‚¢‚©‚É“WŠJ‚·‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ4‰ñ‘啪SŒŒŠÇŒ€‹†‰ï (2011/8/9), ‘啪.

731032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, ‚¢‚©‚ɐS•s‘S‚Ɛ킀‚©`ŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹`. ’––”FŒ³ (zŠÂŠí“à): ‘æ1‰ñ‰zŒãƒn[ƒgƒNƒ‰ƒu (2011/8/9), VŠƒ.

731033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚Ì–ò•šŽ¡—Á|—DæŽ¡—Â̖ڕW‚Ì•Ï‘J|. ’ë–ìTˆê (zŠÂŠí“à): –kš’n‹æˆãŽt‰ïŠwpu‰‰‰ï2011 (2011/8/9), Žl“úŽs.

731034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠ³ŽÒ‚ɑ΂·‚鎡—Â̎ÀÛ (1) (2). ’––”FŒ³ (zŠÂŠí“à): •œ¬23”N“xS•s‘S‚Ì—Šw—Ö@uK‰ï (2011/8/10), ‘Š–ÍŒŽ.

731035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, ‚¢‚©‚ɐS•s‘S‚Ɛ킀‚©`‹}«Šú‚©‚ç‚Ý‚œŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹`. ’––”FŒ³ (zŠÂŠí“à): Total Management of Heart Failure`‹}«‚©‚疝«‚܂ŐS•s‘SŽ¡—ÂðÄl‚·‚é` (2011/8/10), ‚’m.

731036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): V2Žó—e‘̝hR–òŠwpu‰‰‰ï (2011/8/11), ŒŽR.

731037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): S•s‘SŠwpu‰‰‰ï`…—˜”A‚ðl‚Š‚é` (2011/8/13), ·‰ª.

731038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, S•s‘S‚Æ‚Ç‚€í‚€‚©`ƒŒƒjƒ“‘jŠQ–ò‚Ö‚ÌŠú‘ҁ`. ’––”FŒ³ (zŠÂŠí“à): ƒ‰ƒWƒŒƒXù”­”„2Žü”N‹L”Ou‰‰‰ï (2011/8/15), ä.

731039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡‚±‚»Šî‘bŒÅ‚߁`S•s‘SƒÀŽÕ’f–ò—Ö@`. ’––”FŒ³ (zŠÂŠí“à): ‘æ6‰ñL“‡ƒÀŽÕ’f–ò‚ðl‚Š‚é‰ï (2011/8/15), L“‡.

731040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): Ã‰ªƒTƒ€ƒXƒJ”­”„‹L”Ou‰‰‰ï (2011/8/15), Ã‰ª.

731041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): ‰ŽsˆãŽt‰ïŠwpu‰‰‰ï (2011/8/16), VŠƒ.

731042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): –kÛƒÀblocker Seminar (2011/8/16), –L’†.

731043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ŠÇEŽ_‰»ƒXƒgƒŒƒX‚ƐS‹ØƒŠƒ‚ƒfƒŠƒ“ƒO. ’ë–ìTˆê (zŠÂŠí“à): ‘æ5‰ñS–[×“®Œ€‹†‰ï (2011/8/17), “Œ‹ž.

731044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘S‚ðƒA[ƒg‚·‚é`•ïŠ‡f—ẪXƒXƒ`. ’––”FŒ³ (zŠÂŠí“à): ‘æ39‰ñŽð“czŠÂŠí’k˜b‰ïŠwpW‰ï (2011/8/18), Žð“c.

731045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œn“—§‚Ä‚œS•s‘Sf—Ã‚ð‚¢‚©‚É“WŠJ‚·‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ1‰ñã_S•s‘SŒ€‹†‰ï (2011/8/19), Œ‹{.

731046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, S•s‘S‚Æ‚Ç‚€í‚€‚©`ŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹`. ’––”FŒ³ (zŠÂŠí“à): ‘æ6‰ñ–k‹ãBzŠÂŠíƒtƒFƒ[ƒVƒbƒvŒ€‹†‰ï (2011/8/21), ¬‘q.

731047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): “‡ªŒ§S•s‘S‚̑̉tŠÇ—‚ðl‚Š‚é‰ï (2011/8/21), Œ].

731048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚Ì–ò•šŽ¡—Á|—Dæ‚·‚ׂ«Ž¡—Éî“ü|. ’ë–ìTˆê (zŠÂŠí“à): ‘æ8‰ñ•s®–¬ƒAƒJƒfƒ~[ (2011/8/21), ‘åã.

731049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •s®–¬Ž¡—Âɂš‚¯‚éARB‚Ì–ðŠ„|ƒAƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Â̐¥”ñ|. ’ë–ìTˆê (zŠÂŠí“à): •s®–¬ƒŒƒNƒ`ƒƒ[ƒ~[ƒeƒBƒ“ƒO2011 (2011/8/21), ˆÉšŒŽ.

731050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): –öˆäˆãŽt‰ïŠwpu‰‰‰ï (2011/8/22), ŽRŒû.

731051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): O‘Oƒgƒ‹ƒoƒvƒ^ƒ“Šwpu‰‰‰ï (2011/8/22), O‘O.

731052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): ‘æ6‰ñ£ŒËˆ®zŠÂŠíŠwpu‰‰‰ï (2011/8/25), –ŒŒÃ‰®.

731053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Torsedes de Pointes‚ð‹É‚ß‚é|ƒxƒvƒŠƒWƒ‹Ž¡—Ã’†S“d}Œo‰ßŠÏŽ@‚É‚š‚¯‚éT”gŒ`‘ԕω»‚̏d—v«|. ’ë–ìTˆê (zŠÂŠí“à): ƒxƒvƒŠƒWƒ‹Œ€‹†‰ï2011 (2011/8/26), “Œ‹ž.

731054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œn“—§‚Ä‚œS•s‘Sf—Ã‚ð‚¢‚©‚É“WŠJ‚·‚é‚©. ’––”FŒ³ (zŠÂŠí“à): –«S•s‘SŽ¡—ÃtƒH[ƒ‰ƒ€ in KOBE (2011/8/27), _ŒË.

731055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): ŒŽRSŒŒŠÇƒtƒH[ƒ‰ƒ€ (2011/8/27), ŒŽR.

731056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’––”FŒ³ (zŠÂŠí“à): ‘æ10‰ñ‹ž“s‘åŠwŠÖŒS•s‘S‚Æ•s®–¬ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/8/27), ‘åã.

731057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): ƒgƒ‹ƒoƒvƒ^ƒ“Šwpu‰‰‰ï (2011/8/28), b•{.

731058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “ú–{zŠÂŠíŠw‰ï–«S•s‘SŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2010”N”Ł@‰ü³‚̃|ƒCƒ“ƒg. ’––”FŒ³ (zŠÂŠí“à): ‘æ75‰ñ–k—¢zŠÂŠíƒZƒ~ƒi[ (2011/8/28), ‘Š–ÍŒŽ.

731059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): ’·–ìzŠÂŠíŽ¡—ÃZƒ~ƒi[ (2011/8/29), ’·–ì.

731060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒ}ƒ‹ƒ`‚ɍl‚Š‚éS•s‘SŠÇ—`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): ‘æ15‰ñ“Œ‹žS‘Ÿ•aŒ€‹†‰ï (2012/3/3), “Œ‹ž.

731061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œ»ê‚©‚çŒê‚ë‚€`S•s‘Sf—ÂŃÀŽÕ’f–ò‚Æ‚Ç‚€•t‚«‡‚€‚©`. ’––”FŒ³ (zŠÂŠí“à): •P˜HS•s‘SƒZƒ~ƒi[ (2012/3/9), •P˜H.

731062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘Sf—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„`ŽÀ‘H•Ò`. ’––”FŒ³ (zŠÂŠí“à): `–k’n‹æˆãŽt‰ïŠwpu‰‰‰ï (2012), ‹e–Œ.

731063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): ‘æ1‰ñ…—˜”A‚ðl‚Š‚é‰ï (2012), ŽD–y.

731064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„`ƒgƒ‹ƒoƒvƒ^ƒ“‚̍¡‚Æ–¢—ˆ`. ’––”FŒ³ (zŠÂŠí“à): ’·èS•s‘SŠwpu‰‰‰ï (2012), ’·è.

731065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, ‚¢‚©‚ɐS•s‘S‚Ɛ킀‚©`ŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹`. ’––”FŒ³ (zŠÂŠí“à): ‰ªŽRS‘ŸŒŒŠÇŒ€‹†‰ï (2012), ‰ªŽR.

731066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡‚Ç‚«‚̐S•s‘Sf—Â𐮗‚·‚é. ’––”FŒ³ (zŠÂŠí“à): ‘æ18‰ñO‘OS•s‘SƒZƒ~ƒi[ (2012), O‘O.

731067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)u¡‚Ç‚«‚́v–«S•s‘SŠÇ—‚ðl‚Š‚é. ’––”FŒ³ (zŠÂŠí“à): ‘æ2‰ñŽl“úŽsS•s‘SŠwpu‰‰‰ï (2012
), Žl“úŽs.

731068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡, ‰ü‚ß‚Ä–â‚€S•s‘SŽÀ—Տ°‚ł̃ÀŽÕ’f–òŽ¡—Ã. ’––”FŒ³ (zŠÂŠí“à): ì‰zS‘Ÿ•aƒZƒ~ƒi[ (2012), ì‰z.

732022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) dÇS•s‘S‚ÌŽ¡—Ð헪|–ò•š—Ö@|. ’––”FŒ³ (zŠÂŠí“à): ‘æ63‰ñ_“ސìzŠÂŠíu‰‰‰ï (2011/8/2), ‰¡•l.

732023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹•ŒŒ«S•s‘S‚É‚Í, –{“–‚ɃÀŽÕ’f–ò‚ÍŽ•‚ª—§‚¿‚É‚­‚¢‚Ì‚©? ’––”FŒ³ (zŠÂŠí“à): DSzŠÂŠíƒtƒH[ƒ‰ƒ€2011S•s‘SUp-to-date (2011/8/30), “Œ‹ž.

732024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) PDE‘jŠQ–ò vs. Dobutamine|‚¢‚Á‚œ‚¢‰œ‚ªˆá‚€‚Ì‚©?|. ’––”FŒ³ (zŠÂŠí“à): ‘æ8‰ñ‹}«S•s‘SŒ€‹†‰ï (2012/1/28), ‘åã.

733080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) SƒTƒ‹ƒRƒCƒh[ƒVƒX‚ª‹^‚í‚ê‚œŠ³ŽÒ‚É‚š‚¯‚éƒKƒŠƒEƒ€SPECT/CT‚ƐS‘ŸMRI‚Ì”äŠr. ²“¡F“T1, •iì–íl1, ’––”FŒ³1, ˜aò@“O1, ó–ì—Y“ñ2, ŒŽ@•q«2, “ü]‚‚®‚Ý2, ¬Š}ŒŽ‹2, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ˆäã—D‰î2, ‹e’r@Œh3, `@”Ž•¶3 (1zŠÂŠí“à, 2•úŽËü (‰æ‘œ), 3•úŽËü•”): ‘æ75‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/7/23), “Œ‹ž, ŠjˆãŠw 2011; 48 (4): 457.

733081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚閝«S•s‘S•af˜AŒg‚ÌŽÀÛ. ’¬“c—z“ñ1, ’––”FŒ³1, ÂŽR’Œ‘P1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ64‰ñ_“ސìzŠÂŠíu‰‰‰ï (2011/8/17), ‰¡•l.

733082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šg’£Œ^S‹ØÇ‚Æ‚µ‚ÄŒo‰ßŠÏŽ@‚³‚ê–UŒŸ‚ŐS‹Ø‰Š‚Ə‰‚߂Đf’f‚³‚ê‚œdÇS•s‘S‚Ì1—á. Îˆär•ã1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ33‰ñS‹Ø¶ŒŸŒ€‹†‰ï (2011/11/26), ‹ž“s.


_Œo“à‰ÈŠw

[Šwp˜_•¶]

110104. [ŒŽ’˜] RGMa modulates T cell@responses and is involved in autoimmune encephalomyelitis. Muramatsu R, Kubo T, Mori M, Nakamura Y, Fujita Y, Akutsu T, Okuno T, Taniguchi J, Kumanogoh A, Yoshida M, Mochizuki H1, Kuwabara S, Yamashita T: Nat Med 2011/4; 17 (4): 488-94. (–]ŒŽGŽ÷1: 1_Œo“à)

110105. [ŒŽ’˜] Comparisons of acoustic function in SCA31 and other forms of ataxias. Ikeda Y, Nagai 1, Kurata T, Yamashita T, Ohta Y, Nagotani S, Deguchi K, Takehisa Y, Shiro Y, Matsuura T, Abe K: Neurol Res 2011/5; 33 (4): 427-32. (‰iˆä^‹MŽq1: 1_Œo“à)

110106. [ŒŽ’˜] Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. Miyazaki K, Ohta Y, Nagai M1, Morimoto N, Kurata T, Takehisa Y, Ikeda Y, Matsuura T, Abe K: J Neurosci Res 2011/5; 89 (5): 718-28. (‰iˆä^‹MŽq1: 1_Œo“à)

110107. [ŒŽ’˜] Compensation of depleted neuronal subsets by new neurons in a local area of the adult olfactory bulb. Murata K, Imai M, Nakanishi S, Watanabe D, Pastan I, Kobayashi K, Nihira T, Mochizuki H1, Yamada S, Mori K, Yamaguchi M: J Neurosci 2011/7; 31 (29): 10540-57. (–]ŒŽGŽ÷1: 1_Œo“à)

110108. [ŒŽ’˜] Parkin-mediated dopaminergic neuroprotection in an MPTP-minipump mouse model of Parkinson's disease. Yasuda T, Hayakawa H, Nihira T, Ren Y-R, Nakata Y, Nagai M1, Hattori N, Miyake K, Takada M, Shimada T, Mizuno Y, Mochizuki H1: J Neuropathol Exp Neurol 2011/8; 70 (8): 686-97. (‰iˆä^‹MŽq1, –]ŒŽGŽ÷1: 1_Œo“à)

110109. [ŒŽ’˜] Adeno-associated viral vector-mediated gene transduction in mesencephalic slice culture. Nihira T, Yasuda T, Hirai Y, Shimada T, Mizuno Y, Mochizuki H1: J Neurosci Methods 2011/9; 201 (1): 55-60. (–]ŒŽGŽ÷1: 1_Œo“à)

110110. [ŒŽ’˜] Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. Iizuka T1, Takahashi Y, Sato M1, Yonekura J1, Miyakawa S1, Endo M, Hamada J1, Kan S2, Mochizuki H1, Momose Y, Tsuji S, Sakai F: J Neurol Neurosurg Psychiatry 2012/2; 83 (2): 205-12. (”ђˍ‚_1, ²“Œ–ƒ‹|1, •Ä‘qƒŽq1, ‹{ì¹D1, à_“cˆê1, ›@Mˆê2, –]ŒŽGŽ÷1: 1_Œo“à, 2•úŽËü (‰æ‘œ))

310006. [Ç—á•ñ] A case of parkinsonism and dopa-induced severe dyskinesia associated with novel mutation in the GTP cyclohydrolase I gene. Irie S, Kanazawa N, Ryoh M, Mochizuki H1, Nomura Y, Segawa M: Parkinsonism Relat Disord 2011/12; 17 (10): 769-70. (–]ŒŽGŽ÷1: 1_Œo“à)

522053. [uÀ]y“ÁW: ’†•_ŒoŒnŠŽõÇ‚ÌUp to datezÀ’k‰ï: RNMDAŽó—e‘Ì”]‰Š‚É‚š‚¯‚é–¢‰ðŒˆ‚Ì–â‘è. ’r“cCˆê, ‚‹ŽK—˜, ”ђˍ‚_1, ‹Tˆä@‘ (1_Œo“à): ÅVˆãŠw 2011/5; 66 (5): 941-52.

522054. [uÀ]y“ÁW: ’†•_ŒoŒnŠŽõÇ‚ÌUp to datez•a‘Ô: RNMDAŽó—e‘Ì”]‰Š‚É‚š‚¯‚éÅ‹ß‚̐i•à. ”ђˍ‚_1, ˆÀ“c@“O, –]ŒŽGŽ÷1 (1_Œo“à): ÅVˆãŠw 2011/5; 66 (5): 973-83.

522055. [uÀ]yƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Á|New StandardszˆÚAEˆâ“`ŽqŽ¡—Ã: ×–EˆÚAŽ¡—Ã. ‰iˆä^‹MŽq1, –]ŒŽGŽ÷1 (1_Œo“à): Clinical Neuroscience 2011/5; 29 (5): 590-1.

522056. [uÀ]y_ŒoŽŸŠ³common disease‚̐f‚©‚œ@“à‰Èˆã‚Ì‚œ‚ß‚Ìminimum requirementzfŽ@–@‚Ɛ_ŒoÇŒó‚©‚ç‚̃Aƒvƒ[ƒ`|ÇŒó‚©‚ç‚̃Aƒvƒ[ƒ`: “ª’ɂ̐f‚©‚œ|. ˆ¢‹v’Óñ•v (_Œo“à): ƒƒfƒBƒ`[ƒi 2011/8; 48 (8): 1332-5.

522057. [uÀ]RNMDAŽó—e‘Ì”]‰Š‚̍ŐV‚Ì“®Œü. ”ђˍ‚_ (_Œo“à): —Տ°–ƒŒ 2011/8; 35 (8): 1257-63.

522058. [uÀ]y‘æ38‰ñ“ú–{“ª’ÉŠw‰ï‘‰ïƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€ MSS 2010zFHM2‚É‚š‚¯‚é‘J‰„«‘O’›‚Ì‚³‚Ü‚Ž‚Ü‚È•a‘Ô. ”ђˍ‚_ (_Œo“à): Headache Clinical Science 2011/11; 2 (2): 58-60.

522059. [uÀ]y_Œo“à‰ÈƒGƒ}[ƒWƒFƒ“ƒV[@“úí—Տ°‚Å‚Ç‚±‚܂őΉž‚Å‚«‚é‚©z‚Ç‚Ì‚æ‚€‚ÈŽ¡—Âðs‚€‚©|ŽÀ‘H“IƒAƒvƒ[ƒ`@”]ŒŒŠÇáŠQ: ”][Ç. ˆ¢‹v’Óñ•v (_Œo“à): ƒƒfƒBƒ`[ƒi 2012/4; 49 (4): 638-43.

[’˜@‘]

620069. [Šwp‘] (•ª’SŽ·•M)y•KŒg”]‘²’†ƒnƒ“ƒhƒuƒbƒN‰ü’ù‘æ2”Łz‘æI•” ‘˜_: •aŒ^•ª—Þ‚ÆŠeŽŸŠ³‚ÌŠT—ª@8 ‚»‚Ì‘Œ‚Ì”]‘²’†ŠÖ˜AŽŸŠ³@F MELAS, p.134-7. ”ђˍ‚_ (_Œo“à), •Ò: “c’†k‘Ÿ˜Y, ‚“ˆC‘Ÿ˜Y, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2011/6”­s.

620070. [Šwp‘] (•ª’SŽ·•M)y‚æ‚­•ª‚©‚éƒp[ƒLƒ“ƒ\ƒ“•a‚Ì‚·‚ׂā@‰ü’ù‘æ2”Łzƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŒŽˆö, p.359-78. ‰iˆä^‹MŽq1, –]ŒŽGŽ÷1 (1_Œo“à), •Ò: …–ì”ü–M, ‹ß“¡’q‘P, ‰iˆä‘“X, ‘åã, 2011/8”­s.

620071. [Šwp‘] (•ª’SŽ·•M)yƒAƒNƒ`ƒ…ƒA ƒ‹”]E_EoŽŸŠ³‚̗Տ°@Ž¯‚é f‚é Ž¡‚·@“ª’É‚Ì‚·‚ׂāzI. “ª’ɂ̃AƒEƒgƒ‰ƒCƒ“@“ª’É‚Í‚Ç‚±‚ª’É‚Þ‚©, p.15-27. ”ђˍ‚_ (_Œo“à), ê–å•ÒW: —é–Ø‘¥G, ‘•ÒW: ’ҁ@ÈŽŸ, ’†ŽR‘“X, “Œ‹ž, 2011/11”­s.

620072. [Šwp‘] (•ª’SŽ·•M)y_Œo“ï•a‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“@Ç—á‚ð’Ê‚µ‚ÄŠw‚Ô (CLINICAL REHABILITATION•Êû)z‘æ2Í Ç—á‚ð’Ê‚µ‚ÄŠw‚Ԑ_Œo“ï•a‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“@5. ‹ØˆÞk«‘€õd‰»Ç@1) ŒÄ‹z‹@”\áŠQ‚ɑ΂·‚éƒAƒvƒ[ƒ`‚ðs‚Á‚œÇ—á, p.103-7. ‰¬–ì”üŒbŽq (_Œo“à), ŠÄC: ]“¡•¶•v, ’†”nF—e, Š‹ŒŽ–ÎŽ÷, ˆãŽ•–òo”Å, “Œ‹ž, 2012/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713041. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Hyperperfusion associated with Prolonged Aura in FHM with a Novel ATP1A2 Gene Mutation in Japan. Iizuka T1, Takahashi Y, Sato M1, Hamada J1, Tsuji S, Mochizuki H1, Sakai F: The American Academy of Neurology's 63rd Annual Meeting in Hawaii (2011/4/12), Hawaii, USA. (”ђˍ‚_1, ²“Œ–ƒ‹|1, à_“cˆê1, –]ŒŽGŽ÷1: 1_Œo“à)

713042. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Non-motor symptoms of PARK8 I2020T of Sagamihara familial parkinsonism. Ryo M, Masuda R1, Furusawa E, Mizuno Y, K Hasegawa1, H Mochizuki1: 15th International Congress of Parkinson's Disease and Movement Disorders (2011/6/8), Tront, Canada. (‘“c@—ã1, ’·’JìˆêŽq1, –]ŒŽGŽ÷1: 1_Œo“à)

713043. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Mechanism of Angiotensin II toward Cortical Spreading Depression in Migraine Model Rat. Masuda R1, Hamada J1, Kitamura E1, Yonekura J1, Mochizuki H1: 15th Congress of the International Headache Society (2011/8/24), Berlin, Germany. (‘“c@—ã1, à_“cˆê1, –k‘º‰p“ñ1, •Ä‘qƒŽq1, –]ŒŽGŽ÷1: 1_Œo“à)

722060. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yALSŠ³ŽÒ‚Ì‘åŠw|Ý‘îˆã—ØAŒgzƒVƒ“ƒ|ƒWƒEƒ€2: _Œo“ï•a‚ɑ΂·‚é_Œo“à‰È‚Ì–ðŠ„‚ÆÝ‘îˆã‚Ƃ̘AŒg. ‰¬–ì”üŒbŽq (_Œo“à): ‘æ14‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2012/3/18), “Œ‹ž.

723166. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ALS–UŒŸÒ‘‚̖ƉuõF‚É‚æ‚錟“¢. ‰iˆä^‹MŽq1, ‘ì‰p‹K, ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/18), –ŒŒÃ‰®.

723167. [Šw‰ï (‘SEE] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FHM2‰ÆŒn‚É‚š‚¯‚é•Ð–ƒáƒ«•Ð“ª’É”­ì‹}«Šú‚Ì•a‘Ô‚ÉŠÖ‚·‚élŽ@. ”ђˍ‚_1, ²“Œ–ƒ‹|1, ‹{ì¹D1, à_“cˆê1, ‚‹Ž—S“ñ, ’ҁ@ÈŽŸ, âˆä•¶•F, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/18), –ŒŒÃ‰®.

723168. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]ƒRƒŒƒXƒeƒŠƒ“ÇðÇ‚š‚¯‚éãs‘å“®–¬‚ÌŒŸ“¢. ˆ¢‹v’Óñ•v1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/18), –ŒŒÃ‰®.

723169. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ALSŠ³ŽÒ‚É‚š‚¯‚鍕Ž¿_Œo×–E’E—Ž‚ÌŒŸ“¢. ‰““¡@Šî, ‘ì‰p‹K, —À@³•£, ‰iˆä^‹MŽq1, ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/19), –ŒŒÃ‰®.

723170. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Angiotensin II‚Ɣ玿Šg‰„«—}§”­¶•p“x‚ÌŠÖ˜A«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘“c@—ã1, à_“cˆê1, •Ä‘qƒŽq1, –k‘º‰p“ñ1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/19), –ŒŒÃ‰®.

723171. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•a‚É‚š‚¯‚éSTN-DBSŒã‚É”­Ç‚·‚é”F’mž_‹@”\áŠQ‚Ì—\‘ªˆöŽq‚ÌŒŸ“¢. ‘êŽR—eŽq1, ²“¡Ÿl, ‰¬–ì@—T1, ‰¬–ì”üŒbŽq1, âE–{–Ÿ•F, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/19), –ŒŒÃ‰®.

723172. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«‹h‹t‚É‚š‚¯‚éRƒAƒNƒAƒ|ƒŠƒ“4R‘Ì‚ÌŠÖ—^. ‹àŽq~‘Ÿ˜Y1, ”ђˍ‚_1, “à–쏲Žq1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/19), –ŒŒÃ‰®.

723173. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆê‰ß«”]‹•ŒŒ”­ì‚ª‘O‹ì‚µ‚œ”][ÇŠ³ŽÒ‚ÌŒŸ“¢. ˆ¢‹v’Óñ•v1, ‘“c@—ã1, ‘êŽR—eŽq1, ”ђˍ‚_1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ36‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï (2011/7/31), ‹ž“s.

723174. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “‡Žž’²Ç—lÇó‚Å”­Ç‚µ, L”͈͂ȓªŠW“à•‚Žî«•a•Ï‚ð’悵‚œ33Î—«—á. ‹{ì¹D1, ‰iˆä^‹MŽq1, “à–쏲Žq1, ”ђˍ‚_1, ‘ºŽR”É—Y, ‰¬–ì”üŒbŽq1 (1_Œo“à): ‘æ23‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2011/9/17), “Œ‹ž.

723175. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –Ɖu—Ö@‚ª‘tŒø‚µ‚œŒŽˆö•s–Ÿ‚̓«áz¹dÏ”­ì‚ð’悵‚œ17Î’j«—á: Ž©ŒÈ–ƉuŠw“I‹@˜‚©‚ç‚Ý‚œlŽ@. ‹àŽq~‘Ÿ˜Y1, ”ђˍ‚_1, ˆä“‡‘å•ã1, “à–쏲Žq1, à_“cˆê1 (1_Œo“à): ‘æ23‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2011/9/17), “Œ‹ž.

723176. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]zŠÂ‘ãŽÓ‚©‚ç‚Ý‚œ, MELAS‚Ì”]‘²’†—l”­ì‹}«Šú‚Ì•a‘Ô‚ÉŠÖ‚·‚élŽ@. ”ђˍ‚_1, âˆä•¶•F, à_“cˆê1 (1_Œo“à): ‘æ23‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2011/11/4), “Œ‹ž.

723177. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) áz«‘Ζƒáƒ‚Å”­Ç‚µ, 7”NŒã‚É•Ó‰Œn”]‰Š‚ð‡•¹‚µ‚œRCRMP5/CV2R‘ÌŠÖ˜A”]‰Š‚Ì48Î—«—á. ‘“c@—ã1, ‰Y–ì‹`Í1, ‹àŽq~‘Ÿ˜Y1, ”ђˍ‚_1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ29‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2011/11/17), •Ÿˆä.

723178. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽO³_ŒoØ’fp‚ª”玿Šg‰„«—}§‚É—^‚Š‚é‰e‹¿. ‘“c@—ã1, à_“cˆê1, •Ä‘qƒŽq1, –k‘º‰p“ñ1, à_“cˆê1 (1_Œo“à): ‘æ39‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2011/11/26), é‹Ê.

723179. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ä”­«“«“ª’É‚ð’悵‚œ“÷‰èŽî«‰º‚‘̉Š‚̈ê—á. •x‰i“Þ•Û”ü1, ”ђˍ‚_1, ‰Y–ì‹`Í1, ŒŽ@“ÖŽq2, ‰ª@GG3, –k‘º‰p“ñ1, à_“cˆê1 (1_Œo“à, 2•a—, 3”]ŠO): ‘æ39‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2011/11/26), é‹Ê.

731069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ž©ŒÈ–Ɖu«ƒVƒiƒvƒX”]Ç‚ÉŠÖ‚·‚éÅ‹ß‚̘b‘è|RNMDAR”]‰Š‚𒆐S‚Ɂ|. ”ђˍ‚_ (_Œo“à): ‘æ4‰ñMetropolitan Neuroimmune NetworkŒ€‹†‰ï (2011/8/8), “Œ‹ž.

731070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) RNMDAŽó—e‘Ì”]‰Š‚É‚š‚¯‚éˆÙí‰^“®‚̗Տ°‚Æ•a‘Ô. ”ђˍ‚_ (_Œo“à): ‘æ43‰ñ“ú–{‰^“®áŠQŒ€‹†‰ï (2012/1/14), “Œ‹ž.

732025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹}«Šú•a“‚É‚š‚¯‚鍂ŽŸ”]‹@”\áŠQ‘΍ô. ‘“c@—ã (_Œo“à): ‘æ12‰ñ–k—¢ì‹Æ—Ö@Šw‰ïŠwpW‰ï (2011/12/10), ‘Š–ÍŒŽ.

733083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ‰ƒŠƒAŠŽõŒã‚Ɉӎ¯áŠQ‚𗈂œ‚µ‚œ21Î’j«—á. ‚ŠÝŠG—¢Žq, ‘“c@—ã1, ‰Y–ì‹`Í1, ’†‘º@Œ’2, –]ŒŽGŽ÷1 (1_Œo“à, 2Šñ¶’Ž): ‘æ197‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2011/6/4), “Œ‹ž.

733084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RNMDAŽó—e‘Ì”]‰Š‚É‚š‚¯‚鎩ŒÈR‘̂ƗՏ°Çó‚ÌŠÖŒW. ”ђˍ‚_ (_Œo“à): ‘æ2‰ñ–k—¢_Œo‰ÈŠwƒtƒH[ƒ‰ƒ€ (2011/6/20), _“ސì.

733085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒŠÇ“àƒŠƒ“ƒpŽî‚É”º‚€is«‘œ”­«”][Ç‚̈ê—á. ‹{“c‰pŽ¡, ‘“c@—ã1, ’†‘º—m”Í, ‹àŽq~‘Ÿ˜Y1, ‰Y–ì‹`Í1, Œ‰ª˜aº2, ’†–ì•q–Ÿ3, ŒŽ@“ÖŽq4, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à, 2ŒŒ‰t“à, 3”畆, 4•a—): ‘æ14‰ñ neurovascular conference (2011/7/15), ‘Š–ÍŒŽ.

733086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŽŠoáŠQ‚𔺂€•Ð“ª’É‚Æ‚ÌŠÓ•Ê‚ð—v‚µ‚œ‰„‘ŠO‘€[Ç‚̈ê—á. ¬ÀC‘Ÿ, ‘“c@—ã1, ‰Y–ì‹`Í1, –k‘º‰p“ñ1, à_“cˆê1 (1_Œo“à): ‘æ15‰ñ neurovascular conference (2011/8/2), ‘Š–ÍŒŽ.

733087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«‹h‹t‚Å”­Ç‚µ‚œRƒAƒNƒAƒ|ƒŠƒ“4R‘Ì—z«‚Ì2—á. ‹àŽq~‘Ÿ˜Y1, ”ђˍ‚_1, “à–쏲Žq1, ‚‹Ž—˜K, à_“cˆê1 (1_Œo“à): ‘æ4‰ñMetropolitan Neuroimmune NetworkŒ€‹†‰ï (2011/8/8), “Œ‹ž.

733088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “œ”A•a‚Ɛ_ŒoáŠQ. ‘“c@—ã (_Œo“à): –k—¢‘åŠw•a‰@‘Š–͉ï•×‹­‰ï (2011/8/31), ‘Š–ÍŒŽ.

733089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Post-malaria neurological syndrome‚̈ê—á. ‘“c@—ã1, ‚ŠÝŠG—¢Žq, ‰Y–ì‹`Í1, ’†‘º@Œ’2, à_“cˆê1 (1_Œo“à, 2Šñ¶’Ž): ‘æ15‰ñ_“ސìƒjƒ…[ƒƒTƒCƒGƒ“ƒXƒWƒ‡ƒCƒ“ƒgƒZƒ~ƒi[ (2011/10/28), ‘Š–ÍŒŽ.

733090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”玿«”­˜báŠQ‚ª’·Šúæs‚µŒÄ‹z‹ØáŠQ‚ÅŒ°«‰»‚µ‚œALS‚Ì73Î—«—á. ‘êŽR—eŽq1, Œ¢’Ë—S‰î, –k‘º‰p“ñ1, ‰¬–ì”üŒbŽq1, à_“cˆê1 (1_Œo“à): ‘æ199‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2011/11/26), “Œ‹ž.

733091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Post-malaria neurological syndrome‚̈ê—á. ‘“c@—ã1, ‚ŠÝŠG—¢Žq, ‰Y–ì‹`Í1, ’†‘º@Œ’2, à_“cˆê1 (1_Œo“à, 2Šñ¶’Ž): ‘æ380‰ñ_“ސì_Œo§’k‰ï (2012/1/19), ‰¡•l.

733092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Z«‹¹‘BŽîÄ”­‚É”º‚¢”­Ç‚µ‚œdÇ‹Ø–³—͏ǂÌ79Î—«. ‹àŽq~‘Ÿ˜Y1, ‘“c@—ã1, ãˆä䝗LŽq, ‘êŽR—eŽq1, ‰¬–ì”üŒbŽq1, à_“cˆê1 (1_Œo“à): “«MG‚ÌŽ¡—Âðl‚Š‚é (2012/2/3), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110003. [ŒŽ’˜] Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements. Cao X, Yasuda T, Uthayathas S, Watts RL, Mouradian MM, Mochizuki H1, Papa SM: J Neurosci 2010/5; 30 (21): 7335-43. (–]ŒŽGŽ÷1: 1_Œo“à)

H22-110004. [ŒŽ’˜] Maternal obesity impairs hippocampal BDNF production and spatial learning performance in young mouse offspring. Tozuka Y, Kumon M, Wada E, Onodera M, Mochizuki H1, Wada K: Neurochem Int 2010/10; 57 (3): 235-47. (–]ŒŽGŽ÷1: 1_Œo“à)

H22-110005. [ŒŽ’˜] Ectopic expression of alpha-synuclein affects the migration of neural stem cells in mouse subventricular zone. Tani M, Hayakawa H, Yasuda T, Nihira T, Hattori N, Mizuno Y, Mochizuki H1: J Neurochem 2010/11; 115 (4): 854-63. (–]ŒŽGŽ÷1: 1_Œo“à)

H22-110006. [ŒŽ’˜] Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. Kurata T, Miyazaki K, Kozuki M, Panin VL, Morimoto N, Ohta Y, Nagai M1, Ikeda Y, Matsuura T, Abe K: Brain Res 2011/1; 1371: 161-70. (‰iˆä^‹MŽq1: 1_Œo“à)

H22-110007. [ŒŽ’˜] In vivo application of an RNAi strategy for the selective suppression of a mutant allele. Kubodera T, Yamada H, Anzai M, Ohira S, Yokota S, Hirai Y, Mochizuki H1, Shimada T, Mitani T, Mizusawa H, Yokota T: Hum Gene Ther 2011/1; 22 (1): 27-34. (–]ŒŽGŽ÷1: 1_Œo“à)

[Šw‰ïEŒ€‹†‰ï“™]

H22-723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Šúf’f‚ÉàhŽ†ŒŒŒŸ‘Ì–@‚É‚æ‚郿-galactosidase AŠˆ«‘ª’肪—LŒø‚Å‚ ‚Á‚œ¬l”­ÇFabry•a‚̈ê—á. ‘“c@—ã1, ˜@À’qŽq, r–؏®”ü, ‰H“cŒb—, ˆÀ–{—Ž”n, ’†‘ºŒör, ‰““¡•¶•v, à_“cˆê1, –]ŒŽGŽ÷1, ‚“cŽj’j2 (1_Œo“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ17‰ñ“ú–{ˆâ“`Žqf—Êw‰ï‘å‰ï (2010/8/6), ’Ã.

H22-72009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V‹K•ÏˆÙ del 1b (#207) ‚ð”F‚ß‚œFabry•a‚̈ê‰ÆŒn. à_“cˆê1, ‘“c@—ã1, r–؏®”ü, ˜@À’qŽq, ˆÀ–{—Ž”n, ’†‘ºŒör, ‰““¡•¶•v, –]ŒŽGŽ÷1, ‚“cŽj’j2 (1_Œo“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{l—Þˆâ“`Šw‰ï‘æ55‰ñ‘å‰ï (2010/10/29), ‚³‚¢‚œ‚Ü.


ŒŒ‰t“à‰ÈŠw

[Šwp˜_•¶]

110111. [ŒŽ’˜] Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell lines. Watanabe M1, Nakano K, Togano T1, Nakashima M, Higashihara M1, Kadin ME, Watanabe T, Horie R1: Oncol Res 2011; 19 (10-11): 463-9. (“n粐^—Žq1, ’Ì–ì•x‹P1, “ŒŒŽ³–Ÿ1, –x]—Ljê1: 1ŒŒ‰t“à)

320015. [Ç—á•ñ] ŒŽ”­«—Œ‘€•›tDLBCL‚Ì2—á. Œ‰ª˜aº1, —§‰Ô‹MŽj1, ‰Ôèr•ã1, Â–Ø‘ì–€1, •ÐŽR‘쎢1, Š™“c_–«1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): _“ސ쌌‰tŒ€‹†‰ïŽ 2011; 31; 30-40.

320016. [Ç—á•ñ] Ž©ŒÈ–Ɖu«•\”琅ávÇ‚ɍ‡•¹‚µ‚œŒã“V«ŒŒ—F•aA‚̈ê—á. Žª“c^ˆê1, Œ‰ª˜aº1, Š™“c_–«1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): _“ސ쌌‰tŒ€‹†‰ïŽ 2011; 31: 53-5.

520026. [‘à] Lymphoid malignancies: progress in diagnosis and treatment. “ŒŒŽ³–Ÿ (ŒŒ‰t“à): “ú–{“à‰ÈŠw‰ïŽGŽ: 2011/7; 100 (7): 1749-52.

520027. [‘à]yƒŠƒ“ƒpŒnŽîá‡: f’f‚ÆŽ¡—Â̐i•àzƒgƒsƒbƒNƒX@—\Œã‚Æ•af’f˜AŒg, ƒŠƒ“ƒp‹…ŒnŽîᇂ̗\ŒãE—\ŒãˆöŽq. ’hŒŽŠ²¶1, Š™“c_–«1, ‰¥@‘cœ1 (1ŒŒ‰t“à): “ú–{“à‰ÈŠw‰ïŽGŽ 2011/7; 100 (7): 1898-907.


[’˜@‘]

620073. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNzƒXƒRƒbƒgÇŒóŒQ, p.357. HŽRŒ[•ã1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à), •Ò: •ŸˆäŽŸ–î, ‘•ÒW: ˆä‘º—T•v, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

620074. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNzƒGƒvƒXƒ^ƒCƒ“ÇŒóŒQ, p.360. ‹{è_“ñ1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à), •Ò: •ŸˆäŽŸ–î, ‘•ÒW: ˆä‘º—T•v, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

620075. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNzƒOƒŒƒCŒŒ¬”njóŒQ, p.361. ‰®‘㐳W, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à), •Ò: •ŸˆäŽŸ–î, ‘•ÒW: ˆä‘º—T•v, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

620076. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNzƒxƒ‹ƒi[ƒ‹EƒX[ƒŠƒGÇŒóŒQ, p.362-3. “ŒŒŽ³–Ÿ (ŒŒ‰t“à), •Ò: •ŸˆäŽŸ–î, ‘•ÒW: ˆä‘º—T•v, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

620077. [Šwp‘] (•ª’SŽ·•M)yƒp[ƒtƒFƒNƒgƒKƒCƒh@ŒŸž’lŽ«“TzIII. ŒŒ‰tE‹ÃŒÅEü—eŒnŒŸž@ƒAƒ“ƒ`ƒgƒƒ“ƒrƒ“ (AT), ƒgƒƒ“ƒrƒ“EƒAƒ“ƒ`ƒgƒƒ“ƒrƒ“•¡‡‘Ì (TAT), ƒgƒƒ“ƒ{ƒ‚ƒWƒ…ƒŠƒ“ (TM) , ƒvƒƒeƒCƒ“‚b (PC), ƒvƒƒeƒCƒ“S (PS), ‘gDƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒ`ƒx[ƒ^ (t-PA), ƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒ`ƒxE[ƒ^EƒCƒ“ƒqƒrƒ^[1 (PAI-1), t-PAEPAI-1•¡‡‘Ì (PAIC), ƒvƒ‰ƒXƒ~ƒmƒQ (PIg), ƒ¿2-ƒvƒ‰ƒXƒ~ƒ“ƒCƒ“ƒqƒrƒ^[ (ƒ¿2-PI), ƒvƒ‰ƒXƒ~ƒ“Eƒ¿2-ƒvƒ‰ƒXƒ~ƒ“ƒCƒ“ƒqƒrƒ^[•¡‡‘Ì (PPIC) (PICƒeƒXƒg), p.351-61. “ŒŒŽ³–Ÿ (ŒŒ‰t“à), ŠÄC: ’†ŒŽˆê•F, ‘‡ˆãŠwŽÐ, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713044. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) An open-label extension study evaluating the safety and efficacy of up to 3.5 years of romiplostim in thrombocytopenic Japanese patients with immune thrombocytopenia (ITP). Miyazaki K1, Shirasugi Y, Ando K, Tomiyama Y, Iwato K, Okamoto S, Kurokawa M, Kirito K, Hashino S, Ninomiya H, Mori S, Yonemura Y, Usuki K, Wei H, Lizambri R: 16th Congress of European Hematology Association (2011/6/9), UK. (‹{è_“ñ1: 1ŒŒ‰t“à)

723180. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) (—DG‰‰‘èÜŒó•â‰‰‘è) ATL×–E–Œ•\–Ê‚Ö‚ÌCD3‚Ì”­Œ»‚ɂ̓~ƒIƒVƒ“Œyœ (MYL9) ‚ª•s‰ÂŒ‡‚Å‚ ‚é. Â–Ø‘ì–€1, ‹{è_“ñ1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ53‰ñ“ú–{•œŠŠ‹ØŠw‰ï‘‰ï (2011/8/3), “Œ‹ž.

723181. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A case of Hodgkin lymphoma with myelofibrosis. •ÐŽR‘쎢1, Â–Ø‘ì–€1, Š™“c_–«1, –Ø‘º—T˜a1, ‹{è_“ñ1, ’hŒŽŠ²¶1, “ŒŒŽ³–Ÿ1, ‹g“c@Œ÷2, ŽOã“N•v2 (1ŒŒ‰t“à, 2•a—): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/14), –ŒŒÃ‰®.

723182. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of lenalidomaide and dexamethasone on refractory multiple myeloma in s single institution. –Ø‘º—T˜a1, ‹{è_“ñ1, HŽRŒ[•ã1, “cŽ›”͍s1, ‰Ôèr•ã1, Î“c@—²1, ¬ˆä–Ÿ‰Ø1, Œ‰ª˜aº1, Â–Ø‘ì–€1, Š™“c_–«1, ‰¥@‘cœ1, Îˆä—²Ži1, •ÐŽR‘쎢1, ’Ì–ì•x‹P1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/14), –ŒŒÃ‰®.

723183. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Sixty five cases of rh-thrombomodulin treatment including two cases of fibrinolytic activated DIC. Š™“c_–«1, Ôì’Œ”V1, HŽRŒ[•ã1, “cŽ›”͍s1, ‰Ôèr•ã1, Î“c@—²1, ¬ˆä–Ÿ‰Ø1, Œ‰ª˜aº1, –Ø‘º—T˜a1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/14), –ŒŒÃ‰®.

723184. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Three cases that developed pulmonary hypertension for blood disorder. ‰¥@‘cœ1, ‘呺ŒbØ1, Î“c@—²1, ¬ˆä–Ÿ‰Ø1, Œ‰ª˜aº1, Š™“c_–«1, –Ø‘º—T˜a1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/14), –ŒŒÃ‰®.

723185. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HodgkinƒŠƒ“ƒpŽî‚Ì‘O‹ì×–E‚É‚š‚¯‚镪ŽqŠî”Ղ̉ðÍ‚Æ•ªŽq•W“I—Ö@‚ÌŠî‘b“IŒŸ“¢. –x]—Ljê1, ’†“‡@œ, “n糐^—Žq1, ’Ì–ì•y‹P1, ”~àVˆê•v, “n糏rŽ÷, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ïŠwpW‰ï (2011/10/15), –ŒŒÃ‰®.

723186. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Two cases of primary bilateral adrenal DLBCL. Œ‰ª˜aº1, Ôì’Œ”V1, HŽRŒ[•ã1, “cŽ›”͍s1, ‰Ôèr•ã1, ¬ˆä–Ÿ‰Ø1, Î“c@—²1, ‰¥@‘cœ1, Š™“c_–«1, –Ø‘º—T˜a1, Â–Ø‘ì–€1, Îˆä—²Ži1, •ÐŽR‘쎢1, ‘åâ@Šw1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/15), –ŒŒÃ‰®.

723187. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ITP-like thrombocytopenia by dasatinib in a patient with CML-CP: A case report. ’Ì–ì•x‹P1, ‘呺ŒbØ1, Š™“c_–«1, Îˆä—²Ži1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/15), –ŒŒÃ‰®.

723188. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)y—DGƒ|ƒXƒ^[zThe efficacy and safety of piperacilline-tazobactam for febrile neutropenic Japanese patients. ‹{è_“ñ1, Š™“c_–«1, –Ø‘º—T˜a1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/14), –ŒŒÃ‰®.

723189. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The 5-aza-2'-deoxycytidine effect on cell cycle is related to the expression level of PU.1. ÂŽRŽÑ—R—¢, ˆä–{–Ÿ”ü, ¬ì—Y‘å, —é–؍²˜a”ü, ’hŒŽŠ²¶1, “ŒŒŽ³–Ÿ1, ’£‘֏G˜Y, ‚‹ŽLˆê˜Y (1ŒŒ‰t“à): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïŠwpW‰ï (2011/10/15), –ŒŒÃ‰®.

732026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Ê‹³ˆçu‰‰) ŒŒ¬”ÂŒž­Ç‚̗Տ°|ITP‚𒆐S‚Ɂ|. “ŒŒŽ³–Ÿ (ŒŒ‰t“à): ‰¡•lÅVŽ¡—ÃtƒH[ƒ‰ƒ€ (2011/4/22), ‰¡•l.

732027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Ê‹³ˆçu‰‰) ITP‚̐f’f‚ÆŽ¡—Á|overview|. “ŒŒŽ³–Ÿ (ŒŒ‰t“à): E_“ސ샌ƒ{ƒŒ[ƒhŒ€‹†‰ï (2011/9/9), ‰¡•l.

733093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚Åpreemptive/empirical‚ÉŽ¡—Âðs‚Á‚œ^‹ÛŠŽõÇ. –x•Ä—Sˆê1, Î“c@—²1, –Ø‘º–Ÿ‰Ø1, HŽRŒ[•ã1, “cŽ›”͍s1, ‰Ôèr•ã1, Œ‰ª˜aº1, Š™“c_–«1, –Ø‘º—T˜a1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ1, ’dŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ5‰ñ‚³‚ª‚ݐ^‹ÛÇŒ€‹†‰ï (2011/6/2), ‘Š–ÍŒŽ.

733094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ä”­HodgkinƒŠƒ“ƒpŽî‚É‹}«‘Oœ‘‹…«”’ŒŒ•a‚ð‡•¹‚µ‚œˆêÇ—á. ¬–ì—Y‘å1, HŽRŒ[•ã1, “cŽ›”͍s1, ‰Ôèr•ã1, Î“c@—²1, ¬ˆä–Ÿ‰Ø1, Œ‰ª˜aº1, Š™“c_–«1, –Ø‘º—T˜a1, ’hŒŽŠ²¶1, ‹{è_“ñ1, –x]—Ljê1, ‹g“c@Œ÷2, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à, 2,•a—): ‘æ16‰ñÃ“쌌‰tƒZƒ~ƒi[ (2011/6/23), ‘Š–ÍŒŽ

733095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž©ŒÈ–Ɖu«•\”琅ávÇ‚ɍ‡•¹‚µ‚œŒã“V«ŒŒ—F•aA‚̈ê—á. ˜ð“c@ˆ²1, Žª“c^ˆê1, ‹{è_“ñ1, “cŽ›”͍s1, ‰Ôèr•ã1, HŽRŒ[•ã1, Œ‰ª˜aº1, ¬ˆä–Ÿ‰Ø1, Î“c@—²1, Š™“c_–«1, –Ø‘º—T˜a1, Â–Ø‘ì–€1, •ÐŽR‘쎢1, ’Ì–ì•x‹P1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ166‰ñ“ú–{ŒŒ‰tŠw‰ï—á‰ï (2011/7/2). “Œ‹ž.

733096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ITPŠ³ŽÒ‚ɑ΂·‚éƒgƒƒ“ƒ{ƒ|ƒGƒ`ƒ“Žó—e‘̍쓮–òƒGƒ‹ƒgƒƒ“ƒ{ƒpƒO‚ÌŽg—pŒoŒ±. ‰¡ŽR^Šì1, Š™“c_–«1, –Ø‘º—T˜a1, ‘åâ@Šw1, ‹{è_“ñ1, ’dŒŽŠ²¶1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ64‰ñ_“ސ쌌‰tŒ€‹†‰ï (2011/9/3), ‰¡•l.

733097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˜’ɁEŒŒ”A‚Å”­Ç‚µ‚œ‘æVˆöŽqŒ‡–RÇ‚̈ê—á. Œ‰ª˜aº1, HŽRŒ[•ã1, “cŽ›”͍s1, ‰Ôèr•ã1, Î“c@—²1, ¬ˆä–Ÿ‰Ø1, Š™“c_–«1, –Ø‘º—T˜a1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ1, ’dŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ64‰ñ_“ސ쌌‰tŒ€‹†‰ï (2011/9/3). ‰¡•l.

733098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Jurkat×–E–Œ•\–Ê‚Ö‚ÌCD3‚Ì”­Œ»‚ɂ̓~ƒIƒVƒ“Œyœ (MYL9) ‚ª•s‰ÂŒ‡‚Å‚ ‚é. Â–Ø‘ì–€1, ‹{è_“ñ1, •ÐŽR‘쎢1, “n粐^—Žq1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ14‰ñ_“ސ쌌‰t–ƉuƒtƒH[ƒ‰ƒ€(2011/11/11), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110008. [ŒŽ’˜] Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan. Kume H, Yamazaki T, Togano T1, Abe M, Tanuma H, Kawana S, Okudaira M: Med Mycol J 2011/2; 52 (2): 117-27. (’Ì–ì•x‹P1: 1ŒŒ‰t“à)

[Šw‰ïEŒ€‹†‰ï“™]

H22-733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}«’P‹…«”’ŒŒ•a‚É”x‚ŒŒˆ³Ç‚ð‡•¹‚µ‚œˆê—á. ‘呺ŒbØ1, Œ‰ª˜aº1, ‰¥@‘cœ1, Š™“c_–«1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ63‰ñ_“ސ쌌‰tŒ€‹†‰ï (2011/2/5). ‰¡•l.


ŒÄ‹zŠí“à‰ÈŠw

[Šwp˜_•¶]

110112. [ŒŽ’˜] Prognostic significance of Nestin expression in resected non-small cell lung cancer. Ryge S1, Sato Y, Wang G2, Matsumoto T, Jiang SX3, Katono K1, Inoue H, Satoh Y4, Masuda N1: Chest 2011/4; 139 (4): 862-9. (—Ž‰ØTˆê˜Y1, ²“¡—Yˆê, ‰€@‘‹Õ2, Œ–{r‰p, Ó@¢ˆ®3, ã‰“–쌒1, ˆäã”¹l, ²“¡”Vr4, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2—Տ°Œ€‹†EŠé‰æ, 3•a—, 4ŒÄ‹zŠíŠO)

110113. [ŒŽ’˜] Prevalence of topoisomerase I genetic mutations and UGT1A1 polymorphisms associated with irinotecan in individuals of Asian descent. Fukui T1, Mitsufuji H1, Kubota M1, Inaoka H, Hirose M, Iwabuchi K2, Masuda N1, Kobayashi H: Oncol Lett 2011/9; 2 (5): 923-8. (•Ÿˆä•ü–ç1, ŽO“¡@‹v1, ‹v•Û“cŸ1, ŠâŸºŒ[ˆê2, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2•a—)

110114. [ŒŽ’˜] Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer. Hosomi Y, Shibuya M, Niho S, Ichinose Y, Kiura K, Sakai H, Takeda K, Kudo S, Eguchi K, Matsui K, Masuda N1, Ando M, Watanabe K: Anticancer Res 2011/10; 31 (10): 3449-56. (‰v“c“TK1: 1ŒÄ‹zŠí“à)

110115. [ŒŽ’˜] Impacts of treatment lines and initiation timing of erlotinib for advanced non-small cell lung cancer. Aoki T, Igawa S1, Furuya N, Katagiri M, Hisata J, Tajiri S, Hayama N, Mineshita M, Urano T, Miyazawa T, Masuda N1, Abe T: Anticancer Res 2012/2; 32 (2): 601-8. (ˆäì@‘1, ‰v“c“TK1: 1ŒÄ‹zŠí“à)

110116. [ŒŽ’˜] CAXII is a sero-diagnostic marker for lung cancer. Kobayashi M, Matsumoto T, Ryuge S1, Yanagita K, Nagashio R, Kawakami Y, Goshima N, Jiang SX2, Saegusa M2, Iyoda A3, Satoh Y3, Masuda N1, Sato Y: PLoS One 2012/3; 7 (3): e33952. (—Ž‰ØTˆê˜Y1, Ó@¢ˆ®2, ŽOŽ}@M2, ˆÉ˜¬“c–Ÿ3, ²“¡”Vr3, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2•a—, 3ŒÄ‹zŠíŠO)

110117. [ŒŽ’˜] Rapid deconjugation of SN-38 glucuronide and adsorption of released free SN-38 by interstinal microorganisms in rat. Takakura A1, Kurita A, Asahara T, Yokoba M, Yamamoto M1, Ryuge S1, Igawa S1, Yasuzawa Y, Sasaki J, Kobayashi H, Masuda N1: Oncol Lett 2012/3; 3 (3): 520-4. (‚‘q@W1, ŽR–{—ÏŽq1, —Ž‰ØTˆê˜Y1, ˆäì@‘1, ‰v“c“TK1: 1ŒÄ‹zŠí“à)

110118. [ŒŽ’˜] Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI). Harada H, Seto T, Igawa S1, Tsuya A, Wada M1, Kaira K, Naito T, Hayakawa K2, Nishimura T, Masuda N1, Yamamoto N1: Int J Radiat Oncol Biol Phys 2012/4; 82 (5): 1777-82. (ˆäì@‘1, ˜a“c^—RŽq1, ‘ì˜ad2, ‰v“c“TK1, ŽR–{—ÏŽq1: 1ŒÄ‹zŠí“à, 2•úŽËü (Žîá‡))

110119. [ŒŽ’˜] Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung. Ryuge S1, Sato Y, Jiang SX2, Wang G3, Matsumoto T, Katono K1, Inoue H, Iyoda A4, Satoh Y4, Yoshimura H4, Masuda N1: Lung Cancer 2012/8; 77 (2): 415-20. (—Ž‰ØTˆê˜Y1, ²“¡—Yˆê, Ó@¢ˆ®2, ‰€@‘‹Õ3, Œ–{r‰p, ã‰“–쌒1, ˆäã”¹l, ˆÉ˜¬“c–Ÿ4, ²“¡”Vr4, ‹g‘º”Ž–M4, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2•a—, 3—Տ°Œ€‹†EŠé‰æ, 4ŒÄ‹zŠíŠO)

120012. [ŒŽ’˜] ‚—îŽÒŠùŽ¡—Ðis”ñ¬×–E”xŠàŠ³ŽÒ‚ɑ΂·‚éPemetrexed’PÜ‚ÌŒŸ“¢. ‘å’JçŽq1, ˆäì@‘1, ^–؍K‘ã1, ‰i“‡—YŽŸ˜Y1, —с@L[1, –Ø‘º”ü’qŽq1, Š}“‡^Žu1, “ú‹gNO1, ã‰“–쌒1, ‚‘q@W1, ŽO“¡@‹v1, ‹v•Û“cŸ1, •Ð‹Ë^l2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): Šà‚Ɖ»Šw—Ö@ 2012/1; 39 (1): 59-62.

220004. [€ŒŽ’˜ (—Տ°•ñ)] ŒF–{Œ§u‚ª‚ñf—ØAŒgƒpƒXv‚ÌŽŽ‚݂Ɖۑè. ‹«@Œ’Ž¢, X–k’C”n, ˜a“c“ޏŽq, ‹g“c@–«, •ÐŸº@–Î, ŠÝ@—Tl, à_Œû—TŒõ, ²X–ØŽ¡ˆê˜Y1, •ÐŸºG—² (1ŒÄ‹zŠí“à): Šà‚Ɖ»Šw—Ö@ 2011/4; 38 (4): 621-5.

310007. [Ç—á•ñ] Advanced thymic carcinoma showing a stable disease reaction to single-agent amrubicin as a third-line chemotherapy: case report. Igawa S1, Yanagisawa N2, Hiyoshi Y1, Kimura M1, Kasajima M1, Ishihara M1, Maki S1, Otani S1, Hayashi N1, Nagashima Y1, Masuda N1: Kitasato Med J 2011/9; 41 (2): 193-6. (ˆäì@‘1, –öàVM”V2, “ú‹gNO1, –Ø‘º”ü’qŽq1, Š}“‡^Žu1, ÎŒŽ–¢ŠóŽq1, ^–؍K‘ã1, ‘å’JçŽq1, —с@L[1, ‰i“‡—YŽŸ˜Y1, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2•a—)

320017. [Ç—á•ñ] KL-6‚ª‚’l‚ð’悵‚œƒoƒ‹ƒTƒ‹ƒ^ƒ“‚É‚æ‚é–òÜ«”x‰Š‚Ì1—á. ‚‘q@W1, ‹v•Û“cŸ1, ‘å’JçŽq1, ã‰“–쌒1, ŽR–{—ÏŽq1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): “ú–{ŒÄ‹zŠíŠw‰ïŽGŽ 2011/7; 49 (7): 523-7.

320018. [Ç—á•ñ] ‘œ”­”X–E«”x•a•Ï‚ð’·ŠúŒo‰ßŠÏŽ@‚µ‚Š‚œŒŽ”­«ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ì1—á. ŽR–{—ÏŽq1, ‹v•Û“cŸ1, ‰i“‡—YŽŸ˜Y1, ã‰“–쌒1, ˜a“c^—RŽq1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): “ú–{ŒÄ‹zŠíŠw‰ïŽGŽ 2011/11; 49 (11): 843-7.

320019. [Ç—á•ñ] ’†ŒãcŠu‚É•a•Ï‚ð”F‚ß‚œIgG4ŠÖ˜AŽŸŠ³‚Ì1—á. ^–؍K‘ã1, ‚‘q@W1, “ú‹gNO1, ‰¡ê³“T2, ‰v“c“TK1, •Ð‹Ë^l2 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): “ú–{ŒÄ‹zŠíŠw‰ïŽGŽ 2011/12; 49 (12): 908-12.

320020. [Ç—á•ñ] ”xŠàžž’†‚É‹ô‘R”­Œ©‚³‚ê‚œ‹CŠÇŽxè÷—±×–EŽî‚Ì1—á. ã‰“–쌒1, ‹v•Û“cŸ1, “ú‹gNO1, —с@L[1, ‘å’JçŽq1, ‚‘q@W1, ‰¡ê³“T2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): “ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŽGŽ 2012/1; 34 (1): 74-9.

522060 [uÀ]y“ÁW: ‚ª‚ñ‰»Šw—Ö@‚̐i•àzA. ‚ª‚ñ‰»Šw—Ö@‚̐®”õ‚É‚Þ‚¯‚ā@(4) ŠO—ˆ‰»Šw—Ö@‚̃GƒbƒZƒ“ƒX. ²X–ØŽ¡ˆê˜Y (ŒÄ‹zŠí“à): ‰»Šw—Ö@‚̗̈æ 2011/4; 27 (S-1): 34-9.

522061. [uÀ]yŠ³ŽÒE‰Æ‘°‚Ì‘Š’k‚ɉž‚Š‚邪‚ñf—ÃTƒ|[ƒgƒKƒCƒhz”x‚ª‚ñ@‚©‚©‚è‚‚¯ˆã‚©‚ç: ”ñ¬×–E‚ª‚ñ‚Å•aŠú (is“x‚²‚Æ‚Ì) ‚É‚æ‚鎡—Ö@‚Ì‘I‘ð•ûj‚Æ‚»‚Ì“à—e‚ð‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. ²X–ØŽ¡ˆê˜Y (ŒÄ‹zŠí“à): Ž¡—à 2011/4; 93 (‘Š§): 974-7.

522062. [uÀ]yŽ_‘f—Ö@zÝ‘îŽ_‘f—Ö@‚ÌŒ»ó‚Ɖۑè. ‹v•Û“cŸ (ŒÄ‹zŠí“à): Clinical Engineering 2011/9; 22 (10): 970-6.

522063. [uÀ]yŒÄ‹z‹@”\ŒŸžzŒÄ‹z‹@”\ŒŸž‚̊’l‚Æ‚»‚ÌŽg‚¢•û, ¡Œã‚̉ۑè@ (3) ”x‹C—Ê (FRC, RV, TLC, RV/TLC). ‹v•Û“cŸ1, ¬—эO—S2 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): ŒÄ‹z 2011/9; 30 (9): 794-800.

522064. [uÀ]y“ÁW: ”xŠà-ƒpƒ‰ƒ_ƒCƒ€ƒVƒtƒg‚ðŒ}‚Š‚œ”xŠàŽ¡—Áz ”xŠà@is”ñ¬×–E”xŠà‚̌•ʉ»Ž¡—Â̍l‚Š•û. ‚‹Ž˜a‹v, ’·’JìD‹K, ²X–ØŽ¡ˆê˜Y1 (1ŒÄ‹zŠí“à): ƒJƒŒƒ“ƒgƒeƒ‰ƒs[ 2011/11; 29 (11): 1054-63.

522065. [uÀ]y“ÁW: “~‹G‚É‚æ‚­‚Ý‚éŒÄ‹zŠíŠŽõÇz ŠeŽíŒÄ‹zŠíŠŽõÇ@”x‰Š@”ñ’èŒ^•aŒŽ‹Û‚É‚æ‚é”x‰Š. ²X–ØŽ¡ˆê˜Y1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): —Õଂƌ€‹† 2011/12; 88 (12): 1518-24.

522066. [uÀ]y“O’ꕪÍƒVƒŠ[ƒY: Å‹ß‚ÌŠàŽ¡—Áz S”x‹@”\—\”õ—Í‚Ö‚ÌŠà–ò•š—Ö@‚̉e‹¿: Žå–ð‚ð•‚¯‚é˜e–ð‚È‚Ì‚ÉŽž‚Ɉ«–ð‚É‚È‚éŠàŽ¡—Öò. ²X–ØŽ¡ˆê˜Y1, ‘å’JçŽq1, ˆäì@‘1 (1ŒÄ‹zŠí“à): LiSA 2012/2; 19 (2): 122-30.

522067. [uÀ]y“ÁW: ”xŠàUPDATEz—\–h‚ÆŒŸf@‹Ö‰Œ‚Æ”x‚ª‚ñ—\–hí—ª|EBM‚ÉŠî‚­”x‚ª‚ñ—\–h. ²X–ØŽ¡ˆê˜Y1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): ˆãŠw‚Ì‚ ‚ä‚Ý 2012/3; 240 (13): 1027-33.

[’˜@‘]

620078. [Šwp‘] (•ª’SŽ·•M)yŠàf—ÃŽwj‚Ì‚œ‚ß‚Ì•a—f’fƒvƒ‰ƒNƒeƒBƒX@”xŠàz•a—f’f‚ÌŽQlŽ–€@‹CŠÇŽx”x–Eôò, p.26-30. ‹v•Û“cŸ1, ²“¡”Vr2 (1ŒÄ‹zŠí“à, 2ŒÄ‹zŠíŠO), ê–å•ÒW: ŒŒŽ@C, ‘•ÒW: ÂùŽ”V, ’†ŽR‘“X, “Œ‹ž, 2011/4”­s.

620079. [Šwp‘] (•ª’SŽ·•M)yEBMŒÄ‹zŠíŽŸŠ³‚ÌŽ¡—Ã2011-2012z˜22. Žîᇊ֌W@C. •úŽËüŽ¡—ÁEÇóŠÉ˜aŽ¡—ÂȂǁ@5. ”xŠàœ“]ˆÚ‚Ì–ò•š—Ö@: Å‹ß‚̃Gƒrƒfƒ“ƒX, p.485-90. ²X–ØŽ¡ˆê˜Y (ŒÄ‹zŠí“à), •Ò: ‰iˆäŒúŽu, ‘å“c@Œ’, ]ŒûŒ€“ñ, ‹Ž–{@C, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713045. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Metabolic profiles as predictive biomarkers of erlotinib-induced adverse effects in patients with non-small cell lung cancer. Hamada A, Sasaki J1, Sho Saeki, Iwamoto N, Inaba M, Ushijima S, Kishi H, Fujii S, Semba H, Kashiwabara K, Tsubata Y, Kai Y, Isobe T, Kourogi H, Saito H: 2011 ASCO Annual Meeting (2011/6/6), Chicago, USA. (²X–ØŽ¡ˆê˜Y1: 1ŒÄ‹zŠí“à)

713046. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The influence of gastric secretion inhibitors on gefitinib therapy in patients with non-small cell lung cancer. Saeki S, Sasaki J1, Sakata S, Sato R, Ichiyasu H, Fujii K, Saita N, Kohrogi H: 14th World Conference on Lung Cancer (2011/7/6), Amsterdam, The Netherlands. (²X–ØŽ¡ˆê˜Y1: 1ŒÄ‹zŠí“à)

713047. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Relationship between inspiratory muscle training with abdominal breathing and changing of diaphragmatic thickness. Ichikawa T, Kimura M1, Yokoba M2, Takahashi Y, Takakura A1, Mitsui Y, Katagiri M2, Matsunaga A: The 16th Congress of the APSR (2011/11/4), Shanghai, China. (–Ø‘º”ü’qŽq1, ‰¡ê³“T2, ‚‘q@W1, •Ð‹Ë^l2: 1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”)

713048. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The effects of long acting ƒÀ2-agonist on inspiratory and expiratory muscles during hypercapnia. Yokoba M1, Ichikawa T, Takakura A2, Maki S2, Otani S2, Wada M2, Masuda N2, Abe T, Easton PA, Katagiri M1: The 16th Congress of the APSR (2011/11/4), Shanghai, China, Respirology 2011; 16 (Suppl. 2): 291. (‰¡ê³“T1, ‚‘q@W2, ^–؍K‘ã2, ‘å’JçŽq2, ˜a“c^—RŽq2, ‰v“c“TK2, •Ð‹Ë^l1: 1ˆã—Éq¶Šw•”, 2ŒÄ‹zŠí“à)

713049. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The effects of short acting ƒÀ2-agonist on inspiratory and expiratory muscles during hypercapnia. Takakura A1, Ichikawa T, Yokoba M2, Katono K1, Ryuge S1, Yamamoto M1, Masuda N1, Abe T, Easton PA, Katagiri M2: The 16th Congress of the APSR (2011/11/4), Shanghai, China, Respirology 2011; 16 (Suppl. 2): 291. (‚‘q@W1, ‰¡ê³“T2, ã‰“–쌒1, —Ž‰ØTˆê˜Y1, ŽR–{—ÏŽq1, ‰v“c“TK1, •Ð‹Ë^l2: 1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”)

722061. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‚ª‚ñf—Âɂš‚¯‚éŒÄ‹zŠí‰Èˆã‚Ì–ðŠ„@‚ª‚ñ‘΍ôŠî–{–@Ž{s‚𓥂܂Š‚Ä ŒF–{Œ§‚Ì‚ª‚ñf—ØAŒg‚ð[ŽÀ‚³‚¹‚éƒc[ƒ‹‚ƃlƒbƒgƒ[ƒN. ²X–ØŽ¡ˆê˜Y (ŒÄ‹zŠí“à): ‘æ51‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2011/4/23), “Œ‹ž.

722062. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) The regional cancer care critical paths with patient information will be a useful tool for Advance Cancer Care Planning. ²X–ØŽ¡ˆê˜Y1, ŠÝ@—Tl, •ÐŸº@–Î, ‹«@Œ’Ž¢, ‹g“c@–«, •ÐŸºG—² (1ŒÄ‹zŠí“à): ‘æ70‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2011/10/4), EŒŒÃ‰®.

723190. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚’YŽ_ƒKƒXŽhŒƒŽž‚É‚š‚¯‚éƒqƒgŒÄ‹z‹Ø‚Ö‚Ì’ZŽžŠÔì—pŒ^‚š‚æ‚Ñ’·ŽžŠÔì—pŒ^ƒÀ2ŽhŒƒ–ò‚̉e‹¿. ‰¡ê³“T1, ‚‘q@W2, —с@L[2, ŽR–{—ÏŽq2, ¬–ì“cŽ, ŽO“¡@‹v2, ¬—эO—S1, –î“ߐ£M—Y3, ‰v“c“TK2, •Ð‹Ë^l1, ˆ¢•”@’Œ (1ˆã—Éq¶Šw•”, 2ŒÄ‹zŠí“à, 3ŠÅŒìŠw•”): ‘æ51‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2011/4/23), “Œ‹ž, “ú–{ŒÄ‹zŠíŠw‰ïŽGŽ 2011; 49 (‘Š§): 183.

723191. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘̏d‚ª“Á”­«ŠÔŽ¿«”x‰ŠŠ³ŽÒ‚Ì”xŠˆ—Ê‚Æ”xŠgŽU”\—Í‚É‹y‚Ú‚·‰e‹¿. ‹v•Û“cŸ1, ã‰“–쌒1, Š}“‡^Žu1, –Ø‘º”ü’qŽq1, ÎŒŽ–¢ŠóŽq1, “ú‹gNO1, ‰i“‡—YŽŸ˜Y1, ^–؍K‘ã1, ‚‘q@W1, ˆäì@‘1, ”šÎ—²Ž¡1, ‰¡ê³“T2, •Ð‹Ë^l2, –î“ߐ£M—Y3, ‰v“c“TK1, ¬—эO—S2 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ51‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2011/4/23), “Œ‹ž.

723192. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ¬×–E«”xŠà‚É‚š‚¯‚éHADHA‚̍RŠàÜŠŽŽó«—\‘ªƒ}[ƒJ[‚ð‚µ‚Ä‚Ì—L—p«. ŒiŽR‘וœ, —Ž‰ØTˆê˜Y1, ’·‰–@—º, Œ–{r‰p, Ó@¢ˆ®2, ŽOŽ}@M2, ²“¡—Yˆê (1ŒÄ‹zŠí“à, 2•a—): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/28), ‰¡•l.

723193. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹•”“®‘̒ǐՕúŽËüŽ¡—Â̂œ‚ߌo‹CŠÇŽx“I‚É‹àƒ}[ƒJ[—¯’u‚ðs‚È‚Á‚œÇ—á‚ÌŒŸ“¢. ŽO“¡@‹v1, •Ð‹Ë^l2, –î“ߐ£M—Y3, ‰i“‡—YŽŸ˜Y1, —с@Lˆò1, ^–؍K‘ã1, ‘å’JçŽq1, ‚‘q@W1, ã‰“–쌒1, ˜a“c^—RŽq1, —Ž‰ØTˆê˜Y1, ŽR–{—ÏŽq1, ¬–ì“cŽ, ˆäì@‘1, ‰¡ê³“T2, ‹v•Û“cŸ1, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ34‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠwpW‰ï (2011/6/16), •lŒ, ‹CŠÇŽxŠw 2011; 33 (‘Š§†): S174.

723194. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠùŽ¡—Ðis”ñ¬×–E”xŠà‚ɑ΂·‚éƒyƒƒgƒŒƒLƒZƒh’PÜ‚ÌŽ¡—ÃŒoŒ±. ˆäì@‘1, ’©ŒG–ƒˆßŽq, ‰v“c“TK1, ‰¡ê³“T2, •Ð‹Ë^l2, –î“ߐ£M—Y3 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ9‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2011/7/22), ‰¡•l, “ú–{—Տ°Žîᇊw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; Vol. 9: 420.

723195. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A Clinical Phase II Study of S-1 monotherapy in Patients with Previously Treated, Advanced Non-small cell Lung Cancer. ˜a“c^—RŽq1, ŽR–{—ÏŽq1, —Ž‰ØTˆê˜Y1, Eú‹gNO1, –Ø‘º”ü’qŽq1, —с@L[1, ‰i“‡—YŽŸ˜Y1, ^–؍K‘ã1, ‘å’JçŽq1, ‚‘q@W1, ã‰“–쌒1, ˆäì@‘1, ŽO“¡@‹v1, ‹v•Û“cŸ1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): ‘æ9‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2011/7/23), ‰¡•l.

723196. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒF–{‚ª‚ñƒTƒƒ“@Š³ŽÒEˆã—Ë@ŠÖEs­‚ÌŽOˆÊˆê‘Ì‚É‚æ‚éÝ—§Šˆ“®•ñ. ²X–ØŽ¡ˆê˜Y1, ’r“c—E“ñ, –x“c‚ß‚®‚Ý, ‰ÍŠì‘œ‚Í‚é‚Ý, “c’†“Þ•ä, –؉ºG”ü, t–؁@i, •û”üân, ã‘º—TŽq, ’†ì¹Žq, Žè“ˆ‹`–Ÿ, “í–{œ“ñ, •B“cŒNŽq, Šâ£OŒh (1ŒÄ‹zŠí“à): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/29), –ŒŒÃ‰®.

723197. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠO—ˆ‰»Šw—Ö@Ž{s’†‚Ì”xŠàŠ³ŽÒ‚ɏI––Šú‚ðŒ©‰z‚µ‚œACP (Advance Care Planning) ‚͉”\‚©? ²X–ØŽ¡ˆê˜Y1, ²”Œ@Ë, ²“¡@—º, â“cW–ç, â–{ˆÀŒ©Žq, ‹»ž‘”ŽŽŸ (1ŒÄ‹zŠí“à): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/3), ‘åã.

723198. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x‘å×–E_Œo“à•ª”åŠà‚É‚š‚¯‚éNestin‚Ì”­Œ»‚Æ—\Œã‚ÉŠÖ‚·‚錟“¢. —Ž‰ØTˆê˜Y1, ‘å’JçŽq1, ã‰“–쌒1, ‚‘q@W1, ’©ŒG–ƒˆßŽq, ˜a“c^—RŽq1, ŽR–{—ÏŽq1, ‰¡ê³“T2, ‹v•Û“cŸ1, •Ð‹Ë^l2, ¬—эO—S2, –î“ߐ£M—Y3, ‰v“c“TK1, ²“¡—Yˆê2, Ó@¢ˆ®4, ²X–ØŽ¡ˆê˜Y1, ˆÉ˜¬“c–Ÿ5, ²“¡”Vr5 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”, 4•a—, 5ŒÄ‹zŠíŠO): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/4), ‘åã, ”xŠà 2011; 51 (5): 622.

723199. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)‚—îŽÒŠùŽ¡—Ðis”ñ¬×–E”xŠà‚ɑ΂·‚éƒyƒƒgƒŒƒLƒZƒh’PÜ‚ÌŽ¡—ÃŒoŒ±. ˆäì@‘1, ‘å’JçŽq1, ^–؍K‘ã1, ‰i“‡—YŽŸ˜Y1, –Ø‘º”ü’qŽq1, “ú‹gNO1, ‹v•Û“cŸ1, ²X–ØŽ¡ˆê˜Y1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/3-4), ‘åã.

732028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰»Šw—Ö@‚ðŠó–]‚·‚éI––Šú”xŠàŠ³ŽÒ‚ɑ΂·‚éƒg[ƒ^ƒ‹ƒPƒA. ²X–ØŽ¡ˆê˜Y (ŒÄ‹zŠí“à): ‘æ66‰ñ“ú–{ŒÄ‹zŠíŠw‰ïE“ú–{Œ‹Šj•aŠw‰ï‹ãBŽx•”t‹GŠwpu‰‰‰ï (2011/6/25), ŒF–{.

733099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒLƒVƒXƒƒ}ƒCƒVƒ““à•ž‚ª—LŒø‚Å‚ ‚Á‚œ”xƒ‰ƒ“ƒQƒ‹ƒnƒ“ƒX×–E‘gD‹…Ç (LCH) ‚Ì1—á. ‘å’JçŽq1, “ú‹gNO1, ŽR–{—ÏŽq1, ˜a“c^—RŽq1, —Ž‰ØTˆê˜Y1, ŒˆäNl1, ‹v•Û“cŸ1, •Ð‹Ë^l2, ¬—эO—S2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): ‘æ194‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠÖEŒ’n•û‰ï (2011/5/28), “Œ‹ž.

733100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠ–ƒŒ‰º‹¹o‹ŸŒŸž‚ªf’f‚É—L—p‚Å‚ ‚Á‚œ“Á”­«DŽ_‹…‘‘œÇŒóŒQ‚Ì1—á. –Ø‘º”ü’qŽq1, ã‰“–쌒1, Š}“‡^Žu1, ‰i“‡—YŽŸ˜Y1, —с@L[1, ŽO“¡@‹v1, ‹v•Û“cŸ1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): ‘æ139‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”‰ï (2011/12/3), “Œ‹ž.

733101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠ–ƒŒ‰º‹¹o‹Ÿ‰º‹¹–Œ¶ŒŸ‚Őf’f‚µ“Ÿ‚œ‹¹…‡•¹”xMALTƒŠƒ“ƒpŽî‚Ì1—á. ‰i“‡—YŽŸ˜Y1, —Ž‰ØTˆê˜Y1, “ú‹gNO1, Š}“‡^Žu1, —с@L[1, ‘å’JçŽq1, ã‰“–쌒1, ŽR–{—ÏŽq1, ”šÎ—²Ž¡1, ‰¡ê³“T2, ŽO“¡@‹v1, ‹v•Û“cŸ1, •Ð‹Ë^l2, –î“ߐ£M—Y3, ’hŒŽŠ²¶4, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”, 4ŒŒ‰t“à): ‘æ140‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”‰ï (2012/3/17), “Œ‹ž.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H9-110001. [ŒŽ’˜] Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein. Makino K, Kuwahara H, Masuko N, Nishiyama Y, Morisaki T, Sasaki J1, Nakao M, Kuwano A, Nakata M, Ushio Y, Saya H: Oncogene 1997/5; 14 (20): 2425-33. (²X–ØŽ¡ˆê˜Y1: 1ŒÄ‹zŠí“à)

H21-110002. [ŒŽ’˜] Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Igawa S1you, Murakami H, Takahashi T, Nakamura Y, Tsuya A, Naito T, Kaira K, Ono A, Shukuya T, Tamiya A, Endo M, Yamamoto N: Lung Cancer 2010/2; 67 (2): 194-7. (ˆäì@‘1: 1ŒÄ‹zŠí“à)


“à•ª”å‘ãŽÓ“à‰ÈŠw

[Šwp˜_•¶]

110120. [ŒŽ’˜] Distinct systemic distribution of salusin-ƒ¿ and salusin-ƒÀ in the rat. Suzuki N, Shichiri M1, Tateno T, Sato K, Hirata Y: Peptides 2011/4; 32 (4): 805-10. (Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à)

110121. [ŒŽ’˜] The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion into extracellular space. Yoshikawa A, Aizaki Y, Kusano K, Kishi F, Susumu T, Iida S, Ishiura S, Nishimura S, Shichiri M1, Senbonmatsu T: Hypertens Res 2011/5; 34 (5): 599-605. (Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à)

110122. [ŒŽ’˜] The roles of salusins in atherosclerosis and related cardiovascular diseases. Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T, Shichiri M1: J Am Soc Hypertens 2011/9-10; 5 (5): 359-65. (Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à)

110123. [ŒŽ’˜] Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo-and microalbuminuric type 2 diabetes. Moriya T1, Tsuchiya A1, Okizaki S2, Hayashi A3, Tanaka K, Shichiri M1: Kidney Int 2012/3; 81 (5): 486-93. (Žç‰®’B”ü1, “y‰®»Žq1, ‰«èiˆê˜Y2, —с@“N”Í3, Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‘‡f—Ã)

120013. [ŒŽ’˜] ‘ŠútÇŠú‚̍‚ŒŒˆ³‡•¹2Œ^“œ”A•aŠ³ŽÒ‚É‚š‚¯‚éƒeƒ‹ƒ~ƒTƒ‹ƒ^ƒ“/ƒAƒ€ƒƒWƒsƒ“•¹—pŽž‚ÌŒ°«tÇ‚ւ̈ڍs—}§Œø‰Ê|INNOVATIONŽŽŒ±’ljÁ‰ðÍ|. ꠖ씎Žj, ˆÉ“¡’å‰Ã, •ÐŽR–ΗT, Šâ–{ˆÀ•F, ‰Í·—²‘¢, ”nê‰€“N–ç, Žç‰®’B”ü1, ’|“à³O, ‰H“cŸŒv (1“à•ª”å‘ãŽÓ“à): ŒŒˆ³ 2011/10; 18 (10): 1001-8.

220005. [€ŒŽ’˜] ”DP“œ”A•a‚š‚æ‚Ñ“œ”A•a”DP—×{‚ւ̐æi“IŽæ‚è‘g‚݁|“œ”A•a‡•¹”DP‚ɑ΂·‚écontinuous glucose monitoring (CGM) ‚ÌŽg—p‚É‚æ‚蕪‚©‚邱‚Ɓ|. Žç‰®’B”ü1, Žá‘q‰‘”ü1, —с@“N”Í2, ¬ìŒ°Žj1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã): “œ”A•a‚Æ”DP 2011/8; 11 (1): 47-50.

310008. [Ç—á•ñ] A woman with salt-wasting congenital adrenal hyperplasia presenting with a mucinous ovarian cystadenoma during pregnancy. Kamata Y1, Hayashi A2, Ogawa A1, Ichikawa R1, Moriya T1, Shichiri M1: Intern Med 2011; 50 (18): 1981-5. (Š™“c—T“ñ1, —с@“N”Í2, ¬ìŒ°Žj1, Žsì—‹Žt1, Žç‰®’B”ü1, Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã)

520028. [‘à]y“œ”A•a«tÇ|•a‘Ԃ̉𖟂ƍŐVŽ¡—Ð헪zƒRƒz[ƒgŒ€‹†‚©‚ç‚̍ŐV’mŒ©: JDCS (Japan Diabetes Complications Study) (‰ðà/“ÁW). •ÐŽR–ΗT1, Žç‰®’B”ü2, “c’†Ži˜N, ‘å‹Ž–õ—Y, ‘]ª”Žm (1é‹Êˆã‰È‘åŠw“à•ª”åE“œ”A•a“à‰È, 2“à•ª”å‘ãŽÓ“à): ˆãŠw‚Ì‚ ‚ä‚Ý 2011/8; 238 (9): 829-32.

520029. [‘à]y“œ”A•a”D•w‚ÌŒµŠi‚ÈŒŒ“œŠÇ—‚Ì‚œ‚ß‚ÉŽg—p‚·‚é‚È‚ç‚΁c?z(Debate 1)@ŒŒ“œ‘ª’èŠí@SMBG vs.CGM@“œ‘ãŽÓˆÙí‡•¹”DP‚̗ǍD‚ÈŒŒ“œƒRƒ“ƒgƒ[ƒ‹‚ð’B¬‚·‚é‚œ‚ß‚É‚Í, ‚º‚ÐCGM‚ÌŽg—p‚ð (‰ï‹c˜^). Žç‰®’B”ü (“à•ª”å‘ãŽÓ“à): “œ”A•a‚Æ”DP 2011/10; 11 (2): S-52.

520030. [‘à]yƒvƒ‰ƒCƒ}ƒŠƒPƒAEƒ}ƒXƒ^[ƒR[ƒX|ŽŸŠ³•Ê“Š–òƒAƒvƒ[ƒ`: u‚±‚±‚©‚çŽn‚Ü‚é! V–òî•ñvz(10) œ‘e頏ǕÒ. ¬ìŒ°Žj1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): “ú–{ˆãŽ–V•ñ 2012/1; 4576: 23-6.

522068. [uÀ]y“ÁW: “œ”A•a«tÇ‚ÆCKD|V‚œ‚È“WŠJ‚ÆŽ¡—Ö@‚Ì‘I‘ð|z4. “œ”A•a«tÇ‚Ì•a—‘gD•ª—Þ (•Ä‘t‘ŸŠw‰ï•ª—ނ̑Ó–«). Žç‰®’B”ü1, “y‰®»Žq1 (1“à•ª”å‘ãŽÓ“à): ŒŽŠ§“œ”A•a 2011/7; 3 (7): 39-50.

522069. [uÀ]y“ÁW: ARB + HCTZ vs. ARB + CCBz“œ”A•aE”ì–ž‡•¹‚ŒŒˆ³Š³ŽÒ. Š™“c—T“ñ1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ŒŒˆ³ 2011/9; 18 (9): 840-5.

522070. [uÀ]y“ÁW: CGM‚Ì‚·‚ׂā|Ž‘±ŒŒ“œƒ‚ƒjƒ^[‚ÌŠî–{‚Ɖž—p|zI. CGM‚Ì—ðŽj@CGM‚̉ߋŽEŒ»ÝE–¢—ˆ. ‘吙@–ž, ì‘º’qs, Žç‰®’B”ü1, Œ‘º—–Ÿ (1“à•ª”å‘ãŽÓ“à): “œ”A•aƒŒƒNƒ`ƒƒ[ 2011/10; 2 (3): 449-69.

522071. [uÀ]y“ÁW: CGM‚Ì‚·‚ׂā|Ž‘±ŒŒ“œƒ‚ƒjƒ^[‚ÌŠî–{‚Ɖž—p|zIII. CGM‚̃pƒ^[ƒ“‚©‚çŠw‚Ô“KØ‚È–ò•š—Ö@@Q12. BOT‚ÌŒŒ“œ“®‘Ԃɂ‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. ¬ìŒ°Žj1, —с@“N”Í2, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã): “œ”A•aƒŒƒNƒ`ƒƒ[ 2011/10; 2 (3): 535-41.

522072. [uÀ]y“ÁW1: t‚É‚š‚¯‚é“à•ª”åŠÖ˜AƒgƒsƒbƒNƒXz˜˜_: ƒzƒ‹ƒ‚ƒ“‚̍ì—p‹@˜. Žµ—¢áÁ‹` (“à•ª”å‘ãŽÓ“à): t‚Æ“§Í 2011/11; 71 (5): 655-7.

522073. [uÀ]y“ÁW: •Ï–e‚·‚é“œ”A•aŽ¡—Áz”DP‚Æ“œ”A•a. Žsì—‹Žt1, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à): —Õଂƌ€‹† 2012/1; 89 (1): 67-73.

522074. [uÀ]y“ÁW: “œ”A•a«tÇŽ¡—ÂƐtÇŽ¡—Öò‚̐V‚µ‚¢“W–]z4. “œ”A•a«tÇ‚Ì•a—. Žç‰®’B”ü (“à•ª”å‘ãŽÓ“à): MEDICINAL 2012/2; 2 (2): 31-41.

540012. [‚»‚Ì‘Œ]y‰ï‹c˜^zIn silicoƒyƒvƒ`ƒh’Tõ–@‚É‚æ‚éV‹K¶—Šˆ«ƒyƒvƒ`ƒh“¯’è–@. Žµ—¢áÁ‹` (“à•ª”å‘ãŽÓ“à): ŒŒŠÇ 2012/1; 35 (1): 18.

[’˜@‘]

620080. [Šwp‘] (•ª’SŽ·•M)y“§Í‚Ì‚·‚ׂā|ŒŽ—E‹ZpE—Տ°| (Clinical Engineering•Êû)z14 ˆÛŽ“§ÍŠ³ŽÒ‚Ì•a‘Ԑ¶—@14-9. “à•ª”åŒn (•›bó‘BˆÈŠO), p.254-8. Žµ—¢áÁ‹` (“à•ª”å‘ãŽÓ“à), •Ò: ŽÂ“cr—Y, •ô“‡ŽOç’j, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2011/6”­s.

620081. [Šwp‘] (•ª’SŽ·•M)y•a‹C‚Ì•ªŽqŒ`‘ÔŠwz‘æ“ñÍ Še˜_@VI. t‘Ÿ‚ÌŽŸŠ³@VI-3. ‹}E¬“€Œ‹EƒfƒB[ƒvƒGƒbƒ`ƒ“ƒO–@‚É‚æ‚éƒqƒg“œ”A•atŽ…‹…‘Ì‚Ì”÷×\‘¢, p.209-11. Žç‰®’B”ü1, —с@“N”Í2 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã), •ÒW: “ú–{—Տ°•ªŽqŒ`‘ÔŠw‰ï, ŠwÛŠé‰æ, “Œ‹ž, 2011/8”­s.

620082. [Šwp‘] (•ª’SŽ·•M)yƒCƒ“ƒ^[ƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹Eƒwƒ‹ƒXƒPƒA@ŽÀ‘H@ƒ`[ƒ€ˆã—Ø_zII ŽÀ‘H•Ò ƒ`[ƒ€ˆã—Â̎ÀÛ@2. ƒ`[ƒ€ˆã—ɉK‚Ì“WŠJ—á@4) “œ”A•a‚ƍ‡•¹Ç|tÇf—Âɂš‚¯‚éƒ`[ƒ€ˆã—Â̏d—v«@1. tÇf—Âɂš‚¯‚éƒ`[ƒ€ˆã—Â̏d—v«, p.201-8. Žç‰®’B”ü1, lŒ©–ƒ”üŽq2 (1“à•ª”å‘ãŽÓ“à, 2‰h—{•”), •Ò’˜: …–{Ž‹v, ˆãŽ•–òo”Å, “Œ‹ž, 2011/10”­s.

620083. [Šwp‘] (•ª’SŽ·•M)y‹Ù‹}“xEdÇ“x‚©‚ç‚Ý‚œÇó•ÊŠÅŒì‰ß’ö + •a‘ÔŠÖ˜A}z‘æ6Í Á‰»ŠíŒn@42. ŒûŠ‰, p.717-22. ’†ŽRç—¢, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à), •Ò: ˆäã’qŽq, ²“¡çŽj, ˆãŠw‘‰@, “Œ‹ž, 2011/11”­s.

[Šw‰ïEŒ€‹†‰ï“™]

723200. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”ÄŒŒ‹…Œž­‚𔺂Á‚œƒoƒZƒhƒE•a‚̈ê—á. ³–ØŽkl1, Š™“c—T“ñ1, ŠÖªŠG—œŽq, •œ“ˆ—EŽm1, Žá‘q‰‘”ü1, —с@“N”Í2, ¬ìŒ°Žj1, ‰«èiˆê˜Y3, Žsì—‹Žt1, ‚“c“NG1, Žç‰®’B”ü1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ84‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2011/4/21-23), _ŒË, “ú–{“à•ª”åŠw‰ïŽGŽ 2011/4; 87 (1): 373.

723201. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) 2Œ^“œ”A•a‚̐³í|”÷—ʃAƒ‹ƒuƒ~ƒ“”AŠú‚̐t‹@”\‚ÌŒo‰ß‚𓜔A•a«–Ô–ŒÇ‚š‚æ‚Ñ”A’†ƒAƒ‹ƒuƒ~ƒ“‚Ì—Œ•û‚ðl—¶‚µ‚ÄŒŸ“¢‚·‚é|. “y‰®»Žq1, Žç‰®’B”ü1, ¬ì“Õ˜Y1, ‘å’ë˜al, Žá‘q‰‘”ü1, —с@“N”Í2, ‰«èiˆê˜Y3, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): 54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-227.

723202. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) t¶ŒŸ‚É‚ÄŠm’èf’f‚³‚ê‚œ³í|”÷—ʃAƒ‹ƒuƒ~ƒ“”AŠú‚Ì“œ”A•a«tÇ‚̐t‹@”\‚ɉe‹¿‚ð—^‚Š‚éˆöŽq‚Æ‚Í?|. Žç‰®’B”ü1, “y‰®»Žq1, ¬ì“Õ˜Y1, ‘å’ë˜al, Žá‘q‰‘”ü1, —с@“N”Í2, ‰«èiˆê˜Y3, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): 54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-228.

723203. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “ú–{l1Œ^‚š‚æ‚Ñ2Œ^“œ”A•a³íƒAƒ‹ƒuƒ~ƒ“”A (NA) Šú‚̐t‘gDŠŒ©‚Æ‹@”\‚͈قȂ邩? (‰ï‹c˜^). ‘å’ë˜al, Žç‰®’B”ü1, Žá‘q‰‘”ü1, ¬ì“Õ˜Y1, —с@“N”Í2, ‰«èiˆê˜Y3, “y‰®»Žq1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): 54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-228.

723204. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•a«tÇ‹³ŽºŽóuŠ³ŽÒ‚Ì—\Œã‚Æ“§Í“±“ü‚̊댯ˆöŽq‚ɂ‚¢‚Ä. •œ“‡—EŽm1, Žç‰®’B”ü1, ‘å’ë˜al, Žá‘q‰‘”ü1, ¬ì“Õ˜Y1, —с@“N”Í2, ¬ìŒ°Žj1, ‰«èiˆê˜Y3, Žsì—‹Žt1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-250.

723205. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Continuous Glucose Monitoring (CGM) ‚É‚æ‚é“œ”A•a‡•¹”DP‚̐HŒãŒŒ“œpeakŽžŠÔ‚ÌŒŸ“¢. Žá‘q‰‘”ü1, Žç‰®’B”ü1, —с@“N”Í2, ³–ØŽkl1, ŠÖªŠG—œŽq, ¬ìŒ°Žj1, Žsì—‹Žt1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-311.

723206. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “ü‰@ŠÇ—‚É‚æ‚茌“œŠÇ—‚ª—ǍD‚Æ‚È‚Á‚œ‘Ï“œ”\áŠQ‡•¹”D•w‚Ì—\Œã. Žsì—‹Žt1, Žç‰®’B”ü1, ³–ØŽkl1, ŠÖªŠG—œŽq, Žá‘q‰‘”ü1, ¬ì“Õ˜Y1, •œ“ˆ—EŽm1, —с@“N”Í2, “n•Ó“¹Žq1, ‰«èiˆê˜Y3, ¬ìŒ°Žj1, Š™“c—T“ñ1, ŒŒŽ‚Ü‚Ç‚©4, ‚“c“NG1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4—ÕŒŸŠw): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-312.

723207. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “œ”A•a“§ÍŠ³ŽÒ‚ÌŒŒ“œƒRƒ“ƒgƒ[ƒ‹‚ÌŽw•W‚Æ‚µ‚ăOƒŠƒRƒAƒ‹ƒuƒ~ƒ“ (GA) ‚Í—L—p‚©?|Ž‘±ŒŒ“œ‘ª’è (CGM) ‚É‚æ‚錟“¢|. ¬ìŒ°Žj1, Žç‰®’B”ü1, ³–ØŽkl1, ŠÖªŠG—œŽq, ‘å’ë˜al, ¬ì“Õ˜Y1, •œ“ˆ—EŽm1, Žá‘q‰‘”ü1, —с@“N”Í2, ‰«èiˆê˜Y3, Žsì—‹Žt1, Š™“c—T“ñ1, ‚“c“NG1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-327.

723208. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒVƒXƒ^ƒ`ƒ“C‚©‚ç‚̐„’èGFRŽ® (eGFR cys) ì¬‚ÌŽŽ‚݁|iohexol-GFR‚ƃNƒŒƒAƒ`ƒjƒ“‚©‚ç‚̐„’èGFR (eGFR Cr) ‚Æ‚Ì”äŠrŒŸ“¢|. ‰«èiˆê˜Y1, Žç‰®’B”ü2, ‘å’ë˜al, —с@“N”Í3, ¬ìŒ°Žj2, ¬ì“Õ˜Y2, Žá‘q‰‘”ü2, •œ“ˆ—EŽm2, ŠÖªŠG—œŽq, ³–ØŽkl2, Š™Ec—T“ñ2, ‚“c“NG2, Žsì—‹Žt2, “n•Ó“¹Žq2, Žµ—¢áÁ‹`2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2“à•ª”å‘ãŽÓ“à, 3‘‡f—Ã): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-328.

723209. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é“œ”A•a–«‡•¹ÇŠO—ˆ‚ÌŒ»ó. “n•Ó“¹Žq1, Žç‰®’B”ü1, ‘å’ë˜al1, •œ“ˆ—EŽm1, —с@“N”Í2, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-362.

723210. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‰Â—nŒ^ (ƒvƒ) ƒŒƒjƒ“Žó—e‘Ì‚Ì”­Œ»E•ª•z‚Ƒ̉t’†‚Ì‘¶Ý—lŽ®. ’J@—SŽŠ, ²“¡Œ’Œá, ‘–쌫ˆê, ŠÝƒtƒNŽq, i@Æ•v, —é–Ø‹IŽq, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ34‰ñ“ú–{‚ŒŒˆ³Šw‰ï‘‰ï (2011/10/20), “È–Ø, ‘æ34‰ñ“ú–{‚ŒŒˆ³Šw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/10; p.442.

723211. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)“œ”A•a‡•¹”D•w‚É‚š‚¯‚éCGM‚̐³Šm«. ç“c«”n, ¬ìŒ°Žj1, —с@“N”Í2, ŠÝŒŽŠG—œŽq, ¬ì“Õ˜Y1, ŽRŠÝ‹M”Ž1, Žá‘q‰‘”ü1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚“c“NG1, Žç‰®’B”ü1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã): ‘æ27‰ñ“ú–{“œ”A•aE”DPŠw‰ï (2011/11/12), _ŒË, “œ”A•a‚Æ”DP 2011/10; 11 (2): S-87.

723212. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒûŠ‰’†•áŠQ‚Æ’˜–Ÿ‚È—§ˆÊ«•‚Žî‚𔺂Á‚œ”A•öÇ‚Ì1—á. ‚“c“NG1, ŠÝŒŽŠG—œŽq, ¬ì“Õ˜Y1, Žá‘q‰‘”ü1, —с@“N”Í2, Š™“c—T“ñ1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã): ‘æ21‰ñ—Տ°“à•ª”å‘ãŽÓUpdate (2012/1/27), •lŒ, “ú–{“à•ª”åŠw‰ïŽGŽ 2011/12; 87 (3): 930.

723213. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V2Žó—e‘̝hR–ò tolvaptan‚É‚æ‚è’˜–Ÿ‚ȑ̉t’™—¯‚̉ü‘P‚ªŒ©‚ç‚ꓧÍ“±“ü‚ð‰ñ”ð‚Å‚«‚œ, “œ”A•a«tÇ‚É‚æ‚ét•s‘S‚Ì2Ç—á. ‚“c“NG1, ‹g–쉑”ü1, ¬ì“Õ˜Y1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ41‰ñ“ú–{S–¬ŠÇì“®•šŽ¿Šw‰ï (2012/2/10), H“c, ŒŒŠÇ 2012/1; 35 (1): 37.

723214. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒgŒŒ’†salusin-ƒÀ‚Ì•ªŽq‘¶Ý—lŽ®‚ÆŒŒˆ³‚Æ‚ÌŠÖ˜A. “¡–{˜aŽÀ, ¬ŽR‚•q, —с@“N”Í1, ¬ìŒ°Žj2, ‚“c“NG2, Žµ—¢áÁ‹`2 (1‘‡f—Ã, 2“à•ª”å‘ãŽÓ“à): ‘æ41‰ñ“ú–{S–¬ŠÇì“®•šŽ¿Šw‰ï (2012/2/10), H“c, ŒŒŠÇ 2012/1; 35 (1): 38.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110009. [ŒŽ’˜] Physicochemical characteristics of salusin-beta and establishment of the radioimmunoassay. Sato K, Koyama T, Shichiri M1: Rinsho Byori 2011/2; 59 (2): 121-7. (Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à)

[’˜@‘]

H22-620002. [Šwp‘] (•ª’SŽ·•M)yŒoÃ–¬Ž¡—ÃI[ƒ_[ƒ}ƒjƒ…ƒAƒ‹ ‰ü’ù”Łz‰º‚‘Ì‘O—t‹@”\’ቺÇ, p.300-3. Žµ—¢áÁ‹`1, •œ“cŒ‹Šì (1“à•ª”å‘ãŽÓ“à), •Ò: ¬ì@—Ž, “‡èCŽŸ, ”Ñ–ì–õ•F, ŒÜ\—’—², •Ÿ“‡—ºŽ¡, ‘å’ː»–òHê, “¿“‡, 2011/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H22-723010. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚ŒŒˆ³‚ð‡•¹‚µ‚œ2Œ^“œ”A•aŒ°«tÇ‚ɑ΂·‚éW–ñ“IŽ¡—ÃŒø‰Ê‚ɂ‚¢‚Ä‚ÌABPM‚É‚æ‚錟“¢. ‹à‰ª’m•F, “c‘ºŒ÷ˆê, “c’†Œ[Ži, Žç‰®’B”ü1, ‹ß“¡@‘, ¡–ì—Y‰î, —é–Ø‘å•ã, –L“c‰ë•v, ”~‰€•ü–ç, ŽRì@³, ‰ª–ì‘׎q, ¬àV‘fŽq, ŽO‹Ž@—m, ŒË’J‹`K, ”~‘º@•q (1“à“à•ª”å‘ãŽÓ“à): ‘æ33‰ñ“ú–{‚ŒŒˆ³Šw‰ï‘‰ï (2010/10/15-17), •Ÿ‰ª, ‘æ33‰ñ“ú–{‚ŒŒˆ³Šw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/10; p.331.

H22-723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒg’P‹…—R—ˆ×–E‚©‚ç‚Ìsalusin-ƒÀ•ª”å‹y‚ÑELISAŒn‚ÌŠm—§. “¡–{˜aŽÀ, ²“¡Œ’Œá, Žµ—¢áÁ‹`1, ¬ŽR‚•q (1“à•ª”å‘ãŽÓ“à): ‘æ83‰ñ“ú–{¶‰»Šw‰ï‘å‰ïE‘æ33‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï‡“¯‘å‰ï (2010/12/7-10), _ŒË, ‘æ83‰ñ“ú–{¶‰»Šw‰ï‘å‰ïE‘æ33‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï‡“¯‘å‰ïu‰‰—vŽ|W 2010/12; P-0297.

H22-733004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ³íƒAƒ‹ƒuƒ~ƒ“”AŠú‚©‚瓧Í—Ö@‚ÉŽŠ‚é‚Ü‚Å‚ÌŒo‰ß‚ðŠÏŽ@‚Å‚«‚œ2Œ^“œ”A•a‚Ì1—á. “y‰®»Žq1, Žç‰®’B”ü1, Žá‘q‰‘”ü1, —с@“N”Í2, ‰«èiˆê˜Y3, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘‡f—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): 48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/1/29), “Œ‹ž, “œ”A•a 2011/9; 54 (9): 766.

H22-733005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 16”NŠÔ‚É‚í‚œ‚èŒo‰ßŠÏŽ@‚µ‚Š‚œ2Œ^“œ”A•a‚̗Տ°‘œ‚ÆŽ¡—Ïã‚̉ۑè‚ɂ‚¢‚Ä. •ŸŒ’qŽq1, “¡“c–F–M, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à): ‘æ48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/1/29), “Œ‹ž.“œ”A•a 2011/9; 54 (9): 768.


t‘Ÿ“à‰ÈŠw

[Šwp˜_•¶]

110124. [ŒŽ’˜] Antigen-binding abilities of anti-nephrin antibody are prescribed by signal sequence of expression vector in genetic immunization. Naito S1, Kamata K1, Aoyama T1, Yamanaka N, Okamoto T1, Tazaki H1: Clin Exp Nephrol 2011/6; 15 (3): 339-45. (“à“¡³‹g1, Š™“cvšæ1, ÂŽR“ŒŒá1, ‰ª–{’qŽq1, “cèq”ü1: 1t‘Ÿ“à)

110125. [ŒŽ’˜] Injection of rabbit polyclonal antibody induced by genetic immunization with rat nephrin cDNA caused massive proteinuria in rat, a new model of rat nephritic syndrome. Okamoto T1, Kamata K1, Naito S1, Aoyama T1, Tazaki H1, Yamanaka N: Kitasato Med J 2011/9; 41 (2): 115-22. (‰ª–{’qŽq1, Š™“cvšæ1, “à“¡³‹g1, ÂŽR“ŒŒá1, “cèq”ü1: 1t‘Ÿ“à)

120014. [ŒŽ’˜] t•s‘SŠ³ŽÒ‚ð‘ΏۂƂµ‚œOPF-102‚̗Տ°ŽŽŒ± (‘æIII‘Š): ‚æ‚èˆÀ‘S‚ÈŒoÃ–¬“IƒŠƒ“•â‹‹‚ÉŒü‚¯‚Ä. H—t@—², “c‘º’õˆê, Š™“cvšæ1, …Œû@, Œˆä‘¥–Ÿ (1t‘Ÿ“à): “§Í‰ïŽ 2011/6; 44 (6): 567-75.

320021. [Ç—á•ñ]y–òÜ‚É‚æ‚鐅E“d‰ðŽ¿ˆÙíEŽ_‰–Šî•œtzH“¹Šà‚̉»Šw—Ö@’†‚É“d‰ðŽ¿ˆÙí‚𔺂¢áz¹dÏ”­ì‚𐶂¶‚œ1Ç—á. —Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, ‰¡“c˜aŽq1, ŽðˆäŒ’Žj1, ŒÃ’J¹Žq1, Š™“c^—Žq1, Œ˜“ce—˜2, “à“¡³‹g1, “à“c–ž”üŽq1, ²–ì@—²1, â–{®“o3, Š™“cvšæ1 (1t‘Ÿ“à, 2Á‰»Ší“à, 3ˆã—ËZp‹³ˆç): —Տ°‘̉t 2011/10; 38: 59-64.

320022. [Ç—á•ñ] Ž©ŒÈŒŒ—AŒŒŒã‚É‹}«”A×ŠÇ‰óŽ€‚É‚æ‚é‹}«t•s‘S‚𔭏ǂµ, ŒŽˆö‚Æ‚µ‚ăwƒ‚ƒOƒƒrƒ“”AÇ‚ª‹^‚í‚ê‚œˆê—á. ‰ª–{’qŽq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, “à“¡³‹g1, “à“c–ž”üŽq1, ’|“àN—Y1, Š™“cvšæ1 (1t‘Ÿ“à): t‰ŠÇ—ጀ‹† 2012/2; 28: 166-77.

522075. [uÀ]y“ÁW: –Œ«tÇz–Œ«tÇ‚Ì•aˆöII: ŽÀŒ±t‰Š‚©‚ç‚Ý‚œƒqƒg–Œ«tÇ. Š™“cvšæ (t‘Ÿ“à): “ú–{t‘ŸŠw‰ïŽ 2011/7; 53 (5): 672-6.

522076. [uÀ]y“ÁW: “§Í—Ö@‚É‚š‚¯‚郂ƒjƒ^ƒŠƒ“ƒO‹Zp‚̐i•à‚Æ‚»‚̉ž—pzŒõƒtƒ@ƒCƒo‚ð—p‚¢‚œ˜RŒŒƒZƒ“ƒTì»‚ÌŽŽ‚Ý. ’|“àº”Ž, ²“¡‰hŽ¡, ¬ŽR@œ, Š™“cvšæ1 (1t‘Ÿ“à): Clinical Engineering 2011/11; 22 (12): 1136-8.

522077. [uÀ]y“ÁW: …‚Æ“d‰ðŽ¿ˆÙízƒŠƒ“‘ãŽÓˆÙí‚ÆŽ¡—Ã. ’·ê@‘×1, Š™“cvšæ1 (1t‘Ÿ“à): Nephrology Frontier 2011/12; 10 (4): 36-9.

[’˜@‘]

620084. [Šwp‘] (•ª’SŽ·•M)yƒXƒ^ƒ“ƒ_[ƒh“§Í—Ö@ (t‚Æ“§Í70Šª (‘Š§))z‡•¹Ç‚ÆŠÇ—Šî€, ŠÇ—–@@8. Á‰»ŠÇáŠQ, p.265-7. ’·ê@‘×1, Š™“cvšæ1 (1t‘Ÿ“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2011/6”­s.

620085. [Šwp‘] (•ª’SE·•M)y“§ÍŠ³ŽÒ‚Ì•a‘Ԃւ̃Aƒvƒ[ƒ`@‰ü’ù2”Łz“§ÍŠ³ŽÒ‚Ì”DP, oŽY, p.320-5. Š™“cvšæ (t‘Ÿ“à), •ÒW: [ì‰ëŽj, ‹à–F“°, ‹ž“s, 2011/9”­s.

620086. [Šwp‘] (•ª’SŽ·•M)y“§ÍŠ³ŽÒ‚Ì•a‘Ԃւ̃Aƒvƒ[ƒ`@‰ü’ù2”ŁzŒŒ‰tò‰»—Ö@‚ÌŒŽ—‚Æ‘I‘ð, p.45-52. ‹Ž–{ƒqƒƒR1, ŽR–{—TN (1t‘Ÿ“à), •ÒW: [ì‰ëŽj, ‹à–F“°, ‹ž“s, 2011/9”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712020. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Antigen binding abilities of antibody are prescribed by signal sequence of expression vector in genetic immunization. Kamata K1, Naito S1, Aoyama T1, Okamoto T1, Okina C1, Kamata M1, Yamanaka N: BIT's 4th Annual International Congress of Antibodies (2012/3/26), Beijing, China. (Š™“cvšæ1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ‰ª–{’qŽq1, ‰¥çŽq1, Š™“c^—Žq1: 1t‘Ÿ“à)

713050. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Eplerenone effectively diminish renal magnesium wasting associated with cisplatin nephrotoxicity. Hayashi M1, Murano J1, Yokota K1, Sakai T1, Furuya M1, Kamata M1, Katada C2, Naito S1, Uchida M1, Sano T1, Kamata K1, Sakamoto H3: World Congress of Nephrology 2011 (2011/4/11), Vancouver. (—Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, ‰¡“c˜aŽq1, ŽðˆäŒ’Žj1, ŒÃ’J¹Žq1, Š™“c^—Žq1, Œ˜“ce—˜2, “à“¡³‹g1, “à“c–ž”üŽq1, ²–ì@—²1, Š™“cvšæ1, â–{®“o3 (1t‘Ÿ“à, 2Á‰»Ší“à, 3ˆã—ËZp‹³ˆç)

713051. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Injection of rabbit polyclonal antibodies induced by genetic immunization with rat nephrin cDNA causes massive proteinuria in the rat. Okamoto T1, Kamata K1, Naito S1, Aoyama T1, Tazak H1, Yamanaka N: 48th Medical Congress of ERA-EDTA (European Renal Association-European Dialysis and Transplant Association) (2011/6/23-26), Praha. (‰ª–{’qŽq1, Š™“cvšæ1, “à“¡³‹g1, ÂŽR“ŒŒá1, “cèq”ü1: 1t‘Ÿ“à )

713052. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Antigen binding abilities of antibody are prescribed by signal sequence of expression vector in genetic immunization. Kamata K1, Naito S1, Aoyama T1, Okamoto T1, Okina C1, Kamata M1, Yamanaka N: BIT's 4th Annual International Congress of Antibodies (2012/3/26), Beijing. (Š™“cvšæ1, “à“¡³‹g1, ÂŽR“ŒŒá1, ‰ª–{’qŽq1, ‰¥çŽq1, Š™“c^—Žq1: 1t‘Ÿ“à)

723215. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ɂĐf’fEŽ¡—Âðs‚Á‚œANCAŠÖ˜At‰Š‚É‹N‚Á‚œ”x•a•Ï‚ÌŒŸ“¢. ŽáV•‡”ü1, –q–앐Žu1, ’·ê@‘×1, “‡“c@”£1, Š™“cvšæ2 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2t‘Ÿ“à): ‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2011/6/15), ‰¡•l, “ú–{t‘ŸŠw‰ïŽ 2011/5; 53 (3): 399.

723216. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éIgAtÇ‚ɑ΂·‚éuG“E + ƒXƒeƒƒCƒhŽ¡—ÁvŒø‰Ê‚ÌŒŸ“¢. –q–앐Žu1, ’·ê@‘×1, ŽáV•‡”ü1, “‡“c@”£1, Š™“cvšæ2 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2t‘Ÿ“à): ‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2011/6/15), ‰¡•l, “ú–{t‘ŸŠw‰ïŽ 2011/5; 53 (3): 401.

723217. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÛŽŒŒ‰t“§Í (HD) Š³ŽÒ‚É‚š‚¯‚錌’†C-‚؃vƒ^ƒCƒh (CPR) ‘ª’è‚ɂ‚¢‚ā|“œ”A•aŒQ‚Æ”ñ“œ”A•aŒQ‚Ì”äŠr|. XŒû‚¢‚Ô‚«1, ˆÉ“¡—zŽq1, ¬—Ñ’Œ”V1, ‘å‹v•Û[l1, ’|“àN—Y2, “à“¡³‹g2, ¬—с@Œ\2, “cèq”ü2, Žç‰®’B”ü3, Žµ—¢áÁ‹`3, Š™“cvšæ2 (1‘Š•‘äƒj[ƒŒƒ“ƒNƒŠƒjƒbƒN, 2t‘Ÿ“à, 3“à•ª”å‘ãŽÓ“à): ‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2011/6/15), ‰¡•l, “ú–{t‘ŸŠw‰ïŽ 2011/5; 53 (3): 419.

723218. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) TNF alfa‚Í“œœáŠQ‚ðŽ‚ÂƒlƒtƒŠƒ“’`”’‚𑝉Á‚³‚¹¬–E‘̃XƒgƒŒƒX‚𘎐i‚³‚¹‚é. “à“¡³‹g1, ÂŽR“ŒŒÜ1, ‰ª–{’qŽq1, “cèq”ü1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2011/6/16), ‰¡•l, “ú–{t‘ŸŠw‰ïŽ 2011/5; 53 (3): 369.

723219. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒgƒlƒtƒŠƒ“cDNA—U“±‰Æ“eIgGR‘Ì“Š—^‚É‚æ‚é, V‚œ‚ȃ‰ƒbƒgƒlƒtƒ[ƒ[ÇŒóŒQƒ‚ƒfƒ‹‚ÌŠm—§. ‰ª–{’qŽq1, Š™“cvšæ1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, “cèq”ü1, ¬—с@Œ\1, ŽR’†@–]2 (1t‘Ÿ“à, 2–h‰qˆã‰È‘åŠwZŠO‰ÈŠw): ‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2011/6/17), ‰¡•l, “ú–{t‘ŸŠw‰ïŽ 2011/5; 53 (3): 377.

723220. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •Û‘¶Šút•s‘S‚É‚š‚¯‚ét«•nŒŒ‚ÌŽ¡—ÃŒø‰Ê‚ɂ‚¢‚ā`ƒ_ƒ‹ƒxƒ|ƒGƒ`ƒ“ƒ¿Ã’vsƒGƒ|ƒGƒ`ƒ“ƒÀ”牺’`. –q–앐Žu1, ŽáV•‡”ü1, ’·ê@‘×1, “‡“c@”£1, Š™“cvšæ2 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@t‘Ÿ“à‰È, 2t‘Ÿ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGEE2011/5; 44 (Suppl 1): 364.

723221. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆÛŽ“§ÍŠ³ŽÒ‚Ì•s–Ÿ”Mžž‚Å”­Œ©‚³‚ê‚œIgG4ŠÖ˜AŽŸŠ³‚Ì2Ç—á. Š™“c^—Žq1, “à“c–ž”üŽq1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, ŒÃ’J¹Žq1, ‘º–쏇–ç1, “à“¡³‹g1, ²–ì@—²1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 395.

723222. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚é––Šút•s‘SŽ¡—ÑI‘ðà–ŸƒVƒXƒeƒ€‚̐U‚è•Ô‚è: Š³ŽÒ‚ÌŽ©ŒÈŒˆ’è‚Ö‚ÌŽx‰‡‚ð–ÚŽw‚µ‚Ä. ‘“cŽ”ü, ŠÛ‰ª­”Ž, Vˆä”ü’qŽq, •Ÿ‰ª”ü—R‹I, ²–ì~Žq, –q–앐Žu, ’·ê@‘×1, “‡“c@”£ (1t‘Ÿ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 421.

723223. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒ“ƒWƒ^H“¹‰Š‚ðŒ_‹@‚ÉAIDS‚Ɛf’f‚³‚ê‚œˆÛŽ“§ÍŠ³ŽÒ‚̈ê—á. —Ñ‚Ý‚ä‚«1, “à“c–ž”üŽq1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, ŒÃ’J¹Žq1, ‘º–쏇–ç1, “à“¡³‹g1, ²–ì@—²1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 587.

723224. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒCƒ“ƒXƒŠƒ“—Ö@‚©‚çGLP-1ƒAƒiƒƒO»Ü (ƒŠƒ‰ƒOƒ‹ƒ`ƒh) ‚ɕύX‚µŒo‰ßŠÏŽ@’†‚Ì“œ”A•a«“§ÍŠ³ŽÒ‚Ì1—á. ¬—с@Œ\1, ˆÉ“¡—zŽq2, XŒû‚¢‚Ô‚«2, “n糐m”ü2, ’|’†@œ2, ¬—Ñ’Œ”V2, ‘å‹v•Û[l2, ’|“àN—Y1, “à“¡³‹g1, “cèq”ü1, Žç‰®’B”ü3, Š™“cvšæ1 (1t‘Ÿ“à, 2‘Š•‘äƒj[ƒŒƒ“ƒNƒŠƒjƒbƒN, 3“à•ª”å‘ãŽÓ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 592.

723225. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) t•s‘SŠ³ŽÒ‚ð‘ΏۂƂµ‚œOPF-102‚̗Տ°ŽÀŒ± (‘æIII‘Š)`‚æ‚èˆÀ‘S‚ÈŒoÃ–¬“IƒŠƒ“•â‹‹‚ÉŒü‚¯‚ā`. H—t@—²1, “c‘º’õˆê2, Š™“cvšæ3, …Œû@4, Œˆä‘¥–Ÿ5 (1“Œ‹ž—Žqˆã‰È‘åŠwŒŒ‰tò‰»—Ö@‰È, 2‰¡{‰ê‹€Ï•a‰@t‘Ÿ“à‰È, 3t‘Ÿ“à, 4ì“‡•a‰@t‘Ÿ“à‰È, 5“y‰Y‹Š“¯•a‰@“à‰È): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 433.

723226. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚ÅŒoŒ±‚µ‚œˆÛŽ“§ÍŠ³ŽÒ‚É”­Ç‚µ‚œÒ’ÅŽüˆÍ”^ᇂÌ4Ç—á. ŽáV•‡”ü1, –q–앐Žu1, ’·ê@‘×1, “‡“c@”£1, Š™“cvEE (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@t‘Ÿ“à‰È, 2t‘Ÿ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 437.

723227. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŒŒ‰t“ñdàh‰ß–@‚ƉÁ‰·Ž®ÄzŠÂ“ñdàh‰ß–@‚Ì”äŠrŒŸ“¢: œ‹Ž—Š‚ƃAƒ‹ƒuƒ~ƒ“‘¹Žž. VˆäŽÀ‰„, ‚‹Ž”Ž‹v, ‘“cŽ”ü, –q–앐Žu, ’·ê@‘×1, “‡“c@”£ (1t‘Ÿ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 458.

723228. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tŽüˆÍoŒŒ‚𗈂µ‚œˆÛŽ“§ÍŠ³ŽÒ5—á‚ÌŒŸ“¢. “à“c–ž”üŽq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, ŒÃ’J¹Žq1, —Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, “à“¡³‹g1, ’†–ì‘fŽq1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 697.

723229. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “œ”A•a«ˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚錌’†C-‚؃vƒ^ƒCƒh (CPR) ‘ª’è‚ɂ‚¢‚Ä. ˆÉ“¡—zŽq1, XŒû‚¢‚Ô‚«1, ¬—Ñ’Œ”V1, ‘å‹v•Û[l1, ¬—с@Œ\2, ’|“àN—Y2, “à“¡³‹g2, “cèq”ü2, ŒË’J‹`K3, ”~‘º@•q3, Žç‰®’B”ü4, Š™“cvšæ2 (1‘Š•‘äƒj[ƒŒƒ“ƒNƒŠƒjƒbƒN, 2t‘Ÿ“à, 3‰¡•lŽs—§‘åŠw‘åŠw‰@•a‘Ԑ§Œä“à‰ÈŠw, 4“à•ª”å‘ãŽÓ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 501.

723230. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÛŽ“§ÍŠ³ŽÒ‚É”­Ç‚µ‚œ¬lT×–E«”’ŒŒ•a‚Ì1–UŒŸ—á. ŽðˆäŒ’Žj1, ²–ì@—²1, ŠâŸºŒ[ˆê2, ŽáV•‡”ü1, Š™“c^—Žq1, ŒÃ’J¹Žq1, —Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, “à“¡³‹g1, “à“c–ž”üŽq1, â–{®“o3, Š™“cvšæ1 (1t‘Ÿ“à, 2•a—, 3ˆã—ËZp‹³ˆç): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 797.

723231. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “§Í“±“ü‚ðŒ_‹@‚É• …‚ÌŒž­‚ð”F‚ß‚œƒ‹[ƒvƒX• –Œ‰Š‚̈ê—á. ŒÃ’J¹Žq1, ²–ì@—²1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, Š™“c^—Žq1, ‘º–쏇–ç1, “à“¡³‹g1, “à“c–ž”üŽq1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl 1): 801.

731071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –«t‘Ÿ•a‚Ì•a‘Ô‚ÆŽ¡—Ã. Š™Ecvšæ (t‘Ÿ“à):‘æ4‰ñ¶ŠU‹³ˆçEuÀ(Š™‘qŽsˆãŽt‰ï) (2011/7/15), Š™‘q.

731072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) RƒŠƒ“Ž‰Ž¿R‘̏njóŒQ‚Ì•a‘Ô‚ÆŽ¡—Ã. Š™“cvšæ (t‘Ÿ“à): ‘æ15‰ñtŠÔŽ¿áŠQŒ€‹†‰ï (2011/9/10), “Œ‹ž.

731073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “Œ“ú–{‘åkÐ‚©‚çŠw‚Ô. Š™“cvšæ (t‘Ÿ“à): ‘æ19‰ñ‘Š–ÍŒŽ‚Æ‚»‚ÌŽü•Ó’n‹æ“§Í’k˜b‰ï (2011/10/9), ‘Š–ÍŒŽ.

731074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ˆâ“`Žq–Ɖu–@‚̐tŽŸŠ³Œ€‹†‚ւ̉ž—p. Š™“cvšæ (t‘Ÿ“à): ‘æ33‰ñŠÖ“ŒtŒ€‹†‰ï (2012/1/21), “Œ‹ž.

731075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –«t‘Ÿ•aŽ¡—Â̐i•à. Š™“cvšæ (t‘Ÿ“à): ‘Š–ÍŒŽŽsˆãŽt‰ï’nˆæˆã—ÃŒ€‹†‰ï (2012/2/13), ‘Š–ÍŒŽ.

733102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬’°ŒÀ‹Ç«”S–Œ•‚Žî‚É‚æ‚薃ა«ƒCƒŒƒEƒX‚ð”F‚ß‚œ“§Í“±“üŠ³ŽÒ‚̈ê—á. ŽðˆäŒ’Žj1, ’|“àN—Y1, ŽáV•‡”ü1, —Ñ‚Ý‚ä‚«1, ŒÃ’J¹Žq1, Š™“c^—Žq1, ‰ª–{’qŽq1, “à“¡³‹g1, ²–ì@—²1, “à“c–ž”üŽq1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ81‰ñ_“ސìtŒ€‹†‰ï (2011/7/2), ‰¡•l, _“ސìtŒ€‹†‰ïŽ 2011/7; 81: 5.

733103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©ŒÈŒŒ—AŒŒŒã‚É‹}«”A×ŠÇ‰óŽ€‚É‚æ‚é‹}«t•s‘S‚𔭏ǂµ, ŒŽˆö‚Æ‚µ‚ăwƒ‚ƒOƒƒrƒ“”AÇ‚ª‹^‚í‚ê‚œˆê—á. ‰ª–{’qŽq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, “à“¡³‹g1, “à“c–ž”üŽq1, ’|“àN—Y1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ56‰ñ_“ސìt‰ŠŒ€‹†‰ï (2011/9/17), ‰¡•l.

733104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÔŽ¿«”x‰Š‚ÌŒo‰ß’†‚É”x‚ª‚ñ‚𔭏ǂµ, Ž¡—Ã’†‚ÉANCAŠÖ˜At‰Š‚ð’悵‚œÇ—á. –q–앐Žu1, ’·ê@‘×1, “‡“c@”£1, Š™“cvšæ2 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@t‘Ÿ“à‰È, 2t‘Ÿ“à): ‘æ41‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/14), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2011/10; 53 (6): 935.

733105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒvƒƒsƒ‹ƒ`ƒIƒEƒ‰ƒVƒ‹“à•ž’†‚É”­Ç‚µ‚œdouble ANCA—z«Œ°”÷‹Ÿ“I‘œ”­ŒŒŠÇ‰Š‚Ì1—á. ŽáV•‡”ü1, “à“c–ž”üŽq1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, ŒÃ’J¹Žq1, —Ñ‚Ý‚ä‚«1, ‰ª–{’qŽq1, “à“¡³‹g1, ²–ì@—²1, ’|“àN—Y1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ41‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/14), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2011/10; 53 (6): 935.

733106. [Šw‰ï (En•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tƒAƒ~ƒƒCƒh[ƒVƒX‚ð‡•¹‚µ‚œŒŽ”­«ƒ}ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ‚̈ê—á. ŒÃ’J¹Žq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, Š™“c^—Žq1, ‘º–쏇–ç1, “à“¡³‹g1, “à“c–ž”üŽq1, ’|“àN—Y1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ41‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/15), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2011/10; 53 (6): 880.

733107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’`”’Ž‰–b§ŒÀH‚Őt‹@”\‰ü‘P‚Æ”A’`”’Œž­‚ð“Ÿ‚œLCATŒ‡‘¹Ç‚Ì1—á. Š™“c^—Žq1, “à“¡³‹g1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, ŒÃ’J¹Žq1, ‰¥çŽq1, ‘º–쏇–ç1, “à“c–ž”üŽq1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ41‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/15), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2011/10; 53 (6): 945.

733108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —ǍD‚ÈŽ¡—ÃŒo‰ß‚ð“Ÿ‚œtŒyœ’Ÿ’…Ç‚̈ê—á. ŽðˆäŒ’Žj1, ²–ì@—²1, ŽáV•‡”ü1, —Ñ‚Ý‚ä‚«1, ŒÃ’J¹Žq1, Š™“c^—Žq1, ‰ª–{’qŽq1, “à“¡³‹g1, “à“c–ž”üŽq1, ’|“àN—Y1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ41‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/15), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2011/10; 53 (6): 948.

733109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MCNS‚ւ̃XƒeƒƒCƒhŽ¡—Ã’†‚É”­Ç‚µ‚œ¬l”­Ç‚̃Nƒ‹•a‚̈ê—á. “¡“c˜aŒÈ1, ’†–ì‘fŽq1, “n‰ï—œŽÑŽq1, Š™“cvšæ2 (1’¬“cŽs–¯•a‰@“à‰È, 2t‘Ÿ“à): ‘æ41‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/15), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2011/10; 53 (6): 953.

733110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒŒƒXƒeƒ[ƒ‹ÇðÇ‚É‚æ‚é”]‹@”\áŠQ‚Ì2–UŒŸ—á. —Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, ŒÃ’J¹Žq1, “à“¡³‹g1, ²–ì@—²1, “à“c–ž”üŽq1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ41‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2011/10/15), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2011/10; 53 (6): 954.

733111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t‹@”\áŠQ‚ÌCa‘ãŽÓ‚É‹y‚Ú‚·‰e‹¿‚ð‰Á–¡‚µ‚œŒŽ”­«•›bó‘B‹@”\˜ŽiÇ (PHPT) ‚̊ӕʐf’f. ‘º–쏇–ç1, â–{®“o2, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, ‰ª–{’qŽq1, “à“¡³‹g1, “à“c–ž”üŽq1, ²–ì@—²1, ’|“àN—Y1, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ43‰ñ—Տ°‘̉tŒ€‹†‰ï (2011/10/29), “Œ‹ž, —Տ°‘̉tŒ€‹†‰ïŽ 2011/10; 43: 15.

733112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MRSAt‰Š‰Á—Ã’†‚É”­Ç‚µ‚œANCA—z«Œ°”÷‹Ÿ“I‘œ”­ŒŒŠÇ‰Š‚Ì1—á. ŽáV•‡”ü1, “à“¡³‹g1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, ŒÃ’J¹Žq1, Š™“c^—Žq1, ‰ª–{’qŽq1, ²–ì@—²1, “à“c–ž”üŽq1, ’|“àN—Y1, â–{®“o2, Š™“cvšæ1 (1t‘Ÿ“à, 2ˆã—ËZp‹³ˆç): ‘æ82‰ñ_“ސìtŒ€‹†‰ïE‘æ27‰ñ_“ސ쌧“§ÍŽ{Ý˜A—‹Š‹c‰ï‡“¯Œ€‹†‰ï (2011/11/20), ‰¡•l, _“ސìtŒ€‹†‰ïŽ 2011/11; 82: 8.

733113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) t“®–¬‚ÉŒÀ‹Ç‚µ‚œ•ªß«“®–¬’†–Œ—Z‰ðÇ (SAM) ‚Ì1—á. ‘º™@u1, “à“c–ž”üŽq1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, ‰ª–{’qŽq1, ²–ì@—²1, ’|“àN—Y1, Š™“cvšæ1, ƒEƒbƒhƒnƒ€ƒX—æŽq2 (1t‘Ÿ“à, 2•úŽËü (‰æ‘œ)): ‘æ584‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2011/12/10), “Œ‹ž, 2011; 584: 30.

733114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”AŠŒ©³í‚Å‘¢‰eCT‚ɂĐf’f‚³‚ê‚œ‹}«‘ƒó×‹Û«t‰Š‚̐¬l—á. ŽRŒû—F‹I—Y, –q–앐Žu1, “‡“c–F—², —ÑŒ’‘Ÿ˜Y, ’·ê@‘×1, œA£—²ˆê, “‡“c@”£ (1t‘Ÿ“à): ‘æ586‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2012/3/10), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï586‰ñŽ˜^W 2012/3; p.49.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-120001. [ŒŽ’˜] ”DP’†‚ÉŒŒ‰t“§Í‚ð•K—v‚Æ‚µ‚œt•s‘S‡•¹”DP‚̗Տ°‘œ. ÂŽR“ŒŒÜ1, Š™“cvšæ1 (1t‘Ÿ“à): –k—¢ˆãŠw 2010/12; 40 (2): 101-6.

H22-522004. [uÀ]y“ÁW: “±“üŠî€‚©‚ç’·Šú‡•¹Ç‚܂Ł@‰p—ªŒê‚ÅŠî‘b‚ª‚í‚©‚é! “§Í—Ö@‚ÌABCz2-8 PD. Ž…Œ’Žj1, ‰¡“cáÁ“ñ (1t‘Ÿ“à): “§ÍƒPƒA 2011/2; 17 (2): 41.

H22-522005. [uÀ]y“ÁW: “±“üŠî€‚©‚ç’·Šú‡•¹Ç‚܂Ł@‰p—ªŒê‚ÅŠî‘b‚ª‚í‚©‚é! “§Í—Ö@‚ÌABCz2-9 RTx. ‰¡“cáÁ“ñ, Ž…Œ’Žj1 (1t‘Ÿ“à): “§ÍƒPƒA 2011/2; 17 (2): 42.

H22-522006. [uÀ]y“ÁW: “±“üŠî€‚©‚ç’·Šú‡•¹Ç‚܂Ł@‰p—ªŒê‚ÅŠî‘b‚ª‚í‚©‚é! “§Í—Ö@‚ÌABCz4-5 EPO/ESA. ‰¡“cáÁ“ñ, Ž…Œ’Žj1 (1t‘Ÿ“à): “§ÍƒPƒA 2011/2; 17 (2): 56.

[Šw‰ïEŒ€‹†‰ï“™]

H22-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ‚ŒŒˆ³‚Ɛt‘Ÿ•a. Ž…Œ’Žj (t‘Ÿ“à): ‘Š–Í‚ª‹u’nˆæŒ’NuÀ (2011/2/9), ÀŠÔ.


äPŒŽ•aEŠŽõ“à‰ÈŠw

[Šwp˜_•¶]

110126. [ŒŽ’˜] Elevation of interleukin 8 in cerebrospinal fluid in neuropsychiatric systemic lupus erythematosus. Ishikawa A1, Asako K, Hirohata S1: Kitasato Med J 2011/9; 41 (2): 160-4. (Îì@Í1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

110127. [ŒŽ’˜] Induction of type B synoviocyte-like cells from plasmacytoid dendritic cells of the bone marrow in rheumatoid arthritis and osteoarthritis. Hirohata S1, Nagai T1, Asako K, Tomita T, Yoshikawa H: Clin Immunol 2011/9; 140 (3): 276-83. (œA”šr¬1, ‰iˆä—§•v1: 1äPŒŽ•aEŠŽõ“à)

110128. [ŒŽ’˜] Predictors of survival and causes of death in Japanese patients with systemic sclerosis. Hashimoto A1, Tejima S, Tono T, Suzuki M, Tanaka S1, Matsui T, Tohma S, Endo H, Hirohata S1: J Rheumatol 2011/9; 38 (9): 1931-9. (‹Ž–{@“Ä1, “c’†Z–Ÿ1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

110129. [ŒŽ’˜] IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S1, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC, Jr, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg JC, Kimberly RP: Proc Natl Acad Sci U S A 2011/12; 108 (51): 20736-41. (“c’†Z–Ÿ1: 1äPŒŽ•aEŠŽõ“à)

110130. [ŒŽ’˜] Efficacy of serum angiopoietin-1 measurement in the diagnosis of early rheumatoid arthritis. Ishikawa A1, Okada J2, Nishi K1, Hirohata S1: Clin Exp Rheumatol 2011/7-8; 29 (4): 604-8. (Îì@Í1, ‰ª“c@ƒ2, Œ@˜a’j1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à, 2Œ’NŠÇ—ƒZ)

120015. [ŒŽ’˜] RƒŠƒ{ƒ\[ƒ€PR‘Ì‚ÌŠÖ—^‚ªŽŠŽ‚³‚ê‚œƒ‹[ƒvƒXt‰Š‚Ì1—á. Žè“ˆ’qŽq, ¬ì‰p—C, ‰iˆä—§•v1, “c’†Z–Ÿ1, Îì@Í, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): —Տ°ƒŠƒEƒ}ƒ` 2011/12; 23 (4): 329-34.

310009. [Ç—á•ñ] Histopathological analysis of cerebral hemorrhage in systemic lupus erythematosus complicated with antiphospholipid syndrome. Arinuma Y1, Kikuchi H, Aramaki K, Kyogoku M, Hirohata S1: Mod Rheumatol 2011/10; 21 (5): 509-13. (—LÀ—ǍK1, œAEšr¬1: 1äPŒŽ•aEŠŽõ“à)

320023. [Ç—á•ñ] ¶•šŠw“I»Ü“Š—^’†Ž~Œã‚Ƀjƒ…[ƒ‚ƒVƒXƒ`ƒX”x‰Š‚ðÄ”­‚µ‚œŠÖßƒŠƒEƒ}ƒ`‚Ì1—á. Ž™‹Ê‰ØŽq1, ‰iˆä—§•v1, ¬ì‰p—C1, “c’†~ˆê1, ¯@Œ’‘Ÿ1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): –k—¢ˆãŠw 2011/12; 41 (2): 127-31.

510006. [‘à] Anti-ribosomal P antibodies and lupus nephritis. Hirohata S1: Clin Exp Nephrol 2011/8; 15 (4): 471-7. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

520031. [‘à] Behcet•a‚̐f’f‚ÆŽ¡—Â̐i•à. œA”šr¬ (äPŒŽ•aEŠŽõ“à): “ú“à‰ïŽ 2011/9; 100 (9): 2662-6.

521016. [‰ðà]y–Ú‚ÅŒ©‚éƒVƒŠ[ƒYzƒx[ƒ`ƒFƒbƒg•a. œA”šr¬ (äPŒŽ•aEŠŽõ“à): Frontiers in Rheumatology & Clinical Immunology 2011/5; 5 (2): 80-3.

521017. [‰ðà]yƒŠƒEƒ}ƒ`f—Ãtƒƒ“ƒeƒCƒA@Žl”Œ¢‹I‚̐i•à‚Æ“W–]zŠ°‰ð“±“üŒã‚¢‚©‚Ɉێ‚µ‚Ä‚¢‚­‚©‚ɉۑè. œA”šr¬ (äPŒŽ•aEŠŽõ“à): Medical ASAHI 2011/5; 40 (5): 34-5.

522078. [uÀ]yäPŒŽ•a‚ÌŽÀ’nf—Ã: ƒ‰ƒCƒ}ƒŠƒPƒA‚Ɠ«•a‘Ԃ̍Ž•žzƒgƒsƒbƒNƒX: ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì•a‘ԂƍRƒŠƒ{ƒ\[ƒ€PR‘Ì. ‰iˆä—§•v (äPŒŽ•aEŠŽõ“à): Medical Practice 2011/7; 28 (7): 1244-6.

522079. [uÀ]y“ÁWII: Behcet•azBehcet•a‚Ì•a‘ԂƉŠÇ«ƒTƒCƒgƒJƒCƒ“. œA”šr¬ (äPŒŽ•aEŠŽõ“à): ‰ŠÇ‚ƖƉu 2011/8; 19 (5): 58-62.

[’˜@‘]

610009. [Šwp‘] (•ª’SŽ·•M)yChallenges in RheumatologyzChapter 3@Role of Bone Marrow in the Pathogenesis of Rheumatoid Arthritis, p.27-40. Hirohata S1, Edited by Harjacek M, InTech, 2011/10”­s. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

620087. [Šwp‘] (•ÒW)y¡“ú‚̗Տ°ŒŸž2011-2012zŠÄC: ŸN—шè”V‰î, •Ò: ŸN—шè”V‰î, ¯@ŒbŽq, œA”šr¬1, –î•y@—T, Î•ŒúŽŠ (1äPŒŽ•aEŠŽõ“à), “ì]“°, “Œ‹ž, 2011/4”­s.

620088. [Šwp‘] (•ª’SŽ·•M)yÇŒóŒQƒnƒ“ƒhƒuƒbƒNzƒx[ƒ`ƒFƒbƒgÇŒóŒQ, p.631. œA”šr¬ (äPŒŽ•aEŠŽõ“à), •Ò: •ŸˆäŽŸ–î, ‘•ÒW: ˆä‘º—T•v, ’†ŽR‘“X, “Œ‹ž, 2011/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713053. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Enhanced expression of flt3 mRNA and increased differentiation of immature plasmacytoid dendritic cells in CD34+ cells of the bone marrow in rheumatoid arthritis. Hirohata S1, Tomita T, Yoshikawa H: EULAR 2011 (2011/5/27), London, UK. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713054. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Utility of quantitative determination of brainstem atrophy in the diagnosis of chronic progressive type neuro-Behet's disease. Takayama M, Asako K, Kikuchi H, Kono H, Hirohata S1: EULAR 2011 (2011/5/27), London, UK. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713055. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Induction of type B synoviocyte-like cells from plasmocytoid dendritic cells of the bone marrow in rheumatoid arthritis and osteoarthritis. Hirohata S1, Tomita T, Yoshikawa H: EAGOR 2011 (2011/6/15), Tokyo. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713056. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Enhanced expression of mRNA for interleukin 6 and tumor necrosis factor-alpha in CD34+ cells of the bone marrow in osteoarthritis. Hirohata S1, Yanagida T, Tomita T, Yoshikawa H: 75th Annual Scientific Meeting, American College of Rheumatology (2011/11/4-9), Chicago, USA. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713057. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Retrospective analysis of the efficacy of tacrolimus in rheumatoid arthritis: suggestive synergistic effects with methotrexate. Hoshi K1, Tanaka S1, Wada T1, Tanaka J1, Nagai T1, Hirohata S1: ACR/ARHP Annual Scientific Meeting 2011 (2011/11/5), Chicago, USA. (¯@Œ’‘Ÿ1, “c’†Z–Ÿ1, ˜a“c’B•F1, “c’†~ˆê1, ‰iˆä—§•v1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713058. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Serum brain natriuretic peptide is a reliable marker for survival of pulmonary arterial hypertension associated with connective tissue diseases, including systemic sclerosis, mixed connective tissue disease and systemic lupus erythematosus. Tanaka S1, Hoshi K1, Tanaka J1, Wada T1, Okada J2, Nagai T1, Hirohata S1: ACR/ARHP Annual Scientific Meeting (2011/11/7), Chicago, USA. (“c’†Z–Ÿ1, ¯@Œ’‘Ÿ1, “c’†~ˆê1, ˜a“c’B•F1, ‰ª“c@ƒ2, ‰iˆä—§•v1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à, 2Œ’NŠÇEƒZ)

713059. [Šw‰ï (E‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The risk of cancer in Japanese patients with systemic sclerosis. Hashimoto A, Endo H, Matsui T, Tohma S, Tanaka S1, Hirohata S1: ACR/ARHP Annual Scientific Meeting 2011 (2011/11/7), Chicago, USA. (“c’†Z–Ÿ1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

722063. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Behet•a. œA”šr¬1, ‹e’nO•q (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/18), _ŒË.

722064. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) œ‘Œ`Ž¿×–E—l‹@ó×–E‚ÌBŒ^ŠŠ–Œ×–E—l×–E‚Ö‚Ì•ª‰»”\. œA”šr¬1, •y“c“N–ç, ‹gìGŽ÷ (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/18), _ŒË.

723232. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«isŒ^_Œoƒx[ƒ`ƒFƒbƒg•a‚̐f’f‚É‚š‚¯‚é”]Š²•”’è—ʉðÍ‚Ì—L—p«. ‚ŽR^Šó, óŽq—ˆ”ü, ‹e’nO•q, ‰Í–ì@”£, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/19), –ŒŒÃ‰®.

723233. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œŽ{ÝŒã‚ëŒü‚«ƒRƒz[ƒg’²ž‚ÉŠî‚­‹}«Œ^_Œo‚š‚æ‚Ñ–«isŒ^_Œoƒx[ƒ`ƒFƒbƒg•a‚̐f’fŠî€‚̍쐬. œA”šr¬1, ‹e’nO•q, ‘ò“c“NŽ¡, ‰iŸº—TŽq, ŒK–Œ³—², Šx–ìŒõ—m, Îƒ–’Ø—Ç–Ÿ (1äPŒŽ•aEŠŽõ“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/19), –ŒŒÃ‰®.

723234. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶•šŠw“I»Ü‚ÆŽèp ŠÖßƒŠƒEƒ}ƒ`Š³ŽÒ‚É‚š‚¯‚鐶•šŠw“I»Ü“Š—^’†‚̐®Œ`ŠO‰ÈŽèp‚ÌŒŸ“¢. “c’†Z–Ÿ (äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/17), “Œ‹ž.

723235. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äPŒŽ•af—Âɂš‚¯‚é”x‚ŒŒˆ³Ç‚̃sƒbƒgƒtƒH[ƒ‹. “c’†Z–Ÿ (äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/17), “Œ‹ž.

723236. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŠúRA‚ɑ΂·‚éƒuƒVƒ‰ƒ~ƒ“ + ƒTƒ‰ƒ]ƒXƒ‹ƒtƒ@ƒsƒŠƒWƒ“•¹—p‚ÆŠe’PÜ‚Ì‘œŽ{Ý–³ìˆ×‰»ŽŽŒ±. —é–؍N•v, œA”šr¬1, ’·‰ªÍ•œ, ácŠÔdl (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/18), _ŒË.

723237. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éNPSLEŠ³ŽÒ‚Ì”äŠrŒŸ“¢. ¬ì‰p—C1, “c’†Z–Ÿ1, ŒŽ@—º—S1, H“¡—Y‘å1, “Œ–ìr—m, “Œ–ì‹IŽq1, Žè“ˆ’qŽq, ˜a“c’B•F1, “c’†~ˆê1, ¯@Œ’‘Ÿ1, ‰iˆä—§•v1, Îì@Í, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/18), _ŒË.

723238. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MTMR6-C8orf12—̈æ‚ÆFAM167A-BLK—̈æ‚Í, “ú–{lW’c‚É‚š‚¢‚Ä, “Æ—§‚ÉSLE‚ÉŠÖ˜A‚·‚é. “y‰®®”V, ˆÉ“ŒˆèŒb, ‹ß“¡—T–ç, —с@‘Ÿ’q, Œ–{@Œ÷, Z“cF”V, ˆÉ“¡@‘, ‘¶^‹K—Y, ‚è–F¬, ‹Ž–{”ŽŽj, £ŒËŒû‹žŒá, ‰iˆä—§•v1, œA”šr¬1, ŒÃì@G, ácŠÔdl (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/19), _ŒË.

723239. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶•šŠw“I»Ü‚̃qƒg’PŠj‹…‚Ìin vitro IL-17ŽY¶‚ɑ΂·‚éŒø‰Ê‚ɂ‚¢‚Ä. Žè“ˆ’qŽq, “Œ–ìr—m, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/19), _ŒË.

723240. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶•š»Ü‚Ìin vitro––œŒŒ’PŠj‹…‚ÌIgMŽY¶‚ɑ΂·‚éŒø‰Ê‚ÌŒŸ“¢. “Œ–ìr—m, Žè“ˆ’qŽq, “Œ–ì‹IŽq1, –Ø‘º”ü•Û, ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/19), _ŒË.

723241. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”jœ×–E•ª‰»‚É‹y‚Ú‚·FKBP5 (FK506-binding-protein5) ˆâ“`Žq‚̉e‹¿. –Ø‘º”ü•Û, Œ‰º—çŽq1, ‹Ž–{@“Ä1, ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/19), _ŒË.

723242. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x‚ŒŒˆ³Ç‚Å”­Ç‚µ‚œ‰¡’f«Ò‘‰ŠEŽUÝ«”]Š²”]‰Š‚ð‡•¹‚µ‚œSLE‚Ì1–UŒŸ—á. H“¡—Y‘å1, “c’†~ˆê1, ŒŽ@—º—S1, ¬ì‰p—C1, “Œ–ìr—m, ¯@Œ’‘Ÿ1, ‰iˆä—§•v1, “c’†Z–Ÿ1, Îì@Í, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/19), _ŒË.

723243. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xtÇŒóŒQ‚𗈂µ‚œ‹­”çÇ‚Ì1—á. ŒŽ@—º—S1, ¯@Œ’‘Ÿ1, H“¡—Y‘å1, ¬ì‰p—C1, “c’†~ˆê1, ‰iˆä—§•v1, “c’†Z–Ÿ1, Îì@Í, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/19), _ŒË.

723244. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äPŒŽ•a‚ɍ‡•¹‚·‚é”x“®–¬«”x‚ŒŒˆ³Ç‚̜늳—Š‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “c’†Z–Ÿ1, ¬ì‰p—C1, ¯@Œ’‘Ÿ1, “c’†~ˆê1, ˜a“c’B•F1, ‰iˆä—§•v1, ‰ª“c@ƒ2, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à, 2Œ’NŠÇ—ƒZ): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/19), _ŒË.

723245. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`‚É‚š‚¯‚éTNF‘jŠQ–ò‚É‚æ‚éŠÖßŠŠ–Œ‚Ì•a—“I•Ï‰». œA”šr¬1, •y“c“N–ç, ‹gìGŽ÷, ‹ž‹É•û‹v (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/20), _ŒË.

723246. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`Ž¡—Âɂš‚¯‚éƒ^ƒNƒƒŠƒ€ƒX‚ƃƒgƒgƒŒƒLƒT[ƒg•¹—p—Ö@‚Ì—L—p«‚ÌŒŸ“¢. ¯@Œ’‘Ÿ1, “c’†Z–Ÿ1, “c’†~ˆê1, ˜a“c’B•F1, ‰iˆä—§•v1, Îì@Í, ‰ª“c@ƒ2, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à, 2Œ’NŠÇ—ƒZ): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/20), _ŒË.

723247. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RƒŠƒ{ƒ\[ƒ€PR‘̂̓qƒg––œŒŒƒŠƒ“ƒp‹…‚Ìin vitro‚ÌIL-17ŽY¶‚𑣐i‚·‚é. ‰iˆä—§•v1, Žè“ˆ’qŽq, “Œ–ìr—m, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/20), _ŒË.

723248. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚É‚š‚¯‚éƒ}ƒNƒƒtƒ@[ƒWŠˆ«‰»ÇŒóŒQ(MAS)‚ƍRƒŠƒ{ƒ\[ƒ€PR‘Ì. Žè“ˆ’qŽq, “Œ–ìr—m, “Œ–ì‹IŽq1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/20), _ŒË.

732029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)yƒVƒ“ƒ|ƒWƒEƒ€1: äPŒŽ•a‚Ì‘ŸŠí•ÊŽ¡—Ð헪zCNSƒ‹[ƒvƒX‚Ì•a‘ԂƐf’fEŽ¡—Ã. œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ62‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”Šwp‘å‰ï (2011/11/19), Žl“úŽs.

733115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶•šŠw“I»Ü‚Ì“Š—^’†Ž~Œã‚Ƀjƒ…[ƒ‚ƒVƒXƒ`ƒX”x‰Š‚̍Ĕ­‚𗈂µ‚œŠÖßƒŠƒEƒ}ƒ`‚Ì1—á. Ž™‹Ê‰ØŽq, ‰iˆä—§•v1, ŒŽ@—º—S1, H“¡—Y‘å1, ¬ì‰p—C1, ¯@Œ’‘Ÿ1, “c’†~ˆê1, “c’†Z–Ÿ1, Îì@Í, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ579‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2011/9/11), “Œ‹ž.

733116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒNƒƒtƒ@[ƒWŠˆ«‰»ÇŒóŒQ‚ð’悵‚œRƒŠƒ{ƒ][ƒ}ƒ‹PR‘Ì—z«‚Ì‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì1—á. ò“c_”V, œA”šr¬1, “c’†Z–Ÿ1, ¯ŽR—²s1, ‰iˆä—§•v1, “c’†~ˆê1, ¯@Œ’‘Ÿ1, ˜a“c’B•F1 (1äPŒŽ•aEŠŽõ“à): ‘æ582‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2011/10/8), “Œ‹ž.

733117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‹[ƒvƒXž_•a‚ÌŠ°‰ðŠú‚É’E‘•a•Ï‚ª¶‚¶‚œ‘Sg«ƒGƒŠƒeƒ}ƒg[EfƒX‚Ì1—á. ’†‘ºŠ²º, ŽRŒû—TŽq1, ¯ŽR—²s1, “c’†~ˆê1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ583‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2011/11/12), “Œ‹ž.

733118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •s–Ÿ”M‚ɑ΂µ‚ăRƒ‹ƒqƒ`ƒ“‚ª’˜Œø‚µ‚œŽ©ŒÈ‰ŠÇ«ÇŒóŒQ‚ª‹^‚í‚ê‚鍂—îŽÒ‚Ì1—á. âˆä“ߌb, ŽRŒû—TŽq1, “c’†~ˆê1, H“¡—Y‘å1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ586‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2012/3/10), “Œ‹ž.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-522007. [uÀ]y˜AÚ: _ŒoŽŸŠ³Ž¡—Ãm[ƒgz‰ŠÇ«ŽŸŠ³‚É”º‚€_ŒoáŠQ|ƒx[ƒ`ƒFƒbƒg•a|. œA”šr¬ (äPŒŽ•aEŠŽõ“à): Clinical Neuroscience 2011/2; 29 (2): 234-5.


ŠO‰ÈŠw

[Šwp˜_•¶]

110131. [ŒŽ’˜] Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. Ooki A1, Yamashita K1, Kikuchi S1, Sakuramoto S1, Katada N1, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M1: BMC Cancer 2011/4; 11: 122. (‘å–؁@‹Å1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y1, ÷–{Mˆê1, •Ð“c‰Ä–ç1, ˜m’J”ü“Þ, ‰Í–”@Š°, Œ‹{—mŽj, ’†‘º˜a“¿, “n粏¹•F1: 1ŠO‰È)

110132. [ŒŽ’˜] Oncological outcomes of laparoscopic surgery in elderly patients with colon cancer: a comparison of patients 64 years or younger with those 75 years or older. Nakamura T1, Mitomi H, Onozato W1, Sato T1, Ikeda A1, Naito M1, Ogura N1, Kamata H1, Ooki A1, Watanabe M1: Hepatogastroenterology 2011/7; 58 (109): 1200-4. (’†‘º—²r1, ¬–ì—¢q1, ²“¡•˜Y1, ’r“c@“Ä1, “à“¡³‹K1, ¬‘q’Œl1, Š™“cOŽ÷1, ‘å–؁@‹Å1, “n粏¹•F1: 1ŠO‰È)

110133. [ŒŽ’˜] Lymphatic tumor emboli detected by D2-40 immunostaining can more accurately predict lymph-node metastasis. Moriya H1, Ohbu M2, Kobayashi N, Tanabe S3, Katada N1, Futawatari N1, Sakuramoto S1, Kikuchi S1, Okayasu I4, Watanabe M1: World J Surg 2011/9; 35 (9): 2031-7. (X’JGŒõ1, ‘å•”@œ2, “c糁@‘3, •Ð“c‰Ä–ç1, “ñ“nM]1, ÷–{Mˆê1, ‹e’rŽj˜Y1, ‰ªˆÀ@ŒM4, “n粏¹•F1: 1ŠO‰È, 2ˆã—Éq¶Šw•”, 3Á‰»Ší“à, 4•a—)

110134. [ŒŽ’˜] Prognostic effect of Preoperative obstruction on poor clinical outcome in stage III colorectal cancer.. Katoh H1, Yamashita K1, Wang G2, Sato T1, Nakamura T1, Watanabe M1: Ann Surg Oncol 2011/9; 18 (9): 2432-41. (‰Á“¡@O1, ŽR‰ºŒpŽj1, ‰€@‘‹Õ2, ²“¡•˜Y1, ’†‘º—²r1, “n粏¹•F1: 1ŠO‰È, 2—Տ°Œ€‹†EŠé‰æ)

110135. [ŒŽ’˜] Prognostic Significance of Preoperative Bowel Obstruction in Stage III Colorectal Cancer. Katoh H1, Yamashita K1, Wang G2, Sato T1, Nakamura T1, Watanabe M1: Ann Surg Oncol 2011/9; 18 (9): 2432-41. (‰Á“¡@O1, ŽR‰ºŒpŽj1, ‰€@‘‹Õ2, ²“¡•˜Y1, ’†‘º—²r1, “n粏¹•F1: 1ŠO‰È, 2—Տ°Œ€‹†EŠé‰æ)

110136. [ŒŽ’˜] Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. Sasako M, Sakuramoto S1, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, Nashimoto A, Fujii M, Nakajima T, Ohashi Y: J Clin Oncol 2011/11; 29 (33): 4387-93. (÷–{Mˆê1: 1ŠO‰È)

110137. [ŒŽ’˜] Short- and long-term outcomes of laparoscopic surgery in patients with pathological stage II and III colon cancer. Nakamura T1, Mitomi H, Onozato W1, Sato T1, Ikeda A1, Naito M1, Ogura N1, Kamata H1, Ooki A, Watanabe M1: Hepatogastroenterology 2011/11; 58 (112): 1947-50. (’†‘º—²r1, ¬–ì—¢q1, ²“¡•˜Y1, ’r“c@“Ä1, “à“¡³‹K1, ¬‘q’Œl1, Š™“cOŽ÷1, “n粏¹•F1: 1ŠO‰È)

110138. [ŒŽ’˜] Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer. Kosaka Y1, Mimori K, Fukagawa T, Ishikawa K, Etoh T, Katai H, Sano T, Watanabe M1, Sasako M, Mori M: Ann Surg Oncol 2012/7; 19 (Suppl 3): S430-7. (¬â–ùŒ«1, “n粏¹•F1: 1ŠO‰È)

320024. [Ç—á•ñ] ‘Of’f‚µ‚œ¬¿œEƒwƒ‹ƒjƒA‚Ì1—á. ]ŠÔ@—æ1, ¬–ö˜a•v, ’†ìŠîl, ó‰z’C’j, Œ–{Œ\ŒÜ, ‰i£„Ži, ‰ª—э„Žj, Œ@’m•F, •“c@^, ‹àˆäÎ—Y (1ŠO‰È): “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ 2011/4; 44 (4): 504-9.

320025. [Ç—á•ñ] ^«’°Î‚𔺂Á‚œ¬lƒƒbƒPƒ‹ŒeŽºúE‚Ì1—á. M‘ŸºŽq1, ¬âEùŒ«1, ‘å‹v•Û”Ž¢, Š™“cOŽ÷1, ’†‘ºE²r1, “n粏¹•F1 (1ŠO‰È): “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2011/9; 72 (9): 2298-301.

320026. [Ç—á•ñ] ‰»Šw—Ö@’†‚É‘‘債‚œTriple negativeE‹‘å•›“ûŠà‚Ì1—á. —с@‹žŽq1, ¬â–ùŒ«1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): Šà‚Ɖ»Šw—Ö@ 2011/11; 38 (12): 2071-74.

320027. [Ç—á•ñ] p‘O‹Ù‹}•úŽËüÆŽË‚É‚Ä—LŒø‚ÈŽ~ŒŒ‚ð“Ÿ‚œ“û‘BG•œã”çŠà‚Ì1—á. ‹ß“¡NŽj1, ’†ŒF‘žŽm, ‹v•Û”CŽj1, “ñ“nM]1, ‚‹Ž’õl1, Œ@”ªŽk, ”ª\ì—v•œ, ¬â–ùŒ«1, —с@‹žŽq1, åÎ‹I•F1, ‘ •À@Ÿ1 (1ŠO‰È): Šà‚Ɖ»Šw—Ö@ 2011/11; 38 (12): 2174-6.

320028. [Ç—á•ñ] ’·Œa40cm,d—Ê20.5kg‚É‚š‚æ‚Ԍ㕠–ŒŽ‰–b“÷Žî‚Ì1—á. ‘å‹v•Û”Ž¢, ¬â–ùŒ«1, ‚‹Ž’õl1, M‘ŸºŽq1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2011/11; 72 (11): 2973-7.

320029. [Ç—á•ñ] Á‰»ŠÇŒŒŠÇŽî‚ð‚·‚×‚ÄØœ‚µ‚œblue rubber bleb nevus syndrome‚Ì1—á. ]ŠÔ@—æ, “c’†@Œ‰1, •“cŒ›Žq1, ’†ŠÚ®–ç, “n粏¹•F1 (1ŠO‰È): “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ 2011/12; 47 (7): 1053-7.

320030. [Ç—á•ñ] 17”NŒã‚ɍĔP“]‚ð‚«‚œ‚µ, ‘å—Ê’°Øœ‚ð•K—v‚Æ‚µ‚œ’°‰ñ“]ˆÙíÇ‚Ì1—á. “c’†@Œ‰1, •“cŒ›Žq1, ‚ˆÀ@”£, ŽR–{Œöˆê1, •Ð‰ª—Sˆê2, “n粏¹•F1 (1ŠO‰È, 2‹~–œ): “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ 2012/2; 48 (1): 76-80.

522080. [uÀ]y“ÁW: ÅV ˆÝE’°EH“¹ŽèpzIV. Œ‹’°E’Œ’°Eãè–å@12. • o‹Ÿ‰º• ‰ï‰AŽ®’Œ’°Ø’fp. ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): Žèp 2011/5; 65 (6): 925-9.

522081. [uÀ]y“ÁW: p–ì‚Ì“WŠJ; ˆÀ‘S‚ÈŽèp‚ði‚ß‚é‚œ‚߂Ɂz5. ’Œ’°ŠàŽèp‚É‚š‚¯‚ép–ì‚Ì“WŠJ. ’r“c@“Ä1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, ¬‘q’Œl1, “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): Á‰»ŠíŠO‰È 2011/9; 34 (10): 1481-91.

522082. [uÀ]y“ÁW: ‘Šú‘å’°Šà‚Ì“àŽ‹‹ŸŽ¡—ÁEŠO‰ÈŽèp‚̍őOüz • o‹Ÿ‰ºŽèp‚É‚æ‚鑁Šú‘å’°Šà‚ÌŽ¡—Ã. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘å’°ŠàFrontier 2011/9; 4 (3): 277-80.

522083. [uÀ]y“ÁW: ÅVî•ñ‚©‚ç‚Ý‚œŽüŽYŠúˆã—ÂƉ摜f’fzo¶‘Of’f‚³‚ê‚œ—‘‘ƒ”XŽî‚ÌŽ¡—Õûj. “c’†@Œ‰ (ŠO‰È): ŽY•wl‰ÈŽ¡—à 2011/9; 103 (3): 301-5.

522084. [uÀ]y“ÁW: ‚—îŽÒ‚ɑ΂·‚邪‚ñŽ¡—Â̍H•v‚ƁEՏ°ŽŽŒ±z‚—îŽÒ‚Ì‚ª‚ñŽ¡—Ã. ’†‘º—²Er1, “n粏¹•F1 (1ŠO‰È): Žîᇓà‰È 2011/9; 8 (3): 246-50.

522085. [uÀ]y“ÁW: Žá‚«“–’Œˆã‚Ì”Y‚݁@• •”‹~‹}Q•AzIV. ƒgƒsƒbƒN‚ƃL[ƒ[ƒh‚©‚çŠw‚Ô• •”‹~‹}@Q31 Oncology Emergency. ’r“c@“Ä1, “n粏¹•F1 (1ŠO‰È): ‹~‹}EW’†Ž¡—à 2011/11; 23 (9E10): 1569-75.

522086. [uÀ]y“ÁW: • o‹Ÿ‰ºŽèp‚É”º‚€‹ô”­Ç‚ւ̑Ήžz• o‹Ÿ‰º’Œ’°ŠàŽèp‚É‚š‚¯‚é‹ô”­Ç. ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2012/1; 32 (1): 31-6.

522087. [uÀ]y“ÁW: ˆÝØœŒãÄŒšp|‚±‚±‚ªÅd—vƒ|ƒCƒ“ƒg|z7. • o‹Ÿ•â•‰ºˆÝ‘S“EpŒã: ƒT[ƒLƒ…ƒ‰[ƒXƒeƒCƒvƒ‰[–@|ˆÀ‘S‚ÈŠíŠB•«‡‚Ì‚œ‚߂̃|ƒCƒ“ƒg|. ÷–{Mˆê1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ŽÄ“c’q—², ª–{¹”V1, “n粏¹•F1 (1ŠO‰È): Žèp 2012/1; 66 (1): 43-9.

[’˜@‘]

620089. [Šwp‘] (•ª’SŽ·•M)yƒAƒgƒ‰ƒX‚ÅŠw‚ԁ@’Bl‚ÌŽèp (Á‰»ŠíŠO‰È2011”N5ŒŽ—ÕŽž‘Š§†)zIII ¬’°EŒ‹’°‚ÌŽèp@7. • o‹Ÿ‰ºSóŒ‹’°Øœp, p.830-8. ’r“c@“Ä1, “n粏¹•F1 (1ŠO‰È), ‚Ö‚é‚·o”Å, “Œ‹ž, 2011/5”­s.

620090. [Šwp‘] (•ª’SŽ·•M)yäB‘Ÿ|Šî‘b‚ƗՏ°|zäB‘Ÿ‚ÆŠÖ˜A‚µ‚œŽŸŠ³@A. äBŒŽ”­‚ÌŽŸŠ³@äB“®–¬áŽ, p.117-24. •œ“cŒõ”Ž1, “c‘ºK•ä1, “à“c‘׎Š1, ŒŠª@”Ž, Œ‰iŒ[“ñ2, ƒEƒbƒhƒnƒ€ƒX—æŽq2, •Ð‰ª—Sˆê3, “n粏¹•F1 (1ŠO‰È, 2•úŽËü (‰æ‘œ), 3‹~–œ), •Ò: ™t‰iŒ÷‘Ÿ, ‚Ö‚é‚·o”Å, “Œ‹ž, 2011/5”­s.

620091. [Šwp‘] (•ª’SŽ·•M)y‚ª‚ñŠ³ŽÒ‚ÌŽüpŠúŠÇ—‚Ì‚·‚×‚Ä (ŠO‰ÈŽ¡—à 104 (‘Š§))z˜3. pŒã‚ÌŽå‚ȍ‡•¹Ç‚Æ‚»‚̑΍ô@pŒã’°ŠÇ–ü’…, p.767-71. ¬‘q’Œl1, ¬–ì—¢q1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È), ‰iˆä‘“X, ‘åã, 2011/5”­s.

620092. [Šwp‘] (•ª’SŽ·•M)yƒIƒ“ƒRƒƒW[ƒNƒŠƒjƒJƒ‹ƒKƒCƒh@Á‰»ŠíŠà‰»Šw—Ö@@‰ü’ù3”ŁzÁ‰»ŠíŠà‰»Šw—Ö@‚ÌŠàŽí•ÊŽ¡—Ð헪@3 ‘å’°Šà‚ɑ΂·‚鉻Šw (•úŽËü) —Ö@@1) Øœ•s”\EÄ”­‘å’°Šà‚É‚š‚¯‚鉻Šw—Ö@, p.253-61. ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È), •Ò: ‘呺Œ’“ñ, ‘ë“à”ä˜C–ç, “ì]“°, “Œ‹ž, 2011/11”­s.

620093. [Šwp‘] (•ª’SŽ·•M)yæ’[ˆã—ÃVƒŠ[ƒY42@Á‰»ŠíŽŸŠ³‚̍ŐVˆã—Áz‘æ15Í@“àŽ‹‹Ÿ‰ºŽ¡—Á•ƒXƒeƒ“ƒg—Ö@‚̐i•à@1. ‹ŸŽ‹‰ºŽèp‚Ì“K‰žŠg‘å, p.258-62. ¬‘q’Œl1, ²“¡•˜Y1, ’r“c@“Ä1, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È), æ’[ˆã—ËZpŒ€‹†Š, “Œ‹ž, 2011”­s.

620094. [Šwp‘] (•ª’SŽ·•M)yƒKƒCƒhƒ‰ƒCƒ“ŠO—ˆf—Ã2012zŠàf—Â̌»ó@4. ‘å’°Šà, p.528-31. ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È), •ÒWŽåŠ²: ò@F‰p, “úŒoƒƒfƒBƒJƒ‹ŠJ”­, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712021. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Treatment of high grade dysplasia and intramucosal carcinoma:surgical treatment. Katada N1: International Surgical Week 2011 (2011/8/29), Yokohama. (•Ð“c‰Ä–ç1: 1ŠO‰È)

713060. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RAMP1 Essentialize Protect Roles for Mouse DSS-induced Colitis : Implications of Effect of CGRP via TRPV1 in Inflammatory Bowel Disease. Kawashima-Takeda N1, Tanaka K1, Watanabe M1, Majima M2: 12th European Congress of Paediatric Surgery (EUPSA) (2011/6/15-18), Barcelona, Spain. (•“cŒ›Žq1, “c’†@Œ‰1, “n粏¹•F1, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—)

713061. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A comparative study of laparoscopic anti-reflux surgery for GERD;Nissen versus Toupet. Katada N1, Shibata T1, Nemoto M1, Mieno H1, Yamashita K1, Sakuramoto S1, Kikuchi S1, Watanabe M1: 21st World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2011/8/10), Tokyo. (•Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1: 1ŠO‰È)

713062. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Oncologic emergency of large bowel cancer:Experience in our hospital. Ikeda A1: 21st World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2011/8/10), Tokyo. (’r“c@“Ä1: 1ŠO‰È)

713063. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A study of laparoscopic colectomy for patients with heart disease classified as class3 patients by the American Society of Anesthesiologists (ASA). Onozato W1, Nkamura T1, Ooki A1, Ogura N1, Naito M1, Ikeda A1, Sato T1, Watanabe M1: International Surgical Week 2011 (2011/8/29), Yokohama. (¬–ì—¢q1, ’†‘º—²r1, ‘å–؁@‹Å1, ¬‘q’Œl1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1: 1ŠO‰È)

713064. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Preoperative blood vessel imaging by three-dimensional CT: in laparoscopic colectomy for right-side colon cancer. Ikeda A1, Sato T1, Watanabe M1: International Surgical Week 2011 (2011/8/30), Yokohama. (’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1: 1ŠO‰È)

713065. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Surgical Outcomes in Patients with Ruptured Abdominal Aortic Aneurysms. Ohkubo H1, Uchida Y1, Tamura Y1, Hirata M1, Watanabe M1: International Surgical Week 2011 (2011/8/30), Yokohama. (‘å‹v•Û”Ž¢1, “à“c‘׎Š1, “c‘ºK•ä1, •œ“cŒõ”Ž1, “n粏¹•F1: 1ŠO‰È)

713066. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Therapeutic usefulness of stent implantation in iliac compression syndrome. Tamura Y1, Hirata M1, Nishimaki H, Uchida Y1, Ohkubo H1, Mishima T1, Watanabe M1: International Surgical Week 2011 (2011/8/30), Yokohama. (“c‘ºK•ä1, •œ“cŒõ”Ž1, ŒŠª@”Ž, “à“c‘׎Š1, ‘å‹v•Û”Ž¢1, ”ü“‡—˜º1, “n粏¹•F1: 1ŠO‰È)

713067. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Two cases of unresectable colorectal cancer with long-term survival treated by UFT/CPT11. Sato T1, Nakamura T1, Naito M1, Ogura N1, Ikeda A1, Ooki A1, Onozato W1, Watanabe M1: International Surgical Week 2011 (2011/8/30), Yokohama. (²“¡•˜Y1, ’†‘º—²r1, “à“¡³‹K1, ¬‘q’Œl1, ’r“c@“Ä1, ‘å–؁@‹Å1, ¬–ì—¢q1, “n粏¹•F1: 1ŠO‰È)

713068. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Usefulness of tartrate-resistant acid phosphatase bone-specific isozime (TRACP-5b) as a marker of metastases from breast. Sengoku N1, Kosaka Y1, Hayashi K1, Enomoto T1, Kuranami M1, Watanabe M1: International Surgical Week 2011 (2011/8/30), Yokohama. (åÎ‹I•F1, ¬â–ùŒ«1, —с@‹žŽq1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹•F1: 1ŠO‰È)

713069. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A case of primary mammary malignant lymphoma successfully treated without partial mastectomy. Hayashi K1, Kosaka Y1, Sengoku N1, Enomoto T1, Kuranami M1, Watanabe M1: International Surgical Week 2011 (2011/8/31), Yokohama. (—с@‹žEq1, ¬â–ùŒ«1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹•F1: 1ŠO‰È)

713070. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Efficacy of endvascular aortic repair in patients with abdominal aortic aneurysms for which endvascular aortic repair is not indicated according to the instruction for use. Hirata M1, Tamura Y1, Nishimaki H, Uchida Y1, Okubo H1, Watanabe M1: International Surgical Week 2011 (2011/8/31), Yokohama. (•œ“cŒõ”Ž1, “c‘ºK•ä1, ŒŠª@”Ž, “à“c‘׎Š1, ‘å‹v•Û”Ž¢1, “n粏¹•F1: 1ŠO‰È)

713071. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Outcomes of percutaneous transluminal angioplasty and stenting in patients with aortoiliac occlusive disease accompanied by total occlusion:efficacy and safety. Uchida Y1, Hirata M1, Tamura Y1, Mishima T1, Ohkubo H1, Watanabe M1: International Surgical Week 2011 (2011/8/31), Yokohama. (“à“c‘׎Š1, •œ“cŒõ”Ž1, “c‘ºK•ä1, ”ü“‡—˜º1, ‘å‹v•Û”Ž¢1, “n粏¹•F1: 1ŠO‰È)

713072. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A case of malignant peritoneal mesothelioma were diagnosed by laparoscopic biopsy. Harada H1, Watanabe M1, Naito M1, Sato T1, Ikeda A1, Ogura N1, Onozato W1, Nakamura T1: International Surgical Week 2011 (2011/8/28-9/1), Yokohama. (ŒŽ“cG‹P1, “n粏¹•F1, “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1: 1ŠO‰È)

713073. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Inguinal hernias containing uterus, fallopian tube and ovary in female infants. Takayasu H1, Tanaka K1, Takeda N1, Watanabe M1: International Surgical Week 2011 (2011/8/28-9/1), Yokohama. (‚ˆÀ@”£1, “c’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1: 1ŠO‰È)

713074. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for colorectal cancer with the umbilical reconstruction: The examination of validity for cosmetic and surgical site infection. Naito M1, Sato T1, Ikeda A1, Ogura N1, Onozato W1, Nakamura T1, Watanabe M1: International Surgical Week 2011 (2011/8/28-9/1), Yokohama. (“à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1: 1ŠO‰È)

713075. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Mesenteric panniculitis after colon cancer surgery : five cases reports and a review of the literature in Japan. Naito M1, Watanabe M1, Sato T1, Ikeda A1, Ogura N1, Onozato W1, Nakamura T1: International Surgical Week 2011 (2011/8/28-9/1), Yokohama. (“à“¡³‹K1, “n粏¹•F1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1: 1ŠO‰È)

713076. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Our device of management of stoma. Ogura N1, Watanabe M1: International Surgical Week 2011 (2011/8/28-9/1), Yokohama. (¬‘q’Œl1, “n粏¹•F1: 1ŠO‰È)

713077. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RAMP1 essentialize protect roles for mouse DSS-induced colitis: implications of effect of CGRP via TRPV1 in inflammatory bowel disease. Kawashima-Takeda N1, Tanaka K1, Watanabe M1, Majima M2: International Surgical Week 2011 (2011/8/28-9/1), Yokohama. (•“cŒ›Žq1, “c’†@Œ‰1, “n粏¹•F1, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—)

713078. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Adaptation of Laparoscopic surgery for right side colon cancer - learn from open colectomy cases. Ikeda A1, Tsutsui A1, Miura H1, Ogura N1, Naito M1, Watanabe M1: SAGES 2012 (2012/3/7), SanDiego, USA. (’r“c@“Ä1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, ¬‘q’Œl1, “à“¡³‹K1, “n粏¹•F1: 1ŠO‰È)

713079. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for colorectal cancer with the high ligation using automatic stapling device: examination of oncologic validity and technically safety. Naito M1, Watanabe M1, Sato T1, Ikeda A1, Ogura N1: SAGES 2012 (2012/3/7), SanDiego, USA. (“à“¡³‹K1, “n粏¹•F1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1: 1ŠO‰È)

722065. [Šw‰ï(‘S‘)] (ƒT[ƒWƒJƒ‹ƒtƒH[ƒ‰ƒ€) Clinical T3/T4‹¹•”H“¹Šà‚ɑ΂·‚éDocetaxelECisplatinE5FU•¹—p—Ö@ (DCF—Ö@) ‚ðæsŽ¡—ÂƂµ‚œWŠw“IŽ¡—Â̑œŽ{Ý’²ž. Œ‰º®”V1, •l–{N•v, •Ð“c‰Ä–ç2, Œ˜“ce—˜3, ×“cD‘¥, ’·£’Ê—², “¡ˆä”Ž•¶, Ž…Gº, ×ì@•à, “ˆ“c@—T, ’Ë“cˆê”Ž, ¬ò˜aŽO˜Y3 (1“È–ØŒ§—§‚ª‚ñƒZƒ“ƒ^[, 2ŠO‰È, 3Á‰»Ší“à): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/5/26-28), “Œ‹ž (Ž†ã), “ú–{ŠO‰ÈŠw‰ïŽGŽ 2011/5; 112 (—Õ‘1-2 ): 369.

722066. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒAƒJƒ‰ƒVƒAŽæ‚舵‚¢‹K–ñ (‘æ3”Å) ‚É‚š‚¯‚éŠg’£Œ^•ª—Þ‚Ì–â‘è“_: V‹K–ñ‚ł̉ü’è‚ÉŒü‚¯‚Ä. •Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2011/9/26), å‘ä.

722067. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹É/’Ž’áo¶‘̏dŽ™‚É‚š‚¯‚éÁ‰»ŠÇúE—á‚ÌŒŸ“¢. “c’†@Œ‰1, ‚ˆÀ@”£1, “n•Ó‰hˆê˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ27‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2011/10/29), ‘åã.

722068. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰º‘å’°Øœp‚ðˆÀ‘S‚ɍs‚€‚œ‚ß‚ÌŽè‹Z@p–ì‚Ì“WŠJ‚ƃ‰ƒ“ƒhƒ}[ƒN. ’r“c@“Ä1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, ¬‘q’Œl1, “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ73‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2011/11/18), “Œ‹ž.

722069. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰¡sŒ‹’°Šà‚Ì‹ŸŽ‹‰ºŽèp “–‰@‚É‚š‚¯‚鉡sŒ‹’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚ÌŒ»ó. “à“¡³‹K1, ¬‘q’Œl1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, ’r“c@“Ä1, ²“¡•˜Y1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2011/11/25), “Œ‹ž.

722070. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)y‰E‘€Œ‹’°Šà‚Ì•W€pŽ®zOSEHALSELAC ‚æ‚èˆÀ‘S‚ȗ̈惊ƒ“ƒpß‚ÌŠ®‘SŠsŽ‚ð‚ß‚Ž‚µ‚ā|p‘OŒŒŠÇ‘–s‚Ì•]‰¿|. ’r“c@“Ä1, ²“¡•˜Y1, ¬‘q’Œl1, “à“¡³‹K1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2011/11/26), “Œ‹ž.

722071. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)y‹ÇŠ‚“xis’Œ’°Šà‚ɑ΂·‚鎡—Ð헪zT4‹ÇŠis’Œ’°Šà‚ɑ΂·‚ép‘O‰»Šw•úŽËü—Ö@‚̈Ӌ`. ²“¡•˜Y1, “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, “›ˆä“ÖŽq1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2011/11/26), “Œ‹ž.

722072. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰ºŒ‹’°ŠàŽèp‚̏pŒã‡•¹Ç‚š‚æ‚Ñ’·Šú—\Œã‚ÌŒŸ“¢. ’†‘º—²r1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, ¬‘q’Œl1, ’r“c@“Ä1, “à“¡³‹K1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ24‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2011/12/8), ‘åã.

722073. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹ŸŽèp‚Ì’èŒ^‰»‚Æ“àŽ‹‹Ÿ‹Zp”F’èˆã‚̈琬. ²“¡•˜Y1, ’†‘º—²r1, ’r“c@“Ä1, “àE¡³‹K1, ¬‘q’Œl1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ24‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2011/12/8), ‘åã.

723249. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¶œœ‰º“®–¬‹·ó‚ɑ΂µŒoƒJƒe[ƒeƒ‹“IŒŒŠÇŒ`¬p‚ðŽ{s‚µ‚œ3—á. “c‘ºK•ä1, •œ“cŒõ”Ž1, ŒŠª@”Ž2, “à“c‘׎Š1, ƒEƒbƒhƒnƒ€ƒX—æŽq3, ‘å‹v•Û”Ž¢1, ”ü“‡—˜º1, “n糏¹•F1 (1ŠO‰È, 2‹~–œ, 3•úŽËü (‰æ‘œ)): ‘æ39‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2011/4/20), ‰«“ê, “ú–{ŒŒŠÇŠO‰ÈŽGŽ 2011; 20 (2): 632.

723250. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÙ‚È‚éŒo‰ß‚ðŽŠ‚µ‚œŠŽõ«• •”‘å“®–¬‰Š‚Ì2—á. “à“c‘׎Š1, ‘å‹v•Û”Ž¢1, Ö“¡Œöˆê˜Y1, ”ü“‡—˜º1, “c‘ºK•ä1, •œ“cŒõ”Ž1, “n粏¹•F1 (1ŠO‰È): ‘æ39‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (2011/4/21), ‰«“ê.

723251. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ºŽˆ‹}«“®–¬•ÂÇÇ‚ɑ΂·‚écatheter-directed thrombolysis‚ÌŒŸ“¢. ‘å‹v•Û”Ž¢1, “c‘ºK•ä1, “à“c‘׎Š1, •œ“cŒõ”Ž1, “n粏¹•F1 (1ŠO‰È): ‘æ39‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (2011/4/21), ‰«“ê.

723252. [Šw‰ï(‘S‘)] (ˆê”ÊŒû‰‰) ŠÌ×–EŠà‚É‚š‚¯‚éCTGF”­Œ»•ª•z‚š‚æ‚їՏ°•a—Šw“IˆÓ‹`‚ɂ‚¢‚Ä. ‘å•”@œ1, •Ð‹ËŠ°”V2, ÎˆäŒ’ˆê˜Y2, “ú‚@‰›3, ’†àV‹MG3 (1ˆã—Éq¶Šw•”, 2ŠO‰È, 3Á‰»Ší“à): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/30), ‰¡•l, “ú–{•a—Šw‰ï‰ïŽ 2011/3; 100 (1): 360.

723253. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹Šà‚É‚š‚¯‚é•\”瑝BˆöŽqEGFR”­Œ»‚š‚æ‚їՏ°•a—Šw“IŒŸ“¢. ŠÖ’JŒ³Š², •Ð“c‰Ä–ç1, “c糁@‘2, ‘å•”@œ3 (1ŠO‰È, 2Á‰»Ší“à, 3ˆã—Éq¶Šw•”): ‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï (2011/4/30), ‰¡•l.

723254. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’°œ“®–¬Š®‘S•ÂÇÇ—á‚ɑ΂·‚éIVRŽ{sŽž‚ÌŒŒŠÇ‘¹‚ɑ΂µ‚ÄIVR‚ÅŽ¡—µ‚œ1—á. •œ“cŒõ”Ž1, “c‘ºK•ä1, ŒŠª@”Ž2, ƒEƒbƒhƒnƒ€ƒX—æŽq3, “à“c‘׎Š1, ‘å‹v•Û”Ž”V1, “n粏¹•F1 (1ŠO‰È, 2‹~–œ, 3•úŽËü (‰æ‘œ)): ‘æ40‰ñ“ú–{IVRŠw‰ï‘‰ï (2011/5/19), ÂX, IVR 2011; 26 (suppl): 145.

723255. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é“û‚ª‚ñp‘O‰»Šw—Ö@‚ÌŒø‰Ê, Ä”­ˆöŽq‚ÉŠÖ‚·‚錟“¢. ¬â–ùŒ«1, ‰Á“¡@O1, ‹ß“¡NŽj1, ‰|–{‘ñ–Î1, —с@‹žŽq1, åÎ‹I•F1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/5/26-28), “Œ‹ž (ŽãŠJÃ).

723256. [Šw‰ï (ES‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) STEPŽèp‚É‚æ‚èŒoÃ–¬‰h—{‚©‚ç—£’E‚µ‚Š‚œ’Z’°ÇŒóŒQ‚̈ê—á. ”ö‰Ô˜aŽq, ‘å–î’mž, –Ø‘ºŽé—¢, “c’†@Œ‰1 (1ŠO‰È): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/5/26-28), “Œ‹ž (ŽãŠJÃ).

723257. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŠƒ“ƒpŠÇŽî‚ɑ΂·‚鎡—ÂƖâ‘è“_. “c’†@Œ‰1, ‚ˆÀ@”£1, “n粏¹•F1 (1ŠO‰È): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/5/26-28), “Œ‹ž (ŽãŠJÃ).

723258. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒŠƒjƒJƒ‹ƒpƒX‚ð—p‚¢‚œ‘å’°ŠàŽèp‚É‚š‚¯‚é“ü‰@ŠúŠÔ‚̑Ó–«‚ÌŒŸ“¢. ¬‘q’Œl1, ¬–ì—¢q1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/5/26-28), “Œ‹ž (ŽãŠJÃ).

723259. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇGERDÇ—á‚̐H“¹‰^“®‹@”\áŠQ‚Í• o‹Ÿ‰ºŽèp‚É‚æ‚è‰ü‘P‚³‚ê‚é. •Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/5/26-28), “Œ‹ž (ŽãŠJÃ).

723260. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà• –Œ“]ˆÚ‚ɑ΂·‚鎊“KŽ¡—Ö@‚ÌŒŸ“¢. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/5/26-28), “Œ‹ž (ŽãŠJÃ).

723261. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰º‘åÃ–¬ƒtƒBƒ‹ƒ^[‚Ì”²‹Ž‚É“ïa‚µ‚œ2Ç—á. “c‘ºK•ä1, ŒŠª@”Ž2, •œ“cŒõ”Ž1, “à“c‘׎Š1, ƒEƒbƒhƒnƒ€ƒX—æŽq3, ‘å‹v•Û”Ž¢1, “n粏¹•F1 (1ŠO‰È, 2‹~–œ, 3•úŽËü (‰æ‘œ)): ‘æ17‰ñ“ú–{ŒŒŠÇ“àŽ¡—Êw‰ï‘‰ï (2011/6/10), ‰«“ê.

723262. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘OS”x’âŽ~ó‘ԂɊׂÁ‚œ’x”­«‰¡Šu–Œƒwƒ‹ƒjƒA‚Ì1—á. “c’†@Œ‰1, ‚ˆÀ@”£1, â“Œ—R‹I2, ©@L–ç2, ‘剪–ƒ—2, “n粏¹•F1 (1ŠO‰È, 2¬Ž™): ‘æ25‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ï (2011/6/11), “Œ‹ž.

723263. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) o¶‘Of’f‚³‚ê, ¶Œã‹}‘¬‚É‘‘債Kasabach-MerrittÇŒóŒQ‚ð’悵‚œŠÌŒŒŠÇ“à”çŽî: •Û‘¶—Ö@‚ɂďk¬‚µ‚œ1—á. “c’†@Œ‰1, ‚ˆÀ@”£1, “n粏¹•F1, –ì“n³•F2 (1ŠO‰È, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/11), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 478.

723264. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|EXƒ^[) äB‘¹‚Å”­Ç‚µ‚œŒŒ—F•aA‚̐V¶E™—E ‰¡“c˜aŽq1, ‚ˆÀ@”£1, “c’†@Œ‰1, “n粏¹•F1, ‘剪–ƒ—2, ŒÏè‰ëŽq2, –ì“n³•F3, Îˆä³_2 (1ŠO‰È, 2¬Ž™, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/11), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 504.

723265. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚Ì‚š‚¯‚élHãè–å‚ÌŠÇ—‚ƍH•v. ¬‘q’Œl1, ¬–ì—¢q1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2011/7/13), –ŒŒÃ‰®.

723266. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà“¯Žž«ŠÌ“]ˆÚ‚ɑ΂·‚鎡—Ð헪. ²“¡•˜Y1, “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, ‘å–؁@‹Å1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2011/7/14), –ŒŒÃ‰®.

723267. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SŽŸŠ³ŽŸŠ³‡•¹Ç—á‚ɑ΂·‚é• o‹Ÿ‰º‘å’°Øœp‚Ì“K‰ž‚Ƒ΍ô. ¬–ì—¢q1, ’†‘º—²r1, ‘å–؁@‹Å1, ¬‘q’Œl1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2011/7/15), –ŒŒÃ‰®.

723268. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) GERD‚ɑ΂·‚é• o‹Ÿ‰ºŽèp: H“¹‘Ì•”‰^“®‹@”\áŠQ‚Ì—L–³‚É‚æ‚épŽ®‚Ì‘I‘ð. •Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2011/7/15), –ŒŒÃ‰®.

723269. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà• –Œ“]ˆÚÇ—á‚ɑ΂·‚鎡—ÃAƒ‹ƒSƒŠƒYƒ€‚̑Ó–«‚ÌŒŸ“¢. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬–ì—¢q1, ¬‘q’Œl1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2011/7/15), –ŒŒÃ‰®.

723270. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Œ’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚Ì’ZŠú, ’·Šú¬Ñ‚ÌŒŸ“¢. ’†‘º—²r1, ¬–ì—¢q1, ’r“c@“Ä1, ¬‘q’Œl1, “à“¡³‹K1, ²“¡•˜Y1, ‘å–؁@‹Å1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2011/7/13-15), –ŒŒÃ‰®.

723271. [Šw‰ï(‘S‘)] (ˆê”ʍu‰‰) ‹¹•”isH“¹Šà‚ÉDocetaxelECisplatinE5FU•¹—p—Ö@ (DCF—Ö@) ‚ðp‘O/“±“ü‰»Šw—Ö@‚Æ‚µ‚Ä—p‚¢‚œWŠw“IŽ¡—Ã. ª–{¹”V1, •Ð“c‰Ä–ç1, Œ˜“ce—˜2, ŽR‰ºŒpŽj1, ŽÄ“c’q—²1, ŽOd–ì_˜N1, ÷–{Mˆê1, ‹e’rŽj˜Y1, ¬ò˜aŽO˜Y2, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à): EE6‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2011/7/13-15), –ŒŒÃ‰®, ‘æ66‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/7; p.772.

723272. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÇŠïŒ`‚ɑ΂·‚éƒ|ƒŠƒhƒJƒm[ƒ‹‚ð—p‚¢‚œd‰»—Ö@. “c’†@Œ‰1, ‚ˆÀ@”£1, “n粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2011/7/20-22), “Œ‹ž.

723273. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Ž™ŠŠ’E‘lŒaƒwƒ‹ƒjƒA, “Á‚ÉŽq‹{’Eo‚𔺂€Ç—á‚ɂ‚¢‚Ä. ‚ˆÀ@”£1, “c’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2011/7/20-22), “Œ‹ž.

723274. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’mŠo_ŒoŒnCGRP‚Ì’°‰Š‚ɑ΂·‚é•ÛŒìì—p: IBD‚ɑ΂·‚éƒJƒvƒTƒCƒVƒ“Œø‰Ê‚̉”\«. •“cŒ›Žq1, “c’†@Œ‰1, “n粏¹•F1, ”n“ˆ³—²2 (1ŠO‰È, 2–ò—): ‘æ48‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2011/7/20-22), “Œ‹ž.

723275. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • •”‹~‹}f—Âɂš‚¯‚éOncology emergency (¬Ž™, ¬l) ‘å’°Šà‚ÌOncologic Emergency‚ɑ΂·‚éƒAƒ‹ƒSƒŠƒYƒ€‚ÌŒŸ“¢. “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/11-12), •Ÿ‰ª.

723276. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠàŽîᇃ}[ƒJ[‚Æ‚µ‚Ä‚ÌŒŒŽ’†HER2’`”’‘ª’è‚ÌŒŸ“¢. åÎ‹I•F1, ˜m’J”ü“Þ1, ¬â–ùŒ«1, —с@‹žŽq1, ‰|–{‘ñ–Î1, Š“cç”ü”T2, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•a—): ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2011/9/2), å‘ä, ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.274.

723277. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰»Šw—Ö@‚ðŽ{s‚µ‚œtripple negative “ûŠà‚ÌŽ¡—ЬÑ. ¬â–ùŒ«1, Œ‹{—mŽj, —с@‹žŽq1, ‰|–{‘ñ–Î1, ‹ß“¡NŽj1, Š“cç”ü”T2, åÎ‹I•F1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•a—): ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2011/9/2), å‘ä, ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.307.

723278. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚ép‘OŽîᇃ}[ƒJ[’l‚Æ10”N¶‘¶—Š‚ÉŠÖ‚·‚錟“¢. Œ‹{—mŽj1, ¬â–ùŒ«2, —с@‹žŽq2, ‰|–{‘ñ–Î2, Š“cç”ü”T3, åÎ‹I•F2, ‘ •À@Ÿ2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3•a—): ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2011/9/2), å‘ä, ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.318.

723279. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’j«“ûŠàŠ³ŽÒ‚É‚š‚¯‚é•â•—Ö@‚Æ‚µ‚Ä‚ÌAIÜœ‰–—ʂɑ΂·‚é‰e‹¿‚ÌŒŸ“¢. ‰Í–ì—uŽq1, åÎ‹I•F1, ˜m’J”ü“Þ1, ¬â–ùŒ«1, —с@‹žŽq1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2011/9/2), å‘ä, ‘æ19‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.321.

723280. [Šw‰ï(‘S‘)] (ˆê”ʍu‰‰) ’è—ÊRT-PCR–@‚ð—p‚¢‚œCTGF, TFG-ƒÀ”­Œ»ŒŸõ‚É‚æ‚éŠÌüˆÛ‰»•]‰¿‚ÌŽŽ‚Ý. ‘å•”@œ1, ÎˆäŒ’ˆê˜Y2, •Ð‹ËŠ°”V2, “ú‚@‰›3 (1ˆã—Éq¶Šw•”, 2ŠO‰È, 3Á‰»Ší“à): ‘æ18‰ñ“ú–{–å–¬˜ŽiÇŠw‰ï‘‰ï (2011/9/15), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 119.

723281. [Šw‰ï(‘S‘)] (ˆê”ÊŒû‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éT4H“¹Šà‚ɑ΂·‚鎡—Ã. ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, Œ˜“ce—˜2, ª–{¹”V1, ŽÄ“c’q—²1, X’JGŒõ1, ”óŒûŸ•F2, ÷–{Mˆê1, ¬ò˜aŽO˜Y2, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à): ‘æ65‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2011/9/26), å‘ä, ‘æ65‰ñ“ú–{H“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/9; p.215.

723282. [Šw‰ï(‘S‘)] (ˆê”ÊŒû‰‰Eƒ|ƒXƒ^[) cStage II/IIIH“¹Šà‚ɑ΂·‚ép‘O‰»Šw—Ö@DocetaxelECisplatinE5FU•¹—p—Ö@‚Ì•]‰¿. ª–{¹”V1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, Œ˜“ce—˜2, ŽÄ“c’q—²1, ŽOd–ì_˜N1, ÷–{Mˆê1, ”óŒûŸ•F2, “c糁@‘2, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à): ‘æ65‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2011/9/26), å‘ä, ‘æ65‰ñ“ú–{H“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/9; p.334.

723283. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) bó‘B–¢•ª‰»Šà‚ɑ΂µpŒã‰»Šw—Ö@ (weekly PTX) ‚ª‘tŒ÷‚µ‚œˆê—á. ‰|–{‘ñ–Î1, —с@‹žŽq1, ‹e’r^—Žq1, ‰Í–ì—uŽq1, Œ‹{—mŽj, ¬â–ùŒ«1, åÎ‹I•F1, ”Ñ’Ë”ü1, ‹ß“¡NŽj1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ44‰ñ“ú–{bó‘BŠO‰ÈŠw‰ïŠwpW‰ï (2011/10/7), •ÄŽq, ‘æ44‰ñ“ú–{bó‘BŠO‰ÈŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.123.

723284. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒJƒ‰ƒVƒAŽæ‚舵‚¢‹K–ñ (‘æ3”Å) ‚É‚š‚¯‚éŠg’£Œ^•ª—Þ‚Ì–â‘è“_: V‹K–ñ‚ł̉ü’è‚ÉŒü‚¯‚Ä. •Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ53‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2011/10/20), •Ÿ‰ª.

723285. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰º‘åÃ–¬ƒtƒBƒ‹ƒ^[‚Ì”²‹Ž‚É“ïa‚µ‚œ2Ç—á. “c‘ºK•ä1, ŒŠª@”Ž, •œ“cŒõ”Ž1, “à“c‘׎Š1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ‘å‹v•Û”Ž¢1, En粏¹•F1 (1ŠO‰È, 2•úŽËü (‰æ‘œ)): ‘æ52‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (2011/10/20-22), Šò•Œ.

723286. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà“¯Žž«ŠÌ“]ˆÚ‚ɑ΂·‚鎡—Ð헪. ²“¡•˜Y1, “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/27), –ŒŒÃ‰®.

723287. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º¶ŒŸ‚É‚æ‚舫«• –Œ’†”çŽî‚Ɛf’f‚µ‚Š‚œ1—á. ŒŽ“cG‹P1, “à“¡³‹K1, ²“¡•˜Y1, ¬‘q’Œl1, ’r“c@“Ä1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/27), –ŒŒÃ‰®.

723288. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒpƒ`ƒjƒu/ƒJƒyƒVƒ^ƒrƒ“—Ö@‚É‚æ‚è’·Šú‘tŒø‚ð“Ÿ‚ç‚ê‚œ“ûŠà”]“]ˆÚ‚̈ê—á. ‰Í–ì—uŽq1, ¬â–ùŒ«1, ‹e’r^—Žq1, Œ‹{—mŽj, ‹ß“¡NŽj1, —с@‹žŽq1, ‰|–{‘ñ–Î1, åÎ‹I•F1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/27), –ŒŒÃ‰®.

723289. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) L”Í‚ÈDCIS‚𔺂Á‚œ“û‘B‘B—lùN–EŠà‚Ì1—á. ‰¡“c˜aŽq1, åÎ‹I•F1, ‰Í–ì—uŽq1, ‹e’n^—Žq1, ¬â–ùŒ«1, —с@‹žŽq1, ‹ß“¡NŽj1, ‰|–{‘ñ–Î1, Š“cç”ü”T2, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•a—): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/27), –ŒŒÃ‰®.

723290. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠàŠ³ŽÒ‚ɑ΂·‚éTrastuzumab‚Ì’·ŠúŽg—pŒoŒ±. ‘ •À@Ÿ1, åÎ‹I•F1, ¬â–ùŒ«1, —с@‹žŽq1, ‹e’r^—Žq1, ‰Í–ì—uŽq1, ‹ß“¡NŽj1, ‰|–{‘ñ–Î1, “n粏¹•F1 (1ŠO‰È): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/27), –ŒŒÃ‰®.

723291. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‘å’°ŠàŽèp‚É‚š‚¯‚鎩“®–D‡Ší‚ð—p‚¢‚œƒŠƒ“ƒpßŠsŽ‚̑Ó–«‚ÌŒŸ“¢. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, ŒŽ“cG‹P1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®.

723292. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Ž’áo¶‘̏dŽ™‚É‚š‚¯‚é‘lŒaƒwƒ‹ƒjƒA‚ɑ΂·‚錟“¢. ‚ˆÀ@”£1, “c’†@Œ‰1, “n•Ó‰hˆê˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ27‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2011/10/29), ‘åã.

723293. [Šw‰ï(‘S‘)] (ˆê”ÊŒû‰‰)y—v–]‰‰‘èzcStageII/III (cT4‚ðœ‚­) H“¹Šà‚ɑ΂·‚ép‘O‰»Šw—Ö@FP‚š‚æ‚ÑDCF—Ö@‚Ì•]‰¿. ª–{¹”V1, •Ð“c‰Ä–ç1, Œ˜“ce—˜2, ŽR‰ºŒpŽj1, ŽÄ“c’q—²1, ŽOd–ì_˜N1, ÷–{Mˆê1, ”óŒûŸ•F2, “c糁@‘2, ¬ò˜aŽO˜Y2, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à): ‘æ73‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2011/11/17), “Œ‹ž, “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2011/10; 72 (‘Š§): 522.

723294. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°ŠàŠÌ“]ˆÚ‚ÌŽ¡—Ð헪. ¬‘q’Œl1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ66‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2011/11/25), “Œ‹ž.

723295. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºSóŒ‹’°E’Œ’°Žèp‚É‚š‚¯‚é’°ŠÇØ—£‚̍H•v. ¬‘q’Œl1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ24‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2011/12/8), ‘åã.

723296. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‘å’°ŠàŽèp‚É‚š‚¯‚鎩“®–D‡Ší‚ð—p‚¢‚œ‚ˆÊŒ‹ãF‚É‚æ‚郊ƒ“ƒpßŠsŽ. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ24‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2011/12/8), ‘åã.

723297. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚ɑ΂·‚é• o‹ŸŽèp‚Ì•Ï‘J‚ƏpŒã¬Ñ. ’r“c@“Ä1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, ¬‘q’Œl1, “à“¡³‹K1, ¬àV•œ‘Ÿ1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ24‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2011/12/9), ‘åã.

723298. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º’Œ’°Øœ‚É‚š‚¯‚éŽèp¢“ï—á. ŽO‰YŒ[Žõ1, ’†‘º—²r1, “›ˆä“ÖŽq1, ¬‘q’Œl1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ24‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2011/12/7-9), ‘åã.

723299. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHãè–å‘¢ÝŒã‚ÉARDS‚𕹔­‚µ‚œ‘å’°ŠàƒCƒŒƒEƒX‚Ì1—á. ”óŒû@Ši1, “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, –{“c@•ü1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2012/3/14), ‹à‘ò.

723300. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°ŠàpŒã‚É’°•ÂÇ‚ð‚«‚œ‚µ‚œ’°ŠÇ–ŒŽ‰–bD‰Š‚Ì1—á. –{“c@•ü1, “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, ”óŒû@Ši1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2012/3/14), ‹à‘ò.

723301. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°ŠàƒCƒŒƒEƒX‚ɑ΂·‚鎡—ÃAƒ‹ƒSƒŠƒYƒ€‚̍쐬. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2012/3/15), ‹à‘ò.

731076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •a‘Ô‚©‚çl‚Š‚éGERD‚ÌŽ¡—Ã: Å‹ß‚̘b‘è‚ðŠÜ‚ß‚Ä. •Ð“c‰Ä–ç (ŠO‰È): ‘Š–ÍŒŽÁ‰»Šíƒ~[ƒeƒBƒ“ƒO (2011/9/12), ‘Š–ÍŒŽ.

731077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) GERD, ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚é“àŽ‹‹ŸŽèp|“K‰ž‚ÆŽèpŽè‹Z‚̃|ƒCƒ“ƒg|. •Ð“c‰Ä–ç (ŠO‰È): ‘æ1‰ñ_“ސìã•”Á‰»ŠÇ“àŽ‹‹ŸŠO‰ÈŒ€‹†‰ï (2011/11/4), ‰¡•l.

731078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) š‹‰ºáŠQ‚ð‚«‚œ‚·•a‘Ô‚ÆŽŸŠ³‚̍l‚Š•û. •Ð“c‰Ä–ç (ŠO‰È): ‘æ4‰ñ‘啪ƒvƒ‰ƒCƒ}ƒŠEƒPƒA“¹ê (2012/1/19), ‘啪.

732030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ˆÀ‘SŠmŽÀ‚È‹¹o‹Ÿ‰ºH“¹ŠàŽèp‚ð–ÚŽw‚µ‚ā|‘€‰çˆÊ‚ł̍H•v‚Æ‚»‚Ì—L—p«|. •Ð“c‰Ä–ç1, ª–{¹”V1, ŽÄ“c’q—²1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ40‰ñ_“ސ쌧Á‰»ŠíŠO‰ÈŒ€‹†‰ï (2011/6/4), ‰¡•l.

733119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äB‘¹‚Å”­Ç‚µ‚œŒŒ—F•aA‚̐V¶Ž™—á. ‰¡“c˜aŽq1, ‘剪–ƒ—2, ŒÏè‰ëŽq2, –ì“n³•F3, Îˆä³_2, ‚ˆÀ@”£1, “c’†@Œ‰1, “n粏¹•F1 (1ŠO‰È, 2¬Ž™, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ24‰ñ“ú–{¬Ž™äB‘ŸŒ€‹†‰ï (2011/5/14), b•{.

733120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰»Šw—Ö@’†‚É‘‘債‚œtriple negative‚Ì‹‘å•›“ûŠà‚Ì1—á. —с@‹žŽq1, ¬â–ùŒ«1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ‹ß“¡NŽj1, Š“cç”ü”T2, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•a—): ‘æ33‰ñ“ú–{Šà‹ÇŠ—Ö@Œ€‹†‰ï (2011/6/10), ‘åã.

733121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ªŽ¡‚ð–ÚŽw‚µ‚œ• o‹ŸŽèp. ’r“c@“Ä (ŠO‰È): ‘æ48‰ñ_“ސì‘å’°ŽŸŠ³Œ€‹†‰ï (2011/6/16), _“ސì.

733122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚Ì’Œ’°Ø—£–@‚̍H•v. ¬‘q’Œl1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ40‰ñ_“ސìÁ‰»ŠíŠO‰ÈŒ€‹†‰ï (2011/6), ‰¡•l.

733123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆêEʍu‰‰Eƒ|ƒXƒ^[) ‘å—ʉºŒŒ‚É‚æ‚è‘å’°ˆŸ‘S“E‚ð—]‹V‚È‚­‚³‚ê‚œWiskott-AldrichÇŒóŒQ‚Ì“ûŽ™—á. ‚ˆÀ@”£1, “c’†@Œ‰1, “n粏¹•F1 (1ŠO‰È): ‘æ38‰ñ“ú–{¬Ž™“àŽ‹‹ŸŒ€‹†‰ï (2011/7/2), Œyˆä‘ò.

733124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒŠÇŠïŒ`‚ɑ΂·‚éƒ|ƒŠƒhƒJƒm[ƒ‹‚ð—p‚¢‚œd‰»—Ö@. “c’†@Œ‰1, ‚ˆÀ@”£1, “n•Ó‰hˆê˜Y1, ŒŽ“cG‹P1, “n粏¹•F1 (1ŠO‰È): ‘æ55‰ñ_“ސ쏬Ž™Žîᇌ€‹†‰ï (2011/9/10), ‰¡•l.

733125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘OŽ¡—Â̂Ȃ¢“ûŠàŽèpÇ—á‚Ì10”N¶‘¶—Š‚Əp‘OŽîᇃ}[ƒJ[‚ÌŒŸ“¢. Œ‹{—mŽj, ŽR‰ºŒpŽj1, ¬â–ùŒ«1, ‰Á“¡@O1, Š“cç”ü”T2, —с@‹žŽq1, ‰|–{‘ñ–Î1, åÎ‹I•F1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•a—): ‘æ31‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ€‹†‰ï (2011/10/2), –ŒŒÃ‰®.

733126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) TAE (transcatheter arterial embolization) ‚É‚Ä‹~–œ‚µ‚Š‚œoŒŒ«ƒVƒ‡ƒbƒN‚ɊׂÁ‚œˆÝ\“ñŽw’°‰Œ«“®–¬áŽ”j—ô‚É‹Nˆö‚µ‚œ\“ñŽw’°’×ᇏoŒŒ‚Ì1—cŽ™—á. “n•Ó‰hˆê˜Y1, “c’†@Œ‰1, ‚ˆÀ@”£1, ŒŽ“cG‹P1, “n粏¹•F1, ’†”š–퐶2, ‹àŽq’‰O3, ]”gŒËF•ã2 (1ŠO‰È, 2¬Ž™, 3‹~–œ): ‘æ46‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/10/8), ‘O‹Ž.

733127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú—î6‚ɋ󒰐úE‚ð‚«‚œ‚µ, ‚»‚ÌŒãHirschspring•a‚Ɛf’f‚³‚ê‚œ1—á. ŒŽ“cG‹P1, “c’†@Œ‰1, ‚ˆÀ@”£1, “n•Ó‰hˆê˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ46‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/10/8), ‘O‹Ž.

733128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ç—ጟ“¢. •Ð“c‰Ä–ç (ŠO‰È): ‘æ4‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïH“¹¢“ïÇ—ጟ“¢‰ï (2011/10/10), –ŒŒÃ‰®.

733129. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‘å’°Øœp‚ÌŒ»ó‚Ɛ¬Ñ. ¬–ì—¢q1, ¬–ìè’q”V1, ˜a“c@Ž¡1, ‹v•Û”CŽj1, “ñ“nM]1, ‹ß“¡NŽj1, ‚‹Ž’õl1 (1ŠO‰È): ‘æ23‰ñ–k‘«—§ŒSŽsˆãŽt‰ïˆãŠw‰ï (2011/10/22), é‹Ê.

733130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ùN–E«—‘‘ƒŽîᇓEoŽž‚̍H•v|•¢•zÚ’…‚É‚æ‚é“à—e‰t‚Ì• o“à˜Ro‚Ì–hŽ~|. “n•Ó‰hˆê˜Y1, “c’†@Œ‰1, ‚ˆÀ@”£1, ŒŽ“cG‹P1, “n粏¹•F1 (1ŠO‰È): ‘æ31‰ñ“ú–{¬Ž™“àŽ‹‹ŸŠO‰ÈEŽèpŽè‹ZŒ€‹†‰ï (2011/10/28), ‘åã.

733131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}«ã’°ŠÔ–Œ“®–¬•ÂÇÇ‚ɑ΂·‚éCDT‚Ì1EE “ì’JØ•äŽq1, ‹‹vGŽ÷1, ‘å‹v•Û”Ž¢1, “à“c‘׎Š1, “c‘ºK•ä1, •œ“cŒõ”Ž1, “n粏¹•F1 (1ŠO‰È): ‘æ19‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/11/5), ìè.

733132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŽõ«‘å‘Ú“®–¬áŽ‚̈ê—á. •œ“cŒõ”Ž1, “ì’JØ•äŽq1, ‘å‹v•Û”Ž¢1, “à“c‘׎Š1, “c‘ºK•ä1, “n粏¹•F1 (1ŠO‰È): ‘æ150‰ñŒŒŠÇŠO‰ÈÇ—ጟ“¢‰ï (2011/12/10), “Œ‹ž.

733133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Ž™ŠŠ’E‘lŒaƒwƒ‹ƒjƒA, “Á‚ÉŽq‹{’Eo‚𔺂€Ç—á‚ɂ‚¢‚Ä. ‚ˆÀ@”£1, “c’†@Œ‰1, “n•Ó‰hˆê˜Y1, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È): ‘æ3‰ñ_“ސìƒwƒ‹ƒjƒAŒ€‹†‰ï (2011/12/10), ‰¡•l.

733134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‘å’°Øœp‚Å‚Ì”—£‚Ɛؗ£‘€ì. ’r“c@“Ä1, ²“¡•˜Y1, ¬‘q’Œl1, “à“¡³‹K1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ12‰ñ_“ސì‘å’°ŽŸŠ³• o‹Ÿ‰ºŽèpƒZƒ~ƒi[ (2011/5/26), ‰¡•l.

733135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà• –Œ“]ˆÚÇ—á‚É‚š‚¯‚鎡—ЬÑ‚ÌŒŸ“¢|‘Ó–‚ÈŽ¡—Ð헪‚ÌŠm—§‚ð–ÚŽw‚µ‚ā|. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ76‰ñ‘å’°ŠàŒ€‹†‰ï (2012/1/20), ‰F“s‹{.

733136. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MMIHS (Megacystis Microcolon Intestinal Hypoperistalsis Syndrome) ‚̈ê—á. ‚ˆÀ@”£1, “c’†@Œ‰1, “n•Ó‰hˆê˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ42‰ñ“ú–{¬Ž™Á‰»ŠÇ‹@”\Œ€‹†‰ï (2012/2/18), Ž­Ž™“‡.

733137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ùN–E«—‘‘ƒŽîᇓEoŽž‚̍H•v|•¢•zÚ’…‚É‚æ‚é“à—e‰t‚Ì• o“à˜Ro‚Ì–hŽ~|. “n•Ó‰hˆê˜Y1, “c’†@Œ‰1, ‚ˆÀ@”£1, “n粏¹•F1 (1ŠO‰È): ‘æ56‰ñ_“ސ쏬Ž™Žîᇌ€‹†‰ï (2012/3/10), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-522001. [uÀ]y“ÁW: ˆâ“`«‘å’°Šàz3. ‰Æ‘°«‘å’°Šàƒ|ƒŠƒ|[ƒVƒX. ¬‘q’Œl1, ²“¡•˜Y1, ’r“c@“Ä1, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): BIO Clinica 2010/1; 2010”N1ŒŽ†: 25-9.

H22-522008. [uÀ]y“ÁW: ‰º•”’Œ’°‚ª‚ñŽèp; p‘O‰»Šw•úŽËü—Ö@‚Æãè–å‹@”\zp‘O‰»Šw•úŽËü—Ö@‚ŋǏŠEœ”Õ“àÄ”­‚Í0%‚ɏo—ˆ‚é‚©? ²“¡•˜Y1, “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, ’†‘º—²r1, ¬–ì—¢q1, ŽO‰YŒ[Žõ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): Šà‚̗Տ° 2010/8; 56 (8): 591-5.

H22-522009. [uÀ]yƒVƒŠ[ƒY|ŠŽõÇ‚ÆŠà (5)z‘å’°Šà‚ÆŠŽõ. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ƒRƒ“ƒZƒ“ƒTƒXŠàŽ¡—à 2011/2; 10 (1): 48-50.


S‘ŸŒŒŠÇŠO‰ÈŠw

[Šwp˜_•¶]

110139. [ŒŽ’˜] Successful treatment of pediatric endocarditis and pericarditis due to MRSA with linezolid. Miyamoto T1, Tomoyasu T2, Miyaji K3: Jpn J Antibiot 2011/4; 64 (2): 109-12. (‹{–{—²Ž©1, —F•Û‹M”Ž2, ‹{’n@ŠÓ3: 1ŒQ”nŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[, 2‹~–œ, 3S‘ŸŒŒŠÇŠO)

110140. [ŒŽ’˜] Half-turned truncal switch operation for transposition of great arteries with ventricular septal defect and pulmonary regurgitation. Miyaji K1, Itatani K, Inoue N1, Ishii M2: Interact Cardiovasc Thorac Surg 2011/4; 13 (2): 217-9. (‹{’n@ŠÓ1, ”Â’JŒcˆê, ˆäãMK1, Îˆä³_2: 1S‘ŸŒŒŠÇŠO, 2¬Ž™)

110141. [ŒŽ’˜] For what type of constrictive pericarditis is the waffle procedure effective? Yamamoto N1, Ohara K1, Nie M2, Torii S2, Inoue N2, Miyaji K2: Asian Cardiovasc Thorac Ann 2011/4; 19 (2): 115-8. (¬ŒŽ–M‹`1, æс@³Šî2, ’¹ˆäWŽO2, ˆäãMK2, ‹{’n@ŠÓ2: 1ŠC˜V–Œ‘‡•a‰@, 2S‘ŸŒŒŠÇŠO)

110142. [ŒŽ’˜] The lower limit of the pulmonary artery index for the extracardiac Fontan circulation. Itatani K, Miyaji K1, Nakahata Y2, Ohara K3, Takamoto S4, Ishii M2: J Thorac Cardiovasc Surg 2011/7; 142 (1): 127-35. (”Â’JŒcˆê, ‹{’n@ŠÓ1, ’†”š–퐶2, ¬ŒŽ–M‹`3, Îˆä³_2: 1S‘ŸŒŒŠÇŠO, 2¬Ž™, 3ŠC˜V–Œ‘‡•a‰@, 4“Œ‹ž‘åŠwS‘ŸŠO‰È)

110143. [ŒŽ’˜] Long term results with the Cabrol aortic root replacement. Kitamura T1, Kigawa I, Fukuda S, Miyairi T, Takamoto S: Int Heart J 2011/7; 52 (4): 229-32. (–k‘º@—¥1: 1S‘ŸŒŒŠÇŠO)

110144. [ŒŽ’˜] Influence of surgical arch reconstruction methods on single ventricle workload in the Norwood procedure. Itatani K, Miyaji K1, Qian Y, Liu JL, Miyakoshi T, Murakami A, Ono M, Umezu M: J Thorac Cardiovasc Surg 2012/7; 144 (1): 130-8. (‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

110145. [ŒŽ’˜] The effectiveness of high-flow regional cerebral perfusion in Norwood stage I palliation. Miyaji K1, Miyamoto T2, Kohira S3, Yoshii T1, Itatani K, Sato H4, Inoue N1: Eur J Cardiothorac Surg 2011/11; 40 (5): 1215-20. (‹{’n@ŠÓ1, ‹{–{—²Ž©2, ŒÃ•œ@‘3, ‹gˆä@„1, ”Â’JŒcˆê, ˆäãMK1: 1S‘ŸŒŒŠÇŠO, 2ŒQ”nŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[, 3MEƒZEŒŒ‰tò‰»ƒZ, 4“Œ‹ž‘åŠwŒöO‰q¶Šw)

310010. [Ç—á•ñ] Repeated mitral valve replacement in a patient with extensive annular calcification. Kitamura T1, Fukuda S, Sawada T, Miura S, Kigawa I, Miyairi T: J Cardiothorac Surg 2011/11; 6 (11): 149. (–k‘º@—¥1: 1S‘ŸŒŒŠÇŠO)

310011. [Ç—á•ñ] Vascular antispastic medication should take priority over other antihypertensives after coronary artery bypass grafting using a radial artery conduit. Kitamura T1, Motomura N, Higashikuni Y, Ono M: Interact Cardiovasc Thorac Surg 2011/12; 13 (6): 679-81. (–k‘º@—¥1: 1S‘ŸŒŒŠÇŠO)

520032. [‘à] æ“V«SŽŸŠ³‚É‚š‚¯‚é’áNPŠO‰ÈŽ¡—Â̌»‹µ. ‹{’n@ŠÓ (S‘ŸŒŒŠÇŠO): “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2011/12; 27 (6): 257-61.

522088. [uÀ]y“ÁW: ‹¹•”ŠO‰Èf—Âɖ𗧂ŽŸŠ³•ÊÅVƒf[ƒ^zI. S‘ŸŒŒŠÇ—̈æ@12. ’Z—‚Ì‚ ‚é”ñƒ`ƒAƒm[ƒ[«SŽŸŠ³. ‹{’n@ŠÓ (S‘ŸŒŒŠÇŠO): ‹¹•”ŠO‰È 2011/7; 64 (8): 679-84.

[’˜@‘]

620095. [Šwp‘] (•ª’SŽ·•M)yNEWŠO‰ÈŠw@‰ü’ù‘æ3”Łz[Še˜_] ‘æ8Í S‘Ÿ@A. æ“V«SŽŸŠ³@IV. ‰ESŽº—¬o˜H‚Ì‹·ó, V. ‘匌ŠÇ‚Ì“]ˆÊ, VI. –[Žº•Ù‚ÌŠïŒ`, p.448-62. ‹{’n@ŠÓ (S‘ŸŒŒŠÇŠO), •Ò: oŒŽN•v, ŒÃ£@², ™’¬Œ\‘ , “ì]“°, “Œ‹ž, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713080. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Increased Systemic Cardiac Output Improves Arterial Oxygen Saturation in Bidirectional Cavopulmonary Shunt. Oka N1, Miyaji K1, Miyamoto T1, Yoshii T1, Inoue N1: The 48th Annual Meeting of Society of Thoracic Surgeons (STS) (2012/1/30-2.1), ƒtƒƒŠƒ_. (‰ª@“¿•F1, ‹{’n@ŠÓ1, ‹{–{—²Ži1, ‹gˆä@„1, ˆäãMK1: 1S‘ŸŒŒŠÇŠO)

713081. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Moderate prosthesis-patient mismatch may be negligible in elderly patients undergoing conventional aortic valve replacement for aortic stenosis. Kitamura T1, Torii S1, Shibata K1, Oka N1, Inoue N1, Tomoyasu T2, Yoshii T1, Sakaki K1, Fukunishi T1, Miyaji K1: The 20th Annual Meeting of Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2012/3/8-11), ƒoƒŠ. (–k‘º@—¥1, ’¹ˆäWŽO1, ŽÄ“c@u1, ‰ª@“¿•F1, ˆäãMK1, —F•Û‹M”Ž2, ‹gˆä@„1, åŒ’Ži˜N1, •ŸŒ‘ô^1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2‹~–œ)

723302. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) æ“V«SŽŸŠ³‚ɍ‡•¹‚µ‚œ¬lŠŽõ«S“à–Œ‰ŠÇ—á‚ÌŒŸ“¢. ’¹ˆäW‘¢1, ‹{’n@ŠÓ1, {“¡‹±ˆê1, ŽÄ“c@u1, ˆäãMK1, “c‘º’q‹I1, ‹gˆä@„1, —F•Û‹M”Ž2, ùŒŽ‘–L1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (Žã”­•\), “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2011/5; 112 (—Õ‘1-2 ): 705.

723303. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‚̐æ“V«SŽŸŠ³‚ÌŠJSppŒã‚É‚š‚¯‚éŽèpŽº”²ŠÇ‚ÌŒŸ“¢. ùŒŽ‘–L1, ‹{’n@ŠÓ1, ‹gˆä@„1, —F•Û‹M”Ž2, “c‘º’q‹I1, ˆäãMK1, ŽÄ“c@u1, {“¡‹±ˆê1, ’¹ˆäWŽO1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (Žã”­•\), “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2011/5; 112 (—Õ‘1-2 ): 417.

723304. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘å“®–¬ŠïŒ`‚𔺂€•¡ŽGSŠïŒ`‚ÌŠO‰ÈŽ¡—Ã: “–‰@‚É‚š‚¯‚é’áŒ`¬‘å“®–¬‹|‚𔺂€¬Ž™æ“V«SŽŸŠ³‚Ì‘å“®–¬ÄŒšpŽ®‚ƍċ·ó—Š‚ÌŒŸ“¢. ‹gˆä@„1, ‹{’n@ŠÓ1, “c‘º’q‹I1, ùŒŽ‘–L1, ˆäãMK1, ŽÄ“c@u1, ’¹ˆäW‘¢1 (1S‘ŸŒŒŠÇŠO): ‘æ47‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (2011/7/8), •Ÿ‰ª, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2011/7; 27 (Suppl): 121.

723305. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V¶Ž™ŠJSpŒã“«“ûâô˜R‚ɑ΂·‚é‘æ13ˆöŽq•â[—Ö@‚Ì—LŒø«. “c‘º’q‹I1, ‹gˆä@„1, ’¹ˆäWŽO1, ŽÄ“c@u1, ˆäãMK1, ùŒŽ‘–L1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ47‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (2011/7/8), •Ÿ‰ª, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2011/7; 27 (Suppl): 222.

723306. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) æ“V«SŽŸŠ³‚É‚š‚¯‚é’áNPŠO‰ÈŽ¡—Â̌»‹µ. ‹{’n@ŠÓ (S‘ŸŒŒŠÇŠO): ‘æ47‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (2011/7/8), •Ÿ‰ª, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2011/8; 27 (6): 257-61.

723307. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) A Case of Implantation of ICD over 30 Years after CABG for Coronary Arterial Lesions Due to Kawasaki Disease. ’¹ˆäW‘¢1, ‹{’n@ŠÓ1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, ‹ŽìGŽ÷1, ‰ª@“¿•F1,‹gˆä@„1, •ŸŒ‘ô^1 (1S‘ŸŒŒŠÇŠO): ‘æ26‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ï (2011/9/19), •Ÿ‰ª, Journal of Arrhythmia 2011/9; 27 (suppl): 232.

723308. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) æ“V«SŽŸŠ³‚ɍ‡•¹‚µ‚œ¬lŠŽõ«S“à–Œ‰ŠÇ—á‚ÌŒŸ“¢. ’¹ˆäW‘¢1, ‹{’n@ŠÓ1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, ‹ŽìGŽ÷1, ‰ª@“¿•F1, ‹gˆä@„1, •ŸŒ‘ô^1 (1S‘ŸŒŒŠÇŠO): ‘æ64‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï (2011/10/10), –ŒŒÃ‰®, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ 2011/10; 59 (suppl): 282.

723309. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V¶Ž™ŠúNorwoodŒ^Žèp¬Ñ‚ÌŒŸ“¢|High riskÇ—á‚Ö‚Ì—LŒø«|. ‹{’n@ŠÓ1, ‰ª@“¿•F1, ‹gˆä@„1, •ŸŒ‘ô^1, ’¹ˆäW‘¢1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, ‹ŽìGŽ÷1, ‹{–{—²Ži1,2 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–Œ‘‡•a‰@): ‘æ64‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï (2011/10/12), –ŒŒÃ‰®, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ 2011/10; 59 (suppl): 392.

723310. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Polyetrafluoroethylene 1•Ù•t‚«ƒpƒbƒ`‚ð—p‚¢‚œ‰EŽº—¬o˜HÄŒšpŒã’†Šú‰“Šu¬Ñ‚ÌŒŸ“¢. ‹gˆä@„1, ‰ª@“¿•F1, •ŸŒ‘ô^1, ’¹ˆäW‘¢1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, ‹ŽìGŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ64‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï (2011/10/12), –ŒŒÃ‰®, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ 2011/10; 59 (suppl): 426.

723311. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž©ŒÈ‘gD‚Å‘å“®–¬‹|ÄŒš‚µ‚œNorwoodŽèp‚É‚š‚¯‚闝‘z“I‚È‘å“®–¬‹|Œ`‘Ô‚ÌŒŸ“¢. ”Â’JŒcˆê1, ‹{’n@ŠÓ1, ‘K@@ˆí2, —«@‹à—Ž3, ‹{èãĕœ3, ‰ª@“¿•F1, ‹gˆä@„1, ˆäãMK1, —F•Û‹M”Ž4, •ŸŒ‘ô^1, ”~’ÃŒõ¶3 (1S‘ŸŒŒŠÇŠO, 2‘ˆî“c‘åŠw¶–œˆã—ÍHŠwŒ€‹†Š, 3‘ˆî“c‘åŠw‘n‘¢—HŠw•”‹@ŠBHŠw‰È, 4‹~–œ): ‘æ64‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï (2011/10/12), –ŒŒÃ‰®, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ 2011/10; 59 (suppl): 405

723312. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‚̐æ“V«SŽŸŠ³‚ÌŠJSpŒã‚É‚š‚¯‚éŽèpŽº”²ŠÇ‚ÌŒŸ“¢. •ŸŒ‘ô^1, ‰ª@“¿•F1, ‹gˆä@„1, ’¹ˆäW‘¢1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, ‹ŽìGŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ64‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï (2011/10/12), –ŒŒÃ‰®, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ 2011/10; 59 (suppl): 432.

723313. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘å“®–¬•Ù’uŠ·pEã‚É‘å“®–¬‰ð—£‚𔭏ǂµ‚œ‘å“®–¬“ñë•ÙÇ—áĚŸ“¢. ’¹ˆäW‘¢1, ‹{’n@ŠÓ1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, ‹ŽìGŽ÷1, ‰ª@“¿•F1, ‹gˆä@„1, •ŸŒ‘ô^1 (1S‘ŸŒŒŠÇŠO): ‘æ52‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (2011/10/20-22), Šò•Œ, –¬ŠÇŠw 2011/9; 51 (Suppl): s107-8.

723314. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Sivelestat Attenuates Postoperative Inflammatory Response in Neonate and Early Infant Open Heart Surgery. ˆäãMK1, ‰ª@“¿•F1, ‹gˆä@„1, ‹ŽìGŽ÷1, ’¹ˆäWŽO1, ŽÄ“c@u1, –k‘º@—¥1, •ŸŒ‘ô^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/17), •Ÿ‰ª, Circulation Journal 2012/3; 76 (Suppl): 482.

733138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) IŒ^VSD‚ð”wŒi‚É”­Ç‚µ‚œ3 •Ù‚É‹y‚ÔŠŽõ«S“à–Œ‰Š‚ɑ΂µ‚Ä•Ù‰·‘¶Žèp‚ðŽ{s‚µ“Ÿ‚œ1—á. ŽÄ“c@u1, ’¹ˆäWŽO1, ˆäãMK1, ùŒŽ‘–L1, ‹gˆä@„1, “c‘º’q‹I1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ156‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/6/4), “Œ‹ž, ‘æ156‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2011/6; p.7.

733139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠŽõ«S“à–Œ‰Š‚É‚æ‚蓱ŠÇE¶”x“®–¬ŒŒð•ÂÇ‚ð‚«‚œ‚µ‚œFontanpŒã‚̈ê—á. ‹gˆä@„1, “c‘º’q‹I1, ùŒŽ‘–L1, ˆäãMK1, ŽÄ“c@u1, ’¹ˆäW‘¢1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ156‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/6/4), “Œ‹ž, ‘æ156‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2011/6; p.14.

733140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) pŒã“Ž’²—¥‚É•œ‹A‚µ‚œ–«S–[×“®‡•¹‚Ì‹‘卶–[”S‰tŽî‚̈ê—á. ˆäãMK1, ’¹ˆäW‘¢1, ‹ŽìGŽ÷1, –k‘º@—¥1, ŽÄ“c@u1, •ŸŒ‘ô^1, ‹gˆä@„1, ‰ª@“¿•F1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ157‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/11/12), “Œ‹ž, ‘æ157‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2011/11; p.10.

733141 [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žå—v‘Ì”x“®–¬‘€•›ŒŒs‚ð‡•¹‚µ‚œ–³äBÇ, ‰EŽº«’PSŽºÇ—á‚ɑ΂µFontanŽèp‚ðŽ{s‚µ‚œˆê—á. •ŸŒ‘ô^1, ‰ª@“¿•F1, ‹gˆä@„1, ’¹ˆäW‘¢1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, ‹ŽìGŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ157‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/11/12), “Œ‹ž, ‘æ157‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2011/11; p.14.

733142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Eê”ʍu‰‰) NorwoodŽèp‚É‚š‚¯‚é‘å“®–¬ÄŒšpE®‚̍H•v|—¬‘̃Vƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚æ‚錟“¢|. ‹{’n@ŠÓ (S‘ŸŒŒŠÇŠO): ‘æ23‰ñŠÖ“ŒS‘ŸŠO‰ÈŽèpŽè‹ZŒ€‹†‰ï (2011/11/19), “Œ‹ž.

733143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’iŠK“IC•œp‚ðs‚Á‚œ‘“®–¬ŠÇÇ‚Ì1—á. åŒ’Ži˜N1, ‹gˆä@„1, ‰ª@“¿•F1, ’¹ˆäW‘¢1, ŽÄ“c@u1, –k‘º@—¥1, ˆäãMK1, •ŸŒ‘ô–1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ158‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2012/3/3), “Œ‹ž, ‘æ158‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2012/3; p.12.

733144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘m–[•Ù’uŠ·pŒã‚Ì•Ù—Ö•””^ᇂɑ΂µ‹S–Œ‚ð—p‚¢‚œ•Ù—֍Čš‚ƍĕْuŠ·‚ðŽ{s‚µ‚œ1—á. •ŸŒ‘ô^1, ˆäãMK1, –k‘º@—¥1, ŽÄ“c@u1, ’¹ˆäW‘¢1, åŒ’Ži˜N1, ‹gˆä@„1, ‰ª@“¿•F1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ158‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2012/3/3), “Œ‹ž, ‘æ158‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2012/3; p.16.

733145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) S–[’†ŠuŒ‡‘¹ÇŽèpŒã‚ÉŽûk«S–Œ‰Š‚ð‚«‚œ‚µ‚œˆê—á. “üàV—F•ã1,2, ŽR–{Ms1, ˆäã’“¹1, æс@³Šî1,2, ¬ŒŽ–M‹`1, ‹{’n@ŠÓ2 (1ŠC˜V–Œ‘‡•a‰@, 2S‘ŸŒŒŠÇŠO): ‘æ158‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2012/3/3), “Œ‹ž, ‘æ158‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2012/3; p.21.


ŒÄ‹zŠíŠO‰ÈŠw

[Šwp˜_•¶]

110146. [ŒŽ’˜] Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. Sarkaria IS, Iyoda A1, Roh MS, Sica G, Kuk D, Sima CS, Pietanza MC, Park BJ, Travis WD, Rusch VW: Ann Thorac Surg 2011/10; 92 (4): 1180-6. (ˆÉ˜¬“c–Ÿ1: 1ŒÄ‹zŠíŠO)

110147. [ŒŽ’˜] Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma. Iyoda A1, Travis WD, Sarkaria IS, Jiang SX2, Amano H3, Sato Y, Saegusa M2, Rusch VW, Satoh Y1: Exp Ther Med 2011/11; 2 (6): 1041-5. (ˆÉ˜¬“c–Ÿ1, Ó@¢ˆ®2, “V–ì‰pŽ÷3, ŽOŽ}@M2, ²“¡”Vr1: 1ŒÄ‹zŠíŠO, 2•a—, 3—Տ°Œ€‹†E‘n–òƒV[ƒY)

110148. [ŒŽ’˜] Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung disease. Iyoda A1, Jiang SX2, Amano H3, Ogawa F, Matsui Y, Kurouzu N1, Hara H, Nezu K, Mikami T2, Saegusa M2, Satoh Y1: Exp Ther Med 2011/11; 2 (6): 1073-6. (ˆÉ˜¬“c–Ÿ1, Ó@¢ˆ®2, “V–ì‰pŽ÷3, ‹v˜Y’Ï®”ü1, ŽOã“N•v2, ŽOŽ}@M2, ²“¡”Vr1: 1ŒÄ‹zŠíŠO, 2•a—, 3—Տ°Œ€‹†E‘n–òƒV[ƒY)

110149. [ŒŽ’˜] Clinicopathological findings of non-small-cell lung cancer with high serum progastrin- releasing peptide concentrations. Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Yanagitani N, Hoshi R, Satoh Y1, Motoi N, Hamanaka W, Ishikawa Y, Mun M, Sakao Y, Okumura S, Nakagawa K, Horai T, Nishio M: Lung Cancer 2011/12; 74 (3): 401-4. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

110150. [ŒŽ’˜] The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung. Nasgashio R, Sato Y, Matsumoto T, Kageyama T, Hattori M, Iyoda A1, Satoh Y1, Ryuge S2, Masuda N2, Jiang SX3, Saegusa M3: Lung Cancer 2011/12; 74 (3): 405-10. (ˆÉ˜¬“c–Ÿ1, ²“¡”Vr1, —Ž‰ØTˆê˜Y2, ‰v“c“TK2, Ó@¢ˆ®3, ŽOŽ}@M3: 1ŒÄ‹zŠíŠO, 2ŒÄ‹zŠí“à, 3•a—)

110151. [ŒŽ’˜] RET, ROS1 and ALK fusions in lung cancer. Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y1, Okumura S, Nakagawa K, Mano H, Ishikawa Y: Nat Med 2012/3; 18 (3): 378-81. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

110152. [ŒŽ’˜] Role of thromboxane A2 in enhancement of lung metastasis through the increased adhesion of platelets to tumor cells in mice. Matsui Y1, Amano H2, Ito Y3, Eshima K4, Kato S3, Ogawa F1, Iyoda A5, Narumiya S, Satoh Y5, Majima M6: Kitasato Med J 2012/3; 42 (1): 39-50. (ŒˆäŒ[•v1, “V–ì‰pŽ÷2, ˆÉ“¡‹`–ç3, ]“‡k“ñ4, ‰Á“¡L‘Ÿ˜Y3, ¬ìŽj—m1, ˆÉ˜¬“c–Ÿ5, ²“¡”Vr5, ”n“ˆ³—²6: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2—Տ°Œ€‹†E‘n–òƒV[ƒY, 3ŠO‰È, 4–Ɖu, 5ŒÄ‹zŠíŠO, 6–ò—)

120016. [ŒŽ’˜] ŒŽ”­«”xŠàŽèpŠ³ŽÒ‚̏pŒã•p–¬«•s®–¬‚̑΂·‚鉖Ž_ƒ‰ƒ“ƒWƒIƒ[ƒ‹‚Ì—}§Œø‰Ê‚ÌŒŸ“¢. ª’ÃŒ«Ži1, ¬ìŽj—m, ŒˆäŒ[•v, “V–ì‰pŽ÷2, ŒŽ@‰p‘¥, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2—Տ°Œ€‹†E‘n–òƒV[ƒY): “ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ïŽGŽ 2011/7; 25 (5): 472-8.

521018. [‰ðà] ”xŠàf—Âɂš‚¯‚é×–Ef. ²“¡”Vr (ŒÄ‹zŠíŠO): “ú–{—Տ°×–EŠw‰ïŽRŒ`Œ§Žx•”‰ï•ñ 2011; 30: 11-5.

522089. [uÀ]y‹¹•”ŠO‰È‚ÌŽwjz20 mmˆÈ‰º”x–ì––œ¬Œ^”ñ¬×–E”xŠà‚É‚š‚¯‚鋹o“àƒŠƒ“ƒpß“]ˆÚ—\‘ªˆöŽq|“¢˜_1. ²“¡”Vr (ŒÄ‹zŠíŠO): ‹¹•”ŠO‰È 2012/3; 65 (3): 180-1.

[’˜@‘]

620096. [Šwp‘] (•ª’SŽ·•M)yŠàf—ÃŽwj‚Ì‚œ‚ß‚Ì•a—f’fƒvƒ‰ƒNƒeƒBƒX ”xŠàz¶ŒŸŽè‹Z‚Ɛf’fã‚Ì—¯ˆÓ“_, p.41-50. ‹v˜N’Ï®”ü1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO), ê–å•ÒW: ŒŒŽ@C, ‘•ÒW: ÂùŽ”V, ’†ŽR‘“X, “Œ‹ž, 2011/4”­s.

620097. [Šwp‘] (•ª’SŽ·•M)yŠàf—ÃŽwj‚Ì‚œ‚ß‚Ì•a—f’fƒvƒ‰ƒNƒeƒBƒX ”xŠàzŠO‰È“IŽ¡—Ã, p.58-63. ˆÉ˜¬“c–Ÿ1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO), ê–å•ÒW: ŒŒŽ@C, ‘•ÒW: ÂùŽ”V, ’†ŽR‘“X, “Œ‹ž, 2011/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713082. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Genome-wide DNA methylation analysis of small cell lung cancer. Saito Y, Ninomiya H, Inamura K, Motoi N, Uehara H, Mun M, Sakao Y, Okumura S, Nakagawa K, Nagae G, Satoh T, Kaned Aa, Aburatani H, Satoh Y1, Ishikawa Y: 14th World congress of lung cancer (2011/7/5), Amsterdam, The Netherlands. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

713083. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Circulating tumor cells in peripheral venous blood of primary non-small cell lung cancer patients: detection using adenovirus GFP-labeling. Satoh Y1, Ishii D1, Yamazaki H1, Matsui Y, Ogawa F, Nakashima H, Shiomi K1, Kurouzu N1, Hara H, Nezu K, Iyoda A1, Yoshimura H, Fukui T, Igawa I, Katagiri M, Masuda N, Kawai A, Sato J, Tsujino Y: 14th World congress of lung cancer (2011/7/7), Amsterdam, The Netherlands. (²“¡”Vr1, Îˆä@‘å1, ŽRèGŒp1, ‰–Œ©@˜a1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1: 1ŒÄ‹zŠíŠO)

713084. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical significance of viable circulating tumor cells in peripheral venous blood of primary lung cancer patients. Satoh Y1, Ishii D1, Yamazaki H1, Matsui Y, Ogawa F, Nakashima H, Shiomi K1, Kurouzu N1, Hara H, Iyoda A1, Sato J, Masago A, Tsujino Y: 8th International symposium on minimal residual cancer (2011/9/21-23), Osaka. (²“¡”Vr1, Îˆä@‘å1, ŽRèGŒp1, ‰–Œ©@˜a1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1: 1ŒÄ‹zŠíŠO)

723315. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬’°“]ˆÚ‚ð2‰ñØœ‚µ’·Šú¶‘¶‚µ‚œ”xŠà“÷Žî‚Ì1—á. ˆäã€l, ¬ìŽj—m1, ŒˆäŒ[•v, “V–ì‰pŽ÷2, ‹v˜N’Ï®”ü1, ŒŽ@‰p‘¥, ˆÉ˜¬“c–Ÿ1, ‹g‘º”Ž–M1, ²“¡”Vr1, Ó@¢ˆ®3 (1ŒÄ‹zŠíŠO, 2—Տ°Œ€‹†E‘n‘¢ƒV[ƒY, 3•a—): ‘æ28‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2011/5/12), •Ê•{.

723316. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x‚̑㏞«Ä¶ƒ‚ƒfƒ‹‚É‚š‚¯‚éVEGFŽó—e‘Ì‚ÌŒŸ“¢. ŒˆäŒ[•v1, “V–ì‰pŽ÷2, ¬ìŽj—m1, ‹v˜N’Ï®”ü1, ª’ÃŒ«Ži1, ŒŽ@‰p‘¥1, ˆÉ˜¬“c–Ÿ1, ‹g‘º”Ž–M1, ²“¡”Vr1, ”n“ˆ³—²3 (1ŒÄ‹zŠíŠO, 2—Տ°Œ€‹†E‘n‘¢ƒV[ƒY, 3–ò—): ‘æ28‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2011/5/13), •Ê•{.

723317. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Genome-wide DNA methylation analysis of small cell lung cancer. Saito Y, Ninomiya H, Inamura K, Motoi N, Uehara H, Mun M, Sakao Y, Okumura S, Nakagawa K, Nagae G, Aburatan H, Satoh Y1, Ishikawa Y: ‘æ70‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2011/10/3), –ŒŒÃ‰®. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

723318. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŽ”­«”ñ¬×–E”xŠàØœŽž‚Ì‹¹o“àôò‰t‚É‚š‚¯‚éTRC–@‚É‚æ‚éCEA mRNA‚ÆCK19 mRNA‚̐v‘¬“IŒŸo‚ÌŒŸ“¢. {ŠLKŽq, ‰œ‘º@‰h, â”öK‘¥, •¶@•qŒi, ¬Œ”üŽ÷, ”ö–{‘å•ã, ‘å’‡@Œå, Îì—Yˆê, ²“¡”Vr1, ’†ì@Œ’, ŽO–Ø‹`’j (1ŒÄ‹zŠíŠO): ‘æ70‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2011/10/3), –ŒŒÃ‰®.

723319. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX”x‘S“Eƒ‚ƒfƒ‹‚É‚š‚¯‚é‘㏞«”xÄ¶‚ɑ΂·‚鍜‘—R—ˆCXCR4 + VEGFR1 + ×–E‚Ì–ðŠ„. ŒˆäŒ[•v, Îˆä@‘å1, ŽRèGŒp1,’†“‡—TN, ¬ìŽj—m2, ‰–Œ©@˜a1, ‹v˜N’Ï®”ü1, ŒŽ@‰p‘¥, ˆÉ˜¬“c–Ÿ1, ‹g‘º”Ž–M1, “V–ì‰pŽ÷3, ”n“ˆ³—²4, àF’J³Žj, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3—Տ°Œ€‹†E‘n‘¢ƒV[ƒY, 4–ò—): ‘æ64‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2011/10/11), –ŒŒÃ‰®.

723320. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹‘Bã”琫ŽîᇎèpÇ—á‚ÌŒŸ“¢. ˆÉ˜¬“c–Ÿ1, Ó@¢ˆ®2, ’‡“c“TL2, Îˆä@‘å1, ŽRèGŒp1, ’†“‡—TN, ¬ìŽj—m3, ŒˆäŒ[•v, ‰–Œ©@˜a1, ŒŽE@‰p‘¥, ‹v˜N’Ï®”ü1, ‰v“c“TK4, ‘ì˜ad5, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a—, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ŒÄ‹zŠí“à, 5•úŽËü (Žîá‡)): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/3-4), ‘åã.

723321. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŽ”­«”xŠà‚É‚š‚¯‚é3D-CT angiography‚ð—p‚¢‚œ•a‘ƒ‚Ö‚ÌŒŒŠÇN“ü‚ÌŒŸ“¢. ª’ÃŒ«Ži, ŸŒŽ˜a”Ž, –x“à@~, –Ÿ”ä@r, ‰„ŒŽŒ€“ñ, ¬ìŽj—m1, ŒˆäŒ[•v, ‰–Œ©@˜a2, ‹v˜N’Ï®”ü2, ˆÉ˜¬“c–Ÿ2, ²“¡”Vr2, Žðˆä@Œ˜ (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŒÄ‹zŠíŠO): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/3-4), ‘åã.

723322. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x_Œo“à•ª”åŽîᇂɑ΂·‚éŽèp‚š‚æ‚яpŒã•â•—Ö@‚ÉŠÖ‚·‚錟“¢. ˆÉ˜¬“c–Ÿ1, Ó@¢ˆ®2, Îˆä@‘å1, ŽRèGŒp1, ’†“‡—TN, ¬ìŽj—m3, ŒˆäŒ[•v, ‰–Œ©@˜a1, ŒŽ@‰p‘¥, ‹v˜N’Ï®”ü1, ‰v“c“TK4, ‘ì˜ad5, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a—, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ŒÄ‹zŠí“à, 5•úŽËü (Žîá‡)): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/3-4), ‘åã.

732031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”x‚ª‚ñ‚̍ŐVŽ¡—Ã: Žèp. ²“¡”Vr (ŒÄ‹zŠíŠO): ‘æ3‰ñSagamihara Oncology Seminar (2011/9/15), ‘Š–ÍŒŽ.

733146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹–Œ”dŽî‚ɂĐf’f‚³‚ê‚œ––œ”­¶¬×–E”xŠà‚Ì1—á. ŽRèGŒp1, Îˆä@‘å1, ¬ìŽj—m2, ŒˆäŒ[•v, ‰–Œ©@˜a1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1, ‰v“c“TK3, Ó@¢ˆ®4, ŽOŽ}@M4, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŒÄ‹zŠí“à, 4•a—): ‘æ137‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”‰ï (2011/7/9), “Œ‹ž.

733147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹o‹Ÿ‰º”x•”•ªØœp‚ɂĐf’f‚³‚ê‚œ”xDŽ_‹…«“÷‰èŽîÇ‚̈ê—á. Îˆä@‘å1, Š`ÀœA–M2, ŽRèGŒp1, ŒˆäŒ[•v, ¬ìŽj—m3, ’†“‡—TN, ‰–Œ©@˜a1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1, ŽOã“N•v4, ŽOŽ}@M4, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a‰@•a—•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4•a—): ‘æ25‰ñ“ú–{—Տ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpW‰ï (2011/9/10), ‰¡•l.

733148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯Žž«”xEH“¹d•¡Šà‚ɑ΂µ‚ĈêŠú“IŽèp‚ðŽ{s‚µ‚œ1—á. Îˆä@‘å1, ’†“‡—TN, ŽRèGŒp1, ¬ìŽj—m2, ŒˆäŒ[•v, ‰–Œ©@˜a1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1, ª–{¹”V3, •Ð“c‰Ä–ç3, “n粏¹•F3, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŠO‰È): ‘æ158‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2012/3/3), “Œ‹ž.


”]_ŒoŠO‰ÈŠw

[Šwp˜_•¶]

110153. [ŒŽ’˜] Enhanced Subcortical Spreading Depression in Familial Hemiplegic Migraine Type 1 Mutant Mice. Eikermann-Haerter K1, Yuzawa I2, Qin T1, Wang Y1, Baek K3, Kim YR3, Hoffman U1, Dilekoz E1, Waeber C1, Ferrari MD4, van den Maagdenberg AM4, Moskowitz MA1, Ayata C1 (1Dept. of Radiology, MGH, 2”]ŠO, 3Athinoula A. Martinos Center for Biomedical Imaging Dept. of Radiology, NGH, 4Neurology and Human Genetics, Leiden Univ. Medical Center): J Neurosci 2011/4; 31 (15): 5755-63. (“’àV@ò2)

110154. [ŒŽ’˜] Epstein Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time? Utsuki S1, Oka H1, Miyajima Y1, Kijima C1, Yasui Y2, Fujii K1 (1”]ŠO, 2Œ`‘ÔŒn): Brain Tumor Pathol 2011/4; 28: 145-9. (‰F’Öؑ1, ‰ª@GG1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ˆÀˆä”ü]2, “¡ˆäŽF1)

110155. [ŒŽ’˜] Linear Fractures Invisible on Routine Axial Computed Tomography: A Pitfall at Radiological Screening for Minor Head Injuty. Nakahara K1, Shimizu S1, Kitahara T2, Oka H1, Utsuki S1, Soma K2, Kan S3, Fujii K1 (1”]ŠO, 2‹~–œ, 3•úŽËü (‰æ‘œ)): Neuro Med Chir (Tokyo) 2011/4; 51 (4): 272-4. (’†ŒŽ–M»1, Ž…@ú1, –kŒŽF—Y2, ‰ª@GG1, ‰F’Öؑ1, ‘Š”nˆêˆå2, ›@Mˆê3, “¡ˆäŽF1)

110156. [ŒŽ’˜] Outcome of Vision Impairment and Diabetes Insipidus in Suprasellar Region Germinoma. Utsuki S1, Oka H1, Miyajima Y1, Kijima C1, Fujii K1, Kan S2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): IJCM 2011/5; 2 (2): 82-5. (‰F’Öؑ1, ‰ª@GG1, ‹{“‡—Ç‹P1, –Ø“‡çq1, “¡ˆäŽF1, ›@Mˆê2)

110157. [ŒŽ’˜] Effect of Postoperative Administration of Saireito for Bilateral Chronic Subdural Hematomas. Utsuki S1, Oka H1, Kijima C1, Inukai M1, Abe K1, Sato K1, Suzuki S1, Fujii K1 (1”]ŠO): IJCM 2011/7; 2 (3): 285-8. (‰F’Öؑ1, ‰ª@GG1, –Ø“‡çq1, Œ¢Ž”@‰~1, ˆ¢•”Ž’q1, ²“¡Œör1, —é–؏ː¶1, “¡ˆäŽF1)

110158. [ŒŽ’˜] Dural Arteriovenous Fistulas in the Cavernous Sinus: Clinical Research and Treatment. Kurata A1, Suzuki S1, Iwamoto K1, Nakahara K1, Sasaki M2, Kijima C1, Inukai M1, Abe K1, Niki J1, Sato K1, Fujii K1, Kan S3 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 3•úŽËü (‰æ‘œ)): ISRN Neurology 2011/8; Epub 2011 Aug 2. (‘q“c@²1, —é–؏ː¶1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ²X–Ø—º2, –Ø“‡çq1, Œ¢Ž”@‰~1, ˆ¢•”Ž’q1, m–؁@~1, ²“¡Œör1, “¡ˆäŽF1, ›@Mˆê3)

110159. [ŒŽ’˜] Repositioning of Cranial Bone Flaps Cut with a Diamond-Coated Threadwire Saw: 5-Year Experience with Cosmetic Cranioplasty without Fixation Devices. Shimizu S1, Kondo K, Yamazaki T1, Nakayama K2, Yamamoro I2, Fujii K1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): Skull Base 2011/9; 21 (5): 323-7. (Ž…@ú1, ‹ß“¡GŽ¡, ŽRè—F–ç1, ’†ŽRŒ«Ži2, ŽR–{—E•v2, “¡ˆäŽF1)

110160. [ŒŽ’˜] Contrast stasis in large and giant carotid artery aneurysms as a good prognostic factor for endovascular coil embolization: retrospective study. Suzuki S1, Kurata A1, Yamada M1, Iwamoto K1, Nakhara K1, Niki J1, Sato K1, Fujii K1, Kan S2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): Neurol Res 2011/10; 33 (8): 832-4. (—é–؏ː¶1, ‘q“c@²1, ŽR“c@Ÿ1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, ²“¡Œör1, “¡ˆäŽF1, ›@Mˆê2)

110161. [ŒŽ’˜] Determinants of Poor Outcome After Aneurysmal Subarachnoid Hemorrhage when both Clipping and Coiling Are Available: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan. PRESAT Group (Kurata A1) (1”]ŠO): World Neurosurg 2011/11; 76 (5): 437-45. (‘q“c@²1)

110162. [ŒŽ’˜] Effects of Gratefruit Juice Consumption on Pharmacokinetics of Low Dose Simvastatin: Cross-over Study with a Review of the Literature. Kurata A1, Hagiwara H1, Ohmomo T, Suzuki S1, Nakahara K1, Konno S2, Kijima C1, Inukai M1, Ozawa H3, Fujii K1, Majima M4 (1”]ŠO, 2‹~–œ, 3Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 4–ò—): Med Chem: Current Research 2012; 2 (3): 100113 (open access journal). (‘q“c@²1, ”‹ŒŽG”V1, ‘响ä’m, —é–؏ː¶1, ’†ŒŽ–M»1, ¡–ìTŒá2, –Ø“‡çq1, Œ¢Ž”@‰~1, ¬àV@m3, “¡ˆäŽF1, ”n“ˆ³—²4)

110163. [ŒŽ’˜] Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Eikermann-Haerter K, Lee JH, Yuzawa I1, Liu CH, Zhou Z, Shin HK, Zheng Y, Qin T, Kurth T, Waeber C, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C: Circulation 2012/1; 125 (2): 335-45. (“’‘ò@ò1: 1”]ŠO)

110164. [ŒŽ’˜] A new transvenous approach to the carotid-cavernous sinus via the inferior petrooccipital vein. Kurata A1, Suzuki S1, Iwamoto K1, Nakahara K1, Inukai M1, Niki J1, Satoh K1, Yamada M1, Fujii K1, Kan S2, Katsuta T3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3–k‹ãBŽs—§ˆã—ÃZƒ“ƒ^[): J Neurosurg 2012/3: 116 (3): 581-7. (‘q“c@²1, —é–؏ː¶1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, Œ¢Ž”@‰~1, m–؁@~1, ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2)

110165. [ŒŽ’˜] Altered Hemodynamics Associated with Pathogenesis of the Vertebral Artery Dissecting Aneurysms. Kurata A1, Suzuki S1, Iwamoto K1, Nakahara K1, Abe K1, Inukai M1, Niki J1, Sasaki M2, Fujii K1, Konno S3, Kan S4, Fukasaku K5 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 3‹~–œ, 4•úŽËü (‰æ‘œ), 5—Œ€): Stroke Research and Treatment 2012/3; Epub 2012 Mar 22. (‘q“c@²1, —é–؏ː¶1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, m–؁@~1, ²X–Ø—º2, “¡ˆäŽF1, ¡–ìTŒá3, ›@Mˆê4, [ì˜a–Ÿ5)

110166. [ŒŽ’˜] Cortical spreading depression impairs oxygen delivery and metabolism in mice. Yuzawa I1, SakadzES, Srinivasan VJ, Shin HK, Eikermann-Haerter K, Boas DA, Ayata C: J •]‰¿ƒVƒXƒeƒ€Cereb Blood Flow Metab 2012/2; 32 (2): 376-86. (“’‘ò@ò1: 1”]ŠO)

110167. [ŒŽ’˜] Tentorial detachment technique in the combined petrosal approach for petroclival meningiomas. Kusumi M1, Fukushima T, Mehta AI, Aliabadi H, Nonaka Y, Friedman AH, Fujii K1: J Neurosurg 2012/3; 116 (3): 566-73. (‹v{”ü^—1, “¡ˆäŽF1: 1”]ŠO)

120017. [ŒŽ’˜] ƒ‚ƒoƒCƒ‹Œ^Flat Panel Detector‚ð—p‚¢‚œ˜’Å’Å‹|ªƒXƒNƒŠƒ…[‚ÌŽh“ü. ë“à—²—Y, ‘åàV¬”V, ‹{è•üŽq1, “¡ˆäŽF1 (1”]ŠO): “ú–{Ò‘áŠQˆãŠw‰ïŽ 2011/5; 24 (1): 22-5.

120018. [ŒŽ’˜] èò’Å‘O•ûŽèp‚É‚š‚¯‚éMicroporous polysaccharide hemisheresŽ~ŒŒ‚Ì—L—p«. ë“à—²—Y, ‘åàV¬”V, ‹{è•üŽq1, “¡ˆäŽF1 (1”]ŠO): “ú–{Ò‘áŠQˆãŠw‰ïŽ 2011/5; 24 (1): 26-9.

120019. [ŒŽ’˜] ‘€”]Žº•a•Ï‚É•K—v‚È”÷¬‰ð–U‚ÆŽèpƒAƒvƒ[ƒ`. ‰ª@GG1, ‰Í“‡‰ë“ž2, Ž…@ú1, ‰F’Öؑ1, ‘åàV¬”V, ²“¡Œör1, “¡ˆäŽF1 (1”]ŠO, 2²‰ê‘åŠw”]_ŒoŠO‰È): ”]ŠOŽ 2011/6; 20 (6): 418-23.

120020. [ŒŽ’˜] Cadaver dissection‚ð”]_ŒoŠO‰ÈŽèp‚ɐ¶‚©‚·?: ‚»‚Ì—L—p«‚ÆŒÀŠE. Ž…@ú1, ‘åàV¬”V, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ”]ŠOŽ 2011/10; 20 (suppl 2): 87-98.

120021. [ŒŽ’˜] Dural scoring: ŠJ“ªp‚É‚š‚¯‚éd–ŒˆêŽŸ•Âœ‚̕⏕Žè‹Z. Ž…@ú1, ‹ß“¡GŽ¡, ŽRè—F–ç1, ’†ŽRŒ«Ži2, ŽR–{—E•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): Neurological Surgery 2011/12; 39 (12): 1155-8.

220006. [€ŒŽ’˜] _Œo“àŽ‹‹Ÿ•¹—p‚É‚æ‚铪ŠWˆô“ªŽî‚Ì‹@”\‰·‘¶Žèpí—ª: ‰º‚‘̉·‘¶‚Æ”A•öÇ‚Ì”­¶. ‰ª@GG1, Axel Perneczky2, ‰F’Öؑ1, Ž…@ú1, ’†ŒŽ–M»1, ²“¡Œör1, ‘åàV¬”V, ‹{“‡—Ç‹P1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): “ú–{“à•ª”åŠw‰ïŽGŽ 2011/8; 87 (suppl): 75-7.

220007. [€ŒŽ’˜] ŠÔ”]‰º‚‘̗̈æ‚ÌŽî᎐«•a•Ï‚É‚š‚¯‚éIgG4–Ɖu‘gDŠw“IŒŸ“¢. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, ì–ìM”V, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): “ú–{“à•ª”åŠw‰ïŽGŽ 2011/8; 87 (suppl): 98-100.

220008. [€ŒŽ’˜] Epstein-Barr virus—z«’†•_ŒoŒnŒŽ”­ƒŠƒ“ƒpŽî‚ÌŒŸ“¢. ‰F’Öؑ1, ‰ª@GG1, ‹{“‡—Ç‹P1, –Ø“‡çq1, —é–؏ː¶1, ²“¡Ÿl1, “¡ˆäŽF1 (1”]ŠO): Geriatric Neurosurgery 2011/9; 23: 35-7.

220009. [€ŒŽ’˜] ƒXƒLƒ“ƒXƒeƒCƒvƒ‰[‚É‚æ‚萶‚¶‚é‘n‰–|‚Ì—\–h: èqŽq‘€ì‚Ì•Ï–@. Ž…@ú1, ‹ß“¡GŽ¡, ŽRè—F–ç, ’†ŒŽ–M»1, ’†ŽRŒ«Ži, ŽR–{—E•v, “¡ˆäŽF1 (1”]ŠO): ‘æ3‰ñ“ú–{®—e”]_ŒoŠO‰ÈŒ€‹†‰ï‹L˜^W 2011; p.15-6.

310012. [Ç—á•ñ] Surgical Treatment f a Calcified Rathke's Cleft Cyst with Endoscopic Extended Transsphenoidal Surgery -Case Report-. Arai T1, Horiguchi K1, Saeki N2, Oka H3, Saito T1, Takahashi-Fujigasaki J1, Sakamoto H1, Kato N1, Dobashi H1, Tanaka T1, Hasegawa Y1, Abe T1 (1ŽœŒb‰ïˆã‰È‘åŠw, 2ç—t‘åŠw”]_ŒoŠO‰È, 3”]ŠO): Neurol Med Chir 2011/7; 51: 535-8. (‰ª@GG3)

310013. [Ç—á•ñ] Utility of intraoperative fluorscent diagnosis of residyal hemangioblastoma using 5-aminolevulinic acid. Utsuki S1, Oka H1, Miyajima Y1, Hagiwara H1, Fujii K1 (1”]ŠO): Neurology India 2011/7-8; 59 (4): 612-5. (‰F’Öؑ1, ‰ª@GG1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, “¡ˆäŽF1)

310014. [Ç—á•ñ] Rathke's Cleft Cyst with Xanthogranulomatous Change. Miyajima Y1, Oka H1, Utsuki S1, Fujii K1 (1”]ŠO): Neurol Med Chir (Tokyo) 2011/10; 51 (10): 740-2. (‹{“‡—Ç‹P1, ‰ª@GG1, ‰F’Öؑ1, “¡ˆäŽF1)

310015. [Ç—á•ñ] Anterior-wall aneurysm of the internal carotid artery successfully treated solely by stenting: With special reference to etiology. Kurata A1, Suzuki S1, Inukai M1, Sasaki M, Iwamoto K1, Nakahara K1, Yuzawa I1, Koizumi H1, Fujii K1, Kan S2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): Radiology Case Reports 2011; 6 (4): 1-4. (‘q“c@²1, —é–؏ː¶1, Œ¢Ž”@‰~1, ²X–Ø—º, Šâ–{˜a‹v1, ’†ŒŽ–M»1, “’àV@ò1, ¬òŠ°”V1, “¡ˆäŽF1, ›@Mˆê2)

310016. [Ç—á•ñ] Chronic Recurrent Mutifocal Osteomyelitis Involving the Skull. Koizumi H1, Utsuki S1, Oka H1, Shimizu S1, Fujii K1 (1”]ŠO): The Internet Journal of Neurosurgery 2012; 8 Issue 1. (¬òŠ°”V1, ‰F’Öؑ1, ‰ª@GG1, Ž…@ú1, “¡ˆäŽF1)

310017. [Ç—á•ñ] Endosaccular embolization for a ruptured distal anterior inferior cerebellar artery aneurysm. Koizumi H1, Kurata A1, Suzuki S1, Miyasaka Y, Tanaka C, Fujii K1 (1”]ŠO): Radiol Case Reports 2012; 7 (2): 1-4. (¬òŠ°”V1, ‘q“c@²1, —é–؏ː¶1, ‹{â‰À’j, “c’†ç•F, “¡ˆäŽF1)

310018. [Ç—á•ñ] An Operation in the Park Bench Position Complicated by Massive Tongue Swelling. Koizumi H1, Utsuki S1, Inukai M1, Oka H1, Ohsawa S, Fujii K1 (1”]ŠO): Case Reports in Neurological Medicinne 2012; 2012 (Article ID 165860). (¬òŠ°”V1, ‰F’Öؑ1, Œ¢Ž”@‰~1, ‰ª@GG1, ‘åàV¬”V, “¡ˆäŽF1)

310019. [Ç—á•ñ] Altered Coiling with Stent Assistance for an Iatrogenic Traumatic Aneurysm of the Internal Carotid Artery. Kurata A1, Suzuki S1, Inukai M1, Sasaki M2, Iwamoto K1, Nakahara K1, Konno S3, Kitahara T3, Fujii K1, Kan S4 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 3‹~–œ, 4•úŽËü (‰æ‘œ)): OMICS J Radiol 2012; 1 (1): 100102 (open access journal). (‘q“c@²1, —é–؏ː¶1, Œ¢Ž”@‰~1, ²X–Ø—º2, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ¡–ìTŒá3, –kŒŽF—Y3, “¡ˆäŽF1, ›@Mˆê4)

320031. [Ç—á•ñ] “d“®ƒmƒRƒMƒŠ‚É‚æ‚éŠJ•ú«“ª•”ŠO‚Ì1—á. ¬òŠ°”V1, ‹{â‰À’j, “c’†ç•F, “¡ˆäŽF1 (1”]ŠO): ”]_ŒoŠO‰È 2011/6; 39 (6): 611-4.

520033. [‘à] ƒeƒ“ƒgã”]“®–¬‚̉ð–U. “¡ˆäŽF (”]ŠO): Clinical Neuroscience 2011/10; 29 (10): 1110-4.

520034. [‘à] Atypical Teratoid/Rhabdoid Tumor (AT/RT). ‰ª@GG1, Bernd W Scheithauer2, “¡ˆäŽF1 (1”]ŠO, 2Dept. of Pathol, Mayo clinic and Mayo Foundation): ”]_ŒoŠO‰È‘¬•ñ 2011/12; 21: 1362-7.

520035. [‘à] “ªèò•”ƒXƒeƒ“ƒg. ‘q“c@² (”]ŠO): Þ—¿‚̉Ȋw‚ƍHŠw 2011; 48 (6): 24-9.

521019. [‰ðà]yCurrent Knowledgezê–åˆã‚É‹‚ß‚ç‚ê‚éÅV‚Ì’mŽ¯: ”]Žîᇁ|Atypical Teratoid/Rhabdoid Tumor|. ‰ª@GG1, Bernd W. Scheithauer, “¡ˆäŽF1 (1”]ŠO): ”]_ŒoŠO‰È‘¬•ñ 2011/12; 21 (12): 1362-7.

521020. [‰ðà]yCurrent KnowledgezÅV’mŽ¯‚𑬌øƒ`ƒFƒbƒN! ”]‘¬ƒgƒŒ[ƒjƒ“ƒO. ‰ª@GG (”]ŠO): ”]_ŒoŠO‰È‘¬•ñ 2011/12; 21 (12): 1384.

522090 [uÀ] ƒXƒbƒLƒŠ‰ðŒˆ! Q&A‘æ60‰ñ. ’†ŒŽ–M» (”]ŠO): BRAIN NUSING 2011/5; 27 (5): 76.

522091. [uÀ]y“ÁW: ‘æ20‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€z’†•_ŒoŒnŒŽ”­ˆ««ƒŠƒ“ƒpŽî‚ɑ΂·‚é•W€Ž¡—ÂƂ»‚ÌŒÀŠE|¡Œã‚Ö‚Ì“W–]‚ð‚Ó‚Ü‚Š‚ā|. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ˆÀˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): –k—¢ˆãŠw 2011/6; 41 (1): 49-54.

522092. [uÀ]y“ÁW: ‹~‹}ˆãŠw‹~‹}–òÜƒvƒ‰ƒNƒeƒBƒJƒ‹ƒKƒCƒhzáz¹”­ìEdÏó‘Ô. ’†ŒŽ–M»1, –kŒŽF—Y2 (1”]ŠO, 2‹~–œ): ‹~‹}ˆãŠw 2011/9; 35 (10—Õ‘): 1406-10.

522093. [uÀ]yÀ’k‰ïz”]_ŒoŠO‰È—̈æ‚É‚š‚¯‚é‚Ä‚ñ‚©‚ñ‚Ì–ò•šŽ¡—Ð헪. ‰Á“¡“V”ü, ŽR–{‹M“¹, ÔŒ’ŒŽ÷, ‰ª@GG1 (1”]ŠO): Pharma Medica 2011/12; 29 (12): 127-32.

540013. [‚»‚Ì‘Œ (’Z•ñE‘¬•ñ)] ‘åkÐ”íÐ’n‚ōЊQˆã—ʈ“®‚ÉŒg‚í‚é. ’†ŒŽ–M» (”]ŠO): Hakumon ‚¿‚ã‚€‚š‚€ 2011/7; No.222 (‰Ä‹G†): 32-3.

540014. [‚»‚Ì‘Œ (LETTER)] ”]¶ŒŸ‚̃ƒŠƒbƒg‚à‚ ‚è‚Ü‚·. ‰F’Öؑ (”]ŠO): “ú–{”F’mÇŠw‰ïŽ 2011; 25: 171.

[’˜@‘]

610010. [Šwp‘] (•ª’SŽ·•M)yDiagnostic Techniques and Surgical Management of Brain TumorszChapter 12@Intraoperative Photodynamic Diagnosis of Brain Tumors Using 5-Aminolevulinic Acid, p.227-44. Utsuki S1, Oka H1, Fujii K1, Edited by Abujamra AL, InTech, 2011/9”­s. (‰F’Öؑ1, ‰ª@GG1, “¡ˆäŽF1: 1”]ŠO)

610011. [Šwp‘] (•ª’SŽ·•M)yIn hope of going over the present Clinical PD and PDT: a symposium book in "PACIFICHEM 2010"zDefferential metabolism of 5-ALA in patients with brain tumors, p.160-73. Utsuki S1, Oka H1, Fujii K1, Miyoshi N, Ishizuka M, Takahashi K, Inoue K, Edited by Miyoshi N, Pottier RH, Sankeisha, Japan, 2011/10”­s. (‰F’Öؑ1, ‰ª@GG1, “¡ˆäŽF1, ŽODŒ›—Y, Î’ˏ¹G, ‚‹Ž@‹†, ˆäãŽŽi: 1”]ŠO)

610012. [Šwp‘] (•ª’SŽ·•M)yAdvances in Parkinson's Disease ManagementzSurgical treatment for Parkinson's disease, p.89-95. Sato S1, Mochizuki H2 (1”]ŠO, 2_Œo“à), Editor: Joseph H Friedman3 (3Division of Movement Disorders of the Alpert Medical School of Brown University), 2012/1”­s. (²“¡Ÿl1, –]ŒŽGŽ÷2)

610013. [Šwp‘] (•ª’SŽ·•M)yExplicative Cases of Controversial Issues in NeurosurgeryzEndovascular Approaches to the Carotid Cavernous Sinus for Endovascular Treatment of Carotid Cavernous Fistulas and Hormone Sampling, p.289-318. Kurata A1 (1”]ŠO), Editor: Signorelli F2 (2UniversitEdegli Studi Magna Graecia di Catanzaro, Medicina Sperimentale e Clinica "Gaetano Salvatore", Italy), Croatia, 2012”­s. (‘q“c@²1)

620098. [Šwp‘] (•ª’SŽ·•M)y•W€”]_ŒoŠO‰ÈŠw‘æ12”Łz”]Žîᇠ(”]ŽîᇂƂÍ, ”]Žîᇂ̐f’f, ”]Žîᇂ̊ӕʐf’f, ”]Žîᇂ̎¡—Ã), p.173-83. “¡ˆäŽF1 (1”]ŠO), ŠÄC: Ž™‹Ê“ìŠC—Y2 (2•Ÿ“‡Œ§—§ˆã‰È‘åŠw–Œ—_‹³Žö), •ÒW: ²X–Ø•x’j3, •õ‰YˆêŠì4, Vˆä@ˆê5, •y‰i’î“ñ6 (3‹ãB‘åŠwˆãŠw•””]_ŒoŠO‰È‹³Žö, 4‹ž“s•{—§ˆã‰È‘åŠw”]_ŒoŠO‰È‹³Žö, 5‡“V“°‘åŠwˆãŠw•””]_ŒoŠO‰È‹³Žö, 6EŒ–k‘åŠwˆãŠw•””]_ŒoŠO‰È‹³Žö), ˆãŠw‘‰@, “Œ‹ž, 2011/4”­s.

620099. [Šwp‘] (•ª’SŽ·•M)y”]Žîᇂ̊O‰È|ŽÐ‰ï‚ª–]‚Þ”]ŽîᇊO‰È|z_Œo“àŽ‹‹ŸŽx‰‡“ªŠWˆô“ªŽîŽèp: Š³ŽÒ‚É“K‚µ‚œ—Õ‹@‰ž•ÏƒAƒvƒ[ƒ`, p.169-77. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO), •Ò: ‘唚ŒšŽ¡2 (2‘åãŽs—§‘åŠw‘åŠw‰@ˆãŠwŒ€‹†‰È”]_ŒoŠO‰È‹³Žö), ƒ~ƒbƒN‘åão”Å, ‘åã, 2011/6”­s.

620100. [Šwp‘] (•ª’SŽ·•M)yˆã—Íޗ¿ [ŠO‰È»•iE¶‘̍ޗ¿] ‚̗Տ°ƒj[ƒYWz‘æ1Í ˆãŽt‚Ì‹‚ß‚éˆã—Íޗ¿‚Ƃ́@‘æ4ß ƒvƒ‰ƒ`ƒiƒRƒCƒ‹@”]_ŒoŠO‰Èˆã‚Ì—§ê‚©‚ç, p.25-34. ‘q“c@² (”]ŠO), ‹Zpî•ñ‹Š‰ï, “Œ‹ž, 2011/11”­s.

620101. [Šwp‘] (•ª’SŽ·•M)y”]‘²’†f—Á@‚±‚ñ‚È‚Æ‚«‚Ç‚€‚·‚éQ&A ‘æ2”Łz5. ”]‘²’†‚Ì•aŠúE•aŒ^•ÊŽ¡—Á@‚»‚Ì‘Œ, p.166-8. “¡ˆäŽF1 (1”]ŠO), •Ò’˜ŽÒ: ’I‹Ž‹I•v2, –kì‘׋v3 (2é‹Êˆã‰È‘åŠw_Œo“à‰È‹³Žö, 3“ŒŠC‘åŠw_Œo“à‰È‹³Žö), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722074. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –¬——ô (Choroidal fissure) ‚Ì‹ß–T‚ÌŽèp‚É•K—v‚È”÷¬ŠO‰È‰ð–U. ‰ª@GG1, “¡ˆäŽF1, Albert L Rhoton Jr2 (1”]ŠO, 2ƒtƒƒŠƒ_‘åŠw”]_ŒoŠO‰È): ‘æ31‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX (2011/5/7), ‰¡•l.

722075. [Šw‰ï (‘S‘)] (ƒ‚|ƒjƒ“ƒOƒZƒ~ƒi|) ‚à‚â‚à‚â•a‚É‚š‚¯‚錌ŠÇ•«‡‚ÌŠî–{Žè‹Z. ŽR“c@Ÿ (”]ŠO): ‘æ31‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX (2011/5/8), ‰¡•l.

722076. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ªŠWˆô“ªŽîŽèp‚̐i•à‚Í’·Šú—\Œã‚ð‰ü‘P‚µ‚Ä‚¢‚é‚©?|Œ°”÷‹Ÿ’P“ÆŽèp‚Ɛ_Œo“àŽ‹‹Ÿ•¹—pŽèp|. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/14), ‰¡•l.

722077. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Ò‘“àŽîᇓEop’†‚ÌŒo“ªŠWŽhŒƒ‰^“®—U”­“dˆÊ‚ƏpŒã‹Ø—Í‚Æ‚ÌŠÖŒW. ŽO“‡‘å“¿1, z–K’m–ç1, ŽOˆäŒö•F1, –؉º@L2, ‹g•’ŒK3, ˆÉ“¡@C4 (1”]ŠO, 2‘Š–ÍŒŽ•a‰@–ƒŒ‰È, 3ƒPƒAƒtƒ…[ƒWƒ‡ƒ“EƒWƒƒƒpƒ“, 4‘Š–ÍŒŽ•a‰@–ƒŒ‰ÈME): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/14), ‰¡•l.

722078. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ªŠWˆô“ªŽî‚̐_Œo“àŽ‹‹ŸŽèp‚͍Ĕ­—Š’ቺ‚ÉŠñ—^‚µ‚Ä‚¢‚é‚©?|_Œo“àŽ‹‹Ÿ‚ð—p‚¢‚œ—Õ‹@‰ž•Ï‚ÈŽèpƒAƒvƒ[ƒ`|. ‰ª@GG1, ’†ŒŽ–M»1, ‰F’Öؑ1, ²“¡Œör1, “¡ˆäŽF1 (1”]ŠO): ‘æ18‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2011/11/18), ‰ªŽR.

722079. [Ew‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Petroclival meningioma‚ɑ΂·‚éCombined petrosal approach‚É‚š‚¯‚éƒeƒ“ƒgØ‚̍H•v. ‹v{”ü^—1, •Ÿ“‡F“¿2, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Duke Univ. Medical Center, Division of Neurosurgery): ‘æ21‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2012/3/31), ‘åã.

723323. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ªŠW“à–¢”j—ô“àèò“®–¬áŽ‚ɑ΂µ‚Äflow alteration/reversal‚ð—p‚¢‚ÄŽ¡—µ‚œ1—á. ²“¡Œör1, ˆ¢•”Ž’q1, —é–؏ː¶1, ²“¡Ÿl1, ‰F’Öؑ1, ‰ª@GG1, ŽR“c@Ÿ1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO): ‘æ20‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2011/4/9), “¿“‡.

723324. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽîᇑgD‚Ì‘å•”•ª‚ªƒIƒŠƒS—l×–E‚©‚琬‚鏬”]Žîᇂ̈ê—á. ‰F’Öؑ1, ‰ª@GG1, ˆ¢•”Ž’q1, –Ø“‡çq1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, ˆÀˆä”ü]2, “¡ˆäŽF1, ŒŽ@“ÖŽq3, ì–ìM”V (1”]ŠO, 2Œ`‘ÔŒn, 3•a—): ‘æ29‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2011/5/20), “Œ‹ž.

723325. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]Š²•”ƒOƒŠƒI[ƒ}‚̗Տ°•a—‘œ. ‰ª@GG1, ‰F’Öؑ1, ”‹ŒŽG”V1, ‹{“‡—Ç‹P1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): ‘æ29‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2011/5/20), “Œ‹ž.

723326. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Rhabdoid meningioma‚ÆŠÓ•Ê‚ð—v‚·‚é—ǐ«‘–ŒŽî‚̈ê—á. ‹{“‡—Ç‹P1, ‰ª@GG1, ‰F’Öؑ1, ”‹ŒŽG”V1, ŒŽ@“ÖŽq2, Œ¢Ž”@‰~1, –Ø“‡çq1, ˆÀˆä”ü]3, ì–ìM”V, “¡ˆäŽF1 (1”]ŠO, 2•a—, 3Œ`‘ÔŒn): ‘æ29‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2011/5/20), “Œ‹ž.

723327. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘Sg«ƒŠƒ“ƒpŽî‚Ì”]ŽÀŽ¿“]ˆÚ‚Éfollicular type‚©‚çDLBCL‚Ö‚Ìtrasnformation‚ª‹^‚í‚ê‚œˆê—á. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ˆÀˆä”ü]2, ŒŽ@“ÖŽq3, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn, 3•a—): ‘æ29‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2011/5/20), “Œ‹ž.

723328. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) AIDSŠÖ˜APCNSL‚̐f’f‚ƉÁ—Ã. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ˆÀˆä”ü]2, ŒŽ@“ÖŽq3, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn, 3•a—): ‘æ29‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2011/5/20), “Œ‹ž.

723329. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚—îŽÒ‚Ì”]ŽÀŽ¿“à‚É”­¶‚µ‚œ–¬—‘p“û“ªŽî‚̈ê—á. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, ²“¡Œör1, “¡ˆäŽF1 (1”]ŠO): ‘æ29‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpWEE(2011/5/20), “Œ‹ž.

723330. [Ew‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹}‘¬‚È‘‘åŒXŒü‚ð”F‚ß‚œŽîᇗގ—«•a•Ï‚Ì1—á. ”nŸºˆêŽ÷1, ‰ª@GG1, ‰F’Öؑ1, “¡ˆäŽF1, Šâ–{˜a‹v1, “c’†@—m2 (1”]ŠO, 2Šƒ–èŽs—§•a‰@”]_ŒoŠO‰È): ‘æ29‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2011/5/20), “Œ‹ž.

723331. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”DP•ª•Ø‚ðŒ_‹@‚É’ZŠúŠÔ‚ň««“]‰»‚ð‚«‚œ‚µ‚œdiffuse glioma‚©‚ç. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ11‰ñ“ú–{R‰Á—îˆãŠw‰ï‘‰ï (2011/5/28), ‹ž“s.

723332. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˜’ōd–ŒŠOŽ‰–bÇ‚Ì1—á. ‘åàV¬”V, ë“à—²—Y, ‹{è•üŽq1, “¡ˆäŽF1 (1”]ŠO): ‘æ26‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2011/6/9), À’Ã.

723333. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ò’ŒŠÇ”w‘€‚É’Eo‚µ‚œ˜’ŒŊԔƒwƒ‹ƒjƒA‚Ì1—á. ‘åàV¬”V, ë“à—²—Y, ‹{è•üŽq1, “¡ˆäŽF1 (1”]ŠO): ‘æ26‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2011/6/9), À’Ã.

723334. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˜’Å’Å‹|ªƒXƒNƒŠƒ…[Žh“ü‚É‚š‚¯‚郂ƒoƒCƒ‹Œ^FPDƒVƒXƒeƒ€‚Ì—L—p«. ë“à—²—Y, ‘åàV¬”V, ‹{è•üŽq1, Ž…@ú1, “¡ˆäŽF1 (1”]ŠO): ‘æ26‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2011/6/10), À’Ã.

723335. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) èò’Å‘O•ûŽèp‚É‚š‚¯‚éƒfƒ“ƒvƒ“—R—ˆ‹zŽû«‹ÇŠŽ~ŒŒÞ‚ÌŽg—pŒoŒ±. ë“à—²—Y, ‘åàV¬”V, ‹{è•üŽq1, Ž…@ú1, “¡ˆäŽF1 (1”]ŠO): ‘æ26‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2011/6/10), À’Ã.

723336. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –ü’…«‚­‚à–Œ‰Š‚ð‡•¹‚µ‚œƒLƒAƒŠŠïŒ`2Ç—á‚Ì•ñ. ŽO“‡‘å“¿1, z–K’m–ç1, ŽOˆäŒö•F1 (1”]ŠO): ‘æ26‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2011/6/10), À’Ã.

723337. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œœ‰ËŽ®ƒoƒCƒ|[ƒ‰ƒtƒbƒgƒXƒCƒbƒ`: —§ˆÊpŽÒ‚Ì‚œ‚ß‚Ì‘€ì«‰ü‘P‚ÌŽŽ‚Ý. Ž…@ú1, ‹ß“¡GŽ¡, ŽRè—F–ç1, ’†ŽRŒ«Ži, ŽR–{—E•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): ‘æ26‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2011/6/10), À’Ã.

723338. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 20”NŠÔ‚Å‘‘債‚œ‘œ”­«d‰»Ç‚𔺂€Ò‘‹ó“ŽÇ‚Ì1—á. Ž…@ú1, ŽRè—F–ç1, ‹ß“¡GŽ¡, ’†ŽRŒ«Ži, ŽR–{—E•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): ‘æ26‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2011/6/10), À’Ã.

723339. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]Žîᇂɑ΂·‚é5-ALA‚ð—p‚¢‚œPDD‚Ì—L—p«‚ÆŒÀŠE. ‰F’Öؑ1, ‰ª@GG1, ”‹ŒŽG”V1, ‹{“‡—Ç‹P1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): ‘æ7‰ñ“ú–{”]_ŒoŠO‰ÈŒõü—ÍŠwŠw‰ï (2011/7/9), “Œ‹ž.

723340. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) CASŽüpŠú‚É‚š‚¯‚錌¬”‹ÏW”\ƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì—L—p«. ²X–Ø—º, —é–؏ː¶1, ‘q“c@²1, “¡ˆäŽF1, ¬àV@m2, ‹e’r@Œh, ŽR“à’B–ç2, ŒE‘qF“¹2 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È): ‘æ36‰ñ“ú–{”]‘²’†Šw‰ï (2011/7/31), ‹ž“s.

723341. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Acetazolamide•‰‰×SPECTŒã‚É”][Ç‚ð‚«‚œ‚µ‚œ•nŒŒ‡•¹‚à‚â‚à‚â•a‚Ì1—á. ²“¡Œör1, ˆ¢•”Ž’q1, —é–؏ː¶1, ‰ª@GG1, ŽR“c@Ÿ1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO): ‘æ40‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2011/7/31), ‹ž“s.

723342. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‚à‚â‚à‚â•a‚É‚š‚¯‚é‹•ŒŒÇŒó«‚̐i“W‚ÆFLAIR‘œIvy sign‚̕ω». ŽR“c@Ÿ1, —é–؏ː¶1, ²“¡Œör1, Œ¢Ž”@‰~1, –Ø“‡çq1, ˆ¢•”Ž’q1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO): ‘æ40‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2011/7/31), ‹ž“s.

723343. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –¢”j—ô“®–¬áŽ‚É‚œ‚¢‚·‚éÇðpŒã‚Ì’·ŠúŒo‰ßŠÏŽ@Œ‹‰Ê‚ÌŒŸ“¢. —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, ²X–Ø—º, ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ40‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2011/7/31), ‹ž“s.

723344. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Mild Induced Hypertension‚Í“àèò“®–¬•ÂÇ‚𔺂€’†‘å”]“®–¬•ÂÇ‚É‚š‚¢‚ÄCBF‚ðŠOèò“®–¬‘€•›ŒŒs‚æ‚è‰ü‘P‚·‚é. “’àV@ò1, Shin HK2, Sakadzic S3, Boas DA3, Ayata C3, ŽR“c@Ÿ1, “¡ˆäŽF1 (1”]ŠO, 2Pusan National Univ, 3MGH): ‘æ36‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï (2011/8/1), ‹ž“s.

723345. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CASŒã‚̉ߟ󗬏ó‘Ô‚É‚š‚¢‚ÄSAH‚ð‚«‚œ‚µ‚œ1—á. “¡“c“S•œ1, ²“¡Œör2, ˆ¢•”Ž’q2, —é–؏ː¶2, ‘q“c@²2, “¡ˆäŽF2 (1Œ€Cˆã2”N, 2”]ŠO): ‘æ30‰ñThe Mt. Fuji Workshop on CVD (2011/8/27), ŽD–y.

723346. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬”]‹ŽŠp•”Žîᇂ̏p’†’®Šo‹@”\ƒ‚ƒjƒ^ƒŠƒ“ƒO. ²“¡Ÿl1, ‰ª@GG1, ‰F’Öؑ1, ²“¡Œör1, ‹v{”ü^—1, ¬òŠ°”V1, “¡ˆäŽF1 (1”]ŠO): ‘æ16‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2011/9/9), ‰¡•l.

723347. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Petroclival menigioma‚ɑ΂·‚éCombined petrosal approach‚É‚š‚¯‚éƒeƒ“ƒgØŠJ‚̍H•v. ‹v{”ü^—1, •Ÿ“‡F“¿2, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Dept. of Neurosurgery, West Virginia Univ., Division of Neurosurgery, Duke Univ.): ‘æ16‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2011/9/10), ‰¡•l.

723348. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Combined Petrosal Approach‚ɑ΂·‚éƒ`ƒ^ƒ“ƒvƒŒ[ƒg‚ð—p‚¢‚œd–Œ•ÂÇ–@‚̍H•v. ‹v{”ü^—1, •Ÿ“‡F“¿2, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Dept. of Neurosurgery, West Virginia Univ., Division of Neurosurgery, Duke Univ.): ‘æ16‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2011/9/10), ‰¡•l.

723349. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž‹°oŒŒŒã‚ɏoŒ»‚µ‚œ‘²’†ŒãUí‚ɑ΂µ‚ÄVim-thalamotomy‚ª‘tŒ÷‚µ‚œ1—á. ²“¡Ÿl1, Ž›”ö@‹œ2, –Ø“‡çq1, “c’†r‰p3, ‰ª@GG1, –]ŒŽGŽ÷4, “¡ˆäŽF1 (1”]ŠO, 2Œú–ØŽs—§•a‰@”]_ŒoŠO‰È, 3“Œ‹žŽœŒb‰ïˆã‰È‘åŠw”•a‰@”]_ŒoŠO‰È, 4_Œo“à): ‘æ5‰ñƒp[ƒLƒ“ƒ\ƒ“•aE‰^“®áŠQŽŸŠ³ƒRƒ“ƒOƒŒƒX (2011/10/7), •iì.

723350. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰¡-SóÃ–¬“Ž•”isolated type dural AVF‚ɑ΂·‚鎡—Ð헪. Šâ–{˜a‹v1, ‘q“c@²1, —é–؏ː¶1, “’àV@ò1, ²X–Ø—º2, ”‹ŒŽG”V1, ²“¡Œör1, ‹v{”ü^—1, –Ø“‡çq1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, “¡ˆäŽF1, ›@Mˆê3 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 3•úŽËü (‰æ‘œ)): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/12), ‰¡•l.

723351. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬”]‹ŽŠp•”Žîᇂ̏p’†Ž‹Šo‹@”\ƒ‚ƒjƒ^ƒŠƒ“ƒO. ²“¡Ÿl1, ‰ª@GG1, ‰F’Öؑ1, ²“¡Œör1, ‹v{”ü^—1, ¬òŠ°”V1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/12), ‰¡•l.

723352. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œœ‰ËŽ®ƒoƒCƒ|[ƒ‰ƒtƒbƒgƒXƒCƒbƒ`: —§ˆÊpŽÒ‚Ì‚œ‚ß‚Ì‘€ì«‰ü‘P‚ÌŽŽ‚Ý. Ž…@ú1, ‹ß“¡GŽ¡, ŽRè—F–ç1, ¬òŠ°”V1, ‹{è•üŽq1, ‘åàV¬”V, ë“à—²—Y, ’†ŽRŒ«Ži, ŽR–{—E•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/12), ‰¡•l.

723353. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Mild Induced Hypertension‚Íèò“®–¬•ÂÇ‚𔺂€“¯‘€’†‘å”]“®–¬•ÂÇ‚É‚š‚¢‚ÄCBF‚ðŠOŠOèò“®–¬—R—ˆ‘€•›ŒŒs‚š‚æ‚ÑPcomm.‚ð‰î‚µ‚ĉü‘P‚·‚é. “’àV@ò1, Kyoung AH2, ŽR“c@Ÿ1, “¡ˆäŽF1, Cenk A3 (1”]ŠO, 2Pusan National Univ. MRC for Ischemic Tissue Regeneration, 3MGH Stroke and Neurovascular Regulation Lab.): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/12), ‰¡•l.

723354. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) pillpmyxoid astrocytoma‚̗Տ°E•a—Šw“I“Á’¥‚ÆŽ¡—Âɂ‚¢‚Ä. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/12), ‰¡•l.

723355. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “«‚Ä‚ñ‚©‚ñŽ¡—Âɂš‚¯‚郉ƒ‚ƒgƒMƒŠƒ“ (ƒ‰ƒ~ƒNƒ^[ƒ‹) ‚ÌŽg—pŒoŒ±. ˆ¢•”Ž’q1, ‰ª@GG1, ‰F’Öؑ1, ²“¡Ÿl1, ²“¡Œör1, ”‹ŒŽG”V1, ‹{“‡—Ç‹P1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/13), ‰¡•l.

723356. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒvƒƒ‰ƒNƒ`ƒm[ƒ}‚ÌŽèp“Eo‚Å“à•žŽ¡—Â𒆎~‰Â”\‚©?|‹“Ž™Šó–]EªŽ¡ŽèpŠó–]—á‚𒆐S‚Ɂ|. ‹{“‡—Ç‹P1, ‰ª@GG1, ‰F’Öؑ1, Ž…@ú1, ”‹ŒŽG”V1, ‹ß“¡GŽ¡, ‘åàV¬”V, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/13), ‰¡•l.

723357. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹}«d–Œ‰ºŒŒŽî‚𔺂Á‚œ”j—ô”]“®–¬áŽ‚ÌŽ¡—ЬÑ. ²“¡Œör1, ‰ª@GG1, ŽR“c@Ÿ1, –kŒŽF—Y2, ‰Í“‡‰ë“ž3, —é–؏ː¶1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO, 2‹~–œ, 3²‰ê‘åŠwˆãŠw•””]_ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/13), ‰¡•l.

723358. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ‚ƒoƒCƒ‹Œ^Flat panel detector (FPD) ‚ð—p‚¢‚œŒo”ç“I˜’Å’Å‹|ªƒXƒNƒŠƒ…[Žh“üp. ë“à—²—Y, ‘åàV¬”V, ‹{è•üŽq1, ‹ß“¡GŽ¡, –ö“c@’q2, “¡ˆäŽF1 (1”]ŠO, 2–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@•úŽËü‰È): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/13), ‰¡•l.

723359. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚ÌŽ‹°VimŠj‚ɐ¶‚¶‚é‘̐«ŠŽŠo—U”­«“dê“dˆÊ‚Ì‘Šˆá“¯Šú‚©‚ç‚̍lŽ@|”][•”ŽhŒƒƒeƒNƒjƒbƒN‚̉ü‘P‚ð–Ú“I‚Æ‚µ‚ā|. “n•ÓŽ¬1, ²“¡Ÿl2, áÁ–Ø“ñ—t3, •œŒË­Žj1, ’†“ˆ@„4, D–{—T•œ1 (1ŒQ”n‘åŠwˆãŠw•””]_ŒoŠO‰È, 2”]ŠO, 3¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwˆãŠw•”_Œo“à‰È, 4“Œ‹ž—Žqˆã‰È‘åŠwæ’[¶–œˆã‰ÈŠwŒ€‹†Š): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/13), ‰¡•l.

723360. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÔ”]‰º‚‘̗̈æ‚ÌŽî᎐«•a•Ï‚É‚š‚¯‚éIgG4–Ɖu‘gDŠw“IŒŸ“¢. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, ì–ìM”V, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/13), ‰¡•l.

723361. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬”]äP‰èŽî¬l—á‚ÌŒŸ“¢. ‰F’Öؑ1, ‰ªE@GG1, ”‹ŒŽG”V1, ‹{“‡—Ç‹P1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/14), ‰¡•l.

723362. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘€”]Žº“àŽîᇂ̎¡—Ð헪. ‹v{”ü^—1, •Ÿ“‡F“¿2, Karikari I2, Friedman A2, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Duke Univ. Med. Center, Division of Neurosurgery): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/14), ‰¡•l.

723363. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “Á”­«˜’ōd–ŒŠOŽ‰–bŽîÇ‚̈ê—á. ‘åàV¬”V, ‹ß“¡GŽ¡, ë“à—²—Y, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/14), ‰¡•l.

723364. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —¯’uŒã‚̃Xƒeƒ“ƒgŽ©ŒÈŠg’£—Í‚Ì”äŠr (Precise stent vs Carotid Wallstent). —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, ²X–Ø—º2, ²“¡Œör1, Œ¢Ž”@‰~1, “’àV@ò1, ›@Mˆê3, ‘响ä’m, —с@ËŽj4 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 3•úŽËü (‰æ‘œ), 4–kŒŽ‘Û•a‰@”]_ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ70‰ñŠwp‘‰ï (2011/10/14), ‰¡•l.

723365. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –«d–Œ‰ºŒŒŽîpŒã‚̍Ĕ­—\–h‚ɑ΂·‚鎇—è“’‚ÌŒø‰Ê. ‰F’Öؑ1, ‰ª@GG1, –Ø“‡çq1, ˆ¢•”Ž’q1, —é–؏ː¶1, ²“¡Ÿl1, ²“¡Œör1, “¡ˆäŽF1 (1”]ŠO): ‘æ20‰ñ“ú–{”]_ŒoŠO‰ÈŠ¿•ûˆãŠw‰ïŠwpW‰ï (2011/11/5), “Œ‹ž.

723366. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆÓ}“I‚ŒŒˆ³‚Íèò•”IC•ÂÇ‚𔺂€“¯‘€MCA•ÂÇ‚É‚š‚¢‚ÄCBF ‚ðECAŒn‘€•›˜H‚š‚æ‚ÑPcomm.‚ð‰î‚µ‚ĉü‘P‚·‚é. “’àV@ò1, ŽR“c@Ÿ1, “¡ˆäŽF1, Cenk A2, Kyoung AH3 (1”]ŠO, 2MGH, Stroke and Neurovascular Regulation Laboratory, 3Pusan National Univ., MRV for Ischemic Tissue Regeneration): ‘æ23‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï (2011/11/5), “Œ‹ž.

723367. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œã“ªŠWâ|Žèp‚É•K—v‚Ȑ_Œo“àŽ‹‹Ÿ“I”÷¬”]_ŒoŠO‰È‰ð–U. aãNŽ¡1, ‰ª@GG1, ‰““¡¹F2, “¡ˆäŽF1, ƒAƒ‹ƒo[ƒgELEƒ[ƒgƒ“3 (1”]ŠO, 2Šƒ–è“¿F‰ï‘‡•a‰@”]_ŒoŠO‰È, 3ƒtƒƒŠƒ_‘åŠw”]_ŒoŠO‰È): ‘æ18‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2011/11/17), ‰ªŽR.

723368. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àŽ‹‹ŸŒo’±Œ`œ“ŽŽèp‚Ì”÷¬ŠO‰È‰ð–U. ‘åàV¬”V, ‰ª@GG1, Ž…@ú1, ë“à—²—Y, “¡ˆäŽF1 (1”]ŠO): ‘æ18‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2011/11/17), ‰ªŽR.

723369. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) …EªÇ‚É‚Ä”­Ç‚µ‚œ‚—îŽÒ‘æ3”]ŽºùN–E«“ªŠWˆô“ªŽî‚ɑ΂·‚é_Œo“àŽ‹‹ŸŽèp. ²“¡Œör1, ‰ª@GG1, ‰F’Öؑ1, ’†ŒŽ–M»1, “¡ˆäŽF1 (1”]ŠO): ‘æ18‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2011/11/18), ‰ªŽR.

723370. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œo”ç“I˜’Å’Å‹|ªƒXƒNƒŠƒ…[ˆÀ‘S‚ÉŽh“ü‚·‚é‚œ‚ß‚Ì“–‰@‚̍H•v. ë“à—²—Y, ‹{è•üŽq1, ‘åàV¬”V, ‹ß“¡GŽ¡, Ž…@ú1, “¡ˆäŽF1 (1”]ŠO): ‘æ46‰ñ“ú–{Ò‘áŠQˆãŠw‰ï (2011/11/18), ‘åã.

723371. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ò‘Žèp‚É‚š‚¯‚éƒfƒ“ƒvƒ“—R—ˆ‹zŽû«‹ÇŠŽ~ŒŒÞ‚ð—p‚¢‚œŽ~ŒŒ–@. ë“à—²—Y, ‹{è•üŽq1, ‘åàV¬”V, ‹ß“¡GŽ¡, Ž…@ú1, “¡ˆäŽF1 (1”]ŠO): ‘æ46‰ñ“ú–{Ò‘áŠQˆãŠw‰ï (2011/11/18), ‘åã.

723372. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÔ”]‰º‚‘̗̈æ‚ÌŽî᎐«•a•Ï‚É‚š‚¯‚éIgG4–Ɖu‘gDŠw“IŒŸ“¢. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, ì–ìM”V, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ15‰ñ“ú–{“à•ª”å•a—Šw‰ï (2011/11/23), “Œ‹ž.

723373. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CAS‚É‚š‚¯‚錌ðÇ—\–h‚Ì‚œ‚ß‚ÌŒŒ¬”‹ÏW”\ƒ‚ƒjƒ^ƒŠƒ“ƒO. ²X–Ø—º1, ¬àV@m1, ‹e’r@Œh1, ŽR“à’B–ç1, “Œ“‡ˆÐŽj1, ŒE‘qF“¹1, —é–؏ː¶2, ‘q“c@²2, “¡ˆäŽF2 (1Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 2”]ŠO): ‘æ27‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2011/11/24), –‹’£.

723374. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CASŒã‚̉ߟ󗬏ó‘Ô‚ÅSAH‚ð‚«‚œ‚µ‚œ1—á. ²“¡Œör1, “¡“c“S•œ, ˆ¢•”Ž’q1, —é–؏ː¶1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO): ‘æ27‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2011/11/24), –‹’£.

723375. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆãŒŽ«ŠO«“àèò“®–¬áŽ‚ɑ΂·‚é, ƒGƒ“ƒ^[ƒvƒ‰ƒCƒY•¹—pƒnƒCƒhƒƒRƒCƒ‹Çðp. ’†ŒŽ–M»1, ‘q“c@²1, —é–؏ː¶1, ²X–Ø—º2, ‹v{”ü^—1, Šâ–{˜a‹v1, Œ¢Ž”@‰~1, ˆ¢•”Ž’q1, –Ø“‡çq1, “¡ˆäŽF1, ¡–ìTŒá3, –kŒŽF—Y3 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 3‹~–œ): ‘æ27‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2011/11/24), –‹’£.

723376. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰¡-SóÃ–¬“Ž•” isolated type dural AVF ‚ɑ΂·‚鎡—Ð헪. Šâ–{˜a‹v1, ‘q“c@²1, —é–؏ː¶1, ²X–Ø—º, ’†ŒŽ–M»1, m–؁@~1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, —с@ËŽj2, “¡ˆäŽF1, ›@Mˆê3 (1”]ŠO, 2–kŒŽ‘Û•a‰@”]_ŒoŠO‰È, 3•úŽËü (‰æ‘œ)): ‘æ27‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2011/11/25), –‹’£.

723377. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒGƒ“ƒ^[ƒvƒ‰ƒCƒYƒXƒeƒ“ƒg‚Ì‚Ý‚ÅŽ¡—µ“Ÿ‚œ“àèò“®–¬‘O•Ç“®–¬áŽ‚Ì1—á. Œ¢Ž”@‰~1, ‘q“c@²1, —é–؏ː¶1, ²X–Ø—º, “’àV@ò1, Šâ–{˜a‹v1, m–؁@~1, ˆ¢•”Ž’q1, –Ø“‡çq1, ’†ŒŽ–M»1, ²“¡Œör1, “¡ˆäŽF1 (1”]ŠO): ‘æ27‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2011/11/25), –‹’£.

723378. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž¡—Âɓïa‚µ‚œŠO«CCF‚Ì1—á. m–؁@~1, ”Ñ“cG•v1, ’Jè‹`“¿1, ‘q“c@²1, —é–؏ː¶1, Šâ–{˜a‹v1, ²X–Ø—º2, ²“¡Œör1, ’†ŒŽ–M»1, Œ¢Ž”@‰~1, “¡ˆäŽF1, ›@Mˆê3 (1”]ŠO, 2Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 3•úŽËü (‰æ‘œ)): ‘æ27‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2011/11/25), –‹’£.

723379. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —¯’uŒã‚̃Xƒeƒ“ƒgŽ©ŒÈŠg’£”\—Í‚Ì”äŠr (Precise stent vs Carotid Wallstent). —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, Œ¢Ž”@‰~1, ²X–Ø—º, ²“¡Œör1, “’àV@ò1, “¡ˆäŽF1, ›@Mˆê2, —с@ËŽj3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3–kŒŽ‘Û•a‰@”]_ŒoŠO‰È): ‘æ27‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2011/11/25), –‹’£.

723380. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘åE•””w‘€‘–ŒŽîpŒã, ‰„‘Œã•û‚Ö‚Ì‹ü‹È‚Ɛ…“ªÇ‚ð”F‚ß‚œ1—á. ”nŸºˆêŽ÷1, Šâ–{˜a‹v1, “c’†@—m2, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Šƒ–èŽs—§•a‰@”]_ŒoŠO‰È): ‘æ29‰ñ“ú–{”]Žîᇊw‰ï (2011/11/28), ‰º˜C.

723381. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽO³_Œo’É‚ðŽå‘i‚Æ‚·‚é CPA Epidermoid 2Ç—á‚ÌŒŸ“¢. ‹v{”ü^—1, ‰ª@GG1, ²“¡Ÿl1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, “¡ˆäŽF1 (1”]ŠO): ‘æ14‰ñ“ú–{”]_ŒoŒžˆ³pŠw‰ï (2012/1/19), “Œ‹ž.

723382. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Vim-thalamotomy‚ª—LŒø‚Å‚ ‚Á‚œ‘²’†ŒãŽ‹°Uí‚Ì1—á. –Ø“‡çq1, ²“¡Ÿl1, Ž›”ö@‹œ2, “c’†r‰p3, ¬òŠ°”V1, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Œú–ØŽs—§•a‰@”]_ŒoŠO‰È, 3“Œ‹žŽœŒb‰ïˆã‰È‘åŠw•‘®”•a‰@”]_ŒoŠO‰È): ‘æ51‰ñ“ú–{’èˆÊE‹@”\_ŒoŠO‰ÈŠw‰ï (2012/1/20), “Œ‹ž.

723383. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •Ó‰”玿‚©‚ç“ü—Í‚ðŽó‚¯‚鎋°‰ºŠjƒjƒ…[ƒƒ“‚̐_Œo¶—Šw“I“Á’¥. ²“¡Ÿl1, ’mŒ©‘”ü2, áÁ–Ø“ñ—t3, “¡ˆäŽF1, “ì•”@“Ä2 (1”]ŠO, 2¶—ŠwŒ€‹†Š¶‘̃VƒXƒeƒ€Œ€‹†•”–å, 3¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw_Œo“à‰È): ‘æ51‰ñ“ú–{’èˆÊE‹@”\_ŒoŠO‰ÈŠw‰ï (2012/1/21), “Œ‹ž.

723384. [Šw‰ï (‘S‘)] (ˆê”ʍuEE Rhabdoid meningioma ‚ÆŠÓ•Ê‚ð—v‚·‚é—ǐ«‘–ŒŽî‚̈ê—á. ‹{“‡—Ç‹P1, ‰ª@GG1, ‰F’Öؑ1, ”‹ŒŽG”V1, Œ¢Ž”@‰~1, –Ø“‡çq1, ˆÀˆä”ü]2, “¡ˆäŽF1, ŒŽ@“ÖŽq3, ì–ìM”V (1”]ŠO, 2Œ`‘ÔŒn, 3•a—): ‘æ15‰ñ”]_ŒoŠO‰ÈŽŸŠ³‚̗Տ°‚Æ•a—‚ÌJOINT CONFERENCE (2012/2/18), “Œ‹ž.

723385. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Xanthogranuloma ‚𔺂Á‚œƒ‰ƒgƒPùN–E‚Ì•a—Šw“IŒŸ“¢. ‹{“‡—Ç‹P1, ‰ª@GG1, ‰F’Öؑ1, ‹ß“¡GŽ¡, ‘åàV¬”V, “¡ˆäŽF1 (1”]ŠO): ‘æ22‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2012/2/24), “Œ‹ž.

723386. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹°‰º•”EŽ‹˜H‚É”­¶‚µ‚œpilocytic astrocytoma/pilomyxoid astrocytoma‚ɑ΂·‚鎡—Ð헪. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ22‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2012/2/24), “Œ‹ž.

723387. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _Œo“àŽ‹‹ŸŽèp“±“üŒã‚̏¬Ž™ŠÔ”]‰º‚‘ÌŽîᇂ̌»ó. ‰ª@GG1, ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹2, ‰F’Öؑ1, ’†ŒŽ–M»1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, “¡ˆäŽF1 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ22‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2012/2/25), “Œ‹ž.

723388. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‚—îŽÒ‘æ3”]Žº“àùN–E«“ªŠWˆô“ªŽî‚ɑ΂·‚é_Œo“àŽ‹‹ŸŽèp. ²“¡Œör1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, ’†ŒŽ–M»1, “¡ˆäŽF1 (1”]ŠO): ‘æ22‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2012/2/25), “Œ‹ž.

723389. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ªŠWˆô“ªŽî‚⃉ƒgƒPùN–E‚ɑ΂·‚éIgG4–Ɖu‘gDŠw“I”­Œ»•p“x‚ÌŒŸ“¢. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, ì–ìM”V, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ22‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2012/2/25), “Œ‹ž.

723390. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ªŠW“à–¢”j—ô“àèò“®–¬áŽ‚ɑ΂µ‚Äflow alteration/reversal‚ð—p‚¢‚ÄŽ¡—µ‚œ1—á. ²“¡Œör1, ŽR“c@Ÿ1, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ‘æ21‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2012/3/30), ‘åã.

723391. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –«d–Œ‰ºŒŒŽî‚É‚š‚¯‚é‹C–AŠÇ…€Ší‚ð—p‚¢‚œpŒãŽc‘¶‹ó‹C—ÊŒž­–@: “ªˆÊÝ’è‚̍H•v. ¬òŠ°”V1, Ž…@ú1, ‹{è•üŽq1, ’†ŽRŒ«Ži2, ŽR–{—E•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): ‘æ21‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2012/3/30), ‘åã.

723392. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Combined Petrosal Approach‚ɑ΂·‚éƒ`ƒ^ƒ“ƒvƒŒ[ƒg‚ð—p‚¢‚œd–Œ•Âœ–@‚̍H•v. ‹v{”ü^—1, •Ÿ“‡F“¿2, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Duke Univ. Medical Center, Division of Neurosurgery): ‘æ21‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2012/3/31), ‘åã.

723393. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]_ŒoŠO‰ÈŽèp‚É‚š‚¯‚éˆÀ‰¿Šg‘å‹Ÿ‚ÌŽg—p. ”nŸºˆêŽ÷1, Šâ–{˜a‹v1, “c’†@—m2, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO, 2Šƒ–èŽs—§•a‰@”]_ŒoŠO‰È): ‘æ21‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2012/3/31), ‘åã.

731079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘åŠw•a‰@‚É‚æ‚é”íÐ’nˆæ‚ւ̈ã—ÃŽx‰‡‚ÌŽŽ‚Ý. ’†ŒŽ–M» (”]ŠO): ’†‰›‘åŠwu‰‰‰ï (2011/4/28), ”ª‰€Žq.

731080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰È—̈æ‚É‚š‚¯‚é‚Ä‚ñ‚©‚ñ‚Ì–ò•šŽ¡—Ð헪. ‰ª@GG1, ÔŒ’ŒŽ÷, ŽR–{‹M“¹, ‰Á“¡“V”ü (1”]ŠO): ƒOƒ‰ƒNƒ\EƒXƒ~ƒXƒNƒ‰ƒCƒ““Á•ÊÀ’k‰ï (2011/8/6), “Œ‹ž.

731081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚±‚̍‘‚Ì‚ ‚è•û|–‹––E–ŸŽ¡ˆÈ~|. “¡ˆäŽF (”]ŠO): ‘æ15‰ñ_“ސì”]_ŒoŠO‰ÈŽèpŽè‹ZŒ€‹†‰ï (2011/9/17), ‰¡•l.

731082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚±‚̍‘‚݂̍è•û|“Œ“ú–{‘åkÐ‚ðŒoŒ±‚µ‚ā|. “¡ˆäŽF (”]ŠO): ‘æ29‰ñŽR—œ”]_ŒoŠO‰È§˜b‰ï (2011/9/20), b•{.

731083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]‘²’†‚̐f’f‚ÆŽ¡—Á`ƒ|ƒNƒbƒŠŽ€‚ƐQ‚œ‚«‚è‚ð‹N‚±‚·ŽŸŠ³`. “¡ˆäŽF (”]ŠO): ç—tŒ§–k‘’n‹æ”]‘²’†ƒtƒH[ƒ‰ƒ€2011 (2011/9/30), ²‘q.

731084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) V‹KR‚Ä‚ñ‚©‚ñ–òáƒŒƒxƒ`ƒ‰ƒZƒ^ƒ€â‚ɂ‚¢‚Ä, ‚»‚ÌŽg—pŒoŒ±‚ðŠÜ‚ß‚Ä. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ƒC[ƒPƒvƒ‰”­”„ˆêŽü”N‹L”O“Á•Êu‰‰‰ï in YOKOHAMA (2011/11/25), ‰¡•l.

731085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰Èˆã‚Æ‹³ˆç. “¡ˆäŽF (”]ŠO): ‘æ1‰ñŒF’J”]ŠO‰Èˆã‰ï (2012/1/18), ŒF’J.

731086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]‘²’†Ž¡—Â̌»ó‚ƍ¡Œã‚̉ۑè|SCU‚𓥂܂Š‚ā|. ŽR“c@Ÿ (”]ŠO): ‘å˜aŽsŠwpu‰‰‰ï (2012/2/15), ‘å˜a.

732032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒZƒ~ƒi[) Lateral Subboccipital approach. aãNŽ¡1, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ŽáŽè‚Ì‚œ‚ß‚Ì”÷¬”]_ŒoŠO‰È‰ð–UƒZƒ~ƒi[2011 (2011/5/29), •Ÿ‰ª.

732033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) ˜VE»‚Æ•a`”]‚Ì•a‹C, ‚à‚µ‚È‚Á‚œ‚çc. ‚»‚̑Ώˆ–@I`. ”nŸºˆêŽ÷ (”]ŠO): Šƒ–èŽsŽs–¯uÀ (2011/10/26), Šƒ–è.

732034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”]Žîᇌ€‹†‚ÌŒ»ó‚Æ“W–]: “Œ‹ž”]Žîᇌ€‹†‰ï‚̐¶‚¢—§‚¿‚ÆŒ»ó. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ‘æ41‰ñƒjƒ…[ƒEƒIƒ“ƒRƒƒWƒB‚̉ï (2011/12/3), “Œ‹ž.

733149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œo’±Œ`œ“ŽŽèp. ‘åàV¬”V, Ž…@ú1, ‰ª@GG1, “¡ˆäŽF1, Rhoton AL Jr2 (1”]ŠO, 2ƒtƒƒŠƒ_‘åŠw”]_ŒoŠO‰È): ŽáŽè‚Ì‚œ‚ß‚Ì”÷¬”]_ŒoŠO‰È‰ð–UƒZƒ~ƒi[2011 (2011/5/29), •Ÿ‰ª.

733150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”A•öÇ‚Å”­Ç‚µ‚œErdheim-Chester Disease‚̈ê—á: ’·ŠúŒo‰ßŠÏŽ@—á‚Ì•a—ŠŒ©‚©‚ç. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, “¡ˆäŽF1, –]ŒŽGŽ÷2 (1”]ŠO, 2_Œo“à): ‘æ52‰ñ“ú–{_Œo•a—Šw‰ï‘‰ïŠwpŒ€‹†‰ï (2011/6/4), ‹ž“s.

733151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ‰ƒ“ƒ_ƒ€”畆¶ŒŸ‚É‚æ‚èf’f‚ð‚Š‚œŒŒŠÇ“àƒŠƒ“ƒpŽî‚̈ê—á. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ‘“c@—ã2, ŒŽ@“ÖŽq3, “¡ˆäŽF1 (1”]ŠO, 2_Œo“à, 3•a—): ‘æ22‰ñ_“ސì”]ŽîᇃtƒH[ƒ‰ƒ€ (2011/8/26), ‰¡•l.

733152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Osler•a‚É”º‚€“ïa«•@oŒŒ‚ɑ΂·‚錌ŠÇ“àŽ¡—Â̌oŒ±. ²X–Ø—º1, ¬àV@m1, ‘q“c@²2, —é–؏ː¶2, ˆ¢•”Ž’q2, Œ¢Ž”@‰~2, “¡ˆäŽF2 (1Ž¬“c‘‡•a‰@”]_ŒoŠO‰È, 2”]ŠO): ‘æ115‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2011/9/3), “Œ‹ž.

733153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž¡—Âɓïa‚µ‚œŠO«CCF‚Ì1—á. m–؁@~1, ’Jè‹`“¿1, ”Ñ“cG•v, —é–؏ː¶1, ‘q“c@²1, ’†ŒŽ–M»1, ²“¡Œör1, Œ¢Ž”@‰~1, ˆ¢•”Ž’q1, “¡ˆäŽF1, Šâ–{˜a‹v1, ²X–Ø—º, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ115‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2011/9/3), “Œ‹ž.

733154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ÁˆÙ‚ÈŒo‰ß‚Ɖ摜ŠŒ©‚ð’悵‚œd–ŒŠOŒŒŽî‚̈ê—á. ‘å‹v•Û—mˆê1, ¬²–ì–õŒÈ1, ‰““¡¹F1, aãNŽ¡2 (1Šƒ–è“¿F‰ï‘‡•a‰@”]_ŒoŠO‰È, 2”]ŠO): ‘æ116‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”‰ïŠwpW‰ï (2011/12/10), “Œ‹ž.

733155. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘–ŒŽî‚ð‡•¹‚µ‚œGorlinÇŒóŒQ‚Ì•ªŽqEâ“`Šw“IŒŸ“¢. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, ˆÀˆä”ü]2, “¡ˆäŽF1, ‹{‰ºr”V3 (1”]ŠO, 2Œ`‘ÔŒn, 3•ªŽqˆâ“`): ‘æ116‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”‰ïŠwpW‰ï (2011/12/10), “Œ‹ž.

733156. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž‹°‚â’†”]‚Ì•a•Ï‚ŏoŒ»‚µ‚œUí‚ɑ΂µ, Ž‹°‹ÃŒÅp‚ðŽ{s‚µ‚œ4—á. ²“¡Ÿl1, “¡ˆäŽF1 (1”]ŠO): ‘æ379‰ñ_“ސì_Œo’k˜b‰ï (2011/12/15), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110010. [ŒŽ’˜] Tentorial detachment technique in the combined petrosal approach for petroclival meningiomas. Kusumi M1, Fukushima T, Mehta A, Aliabadi H, Nonaka Y, Friedman A, Fujii K1 (1”]ŠO): J Neurosurg 2011/3; 116 (3): 566-73. (‹v{”ü^—1, “¡ˆäŽF1)

H22-110011. [ŒŽ’˜] A new transvenous approach to the carotid-cavernous sinus via the inferior petrooccipital vein. Kurta A1, Suzuki S1, Iwamoto K1, Nakahara K1, Inukai M1, Niki J1, Sato K1, Yamada M1, Fujii K1, Kan S2, Katsuta T3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3‹ãBˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): J Neurosurg 2011/3; 116: 581-7. (‘q“c@²1, —é–؏ː¶1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, Œ¢Ž”@‰~1, m–؁@~1, ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2, Ÿ“cr˜Y3)

H20-320001. [Ç—á•ñ] “÷‰èŒ`¬‚ðŽå‘Ì‚Æ‚·‚éˆÆã•”ƒ‰ƒgƒPùN–E‚̈ê—á. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, “¿ŽR@é3, ŒŽ@“ÖŽq3, ŠâŸºŒ[ˆê3, ‰ªˆÀ@ŒM3, ì–ìM”V, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn, 3•a—): Neuro-Oncology 2008; 18 (2): 50-5.

H22-530001. [‚»‚Ì‘Œ (LETTER)] MacCarty Keyhole. Shimizu S1 (1”]ŠO): Neurosurg 2011/1; 68: E288. (Ž…@ú1)

H22-540009. [‚»‚Ì‘Œ (LETTER)] Orbitozygomatic approach‚É‚š‚¯‚éŠç–ʐ_Œo‘¹‚ð–h‚®‚œ‚ß‚Ì”÷¬‰ð–U‚̘_•¶‚ɂ‚¢‚ā^Ž…æ¶‚ւ̉ñ“š. Ž…@ú1, –ìŒû–Ÿ’j2 (1”]ŠO, 2ˆÇ—Ñ‘åŠwˆãŠw•””]_ŒoŠO‰È): Neurol Surg 2011/2; 39 (2): 178-9.

[’˜@‘]

H22-620003. [Šwp‘] (•ª’SŽ·•M)yƒCƒ‰ƒXƒgƒŒƒCƒeƒbƒh”]ŽîᇊO‰ÈŠwz‘å”]Š™‘–ŒŽî, p.132-5. “¡ˆäŽF1 (1”]ŠO), •ÒW: ‰Í–{Œ\Ži2, –{‹œˆê”Ž3, ŒI²@ŒO4 (2ŠÖŒˆã‰È‘åŠw”]_ŒoŠO‰È‹³Žö, 3MB‘åŠw”]_ŒoŠO‰È‹³Žö, 4L“‡‘åŠw‘åŠw‰@”]_ŒoŠO‰È‹³Žö), ˆãŠw‘‰@, “Œ‹ž, 2011/3”­s.


¬Ž™‰ÈŠw

[Šwp˜_•¶]

110168. [ŒŽ’˜] Percutaneous bilateral pulmonary artery banding using re-expandable covered stent: preliminary animal study. Nakahata Y1, Tomita H2, Kimura S1, Ando H1, Honda T1, Takanashi M1, Ishii M1: Kitasato Med J 2011/9; 41 (2): 165-69. (’†”š–퐶1, •x“c@‰p2, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –{“c@’1, ‚—œ@Šw1, Îˆä³_1: 1¬Ž™, 2º˜a‘å)

110169. [ŒŽ’˜] Incomplete Kawasaki disease: early findings consist of congestive heart failure due to valvular heart disease. Honda T1, Ogata S1, Ishii M1: Heart Asia 2011/9; 3 (1): 92. (–{“c@’1, •û¹•œ1, Îˆä³_1: 1¬Ž™)

110170. [ŒŽ’˜] Noninvasive assessment of pulmonary vascular resistance and pressure in patients with congenital heart disease: a new method using M-mode echocardiography. Kimura S1, Nakahata Y1, Honda T1, Ando H1, Ogata S1, Akiyama K1, Ogihara Y1, Ishii M1: J Echocardiography 2011; 9 (3): 137-41. (–Ø‘ºƒl1, ’†”š–퐶1, –{“c@’1, ˆÀ“¡@Žõ1, •û¹•œ1, HŽR˜a­1, îŒŽ‹`l1, Îˆä³_1: 1¬Ž™)

110171. [ŒŽ’˜] Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized Trial. Ogata S1, Ogihara Y1, Honda T1, Kon S1, Akiyama K1, Ishii M1: Pediatrics 2012/1; 129 (1): e17-23. (•û¹•œ1, îŒŽ‹`l1, –{“c@’1, ©@L–ç1, HŽR˜a­1, Îˆä³_1: 1¬Ž™)

110172. [ŒŽ’˜] V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlights protean agonism of V2R antagonists. Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, Miura K, Takubo N1, Iida A, Ueda N, Hashimoto M, Fujita T, Igarashi T, Sekine T, Iiri T: J Biol Chem 2012/2; 287 (3): 2099-106. (“c‹v•ÛŒ›s1: 1¬Ž™)

110173. [ŒŽ’˜] HLA-class II and class I genotypes among Japanese children with Type 1A diabetes and their families. Sugihara S, Ogata T, Kawamura T, Urakami T, Takemoto K, Kikuchi N, Takubo N1, Tsubouchi K, Horikawa R, Kobayashi K, Kasahara Y, Kikuchi T, Koike A, Mochizuki T, Minamitani K, Takaya R, Mochizuki H, Nishii A, Yokota I, Kizaki Z, Mori T, Shimura N, Mukai T, Matsuura N, Fujisawa T, Ihara K, Kosaka K, Kizu R, Takahashi T, Matsuo S, Hanaki K, Igarashi Y, Sasaki G, Soneda S, Teno S, Kanzaki S, Saji H, Tokunaga K, Amemiya S (The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes (JSGIT)): Pediatr Diabetes 2012/2; 13 (1): 33-44. (“c‹v•ÛŒ›s1: 1¬Ž™)

110174. [ŒŽ’˜] Late intravenous immunoglobulin treatment in patients with Kawasaki disease. Muta H, Ishii M1, Yashiro M, Uehara R, Nakamura Y: Pediatrics 2012/2; 129 (2): e291-7. (Îˆä³_1: 1¬Ž™)

120022. [ŒŽ’˜] ¬Ž™Šú‚ÌŒŒ—¬ˆË‘¶«ŒŒŠÇŠg’£”œ‰ž‚ÉŠÖ‚·‚鑪’è•û–@‚Ì•W€‰»‚Ɗ’l‚ÌŒŸ“¢|‘Šú“®–¬d‰»‚Ì•]‰¿‚Ì‚œ‚߂Ɂ|. ‚’J—³ŽO1, •ÐŽR”ŽŽ‹, X •Û•F, ‰œ‘ºŒªˆê, ‹Êˆä@_, ‰ª“c’m—Y, ”\“oMF, ŒŽ@Œõ•F, Îˆä³_2, ˆîˆä@Œc, ’†Œ•q—Y, ™ŒŽ–΍F, ˆÉ“¡‚¯‚¢Žq, ¬—э_Ži, ’·—䌒ŽŸ˜Y, ‹g‰i³•v, Îì‹M[, ‘åŠÖ••F (1‘åãˆã‰È‘åŠw, 2¬Ž™): ”ì–žŒ€‹† 2011/4; 17 (1): 49-53.

120023. [ŒŽ’˜] ’·ŠúŠÇ—’†‚̏¬Ž™‹CŠÇŽxšb‘§Š³ŽÒ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚̉e‹¿. ³“c“N—Y1, ˆéè@~1, ŽO‘º@®1, ¬ì—ÏŽj2, –ìŠÔ@„2, ’†‘º—zˆê1, ì–ì@–L1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2011/5; 25 (1): 104-7.

120024. [ŒŽ’˜] šb–”­ì‚Å“ü‰@‚µ‚œ“û—cŽ™‚̗Տ°”wŒi‚É‚æ‚éŠK‘w“IƒNƒ‰ƒXƒ^[•ªÍ‚ÌŽŽ‚Ý. ˆéè@~1, ³“c“N—Y1, ŽO‘º@®1, ¬ì—ÏŽj2, –ìŠÔ@„2, ‰Í–ì“O–ç1, ’†‘º—zˆê1, ì–ì@–L1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ƒAƒŒƒ‹ƒM[ 2011/5; 60 (5): 586-92.

120025. [ŒŽ’˜] ‹¹…’™—¯‚ð‡•¹‚µ‚œìè•a5—á‚É‚š‚¯‚錌’†VEGF”Z“x‚ÌŒŸ“¢. îŒŽ‹`l1, •û¹•œ1, ‹k“cˆê‹P1, HŽR˜a­1, ‹àŽq’‰O1, ©@L–ç1, –{“c@’1, Îˆä³_1 (1¬Ž™): “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/6; 115 (6): 1045-9.

120026. [ŒŽ’˜] •êŽq‚Æ‚à‚ɐ¶Œã1”NˆÈ“à‚Ì“ûŽ™Šú‚É”­Ç‚µ‚œ1Œ^“œ”A•aeŽq—á. —é–Ø“Þ’ÃŽq1, “c’†GŽ÷1, ‘åXˆÀŒb1, “c‹v•ÛŒ›s2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™): “œ”A•a‚Æ”DP 2011/8; 11 (1): 111-5.

120027. [ŒŽ’˜] ¬Ž™1Œ^“œ”A•aŠ³ŽÒ‚É‚š‚¯‚錌’†ƒPƒgƒ“‘ÌŽ©ŒÈ‘ª’è‚Ì—L—p«‚ÌŒŸ“¢. ¬—э_Ži1, Œüˆä“¿’j2, ŒÜ\—’—T3, ‰Yã’B•F4, “c‹v•ÛŒ›s5, ‹e’rMs6, ‹e’r@“§7, Œ‰YM•v8, ì‘º’qs9, ‰J‹{@L10 (1ER—œ‘åŠw, 2ˆ®ìˆã‰È‘åŠw, 3ŒÜ\—’¬Ž™‰È, 4“ú–{‘åEw, 5¬Ž™, 6‰¡•lŽs—§‘åŠw, 7VŠƒ‘åŠw, 8¹“¿‘åŠw, 9‘åãŽs—§‘åŠw, 10é‹Êˆã‰È‘åŠw): “ú–{æi“œ”A•aŽ¡—ÃŒ€‹†‰ïŽGŽ 2011/10; 7 (suppl): 24-8.

120028. [ŒŽ’˜] _“ސ쌧Œ§‰›–k‘Š’n‹æ‚É‚š‚¯‚éLate pretermŽ™‚̏o¶ó‹µ‚ÆPalivizumab“Š—^‚ÉŠÖ‚·‚錟“¢. ˆÉâ‰ës1,2, ‰¡ŠÖ—Sˆê˜Y1,2, –ì“n³•F1,3, Îˆä³_1 (1‘Š–Í–ì•a‰@, 2¬Ž™, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/12; 47 (4): 878-81.

120029. [ŒŽ’˜] •› (–T) ˆô“ªŠÔŒ„”^ᇂðŒ_‹@‚É”­Ç‚µ‚œGriselÇŒóŒQ (”ñŠO«ŠÂŽ²’ňŸ’E‰P) ‚Ì1—á. •ô”öŒb—œ1,2, ‰¡“csŽj1, ‚—œ@Šw1,2, ²”Œ•q—º1, ¡ˆä@“T2, Ä“¡@—T2, ‰ª–{‰p–Ÿ2, ‰i·—T‰ÀŽq1,2, –{“c@’1,2, Îˆä³_2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ¬Ž™“à‰È 2012/1; 44 (1): 135-8.

120030. [ŒŽ’˜] ’†•_ŒoÇó‚𔺂€”N’·Ž™‚ÌPandemic (H1N1) 2009 ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚̐‘‰tƒTƒCƒgƒJƒCƒ“. –ìX“c–L1, Šâèr”V1, HŽR˜a­1, îŒŽ‹`l1, ‹k“cˆê‹P1, •û¹•œ1, Îˆä³_1 (1¬Ž™): “ú–{¬Ž™‹~‹}ˆãŠw‰ïŽGŽ 2012/3; 11 (1): 78-82.

522094. [uÀ]y“ÁW: ìè•a‰“ŠuŠú‚̏”–â‘èz˜•¶. Îˆä³_ (¬Ž™): zŠÂŠí“à‰È 2011/4; 69 (4): 317.

522095. [uÀ]y“ÁW: ìè•a‰“ŠuŠú‚̏”–â‘èzìè•a‹}«Šúf’f. ²“¡‰Á‘ãŽq1,2, Îˆä³_2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™): zŠÂŠí“à‰È 2011/4; 69 (4): 318-23.

522096. [uÀ]y“ÁW: ìè•a‚Ì–{‘Ô‚É‚¹‚Ü‚é|ŒÃ‚­‚ĐV‚µ‚¢Œ€‹†‚©‚ç|zIII Ž¡—Âɂ¹‚Ü‚é (Ž¡—Ö@E—L—p«‚©‚ç–{‘Ô‚É‚¹‚Ü‚é)@–ƉuƒOƒƒuƒŠƒ“‚̍ì—p‹@˜‚Æ•s‰ž—á. îŒŽ‹`l1, Îˆä³_1 (1¬Ž™): ¬Ž™‰Èf—à 2011/8; 74 (8): 1175-81.

522097. [uÀ]y“ÁW: ¬Ž™ƒAƒŒƒ‹ƒM[ŽŸŠ³2011: ˆâ“`Žq‚©‚çŽÀ’nˆã—Â܂ŁzƒRƒ‰ƒ€@ƒAƒŒƒ‹ƒM[ŽŸŠ³f—Âɂš‚¯‚éIgE RASTŒŸž‚̈Ӗ¡‚ÆŒÀŠE. –ìŠÔ@„ (¬Ž™): ¬Ž™“à‰È 2011/11; 43 (11): 1942-46.

522098. [uÀ]y“ÁW: Šg’£‹@”\‚ðŒ©’Œ‚·z¬Ž™‚É‚Ý‚ç‚ê‚éŠg’£‹@”\áŠQ. –{“c@’1, Îˆä³_1 (1¬Ž™): SƒGƒR[ 2011/12; 12 (12): 1164-70.

522099. [uÀ]y“ÁW: ¬Ž™‚Ìšq“f|f’f, Ž¡—Ã, ŠÇ—‚̐i•àz‘˜_@Šw“¶ŠúˆÈ~‚Ìšq“f‚ÌŒŽˆö‚Ɛf’fEŠÇ—Žè‡. “¡•‹`l (¬Ž™): ¬Ž™“à‰È 2011/12; 43 (12): 1986-90.

522100. [uÀ]y“ÁW: ¬Ž™Á‰»ŠÇ“àŽ‹‹Ÿ: f’f‚ÆŽ¡—Â̍őOüEzDieulafoy’×ᇂɑ΂·‚é“àŽ‹‹ŸŽ¡—Ã. “¡•‹`l (¬EE: ¬Ž™ŠO‰È 2012/3; 44 (3): 268-71.

540015. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]y•œ¬21”N“x`•œ¬23”N“x‰ÈŠwŒ€‹†”ï•â•‹àŠî”ÕŒ€‹† (C)uìè•a‚ÌŒø‰Ê“IŽ¡—Ö@‚ÌŠJ”­‚Æ•aˆö‹†–Ÿvz•ªŽqˆâ“`Šw“IŠî”ՂƃvƒƒeƒI[ƒ€‰ðÍ. Îˆä³_1, ’†”š–퐶1, –Ø‘ºƒl1 (1¬Ž™): •œ¬21”N“x`•œ¬23”N“x‰ÈŠwŒ€‹†”ï•â•‹àŠî”ÕŒ€‹† (C) Œ€‹†¬‰Ê•ñ‘ 2012/3; p.1-208.

[’˜@‘]

620102. [Šwp‘] (•ª’SŽ·•M)y¬Ž™‰ÈŠw ‰ü’ù‘æ10”Łzìè•a, p.548-53. Îˆä³_ (¬Ž™), •Ò: ŒÜ\—’—², •¶Œõ“°, “Œ‹ž, 2011/4”­s.

620103. [Šwp‘] (•ª’SŽ·•M)y¬Ž™‹~‹}Ž¡—ÃKƒCƒhƒ‰ƒCƒ“ ‰ü’ù‘æ2”ŁzIII ‚š‚à‚È‹~‹}ŽŸŠ³@C zŠÂŠíŽŸŠ³@4. ìè•a, p.259-64. Îˆä³_1, îŒŽ‹`l1 (1¬Ž™), •Ò: ŽsìŒõ‘Ÿ˜Y, f’f‚ÆŽ¡—ÃŽÐ, 2011/4”­s.

620104. [Šwp‘] (•ª’SŽ·•M)y¬Ž™‰Èf—ÃKƒCƒhƒ‰ƒCƒ“|ÅV‚̐f—ÃŽwj|‘æ2”Łz4. zŠÂŠíŽŸŠ³@ìè•a, p.128-32. Îˆä³_1, îŒŽ‹`l1 (1¬Ž™), •Ò: ŒÜ\—’—², ‘‡ˆãŠwŽÐ, 2011/5”­s.

620105. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̐S‘ŸŽèp‚Ì“K‰ž‚ÆŽŠ“KŽžŠúzIII. æ“V«SŽŸŠ³‚š‚æ‚я¬Ž™SŽŸŠ³‚ÌŽèp“K‰ž‚ÆŽŠ“KŽžŠú@8. ìè•a@¬Ž™‰È, p.251-4. Îˆä³_ (¬Ž™), ŠÄC: ‹gìƒˆê, •Ò: ˆÉ“¡@_, ‚—œGˆê˜Y, Œ‹{Œì˜Y, “n•ÓO”V, ‘å–å‰ë•v, •¶Œõ“°, “Œ‹ž, 2011/9”­s.

620106. [’˜‘] (•ª’SŽ·•M)y‹^–â‰ðŒˆ@¬Ž™‚̐f‚©‚œ (¬Ž™“à‰È 43 (‘Š§))zII. ¬Ž™‚̐fŽ@–@@18. SŽG‰¹‚Ì’®f‚Ì’ˆÓ“_‚ð‹³‚Š‚Ä‚­‚Ÿ‚³‚¢, p.132-5. Îˆä³_ (¬Ž™), ‹€•Ò:w¬Ž™“à‰Èxw¬Ž™ŠO‰Èx•ÒWˆÏˆõ‰ï, “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2011/12”­s.

620107. [’˜‘] (•ª’SŽ·•M)y‹^–â‰ðŒˆ@¬Ž™‚̐f‚©‚œ (¬Ž™“à‰È 43 (‘Š§))zVIII. ŽŸŠ³•Ê‚̐f—Á@G. zŠÂŠíŽŸŠ³(—cŽ™Šú)@6. Š¥“®–¬Šg’£‚ª‚ ‚Á‚œìè•a‚ŃAƒXƒsƒŠƒ“‚𒆎~‚·‚é‚©‚Ç‚€‚©‚Í‚Ç‚Ì‚æ‚€‚ÉŒˆ‚ß‚œ‚ç‚æ‚¢‚Å‚·‚©, p.615-6. Îˆä³_ (¬Ž™), ‹€•Ò:w¬Ž™“à‰Èxw¬Ž™ŠO‰Èx•ÒWˆÏˆõ‰ï, “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2011/12”­s.

620108. [’˜‘] (•ª’SŽ·•M)y‹^–â‰ðŒˆ@¬Ž™‚̐f‚©‚œ (¬Ž™“à‰È 43 (‘Š§))zVIII. ŽŸŠ³•Ê‚̐f—Á@H. Á‰»ŠíŽŸŠ³@7. Å‹ß‚̉º—Ÿ‚ɑ΂·‚éHŽ–—Ö@‚̍l‚Š‚©‚œ‚ɂ‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢, p.684-7. “¡•‹`l (¬Ž™), ‹€•Ò:w¬Ž™“à‰Èxw¬Ž™ŠO‰Èx•ÒWˆÏˆõ‰ï, “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2011/12”­s.

620109. [’˜‘] (•ª’SŽ·•M)y‹^–â‰ðŒˆ@¬Ž™‚̐f‚©‚œ (¬Ž™“à‰È 43 (‘Š§))zVIII. ŽŸŠ³•Ê‚̐f—Á@K. _ŒoŽŸŠ³@7. R‚Ä‚ñ‚©‚ñ–ò‚ð‘I‘ð‚·‚éÛ‚Ì’ˆÓ“_‚ð‹³‚Š‚Ä‚­‚Ÿ‚³‚¢, p.804-7. Šâèr”V (¬Ž™), ‹€•Ò:w¬Ž™“à‰Èxw¬Ž™ŠO‰Èx•ÒWˆÏˆõ‰ï, “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2011/12”­s.

620110. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽwj 2012”N”Ł|Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚ézæ“V«SŽŸŠ³‚Ì’áŽ_‘f”­ì, p.1151-2. Îˆä³_ (¬Ž™), •ÒW: ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ‹ž, 2012/1”­s.

620111. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̏¬Ž™Ž¡—ÃŽwj ‘æ15”ŁzŽ_‘f—Ö@ (Ý‘îŽ_‘f—Ö@‚ðŠÜ‚Þ), p.55-6. Îˆä³_ (¬Ž™), •ÒW: ‘åŠÖ••F, ŒÃì@‘Q, ‰¡“crˆê˜Y, …Œû@‰ë, ˆãŠw‘‰@, “Œ‹ž, 2012/2”­s.

620112. [Šwp‘] (•ª’SŽ·•M)yÃ’—p–ƉuƒOƒƒuƒŠƒ“»Üƒnƒ“ƒhƒuƒbƒNzìè•a‹}«Šú, p.91-100. Îˆä³_ (¬Ž™), ŠÄC: ³‰ª@“O, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711006. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Cardiovascular problems and management of Kawasaki disease. Ishii M1: UCSD grandround 2011 (2011/11/12), San Diego, USA. (Îˆä³_1: 1¬Ž™)

712022. [Šw‰ï (‘Û)] (Keynote Lecture III) Percutaneous coronary intervention for Kawasaki Disease. Ishii M1: The 10th International Kawasaki Disease Symposium (2012/2/9), Kyoto. (Îˆä³_1: 1¬Ž™)

713085. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Quantitative Evaluation of the Hemodynamics in Fontan Circulation. Honda T1, Itatani K2, Kimura S1, Nakahata Y1, Miyaji K3, Ishii M1: 45th Annual Meeting of the Association for European Pediatric Cardiology (2011/5/19), Granada, Spain. (–{“c@’1, ”Â’JŒcˆê2, –Ø‘ºƒl1, ’†”š–퐶1, ‹{’n@ŠÓ3, Îˆä³_1: 1¬Ž™, 2“Œ‹ž‘åŠw, 3S‘ŸŒŒŠÇŠO)

713086. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The efficacy and safety of new strategy for refractory Kawasaki disease. Ishii M1, Ogata S1, Honda T1, Ogihara Y1: 45th Annual Meeting of the Association for European Pediatric Cardiology (2011/5/20), Granada, Spain. (Îˆä³_1, •û¹•œ1, –{“c@’1, îŒŽ‹`l1: 1¬Ž™)

713087. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Hypothyroxinemia in low birth weight infants detected by neonatal mass-screening; a hospital-based study. Ito T1, Yokota M, Nowatashi M2, Ishii M1: ‘æ10‰ñ¢ŠEŽüŽYŠúŠw‰ï (2011/11/8-11), ƒ‚ƒ“ƒeƒrƒfƒI, ƒEƒ‹ƒOƒAƒC, JPM (Journal of Perinatal Medicine) 2011; 39†. (ˆÉ“¡®Žu1, –ì“n³•F2, Îˆä³_1: 1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã)

713088. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The immune dynamics of Kawasaki disease and vaccination. Sato K1,2, Inagaki H1, Kon S1, Ogihara Y1, Soeda Y2, Iwanami N2, Nonoyama K2, Minoura K2, Ishii M2: The 10th International Kawasaki Disease Symposium (2012/2/8), Kyoto. (²“¡‰Á‘ãŽq1,2, ˆîŠ_@“µ1, ©@L–ç1, îŒŽ‹`l1, “Y“c—RŠóŽq2, Šâ”g’Œ”ü2, –ìXŽRŸl2, –¥‰YŽ‘¥2, Îˆä³_2: 1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™)

713089. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Use@of z-score to compare coronary artery outcomes between the US and Japan. Ogata S1, Ueda K, Tremouler A, Ogihara Y1, Ishii M1, Burns JC: The 10th International Kawasaki Disease Symposium (2012/2/8), Kyoto. (•û¹•œ1, îŒŽ‹`l1, Îˆä³_1: 1¬Ž™)

713090. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Use of Egami Score to Predict Coronary Artery Abnormality. Ogihara Y1, Ogata S1, Ebato K1, Sato K1, Honda T1, Ishii M1: The 10th International Kawasaki Disease Symposium (2012/2/8), Kyoto. (îŒŽ‹`l1, •û¹•œ1, ]”gŒËF•ã1, ²“¡‰Á‘ãŽq1, –{“c@’1, Îˆä³_1: 1¬Ž™)

713091. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical utility of 3 scoring systems in predicting resistance of intravenous immunoglobulin: a comparison study. Ogihara Y1, Ogata S1, Ebato K1, Sato K1, Honda T1, Ishii M1: The 10th International Kawasaki Disease Symposium (2012/2/8), Kyoto. (îŒŽ‹`l1, •û¹•œ1, ]”gŒËF•ã1, ²“¡‰Á‘ãŽq1, –{“c@’1, Îˆä³_1: 1¬Ž™)

713092. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Microarray study of gene expression after infliximab treatment in patients with Kawasaki disease. Ogihara Y1, Ogata S1, Ebato K1, Sato K1, Honda T1, Ishii M1: The 10th International Kawasaki Disease Symposium (2012/2/9), Kyoto. (îŒŽ‹`l1, •û¹•œ1, ]”gŒËF•ã1, ²E¡‰Á‘ãŽq1, –{“c@’1, Îˆä³_1: 1¬Ž™)

713093. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Left ventricular aneurysm long after Kawasaki disease: a case report. Ebato K1, Ogihara Y1, Sato K1, Honda T1, Ando H1, Kimura S1, Nakahata Y1, Ishii M1: The 10th International Kawasaki Disease Symposium (2012/2/9), Kyoto. (]”gŒËF•ã1, îŒŽ‹`l1, ²“¡‰Á‘ãŽq1, –{“c@’1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ’†”š–퐶1, Îˆä³_1: 1¬Ž™)

713094. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical utility of a new strategy for preventing coronary artery lesions in refractory Kawasaki disease patients: a randomized prospective study. Ishii M1, Ogata S1, Ogihara Y1, Sato K1, Ebato K1: The 10th International Kawasaki Disease Symposium (2012/2/9), Kyoto. (Îˆä³_1, •û¹•œ1, îŒŽ‹`l1, ²“¡‰Á‘ãŽq1, ]”gŒËF•ã1: 1¬Ž™)

722080. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y¬Ž™SŽŸŠ³‚̍ŐVŽ¡—Ázìè•a‚̐¬lŠú‚Ì–â‘è“_‚ÆŽ¡—Ã. Îˆä³_ (¬Ž™): ‘æ59‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2011/9/23), _ŒË, “ú–{S‘Ÿ•aŠw‰ïŽ 2011/8; 6 (Suppl I): 174.

722081. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‹³ˆçƒZƒbƒVƒ‡ƒ“zìè•a‚ÌŠî–{‚©‚猩’Œ‚·@6 ‡•¹ÇuS‘ŸŒŒŠÇŒn‡•¹Ç‚ɂ‚¢‚āv. Îˆä³_ (¬Ž™): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/10/1), ‰¡•l, Ž˜^W 2011; p.27.

722082. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)–ƉuŠw“IŠÏ“_‚©‚猩‚œ‘å‹C‰˜õ: ƒwƒ‹ƒp[T×–Eƒpƒ‰ƒ_ƒCƒ€‚ÆŽŸŠ³‚Ì”­Ç. –ìŠÔ@„ (¬Ž™): ‘æ48‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï^‘æ16‰ñƒAƒWƒA‘Ÿ•œ—m¬Ž™ƒAƒŒƒ‹ƒM[ŒÄ‹zŠí–ƉuŠw‰ï‡“¯Šwp‘å‰ï (2011/10/30), •Ÿ‰ª, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2011/8; 25 (3): 467.

722083. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) Meet the Expert 1 Quality of Life and Vascular Function in Long-term after Kawasaki Disease Patients. Îˆä³_ (¬Ž™): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/16), •Ÿ‰ª, ‘æ76‰ñŠwpW‰ïŽ˜^CDEƒvƒƒOƒ‰ƒ€ Circulation Journal 2012; 76 (Suppl I): 445.

723394. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) speckle tracking–@‚ªSŽºÄ“¯Šú‚Ì•]‰¿‚É—LŒø‚Å‚ ‚Á‚œ’PS–[’PSŽº‚Ì1—á. –Ø‘ºƒl1, ’†”š–퐶1, ‘å˜a“c‰ÄŽq1, ˆÀ“¡@Žõ1, –{“c@’1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ22Eñ“ú–{SƒGƒR[}Šw‰ïŠwpW‰ï (2011/4/21), Ž­Ž™“‡.

723395. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Acrodysostosis‚Ɛf’f‚µ‚œƒNƒŒƒ`ƒ“Ç‚ÆPHP‚̈ٓ¯|GNAS1ˆâ“`Žq‰ðÍ‚ÆPTH•‰‰×ŽŽŒ±|. Œ‰YM•v1, •HÀ@º2, ‘åŽR‹XG3, ŽÂŒŽ@Ž¡4, ‰¡“csŽj5, ‘å’Ь”V6, “c‹v•ÛŒ›s6 (1¹“¿‘åŠw, 2àՋŠˆã‰È‘åŠw, 3‘åŽR¬Ž™‰È, 4‚µ‚̂͂珬Ž™ƒNƒŠƒjƒbƒN, 5‘Š–ÍŒŽ‹Š“¯•a‰@, 6¬Ž™): ‘æ84‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2011/4/21), _ŒË, “ú–{“à•ª”åŠw‰ïŽGŽ 2011/4; 87 (1): 266.

723396. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 3ƒÀHSD‘jŠQÜ‚ª‘tŒ÷‚µ‚œACTH”ñˆË‘¶«CushingÇŒóŒQ‚̏¬Ž™2Ç—á. “c‹v•ÛŒ›s1,2, ‹k“cˆê‹P2, ‘å’Ь”V2, •—’£áÁ—R”ü2, ‰¡“csŽj3, Îˆä³_2 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2¬Ž™, 3‘Š–ÍŒŽ‹Š“¯•a‰@): ‘æ84‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2011/4/23), _ŒË, “ú–{“à•ª”åŠw‰ïŽGŽ 2011/4; 87 (1): 382.

723397. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)Œ{—‘ƒAƒŒƒ‹ƒM[Š³Ž™‚ɑ΂·‚éŠÉ™“ÁˆÙ“IŒoŒû–Ɖu—U“±—Ö@‚ÌŽŽ‚Ý. ¬ì—ÏŽj1,2, ŽOãŒ’‘Ÿ˜Y1, ‘åŽÄW—m3, ˆéè@~4, ì–ì@–L4, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@, 4‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@): ‘æ23‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï (2011/5/14), ç—t, ƒAƒŒƒ‹ƒM[ 2011/4; 60 (3-4): 474.

723398. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÉ™“ÁˆÙ“IŒoŒû–Ɖu—U“±—Ö@‚ðŽŽ‚Ý‚œ¬”žƒAƒŒƒ‹ƒM[Š³Ž™‚Ì2Ç—á. ŽOãŒ’‘Ÿ˜Y1, ¬ì—ÏŽj1,2, ‘åŽÄW—m3, ˆéè@~4, ì–ì@–L4, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@, 4‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@): ‘æ23‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï (2011/5/14), ç—t, ƒAƒŒƒ‹ƒM[ 2011/4; 60 (3-4): 474.

723399. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¶Ž™E“ûŽ™Á‰»ŠÇƒAƒŒƒ‹ƒM[ (FPIES) ‚Ì‘o‘Ù2‘gÇ—á. ²“¡‰Á‘ãŽq1,2, “yŠò@•œ1,2, •ô”öŒb—œ1,2, îŒŽ‹`l2, •û¹•œ2, ª–{•¶Žq1,2, â“Œ—R‹I2, Îˆä³_2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™): ‘æ23‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï (2011/5/14), ç—t, ƒAƒŒƒ‹ƒM[ 2011/4; 60 (3-4): 466.

723400. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œg‘Ñ“d˜b‚ð—p‚¢‚œƒŠƒAƒ‹ƒ^ƒCƒ€¬Ž™‹CŠÇŽxšb‘§ŠÇ—ƒVƒXƒeƒ€ (ARMS) ‚ÌŽŽ‚Ý. ˆéè@~1, ì–ì@–L1, ¬ì—ÏŽj2, –ìŠÔ@„2, ‰Í–ì“O–ç1, ’†‘º—zˆê1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ‘æ23‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï (2011/5/15), ç—t, ƒAƒŒƒ‹ƒM[ 2011/4; 60 (3-4): 494.

723401. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žá”N”­Ç2Œ^“œ”A•a‚̐S—ŽÐ‰ï“I”wŒi‚̉ðÍ|–k—¢‘åŠw•a‰@‚É‚š‚¯‚é‰ß‹Ž30”NŠÔ‚ÌŒŸ“¢|. ‘å’Ь”V1, ‰º•l^—¢Žq1, “c‹v•ÛŒ›s1 •—’£^—R”ü1, ‰¡“csŽj2, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ‹Š“¯•a‰@): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-368.

723402. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Gabapentin‚ð3”NŠÔ“à•ž‚µ‚œ•”•ª”­ì20—á‚É‚š‚¯‚錌’†”Z“x‚Ì—L—p«. Šâèr”V1, –ìX“c–L1, ×“c‚Ì‚Œ‚Ý1,2, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ—È牀): ‘æ53‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (2011/5/27), ‰¡•l, ”]‚Æ”­’B 2011/5; 43 (Suppl): S313.

723403. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ’èŒ^“IŒo‰ß‚ð‚Æ‚éƒEƒBƒ‹ƒ\ƒ“•a‚̐f’f‚ÉŠÖ‚·‚錟“¢. ˆéŠL“TŽq1, ¬ìˆºŽq1, ˆäã”ü¹Žq1, •œˆä@1, …Œû_ˆê1, ŠÖªFŽi1, –ìX“c–L2, ’†‘ºM–ç2, â“Œ—R‹I2, Â–ØŒp–«1 (1“Œ–M‘åŠw, 2¬Ž™): ‘æ53‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (2011/5/28), ‰¡•l, ”]‚Æ”­’B 2011/5; 43 (Suppl): S250.

723404. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šw—îŠúd“x”]«–ƒáƒŽ™‚ÉŒ©‚ç‚ê‚é‘ÌŠ²•ÏŒ`‚Ì’è—Ê“I•]‰¿|‰ñù•ÏŒ`‚𖳎‹‚µ‚Ä‚æ‚¢‚©?|. ²“¡t•F1, Šâèr”V2 (1ˆã—Éq¶Šw•”, 2¬Ž™): ‘æ46‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2011/5/28), ‹{è, —Šw—Ö@Šw 2011/4; 38 (Suppl 2): OF2-039 (CD-ROM).

723405. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žá”N”­Ç‚QŒ^“œ”A•a‚ɍ‡•¹‚·‚éS—“I–â‘è‚ÌŒŸ“¢. ‘å’Ь”V (¬Ž™): ‘æ52‰ñ“ú–{SgˆãŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2011/6/9), ‰¡•l, SgˆãŠw 2011/6; 51 (6): 535.

723406. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒ^ƒEƒCƒ‹ƒXŠŽõÇ‚É‚Æ‚à‚È‚¢d“ĂȐ_ŒoŠw“IŒãˆâÇ‚ð‚«‚œ‚µ‚œ2—á. –{“c@’1, ‹àŽq’‰O1, –ìX“c–L1, ’†”š–퐶1, –ì“n³•F2, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ25‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ï (2011/6/10), “Œ‹ž, “ú–{¬Ž™‹~‹}ˆãŠw‰ïŽGŽ 2011/6; 10 (2): 245.

723407. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FontanzŠÂ‚É‚š‚¯‚éƒGƒlƒ‹ƒM[‘¹Žž‚É‚æ‚éS•‰‰×‚Ì’è—Ê•]‰¿. –{“c@’1, ”Â’JŒcˆê2, –Ø‘ºƒl1, ’†”š–퐶1, ‹{’n@ŠÓ3, Îˆä³_1 (1¬Ž™, 2“Œ‹ž‘åŠw, 3S‘ŸŒŒŠÇŠO): ‘æ47‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2011/7/6), •Ÿ‰ª, “ú–{¬Ž™zŠÂŠíŠw‰ïEGŽ 2011/6; 27 (Suppl): 183.

723408. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SŽºÄ“¯Šú—Ö@‚ªS‹@”\‰ü‘P‚É—LŒø‚Å‚ ‚Á‚œ’PS–[’PSŽº‚Ì1—á. –Ø‘ºƒl1, ’†”š–퐶1, ˆÀ“¡@Žõ1, ‘å˜a“c‰ÄŽq1, –{“c@’1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ47‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2011/7/6), •Ÿ‰ª, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2011/6; 27 (Suppl): 287.

723409. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äPŒŽ•a‡•¹”DP‚ƐV¶Ž™‚ÌŒo‰ß‚ÉŠÖ‚·‚錟“¢. ŽRŒûˆ»”T1, îŒŽ‹`l1, ‘剪–ƒ—¢1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ˆÉâ‰ës1, ŒÇè‰ëŽq1, –ì“n³•F2, â“Œ—R‹I1, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 380.

723410. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _“ސ쌧‚É‚š‚¯‚éV¶Ž™‘h¶–@ (NCPR) •‹y‘£i‚ÌŒ»ó. ¯–ì—€•v1,2, ’–’J‘׎j1, ŠâèŽu•ä1, Šì‘œ–ƒˆßŽq1, ù–{—D‰À1, “‡‘ܗяG1, ŠÖ@˜a’j1, ŒàV‘PŽ÷1, ŒŠª@Ž 1, –ì“n³•F1,3, ³–؁@G1, é@—T”V1 (1V¶Ž™‘h¶–@•‹yŽ–‹Æ_“ސ쐄iˆÏˆõ‰ï(_“ސìNCPRˆÏˆõ‰ï), 2_“ސ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[, 3¬Ž™): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 414.

723411. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _“ސ쌧Œ§‰›–k‘Š’n‹æ‚É‚š‚¯‚éLate pretermŽ™‚ÌŠÇ—ó‹µ‚Æpalivizumab“Š—^. ˆäâ‰ës1, Îˆä³_1 (1¬Ž™): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 433.

723412. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) AllgroveÇŒóŒQ‚Ɛf’f‚µ‚œ’Ž’áo¶‘̏dŽ™‚Ì1—á. ŒÏè‰ëŽq1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ˆÉâ‰ës1, ‘å’Ь”V1, –ì“n³•F2, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 559.

723413. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œJoubertÇŒóŒQ‚Ì2—á. ™ŽR®l1, ‘剪–ƒ—1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, HŽR˜a­1, ŒÏè‰ëŽq1, –ì“n³•F2, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 563.

723414. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÔŽ¿«”x‰Š‚ð‡•¹‚µ‚œUniversal acquired melanosis (Carbon baby) ‚ƍl‚Š‚ç‚ê‚é’jŽ™—á. ‹àŽq’‰O1, “ì–쏉1, •Ÿ“‡’‹`1, ã“cN‹v1, ŒŽ@^l1, â“Œ—R‹I1, Îˆä³_1, VŽRŽj˜N2, Ÿ‰ªŒ›¶2 (1¬Ž™, 2”畆): ‘æ35‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ïŠwp‘å‰ï (2011/7/23), ‰¡•l.

723415. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) NICU‚É‚š‚¯‚é”畆•ÛŒì‚ÆŠÇ—FÝ‘ُT”‚É‚æ‚鉊Ç•Ï‰». ‘剪–ƒ—¢1, ˆÉ“¡®Žu1, ˆäâ‰ës1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, –ì“n³•F2, â“Œ—R‹I1, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ35‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ïŠwp‘å‰ï (2011/7/23), ‰¡•l.

723416. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —nŒŒ«”A“ŏǐ«ÇŒóŒQ‚ւ̐V‚µ‚¢ƒAƒvƒ[ƒ`|ƒgƒƒ“ƒ{ƒ‚ƒfƒ…ƒŠƒ“ƒ¿‚ÌŽg—pŒoŒ±|. –{“c@’1, •û¹•œ1, •ô”öŒb—œ1, ‰i·—T‰ÀŽq1, ŽRŒûˆ»”T1, ‹àŽq’‰O1, “¡•‹`l1, ’†‘ºM–ç1, Îˆä³_1 (1¬Ž™): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/12), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 388.

723417. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠJSpŒãŠ³Ž™‚ÌŽŠ“K—\–hÚŽíŽžŠú‚ÌŒŸ“¢|×–E«‚š‚æ‚щt«–Ɖu”\‚©‚ç‚̃Aƒvƒ[ƒ`|. ’†”š–퐶1, •û¹•œ1, ‘å˜a“c‰ÄŽq1, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/12), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 405.

723418. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “û—cŽ™‚̈ݒ°‰Š‚É”º‚€áz¹”­ì‚̗Տ°ŒŸ“¢. ‚—œ@Šw1,2, Œì‹ÅŽq2, •ô”öŒb—œ1,2, Îˆä³_2, ²”Œ•q—º1, ’†ŠÚ®–ç1, ‰¡“csŽj1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/13), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 299.

723419. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰fŽž‚É’˜–Ÿ‚ÈŒŒŽNaˆÙí‚ð’悵‚œ2Ç—á. Œì‹ÅŽq1,2, ‰¡“csŽj1, ’†ŠÚ®–ç1, ²“¡•qs1, ©@L–ç1,2, ‘剪–ƒ—¢1,2, ‰¡ŠÖ—Sˆê˜Y2, â“Œ—R‹I2, Îˆä³_2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/13), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 435.

723420. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™Šú×‹Û«‘–Œ‰Š11—á‚̗Տ°ŒŸ“¢. •ô”öŒb—œ1,2, Œì‹ÅŽq1,2, ‚—œ@Šw1,2, ²”Œ•q—º1, ‰¡“csŽj1, ’†ŠÚ®–ç1, Îˆä³_2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïEwpW‰ï (2011/8/13), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 457.

723421. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ìè•aŠ³ŽÒ‚É‚š‚¯‚é11`20•a“ú‚ÉŠJŽn‚³‚ê‚œ–ƉuƒOƒƒuƒŠƒ“‚ÌŽ¡—ÃŒø‰Ê. –Ž“cLŽÀ1, Îˆä³_2, ‰®‘ã^‹|3, ãŒŽ—¢’ö3, ’†‘ºDˆê3 (1”Ñ’ËŽs—§•a‰@, 2¬Ž™, 3Ž©Ž¡ˆã‰È‘åŠw): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/13), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 459.

723422. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”D•w‚ƐV¶Ž™‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1 pdm) ƒƒNƒ`ƒ“‚ÌŒø‰Ê‚̖ƉuŠw“IŒŸØ. ’†“‡@Œ\1, ŒÏè‰ëŽq1, –ì“n³•F2, ”Ñ“‡^‹IŽq1, â“Œ—R‹I1, Îˆä³_1, “V–ì@Š®3, ¯“c@—²3, ’·ˆä³º4, “n糕ô—Y5 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3ŽY‰È, 4–k—¢Œ€‹†Š¶•š»ÜŒ€‹†Š, 5–k—¢¶–œ‰ÈŠwŒ€‹†Š): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/14), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 342.

723423. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«ìè•a‚ɑ΂·‚鎡—Ð헪|”N—î‘w•Ê‚̃Aƒvƒ[ƒ`|. îŒŽ‹`l1, •û¹•œ1, –{“c@’1, –Ø‘ºƒl1, ’†”š–퐶1, Îˆä³_1 (1¬Ž™): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/14), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 372.

723424. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –Œ«‘B«Ž…‹…‘̐t‰Š‚ɑ΂µƒVƒNƒƒXƒ|ƒŠƒ“‚ðŽg—p‚µ’·ŠúŒo‰ßŠÏŽ@‚ðs‚Á‚œ—Ž™—á. ©@L–ç1, ’†‘ºM–ç1, “Y“c—RŠóŽq2, Šâ”g’Œ”ü2, ‰z–ì_]3, Žç‰®r‰î4, ‰ÍŒ‹Iº1, ”э‚Šì‹v—Y5, Îˆä³_1 (1¬Ž™, 2ŠC˜V–Œ‘‡•a‰@, 3‰z–쏬Ž™‰È, 4Ã“ìƒLƒbƒYƒNƒŠƒjƒbƒN, 5–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/14), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2; 115 (2): 478.

723425. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) OmmayaƒŠƒU[ƒo‚©‚ç‚̐‘‰t”r‰t’†‚É’áNa, ‚KŒŒÇ‚ð‚«‚œ‚µ‚œoŒŒŒã…“ªÇ‚Ì1—á. ]”gŒËF•ã1, –ìX“c–L1, Šâèr”V1, ©@L–ç1, ŒÏè‰ëŽq1, –ì“n³•F2, Îˆä³_1, Œ¢Ž”@‰~3, ’†ŒŽ–M»3 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3”]ŠO): ‘æ114‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2011/8/14), “Œ‹ž, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2011/2: 115 (2): 505.

723426. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹v—¯•ÄƒXƒRƒA‚É‚æ‚銥“®–¬•a•Ï‚Ì—\‘ª. îŒŽ‹`l1, ²“¡‰Á‘ãŽq1, –{“c@’1, Îˆä³_1 (1¬Ž™): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/9/30), ‰¡•l, ŽE^W 2011; p.57.

723427. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ìè•a‚̖Ɖu“®‘Ô; —\–hÚŽí‚Æ‚ÌŠÖ˜A. ²“¡‰Á‘ãŽq1,2, ˆîŠ_@“µ1,2, ©@L–ç1,2, îŒŽ‹`l2, “Y“c—RŠóŽq1, Šâ”g’Œ”ü1, –ìXŽRŸl1, –¥‰YŽ‘¥1, Îˆä³_2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/10/1), ‰¡•l, Ž˜^W 2011; p.65.

723428. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ìè•aŠ³ŽÒ‚É‚š‚¯‚é11`20•a“ú‚ÉŠJŽn‚³‚ê‚œ–ƉuƒOƒƒuƒŠƒ“‚ÌŽ¡—ÃŒø‰Ê. –Ž“cLŽÀ1, Îˆä³_2, ‰®‘ã^‹|3, ãŒŽ—¢’ö3, ’†‘ºDˆê3 (1”Ñ’ËŽs—§•a‰@, 2¬Ž™, 3Ž©Ž¡ˆã‰È‘åŠw): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/10/1), ‰¡•l, Ž˜^W 2011; p.70.

723429. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –ƉuƒOƒƒuƒŠƒ“•s‰ž—\‘ªƒXƒRƒA‚Ì”äŠrŒŸ“¢. îŒŽ‹`l1, ²“¡‰Á‘ãŽq1, –{“c@’1, Îˆä³_1 (1¬Ž™): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/10/1), ‰¡•l, Ž˜^W 2011; p.82.

723430. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«ìè•a‚ɑ΂·‚鏉ŠúŽ¡—ÂƂµ‚Ă̖ƉuƒOƒƒuƒŠƒ“‚ƃXƒeƒƒCƒhƒpƒ‹ƒX‚Ì•¹—p—Ö@‚ªŠ¥“®–¬•a•Ï‚É—^‚Š‚é‰e‹¿: ‘OŽ‹–@“IŒŸ“¢. Îˆä³_1, •û¹•œ1, îŒŽ‹`l1, –{“c@’1 (1¬Ž™): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/10/1), ‰¡•l, Ž˜^W 2011; p.85.

723431. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽŸ¢‘ãƒV[ƒNƒGƒ“ƒT[‚É‚æ‚éìè•a‚Ì•aŒŽ‘ÌŒó•â‚Ì’Tõ. •“c@œ1, ”ђˍ„Žj1, •Ð–쐰—²1, ŒŠŠª‹ÅŽq1, •l“c—m’Ê2, Ž›ˆä@Ÿ2, ‘åê–MO3, •û¹•œ4, ²“¡œˆê5, X@‰ë—º6, …’J“N–ç1 (1‘—§ŠŽõÇŒ€‹†Š, 2“Œ‹ž—Žqˆã‰È‘åŠw, 3Œö—§º˜a•a‰@, 4¬Ž™, 5VŠƒŽs–¯•a‰@, 6‰¡•lŽs—§‘åŠw): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/10/1), ‰¡•l, Ž˜^W 2011; p.95.

723432. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ìè•aœëŠ³—ðŒã, Š¥“®–¬‚É•a•Ï‚Ì‚È‚¢¶SŽºáŽ‚ð”F‚ß‚œ1—Ž™—á. îŒŽ‹`l1, ²“¡‰Á‘ãŽq1, –{“c@’1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ’†”š–퐶1, Îˆä³_1 (1¬Ž™): ‘æ31‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2011/10/1), ‰¡•l, Ž˜^W 2011; p.110.

723433. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “‚ȋǍ݊֘A«‚Ä‚ñ‚©‚ñ7Ç—á‚É‚š‚¯‚élevetiracetam‚̗Տ°“IŒø‰Ê‚È‚ç‚Ñ‚ÉŒŒ’†”Z“x‚Ì—L—p«. Šâèr”V1, –ìX“c–L1, ×“c‚Ì‚Œ‚Ý1,2, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ—È牀): ‘æ45‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï (2011/10/7), VŠƒ, ‚Ä‚ñ‚©‚ñŒ€‹† 2011; 29 (2): 393.

723434. [Šw‰ï (‘S‘)] (ˆê”ʍuE‰Eƒ|ƒXƒ^[) ACTH•s‰žÇ‚É–³—ÜÇ‚ð‡•¹‚µ‚œ’Ž’áo¶‘̏dŽ™‚Ì1—á. ]”gŒËF•ã1, ‘å’Ь”V1, ‰º•l^—¢Žq1, “c‹v•ÛŒ›s1,3, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ŒÏè‰ëŽq1, –ì“n³•F1, ‰¡“csŽj2, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ‹Š“¯•a‰@, 3–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ45‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠwpW‰ï (2011/10/8), ‘å‹{, ‘æ45‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠwpW‰ïŽ˜^W 2011; p.205.

723435. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@¬Ž™‰È‚É‚š‚¯‚éRSTŠˆ“®‚ƍ¡Œã‚̉ۑè‚ɂ‚¢‚Ä. ‹àŽq’‰O1, ã“cN‹v1, “ì–쏉1, •Ÿ“‡’‹`1, ŒŽ^@l1, ”~ŒŽ@ŽÀ1, Îˆä³_1 (1¬Ž™): ‘æ44‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï (2011/10/15), ‰F“s‹{, “ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ïŽGŽ 2011/9; 22 (Suppl ): 134.

723436. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÅ‚ä‚ÅŒ{—‘‚É‚æ‚éŠÉ™ŒoŒû–ƉuŠ°—e—U“±—Ö@Ž{s—á‚É‚š‚¯‚鐶Œ{—‘•‰‰×ŽŽŒ±‚ÌŒŸ“¢|Çó”­Œ»‚ÌŒŸ“¢|. ŽOãŒ’‘Ÿ˜Y1, ¬ì—ÏŽj1,2, ŽO‘º@®3, ‚àV—æŽq4, ‘åŽÄW—m5, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3ìŒûŽs—§ˆã—ÃZƒ“ƒ^[, 4“Œ‹ž–kŽÐ‰ï•ÛŒ¯•a‰@, 5“Œ‹žŒú¶”N‹à•a‰@): ‘æ48‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï^‘æ16‰ñƒAƒWƒA‘Ÿ•œ—m¬Ž™ƒAƒŒƒ‹ƒM[ŒÄ‹zŠí–ƉuŠw‰ï‡“¯Šwp‘å‰ï (2011/10/30), •Ÿ‰ª, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2011/8; 25 (3): 563.

723437. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ{—‘ƒAƒŒƒ‹ƒM[Š³Ž™‚É‚š‚¯‚é—cŽ™ŠúŠÉ™ŒoŒû–ƉuŠ°—e—U“±—Ö@‚ÌŒŸ“¢. ¬ì—ÏŽj1,2, ŽOãŒ’‘Ÿ˜Y1, ‘åŽÄW—m3, ŽO‘º@®4, ì–ì@–L5, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@, 4ìŒûŽs—§ˆã—ÃZƒ“ƒ^[, 5é‹ÊŒ§¬Ž™ˆã—ÃZƒ“ƒ^[): ‘æ48‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï^‘æ16‰ñƒAƒWƒA‘Ÿ•œ—m¬Ž™ƒAƒŒƒ‹ƒM[ŒÄ‹zŠí–ƉuŠw‰ï‡“¯Šwp‘å‰ï (2011/10/30), •Ÿ‰ª, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2011/8; 25 (3): 564.

723438. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H•šƒAƒŒƒ‹ƒM[‚É‚æ‚éƒAƒiƒtƒBƒ‰ƒLƒV[A“ñ‘Š«”œ‰ž‚ð’悵‚œ4Î’jŽ™—á. ŽO‘º@®1, ˆéè ~1, ¬ì—ÏŽj2, –ìŠÔ@„2, ‘åŽÄW—m3, ì–ì@–L1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@): ‘æ48‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï^‘æ16‰ñƒAƒWƒA‘Ÿ•œ—m¬Ž™ƒAƒŒƒ‹ƒM[ŒÄ‹zŠí–ƉuŠw‰ï‡“¯Šwp‘å‰ï (2011/10/30), •Ÿ‰ª, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2011/8; 25 (3): 572.

723439. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éƒpƒ“ƒfƒ~ƒbƒN (H1N1) 2009 (2009/10ƒV[ƒYƒ“) ‚ƉߋŽ5ƒV[ƒYƒ“‚̃Cƒ“ƒtƒ‹ƒGƒ“ƒU“ü‰@Š³ŽÒ‚ÌŒŸ“¢. ²”Œ•q—º1, Œì‹ÅŽq1,2, ‘剪–ƒ—1,2, ©@L–ç1,2, ŒÃì^—S1,2, ‰¡“csŽj1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ43‰ñ“ú–{¬Ž™ŠŽõÇŠw‰ï‘‰ïEŠwpW‰ï (2011/10/30), ‰ªŽR, ¬Ž™ŠŽõ–Ɖu 2011/7; 23 (2): 191.

723440. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •¡”H•šƒAƒŒƒ‹ƒM[Š³ŽÒ‚É‚š‚¯‚éŠÉ™ŒoŒû–ƉuŠ°—e—U“±—Ö@‚Ì—L—p«. ¬ì—ÏŽj1,2, ŽOãŒ’‘Ÿ˜Y1, ‘åŽÄW—m3, ì–ì@–L4, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@, 4é‹ÊŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[): ‘æ61‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2011/11/11), “Œ‹ž, ƒAƒŒƒ‹ƒM[ 2011/10; 60 (9-10): 1407.

723441. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}«Šú“û—cŽ™šb–«ŽŸŠ³‚É‚š‚¯‚鍂—p—Ê‹z“üƒXƒeƒƒCƒh‚ÌŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢. ŽO‘º@®1,2, ˆéè@~1, ¬ì—ÏŽj3, –ìŠÔ@„3, ‘åŽÄW—m4, ’†‘º—zˆê1, ì–ì@–L1,5 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2ìŒûŽs—§ˆã—ÃZƒ“ƒ^[, 3¬Ž™, 4“Œ‹žŒú¶”N‹à•a‰@, 5é‹ÊŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[): ‘æ61‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2011/11/12), “Œ‹ž, ƒAƒŒƒ‹ƒM[ 2011/10; 60 (9-10): 1444.

723442. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“—LŠQŽ–ÛŽÒ (”畆ƒAƒŒƒ‹ƒM[) 2—á‚É”­Ç‚µ‚œdÇƒCƒ“ƒtƒ‹ƒGƒ“ƒU”x‰Š‚Ì•a‘Ô. •ô”öŒb—œ1, â“Œ—R‹I1 (1¬Ž™): ‘æ61‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2011/11/12), “Œ‹ž, ƒAƒŒƒ‹ƒM[ 2011/10; 60 (9-10): 1446.

723443. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÅ‚ä‚ÅŒ{—‘‚É‚æ‚éŠÉ™ŒoŒû–ƉuŠ°—e—U“±—Ö@Ž{s—á‚É‚š‚¯‚鐶Œ{—‘•‰‰×ŽŽŒ±‚ÌŒŸ“¢|–ƉuƒAƒŒƒ‹ƒM[ŒŸž|. ŽOãŒ’‘Ÿ˜Y1, ¬ì—ÏŽj1,2, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™): ‘æ61‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2011/11/12), “Œ‹ž, ƒAƒŒƒ‹ƒM[ 2011/10; 60 (9-10): 1448.

723444. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •\Œ»Œ^‚̈قȂ郂ƒUƒCƒNŒ^21ƒgƒŠƒ\ƒ~[‚̈ꗑ«‘o‘Ù‚Ì1—á. ŒÇè‰ëŽq1,2, ‘剪–ƒ—2, ‰¡ŠÖ—Sˆê˜Y2, ˆÉ“¡®Žu2, ˆÉâ‰ës2, çݎ@Šw2, –]ŒŽƒŽq3, –ì“n³•F2, ‚“cŽj’j4, Îˆä³_2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™, 3ŽY‰È, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ56‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ïEŠwpW‰ï (2011/11/14), “Œ‹ž, “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ 2011/10; 23 (3): 580.

723445. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ÙŽ™bó‘BŽî‚ɑ΂µ‚Ä‘Ù“àŽ¡—Âðs‚Á‚œ1—á. “¡‹g˜a”Ž1, ˆÉ“¡®Žu1, ‰¡ŠÖ—Sˆê˜Y1, –ì“n³•F1, Îˆä³_1 (1¬Ž™): ‘æ56‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ïEŠwpW‰ï (2011/11/14), “Œ‹ž, “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ 2011/10; 23 (3): 657.

723446. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¶Ž™dÇŒ^ƒOƒ‹ƒ^ƒ‹Ž_”AÇIIŒ^‚ƍl‚Š‚ç‚ê‚œ1—á. ‰i·—T‰ÀŽq1, ˆÉ“¡®Žu1, ‰¡ŠÖ—Sˆê˜Y1, –ì“n³•F2, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ56‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ïEŠwpW‰ï (2011/11/14), “Œ‹ž, “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ 2011/10; 23 (3): 661.

723447. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹•Ç“à‚ɐL“W‚µ‚œŽ‰–b‰èŽî‚Ì1—á. Œ–{“TŽq1, “c’†@Œ‰2, ‚ˆÀ@”£2, “n粏¹•F2 (1¬Ž™, 2ŠO‰È): ‘æ53‰ñ“ú–{¬Ž™ŒŒ‰tE‚ª‚ñŠw‰ïŠwpW‰ï (2011/11/25-27), ‘O‹Ž.

723448. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FontanŽèpŒã‰“ŠuŠú‚Ì‚€‚ÁŒŒ«ŠÌáŠQ‚Ì1—á. “¡•‹`l1, –{“c@’1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ’†”š–퐶1, Îˆä³_1 (1¬Ž™): “ú–{¬læ“V«SŽŸŠ³Šw‰ï (2012/1/14), “Œ‹ž.

723449. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ºŽˆ‚̍¶‰E·‚Å”­Œ©‚³‚ê‚œƒJƒe[ƒeƒ‹Ž¡—ÃŒã‚̑响“®Ã–¬@‚̈ê—á. ‚—œ@Šw1, ’†”š–퐶1, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –{“c@’1, •œ“cŒõ”Ž2, Îˆä³_1 (1¬Ž™, 2ŠO‰È): ‘æ23‰ñ“ú–{Pediatric Interventional CardiologyŠw‰ïŠwpW‰ï (2012/1/19), H“c.

723450. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ÙŽ™Šú‚æ‚苐‘å‰EŽºáŽ‚ð”F‚ß‚œ•s®–¬Œ¹«‰EŽºS‹ØÇ (ARVC) ‚Ì1—á. –{“c@’1, ˆÀ“¡@Žõ1, ’†”š–퐶1, –Ø‘ºƒl1, ‚—œ@Šw1, Îˆä³_1 (1¬Ž™): ‘æ18‰ñ“ú–{‘ÙŽ™S‘Ÿ•aŠw‰ï‘‰ïŠwpW‰ï (2012/2/17), ’}”g.

731087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ìè•a‚̍ŐV‚Ì’mŒ©: •aˆö, ‹}«ŠúŽ¡—Ã, ‰“ŠuŠú‚̏”–â‘è. Îˆä³_ (¬Ž™): ‘æ60‰ñ“ú–{¬Ž™‰ÈŠw‰ï²‰ê’n•û‰ï—á‰ï (2011/4/9), ²‰ê.

731088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬lŠú‚̐ìè•a, ‚Ç‚Ì‚æ‚€‚È“_‚𒍈ӂµ‚Ä‚Ý‚Ä‚¢‚¯‚Ηǂ¢‚©. Îˆä³_ (¬Ž™): ‘æ4‰ñ¬læ“V«VŽŸŠ³ƒZƒ~ƒi[ (2011/5/14), “Œ‹ž.

731089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ìè•a‚̍ŐV‚Ì’mŒ©, •aˆö‚š‚æ‚щ“ŠuŠú‚̏”–â‘è. Îˆä³_ (¬Ž™): ”ª”Š¬Ž™‰Èˆã‰ï (2011/7/28), •Ÿ‰ª.

731090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬Ž™’Ž‰¹”gf’f‚ÌŒ»‹µ. Îˆä³_ (¬Ž™): 10th`‹æ¬Ž™zŠÂŠíƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/12/3), ‰¡•l.

731091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬Ž™IgAtÇ‚ÌŽ¡—Â̌»ó. ’†‘ºM–ç (¬Ž™): `–ì–òÜŽt‰ïu‰‰‰ï (2012/1/26), `–ì.

731092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ìè•a‚Ì‹}«ŠúŽ¡—Ã. Îˆä³_ (¬Ž™): ‘æ3‰ñ‘q•~¬Ž™ŽŸŠ³ƒtƒH[ƒ‰ƒ€ (2012/3/8), ‘q•~.

731093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ìè•a‚̍ŐV‚Ì’mŒ©. Îˆä³_ (¬Ž™): ‘æ315‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2012/3/17), ‰¡•l.

733157. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒPƒgƒAƒVƒh[ƒVƒX‚Å“œ”A•a‚𔭏ǂµ‚œ13ƒgƒŠƒ\ƒ~[ÇŒóŒQ‚Ì1—á. ‰i·—T‰ÀŽq1, ²“¡T‘Ÿ˜Y1, –{“c@’1, ©@L–ç1, –Ø‘ºƒl1, –ìX“c–L1, ‘å’Ь”V1, –ì“n³•F2, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ310‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/4/23), ‰¡•l.

733158. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äB‘¹‚Å”­Ç‚µ‚œŒŒ—F•aA‚̐V¶Ž™—á. ‰¡“c˜aŽq1, ‘剪–ƒ—1, ŒÏè‰ëŽq1, –ì“n³•F2, Îˆä³_1, ‚ˆÀ@”£3, “c’†@Œ‰3, “n粏¹•F3 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3ŠO‰È): ‘æ24‰ñ“ú–{¬Ž™äB‘ŸŒ€‹†‰ï (2011/5/14), ŽR—œ, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ 2011; 47 (5): 883.

733159. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Late pretermŽ™‚̌ċzáŠQ‚ɂ‚¢‚Ä‚ÌŒ€‹†D_“ސìV¶Ž™–¢nŽ™˜A—‰ï. ‰¡ŠÖ—Sˆê˜Y1, HŽR˜a­1, ˆÉ“¡®Žu1, ŒÏè‰ëŽq1, ˆÉâ‰ës1, çݎ@Šw1, –ì“n³•F2, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ƒT[ƒtƒ@ƒNƒ^ƒ“ƒgERDSŠÖ˜AŒŸ“¢‰ï (2011/5/26), ‰¡•l.

733160. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™«‘BˆÙíÇ‚Ì2—á. Œ–{“TŽq1, Œì‹ÅŽq1, ‘å’Ь”V1 (1¬Ž™): ‘Š–ÍŒŽŽs¬Ž™‰Èˆã‰ïŒŽ—፧˜b‰ï (2011/6/15), ‘Š–ÍŒŽ.

733161. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “Œ“ú–{‘å’nkˆã—ÃŽx‰‡•ñ: ”íÐŽÒ‚ւ̈ã—ÃŽx‰‡‚Ì‚ ‚è•û. ©@L–ç (¬Ž™): ‘Š–ÍŒŽŽs¬Ž™‰Èˆã‰ïŒŽ—፧˜b‰ï (2011/6/15), ‘Š–ÍŒŽ.

733162. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “Œ“ú–{‘å’nkˆã—ÃŽx‰‡•ñ: ‘å‘D“nŽs‚Ö‚Ì‘Š–ÍŒŽŽsE‘åŠw•a‰@Žx‰‡ƒ`[ƒ€Šˆ“®. â“Œ—R‹I (¬Ž™): ‘Š–ÍŒŽŽs¬Ž™‰Èˆã‰ïŒŽ—፧˜b‰ï (2011/6/15), ‘Š–ÍŒŽ.

733163. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •›ˆô“ªŠÔŒ„”^ᇂðŒ_‹@‚É”­Ç‚µ‚œŠÂŽ²’ŁEŸ’E‰P‚̈ê—á. •ô”öŒb—œ1,2, ‚—œ@Šw1,2, ²”Œ•q—º1, ‰¡“csŽj1, ‰ª–{‰p–Ÿ1, ‰i·—T‰ÀŽq1,2, –{“c@’1,2, Îˆä³_2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ311‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/6/18), ‰¡•l.

733164. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 1Œ^“œ”A•aƒTƒ}[ƒLƒƒƒ“ƒv‚É‚š‚¯‚éƒZƒ‹ƒtƒPƒA‚𑣂·Žx‰‡. “c‹v•Û—R”üŽq1, “c‹v•ÛŒ›s2,3, Œ”ö”ü’qŽq4, £ŒË‰Á“ÞŽq5, ‘åŠÑŒbŽq6, ’·–ìm”ü6, X@‹MŽq7, ‹k“cˆê‹P3, ‘å’Ь”V3, •—’£áÁ—R”ü3, ‰¡“csŽj8, Œ‰YM•v9 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 3¬Ž™, 4ƒNƒŠƒjƒJƒ‹ƒ|[ƒ^[Š”Ž®‰ïŽÐ, 5“Œ–M‘åŠw, 6ŠÅŒì•”, 7‘—§¬ˆçˆã—ÃŒ€‹†ƒZƒ“ƒ^[, 8‘Š–ÍŒŽ‹Š“¯•a‰@, 9¹“¿‘åŠw): ‘æ17‰ñ¬Ž™EŽvtŠú“œ”A•aƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/17), “Œ‹ž.

733165. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒm[ƒxƒ‹ƒo[ƒ‹‚ª—LŒø‚Å‚ ‚Á‚œ–³ŒÄ‹z”­ì‚̈ê—á. –ìX“c–L1, Šâèr”V1, ×“c‚Ì‚Œ‚Ý1,2, ”’ˆäGK1,3, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ—È牀, 3‘Š–Í‘ä•a‰@): ‘æ68‰ñ_“ސì‚Ä‚ñ‚©‚ñ§˜b‰ï (2011/7/30), ‰¡•l.

733166. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) JoubertÇŒóŒQ‚Ì2—á. ™ŽR®l1, ‘剪–ƒ—1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ŒÏè‰ëŽq1, –ì“n³•F2, Îˆä³_1 (1¬Ž™, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ312‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/9/17), ‰¡•l.

733167. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘å“®–¬•Ù•Âœ•s‘SÇ‚ð‡•¹‚µ‚œìè•a‚Ì2—á. ˆîŠ_@“µ1,2, ²“¡‰Á‘ãŽq1,2, Šâ”g’Œ”ü1, –ìXŽRŸl1, –¥‰YŽ‘¥1, îŒŽ‹`l2, Îˆä³_2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™): ‘æ312‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/9/17), ‰¡•l.

733168. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒoƒ‹ƒvƒŽ_“à•ž‚ª—LŒø‚Å‚ ‚Á‚œŽüŠú«šq“fÇ‚Ì2—Ž™—á. îŒŽ‹`l1, ²“¡T‘Ÿ˜Y1, Šâèr”V1, Îˆä³_1, ˆîŠ_@“µ1,2, ²“¡‰Á‘ãŽq1,2, “Y“c—RŠóŽq2, Šâ”g’Œ”ü2, –ìXŽRŸl2, –¥‰YŽ‘¥2 (1¬Ž™, 2ŠC˜V–Œ‘‡•a‰@): ‘æ312‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/9/17), ‰¡•l.

733169. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘Sg‚̃Šƒ“ƒpßŽî’£‚ÆŒJ‚è•Ô‚·ŒÄ‹zŠíŠŽõÇ‚©‚ç–Ɖu•s‘SÇ‚ð‹^‚Á‚œÇ—á. â“Œ—R‹I (¬Ž™): ‘æ2‰ñŠÖ“ŒbM‰z–Ɖu•s‘SÇŒ€‹†‰ï (2011/9/18), “Œ‹ž.

733170. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”­’BáŠQ‚Æ‚Ä‚ñ‚©‚ñ‚ɍ‡•¹‚µ‚œ’áƒÁƒOƒƒuƒŠƒ“ŒŒÇ‚̈ê—á. ˜ð“c‹v”üŽq1, ‘剪–ƒ—1, ŽRŒûˆ»”T1, ]”gŒËF•ã1, îŒŽ‹`l1, •û¹•œ1, âEŒ—R‹I1, Îˆä³_1, •ˆäŒ€“ñ2 (1¬Ž™, 2•ˆä¬Ž™‰Èˆã‰@): ‘æ2‰ñŠÖ“ŒbM‰z–Ɖu•s‘SÇŒ€‹†‰ï (2011/9/18), “Œ‹ž.

733171. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰©FƒuƒhƒE‹…‹ÛH’†“Å‚É‚æ‚èáz¹dÏEŒ€ÇŒ^ŠÌ•s‘S‚ð’悵‚œ1’jŽ™—á. Î“c—Ï–ç1, ‹àŽq’‰O1, ²“¡T‘Ÿ˜Y1, ˆÀ“¡@Žõ1, –ìX“c–L1, –ìXŽRŸl1, â“Œ—R‹I1, Îˆä³_1, ’†’JŒ€“l2, ãžŠ‹gl2, ‘Š”nˆêˆå2 (1¬Ž™, 2‹~–œ): ‘æ70‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2011/9/24), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2012/1; 39 (1): 115.

733172. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘ÙŽ™Šú‚ɐf’f‚³‚ê‚œ‹‘å‰ESŽºáŽ‚Ì1—á. –{“c@’1, ˆÀ“¡@Žõ1, ’†”š–퐶1, –Ø‘ºƒl1, ‚—œ@Šw1, Îˆä³_1 (1¬Ž™): ‘æ47‰ñ_“ސ쏬Ž™zŠÂŠíŒ€‹†‰ï (2011/10/8), ‰¡•l.

733173. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰ESŒn‚̏zŠÂŒø—Š‚ªFontanzŠÂ‚Ö—^‚Š‚é‰e‹¿. –{“c@’1, ”Â’JŒcˆê2, ’†”š–퐶1, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, ‚—œ@Šw1, ‹{’n ŠÓ3, Îˆä³_1 (1¬Ž™, 2“Œ‹ž‘åŠw, 3S‘ŸŒŒŠÇŠO): ‘æ31‰ñ“ú–{¬Ž™zŠÂ“®‘ÔŒ€‹†‰ï (2011/10/31), ‰ªŽR.

733174. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰©FƒuƒhƒE‹…‹ÛH’†“Å‚É‚æ‚èáz³dÏEŒ€ÇŒ^ŠÌ•s‘S‚ð’悵‚œ1’jŽ™—á. ²“¡T‘Ÿ˜Y1, ‹àŽq’‰O1, Î“c—Ï–ç1, “¡•‹`l1, ˆÀ“¡@Žõ1, –ìX“c–L1, –ìXŽRŸl1, â“Œ—R‹I1, Îˆä³_1, ’†’JŒ€“l2, ãžŠ‹gl2, ‘Š”nˆêˆå2 (1¬Ž™, 2‹~–œ): ‘æ313‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/11/19), ‰¡•l.

733175. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘J‰„«‰©át‚ƍ‚ƒCƒ“ƒXƒŠƒ“«’ጌ“œ‚ð”F‚ß‚œXõF‘ُ̈í‚Ì“ûŽ™—á. “¡–{‚Ü‚ä1, Î“c—Ï–ç1, Œì‹ÅŽq1, “¡•‹`l1, â“Œ—R‹I1, Îˆä³_1 (1¬Ž™): ‘æ313‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/11/19), ‰¡•l.

733176. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “M…‚ðŒ_‹@‚ÉŒ‡_‚Ä‚ñ‚©‚ñ‚Ɛf’f‚³‚ê‚œˆê—á. –ìX“c–L1, Šâèr”V1, ×“c‚Ì‚Œ‚Ý1,2, ”’ˆäGK1,3, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ—È牀, 3‘Š–Í‘ä•a‰@): ‘æ69‰ñ_“ސì‚Ä‚ñ‚©‚ñ§˜b‰ï (2012/1/21), ‰¡•l.

733177. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) [Ç—l•a•Ï‚ðŒJ‚è•Ô‚µ‚œReversible cerebral vasoconstriction syndrome‚̈ê—á. –ìX“c–L1, Šâèr”V1, ×“c‚Ì‚Œ‚Ý1,2, ”’ˆäGK1,3, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ—È牀, 3‘Š–Í‘ä•a‰@): ‘æ49‰ñ_“ސ쏬Ž™_Œo§˜bEE(2012/1/28), ‰¡•l.

733178. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) d“xŽ‹°‰º•”«bó‘B‹@”\’ቺÇ’jŽq2—á‚É‚š‚¯‚éPRL•ª”å”\. Œ‰YM•v1, ŽÄŽRŒ[Žq2, ‘å’Ь”V2, “c‹v•ÛŒ›s2, ‹k“cˆê‹P2 (1¹“¿‘åŠw, 2¬Ž™): ‘æ21‰ñ—Տ°“à•ª”å‘ãŽÓupdate (2012/1/28), •lŒ, “ú–{“à•ª”åŠw‰ïŽGŽ 2011/12; 87 (3): 980.

733179. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ãó×–EŽíŽ¡—ÃŒã‚É‘œÊ‚È“à•ª”å‘ãŽÓˆÙí‚ð‡•¹‚µ‚œ1—á. Œ–{“TŽq1, ‘å’Ь”V1, ”’ˆäG’Œ1, ™ŽR®l1, ‹g–색ƒ‚ƒi1, ‚—œ@Šw1, “¡•‹`l1, â“Œ—R‹I1, Îˆä³_1 (1¬Ž™): ‘æ315‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2012/3/17), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110012. [ŒŽ’˜] Regulation of Kv2.1 phosphorylation in an animal model of anoxia. Ito T1, Nuriya M, Masato Yasui M: Neurobiol Dis 2010/8; 38 (1): 85-91. (ˆÉ“¡®Žu1: 1¬Ž™)

H22-110013. [ŒŽ’˜] Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer. Kaida M1, Morita-Hoshi Y, Soeda A, Wakeda T, Yamaki Y, Kojima Y, Ueno H, Kondo S, Morizane C, Ikeda M, Okusaka T, Takaue Y, Heike Y: J Immunother 2011/1; 34 (1): 92-9. (ŠJ“c”ü•Û1: 1¬Ž™)

[’˜@‘]

H22-620004. [Šwp‘] (•ª’SŽ·•M)yEBM¬Ž™ŽŸŠ³‚ÌŽ¡—Ã2011-2012zI. zŠÂŠí@4. EBM‚ÉŠî‚­ÅV‚Ì’Ž‰¹”gf’fp: ŽOŽŸŒ³ƒGƒR[‚š‚æ‚ѐV‹Zp, p.86-91. –Ø‘ºƒl1, Îˆä³_1 (1¬Ž™), ŠÄC: ŒÜ\—’—², ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/2”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-713004. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of 30% global maternal nutrient reduction (MNR) on brain-derived neurotrophic factor (BDNF) protein expression in near-term fetal baboon brain. Kemmochi M1, C Li, M Nakamura, J Choi, K Mitsuya, PW Nathanielsz, TJ McDonald: SGI 57th Annual meeting (2010/3/24-27), Orland, USA. (çݎ@Šw1: 1¬Ž™)

H22-713005. [Šw‰ï (‘Û) Maternal Nutrient Restriction (MNR) is Associated with Decreased Nerve Growth Factor (NGF) Expression in Late Gestation (G) Fetal Baboon Frontal Cortex. Kemmochi M1, Li C, Nakamura M, Nathanielsz PW, McDonald TJ: SGI 58th Annual meeting (2011/3/16-19), Miami, USA. (çݎ@Šw1: 1¬Ž™)

H22-733006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“E1»ÜŒoŒû“Š—^‚É‚æ‚èÝ‘îŠÇ—‰Â”\‚Æ‚È‚Á‚œ13ƒgƒŠƒ\ƒ~[‚Ì1—á. “yŠò@•œ1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ŒÏè‰ëŽq1, ˆÉâ‰ës1, çݎ@Šw1, –ì“n³•F1, Îˆä³_1 (1¬Ž™): ‘æ306‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2010/9/18), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2011/7; 38 (2): 222.

H22-733007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}«Ž…‹…‘̐t‰Š‚Æ—n˜A‹ÛŠŽõŒã”œ‰ž«ŠÖß‰Š‚ð‡•¹‚µ‚œ1—á. ‘剪–ƒ—1, ’†‘ºM–ç1, îŒŽ‹`l1, “Y“c—RŠóŽq1, Šâ”g’Œ”ü1, â“Œ—R‹I1, ‰ÍŒ‹Iº1, Îˆä³_1 (1¬Ž™): ‘æ307‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2010/11/20), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2011/7; 38 (2): 224-5.

H22-733008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ìè•a‚̍ŐV‚Ì’mŒ©: •aˆö, ‹}«ŠúŽ¡—Ã, ‰“ŠuŠú‚̐SŒŒŠÇ•a•Ï‚š‚æ‚ÑŠ³Ž™‚ÌQuality of Life. Îˆä³_ (¬Ž™): ‘æ336‰ñ‘啪Žs¬Ž™‰Èˆã‰ïu‰‰‰ï (2011/1/29), ‘啪.

H22-733009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Vero Toxin‚ªŠm”F‚³‚ê‚È‚©‚Á‚œ’°ŠÇoŒŒ«‘å’°‹ÛŠŽõÇ‚É‚æ‚é—nŒŒ«”A“ŏǐ«ÇŒóŒQ‚Ì2Ç—á. ‰i·—T‰ÀŽq1, –{“c@’1, •û¹•œ1, •ô”öŒb—œ1, ŽRŒûˆ»”T1, ‹àŽq’‰O1, ’†‘ºM–ç1, â“Œ—R‹I1, Îˆä³_1, Šâ”g’Œ”ü2, îŒŽ‹`l1,2, –ìXŽRŸl2 (1¬Ž™. 2ŠC˜V–Œ‘‡•a‰@): ‘æ308‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2011/2/19), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2011/7; 38 (2): 230.

H22-733010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ìè•aœëŠ³—ðŒã, Š¥“®–¬‚É•a•Ï‚ð”F‚ß‚È‚¢¶ŽºáŽ‚ð”F‚ß‚œ1—Ž™—á. îŒŽ‹`l1, ²“¡‰Á‘ãŽq1, –{“c@’1, ’†”š–퐶1, Îˆä³_1 (1¬Ž™): ‘æ6‰ñ_“ސììè•aŒ€‹†‰ï (2011/2/26), ‰¡•l.


ŽY‰ÈŠw^•wl‰ÈŠw

[Šwp˜_•¶]

110175. [ŒŽ’˜] Serous adenocarcinoma of the uterine cervix: a clinicopathological study of 12 cases and a review of the literature. Togami S, Kasamatsu T, Sasajima Y, Onda T1, Ishikawa M, Ikeda S, Kato T, Tsuda H: Gynecol Obstet Invest 2012/1; 73 (1): 26-31. (‰¶“c‹MŽu1: 1•wl)

110176. [ŒŽ’˜] Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma. Uehara T, Onda T1, Togami S, Amano T, Tanikawa M, Sawada M, Ikeda S, Kato T, Kasamatsu T: Int J Gynecol Cancer 2012/2; 22 (2): 280-5. (‰¶“c‹MŽu1: 1•wl)

120031. [ŒŽ’˜] ³í”D•w‚É‚š‚¯‚é”DP’†Šú‚š‚æ‚ÑŒãŠú‚ÌŽq‹{“®–¬ŒŒ—¬’ïRŽw” (resistance index) Šî€’lì¬‚Ì‚œ‚ß‚ÌŒã•ûŽ‹“IŒŸ“¢. ‹àˆä—Y“ñ1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): –k—¢ˆãŠw 2011/6; 41 (1): 15-22.

310020. [Ç—á•ñ] A rare case of recurrent ovarian cancer presenting as a round ligament metastasis. Togami S, Kato T, Oi T, Ishikawa M, Onda T1, Ikeda S, Kasamatsu T: World J Surg Oncol 2011/11; 9 (1): 144. (‰¶“c‹MŽu1: 1•wl)

510007. [‘à] The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG). Onda T1, Konishi I, Yoshikawa H, Kamura T: Jpn J Clin Oncol 2011/10; 41 (10): 1156-61. (‰¶“c‹MŽu1: 1•wl)

522101. [uÀ]y“ÁW: —r…‚̗Տ°z12. —r…•â[—Ö@. “V–ì@Š® (ŽY‰È): ŽY‰È‚Æ•wl‰È 2011/10; 78 (10): 1246-50.

522102. [uÀ]y•êŽ™‚ɂ₳‚µ‚¢•ª•Ø`ŽY‰È–ƒŒ‚ւ̏µ‘ҁzd–ŒŠO’Á’É–@`•ª•Ø—\Œã, ‘ÙŽ™EV¶Ž™‚ւ̉e‹¿. “V–ì@Š® (ŽY‰È): “ú–{ŽY‰È•wl‰ÈŠw‰ïŽ 2011/12; 63 (12): N282-6.

522103. [uÀ]–k—¢‘åŠw‚É‚š‚¯‚镪•ØŽž’Á’É–@‚Ì•Ï‘J‚ÆŒ»ó. “V–ì@Š® (ŽY‰È): •ª•Ø‚Æ–ƒŒ 2011/12; 93: 77-81.

522104. [uÀ]y“ÁW: •wl‰Èˆ««Žîᇂ̐f’fŽ¡—ÃAƒbƒvƒf[ƒgzIV. —‘‘ƒ‚ª‚ñ@3. ŠO‰ÈŽ¡—Ã. ‰¶“c‹MŽu (•wl): ŽY•wl‰È‚ÌŽÀÛ 2012/3; 61 (3): 409-15.

[’˜@‘]

620113. [Šwp‘] (•ª’SŽ·•M)y–òÜŽt‚Ì‚œ‚ß‚Ì‹~‹}EW’†Ž¡—×̈æ•W€ƒeƒLƒXƒgzIV •a‘ÔŠe˜_@10. ŽY•wl‰ÈŒnŽŸŠ³. “V–ì@Š® (ŽY‰È), ŠÄC: “ú–{•a‰@–òÜŽt‰ï, “ú–{—Տ°‹~‹}ˆãŠw‰ï, •Ò: “ú–{—Տ°‹~‹}ˆãŠw‰ï, ‹~‹}”F’è–òÜŽt”F’èˆÏˆõ‰ï, ‚Ö‚é‚·o”Å, 2011/5”­s.

620114. [Šwp‘] (•ª’SŽ·•M)yŽüŽYŠúŠwƒVƒ“ƒ|ƒWƒEƒ€Ž˜^W No.29zƒVƒ“ƒ|ƒWƒEƒ€Œß‘O‚Ì•”: •ê‘Ì‚Ì–ƒŒ@’鉀ØŠJpŒã’Á’É–@‚Æ‚µ‚Ä‚Ì• ‰¡‹Ø–Œ–ʃuƒƒbƒN‚Ì—LŒø«, p.61-6. ‘同—fŽq1, ‰œ•xr”V2, ‹àˆä—Y“ñ1, –]ŒŽƒ1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2–ƒŒ), •Ò: “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï ŽüŽYŠúŠwƒVƒ“ƒ|ƒWƒEƒ€‰^‰cˆÏˆõ‰ï, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2011/9”­s.

620115. [Šwp‘] (•ª’SŽ·•M)yŽüŽYŠúŠwƒVƒ“ƒ|ƒWƒEƒ€Ž˜^W No.29z•ê‘́E̖ƒŒ@Neuraxial analgesia‚É‚æ‚é–³’É•ª•Ø‚Å‚ÌŽ™“ª‰ñùˆÙí”­¶—Š‚ɂ‚¢‚ā|–ƒŒ–@•Ê‚É‚æ‚錟“¢|, p.45-9. ‰ª“c®Žq, “V–ì@Š®1, ‰œ•xr”V2, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È, 2–ƒŒ), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2011/9”­s.

620116. [Šwp‘] (‹€’˜)y‘æ2”Ł@ƒJƒ‰[}‰ð@l‘̂̐³í\‘¢‚Æ‹@”\@‘æ6Šª@¶BŠíz”NXŽ—², ì“à”Žl1 (1•wl), “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712023. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Effects of neuraxial analgesia on fetal head malrotation. Amano K1, Okada H, Ohnishi Y1, Okutomi T2, Unno N1: ‘æ15‰ñŠØ‘ŽY‰È–ƒŒŠw‰ï (2011/6/18), Seoul, Korea. (“V–ì@Š®1, ‘同—fŽq1, ‰œ•xr”V2, ŠC–ìM–ç1: 1ŽY‰È, 2–ƒŒ)

721001. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)yÀ’·zŽY‰ÈoŒŒ‚ɑ΂·‚éinterventional radiology (IVR). “V–ì@Š® (ŽY‰È): ‘æ115‰ñ“ú–{ŽY‰È–ƒŒŠw‰ï (2011/12/3), ‰¡•lƒVƒ“ƒ|ƒWƒA.

722084. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zŽŸ¢‘ãŽüŽYŠú‚ւ̐lÞˆç¬. ŠC–ìM–ç (ŽY‰È): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/11), ŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[EŽD–yŽsŽY‹ÆU‹»ƒZƒ“ƒ^[.

722085. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)u•êŽ™‚ɂ₳‚µ‚¢•ª•Ø`ŽY‰È–ƒŒ‚ւ̏µ‘ҁv•ª•Ø—\Œã, ‘ÙŽ™EV¶Ž™‚ւ̉e‹¿. “V–ì@Š® (ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/31), ‘åã.

723451. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 1Ž™‚ªƒ_ƒEƒ“ÇŒóŒQ, ‘Œ‚Ì1Ž™‚ª³í‚Ì•\Œ»Œ^‚ð’悵‚œƒ‚ƒUƒCƒNŒ^21ƒgƒŠƒ\ƒ~[‚̈ꗑ«‘o¶Ž™. –]ŒŽƒŽq1, ŒÏè‰ëŽq2, “V–ì@Š®1, ŠC–ìM–ç1, ‚“cŽj’j3 (1ŽY‰È, 2¬Ž™, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ35‰ñ“ú–{ˆâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ï^‘æ18‰ñˆâ“`ˆãŠw‡“¯ŠwpW‰ï (2011/6/16-19), ‹ž“s‘åŠw•SŽü”NŽžŒv‘ä‹L”OŠÙ.

723452. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) severe FGR‚ÌŽüŽYŠú—\Œã. Vˆä‰r”ü1, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/11), ŽD–y.

723453. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) æ“V«‰¡Šu–Œƒwƒ‹ƒjƒA‚ÌŽüŽYŠúŠÇ—. –]ŒŽƒŽq1, ‹àˆä—Y“ñ1, “c’†@Œ‰2, –ì“n³•F3, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2ŠO‰È, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 394.

723454. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •ê‘̂ւ̃XƒeƒƒCƒh“Š—^ŽžŠú‚ƐV¶Ž™—\. ‰Í–ìÆŽq, ‘同—fŽq1, –ì“n³•F2, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/12), ŽD–y, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2011/6; 47 (2): 380.

723455. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹æˆæ–ƒŒ‚ª•ª•Ø—\Œã, ‘ÙŽ™EV¶Ž™‚É‹y‚Ú‚·‰e‹¿. ‰ª“c®Žq, “V–ì@Š®1, ‰œ•xr”V2, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È, 2–ƒŒ): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/10-12), ŽD–y.

723456. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ä`’°ŠÇᑎèp‘Ò‹@’†‚ɏ¬’°‚ª”œ“]’Eo‚µ›Æ“Ú‚ð‹N‚±‚µ‚œV¶Ž™‚Ì1—á. ì“à‰ëŽq1, “c’†@Œ‰2, ‚ˆÀ@”£2, “n粏¹•F2 (1ŽY‰È, 2ŠO‰È): ‘æ47‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2011/7/10-12), ŽD–y.

723457. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —‘ŠÇŠà21Ç—á‚̗Տ°ŠŒ©‚Əp‘Of’f. “‡‰ª‹¶1, ã–V•qŽq, À“c@Ê1, ¬–ìd–ž2, Vˆä@“w2, ìŒû”ü˜a2, Vˆä³G2, Šp“cV•œ2, “à–ì’ŒŽ÷ (1ŽY‰È, 2•wl): ‘æ50‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï (2011/7/22), ŽD–y.

723458. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠJ• Žq‹{‹ØŽîŠjopŒã‚Ì–ü’…”­¶‚ɑ΂·‚é‰t«–ü’…—\–h‚ÌŒø‰Ê. À”ö²Žq1, ì“à”Žl1, ‰¬–ì‹|ŠóŽq1, Îì‰ëˆê1, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ51‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹ŸŠw‰ï (2011/8/5), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã.

723459. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) p‘O×–Ef‚ÅŽq‹{‘Ì•”Šà“÷Žî‚Ɛf’f‚³‚ê‚œ5—á‚̍זEŠw“IŒŸ“¢. ¬–ìd–ž1, Vˆä@“w1, Vˆä³G1, Šp“cV•œ1, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ25‰ñ“ú–{—Տ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpu‰‰‰ï (2011/8/5), ƒpƒVƒtƒBƒR‰¡•l.

723460. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •i‘Ù”DP‚ÌŽüŽYŠú—\Œã. “cŽG—L‹I1, Îì—²ŽO1, ‰Í–ìÆŽq, ‘同—fŽq2, Vˆä‰r”ü2, ‹àˆä—Y“ñ2, –]ŒŽƒŽq2, ¯“c@—²2, “V–ì@Š®2, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/29), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 554.

723461. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “‡Žž’²Ç‡•¹”DP‚ÌŽüŽYŠúŠÇ—. Îì—²ŽO1, ‹àˆä—Y“ñ2, –]ŒŽƒŽq2, ¯“c@—²2, “V–ì@Š®2, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/29), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 557.

723462. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’oŠÉoŒŒ—á‚ɑ΂·‚éŒoƒJƒe[ƒeƒ‹“®–¬ŠŠðp‚Ì—L—p«. “‡‰ª‹¶1, ‚–؈»Žq1, ŽR“c‹¿Žq2, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2ŽY•w): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/29), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 586.

723463. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚킪‘‚Ì”DŽY•w‚̃Cƒ“ƒtƒ‹ƒGƒ“ƒUH1N1: 2009ŠŽõó‹µ‚Æ‚»‚̑΍ô‚ÉŠÖ‚·‚é’²ž. ’†ˆäÍl1, …ã®“T2, âV“¡@Ž 3, ŠC–ìM–ç4 (1“ú–{ˆã‘å, 2–kŠC“¹‘å, 3•xŽR‘å, 4ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/29), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 615.

723464. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _“ސ쌧‰º‚É‚š‚¯‚éŽq‹{“à–ŒÇf—Â̌»ó‘æ2•ñ|ƒWƒFƒmƒQƒXƒg’·Šú“Š—^‚É‚š‚¯‚éŒp‘±—á‚Æ’†Ž~—á‚ÌŒŸ“¢|. ó–ì—ÁŽq1, ˜aòrˆê˜Y2, åŒŽG–ç1, —é–Ø—²O2, ì“à”Žl3, “c‘º‚Ý‚Ç‚è4, ‹g“c@_5, ’†–ìáÁ²’j6, ˆäã—T”ü7, ¬“c@—Í8, Îì‰ë•F5 (1‰¡•lŽs‘å, 2“ŒŠC‘å, 3•wl, 4¹ƒ}ƒŠƒAƒ“ƒiˆã‘å, 5‰¡•lŽs‘åŽs–¯‘‡ˆã—ÃZƒ“ƒ^[, 6‚¯‚¢‚ä‚€•a‰@, 7Ã“슙‘q‘‡•a‰@, 8`–ìÔ\Žš•a‰@): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/29), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 686.

723465. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) hMG-hCG—Ö@Œã‚É”][Ç‚𔭏ǂµ‚œ—‘‘ƒ‰ßèŽhŒƒÇŒóŒQ‚̈ê—á. ‰¬–ì‹|ŠóŽq1, ‚–؈»Žq2, À”ö²Žq1, ì“à”Žl1, Îì‰ëˆê1, ‘å—ÞŒb”üŽq1, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 708

723466. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’鉀ØŠJpŒã’Á’É–@‚Æ‚µ‚ÄTAP block‚Í—LŒø‚©? ‘同—fŽq1, ŽR“c‹¿Žq2, ‚–؈»Žq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2ŽY•w): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 729.

723467. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{èòŠàL”Ä‘S“EŒã–T‘å“®–¬ƒŠƒ“ƒpß‰‰ñÄ”­—á‚̉ðÍ|pŒãPAN—̈æ‚Ö‚ÌŽ¡—ÓK‰ž‚ÌŒŸ“¢|. —с@@—D1, À“c@Ê2, Vˆä³G2, Šp“cV•œ2, –îì“Þ”üŽq3, —éE؁@’Œ3, –ØŒûˆê¬3, ’·’JìŽŽu4, ‰F“cìN”Ž4, ‘ºŒrE¬1, ŽOãŠ²’j1 (1“ŒŠC‘å, 2•wl, 3¹ƒ}ƒŠ, 4“¡“c•ÛŒ’): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 766.

723468. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{‘ÌŠà‚Ì• o×–Ef—z«—á‚ÌŒŸ“¢. Vˆä@“w1, “cŽG—L‹I1, À“c@Ê1, ¬–ìd–ž1, ìŒû”ü˜a1, Vˆä³G1, Šp“cV•œ1, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 798.

723469. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ã”琫—‘‘ƒŠà, —‘ŠÇŠà, • –ŒŠà‰‰ñŽ¡—ÏǗá‚ɑ΂·‚éweekly Docetaxel + Carboplation•¹—p‰»Šw—Ö@‚ÌŒŸ“¢ (—Տ°‘æII‘ŠŽŽŒ±). •œàV@–Ò1, ‘ºŒr¬1, Vˆä³G2, Šp“cV•œ2, —é–؁@’Œ3, ŽOãŠ²’j1, ã–V•qŽq4, –ØŒûˆê¬3 (1“ŒŠC‘å, 2•wl, 3¹ƒ}ƒŠ, 4‘Š–Í–ì•a‰@): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 858.

723470. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÙŠ«Žq‹{“à–Œ‘gD‚Ì‘B‚É‚š‚¯‚é—U“±Œ^PGE‡¬y‘fmPGES-1‚Ì–ðŠ„. À”ö²Žq1, ì“à”Žl1, ‰¬–ì‹|ŠóŽq1, ‘å—ÞŒb”üŽq1, Îì‰ëˆê1, ”n“ˆ³—²2, ŠC–ìM–ç3, “c‘ã^Šó (1•wl, 2–ò—, 3ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 905.

723471. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·zŽq‹{‘Ì•”ˆ««ŽîᇁEŠî‘b1. Šp“cV•œ (•wl): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 285.

723472. [Šw‰ï (‘S‘)] (ISƒvƒƒOƒ‰ƒ€)yÀ’·zBeiging United Family Hospital Ling Chang. ŠC–ìM–ç (ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/30), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 314.

723473. [Šw‰ï (‘S‘)] (¶ŠUŒ€CƒvƒƒOƒ‰ƒ€)yÀ’·z“ú–{ŽY‰È–ƒŒŠw‰ï‹€“¯Šé‰æ: •êŽ™‚ɂ₳‚µ‚¢•ª•Ø`ŽY‰È–ƒŒ‚ւ̏µ‘Ò. ŠC–ìM–ç (ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/31), ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰ÈEwl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 218.

723474. [Šw‰ï (‘S‘)] (¶ŠUŒ€CƒvƒƒOƒ‰ƒ€) •ª•Ø—\Œã, ‘ÙŽ™, V¶Ž™‚ւ̉e‹¿. “V–ì@Š® (ŽY‰È): ‘æ63‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/8/31): ‘åã‘Û‰ï‹cê/ƒŠ[ƒKƒƒCƒ„ƒ‹ƒzƒeƒ‹‘åã, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2011/2; 63 (2): 219.

723475. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”DPE•ª•Ø’†‚É”­Ç‚µ‚œ”xŒŒðÇðÇ. ì“à‰ëŽq1, –]ŒŽƒŽq1, ¯“c@—²1, ‰Á“¡—¢ŠG2, ‰œ•xr”V2, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2–ƒŒ): ‘æ115‰ñ“ú–{ŽY‰È–ƒŒŠw‰ï (2011/12/3), ‰¡•lƒVƒ“ƒ|ƒWƒA.

731094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •ª•ØŒãoŒŒ‚ɑ΂·‚éinterventional radiology. “V–ì@Š® (ŽY‰È): ‘æ21‰ñÃ“ìŽY•wl‰ÈŒ€C‰ï (2011/9/13), Šƒ–è.

731095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”D•w‚©‚ç‚̖⍇‚É‚Ç‚€‘Ήž‚·‚é‚©? “V–ì@Š® (ŽY‰È): ‘æ29‰ñŽY‰ÈŠÅŒìŒ€C‰ï (2011/10/23), ‰¡•l.

732035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) HPVƒƒNƒ`ƒ“‚̈À‘S«‚ɂ‚¢‚Ä. Šp“cV•œ (•wl): ƒZƒ~ƒi[—«‚Ì‚ª‚ñ (2011/6/18), ‚Í‚Ü‚¬‚ñƒz[ƒ‹ƒ”ƒBƒAƒ}[ƒŒ.

732036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[)yŽY•wl‰Èˆã‚Ì‚œ‚ß‚Ì•KC’mŽ¯z‘ÙŽ™S”””gŒ`‚Ì•ª—Þ‚ÉŠî‚­•ª•ØŽž‘ÙŽ™ŠÇ—‚ÌŽwj. ¯“c@—² (ŽY‰È): ‘æ394‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2011/7/2), ‰¡•lî•ñ•¶‰»ƒZƒ“ƒ^[, “ú–{ŽY‰È•wl‰ÈŠw‰ï˜ð_“ސì’n•û•”˜ð‰ïŽ 2012/1; 48 (2): 30.

732037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ä”­—‘‘ƒ‚ª‚ñŽ¡—à (Žèp—Ö@) ‚ɂ‚¢‚Ä. ‰¶“c‹MŽu (•wl): ‘æ122‰ñŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/10/30), ‰¡•l.

732038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) –³’É•ª•Ø‚Ì•û–@‚Æ‘ÙŽ™S””}ŠŒ©. “V–ì@Š® (ŽY‰È): ‘æ38‰ñ“ú–{•ª•ØŠÄŽ‹Œ€‹†‰ï (2011/11/5), “Œ‹ž.

732039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –³’É•ª•Ø‚Ì•Ï‘J‚Æ“ú–{ŽY‰È–ƒŒŠw‰ï (JSOAP) ‚Ì“®Œü. “V–ì@Š® (ŽY‰È): ‘æ38‰ñ‹ß‹EŽY‰È–ƒŒ§˜b‰ï (2011/11/12), ‘åã.

732040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[) ”D•w‚Ì‘Ï“œ”\ŒŸž. ¯“c@—² (ŽY‰È): ‘æ397‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ï (2012/3/10), –ŸŽ¡ˆÀ“c¶–œƒ‰ƒWƒI“ú–{ƒrƒ‹Eƒ‰ƒWƒAƒ“ƒgƒz[ƒ‹.

733180. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žq‹{Œz•”ƒŠƒ“ƒpã”çŽî—lŠà‚Ì3—á. ŽR“c‹¿Žq (ŽY•w): ‘æ13‰ñ_“ސì•wl‰ÈŽîᇌ€‹†‰ï (2011/5/14), ƒuƒŠ[ƒYƒxƒCƒzƒeƒ‹ (‰¡•l).

733181. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘å’°Šà‚ɍ‡•¹‚µ‚œŒŽ”­•s–Ÿ‚Ì–Ÿ×–E‘BŠà‚̈ê—á. “cŽG—L‹I (ŽY‰È): ‘æ13‰ñ_“ސì•wl‰ÈŽîᇌ€‹†‰ï (2011/5/14), ƒuƒŠ[ƒYƒxƒCƒzƒeƒ‹ (‰¡•l).

733182. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰º”Œg–ƒáƒ‚Å”À‘—‚³‚ê‚œHELLPÇŒóŒQ‚̈ê—á. ãˆä䝗LŽq1, ŽR“c‹¿Žq1, ‘同—fŽq2, ‹àˆä—Y“ñ2, ‰Í–ìÆŽq2, Vˆä‰r”ü2, –]ŒŽƒŽq2, ¯“c@—²2, “V–ì@Š®2, ŠC–ìM–ç2 (1ŽY•w, 2ŽY‰È): ‘æ393‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2011/5/28), ƒpƒVƒtƒBƒR‰¡•l, “ú–{ŽY‰È•wl‰ÈŠw‰ï˜ð_“ސì’n•û•”˜ð‰ïŽ 2012/1; 48 (2): 27.

733183. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒoäT’Ž‰¹”g‚Ő„’肵‚œ—‘ŠÇŠà‚̈ê—á. “‡‰ª‹¶1, ã–V•qŽq, Œˆä•¶”T, ˆÀ“¡G”ü1, ¬–쐣‚Ý‚Ç‚è, ª–{—æŽq, ‘å–ì@•×, –]ŒŽˆ€˜Y2, “à–ì’ŒŽ÷ (1ŽY‰È, 2•wl): ‘æ393‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2011/5/28), ƒpƒVƒtƒBƒR‰¡•l, “ú–{ŽY‰È•wl‰ÈŠw‰ï˜ð_“ސì’n•û•”˜ð‰ïŽ 2012/1; 48 (2): 28.

733184. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”DPŒo‰ß’†‚ɐt“®–¬ŠŠðp‚ðs‚Á‚œ2Ç—á. ‚–؈»Žq1, ŽR“c‹¿Žq2, Îì—²ŽO1, ‘同—fŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2ŽY•w): ‘æ121‰ñŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/6/12), “sŽsƒZƒ“ƒ^[ƒzƒeƒ‹, ŠÖ“ŒŽY•wŽ 2011; 48 (2): 140.

733185. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)yÀ’·z‘Ù”Õ‚ÆãO–ѐ«ŽŸŠ³. ì“à”Žl (ŽY‰È): ‘æ121‰ñŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/6/12), “sŽsƒZƒ“ƒ^[ƒzƒeƒ‹, ŠÖ“ŒŽY•wŽ 2011; 48 (2): 143.

733186. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŽY‰È–ƒŒŽž‚ÌŠë‹@ŠÇ—. ŒàVW‘ã1, Šâ’[r•ã, ŠÖŒû˜aŠé1, ‰Á“¡—¢ŠG2, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2–ƒŒ): ‘æ365‰ñŽl…‰ï (2011/6/22), Œcœä‹`m‘åŠw.

733187. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œ€Cˆãu‰‰) ”DP10T, ‹}«• Ç‚µ‚œ1—á. ‰º“c—²m, ‚–؈»Žq1, ŽR“c‹¿Žq2, ŒàVW‘ã1, “‡‰ª‹¶1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È, 2ŽY•w): ‘æ394‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2011/7/2), ‰¡•lî•ñ•¶‰»ƒZƒ“ƒ^[, “ú–{ŽY‰È•wl‰ÈŠw‰ï˜ð_“ސì’n•û•”˜ð‰ïŽ 2012/1; 48 (2): 30.

733188. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œ€Cˆãu‰‰) •œ¬22”N“x_“ސ쌧ŽY‰È•wl‰Èˆã‰ï: •wl‰Èˆ««Žîᇓo˜^WŒv•ñ. ™‰Y@Œ«, ‰J‹{@Ž, ‰¡ŽR˜a•F, Šp“cV•œ1, ‹{é‰xŽq, ¬ŽRGŽ÷, ’‡‘òŒo•v, “y‹‘å—S, •œàV@–Ò, —с@NŽq, —с@—åŽq, –ؔҍvŽœ, ²X–؍N, –Γc”Žs, ‹ß“¡t—T, “c“‡•q‹v, ‰Á“¡‹v·, “ŒžŠ—Ž‘Ÿ˜Y (1•wl): ‘æ394‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2011/7/2), ‰¡•lî•ñ•¶‰»ƒZƒ“ƒ^[, “ú–{ŽY‰È•wl‰ÈŠw‰ï˜ð_“ސì’n•û•”˜ð‰ïŽ 2012/1; 48 (2): 30.

733189. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆâ“`«ŽŸŠ³‚ð‚݂‚¯‚œ‚ç. –]ŒŽƒŽq (ŽY‰È): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï (2011/7/27), ‘Š–ÍŒŽ“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733190. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “V–ì@Š® (ŽY‰È): ‘æ21‰ñÃ“ìŽY•wl‰ÈŒ€C‰ï (2011/9/10), Šƒ–è‰wƒrƒ‹.

733191. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O×–Ef‚ÅŽq‹{‘Ì•”Šà“÷Žî‚Ɛf’f‚³‚ê‚œ5—á‚̍זEŠw“IŒŸ“¢. ¬–ìd–ž1, Šp“cV•œ1, Vˆä³G1, Vˆä@“w1 (1•wl): ‘æ25‰ñ“ú–{—Տ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpW‰ï (2011/9/10), ƒpƒVƒtƒBƒR‰¡•l.

733192. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}Œƒ‚ÈŒo‰ß‚ð‚œ‚Á‚Ç‚œ—‘‘ƒŠà‚̈ê—á. ‚–؈»Žq1, Vˆä³G1, Vˆä@“w1, ¬–ìd–ž1, Šp“cV•œ1, ‰¶“c‹MŽu1, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ366‰ñŽl…‰ï (2011/11/9), “Œ‹ž—Žqˆã‘å•a‰@.

733193. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žq‹{‘Ì•”ŒŽ”­–¢•ª‰»Šà‚Ì1—á. ¬–쐣‚Ý‚Ç‚è1, “‡‰ª‹¶2, Œˆä•¶”T1, ˆÀ“¡G”ü2, ª–{—æŽq1, ‘å–ì@•×1, “cŒû@–Ÿ1, ã–V•qŽq1 (1‘Š–Í–ì•a‰@, 2ŽY‰È): ‘æ396‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/11/13), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733194. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}Œƒ‚ÈŒo‰ß‚ð‚œ‚Á‚Ç‚œ—‘‘ƒŠà‚̈ê—á. ‚–؈»Žq1, Vˆä³G2, Vˆä@“w2, ¬–ìd–ž2, Šp“cV•œ2, ‰¶“c‹MŽu2, ŠC–ìM–ç1 (1ŽY‰È, 2•wl): ‘æ396‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/11/13), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733195. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Pseudo-MeigsÇŒóŒQ‚ð’悵‚œ—‘‘ƒŽîᇂÌ3—á. “cŽG—L‹I1, ìŒû”ü˜a1, ª–{‘‘ˆê2, ’F@‰pŽ÷3 (1•wl, 2‘Š–ÍŒŽ•a‰@, 3ŽY‰È): ‘æ396‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/11/13), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733196. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï) (Œ€Cƒm[ƒgEuŽt) ƒzƒ‹ƒ‚ƒ“—Ö@‚Ì‚·‚ׂÄ. ‰¬–ì‹|ŠóŽq (•wl): •œ¬23”N“x_“ސ쌧•ê‘Ì•ÛŒì–@Ew’èˆãŽtŒ€C‰ï (2011/11/13), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[EŠ–Í‘å–ì.

733197. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï) (Œ€Cƒm[ƒgEuŽt) ƒƒNƒ`ƒ“‚Ì‚·‚ׂÄ. ŠÖŒû˜aŠé (ŽY‰È): •œ¬23”N“x_“ސ쌧•ê‘Ì•ÛŒì–@Žw’èˆãŽtŒ€C‰ï (2011/11/13), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733198. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚éŽq‹{‘ÌŠà‚Ì• o×–Ef—z«—á‚ÌŒŸ“¢. Vˆä@“w (•wl): ‘æ29‰ñ_“ސì3‘åŠwƒIƒ“ƒRƒƒWƒXƒg‚̉ï (2011/11/18), ƒUƒGƒ‹ƒVƒC’¬“c.

733199. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) hMG-hCG—Ö@Œã‚É”­Ç‚µ‚œ”]“®–¬[Ç‚Ì1—á. ‚–؈»Žq (•wl): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï (2012/2/1), ‘Š–ÍŒŽŽs“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733200. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’éØŒã‚É”A•öÇ‚𔭏ǂµ‚œPIH‚Ì1—á. “‡‰ª‹¶1, ˆÀ“¡G”ü1, ‹gŒŽ@ˆê, “à–ì’ŒŽ÷ (1ŽY‰È): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï (2012/2/1), ‘Š–ÍŒŽŽs“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733201. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’°ŠÇ’ŒÚZ‚ð‚«‚œ‚µ‚œ—‘‘ƒŠà‚ÌŽèpÇ—á. “cŽG—L‹I1, ìŒû”ü˜a1, ª–{‘‘ˆê, ’F@GŽ÷2 (1•wl, 2ŽY‰È): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï (2012/2/1), ‘Š–ÍŒŽŽs“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733202. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)]y’S“–¢˜blzì“à”Žl (•wl): ‘æ6‰ñ_“ސì4‘åŠwE¶BˆãŠw•×‹­‰ï@ŽáŽèƒ[ƒNƒVƒ‡ƒbƒv (2012/2/8), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733203. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰I)yÀ’·zŠC–ìM–ç (ŽY‰È): ‘æ12‰ñ_“ސ쌧Œ§ˆæ’n‹æŽY•wl‰ÈŒ€C‰ï (2012/3/8), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110014. [ŒŽ’˜] Intracranial hemorrhage in full-term infants following vaginal delivery in a Japanese Perinatal Center. Kanai Y1, Amano K1, Numao A1, Mochizuki J1, Nowatari M2, Okutomi T3, Unno N1: Kitasato Med J 2011/3; 41 (2): 123-6. (‹àˆä—Y“ñ1, “V–ì@Š®1, À”ö²Žq2, –]ŒŽƒŽq1, –ì“n³•F3, ‰œ•xr”V4, ŠC–ìM–ç1: 1ŽY‰È, 2•wl, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 4–ƒŒ)

[’˜@‘]

H20-620001. [Šwp‘] (’P’˜)yƒx[ƒVƒbƒN•ƒXƒeƒbƒvƒAƒbƒvuÀ@ŽüŽYŠú’Ž‰¹”g‚Ì‚Ý‚©‚œz‹àˆä—Y“ñ (ŽY‰È), ƒƒfƒBƒJo”Å, ‘åã, 2008/8”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H14-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) íˆÊ‘Ù”Õ‘Šú”—£‚ð˜A‘±4‰ñ‚­‚è•Ô‚µ‚œ1—á. À”ö²Žq1, ‹àˆä—Y“ñ2, “V–ì@Š®2 (1•wl, 2ŽY‰È): ‘æ103‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï (2002/6/9), “Œ‹ž.


®Œ`ŠO‰ÈŠw

[Šwp˜_•¶]

110177. [ŒŽ’˜] Elevation of pancreatic oxidative stress in STR/Ort mice. Uchida K1, Naruse K1, Ogawa Z, Suto K1, Urabe K1, Takaso M1: Journal of Applied Animal Research 2011/6; 39 (2): 149-52. (“à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1, {“¡D1, è•”@Œ›1, ‚‘Š»Žm1: 1®ŠO)

110178. [ŒŽ’˜] Hammering force during cementless total hip arthroplasty and risk of microfracture. Sakai R, Takahashi A, Takahira N, Uchiyama K1, Yamamoto T1, Uchida K1, Fukushima K1, Moriya M1, Takaso M1, Itoman M1, Mabuchi K: Hip Int 2011/6; 21 (3): 330-5. (Žðˆä—˜“Þ, ‚‹Ž—ºŽq, ‚•œ®L, “àŽRŸ•¶1, ŽR–{‹–Ÿ1, “à“cŒ’‘Ÿ˜Y1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚‘Š»Žm1, Ž…–ž·Œ›1: 1®ŠO)

110179. [ŒŽ’˜] Low intensity pulsed ultrasound accelerates delayed healing process by reducing the time required for the completion of endochondral ossification in aged mouse femur fracture model. Katano M1, Naruse K1, Uchida K1, Mikuni-Takagaki Y, Takaso M1, Itoman M1, Urabe K1: Exp Anim 2011/7; 60 (4): 385-95. (•Ð–ì‘fº1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, ‚Š_—TŽq, ‚‘Š»Žm1, Ž…–ž·Œ›1, è•”@Œ›1: 1®ŠO)

110180. [ŒŽ’˜] A novel underuse model shows that inactivity but not ovariectomy determines the deteriorated material properties and geometry of cortical bone in the tibia of adult rats. Miyagawa K, Kozai Y, Ito Y, Furuhama T, Naruse K1, Nonaka K, Nagai Y, Yamato H, Kashima I, Ohya K, Aoki K, Mikuni-Takagaki Y: J Bone Miner Metab 2011/7; 29 (4): 422-36. (¬£NŽ¡1: 1®ŠO)

110181. [ŒŽ’˜] Influence of internal fixator flexibility on murine fracture healing as characterized by mechanical testing and microCT imaging. Steck R, Ueno M1, Gregory L, Rijken N, Wullschleger ME, Itoman M1, Schuetz MA: J Orthop Res 2011/8; 29 (8): 1245-50. (ã–쐳Šì1, Ž…–ž·Œ›1: 1®ŠO)

110182. [ŒŽ’˜] Treatment of infected total knee arthroplasty by a local drug-delivery system with retention of the metal components. Aikawa J1, Urabe K1, Fujita M1, Minehara H2, Naruse K1, Iwase D1, Itoman M1, Takaso M1: Kitasato Med J 2011/9; 41 (2): 178-83. (‘Šì@~1, è•”@Œ›1, “¡“c@Œì1, •ôŒŽG¹2, ¬£NŽ¡1, Šâ£@‘å1, Ž…–ž·Œ›1, ‚‘Š»Žm1: 1®ŠO, 2‹~–œ)

110183. [ŒŽ’˜] Low-intensity pulsed ultrasound promites the osteigenic effect induced by bone allograft. Aikawa J1, Naruse K1, Uchida K1, Mikuni-Takagaki Y, Kozai Y, Kashima I, Takaso M1, Itoman M1, Urabe K1: Kitasato Med J 2011/9; 41 (2): 184-92. (‘Šì@~1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, ‚‘Š»Žm1, Ž…–ž·Œ›1, è•”@Œ›1: 1®ŠO)

110184. [ŒŽ’˜] Distribution of bone marrow-derived cells in fracture callus during plate fixation in a green fluorescent protein-chimeric mouse model. Ueno M1, Uchida K1, Takaso M1, Minehara H2, Suto K1, Takahira N3, Steck R, Schuetz MA, Itoman M1: Exp Anim 2011/10; 60 (5): 455-62. (ã–쐳Šì1, “à“cŒ’‘Ÿ˜Y1, ‚‘Š»Žm1, •ôŒŽG¹2, {“¡D1, ‚•œ®L3, Ž…–ž·Œ›1: 1®ŠO, 2‹~–œ, 3ˆã—Éq¶Šw•”)

110185. [ŒŽ’˜] Hammerig sound frequency analysis and prevention of intraperative periprosthetic fractures during total hip arthroplasty. Sakai R, Kikuchi A, Morita T, Takahira N, Uchiyama K1, Yamamoto T1, Moriya M1, Uchida K1, Fukushima K1, Tanaka K, Takaso M1, Itoman M1, Mabuchi K: Hip Int 2011/11; 21 (6): 718-23. (“àŽRŸ•¶1, ŽR–{‹–Ÿ1, X’JŒõr1, “à“cŒ’‘Ÿ˜Y1, •Ÿ“‡Œ’‰î1, ‚‘Š»Žm1, Ž…–ž·Œ›1: 1®ŠO)

110186. [ŒŽ’˜] Simulation of the effect of flexible and rigid plate designs on murine fracture healing. Sakai R , Steck R, Ueno M1, Uchida K1, Minehara H2, Tanaka K, Takaso M1, Itoman M1, Mabuchi K. Schuetz M: The Journal of Biomechanical Science and Engineering 2011; 6 (4): 311-21. (ã–쐳Šì1, “à“cŒ’‘Ÿ˜Y1, •ôŒŽG¹2, ‚‘Š»Žm1, Ž…–ž·Œ›1: 1®ŠO, 2‹~–œ)

110187. [ŒŽ’˜] Differential age-related bone architecture changes between female and male STR/Ort mice. Uchida K1, Urabe K1, Naruse K1, Kozai Y, Onuma K1, Mikuni-Takagaki Y, Kashima I, Sakai R, Itoman M1, Takaso M1: Exp Anim 2012/1; 61 (1): 59-66. (“à“cŒ’‘ŸEY1, è•”@Œ›1, ¬£NŽ¡1, ¬ÀŒ«Ž¡1, Ž…–ž·Œ›1, ‚‘Š»Žm1: 1®ŠO)

110188. [ŒŽ’˜] Quality assessment for processed and sterilized bone using Raman spectroscopy. Yamamoto T1, Uchida K1, Naruse K1, Suto M1, Urabe K1, Uchiyama K1, Suto K1, Moriya M1, Itoman M1, Takaso M1: Cell Tissue Bank 2012/8; 13 (3): 409-14. (ŽR–{‹–Ÿ1, “à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1, {“¡Œõ•q1, è•”@Œ›1, “àŽRŸ•¶1, {“¡D1, X’JŒõr1, Ž…–ž·Œ›1, ‚‘Š»Žm1: 1®ŠO)

110189. [ŒŽ’˜] Allogenic serum improves cold preservation of osteochondral allografts. Onuma K1, Urabe K1, Naruse K1, Uchida K1, Itoman M1: Clin Orthop Relat Res 2012/10; 470 (10): 2905-14. (¬ÀŒ«Ž¡1, è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, Ž…–ž·Œ›1: 1®ŠO)

120032. [ŒŽ’˜] –ƒáƒ«ŒÒŠÖß’E‰P, ˆŸ’E‰P‚ɑ΂·‚鐮Œ`ŠO‰È“IŽèp‚Ì’†Šú¬Ñ. Œ”ö@“Ä, ›–ì“O•v, Œ”ö@—², è•”@Œ›1, ‘Šì@~1, Šâ£@‘å1 (1®ŠO): “ú–{”]«–ƒáƒ‚ÌŠO‰ÈŒ€‹†‰ïŽ 2011/6; 21: 7-15.

120033. [Ç—á•ñ] ‘å‘ڍœ“ª‚·‚ׂèÇpŒã‚É”­¶‚µ‚œ‘å‘ڍœ“ª‰óŽ€Ç‚ɑ΂µ‘å‘ڍœ“ªŒã•û‰ñ“]œØ‚èp‚ðŽ{s‚µ‚œ2—á. ‰Í‘º@’Œ1, ‚•œ®L2, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚‘Š»Žm1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): “Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2011/6; 23 (2): 189-94.

120034. [ŒŽ’˜] Duetto SI stemŽüˆÍœ‚É‚š‚¯‚鍜–§“x‚Ɖž—Í’l‚ÌŽZo. Žðˆä—˜“Þ1, ŽR–{‹–Ÿ2, ‘qŒ®˜Ðˆê˜Y1, “àŽRŸ•¶2, ‚•œ®L1, “à“cŒ’‘Ÿ˜Y2, •Ÿ“‡Œ’‰î2, X’JŒõr2, Ž…–ž·Œ›2, ‚‘Š»Žm2, ”nŸºŽŽ‘1 (1ˆã—Éq¶Šw•”, 2®ŠO): ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ïŽ 2011/8; 35 (3): 191-6.

120035. [ŒŽ’˜] ‰PŠWŒ`¬•s‘SŒÒ‚É‚š‚¢‚ÄAcetabular retroversion ‚ÍŽ©‘RŒo‰ß‚ɉe‹¿‚·‚é‚©. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ‚•œ®L2, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Joint 2011/9; 37: 254-6.

120036. [ŒŽ’˜] “–‰@‚É‚š‚¯‚éCurved periacetabular osteotomy |2005”N‚©‚ç‚Ì’ZŠú¬Ñ|. “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, ‚‘Š»Žm1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Joint 2011/9; 37: 733-7.

120037. [ŒŽ’˜] •ÏŒ`«ŒÒŠÖßÇ‚ɑ΂·‚é“à”œœØ‚èp‚Ì“K‰ž. X’JŒõr1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ‚èƒEF1, ŽR–{‹–Ÿ1, è•”@Œ›1, ‚‘Š»Žm1, ‚•œ®L2, Ž…–ž·EE (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Joint 2011/9; 37: 744-8.

120038. [ŒŽ’˜] R‹ÃŒÅ–òŽg—p‰º‚̌Ҋ֐ߍœØ‚èp‚ ‚é‚¢‚͐lHœ“ª’uŠ·p, lHŒÒŠÖß‘S’uŠ·p‚É‚š‚¯‚é[•”Ã–¬ŒŒðÇ‚š‚æ‚Ñ—LŠQŽ–Û‚Ì”­¶—Š‚Ì”äŠr. ‰Í‘º@’Œ1, ‚•œ®L2, “àŽRŸ•¶1, ‚èƒF1, •Ÿ“‡Œ’‰î1, X’JŒõr1, è•”@Œ›1, ‚‘Š»Žm1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip joint 2011/9; 37: 766-70.

120039. [ŒŽ’˜] Šw“¶ŠúƒXƒ|[ƒc­”N’c‚É‚š‚¯‚é–ì‹…•IŒŸf. –Ø“‡ä”Ž, “ŒŽR—玡1, ‚XˆÑ”V, “n糉pˆê˜Y, •œŽR”Ž‹v, ‘Ÿ“cC•œ (1®ŠO): Ã‰ªŒ§®Œ`ŠO‰ÈˆãŠwŽGŽ 2011/11; 4 (2): 137-40.

120040. [ŒŽ’˜] ƒCƒ“ƒvƒ‰ƒ“ƒgŠE–Ê‚ÉŽc—¯‚·‚é’èí‰×d‚̍œ‘gD‚ւ̉e‹¿. ”nŸºŽŽ‘, –òŽt_G, Žðˆä—˜“Þ, “à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1 (1®ŠO): —Տ°ƒoƒCƒIƒƒJƒjƒNƒX 2011; 32: 225-9.

120041. [ŒŽ’˜] lH•GŠÖß‘S’uŠ·pŒã‚É‚š‚¯‚鎝‘±‘å‘ڐ_ŒoƒuƒƒbƒN‚ÌŒø‰Ê‚ƍ‡•¹Ç. ‘Šì@~1, è•”@Œ›1, “¡“c@Œì, X–{@Ê, ’·’Jì—TŽq, ‚‘Š»Žm1 (1®ŠO): “Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2012/3; 24 (1): 6-12.

220010. [€ŒŽ’˜] ƒXƒeƒƒCƒh«‘å‘ڍœ“ª‰óŽ€Ç‚ɑ΂·‚élHœ“ª’uŠ·‚Í—L—p‚©? X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, ‚èƒF1, ‰Í‘º@’Œ1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): “ú–{lHŠÖßŠw‰ïŽ 2011; 41: 486-7.œ’ljÁ•ª

310021. [Ç—á•ñ] Revision total hip replacement using a cementless interlocking distal femoral stem with allograft-cemented composite and the application of intramedullary and onlay cortical strut allografts: two case reports. Uchiyama K1, Takahira N2, Narahara H1, Fukushima K1, Yamamoto T1, Moriya M1, Kawamura T1, Urabe K1, Sakai R2, Itoman M1, Takaso M1: J Orthop Sci 2012/5; 17 (3): 323-7. (“àŽRŸ•¶1, ‚•œ®L2, “茎G”V1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, ‰Í‘º@’Œ1, è•”@Œ›1, Žðˆä—¢“Þ2, Ž…–ž·Œ›1, ‚‘Š»Žm1: 1®ŠO, 2ˆã—Éq¶Šw•”)

320032. [Ç—á•ñ] ’‹Œ«‘«ŠÖßŠO‘€x‘Ñ‘¹‚Æ‘«ŠÖßŒã•ûƒCƒ“ƒsƒ“ƒWƒƒ“ƒgÇŒóŒQ‚ð‡•¹‚µ‚œ3—á. “ŒŽR—玡 (®ŠO): “ú–{‘«‚ÌŠO‰ÈŠw‰ïŽGŽ 2011/5; 32 (2): 60-4.

320033. [Ç—á•ñ] ‘å‘ڍœ‚Ɋ֐ߊO•ÏŒ`‚ð—L‚·‚é•ÏŒ`«•GŠÖßÇ‚ɑ΂µ‚ĐlH•GŠÖß‘S’uŠ·pEðŽ{s‚µ‚œ3—á‚ÌŒŸ“¢. “ì’J@~1, è•”@Œ›1, ‘Šì@~1, “¡“c@Œì, Šâ£@‘å1, ‚‘Š»Žm1 (1®ŠO): “ú–{lHŠÖßŠw‰ïŽ 2011/12; 41: 426-7.

320034. [Ç—á•ñ] ‘å‘ڍœŒz•”œŽîᇂ̑~àŠŒã‚Éstrut bone allograft‚ð—p‚¢‚čČš‚ð‚š‚±‚È‚Á‚œ2—á. “¡ŠªŽõŽq1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, è•”@Œ›1, ¬£NŽ¡1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): _“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ïŽGŽ 2012/3; 24 (5): 217-20.

520036. [‘à]y“ÁW: ‹@”\‚©‚ç‚Ý‚œ‰^“®ŠíŽŸŠ³‚Ì‚·‚ׂāzPART.4 “®ìŽž‚ÌŽpš‚𐧌䂷‚鉺Žˆ@‹@”\‚©‚ç‚Ý‚œŒÒŠÖß. “àŽRŸ•¶1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‚©‚ç‚Ÿ‚̉Ȋw 2011/11; 271: 90-5.

522105. [uÀ]y“ÁW: Femoroacetabular impingement|•a‘Ô‚ÆŽ¡—Á|zFAI‚ÌŽ©‘RŒo‰ß|“Á‚Éacetabular retroversion‚ð—L‚·‚éÇ—á‚ÉŠÖ‚µ‚ā|. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, ‚•œ®L2, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): Mon Book Orthopaedics 2011/4; 24 (4): 9-15.

522106. [uÀ]yŽ‹ÀzåKåN‚͔̍|‚Æ,ul‚‚­‚è, l‚»‚Ÿ‚āv. ‚‘Š»Žm (®ŠO): —Տ°®Œ`ŠO‰È 2011/5; 46 (5): 393-4.

522107. [uÀ]y“ÁW: Žá”NŽÒ (40Î–¢–ž) ‚̐isŠúE––ŠúŒÒŠÖßÇ‚Ì•a‘Ô‚ÆŽ¡—Áz1. •a‘ԁ@FAI‚Ì•a‘ԂƐf’f|‚킪‘‚É‚š‚¯‚é•p“x‚ðŠÜ‚߂ā|. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, ‚•œ®L2, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖßŠO‰È 2011/9; 30 (9): 21-6.

522108. [uÀ]y“ÁW: Žá”NŽÒ (40Î–¢–ž) ‚̐isŠúE––ŠúŒÒŠÖßÇ‚Ì•a‘Ô‚ÆŽ¡—Áz4. ŠÖß‰·‘¶Žèp@Žá”NŽÒ‚̐isŠúE––ŠúŒÒŠÖßÇ‚ɑ΂·‚éŠÖß‰·‘¶Žèp. ‚•œ®L1, “àŽRŸ•¶2, •Ÿ“‡Œ’‰î2, X’JŒõr2, Ž…–ž·Œ›2 (1ˆã—Éq¶Šw•”, 2®ŠO): ŠÖßŠO‰È 2011/9; 30 (9): 63-8.

522109. [uÀ]y‘‘å“ÁW: ‹ØŽŸŠ³updatez_Œo‹ØŒŽ«‘€œ^Ç‚ɑ΂·‚鎡—ẪGƒrƒfƒ“ƒX|DuchenneŒ^‹ØƒWƒXƒgƒƒtƒB[‚É”º‚€‘€œ^Ç‚ÌŽ¡—ÂɊւ·‚éŠCŠO•¶Œ£‚Ìreview‚𒆐S‚É. âV“¡@˜j1, ‚‘Š»Žm1 (1®ŠO): BRAIN and NERVE 2011/11; 63 (11): 1237-44.

522110. [uÀ]y“ÁW: FAI (femoroacetabular impingement)|f’f‚ÆŽ¡—ÂÌup to date|z’PƒXü‘œ‚É‚æ‚éFAI‚̐f’f. •Ÿ“‡Œ’‰î1, Siebenrock, K, ‚•œ®L2, “àŽRŸ•¶1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖßŠO‰È 2011/12; 30 (12): 26-32.

522111. [uÀ]yƒCƒ“ƒvƒ‰ƒ“ƒgŽü•ÓœÜ‚ւ̑΍ôzlHœ“ª¥lHŒÒŠÖßƒXƒeƒ€ŽüˆÍœÜ (Vancouver•ª—Þtype-B3) ‚ɑ΂·‚éallograft-prosthesis composite‚ð—p‚¢‚œÄ’uŠ·p. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚‘Š»Žm1, ‚•œ®L2, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ®Œ`¥ÐŠQŠO‰È 2011/12; 54 (13): 1597-602.

[’˜@‘]

620117. [Šwp‘] (•ª’SŽ·•M)yÒ‘«‹ØˆÏkÇfŽ@ƒ}ƒjƒ…ƒAƒ‹z10Í Žèp—Ö@@10-3 ‘€œ^|Ò’Œ•ÏŒ`‹ž³p, p.102-5. ‚‘Š»Žm1, âV“¡@˜j1, ã–쐳Šì1, ’†àVr”V1, ˆä‘º‹M”V1 (1®ŠO), •Ò: SMAf—Ã}ƒjƒ…ƒAƒ‹•ÒWˆÏˆõ‰ï, ‹à–F“°, ‹ž“s, 2012/5”­s.

620118. [Šwp‘] (•ª’SŽ·•M)y“úíf—Âŏo‰ï‚€˜’ɂ̐f‚©‚œzII. Še˜_@19. Ò’ÅŽîá‡, p.206-11. ‚‘Š»Žm (®ŠO), •Ò: ‚‹Ž˜a‹v, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2012/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713095. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Stability of internal fixation for distal clavicular fractures. Matsuura T1, Sakai R, Tanaka K, Uchino M1, Minehara H2, Suzuki T2, Itoman M1, Mabuchi K, Takaso M1: The 12th European Congress of Trauma and Emergency Surgery (2011/4/27-30), Milan, Italy. (Œ‰YW³1, “à–쐳—²1, •ôŒŽG¹2, —é–؁@‘ì2, Ž…–ž·Œ›1, ‚‘Š»Žm1: 1®ŠO, 2‹~–œ)œ’ljÁ•ª

713096. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Evaluation of bipolar hemiarthroplasty for the treatment of steroid-induced osteonecrosis of the femoral head. Moriya M1, Uchiyama K1,Takahira N2, Fukushima K1, Yamamoto T1, Kawamura T1, Itoman M3, Takaso M1: SICOT XXV Triennial World Congress (2011/9/7), Praha, Czech. (X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, ‰Í‘º@’Œ1, Ž…–ž·Œ›3, ‚‘Š»Žm1: 1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@)

713097. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Proximal femoral allograft]prosthesis composites with cementless distal interlocking stems in revision total hip replacement. Uchiyama K1, Takahira N2, Fukushima K1,Yamamoto T1, Moriya M1, Kawamura T1, Sakai R, Itoman M3, Takaso M1: SICOT XXV Triennial World Congress (2011/9/9), Praha, Czech. (“àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, ‰Í‘º@’Œ1, Žðˆä—˜“Þ, Ž…–ž·Œ›3, ‚‘Š»Žm1: 1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@)

713098. [ŠwEE(‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Lateral instability of the ankle and posterior ankle impingement syndrome:a report of 7 cases. Higashiyama R1, Watanabe E, Takaso M1: 4th Meeting of International Federation of Foot & Ankle Societies (2011/9/21), Nara. (“ŒŽR—玡1, ‚‘Š»Žm1: 1®ŠO)

722086. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “¯ŽíœˆÚA‚Ì—ðŽj‚Ɛi•à. è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, “à–쐳—²1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ‰Í‘º@’Œ1, Š}ŒŽ‚Ý‚Ç‚è, ¬—ѐçŒb, ‚‘Š»Žm1, Ž…–ž·Œ›2 (1®ŠO, 2‹ãB˜JÐ•a‰@): ‘æ84‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2011/5/12), WebŠJÃ.

722087. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) THRpŒãŠŽõ‚ɑ΂·‚éR‹Û–òŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚ð—p‚¢‚œ“ñŠú“IÄ’uŠ·p‚̍H•v. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚‘Š»Žm1, ‚•œ®L2, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ39‰ñ“ú–{ŠÖß•aŠw‰ï (2011/11/12), ‰¡•l.

722088. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) isŠú¥––ŠúŒÒŠÖßÇ‚ɑ΂·‚éŒÒŠÖßœØ‚èp‚Ì’·Š‚Æ’ZŠ,¡Œã‚̉ۑè. ‚•œ®L1, “àŽRŸ•¶2, •Ÿ“‡Œ’‰î2, X’JŒõr2, ‚‘Š»Žm2, Ž…–ž·Œ›3 (1ˆã—Éq¶Šw•”, 2®ŠO, 3‹ãB˜JÐ•a‰@): ‘æ39‰ñ“ú–{ŠÖß•aŠw‰ï (2011/11/12), ‰¡•l.

722089. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –Ml‚É‚š‚¯‚é, FAI‚Ì•a‘Ô”cˆ¬‚Æ•p“x. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ‚•œ®L2, Ž…–ž·Œ›3, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ39‰ñ“ú–{ŠÖß•aŠw‰ï (2011/11/12), ‰¡•l.

722090. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) R‹ÃŒÅ–òŽg—p‰º‚ł̌Ҋ֐ߎèp‚É‚š‚¯‚é[•”Ã–¬ŒŒðÇ‚Ì”­¶•p“x‚ÌŒŸ“¢. ‰Í‘º@’Œ1, ‚•œ®L2, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚‘Š»Žm1, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ39‰ñ“ú–{ŠÖß•aŠw‰ï (2011/11/13), ‰¡•l.

723476. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚T—ƒbƒg•às‰^“®—}§ƒ‚ƒfƒ‹‚Ì•a‘Ô. “ˆ“cçˆÀ‹I, è•”@Œ›1, ¬£NŽ¡1, {“¡Œõ•q, “à“cŒ’‘Ÿ˜Y1, ”nŸºŽŽ‘2, Ž…–ž·Œ›3, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ31‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (2011/5/14), “Œ‹ž.

723477. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘SlHŒÒŠÖß’uŠ·p‚ÌŽžŒn—ñ‚Å‚Ìstem ŽüˆÍ‚ÌBMD•Ï‰»‚Ɖž—Í’l‚ÌŒŸ“¢. ŽR–{‹–Ÿ1, Žðˆä—˜“Þ, “àŽRŸ•¶1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, {“¡Œõ•q, {“¡D1, ã–쐳Šì1, Ž…–ž·Œ›2, ”nŸºŽŽ‘3, ‚‘Š»Žm1 (1®ŠO, 2‹ãB˜JÐ•a‰@, 3ˆã—Éq¶Šw•”): ‘æ31‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (2011/5/14), “Œ‹ž.

723478. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 50ÎˆÈ‰º‚̐isŠú¥––Šú•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂·‚éŠÖßÄ¶Žèp|‘å‘ڍœŠO”œœØ‚èp‚ÆChiariœ”ՍœØ‚èp‚̍‡•¹Žèp‚Ì’·Šú¬Ñ|. “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚èƒF1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ84‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2011/5/14), WebŠJÃ.

723479. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Chiari œ”ՍœØ‚èpŒã‚̐lHŒÒŠÖß‘S’uŠ·p‚É‚š‚¯‚é‰PŠW‘€‚ÌŽ¡—ЬÑ. X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ‚èƒF1, ŽR–{‹–Ÿ1, Ž…–ž·Œ›3, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ84‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2011/5/14), WebŠJÃ.

723480. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒHƒ“ƒ_ƒpƒŠƒkƒNƒX‚ ‚é‚¢‚̓GƒmƒLƒTƒpƒŠƒ“Žg—p‰º‚ł̌Ҋ֐ߎèp‚É‚š‚¯‚é[•”Ã–¬ŒŒðÇ‚Ì”­¶•p“x|pŽ®‚È‚Ç‚Ì‘œŠp“IŽ‹“_‚©‚ç|. ‰Í‘º@’Œ1, ‚•œ®L2, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ84‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2011/5/15), WebŠJÃ.

723481. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@œƒoƒ“ƒN (KUBB) ’ñ‹Ÿ“¯Žíœ‚̈À‘S«. è•”@Œ›1, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, Š}ŒŽ‚Ý‚Ç‚è, ¬—ѐçŒb, Ž…–ž·Œ›2, ‚‘Š»Žm1 (1®ŠO, 2‹ãB˜JÐ•a‰@): ‘æ84‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2011/5/15), WebŠJÃ.

723482. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·pŒã‚É‚š‚¯‚鎝‘±‘å‘ڐ_ŒoƒuƒƒbƒN‚ÌŒŸ“¢. “ì’J@~1, ‘Šì@~1, “¡“c@Œì1, è•”@Œ›1, Šâ£@‘å1, X–{@Ê, ’·’Jì—TŽq, ‚‘Š»Žm1 (1®ŠO): ‘æ3‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (2011/6/16), ŽD–y.

723483. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ãøœ‹ßˆÊ’[‹×–EŽîØœŒã‚̍œ“Œ‡‘¹‚ɑ΂µ‚Ä“€Œ‹•Û‘¶“¯Žíœ“ˆÚA‚ðs‚Á‚œ1—á. ‚–쏞‘Ÿ˜Y1, ‘Šì@~1, è•”@Œ›1, “ŒŽR—玡1, ‚‘Š»Žm1, Ž…–ž·Œ›2 (1®ŠO, 2‹ãB˜JÐ•a‰@): ‘æ3‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (2011/6/16), ŽD–y.

723484. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æùœœ“àŽ‰–bŽî‚ɑ΂µ‚Ä‹ŸŽ‹‰º‘~àŠp‚ðŽ{s‚µ‚œ1Ç—á. “ŒŽR—玡1, ‰i“ˆ—Ç‘Ÿ, •P–ì‘å•ã, –kŒŽ‘‘Ÿ, ŒŽ“c‹`’‰ (1®ŠO): ‘æ3‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (2011/6/16), ŽD–y.

723485. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) žôœ‰“ˆÊ’[œÜ‚ÌŽ¡—ÂŎg—p‚µ‚Ä‚¢‚éK-nail‚ÌŽh“ü“_‚ÌŒŸ“¢. •“cŒ«“ñ1, ¬—Ñ–Ÿ—Y1, ‘ë–{@ƒ1, ‹gŒŽ@Œ‰2, àVò‘ìÆ3, “àŽRŸ•¶4 (1•‰Í“à•a‰@, 2ŽOŒ¬’ƒ‰®‘æˆê•a‰@, 3“ú–{ˆã‘å•a‰@, 4®ŠO): ‘æ37‰ñ“ú–{œÜŽ¡—Êw‰ï (2011/7/1), ‰¡•l, œÜ 2011; 33 (Suppl): S303.

723486. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŠƒEƒ}ƒ`‚Å‚ÌTHAÄ’uŠ·pŽž‚Ì“¯ŽíœˆÚA‚𕹗p‚µ‚œÄŒš–@. ‚•œ®L1, “àŽRŸ•¶2, •Ÿ“‡Œ’‰î2, ‰Í‘º@’Œ2, X’JŒõr2, ‚‘Š»Žm2, Ž…–ž·Œ›3 (1ˆã—Éq¶Šw•”, 2®ŠO, 3‹ãB˜JÐ•a‰@): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/17-20), _ŒË, ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï¥‘æ20‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ƒvƒƒOƒ‰ƒ€¥Ž˜^W 2011/6; p.155.

723487. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`Š³ŽÒ‚É‚š‚¯‚鐶•šŠw“I»Ü“Š—^’†‚̐®Œ`ŠO‰ÈŽèp‚ÌŒŸ“¢. “¡“c@Œì1, è•”@Œ›1, ‘Šì@~1, “àŽRŸ•¶1, ¬ÀŒ«Ž¡1, Îì@Í, “c’†Z–Ÿ2, œA”šr¬2, ‰ª“c@ƒ3, ‰““¡•œm (1®ŠO, 2äPŒŽ•aEŠŽõ“à, 3Œ’NŠÇ—ƒZ): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/17-20), _ŒË, ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï¥‘æ20‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ƒvƒƒOƒ‰ƒ€¥Ž˜^W 2011/6; p.417.

723488. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Ž‰¹”gŒŸž‚ªp‘Of’f‚É—L—p‚Å‚ ‚Á‚œŠÖßƒŠƒEƒ}ƒ`Trigger wrist‚Ì2Ç—á. ¬ÀŒ«Ž¡1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ55‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2011/7/20), _ŒË.

723489. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@œƒoƒ“ƒN‚É‚š‚¯‚é‘gDÌŽæŽž‚̃Rƒ“ƒ^ƒ~ƒl[ƒVƒ‡ƒ“‚ɑ΂·‚éŽæ‚è‘g‚Ý. Š}ŒŽ‚Ý‚Ç‚è, è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ˆä‘º‹M”V1, ¬—ѐçŒb, Ž…–ž·Œ›2, ‚‘Š»Žm1 (1®ŠO, 2‹ãB˜JÐ•a‰@): ‘æ10‰ñ“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ï (2011/8/6), “Œ‹ž.

723490. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`‚É”º‚€‘O‘«•”•ÏŒ`‚ɑ΂·‚é“–‰@‚ÌŽ¡—ЬÑ. Šâ£@‘å1, ‘Šì@~1, “ŒŽR—玡1, –Œ‘q’Œd1, ¬ÀŒ«Ž¡1, è•”@Œ›1, “ì’J@~1, “¡“c@Œì1, ‚‘Š»Žm1 (1®ŠO): ‘æ36Eñ“ú–{‘«‚ÌŠO‰ÈŠw‰ïEŠwpW‰ï (2011/9/21), “Þ—Ç.

723491. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†”N’j«‚É”­Ç‚µ‚œFreiberg•a‚ɑ΂µŽ©‰Æœ“’ŒˆÚAp‚ðŽ{s‚µ‚œ1—á. “ŒŽR—玡1, ‘Šì@~1, Šâ£@‘å1, ‚‘Š»Žm1 (1®ŠO): ‘æ36‰ñ“ú–{‘«‚ÌŠO‰ÈŠw‰ïEŠwpW‰ï (2011/9/21), “Þ—Ç.

723492. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž¡—Âɓïa‚µ‚œ—Œ‘€’°˜‹Ø”^ᇂɂæ‚é—Œ‘€‰»”^«ŒÒŠÖß‰Š‚Ì1—á. •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, “hŽR³G1, ‚‘Š»Žm1, “ì’J@~1, ‚•œ®L2, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ38‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2011/10/7), Ž­Ž™“‡.

723493. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‘ڍœ“ª‚·‚ׂèÇ‚ɑ΂·‚鍜Ø‚èp‚É‚š‚¯‚é3ŽŸŒ³H‰–ƒ‚ƒfƒ‹‚ð—p‚¢‚œp‘OƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“. “hŽR³G1, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ‚•œ®L2, Š‹”—~ˆê3, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”, 3SONY): ‘æ38‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2011/10/7), Ž­Ž™“‡.

723494. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 40ÎˆÈ‰º‚̐isŠúE––Šú•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂·‚éŠO”œœØ‚èp‚Ì’†Šú¬Ñ. X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ‰Í‘º@’Œ1, ŽR–{‹–Ÿ1, ‚‘Š»Žm1, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ38‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2011/10/8), Ž­Ž™“‡.

723495. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 40ÎˆÈ‰º‚̐isŠúE––Šú•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂·‚é‘å‘ڍœŠO”œœØ‚èp‚ÆChiariœ”ՍœØ‚èp‚Ì•¹—pŽèp‚Ì’·Šú¬Ñ. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1, ‚èƒF2, ‰Í‘º@’Œ3, ‚•œ®L4, Ž…–ž·Œ›5 (1®ŠO, 2•£–ì•Ó‘‡•a‰@, 3–k—¢‘åŠwŒ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 4ˆã—Éq¶Šw•”, 5‹ãB˜JÐ•a‰@): ‘æ38‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2011/10/8), Ž­Ž™“‡.

723496. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Crossover sign‚Í•ÏŒ`«ŒÒŠÖßÇ‚̊댯ˆöŽq‚Æ‚È‚è“Ÿ‚é‚©|¶‘¶•ªÍ‚ð—p‚¢‚œŒŸ“¢|. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ‚•œ®L2, Ž…–ž·Œ›3, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ38‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2011/10/8), Ž­Ž™“‡.

723497. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHœ“ª’uŠ·pŒã3TŒo‰ß‚µ‚Ä‚©‚ç[•”Ã–¬ŒŒðÇ‚ª”­¶‚µIVC filter‚ð‘}“ü‚µ‚œ1—á. ‰Í‘º@’Œ1, ‚•œ®L2, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, •œì‹IŽq1, ‚‘Š»Žm1, Ž…–ž·EE (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ38‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2011/10/8), Ž­Ž™“‡.

723498. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒXƒvƒŒ[ƒgŒÅ’荜Üƒ‚ƒfƒ‹‚ð—p‚¢‚œGFPœ‘ƒLƒƒ‰ƒ}ƒEƒX‚É‚š‚¯‚鍜‘—R—ˆ×–E‚Ì•ª•z. ã–쐳Šì1, “à“cŒ’‘Ÿ˜Y1, ‚‘Š»Žm1, •ôŒŽG¹2, ŽR–{‹–Ÿ1, {“¡D1, Steck Roland, Schuetz Michael, Ž…–ž·Œ›3 (1®ŠO, 2‹~–œ, 3‹ãB˜JÐ•a‰@): ‘æ26‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2011/10/21), ŒQ”n.

723499. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DuchenneŒ^‹ØƒWƒXƒgƒƒtƒB[‚É”º‚€Ò’Œ‘€œ]ÇŽèp‚É‚š‚¯‚éöÝ“IŽüpŠú‡•¹Ç‚Ì—vˆö•ªÍ. âV“¡@˜j1, ã–쐳Šì1, ˆä‘º‹M”V1, ’†àVr”V1, V’J‚è‚å‚€‰î1, “à“cŒ’‘Ÿ˜Y1, ‚•œ®L2, ‚‘Š»Žm1, ’|˜Q–¯]3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3–ƒŒ): ‘æ45‰ñ“ú–{‘€œ^ÇŠw‰ï (2011/10/26), ‹v—¯•Ä.

723500. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Å‹ß7”NŠÔ‚Ì“Œ‹ž“s‚É‚š‚¯‚éŽvtŠú“Á”­«‘€œ]Ç‚̉uŠw’²ž. ã–쐳Šì1, ‚‘Š»Žm1, ’†àVr”V1, ˆä‘º‹M”V1, âV“¡@˜j1, V’J‚è‚å‚€‰î1, ‚•œ®L2, “à“cŒ’‘Ÿ˜Y1, ÔàV@“w, ¬’Jr–Ÿ, “ì@¹•œ (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ45‰ñ“ú–{‘€œ^ÇŠw‰ï (2011/10/26), ‹v—¯•Ä

723501. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒL[ƒp[—ûK’†‚É’†S«èò‘‘¹‚𔭏ǂµ‚œ—ŽqƒTƒbƒJ[‘IŽè‚Ì1—á. “ŒŽR—玡1, “n•Ó‰pˆê˜Y, ‚‘Š»Žm1 (1®ŠO): ‘æ22‰ñ“ú–{—Տ°ƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï (2011/11/5), ÂX.

723502. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬’·Šú’jŽqƒTƒbƒJ[‘IŽè‚É‚š‚¯‚鎲‘«‚ÌOsgood-Schlatter•a”­Ç—vˆö‚ÌŒŸ“¢. “¡ˆä@Žü, “n粗T”V, “ŒŽR—玡1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ22‰ñ“ú–{—Տ°ƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï (2011/11/6), ÂX.

723503. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) TKAŠ³ŽÒ‚É‚š‚¯‚é•GŠWäFÄŒšpŒã‚ÌŠŽõ‚ɑ΂·‚ésalvageŽèp. ‘Šì@~1, Šâ£@‘å1, “ŒŽR—玡1, “ì’J@~1, •õŠÝ—mŽŸ˜Y1, ‚–쏞‘Ÿ˜Y1, ¬£NŽ¡1, ‚‘Š»Žm1, è•”@Œ›1 (1®ŠO): ‘æ39‰ñ“ú–{ŠÖß•aŠw‰ï (2011/11/12), ‰¡•l.

723504. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]«–ƒáƒ‚É”º‚€ŒÒŠÖß’E‰PEˆŸ’E‰P‚ɑ΂·‚é‘å‘ڍœŒž”P“à”œœØ‚èp‚ÌŽ¡—ЬÑ‚ƉƑ°‚Ì–ž‘«“x. Šâ£@‘å1, ‘Šì@~1, “ŒŽR—玡1, “ì’J@~1, ‚‘Š»Žm1, è•”@Œ›1, Œ”ö@—², ›EEO•v, Œ”ö@“Ä (1®ŠO): ‘æ22‰ñ“ú–{¬Ž™®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (2011/12/8), ‹ž“s.

723505. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]«–ƒáƒŽ™‚É‚š‚¯‚é‘ÌŠ²‹Ø‰ð—£p‚̐V‚µ‚¢ŽŽ‚݁|‰~”w•ÏŒ`‚ɑ΂·‚é|. Œ”ö@“Ä, ›–ì“O•v, Œ”ö@—², ‘Šì@~1, Šâ£@‘å1 (1®ŠO): ‘æ22‰ñ“ú–{¬Ž™®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (2011/12/8), ‹ž“s.

723506. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •sˆÀ’èŒ^•IŠÖß’E‰PœÜ‚ÌŽ¡—ÃŒoŒ±: Terrible triad‘¹‚Ì4—á. •ì_Žm1, ¬ÀŒ«Ž¡1, Œ©–Ú’q‹I1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ24‰ñ“ú–{•IŠÖßŠw‰ïŠwpW‰ï (2012/2/18), VŠƒ.

723507. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‚ƒfƒ…ƒ‰[ƒ[ƒe[ƒeƒBƒ“ƒOƒqƒ“ƒWlH•GŠÖßƒVƒXƒeƒ€‚ðlH•GŠÖß’uŠ·p‚ðŽ{s‚µ‚œ2—á. ‚–쏞‘Ÿ˜Y1, ‘Šì@~1, Šâ£@‘å1, “ì’J@~1, “ŒŽR—玡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/24), ‰«“ê.

723508. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰º‘ÚŠJ•úœÜ‚Æ‘å‘ڍœèò•”œÜ‚𔺂Á‚œ‘œ”­ŠO‚ɑ΂µ‚Ä‘å‘ڐؒfpŒã‚ɐlHœ“ª’uŠ·p‚ðŽ{s‚µ‚œ1—á. “¡ŠªŽõŽq1, “àŽRŸ•¶1, X’JŒõr1, ‚–쏞‘Ÿ˜Y1, V’J‚è‚å‚€‰î1, ‚‘Š»Žm1, •ôŒŽG¹2, Œ‰YW³, —é–؁@‘ì2, ‚•œ®L3 (1®ŠO, 2‹~–œ, 3ˆã—Éq¶Šw•”): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/24), ‰«“ê.

723509. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) L”͈͍œŒ‡‘¹‚𔺂Á‚œlH•GŠÖß’uŠ·p‚Ö‚Ì“¯ŽíœˆÚAp‚Ì’ZŠú¬Ñ. Šâ£@‘å1, ‘Šì@~1, ¬£NŽ¡1, “ŒŽR—玡1, “ì’J@~1, ‚‘Š»Žm1, è•”@Œ›1 (1®ŠO): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/24), ‰«“ê.

723510. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·p (TKA)Œã‚Ì‘å‘ڍœè÷ãœÜ‚ɑ΂·‚é“àŒÅ’è•û–@‚ƏpŒãŽ¡—ЬÑ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •œì‹IŽq1, ¬£NŽ¡1, “à–쐳—²1, è•”@Œ›1, ‘Šì@~1, Šâ£@‘å1, “ŒŽR—玡1, “ì’J@~1, Ž…–ž·Œ›2, “à“cŒ’‘Ÿ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2‹ãB˜JÐ•a‰@): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/24), ‰«“ê.

723511. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 3Ž{Ý‚É‚š‚¯‚éƒtƒHƒ“ƒ_ƒpƒŠƒkƒNƒX‚ ‚é‚¢‚̓GƒmƒLƒTƒpƒŠƒ“Žg—p‰º‚ł̐lHŒÒŠÖß’uŠ·p‚É‚š‚¯‚é[•”Ã–¬ŒŒðÇ‚Ì”­¶•p“x. ‰Í‘º@’Œ1, ‚•œ®L2, “茎G”V1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, “ì’J@~1, ‹{“‡Œº—z1, ‚‘Š»Žm1, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/25), ‰«“ê.

723512. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHŒÒŠÖß’uŠ·pŽž‚̃Xƒeƒ€‘Å‚¿ž‚݉¹‚ÌŽü”g”‰ðÍ‚Ɖž—͂̐„’è‚É‚æ‚ép’†œÜ‚Ì—\‘ª. ŽR–{‹–Ÿ1, “àŽRŸ•¶1, X’JŒõr1, •Ÿ“‡Œ’‰î1, “hŽR³G1, •õŠÝ—mŽŸ˜Y1, Ž…–ž·Œ›2, ‚‘Š»Žm1, Žðˆä—˜“Þ3, ‚•œ®L3, ”nŸºŽŽ‘3 (1®ŠO, 2‹ãB˜JÐ•a‰@, 3ˆã—Éq¶Šw•”): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/25), ‰«“ê.

723513. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’˜‚µ‚¢œ—Z‰ð‚𐶂¶‚œ‚œ‚ß•ªßó“¯Ží”玿œ‚É‚æ‚éÄ’uŠ·p‚ð—v‚µ‚œ1Ç—á. X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, ‰Í‘º@’Œ1, “hŽR³G1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/25), ‰«“ê.

723514. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€“¯“úlHŒÒŠÖß’uŠ·p‚Ì“K‰ž‚Æ—L—p«. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚‘Š»Žm1, ‚•œ®L2, ‰Í‘º@’Œ3, Ž…–ž·Œ›4 (1®ŠO, 2ˆã—Éq¶Šw•”, 3–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 4‹ãB˜JÐ•a‰@): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/25), ‰«“ê.

731096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Å‹ß‚̐ҒŒ•ÏŒ`‚ÌŽèp“IŽ¡—Ã. ‚‘Š»Žm (®ŠO): _“ސìÒ’Å21 (2011/7/1), ‰¡•l.

731097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚“xÒ’Œ•ÏŒ`‚ÌŒŽˆö‚ÆŽ¡—Ã. ‚‘Š»Žm (®ŠO): ‘æ12‰ñŽOdŒ§®Œ`ŠO‰ÈH‹GƒZƒ~ƒi[ (2011/9/29), ’Ã.

731098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ò’Œ•ÏŒ`‚̐f’f‚ÆŽ¡—Ã. ‚‘Š»Žm (®ŠO): –kM®Œ`ŠO‰Èˆã‰ï (2011/11/12), ’·–ì.

731099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “úíf—ÂŖ𗧂ҒŒ‘€œ]Ç‚̐f’f‚ƍŐV‚ÌŽ¡—Ã. ‚‘Š»Žm (®ŠO): –k‘«—§ŒSŽs®Œ`ŠO‰Èˆã‰ï (2012/2/2), –k–{.

731100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ò’Œ‘€œ]Ç‚̐f’f‚ƍŋ߂̎¡—Âɂ‚¢‚Ä. ‚‘Š»Žm (®ŠO): ‘æ22‰ñŽ­Ž™“‡Ò’ŐҐ‘Œ€‹†‰ï (2012/2/13), Ž­Ž™“‡.

731101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ò’Œ‘€œ]Ç‚̐f’f‚ÆŽ¡—Ã. ‚‘Š»Žm (®ŠO): ‘æ8‰ñ‘œ–€ì—Տ°®Œ`ŠO‰Èˆã‰ï (2012/2/24), ‰¡•l.

731102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ò’ŒŠÇ‹·óÇ‚̐f’f‚ÆŽ¡—Ã. ‚‘Š»Žm (®ŠO): ‘æ20‰ñ–k—¢ƒƒfƒBƒJƒ‹ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2012/2/29), ‘Š–ÍŒŽ.

732041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVE“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŠÔŒ‡æês‚Ì•a‘Ô‚ÆŽ¡—Ã. ˆä‘º‹M”V1, ‚‘Š»Žm1, ’†àVr”V1, ã–쐳Šì1, âV“¡@˜j1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ142‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2011/6/25), ‰¡•l.

732042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŒÒŠÖßŠŠ–Œ«œ“ŽíÇ‚ɑ΂·‚é, ‹ŸŽ‹‰ºŽè‹Z‚ÆMIS-DAA‚ð—p‚¢‚œŠÏŒŒ“IŽè‹Z‚Ì•¹—p. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ60‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï^‘æ51‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2011/9/16), ‚‚­‚Î.

732043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) University of Bern,Inselspital‚͍¡, ‚±‚€l‚Š‚Ä‚¢‚é. •Ÿ“‡Œ’‰î (®ŠO): ŒÒŠÖß‹ŸŒ€‹†‰ï2012“~ (2012/1/22), ‘åã.

732044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) 3Ž{Ý‚É‚š‚¯‚éR‹ÃŒÅ–òŽg—p‰º‚ł̐lHŒÒŠÖß’uŠ·p‚É‚š‚¯‚é[•”Ã–¬ŒŒðÇ‚Ì”­¶•p“x. ‰Í‘º@’Œ1, ‚•œ®L2, “茎G”V1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚‘Š»Žm1, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ52‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2012/3/23), ‰¡•l, ŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2012/3; 43 (—Õ‘): p.43.

732045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “–‰È‚É‚š‚¯‚éŒÒŠÖß‹ŸŽ‹‰ºŽèp‚Ö‚ÌŽæ‚è‘g‚Ý. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, “hŽR³G1, ‚‘Š»Žm1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ144‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2012/3/24), ‰¡•l, _“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ïŽGŽ 2012/3; 24(4): 161.

733204. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šw“¶ŠúƒXƒ|[ƒc­”N’c‚É‚š‚¯‚é–ì‹…•IŒŸf. “ŒŽR—玡1, –Ø“‡ä”Ž, ‚XˆÑ”V, “n糉pˆê˜Y, •œŽR”Ž‹v (1®ŠO): ‘æ165‰ñÃ‰ªŒ§®Œ`ŠO‰Èˆã‰ï (2011/7/9), Ã‰ª.

733205. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)u‚Þ‚©‚Å‹£‘ˆv‚É‚š‚¯‚éŠO’²ž (‘æ2•ñ). “ŒŽR—玡1, –Ø“‡ä”Ž, ‚XˆÑ”V, •œŽR”Ž‹v, ™ŒŽ—²”V, ‹{–{Žüˆê, “n糉pˆê˜Y, ‚‘Š»Žm1 (1®ŠO): ‘æ165‰ñÃ‰ªŒ§®Œ`ŠO‰Èˆã‰ï (2011/7/9), Ã‰ª.

733206. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw‚É‚š‚¯‚éPrimary THR‚Ì—ðŽj‚Æ‹@Ží‚Ì‘I‘ð. “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, •Ÿ“‡Œ’‰î1, “hŽR³G1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1, ‚•œ®L2, Žðˆä—˜“Þ2, ”nŸºŽŽ‘2, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—ÉqE¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ19‰ñHip Forum (2011/7/30), ‰¡{EE

733207. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œã\Žšx‘Ñ (PCL) •t’…•”—ô—£œÜ‚ɑ΂·‚épull out wirngŒÅ’è. ‘Šì@~1, è•”@Œ›1, “¡“c@Œì1, Šâ£@‘å1, “ŒŽR—玡1, “ì’J@~1, •ôŒŽG¹2, ¬£NŽ¡1, ‚‘Š»Žm1 (1®ŠO, 2‹~–œ): ‘æ60‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï^‘æ51‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2011/9/16), ‚‚­‚Î.

733208. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œã•û‹ž³ŒÅ’èp‚ðŽ{s‚µ‚œèò’ŏd“xŒãœ]Ç‚Ì1—á. âV“¡@˜j1, ˆä‘º‹M”V1, ã–쐳Šì1, •Ÿ“‡Œ’‰î1, ’†àVr”V1, ‚‘Š»Žm1 (1®ŠO): ‘æ60‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï^‘æ51‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2011/9/16), ‚‚­‚Î.

733209. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·pŒã‚É‚š‚¯‚鎝‘±‘å‘ڐ_ŒoƒuƒƒbƒN‚Ì—¯’uŠúŠÔ‚̈Ⴂ‚É‚æ‚éŒø‰Ê‚ÌŒŸ“¢. X–{@Ê, ’·’Jì—TŽq, rì–@Žq, •õ–{ŒN], ‘Šì@~1, “ì’J@~1, ‚‘Š»Žm1, “¡“c@Œì1, è•”@Œ›1 (1®ŠO): ‘æ60‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï^‘æ51‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2011/9/17), ‚‚­‚Î.

733210. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒ³Œv‘ª‚É‚æ‚él‚̈ړ®”\—Í‚š‚æ‚ьҊ֐߂ɓ­‚­‘‹Ø—Í‚Ì’è—Ê•]‰¿. Šâ£@‘å1, ‘Šì@~1 (1®ŠO): ‘æ28‰ñ”]«‚܂Ђ̊O‰ÈŒ€‹†‰ï (2011/10/22), ŒF–{.

733211. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œy“x‰PŠWŒ`¬•s‘S‚ð—L‚·‚éŽá”NŽÒ‚ɑ΂·‚éŽèp“I‰Á—Â̑I‘ð`œØ‚è or ‹ŸŽ‹‰ºŽèp`. •Ÿ“‡Œ’‰î1, ‚•œ®L2, “àŽRŸ•¶1, X’JŒõr1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ35‰ñŠÖ“ŒŒÒŠÖß§˜b‰ï (2011/10/29), “Œ‹ž.

733212. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽÒ‚Ì•sˆÀ’è‘å‘ڍœ“]Žq•”œÜ‚ɑ΂µ‚ĉ“ˆÊŒÅ’èŒ^ƒXƒeƒ€‚̐lHœ“ª’uŠ·p‚ðŽ{s‚µ‚œ2—á. “ï”gF“¿1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚–쏞‘Ÿ˜Y1, ‚‘Š»Žm1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ143‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2011/10/29), ‰¡•l.

733213. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·p (TKA) Œã‚Ì‘å‘ڍœè÷ãœÜ‚ÌŠÏŒŒ“IŽ¡—Ö@‚Ì‘I‘ð‚ƏpŒãŽ¡—ЬÑ‚ɂ‚¢‚Ä. •œì‹IŽq1, ¬£NŽ¡1, “à–쐳—²1, è•”@Œ›1, ‘Šì@~1, Šâ£@‘å1, “ŒŽR—玡1, “ì’J@“Õ1, Ž…–ž·Œ›2, “à“cŒ’‘Ÿ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2‹ãB˜JÐ•a‰@): ‘æ143‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2011/10/29), ‰¡•l.

733214. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘€œ^Ç‚ð‡•¹‚µ‚œTurnerÇŒóŒQ‚Ì2—á. ’†˜e[Í1, ˆä‘º‹M”V1, âV“¡@˜j1, ã–쐳Šì1, ’†àVr”V1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ660‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2011/11/26), “Œ‹ž.

733215. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DuchenneŒ^‹ØƒWƒXƒgƒƒtƒB[‚É”º‚€Ò’Œ‘€œ^ÇŽèp‚É‚š‚¯‚éöÝ“IŽüpŠú‡•¹Ç‚Ì—vˆö•ªÍ. âV“¡@˜j1, ã–쐳Šì1, ˆä‘º‹M”V1, ’†àVr”V1, ‚•œ®L2, ‚‘Š»Žm1, ’|˜Q–¯]3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3–ƒŒ):w‹ØƒWƒXƒgƒƒtƒB[‚ÌŽ¡Œ±‹’“_®”õ, •ïŠ‡“If—ÃKƒCƒhƒ‰ƒCƒ“‚ÌŒ€‹†x”ljï‹c (2011/12/3), “Œ‹ž.

733216. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šw“¶ŠúƒXƒ|[ƒc­”N’c‚É‚š‚¯‚é–ì‹…•IŒŸf. –Ø“‡ä”Ž, “ŒŽR—玡1, ‚XN”V, “n糉pˆê˜Y, ™ŒŽ—²”V, •œŽR”Ž‹v (1®ŠO): ‘æ1229‰ñç—tˆãŠw‰ï®Œ`ŠO‰È—á‰ï (2011/12/3), ç—t.

733217. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Þ‚©‚Å‹£‘ˆ‚É‚š‚¯‚éŠO’²ž (‘æ3•ñ). “ŒŽR—玡1, ‹{–{Žüˆê, ‚XˆÑ”V, •œŽR”Ž‹v, “n糉pˆê˜Y, Œ©–Ú’q‹I1, ‚‘Š»Žm1 (1®ŠO): ‘æ1229‰ñç—tˆãŠw‰ï®Œ`ŠO‰È—á‰ï (2011/12/4), ç—t.

733218. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘«ŠÖßŒã•ûƒCƒ“ƒsƒ“ƒWƒƒ“ƒgÇŒóŒQ‚Æ‘«ŠÖßŠO‘€•sˆÀ’èÇ‚ð‡•¹‚µ‚œ5—á. “ŒŽR—玡1, ‚XˆÑ”V, •œŽR”Ž‹v, “n•Ó‰pˆê˜Y, Œ©–Ú’q‹I1, ‚‘Š»Žm1 (1®ŠO): ‘æ1229‰ñç—tˆãŠw‰ï®Œ`ŠO‰È—á‰ï (2011/12/4), ç—t.

733219. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚAŒã‚ÌJeuneÇŒóŒQ‚ɑ΂µ‘€œ^ÇŽèp‚ðŽ{s‚µ‚œˆê—á. ‚–쏞‘Ÿ˜Y1, âV“¡@˜j1, –Œ‘q’Œd1, V’J‚è‚å‚€‰î1, ã–쐳Šì1, ˆä‘º‹M”V1, ’†àVr”V1, ‚‘Š»Žm1 (1®ŠO): ‘æ661‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2011/12/17), “Œ‹ž.

733220. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •G•¡‡x‘Ñ‘¹‚ɑ΂·‚é‹ŸŽ‹‰ºŽèp. “ŒŽR—玡1, –kŒŽ‘‘Ÿ, ‰i“ˆ—Ç‘Ÿ (1®ŠO): ç—tƒXƒ|[ƒcˆãŠwŒ€‹†‰ï (2012/1/28), ç—t.

733221. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žá”NŽÒ‚Ì•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂µ‘å‘ڍœ“ªŒã•û‰ñ“]œØ‚èp‚ðŽ{s‚µ12”NŒo‰ß‚µ‚œ1—á. •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, “hŽR³G1, ‚‘Š»Žm1, ‚•œ®L2, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ52‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2012/3/22), ‰¡•l.

733222. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –ƒáƒ«“à”œë‘«‚ɑ΂µƒCƒŠƒUƒƒt‘nŠOŒÅ’èŠí‚ð—p‚¢‚Ä‘«ŠÖß‘SŒÅ’èp‚ðŽ{s‚µ‚œ2—á. V’J‚è‚å‚€‰î1, ‘Šì@~1, è•”@Œ›1, Šâ£@‘å1, •ì_Žm1, ‚‘Š»Žm1 (1®ŠO): ‘æ52‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2012/3/22), ‰¡•l.

733223. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ¶‘̃hƒi[‚É‚æ‚铯Žíœ•t‚«•GŠWäF‚ð—p‚¢‚œACL ÄŒšpŒã‚ÌŽ¡—ЬÑ. •œì‹IŽq1, ‘Šì@~1, “ì’J@~1, ‚–쏞‘Ÿ˜Y1, Šâ£@‘å1, “ŒŽR—玡1, ¬£NŽ¡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO): ‘æ52‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2012/3/23), ‰¡•l.

733224. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚“xÒ’Œ•ÏŒ`‚ɑ΂·‚éŽèp‚̍H•v. ‚‘Š»Žm (®ŠO): ‘æ52‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2012/3/23), ‰¡•l.

733225. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘«ŠÖßŒã•ûƒCƒ“ƒsƒ“ƒWƒƒ“ƒgÇŒóŒQ‚ƒ‹Œ«‘O‹—äCx‘Ñ‘¹‚̍‡•¹—á‚ɑ΂µ‚ÄŽèpŽ{sŒãscrew‚Ì’E“]‚𗈂µ‚œ1—á. ŠÖŒû”Ž”V, ¬–q—SŽq, “ŒŽR—玡1, ‘Šì@~1, Šâ£@‘å1, ‚‘Š»Žm1 (1®ŠO): ‘æ144‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2012/3/24), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H19-110002. [ŒŽ’˜] Previous and current issues affecting preservation and transfer of banked bone allografts in Kitasato university hospital bone bank and experiments to establish suitable transfer conditions. Urabe K1, Naruse K1, Ikebe S, Uchiyama K1, Onuma K1, Uchida K1, Itoman M1: Low Temprature Medicine 2007/12; 33 (4): 46-50. (è•”@Œ›1, ¬£NŽ¡1, ’r•Ó¹D, “àŽRŸ•¶1, ¬ÀŒ«Ž¡1, “à“cŒ’‘Ÿ˜Y1, Ž…–ž·Œ›1: 1®ŠO)

H20-110004. [ŒŽ’˜] Cold preservation of rat osteochondral tissues in two types of solid organ preservation solution, culture medium and saline. Onuma K1, Urabe K1, Naruse K1, Park HJ1, Uchida K1, Itoman M1: Cell and Tissue Banking 2009/2; 10 (1): 1-9. (¬ÀŒ«Ž¡1, è•”@Œ›1, ¬£NŽ¡1, –p@W³1, “à“cŒ’‘Ÿ˜Y1, Ž…–ž·Œ›1: 1®ŠO)

H20-110005. [ŒŽ’˜] The effect of cryopreservation or heating on the mechanical properties and histomorphology of rat bone-patellar tendon-bone. Park HJ1, Urabe K1, Naruse K1, Onuma K1, Nemoto N, Itoman M1: Cell Tissue Bank 2009/2; 10 (1): 11-8. (Œ‰YW³1, è•”@Œ›1, ¬£NŽ¡1, ¬ÀŒ«Ž¡1, ª–{“TŽq, Ž…–ž·Œ›1: 1®ŠO)

H21-110003. [ŒŽ’˜] In vitro comparison of elution characteristics of vancomycin from calcium phosphate cement and polymethylmethacrylate. Urabe K1, Naruse K1, Hattori H, Hirano M, Uchida K1, Onuma K1, Park HJ1, Itoman M1: J Orthop Sci 2009; 11; 14 (6): 784-93. (è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, ¬ÀŒ«Ž¡1, Œ‰YW³1, Ž…–ž·Œ›1: 1®ŠO)

[Šw‰ïEŒ€‹†‰ï“™]

H19-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The effect of different sterilization processes on the mechanical properties and histomorphology of rat bone-patellar tendon-bones. Park HJ1, Urabe K1, Naruse K1, Onuma K1, Itoman M2: 7th International cartilage repair society (2007/9/29-10/2), Warsaw, Poland (Œ‰YW³1, è•”@Œ›1, ¬£NŽ¡1, ¬ÀŒ«Ž¡1, Ž…–ž·Œ›2: 1®ŠO, 2‹ãB˜JÐ•a‰@)

H21-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒVƒjƒAƒSƒ‹ƒtƒ@[‚É”­¶‚µ‚œ¬Žw[Žw‹ü‹ØäF”牺’f—ô‚Ì1—á. ¬ÀŒ«Ž¡1, ‰ª“c‹M[, ‰Í‘º@’Œ1, ‚•œ®L2, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3‹ãB˜JÐ•a‰@): ‘æ24‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ€‹†‰ï (2010/2/12), é‹Ê.

H22-723012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯ŽíœˆÚA‚̍׋ۊw“I–â‘è‚š‚æ‚шã—Õی¯ã‚ÌŽæ‚舵‚¢‚ÉŠÖ‚·‚é’²ž. “à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ¬£NŽ¡1, Š}ŒŽ‚Ý‚Ç‚è, ¬—ѐçŒb, Ž…–ž·Œ›2, ‚‘Š»Žm1 (1®ŠO, 2‹ãB˜JÐ•a‰@): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à: –ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³“™—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (H22-–Ɖu-ˆê”Ê-011)|‚æ‚èˆÀ‘S‚Å—ÇŽ¿‚È“¯Žíœ‚ð‹Ÿ‹‹‚·‚é‚œ‚߂̎ЉïŠî”Ր®”õ|•œ¬22”N“x”ljï‹c (2011/2/25), ¬‘q.

H22-733011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±‘å‘ڐ_ŒoƒuƒƒbƒN‚Ì—¯’uŒp‘±•s‰Â—vˆö‚Æ•ûô‚ÌŒŸ“¢. X–{@Ê, ’·’Jì—TŽq, rì–@Žq, —ä–{ŒN], “¡“c@Œì1, ‘Šì@~1, “ì’J@~1, è•”@Œ›1, Ž…–ž·Œ›2 (1®ŠO, 2‹ãB˜JÐ•a‰@): ‘æ59‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17), ·‰ª.

H22-733012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰óás«”^”çÇ‚ɍ‡•¹‚µ‚œŽŠŽw’†ßœ–³‹Û«œ‘‰Š‚ÆŽv‚í‚ê‚œ1—á. •ì_Žm1, ¬ÀŒ«Ž¡1, ‰ª“c‹M[, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ25‰ñ“Œ“ú–{ŽèŠO‰ÈŒ€‹†‰ï (2011/2/25), “Œ‹ž.


Œ`¬ŠO‰ÈE”ü—eŠO‰ÈŠw

[Šwp˜_•¶]

110190. [ŒŽ’˜] Effect of EGF and bFGF on Fibroblast Proliferation and Angiogenic Cytokine Production from Cultured Dermal Substitutes. Yu A, Matsuda Y, Takeda A1, Uchinuma E1, Kuroyanagi Y: J Biomater Sci Polym Ed 2011/6 [Epub ahead of print]. (˜°‚ ‚©‚Ë, •“c@Œ[1, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO)

110027. [ŒŽ’˜] Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema. Kashiwagi S1,2, Hosono K1, Suzuki T1, Takeda A2, Uchinuma E2, Majima M1: Lab Invest 2011/9; 91 (9): 1314-25. (”–ؐT–ç1,2, ×–ì‰Á“ÞŽq1, —é–Ø—§‹I1, •“c@Œ[2, “àÀ‰hŽ÷2, ”n“ˆ³—²1: 1–ò—, 2Œ`¬E”üŠO)

110191. [ŒŽ’˜] Characterization of dense artificial connective tissues generated in a newly designed bioreactor. Iwashiro H1, Hosoya S, Mima T2, Ohhashi S, Aihara T, Ohara S, Adachi E2: Connect Tissue Res 2011; 52 (4): 340-52. (ŠâéŒ[C1, ”üŠÔŒ’•F2, ˆÀ’B‰hŽ¡˜Y3: 1Œ`¬E”üŠO, 2”÷¶•š, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110192. [ŒŽ’˜] Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia. Sato A1, Takeda A2: J Dermatol 2012/1; 39 (1): 27-32. (•“c@Œ[2: 1ƒNƒŠƒjƒbƒN•œŽR, 2Œ`¬E”üŠO)

120042. [ŒŽ’˜] œŠi«‰ºŠ{‘O“ˏǂɂš‚¯‚éŠ{‹ž³Žèp‘OŒã‚̐㍜ˆÊ’u‚̕ω»‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’r–{”ɍO1, Â–ö˜a–ç1, ŽRèˆÀ°1, £èWˆê˜Y1, “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): –k—¢ˆãŠw 2011/6; 41 (1): 9-14.

120043. [ŒŽ’˜] –k—¢‘åŠw•a‰@Œ`¬ŠO‰ÈE”ü—eŠO‰È‚ɉ—‚¯‚é‰ß‹Ž12”NŠÔ‚ÌŠç–ʍœœØ‚èŽèp‚ɑ΂·‚é—Տ°“IŒŸ“¢. Â–ö˜a–ç1, ’r–{”ɍO1, ŽRèˆÀ°1, £èWˆê˜Y1, •“c@Œ[1, “àÀ‰hŽ÷1, Î“n–õ•v (1Œ`¬E”üŠO): –k—¢ˆãŠw 2011/6; 41 (1): 23-32.

120044. [ŒŽ’˜] —²‹N«”畆üˆÛ“÷Žî‚̗Տ°“IŒŸ“¢. –p@Œ\ˆê1, •“c@Œ[1, Žðˆä’Œ•F, ‚‹ŽŽk–Ÿ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ2011/7; 31 (7): 462-8.

120045. [ŒŽ’˜] Šááىº‚ŽèpÇ—á‚ÌŒŸ“¢. Î•‹§Žj1, Œ”ö‚ ‚š‚¢2, ‰i“‡˜a‹M2, ã–쑏ˆê˜Y, ”nêŽq2, •“c@Œ[2, “àÀ‰hŽ÷2 (1–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2Œ`¬E”üŠO): é‹ÊŒ§ˆãŠw‰ïŽGŽ 2011/10; 46 (1): 215-21.

120046. [ŒŽ’˜] ŽèŽwPIPŠÖß¶‘€”w‘€’E‰PœÜ‚ɑ΂µ‚ÄDynamic Distraction Apparatus‚ÆŠÏŒŒ“IœÚ‡p‚𕹗p‚µ‚œŽ¡—ÃŒoŒ±. ŠâéŒ[C1,2 (1Œ`¬E”üŠO, 2”‹Ž’†‰›‘‡•a‰@): “ú–{ŽèŠO‰ÈŠw‰ïŽGŽ 2011; 28 (4): ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹.

120047. [ŒŽ’˜] ŽèŽwEŽèŠÖß‚É”­Ç‚µ‚œƒKƒ“ƒOƒŠƒIƒ““EopŒãÄ”­—á‚ÌŒŸ“¢. ŒFàVŒ›ˆê, ª–{@[1, H–{•ôŽ1, ÎìS‰î1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): “ú–{ŽèŠO‰ÈŠw‰ïŽGŽ 2011; 28 (4): ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹.

320035. [Ç—á•ñ] ôòÜ‚É‚æ‚é‘«”w•”ƒAƒ‹ƒJƒŠ‘¹‚Ì1—á. Î•‹§Žj1, Œ”ö‚ ‚š‚¢1, ‰i“‡˜a‹M1, ÎìS‰î1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ŽY‹ÆˆãŠwƒWƒƒ[ƒiƒ‹ 2011/5; 34 (3): 28-31.

320036. [Ç—á•ñ] ŒûOŒûŠW—ô‚ð‡•¹‚µ‚œ—r–Œ”j—ôƒV[ƒNƒGƒ“ƒX‚Ì2—á. •XŒ©˜a–€1, £èWˆê˜Y1, ŽRèˆÀ°1, ’r–{”ɍO1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): –k—¢ˆãŠw 2011/12; 41 (2): 123-5.

320037. [Ç—á•ñ] ÛHŽžˆÙí—¬—܁g˜k‚Ì—ÜŒ»Ûh‚ɑ΂µ¬Â—³“’‚ª—LŒø‚Å‚ ‚Á‚œ1—á. ”nêŽq1, ã“cWŽq, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): Š¿•û‚Ɛf—à 2011/12; 2 (4): 267.

520037. [‘à] ”_–ò’†“Å‚ÌŒ»ó‚Ƒ΍ô. ‰ÄìŽü‰î, ŒŠ_—Ç•v, ‰ª“c–M•F, ‘å’J’˱”V1, ‰i”ü‘åŽu (1Œ`¬E”üŠO): “ú–{ˆãŽ–V•ñ 2011/6; 4546: 90-4.

522112. [uÀ]y“ÁW: ƒTƒƒ“ƒ[ƒN‚ɖ𗧂ƒVƒ~E‚­‚·‚ݑΉžôzˆã—Ë@ŠÖ‚É‚š‚¯‚éƒVƒ~, ‚­‚·‚݂̑Ήž. ²“¡‰p–Ÿ1,2 (1Œ`¬E”üŠO, 2–k—¢Œ€‹†Š•a‰@): Creabeaux 2011/4; 66: 25-9.

522113. [uÀ]y“ÁW: ŒûŠW—ôŽ¡—ÂÌupdate|‰‰ñŽèp‚Ì’·Šú¬Ñz d“îŒûŠW—ô‚ɑ΂·‚éFurlow–@. £èWˆê˜Y1, ’r–{”ɍO1, ŽRèˆÀ°1, ’†‹v–؍Nˆê, Â–ö˜a–ç1, “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): Œ`¬ŠO‰È 2011/9; 54 (9): 975-82.

522114. [uÀ]y“ÁW: ‚€‚Ü‚­‚¢‚©‚È‚¢‚̂̓RƒŒ‚ªŒŽˆö?@åñጃPƒA‚́g—Ž‚Æ‚µŒŠhz‚³‚Ü‚Ž‚Ü‚ÈŽ‹“_‚©‚çg—Ž‚Æ‚µŒŠh‚ð—\‘ª|g’T’ãh‚Ì‚æ‚€‚Éåñጔ­¶—vˆö‚ð’T‚ë‚€|. ‘å’J’˱”V (Œ`¬E”üŠO): ƒRƒ~ƒ…ƒjƒeƒBƒPƒA 2011/9; 13 (10): 31-4.

522115. [uÀ]y”ü—eˆã—Ã: Ž„‚Ì•û–@‚ƍ‡•¹Ç‰ñ”ð‚̃RƒczIII ŽèpŽè‹Z‚É‚æ‚鎡—Á@6. “û–[Œ`¬p@4) Š×–v“û“ª‚ÌŒ`¬p. “‡‘qNl1, “àÀ‰hŽ÷1, Žðˆä’Œ•F (1Œ`¬E”üŠO): Œ`¬ŠO‰È 2011; 54 (‘): 243-8.

540016. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•¶•”‰ÈŠwÈ‰ÈŠwŒ€‹†”ïzÄ¶ˆãHŠw‚ð—p‚¢‚œ’°œŠC–ȍœ”ñˆË‘¶Œ^Š{—ô•”œˆÚA‚̗Տ°“WŠJ‚̉”\«‚ɂ‚¢‚Ä. ŽRèˆÀ°1, ’r–{”ɍO1, ”nêŽq1, Â–ö˜a–ç1, Î•‹§Žj1 (1Œ`¬E”üŠO): •¶•”‰ÈŠwÈ‰ÈŠwŒ€‹†”ï•â•‹à•ñ‘ 2011.

[’˜@‘]

620119. [Šwp‘] (•ª’SŽ·•M)yŒ©‚œ–ڂ̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒO@”畆E—e–eE‘ÌŒ^‚ÌŽá•Ô‚è‚ÌŽè–@zŠe˜_@2. —e–e@4) ŠááقɊւí‚é‰Á—ƒJƒjƒYƒ€‚ÆŽ¡—Ã, p.110-8. ²“¡‰p–Ÿ1,2 (1Œ`¬E”üŠO, 2–k—¢Œ€‹†Š•a‰@), •ÒW: “ú–{R‰Á—îˆãŠw‰ï•ª‰È‰ïEŒ©‚œ–ڂ̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒOŒ€‹†‰ï, •¶Œõ“°, “Œ‹ž, 2011/5”­s.

620120. [Šwp‘] (ŠÄC)yƒƒX‚ð—p‚¢‚È‚¢ƒVƒŽ¡—Á|Žž”s‚µ‚È‚¢ƒ{ƒcƒŠƒkƒX—Ö@z‘ŠÄC: ì“‡@áÁ, ŒÃŽR“o—², ŠÄC: ‰F’ÖؗŽˆê, •ûŽõ•v, ²“¡‰p–Ÿ1,2, ’†–kMº, ŽR‰º—ŠG (1Œ`¬E”üŠO, 2–k—¢Œ€‹†Š•a‰@), ƒƒfƒBƒJƒ‹EƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹EƒŠƒŒ[ƒVƒ‡ƒ“ƒY (Š”), “Œ‹ž, 2011/6”­s.

620121. [Šwp‘] (•ª’SŽ·•M)y•Êû@—Տ°‰Æ‚Ì‚œ‚ß‚Ì‹ž³YEAR BOOK '11z[ŒûoŠO‰ÈŠÖ˜A] III‹‰Š{•ÏŒ`Ç‚É‚š‚¯‚éŠç–e•s’²˜a‚̐헪“I‰ü‘P, p.67-70. ’r–{”ɍO1, ˆî–ÑŽ Ž©, Â–ö˜a–ç1, ŽRèˆÀ°1 (1Œ`¬E”üŠO), •Ò: ˆÉ“¡ŠwŽ§, ’†“‡žÄˆê˜Y, ꠍG‘Ÿ˜Y, âV“¡@Œ÷, Žsì˜a”Ž, ƒNƒCƒ“ƒeƒbƒZƒ“ƒXo”Å, “Œ‹ž, 2011/9”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712024. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Development of Hydrocolloid Wound Dressing with Silver Sulfadiazine. Takeda A1, Uchinuma E1, Kubo T2, Iwasaki T2: The 21st Japan-China Joint Meeting on Plastic Surgery (2011/11/2-4), Fukuoka. (•“c@Œ[1, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO, 2ƒAƒ‹ƒPƒA (Š”))

712025. [Šw‰ï (‘Û)] (Hands-On Workshop) Hands-On Workshop Lower 3rd face. Sato H1,2, Liew S: Asia Pacific Medical Aesthetics Congress (2011/3/19-20), Cebu, Philippines. (²“¡‰p–Ÿ1,2: 1Œ`¬E”üŠO, 2–k—¢Œ€‹†Š•a‰@)

713099. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Upper Blepharoplasty for Asian. Sato H1,2, Mouri M, Yazawa K, Uchinuma E1: 16th World Congress of IPRAS (2011/5/22-27), Vancouver, Canada. (²“¡‰p–Ÿ1,2, –Ñ—˜–ƒ—¢, –î‘òŒcŽj, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO, 2–k—¢Œ€‹†Š•a‰@)

713100. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical feature of primary vein graft in free tissue transfers. Nemot M1, Kumazawa K, Ishikawa S1, Uchino M2, Uchinuma E1: 6th congress of the world society for reconstructive microsurgery (2011/7/1), Helsinki, Finland. (ª–{@[1, ÎìS‰î1, “à–쐳—²2, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO, 2®ŠO)

722091. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) V‚µ‚¢ŠT”O‚ÌMimetic Muscle Extended Forehead lift (MMEF). ‰F’ÖؗŽˆê, ‰Í–ì‘Ÿ˜Y, ‰œ‘º@m, ²“¡‰p–Ÿ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

722092. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹~–œ‹~‹}ƒZƒ“ƒ^[ê”CŒ`¬ŠO‰Èˆã‚É‚æ‚é”MŽ¡—Ã. ª–{@[1, ŒFàVŒ›ˆê, V”ü—T‘Ÿ1, “àÀ‰hŽ÷1, ‘Š”nˆêˆå2 (1Œ`¬E”üŠO, 2‹~–œ): ‘æ37‰ñ“ú–{”MŠw‰ï‘‰ïEŠwpW‰ï (2011/6/2-3), “Œ‹ž, ‘æ37‰ñ“ú–{”MŠw‰ï‘‰ïEŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.21.

722093. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) lH^”ç‚Ì—LŒø—˜—p|•@E•@ŽüˆÍ‚̐®—e“I‚ȍČš|. ŽR“c’Œl (Œ`¬E”üŠO): ‘æ3‰ñ“ú–{‘nŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/7/8-9), ŽD–y.

722094. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yŠO•@Žèp‚̃sƒbƒgƒz[ƒ‹z“–‰@‚É‚š‚¯‚é•@ˆÙ•šC•œÇ—á‚ÌŒŸ“¢. “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ111‰ñ“ú–{”ü—eŠO‰ÈŠw‰ïŠwpW‰ï (2011/7/16), “Œ‹ž.

722095. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŠááَèp‚̃sƒbƒgƒz[ƒ‹zC³Žèp‚ð—]‹V‚È‚­‚³‚ê‚œŠááىº‚Žèp‚ÌPitfall. ‰F’ÖؗŽˆê, ‰Í–ì‘Ÿ˜Y, ²“¡‰p–Ÿ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ111‰ñ“ú–{”ü—eŠO‰ÈŠw‰ïŠwpW‰ï (2011/7/16), “Œ‹ž.

722096. [Šw‰ï (‘S‘)] (ŒöŠJuÀE‹³ˆçu‰‰) ”ü—ef—Â̒†‚ŃWƒ…[ƒ‹‚ª‰Ê‚œ‚·–ðŠ„`Šî‘b‚ÆŽÀÛ`. ²“¡‰p–Ÿ1,2 (1Œ`¬E”üŠO, 2–k—¢Œ€‹†Š•a‰@): ‘æ29‰ñ“ú–{”ü—e”畆‰ÈŠw‰ï‘‰ïEŠwp‘å‰ï (2011/9/10-11), ‰ºŠÖ.

722097. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‰ºŠááفE’†Šç–ʁ@Lid-Cheek Junction‚̉ü‘P (Interactive Video“¢˜_‚ðŠÜ‚Þ)zƒƒX‚ðŽg‚í‚È‚¢Lid-Cheek Junction‚ðŠÜ‚ß‚œ’†Šç–Ê‚ÌŽá•Ô‚è|ƒXƒŒƒbƒhƒŠƒtƒg‚ÆŽ‰–b’“ü‚É‚æ‚éŽá•Ô‚莡—Á|. Žðˆä’Œ•F1, ‹à“c“¡1, ŽR–{@”Ž1, ’Ò–ìˆê˜Y1, Xã˜aŽ÷1, •“c@Œ[2, “‡‘qNl2 (1é–{ƒNƒŠƒjƒbƒNVh‰@, 2Œ`¬E”üŠO): ‘æ34‰ñ“ú–{”ü—eEO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

722098. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŠç–ʍœŠiŒ`¬zŽó‚¯ŒûŠç–e (œŠi«‰ºŠ{‘O“ˏÇ) ‚ɑ΂·‚鎡—Ð헪. ’r–{”ɍO1, ˆî–ÑŽ Ž©, Â–ö˜a–ç1, ŽRèˆÀ°1, “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ34‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

722099. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šááىº‚ÇŽèp‚É‚š‚¯‚鍶‰E·‰ü‘P‚Ö‚Ì‚±‚Ÿ‚í‚è. ²“¡‰p–Ÿ1, ’¹‹”ŽŽq1, •XŒ©˜aŒÈ1, –Ñ—˜–ƒ—¢, ‰F’ÖؗŽˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ34‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

722100. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “Œ—ml‚É“K‚µ‚œƒtƒFƒCƒXƒŠƒtƒg‚ÌŠJ”­‚Æ, ‚æ‚èŒø‰Ê“I‚É‚·‚é‚œ‚߂̍H•v. ‰F’ÖؗŽˆê, ‰Í–ì‘Ÿ˜Y, ²“¡‰p–Ÿ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ34‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

722101. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) •@Œ`¬ ×•ÐŽšb‰î“E‹Ø–ŒˆÚA‚É‚æ‚é—²•@p‚Ì’†’·ŠúŒo‰ß‚Æ“ñŽŸC³Ç—á‚ɂ‚¢‚Ä. ’†–kMº, ŒÃŽR“o—², •“c@Œ[1, “àÀ‰hŽ÷1, ŽOŽ}@M2 (1Œ`¬E”üŠO, 2•a—): ‘æ34‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

723515. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”畆—Lž™×–EŠà‚̃Šƒ“ƒpß“]ˆÚÇ—á‚ÌŒŸ“¢. H–{•ôŽ1, •“c@Œ[1, •XŒ©˜a–€1, é‰º@W1, XŽRŒc‘Ÿ1, ª–{@[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13), “¿“‡.

723516. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EŒû‰‰) ŠO•@”畆ˆ««Žîᇂɑ΂·‚épŽ®‚ÌŒŸ“¢. •“c@Œ[1, ™–{‰À, H–{•ôŽ1, ÎìS‰î1, ŽÄ“c’m‹`1, ”–ؐT–ç, Žðˆä’Œ•F, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723517. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) A”çp‚̌Œè‚É‹ê—¶‚·‚é•”•ª‚ɑ΂·‚é‹ÇŠ‰Aˆ³•Âœ—Ö@‚Ì—˜—p. ‚ŽR“ÖŽq1, ŽR“c’Œl1, ŽOD@G, “àÀ‰hŽ÷1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723518. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒAƒNƒŠƒ‹lH’ܗÖ@‚É‚æ‚éŠ×“ü’Ü‚ÌŽ¡—ÃŒoŒ±. ŽOD@G, ‚ŽR“ÖŽq1, ŽR“c’Œl1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723519. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚鎚‰îƒPƒƒCƒhŽèpÇ—á‚ÌŒŸ“¢. “‡‘qNl1, •“c@Œ[1, £èWˆê˜Y1, ª–{@[1, ’rE{”ɍO1, Â–ö˜a–ç1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723520. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Lž™×–EŠà—l‘gD‘œ‚ð’悵‚œ‰óás«”^”çÇ‚Ì1—á. ”nêŽq1, Î•‹§Žj1, Œ”ö‚ ‚š‚¢1, ‰i“‡˜a‹M1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723521. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ªŠW“ài“W‚ð”F‚ß‚œŠO«‘O“ª“Ž”X–E‚Ì1—á. Î•‹§Žj1, Œ”ö‚ ‚š‚¢1, ‰i“‡˜a‹M1, ”nêŽq1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723522. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚éŽèŽ‰–bŽî‚Ì9—á. ÎìS‰î1, •“c@Œ[1, ãŒŽ—Œb1, ŽÄ“c’m‹`1, •XŒ©˜a–€1, •–ö”ü—¢1, ª–{@[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723523. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠwŒ`¬ŠO‰ÈE”ü—eŠO‰È‚É‚š‚¯‚é35”NŠÔ‚Ì“û–[ŠOPaget•aŠ³ŽÒ‚Ì“Œv. ŽÄ“c’m‹`1, •“c@Œ[1, ÎìS‰î1, H–{•ôŽ1, ‹g’|r—T1, •–ö”ü—¢1, ª–{@[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723524. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”畆‹Ø‰Š‚ɍ‡•¹‚µ‚œ‰E•I•”“«”畆’×ᇂÌ1—á. ‹g’|r—T1, ª–{@[1, ‰i“‡˜a‹M1, V”ü—T‘Ÿ1, •XŒ©˜a–€1, ãŒŽ—Œb1, ÎìS‰î1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723525. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰Á—Šááىº‚Ç‚Í”ü—eã‚Í7’¥Œó‚Ì•¡‡ŽŸŠ³‚Æ‚µ‚ÄŽ¡—ª•K—v. ‰F’ÖؗŽˆê, ‰Í–ì‘Ÿ˜Y, “잊º—Y, ²“¡‰p–Ÿ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723526. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Œ‘€ãüâ|‚ɐ¶‚¶‚œƒAƒ|ƒNƒŠƒ“‘BŠà‚Ì1—á. é‰º@W1, •“c@Œ[1, Žç’JˆŸŠóŽq1, ‹g’|•q—T1, •XŒ©˜a–€1, ÎìS‰î1, H–{•ôŽ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723527. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Rhytidectomy‚ÌŒø‰Ê‚ªo‚É‚­‚¢Ç—á‚ÉŠÖ‚µ‚Ä. ²“¡‰p–Ÿ1, –Ñ—˜–ƒ—¢, –î‘òŒcŽj, ‰F’ÖؗŽˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/13-15), “¿“‡.

723528. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’܏°‘¹‚ɑ΂µ•t‚¯’Ü‚ð—p‚¢‚œŽ¡—ÃŒoŒ±. ŽREc’Œl1, ª–{@[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/4/15), “¿“‡.

723529. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽèŽwPIPŠÖß¶‘€”w‘€’E‰PœÜ‚ɑ΂µ‚ÄDynamic Distraction Apparatus‚ÆŠÏŒŒ“IœÚ‡p‚𕹗p‚µ‚œŽ¡—ÃŒoŒ±. ŠâéŒ[C1, ”䍲Œ’“ñ, ‘ºã@êŸ, ’†¬˜H‘ñ (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{ŽèŠO‰ÈŠw‰ïŠwpW‰ï (2011/4/15-7/31), webŠJÃ (ÂX).

723530. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •êŽw“à“]Sk‰ðœ‚É—p‚¢‚œ”ç•Ù‚ÌŒŸ“¢. ª–{@[1, ŒFàVŒ›ˆê, ÎìS‰î1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{ŽèŠO‰ÈŠw‰ïŠwpW‰ï (2011/4/15-7/31), webŠJÃ (ÂX), “ú–{ŽèŠO‰ÈŠw‰ïŽGŽ 2011; 28: s266

723531. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒKƒ“ƒOƒŠƒIƒ“pŒãÄ”­Ç—á‚ÌŒŸ“¢. ŒFàVŒ›ˆê, ª–{@[1, ÎìS‰î1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ54‰ñ“ú–{ŽèŠO‰ÈŠw‰ïŠwpW‰ï (2011/4/15-7/31), webŠJÃ (ÂX), “ú–{ŽèŠO‰ÈŠw‰ïŽGŽ 2011; 28: s313

723532. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ï‹É“I•Û‘¶—Ö@‚ðs‚Á‚œ—cŽ™‰ºŠ{œœÜ‚Ì1—á. ŽRèˆÀ°1, •{ìr•F, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ65‰ñ“ú–{Œûo‰ÈŠw‰ïŠwpW‰ï (2011/4/21-22), “Œ‹ž.

723533. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ÄŒšŠ{’çEŽ•‘…’ç‚É–„“ü‚³‚ê‚œlHŽ•ª‚ÌŽ¡—Õ]‰¿. ŽRèˆÀ°1, ”öŠÖ‰ë•F, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ65‰ñ“ú–{Œûo‰ÈŠw‰ïŠwpW‰ï (2011/4/21-22), “Œ‹ž.

723534. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰‰ñŒûOŒ`¬EŒûŠWŒ`¬Žž‚Ì”S–Œœ–Œá­‚ªŠ{—ô•”œˆÚA‚Ì”S–Œœ–Œ•Ù‚É—^‚Š‚é‰e‹¿. ŽRèˆÀ°1, ’r–{”ɍO1, £èWˆê˜Y1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ35‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2011/5/25-26), VŠƒ.

723535. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •Ð‘€Š®‘SOŠ{ŒûŠW—ô‚ɑ΂·‚éŒûOŒûŠW“¯ŽžŒ`¬pŒã‚̍\‰¹. ‰ª•”‘•c, —é–ØŒbŽq, ‹ù“cO”ü, £èWˆê˜Y1, ’r–{”ɍO1, ŽRèˆÀ°1, ³–؁@—², ’†‹v–؍Nˆê, Î“n–õ•v (1Œ`¬E”üŠO): ‘æ35‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2011/5/25-26), VŠƒ.

723536. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) o¶Žž‚æ‚èŠÇ—‚ðs‚Á‚Ä‚¢‚é•Ð‘€OŠ{ŒûŠW—ô‚̈ê—á|Furlow•Ï–@‚ÅŒûŠWŒ`¬‚ðs‚Á‚œÇ—á|. Î“n–õ•v, ‹Ž–{KŽ¡, ŒÃìKŽ}, £èWˆê˜Y1, ŽRèˆÀ°1, ’r–{”ɍO1, —é–ØŒbŽq, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ35‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2011/5/25-26), VŠƒ.

723537. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž•‚́EڐA‚ƃCƒ“ƒvƒ‰ƒ“ƒg‚ōĎ¡—Âðs‚Á‚œ¬l—Œ‘€OŠ{ŒûŠW—ôŠ³ŽÒ. Î“n–õ•v, ‹Ž–{KŽ¡, ŒÃìKŽ}, ŽRèˆÀ°1, £èWˆê˜Y1, ’r–{”ɍO1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ35‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2011/5/25-26), VŠƒ.

723538. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽÒ”畆—Lž™×–EŠàŽèpÇ—á‚ÌŒŸ“¢. •“c@Œ[1, H–{•ôŽ1, ™–{‰À, ÎìS‰î1, ŽÄ“c’m‹`1, £èWˆê˜Y1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ11‰ñ“ú–{R‰Á—îˆãŠw‰ï‘‰ï (2011/5/27-29), ‹ž“s.

723539. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒtƒFƒCƒXƒŠƒtƒgÅ‹ß10”N‚̐i•à|Åæ’[‚ÌŽèp‚ÌŒø‰Ê‚Æ“K‰ž|. ‰F’ÖؗŽˆê, ²“¡‰p–Ÿ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ11‰ñ“ú–{R‰Á—îˆãŠw‰ï‘‰ï (2011/5/27-29), ‹ž“s.

723540. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠO‰È“IƒŠƒ“ƒp•‚Žîƒ‚ƒfƒ‹‚̃Šƒ“ƒpŠÇV¶‚É‚š‚¯‚écyclooxygenase-2‚Ì–ðŠ„‚Æƒ}ƒNƒƒtƒ@[ƒW‚ÌŠÖ—^. ”–ؐT–ç1,2, ”n“ˆ³—²2 (1Œ`¬E”üŠO, 2–ò—): ‘æ35‰ñ“ú–{ƒŠƒ“ƒpŠw‰ï‘‰ï (2011/6/3-4), “Œ‹ž.

723541. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šç–ʍœÜŒã•ÏŒ`Ž¡–ü‚ɑ΂·‚éWŠw“IŽ¡—Ã. ŽRèˆÀ°1, •{ìr•F, Î“n–õ•v, ”öŠÖ‰ë•F, Â–ö˜a–ç1, ’r–{”ɍO1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ21‰ñ“ú–{Š{•ÏŒ`ÇŠw‰ï‘‰ï¥30Žü”N‹L”O‘ÛƒVƒ“ƒ|ƒWƒEƒ€ (2011/6/16-17), “Œ‹ž.

723542. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@Œ`¬ŠO‰ÈE”ü—eŠO‰È12”NŠÔ‚ÌŠç–ʍœØ‚èŽèp‚̐„ˆÚ. Â–ö˜a–ç1, ’r–{”ɍO1, ŽRèˆÀ°1, £èWˆê˜Y1, •“c@Œ[1, “àÀ‰hŽ÷1, Î“n–õ•v (1Œ`¬E”üŠO): ‘æ21‰ñ“ú–{Š{•ÏŒ`ÇŠw‰ï‘‰ïE30Žü”N‹L”O‘ÛƒVƒ“ƒ|ƒWƒEƒ€ (2011/6/16-17), “Œ‹ž.

723543. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘«’ê‚É”­Ç‚µ“ÁˆÙ‚ÈŒ`‘Ô‚ðŽŠ‚µ‚œ”牺ŽîᇂÌ1—á. ˆêŽr¢, ŽOD@G, ’¹‹”ŽŽq1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ3‰ñ“ú–{‘nŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/7/8-9), ŽD–y.

723544. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àˆö«Œ™‹C«‹Ûƒtƒ]ƒoƒNƒeƒŠƒEƒ€‚É‚æ‚é‘Sg‘œ”­”^ᇂÌ1—á. ŒFàVŒ›ˆê, •“c@Œ[1, –öàV³”V1, V”ü—T‘Ÿ1, ‹g’|r—T1, “àÀ‰hŽ÷1, _œä’m“¹2, ‘Š”nˆêˆå2 (1Œ`¬E”üŠO, 2‹~–œ): ‘æ3‰ñ“ú–{‘nŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/7/8-9), ŽD–y, ‘æ3‰ñ“ú–{‘nŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/7; p.119.

723545. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –éŠÔ2ŽžŠÔ‚²‚Ƃ̑̈ʕϊ·‚Í•K—v‚È‚Ì‚©?`ˆÀ–°‚ð–W‚°‚ç‚ê‚Ä‚¢‚œÇ—á‚ð’Ê‚¶‚ā`. Œ–{•Žu, ’†“‡•¶, ¯–ì–ŸŽq, ’†‘º@Œ’, ‘å’J’˱”V1 (1Œ`¬E”üŠO): ‘æ13‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2011/8/26), •Ÿ‰ª.

723546. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”M’†Ç‚É‚æ‚éˆÓŽ¯áŠQ‚©‚çåœ•”‚ÉDTI‚𐶂¶, “KØ‚ÈŽ¡—ÂƊŌ삪’x‚ê‚œˆêÇ—á. ’†“‡•¶, ‘å’J’˱”V1 (1Œ`¬E”üŠO): ‘æ13‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2011/8/27), •Ÿ‰ª.

723547. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EŒû‰‰) ’Ž‰¹”gƒƒX‚É‚æ‚éãüLÇ‚ÌŽ¡—ЬÑ. •“c@Œ[1, —é–Ø•q•F, ‚ŽR“ÖŽq1, ŽR“c’Œl1, “‡‘qNl1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ34‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

723548. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EŒû‰‰) “î•”‘gD•Ù‚𕹗p‚µ‚œƒXƒgƒ‰ƒbƒg–@‚É‚æ‚é•@ëk¬p. Žðˆä’Œ•F1, ‹à“c“¡1, ŽR–{@”Ž1, ’Ò–ìˆê˜Y1, Xã˜aŽ÷1, •“c@Œ[2, “‡‘qNl2, V”ü—T‘Ÿ2, “àÀ‰hŽ÷2 (1é–{ƒNƒŠƒjƒbƒNVh‰@, 2Œ`¬E”üŠO): ‘æ34‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

723549. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EŒû‰‰) 100 kg’Ž‚ÌŒž—Ê‚É‚æ‚萶‚¶‚œ”畆‰º‚‚ɑ΂µ—]è”畆Øœ‚ðs‚Á‚œ1—á. “‡‘qNl1, •“c@Œ[1, ²“¡‰p–Ÿ1, ’r–{”ɍO1, Â–ö˜a–ç1, H–{•ôŽ1, V”ü—T‘Ÿ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ34‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2011/9/29-30), •Ÿ‰ª.

723550. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒRƒ‰[ƒQƒ“Œ‹‡Œ^VEGF‹ÇŠ“Š—^‚É‚æ‚é”ç•Ù‰óŽ€‚ւ̉e‹¿. H–{•ôŽ1, •“c@Œ[1, ƒ’r“Þ’ÃŽq, ‘]ª—R”üŽq, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ20‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2011/10/6-7), “Œ‹ž.

723551. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œ—R—ˆŠÔ—tŒn×–E‚ÌFBS“Y‰Á”|’n, ƒqƒgŒŒŽ“Y‰Á”|’n, –³ŒŒŽ”|’n‚ł̍œŒ`¬”äŠrŒŸ“¢. Î•‹§Žj1, ”nêŽq1, ŽRèˆÀ°1, •“c@Œ[1, ‘]ª—R”üŽq1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ20‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2011/10/6-7), “Œ‹ž.

723552. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠO‰È“IƒŠƒ“ƒp•‚Žîƒ‚ƒfƒ‹‚̃Šƒ“ƒpŠÇV¶‚É‚š‚¯‚écyclooxygenase-2‚Ì–ðŠ„‚Æƒ}ƒNƒƒtƒ@[ƒW‚ÌŠÖ—^. ”–ؐT–ç1, ‘]ª—R”üŽq, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ20‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2011/10/6-7), “Œ‹ž.

723553. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚éClass IIIŠ{•ÏŒ`Ç‚ɑ΂·‚éŠç–eƒoƒ‰ƒ“ƒX‚̉ü‘P. ’r–{”ɍO1, ˆî–ÑŽ Ž©, ŽRèˆÀ°1, EàÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ56‰ñ“ú–{ŒûoŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2011/10/21-23), ‘åã.

723554. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘«’ê‰×d•”ÄŒš—á‚ÌŒŸ“¢. •–ö”ü—¢1, ª–{@[1, H–{•ôŽ1, ŒFàVŒ›ˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ38‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ïŠwpW‰ï (2011/11/10-12), VŠƒ, ‘æ38‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.271.

723555. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ®—e“IC³p‚ð—v‚µ‚œŽlŽˆÄŒš—á‚ÌŒŸ“¢|‹@”\“I, ®—e“IÄŒš‚ð–ÚŽw‚µ‚ā|. ª–{@[1, ŒFàVŒ›ˆê, ÎìS‰î1, ”–ؐT–ç, H–{•ôŽ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ38‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ïŠwpW‰ï (2011/11/10-12), VŠƒŽs, ‘æ38‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.162.

723556. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) A˜JŽž‚̎󏝂ɂæ‚èŽèp‚ð•K—v‚Æ‚µ‚œ”MÇ—á‚ÌŒŸ“¢. Î•‹§Žj1, Œ”ö‚ ‚š‚¢1, ‰i“‡˜a‹M1, ”nêŽq1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ59‰ñ“ú–{E‹ÆEÐŠQˆãŠw‰ïŠwp‘å‰ï (2011/11/11-12), “Œ‹ž.

723557. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) • •Ç”^ᇂƊӕʂð—v‚µ‚œ• ’Œ‹ØâŒŒŽî‚Ì1—á. ”nêŽq1, ã“cWŽq, Î•‹§Žj1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ59‰ñ“ú–{E‹ÆEÐŠQˆãŠw‰ïŠwp‘å‰ï (2011/11/11-12), “Œ‹ž.

723558. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒRƒ“ƒNƒŠ[ƒg‘…‚É“]—Ž‚µŽó‚µ‚œ”M‚Ì1—á. Œ”ö‚ ‚š‚¢1, ‰i“‡˜a‹M1, Î•‹§Žj1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ59‰ñ“ú–{E‹ÆEÐŠQˆãŠw‰ïŠwp‘å‰ï (2011/11/11-12), “Œ‹ž.

723559. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) LeFortEŒ^œØ‚èp‚É‚š‚¯‚éãŠ{œˆÊ’uŒˆ‚ß‚Ì–â‘è“_. ’r–{”ɍO1, Â–ö˜a–ç1, “‡‘qNl1, ŽRèˆÀ°1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ29‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2011/11/24-25), “Œ‹ž.

723560. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™Šáâ|’êüóœÜ‚É‚š‚¯‚鉺’Œ‹ØiN‰ðœ‚Ü‚Å‚ÌŽžŠÔ‚Æ—\Œã‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’r–{”ɍO1, ™–{‰À, ™–{F”V1, –öàV³”V1, ŒF‘òŒ›ˆê, V”ü—T‘Ÿ1, “‡‘qNl1, ª–{@[1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ29‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2011/11/24-25), “Œ‹ž.

723561. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Craniosynostosis syndrome‚É‚š‚¯‚éCervical spine anomalies‚ÌŒŸ“¢. ™–{F”V1, ¬—ÑáÁŽi, ›ŒŽ@‡, ã–ì@—Ž, ˆÉ“¡@i (1Œ`E¬E”üŠO): ‘æ29‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2011/11/24-25), “Œ‹ž.

723562. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒûŠW—ô‚ð‡•¹‚µ‚œæ“V«Š{ŠÖß‹­’ŒÇ‚Ì1—á. ›ŒŽ@‡, ¬—ÑáÁŽi, ™–{F”V1 (1Œ`¬E”üŠO): ‘æ29‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2011/11/24-25), “Œ‹ž.

723563. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ï‹É“I•Û‘¶—Ö@‚ðs‚Á‚œ—cŽ™‰ºŠ{œœÜ‚Ì1—á. Â–ö˜a–ç1, ’r–{”ɍO1, ŽRèˆÀ°1, £èWˆê˜Y1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ29‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2011/11/24-25), “Œ‹ž.

723564. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Q-switched Nd-YAG Laser‚É‚æ‚郌[ƒU[ƒs[ƒŠƒ“ƒO‚Ì“–‰@‚É‚š‚¯‚鎡—ÃŒø‰Ê. “c’†‘•c, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/24-25), ‰¡•l, “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ (JJSLSM) 2011/11; 32 (3): 316.

723565. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •\–ʂ̉š“ʂ̉ü‘P‚ªu”ü‚µ‚³v‚ɂ‚Ȃª‚é. ²“¡‰p–Ÿ1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ30‰ñ“ú–{—Տ°”畆ŠO‰ÈŠw‰ï‘‰ï (2012/2/11-12), ƒnƒmƒC (ƒxƒgƒiƒ€).

732046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) Ý‘îåñጊ³ŽÒ‚³‚ñ‚Ì‚Ý‚©‚œ‚̃Rƒc. ‘å’J’˱”V (Œ`¬E”üŠO): ‘æ7‰ñåñጃZƒ~ƒi[ in Yamanashi^‘æ4‰ñ“ú–{åñጊw‰ïŽR—œŒ§Ý‘îåñጃZƒ~ƒi[‡“¯ƒZƒ~ƒi[ (2011/4/10), b•{.

732047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) ”ü—eˆã—Âɂ‚¢‚ā`”ü—e”畆‚𒆐S‚Ɂ`. “c’†‘•c1,2 (1Œ`¬E”üŠO, 2ƒXƒNƒGƒAƒNƒŠƒjƒbƒN): ‹ú˜HŽsˆãŽt‰ï—«ˆãŽt‚̉ï (2011/11/11), ‹ú˜H.

732048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) “~‚Ì‘f”§”üƒZƒ~ƒi[`‘ãŽÓ‚ð‚æ‚­‚·‚é‚Æ”ü”§‚ª‚©‚È‚€`. “c’†‘•c1,2 (1Œ`¬E”üŠO, 2ƒXƒNƒGƒAƒNƒŠƒjƒbƒN): ”ü—eƒNƒŠƒjƒbƒNƒZƒ~ƒi[ (2012/2/4), “Œ‹ž.

733226. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Catheter ablation‚É‹Nˆö‚·‚é•úŽËü”畆áŠQ‚Ì1—á. ’†‘º@Œ’, ‘å’J’˱”V1, ƒ’r“Þ’ÃŽq1 (1Œ`¬E”üŠO): ‘æ7‰ñ“ŒM”畆‰ÈŒ`¬ŠO‰È˜A—‰ï‹c (2011/5/14), ²‹v.

733227. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ|ƒWƒVƒ‡ƒjƒ“ƒOƒNƒbƒVƒ‡ƒ“‘}“ü•û–@‚É‚æ‚éåœ•”‚̑̏d•Ï‰». ’†“‡•¶, Œ–{•Žu, ’†‘º@Œ’, ‘å’J’˱”V1 (1Œ`¬E”üŠO): ‘æ8‰ñ“ú–{åñጊw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/6/4), ‰¡•l.

733228. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰Õ«ƒ\[ƒ_ (…Ž_‰»ƒiƒgƒŠƒEƒ€) ‚É‚æ‚Á‚悶‚œŠá‹…‰»Šw”M‚̈ê—á. ‘å’J’˱”V1, ’†‘º@Œ’, ƒTƒŠƒoƒ““Þ’ÃŽq, ŽO‰Y•¶‰p, ‹÷@’B‘¥, ‰ª“c–M•F (1Œ`¬E”üŠO): ‘æ24‰ñ“ú–{”MŠw‰ïbM’n•û‰ï (2011/6/18), Œ–{.

733229. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚é”牺‚š‚æ‚Ñ‹Ø“÷“àŒŒŽî‚ÌŒŸ“¢. ’†‘º@Œ’, ‘å’J’˱”V1, ƒTƒŠƒoƒ““Þ’ÃŽq, XŽRŒc‘Ÿ1 (1Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ31‰ñ‘‰ï‚š‚æ‚Ñ‘æ62‰ñ—á‰ï (2011/6/18), Œ–{.

733230. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —LŒs‘å‘Ú‹Ø–Œ’£‹Ø”ç•Ù‚É‚æ‚é• •ÇÄŒš‚ÌŒoŒ±. é‰º@W1, ŽÄ“c’m‹`1, –p@Œ\ˆê1, ‚‹ŽŽk–Ÿ1 (1Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ31‰ñ‘‰ï‚š‚æ‚Ñ‘æ62‰ñ—á‰ï (2011/6/18), Œ–{.

733231. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) —Œ‘€‡ŽwA—Œ‘€—ô‘«Ç—á‚ÌŽ¡—Ã. ŽR“c’Œl1, ‚ŽR“ÖŽq1 (1Œ`¬E”üŠO): •œ¬23”N_“ސìÇ—ጟ“¢‰ï (2011/6/18), ˆÉšŒŽ.

733232. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) ’˜‚µ‚­Šç–ʍœ‚Ì•ÏŒ`‚ð‚«‚œ‚µ‚œSturge-WeberÇŒóŒQ‚Ì1—á. ›ŒŽ@‡, ¬—ÑáÁŽi, ™–{F”V1 (1Œ`¬E”üŠO): •œ¬23”N_“ސìÇ—ጟ“¢‰ï (2011/6/18), ˆÉšŒŽ.

733233. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’†Šç–Ê‚Ì’áŒ`¬‚ɑ΂µ“àŒÅ’èŒ^œ‰„’·Ší‚ð—p‚¢‚œ1—á. ›ŒŽ@‡, ¬—ÑáÁŽi, ™–{F”V1 (1Œ`¬E”üŠO): ‘æ7‰ñCraniosynostosisŒ€‹†‰ï (2011/7/16), “Œ‹ž.

733234. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Craniosynostosis syndrome‚É‚š‚¯‚éCervical spine anomalies‚ÌŒŸ“¢. ™–{F”V1, ¬—ÑáÁŽi, ›ŒŽ@‡, ã–ì@—Ž, ˆÉ“¡@i (1Œ`¬E”üŠO): ‘æ7‰ñCraniosynostosisŒ€‹†‰ï (2011/7/16), “Œ‹ž.

733235. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’†Šç–ʍœ‰„’·p‚ÌŽžŠú‚ƏpŽ®. ¬—ÑáÁŽi, ™–{F”V1, ›ŒŽ@‡, •{ìr•F, •œì@’, ã–ì@—Ž, ˆÉ“¡@i (1Œ`¬E”üŠO): ‘æ7‰ñCraniosynostosisŒ€‹†‰ï (2011/7/16), “Œ‹ž.

733236. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}‘à‚É‚æ‚é•a‰@‘O”M•]‰¿‚ÌŒŸ“¢. –öàV³”V1, ŒFàVŒ›ˆê, V”ü—T‘Ÿ1, ª–{@[1, H–{•ôŽ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ19‰ñVh”MƒtƒH[ƒ‰ƒ€ (2011/9/2), “Œ‹ž.

733237. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éåñጕۗLŽÒ‚Ì•ªÍ‚ƍ¡Œã‚̉ۑè. ’†“‡•¶, ŽO‰Y“ÄŽj, Œ–{•Žu, ’†‘º@Œ’, ‘å’J’˱”V1 (1Œ`¬E”üŠO): ‘æ8‰ñ’·–쌧åñግ§˜b‰ï (2011/10/23), ‰ª’J.

733238. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}«Šúåñጂ̃sƒbƒgƒz[ƒ‹: Suspected Deep Tissue Injury‚̈ê—á. ‘å’J’˱”V1, ’†‘º@Œ’, XŽRŒc‘Ÿ1, ’†“‡•¶ (1Œ`¬E”üŠO): ‘æ56‰ñ“ŒMˆãŠw‰ï (2011/10/29), ã“c, ’·–쌧ˆãŠw‰ïŽ 2011; 42: 151-2.

733239. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) ‹¹•”‘å“®–¬”j—ôŒã‚Ì‹CŠÇŽxᑂƋ¹•”ŠJ•ú‘n‚ɑ΂µ, ‘å–ԏ[“Up‹y‚ё勹‹Ø•Ù[“Up‚ðŽ{s‚µ‹~–œ‚µ‚Š‚œ1—á. XŽRŒc‘Ÿ1, ‘å’J’˱”V1, ’†‘º@Œ’ (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733240. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) ‘–Œ‰Š‚Å‹C‚©‚ê‚œˆ««•FŽî‰“Šu“]ˆÚ‚Ì1—á. ’†‘ºL‘Ÿ˜Y, ”–ؐT–ç, –p@Œ\ˆê1, –k‘º—ŠGŽq1 (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733241. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) collagen anchoring VEGF‚É‚æ‚錌ŠÇV¶‚ÆŒ`¬ŠO‰ÈŽèp‚ւ̉”\«. ƒ’r“Þ’ÃŽq1, •“c@Œ[1, H–{•ôŽ1, ‘]ª—R”üŽq, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733242. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) œ—R—ˆŠÔ—tŒn×–E‚ÌFBS“Y‰Á”|’n, ƒqƒgŒŒŽ“Y‰Á”|’n, –³ŒŒŽ”|’n‚ł̍œŒ`¬”äŠrŒŸ“¢. Î•‹§Žj1, ”nêŽq1, ŽRèˆÀ°1, ’r–{”ɍO1, •“c@Œ[1, ‘]ª—R”üŽq, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733243. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) Žš‰î‚©‚ç‚Ì•¡‡‘gDˆÚA‚É‚æ‚鉺ŠááٍȚ. ÎìS‰î1, ¬–쌒‘Ÿ˜Y, ŽR˜eF“¿, ¬Œˆê¬, ŒˆäŽq, ‘å’|®”V1 (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733244. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) •@ˆôo•Âœ•s‘S‚Å”­Œ©‚³‚ê‚œBilateral Perisylvian Syndrome‚Ì1—á. ™–{F”V1, ¬—ÑáÁŽi, ›ŒŽ@‡ (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733245. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) ƒXƒ|ƒbƒg—nÚ‚É‚æ‚éŽèŽw”M‚Ì1—á. ˆêŽr¢, ŽOD@G, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733246. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) –k—¢‘åŠw•a‰@Œ`¬ŠO‰È‚É‚š‚¯‚é, ƒGƒXƒeƒeƒBƒVƒƒƒ“EªŠ³ŽÒ‚ÌQOL‚É—^‚Š‚é‰e‹¿‚ɂ‚¢‚ā`Skindex-16‚ð—p‚¢‚œŒŸ“¢`. E™–{‰À1, ‚ŽR“ÖŽq1, “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ14‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2011/11/19), ‰¡•l.

733247. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘勹‹Ø•Ù‚É‚æ‚élHŒŒŠÇ‚̔핢‚Æ‹¹•”³’†‘n‚̏[“U, ‘å–Ô‚É‚æ‚é‹CŠÇŽxᑂ̔핢‚ðs‚¢‹~–œ‚µ“Ÿ‚œMRSAcŠu‰Š‡•¹‹¹•”‘å“®–¬áŽ”j—ôpŒãŠ³ŽÒ‚̈ê—á. ‘å’J’˱”V1, ’†‘º@Œ’, XŽRŒc‘Ÿ1 (1Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ63‰ñ—á‰ï (2011/12/3), ˆÀ“Ü–ì.

733248. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ}ƒbƒT[ƒW‚ªŒŽˆö‚ƍl‚Š‚ç‚ê‚œŠO«ŒŒŽî‚Ì2—á. ŽÄ“c’m‹`1, é‰º@W1, ‚‹ŽŽk–Ÿ1 (1Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ63‰ñ—á‰ï (2011/12/3), ˆÀ“Ü–ì.

733249. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰EŒû‰‰) ¬Ž™’Ü•”bF‘füð•a•Ï‚̈ê—á. Žç’JˆŸŠóŽq1, •“c@Œ[1, ‹g’|r—T1, XŽR˜a‚Ì1, H–{•ôŽ1, ƒ’r“Þ’ÃŽq1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): •œ¬24”N_“ސìÇ—ጟ“¢‰ï (2012/1/14), ‰¡•l.

733250. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œ`¬ŠO‰Èf—ÂŊˆ—p‚µ‚œŠ¿•û–ò. ”nêŽq (Œ`¬E”üŠO): ì‰zŽáŽèŠ¿•ûŒ€‹†‰ï (2012/3/8), ì‰z.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-310001. [Ç—á•ñ] Reconstruction for a mucocele of an old frontal sinus fracture. V”ü—T‘Ÿ1, ª–{@[1, ‘å’J’˱”V1, ’†‘º@Œ’, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): Kitasato Med J 2011/3; 41 (1): 84-9.

H22-522010. [uÀ]y“ÁW: Šááق̑ލs«ŽŸŠ³‚ɑ΂·‚éŠáŒ`¬ŠO‰ÈŽèpzIII. ‘ލs« (‰Á—) ŠááَŸŠ³‚ÌŽèp‚É‚š‚¯‚钍ˆÓŽ–€@Šááَèp‚É‚š‚¯‚éƒGƒXƒeƒeƒBƒbƒNƒ}ƒCƒ“ƒh. ²“¡‰p–Ÿ1,2, ‰F’ÖؗŽˆê (1Œ`¬E”üŠO, 2–k—¢Œ€‹†Š•a‰@): PEPARS 2011/3; 51: 132-46.


”畆‰ÈŠw

[Šwp˜_•¶]

110193. [ŒŽ’˜] Hair follicle stem cell marker nestin expression in regenerating hair follicles of patients with alopecia areata. Amoh Y1, Maejima H1, Niiyama S1, Mii S1, Hamada Y, Saito N1, Katsuoka K1: Eur J Dermatol 2011/4; 21 (2): 209-12. (“V‰HN”V1, ‘O“‡‰pŽ÷1, VŽRŽj˜N1, ŽOˆäƒá1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1: 1”畆)

110194. [ŒŽ’˜] Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Kishimoto H, Aki R1, Urata Y, Bouvet M, Momiyama M, Tanaka N, Fujiwara T, Hoffman RM: Cell Cycle 2011/8; 10 (16): 2737-41. (ˆÀåY—Ljê1: 1”畆)

110195. [ŒŽ’˜] Hes1 regulates the number and anterior-posterior patterning of mesencephalic dopaminergic neurons at the mid/hindbrain boundary (isthmus). Kameda Y, Saitoh T, Fujimura T1: Dev Biol 2011/10; 358 (1): 91-101. (“¡‘º‹¿’j1: 1”畆)

110196. [ŒŽ’˜] Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papillomavirus. Mii S1, Amoh Y1, Tanabe K1, Kitasato H, Sato Y, Katsuoka K1: Eur J Dermatol 2011/7-8; 21 (4): 515-9. (ŽOˆäƒá1, “V‰HN”V1, “c•ÓŒ’ˆê1, Ÿ‰ªŒ›¶1: 1”畆)

110197. [ŒŽ’˜] Expression of bleomycin hydrolase in keratinization disorders. Kamata Y, Maejima H1, Watarai A1, Saito N1, Katsuoka K1, Takeda A, Ishihara K: Arch Dermatol Res 2012/1; 304 (1): 31-8. (‘O“‡‰pŽ÷1, “n˜ð@W1, âV“¡“T[1, Ÿ‰ªŒ›¶1: 1”畆)

110198. [ŒŽ’˜] Multipotent nestin-positive hair follicle pluripotent stem (hfPS) cells can promote regeneration of impinged peripheral nerve injury. Amoh Y1, Aki R1, Hamada Y, Niiyama S1, Eshima K2, Kawahara K3, Sato Y, Tani Y, Hoffman RM, Katsuoka K1: J Dermatol 2012/1; 39 (1): 33-8. (“V‰HN”V1, ˆÀåY—Ljê1, VŽRŽj˜N1, ]“‡k“ñ2, ‰ÍŒŽŽ‰ë3, Ÿ‰ªŒ›¶1: 1”畆, 2–Ɖu, 3¶—)

110199. [ŒŽ’˜] In vivo imaging of nuclear-cytoplasmic deformation and partition during cancer cell death due to immune rejection. Amoh Y1, Hamada Y, Katsuoka K1, Hoffman RM: J Cell Biochem 2012/2; 113 (2): 465-72. (“V‰HN”V1, Ÿ‰ªŒ›¶1: 1”畆)

110200. [ŒŽ’˜] Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases. Taniguchi T1, Amoh Y1, Tanabe K1, Katsuoka K1, Kuroyanagi Y: J Artif Organs 2012/3; 15 (1): 77-82. (’JŒû—F‘¥1, “V‰HN”V1, “c•ÓŒ’ˆê1, Ÿ‰ªŒ›¶1: 1”畆)

120048. [ŒŽ’˜] ‘n“àŽ‘±‰Aˆ³ôò—Ö@‚ª—LŒø‚Å‚ ‚Á‚œ”w•””牺”^ᇂÌ1—á. Š‰YEqŽk, ã“c‹ªŽm, ‹{àV—ŒbŽq, VŽRŽj˜N1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, E”I@‹B (1”畆): ”畆‰È‚̗Տ° 2011/9; 53 (9): 1249-52.

210004. [€ŒŽ’˜] Asian variant of intravascular large B cell lymphoma associated with skin eruption. Maejima H1, Tanei R, Morioka T, Miyakoshi S: Acta Derm Venereol 2011/5; 91 (3): 339-40. (‘O“‡‰pŽ÷1, Žíˆä—Ç“ñ, X‰ªŒ’•F, ‹{‰zdŽO˜Y: 1”畆)

210005. [€ŒŽ’˜] A psoriasiform drug eruption induced by polyethylene glycol interferon-alpha-2b, successfully treated by narrow band ultraviolet B therapy. Kuwabara S, Maejima H1, Watarai A1, Hamada Y, Katsuoka K1: Eur J Dermatol 2012/1-2; 22 (1): 150-1. (‘O“‡‰pŽ÷1, “n˜ð@W1, Ÿ‰ªŒ›¶1: 1”畆)

220011. [€ŒŽ’˜] ‰~Œ`’E–яǂɑ΂·‚é‹ÇŠ–Ɖu—Ö@‚ɂ‚¢‚Ä. ꎓ¡“T[ (”畆): “ú–{”畆‰ÈŠw‰ïŽGŽ 2011/12; 121 (13): 2729-31.

310022. [Ç—á•ñ] Successful treatment of verrucae planae with imiquimod 5% cream. Niiyama S1, Amoh Y1, Katsuoka K1: Acta Dermatovenerol Croat 2011/4; 19 (4): 273-4. (VŽRŽj˜N1, “V‰HN”V1, Ÿ‰ªŒ›¶1: 1”畆)

310023. [Ç—á•ñ] Chlamydophila pneumoniae Infection Induced Nodular Vasculitis. Sakuma H1, Niiyama S1, Amoh Y1, Katsuoka K1: Case Rep Dermatol 2011/9; 3 (3): 263-7. (²‹vŠÔGs1, VŽRŽj˜N1, “V‰HN”V1, Ÿ‰ªŒ›¶1: 1”畆)

310024. [Ç—á•ñ] Malignant chondroid syringoma: report of a case with lymph node metastasis 12 years after local excision. Watarai A1, Amoh Y1, Aki R1, Takasu H1, Katsuoka K1: Dermatol Online J 2011/9; 17 (9): 5. (“n˜ð@W1, “V‰HN”V1, ˆÀåY—Ljê1, ‚{@”Ž1, Ÿ‰ªŒ›¶1: 1”畆)

310025. [Ç—á•ñ] Multicentric reticulohistiocytosis presenting with the cutaneous features of photosensitivity dermatitis. Arai S1, Katsuoka K1, Ishikawa A: J Dermatol 2012/2; 39 (2): 180-1. (Vˆä@’B1, Ÿ‰ªŒ›¶1: 1”畆)

310026. [Ç—á•ñ] A case of psoriasis vulgaris with diffuse idiopathic skeletal hyperostosis involved with ossifications of posterior and anterior longitudinal ligament. Taniguchi T1, Maejima H1, Watarai A1, Aki R1, Katsuoka K1: Rheumatol Int 2012/5; 32 (5): 1343-5. (’JŒû—F‘¥1, ‘O“‡‰pŽ÷1, “n˜ð@W1, ˆÀåYELjê1, Ÿ‰ªŒ›¶1: 1”畆)

320038. [Ç—á•ñ] Œo‰ß’†‚É“÷‰èŽî«”x•a•Ï‚𔺂Á‚œ‰óás«”^”çÇ. “c•ÓŒ’ˆê1, Vˆä@’B1, ˆÀåY—Ljê1, ²“¡ŠšŽ¡1, Ÿ‰ªŒ›¶1, ˜a“c^—RŽq1 (1”畆): Œ“ú–{”畆‰È 2011/4; 73 (2): 144-7.

320039. [Ç—á•ñ] ˆ««•F•\”çŽî‚Ì1—á. ŒKŒŽTŽ¡1, ŽOˆäƒá1, ‘O“‡‰pŽ÷1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1, Œ˜“ce—˜2 (1”畆, 2Á‰»Ší“à): ”畆‰È‚̗Տ° 2011/6; 53 (6): 861-4.

320040. [Ç—á•ñ] Spindle cell typeŽá”N«‰©F“÷‰èŽî‚Ì2—á. ‘O“‡‰pŽ÷1, ‚{@”Ž1, Ÿ‰ªŒ›¶1 (1”畆): “ú–{¬Ž™”畆‰ÈŠw‰ïŽGŽ 2012/2; 31 (1): 49-54.

320041. [Ç—á•ñ] ‹}‘¬‚ɐis‚µ‚œãèˆÍ“û–[ŠOPaget•a‚Ì1—á. ¬ŒŽGÆ, ã“c‹ªŽm, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, ‘å–؁@˜a (1”畆): ”畆‰È‚̗Տ° 2012/3; 54 (3): 496-500.

521021. [‰ðà]y˜AÚ: ƒKƒCƒhƒ‰ƒCƒ“‚ð–ò‹Ç“X“ª‚ÅŠˆ‚©‚·z’j«Œ^’E–яǐf—ÃKƒCƒhƒ‰ƒCƒ“. ꎓ¡“T[ (”畆): ’²Ü‚Əî•ñ 2011/8; 17 (8): 1039-45.

521022. [‰ðà] ’j«‚Ə—«‚Ì”²‚¯–Ñ, ”––Ñ‚Ì”Y‚Ý. ꎓ¡“T[ (”畆): ‚·‚±‚Ô‚é 2011; 146: 6-12.

521023. [‰ðà]y’E–яÇupdate|ÅV’mŒ©‚ƗՏ°‚ÌŽÀÛ|z‰~Œ`’E–яÇ: ‹ÇŠ–Ɖu—Ö@. ꎓ¡“T[ (”畆): Monthly Book Derma 2012/3; 189: 51-6.

522116. [uÀ]y“ÁW: Å‹ß‚̃gƒsƒbƒNƒX2011@Clinical Dermatology 2011z1. Å‹ß˜b‘è‚̔畆ŽŸŠ³@ŒŒŠÇ‰Šf—ÃKƒCƒhƒ‰ƒCƒ“‚̃|ƒCƒ“ƒg. Ÿ‰ªŒ›¶ (”畆): —Տ°”畆‰È 2011/4; 65 (5-‘Š§): 20-3.

522117. [uÀ]y“ÁW: ‚±‚±‚Ü‚Å‚Í’m‚Á‚Ä‚š‚«‚œ‚¢! ŠŽõÇ‚ÌŠî‘b’mŽ¯zƒqƒg‚ÌŠŽõ–hŒäƒVƒXƒeƒ€‚ð‹É‚ß‚é!|”畆‚ÌŠŽõ–hŒä‚Ì‚µ‚­‚Ý‚ð’m‚ë‚€|. “¡‘º‹¿’j1, Ž‹{”ü‰r (1”畆): ŒŽŠ§ƒi[ƒVƒ“ƒO 2011/7; 31 (8): 10-3.

522118. [uÀ]y“ÁW: “úíf—ÂŖӓ_‚Æ‚È‚é”畆‰ÈŽŸŠ³|–Ñ, ’Ü, ”S–Œ‚𒆐S‚Æ‚·‚éQ&A|z1. –с@3) ’E–яǁ@Q8. äPŒŽ•a‚𔺂€’E–яǂƂÍ? Vˆä@’B (”畆): ”畆‰È‚̗Տ° 2011/10; 53 (11): 1519-23.

522119. [uÀ]y“ÁW: ‚¿‚å‚Á‚Æ‹C‚É‚È‚éÇŒó‚Ì‚Ý‚©‚œl‚Š‚©‚œ 2011z”畆‰ÈEŠá‰È“IÇó@’܂ُ̈í. ꎓ¡“T[ (”畆): ¬Ž™“à‰È 2011/10; 43 (10): 1744-6.

522120. [uÀ]y“ÁW: ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŠŽõÇzHHV-6, 7‚š‚æ‚ÑCMV‚̍Ċˆ«‰»‚ðŽŠ‚µ‚œST‡Ü‚É‚æ‚édrug-induced hypersensitivity syndrome (DIHS). ’†ŒŽç•ÛŽq, ‘àV^ŽÀŽq, ꎓ¡“T[1, Ÿ‰ªŒ›¶1 (1”畆): ”畆•af—à 2011/11; 33 (11): 1105-8.

522121. [uÀ]y“ÁW: áy]”œ‰žz—Տ°—á: ˆÝŠàØœŒã‚ɏǏ󂪉ü‘P‚µ‚œ‘œŒ`–«áy]. ŒKŒŽTŽ¡, ]“¡GŒõ1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1 (1”畆): ”畆•af—à 2011/12; 33 (12): 1227-30.

522122. [uÀ]y“ÁW: áy]”œ‰žz—Տ°—á: áy]‹u]‚ª‘œ”­‚µ‚œ–Ø‘º•a. Vˆä@’B1, ‘P‰Æ—R—, •S£—tŽq, ’†–ì•q–Ÿ1, ‰q“¡@Œõ, Œã“¡—T”ü (1”畆): ”畆•af—à 2011/12; 33 (12): 1255-8.

522123. [uÀ]y“ÁW: Œûo”S–ŒEã•a•Ï‚̐f—ÁzŒûo”S–ŒEã•a•Ï‚̐f•û. Ÿ‰ªŒ›¶ (”畆): Monthly Book Derma 2011/12; 187: 1-7.

522124. [uÀ]y“ÁW: ƒAƒgƒs[«”畆‰Š|2012z—Տ°—á: ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚ɐ¶‚¶‚œ‰~Œ`’E–яÇ. ꎓ¡“T[1, Ÿ‰ªŒ›¶1 (1”畆): ”畆•af—à 2012/1; 34 (1): 57-60.

522125. [uÀ]y“ÁW: ‰~Œ`’E–яǃtƒƒ“ƒeƒBƒAz2. ‰~Œ`’E–яǂƃAƒŒƒ‹ƒM[‘fˆö. ꎓ¡“T[ (”畆): ”畆ƒAƒŒƒ‹ƒM[ƒtƒƒ“ƒeƒBƒA 2012/3; 10 (1): 13-7.

522126. [uÀ]y˜AÚz‘Î’k: ‰~Œ`’E–Ñ‚ÌŽ¡—Â̌»ó‚ƍ¡Œã‚Ì“W–]‚ɂ‚¢‚Ä. Ÿ‰ªŒ›¶ (”畆): ”畆ƒAƒŒƒ‹ƒM[ƒtƒƒ“ƒeƒBƒA 2012/3; 10 (1): 41-9.

540017. [‚»‚Ì‘Œ (Letter to the Editors)] Clinical evaluation of 35 cases of lupus miliaris di sseminatus faciei. Amiruddin D, Mii S1, Fujimura T1, Katsuoka K1: Jounal of Dermatology 2011/6; 38 (6): 618-20. (ŽOˆäƒá1, “¡‘º‹¿’j1, Ÿ‰ªŒ›¶1: 1”畆)

540018. [‚»‚Ì‘Œ]yƒ}ƒ‹ƒz”畆‰ÈƒZƒ~ƒi[@No.216z–ѐ¬’·—U“±‚ÌŽå–ð‚Í–Ñ“û“ª×–E? –ѕ×–E? Ÿ‰ªŒ›¶ (”畆): ƒ‰ƒWƒINIKKEI 2012/3; 4-7.

[’˜@‘]

620122. [Šwp‘] (•ª’SŽ·•M)y”畆‰È—Տ°ƒAƒZƒbƒg 5@”畆‚ÌŒŒŠÇ‰ŠEŒŒsáŠQzI ”畆‚ÌŒŒŠÇ‰Š@‘˜_ 3. ”畆‰Èˆã‚ªl‚Š‚錌ŠÇ‰Š‚Ì•ª—Þ‚Æ‚Í, p.17-21. Ÿ‰ªŒ›¶1 (1”畆), ê–å•ÒW: Ÿ‰ªŒ›¶1, ‘•ÒW: ŒÃ]‘—², ’†ŽR‘“X, “Œ‹ž, 2011/7”­s.

620123. [Šwp‘] (•ª’SŽ·•M)y”畆‰È—Տ°ƒAƒZƒbƒg 5@”畆‚ÌŒŒŠÇ‰ŠEŒŒsáŠQzII ”畆‚ÌŒŒsáŠQ@Mondor•a 45. Mondor•a‚̐f’f‚Ɣ畆Çó, p.248-52. ²“¡’ŒÆ1 (1”畆), ê–å•ÒW: Ÿ‰ªŒ›¶1, ‘•ÒW: ŒÃ]‘—², ’†ŽR‘“X, “Œ‹ž, 2011/7”­s.

620124. [Šwp‘] (•ª’SŽ·•M)y”畆‰È—Տ°ƒAƒZƒbƒg 5@”畆‚ÌŒŒŠÇ‰ŠEŒŒsáŠQzII ”畆ĚŒsáŠQ@Mondor•a 46. Mondor•a‚ÌŽ¡—ÂƗՏ°Œo‰ßE—\Œã, p.253-5. ²“¡’ŒÆ1 (1”畆), ê–å•ÒW: Ÿ‰ªŒ›¶1, ‘•ÒW: ŒÃ]‘—², ’†ŽR‘“X, “Œ‹ž, 2011/7”­s.

620125. [Šwp‘] (•ª’SŽ·•M)y”畆‰È—Տ°ƒAƒZƒbƒg 6@’E–яǎ¡—Â̐Ví—ªzI –Ñ‚ÌŠî‘b@3. –ѕ×–E, p.16-22. “V‰HN”V1, Ÿ‰ªŒ›¶1 (1”畆), ê–å•ÒW: ’؈ä—ÇŽ¡, ‘•ÒW: ŒÃ]‘—², ’†ŽR‘“X, “Œ‹ž, 2011/8”­s.

620126. [Šwp‘] (’P’˜)y”畆‰È—Տ°ƒAƒZƒbƒg 6@’E–яǎ¡—Â̐Ví—ªzIV ‚»‚Ì‘Œ‚Ì’E–яǁ@31. äPŒŽ•a‚É”º‚€’E–Ñ, p.192-7. Vˆä@’B (”畆), ê–å•ÒW, ’؈ä—ÇŽ¡, ‘•ÒW: ŒÃ]‘—², ’†ŽR‘“X, “Œ‹ž, 2011/8”­s.

620127. [Šwp‘] (•ª’SŽ·•M)y•a‹C‚Ì•ªŽqŒ`‘ÔŠwz‘æ“ñÍ Še˜_@7. ”畆‚ÌŽŸŠ³@–ѕ×–E—̈æ‚Ɣ畆ŽŸŠ³, p.236-9. “V‰HN”V1, Ÿ‰ªŒ›¶1 (1”畆), •Ò: “ú–{—Տ°•ªŽqŒ`‘ÔŠw‰ï, ŠwÛŠé‰æ, “Œ‹ž, 2011/9”­s.

620128. [Šwp‘] (•ª’SŽ·•M)y“úíf—ÂŖӓ_‚Æ‚È‚é”畆‰ÈŽŸŠ³|–Ñ, ’Ü, ”S–Œ‚𒆐S‚Æ‚·‚éQ&A| (”畆‰È‚̗Տ°2011”N10ŒŽ—ÕŽž‘Š§†)z3. ”S–Œ@4) ã@Q36. ãŠà‚Æ‚ÌŠÓ•Ê‚ª–â‘è‚É‚È‚é•a•Ï‚Í?, p.1662-6. “c•ÓŒ’ˆê (”畆), ‹àŒŽo”Å, “Œ‹ž, 2011/10”­s.

620129. [Šwp‘] (•ª’SŽ·•M)y“úíf—ÂŖӓ_‚Æ‚È‚é”畆‰ÈŽŸŠ³|–Ñ, ’Ü, ”S–Œ‚𒆐S‚Æ‚·‚éQ&A| (”畆‰È‚̗Տ°2011”N10ŒŽ—ÕŽž‘Š§†)z3. ”S–Œ@4) ã@Q35. “à‘ŸŽŸŠ³‚ð‹^‚€ã‚ُ̈í, p.1657-61. ‘O“‡‰pŽ÷1, Ÿ‰ªŒ›¶1 (1”畆), ‹àŒŽo”Å, “Œ‹ž, 2011/10”­s.

620130. [Šwp‘] (•ª’SŽ·•M)yƒIƒ“ƒRƒƒW[ƒNƒŠƒjƒJƒ‹ƒKƒCƒh@Á‰»ŠíŠà‰»Šw—Ö@@‰ü’ù3”ŁzÁ‰»ŠíŠà‰»Šw—Ö@‚Ì•›ì—p‘΍ô@6 ”畆áŠQ, p.333-40. “V‰HN”V1, Ÿ‰ªŒ›¶1 (1”畆), •Ò: ‘呺Œ’“ñ, ‘ë“à”ä˜C–ç, “ì]“°, “Œ‹ž, 2011/11”­s.

620131. [Šwp‘] (•ª’SŽ·•M)y”畆‰Èf—ÃJƒ‰[ƒAƒgƒ‰ƒX‘åŒn@(8)zœ•t‘®Ší‚ÌŽŸŠ³ (’E–яǁE–Ñ”¯‚ُ̈í)@æ“V«”畆Œ‡‘¹Ç, p.40. “V‰HN”V1, ‹àŽqŒ’•F (1”畆), •Ò: —é–ØŒ[”V, _è@•Û, u’kŽÐ, “Œ‹ž, 2011/11”­s.

620132. [Šwp‘] (•ª’SŽ·•M)y”畆‰Èf—ÃJƒ‰[ƒAƒgƒ‰ƒX‘åŒn@(8)zœ•t‘®Ší‚ÌŽŸŠ³ (’E–яǁE–Ñ”¯‚ُ̈í)@pseudopelade, p.51. ꎓ¡“T[ (”畆), •Ò: —é–ØŒ[”V, _è@•Û, u’kŽÐ, “Œ‹ž, 2011/11”­s.

620133. [Šwp‘] (•ª’SŽ·•M)y”çEEȐf—ÃJƒ‰[ƒAƒgƒ‰ƒX‘åŒn@(8)zœ“à‘ŸŽŸŠ³‚Ɣ畆@áy], p.107. ꎓ¡“T[ (”畆), •Ò: —é–ØŒ[”V, _è@•Û, u’kŽÐ, “Œ‹ž, 2011/11”­s.

620134. [Šwp‘] (•ª’SŽ·•M)y”畆‰Èf—ÃJƒ‰[ƒAƒgƒ‰ƒX‘åŒn@(8)zœ“à‘ŸŽŸŠ³‚Ɣ畆@“à‘ŸŽŸŠ³‚É”º‚€”dŽíóŠÂó“÷‰èŽî, p.134. Vˆä@’B (”畆), •Ò: —é–ØŒ[”V, _è@•Û, u’kŽÐ, “Œ‹ž, 2011/11”­s.

620135. [Šwp‘] (•ª’SŽ·•M)y”畆‰Èf—ÃJƒ‰[ƒAƒgƒ‰ƒX‘åŒn@(8)zœ“à‘ŸŽŸŠ³‚Ɣ畆@“§ÍƒAƒ~ƒƒCƒh|ƒVƒX, p.146. ‹{“c‘Žq (”畆), •Ò: —é–ØŒ[”V, _è@•Û, u’kŽÐ, “Œ‹ž, 2011/11”­s.

620136. [Šwp‘] (’P’˜)yDermatology Exercise No.15z”S–ŒŽŸŠ³‚ÆŠÓ•ÊŽŸŠ³. Ÿ‰ªŒ›¶ (”畆), ‘ŠÄC: –k“‡N—Y, ƒoƒCƒGƒ‹–ò•i, ‘åã, 2012/2”­s.

620137. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̔畆ŽŸŠ³Ž¡—ÃŽwj (‘æ4”Å)zŠÔŽC•”‚É‘œ‚¢ŽŸŠ³, p.73-5. Ÿ‰ªŒ›¶ (”畆), •Ò: ‰–ŒŽ“N•v, ‹{’n—ÇŽ÷, “n•ÓWˆê, ²“¡Lˆê, ˆãŠw‘‰@, “Œ‹ž, 2012/3”­s.

620138. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̔畆ŽŸŠ³Ž¡—ÃŽwj (‘æ4”Å)z‚»‚Ì‘Œ‚Ì’E–Ñ, p.919-22. Ÿ‰ªŒ›¶ (”畆), •Ò: ‰–ŒŽ“N•v, ‹{’n—ÇŽ÷, “n•ÓWˆê, ²“¡Lˆê, ˆãŠw‘‰@, “Œ‹ž, 2012/3”­s.

620139. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̔畆ŽŸŠ³Ž¡—ÃŽwj (‘æ4”Å)z‘æ31Í •t‘®ŠíŽŸŠ³@‰~Œ`’E–яÇ. “V‰HN”V (”畆), •Ò: ‰–ŒŽ“N•v, ‹{’n—ÇŽ÷, “n•ÓWˆê, ²“¡Lˆê, ˆãŠw‘‰@, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713101. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The bulge area is the major hair follicle source of nestin-expressing pluripotent stem cells which can repair the spinal cord compared to the dermal papilla. Liu F, Kimura H, Zhao M, Zhang L, Aki R1, Amoh Y1, Saito N1, Katsuoka K1, Hoffman RM: The 71st Annual Meeting of the Society for Investigative Dermatology (2011/5/5), Phoenix, USA. (ˆÀåY—Ljê1, “V‰HN”V1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1: 1”畆)

713102. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Successful treatment with suplatast tosilate for Kimura's disease. Arai T1, Zenke Y, Kajiwara T, Momose Y1, Nakano T1, Eto H, Goto H: 22nd World congress of Dermatology (2011/5/25), Seoul, Korea. (Vˆä@’B1, •S£—tŽq1, ’†–ì•q–Ÿ1: 1”畆)

713103. [Šw‰ï (‘Û)] (ˆêEʍu‰‰Eƒ|ƒXƒ^[) Clinical evaluations of 8 Cutaneous Lupus Erythematosus cases treated with Hydroxychloroquine (HCQ). Arai T1, Momose Y1, Masuzawa M1, Eto H: International workshop of hydroxychloroquine on chronic cutaneous lupus erythematosus (2011/5/30), Wakayama. (Vˆä@’B1, •S£—tŽq1, ‘àV^ŽÀŽq1: 1”畆)

713104. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The difference of multipotenticy in upper parts with hair follicle pluripotent stem (hfPS) cell area (hfPSA), middle, and lower parts in the hair follicle. Hoffman RM, Amoh Y1, Li L, Katsuoka K1: 15th Annual Meeting EHRS (European Hair Research Society) (2011/7/7), Jerusalem, Israel. (“V‰HN”V1, Ÿ‰ªŒ›¶1: 1”畆)

713105. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Invasion of human microvascular endothelial cells by Mycobacterium leprae through Mce1A protein. Sato N1, Abdurahman AH, Miyata T1, Fujimura T1, Katsuoka K1: Internal Union of Microbiological Societies 2011 Congress XIII International Congress of Bacteriology and Applied Microbiology (2011/9/10), Sapporo. (²“¡’ŒÆ1, ‹{“c‘Žq1, “¡‘º‹¿’j1, Ÿ‰ªŒ›¶1: 1”畆)

713106. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) two cases of Churg-Strauss syndrome. Taniguchi T1, Yashiro M1, Funatsu S1, Eto H1, Sato N1, Saito N1, Katsuoka K1: The Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012 (2012/3/29), Tokyo. (’JŒû—F‘¥1, ‰®‘ã–¢‰À1, ‘D’Á@‰h1, ]“¡GŒõ1, ²“¡’ŒÆ1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1: 1”畆)

722102. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) Š£áŽ¡—Âðl‚Š‚é|‚±‚ê‚©‚ç‚ÌŽ¡—Ð헪|. Ÿ‰ªŒ›¶ (”畆): ‘æ26‰ñ“ú–{Š£áŠw‰ïŠwp‘å‰ï (2011/9/9), ‘åã.

722103. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Œø‰Ê“I‚ȃ€ƒ“ƒeƒ‰‚̃|ƒCƒ“ƒg. ꎓ¡“T[ (”畆): AGA Expert Meeting 2011 (2011/11/12), “Œ‹ž.

723566. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ‘‰Š‚ð‡•¹‚µ‚œ‰óás«”^”çÇ‚Ì1—á. ‘O“‡‰pŽ÷1, “n˜ð@W1, “c•ÓŒ’ˆê1, ²“¡’ŒÆ1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, ‹v•Û“c”ü˜a2, ¬ÀŒ«Ž¡3 (1”畆, 2Á‰»Ší“à, 3®ŠO): ‘æ110‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï (2011/4/16), ‰¡•l (ŽãŠJÃ), “ú–{”畆‰ÈŠw‰ïŽGŽ 2011/3; 121 (3): 581.

723567. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) epithelioid hemangioendothelioma ‚Ì1—á. ‚{@”Ž1, ã“c‹ªŽm1, “c•ÓŒ’ˆê1, âV“¡“T[1, Ÿ‰ªŒ›¶1, •XŒ©˜a–€2, •“c Œ[2 (1”畆, 2Œ`¬E”üŠO): ‘æ27‰ñ“ú–{”畆ˆ««Žîᇊw‰ïŠwp‘å‰ï (2011/6/4), “Œ‹ž.

723568. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) BCGÚŽíŒã‚Ì•›”œ‰ž (Œ‹Šj]). “c•ÓŒ’ˆê1, “n‰ï@W1, “V‰HN”V1, Vˆä@’B1, ‹{“c‘Žq1, ‚{@”Ž1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ35‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ïŠwp‘å‰ï (2011/7/23), ‰¡•l.

723569. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™‘gD‹…Žî‚Ì“–‰ÈŒoŒ±—á. ‘O“‡‰pŽ÷1, ‚{@”Ž1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ35‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ïŠwp‘å‰ï (2011/7/24), ‰¡•l.

723570. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™‰~Œ`’E–яNJ³ŽÒ61—á‚ÌŽ¡—š‚æ‚Ñ—\Œã‚ÉŠÖ‚·‚é‰ðÍ. ꎓ¡Ÿ‹`, ‘O“‡‰pŽ÷1, “V‰HN”V1, VŽRŽj˜N1, Œü–ì@“N1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ35‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ïŠwp‘å‰ï (2011/7/24), ‰¡•l.

723571. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š£á«ŠÖß‰ŠŠ³ŽÒ‚ɑ΂·‚郁ƒ\ƒgƒŒƒLƒZ[ƒg‚ÌŽg—pŒoŒ±. ‘O“‡‰pŽ÷1, “n˜ð@W1, ’†–ì•q–Ÿ1, Ÿ‰ªŒ›¶1, •ÐŽR’qŒbŽq1, ŒŽR_”ü1 (1”畆): ‘æ26‰ñ“ú–{Š£áŠw‰ïŠwp‘å‰ï (2011/9/9), ‘åã.

723572. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž„‚Ì’E–яǐf’f‚̃|ƒCƒ“ƒg`’ˆÓ‚·‚ׂ«ŠŒ©‚ɂ‚¢‚ā`. ꎓ¡“T[ (”畆): ‘æ29‰ñ“ú–{”ü—e”畆‰ÈŠw‰ï‘‰ïEŠwp‘å‰ï (2011/9/11), ‰ºŠÖ.

723573. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) QƒXƒCƒbƒ`ƒ‹ƒr[ƒŒ[ƒU[‚ðŽ{s‚µ‚œŠO«ŽhÂ. ‚{@”Ž1, Ÿ‰ªŒ›¶1, ª–{“TŽq (1”畆): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/24), ‰¡•l.

723574. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Mycobacterium leprae can invade in the human microvascular endothelial cells through the Mce1A protein. Tajima Sanako, ²“¡’ŒÆ1, Ahmad Haykal Abdurahman, “¡‘º‹¿’j1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ40‰ñ“ú–{–ƉuŠw‰ïŠwpW‰ï (2011/11/29), –‹’£.

723575. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Recombinant expression and analysis of antimycotic effects of dermcidin against Trichophyton rubrum and Trichophyton mentagrophytes. Nishie M, Yoshino T, “¡‘º‹¿’j1, Abe M, Ÿ‰ªŒ›¶1 (1”畆): “ú–{Œ€‹†”畆‰ÈŠw‰ï‘æ36‰ñ”NŽŸŠwp‘åEEE‘‰ï (2011/12/9), ‹ž“s.

723576. [Šw‰ï (‘S‘)] (ˆêEʍu‰‰Eƒ|ƒXƒ^[) The Bulge Area is the Origin of Nestin-Expressing Pluripotent Stem Cell of the Hair Follicle Determined by Dual-Photon Confocal Imaging. A Uchugonova, J Duong, N Zhang, K Koenig, “V‰HN”V1, ŽOˆäƒá1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1, R M Hoffman (1”畆): “ú–{Œ€‹†”畆‰ÈŠw‰ï‘æ36‰ñ”NŽŸŠwp‘å‰ïE‘‰ï (2011/12/9), ‹ž“s.

723577. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Vascular endothelial cell entry activity of Mycobacterium leprae depends on Mce1A protein. Ahmad Haykal Abdurahman, ²“¡’ŒÆ1, Sanako Tajima, “¡‘º‹¿’j1, Ÿ‰ªŒ›¶1 (1”畆): “ú–{Œ€‹†”畆‰ÈŠw‰ï‘æ36‰ñ”NŽŸŠwp‘å‰ïE‘‰ï (2011/12/9), ‹ž“s.

731103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”畆‹Ø‰Š‚̋ؐ¶ŒŸŠŒ©. Vˆä@’B1, ]“¡GŒõ1 (1”畆): ‘æ9‰ñ”畆äPŒŽ•aŒ€‹†‰ï (2011/6/25), ‰¡•l.

731104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”畆‚©‚ç‚Ý‚œŒŒŠÇ‰Š\’†¬Œ^ŒŒŠÇ‰Š‚̔畆Çó. Ÿ‰ªŒ›¶ (”畆): ‘æ5‰ñt‚ÆäPŒŽ•aŒ€‹†‰ïuŒŒŠÇ‰Š‚ÌUp to datev(2011/7/9), “Œ‹ž.

731105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –ѐ¬’·—U“±‚ÌŽå–ð‚Í–Ñ“û“ª×–E? –ѕ×–E? Ÿ‰ªŒ›¶ (”畆): ƒ}ƒ‹ƒzƒZƒ~ƒi[ (ƒ‰ƒWƒINIKEI) (2011/8/2), “Œ‹ž.

731106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’E–яǂ̐f’f‚ÆŽ¡—Â̌»ó. ꎓ¡“T[ (”畆): ‘æ9‰ñŠâŽèŒ§“ì”畆‰È’k˜b‰ï (2011/11/10), ‰œB.

731107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “à‘Ÿ•a•Ï‚É”º‚€”畆•a•Ï (ƒfƒ‹ƒ}ƒhƒ[ƒ€) ‚ɂ‚¢‚Ä. ꎓ¡“T[ (”畆): ‘æ1‰ñ‘å˜aŽs”畆‰Èˆã‰ï (2012/3/31), ‘Š–ÍŒŽ.

732049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œ€CuK)yŠî‘b‚©‚çŠw‚Ԕ畆ŒŒŠÇ‰Šz1. ŒŒŠÇ‰ŠƒKƒCƒhƒ‰ƒCƒ“ƒ_ƒCƒWƒFƒXƒg. Ÿ‰ªŒ›¶ (”畆): •œ¬23”N“x“ú–{”畆‰ÈŠw‰ïuK‰ï (•K{AƒR[ƒX) (2011/8/27), “Œ‹ž.

732050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –ѕ×–E‚Ì‘œ•ª‰»”\‚ɂ‚¢‚Ä. “V‰HN”V (”畆): ‘æ1‰ñ–Ñ”¯Ä¶‰ï‹c (2011/9/23), “Œ‹ž.

732051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÄ¶ˆã—Â̕ªŽq‹@\z–ѕ×–E‚Ì‘œ•ª‰»”\‚ƍжˆã—Âւ̗Տ°‰ž—p. “V‰HN”V (”畆): ‘æ37‰ñ–k—¢ˆãŠw‰ï‘‰ï (2011/11/19), ‘Š–ÍŒŽ.

732052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) SjoƒEƒ€ƒ‰ƒEƒggrenÇŒóŒQ, V¶Ž™LE, SCLE‚É‚Ý‚ç‚ê‚éŠÂóg”Á‚̗Տ°“I“Á’¥. Vˆä@’B (”畆): ‘æ75‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2012/2/19), “Œ‹ž.

733251. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽxŽ—Ö@: ”畆áŠQ‘΍ô. ꎓ¡“T[ (”畆): Sagamihara Oncology Seminar (2011/5/19), ‘Š–ÍŒŽ.

733252. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒŒƒ“ƒhƒƒ“Ž_ƒiƒgƒŠƒEƒ€“à•ž‚É‚æ‚萶‚¶‚œ“«ã’×ᇂÌ1—á. ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, “”I@‹B (1”畆): ‘æ836‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/6/18), ìè.

733253. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒVƒNƒƒXƒ|ƒŠƒ“ (CyA) “Š—^‚É‚æ‚è––œ_ŒoáŠQ‚ð”F‚ß‚œ”畆‹Ø‰Š‚Ì1—á. ‰®‘㐳W1, ‘D’Á@‰h1, ²‹vŠÔGs1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ836‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/6/18), ìè.

733254. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DŽ_‹…Z‚ð”F‚ß‚È‚¢…áv«—Þ“VáváŒ. ²‹vŠÔGs1, “n˜ð@W1, ã“c‹ªŽm1, ¬ŒŽGÆ1, âV“¡“T[1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, •Ÿ“cr•œ, ‹Ž–{@—², “”I@‹B (1”畆): ‘æ836‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/6/18), ìè.

733255. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ‘‰Š‚𕹔­‚µ‚œ‰óás«”^”çÇ‚Ì1—á. ‘O“‡‰pŽ÷1, “n˜ð@W1, “c•ÓŒ’ˆê1, ²“¡’ŒÆ1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, ‹v•Û“c”ü˜a2, ¬ÀŒ«Ž¡3 (1”畆, 2Á‰»Ší“à, 3®ŠO): ‘æ836‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/6/18), ìè.

733256. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘–ŒŽî‚ð‡•¹‚µ‚œŠî’ê×–E•ê”ǏnjóŒQ‚Ì1—á. ‰®‘ã–¢‰À1, ã“c‹ªŽm1, ‘D’Á@‰h1, ŽOˆäƒá1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ837‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2011/7/9), “Œ‹ž.

733257. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Kaposi“÷Žî—lŒŒŠÇ“à”çŽî. ‚{@”Ž1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ838‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/9/10), _“ސì.

733258. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒ_ƒŠƒ€ƒ}ƒu (ƒqƒ…ƒ~ƒ‰Ò) ‚É‚æ‚é–ò. “c•ÓŒ’ˆê1, Ÿ‰ªŒ›¶1, ‰ª“c@ƒ2 (1”畆, 2Œ’NŠÇ—ƒZ): ‘æ838‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/9/10), _“ސì.

733259. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ã˜rE牺‚ɐ¶‚¶‚œMerkel×–EŠà. “Œ‹V“ß’ÃŽq1, ‚{@”Ž1, Ÿ‰ªŒ›¶1 (1”çEE: ‘æ838‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/9/10), _“ސì.

733260. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “úŒõŠp‰»Ç‚É‚š‚¯‚éƒlƒXƒ`ƒ“”­Œ»‚ÌŒŸ“¢. “c•ÓŒ’ˆê1, “V‰HN”V1, “Œ‹V“ß’ÃŽq1, ŽOˆäƒá1, ‚{@”Ž1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ63‰ñ“ú–{”畆‰ÈŠw‰ïŒ•”Žx•”Šwp‘å‰ï (2011/10/8), ‰«“ê.

733261. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒg“ª•”–Ñ•ï‚É‚š‚¯‚é, ƒoƒ‹ƒW—̈æ‚Æ‘œ•ª‰»”\‚ð—L‚·‚é–ѕ×–E—̈æ‚É‚š‚¯‚銲×–Eˆâ“`Žq‚Ì”­Œ». “V‰HN”V1, “c•ÓŒ’ˆê1, ŽOˆäƒá1, •l“c—SŽq, Ÿ‰ªŒ›¶1 (1”畆): ‘æ63‰ñ“ú–{”畆‰ÈŠw‰ïŒ•”Žx•”Šwp‘å‰ï (2011/10/8), ‰«“ê.

733262. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒg“ª•”–Ñ•ï‚É‚š‚¯‚é, ƒoƒ‹ƒW—̈æ‚Æ‘œ•ª‰»”\‚ð—L‚·‚é–ѕ×–E—̈æ‚É‚š‚¯‚銲×–Eˆâ“`Žq‚Ì”­Œ». “V‰HN”V (”畆): ‘æ25‰ñ•\”ç×–EŒ€‹†‰ï (2011/10/29), ‰¡•l.

733263. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶çG‚Ì”ç“àŒ‹ß‚ð’悵‚œSLE‚Ì2—á. Vˆä@’B1, ’†‘ºm”ü, ‘P‰Æ—R—, •S£—tŽq1, ‘àV^ŽÀŽq1, ‰q“¡@Œõ, ŠÝ–{’š« (1”畆): ‘æ62‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”Šwp‘å‰ï (2011/11/19), Žl“úŽs.

733264. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒGƒyƒŠƒ]ƒ“‰–Ž_‰– (ƒ~ƒIƒi[ƒ‹Ò) “à•ž‚É‚æ‚èƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN‚𐶂¶‚œ1—á. ‰®‘㐳W1, ‘D’Á@‰h1, ’JŒû—F‘¥1, ²‹vŠÔGs1, ’†–ìŽj˜N, ‹{“c‘Žq1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, •Šâ­”V2 (1”畆, 2‹~–œ): ‘æ839‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/11/19), ‰¡•l.

733265. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒuƒŒƒIƒ}ƒCƒVƒ“‚É‚æ‚é”畆‰Š‚ð‹^‚Á‚œ1—á. ‘O“‡‰pŽ÷1, ’J“c—L—¢‰À, ˆÀåY—Ljê1 (1”畆): ‘æ839‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2011/11/19), “Œ‹ž.

733266. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶ŠO‰Ê‚ɐ¶‚¶‚œ•œŠŠ‹Ø“÷Žî‚Ì1—á. ‚–ì“N˜Y1, “c•ÓŒ’ˆê1, ’†–ìŽj˜N, ²“¡’ŒÆ1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, •“c@Œ[2, ‘O“cˆŸŠóŽq1 (1”畆, 2Œ`¬E”üŠO): ‘æ839‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/11/19), ‰¡•l.

733267. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) õF‘ُ̈í (ƒ‚ƒmƒ\ƒ~[7) ‚ðŠl“Ÿ‚µ‚œœ‘ˆÙŒ`«ÇŒóŒQ‚ÌŠ³ŽÒ‚ɐ¶‚¶‚œZ«g”Á. ‹{“c‘Žq1, Ÿ‰ªŒ›¶1, Š™“c_–«2, “ŒŒŽ³–Ÿ2 (1”畆, 2ŒŒ‰t“à): ‘æ839‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ށEE(2011/11/19), ‰¡•l.

733268. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ñd–Œàh‰ßŒŒŸ÷ŒðŠ·—Ö@‚ª‘tŒ÷‚µ‚œqí«“VávጂÌ1—á. ‹{àV—ŒbŽq1, ‘D’Á@‰h1, ’JŒû—F‘¥1, ’†–ìŽj˜N, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ839‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/11/19), ‰¡•l.

733269. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒg“ª•”–Ñ•ï‚É‚š‚¯‚é, ƒoƒ‹ƒW—̈æ‚Æ‘œ•ª‰»”\‚ð—L‚·‚é–ѕ×–E—̈æ‚É‚š‚¯‚銲×–Eˆâ“`Žq‚Ì”­Œ». “V‰HN”V1, “c•ÓŒ’ˆê1, ŽOˆäƒá1, •l“c—SŽq, Ÿ‰ªŒ›¶1 (1”畆): ‘æ19‰ñ–Ñ”¯‰ÈŠwŒ€‹†‰ï (2011/11/26), “Œ‹ž.

733270. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰~Œ`’E–яǂɑ΂·‚é‹ÇŠ–Ɖu—Ö@: ‘œŽ{ÝƒAƒ“ƒP[ƒg‚̉ðÍ. ꎓ¡“T[1, ‘O“‡‰pŽ÷1, VŽRŽj˜N1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ19‰ñ–Ñ”¯‰ÈŠwŒ€‹†‰ï (2011/11/26), “Œ‹ž.

733271. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –эE«G•œ‘Ûᝂɂš‚¯‚éNatural killer (NK) cell”­Œ»‚ÌŒŸ“¢. ‘O“‡‰pŽ÷1, “V‰HN”V1, VŽRŽj˜N1, ²“¡’ŒÆ1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ19‰ñ–Ñ”¯‰ÈŠwŒ€‹†‰ï (2011/11/26), “Œ‹ž.

733272. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒJ‚è•Ô‚·”­”MEŽlŽˆ‹Ø’É‚ÆŽèŽw‚̏¬Ž‡gF”Á‚©‚çf’f‚ÉŽŠ‚Á‚œ¶–[”S‰tŽî‚Ì1—á. ²“¡’ŒÆ1, ˆÀåY—Ljê1, Ÿ‰ªŒ›¶1, ŒˆäŠîŒp2, ˆäãMK, ó’J‰ë•¶ (1”畆, 2zŠÂŠí“à): ‘æ840‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/12/17), ‰¡•l.

733273. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ”­’P_Œo‰Š‚ƐSáŠQ, ”xZ‚ð‡•¹‚µ‚œChurg-StraussÇŒóŒQ‚Ì1—á. ‰®‘ã–¢‰À1, ‘D’Á@‰h1, ’JŒû—F‘¥1, ’†–ì•q–Ÿ1, “V‰HN”V1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ840‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/12/17), ‰¡•l.

733274. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”M•”‚É”­Ç‚µ‚œALK-negative cutaneous anaplastic large cell lymphoma‚Ì1—á. “V‰HN”V1, “c•ÓŒ’ˆê1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, ŒFàV’qŽq (1”畆): ‘æ840‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2011/12/17), ‰¡•l.

733275. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{ŠàpŒã‚ɐ¶‚¶‚œStewart-TrevesÇŒóŒQ‚Ì1—á. ‰®‘㐳W1, ‘D’Á@‰h1, ’JŒû—F‘¥1, “c•ÓŒ’ˆê1, ‘àV^ŽÀŽq1, “V‰HN”V1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, ˆÉ“¡@Ê (1”畆): ‘æ841‰ñ“ú–{”畆‰ÈŠw‰ïEŒ‹ž’n•û‰ï_“ސì (2012/1/21), ‰¡•l.

733276. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žè”w‚ɐ¶‚¶‚œ‰óás«”^”çÇ (…ávŒ^) ‚Ì1—á. ‹{“c‘Žq1, ‰®‘ã–¢‰À1, Ÿ‰ªŒ›¶1, —Ñ‚Ý‚ä‚«2, Š™“cvšæ2 (1”畆, 2t‘Ÿ“à): ‘æ841‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2012/1/21), ‰¡•l.

733277. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –эE«gFâáf]‚Ì1—á. ‘D’Á@‰h1, ‹{“c‘Žq1, ‘O“‡‰pŽ÷1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, ’·‹Ž˜a–î1 (1”畆): ‘æ841‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2012/1/21), ‰¡•l.

733278. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _“ސ쌧”畆‰Èˆã‰ï‚É‚š‚¯‚é”畆ŠŽõÇƒT[ƒxƒCƒ‰ƒ“ƒX‚ÌŒ‹‰Ê•ñ. ‚{@”Ž (”畆): ‘æ12‰ñ_“ސ쐫ŠŽõÇŠw‰ï (2012/2/4), ‰¡•l.

733279. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒPƒuƒlƒ‹Œ»Û‚𔺂¢, “ÁˆÙ‚ȗՏ°‘œ‚ð’悵‚œ‰~”óƒGƒŠƒeƒ}ƒg[ƒfƒX (DLE). Vˆä@’B1, ’†‘ºm”ü, ‘P‰Æ—R—, •S£—tŽq1, ‘àV^ŽÀŽq1, ‰q“¡@Œõ (1”畆): ‘æ35‰ñ”畆–¬ŠÇäPŒŽ•aŒ€‹†‰ï (2012/2/16), “Œ‹ž.

733280. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Churg- StraussÇŒóŒQ‚Ì2—á. ’JŒû—F‘¥1, ’·‹Ž–¢‰À1, ‘D’Á@‰h1, ]“¡GŒõ1, ꎓ¡“T[1, ²“¡’ŒÆ1, ‹{“c‘Žq1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ75‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2012/2/18), “Œ‹ž.

733281. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Primary cutaneous signet ring cell carcinoma ‚Ì1—á. “c•ÓŒ’ˆê1, ‘àV^ŽÀŽq1, “V‰HN”V1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, •“c@Œ[2, Š“cç”ü”T3, ‘ì˜ad4 (1”畆, 2Œ`¬E”üŠO, 3•a—, 4•úŽËü (Žîá‡)): ‘æ75‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2012/2/19), “Œ‹ž.

733282. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”畆•a•Ï‚©‚çf‚œƒtƒbƒgƒPƒA‚̃|ƒCƒ“ƒg. ꎓ¡“T[ (”畆): ‘æ2‰ñ“œ”A•aƒ`[ƒ€ˆã—Á@`ƒtƒbƒgƒPƒA` (2012/2/20), ‰¡•l.

733283. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ò’ʼnŠ‚ð‚«‚œ‚µ‚œqí«Š£á‚Ə¶çG”^ávÇ‚ÌŠeˆê—á. ‘O“‡‰pŽ÷1, ŒŽR_”ü1, ‰®‘ã”ü‰À1, ‘D’Á@‰h1, •ÐŽR’qŒbŽq1, “n˜ð@W1, ’†–ì•q–Ÿ, Ÿ‰ªŒ›¶1, •ÄŒ³N‘  (1”畆): ‘æ4‰ñ_“ސ슣ᝎ¡—ÃŒ€‹†‰ï (2012/3/1), ‰¡•l.

733284. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”畆ˆ««Žîᇁ|‚Ç‚±‚܂Ő؂ê‚é? QOL, ‘Sgó‘Ô‚©‚ç‚Ì”»’f|. ꎓ¡“T[ (”畆): _“ސ쌧”畆‰Èˆã‰ï‘æ138‰ñ—á‰ï (2012/3/4), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110015. [ŒŽ’˜] The bulge area is the major hair follicle source of nestin-expressing pluripotent stem cells which can repair the spinal cord compared to the dermal papilla. Liu F, Uchugonova A, Kimura H, Zhang C, Zhao M, Zhang L, Koenig K, Duong J, Aki R1, Saito N1, Mii S1, Amoh Y1, Katsuoka K1, Hoffman RM: Cell Cycle 2011/3; 10 (5): 830-9. (ˆÀåY—Ljê1, ꎓ¡“T[1, ŽOˆäƒá1, “V‰HN”V1, Ÿ‰ªŒ›¶1: 1”畆)

H22-320002. [Ç—á•ñ] ‰º‘ڂɐis‚·‚é’×ᇐ«•a•Ï‚𐶂¶‚œEpithelioid sarcoma (—ޏã”ç“÷Žî) ‚Ì1—á. ²‹vŠÔGs1, “V‰HN”V1, ŽOˆäƒá1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1, ŠâŸºŒ[ˆê2, Œ–{ œˆê (1”畆, 2•a—): ”畆‰È‚̗Տ° 2011/2; 53 (2): 312-5.

H22-520001. [‘à] –Ñ•ï‚É‚Í‘œ•ª‰»”\‚ð—L‚·‚銲×–E‚ª‘¶Ý‚·‚é. “V‰HN”V (”畆): ”畆‚Æ”ü—e 2011/1; 43 (1): 8-13.

[’˜@‘]

H20-620002. [Šwp‘] (•ª’SŽ·•M)y”畆‰Èf—ÃJƒ‰[ƒAƒgƒ‰ƒX‘åŒn@(1)zœƒAƒŒƒ‹ƒM[«”畆ŽŸŠ³@áy]E”畆‚»‚€áyÇ‚Ɨޏǁ@‘œŒ`–«áy], p.126. ‹{“c‘Žq1, _è@•Û (”畆), •Ò: —é–ØŒ[”V, _è@•Û, u’kŽÐ, “Œ‹ž, 2008/6”­s.

H20-620003. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽwj@2011”N”Łz‘æ20Í ”畆‰ÈŽŸŠ³@œ’E–яǁ|“Á‚ɉ~Œ`’E–яÇ. “V‰HN”V (”畆), •Ò: ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H22-731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)eŠ²×–Efe”畆‘gDf‚̍ж‚ðŽi‚é–ѕ×–E‚Ì‘œÊ‚È–ðŠ„. “V‰HN”V (”畆): ‘æ10‰ñKumamoto Dermatological Academy (2010/10/14), ŒF–{.

H22-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)yÅ‹ß‚Ì–Ñ”¯‰ÈŠw‚̐i•àz–ѕ×–E‚Ì•ª‰»”\. “V‰HN”V (”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2011/2/11), “Œ‹ž.

H22-733013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œãüâ|‚É”­Ç‚µ‚œƒAƒ|ƒNƒŠƒ“ŠŸ‘BŠà. “c•ÓŒ’ˆê1, ŽOˆäƒá1, “V‰HN”V1, ‚{@”Ž1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2011/2/11), “Œ‹ž.


”å”AŠí‰ÈŠw

[Šwp˜_•¶]

110201. [ŒŽ’˜] Renal tumors in solid organ recipients: Clinical and pathologic features. Tsivian M, Caso JR, Kimura M1, Polascik TJ: Urol Oncol 2011/6; Epub ahead of print. (–Ø‘º«‹M1: 1”å”AŠí)

110202. [ŒŽ’˜] 14-3-3 Protein beta/alpha as a urinary biomarker for renal cell carcinoma:proteomic analysis of cyst fluid. Minamida S1, Iwamura M1, Kodera Y, Kawashima Y, Tabata K2, Matsumoto K1, Fujita T1, Satoh T1, Maeda T, Baba S1: Anal Bioanal Chem 2011/7; 401 (1): 245-52. (“ì“c@—@1, Šâ‘º³Žk1, “c”šŒ’ˆê2, Œ–{˜a«1, “¡“c“N•v1, ²“¡ˆÐ•¶1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

110203. [ŒŽ’˜] No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K1, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G: World J Urol 2011/8; 29 (4): 465-72. (Œ–{˜a«1: 1”å”AŠí)

110204. [ŒŽ’˜] Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K1, Kassouf W, Walton TJ, Bastian PJ, Mart’nez-Salamanca JI, Scherr DS, Shariat SF: World J Urol 2011/8; 29 (4): 473-80. (Œ–{˜a«1: 1”å”AŠí)

110205. [ŒŽ’˜] Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K1, Kassouf W, Walton TJ, Tritschler S, Baba S1, Matsushita K1, Bastian PJ, Mart’nez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G: World J Urol 2011/8; 29 (4): 481-6. (Œ–{˜a«1, ”nêŽu˜Y1, Œ‰ºˆêm1: 1”å”AŠí)

110206. [ŒŽ’˜] Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K1, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S1, Bastian PJ, Mart’nez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G: World J Urol 2011/8; 29 (4): 487-94. (Œ–{˜a«1, ”nêŽu˜Y1: 1”å”AŠí)

110207. [ŒŽ’˜] Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. Walton TJ, Novara G, Matsumoto K1, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Mart’nez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF: BJU Int 2011/8; 108 (3): 406-12. (Œ–{˜a«1: 1”å”AŠí)

110208. [ŒŽ’˜] Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model. Kimura M1, Yan H, Rabbani Z, Satoh T1, Baba S1, Yin FF, Polascik TJ, Donatucci CF, Vujaskovic Z, Koontz BF: J Sex Med 2011/8; 8 (8): 2215-26. (–Ø‘º«‹M1, ²“¡ˆÐ•¶1, ”nêŽu˜Y1: 1”å”AŠí)

110209. [ŒŽ’˜] Renal function outcomes after laparoscopic renal cryoablation. Tsivian M, Caso J, Kimura M1, Polascik TJ: J Endourol 2011/8; 25 (8): 1287-91. (–Ø‘º«‹M1: 1”å”AŠí)

110210. [ŒŽ’˜] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin. Matsumoto K1, Noguchi M, Satoh T1, Tabata K2, Fujita T1, Iwamura M1, Yamada A, Komatsu N, Baba S1, Itoh K: BJU Int 2011/9; 108 (6): 831-8. (Œ–{˜a«1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

110211. [ŒŽ’˜] A Treatment of Localized Prostate Cancer with High-energy Transurethral Microwave Thermotherapy after Reduction of Volume of the Prostate by Androgen Deprivation:Eight-year Experiences. Koshiba K, Jujo Y, Suzuki R, Ohori M, Aihara M, Nakajo H, Mizoguchi H1, Shimura S: Thermal Medicine 2011/9; 27 (3): 69-77. (aŒûG”V1: 1”å”AŠí)

110212. [ŒŽ’˜] The radiotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin treatment is an effective therapeutic option in patients with advanced or metastatic bladder cancer. Ikeda M1, Matsumoto K1, Niibe Y2, Satoh T1, Fujita T1, Iwamura M1, Ishiyama H2, Kotani S2, Hayakawa K2, Baba S1: J Radiat Res 2011/9; 52 (5): 674-9. (’r“cŸb1, Œ–{˜a«1, V•”@÷2, ²“¡ˆÐ•¶1, “¡“c“N•v1, Šâ‘º³Žk1, ÎŽR”ŽžŠ2, ¬’J³Žq2, ‘ì˜ad2, ”nêŽu˜Y1: 1”å”AŠí, 2•úŽËü (Žîá‡))

110213. [ŒŽ’˜] Castration-induced changes in mouse epididymal white adipose tissue. Floryk D, Kurosaka S1, Tanimoto R, Yang G, Goltsov A, Park S, Thompson TC: Mol Cell Endocrinol 2011/10; 345 (1-2): 58-67. (•âáÁ“ñ1: 1”å”AŠí)

110214. [ŒŽ’˜] Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy. Ikeda M1, Matsumoto K1, Tabata K2, Minamida S1, Fujita T1, Satoh T1, Iwamura M1, Baba S1: Jpn J Clin Oncol 2011/10; 41 (10): 1214-20. (’r“cŸb1, Œ–{˜a«1, “c”šŒ’ˆê2, “ì“c@—@1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

110215. [ŒŽ’˜] Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy. Kimura M1, Banez LL, Schroeck FR, Gerber L, Qi J, Satoh T1, Baba S1, Robertson CN, Walther PJ, Donatucci CF, Moul JW, Polascik TJ: J Sex Med 2011/10; 8 (10): 2935-43. (–Ø‘º«‹M1, ²“¡ˆÐ•¶1, ”nêŽu˜Y1: 1”å”AŠí)

110216. [ŒŽ’˜] Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract:an international study. Matsumoto K1, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M1, Shariat SF: BJU Int 2011/10; 108 (8 Pt 2): E304-9. (Œ–{˜a«1, Šâ‘º³Žk1: 1”å”AŠí)

110217. [ŒŽ’˜] Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial. Tsumura H1, Satoh T1, Ishiyama H2, Tabata K3, Kotani S2, Minamida S1, Kimura M1, Fujita T1, Matsumoto K1, Kitano M, Hayakawa K2, Baba S1: Int J Radiat Oncol Biol Phys 2011/11; 81 (4): e385-92. (’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê3, ¬’J³Žq2, “ì“c@—@1, –Ø‘º«‹M1, “¡“c“N•v1, Œ–{˜a«1, ‘ì˜ad2, ”nêŽu˜Y1: 1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ)

110218. [ŒŽ’˜] Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? von Bodman C, Matsushita K1, Matikainen MP, Eastham JA, Scardino PT, Akin O, Rabbani F: BJU Int 2011/11; 108 (10): 1566-71. (Œ‰ºˆêm1: 1”å”AŠí)

110219. [ŒŽ’˜] GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy. Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S1, Edamura K, Tabata K2, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D: Clin Cancer Res 2011/11; 17 (22): 7174-82. (•âáÁ“ñ1, “c”šŒ’ˆê2: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

110220. [ŒŽ’˜] Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Minamida S1, Satoh T1, Tabata K2, Kimura M1, Tsumura H1, Kurosaka S1, Matsumoto K1, Fujita T1, Iwamura M1, Baba S1: Urology 2011/12; 78 (6): 1235-9. (“ì“c@—@1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, –Ø‘º«‹M1, ’ѺGN1, •âáÁ“ñ1, Œ–{˜a«1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

110221. [ŒŽ’˜] Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. Yang G, Goltsov AA, Ren C, Kurosaka S1, Edamura K, Logothetis R, DeMayo FJ, Troncoso P, Blando J, DiGiovanni J, Thompson TC: Mol Cancer Res 2012/2; 10 (2): 218-29. (•âáÁ“ñ1: 1”å”AŠí)

110222. [ŒŽ’˜] The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy. Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K1, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF: Eur Urol 2012/2; 61 (2): 245-53. (Œ–{˜a«1: 1”å”AŠí)

110223. [ŒŽ’˜] Complications and postoperative events after cryosurgery for prostate cancer. Caso JR, Tsivian M, Mouraviev V, Kimura M1, Polascik TJ: BJU Int 2012/3; 109 (6): 840-5. (–Ø‘º«‹M1: 1”å”AŠí)

110224. [ŒŽ’˜] Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. Fajkovic H, Cha EK, Jeldres C, Donner G, Chromecki TF, Margulis V, Novara G, Lotan Y, Raman JD, Kassouf W, Seitz C, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K1, Breinl E, Pycha A, Ficarra V, Montorsi F, Karakiewicz PI, Scherr DS, Shariat SF: J Urol 2012/3; 187 (3): 845-51. (Œ–{˜a«1: 1”å”AŠí)

110225. [ŒŽ’˜] The impact of urinary cross-linked N-telopeptide of type I collagen in patients with prostate cancer receiving long-term risedronate treatment and androgen-deprivation therapy. Ikeda M1, Satoh T1, Tabata K2, Matsumoto K1, Ishiyama H3, Inoue Y4, Hayakawa K3, Baba S1: Kitasato Med J 2012/3; 42 (1): 51-6. (’r“cŸb1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, Œ–{˜a«1, ÎŽR”ŽžŠ3, ˆäã—D‰î4, ‘ì˜ad3, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (Žîá‡), 4•úŽËü (‰æ‘œ))

110226. [ŒŽ’˜] EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy. Kurosaka S1, Satoh T1, Chow E, Asano Y2, Tabata K3, Kimura M1, Tsumura H1, Matsumoto K1, Ishiyama H4, Inoue Y2, Hayakawa K4, Baba S1: Ann Nucl Med 2012/7; 26 (6): 485-91. (•âáÁ“ñ1, ²“¡ˆÐ•¶1, ó–ì—Y“ñ2, “c”šŒ’ˆê3, –Ø‘º«‹M1, ’ѺGN1, Œ–{˜a«1, ÎŽR”ŽžŠ4, ˆäã—D‰î2, ‘ì˜ad4, ”nêŽu˜Y1: 1”å”AŠí, 2•úŽËü (‰æ‘œ), 3—Տ°Œ€‹†EŠé‰æ, 4•úŽËü (Žîá‡))

120049. [ŒŽ’˜] HoLEP (Holmium Laser Enucleation of the Prostate): pŒã”A“¹‹·óÇ‚ɑ΂·‚éŽèpŽè‹Z‚ÌŒŸ“¢. Žá“c•”—zŽi1, ÝŠy•q–ç1, Îì—²‘Ÿ1, ‹v•Û¯ˆê1, •œŽR‹M”Ž2, “¡“c“N•v2, Šâ‘º³Žk2, ”nêŽu˜Y2 (1Ÿº–ì•Ó‘‡•a‰@”å”AŠí‰È, 2”å”AŠí): Japanese Journal of Endourology 2011/5; 24 (1): 147-51.

120050. [ŒŽ’˜] • o‹Ÿ‰ºt᱌`¬p: ‰Šú50”AŠÇ‚Ì’·Šú¬Ñ. Šâ‘º³Žk1, Œ@·G1, ’r“cŸb1, “y“c–š”ü1, ù–{Ž¡Žq1, “ì“c@—@1, •ÊŠ‰pŽ¡1, ‘º–{«r, ‘v@¬_, ”nêŽu˜Y1 (1”å”AŠí): Japanese Journal of Endourology and ESWL 2011/9; 24 (2): 282-8.

120051. [ŒŽ’˜] åœ•\–ÊŽ¡—ÓI“d‹CŽhŒƒ–@(ssTES)‚Ì, • o‹Ÿ‰ºªŽ¡“I‘O—§‘B“EœpŒã”A‹Ö§Šl“Ÿ‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä‚Ì‘OŒü‚«ŒŸ“¢. Œ@·G1, Šâ‘º³Žk1, ŽR“c‘׎j1, •âáÁ“ñ1, “c”šŒ’ˆê2, “¡“c“N•v1, Œ–{˜a«1, ²“¡ˆÐ•¶1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): Japanese Journal of Endourology 2011/9; 24 (2): 365-9.

120052. [ŒŽ’˜] ‰ñ•œŠú”]‘²’†Š³ŽÒ‚É‚š‚¯‚é‰ßŠˆ“®äNã÷‚ɑ΂·‚éƒCƒ~ƒ_ƒtƒFƒiƒVƒ“‚ÌŽ¡—ÃŒø‰Ê. ‹àŽqŽu•Û1, “c”šŒ’ˆê2, ‹y”\‹v—²1, Îˆä‘å•ã1, •âáÁ“ñ1, Œ@·G1, ‘åŽR“N•œ1, ‚Œû@‘å1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ”å”AŠíŠO‰È 2011/9; 24 (9): 1481-8.

120053. [ŒŽ’˜] äNã÷‘S“EœpÇ—á‚É‚š‚¯‚ép‘OMVAC‰»Šw—Ö@‚Ì—L—p«|‹ÇŠ“®–¬“à’“ü—Ö@‚Æ‘Sg‰»Šw—Ö@‚ł̗Տ°•a—Šw“IŒŸ“¢|. “ì“c@—@1, Œ–{˜a«1, Šâ‘º³Žk1, ’r“cŸb1, Œ@·G1, Îˆä‘å•ã1, “¡“c“N•v1, ²“¡ˆÐ•¶1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): –k—¢ˆãŠw 2011/12; 41 (2): 111-6.

120054. [ŒŽ’˜] tˆÚAŒãƒŒƒVƒsƒGƒ“ƒg‚ÌŽ©ŒÈŠÇ—s“®‚ÌŽÀ‘Ô‚ÆŒo‰ßŠúŠÔ‚Æ‚ÌŠÖŒW. ¬âŽu•Û, “c’†^‹Õ, Žðˆä’qŽq, •yìL“ñ, ‹g“cˆê¬1, —͐ΒC–ç, ”ŠÔŒbŽq (1”å”AŠí): ˆÚA 2012/3; 47 (1): 60-6.

220012. [€ŒŽ’˜] ƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚ép‘O“à•ª”å—Ö@@pŒã”r”AáŠQ‚ÉŠÖ‚·‚錟“¢. ’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê3, •ÊŠ‰pŽ¡1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, ¬’J³Žq2, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ”å”AŠíŠO‰È 2011/4; 24 (—Õ‘): 521.

220013. [€ŒŽ’˜] is«äNã÷Šà‚ɑ΂·‚éM-VAC•¹—p‰»Šw•úŽËü—Ö@‚ÌŒŸ“¢. ’r“cŸb1, Œ–{˜a«1, V•”@÷2, “c”šŒ’ˆê3, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ÎŽR”ŽžŠ2, ¬’J³Žq2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ”å”AŠíŠO‰È 2011/4; 24 (—Õ‘): 555.

220014. [€ŒŽ’˜] ”å”AŠí• o‹Ÿ‹Zp”F’èŽæ“Ÿˆã‚ÌŽèp¬Ñ: ‰‰ñ‹Zp”F’èˆã‚̃Aƒ“ƒP[ƒg’²ž‚̉ðÍ•ñ. ‰HŸº—F‘¥, Ž›’n•q˜Y, ŽOŒÒ_Œõ, ‹ß“¡Kq, ‹àŽR”Žb, Žsì’q•F, “z“cŒŽ‹I‹v—Y, ŽO–؍PŽ¡, ¬–ì‰À¬, ”nêŽu˜Y1, “à“¡œ“ñ, Œ“cŒöŽu (1”å”AŠí): Japanese Journal of Endourology and ESWL 2011/5; 24 (1): 69-82.

220015. [€ŒŽ’˜] –«t•s‘SŠ³ŽÒ‚Ì‹‘å”X–Et‚ɑ΂·‚éŠJ• E• o‹ŸŽèp‚Ì”äŠrŒŸ“¢. “y‹Ž³l1, ‹g“cˆê¬1, Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, ŽR“c‘׎j1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ˆã–ò‚Ì–å 2011/11; 51 (5): 88.

220016. [€ŒŽ’˜] ’·Šú‘Ò‹@Š³ŽÒ‚ÌŒ£tˆÚA. ŽR“c‘׎j1, Îˆä‘å•ã1, ì‘º•ä1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ¡“ú‚̈ڐA 2011/12; 24 (6): 605-8.

320042. [Ç—á•ñ] äNã÷‘S“EœpŒã21”N–ڂɉ“Šu“]ˆÚ‚𔭏ǂµ‚œäNã÷Šà‚Ì1—á. ’؈ärŽ÷1, Œ–{˜a«1, Œ@·G1, “¡“c“N•v1, ²“¡ˆÐ•¶1, ŽOã“N•v2, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2•a—): –k—¢ˆãŠw 2011/6; 41 (1): 41-3.

320043. [Ç—á•ñ] äNã÷Šà‚̉“Šu“]ˆÚ‘ƒ‚̐f’f‚ÉUroplakin III‚ª—LŒø‚Ÿ‚Á‚œ1—á. •ÊŠ‰pŽ¡1, Œ–{˜a«1, –]ŒŽN•œ1, “¡“c“N•v1, ²“¡ˆÐ•¶1, ˆêŒË¹–Ÿ2, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2•a—): –k—¢ˆãŠw 2011/6; 41 (1): 45-8.

320044. [Ç—á•ñ] ŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚é‘¢‰eÜƒtƒ‹ƒIƒŒƒZƒCƒ“‘¢‰eŒã‚Ì“§Í‚̈Ӌ`: 1“§ÍÇ—á‚ð’Ê‚¶‚Ä. ‰ÍŒŽƒŽq, •º“¡@“§, ‘Ÿ“c¹–M, •œ—Ç—²•Û, “ú‘ä‰p—Y, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/8; 44 (8): 695-8.

320045. [Ç—á•ñ] ƒ\ƒ‰ƒtƒFƒjƒu“Š—^’†‚ɐS‹Ø“]ˆÚ‚𗈂œ‚µ‚œis«t×–EŠà‚Ì1—á. “¿ŽR‰ÀŽq1, Šâ‘º³Žk1, “¡“c“N•v1, ™“c@“Ö1, ‘OŽR—Ç‘Ÿ1, •ÊŠ‰pŽ¡1, Îì@–í1, “c”šŒ’ˆê2, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ”å”AŠí‰È‹I—v 2011/10; 57 (10): 555-8.

510008. [‘à] Immunohistochemical biomarkers for bladder cancer prognosis. Matsushita K1, Cha EK, Matsumoto K1, Baba S1, Chromecki TF, Fajkovic H, Sun M, Karakiewicz PI, Scherr DS, Shariat SF: Int J Urol 2011/9; 18 (9): 616-29. (Œ‰ºˆêm1, Œ–{˜a«1, ”nêŽu˜Y1: 1”å”AŠí)

510009. [‘à] High-intensity focused ultrasound therapy for prostate cancer. Uchida T, Nakano M, Hongo S, Shoji S, Nagata Y, Satoh T1, Baba S1, Usui Y, Terachi T: Int J Urol 2012/3; 19 (3): 187-201. (²“¡ˆÐ•¶1, ”nêŽu˜Y1: 1”å”AŠí)

520038. [‘à]y“ÁW: ‚ª‚ñf—ÃTƒ|[ƒgƒKƒCƒhz‘O—§ü‚ª‚ñ|Š³ŽÒC‰Æ‘°‚©‚ç: ‘O—§ü‚ª‚ñ‚ɑ΂·‚é•úŽËü—Ö@‚ÍŒø‰Ê‚ª‚ ‚è‚Ü‚·‚©? ‚Ç‚Ì‚æ‚€‚È•û–@‚ª‚ ‚è‚Ü‚·‚©? ²“¡ˆÐ•¶ (”å”AŠí): Ž¡—à 2011/4; 93 (‘Š§): 1007-9.

520039. [‘à] ‘O—§‘B‚ª‚ñ‚ÌŽ¡—Á|•úŽËüŽ¡—Á|. ²“¡ˆÐ•¶ (”å”AŠí): —Õଂƌ€‹† 2011/11; 88 (11): 41-6.

520040. [‘à] ˆã—Ẫ`[ƒ€ƒ[ƒN. ‹g“cˆê¬ (”å”AŠí): “ú–{—Տ°”å”AŠí‰Èˆã‰ï_“ސ암‰ï•ñ 2012/1; 15: 1

520041. [‘à]y”å”AŠíŠà‚̃tƒHƒ[ƒAƒbƒv‚É—L—p‚ȉ摜f’f‚ÆŽîᇃ}[ƒJ[zäNã÷‚ª‚ñ‚ɑ΂·‚é–Ɖu‘gDŠw“I’Tõ‚ð—p‚¢‚œ—\Œã—\Œ©‚ɂ‚¢‚Ä. Œ–{˜a« (”å”AŠí): ”å”AŠíŠO‰È 2012/1; 25 (1): 11-6.

522127. [uÀ]y“ÁW: Œ£t“Eo|‰ü³‘ŸŠíˆÚA–@‚ɑΉž‚µ‚ā|zŒ£tƒhƒi[‚Ì“K‰ž (marginal donor‚ðŠÜ‚ß‚Ä). ‹g“cˆê¬1, Îˆä‘å•ã1, ‰““¡’‰—Y (1”å”AŠí): tˆÚAEŒŒŠÇŠO‰È 2011/4; 23 (2): 8-13.

522128. [uÀ]y‚±‚ñ‚È‚Æ‚«‚Ç‚€‚·‚é!? ”å”AŠí‰ÈŽèp‚̃gƒ‰ƒuƒ‹‘Ώˆ–@zI ”A˜H“àŽ‹‹ŸŽèp@EŒo”A“¹“I”AŠÇÓÎp (TUL)@”AŠÇ‚𑹏‚µ‚Ä‚µ‚Ü‚¢ƒKƒCƒhƒƒCƒ„[‚ªt᱂֓ü‚ç‚È‚¢. rì@F, ‰z“c’|˜N, ŽR‰º‰p”V1, ‘å“Œ‹MŽu (1”å”AŠí), —Տ°”å”AŠí‰È 2011/4; 65 (4-‘Š§): 54-6.

522129. [uÀ]y‚±‚ñ‚È‚Æ‚«‚Ç‚€‚·‚é!? ”å”AŠí‰ÈŽèp‚̃gƒ‰ƒuƒ‹‘Ώˆ–@zI ”A˜H“àŽ‹‹ŸŽèp@EŒo”A“¹“I”AŠÇÓÎp (TUL)@ƒoƒ‹[ƒ“Šg’£pŒã‚É‚·‚®‚ÉTUL‚ðs‚Á‚Ä‚æ‚¢‚©. rì@F, ‰z“c’|˜N, ŽR‰º‰p”V1, ‘å“Œ‹MŽu (1”å”AŠí): —Տ°”å”AŠí‰È 2011/4; 65 (4-‘Š§): 57-9.

522130. [uÀ]y‚±‚ñ‚È‚Æ‚«‚Ç‚€‚·‚é!? ”å”AŠí‰ÈŽèp‚̃gƒ‰ƒuƒ‹‘Ώˆ–@zI ”A˜H“àŽ‹‹ŸŽèp@EŒo”A“¹“I”AŠÇÓÎp (TUL)@”AŠÇƒV[ƒX‚Å”AŠÇ‚ð’f—ô‚³‚¹‚Ä‚µ‚Ü‚Á‚œ. rì@F, ‰z“c’|˜N, ŽR‰º‰p”V1, ‘å“Œ‹MŽu (1”å”AŠí): —Տ°”å”AŠí‰È 2011/4; 65 (4-‘Š§): 60-1.

522131. [uÀ]y‚±‚ñ‚È‚Æ‚«‚Ç‚€‚·‚é!? ”å”AŠí‰ÈŽèp‚̃gƒ‰ƒuƒ‹‘Ώˆ–@zIV ŠJ• Žèp@Et᱌`¬p@”AŠÇˆÚs•”‚ðØœ‚µ‚·‚¬‚Ä•«‡‚ª‚Å‚«‚È‚­‚È‚Á‚œ. Šâ‘º³Žk (”å”AŠí): —Տ°”å”AŠí‰È 2011/4; 65 (4-‘Š§): 212

522132. [uÀ]y‚±‚ñ‚È‚Æ‚«‚Ç‚€‚·‚é!? ”å”AŠí‰ÈŽèp‚̃gƒ‰ƒuƒ‹‘Ώˆ–@zIV ŠJ• Žèp@Et᱌`¬p@pŒã‚ɐ…tÇ‚ª‰ü‘P‚µ‚È‚¢. Šâ‘º³Žk (”å”AŠí): —Տ°”å”AŠí‰È 2011/4; 65 (4-‘Š§): 213-4.

522133. [uÀ]y“ÁW: ˆÛŽ“§ÍŠ³ŽÒ‚̐HŽ–—Ö@Ä•]‰¿|ƒƒŠƒbƒgEƒfƒƒŠƒbƒgzŠe˜_: ˆÛŽ“§ÍŠ³ŽÒ‚̐HŽ–—Ö@ƒKƒCƒhƒ‰ƒCƒ“‚ð‚Ç‚€‰ž—p‚µ‚œ‚ç‚æ‚¢‚Å‚µ‚å‚€‚©@ƒŠƒ“‚Í’`”’Ž¿ (g)~15ˆÈ‰º‚Æ‚È‚Á‚Ä‚¢‚Ü‚·‚ª, 1“ú700 mg‚̃Šƒ“ÛŽæ—Ê‚ªÅ‘å‹–—e—Ê‚Æ‚·‚é‚Æ, ’`”’Ž¿‚Í1“ú50 gˆÈ‰º‚É‚µ‚È‚¢‚Æ‚¢‚¯‚È‚­‚È‚è‚Ü‚·‚ª, –µ‚‚µ‚Ü‚¹‚ñ‚©. •º“¡@“§, ìãƒŽq, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): t‚Æ“§Í 2011/5; 70 (5): 777-83.

522134. [uÀ]y“ÁW: ‘æ20‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€zƒŠƒXƒN•ª—Þ‚ð—p‚¢‚œ‘O—§‘BŠà‚É‚š‚¯‚éŒÂ•Ê‰»Ž¡—ÃXƒgƒ‰ƒeƒW[. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê3, ¬’J³Žq2, “ì“c@—@1, ’r“cŸb1, ’ѺGN1, “¡“c“N•v1, Œ–{˜a«1, –k–ì‰ëŽj, ‘“c@Ši4, V•”@÷2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ, 4•úŽËü (‰æ‘œ)): –k—¢ˆãŠw 2011/6; 41 (1): 55-9.

522135. [uÀ]y‘O—§‘B‚ª‚ñ‚̍œ“]ˆÚ‚ɑ΂·‚鎡—Ã-updatezœ“]ˆÚ‚ɑ΂·‚é–ò•š—Ö@: bone health‚ðŒ©˜‚Š‚œ‘Ήž. ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, –Ø‘º«‹M1, ’r“cŸb1, •âáÁ“ñ1, “ì“c@—@1, ’ѺGN1, Œ–{˜a«1, “¡“c“N•v1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ”å”AŠíŠO‰È 2011/8; 24 (8): 1287-9.

522136. [uÀ]yŽ¡—ÁE—\ŒãˆöŽqzœ“]ˆÚ‚ª‚ñŠ³ŽÒ‚ɑ΂·‚éEORTC QOL’²žƒ‚ƒWƒ…[ƒ‹: EORTC QLQ-BM22“ú–{Œê”łɂ‚¢‚Ä. ²“¡ˆÐ•¶1, ¬—э‘•F, –x@‘×—S, ”Ñ“c^‰î, ²“¡@‰·, Î•@—m, Edward Chow, ‰ºÈW“ñ˜Y (1”å”AŠí): ”å”AŠíŠO‰È 2011/8; 24 (8): 1319-20.

522137. [uÀ]y”å”AŠí‚ª‚ñÅV“ÁWz‘O—§‘B‚ª‚ñ‚Ì“]ˆÚEÄ”­Ž¡—Ã. ²“¡ˆÐ•¶ (”å”AŠí): ‚ª‚ñƒTƒ|[ƒg 2011/11; 105 (12): 25-7.

522138. [uÀ]yƒŒ[ƒU[ˆãHŠw‚̐i•àz”å”AŠí‰È‚É‚š‚¯‚郌[ƒU[ˆãHŠw. ”nêŽu˜Y (”å”AŠí): ˆãŠw‚Ì‚ ‚ä‚Ý 2012/2; 240 (6): 497-9.

540019. [‚»‚Ì‘Œ (L•ñŽ)] ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï‚ðŠJÃ‚µ‚Ä. ‹g“cˆê¬ (”å”AŠí): –k—¢‘åŠwˆãŠw•”ƒjƒ…[ƒY 2011/9; 324: 9

[’˜@‘]

610014. [Šwp‘] (•ª’SŽ·•M)yEmerging Research and Treatments in Renal Cell CarcinomazChapter 13@Prognostic Impact of Perirenal Fat or Adrenal Gland Involvement in Renal Cell Carcinoma Exhibiting Venous Vascular Extension, p.289-98. Fujita T1, Iwamura M1, Kurosaka S1, Tabata K2, Matsumoto K1, Yoshida K1, Baba S1, Edited by Amato RJ, InTech, 2012/2”­s. (“¡“c“N•v1, Šâ‘º³Žk1, •âáÁ“ñ1, “c”šŒ’ˆê2, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

620140. [Šwp‘] (•ª’SŽ·•M)y”å”AŠí‰Èf—ÃKƒCƒhz‘æ13Í ”å”AŠí‰ÈŽèp@ŽüpŠú‚ÌŠÇ—, p.239-41. ²“¡ˆÐ•¶ (”å”AŠí), •Ò: Ÿ‰ª—mŽ¡, ‹à–F“°, ‹ž“s, 2011/4”­s.

620141. [Šwp‘] (•ª’SŽ·•M)ypŽ®•Ê”å”AŠí‰È‚̏p‘OEpŒãƒPƒA|Œ©‚邱‚ƁE‚·‚邱‚ƃŠƒXƒg‚ňê–Ú—Ä‘R!| (”å”AŠíƒPƒA2011”N‰Ä‹G‘Š§)z‘æ2•” ”å”AŠí‰ÈŽèp‚̏p‘OEpŒãƒPƒA@5. • o‹Ÿ‰ºt᱌`¬p, p.86-99. Šâ‘º³Žk1, ²“¡—ÇŽq, “c’†‚Ý‚Ç‚è (1”å”AŠí), ŠÄC: ‹àŽR”Žb, ƒƒfƒBƒJo”Å, ‘åã, 2011/6”­s.

620142. [Šwp‘] (•ª’SŽ·•M)y‘O—§‘BŠà (‘æ2”Å) (“ú–{—Õ଑Š§†)z–§••¬üŒ¹—Ö@Œã‚ÌPSA•Ï“®, p.451-454. ²“¡ˆÐ•¶ (”å”AŠí), “ú–{—Õ଎Ð, ‘åã, 2011/6”­s.

620143. [Šwp‘] (•ª’SŽ·•M)yƒCƒ“ƒ^[ƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹Eƒwƒ‹ƒXƒPƒA@ŽÀ‘H ƒ`[ƒ€ˆã—Ø_@ŽÀÛ‚Æ‹³ˆçƒvƒƒOƒ‰ƒ€zII ŽÀ‘H•Ò@ƒ`[ƒ€ˆã—Â̎ÀÛ@2. ƒ`[ƒ€ˆã—ɉK‚Ì“WŠJ—á@9) ‘ŸŠíˆÚA@tˆÚA, p.228-35. ‹g“cˆê¬1 (1”å”AŠí), •Ò: …–{Ž‹v, ‰ª–{–ql2, Îˆä–M—Y, “y–{Š°“ñ (2Žš•@), ˆãŽ•–òo”Å, “Œ‹ž, 2011/10”­s.

620144. [Šwp‘] (•ª’SŽ·•M)y‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï‹L˜^W@tˆÚAÇ—áW2011zƒŒƒVƒsƒGƒ“ƒgƒR[ƒfƒBƒl[ƒ^[@RTC‚É‚æ‚éˆÚAŠÅŒìEŠ³ŽÒŽx‰‡ƒVƒXƒeƒ€‚Ì’nˆæ“à‹€’ʉ»‚ÌŽŽ‚Ý, p.394-7. –ìŒû•¶”T, ’r“c¬], “c’†”üŽ÷, ¯–ì^ƒ, ¬âŽu•Û, ‹g“cˆê¬1 (1”å”AŠí), ŠÄC: “ú–{—Տ°tˆÚAŠw‰ï, •Ò: ‚‹ŽŒö‘Ÿ, Žsì–õ“ñ, “ú–{ˆãŠwŠÙ, “Œ‹ž, 2011/10”­s.

620145. [Šwp‘] (•ª’SŽ·•M)y‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï‹L˜^W@tˆÚAÇ—áW2011ztˆÚA‚É‚š‚¯‚鍂—p—ʃ~ƒ]ƒŠƒrƒ“‚Ì—L—p« (‘æ3•ñ), p.136-8. ‹g“cˆê¬1, ’†ì@Œ’, ¯’·Ž—², ‘Šì@Œú, Ž³ŒËŽˆê˜Y, ‘åé‹g‘¥, Eǖì—F•F, ‘ºˆä@Ÿ, ’·’Jìº (1”å”AŠí), ŠÄC: “ú–{—Տ°tˆÚAŠw‰ï, •Ò: ‚‹ŽŒö‘Ÿ, Žsì–õ“ñ, “ú–{ˆãŠwŠÙ, “Œ‹ž, 2011/10”­s.

620146. [Šwp‘] (•ª’SŽ·•M)y‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï‹L˜^W@tˆÚAÇ—áW2011z–k—¢‘åŠw•a‰@‚É‚š‚¯‚épreemptivetˆÚAÇ—á, p.90-2. Îˆä‘å•ã1, ‹g“cˆê¬1, ¬—ÑŒ’‘Ÿ˜Y1, –]ŒŽN•œ1, “y‹Ž³l1, •âáÁ“ñ1, Žáˆä—zŠó1, ’|“àN—Y2, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à), ŠÄC: “ú–{—Տ°tˆÚAŠw‰ï, •Ò: ‚‹ŽŒö‘Ÿ, Žsì–õ“ñ, “ú–{ˆãŠwŠÙ, “Œ‹ž, 2011/10”­s.

620147. [Šwp‘] (•ª’SŽ·•M)y‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï‹L˜^W@tˆÚAÇ—áW2011z–k—¢‘åŠw•a‰@tˆÚAŠ³ŽÒ‰ï‚Ƃ̈ê”ÊŽs–¯‚Ö‚Ì‘ŸŠíˆÚA•‹yŒ[”­Šˆ“®, p.368-70. ’r“c¬], ‹g“cˆê¬1, —§Œ¹ˆê, Îˆä‘å•ã1, –ìŒû•¶”T, ‚‹Ž@Œb2, rì–@Žq, ’[ŽR˜a”ü, “ü–Ø‹GŒb, ‘ì˜ad3, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2ž_, 3•úŽËü (Žîá‡)), ŠÄC: “ú–{—Տ°tˆÚAŠw‰ï, •Ò: ‚‹ŽŒö‘Ÿ, Žsì–õ“ñ, “ú–{ˆãŠwŠÙ, “Œ‹ž, 2011/10”­s.

620148. [Šwp‘] (•ª’SŽ·•M)yV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.17@t‘ŸÇŒóŒQ (‘æ2”Å) ã|‚»‚Ì‘Œ‚̐t‘ŸŽŸŠ³‚ðŠÜ‚߂ā|zE. ùN–E«tŽŸŠ³@18. t”tŽüˆÍƒŠƒ“ƒpŠÇŠg’£ÇEt“Ž«ùN–E, p.589-91. ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí), •Ò: ꠖ씎Žj, “ú–{—Õ଎Ð, ‘åã, 2012/1”­s.

620149. [Šwp‘] (•ª’SŽ·•M)yV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.17@t‘ŸÇŒóŒQ (‘æ2”Å) ã|‚»‚Ì‘Œ‚̐t‘ŸŽŸŠ³‚ðŠÜ‚߂ā|zVI. ”X–E«tŽŸŠ³@19. t”tŽüˆÍ”X–E, –Tt᱔X–E, p.592-5. Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí), •Ò: ꠖ씎Žj, “ú–{—Õ଎Ð, ‘åã, 2012/1”­s.

620150. [Šwp‘] (•ª’SŽ·•M)y‚ª‚ñœ“]ˆÚŽ¡—Á|ƒrƒXƒzƒXƒzƒl[ƒgŽ¡—Âɂæ‚éBone Management|zPart 2 Bone Management ‚ÌŠÏ“_‚©‚獜“]ˆÚBP Ž¡—Â̗Տ°“IˆÓ‹`‚ð’T‚é@4. ‚ª‚ñŽ¡—×U”­«œ—ÊŒž­‚ɑ΂·‚éBPŽ¡—Á|œ‚̐Ǝ㉻‚ð–h‚®‚œ‚߂Ɂ|, p.56-60. ²“¡ˆÐ•¶1, ”nêŽu˜Y1 (1”å”AŠí), •Ò: ‚‹Žr“ñ, æ’[ˆãŠwŽÐ, “Œ‹ž, 2012/3”­s.

620151. [Šwp‘] (•ª’SŽ·•M)y‚í‚©‚é‚©‚ç‘I‚ׂé! —Ö@‘I‘ðƒTƒ|[ƒgƒuƒbƒN (“§ÍƒPƒA2012”N—ÕŽž‘Š§)z‘æ4Í —Ö@‘I‘ð‚ÌŽ‹“_‚ÅŠeŽ¡—Ö@‚ð—‰ð‚µ‚æ‚€@3. tˆÚA@1. ¶‘̐tˆÚA, p.196-202. ‹g“cˆê¬ (”å”AŠí), •Ò: Ö“¡@–Ÿ, ƒƒfƒBƒJo”Å, ‘åã, 2012/3”­s.

620152. [Šwp‘] (•ª’SŽ·•M)y“ú–{”å”AŠí‰ÈŠw‰ï 2012”N ‘²Œã‹³ˆçƒeƒLƒXEg (‘æ17Šª1†)z‹ÃŒÅEŽ~ŒŒƒfƒoƒCƒX‚ÌŽg‚¢•û, p.111-9. Šâ‘º³Žk (”å”AŠí), “ú–{”å”AŠí‰ÈŠw‰ï, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711007. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Laparoscopic radical nephrectomy:points of technique. Iwamura M1: Advanced Course in Laparoscopic Urological Surgery (ASIA IRCAD) (2011/9/1), Taiwan. (Šâ‘º³Žk1: 1”å”AŠí)

711008. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Pyeloplasty. Iwamura M1: Advanced Course in Laparoscopic Urological Surgery (ASIA IRCAD) (2011/9/1), Taiwan. (Šâ‘º³Žk1: 1”å”AŠí)

711009. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Cystotomy. Iwamura M1: Advanced Course in Laparoscopic Urological Surgery (ASIA IRCAD) (2011/9/2), Taiwan. (Šâ‘º³Žk1: 1”å”AŠí)

711010. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Partial nephrectomy. Iwamura M1: Advanced Course in Laparoscopic Urological Surgery (ASIA IRCAD) (2011/9/3), Taiwan. (Šâ‘º³Žk1: 1”å”AŠí)

712026. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Radiation therapy in Japan. Satoh T1: Korea-Japan GyeongBuk Regional Prostate Cancer Consensus Symposium (2011/11/5), Deagu, Korea. (²“¡ˆÐ•¶1: 1”å”AŠí)

713107. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010). Satoh T1, Yamanaka H, Yamashita T, Aoki M, Egawa S, Saito S, Sakata S, Shibuya H, Sugiura N, Takahashi Y, Nishimura T, Hamada T, Miki T, Yorozu A, Dokiya T: •Ä‘–§••¬üŒ¹—Ö@Šw‰ï (2011/4/15), SanDiego, USA. (²“¡ˆÐ•¶1: 1”å”AŠí)

713108. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Revovery of urinary function after radical prostatectomy;predictors of urinary function on preoperative prostate MRI. von Bodman C, Matsushita K1, Savage C, Matikainen M, Eastham J, Scardino P, Rabbani F, Akin O, Sandhu J: 106th Annual Meeting of the American Urological Association (2011/5/15), Washington DC, USA. (Œ‰ºˆêm1: 1”å”AŠí)

713109. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|EXƒ^[) Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial. Tsumura H1, Satoh T1, Ishiyama H1, Tabata K3, Fujita T1, Kimura M1, Hayakawa K1, Baba S1: 106th Annual Meeting of the American Urological Association (2011/5/16), Washington DC, USA, The Journal of Urology 2011; 185 (4-Supplement): e519. (’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ1, “c”šŒ’ˆê3, “¡“c“N•v1, –Ø‘º«‹M1, ‘ì˜ad1, ”nêŽu˜Y1: 1”å”AŠí, 1•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ)

713110. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Induction of radiation-induced erectile dysfunction of rat after prostate-confined modern radiotherapy. Kimura M1, Yan H, Rabbani Z, Yin FF, Polascik TJ, Donatucci CF, Vujaskovic Z, Koontz BF: 106th Annual Meeting of the American Urological Association (2011/5/14-19), Washington DC, USA. (–Ø‘º«‹M1: 1”å”AŠí)

713111. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database. Kimura M1, Banez LL, Gerber L, Qi J, Donatucci CF, Polascik TJ, Moul JW: 106th Annual Meeting of the American Urological Association (2011/5/14-19), Washington DC, USA. (–Ø‘º«‹M1: 1”å”AŠí)

713112. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effectiveness of Sacral Surface of Therapeutic Electrical Stimulation (ssTES) on early Recovery of Urinary Continence after Laparoscopic Radical Prostatectomy (LRP): A prospective study. Nishi M1, Iwamura M1, Kurosaka S1, Tabata K2, Matsumoto K1, Baba S1: The 41st Annual Meeting of the International Continence Society-ICS 2011 (2011/8/31), Glasgow, UK. (Œ@·G1, Šâ‘º³Žk1, •âáÁ“ñ1, “c”šŒ’ˆê2, Œ–{˜a«1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

713113. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) lymphoproliferative disorders of the central nervous system after renal transplantation: single center experience in Japan. Ishii D1, Yoshida K1, Ikeda M1, Maeyama R1, Tabata K2, Takeuchi Y3, Wakai H1, Endo T, Baba S1: 15th Congress of the European Society for Organ Transplantat (2011/9/4), Glasgow, UK. (Îˆä‘å•ã1, ‹g“cˆê¬1, ’r“cŸb1, ‘OŽR—Ç‘Ÿ1, “c”šŒ’ˆê2, ’|“àN—Y3, Žáˆä—zŠó1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3t‘Ÿ“à)

713114. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Pharmacokinetics and clinical outcomes of de novo renal transplantation with once-daily tacrolimus extended release (TER). Yoshida K1, Tomizawa J, Ishii D1, Kobayashi M, Takeuchi Y2, Wakai H1, Noguchi F, Ikeda M1, Yago K3, Baba S1: 15th Congress of the European Society for Organ Transplantation (2011/9/4), Glasgow, UK. (‹g“cˆê¬1, Îˆä‘å•ã1, ’|“àN—Y2, Žáˆä—zŠó1, ’r“cŸb1, –îŒã˜a•v3, ”nêŽu˜Y1: 1”å”AŠí, 2t‘Ÿ“à, 3–òÜ•”)

713115. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The effort to enlighten about local ctizenorgan donation & transplanation together with transplant patient society. Ikeda M1, Yoshida K1, Ishii D1, Yamamoto K2, Tatematsu S, Noguchi F, Endo T, Sakai T, Baba S1: 15th Congress of the European Society for Organ Transplantat (2011/9/4), Glasgow, UK. (’r“cŸb1, ‹g“cˆê¬1, Îˆä‘å•ã1, ŽR–{Œ«Ži2, ”nêŽu˜Y1: 1”å”AŠí, 2ž_)

713116. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Analysis of the kidney transplantation after long-term hemodialysis. Ishii D1, Yoshida K1, Ikeda M1, Kawamura M1, Yamada Y1, Wakai H1, Takeuchi Y2, Endo T, Baba S1: The 12th Congress of the Asian Society of Transplantation (CAST 2011) (2011/9/26), Seoul, Korea. (Îˆä‘å•ã1, ‹g“cˆê¬1, ’r“cŸb1, ì‘º•ä1, ŽR“c‘׎j1, Žáˆä—zŠó1, ’|“àN—Y2, ”nêŽu˜Y1: 1”å”AŠí, 2t‘Ÿ“à)

713117. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Surgical reconstruction for urological complications post renal transplantation. Ishii D1, Yoshida K1, Noguchi F, Kawamura M1, Yamada Y1, Sugita A1, Baba S1: The 12th Congress of the Asian Society of Transplantation (CAST 2011) (2011/9/27), Seoul, Korea. (Îˆä‘å•ã1, ‹g“cˆê¬1, ì‘º•ä1, ŽR“c‘׎j1, ™“c@“Ö1, ”nêŽu˜Y1: 1”å”AŠí)

713118. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Efforts of enlightenment and to increase organ donation by foundation of the transplantation support office in hospital. Yoshida K1, Ishii D1, Kitahara T2, Arakawa N, Takahashi M, Ikeda M1, Iriki R, Kogoshi A, Noguchi F, Hayakawa K3: The 12th Congress of the Asian Society of Transplantation (CAST 2011) (2011/9/28), Seoul, Korea. (‹g“cˆê¬1, Îˆä‘å•ã1, –kŒŽF—Y2, ’r“cŸb1, ‘ì˜ad3: 1”å”AŠí, 2‹~–œ, 3•úŽËü (Žîá‡))

713119. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Oxidative Stress after Radiotherapy-Induced Erectile Dysfunction in a Rat Model. Kimura M1, Rabbani Z, Zodda AR, Yan H, Polascik TJ, Donatucci CF, Moul JW, Vujaskovic Z, Koontz BF: 2011 Fall Meeting of the Sexual Medicine Society of North America (SMSNA) (2011/11/10), Las Vegas, USA. (–Ø‘º«‹M1: 1”å”AŠí)

713120. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Is hypogonadism associated with degree of penile deformity I Peyronie's disease? Matsushita K1, von Bodman C, Nelson C, Mulhall J: 2011 Fall Meeting of the Sexual Medicine Society of North America (SMSNA) (2011/11/12), Las Vegas, USA. (Œ‰ºˆêm1: 1”å”AŠí)

713121. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) HoLEP; analyzing of total energy used. Shitara T, Dobashi M1, Kubo S, Wakatabe Y1, Ishikawa R, Hirayama T1, Fujita T1, Iwamura M1, Baba S1: The 8th Annual Meeting of the East Asian Society of Endourology (EASE 2011) (2011/11/29), Kyoto. (“y‹Ž³l1, Žá“c•”—zŽi1, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí)

713122. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Laparoscopic live donor nephrectomy at a single center experience. Ishi D1, Yoshida K1, Kawamura M1, Hirano S1, Sugita A1, Fujita T1, Iwamura M1, Baba S1: The 8th Annual Meeting of the East Asian Society of Endourology (EASE 2011) (2011/11/29), Kyoto. (Îˆä‘å•ã1, ‹g“cˆê¬1, ì‘º•ä1, •œ–ìC•œ1, ™“c@“Ö1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí)

713123. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Laparoscopic pyeloplasty for ureteropelvic junction obstruction: Kitasato experience in consecutive 125 ureters. Iwamura M1, Nishi M1, Ikeda M1, Matsumoto K1, Fujita T1, Satoh T1, Soh S, Baba S1: The 8th Annual Meeting of the East Asian Society of Endourology (EASE 2011) (2011/11/29), Kyoto. (Šâ‘º³Žk1, Œ@·G1, ’rEcŸb1, Œ–{˜a«1, “¡“c“N•v1, ²“¡ˆÐ•¶1, ”nêŽu˜Y1: 1”å”AŠí)

713124. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Trends in the complications with laparoscopic radical nephrectomy for renal cell carcinoma. Fujita T1, Iwamura M1, Kurosaka S1, Tabata K2, Ishii D1, Yoshida K1, Baba S1: The 8th Annual Meeting of the East Asian Society of Endourology (EASE 2011) (2011/11/29), Kyoto. (“¡“c“N•v1, Šâ‘º³Žk1, •âáÁ“ñ1, “c”šŒ’ˆê2, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

713125. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Benign pathological lesions after laparoscopic partial nephrectomy in preoperative imaging diagnosis of T1a renal Cell carcinoma. Fujita T1, Iwamura M1, Nishi M1, Ishii D1, Matsumoto K1, Yoshida K1, Baba S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/11/30), Kyoto. (“¡“c“N•v1, Šâ‘º³Žk1, Œ@·G1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1: 1”å”AŠí)

713126. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Laparoscopic live donor nephrectomy at a single center experience. Ishi D1, Yoshida K1, Kawamura M1, Hirano S1, Sugita A1, Fujita T1, Iwamura M1, Baba S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/11/30), Kyoto. (Îˆä‘å•ã1, ‹g“cˆê¬1, ì‘º•ä1, •œ–ìC•œ1, ™“c@“Ö1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí)

713127. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic pyeloplasty for ureteropelvic junction obstruction: Kitasato experience in consecutive 125 ureters. Iwamura M1, Nishi M1, Ikeda M1, Matsumoto K1, Fujita T1, Satoh T1, Soh S, Baba S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/11/30), Kyoto. (Šâ‘º³Žk1, Œ@·G1, ’r“cŸb1, Œ–{˜a«1, “¡“c“N•v1, ²“¡ˆÐ•¶1, ”nêŽu˜Y1: 1”å”AŠí)

713128. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Laparoscopic pyeloplasty for ureteral obstruction associated with horseshoe kidney. Nishi M1, Iwamura M1, Kurosaka S1, Sugita A1, Murakami Y1, Baba S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/11/30), Kyoto. (Œ@·G1, Šâ‘º³Žk1, •âáÁ“ñ1, ™“c@“Ö1, ‘ºã‘אŽ1, ”nêŽu˜Y1: 1”å”AŠí)

713129. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Oncologic outcome and urinary continence following laparoscopic radical prostatectomy as several modifications of surgical procedure. Irie A1, Mochiduki K1, Ohyama T1, Wakatabe Y1, Murakami Y1, Dobashi M1, Minamida S1, Kimura M1, Ishii J1, Minei S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/11/30), Kyoto. (“ü]@Œ[1, –]ŒŽN•œ1, ‘åŽR“N•œ1, Žá“c•”—zŽi1, ‘ºã‘אŽ1, “y‹Ž³l1, “ì“c@—@1, –Ø‘º«‹M1, Îˆä~ˆê˜Y1, —äˆä’èŽk1: 1”å”AŠí)

713130. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Quality of life of men treated for localized prostate cancer. Kurosaka S1, Iwamura M1, Yamashita H1, Tabata K2, Satoh T1, Ishiyama H3, Hayakawa K3, Baba S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/11/30), Kyoto. (•âáÁ“ñ1, Šâ‘º³Žk1, ŽR‰º‰p”V1, “c”šŒ’ˆê2, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ3, ‘ì˜ad3, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (Žîá‡))

713131. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) HoLEP; analyzing of total energy used. Shitara T, Dobashi M1, Kubo S, Wakatabe Y1, Ishikawa R, Hirayama T1, Fujita T1, Iwamura M1, Baba S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/12/2), Kyoto. (“y‹Ž³l1, Žá“c•”—zŽi1, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí)

713132. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Holmium laser enucleation of prostate (HoLEP) for the patients with urinary retention. Dobashi M1, Shitara T, Kubo S, Wakatabe Y1, Hirayama T1, Fujita T1, Iwamura M1, Baba S1: The 29th World Congress of Endourology & SWL (WCE2011) (2011/12/2), Kyoto. (“y‹Ž³l1, Žá“c•”—zŽi1, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí)

713133. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy. Ikeda M1, Matsumoto K1, Tabata K2, Minamida S1, Fujita T1, Satoh T1, Iwamura M1, Baba S1: European Association of Urology (EAU) 27th Annual Congress (2012/2/27), Paris, France. (’r“cŸb1, Œ–{˜a«1, “c”šŒ’ˆê2, “ì“c@—@1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1: 1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ)

722104. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ƒGƒLƒXƒp[ƒg‚É•·‚­! ‹Zp”F’èŽæ“Ÿ‚̃|ƒCƒ“ƒg`’m‚Á‚Ä‚š‚«‚œ‚¢Energy Devices‚Ì‘I‘ð‚ÆŽg‚¢•û`. Šâ‘º³Žk (”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 77.

722105. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ‘O—§‘BŠàœ“]ˆÚáu’ɂɑ΂·‚éƒXƒgƒƒ“ƒ`ƒEƒ€89‚Ì—LŒø«‚ɂ‚¢‚Ä. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 78.

722106. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) 2009`2010”NPandemicŽž‚É‚š‚¯‚éŠO—ˆHDŠ³ŽÒ‚̐VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUHAƒƒNƒ`ƒ“‚š‚æ‚Ñ‹Gß«ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“ÚŽí‚ł̍R‘̉¿Šl“Ÿó‹µ‚š‚æ‚ÑŠŽõó‹µ. ²“¡’Œ”V, •º“¡@“§, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 299.

722107. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘O—§‘BŠàœ“]ˆÚ‚ɑ΂·‚郉ƒWƒIƒAƒCƒ\ƒg[ƒvŽ¡—Ã: Sr-89‚È‚ç‚Ñ‚ÉRa-223‚Ì—LŒø«. ²“¡ˆÐ•¶1, ó–ì—Y“ñ2, •âáÁ“ñ1, “c”šŒ’ˆê3, ÎŽR”ŽžŠ4, ˆäã—D‰î2, ‘ì˜ad4, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (‰æ‘œ), 3—Տ°Œ€‹†EŠé‰æ, 4•úŽËü (Žîá‡)): ‘æ51‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ï (2011/10/29), ‚‚­‚Î, “ú–{ŠjˆãŠw‰ï‹@ŠÖŽ 2011; 48 (3): 235.

722108. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒzƒ‹ƒ~ƒEƒ€ƒŒ[ƒU[‘O—§‘BŠjop|HoLEP|. ÝŠy•q–ç, “y‹Ž³l1, ‹v•Û¯ˆê, “¡“c“N•v1, Œ–{˜a«1, Žá“c•”—zŽi1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/25), ‰¡•l, “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ 2011; 32 (3): 302.

722109. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰ºt•”•ªØœp‚ÌŽüpŠú‡•¹Ç‚Æ’·ŠúŽîᇊw“IƒAƒEƒgƒJƒ€: “ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘œŽ{Ý‹€“¯Œ€‹†. Ö“¡‰p˜Y, Œ“cŒöŽu, “c粈ꐬ, Ž›’n•q˜Y, Šâ‘º³Žk1, ’†ì@Œ’, ”É“c³M, ‰Í“à–ŸG, “à“¡œ“ñ, ˆÉ“¡–ŸG, rˆä—zˆê (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 64.

722110. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”å”AŠí• o‹Ÿ‹Zp”F’èRž‚É‚š‚¯‚é–â‘èŽè‹Z‚Æ–]‚Ü‚ê‚éŽè‹Z. Šâ‘º³Žk (”å”AŠí): ‘æ14‰ñ”å”AŠí• o‹Ÿƒ[ƒNƒVƒ‡ƒbƒv (2011/12/1), ‹ž“s.

722111. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Œ£tÌŽæ‚̃Tƒ|[ƒgƒVƒXƒeƒ€ (_“ސ쌧‚ÌŽæ‚è‘g‚Ý). —͐ΒC–ç, ²“¡—Yˆê, ‹{–썲“N, ²X–؏G˜Y, ‹g“cˆê¬1, Îˆä‘å•ã1, ŠÛˆä—S“ñ, ’†‘º“¹˜Y, Šp“c—²r (1”å”AŠí): ‘æ45‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2012/2/2), Œyˆä‘ò.

723578. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚ɑ΂·‚éƒlƒIƒAƒWƒ…ƒoƒ“ƒgHSV-tkˆâ“`ŽqŽ¡—Â̌Ÿ“¢. ²“¡ˆÐ•¶1, ‹v•Û@œ, “c”šŒ’ˆê2, •âáÁ“ñ1, –öàVM”V3, Œ–{˜a«1, “¡“c“N•v1, ²“¡ŠG—¢“Þ, ˆÉ“Œˆê˜Y, ¬”Š•¶–í, “ߐ{•Û—F, Œö•¶—TŒÈ, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•a—): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/21), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 310.

723579. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鐶‘̐tˆÚA‚—î (>60Î) ƒŒƒsƒVƒGƒ“ƒg‚ÉŠÖ‚·‚錟“¢. Îˆä‘å•ã1, ‹g“cˆê¬1, ’†‘º@Œ›, ¬—ÑŒ’‘Ÿ˜Y1, ‚Œû@‘å1, “y‹Ž³l1, •âáÁ“ñ1, –ìŒû•¶”T2, Žáˆä—zŠó1, ’|“àN—Y3, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/21), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 371.

723580. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒjƒ`ƒjƒuŽ¡—Âɂš‚¯‚é—LŠQŽ–Û‚ÌŒŸ“¢. ŽR“c‘׎j1, “¡“c“N•v1, Šâ‘º³Žk1, “y‹Ž³l1, ’r“cŸb1, Îˆä‘å•ã1, “c”šŒ’ˆê2, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/21), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 376.

723581. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚é• o‹Ÿ‰º‘O—§‘B‘S“Eœp‚̏‰ŠúŽ¡—Ã. ù–{Ž¡Žq1, ‰©@‰p–Î1, “ì“c@—@1, “ü]@Œ[1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/21), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 392.

723582. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –§••¬üŒ¹—Ö@‚É‚š‚¯‚ép‘O“à•ª”å—Ö@: Dutasteride‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ì‘º•ä1, ²“¡ˆÐ•¶1, “ì“c@—@1, “c”šŒ’ˆê2, ™“c@“Ö1, ”‹ŒŽ³”Ž1, ‰¡ŽR‰p“ñ, ì‘º’ŒŽ÷, ŠÛ@“T•v, H“¡@Ž¡, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/21), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 393.

723583. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚é2 cm‚ð’Ž‚Š‚étŒ‹Î‚ɑ΂·‚éf-TUL‚𒆊j‚Æ‚µ‚œŽ¡—ЬÑ. ‰z“c’|˜N, ŽR‰º‰p”V1, ‘å“Œ‹MŽu, rì@F (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/21), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 398.

723584. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src-signaling. ŽR‰º‰p”V1, ƒŒƒ”ƒBƒbƒgEƒWƒ‡ƒiƒTƒ“, ƒWƒƒƒ“EƒEƒFƒCƒS, ƒTƒ“ƒpƒ”ƒfEƒOƒ‹, ƒ‰[ƒi[EƒZƒX (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 270.

723585. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –§••¬üŒ¹—Ö@‚É‚š‚¯‚éƒlƒIƒAƒWƒ…ƒoƒ“ƒgEƒAƒWƒ…ƒoƒ“ƒg|ƒAƒ“ƒhƒƒQƒ“œ‹Ž—Ö@: ƒeƒXƒgƒXƒeƒƒ“ƒŠƒJƒoƒŠ[‚ÌŒŸ“¢|. ’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê3, “ì“c@—@1, •âáÁ“ñ1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, ¬’J³Žq2, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 284.

723586. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œo’Œ’°“I‘O—§‘B¶ŒŸ‚É‚š‚¯‚é—\–h“IR‹Û–ò: ƒjƒ…[ƒLƒmƒƒ“‘ϐ«‘å’°‹Û‚É‚æ‚銎õÇ‚ÌŒŸ“¢. “ì“c@—@1, ²“¡ˆÐ•¶1, ‘呐@—m1, ‘OŽR—Ç‘Ÿ1, “y‹Ž³l1, ’r“cŸb1, “c”šŒ’ˆê2, Œ–{˜a«1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 326.

723587. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘O—§‘BŠà‚ɑ΂·‚éPSAŠÄŽ‹—Ö@‚Ì’·Šú¬Ñ. ”‹ŒŽ³”Ž1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, –Ø‘º«‹M1, ²“¡ŠG—¢“Þ, ’ѺGN1, ‘呐@—m1, Œ–{˜a«1, ‰oì@W, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 333.

723588. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠOÆŽËÄ”­‘O—§‘BŠà‚ɑ΂·‚éFocal Salvage HDR brachytherapy‚ÌŒŸ“¢. ’†‘º@Œ›, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, –Ø‘º«‹M1, ù–{Ž¡Žq1, ŽR‰º‰p”V1, Œ–{˜a«1, –k–ì‰ëŽj, ‘“c@Ši3, ÎŽR”ŽžŠ3, ¬’J³Žq3, ‘ì˜ad3, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (Žîá‡)): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 335.

723589. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HoLEP (Holmium Laser Enucleation of the Prostate):Kn“x”»’è‚̐V‚µ‚¢•]‰¿–@|learning curve‚Ì’Zk‚ð–ÚŽw‚µ‚ā|. Žá“c•”—zŽi1, ÝŠy•qEE •œŽR‹M”Ž1, Îì—²‘Ÿ, “¡“c“N•v1, Šâ‘º³Žk1, ‹v•Û¯ˆê, ‰¡ŽR‰p“ñ, ^‰ºß•v, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 412.

723590. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HoLEP: ƒGƒlƒ‹ƒM[‚̈Ⴂ‚É‚š‚¯‚é—Տ°¬Ñ‚Ì”äŠr (78W vs 100W). Îì—²‘Ÿ, ÝŠy•q–ç, Žá“c•”—zŽi1, ‹v•Û¯ˆê, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 412.

723591. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰AŒsŠàÇ—á‚É‚š‚¯‚éHPV”­Œ»‚š‚æ‚їՏ°“IŒŸ“¢. ‘OŽR—Ç‘Ÿ1, Œ–{˜a«1, Œ@·G1, ŒŽ@˜a–ç, “¡“c“N•v1, Ÿ“c^s1, ²“¡ˆÐ•¶1, •º“¡@“§, ‚‹Ž—Tˆê˜Y, Šâ‘º³Žk1, –k—¢‰p˜Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/22), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 428.

723592. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒvƒƒeƒIƒ~ƒNƒX‚ÌŽè–@‚ð—p‚¢‚œtŠàV‹KŽîᇃ}[ƒJ[‚Ì’Tõ‚Æ‘œŒŸ‘Ì”äŠrŽŽŒ±. “ì“c@—@1, Šâ‘º³Žk1, ¬Ž›‹`’j, ì“‡—S‰î, Œ@·G1, •âáÁ“ñ1, “¡“c“N•v1, ‘O“c’‰Œv, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 345.

723593. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚Ì“§ÍŠÔ‚̑̏d‘‰Á—Ê (…•ª‘‰Á—Ê) ‚Í1 L“–‚œ‚艖•ªÛŽæ (’~Ï) —Ê–ñ8.0 g‚É‘Š“–‚·‚é. •º“¡@“§, Žáˆä—zŠó1, ‘呐@—m1, “c”šŒ’ˆê2, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, ‰““¡’‰—Y, “ú‘ä‰p—Y, ã“c³L, “n粌’Žu, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 435.

723594. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Sorafenib‚É‚æ‚éãè–åŽüˆÍ‚̔畆Çó‚ð’悵‚œ2Ç—á. “y“c–š”ü1, {ŽRˆê•ä, ¯ŽiŽŽu (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 441.

723595. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒjƒ`ƒjƒu‚É‚æ‚ép‘O‰»Šw—Ö@‚ª—LŒø‚Å‚ ‚Á‚œ‰º‘åÃ–¬Žîᇍǐð‚𔺂Á‚œt×–EŠà‚Ì1Ç—á. ‰©@‰p–Î1, ù–{Ž¡Žq1, “ì“c@—@1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 441.

723596. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒjƒ`ƒjƒup‘O•â•—Ö@‚ðs‚Á‚œis«t×–EŠà‚Ì1—á. –]ŒŽN•œ1, “¡“c“N•v1, Šâ‘º³Žk1, ™“c@“Ö1, ‘OŽR—Ç‘Ÿ1, ŽR“c‘׎j1, “y‹Ž³l1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 441.

723597. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) M-VAC•¹—p‰»Šw•úŽËü—Ö@‚̐is«äNã÷Šà‚ɑ΂·‚鎡—ЬÑ. ’r“cŸb1, Œ–{˜a«1, V•”@÷2, “c”šŒ’ˆê3, “¡“c“N•v1, ²“¡ˆÐ•¶1, ‰F“s‹{‘ñŽ¡, Šâ‘º³Žk1, ÎŽR”ŽžŠ2, ¬’J³Žq2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 445.

723598. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) MVAC—Ö@Œã‚ɐisEÄ”­‚𗈂œ‚µ‚œäNã÷ŠàÇ—á‚ɑ΂·‚éƒe[ƒ‰[ƒƒCƒhŠàƒyƒvƒ`ƒhƒƒNƒ`ƒ“—Ö@‚ÌŒŸ“¢. Œ–{˜a«1, –ìŒû³“T, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, ’ѺGN, Šâ‘º³Žk1, ŽR“c@—º, ¬Œœ˜a, ˆÉ“Œ‹±Œå, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 445.

723599. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷ŠàpŒã‚Ì‘ã—päNã÷“à‚É‹ô”­“I‚É‘å’°Šà‚ª”F‚ß‚ç‚ê‚œ1—á. “¿ŽR‰ÀŽq1, Îì@–í1, •œˆäËŽi, ŠÛ@“T•v, ™“c@“Ö1, “¡“c“N•v1, •œŽR‹M”Ž1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 449.

723600. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘B”ì‘åÇ‚ɑ΂·‚éƒiƒtƒgƒsƒWƒ‹ (ƒAƒrƒVƒ‡ƒbƒg) ‚©‚牖Ž_ƒ^ƒ€ƒXƒƒVƒ“‚ւ̕ύXÇ—á‚ÌŒŸ“¢. aŒûG”V1, Žu‘º@“N (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 454.

723601. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚ép‘O“à•ª”å—Ö@: pŒã”r”AáŠQ‚ÉŠÖ‚·‚錟“¢. ‘ºã‘אŽ1, ²“¡ˆÐ•¶1, ’ѺGN1, ÎŽR”ŽžŠ2, ¬’J³Žq2, “c”šŒ’ˆê3, “¡“c“N•v1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/23), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 463.

723602. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tŽîᇂɑ΂·‚é• o‹Ÿ‰ºt•”•ªØœp‚̗Տ°“IŒŸ“¢. Œ@·G1, Šâ‘º³Žk1, “¡“c“N•v1, ŽR“c‘׎j1, “y‹Ž³l1, ‘ºã‘אŽ1, ù–{Ž¡Žq1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñEú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 494.

723603. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) T1at×–EŠà‚É‚š‚¯‚éŽèppŽ®‹y‚Ñ•a—‘gDŠw“IŒŸ“¢. “¡“c“N•v1, Šâ‘º³Žk1, ŽR“c‘׎j1, Œ@·G1, “c”šŒ’ˆê2, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 495.

723604. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Stractual maintenance of Chromsomes3”A×–Ef‚Ì—L—p«‚ÌŒŸ“¢. ‘呐@—m1, Œ–{˜a«1, •ž•”@Šw, ¬Ž›‹`’j, ‘O“c’‰Œv, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 503.

723605. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘BŠà‚É‚š‚¯‚éGLIPR1’`”’‚ƃhƒZƒ^ƒLƒZƒ‹•¹—p—Ö@Œø‰Ê‚ÌŒŸ“¢. •âáÁ“ñ1, •œŽR‹M”Ž1, “c”šŒ’ˆê2, “¡“c“N•v1, ²“¡ˆÐ•¶1, Ž}‘ºN•œ, ’J–{—³‘Ÿ, ƒgƒ“ƒvƒ\ƒ“EƒeƒBƒ‚ƒV[, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 507.

723606. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’pœŒãŽ®‘O—§‘B‘S“EœpŒã‘lŒaƒwƒ‹ƒjƒA”­Ç—\–h‚ÌŽè‹ZŽè‹Z‚̍H•v. “c‰ª‰ÀŒ›, Â@‹Pº, ’؈ärŽ÷1, ‚Œû@‘å1, ‘ºã‘אŽ1 (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 510.

723607. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚鍪Ž¡“I‘O—§‘B“Eœp: 15”N¬Ñ‚ÌŒŸ“¢. “y‹Ž³l1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, ‰oì@W, ’r“cŸb1, ‘å–x@—, “à“c–Lº, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 512.

723608. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚Å‚Ì‘O—§‘BŠàŠ³ŽÒ‚É‚š‚¯‚ébone health‚ÌŒŸ“¢. ‰œ–ì‹I•F1, –{“c’ŒN (1”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 519.

723609. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒAƒ“ƒhƒƒQƒ“œ‹Ž—Ö@‚É‚š‚¯‚éƒrƒXƒtƒHƒXƒtƒHƒl[ƒg»Ü: ’·Šú“Š—^‚É‚š‚¯‚éSSBT‚ÌŒŸ“¢. ¬—ÑŒ’‘Ÿ˜Y1, ²“¡ˆÐ•¶1, ’r“cŸb1, “c”šŒ’ˆê2, ’ѺGN1, •º“¡@“§, “¡“c“N•v1, Œ–{˜a«1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 520.

723610. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚é’·Šú«‹@”\•Ï‰»‚ÌŒŸ“¢. ™“c@“Ö1, –Ø‘º«‹M1, ²“¡ˆÐ•¶1, Žu‘º@“N, “c”šŒ’ˆê2, “¡“c“N•v1, Œ–{˜a«1, ìã³Œå, Îì”ŽžŠ3, –k–ì‰ëŽj, ¬’J³Žq3, ‘ì˜ad3, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (Žîá‡)): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 529.

723611. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒGƒ|ƒGƒ`ƒ“ƒx[ƒ^Eƒ_ƒ‹‚׃|ƒGƒ`ƒ“‚©‚çƒGƒ|ƒGƒ`ƒ“ƒJƒbƒp‚ւ̐ؑւŠ‚Ì”äŠr. Â–Ø–ÎŽ÷, ‚‹Ž—Tˆê˜Y, “y‹Ž³l1, Îˆä‘å•ã1, ‹g“cˆê¬1, ‚‹Ž_—Y, —é–؁@‘å, Šp“c—²r (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 383.

723612. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šg’£Œ^S‹ØÇ‚ɑ΂·‚é–Ɖu‹z’…—Ö@‚ÌŽ{H•û–@‚Æ‚»‚̈À‘S«. ‘ºŽR@Í, ”nê²‘×, Žá—Ñ–õ‹v, —äˆä’èŽk1, “n粗jŽq, ‹{–k—R‰Ë (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 389.

723613. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž©“®•ÔŒŒ‘•’u (NCV-2) ‚ÌŠÅŒì‹Æ–±‚É‚š‚¯‚é•]‰¿. —Ž‡—¢“Þ, ‰Ô“cGŽq, ‚‹Ž—Tˆê˜Y, “y‹Ž³l1, Îˆä‘å•ã1, ‹g“cˆê¬1, ‚‹Ž_—Y, —é–؁@‘å, Šp“c—²r (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/17), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 610.

723614. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “§ÍƒNƒŠƒjƒbƒN‚ªÝ‘î—×{Žx‰‡f—ÏŠ‚ƂȂ邱‚Ƃ̃ƒŠƒbƒg‚ƃfƒƒŠƒbƒg. Žáˆä—zŠó1, ì”š@Ÿ, ”Š_^—R”ü, ˆ¢•”“ޒÔü, ŽÄ“c—T”ü, •º“¡@“§, ‹g“cˆê¬1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 426.

723615. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒ‰t“§Í‚ł̃Šƒ“œ‹Ž‚ÉŠÖ‚·‚éÄlŽ@. ‰ÍŒŽƒŽq, •º“¡@“§, ‘Ÿ“c¹–M, ŒIŒŽ³–€, –{ŠÔ@’, ²“¡ˆÐ•¶1, ’|ìŸŽ¡, Žu‘º@“N, ‹g“cˆê¬1, ‰““¡’‰—Y, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 430.

723616. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒi[ƒX‚̍s‚€‰h—{Žw“±‚ÌŽŽ‚Ý‘æ1•ñ: ‰–•ªEKEPÛŽæ—Ê‚Ì’ñŽŠŽw“±ŠJŽn4ƒJŒŽ–Ú‚Å‚ÌHDŠ³ŽÒ‚Ì’mŽ¯K“Ÿ‚Ì’ö“x. ŽR–{ƒXƒ~Žq, •º“¡@“§, “y–å‚ä‚©‚è, [’¬‰”ü, ”ª–ؘaŽq, ‘åŽRƒgƒˆŽq, ²’|Œb”ü, •œ—Ç—²•Û, Îˆä‘å•ã1, ‹g“cˆêE¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 479.

723617. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒi[ƒX‚̍s‚€ŠÈ’P‚ȉh—{Žw“±‚ÌŽŽ‚Ý‘æ1•ñ: ’`”’ˆÙ‰»—Š (PCR) ‚ð—˜—p‚µ‚œPÛŽæ—Ê‚Ì’ñŽŠ‚É‚æ‚éŽw“±‚ÌŒø‰Ê. ²’|Œb”ü, •º“¡@“§, “y–å‚ä‚©‚è, [’¬‰”ü, ”ª–ؘaŽq, ‘åŽR‚Æ‚æŽq, ŽR–{ƒXƒ~Žq, Îˆä‘å•ã1, •œ—Ç—²•Û, ‹g“cˆê¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 479.

723618. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’ʉ@ˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚̍ݑ: –{l‚̈ӎv‚ª‘žd‚³‚ê‚œ2Ç—á. ŽR–{ƒXƒ~Žq, •º“¡@“§, Šp“c”ü—R‹M, ŒïŸºç‘ãŽq, —é–؁@—Î, ›””n•¶Žq, •œ—Ç—²•Û, “¡é‹M‹³1, “¡“c“N•v1, ‹g“cˆê¬1, “à“c–Lº, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 483.

723619. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žñ“sŒ—“sŽs•”‚É‚š‚¯‚éÝ‘‰t“§Í•‹y‚Ì“W–]‚Ɖۑè. Žáˆä—zŠó1, ì”š@Ÿ, ”Š_^—R”ü, ˆ¢•”“ޒÔü, ŽÄ“c—T”ü, •º“¡@“§, ‹g“cˆê¬1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 619.

723620. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ý‘‰t“§Í‚Ì”²j•û–@‚ÌŒP—û‚ɂ‚¢‚Ä. ì”š@Ÿ, Žáˆä—zŠó1, ”Š_^—R”ü, ‹eì’qŒb, ˆ¢•”“ޒÔü, ŽÄ“c—T”ü, ‹g“cˆê¬1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 648.

723621. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒpƒ“ƒfƒ~ƒbƒNŒã‚̃Cƒ“ƒtƒ‹ƒGƒ“ƒU—\–hô‚ÌŒ»ó. ²“¡’Œ”V, •º“¡@“§, ŽR–{ƒXƒ~Žq, •œ—Ç—²•Û, ‘呐@—m1, “c”šŒ’ˆê2, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 674.

723622. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒ‰t“§ÍŠ³ŽÒ‚ɑ΂·‚é‘I‘ð“IDPP-4‘jŠQ–òƒrƒ‹ƒ_ƒOƒŠƒuƒ`ƒ“ (ƒGƒNƒAù) ‚ÌŒø‰Ê. •º“¡@“§, –ìŒû’q‰i, ùì@¬, X@—²Ži, —Lˆä’B˜Y, •œ—Ç—²•Û, Îˆä‘å•ã1, ‹g“cˆê¬1, “ú‘ä‰p—Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 502.

723623. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒ‰t“§ÍŠ³ŽÒ‚ɑ΂·‚éGLP1ƒAƒiƒƒO»ÜƒŠƒ‰ƒOƒ‹ƒ`ƒh (ƒrƒNƒg[ƒU”牺’) ‚ÌŒø‰Ê: DPP-4‘jŠQ–òƒrƒ‹ƒ_ƒOƒŠƒuƒ`ƒ“‚©‚ç‚̕ύX—á‚Å‚ÌŒŸ“¢. •º“¡@“§, “n•Ó‹žŽq, •œ—Ç—²•Û, aŒûG”V1, ’ѺGN1, ‚“‡—Í–í, ŽR‰º‰p”V1, ‹g“cˆê¬1, “ú‘ä‰p—Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 503.

723624. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “§ÍŠ³ŽÒ‚ÌRestless Legs Syndrome‚ÌŽ¡—Âɂ‚¢‚Ä. Ö“¡@‹B, —é–؁@•à, ×’JLŠC, ŠÛŽR’ŒŽq, ’©“ú‘åŽ÷, ŽR“à•‡”ü, Š™“c‚¯‚¢Žq, Š™“c‰ëŽq, ²X–Ø‚¯‚¢Žq, ŸNˆäŒ’Ž¡, Îˆä‘å•ã1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 523.

723625. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “§ÍúŽh—p‹ÇŠ–ƒŒ“\•t—pƒe[ƒv‚š‚æ‚Ñ“§Í‰ñ˜HŒÅ’èƒe[ƒv‚É‚æ‚é”畆•a•Ï‚ɑ΂·‚éƒsƒ…ƒAƒoƒŠƒAHDƒ‚ƒCƒXƒgƒWƒFƒ‹‚Ì—LŒø«‚ÌŒŸ“¢. ²’|Œb”ü, •º“¡@“§, ŽR–{ƒXƒ~Žq, “y‹Ž³l1, –Ø‘º«‹M1, “y“c–š”ü1, •œŽR‹M”Ž1, Îˆä‘å•ã1, ²“¡ˆÐ•¶1, ‹g“cˆê¬1, “ú‘ä‰p—Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 556.

723626. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tˆÚAŠ³ŽÒ‚Ì•›bó‘B‹@”\˜ŽiÇ‚ɑ΂·‚éƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—ÏǗá‚ÌŒŸ“¢. Îˆä‘å•ã1, ‹g“cˆê¬1, “y‹Ž³l1, ŽR“c‘׎j1, Žáˆä—zŠó1, ’|“àN—Y2, •º“¡@“§, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 745.

723627. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ùN–E“àoŒŒ‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚œŒã“V«ùN–E«tÇ (ACDK) ‡•¹t×–EŠà (RCC) ‚Ì1—á. “y“c–š”ü1, {ŽRˆê•ä, ¯ŽiŽŽu, ‹g“cˆê¬1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 755.

723628. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •Û‘¶Šú–«t•s‘S‚É‚š‚¯‚鍂”Z“xH•š‘@ˆÛŠÜ—L’á’`”’ƒNƒbƒL[ (RKF-1) ‚ª—L—p‚Å‚ ‚Á‚œ1Ç—á (41ƒ•ŒŽŠÔ‚ÌŠÏŽ@). ²“¡Œb”üŽq, •º“¡@“§, •œ—Ç—²•Û, Îˆä‘å•ã1, Žu‘º@“N, ‹g“cˆê¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí) ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 777.

723629. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šá‰È—pŒuŒõ‘¢‰eÜƒtƒ‹ƒIƒŒƒZƒCƒ“‚Ì“§Í«‚ÌŒŸ“¢. ‰ÍŒŽƒŽq, •º“¡@“§, ‘Ÿ“c¹–M, ŒIŒŽ³–€, –{ŠÔ@’, E呐@—m1, “c”šŒ’ˆê2, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, “ú‘ä‰p—Y, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 807.

723630. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚ÌPÛŽæ—Ê‚ÆP‹z’…—Ê‚Æ‚ÌŠÖŒW. ²“¡Œb”üŽq, •º“¡@“§, ŽR–{ƒXƒ~Žq, •œ—Ç—²•Û, Îˆä‘å•ã1, ‹g“cˆê¬1, “à“c–Lº, “ú‘ä‰p—Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 829.

723631. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚̉–•ªÛŽæ—ʂ̊ȈՐ„’莮‚̍쐬‚Æ—˜—p–@. ²“¡Œb”üŽq, •º“¡@“§, •œ—Ç—²•Û, Îˆä‘å•ã1, ’|ìŸŽ¡, ‹g“cˆê¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 833.

723632. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œ£tˆÚA‘Ò‹@Š³ŽÒ‚ƐtˆÚAŠ³ŽÒ‚Ƃ̃[ƒLƒ“ƒOƒOƒ‹[ƒv‚ð’Ê‚µ‚œtˆÚA‚Ö‚Ì•sˆÀŠÉ˜a‚ÌŠˆ“®. ’r“c¬]1, –ìŒû•¶”T2, Îˆä‘å•ã1, ’|“àN—Y3, Žáˆä—zŠó1, •º“¡@“§, ‹g“cˆê¬1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/19), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl 1): 842.

723633. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘ã—päNã÷“àŒ‹Î‚ɑ΂µ, • o‹Ÿ—pƒgƒƒJ[‚ð—p‚¢‚œ“àŽ‹‹Ÿ‰ºŒ‹Î“Eop‚ðŽ{s‚µ‚œ1—á. Œ@·G1, Šâ‘º³Žk1, ‘ºã‘אŽ1, ŽR“c‘׎j1, •âáÁ“ñ1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ20‰ñ“ú–{¬Ž™”å”AŠí‰ÈŠw‰ï‘‰ï (2011/7/15), H“c, “ú–{¬Ž™”å”AŠí‰ÈŠw‰ïŽGŽ 2011; 20 (2): 116.

723634. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œŽ{ÝˆãŽt’cŽå“±‚É‚æ‚é‘ŸŠí’ñ‹ŸŒ[”­‚Ì‚œ‚ß‚ÌŽs–¯ŒöŠJuÀ‚ðs‚Á‚ā|—ˆêŽÒ‚̃Aƒ“ƒP[ƒg’²žŒ‹‰Ê‚©‚ç|. ŠÛˆä—S“ñ, —͐ΒC–ç, ‹g“cˆê¬1, •œŒ³@Žü, —с@@‹M, ’†‘º°”ü, ’r“c¬]1, ’†–ڐ^—Žq, ‰ÍŒŽ‚Ý‚«, Œ‘º—L‹IŽq (1”å”AŠí): ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/5), å‘ä, “ú–{ˆÚAŠw‰ïŽGŽ 2011; 46 (‘‰ï—ÕŽž†): 185.

723635. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘ŸŠí’ñ‹ŸEˆÚAŒ[”­‚ׂ̈̎s–¯ŒöŠJuÀ, Œp‘±‚Ì•K—v«‚Æ–â‘è“_. ‹g“cˆê¬1, —͐ΒC–ç, •œŒ³@Žü, ’r“c¬]1, ’†‘º°”ü, ’†–ڐ^—Žq, ŠÛˆä—S“ñ, —с@@‹M, –L“c@—m, Ž›Œ~ˆê, ‰ÍŒŽ‚Ý‚« (1”å”AŠí): ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/5), å‘ä, “ú–{ˆÚAŠw‰ïŽGŽ 2011; 46 (‘‰ï—ÕŽž†): 199.

723636. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 12”NŠÔŒp‘±ŠJÃ‚̐tˆÚA§’k‰ï‚ōs‚Á‚œƒ[ƒLƒ“ƒOƒOƒ‹[ƒv‚̐¬‰Ê|Šeê–å—̈æ‚̃Tƒ|[ƒg‚𓟂ā|. ’r“c¬]1, ‹g“cˆê¬1, Îˆä‘å•ã1, –ìŒû•¶”T2, ’|“àN—Y3, Žáˆä—zŠó1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à) ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/6), å‘ä, “ú–{ˆÚAŠw‰ïŽGŽ 2011; 46 (‘‰ï—ÕŽž†): 265.

723637. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’·ŠúŠÔ“§ÍŠ³ŽÒ‚ւ̐tˆÚA‚ÌŒŸ“¢. ™“c@“Ö1, Îˆä‘å•ã1, ì‘º•ä1, ŽR“c‘׎j1, ‘ºã‘אŽ1, ’|“àN—Y2, ‹g“cˆê¬1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à): ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/6), å‘ä, “ú–{ˆÚAŠw‰ïŽGŽ 2011; 46 (‘‰ï—ÕŽž†): 282.

723638. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ªŽ¡“It“EœŒã5”NŒã‚ɐtˆÚA‚ð‚š‚±‚È‚¢Ä”­‚𗈂œ‚µ‚œt×–EŠà‚̈ê—á. Îˆä‘å•ã1, ‹g“cˆê¬1, ì‘º•ä1, ™“c@“Ö1, ”‹ŒŽ³”Ž1, ŽR“c‘׎j1, –ìŒû•¶”T2, Žáˆä—zŠó1, ’|“àN—Y3, ’r“c¬]1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à): ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/6), å‘ä, “ú–{ˆÚAŠw‰ïŽGŽ 2011; 46 (‘‰ï—ÕŽž†): 295.

723639. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘ŸŠí’ñ‹Ÿ‚Ì•‹y‚ð–Ú“I‚Æ‚µ‚œŽs–¯ŒöŠJuÀ‚ÌŽæ‚è‘g‚݁EE_“ސì‚Ì‘æˆê•à. —͐ΒC–ç, ’†–ڐ^—Žq, ’†‘º°”ü, •œŒ³@Žü, ‹g“cˆê¬1, ’r“c¬]1, ŠÛˆä—S“ñ, •yìL“ñ, Ž›Œ~ˆê, –L“c@—m, —с@@‹M (1”å”AŠí): ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/6), å‘ä, “ú–{ˆÚAŠw‰ïŽGŽ 2011; 46 (‘‰ï—ÕŽž†): 310.

723640. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) High grade‹Ø‘w”ñZ«äNã÷Šà‚É‚š‚¯‚é•¡”‚Ì•ªŽq’`”’‚ð—p‚¢‚œ—\Œã—\‘ªˆöŽq‚ÌŒŸ“¢. ’ѺGN1, Œ–{˜a«1, ²“¡—Yˆê, ’r“cŸb1, Œ@·G1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïŽ˜^† 2011; 46 (2): DVD.

723641. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) MVAC‘ϐ«Ä”­is”A˜Hã”çŠà‚ɑ΂·‚égemcitabine/paclitaxel—Ö@‚ÌŽ¡—ЬÑ. ’r“cŸb1, Œ–{˜a«1, “c”šŒ’ˆê2, “ì“c@—@1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïŽ˜^† 2011; 46 (2): DVD.

723642. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éƒXƒjƒ`ƒjƒuŽ¡—Âɂš‚¯‚éRŽîᇌø‰Ê—\‘ªˆöŽq‚ÌŒŸ“¢. “¡“c“N•v1, Šâ‘º³Žk1, ’r“cŸb1, Œ@·G1, “c”šŒ’ˆê2, Œ–{˜a«1, ²“¡ˆÐ•¶1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïŽ˜^† 2011; 46 (2): DVD.

723643. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷ŠàÇ—á‚É‚š‚¯‚éS100A8/9”­Œ»‚ÌŒŸ“¢. Œ–{˜a«1, ²“¡—Yˆê, “ì@@®, ’r“cŸb1, Œ@·G1, ’ѺGN1, “c”šŒ’ˆê2, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïŽ˜^† 2011; 46 (2): DVD.

723644. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷ŠàÇ—á‚É‚š‚¯‚錌ŽS100A6”­Œ»‚ÌŒŸ“¢. Œ@·G1, Œ–{˜a«1, Œ–{r‰p, ’r“cŸb1, ’ѺGN1, “¡“c“N•v1, Šâ‘º³Žk1, ²“¡—Yˆê, ”nêŽu˜Y1 (1”å”AŠí): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïŽ˜^† 2011; 46 (2): DVD.

723645. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚ɑ΂·‚éƒlƒIƒAƒWƒ…ƒoƒ“ƒgHSV-tkˆâ“`ŽqŽ¡—Â̌Ÿ“¢. ²“¡ˆÐ•¶1, ‹v•Û@œ, “c”šŒ’ˆê2, •âáÁ“ñ1, –öàVM”V3, Œ–{˜a«1, “¡“c“N•v1, ²“¡ŠG—¢“Þ, ˆÉ“Œˆê˜Y, ¬”Š•¶–í, ŽOŽ}@M3, ‰ªˆÀ@ŒM3, “ߐ{•Û—F, Œö•¶—T–€, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•a—): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/29), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïŽ˜^† 2011; 46 (2): DVD.

723646. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) HoLEP‚É‚š‚¯‚é’áƒGƒlƒ‹ƒM[Ž~ŒŒ–@‚ÌŒŸ“¢. “y‹Ž³l1, ÝŠy•q–ç, ‹v•Û¯ˆê, Žá“c•”—zŽi1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/24), ‰¡•l, “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ 2011; 32 (3): 319.

723647. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒŒ[ƒU[‚É‚æ‚éŒo”A“¹“IäNã÷ÓÎp‚ÌŒoŒ±. “¿ŽR‰ÀŽq1, ŠÛ@“T•v, •œˆäËŽi, Îì@–í1, ™“c@“Ö1, Œ@·G1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/24), ‰¡•l, “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ 2011; 32 (3): 319.

723648. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒˆƒE‘f125–§••¬üŒ¹—Ö@Œã‚Ì”r”AáŠQ‚ɑ΂·‚éƒzƒ‹ƒ~ƒEƒ€ƒŒ[ƒU[öŽUp (HoLAP) ‚ÌŒŸ“¢. ‹àŽqŽu•Û1, ²“¡ˆÐ•¶1, ŠÛ@“T•v, “c”šŒ’ˆê2, Îì@–í1, •œˆäËŽi, “¿ŽR‰ÀŽq1, ‰¡“cáÁ“ñ, Œ–{˜a«1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/24), ‰¡•l, “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ 2011; 32 (3): 320.

723649. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) äNã÷Šà×–E‚ɑ΂·‚éƒAƒNƒŠƒWƒ“ƒIƒŒƒ“ƒW‚ÌŽE×–EŒø‰Ê‚ÌŒŸ“¢. Œ@·G1, ”ä—¯ŠÔO”ü2, ù–{Ž¡Žq1, ˆé’†—¹2, ìã@—Ï2, ”nêŽu˜Y1 (1”å”AŠí, 2¶—): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/24), ‰¡•l, “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ 2011; 32 (3): 325.

723650. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”A˜Hã”çŠà‚É‚š‚¯‚é’Ž‚‘¬ƒIƒvƒeƒBƒJƒ‹EƒRƒq[ƒŒƒ“ƒXEƒgƒ‚ƒOƒ‰ƒtƒB[ (OCT) ‚ð—p‚¢‚œƒŠƒAƒ‹ƒ^ƒCƒ€3ŽŸŒ³—§‘Ì’f‘w‰æ‘œ‚ÌŒoŒ±. ’r“cŸb1, Œ–{˜a«1, ›Á@“ŒŠw, “c”šŒ’ˆê2, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ‘å—эN“ñ, Ž…Œö–ç3, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3Šá‰È): ‘æ32‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï (2011/11/25), ‰¡•l, “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ 2011; 32 (3): 335.

723651. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”A•ÂÇ—á‚ɑ΂·‚éHoLEP‚ÌŒŸ“¢. “y‹Ž³l1, ÝŠy•q–ç, ‹v•Û¯ˆê, Žá“c•”—zŽi1, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 83.

723652. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • o‹Ÿ‰ºt•”•ªØœp‚ÌŽèp¬Ñ‚š‚æ‚Ñoncological outcome: “ú–{‚É‚š‚¯‚é‘œŽ{Ý‹€“¯Œ€‹†1,375—á‚̉ðÍ‚æ‚è. Ö“¡‰p˜Y, Œ“cŒöŽu, “c粈ꐬ, Ž›’n•q˜Y, Šâ‘º³Žk1, ’†ì@Œ’, ”É“c³M, ‰Í“à–ŸG, “à“¡œ“ñ, ˆÉ“¡–ŸG, rˆä—zˆê (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 90.

723653. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹ŸŽ‹‰º‘O—§‘B‘S“Eœp‚̏pŽ®•ÏX‚É”º‚€Žèp¬Ñ‚Ì”äŠrŒŸ“¢. “ü]@Œ[1, –]ŒŽN•œ1, ‘åŽR“N•œ1, Žá“c•”—zŽi1, ‘ºã‘אŽ1, “y‹Ž³l1, “ì“c@—@1, –Ø‘º«‹M1, Îˆä~ˆê˜Y1, —äˆä’èŽk1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 92.

723654. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”n’ût‚ɍ‡•¹‚µ‚œ…tÇ‚ɑ΂·‚é• o‹Ÿ‰ºt᱌`¬p‚ÌŽ¡—ЬÑ‚ÌŒŸ“¢. Œ@·G1, Šâ‘º³Žk1, •âáÁ“ñ1, ™“c@“Ö1, ‘ºã‘אŽ1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 105.

723655. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) t᱔AŠÇˆÚs•”•ÂÇ‚ɑ΂·‚é• o‹Ÿ‰ºt᱌`¬p: –k—¢‘åŠw‚É‚š‚¯‚é125—á‚ÌŒoŒ±. Šâ‘º³Žk1, Œ@·G1, ’r“cŸb1, Œ–{˜a«1, “¡“c“N•v1, ²“¡ˆÐ•¶1, ‘v@¬_, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 106.

723656. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é• o‹Ÿ‰ºƒhƒi[t“Eœp‚ÌŒŸ“¢. Îˆä‘å•ã1, ‹g“cˆê¬1, ì‘º•ä1, •œ–ìC•œ1, ™“c@“Ö1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 109.

723657. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • o‹Ÿ‰ºt•”•ªØœp‚É‚š‚¯‚é—ǐ«t•a•Ï‚ÌŒŸ“¢. “¡“c“N•v1, Šâ‘º³Žk1, Œ@·G1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 118.

723658. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒÀ‹Ç«‘O—§‘BŠà‚ɑ΂·‚鍪Ž¡—Ö@•ÊQOL•]‰¿. •âáÁ“ñ1, Šâ‘º³Žk1, ŽR‰º‰p”V1, “c”šŒ’ˆê2, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ3, ‘ì˜ad3, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (Žîá‡)): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 132.

723659. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HoLEP; Žg—pƒGƒlƒ‹ƒM[—Ê‚ÌŒŸ“¢. ÝŠy•q–ç, “y‹Ž³l1, ‹v•Û¯ˆê, Žá“c•”—zŽi1, Îì—²‘Ÿ, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30): ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 148.

723660. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œo”A“®“I‘O—§‘BŠjop (HoLEP) ‚É‚š‚¯‚郂[ƒZƒŒ[ƒVƒ‡ƒ“Œø—Š‚ÆŠjod—Ê‚ÉŠÖ‚·‚錟“¢. Îì—²‘Ÿ, ÝŠy•q–ç, Žá“c•”—zŽi1, ‹v•Û¯ˆê, •œŽR‹M”Ž1, “¡“c“N•v1, “y‹Ž³l1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 148.

723661. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) TURBT‚É‚æ‚è“Ÿ‚œHigh grade‹Ø‘w”ñZ«äNã÷Šà‚É‚š‚¯‚é–ƉuõF–@‚ð—p‚¢‚œ—\Œã—\‘ªˆöŽq‚ÌŒŸ“¢. ’ѺGN1, Œ–{˜a«1, ²E¡—Yˆê, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 154.

723662. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒÀ‹Ç«‘O—§‘BŠà‚ɑ΂·‚éHIFU focal therapy‚ÌŽŽ‚Ý. ŽR‰º‰p”V1, ‰z“c’|˜N, rì@F, ‘å“Œ‹MŽu (1”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 173.

723663. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éŒo’Œ’°“I‘O—§‘Bj¶ŒŸpƒNƒŠƒeƒBƒJƒ‹ƒpƒX‚ÌŒoŒ±. “n粒C˜Y, ‘呐@—m1, ¬—ÑŒ’‘Ÿ˜Y1, “¡é‹M‹³1, ’r–{@Œb, ‚‰ª—ÇŽq, ²“¡”ü•ä, ‰F“s‹{‘ñŽ¡, ‚–ì–õŒå (1”å”AŠí): ‘æ12‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŠwpW‰ï (2011/12/10), “Œ‹ž.

723664. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O—§‘BŠàƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚é6”NŽ¡—ЬÑ: Gleason 6 Vs 7‚Ì”äŠrŒŸ“¢. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, ’ѺGN1, ¬’J³Žq2, “c”šŒ’ˆê3, “ì“c@—@1, •âáÁ“ñ1, ’r“cŸb1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, ‘“c@Ši2, –k–ì‰ëŽj, ‘Ÿ“cK—˜, ã‘O•ôŽq, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ‘æ27‰ñ‘O—§‘BƒVƒ“ƒ|ƒWƒEƒ€ (2011/12/11 “Œ‹ž.

723665. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚA‚É‚š‚¯‚鍂—p—ʃ~ƒ]ƒŠƒrƒ“‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢ (‘æ4•ñ). ‘åé‹g‘¥, ’†ì@Œ’, ¯’·Ž—², ‘Šì@Œú, Ž³ŒËŽˆê˜Y, ‹g“cˆê¬1, ó–ì—F•F, ‘ºˆä@Ÿ, ’·’Jìº (1”å”AŠí): ‘æ45‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2012/2/2), Œyˆä‘ò.

723666. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚAƒŒƒVƒsƒGƒ“ƒg‚Ì’èŠúŠàŒŸfŽófó‹µ. ¬âŽu•Û, “c’†^‹Õ, Žðˆä’qŽq, •yìL“ñ, ‹g“cˆê¬1, —͐ΒC–ç, ”ŠÔŒbŽq (1”å”AŠí): ‘æ45‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2012/2/2), Œyˆä‘ò.

723667. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw‚É‚š‚¯‚é’Ž’·Šú (30”N) ¶’…Ç—á‚̗Տ°“IŒŸ“¢. Îˆä‘å•ã1, ‹g“cˆê¬1, •œ–ìC•œ1, ”‹ŒŽ³”Ž1, ‘ºã‘אŽ1, ™“c@“Ö1, –ìŒû•¶”T2, ’|“àN—Y3, Žáˆä—zŠó1, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à): ‘æ45‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2012/2/2), Œyˆä‘ò.

723668. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ£tˆÚAŠó–]’·Šú‘Ò‹@Š³ŽÒ‚̍ĐfŠO—ˆŽóf‚Ö‚ÌRTC‚Ì–ðŠ„|‚»‚Ì1|. ’r“c¬]1, –ìŒû•¶”T2, Îˆä‘å•ã1, ‹g“cˆê¬1, Žáˆä—zŠó1, ’|“àN—Y3, •º“¡@“§, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à): ‘æ45Eñ“ú–{—Տ°tˆÚAŠw‰ï (2012/2/2), Œyˆä‘ò.

723669. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ž“x‘̐¬•ª•ªÍ‘•’uInBodyS20‚ð—p‚¢‚œtˆÚAŠ³ŽÒ‚̑̉t—Ê•]‰¿. ™“c@“Ö1, Îˆä‘å•ã1, ”‹ŒŽ³”Ž1, •œ–ìC•œ1, ŽR“c‘׎j1, “y‹Ž³l1, ¬—ÑŒ’‘Ÿ˜Y1, ’|“àN—Y2, Žáˆä—zŠó1, ’r“c¬]1, ‹g“cˆê¬1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à): ‘æ45‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2012/2/3), Œyˆä‘ò.

731108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]Ž€‰º‘ŸŠí’ñ‹Ÿ‚Ɖ@“à‘̐§®”õ‚ÌŽÀÛ. ‹g“cˆê¬1, rì–@Žq2 (1”å”AŠí, 2ŠÅŒì•”): ”’‹àŠwpu‰‰‰ï (2011/4/21), “Œ‹ž.

731109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”å”AŠíŠàœ“]ˆÚƒ}ƒlƒWƒƒ“ƒg‚̏d—v«. ²“¡ˆÐ•¶ (”å”AŠí): Novartis Oncology Liveu‰‰‰ï (2011/5/25), ‰¡•l.

731110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ü³‘ŸŠíˆÚA–@‚ʼnœ‚ª•Ï‚í‚è, ‰œ‚ª•Ï‚í‚Á‚Ä‚¢‚È‚¢‚Ì‚©. ‹g“cˆê¬ (”å”AŠí): OCUU”å”AŠíŽŸŠ³Œ€‹†‰ï (2011/6/4), ‘åã.

731111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) CRPC‚ɑ΂·‚鎡—Ð헪. ²“¡ˆÐ•¶ (”å”AŠí): ‘O—§‘BŠà‰»Šw—Ö@u‰‰‰ï (2011/6/17), å‘ä.

731112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠà‚É‚š‚¯‚é’nˆæ˜AŒgƒNƒŠƒjƒJƒ‹ƒpƒXKitasato Prostate Cancer Net work: KP-Net‚̉^—p‚Ɖۑè. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ15‰ñ’}Œã’n‹æ’nˆæˆã—ÃŽx‰‡u‰‰‰ï (2011/6/23), ‹v—¯•Ä.

731113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –Ÿ“ú‚̐f—Âɖ𗧂ƒŒƒWƒfƒ“ƒgŒü‚¯ƒŒƒNƒ`ƒƒ[: V‚µ‚¢‘O—§‘BŠàŠeŽí’è‹`‚̉ðà. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ3‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2011/7/15), “Œ‹ž.

731114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠà‚ɑ΂·‚郈ƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@: ƒAƒEƒgƒJƒ€‚ƍ¡Œã‚Ì“W–]. ²“¡ˆÐ•¶ (”å”AŠí): ŠâŽèŒ§–§••¬üŒ¹Ž¡—ÃŒ€‹†‰ï^ŠâŽèˆã‘å500Ç—á“ž’B‹L”Ou‰‰‰ï (2011/7/29), ·‰ª.

731115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‰ï’·u‰‰) ƒAƒWƒAŠe‘‚Ì“§ÍŽ–î‚ƁuNPO–@l‚¢‚‚łà‚Ç‚±‚Å‚àŒŒ‰tò‰»v‚ÌŠˆ“®‚ð’Ê‚µ‚ÄŒ©‚Š‚Ä‚«‚œ‚à‚Ì. •º“¡@“§, ŽÄŒŽL‹v, ŒŒŽO˜a, ’†“ˆÍ‹M, ŠÛŽR‰h™¬, ×–썂Žu, ÷ˆä—T”ü¢, ŽR–{ƒXƒ~Žq, ‰ª–{’q”V, Žáˆä—zŠó1, ŽR‰º–Ÿ‘×, ’|àV^Œá, ‹g“cˆê¬1, “ú‘ä‰p—Y, ì‘º–Ÿ•v (1”å”AŠí): ‘æ17‰ñ“ú–{HDFŒ€‹†‰ïŠwpW‰ïE‘‰ï (2011/9/4), ‰¡•l.

731116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –§••E¬üŒ¹—Ö@‚ÌŽÀŽ{‚܂ł̃Gƒsƒ\[ƒh. ²“¡ˆÐ•¶ (”å”AŠí): ‘O—§‘B‚ª‚ñæiŽ¡—à (–§••¬üŒ¹—Ö@) u‰‰‰ï (2011/9/8), ‰ºŠÖ.

731117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) • o‹Ÿ‰ºªŽ¡“I‘O—§‘B“Eœp: ‚±‚ê‚©‚çŽn‚ß‚él‚ւ̃AƒhƒoƒCƒX. Šâ‘º³Žk (”å”AŠí): ‘æ26‰ñL“‡EEEŒ€‹†‰ï (2011/10/8), L“‡.

731118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠà‚ɑ΂·‚éÅVŽ¡—ÃAƒbƒvƒf[ƒg. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ4‰ñSagamihara Oncology Seminar (2011/11/17), ‘Š–ÍŒŽ.

731119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) mCRPC Update 2011. ²“¡ˆÐ•¶ (”å”AŠí): CRPCƒRƒ“ƒZƒ“ƒTƒXÀ’k‰ï (2011/11/19), ‰¡•l.

731120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠà‚ɑ΂·‚éV‚µ‚¢•úŽËüŽ¡—Ã. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ13‰ñŽR—œ‘O—§‘BŠàŒ€‹†‰ï (2011/11/22), b•{.

731121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •úŽËü—Ö@Œã‚ÌPSAÄ”­‚ɑ΂·‚鎡—Ð헪. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ8‰ñProstate Cancer Forum (2012/2/18), å‘ä.

732053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Œo‰ßŠÏŽ@E‡•¹Ç. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ13‰ñƒˆƒE‘f125ƒV[ƒhüŒ¹‰i‹v‘}“ü‚É‚æ‚é‘O—§‘BŠà–§••¬üŒ¹—Ö@‹ZpuK‰ï (2011/6/18), “Œ‹ž.

732054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) t×–EŠà‚̏Ǘጟ“¢. ŽR‰º‰p”V (”å”AŠí): RCC CASE Conference (2011/7/1), “Œ‹ž.

732055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv) Ý‘ÍŠó–]Š³ŽÒ‚ÌŽ©ŒÈúŽh”\—͂͋ɂ߂č‚‚¢`VA‚ÍHHD“±“ü‚ÌŽxá‚É‚È‚ç‚È‚¢?`. Žáˆä—zŠó (”å”AŠí): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

732056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) ‘O—§‘B‚ª‚ñ‚Ì“]ˆÚEÄ”­Ž¡—Ã. ²“¡ˆÐ•¶ (”å”AŠí): ‘O—§‘B‚ª‚ñ@‘æ3‰ñŽs–¯ŒöŠJuÀ (2011/8/28), “Œ‹ž.

732057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) ‘O—§‘B‚ª‚ñ‚ÌŽ¡—Á|ŠO‰È“IŽ¡—ÂƕúŽËü—Ö@‚ɂ‚¢‚ā|. Šâ‘º³Žk (”å”AŠí): Žs–¯ŒöŠJuÀ@‘O—§‘B‚ª‚ñƒZƒ~ƒi[ (2011/9/23), ÀŠÔ.

732058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •úŽËüŽè–@Focal therapy‚ðŠÜ‚ß‚œV‚œ‚ȃAƒvƒ[ƒ`‚ɂ‚¢‚Ä. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ18‰ñ“Œ‹ž‘O—§‘BŠàƒtƒH[ƒ‰ƒ€ (2011/10/8), “Œ‹ž.

732059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)yŽs–¯ŒöŠJuÀ2011z‰ü³‘ŸŠíˆÚA–@Ž{s‚©‚ç1”N‚ðŒo‚Ä. ‹g“cˆê¬ (”å”AŠí): ‘ŸŠí’ñ‹ŸEˆÚA‚ðl‚Š‚é_“ސì‚̉ï (2011/10/15), ‰¡•l.

732060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) tŠà‚ɑ΂·‚é• o‹ŸŽèp`ˆÀ‘S‚ÈŽèp‚ðs‚€ˆ×‚̃Rƒc‚ƍH•v`. Šâ‘º³Žk (”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

732061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) f-TUL‚ÆPNL‚Ì’·Š‚Æ’ZŠ. rì@F, ‰z“c’|˜N, ŽR‰º‰p”V1, ‘å“Œ‹MŽu (1”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

732062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ˆÛŽ—Ö@‚ÌŒ»ó. Œ–{˜a« (”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

732063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) isEÄ”­‘O—§‘B‚ª‚ñ‚ÌŽ¡—Ã. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

732064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚ɑ΂·‚éHDR (‚ü—Ê—Š‘gD“àÆŽË) ‚ÌŽ¡—ЬÑ. ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, ’r“cŸb1, •âáÁ“ñ1, ’ѺGN1, “¡“c“N•v1, Œ–{˜a«1, ÎŽR”ŽžŠ3, ¬’J³Žq3, ‘“c@Ši3, –k–ì‰ëŽj, ‘ì˜ad3, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (Žîá‡)): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

732065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv) MVAC‘ϐ«isEÄ”­äNã÷Šà‚ɑ΂·‚éƒe[ƒ‰[ƒƒCƒhŠàƒyƒvƒ`ƒhƒƒNƒ`ƒ“—Ö@‚ÌŒoŒ±. Œ–{˜a«1, –ìŒû³“T, ²“¡ˆÐ•¶1, “c”šŒ’ˆê2, “¡“c“N•v1, Šâ‘º³Žk1, ŽR“c@—º, ¬Œœ˜a, ”nêŽu˜Y1, ˆÉ“Œ‹±Œå (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ“ú–{‘‰ï (2011/11/11), ‹v—¯•Ä.

732066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) tˆÚA‚ÌŽÀÛ. Îˆä‘å•ã (”å”AŠí): ‘æ21‰ñƒNƒŠƒjƒJƒ‹ƒ~[ƒeƒBƒ“ƒO_“ސì (2011/11/17), •œ’Ë.

732067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘ŸŠíˆÚA–@‰ü³Œã‚Ì“ú–{‚̐tˆÚA‚ÌŒ»ó. ‹g“cˆê¬ (”å”AŠí): ‘æ21‰ñƒNƒŠƒjƒJƒ‹ƒ~[ƒeƒBƒ“ƒO_“ސì (2011/11/17), •œ’Ë.

732068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ‘O—§‘BŠà‚ɑ΂·‚éŠO‰È“IŽ¡—Â̍őOü. Šâ‘º³Žk (”å”AŠí): ‘æ81‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (“ú–{—Տ°”å”AŠí‰Èˆã‰ïE_“ސ암‰ï) (2011/11/19), V‰¡•l.

732069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) J-POPS •ª’SŒ€‹† PSAƒoƒEƒ“ƒX|PSA’l•Ï“®‚ɂ‚¢‚ā|. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ7‰ñJ-POPS’†ŠÔ•ñ‰ï (2012/1/21), “Œ‹ž.

733285. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚Ì“§ÍŠÔ‚̑̏d‘‰Á—Ê (…•ª‘‰Á—Ê) ‚Í1L“–‚œ‚艖•ªÛŽæ (’~Ï) —Ê–ñ8.0 g‚Æ‚µ‚đÓ–‚Å‚ ‚é. ²“¡Œb”üŽq, •º“¡@“§, ‘Ÿ“c¹–M, ‰ÍŒŽƒŽq, ŽR–{ƒXƒ~Žq, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí): t‘Ÿ•a‚Ɖh—{E‘ãŽÓEHŽ–ƒtƒH[ƒ‰ƒ€2011 (2011/4/23), “Œ‹ž.

733286. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’·Šú‘Ò‹@Š³ŽÒ‚ÌŒ£tˆÚA‚ÌŒŸ“¢. ŽR“c‘׎j1, Îˆä‘å•ã1, ì‘º•ä1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ17‰ñ“ú–{ˆÚA–ò•š—Ö@Œ€‹†‰ï (2011/6/4), “Œ‹ž.

733287. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ꋌa•”‚É”­¶‚µ‚œmesothelial cyst‚Ì1—á. “¿ŽR‰ÀŽq1, ŠÛ@“T•v, —äˆä’è‹I1, Îì@–í1, •œˆäËŽi, ™“c@“Ö1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ119‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‰«“ê’n•û‰ï (2011/6/4), ‰«“ê.

733288. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘åŒã• –ŒŽ‰–b“÷Žî‚̈ê—á. •œ–ìC•œ1, •âáÁ“ñ1, —§‰Ô‹MŽj, Žá“c•”—zŽi1, ™“c@“Ö1, Œ@·G1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ80‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2011/6/11), ìè.

733289. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tŽüˆÍŽ‰–bD“à‚ɍœ‰»¶‚𐏔º‚µ‚œŒã• –ŒŽ‰–b“÷Žî‚̈ê—á. ‘åŽR“N•œ1, “ü]@Œ[1, Îˆä~ˆê˜Y1, —äˆä’èŽk1, ‚“ˆ—Í–í1, ‚‹Ž—Tˆê˜Y, –å˜e˜ab, •âáÁ“ñ1, X‰i³“ñ˜Y (1”å”AŠí): ‘æ606‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2011/6/18), “Œ‹ž.

733290. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒOƒŠƒZƒŠƒ“Ÿ¯’°‚É‚æ‚è—nŒŒ‚ð‚«‚œ‚µ‚œ1—á. Œ“c‘å‰î (”å”AŠí): ‘æ3‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2011/7/15), “Œ‹ž.

733291. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) |Ž_ƒŠƒ…[ƒvƒƒŒƒŠƒ“‚É‚æ‚éŠÔŽ¿«”x‰Š‚Ì1Ç—á. –]ŒŽN•œ (”å”AŠí): ‘æ3‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2011/7/15), “Œ‹ž.

733292. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O—§‘Bˆ««—tóŽîᇂÌ1—á. ù–{Ž¡Žq (”å”AŠí): ‘æ3‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2011/7/15), “Œ‹ž.

733293. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O—§‘B¶ŒŸ‚É‚æ‚é”sŒŒÇ‚Ì1—á. ‘OŽR—Ç‘Ÿ (”å”AŠí): ‘æ3‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2011/7/15), “Œ‹ž.

733294. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”A•Â‚ðŒ_‹@‚ɐf’f‚³‚ê‚œ‘O—§‘BŒŽ”­_Œo“à•ª”åŽîᇂ̈ê—á. ‚Œû@‘å (”å”AŠí): ‘æ3‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2011/7/15), “Œ‹ž.

733295. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O—§‘BŠàƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚é6”NŽ¡—ЬÑ: Gleason 6 vs. 7‚Ì”äŠrŒŸ“¢. ²“¡ˆÐ•¶ (”å”AŠí): ‘攪‰ñ‘O—§‘BŠà–§••¬üŒ¹‰i‹v‘}“üŽ¡—ÃŒ€‹†‰ï (2011/7/17), “Œ‹ž.

733296. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒi[ƒX‚̍s‚€‰h—{Žw“±: ‰–•ªEKEPÛŽæ—Ê‚Ì’ñŽŠŽw“±ŠJŽnŒã‚ÌHDŠ³ŽÒ‚Ì—‰ð“x. ²’|Œb”ü, •º“¡@“§, ŽR–{ƒXƒ~Žq, ‘呐@—m1, “c”šŒ’ˆê2, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, “ú‘ä‰p—Y, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733297. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œã“V«ùN–EtŽ©‘R”j—ô‚̈ê—á. ™“c‰ÀŽq1, ŠÛ@“T•v, Îì@–í1, •œˆäËŽi, Ž…Œ’Žj2, ‰¡“cáÁ“ñ, ™“c@“Ö1, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733298. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘̐tˆÚAŒã‚É’°œÃ–¬ŒŒðÇ‚𗈂œ‚µ‚œˆê—á. ™“c@“Ö1, Îˆä‘å•ã1, ‚Œû@‘å1, ’r“cŸb1, “y‹Ž³l1, –ìŒû•¶”T2, ’|“àN—Y3, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733299. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚Ì“]“|”­¶‚ÌŽÀ‘Ô‚Æ“]“|‚̊댯ˆöŽq‚ÉŠÖ‚·‚錟“¢|1”NŠÔ‚Ì‘OŒü‚«’²ž|. Îˆä@—æ, Œ‰i“Ä•F, ˆíŒ©–[‘ã, Œ‘ò—Ç‘Ÿ, –{‹Ž²’mŽq, ‚–؁@—T, Îˆä‘å•ã1, ‹g“c@àˆ, ‘“c@‘ì (1”å”AŠí): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733300. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’ʉ@ˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚̍ݑ: –{l‚̈ӎv‚ª‘žd‚³‚ê‚œ2Ç—á. ŽR–{ƒXƒ~Žq, •º“¡@“§, ²’|Œb”ü, ‘呐@—m1, “c”šŒ’ˆê2, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”åEAŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733301. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “§ÍƒAƒ~ƒƒCƒhÇ‚̍‡•¹‚ªãŽˆ‚ð—p‚¢‚œ“úí¶ŠˆŠˆ“®“®ìŽž‚ÌŽ©Šo“I¢“‚É‹y‚Ú‚·‰e‹¿. Œ‘ò—Ç‘Ÿ, Œ‰i“Ä•F, Îˆä@—æ, Žº“à’ŒŽ÷, ˆ¢•”‹`Žj, –¥—֏r–ç, ‚–؁@—T, ‹g“c@àˆ, Îˆä‘å•ã1, ‚•œ®L (1”å”AŠí): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733302. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tŠà‚̃vƒƒeƒIƒ~ƒNƒX. “ì“c@—@ (”å”AŠí): ‘æ9‰ñ–k—¢ŽŸŠ³ƒvƒƒeƒI[ƒ€Œ€‹†‰ï (2011/7/27), “Œ‹ž.

733303. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äNã÷Šà‚É‚š‚¯‚éŽîᇃ}[ƒJ[ŒŸo‚ÌŽŽ‚Ý. Œ–{˜a« (”å”AŠí): ‘æ9‰ñ–k—¢ŽŸŠ³ƒvƒƒeƒI[ƒ€Œ€‹†‰ï (2011/7/27), “Œ‹ž.

733304. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰EƒŠƒ“ƒpßŽî‘å‚©‚ç”­Œ©‚³‚ê‚œŒŽ”­•s–Ÿ”A˜Hã”çŠà‚̈ê—á. ì‘º•ä1, •âáÁ“ñ1, ’†‘º@Œ›, ”‹ŒŽ³”Ž1, Žá“c•”—zŽi1, ™“c@“Ö1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ44‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2011/9/8), V‰¡•l.

733305. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œo”A“¹ŽîᇂÌ1—á. ‘OŽR—Ç‘Ÿ1, ‘呐@—m1, “¡é‹M‹³1 (1”å”AŠí): ‘æ44‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2011/9/8), V‰¡•l.

733306. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒã‚Ì”AŠÇᑂɑ΂µ, ”AŠÇ•ÂÇp‚ðŽ{s‚µ‚œ2—á. ‹Ž–{³O, ¬ìŒ’“ñ, {ŽRˆê•ä, “y“c–š”ü1 (1”å”AŠí): _“ސ쌧•úŽËüˆã‰ï‘‰ï‹y‚Ñ‘æ52‰ñ—á‰ï (2011/9/17), ‰¡•l.

733307. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äNã÷ŠàNested Variant‚̈ê—á. ŽR“c‘׎j1, Œ“c‘å‰î1, ìã’B‰›, ‘åì‚ ‚³Žq (1”å”AŠí): ‘æ110‰ñ‘œ–€”å”AŠí‰Èˆã‰ï (2011/9/30), —§ì.

733308. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚA‚̍ŐVŽ–î`ESAŽ¡—ÂàŠÜ‚߂ā`. Îˆä‘å•ã (”å”AŠí): ‘æ19‰ñ‘Š–ÍŒŽ‚Æ‚»‚ÌŽü•Ó’n‹æ“§Í’k˜b‰ï (2011/10/9), ‘Š–ÍŒŽ.

733309. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œo’Œ’°“I‘O—§‘B¶ŒŸÇ—á‚É‚š‚¯‚éƒjƒ…[ƒLƒmƒƒ“‘ϐ«‘å’°‹Û•Û‹Û—Š‚ÌŒŸ“¢. ‹àŽqŽu•Û1, ²“¡ˆÐ•¶1, “ì“c@—@1, ‘呐@—m1, ‘OŽR—Ç‘Ÿ1, “c”šŒ’ˆê2, ’r“cŸb1, •âáÁ“ñ1, Œ–{˜a«1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

733310. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) t×–EŠà‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚œ‹‘åtƒIƒ“ƒRƒTƒCƒg|ƒ}‚̈ê—á. “¿ŽR‰ÀŽq1, ŠÛ@“T•v, Îì@–í1, •œˆäËŽi, ™“c@“Ö1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

733311. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘O—§‘BŠàƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚é6”NŽ¡—ЬÑ: Gleason 6‚Æ7‚Ì”äŠrŒŸ“¢. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, ’ѺGN1, ¬’J³Žq2, “c”šŒ’ˆê3, “¡“c“N•v1, “ì“c@—@1, •âáÁ“ñ1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

733312. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –§••¬üŒ¹—Ö@‚É‚š‚¯‚éƒlƒIƒAƒWƒ…ƒoƒ“ƒgEƒAƒWƒ…ƒoƒ“ƒg|ƒAƒ“ƒhƒƒQƒ“œ‹Ž—Ö@: ƒeƒXƒgƒXƒeƒƒ“ƒŠƒJƒoƒŠ[‚ÌŒŸ“¢|. •œ–ìC•œ1, ²“¡ˆÐ•¶1, ’ѺGN1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê3, “ì“c@—@1, •âáÁ“ñ1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, ¬’J³Žq2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3—Տ°Œ€‹†EŠé‰æ): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

733313. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) t᱂š‚æ‚я㕔”AŠÇ‚É”­¶‚µ‚œtŒŽ«‘BŽî (Nephrogenic adenoma) ‚̈ê—á. ‘åŽR“N•œ1, “ü]@Œ[1, Îˆä~ˆê˜Y1, —äˆä’èŽk1, ‚“ˆ—Í–í1, ‚‹Ž—Tˆê˜Y, –å˜e˜ab, –î“àŒŽ‹v2, X‰i³“ñ˜Y (1”å”AŠí, 2•úŽËü (‰æ‘œ)): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

733314. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ‘O—§‘B‘S“Eœp‚É‚š‚¯‚éƒhƒŒ[ƒ“—ʂ̈Ӌ`‚ÌŒŸ“¢. ’؈ärŽ÷1, ‚Œû@‘å1, ‘åŽR“N•œ1, “c‰ª‰ÀŒ›, Â@‹Pº (1”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/21), ‰¡•l.

733315. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) High grade‹Ø‘w”ñZ«äNã÷Šà‚É‚š‚¯‚é•¡”‚Ì•ªŽq’`”’‚ð—p‚¢‚œ—\Œã—\‘ªˆöŽq‚ÌŒŸ“¢. ’ѺGN1, Œ–{˜a«1, ²“¡—Yˆê, ’r“cŸb1, Œ@·G1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733316. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ƒXƒgƒƒ“ƒ`ƒEƒ€-89 (Sr-89) Ž¡—ÂðŽó‚¯‚œ—L’ɐ«œ“]ˆÚ‚ð—L‚·‚é‘O—§‘BŠàŠ³ŽÒ‚É‚š‚¯‚éEORTC QLQ-BM22‚ÆEORTC QLQ-C30‚ð—p‚¢‚œQOL•]‰¿. •âáÁ“ñ1, ²“¡ˆÐ•¶1, Chow Edward, “y‹Ž³l1, –Ø‘º«‹M1, ’ѺGN1, Œ–{˜a«1, “c”šŒ’ˆê2, ó–ì—Y“ñ3, ÎŽR”ŽžŠ4, ˆäã—D‰î3, ‘ì˜ad4, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (‰æ‘œ), 4•úŽËü (Žîá‡)): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733317. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ƒXƒjƒ`ƒjƒuŽ¡—Âɂš‚¯‚é—LŠQŽ–Û‚ƍRŽîᇌø‰Ê‚Æ‚ÌŠÖ˜A. Žá“c•”—zŽi1, “¡“c“N•v1, Šâ‘º³Žk1, ‘ºã‘אŽ1, ŽR“c‘׎j1, “y‹Ž³l1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733318. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚é’·Šú«‹@”\•Ï‰»‚ÌŒŸ“¢. ™“c@“Ö1, –Ø‘º«‹M1, ²“¡ˆÐ•¶1, Žu‘º@“N, “c”šŒ’ˆê2, ÎŽR”ŽžŠ3, –k–ì‰ëŽj, ¬’J³Žq3, ‘ì˜ad3, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ, 3•úŽËü (Žîá‡)): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733319. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ŒŽ”­‘ƒ”ñ“Eœt×–EŠà‚ɑ΂·‚éƒXƒjƒ`ƒjƒuŽ¡—Â̌Ÿ“¢. ‚Œû@‘å1, “¡“c“N•v1, Šâ‘º³Žk1, ™“c@“Ö1, ‘OŽR—Ç‘Ÿ1, ²“¡ˆÐ•¶1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733320. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ”A˜HŒŽ”­¬×–EŠà‚Ì2—á. –]ŒŽN•œ1, Œ–{˜a«1, “c”šŒ’ˆê2, •œ–ìC•œ1, ”‹ŒŽ³”Ž1, ì‘º•ä1, ™“c@“Ö1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733321. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚錌‰tŒ^•s“K‡tˆÚA‚ÌŒŸ“¢. Îˆä‘å•ã1, ‹g“cˆê¬1, ì‘º•ä1, ŽR“c‘׎j1, ™“c@“Ö1, •âáÁ“ñ1, –ìŒû•¶”T2, ’r“c¬]1, ”‹ŒŽ³”Ž1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2ŠÅŒì•”): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733322. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éƒGƒxƒƒŠƒ€ƒXŽ¡—Â̌Ÿ“¢. “¡“c“N•v1, Šâ‘º³Žk1, Œ@·G1, •âáÁ“ñ1, “c”šŒ’ˆê2, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2—Տ°Œ€‹†EŠé‰æ): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/22), ‰¡•l.

733323. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚAŒã‚ÉŠŽõ«MRSAèò’ŒŊԔ‰Š‚𔭏ǂµ‚œ1—á. ™“c@“Ö1, Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, –]ŒŽN•œ1, ‘OŽR—Ç‘Ÿ1, ŽR“c‘׎j1, “y‹Ž³l1, ‹g“cˆê¬1 (1”å”AŠí): ‘æ8‰ñ‘ŸŠí•s‘SŠ³ŽÒ‚ɑ΂·‚éŠO‰ÈEŠÇ—Œ€‹†‰ï (2011/11/12), “Œ‹ž.

733324. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ”A“¹ƒJƒe[ƒeƒ‹—¯’uÇ—á‚ɑ΂·‚éHoLEP‚ÌŒŸ“¢. “y‹Ž³l1, ÝŠy•q–ç, ‹v•Û¯ˆê, Žá“c•”—zŽi1, ŽR“c‘׎j1, ™“c@“Ö1, ‘OŽR—Ç‘Ÿ1, ‘ºã‘אŽ1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ“ú–{‘‰ï (2011/11/12), ‹v—¯•Ä.

733325. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢Œ€‹†Š•a‰@‚É‚š‚¯‚éESWL (DornierŽÐ»Delta II) ‚ÌŽ¡—ЬÑ‚ƍ‡•¹Ç‚ÌŒŸ“¢. —äˆä’èŽk1, ‘åŽR“N•œ1, –]ŒŽN•œ1, Îˆä~ˆê˜Y1, “ü]@Œ[1, —äˆä’è‹I1, —äˆä’èˆê (1”å”AŠí): ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ“ú–{‘‰ï (2011/11/12), ‹v—¯•Ä.

733326. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x“]ˆÚ‚ɑ΂µƒXƒjƒ`ƒjƒu‚ª’˜Œø‚µ‚œ1—á. ‘呐@—m1, ¬—ÑŒ’‘Ÿ˜Y1, “¡é‹M‹³1, ‰F“s‹{‘ñŽ¡ (1”å”AŠí): _“ސ쐌•”tŠà•ªŽq•W“I–òŽ¡—ÃZƒ~ƒi[ (2011/11/18), ˆÉšŒŽ.

733327. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆâ”A‚É‚ÄŽóf‚µ, •›”A“¹‚É‚æ‚é”A“¹‹·ó‚Ɛf’f‚³‚ê‚œˆê—á. ‚Œû@‘å1, Œ@·G1, Šâ‘º³Žk1, ‘ºã‘אŽ1, ²“¡ˆÐ•¶1, Œ–{˜a«1, “¡“c“N•v1, •âáÁ“ñ1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ81‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2011/11/19), V‰¡•l.

733328. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tŠà‚̃vƒƒeƒIƒ~ƒNƒX. “ì“c@—@ (”å”AŠí): ‘æ8‰ñç—tŽŸŠ³ƒvƒƒeƒIƒ~ƒNƒXŒ€‹†‰ï (2011/11/26), “Œ‹ž.

733329. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ªŽ¡“It“EœŒã5”NŒã‚ɐtˆÚA‚ð‚š‚±‚È‚¢Ä”­‚𗈂œ‚µ‚œt×–EŠà‚̈ê—á. Îˆä‘å•ã (”å”AŠí): ‘æ7‰ñ_“ސìtˆÚAƒŒƒsƒVƒGƒ“ƒgƒR[ƒfƒBƒl[ƒ^[˜A—‰ï (2011/12/3), ‰¡•l.

733330. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŸŠí’ñ‹ŸEˆÚAŒ[”­‚ׂ̈̎s–¯ŒöŠJuÀ, Œp‘±‚Ì•K—v«‚Æ–â‘è“_. ‹g“cˆê¬ (”å”AŠí): ‘æ7‰ñ_“ސìtˆÚAƒŒƒsƒVƒGƒ“ƒgƒR[ƒfƒBƒl[ƒ^[˜A—‰ï (2011/12/3), ‰¡•l.

733331. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽüpŠúŠÇ—‚É‹ê˜J‚µ‚œ’·Šú“§ÍŠ³ŽÒ‚Ö‚ÌŒ£tˆÚA—á. ™“c@“Ö (”å”AŠí): ‘æ21‰ñ_“ސìEtˆÚA‚ð•×‹­‚·‚é‰ï (2011/12/10), ‰¡•l.

733332. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) oŒŒ«ùN–E‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚œŒã“V«ùN–E«tÇ (ACDK) ‡•¹t×–EŠà (RCC) ‚Ì1—á. “y“c–š”ü1, {ŽRˆê•ä, ¯ŽiŽŽi (1”å”AŠí): ‘æ2‰ñ‚±‚€‚©‚ñƒVƒ“ƒ|ƒWƒEƒ€ (2011/12/10), ìè.

733333. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝ“àŽ‹‹Ÿ‚ðŒ_‹@‚ɐf’f‚³‚ê‚œ”~“Å‚Ì1—á. ™“c@“Ö1, Œ–{˜a«1, •º“¡@“§, Îì@Í, ˜a“c’B•F2, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2äPŒŽ•aEŠŽõ“à): ‘æ12‰ñ_“ސ쐫ŠŽõÇŠw‰ï (2012/2/4), ‰¡•l.

733334. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œã• –ŒüˆÛÇ‚Ì‹}«‘žˆ«‚É‚ÄŽ€–S‚µ‚œˆê—á. ‘OŽR—Ç‘Ÿ1, •âáÁ“ñ1, ‘ºã‘אŽ1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ45‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2012/2/16), V‰¡•l.

733335. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HoLEP‚ðŒ_‹@‚É‘Sg”dŽí‚𗈂œ‚µ‚œ‘O—§‘BŠà‚Ì1—á. ‚Œû@‘å (”å”AŠí): ‘æ4‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2012/2/17), “Œ‹ž.

733336. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒ—F•aŠ³ŽÒ‚ɑ΂·‚éHoLEP‚Ì1—á. “y‹Ž³l (”å”AŠí): ‘æ4‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2012/2/17), “Œ‹ž.

733337. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž~ŒŒ¢“ï‚Å‚ ‚Á‚œTUR-PÇ—á. ŽR“c‘׎j (”å”AŠí): ‘æ4‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2012/2/17), “Œ‹ž.

733338. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”r”AáŠQ‚ð’悵‚œ‘O—§‘B”X–E‚Ì1—á. ù–{Ž¡Žq (”å”AŠí): ‘æ4‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2012/2/17), “Œ‹ž.

733339. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘‰t“§Í‚ÌŒ»ó‚Ɖۑè. Žáˆä—zŠó1, ì”š@Ÿ, ˆ¢•”“ޒÔü (1”å”AŠí): ‘æ16‰ñ_“ސ쌧tŽŸŠ³‘‡ˆã—ÃZƒ“ƒ^[–k—¢‘åŠw•a‰@ŒŒ‰tò‰»ƒZƒ“ƒ^[‡“¯Œ€‹†‰ï (2012/2/26), ‘Š–ÍŒŽ.

733340. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éPrimary Non-function‚ÌŒŸ“¢. ‘ºã‘אŽ (”å”AŠí): ‘æ22‰ñ_“ސìEtˆÚA‚ð•×‹­‚·‚é‰ï (2012/3/3), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-120002. [ŒŽ’˜] HoLEP (Holmium Laser Enucleation of the Prostate): pŒã”A“¹‹·óÇ‚ɑ΂·‚éŽèpŽè‹Z‚ÌŒŸ“¢. Žá“c•”—zŽi1, ÝŠy•q–ç, Îì—²‘Ÿ, ‹v•Û¯ˆê, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): Japanese Journal of Endourology and ESWL 2010/10; 24 (1): 147-51.

[Šw‰ïEŒ€‹†EE™]

H22-722008. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ý‘‰t“§Í“±“üŠî€‚Ì•W€‰»‚ɂ‚¢‚Ä. ì”š@Ÿ, Žáˆä—zŠó1, ”Š_^—R”ü, ‹eì’qŒb, ŽÄ“c—T”ü, ‹g“cˆê¬1 (1”å”AŠí): ‘æ8‰ñ“ú–{Ý‘ÍŽx‰‡‰ï‹cE‘‰ï^‘æ14‰ñÝ‘‰t“§ÍŒ€‹†‰ïE‹€“¯ŠJÃ (2011/2/27), é‹Ê.


Šá‰ÈŠw

[Šwp˜_•¶]

110227. [ŒŽ’˜] Comparison of corneal power, corneal astigmatism, and axis location in normal eyes obtained from an autokeratometer and a corneal topographer. Kobashi H1, Kamiya K2, Igarashi A2, Ishii R1,2, Sato N1, Wang G3, Shimizu K2: J Cataract Refract Surg 2011/4; 38 (4): 648-54. (¬‹Ž‰p’·1, _’J˜aF2, ŒÜ\—’ÍŽj2, Îˆä—œŠG1,2, ²“¡M”V1, ‰€@‘‹Õ3, Ž…Œö–ç2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3—Տ°Œ€‹†EŠé‰æ)

110228. [ŒŽ’˜] Clinical outcomes of posterior chamber toric phakic intraocular lens implantation for the correction of high myopic astigmatism in eyes with keratoconus: 6-month follow-up. Kamiya K1, Shimizu K1, Kobashi H1, Komatsu M1, Nakamura A, Nakamura T, Ichikawa K1: Graefes Arch Clin Exp Ophthalmol 2011/7; 249 (7): 1073-80. (_’J˜aF1, Ž…Œö–ç1, ¬‹Ž‰p’·1, ¬Œ^—1, Žsìˆê•v1: 1Šá‰È)

110229. [ŒŽ’˜] Modulation transfer function of intraocular collamer lens with a central artificial hole. Uozato H1, Shimizu K2, Kawamorita T1, Ohmoto F2: Graefes Arch Clin Exp Ophthalmol 2011/7; 249 (7): 1081-5. (‹›—¢@”Ž1, Ž…Œö–ç2, ìŽç“c‘ñŽu1, ‘å–{•¶Žq2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

110230. [ŒŽ’˜] Factors influencing the changes in coma-like aberrations after myopic kaser in situ keratomileusis. Kamiya K1, Umeda K1, Igarashi A1, Ando W1, Shimizu K1: Curr Eye Res 2011/10; 36 (10): 905-9. (_’J˜aF1, ”~“c‹žŽq1, ŒÜ\—’ÍŽj1, ˆÀ“¡˜a‰ÌŽq1, Ž…Œö–ç1: 1Šá‰È)

110231. [ŒŽ’˜] Clinical outcomes of photoastigmatic refractive keratectomy for the correction of residual refractive errors following cataract surgery. Kamiya K1, Umeda K1, Ando W1, Igarashi A1, Shimizu K1: J Refract Surg 2011/11; 27 (11): 826-31. (_’J˜aF1, ”~“c‹žŽq1, ˆÀ“¡˜a‰ÌŽq1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1: 1Eá‰È)

110232. [ŒŽ’˜] Pseudophakic monovision using monofocal and multifocal intraocular lenses: hybrid monovision. Iida Y1, Shimizu K1, Ito M2: J Cataract Refract Surg 2011/11; 37 (11): 2001-5. (”Ñ“c‰Ã•F1, Ž…Œö–ç1, ˆÉ“¡”ü¹ŠG2: 1Šá‰È, 2ˆã—Éq¶Šw•”)

110233. [ŒŽ’˜] Effects of preoperative punctal plug treatment on visual function and wound healing in laser epithelial keratomileusis. Kojima T1,2, Watabe T3, Nakamura T1, Ichikawa K4,5, Satoh Y3 (1Nagoya Eye Clinic, 2Department of Ophthalmology, Keio University School of Medicine, 3Satoh Yuya Eye Clinic, 4Social Insurance Chukyo Hospital): J Refract Surg 2011/12; 27 (12): 894-8. (Žsìˆê•v4,5: 4ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 5Šá‰È)

110234. [ŒŽ’˜] Effect of pupil size on uncorrected visual acuity in astigmatic eyes. Kamiya K1, Kobashi H2, Shimizu K1, Kawamorita T3, Uozato H3: Br J Ophthalmology 2012/2; 96 (2): 267-70. (_’J˜aF1, ¬‹Ž‰p’·2, Ž…Œö–ç1, ìŽç“c‘ñŽu3, ‹›—¢@”Ž3: 1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”)

110235. [ŒŽ’˜] Corneal biomechanical properties in normal-tension glaucoma. Morita T1, Shoji N2, Kamiya K1, Fujimura F2, Shimizu K1: Acta Ophthalmol 2012/2; 90 (1): e48-53. (X“c“N–ç1, ¯ŽiMs2, _’J˜aF1, “¡‘º•‡²Žq2, Ž…Œö–ç1: 1Šá‰È, 2ˆã—Éq¶Šw•”)

110236. [ŒŽ’˜] Effect of Astigmatism on Apparent Accommodation in Pseudophakic Eyes. Kamiya K1, Kawamorita T2, Uozato H2, Kasugai H1, Shimizu K1: Optom Vis Sci 2012/2; 89 (2): 148-154. (_’J˜aF1, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2, t“úˆähŽq1, Ž…Œö–ç1: 1Šá‰È, 2ˆã—Éq¶Šw•”)

110237. [ŒŽ’˜] Daytime Variation in Pupil size under Photopic Conditions. Kobashi H1, Kamiya K2, Ishikawa H3, Goseki T2, Shimizu K2: Optom Vis Sci 2012/2; 89 (2): 197-202. (¬‹Ž‰p’·1, _’J˜aF2, Îì‹Ï3, ŒãŠÖ—˜–Ÿ2, Ž…Œö–ç2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ˆã—Éq¶Šw•”)

110238. [ŒŽ’˜] Leber's hereditary optic neuropathy with the 3434, 9011 mitochondrial DNA point mutation. Shidara K1, Wakakura M1,2: Jpn J Ophthalmol 2012/3; 56 (2): 175-80. (Žá‘q‰ë“o1,2: 1ˆäãŠá‰È•a‰@, 2Šá‰È)

110239. [ŒŽ’˜] Effects of selective-wavelength block filters on pupillary light reflex under red and blue light stimuli. Ishikawa H1, Onodera A, Asakawa K1, Nakadomari S, Shimizu K2: Jpn J Ophthalmol 2012/3; 56 (2): 181-6. (Îì@‹Ï1, óì@Œ«1, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

110240. [ŒŽ’˜] Correlation of corneal elevation with severity of keratoconus by means of anterior and posterior topographic analysis. Ishii R1, Kamiya K1, Igarashi A1, Shimizu K1, Utsumi Y1,2, Kumanomido T1,3: Cornea 2012/3; 31 (3): 253-8. (Îˆä—œŠG1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1, ‰F’ÃŒ©‹`ˆê1,2, ŒF”WŒä“°—²1,3: 1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@, 3ƒNƒ}ƒmƒ~ƒh[Šá‰È)

110241. [ŒŽ’˜] Early clinical outcomes of implantation of posterior chamber phakic intraocular lens with a central hole (Hole ICL) for moderate to high myopia. Shimizu K1, Kamiya K1, Igarashi A1, Shiratani T1: Br J Ophthalmol 2012/3; 96 (3): 409-12. (Ž…Œö–ç1, _’J˜aF1, ŒÜ\—’ÍŽj1, ”’’J@“O1: 1Šá‰È)

110242. [ŒŽ’˜] The magnitude of stereopsis in peripheral visual fields. Mochizuki H1, Shoji N2, Ando E, Otsuka M, Takahashi K, Handa T2: Kitasato Med J 2012/3; 42 (1): 1-5. (–]ŒŽ_Žu1, ¯ŽiMs2, ”Œ“c’m–ç2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”)

110243. [ŒŽ’˜] An attempt to detect visual field defects in normal subjects using stereopsis. Mochizuki H1, Shoji N2: Kitasato Med J 2012/3; 42 (1): 15-21. (–]ŒŽ_Žu1, ¯ŽiMs2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”)

120055. [ŒŽ’˜] ‰–‰»ƒxƒ“ƒUƒ‹ƒRƒjƒEƒ€”ñŠÜ—Lƒgƒ‰ƒ{ƒvƒƒXƒg“_Šá–ò‚Ì‹…Œ‹–Œ[ŒŒ. ”ä‰Ã—œ¹Žq1, ˆäãŒ«Ž¡1, ‰–ì”üØŽq1, ›ŒŽ“¹F1, ‘–{”üŽ}Žq1, Žá‘q‰ë“o1,4, ‘ŠŒŽ@ˆê2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰ÈŠO‰ÈŠwêUŠá‰ÈŠw, 3“Œ–M‘åŠwˆãŠw•”Šá‰ÈŠw‘æ“ñuÀ, 4Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/4; 28 (4): 563-7.

120056. [ŒŽ’˜] ŽÀŒ±“I•s“¯Ž‹‚É‚š‚¯‚é’²ß‹@”\‚ÌŒŸ“¢. óì@Œ«1, “n糔üK, ›ŒŽçŠG, Îì@‹Ï1 (1ˆã—Éq¶Šw•”): Ž©—¥_Œo 2011/4; 28 (2): 136-9.

120057. [ŒŽ’˜] Šá‰ÈŠwZ•ÛŒ’‚ÉŠÖ‚·‚é‘S‘’²ž‚Ì•ñ. ‹{‰Y@“O1, ‰F’ÃŒ©‹`ˆê1,2, ‚‹Ž˜a”Ž1, •Ÿ‰ºŒöŽq1, E‚–E@”É1 (1(ŽÐ) “ú–{Šá‰Èˆã‰ïŠwZ•ÛŒ’•”, 2Šá‰È): “ú–{‚ÌŠá‰È 2011/5; 82 (5): 648-60.

120058. [ŒŽ’˜] •œ¬22”N“xŠá‹Ÿ‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²ž‚̏WŒvŒ‹‰Ê•ñ. ‚‹Ž˜a”Ž1, ‰F’ÃŒ©‹`ˆê1,2, “¡“°Ÿ–€1, ‹›’J@ƒ1, •Ÿ‰ºŒöŽq1, ‚–ì@”É1 (1(ŽÐ) “ú–{Šá‰Èˆã‰ïŠwZ•ÛŒ’•”, 2Šá‰È): “ú–{‚ÌŠá‰È 2011/5; 82 (5): 675-80.

120059. [ŒŽ’˜] ƒŠƒtƒ@ƒuƒ`ƒ“‚ÉŠÖ˜A‚µ‚œ‘O–[’~”^‚𔺂€‚Ô‚Ç‚€–Œ‰Š. ”Ñ“‡@Œh1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/5; 28 (5): 693-5.

120060. [ŒŽ’˜] –Ɖu³íŽÒ‚É”­Ç‚µ‚œƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒX–Ô–Œ‰Š‚Ì1—á. ›ŒŽ“¹F1, –{“c–ŸŽq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/5; 28 (5): 702-5.

120061. [ŒŽ’˜] p’†“øÊ‹Ù’£’ቺÇŒóŒQ‚ÌŽèpí—ª|“øÊ’Eo‚ɑ΂·‚éƒ^ƒbƒZƒ‹–@‚ÌŽŽ‚݁|. ”ä‰Ã—˜¹Žq1, ‘å“à‰ë”V2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,3 (1ˆäãŠá‰È•a‰@, 2‘å“àŠá‰È, 3Šá‰È): IOL&RS 2011/6; 25 (2): 228-32.

120062. [ŒŽ’˜] Œã–[Œ^ƒg[ƒŠƒbƒN—L…»‘ÌŠá“àƒŒƒ“ƒY (TICL) ‚̏pŒã3”N‚̐¬Ñ. Œ‘ºˆêO1, ¬Œ^—1, ŒÜ\—’ÍŽj2, _’J˜aF2, Ž…Œö–ç2 (1ŽR‰€•a‰@Šá‰È, 2Šá‰È): IOL&RS 2011/6; 25 (2): 247-53.

120063. [ŒŽ’˜] ‰~Šp–ŒŠá‚É‚š‚¯‚éEnhanced Ectasia Display‚Ì—L—p«. Îˆä—œŠG1, _’J˜aF2, ŒÜ\—’ÍŽj2, Ž…Œö–ç2, ‰F’ÃŒ©‹`ˆê2,3, ŒF”WŒä“°—²2,4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3‰F’ÃŒ©Šá‰È, 4ƒNƒ}ƒmƒ~ƒh[Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/7; 28 (7): 1039-42.

120064. [ŒŽ’˜] ³íŠáˆ³—Γàá‚ɑ΂·‚éƒ^ƒtƒ‹ƒvƒƒXƒg“_Šá–ò‚̊ሳ‰º~Œø‰Ê‚ƈÀ‘S«. ‰ª“c“ñ—t1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,3, •x“c„Ži2 (1ˆäãŠá‰È•a‰@, 2“Œ–M‘åŠwˆãŠw•”Šá‰ÈŠw‘æ“ñuÀ, 3Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/7; 28 (7): 1043-6.

120065. [ŒŽ’˜] “ú‹A‚è”’“àáŽèp‚̃PƒAƒ}ƒlƒWƒƒ“ƒg‚ɂ‚¢‚Ä. â–{ˆß—¢, Œ–{_”V1, ˆø“cŽj‰À2 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): _“ސìˆã‰ïŽGŽ 2011/7; 38 (2): 1-7.

120066. [ŒŽ’˜] ƒRƒ“ƒgƒ‰ƒXƒgŠŽ“x‚ÆŽ‹—͂ɉe‹¿‚·‚éƒtƒŒƒlƒ‹–ŒƒvƒŠƒYƒ€‚̍ŏ¬“x” (Effects of Fresnel Prism Power on Contrast Sensitivity and Visual Acuity). óì@Œ«1,2, ’†ŽR“ށX”ü2, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Ž‹Šo‚̉Ȋw 2011/8; 31 (4): 129-33.

120067. [ŒŽ’˜] —Ž‹‚Ì“µEˆË‘¶«|Ž‹E@”\‚ւ̉e‹¿| (Pupil size and Astigmatism-Effect on Visual Function-). ŽRE{^–ç1,3, ‹›—¢@”Ž2,3, ìŽç“c‘ñŽu2,3, ’†ŽR“ށX”ü2, ’†’JŸŒÈ2, ‰¶“c@Œ’1 (1•£–ì•Ó‘‡•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): Ž‹Šo‚̉Ȋw 2011/8; 31 (4): 134-9.

120068. [ŒŽ’˜] 3D‰f‰æŠÓÜŒã, “àŽÎŽ‹‚𔭏ǂµ‚œ1—á (A Case of Esotropia after Watching 3D Movie). ‹Ž–{“Ä•¶1,2, –î–ì@—²1,3, “¡ŒŽ˜aŽq2, ‘ŠàV‘å•ã1,2,3, Îì@‹Ï4 (1ŠC˜V–ŒƒƒfƒBƒJƒ‹ƒvƒ‰ƒU, 2Šá‰È, 3ŠC˜V–Œ‘‡•a‰@, 4ˆã—Éq¶Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2011/9; 28 (9): 1361-3.

120069. [ŒŽ’˜] V‚µ‚¢ŒõŠ±ÂŽ®ŠáŽ²’·‘ª’è‘•’u‚Ì‘ª’萞“x‚ƍČ»«. ’†ŽR“ށX”ü1, ‹›—¢@”Ž1,2, ìŽç“c‘ñŽu1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2011/9; 28 (9): 1337-40.

120070. [ŒŽ’˜] ‚Z¶‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ƃRƒ“ƒ^ƒNƒgƒŒƒ“ƒYƒP[ƒX‚̉˜õó‹µ (Bacterial Contamination of High Shool Students' Contact Lenses and Storage Cases). â–{‘¥•q1,2, ‰F’ÃŒ©‹`ˆê1, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2â–{Šá‰ÈÃ“ìƒNƒŠƒjƒbƒN): “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ïŽ 2011/9; 53 (3): 198-203.

120071. [ŒŽ’˜] “øÊ•t‚«ƒJƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿ (Influence of Cosmetically Tinted Soft Contact Lenses on Visual Function). “¡‘º•‡²Žq1, ‰ª–{ç‰À, “n•Óç‘, ¯ŽiMs1 (1ˆã—Éq¶Šw•”): “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ïŽ 2011/9; 53 (3): 204-8.

120072. [ŒŽ’˜] Šáâ|ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ”–؍LÆ1,2, ŒŽ“c—²•¶, ˆÉ“¡ˆÈ’m˜Y, “n粗íŽq, “à“¡—§‹Å, ŒˆäG–Ÿ (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): —Տ°Šá‰È 2011/10; 65 (10): 1595-600.

120073. [ŒŽ’˜] Šá‰È•a‰@‚É‚š‚¯‚鎋ŠoáŠQ‚É‚æ‚ég‘̏áŠQŽÒŽè’ \¿ŽÒ‚ÌŽŸŠ³•Ê“Á’¥ (2009”N). ‰ª“c“ñ—t1, ’߉ªŽOŒbŽq2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,3, ‹{‰i‰Ã—²2 (1ˆäãŠá‰È•a‰@, 2ŒŠ‹ŒˆäãŠá‰È•a‰@, 3Šá‰È): Šá‰È—Տ°‹I—v 2011/11; 4 (11): 1048-53.

120074. [ŒŽ’˜] ’†S–¬—–ŒŒú‚Ì“ú“à•Ï“® (Diurnal variation of central choroidal thickness). ˆÉ“¡ŽuD1, Žs糋`Í1, åŒŽŽµd2, íœAr‘Ÿ˜Y1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): Šá‰È—Տ°‹I—v 2011/11; 4 (11): 1054-9.

120075. [ŒŽ’˜] Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[‚É‚š‚¯‚éƒAƒCƒoƒ“ƒN‚ÌŒ»ó‚ÆŽæ‚è‘g‚Ý. ”–؍LÆ1,2, ‘åã@›Ô, ¬ŒF—R”ü, •äÏ‰ëŽq, –x“cŠì—T (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/11; 28 (11): 1655-7.

120076. [ŒŽ’˜] ‰©”Áã–Œ‚É‚š‚¯‚éIOLƒ}ƒXƒ^[TM‚ð—p‚¢‚œŠáŽ²’·‘ª’è‚ƏpŒã‹üÜŒë·‚ÌŒŸ“¢. “¡ŒŽ˜aŽq, –ö“c’q•F1, ‚‹ŽŒcŽq, ŽžàV‚Š‚èŽq, Ž…Œö–ç1 (1Šá‰È): —Տ°Šá‰È 2011/11; 65 (12): 1833-7.

120077. [ŒŽ’˜] ƒrƒ}ƒgƒvƒƒXƒg“_Šá–ò‚Ì‹…Œ‹–Œ[ŒŒ (Conjunctival hyperemia after dosing with bimatoprost ophthalmic solution). ˆäãŒ«Ž¡1, ’·“‡²’mŽq1, ‰–ì”üØŽq1, ‘–{”üŽ}Žq1, –ìŒû@Œ\1, àV“c‰pŽq1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åŠwˆãŠw•”Šá‰ÈŠw‘æ“ñuÀ): Šá‰È—Տ°‹I—v 2011/12; 4 (12): 1159-63.

120078. [ŒŽ’˜] ¬Ž™Ž‹_ŒoŽŸŠ³‚Ì“Á’¥ (Optic Neuropathy in Childhood). •û’qŒbŽq1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): _ŒoŠá‰È 2011/12; 28 (4): 394-9.

120079. [ŒŽ’˜] ƒwƒbƒhƒ}ƒEƒ“ƒgƒfƒBƒXƒvƒŒƒC‚ð—p‚¢‚œV‚µ‚¢—ŒŠáŽ‹‹@”\ŒŸž‘•’u‚ÌŽg—pŒoŒ± (Application of New Tessting Device for Binocular Function). i“¡^‹I1, ŽÄ“c—DŽq1, ’†ŽR“ށX”ü1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): Ž‹Šo‚̉Ȋw 2012/3; 32 (4): 90-4.

220017. [€ŒŽ’˜] 6ÎŽž‚ÉŠm’èf’f‚³‚ê‚œ”’“_ó–Ô–Œ‰Š‚Ì1—á (A case of retinitis punctata albescens diagnosed at 6 years old). ‰i–ì‰ëŽq1, Îˆä—SŽq1, “¿“c–F_1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): Šá‰È—Տ°‹I—v 2011/4; 4 (4): 368-72.

220018. [€ŒŽ’˜] (—Տ°Œ€‹†) ”’“àáŽèp‘O‚ÌŠp–Œ—Ž‹. ŽO‘îr”V1, _’J˜aF1, “V–엝Œb1, Ž…Œö–ç1 (1Šá‰È): “ú–{Šá‰ÈŠw‰ïŽGŽ 2011/5; 115 (5): 447-53.

220019. [€ŒŽ’˜] ƒŠƒtƒ@ƒuƒ`ƒ“‚ÉŠÖ˜A‚µ‚œ‘O–[’~”^‚𔺂€‚Ô‚Ç‚€–Œ‰Š (Rifabutin-associated Hypopyon Uveitis). ”Ñ“‡@Œh1, Žs粋`Í1, Ž…Œö–ç1 (1Šá‰È): “ú–{Šá‰ŠÇŠw‰ïŽ 2011/6; 13: 17-9.

220020. [€ŒŽ’˜] –Ɖu³íŽÒ‚É”­Ç‚µ‚œƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒX–Ô–Œ‰Š‚Ì1—á (A Case of Cytomegalovirus Retinitis in an Immunocompetent Patient). ›ŒŽ“¹F1, –{“c–ŸŽq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): “ú–{Šá‰ŠÇŠw‰ïŽ 2011/6; 13: 26-9.

220021. [€ŒŽ’˜] (—Տ°•ñ) ‰©”Áã–Œ‚É‚š‚¯‚éIOLƒ}ƒXƒ^[TM‚ð—p‚¢‚œŠáŽ²’·‘ª’è‚ƏpŒã‹üÜŒë·‚ÌŒŸ“¢ (Axial length and refractive error measured by IOLMasterTM in eyes with epiretinal membrane). “¡ŒŽ˜aŽq1, –ö“c’q•F1, ‚‹ŽŒcŽq, ŽžàV‚Š‚èŽq, Ž…Œö–ç1 (1Šá‰È): —Տ°Šá‰È 2011/11; 65 (12): 1833-7.

220022. [€ŒŽ’˜] dÇSgáŠQŽÒ‚̗Èç‚É‚š‚¯‚鎋ŠÂ‹«®”õ‚ÌŽŽ‚݁|Ž‹”\ŒP—ûŽm‚ƍì‹Æ—Ö@Žm‚Ì‹Š“­‚É‚æ‚鐬‰Ê| (A trial of the improvement of a visual environment in occupational therapy for the adult case with severe motor and intellectual disability-outcomes in collaboration with a orthoptist and a occupational therapist-). ¬’¬—SŽq1, Vˆä“cF—T1,2, —é–ØŒ«Ž¡1, ŠÖX‰pL3, •œ–ì‘å•ã4, —с@D5, ‰¶“cKŽq5, ‰ºòG•v5 (1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È, 3‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”ì‹Æ—Ö@Šw‰È, 4‘Ûˆã—ÕŸŽƒ‘åŠw¬“cŒŽ•ÛŒ¯ˆã—Êw•”ì‹Æ—Ö@Šw‰È, 5‘Ûˆã—ÕŸŽƒƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[‚È‚·—È牀): Šá‰È—Տ°‹I—v 2012/3; 5 (3): 260-5.

220023. [€ŒŽ’˜] —LF‰Æ“e‚ÌŒõŽó—eŠí‚ɑ΂·‚é‹@”\“I•]‰¿‚Æ‘gDŠw“IŠÏŽ@. óì@Œ«1, Îì@‹Ï1, ‰F‰ê–ÎŽO2, ^‰º‹I”ü‘ã2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): “ú–{Šá‰ÈŠw‰ïŽGŽ 2012/3; 116 (3): 348-9.

310027. [Ç—á•ñ] Dissatisfaction after bilateral multifocal intraocular lens implantation: an electrophysiology study. Shimizu K1, Ito M2: J Refract Surg 2011/4; 27 (4): 309-12. (Ž…Œö–ç1, ˆÉ“¡”ü¹ŠG2: 1Šá‰È, 2ˆã—Éq¶Šw•”)

320046. [Ç—á•ñ] ƒŠƒtƒ@ƒuƒ`ƒ“‚ÉŠÖ˜A‚µ‚œ‘O–[’~”^‚𔺂€‚Ô‚Ç‚€–Œ‰Š. ”Ñ“‡@Œh1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/5; 28 (5): 693-5.

320047. [Ç—á•ñ] –Ɖu³íŽÒ‚É”­Ç‚µ‚œƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒX–Ô–Œ‰Š‚Ì1—á. ›ŒŽ“¹F1, –{“c–ŸŽq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/5; 28 (5): 702-5.

320048. [Ç—á•ñ] ‚—îŽÒ‚̋ߎ‹«—Ž‹‚ÌŽ¡—Á`45ÎˆÈã‚̏Ǘá‚ð‚Ç‚€l‚Š‚é‚©`. ‘ŠàV‘å•ã1,2 (1ŠC˜V–Œ‘‡•a‰@, 2Šá‰È): IOL&RS 2011/10; 25 (3): 379-81.

320049. [Ç—á•ñ] “ñd–Œàh‰ßŒŒŸ÷ŒðŠ·‚ª’˜Œø‚µ‚œRƒAƒNƒAƒ|ƒŠƒ“4R‘Ì—z«Ž‹_Œo‰Š‚Ì1—á (A Case of Anti-Aquaporin 4 Antibody-Positive Optic Neuritis that Responded Well to Double Filtration Plasmapheresis). ‚@ˆè‰Ã1, ŒãŠÖ—˜–Ÿ1, Žs糋`Í1, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): _ŒoŠá‰È 2011/12; 28 (4): 419-24.

520042. [‘à]y¡ŒŽ‚̘b‘èz—L…»‘ÌŠá“àƒŒƒ“ƒY‚ÌŒ»ó‚Æ“W–]. _’J˜aF (Šá‰È): —Տ°Šá‰È 2011/5; 65 (5): 595-9.

520043. [‘à]y“d‹C¶—‚Ɛ_ŒoŠá‰ÈzŠáˆÊEŠá‹…‰^“®ŒŸž“ü–å. ‘O“cŽj“Ä1, ‰ª^—R”ü, óì@Œ«1 (1Šá‰È): _ŒoŠá‰È 2011/6; 28 (2): 226-30.

520044. [‘à]y“ÁW: ˆâ“`«–Ô–ŒE‰©”ÁƒWƒXƒgƒƒtƒB ƒAƒbƒvƒf[ƒgz˜VŽ‹‚Ì’è‹`‚Ɛf’fŠî€2010. ˆäŽè@•1,2,3, •s“ñ–叮1,4, ‘O“c’Œ”V1,4, ‘厭“N˜Y1,5, ƒrƒbƒZƒ“‹{“‡OŽq1,6, •â‘原˜Y1,7, ŒË“cˆèŽq1,2,8, rˆäGK1,9, ‰ª–{–ÎŽ÷1,10, •B“c@–q1,11, ‹›—¢@”Ž1,12, ªŠÝˆê”T1,8, ’Ø“cˆê’j1,8 (1˜VŠáŒ€‹†‰ï, 2“ìÂŽRƒAƒCƒNƒŠƒjƒbƒN, 3Œc‰ž‹`m‘åŠwˆãŠw•”Šá‰ÈŠw‹³Žº, 4‘åã‘åŠw, 5’}”g‘åŠw, 6“Œ‹žŽ•‰È‘åŠw…“¹‹Ž•a‰@, 7ŠâŽèˆã‰È‘åŠw, 8Œc‰ž‹`m‘åŠw, 9‚Ý‚È‚Æ‚Ý‚ç‚¢ƒAƒCƒNƒŠƒjƒbƒN, 10‰ª–{Šá‰ÈƒNƒŠƒjƒbƒN, 11‹ž“s•{—§ˆã‰È‘åŠw, 12ˆã—Éq¶Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2011/7; 28 (7): 985-8.

520045. [‘à] 3D‰f‘œ‚ÌŒ»ó‚Ɛ¶‘̈À‘S«. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): “ú–{‚ÌŠá‰È 2011/8; 82 (8): 1044-8.

520046. [‘à] —§‘ÌŽ‹‚̐¬—§‚É•K—v‚ÈðŒ‚Æ‹–—eŒÀŠE (The Necessary Conditions and Permissible Values for Maintaining Stereoacuity). óì@Œ«1, ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”): Ž‹Šo‚̉Ȋw 2011/10; 32 (1): 3-7.

521024. [‰ðà]yVlƒXƒ^ƒbƒt‚Ì‚œ‚ß‚Ì Šá‰È‚ÌŒŸžEŽèp‹@ŠíŠ®‘Sƒ}ƒjƒ…ƒAƒ‹z1•” Šá‰ÈŒŸž‹@Ší@1Í-Ž‹—ÍŒŸž@1. Ž‹—Í•\. óì@Œ«1, ¯ŽiMs1 (1ˆã—Éq¶Šw•”): Šá‰ÈƒPƒA 2011/6; 13 (‰Ä‹G‘Š§): 12-3.

521025. [‰ðà]yVlƒXƒ^ƒbƒt‚Ì‚œ‚ß‚Ì Šá‰È‚ÌŒŸžEŽèp‹@ŠíŠ®‘Sƒ}ƒjƒ…ƒAƒ‹z1•” Šá‰ÈŒŸž‹@Ší@1Í-Ž‹—ÍŒŸž@2. Žš‚ЂƂŽ‹—Í•\. óì@Œ«1, ¯ŽiMs1 (1ˆã—Éq¶Šw•”): Šá‰ÈƒPƒA 2011/6; 13 (‰Ä‹G‘Š§): 14-5.

521026. [‰ðà]yVlƒXƒ^ƒbƒt‚Ì‚œ‚ß‚Ì Šá‰È‚ÌŒŸžEŽèp‹@ŠíŠ®‘Sƒ}ƒjƒ…ƒAƒ‹z1•” Šá‰ÈŒŸž‹@Ší@2Í-‹üÜŒŸž@1. ƒI[ƒgƒŒƒtƒ‰ƒNƒgƒ[ƒ^. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”): Šá‰ÈƒPƒA 2011/6; 13 (‰Ä‹G‘Š§): 25-9.

521027. [‰ðà]yVlƒXƒ^ƒbƒt‚Ì‚œ‚ß‚Ì Šá‰È‚ÌŒŸžEŽèp‹@ŠíŠ®‘Sƒ}ƒjƒ…ƒAƒ‹z1•” Šá‰ÈŒŸž‹@Ší@2Í-‹üÜŒŸž@2. ƒŒƒ“ƒYƒ[ƒ^. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”): Šá‰ÈƒPƒA 2011/6; 13 (‰Ä‹G‘Š§): 30-7.

521028. [‰ðà]y—{Œì‹³—@‚Ì‚œ‚ß‚Ì‹³ˆçŽÀ‘H‚ɖ𗧂ÂQ&AWIV|•ÛŒ’Žw“±‚ð‚ß‚®‚é‹^–âEŽ¿–â‚𒆐S‚Ɂzchapter 02@¶ŠˆKŠµ‚ɂ܂‚í‚é‚p•‚`@Q11. ’†Šw¶‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—p‚ÍŽžŠú‚ª‘‚·‚¬‚é?. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): Œ’N‹³Žº 2011/7; 62 (9 ‘Š§): 42-4.

521029. [‰ðà]yƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“ƒR[ƒi[zƒGƒLƒXƒp[ƒg‚É•·‚­: ‰ñ“š1. ‘å–ìWŽi1,2,3, ŒŽ@’Œl1,3 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2‘å–ìŠá‰Èˆã‰@, 3Šá‰È): IOL&RS 2012/2; 25 (4): 606-7.

521030. [‰ðà]yƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“ƒR[ƒi[zƒGƒLƒXƒp[ƒg‚É•·‚­: ‰ñ“š5. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): IOL&RS 2012/2; 25 (4): 609-10.

522139. [uÀ]y“ÁW: ˜VŽ‹ƒAƒbƒvƒf[ƒgz’²ß‚Ì‘ª’è•û–@ (Methods and Instruments for Measuring Accommodation). óì@Œ«1, Îì@‹Ï1 (1ˆã—Éq¶Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2011/5; 28 (5): 609-13.

522140. [uÀ]y“ÁW: ƒtƒFƒgƒ€ƒZƒJƒ“ƒhƒŒ[ƒU[‰ž—p‚ÌŽÀÛz¡Œã‚Ì“W–]. _’J˜aF (Šá‰È): IOL&RS 2011/4; 21 (1): 41-6.

522141. [uÀ]yƒZƒ~ƒi[z‹üÜ‹ž³Žèp: Œã–[Œ^—L…»‘ÌŠá“àƒŒƒ“ƒYŠá‚Ì’²ß—Í. _’J˜aF (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/5; 28 (5): 659-60.

522142. [uÀ]y“ÁW: Šá“àƒŒƒ“ƒY‚ɂ܂‚í‚éƒgƒ‰ƒuƒ‹z2. ‘œÅ“_Šá“àƒŒƒ“ƒY‚Ì–â‘è“_ (Problems of the multifocal intraocular lens). ”Ñ“c‰Ã•F1, Ž…Œö–ç1 (1Šá‰È): Šá‰È 2011/5; 53 (5): 649-54.

522143. [uÀ]y“ÁW: Šá“àƒŒƒ“ƒY‚ɂ܂‚í‚éƒgƒ‰ƒuƒ‹z4. ƒ‚ƒmƒrƒWƒ‡ƒ“‚Ì–â‘è“_ (Problems with pseudophakic monovision). “V–엝Œb (Šá‰È): Šá‰È 2011/5; 53 (5): 661-5.

522144. [uÀ]y“ÁW: 7ƒpƒ^[ƒ“‚Å‚Ý‚é! Šá“àƒŒƒ“ƒY‘I‘ð‚Ü‚Å‚Ì—¬‚êz3. Šá“àƒŒƒ“ƒYˆ•û‚Ì—¬‚ê@ƒpƒ^[ƒ“E’…FŠá“àƒŒƒ“ƒY. Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Šá‰È): Šá‰ÈƒPƒA 2011/6; 13 (6): 542-6.

522145. [uÀ]y“ÁW: 7ƒpƒ^[ƒ“‚Å‚Ý‚é! Šá“àƒŒƒ“ƒY‘I‘ð‚Ü‚Å‚Ì—¬‚êz4. Šá“àƒŒƒ“ƒYˆ•û‚Ì—¬‚ê@ƒpƒ^[ƒ“Eƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY. _’J˜aF (Šá‰È): Šá‰ÈƒPƒA 2011/6; 13 (6): 548-52.

522146. [uÀ]yCLƒoƒgƒ‹ƒƒCƒ„ƒ‹ƒT[ƒhƒXƒe[ƒW‘æ25‰ñz¬Šw¶‚ɑ΂·‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ïŽ 2011/6; 53 (2): 95-9.

522147. [uÀ]y“ÁW: ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚ÌŒ»ózƒg[ƒŠƒbƒNŠáEàƒŒƒ“ƒY‚Ì—ðŽj. _’J˜aF (Šá‰È): Šá‰ÈŽèp 2011/7; 24 (3): 268-71.

522148. [uÀ] ITŠÂ‹«‚É‚š‚¯‚éƒrƒWƒ…ƒAƒ‹ƒXƒgƒŒƒX‚Æ3D‰f‘œ‚ª‹y‚Ú‚·‹ßŒ©”œ‰ž‚ւ̉e‹¿|‰f‘œ‚É‚æ‚èˆø‚«‹N‚±‚³‚ê‚œ—Տ°Ž©Œ±—á‚𒆐S‚É—\–hô‚ðl‚Š‚é|. ŒŽ@’Œl1,2 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È): “ú–{‚ÌŠá‰È 2011/8; 82 (8): 1058-63.

522149. [uÀ]y“ÁW: ‹­“x‹ßŽ‹‚Ɛ_ŒoŠá‰Èz˜˜_. ŒãŠÖ—˜–Ÿ (Šá‰È): _ŒoŠá‰È 2011/9; 28 (3): 279-80.

522150. [uÀ]y_ŒoŠá‰È“ü–åƒVƒŠ[ƒY93@Šá‰ÈŒŸž“ü–å3zŠá’ê‰æ‘œŒŸž. “¡ŒŽ“Ä”V1, ŽR‰º@—Í2, óì@Œ«3, ‘O“cŽj“Ä2 (1ì‘åŠwˆãŠw•”•t‘®•a‰@Šá‰È, 2ìèˆã—ÕŸŽƒ‘åŠwˆã—ËZpŠw•”ŠŽŠo‹ž³Šw, 3ˆã—Éq¶Šw•”): _ŒoŠá‰È 2011/9; 28 (3): 342-55.

522151. [uÀ]yCLƒoƒgƒ‹ƒƒCƒ„ƒ‹ƒT[ƒhƒXƒe[ƒW‘æ26‰ñz’†Šw¶E‚Z¶‚ɑ΂·‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ïŽ 2011/9; 53 (3): 191-7.

522152. [uÀ]y“ÁW: Šá‰ÈÅVŽèpzŠe˜_ (ÅV‚̃gƒsƒbƒNƒX‚𒆐S‚É)@3. Šá“àƒŒƒ“ƒY‹ž³Žèp@Œã–[Œ^phakic IOL‚É‚æ‚鍂“x‹ßŽ‹Ž¡—Ã. Ž…Œö–ç1, ŒÜ\—’ÍŽj1 (1Šá‰È): Šá‰È 2011/9; 53 (10—ÕŽž‘Š§†): 1418-23.

522153. [uÀ]y“ÁW: 5”N‘O‚̏펯‚Í, Œ»Ý‚Ì”ñíŽ¯!z1. ‹üÜE’²ß‚ُ̈íC”’“àá@E”’“àá‚ÌŽ¡—ÁkƒXƒyƒVƒƒƒ‹ƒŒƒNƒ`ƒƒ[l—L…»‘ÌŠá“àƒŒƒ“ƒY. _’J˜aF (Šá‰È): —Տ°Šá‰È 2011/10; 65 (11): 80-2.

522154. [uÀ]y“ÁW: 5”N‘O‚̏펯‚Í, Œ»Ý‚Ì”ñíŽ¯!z2. Šá•\–ʁEŠp–ŒŽŸŠ³@EŒŸž@‘OŠá•”‰æ‘œ‰ðÍ‘•’u (ƒyƒ“ƒ^ƒJƒ€‚È‚Ç). ìŽç“c‘ñŽu1, ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”): —Տ°Šá‰È 2011/10; 65 (11): 91-100.

522155. [uÀ]yƒZƒ~ƒi[z‹üÜ‹ž³Žèp: ’†‚”NŽÒ‚É‚š‚¯‚郂ƒmƒrƒWƒ‡ƒ“–@‚ð—p‚¢‚œLASIK. ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2011/10; 28 (10): 1435-6.

522156. [uÀ]y_ŒoŠá‰È“ü–åƒVƒŠ[ƒY@Šá‰ÈŒŸž“ü–åzŽ‹–ì’²ž. ‘O“cŽj“Ä1, ‘O“c‰Á“ÞŽq2, óì@Œ«3 (1ìèˆã—ÕŸŽƒ‘åŠwˆã—ËZpŠw•”ŠŽŠo‹ž³Šw, 2ƒcƒJƒUƒL•a‰@Šá‰È, 3ˆã—Éq¶Šw•”): _ŒoŠá‰È 2011/12; 28 (4): 445-9.

522157. [uÀ]y“ÁW: —ΓàáŽèp‚ÌEBMz˜_“_. _’J˜aF (Šá‰È): Šá‰ÈŽèp 2012/1; 25 (1): 45.

522158. [uÀ]y“ÁW: —L…»‘ÌŠá“àƒŒƒ“ƒY‚ÌŒ»ózŒã–[Œ^ƒŒƒ“ƒY. ŒÜ\—’ÍŽj (Šá‰È): Šá‰ÈŽèp 2012/1; 25 (1): 66-70.

522159. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzA. ‹üÜ‹ž³‚ÌŠî‘b@1. Šá‚Ì‹üÜŒn. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 3-7.

522160. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzB. ‹üÜŒŸž@2. ¬l‚Ì‹üÜŒŸž. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 28-33.

522161. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzD. ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY-ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̏ˆ•û@a. ¬Ž™‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYˆ•û. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 73-6.

522162. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzC. PRK‚ÆEpi-LASIK@1. “K‰ž‚Əp‘OŒŸž. ²“¡M”V1, Ž…Œö–ç1 (1Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 155-7.

522163. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzC. PRK‚ÆEpi-LASIK@2. Å‹ß‚ÌŽèp (MMC‚ðŠÜ‚ß‚Ä). ŒÜ\—’ÍŽj (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 158-60.

522164. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzD. Šp–ŒØŠJ‚É‚æ‚é‹üÜ‹ž³ (AK, LRI) @4. pŒãŒŸž‚ƍ‡•¹Ç. _’J˜aF (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 177-80.

522165. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzF. ÅV‚Ì‹üÜ‹ž³Žèp@2. ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚Ì‚Ý‚Ì‹üÜ‹ž³. _’J˜aF (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 193-6.

522166. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzB. —L…»‘ÌŠá“àƒŒƒ“ƒY|1. Œã–[Œ^ƒŒƒ“ƒY@b. ƒŒƒ“ƒYŒˆ’è, ŽÀÛ‚Ì‘}“ü–@. _’J˜aF (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 208-10.

522167. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzC. …»‘Ì“EoŒã‚ÌŠá“àƒŒƒ“ƒY|4. ƒ‚ƒmƒrƒWƒ‡ƒ“@a. p‘OŒŸž‚Æ“K‰ž. “V–엝Œb (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 262-4.

522168. [uÀ]y“ÁW: ‹üÜ‹ž³‚̐V‚µ‚¢—¬‚êzC. …»‘Ì“EoŒã‚ÌŠá“àƒŒƒ“ƒY|4. ƒ‚ƒmƒrƒWƒ‡ƒ“@b. pŒãŒŸž‚Ɛ¬Ñ. ]•—Ft (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/1; 28 (—ÕŽž‘Š§†): 265-7.

522169. [uÀ]y“ÁW: ˜VŽ‹‚ÌŽ¡—Â͂ǂ±‚܂ʼn”\‚©z3. ƒ‚ƒmƒrƒWƒ‡ƒ“–@ (Pseudophakic monovision). Ž…Œö–ç (Šá‰È): Šá‰È 2012/2; 54 (2): 129-34.

522170. [‚»‚Ì‘Œ]y“ÁW: Šá‰ÈŽŸŠ³‚Ì•a‘ԂƐf’fEŽ¡—à (II)z”ò‰áÇ. –ö“c’q•F1, Ž…Œö–ç1 (1Šá‰È): ˆãŠw‚Æ–òŠw 2012/2; 67 (2): 207-12.

522171. [uÀ]y“ÁW: ‹üÜ‹ž³Žèp‚ÌNew TechnologyzPhakic IOL. _’J˜aF (Šá‰È): IOL&RS 2012/2; 25 (4): 476-82.

522172. [uÀ]y“ÁW: Šá“àƒŒƒ“ƒYŽèp|“ïÇ—á‚ւ̑Ώˆ–@z‹­“x‹ßŽ‹Šá‚Ì”’“àáŽèp. _’J˜aF (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/2; 29 (2): 169-75.

522173. [uÀ] “ÁW: ‹­“x‹ßŽ‹Šá‚Ì”’“àáŽèp. _’J˜aF (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2012/2; 29 (2): 169-75.

540020. [‚»‚Ì‘Œ] (’²ž•ñ) ŠwZ‹ßŽ‹‚ÌŒ»‹µ‚ÉŠÖ‚·‚é2010”N“xƒAƒ“ƒP[ƒg’²ž•ñ. ’¹‹G¬1, •s“ñ–叮1, ‰F’ÃŒ©‹`ˆê1,2,3 (1“ú–{Šá‰Èˆã‰ïu‹ßŽ‹is–hŽ~‚Æ‹üÜ‹ž³vŒ€‹†”Ç, 2“ú–{Šá‰ÈˆãŽt‰ïŠwZ•ÛŒ’•”’S“–í”C—Ž–‰F’ÃŒ©Šá‰Èˆã‰@, 3Šá‰È): “ú–{‚ÌŠá‰È 2011/4; 82 (4): 97-107.

540021. [‚»‚Ì‘Œ] (’²ž•ñ) ŠwZ‹ßŽ‹‚ÌŒ»‹µ‚ÉŠÖ‚·‚é2010”N“xƒAƒ“ƒP[ƒg’²ž•ñ. ’¹‹G¬1, •s“ñ–叮1, ‰F’ÃŒ©‹`ˆê1,2,3 (1“ú–{Šá‰Èˆã‰ïu‹ßŽ‹is–hŽ~‚Æ‹üÜ‹ž³vŒ€‹†”Ç, 2“ú–{Šá‰ÈˆãŽt‰ïŠwZ•ÛŒ’•”’S“–í”C—Ž–‰F’ÃŒ©Šá‰Èˆã‰@, 3Šá‰È): “ú–{‚ÌŠá‰È 2011/4; 82 (4): 531-41.

540022. [‚»‚Ì‘Œ] (TOPICS) Refractive Lenticule Extraction (ReLEx). _’J˜aF (Šá‰È): Šá‰ÈŽèp 2011/4; 24 (2): 186-90.

540023. [‚»‚Ì‘Œ]y‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ïˆóÛ‹Lzˆê”ÊŒû‰‰: _ŒoŠá‰È. Îì@‹Ï (ˆã—Éq¶Šw•”): Šá‰È 2011/4; 53 (4): 557.

540024. [‚»‚Ì‘Œ]y‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ïˆóÛ‹Lzˆê”ÊŒû‰‰: ‹üÜ‹ž³EIOL. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): Šá‰È 2011/4; 53 (4): 593-4.

540025. [‚»‚Ì‘Œ] (‹LŽ–)y‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ïz—L…»‘ÌŠá“àƒŒƒ“ƒY: ƒŒ[ƒVƒbƒN•s“K‰ž‚̋ߎ‹‚È‚Ç‚É—L—p. ‹{“c˜a“T1, _’J˜aF2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): Medical Tribune 2011/4; 44 (14): 10-1.

540026. [‚»‚Ì‘Œ] (ŠÄ–ó) ¬Ž™‚Ì‹üÜ‹ž³Žèp‚É“KØ‚ÈŽžŠú‚Í‚¢‚‚©? (When is Refractive Surgery Right for Children?). ¬Œ^—1,2 (1ŽR‰€•a‰@Šá‰È^‘Ûˆã—ÕŸŽƒ‘åŠw—Տ°ˆãŠwŒ€‹†ƒZƒ“ƒ^[, 2Šá‰È): ‹GŠ§ ƒ”ƒBƒWƒ‡ƒ“ƒ^ƒCƒ€ƒY (VISION TIMES) 2011/5; 18 (2): 1-3.

540027. [‚»‚Ì‘Œ] (V•·‹LŽ–)y‚ EȂœ‚Ì‘I‘ð‚ÍŠÔˆá‚Á‚Ä‚¢‚é@Œã‰÷‚µ‚È‚¢Ž¡—Áq49rz‘œÅ“_Šá“àƒŒƒ“ƒY‚É”ò‚т‚­‚È. Ž…Œö–ç (Šá‰È): “úŠ§ƒQƒ“ƒ_ƒC 5ŒŽ12“ú† 2011/5.

540028. [‚»‚Ì‘Œ] (ƒhƒ‰ƒCƒAƒCŠO—ˆÅ‘Oü) –k—¢‘åŠw•a‰@ƒhƒ‰ƒCƒAƒCŠO—ˆ. ’†Œ@Šî (Šá‰È): Frontiers in Dry Eye|—܉t‚©‚猩‚œƒIƒLƒ…ƒ‰[ƒT[ƒtƒFƒX 2011/5; 6 (1): 60-2.

540029. [‚»‚Ì‘Œ] (ŠO‘Ž—v——) ’†“™“xE‹­“x‹ßŽ‹«—Ž‹Šá‚É‚š‚¯‚éŒã–[Œ^ƒg[ƒŠƒbƒN—L…»‘ÌŠá“àƒŒƒ“ƒY‘}“üp‚̗Տ°¬Ñ (One-Year Follow-up of Posterior Chamber Toric Phakic Intraocular Lens Implantation for Moderate to High Myopic Astigmatism). _’J˜aF1, Ž…Œö–ç1, ‘ŠàV‘å•ã1, ŒÜ\—’ÍŽj1, ¬Œ^—1,2, ’†‘º’O—Y3 (1Šá‰È, 2ŽR‰€•a‰@, 3’†‘ºŠá‰È): “ú–{Šá‰ÈŠw‰ïŽGŽ 2011/6; 115 (6): 551.

540030. [‚»‚Ì‘Œ] (u‰‰—vŽ|) ‘O•”‹•ŒŒ«Ž‹_ŒoÇ (AION) ‚É—ŒŠá‚Ô‚Ç‚€–Œ‰Š‚ð‡•¹‚µ‚œ‚ÆŽv‚í‚ê‚œÇ—á. “¡–{—²Žu1, ›ŒŽ“¹F1, ÝŠy‹±Žq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): “ú–{Šá‰ŠÇŠw‰ïŽ 2011/6; 13: 42.

540031. [‚»‚Ì‘Œ] (˜AÚ)yŽ„‚Ì’ñŒŸ, ‹êŒŸ, •úŒŸz‘æ˜Z\‰ñ@Ž‹–ì‚̉º”Œ•ª‚̏d—v«. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): Šá‰ÈƒPƒA 2011/6; 13 (6): 584-5.

540032. [‚»‚Ì‘Œ] …»‘Ì‚ÌŒ`‘ÔŠw“IŒ€‹†‚ÉŒg‚í‚Á‚Ä (Experiences in Morphological Study of Crystalline Lens). ‰F‰ê–ÎŽO (Šá‰È): “ú–{”’“àáŠw‰ïŽGŽ 2011/6; 23: 8.

540033. [‚»‚Ì‘Œ] (ŠO‘Ž—v——) Š±ÂŒõ‘ª’è‚ð—p‚¢‚œƒhƒ‰ƒCƒAƒC‚É‚š‚¯‚éŠp–Œ‘O—܉t‘wŒú‚Ì•]‰¿ (Interferometry in the Evaluation of Precorneal Tear Film Thickness in Dry Eye). •ÛâŠG—1, ìŽç“c‘ñŽu2,3, ¬Š}ŒŽ—DŽq1, ’†ŽR“ށX”ü2, ‹›—¢@”Ž2,3, Ž…Œö–ç4, ‘ºŒËƒh[ƒ‹5,6, ’Ø“cˆê’j5, Œã“¡‰pŽ÷1 (1’ߌ©‘åŠwŽ•Šw•”Šá‰ÈŠw, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”, 4Šá‰È, 5Œc‰ž‹`m‘åŠwˆãŠw•”Šá‰È‹³Žº, 6Œc‰ž‹`m‘åŠwˆãŠw•”ƒWƒ‡ƒ“ƒ\ƒ“EƒAƒ“ƒhEƒWƒ‡ƒ“ƒ\ƒ“ƒIƒLƒ…ƒ‰[ƒT[ƒtƒFƒXŠáŒõŠwuÀ): “ú–{Šá‰ÈŠw‰ïŽGŽ 2011/7; 115 (7): 630.

540034. [‚»‚Ì‘Œ] ŠwZ‚Å‚ÌŠá‰È‚ÌŒ’NŠÇ—. ‰F’ÃŒ©‹`ˆê1,2 (1ŠwZ•ÛŒ’’S“–•›‰ï’·, 2Šá‰È): ‰¡•lŽsŠá‰Èˆã‰ï•ñ 2011/7; (55): 16-27.

540035. [‚»‚Ì‘Œ] •œ¬22”N“x‰¡•lŽsŠwZ•ÛŒ’—D—ǍZ@ŽÀ’nRž•ñ (•œ¬22”N10ŒŽ21“ú). —é–؍‚‰“1,2 (1‰¡•lŽsŠá‰Èˆã‰ï‰ï’·, 2Šá‰È): ‰¡•lŽsŠá‰Èˆã‰ï•ñ 2011/7; (55): 49.

540036. [‚»‚Ì‘Œ] ‘æ41‰ñ‘S‘ŠwZ•ÛŒ’ŠwZˆã‘å‰ï (•œ¬22”N11ŒŽ20“ú). —é–؍‚‰“1,2 (1‰¡•lŽsŠá‰Èˆã‰ï‰ï’·, 2Šá‰È): ‰¡•lŽsŠá‰Èˆã‰ï•ñ 2011/7; (55): 51-6.

540037. [‚»‚Ì‘Œ] ‘æ41‰ñ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï•ñ (•œ¬22”N11ŒŽ20“ú). ‰F’ÃŒ©‹`ˆê1,2 (1ŠwZ•ÛŒ’’S“–•›‰ï’·, 2Šá‰È): ‰¡•lŽsŠá‰Èˆã‰ï•ñ 2011/7; (55): 57-8.

540038. [‚»‚Ì‘Œ] ‘æ18‰ñ‰¡•l—Տ°ˆãŠw‰ïŠwpW’k‰ï•ñ (•œ¬22”N12ŒŽ11“ú). ‰F’ÃŒ©‹`ˆê1,2 (1ŠwZ•ÛŒ’’S“–•›‰ï’·, 2Šá‰È): ‰¡•lŽsŠá‰Èˆã‰ï•ñ 2011/7; (55): 59.

540039. [‚»‚Ì‘Œ] ŽóÜŽÒ‚ÌŒŸ—t: ’†ìÜ‚ðŽóÜ‚µ‚Ä. óì@Œ« (ˆã—Éq¶Šw•”): “ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‰ï•ñ 2011/8; 47 (133): 7.

540040. [‚»‚Ì‘Œ] (ˆóÛ‹L) ‹ßÔŠO•ªŒõ–@ (NIRS) ‚ð—p‚¢‚œ3D‰f‘œ’Ž‹Žž‚Ì”]‹@”\‚ÌŒŸ“¢. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): “ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‰ï•ñ 2011/8; 47 (133): 25.

540041. [‚»‚Ì‘Œ] (ˆóÛ‹L) ŽÎˆÊ‹ßŽ‹p‘OŒã‚É‚š‚¯‚é‘Š‘Îçt–©•Ï‰». åŒŽŽµd (ˆã—Éq¶Šw•”): “ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‰ï•ñ 2011/8; 47 (133): 31-2.

540042. [‚»‚Ì‘Œ] (¡ŒŽ‚Ì•\Ž†) von Recklinghausen•a. ŽRŒû@ƒ1, “V–ìŽj˜Y2 (1Šá‰È, 2“Œ‹ž‘åŠwŠá‰È): —Տ°Šá‰È 2011/9; 65 (9): 1405.

540043. [‚»‚Ì‘Œ] ŽóÜŽÒ‚ÌŒŸ—t: œAÎÜ‚ðŽóÜ‚µ‚Ä. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): “ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï•ñ 2011/9; 47 (1): 7.

540044. [‚»‚Ì‘Œ] ”’“àáŽèp`–Ú‚©‚ç”], ‚»‚µ‚ÄŠá‚ց`. Ž…Œö–ç (Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ïƒfƒCƒŠ[ƒjƒ…[ƒX 2011/10; (3): 3.

540045. [‚»‚Ì‘Œ] ’PÅ“_E‘œÅ“_IOL‚Ì‘g‚ݍ‡‚킹‚ʼn“•ûE‹ß•û‚Æ‚à—ǍD‚ÈŽ‹—Í‚ðŠl“Ÿ. ”Ñ“c‰Ã•F (Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ïƒfƒCƒŠ[ƒjƒ…[ƒX 2011/10; (2): 4.

540046. [‚»‚Ì‘Œ] (ŠÄ–ó, ƒRƒƒ“ƒg) ˜VŽ‹‹ž³ƒŒƒ“ƒY: ‰Ø‚â‚©‚Ȑé“`‚ÌŒã‚ɍ¡‘I‚Ô‚à‚Ì (After the Hype: Which Presbyopic IOL?). ¬Œ^—1,2 (1ŽR‰€•a‰@Šá‰È^‘Ûˆã—ÕŸŽƒ‘åŠw—Տ°ˆãŠwŒ€‹†ƒZƒ“ƒ^[, 2Šá‰È): ‹GŠ§ ƒ”ƒBƒWƒ‡ƒ“ƒ^ƒCƒ€ƒY (VISION TIMES) 2011/11; 18 (4): 14-8.

540047. [‚»‚Ì‘Œ] (ˆóÛ‹L) ‘æ27‰ñ^’߃Zƒ~ƒi[ˆóÛ‹L. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2 (1Šá‰È, 2ˆã—Éq¶Šw•”): _ŒoŠá‰È 2011/12; 28 (4): 450-1.

540048. [‚»‚Ì‘Œ] (V•·‹LŽ–) •s‹ï‡‚ðƒŒƒ“ƒY‚ŏ•‚¯–Ô–Œ‚Ƀsƒ“ƒg‚ð‡‚í‚¹‚é. ŒãŠÖ—˜–Ÿ (Šá‰È): –ˆ“ú¬Šw¶V•· 2011/12; 26277: 4-5.

540049. [‚»‚Ì‘Œ] (˜AÚ)y‚±‚ñ‚°‚‚̊p–ŒzççŽq•ª•Ø‚É‚æ‚éƒfƒXƒ–Œ”j—ô. ŽRŒû@ƒ (Šá‰È): Šá‰ÈƒPƒA 2011/12; 13 (12): 1169.

540050. [‚»‚Ì‘Œ] (TOPICS) V‚µ‚¢Šá‹…ŒõŠw“Á«‰ðÍ‘•’uOQAS II. _’J˜aF (Šá‰È): Šá‰ÈŽèp 2012/1; 25 (1): 77-83.

540051. [‚»‚Ì‘Œ] (Šw‰ïˆóÛ‹L) 2011”NƒEƒC[ƒ“ESCRSˆóÛ‹L. Žsìˆê•v (Šá‰È): Ž‹Šo‚̉Ȋw 2012/1; 32 (3): 80.

540052. [‚»‚Ì‘Œ] (ƒRƒ‰ƒ€) ŠáŒõ‰s‚­|ƒvƒŠƒYƒ€‚̏d‚ˍ‡‚킹|. ‹›—¢@”Ž (ˆã—Éq¶Šw•”): Tomey Ophthalmology News 2012/1; (48): 15.

540053. [‚»‚Ì‘Œ] (Šw‰ïƒgƒsƒbƒNƒX)y‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïz—LF‰Æ“e‚ÌŒõŽó—eŠí‚ɑ΂·‚é‹@”\“I•]‰¿‚Æ‘gDŠw“IŠÏŽ@. óì@Œ«1, Îì@‹Ï1, ‰F‰ê–ÎŽO1, ^‰º‹I”ü‘ã2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): “ú–{Šá‰ÈŠw‰ïŽGŽ 2012/3; 116 (3): 348-9.

540054. [‚»‚Ì‘Œ] ‰Á—”Á•Ï«|ƒƒKƒl‚ª‡‚í‚È‚­‚È‚Á‚œ‚ÆŽv‚€‘O‚Ɂ|. Žs糋`Í (Šá‰È): Œ’N‚³‚ª‚Ý‚Í‚ç 2012/3; p.2.

[’˜@‘]

610015. [Šwp‘] (•ª’SŽ·•M)yCataract and Refractive Surgery Today (CRST) EuropezThe Next-Generation Visian ICL, p.3-5. Ž…Œö–ç (Šá‰È), Bryn Mawr Communications LLC, USA 2012/1”­s.

620153. [Šwp‘] (’˜‘)yŒ’N‚́qŠár‚É‚«‚¯@–Œˆã‚ª‹³‚Š‚éŠá‚ƐS‚ÌSOSzŽá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È), tHŽÐ, “Œ‹ž, 2011/4”­s.

620154. [Šwp‘] (•ª’SŽ·•M)y‘ŽŽ105|‘æ105‰ñˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘zp.275. p.398-9. P.453-4. Žs糋`Í (Šá‰È), •Ò ˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘•ÒWˆÏˆõ‰ï, ˆãŠw•]˜_ŽÐ, “Œ‹ž, 2011/4”­s.

620155. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŠw@Textbook of Ophthalmology@‘æ2”ŁzIŠª@I. \‘¢‚Æ‚»‚Ì•a‘ԁ@K. Ž‹_Œo@2. Ž‹_ŒoŽŸŠ³‚ÌŠî–{•aŒ^‚Ɛf’f, p.518-20. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È), ŠÄC: ŠÛ”ö•q•v3, –{“cEŽm4, ‰Pˆä³•F5 (3’é‹ž‘åŠw, 4‹ž“s‘åŠw, 5“Œ‹žˆã‰È‘åŠw), •ÒW: ‘厭“N˜Y6 (6’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2011/5”­s.

620156. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŠw@Textbook of Ophthalmology@‘æ2”ŁzIŠª@I. \‘¢‚Æ‚»‚Ì•a‘ԁ@M. “µE@1. “µE‚̐³í\‘¢‚Æ‹@”\, p.588-90. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2 (1Šá‰È, 2ˆã—Éq¶Šw•”), ŠÄC: ŠÛ”ö•q•v3, –{“cEŽm4, ‰Pˆä³•F5 (3’é‹ž‘åŠw, 4‹ž“s‘åŠw, 5“Œ‹žˆã‰È‘åŠw), •ÒW: ‘厭“N˜Y6 (6’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2011/5”­s.

620157. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŠw@Textbook of Ophthalmology@‘æ2”ŁzIŠª@I. \‘¢‚Æ‚»‚Ì•a‘ԁ@M. “µE@2. “µE‚ÌŒŸž‚Ɛf’f, p.590-4. óì@Œ«1, Îì@‹Ï1 (1ˆã—Éq¶Šw•”), ŠÄC: ŠÛ”ö•q•v2, –{“cEŽm3, ‰Pˆä³•F4 (2’é‹ž‘åŠw, 3‹ž“s‘åŠw, 4“Œ‹žˆã‰È‘åŠw), •ÒW: ‘厭“N˜Y5 (5’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2011/5”­s.

620158. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŠw@Textbook of Ophthalmology@‘æ2”ŁzIŠª@I. \‘¢‚Æ‚»‚Ì•a‘ԁ@M. “µE@3. “µE‚Ì•a‘Ô, p.594-602. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2 (1Šá‰È, 2ˆã—Éq¶Šw•”), ŠÄC: ŠÛ”ö•q•v3, –{“cEŽm4, ‰Pˆä³•F5 (3’é‹ž‘åŠw, 4‹ž“s‘åŠw, 5“Œ‹žˆã‰È‘åŠw), •ÒW: ‘厭“N˜Y6 (6’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2011/5”­s.

620159. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŠw@Textbook of Ophthalmology@‘æ2”ŁzIŠª@II. ‹@”\‚Æ‚»‚Ì•a‘ԁ@H. ’²ß@1. ’²ß‚̐¶—, p.898-902. ‹›—¢@”Ž1, ’†ŽR“ށX”ü2 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È), ŠÄC: ŠÛ”ö•q•v3, –{“cEŽm4, ‰Pˆä³•F5 (3’é‹ž‘åŠw, 4‹ž“s‘åŠw, 5“Œ‹žˆã‰È‘åŠw), •ÒW: ‘厭“N˜Y6 (6’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2011/5”­s.

620160. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@E‘SgŽŸŠ³‚ÆŠáz16. Sˆö«Ž‹ŠoáŠQ@”ñŠíŽ¿“IŽ‹ŠoáŠQ, p.242-6. Žá‘q‰ël1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È), ‘•ÒW: ‘厭“N˜Y3, ‘å‹Ž—Tˆê4 (3’}”g‘åŠw, 4ˆ€•Q‘åŠw), •ÒW: ‘º“c•q‹K5 (5MB‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2011/6”­s.

620161. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@EƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽ©—RŽ©Ýz2. ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ðˆ•û‚·‚é@ƒNƒŠƒjƒJƒ‹EƒNƒGƒbƒVƒ‡ƒ“: ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYˆ•û‚¹‚ñ‚ɂ‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢, p.78-81. ‰F’ÃŒ©‹`ˆê1 (1Šá‰È), ‘•ÒW: ‘厭“N˜Y2, ‘å‹Ž—Tˆê3 (2’}”g‘åŠw, 3ˆ€•Q‘åŠw), •ÒW: ‘å‹Ž—Tˆê4, ’†ŽR‘“X, “Œ‹ž, 2011/7”­s.

620162. [Šwp‘] (•ª’SŽ·•M)yVES Now 7@‹üÜ‹ž³‚ðl‚Š‚œŠá“àƒŒƒ“ƒYŽèp@‚æ‚è—Ç‚¢—‡ŠáŽ‹—Í‚ð‚ß‚Ž‚µ‚āz‹üÜ‚ɉe‹¿‚·‚é—vˆö, p.14-23. ‹›—¢@”Ž1 (1Šá‰È), •ÒWˆÏˆõ: ŽR–{“N–ç, ]ŒûGˆê˜Y, ƒrƒbƒZƒ“‹{“‡OŽq, –å”V‰€ˆê–Ÿ, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2011/7”­s.

620163. [Šwp‘] (•ª’SŽ·•M)yVES Now 7@‹üÜ‹ž³‚ðl‚Š‚œŠá“àƒŒƒ“ƒYŽèp@‚æ‚è—Ç‚¢—‡ŠáŽ‹—Í‚ð‚ß‚Ž‚µ‚āzƒŒƒ“ƒY‡‚킹‚É‚æ‚闐Ž‹‹ž³—˜_‚ÆŽ²‡‚킹‚́ERƒc, p.68-77. _’J˜aF1 (1Šá‰È), •ÒWˆÏˆõ: ŽR–{“N–ç, ]ŒûGˆê˜Y, ƒrƒbƒZƒ“‹{E‡OŽq, –å”V‰€ˆê–Ÿ, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2011/7”­s.

620164. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@EŽ‹_ŒoŽŸŠ³‚Ì‚·‚ׂāz4. ˆ³”—«Ž‹_ŒoÇ@Ž‹_ŒoäPŽî, p.101-3. ”–؍LÆ1,2 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È), ‘•ÒW: ‘厭“N˜Y3, ‘å‹Ž—Tˆê4 (3’}”g‘åŠw, 4ˆ€•Q‘åŠw), •ÒW: ’†”nGŽ÷5 (5‹{è‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2011/8”­s.

620165. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@EŽ‹_ŒoŽŸŠ³‚Ì‚·‚ׂāz4. ˆ³”—«Ž‹_ŒoÇ@Šá“®–¬áŽ, p.110-3. ŒŽ@’Œl1,2, ’†ì@’‰, Œü–ì˜a—Y1,2 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È), ‘•ÒW: ‘厭“N˜Y3, ‘å‹Ž—Tˆê4 (3’}”g‘åŠw, 4ˆ€•Q‘åŠw), •ÒW: ’†”nGŽ÷5 (5‹{è‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2011/8”­s.

620166. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@EŽ‹_ŒoŽŸŠ³‚Ì‚·‚ׂāz4. ˆ³”—«Ž‹_ŒoÇ@”ìŒú«d–Œ‰Š, p.120-2. ŒŒ³‹v°1,2 (1ŒŒ³Šá‰Èˆã‰@, 2Šá‰È), ‘•ÒW: ‘厭“N˜Y3, ‘å‹Ž—Tˆê4 (3’}”g‘åŠw, 4ˆ€•Q‘åŠw), •ÒW: ’†”nGŽ÷5 (5‹{è‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2011/8”­s.

620167. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@EŽ‹_ŒoŽŸŠ³‚Ì‚·‚ׂāz5. ‚€‚ÁŒŒ“û“ª@“Á”­«“ªŠW“àˆ³˜ŽiÇ, p.134-9. Œü–ì˜a—Y1,2, ŒŽ@’Œl1,2 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È), ‘•ÒW: ‘厭“N˜Y3, ‘å‹Ž—Tˆê4 (3’}”g‘åŠw, 4ˆ€•Q‘åŠw), •ÒW: ’†”nGŽ÷5 (5‹{è‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2011/8”­s.

620168. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@EŽ‹_ŒoŽŸŠ³‚Ì‚·‚ׂāz9. ’†“Ő«Ž‹_ŒoŽŸŠ³@–òÜ«Ž‹_ŒoÇ, p.192-7. Îì@‹Ï1 (1ˆã—Éq¶Šw•”), ‘•ÒW: ‘厭“N˜Y2, ‘å‹Ž—Tˆê3 (2’}”g‘åŠw, 3ˆ€•Q‘åŠw), •ÒW: ’†”nGŽ÷4 (4‹{è‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2011/8”­s.

620169. [Šwp‘] (•ª’SŽ·•M)yŠá‰È‚ÌŠ³ŽÒà–ŸBOOK@198‚ÌŽ¿–â‚Ɖñ“š—á‚Åà–Ÿ—Í‚ª‚®‚®‚ñ‚ÆUP! (Šá‰ÈƒPƒA2011”N“~‹G‘Š§)z‹üÜ‹ž³, p.160-6. _’J˜aF1 (1Šá‰È), •ÒW: ‹{“c˜a“T2 (2‹{“cŠá‰È•a‰@), ƒƒfƒBƒJo”Å, ‘åã, 2011/11”­s.

620170. [Šwp‘] (•ª’SŽ·•M)yŠáŽèpŠw 5@”’“àázV. ”’“àáŽèp‚ÌŠî–{Žè‹Z@12. Šjˆ— (ˆêŽè–@) , p.189-95. ¬Œ^—1,2, Ž…Œö–ç2 (1ŽR‰€•a‰@Šá‰È, 2Eá‰È), ŠÄCE•ÒW: ‘厭“N˜Y3 (3’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2012/1”­s.

620171. [Šwp‘] (•ª’SŽ·•M)yŠáŽèpŠw 5@”’“àázVI. Šá“àƒŒƒ“ƒY@5. Šá“àƒŒƒ“ƒY‘}“ü–@: ƒVƒŠƒR[ƒ“Œn, p.272-8. Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Šá‰È), ŠÄCE•ÒW: ‘厭“N˜Y3 (3’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2012/1”­s.

620172. [Šwp‘] (•ª’SŽ·•M)yŠáŽèpŠw 5@”’“àázX. pŒãŠÇ—E‡•¹Ç@6. “µE•ÎˆÊ, p.511-5. ¬Œ^—1,2, Ž…Œö–ç2 (1ŽR‰€•a‰@Šá‰È, 2Šá‰È), ŠÄCE•ÒW: ‘厭“N˜Y3 (3’}”g‘åŠw), •¶Œõ“°, “Œ‹ž, 2012/1”­s.

620173. [Šwp‘] (•ª’SŽ·•M)yŠáŽèpŠw 6@—ΓàázIV. üˆÛ’Œ‘ѐ؏œp [ƒgƒ‰ƒxƒNƒŒƒNƒgƒ~[]@B. Šî–{Žè‹Z@4. ‘ãŽÓhR–ò@EŒ‹–ŒØŠJ•û–@‚É‚æ‚éˆá‚¢‚Í?, p.96-102. ¯ŽiMs1 (1ˆã—Éq¶Šw•”), ŠÄC: ‘厭“N˜Y2 (2’}”g‘åŠw), •ÒW: ª–{@º3, ‘ŠŒŽ@ˆê4 (3_ŒË‘åŠw, 4“Œ‹ž‘åŠw), •¶Œõ“°, “Œ‹ž, 2012/1”­s.

620174. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC@EŠá•‘®ŠíŽŸŠ³‚Æ‚»‚Ì•a—z4. Šáâ|@ƒŠƒ“ƒpŽî@ƒNƒŠƒjƒJƒ‹EƒNƒGƒXƒ`ƒ‡ƒ“: Šáâ|ˆ««ŽîᇂɂÍ, ‚Ç‚Ì‚æ‚€‚ȗՏ°‘œ‚ª‚ ‚è‚Ü‚·‚©?, p.287-9. ”–؍LÆ1,2 (1Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È), ‘•ÒW: ‘厭“N˜Y3, ‘å‹Ž—Tˆê4 (3’}”g‘åŠw, 4ˆ€•Q‘åŠw), •ÒW: –ì“cŽÀ5 (5–kŠC“¹‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2012/2”­s.

621001. [‰ðà‘] (•ª’SŽ·•M)y‘ŽŽ105|‘æ105‰ñˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘zŽs糋`Í (Šá‰È), •ÒW: ˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘•ÒWˆÏˆõ‰ï, ˆãŠw•]˜_ŽÐ, “Œ‹ž, 2011/4ŒŽ.

621002. [‰ðà‘] (•ª’SŽ·•M)y‘ŽŽ105|‘æ105‰ñˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘zŒãŠÖ—˜–Ÿ (Šá‰È), •ÒW: ˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘•ÒWˆÏˆõ‰ï, ˆãŠw•]˜_ŽÐ, “Œ‹ž, 2011/4ŒŽ.

621003. [ƒeƒLƒXƒg] (•ª’SŽ·•M)yˆãŽt‘ŽŽŠùo–â‘èWƒTƒNƒZƒXMinor '13 Level I + IIz13. Šá‰È. •Ò’˜: ŒãŠÖ—˜–Ÿ1, Ží“c–F˜Y1 (1Šá‰È), ˆãŠw•]˜_ŽÐ, “Œ‹ž, 2012/3”­s.

621004. [ƒeƒLƒXƒg] (•ª’SŽ·•M)yˆãŽt‘ŽŽŠùo–â‘èWƒTƒNƒZƒXRed '13 Level IIIz_ŒoE‰^“®ŠíŽŸŠ³‘˜_@2. _ŒoÇŒó@Šá‹…‰^“®áŠQ, Šá—ôE“µE‚ُ̈í. •Ò’˜: ŒãŠÖ—˜–Ÿ1, Ží“c–F˜Y1 (1Šá‰È), ˆãŠw•]˜_ŽÐ, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711011. [Šw‰ï (‘Û)] (“Á•Êu‰‰) The Development of KS-AquaportTM and CentraFLOWTM Technology. Shimizu K1: STAAR Surgical 8th International Visian ICL Experts Symposium (2011/9/15), ƒEƒBE[ƒ“, ƒI[ƒXƒgƒŠƒA. (Ž…Œö–ç1: 1Šá‰È)

712027. [Šw‰ï (‘Û)] (ƒZƒbƒVƒ‡ƒ“) Monovision. Shimizu K1: 24th International Congress of German Ophthalmic Surgeons Joint-Meeting DOC-ISRS/AAO (2011/5/20), ƒjƒ…ƒ‹ƒ“ƒxƒ‹ƒN, ƒhƒCƒc. (Ž…Œö–ç1: 1Šá‰È)

712028. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) New ICL. Shimizu K1: Societa Oftalmogica Italiana 9 CONGRESSO INTERNAZIONALE (2011/5/21), ƒ[ƒ}, ƒhƒCƒc. (Ž…Œö–ç1: 1Šá‰È)

712029. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Hole ICL. Shimizu K1: Societa Oftalmogica Italiana 9 CONGRESSO INTERNAZIONALE (2011/5/21), ƒ[ƒ}, ƒhƒCƒc. (Ž…Œö–ç1: 1Šá‰È)

712030. [Šw‰ï (‘Û)] (CASE STUDIES & VIDEO SESSION) A challenging case of ICL as piggyback. Shimizu K1: STAAR Surgical 8th International Visian ICL Experts Symposium (2011/9/15), ƒEƒB[ƒ“, ƒI[ƒXƒgƒŠƒA. (Ž…Œö–ç1: 1Šá‰È)

712031. [Šw‰ï (‘Û)] (ƒpƒlƒŠƒXƒg) Six minutes for my key clinical highlights with the visian ICL. Shimizu K1: STAAR Surgical 8th International Visian ICL Experts Symposium (2011/9/15), ƒEƒB[ƒ“, ƒI[ƒXƒgƒŠƒA. (Ž…Œö–ç1: 1Šá‰È)

712032. [Šw‰ï (‘Û)] (ƒZƒbƒVƒ‡ƒ“) Toric phakic IOL implantation. Shimizu K1: XXIX Congress of the ESCRS (2011/9/19), ƒEƒB[ƒ“, ƒI[ƒXƒgƒŠƒA. (Ž…Œö–ç1: 1Šá‰È)

712033. [Šw‰ï (‘Û)] (ƒ‚ƒfƒŒ[ƒ^[) Phakic IOLs. Shimizu K1: XXIX Congress of the ESCRS (2011/9/20), ƒEƒB[ƒ“, ƒI[ƒXƒgƒŠƒA. (Ž…Œö–ç1: 1Šá‰È)

712034. [Šw‰ï (‘Û)] (ƒZƒbƒVƒ‡ƒ“) Early clinical outcomes of hole ICL implantation for moderate to high myopia. Shimizu K1, Kamiya K1, Igarashi A1: XXIX Congress of the ESCRS (2011/9/20), ƒEƒB[ƒ“, ƒI[ƒXƒgƒŠƒA. (Ž…Œö–ç1, _’J˜aF1, ŒÜ\—’ÍŽj1: 1Šá‰È)

712035. [Šw‰ï (‘Û)] (ƒZƒbƒVƒ‡ƒ“) Functional Characterization of melanopsin-containing retinal ganglion cells on rabbit pupil responses. Asakawa K1, Ishikawa H1, Uga S2, Mashimo K2, Shimizu K2: 29th International Pupil Colloquium (2011/9/27), ƒhƒCƒc. (óì@Œ«1, Îì@‹Ï1, ‰F‰ê–ÎŽO2, áÁ‰º‹I”ü‘ã2, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

712036. [Šw‰ï (‘Û)] (ƒZEbƒVƒ‡ƒ“) Classification of waveform shapes of pupil light responses to chromatic stimuli. Minoru Nakayama, Wioletta Nowak, Ishikawa H1, Asakawa K1, Ichibe Y2: 29th International Pupil Colloquium (2011/9/28), ƒhƒCƒc. (Îì@‹Ï1, óì@Œ«1, Žs糋`Í2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

712037. [Šw‰ï (‘Û)] (ƒZƒbƒVƒ‡ƒ“)yÀ’·zSession 9. Ishikawa H1: 29th International Pupil Colloquium (2011/9/28), ƒhƒCƒc. (Îì@‹Ï1: 1ˆã—Éq¶Šw•”)

712038. [Šw‰ï (‘Û)] (ƒZƒbƒVƒ‡ƒ“) To Maximize effect of Phakic IOL implantation. Shimizu K1: APACRS-KSCRS Seoul 2011 (2011/10/13), ƒ\ƒEƒ‹, ŠØ‘. (Ž…Œö–ç1: 1Šá‰È)

712039. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒ‚ƒfƒŒ[ƒ^[zAnother Lens in the Eye: Phakic IOL Issues. Ramamurthy D, Shimizu K1, Lee KH: APACRS-KSCRS Seoul 2011 (2011/10/14), ƒ\ƒEƒ‹, ŠØ‘. (Ž…Œö–ç1: 1Šá‰È)

712040. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Hole-ICL. Shimizu K1: APACRS-KSCRS Seoul 2011 (2011/10/14), ƒ\ƒEƒ‹, ŠØ‘. (Ž…Œö–ç1: 1Šá‰È)

712041. [Šw‰ï (‘Û)] (ƒvƒŒƒ[ƒ“ƒ^[) Trabectome Global Experiences. Shoji N1: AAO 2011 (2011/10/22), ƒI[ƒ‰ƒ“ƒh, USA. (¯ŽiMs1: 1ˆã—Éq¶Šw•”)

712042. [Šw‰ï (‘Û)] (ƒvƒŒƒ[ƒ“ƒ^[) KS-AP. Shimizu K1: STAAR Experts Meeting (2012/2/15), ƒAƒuƒ_ƒr, UAE. (Ž…Œö–ç1: 1Šá‰È)

712043. [Šw‰ï (‘Û)] (ƒpƒlƒŠƒXƒg) Phakic IOL. Shimizu K1: World Ophthalmology Congress 2012 (2012/2/17), ƒAƒuƒ_ƒr, UAE. (Ž…Œö–ç1: 1Šá‰È)

712044. [Šw‰ï (‘Û)] (ƒvƒŒƒ[ƒ“ƒ^[) KS-AP. Shimizu K1: World Ophthalmology Congress 2012 (2012/2/18), ƒAƒuƒ_ƒr, UAE. (Ž…Œö–ç1: 1Šá‰È)

712045. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Toric IOL. Shimizu K1: Asan Symposium 2012 (2012/3/11), ƒ\ƒEƒ‹, ŠØ‘. (Ž…Œö–ç1: 1Šá‰È)

713134. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 3-dimentional lens densitometry measured with Scheimpflug imaging in eyes with cataract. Kawamorita T1, Uozato H1, Iida Y2, Nakayama N, Shibata Y3, Shindo M3, Shimizu K2: ARVO - The Association for Research in Vision and Ophthalmology 2011 (2011/5/3), Fort Lauderdale, USA. (ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, ”Ñ“c‰Ã•F2, ŽÄ“c—DŽq3, i“¡^‹I3, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713135. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Modulation transfer function of intraocular collamer lens (ICL) with a central artificial hole. Uozato H1, Kawamorita T1, Shimizu K2, Ohmoto F: ARVO - The Association for Research in Vision and Ophthalmology 2011 (2011/5/3), Fort Lauderdale, USA. (‹›—¢@”Ž1, ìŽç“c‘ñŽu1, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

713136. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A Pilot Study of Trabectome in Kitasato University Hospital. Shoji N1, Ko A2, Morita T2, Haruki T2, Shimizu K2: World Glaucoma Congress 2011 (2011/6/29-7/2), ƒpƒŠ, ƒtƒ‰ƒ“ƒX. (¯ŽiMs1, ‚@ˆè‰Ã2, X“c“N–ç2, t–ؐ’G2, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

713137. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A New Glaucoma Staging System Based on Visual Field Index. Hirasawa K1, Shoji N2, Morita T3, Shimizu K3: World Glaucoma Congress 2011 (2011/6/29-7/2), ƒpƒŠ, ƒtƒ‰ƒ“ƒX. (•œàVˆê–@1, ¯ŽiMs2, X“c“N–ç3, Ž…Œö–ç3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È)

713138. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators |Possible mechanism of IFIS. Goseki T1, Ishikawa H2, Ogasawara S, Taguchi Y3, Yago K3, Shimizu K1: 29th International Pupil Colloquium (2011/9/27), ƒhƒCƒc. (ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, “cŒû—SŽq3, –îŒã˜a•v3, Ž…Œö–ç1: 1Šá‰È, 2ˆã—Éq¶Šw•”, 3–òÜ•”)

713139. [Šw‰ï (‘Û)] (free paper) Correlation between Axial Length and Rotation of Toric IOL. Miyake T1, Kamiya K1, Amano R1, Shimizu K1, Iida Y1: APACRS-KSCRS Seoul 2011 (2011/10/15), ƒ\ƒEƒ‹, ŠØ‘. (ŽO‘îr”V1, _’J˜aF1, “V–엝Œb1, Ž…Œö–ç1, ”Ñ“c‰Ã•F1: 1Šá‰È)

713140. [Šw‰ï (‘Û)] (free paper) Pseudophakic Monovision Using Monofocal and Multifocal IOLs: Hybrid Monovision. Iida Y1, Shimizu K1, Ito M2: APACRS-KSCRS Seoul 2011 (2011/10/15), ƒ\ƒEƒ‹, ŠØ‘. (”Ñ“c‰Ã•F1, Ž…Œö–ç1, ˆÉ“¡”üŽÑŠG2: 1Šá‰È, 2ˆã—Éq¶ŠwEE

713141. [Šw‰ï (‘Û)] (free paper) Evaluation of Factors that Affect the Satisfaction in Pseudophakic Mild Monovision. Amano R1, Tsunehiro S1, Ito M2, Shimizu K1, Eguro T1, Iida Y1: APACRS-KSCRS Seoul 2011 (2011/10/15), ƒ\ƒEƒ‹, ŠØ‘. (“V–엝Œb1, íœAr‘Ÿ˜Y1, ˆÉ“¡”üŽÑŠG2, Ž…Œö–ç1, ]•—Ft1, ”Ñ“c‰Ã•F1: 1Šá‰È, 2ˆã—Éq¶Šw•”)

713142. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Five cases of eyelid tumor metastatic to eyelid. Kashiwagi H1: ICOO (International congress ocular oncology meeting) 2011/11/15), ƒuƒGƒmƒXƒAƒCƒŒƒX, ƒAƒ‹ƒ[ƒ“ƒ`ƒ“. (”–؍LÆ1: 1Šá‰È)

721002. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)yÀ’·z‹üÜE˜VŽ‹‹ž³‚É‚š‚¯‚éŠáŒõŠwPitfalls‚ÆPearls. ‹›—¢@”Ž (ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

721003. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)yÀ’·z”’“àáŽèp`–Ú‚©‚ç”], ‚»‚µ‚ÄŠá‚ց`. Ž…Œö–ç (Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

721004. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)yÀ’·zASNOS. Œü–ì˜a—Y1,2 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/25), •ºŒÉ.

721005. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)yÀ’·zJANOS. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/26), •ºŒÉ.

722112. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@. “V–엝Œb (Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

722113. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z—Γàá«Ž‹_ŒoÇ‚ƍ‚ŽŸ”]‹@”\•Ï‰». ‘ŠŒŽ@ˆê1, ¯ŽiMs2 (1“Œ‹ž‘å, 2ˆã—Éq¶Šw•”): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

722114. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zŠááÙáz¹‚ÍŠá‰È‚ÌŽŸŠ³. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

722115. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zí—ª“I”’“àáŽèp. Ž…Œö–ç (Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

722116. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ”r”A‹@”\‰ü‘PÜ (ƒ¿1Žó—e‘ÌŽÕ’f–ò) ‚É‚æ‚éŠááŠQ. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

722117. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Œüž_–ò‚É‚æ‚éŠááŠQ. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

722118. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) —Ž‹‚ðl—¶‚µ‚œ”’“àáŽèp. Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/14), “Œ‹ž.

722119. [Šw‰ï (‘S‘)] (‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ïŠwp“WŽŠ—DGÜŽóÜu‰‰) DSAEKpŒãŽ‹—͂ɉe‹¿‚ð‹y‚Ú‚·ˆöŽq‚ÌŒŸ“¢. ²“¡M”V1, ŒÜ\—’ÍŽj2, _’J˜aF2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/14), “Œ‹ž.

722120. [Šw‰ï (‘S‘)] (ƒTƒuƒXƒyƒVƒƒƒŠƒeƒB[ƒTƒ“ƒf[) LASIK. _’J˜aF (Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/15), “Œ‹ž.

722121. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Œ©‚ÄŠo‚Š‚铵E‚ُ̈í. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/15), “Œ‹ž.

722122. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zŒ©‚ÄŠo‚Š‚æ‚€! _ŒoŠá‰ÈŽŸŠ³. Žá‘q‰ë“o1,2, ’†“‡GŽ÷3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‹{è‘å): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/15), “Œ‹ž.

722123. [Šw‰ï (‘S‘)] (ƒAƒtƒ^ƒk[ƒ“ƒZƒ~ƒi[)yÀ’·zŽŸ¢‘ãƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ÌŽÀ—Í. Ž…Œö–ç (Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

722124. [Šw‰ï (‘S‘)] (ƒAƒtƒ^ƒk[ƒ“ƒZƒ~ƒi[) LASIK‚É‘ã‚í‚ê‚é‚©? V‚µ‚¢‹üÜ‹ž³Žèp. _’J˜aF (Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

722125. [Šw‰ï (‘S‘)] (ƒAƒtƒ^ƒk[ƒ“ƒZƒ~ƒi[) ƒŒƒ“ƒYƒXƒ^[LS900‚É‚æ‚éIOL“x”ŒvŽZ. ”Ñ“c‰Ã•F (Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/18), •Ÿ‰ª.

722126. [Šw‰ï (‘S‘)] (ƒAƒtƒ^ƒk[ƒ“ƒZƒ~ƒi[) V‚µ‚¢Šá‹…ŒõŠw“Á«‰ðÍ‘•’uOQAS II. _’J˜aF (Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/18), •Ÿ‰ª.

722127. [Šw‰ï (‘S‘)] (ƒAƒtƒ^ƒk[ƒ“ƒZƒ~ƒi[)yÀ’·zJFC Cutting EdgeƒZƒ~ƒi[. Ž…Œö–ç (Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/18), •Ÿ‰ª.

722128. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z—L…»‘ÌŠá‚ւ̃Cƒ“ƒvƒ‰ƒ“ƒg: ‚»‚ÌŽíEނƐ¬Ñ. ’Ø“cˆê’j1, _’J˜aF2 (1Œc‰ž‘å, 2Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/18), •Ÿ‰ª.

722129. [Šw‰ï (‘S‘)] (ƒpƒlƒŠƒXƒg)yASCRSƒgƒsƒbƒNƒXƒZƒ~ƒi[: ASCRS‚©‚çŠw‚ԍŐVî•ñz2. ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“. –؉º@–Î1, Ž…Œö–ç2, Œ@‹NŽj3, Hungwon Tchah4, Do-Hyung Lee5 (1‹ž“s•{ˆã‘å, 2Šá‰È, 3ŒŠá‰È•a‰@, 4University of Ulsan, Asan Medical Center, 5Inje University, Ilsan Paik Hospital): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/18), •Ÿ‰ª.

722130. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·zV¢‘ã‚Ì’Ž‰¹”g¶‘ÌŒ°”÷‹ŸVuMax II. Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/18), •Ÿ‰ª.

722131. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) …»‘̂̉Á—î•Ï‰»‚Æ“µE. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/19), •Ÿ‰ª.

722132. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˜VŠá‚Ö‚ÌLASIK. _’J˜aF (Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/19), •Ÿ‰ª.

722133. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[)yÀ’·zŠp–ŒŒ`ó‰ðÍƒAƒbƒvƒf[ƒg. ‘O“c’Œ”V1, ‹›—¢@”Ž2 (1‘åã‘å, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

722134. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[)yÀ’·z‚±‚ê‚È‚ç‚í‚©‚éŠáŒõŠw. ‘厭“N˜Y1, ìŽç“c‘ñŽu2 (1’}”g‘å, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

722135. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Šp–ŒŒ`ó‰ðÍƒAƒbƒvƒf[ƒg: Šp–ŒŒ`ó‰ðÍ‚Ì‘ª’茎—. ‹›—¢@”Ž (ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

722136. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Šp–ŒŒ`ó‰ðÍƒAƒbƒvƒf[ƒg: ƒXƒŠƒbƒgƒXƒLƒƒƒ“Šp–Œƒgƒ|ƒOƒ‰ƒtƒ@[. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

722137. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ‚±‚ê‚È‚ç‚í‚©‚éŠáŒõŠw: ”g“®ŒõŠw‚ÌŠî–{ (‰ñÜ, ŽU—‚È‚Ç). ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

722138. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Šá‰ÈŒŸž–@ƒAƒbƒvƒf[ƒg: Šp–ŒŒ`ó. _’J˜aF (Šá‰È): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ïE‰E(2011/9/4), “Œ‹ž.

722139. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) 3D‰f‘œ‚ª‚à‚œ‚ç‚·Šá‚Æ”] (‚±‚±‚ë) ‚ւ̉e‹¿. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

722140. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zIOLƒ}ƒXƒ^[ (ƒ‚ƒfƒ‹500) ‚яƒ“ƒ‰ƒ“ƒNã‚Ì”’“àáŽèp‚ð. Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

722141. [Šw‰ï (‘S‘)] (ê–å•ÊŒ€‹†‰ï) —Տ°ŠŒ©‚Å“–‰ƒŠƒ“ƒpŽî‚ðl‚Š‚œ, ãŠááيà‚Ì•a—‘gD‘œ. ”–؍LÆ1,2, •û@‘å3, ‹gìŽü²3, ’†ì‰ë—T4, ˆÉ“¡ˆÈ’m˜Y5, “n粗íŽq5, ¯Å@’q6 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[E”畆‰È, 4Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[EŒ`¬ŠO‰È, 5Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[E•a—f’f‰È, 6“¡Ž}Žs—§•a‰@): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

722142. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ƒgƒ‰ƒxƒNƒg[ƒ€Žèp‚Ì‘Šú¬Ñ. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

722143. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) “œ”A•aŠ³ŽÒ‚ÌŽ¡—Õûj6|‚±‚ñ‚ÈŽž‚Ç‚€‚·‚é|. ‚–ì‰ë•F1,6, ‰Á“¡@‘2, A–Ø–ƒ—3, ˆÀ“¡VL˜N4, Œ‘º”ü‘ã5 (1‘Ûˆã—ÕŸŽƒ‘åE”MŠC, 2“Œ‹ž‘å, 3‘åãˆã‘å, 4Ï¶‰ïVŠƒ‘æ“ñ•a‰@, 5‰i“cŠá‰È, 6Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

722144. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“àáƒT[ƒWƒƒƒ“‚à•KŒ©! —L…»‘ÌŠá“àƒŒƒ“ƒY‚ðƒ}ƒXƒ^[‚µ‚æ‚€. Ž…Œö–ç1, _’J˜aF1, Žsìˆê•v1,2, ’†‘º—Fº3, –kàV¢Žu”Ž4 (1Šá‰È, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 3–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 4_“ސìƒAƒCƒNƒŠƒjƒbƒN): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

722145. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒI[ƒKƒiƒCƒU[ RƒAƒNƒAƒ|ƒŠƒ“4R‘Ì—z«Ž‹_Œo‰Š‚̍őOü. Žá‘q‰ë“o1,2, ’†”nGŽ÷3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‹{è‘å): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

722146. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) ‚₳‚µ‚­“Ç‚Ý‰ð‚­ŠááÙáz¹. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

722147. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“àáŽèp‚Æ—Ž‹‹ž³`ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚ðƒ}ƒXƒ^[‚µ‚æ‚€`. ‹{“c˜a“T1, ƒrƒbƒZƒ“‹{“‡OŽq2, _’J˜aF3, ’†‘º–M•F4 (1‹{“cŠá‰È•a‰@, 2“Œ‹žŽ•‘åE…“¹‹Ž, 3Šá‰È, 4‚œ‚È‚µ’†‘ºŠá‰ÈƒNƒŠƒjƒbƒN): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

722148. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) FŠoƒƒJƒjƒYƒ€‚̉ðà‚ƐFŠoˆÙí‚̗Տ°f’f‚š‚æ‚ÑŽw“±. Žsìˆê•v1,2, ’†‘º‰pŽ÷1, ŽRoVˆê3, ‰ª“‡@C4, ’†‘º‚©‚š‚é5 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È, 3Ž ‰êˆã‘å, 4ŽOŠy•a‰@, 5—Žqˆã‘å): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

722149. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —L…»‘ÌŠá“àƒŒƒ“ƒYpŒã. _’J˜aF (Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

722150. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) Žq‚Ç‚à‚̋ߎ‹—\–h‚Æ3D‰f‘œ‚̉e‹¿‚Æ—\–h. ‰F’ÃŒ©‹`ˆê1,2,3, ŒŽ@’Œl3,4, ’·’J•”‘5, ‹{‰Y@“O2, ‚‹Ž˜a”Ž2, •Ÿ‰ºŒöŽq2, ‚–ì@”É2 (1‰F’ÃŒ©Šá‰È, 2“ú–{Šá‰Èˆã‰ï, 3Šá‰È, 4_“ސ쎕‘åE‰¡•l, 5‰ªŽR‘å): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

722151. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒT[ƒWƒJƒ‹ƒKƒCƒ_ƒ“ƒX‚É‚æ‚闐Ž‹‚ðl—¶‚µ‚œ”’“àáŽèp. Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

722152. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zJFC Cutting Edge ƒZƒ~ƒi[|Part2|. Ž…Œö–ç (Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

722153. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‰ðŒˆ! Šá‚ÆŽ‹Šo‚Ì•s’èD‘iE•s–ŸD‘i@‚»‚Ì9) ¢‚Á‚œÇ—áW. Žá‘q‰ë“o1,2, ŽàVŒ¹O3, ŽR“c¹˜a4 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3ŽàVŠá‰Èˆã‰@, 4“Œ‹žˆã—ÃZƒ“ƒ^[): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/10), “Œ‹ž.

722154. [Šw‰ï (‘S‘)] (ƒtƒFƒAƒEƒFƒ‹ƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zŠwZŒ»ê‚ł̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/10), “Œ‹ž.

722155. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹ß”N‚Ì‘ÎŒõ”œŽË‚ɑ΂·‚él‚Š. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2011/10/27), H“c.

722156. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”r”A‹@”\‰ü‘PÜ‚Ì“µE‚Ö—^‚Š‚é‰e‹¿. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2011/10/27), H“c.

722157. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –Y‚ê‚Ä‚Í‚È‚ç‚È‚¢Å“_’²ß‹@”\‚Æ“µE‚Æ‚ÌŠÖŒW`ITŠÂ‹«‚É‚š‚¯‚é‹ßŒ©”œ‰ž‚̕ω»`. ŒŽ@’Œl1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰ÈŠw, 2Šá‰È): ‘æ64‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2011/10/27), H“c.

722158. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·z“µE‚ÌŠî‘b‚ƗՏ°. ‹g•xŒ’Žu1, Îì@‹Ï2 (1H“c‘åŠw‘åŠw‰@ˆãŠwŒ€‹†‰ÈŠá‰ÈŠwuÀ, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2011/10/27), H“c.

722159. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)y‹ßŽ‹ƒƒJƒjƒYƒ€‚Æ‚»‚Ì—\–hE‹ž³zƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ÆŠp–Œ‹üÜ‹ž³Žèp. _’J˜aF (Šá‰È)/15th The IRSJ 2011 (2011/11/12), _“ސì.

722160. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰) ‘Θ_: Ž‹—Í‚Ÿ‚¯‚Å‚ÍŒê‚ê‚È‚¢‚à‚́`ŽÀŠŽ‚Ƙš—£‚·‚鎋—Í. Žá‘q‰ë“o1,2, X‚Ü‚ä‚Ý3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3ƒmƒ“ƒtƒBƒNƒVƒ‡ƒ“ì‰Æ): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

722161. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰)yÀ’·z‘Θ_: Ž‹—Í‚Ÿ‚¯‚Å‚ÍŒê‚ê‚È‚¢‚à‚́`ŽÀŠŽ‚Ƙš—£‚·‚鎋—Í. Žá‘q‰ë“o1,2 (1ˆäãŠá‰Èˆã‰@, 2Šá‰È): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

722162. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) 3D‰f‘œ‚ÌŒ»ó‚ÆŽ‹‹@”\ŒŸžEŒP—û‰ž—p. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/20), _“ސì.

722163. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z3D‰f‘œ‚ªŽ‹‹@”\‹y‚ѐSg‚É—^‚Š‚é‰e‹¿‚ƈÀ‘S«‘΍ô. •s“ñ–叮1, ”Œ“c’m–ç2 (1‘åã‘åŠwˆãŠw•”ŠŽŠo‹@”\Œ`¬Šw, 2ˆã—Éq¶Šw•”): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/20), _“ސì.

722164. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z_ŒoŠá‰È-f’f‚©‚玡—ÂÖ. Žá‘q‰ë“o1,2, ŽO‘º@Ž¡3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3•ºŒÉˆã‰È‘åŠwŠá‰ÈŠw‹³Žº): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/26), •ºŒÉ.

722165. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) “µE‚ÌŒ©•û. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

722166. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ”’“àáƒT[ƒWƒƒƒ“‚É‚Æ‚Á‚Ä‚ÌŠp–Œã”çáŠQ. Ž…Œö–ç (Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

722167. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) —Ž‹‚ðŽc‚³‚È‚¢”’“àáŽèp‚ð‚ß‚Ž‚µ‚ā`ƒT[ƒWƒJƒ‹ƒKƒCƒ_ƒ“ƒX‚É‚æ‚闐Ž‹‹ž³Žèp`. •Ÿ‰ª²’mŽq1, rˆäGK2, Žsìˆê•v3,4 (1‘œª‹L”OŠá‰È•a‰@, 2‚Ý‚È‚Æ‚Ý‚ç‚¢ƒAƒCƒNƒŠƒjƒbƒN, 3ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 4Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

722168. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) pŒãŽ‹‹@”\E–ž‘«“x‚©‚çl‚Š‚é”’“àáŽèp‚Ö. ‘O“c’Œ”V1, ‹{“c˜a“T2, _’J˜aF3 (1‘åã‘å, 2‹{“cŠá‰È, 3Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

722169. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) pŒãŽ‹‹@”\E–ž‘«“x‚©‚çl‚Š‚é”’“àáŽèp‚Ö. Ž…Œö–ç (Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

722170. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ƒgƒ‰ƒxƒNƒŒƒNƒgƒ~[Œã‚ÌŠá“à‰Š‚̐f’f‚ÆŽ¡—Ã. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

722171. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zpŒãŠá“à‰Š|f’f‚ÆŽ¡—Á|. ¬Œ^—1,2, ŽRì—ÇŽ¡3 (1ŽR‰€•a‰@, 2Šá‰È, 3‹v—¯•Ä‘å): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

722172. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ÌŒ»ó. _’J˜aF (Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

722173. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Refractive Lenticule Extraction. Ž…Œö–ç1, _’J˜aF1, •B“c@–q2, ‹{“c˜a“T3, “V–ìŽj˜Y4 (1Šá‰È, 2‹ž“s•{ˆã‘å, 3‹{“cŠá‰È•a‰@, 4“Œ‹ž‘å): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

722174. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –{–M‚̏Á‰»Ší‚ª‚ñ‰»Šw—Ö@‚É‚š‚¯‚éS-1‚̈ʒu‚¯. ˆÀˆä”ŽŽj1, ”–؍LÆ2,3, ŽRèŒ’‘Ÿ˜Y1, ’¬“c@–]1, •Ÿ•y@W1, ŒË‚–ŸŽq1, ’JŒû_–ç1, ›””n—²_1 (1Ã‰ª‚ª‚ñƒZƒ“ƒ^[Á‰»Ší“à‰È, 2Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 3Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

722175. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŒoŒûR‚ª‚ñÜƒeƒB[ƒGƒXƒƒ“_‚É‚æ‚é—Ü“¹áŠQ (Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È‚ÌŒ»ó). ”–؍LÆ1,2 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

722176. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[zƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚̐V‚œ‚ȉž—p. ‹{“c˜a“T1, _’J˜aF2 (1‹{“cŠá‰Èˆã‰@, 2Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

722177. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) pŒãŒŸEž‚̃|ƒCƒ“ƒg. _’J˜aF (Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

722178. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ‰ºŠááÙ“à”œÇ‚̃}ƒl[ƒWƒƒ“ƒg. Œ–{_”V1,2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@, 2Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

722179. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[z‹üÜ‹ž³Žèp‚ÌŠî–{. ‰ª–{–ÎŽ÷1, _’J˜aF2 (1‰ª–{Šá‰ÈƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

723670. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z”’“àáŠî‘b‚ƗՏ°1. Ž…Œö–ç (Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723671. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒJƒXƒ^ƒ}ƒCƒY‚·‚é˜VŽ‹‹ž³`“µE‚ƃ‚ƒmƒrƒWƒ‡ƒ“`. ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç2, ”Ñ“c‰Ã•F2, —`…@Šw2, ŒË’ˁ@Œå2, “V–엝Œb2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723672. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Laser in situ keratomileusis (LASIK) pŒã‚É‚š‚¯‚é’²ß‚É”º‚€Šp–Œ‚ŽŸŽû·‚̕ω». –‘“c_ŽO1, ã“c“N¶1, ‹›—¢@”Ž2 (1“Þ—ÇŒ§ˆã‘å, 2ˆã—Éq¶Šw•”): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723673. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •úŽËóŠp–ŒØŠJŒã‚Ì”’“àáŽèp‚É‚š‚¯‚éŠá“àƒŒƒ“ƒY“x”ŒvŽZ. ”Ñ“c‰Ã•F1, Ž…Œö–ç1, “V–엝Œb1 (1Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723674. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Visual Field Index‚ðƒx[ƒX‚Æ‚·‚éV‚µ‚¢—Γàá•ª—Þ. •œàVˆê–@1, ¯ŽiMs1,2,3, X“c“N–ç3, ‘å’Î’qG3, ¬£—ÁŽq3, Š}ŒŽ³s1,3, ‹œ‰E‹ß”ŽN3, Ž…Œö–ç1,3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723675. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —LF‰Æ“e‚É‚š‚¯‚éˆÙ‚È‚Á‚œFŽhŒƒ‚É‚æ‚é‘ÎŒõ”œŽË‚̍·ˆÙ. Îì@‹Ï1, óì@Œ«1, ^‰º‹I”ü‘ã2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723676. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‚‘¬“xƒJƒƒ‰‚ð—p‚¢‚œ—Z‘œ‰^“®‚Ì“®‘Ô‰ðÍ. ”Œ“c’m–ç1, Îì@‹Ï1, ’r“c“N–ç2, ŒãŠÖ—˜–Ÿ2, Îˆä@—º1, •Ð–쌋—ŠG1, oì@„1, ¯ŽiMs1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723677. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žü•Óî•ñŽhŒƒ‚É”º‚€’²ß‚̕ω». ŽÄ“c—DŽq, i“¡^‹I1, ’†ŽR“ށX”ü1, óì@Œ«2, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723678. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒrƒ}ƒgƒvƒƒXƒg“_Šá‚É‚æ‚éŠá‹ÇŠ•›ì—p‚ÌŒŸ“¢. ˆäãŒ«Ž¡1, ‰–ì”üØŽq1, ›ŒŽ’ʍF1, ”ä‰Ã—˜¹Žq1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723679. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒhƒ‹ƒ]ƒ‰ƒ~ƒh‰–Ž_‰–Eƒ`ƒ‚ƒ[ƒ‹ƒ}ƒŒƒCƒ“Ž_‰–”z‡“_Šá‰t‚̊ሳ‰º~Œø‰Ê. ‰–ì”üØŽq1, ˆäãŒ«Ž¡1, ›ŒŽ“¹F1, Žá‘q‰ë“o1,2, “Y“c®ˆê3, •x“c„Ži4 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3ŒŠ‹ŒEˆäãŠá‰È•a‰@, 4“Œ–M‘åE‘å‹Ž): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723680. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ‰~Šp–ŒŠá‚É‚š‚¯‚éelevation•Ï‰»—Ê‚ÆŠp–Œ¶‘Ì—ÍŠw“Á«‚ÌŠÖ˜A. Îˆä—œŠG1, _’J˜aF2, ŒÜ\—’ÍŽj2, Ž…Œö–ç2, ‰F’ÃŒ©‹`ˆê2, ŒF”WŒä“°—²2,3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ƒNƒ}ƒmƒ~ƒh[Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723681. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ‘OŠá•”Œ`ó‰ðÍ‘•’uTMS-5‚É‚æ‚éŠp–ŒŒa (white to white) ‚̍Č»«‚Æ‘Œ‹@Ží‚Æ‚Ì”äŠrŒŸ“¢. “¡ŒŽ˜aŽq1, “¡‘º•‡²Žq2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723682. [Šw‰ï (‘S‘)] (Šwp“WŽŠ)yÀ’·zŽÎŽ‹ŽãŽ‹, ¬Ž™Šá‰È, _ŒoŠá‰È. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723683. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒ‚ƒmƒrƒWƒ‡ƒ“–@‚É‚š‚¢‚ÄŠá“àƒŒƒ“ƒY‚Ì‹…–ÊŽû·‚ª‹ßŒ©Ž‹‹@”\‚É—^‚Š‚é‰e‹¿. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723684. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒ~ƒgƒRƒ“ƒhƒŠƒADNA14484•ÏˆÙƒŒ[ƒxƒ‹•a7—á‚̗Տ°“I“Á’¥. ‘h‰ä–ÐŽu1, –ìŠÔŒª°1, ‰Í–{‚Ђë”ü1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723685. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) “®‘ÔŽ‹—Í‘ª’莞‚É‚š‚¯‚éŠwKŒø‰Ê‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. H“¡‘å‰î1, ‘ºã@»1, “à“c—Y‰î2, ”Œ“c’m–ç3, ‚‹ŽrŒõ4, –kàV@–Î4 (1‡“V‘å, 2‘ˆî“c‘åEƒXƒ|[ƒc‰ÈŠw, 3ˆã—Éq¶Šw•”, 4‡“V‘åE¶—Šw‘æˆê): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723686. [Šw‰ï (‘S‘)] (Ewp“WŽŠ) ’Œ—Ž‹, “|—Ž‹, ŽÎ—Ž‹‚ª“Ǐ‘”\—Í‚É‹y‚Ú‚·‰e‹¿. ¬‹Ž‰p’·1, _’J˜aF2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/12), “Œ‹ž.

723687. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒqƒg…»‘̏ã”ç×–E‚Ì–§“x‚ÉŠÖ‚·‚é’²ž. ”n“ˆŽ”@1, ‹ß“¡“Þ’Ã2, ŽR–{’ŒŽ÷3, “à“¡®‹v4, Žsìˆê•v5,6 (1Šá‰È–ŸŠá‰@, 2Šò•ŒÔ\Žš•a‰@, 3“¡“c•ÛŒ’‰q¶‘åE‹€“¯—˜—pŒ€‹†Ž{Ý, 4’†‹žŠá‰È, 5’†‹ž•a‰@, 6Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

723688. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) “œ”A•a‚ª…»‘̏ã”ç×–E‚ÌŠj^×–EŽ¿”ä‚É‹y‚Ú‚·‰e‹¿. ‹ß“¡“Þ’Ã1, ”n“ˆŽ”@2, ŽR–{’ŒŽ÷3, ŽðˆäKO4, “à“¡®”V4, Žsìˆê•v5,6 (1Šò•ŒÔ\Žš•a‰@, 2Šá‰È–ŸŠá‰@, 3“¡“c•ÛŒ’‰q¶‘å, 4’†‹žŠá‰È, 5’†‹ž•a‰@, 6Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

723689. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ŠááÙáz¹‚ɑ΂·‚éƒ{ƒcƒŠƒkƒX“Å‘fŽ¡—ÂƃNƒ‰ƒbƒ`ƒƒKƒl‚ÌŒø‰Ê‚Ì”äŠr. ‰Í–{‚Ђë”ü1, ‹v•ÛŽá“Þ1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ115‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2011/5/13), “Œ‹ž.

723690. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”’“àáŽèpŽž‚ɃGƒ“ƒhƒ~ƒ‰[‚ðŽg—p‚µ‚Ä“µEŒ`¬•¹—p‹÷Šp–ü’…‰ð—£p‚ðŽ{s‚µ‚œÇ—á‚ÌŒŸ“¢. ‘å’Î’qG1,2, ’JŒûd—Y3, ¬‘ò’‰•F1 (1¬‘òŠá‰È“à‰È•a‰@, 2Šá‰È, 3º˜a‘åE“¡‚ª‹u): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723691. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒqƒg”’“àá…»‘̂̏ã”ç×–E–§“x‚ÌŒŸõ. ”n“ˆŽ”@1, ‹ß“¡“Þ’Ã2, ŽR–{’ŒŽ÷3, “à“¡®‹v4, ˆÀ—¢’“¿5, Žsìˆê•v5,6 (1Šá‰È–ŸŠá‰@, 2Šò•Œ“úÔ•a‰@, 3“¡“c•ÛŒ’‰q¶‘åŠw‹€—˜Œ€, 4’†‹žŠá‰È, 5’†‹ž•a‰@, 6Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723692. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•a‚Ì—L–³‚É‚æ‚鐅»‘̏ã”ç×–E‚Ì–§“x‚Ì”äŠr. ‹ß“¡“Þ’Ã1, ”n“ˆŽ”@2, ŽR–{’ŒŽ÷3, ŽðˆäKO4, “à“¡®‹v4, Žsìˆê•v5,6 (1Šò•ŒÔ\Žš•a‰@, 2Šá‰È–ŸŠá‰@, 3“¡“c•ÛŒ’‰q¶‘å, 4’†‹žŠá‰È, 5’†‹ž•a‰@, 6Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723693. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) F‚ð—p‚¢‚œV‚µ‚¢Ž‹‹@”\ŒŸž‘•’u‚É‚æ‚鐳íŠá‚Æ’PÅ“_Šá“àƒŒƒ“ƒY‘}“üŠá‚Ì”äŠr. ‰¡ŽR@ãÄ1, ’†‘º‰pŽ÷1, Žsìˆê•v1,2, “c糏َq3, “c’†–FŽ÷4, “c’†@Ž4, “Žˆä—¢ŠG3, ‰Á“¡Km1 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È, 3’†‹žŠá‰È, 4MB‘åEHŠw•”): ‘æ50‰ñEú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723694. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) UBM (VuMax II) ‚É‚æ‚é–Ñ—laŠÔ‹——£‚Ì’ŒÚ‘ª’è‚ð—p‚¢‚œImplantable Collamer Lens (ICL) ƒTƒCƒY‚̍œK‰». ¬“‡—²Ži1, ŒŽ@C–ç1,2, ’†‘º‰pŽ÷2, ‰¡ŽR@ãÄ2, ˆä“¡–ƒ—R1, “Žˆä—¢ŠG1, ’†‘º—Fº1, Žsìˆê•v2,3 (1–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 3Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723695. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ}ƒCƒNƒƒ‚ƒmƒrƒWƒ‡ƒ“–@‚É‚æ‚é˜VŽ‹‹ž³‚àŒ“‚Ë‚œƒŒ[ƒVƒbƒN‚Ì‘Šú¬Ñ. ’†‘º—Fº1, ‹g“c—zŽq1, ¬“‡—²Ži2, ˆé’J®‹P1, ˆä“¡–ƒ—R1, •Ð‰ª“”Ž1, ‘º“c‚ ‚ž‚³1, ŒŽ@CÆ3, Žsìˆê•v3,4 (1–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 2Œc‰ž‘å, 3ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 4Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723696. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) “§–Ÿ…»‘ÌŠá‚ÌŠá“à“üŒõ—ÊŒž‘Þ‚É‚š‚¯‚éŠá—DˆÊ«‚ւ̉e‹¿. ’†ŽR“ށX”ü1,3, ‹›—¢@”Ž1,2, –{•Û@•v3, ²X–؈ê”V3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3“Œ–k•¶‰»EŽ‹Šo‹@”\): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723697. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) YAGƒŒ[ƒU[ÆŽËŒã‚ɍ‚“x‚ÈŽ‹‹@”\áŠQ‚ª¶‚¶‚œ1—á. X@r’j1, Žsìˆê•v1,2, ’†‘º‰pŽ÷1, ‰¡ŽR@ãÄ1 (1ŽÐ•Û’†‹ž•a‰@, 2Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/17), •Ÿ‰ª.

723698. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) IOLƒ}ƒXƒ^[TM (ƒ‚ƒfƒ‹500) ‚̐V‹@”\‚Ì—L—p«|’Ž‰¹”gAƒ‚[ƒh‚Ƃ̃Šƒ“ƒN|‘æ2•ñ. ”ä‰Ã—˜¹Žq1, ‹›—¢@”Ž2, ‘å“à‰ë”V3,4, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,4 (1ˆäãŠá‰È•a‰@, 2ˆã—Éq¶Šw•”, 3‘å“àŠá‰È, 4Šá‰È): ‘æ50‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ26‰ñŠá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2011/6/18), •Ÿ‰ª.

723699. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Monocular double depressor palsy 6—á‚ɑ΂·‚éŽÎŽ‹Žèp‚ÌŒø‰Ê. ŒŽ@’Œl1, ¬Žèì‘׎}, ŒN“‡^ƒ, –]ŒŽ_Žu2, —é–Ø—T”ü1, —L–{‚ ‚±1, Œü–ì˜a—Y1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ67‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ïE‘æ36‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2011/7/1), ‹ž“s.

723700. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) LASIK‚É‚æ‚é‰ß‹ž³‚ÅŽ©ŠoÇó‚ª‰ü‘P‚µ‚œŽÎˆÊ‹ßŽ‹Ç—á. åŒŽŽµd1, Îì@‹Ï1, ŒÜ\—’ÍŽj2, ŒãŠÖEEŸ2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ67‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ïE‘æ36‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2011/7/1), ‹ž“s.

723701. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ‹ßŒ©”œ‰žáz¹‚ªƒAƒgƒƒsƒ““_Šá‚É‚ÄŠ°‰ð‚µ‚œ2Ç—á. Îˆä—SŽq1, ‰i–ì‰ëŽq1, ’·“‡²’mŽq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ67‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ïE‘æ36‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2011/7/1), ‹ž“s.

723702. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒXƒeƒƒCƒhƒZƒ~ƒpƒ‹ƒX‚É’xŒø«‚Å‚ ‚Á‚œŠáâ|Ž‰–bŽ¯‰Š‚ÆŽv‚í‚ê‚œˆê—á. ‘h‰ä–ÐŽi1, ›ŒŽ“¹F1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ45‰ñ“ú–{Šá‰ŠÇŠw‰ï (2011/7/8), ‹ž“s.

723703. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’†E‚Z¶‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—pŽÒE”ñ‘•—pŽÒ‚ÌŒ‹–ŒùN“àD‹C«ŒŸo×–E‚ÌŒŸ“¢. â–{‘¥•q1, ‰F’ÃŒ©‹`ˆê1, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È): ‘æ54‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2011/7/9), ‹ž“s.

723704. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ÈƒXƒy[ƒXŽ‹—Í•\ŒÅŽ‹Žž‚Ì‘ŒŠp“I‹üÜ’l‚Æ“µEŒa. ’†ŽR“ށX”ü1,2, â–{•Û•v1, ìŽç“c‘ñŽu2,3, ‹›—¢@”Ž2,3, ²X–؈ê”V1 (1“Œ–k•¶‰»Šw‰€‘åŠwŽ‹Šo‹@”\Šw, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723705. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žü•ÓŽ‹•W‹P“x‚̍·‚É‚æ‚铵E‚Æ’²ß‚̕ω». ŽÄ“c—DŽq1, i“¡^‹I1, óì@Œ«1,2, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723706. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’è‹üÜ‹ß“_Œvƒ_ƒRƒ‚‚É‚æ‚鉓“_‘ª’è. ’†“‡—²‰î1,2, ’†ìᩕv1,2, “n•Óç”Ž1, •û“Þ•ÛŽq1, ‹›—¢@”Ž2 (1“Þ—ÇŒ§—§ˆã‰È‘åŠwˆãŠw•”Šá‰ÈŠw‹³Žº, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723707. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) F‚ð—p‚¢‚œV‚µ‚¢Ž‹‹@”\ŒŸž‘•’u‚É‚Ä•]‰¿‚µ‚œ³íŠá‚Ì”äŠr. “c’†–FŽ÷1,2, “c’†@Ž1, ‰¡ŽR@ãÄ3, ’†‘º‰pŽ÷3, Žsìˆê•v3,4, “c糏َq5 (1MB‘åŠwHŠw•”“d‹C“dŽqHŠw‰È, 2’†‹žƒƒfƒBƒJƒ‹, 3ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 4Šá‰È, 5Ž‹ŠoŒ€‹†Š): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723708. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “µEŠÔ‹——£‚ÌŒo”N“I•Ï‰»‚ÌŒŸ“¢]3D‰f‘œ‚ւ̉e‹¿. ¬Žèì‘׎}1, ŒŽ@’Œl1, ŒN“‡^ƒ1, –]ŒŽ_Žu2, “n粋v”üŽq1, Œü–ì˜a—Y1,3 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2‘åŠw‰@Eã—ÃŒnŒ€‹†‰È, 3Šá‰È): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723709. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘OŠá•”OCT‚É‚æ‚鐅»‘́E“øÊE–Ñ—l‘Ì‚Ì’²ß«•Ï‰»‚ÌŒv‘ª. Œã“¡“ÖŽi, ²“¡M”V1, ŒÜ\—’ÍŽj1, ›Á“Œ@Šw2, ŒÃì—T”V2, ‘å—эN“ñ3, Ž…Œö–ç1 (1Šá‰È, 2ˆê”Ê‹³ˆç•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723710. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) VumaxE‚ð—p‚¢‚œ’²ßŽž‚Ì‘OŠá•”‚š‚æ‚ѐ…»‘̕ω»‚Ì‘ª’è. •Ð‰ª“”Ž1, ‘º“c‚ ‚ž‚³1, ˆä“¡–ƒ—R1, ˆé’J®‹P1, “Žˆä—¢ŠG1, ‰¡ŽR@ãÄ2, ‹g“c—zŽq1, ¬“‡—²Ži1, ’†‘º—Fº1, Žsìˆê•v2,3 (1ˆã—Ö@lREC–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 3Šá‰È): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723711. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ã‰º•ÎˆÊ‚ª…•œŠáˆÊ‚Æ’²ß—Í‚É—^‚Š‚é‰e‹¿. ‹ààV³Œp1, ŽÄ“c—DŽq1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723712. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z’²ß. ‹›—¢@”Ž1, Š“c‰ë‹`2 (1ˆã—Éq¶Šw•”, 2Š“cŠá‰È): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723713. [Šw‰ï (‘S‘)] (Šwp§—ãÜŽóÜu‰‰) ƒRƒ“ƒgƒ‰ƒXƒgŠŽ“x‚ÆŽ‹—͂ɉe‹¿‚·‚éƒtƒŒƒlƒ‹–ŒƒvƒŠƒYƒ€‚̍ŏ¬“x”. óì@Œ« (ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/3), “Œ‹ž.

723714. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·zIOL“x”ŒvŽZ/‹üÜ‹ž³Žèp. ‘O“c’Œ”V1, ìŽç“c‘ñŽu2 (1‘åã‘å, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/4), “Œ‹ž.

723715. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’ŒE“|EŽÎ—Ž‹‚ªŠá‹…ŒõŠw“Á«‚É‹y‚Ú‚·‰e‹¿. ¬‹Ž‰p’·1, _’J˜aF1, Ž…Œö–ç1, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/4), “Œ‹ž.

723716. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿`’Œ—Ž‹‚Æ“|—Ž‹‚Ì”äŠr`. ŽR–{^–ç1,2, ‹›—¢@”Ž2, ìŽç“c‘ñŽu2, ‰¶“c@Œ’1 (1•£–ì•Ó‘‡•a‰@Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/4), “Œ‹ž.

723717. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ßŒ©Žž‚É‚š‚¯‚闐Ž‹Šá‚ÌŒ‹‘œó‘Ô. i“¡^‹I1, ŽÄ“c—DŽq1, ‹ààV³Œp1, L“c‰ë˜a1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnE€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/4), “Œ‹ž.

723718. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —܉t‘w‚̈À’萫‚ªŠá‹…‚ŽŸŽû·‚É‹y‚Ú‚·‰e‹¿. L“c‰ë˜a1, ŽÄ“c—DŽq1, ŽR–{^–ç1,2, ìŽç“c‘ñŽu1,3, ‹›—¢@”Ž1,3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•£–ì•Ó‘‡•a‰@, 3ˆã—Éq¶Šw•”): ‘æ47‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2011/9/4), “Œ‹ž.

723719. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ³íŠáˆ³—Γàá‚É‚š‚¯‚éŠp–Œ«‘Ì—ÍŠw“Á«‚ÆŽ‹–ì‚ÌŠÖŒW. X“c“N–ç1, ¯ŽiMs2, _’J˜aF1, Š}ŒŽ³s3, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/23), H“c.

723720. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) AGISƒXƒRƒA‚Æ‚Ì”äŠr‚ÉŠî‚­V‚µ‚¢—Γàá•ª—Þ‚Ì•]‰¿. •œàVˆê–@1, ¯ŽiMs2, X“c“N–ç3, Ž…Œö–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/23), H“c.

723721. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –h•…Ü“Y‰Áƒ‰ƒ^ƒmƒvƒƒXƒg‚©‚ç–h•…Ü–³“Y‰Áƒ‰ƒ^ƒmƒvƒƒXƒg‚ւ̕ύX. ÎŒŽ“ñ—t1, ˆäãŒ«Ž¡1, ‘–{”üŽ}Žq1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/23), H“c.

723722. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 5Ží—ނ̃vƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“»Ü‚̏ãŠáâ|aŠ×‰š”­Œ»•p“x‚ÌŒŸ“¢. ‰–ì”üØŽq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/23), H“c.

723723. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“»Ü‚ɑ΂·‚é•›ì—poŒ»‚ ‚é‚¢‚̓mƒ“ƒŒƒXƒ|ƒ“ƒ_[Ç—á‚̃Qƒ‹‰»ƒ`ƒ‚ƒ[ƒ‹“_Šá–ò‚ւ̕ύX. ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/23), H“c.

723724. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —ΓàáŠá‚É‚š‚¯‚é—§‘ÌŠá’êŽÊ^‚É‚æ‚鎋_Œo“û“ª‰ðÍƒpƒ‰ƒ[ƒ^[‚ÆHumphreyŽ‹–ìŒv‚ÌŽ‹–ìŽw•W‚Æ‚Ì‘ŠŠÖ. ‰Á“¡ŽÑ–1, óì@Œ«2, ¯ŽiMs2, X“c“N–ç1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723725. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ‰ƒ^ƒmƒvƒƒXƒg“_Šá–ò‚©‚烉ƒ^ƒmƒvƒƒXƒgEƒ`ƒ‚ƒ[ƒ‹ƒ}ƒŒƒCƒ“Ž_‰–”z‡“_Šá‰t‚ւ̕ύX. “¡–{—²Žu1, ˆäãŒ«Ž¡1, ”ä‰Ã—˜¹Žq1, XŽR@—Á1, ‰Í–{‚Ђë”ü1, “ì‰_‚Í‚é‚©1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723726. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ³íŠáˆ³—ΓàáŠ³E҂ɂš‚¯‚鎝‘±Œ^ƒJƒ‹ƒeƒIƒ[ƒ‹“_Šá3”NŠÔ“Š—^‚ÌŒø‰Ê. ”ä‰Ã—˜¹Žq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723727. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Trabectome‚ð—p‚¢‚œüˆÛ’Œ‘ѐ؊Jp‚Ì’ZŠú¬Ñ. Î“c@‹Å1, ‚@ˆè‰Ã2, ¯ŽiMs3, t–ؐ’G1, Š}ŒŽ³s1, X“c“N–ç1, Ž…Œö–ç1 (1Šá‰È, 2‘Š–Í–ì•a‰@, 3ˆã—Éq¶Šw•”): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723728. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —ΓàáŽ¡—Öò”z‡Ü‚Ì’P‰ñ“_Šá‚É‚æ‚錒íŽÒŽ‹_Œo“û“ªŒŒ—¬‚É‹y‚Ú‚·‰e‹¿. Š}ŒŽ³s1, ¯ŽiMs2, X“c“N–ç1, •œàVˆê–@2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723729. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —Γàá“_Šá–òŽ¯•Ê–@‚ÆŒë”F‚̃ŠƒXƒN—vˆö. ‚‹Ž‰ÃŽq1, ˆäãŒ‹”üŽq1, ŽÄ“c‹vŽq1, ‘œ“c‘”ü1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723730. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —ΓàáŠ³ŽÒ‚É‚š‚¯‚é—§‘ÌŽ‹‚ð—p‚¢‚œŽ‹–ìˆÙíŒŸo‚ÌŽŽ‚Ý. –]ŒŽ_Žu1, ¯ŽiMs1,2, X“c“N–ç2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723731. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —ΓàáŠ³ŽÒ‚Ì•sˆÀ‚ɑ΂·‚éŠÖ‚í‚è. “¡’J‹Ó–ç1, ‘剹Ž1, rì˜aŽq1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723732. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z ˆê”ʍu‰‰: “û“ªE‚»‚Ì‘Œ. ¯ŽiMs1, ŒI–{N•v2 (1ˆã—Éq¶Šw•”, 2_ŒËˆã—ÃZƒ“ƒ^[): ‘æ22‰ñ“ú–{—ΓàáŠw‰ï (2011/9/24), H“c.

723733. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‘}“üp‚Æ”’“àáE—Ö•”Œž’£ØŠJ“¯ŽžŽèp‚Ì—Ž‹‹ž³Œø‰Ê‚Ì”äŠr. ŽO‘îr”V1, Ž…Œö–ç1, _’J˜aF1, “V–엝Œb1, ”Ñ“c‰Ã•F1 (1Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723734. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Hybrid monovision‚Ì’·ŠúŒo‰ß (1”N). ”Ñ“c‰Ã•F1, Ž…Œö–ç1, ˆÉ“¡”ü¹ŠG2, “V–엝Œb1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723735. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒ~ƒgƒRƒ“ƒhƒŠƒADNA“_•ÏˆÙ‚ð—L‚·‚é3—á‚Ì”ñ“TŒ^“IŽ‹_ŒoÇ. ÝŠy‹±Žq1,2, –L“c•¶•F3, ˆäEã—T”ü2, Žs粋`Í2, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3Ž©Ž¡ˆã‘å): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723736. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Refractive Lenticule Extraction‚̏‰Šú—Տ°¬Ñ. _’J˜aF1, ²“¡M”V1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723737. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˜VŽ‹”N—î‚ɑ΂·‚élaser in Situ Keratomileusis (LASIK) ‚̏pŒã’·Šú¬Ñ. Œ‘ºˆêO1,2, ¬Œ^—1,2, ŒÜ\—’ÍŽj2, _’J˜aF2, Ž…Œö–ç2 (1ŽR‰€•a‰@, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723738. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) LASIK‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@‚Ì—L—p«‚ÌŒŸ“¢. ŒÜ\—’ÍŽj1, _’J˜aF1, ¬Œ^—1,2, Ž…Œö–ç1 (1Šá‰È, 2ŽR‰€•a‰@): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723739. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÑ’ʍE•t‚«—L…»‘ÌŒã–[ƒŒƒ“ƒY (Hole ICL) ‚̏‰Šú—Տ°¬Ñ. ”’’J@“O1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, _’J˜aF1 (1Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723740. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –k—¢Ž®ƒXƒEƒFƒvƒgƒ\[ƒX‚ÌOCT‚ð—p‚¢‚œ…»‘Ì‘OŒã–Ê‚Ì’²ßE‰Á—•Ï‰»‚ÌŠÏŽ@. ²“¡M”V1,2, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, Š}ŒŽ³s2, ’†Œ@Šî1,3, ŒÃì—T”V1, œA‰ªG–Ÿ, ›Á“Œ@Šw, _’J˜aF1, ‘å—эN“ñ2 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‘å˜aŽs—§•a‰@): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723741. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ˆäãŠá‰È•a‰@‚É‚š‚¯‚郍[ƒrƒWƒ‡ƒ“ê–åŠO—ˆ‚ÌŽÀÛ. ’߉ªŽOŒbŽq1, ˆäãŒ«Ž¡2, Žá‘q‰ë“o2,3, ‹{‰i‰Ã—²1 (1ŒŠ‹ŒˆäãŠá‰È•a‰@, 2ˆäãŠá‰È•a‰@, 3Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/7), “Œ‹ž.

723742. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒuƒhƒE–ŒŒ‡‘¹—á‚Ì”’“àáŽèp¬Ñ. “¡–{—²Žu1, ÎŒŽ“ñ—t1, “¿“c–F_1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723743. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒgƒŠƒpƒ“ƒuƒ‹[‰t‚ªÉŽq‘̍o‚É–À“ü‚µ‚œ6—á7Šá. ÎŒŽ“ñ—t1, “¡–{—²Žu1, “¿“c–F_1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723744. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) –h•…Ü–³“Y‰Áƒ‰ƒ^ƒmƒvƒƒXƒg“_Šá–ò‚̊ሳ‰º~Œø‰Ê‚ƈÀ‘S«. “ì‰_‚Í‚é‚©1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723745. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒgƒ‰ƒ{ƒvƒƒXƒgEƒ`ƒ‚ƒ[ƒ‹ƒ}ƒŒƒCƒ“Ž_‰–”z‡“_Šá–ò‚̊ሳ‰º~Œø‰Ê. £ŒËìÍ1, ˆäãŒ«Ž¡1, ”ä‰Ã—˜¹Žq1, XŽR@—Á1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723746. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ƒÀŽÕ’f“_Šá–ò‚©‚çƒhƒ‹ƒ]ƒ‰ƒ~ƒh‰–Ž_‰–Eƒ`ƒ‚ƒ[ƒ‹ƒ}ƒŒƒCƒ“Ž_‰–”z‡“_Šá–ò‚ւ̕ύX. ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723747. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ‘œŽ{Ý‚É‚æ‚é—ΓàáŠ³ŽÒ‚ÌŽÀ‘Ô’²ž2009”N“x”Ł|‚—îŽÒ‚ÆŽá”NE’†”NŽÒ|. –ìè—ߌb1, ˆäãŒ«Ž¡1, ‰–ì”üØŽq1, Žá‘q‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åE‘å‹Ž): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723748. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) –k—¢Ž®‘OŠá•”OCT‚É‚æ‚é‹}«ŒŽ”­•ÂÇ‹÷ŠpÇ‚Ì”’“àáŽèp‘OŒã‚Ì‹÷Šp•]‰¿. Š}ŒŽ³s1, ¯ŽiM”V2, X“c“N–ç1, •œàVˆê–@1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723749. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) —Ž‹Šá‚É‚š‚¯‚铵EŒa‚ªŠá‹…ŒõŠw“Á«‚É‹y‚Ú‚·‰e‹¿. ¬‹Ž‰p’·1, _’J˜aF2, Ž…Œö–ç2, ìŽç“c‘ñŽu3, ‹›—¢@”Ž3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ˆã—Éq¶Šw•”): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723750. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) LŽ‹–ì—ŒŠáŠJ•úŒ^“dŽq“µEŒv‚ÌŠJ”­. ”Œ“c’m–ç1, ¯ŽiMs1, ì‘º@—º2, Ž…‹I–F2, ¬ŠâOŽq2, •Ÿ“‡ÈŒá2, àV“cˆêÆ2, ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, Îì@‹Ï1, Ž…Œö–ç3 (1ˆã—Éq¶Šw•”, 2ƒpƒiƒ\ƒjƒbƒN“dH, 3Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723751. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ‰~Šp–Œ‚𔺂€”’“àáŠá‚ɑ΂·‚éŠá“àƒŒƒ“ƒYŒvŽZ‚ÌŒŸ“¢. Žsì@Œc1, ‹Ê’u–Ÿ–ì1, ¬“‡—²Ži2, ˆé’J®‹P2, “Žˆä—ŠG2, ’†‘º—Fº2, Žsìˆê•v1,3 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723752. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@‚̗Տ°Œo‰ß. ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç2, Š±ì—¢ŠG2, ”Ñ“c‰Ã•F2, “V–엝Œb2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723753. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ”’“àá‚ª–Ô–ŒŒ‹‘œ“Á«‚É—^‚Š‚é‰e‹¿. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, HŽRŒ’Žu2, ‰F‰ê–ÎŽO1, Ž…Œö–ç3 (1ˆã—Éq¶Šw•”, 2ƒTƒCƒoƒlƒbƒgƒVƒXƒeƒ€, 3Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723754. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) 26Î’j«‚É”­¶‚µ‚œ–Ñ—l‘̐F‘fã”çŠà‚Ì1—á. ”–؍LÆ1,2, ŽO‰YF•v3, –ö“c˜a•v4, ’†ì‰ë—T5, ˆäãŒ[‘Ÿ5, “n粗íŽq6, ˆÉ“¡ˆÉ’m˜Y6 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È, 3Ã‰ªŒ§—§‘‡•a‰@, 4‚â‚È‚¬‚ŸŠá‰È, 5Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[EŒ`¬ŠO‰È, 6Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[E•a—f’f‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723755. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) CIGTSƒXƒRƒA‚Æ‚Ì”äŠr‚ÉŠî‚­V‚µ‚¢—Γàá•ª—Þ‚Ì•]‰¿. •œàVˆê–@1, ¯ŽiMs2, X“c“N–ç3, Ž…Œö–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723756. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒqƒAƒ‹ƒƒ“Ž_ƒiƒgƒŠƒEƒ€EƒWƒNƒAƒzƒ\ƒ‹ƒiƒgƒŠƒEƒ€“_Šá•¹—p—Ö@‚̗Տ°“IŒŸ“¢. Îˆä—œŠG1,2, _’J˜aF3, ’†Œ@Šî3,4, ŒÜ\—’ÍŽj3, ¬‹Ž‰p’·3,5, ²“¡M”V3, ‘ŠàV‘å•ã5, —é–؉ëM1,3, Ž…Œö–ç3 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Šá‰È, 4‘å˜aŽs—§•a‰@, 5ŠC˜V–Œ‘‡•a‰@): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723757. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) —܉t‚̈À’萫‚ð•]‰¿‚µ‚€‚éV‚µ‚¢f’fŽw•W‚ÌŒŸ“¢. ’†Œ@Šî1,2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2‘å˜aŽs—§•a‰@): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723758. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒ}ƒCƒ‹ƒhƒ‚ƒmƒrƒWƒ‡ƒ“‚Ì–ž‘«“x‚ɉe‹¿‚·‚éˆöŽq‚ÌŒŸ“¢. ]•—Ft1, “V–엝Œb1, íœAr‘Ÿ˜Y1, ”Ñ“c‰Ã•F1, ˆÉ“¡”ü¹ŠG2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723759. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ¬Ž™‚É”­Ç‚µ‹}Œƒ‚ȕω»‚ð‚«‚œ‚µ‚œŒŽˆö•s–Ÿ‚Ì–Ô–ŒŒŒŠÇ‰Š‚̈ê—á. —Žˆä‰‘Žq1, Žs糋`Í1, ’r“c“N–ç1, Ž…Œö–ç1, ™“c@’Œ2, –]ŒŽ@›{2 (1Šá‰È, 2“Œ‹žˆãŽ•‘å): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/8), “Œ‹ž.

723760. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ”ñÚGŒ^LŠpŠÏŽ@Œn‚ÆHHVƒƒjƒXƒJƒXƒŒƒ“ƒY•¹—pÉŽq‘ÌŽèp‚Å‚Ì—˜“_. ‘å–쏮“o1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

723761. [Šw‰ï (ES‘)] (ˆê”ÊŒû‰‰) ƒeƒB[ƒGƒXƒƒ“_‚É‚æ‚é—Ü“¹áŠQ: ‘œŽ{ÝŒ€‹†. âˆä@÷1, ˆäã@N2, ”–؍LÆ3,4, ²X–ØŽŸšæ5 (1Žs—§‰ÁŒ•a‰@, 2ˆäãŠá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 4Šá‰È, 5²X–ØŠá‰È): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

723762. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Ž‹ŠoáŠQŽÒ‚É‚š‚¯‚ég‘̏áŠQŽÒ“™‹‰‚̍ĔF’è‚Ì•K—v«. –öàV”üˆßŽq1,2, ‰Á“¡@‘1, ¬—Ñ‚ß‚®‚Ý1, “n粖œ—¢Žq1, —Ž‡áÁ‹IŽq1, ¯ŽiMs3 (1“Œ‹ž‘å, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ65‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2011/10/9), “Œ‹ž.

723763. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž•‚̈ړ®‚É‚æ‚é’É‚Ý‚ª“µE‚Ì“ú“à•Ï“®‚É—^‚Š‚é‰e‹¿. ‘åê@ƒ1, ŒŽ@’Œl2,3, ¬Žèì‘׎}2, ŒN“‡^ƒ2, –]ŒŽ_Žu2,4, ‹{àVK‹IŽq1, ¬“c”Ž—Y3, Œü–ì˜a—Y2,3 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN‹ž³Ž•‰È, 2_“ސ쎕‰È‘åŠw•‘®•a‰@‹ž³‰È, 3Šá‰È, 4_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È): ‘æ64‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2011/10/27), H“c.

723764. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™•Ð“ª’ɂ̊Ꭹ—¥_Œo‹@”\‚©‚ç‚Ý‚œŽ‹Šo‹@”\‚̏ó‘Ô. ŒŽ@’Œl1,2, ¬Žèì‘׎}1, ŒN“‡^ƒ1, –]ŒŽ_Žu1,3, —é–Ø—T”ü1,2, ‘å–ìWŽi1,2, Œü–ì˜a—Y1,2, ŒÜ\—’‹v‰À4 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4_“ސ쎕‰È‘åŠw‰¡•lƒNƒŠƒjƒbƒN“à‰È): ‘æ64‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2011/10/27), H“c.

723765. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ³–ÊŽ‹‹y‚Ñ“ª•”ŒXŽÎ‰º‚ł̉“Œ©—Z‘œ•‚ÌŒŸ“¢. ²“¡—F1, –î–ì@—²1, ‘ŠàV‘å•ã2,3, ¬‹Ž‰p’·2,3, ”óŒû‘”ü1 (1ŠC˜V–ŒƒƒfƒBƒJƒ‹ƒvƒ‰ƒUˆã—ËZp‰ÛŽ‹”\ŒP—û‰Û, 2ŠC˜V–Œ‘‡•a‰@, 3Šá‰È): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

723766. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 1”NˆÈãŒo‰ßŠÏŽ@‚Å‚«‚œ”ñŠíŽ¿«Ž‹ŠoáŠQ‚ÌŒŸ“¢. ¬àV—D‹M1, ¬—с@1, ŒüˆäÍ‘Ÿ1, ²“¡Œb1, Îˆä—SŽq1, ‰i–ì‰ëŽq1, ¬Œû–F‹v1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

723767. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’Ž‰¹”g‰æ‘œf’f‘•’u‚ð—p‚¢‚œ–Ñ—laŠÔ‹——£‘ª’è. ’†ŽR“ށX”ü1,2, â–{^“Þ”ü1, â–{•Û•v1, ìŽç“c‘ñŽu2,3, ‹›—¢@”Ž2,3, ²X–؈ê”V1 (1“Œ–k•¶‰»Šw‰€‘åŠwˆã—Éq¶, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Ew‰ï (2011/11/19), _“ސì.

723768. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’ŽLŠp‘–žƒŒ[ƒU[ŒŸŠá‹Ÿ‚ª—Տ°‚É‚š‚¢‚Đf’f‚É—L—p‚ÆŽv‚í‚ê‚œÇ—á. ¬Œû@—D1, ‰Á‰ê’BŽu1,2, ‹g“c‘¥•F1, ‹Ê’u–Ÿ–ì1, ‹gèŒ›Ž¡1, ’·£—zŽq1, ‰ªŒË•üŽq1, ‰Á“¡Km1, Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Šá‰È): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

723769. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —Ž‹Ž²‚ªŽ‹—Í‚É‹y‚Ú‚·‰e‹¿. ’†’JŸŒÈ1, “àŽRmŽu2, ‹gŒŽ_“ñ1, ‹›—¢@”Ž3 (1Œ]‘‡ˆã—Ðê–åŠwZŽ‹”\ŒP—ûŽm‰È, 2’¹Žæ‘åŠw’nˆæŠw•”, 3ˆã—Éq¶Šw•”): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

723770. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŒõŠwŽ®ŠáŽ²’·‘ª’è•s”\Šá‚ɑ΂·‚鐅ZŽ®‚ƐڐGŽ®’Ž‰¹”gAƒ‚[ƒh–@‚Ì”äŠr. ‰ªŒË•üŽq1, ‹Ê’u–Ÿ–ì1, ¬“‡—²Ži2, ‰¡ŽR@ãÄ1, ‹g“c‘¥•F1, Žsìˆê•v1,3 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2Œc‰ž‹`m‘åŠwŠá‰ÈŠw‹³Žº, 3Šá‰È): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

723771. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’ŽLŠp‘–žƒŒ[ƒU[ŒŸŠá‹ŸOptos200TxTM‚É‚æ‚éŠá’êŽÊ^ŽB‰e–@. ‰Á“¡Km1, ¬Œû@—D1, ‹Ê’u–Ÿ–ì1, ‹g“c‘¥•F1, ‰Á‰ê’BŽu1,2, Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/19), _“ސì.

723772. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŽåŒoü•ûŒü‚ÌŽ‹•W‚É‚æ‚闐Ž‹Šá‚ÌŒ‹‘œó‘Ô. i“¡^‹I1, ŽÄ“c—DŽq1, L“c‰ë˜a1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/20), _“ސì.

723773. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”’“àáŽèp‘OŒã‚ÌŠáˆÊE—§‘ÌŽ‹•Ï‰». Š±ì—¢ŠG1, ˆÉ“¡”ü¹ŠG2, “V–엝Œb1, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ52‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2011/11/20), _“ސì.

723774. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Šá’ÉŽå‘Ì‚Ìáu’ɐ«áŠQ‚ɑ΂·‚é, ‘I‘ð“IƒZƒƒgƒjƒ“Ä‹zŽû‘jŠQ–ò‚É‚æ‚鎡—Ã. “c’†‚ ‚ä‚Ý1, ŽRã–ŸŽq1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/25), •ºŒÉ.

723775. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”]ŽîᇓEopŒã‚É”­Ç‚µ‚œŠj‰º«Double Depressor Palsy‚̈ê—á. ŒŽ@’Œl1,2, ¬Žèì‘׎}1, ŒN“‡^ƒ1, —é–Ø—T”ü1,2, ‘å–ìWŽi1,2, Œü–ì˜a—Y1,2, Žsì‹P•v3 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È, 3‰¡•lˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠwEE‰EE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/25), •ºŒÉ.

723776. [Šw‰ï (‘SEE] (ƒ|ƒXƒ^[) ¬l‚Ìçtçsáz¹‚Ì5Ç—á‚ÌŒŸ“¢. ŽRã–ŸŽq1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/26), •ºŒÉ.

723777. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) 1‚©ŒŽ–ˆ‚ɕЊáŠááىº‚‚ð‚«‚œ‚µ‚œ—«‚Ì1—á. ŒN“‡^ƒ1, ŒŽ@’Œl1,2, ¬Žèì‘׎}1, —é–Ø—T”ü1,2, ‘å–ìWŽi1,2, Œü–ì˜a—Y1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

723778. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) —LF‰Æ“e‚ÌŒõŽó—eŠí‚ɑ΂·‚é‹@”\“I•]‰¿‚Æ‘gDŠw“IŠÏŽ@. óì@Œ«1, Îì@‹Ï1, ‰F‰ê–ÎŽO1, ^‰º‹I”ü‘ã2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

723779. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ³í‰Æ“e–Ô–Œ‘gDŠw“IŠŒ©‚Æ‘ÎŒõ”œŽË‚ÌŠÖŒW. Îì@‹Ï1, ‰F‰ê–ÎŽO1, óì@Œ«1, ^‰º‹I”ü‘ã2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

723780. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) çt–©•‰‰×‚É”º‚€’²ßE“µE”œ‰ž‚̉Á—•Ï‰»‚ɂ‚¢‚Ä. åŒŽŽµd1, Îì@‹Ï1, ŽÂ‹{䝈ߎq2, ’‡–ì”ü˜a3, “ê“c–œ—¢Œb4, ²“¡‰Ä—t5, M“cŽD6, Ž…Œö–ç5 (1ˆã—Éq¶Šw•”, 2‚ˆäŒË‰w‘OŠá‰È, 3ã‰ªŠá‰Èˆã‰@, 4“ñ–{ŒŠá‰È•a‰@, 5Šá‰È, 6•‘ –ìÔ\Žš•a‰@): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

723781. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠO«‚ŽŸ”]‹@”\áŠQ‚ªŽŠŽ‚³‚ê‚鎋ŠoˆÙíÇ—á. “ì‰_‚Í‚é‚©1, Žá‘q‰ë“o1,2, ÎˆäŒ«“ñ3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ‹ž“sŒ’N’·Žõˆã—ÃZƒ“ƒ^[ƒ|ƒWƒgƒƒ“ˆãŠwŒ€‹†Ž{Ý•‘®f—ÏŠ): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

723782. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠáŽ²‰„’·‚É‚æ‚éŠáˆÊˆÙíÇ—á‚ÌŽèp‘OŒã‚ÌŠOŠá‹Ø‚̈ʒu•Ï‰». ‰Í–{‚Ђë”ü1, ŽRã–ŸŽq1, Vˆä‰Ì“ލ]2, Žá‘q‰ë“o1,3 (1ˆäãŠá‰È•a‰@, 2“Œ‹ž—Žqˆã‰È‘åŠw•a‰@Šá‰È, 3Šá‰È): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

723783. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹ßŽ‹‚É”º‚€ŠJŽU•s‘S—á‚̊Ꮂ’·•Ê”äŠr. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, ’r“c“N–ç1, óì@Œ«2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—ÁEq¶Šw•”): ‘æ49‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ïE‘æ6‰ñƒAƒWƒA_ŒoŠá‰ÈŠw‰ï@‡“¯Šw‰ï (2011/11/27), •ºŒÉ.

723784. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹•ŒŒ«Ž‹_ŒoÇ‚Æ“œ”A•a. t–ؐ’O1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‘æ17‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï (2011/12/2), “Œ‹ž.

723785. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ‹…–ÊŠá“àƒŒƒ“ƒY‚ƏɎq‘̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚Ì‘g‚ݍ‡‚킹‚É‚æ‚éŠá’ê’†‰›Ž‹”F«‚Ì”äŠr. ‰Á‰ê’BŽu1,2, Ž…Œö–ç2, ‹›—¢@”Ž3, ìŽç“c‘ñŽu3, ‹g“c‘¥•F1 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È, 3ˆã—Éq¶Šw•”): ‘æ50‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ï (2011/12/2), “Œ‹ž.

723786. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) ŸøoŒ^‰Á—”Á•Ï«‚ɑ΂·‚éranibizumabÉŽq‘Ì“à“Š—^‚Ì12ƒ–ŒŽŽ¡—ЬÑ. ›ŒŽ“¹F1, ‘å–쏮“o1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ50‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ï (2011/12/3), “Œ‹ž.

723787. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñÚGŽ®LŠpŠÏŽ@Œn—pŠp–ŒŠ£‘‡–hŽ~ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ÌŽg—pŒoŒ±. ‘å–쏮“o1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È, 2Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

723788. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹û—Γàá‚ɑ΂·‚éƒgƒ‰ƒxƒNƒg[ƒ€—¬o˜HÄŒšŽèp‚̏pŒã1”N¬Ñ. “n•ÓŽOŒP1, ‘O“cªG2, Žsìˆê•v1,3, ŒìŽu•ä1, ‘åŠÑ˜a“¿2 (1ŽÐ•Û’†‹ž, 2Šò•ŒÔ\Žš•a‰@, 3Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

723789. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àŽ‹‹Ÿ‚ÅŠÏŽ@‚µ‚œ“ØŠá‚É‚š‚¯‚éƒgƒƒJ[ƒ‹”²‹ŽŽž‚̏Ɏq‘̛ƓÚ. ²“¡—T”V1, ‰Á‰ê’BŽu2,3, X@r’j2, ‹g“c‘¥•F2, Žsìˆê•v2,3 (1”Ñ“cŽs—§•a‰@, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 3Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

723790. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2.8 mm¬ØŠJŠá“àƒŒƒ“ƒY–D’…p‚̏pŒã¬Ñ. ì“YŒ«Žu1, ÝŠy‹±Žq1, XŽR@—Á1, “¿“c–F_1, Žá‘q‰ë“o1,3, ˆäãŒ«Ž¡1, ‹g•x•¶º2 (1ˆäãŠá‰È•a‰@, 2‘åÉ•{‹g•xŠá‰È, 3Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/27), ˆ€’m.

723791. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šá“àƒŒƒ“ƒY‚ªŠá’ê‚É—Ž‰º‚µ‚œÇ—á‚ɑ΂·‚éŽèp‚ƏpŒãŒo‰ß. —с@“aé1, ÝŠy‹±Žq1, XŽR@—Á1, “¿“c–F_1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, ‹g•x•¶º3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‘åÉ•{‹g•xŠá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

723792. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñis«EŒy“x‰~Šp–Œ‚ɑ΂·‚éƒg[ƒŠƒbENŠá“àƒŒƒ“ƒY‘}“üp‚ÌŒŸ“¢. ŽO‘îr”V1, Ž…Œö–ç1, _’J˜aF1, “V–엝Œb1, ”Ñ“c‰Ã•F1 (1Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

723793. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹÷ŠpŽxŽŒ^‘O–[ƒŒƒ“ƒY‚̃‹[ƒv‚ªpŒãŒo‰ß’†‚É‹­–ŒúE‚ð‚«‚œ‚µ‚œ2Ç—á. XŽR@—Á1, ÝŠy‹±Žq1, —с@“aé1, “¿“c–F_1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, ‹g•x•¶º3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‘åÉ•{‹g•xŠá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

723794. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z ”’“àáu”ñ‹…–ÊŠá“àƒŒƒ“ƒYE‚»‚Ì‘Œv. Ž…Œö–ç1, Îˆä@Ž2,3 (1Šá‰È, 2‚³‚¢‚œ‚ܐԏ\Žš, 3“Œ‹ž‘å): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

723795. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) UBM (ultrasound biomicroscopy) ‚É‚æ‚é–Ñ—laŠÔ‹——£‚̍Č»«‚ÌŒŸ“¢. ²“¡M”V1, ŒÜ\—’ÍŽj1, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

723796. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) —Γàá‚ð—L‚·‚élHŠp–Œ (Boston Keratoprosthesis) ˆÚAŠá‚̏pŒãŽ‹–ì‚ÌŒŸ“¢. Ž›“c—T‹IŽq1, X@—mÄ1, Žq“‡—Ç•œ1, “ìŒcˆê˜Y1, ‹{“c˜a“T1, _’J˜aF2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

723797. [Šw‰ï (‘S‘)] (Šwp“WŽŠ)yÀ’·z‹üÜ‹ž³Žèp. —é–؉ëM (Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/28), ˆ€’m.

723798. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) •ÐŠá”’“àápŒã‚É“K‰žáŠQ‚ª¶‚¶‚œˆê—á‚ÌŒŸ“¢. ”ä‰Ã—˜¹Žq1, –{‘œ¹Žq1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, ‘å“à‰ë”V3, ‹›—¢@”Ž4 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‘å“àŠá‰È, 4ˆã—Éq¶Šw•”): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

723799. [Šw‰ï (‘S‘)] (Šwp“WŽŠ) –³…»‘ÌŠá“øÊ— –ʌŒèŠá“àƒŒƒ“ƒY‘}“üŒã‚Ì‘O–[“à‰ŠÇ‚ÆŠp–Œ“à”ç×–E‚ւ̉e‹¿. ŒŽ@CÆ1, ‰Á“¡Km1, ¬“‡—²Ži2, ’†‘º—Fº3, Žsìˆê•v1,4 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Œcœä‘å, 3–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 4Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

723800. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Refractive Lenticle Extraction (ReLEx) ‚ÆWavefront-guided LASIK‚̍‚ŽŸŽû·‚Ì”äŠr. ŒÜ\—’ÍŽj1, _’J˜aF1, ²“¡M”V1, Ž…Œö–ç1 (1Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), E€’m.

723801. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —L…»‘ÌŒã–[ƒŒƒ“ƒY (ICL) ‚ƊђʍE•t‚«ICL (Hole ICL) ‘}“üŠá‚É‚š‚¯‚鎋‹@”\‚Ì”äŠr. ”’’J@“O1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, _’J˜aF1 (1Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

723802. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’†“™“x‹ßŽ‹‚É‚š‚¯‚é—L…»‘ÌŠá“àƒŒƒ“ƒY‚Æwavefront-guided LASIKpŒãŽ‹‹@”\‚Ì”äŠr. _’J˜aF1, Œ‘ºˆêO1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1, ¬Œ^—1,2 (1Šá‰È, 2ŽR‰€•a‰@): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

723803. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) …áv«Šp–ŒÇ‚É‚š‚¯‚éÄ”­«Šp–Œã”ç‚Ñ‚ç‚ñ‚ɑ΂·‚éŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO. Îˆä—œŠG1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): ‘æ35‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2012/1/29), ˆ€’m.

723804. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO‚ðŽ{s‚µ‚œ6—á‚̏‰Šú¬Ñ. ‹ß“¡“Þ’Ã1, ¬“‡—²Ži2, ˆé’J®Ž÷2, ’†‘º—Fº2, Žsìˆê•v3,4 (1Šò•ŒÔ\Žš•a‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 4Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2012/‘æ36‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ28‰ñ“ú–{Šp–ŒˆÚAŠw‰ï (2012/2/24), “Œ‹ž.

723805. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–ŒˆÚApŒã‚ÉŒã–[Œ^ƒtƒFƒCƒLƒbƒNIOL (ICL) ‚ð—p‚¢‚Ä‹üÜ‹ž³‚ðs‚Á‚œ2—á. ’·’JìˆŸ—¢1, ¬“‡—²Ži2, ˆé’J®Ž÷3, ŒŽ@CÆ1, ’†‘º—Fº3, Žsìˆê•v1,4 (1’†‹ž•a‰@, 2Œc‰ž‘å, 3–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 4Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2012/‘æ36‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ28‰ñ“ú–{Šp–ŒˆÚAŠw‰ï (2012/2/24), “Œ‹ž.

731122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŽ‹–쌟ž‚̍ŋ߂̘b‘è. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ2‰ñ—ΓàáƒXƒLƒ‹ƒAƒbƒvƒZƒ~ƒi[ (2011/5/21), ŽD–y.

731123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zR‚ª‚ñÜ‚É‚æ‚é—Ü“¹áŠQ‚ɂ‚¢‚Ä. ”–؍LÆ1,2 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): ‘æ5‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2011/6/10), _“ސì.

731124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z—Γàá–ò•š—Ö@`”z‡Ü¡Œã‚Ì“W–]`. ¯ŽiMs (ˆã—Éq¶Šw•”): ‰¡{‰êŽsŠá‰Èˆã‰ïŠwpu‰‰‰ï (2011/7/5), _“ސì.

731125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z—Γàá‚̐is”»’è‚ÆŽ¡—Ã. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ26‰ñŽOdŒ§Šá‰ÈƒZƒ~ƒi[ (2011/7/10), ŽOd.

731126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•ÊuEEyÀ’·zƒgƒ‰ƒxƒNƒg[ƒ€Žèp‚Ì‘Šú¬Ñ. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ5‰ñ‚³‚ª‚ÝŠá‰ÈŒ€‹†‰ï (2011/7/22), _“ސì.

731127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zƒpƒ^[ƒ“ƒXƒLƒƒƒ“ƒŒ[ƒU[‚Ì“Á’¥‚ÆŽg—p‚·‚éÛ‚Ì’ˆÓ“_. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ5‰ñ‚³‚ª‚ÝŠá‰ÈŒ€‹†‰ï (2011/7/22), _“ސì

731128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŽ‹–쌟ž‚Ì’ˆÓ“_‚š‚æ‚уgƒ‰ƒxƒNƒg[ƒ€‚Ì’ZŠú¬Ñ. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ5‰ñŒcœä—ΓàáƒI[ƒvƒ“ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/8/27), “Œ‹ž.

731129. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z“–‰È‚É‚š‚¯‚éŒõŠ±Â’f‘wŒv‚ð—p‚¢‚œ—Տ°Œ€‹†‚ÌŒ»ó. —é–؍‚‰“1,2 (1‰¡•lŽsŠá‰Èˆã‰ï, 2Šá‰È): ‘æ13‰ñ‰¡•lŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2011/9/3), _“ސì.

731130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z“Á•Êu‰‰. Ž…Œö–ç (Šá‰È): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

731131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z“œ”A•af—Ïî•ñ’ñ‹Ÿ‘‚ð—p‚¢‚œ_“ސ쌧‚É‚š‚¯‚éŠá‡•¹Ç‚ÌŽÀ‘Ô’²ž. —é–؍‚‰“ (Šá‰È): ‘æ124‰ñ_“ސ쌧Šá‰ÈW’k‰ï (‘æ53‰ñ_“ސìˆãŠw‰ï•ª‰È‰ï) (2011/10/13), _“ސì.

731132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠá’ꃌ[ƒU[Œõ‹ÃŒÅŽ¡—Â̗ðŽj‚ƌܑ原Š³‚ÌŽ¡—Ð헪. Ží“c–F˜Y (Šá‰È): ‘æ124‰ñ_“ސ쌧Šá‰ÈW’k‰ï (‘æ53‰ñ_“ސìˆãŠw‰ï•ª‰È‰ï) (2011/10/13), _“ސì.

731133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ð—p‚¢‚œ‹üÜ‹ž³ŽèpReLEx‚Æ—L…»‘ÌŠá“àƒŒƒ“ƒY. Ž…Œö–ç (Šá‰È): ‘æ10‰ñBay Ophthalmic Surgical Seminar (2011/10/29), _“ސì.

731134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŽ‹–쌟ž‚Ì’ˆÓ“_‚š‚æ‚уgƒ‰ƒxƒNƒg[ƒ€‚Ì’ZŠú¬Ñ. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ30‰ñŽR—œŠá‰ÈŒ€‹†‰ï (2011/11/25), b•{.

731135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z3D‰f‘œ‚É‚æ‚鎋Šo‹@”\‚ւ̉e‹¿`ƒŠƒXƒN‚ð”ð‚¯‚È‚ª‚ç3DŠÂ‹«‚ðŠy‚µ‚ށ`. ŒŽ@’Œl1,2 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ9‰ñ‰¡•l—Տ°Šá‰ÈƒVƒ“ƒ|ƒWƒEƒ€ (2011/11/26), _“ސì.

731136. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z”’“àáŽèp‚É‚š‚¯‚é˜VŽ‹‘΍ô. Ž…Œö–ç (Šá‰È): ‘æ4‰ñÔâ—Տ°Šá‰ÈƒNƒ‰ƒu (2012/1/12), “Œ‹ž.

731137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠááوُí: ‚»‚ÌŠî‘b‚Æ‘ã•\“IŽŸŠ³‚̐f’f, Ž¡—Õûj|_ŒoŠá‰È“Il‚Š•û|. Œü–ì˜a—Y (Šá‰È): ‘æ9‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2012/2/2), _“ސì.

731138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠááوُí: ‚»‚ÌŠî‘b‚Æ‘ã•\“IŽŸŠ³‚̐f’f, Ž¡—Õûj|_ŒoŠá‰È“Il‚Š•û|. Ž…Œö–ç (Šá‰È): ‘æ9‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2012/2/2), _“ސì.

731139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z‘OŠá•”OCT‚ÌŠJ”­‚Æ’²ß‚̃ƒJƒjƒYƒ€. Ž…Œö–ç (Šá‰È): ‘æ5‰ñTMDŠá‰ÈƒtƒH[ƒ‰ƒ€ (2012/2/4), “Œ‹ž.

731140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠƒ–èŽs—§•a‰@‚É‚š‚¯‚é‰Á—”Á•Ï«Ç‚̃‹ƒZƒ“ƒeƒBƒXŽ¡—Ã. —é–؍‚‰“1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ40‰ñ_“ސìŠá‰Èˆã‰ï•a‰@uK‰ï (2012/2/18), _“ސì.

731141. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠƒ–èŽs—§•a‰@Šá‰È‚Ì–Ô–ŒÉŽq‘ÌŽŸŠ³‚ÌŽ¡—Â̌»‹µ. Ží“c–F˜Y1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ40‰ñ_“ސìŠá‰Èˆã‰ï•a‰@uK‰ï (2012/2/18), _“ސì.

731142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zOCT‚ÌŠî‘b‚Æ“Ç‚Ý•û. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ1‰ñSanten Glaucoma Seminar in Sapporo (2012/3/3), ŽD–y.

731143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yŽi‰ïz”’“àáŽèp‚ŃPƒƒ“ƒpŽá•Ô‚è. Ž…Œö–ç (Šá‰È): Žs–¯ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€u¶Šˆ‚ÌŽ¿‚ð‚‚ß‚éˆã—Á|¢ŠE‚Ɍւé“ú–{‚ÌŽèp|v(2012/3/10), “Œ‹ž.

731144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zƒCƒ“ƒvƒ‰ƒ“ƒgŽèp. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ23‰ñNG‰ï (2012/3/23), _“ސì.

732070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zˆê”ʍu‰‰. Ž…Œö–ç (Šá‰È): ‘æ3‰ñ_“ސìŠá‰ÈŠw‰ï (2011/4/24), _“ސì.

732071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) –¢nŽ™–Ô–ŒÇ‚Ə¬Ž™‚ÌŽ‹Šo”­’B. ’r“c“N–ç (Šá‰È): ‘æ21‰ñ¬Ž™Šá‰È (ŽÎŽ‹¥ŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2011/6/5), _“ސì.

732072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) Šp–ŒˆÚA‚ÌŒ»ó‚ƍ¡Œã`V‚œ‚ÈŒõ‚ðŽæ‚è–ß‚»‚€`. _’J˜aF (Šá‰È): ‘æ7‰ñÃ“ìƒAƒCƒoƒ“ƒNƒ`ƒƒƒŠƒeƒB[ƒRƒ“ƒT[ƒg (2011/6/5), _“ސì

732073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) ƒgƒ‰ƒxƒNƒg[ƒ€‚ð—p‚¢‚œ‘@ˆÛ’Œ‘ѐ؊Jp‚Ì’ZŠú¬Ñ. Î“c@‹Å1, –Ø‘º“TŒh, X“c“N–ç1, ¯ŽiMs2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ17‰ñƒlƒIƒoƒX‰ï (2011/6/11), VŠƒ

732074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) ƒhƒ‰ƒCƒAƒC‚ÆŠÖ˜AŽŸŠ³@ŒŸžEf’fEŽ¡—Ã. ’†Œ@Šî (Šá‰È): ‘å’ː»–òŽÐ“àu‰‰‰ï (2011/6/17), _“ސì

732075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) PAC (•ÂÇ‹÷ŠpÇ) LI‚Ì“K‰ž‚ðl‚Š‚é. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ14‰ñ‘Š–ÍŒŽƒOƒ‰ƒR[ƒ}ƒ~[ƒeƒBƒ“ƒ“ƒO (2011/6/24), _“ސì

732076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) –³Ž¡—Â̋ؖ³—͏ǂɋ}«Šúbó‘B‹@”\˜ŽiÇ‚ð‡•¹‚µ‚œ1—á. —с@“aé1, ŽRã–ŸŽq1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ81‰ñ_ŒoŠá‰È•×‹­‰ïƒvƒƒOƒ‰ƒ€ (2011/6/29), “Œ‹ž

732077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zŠáâ|Žîᇂ̐f’fƒAƒvƒ[ƒ`‚ÆŽ¡—Ð헪. Žs糋`Í (Šá‰È): ‘æ36‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2011/7/7), _“ސì

732078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z—Γàá‘Šúf’fƒc[ƒ‹‚Æ‚µ‚Ä‚ÌOCT‚̉”\«. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ11‰ñ_“ސìŠá‰ÈƒZƒ~ƒi[ (2011/7/14), _“ސì

732079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) ”]‚ɂ₳‚µ‚¢”’“àáŽèp: Œ©‚Š•û‚ð‘I‚Ô”’“àáŽèp. Ž…Œö–ç (Šá‰È): –k—€Šá‰ÈŠwpƒZƒ~ƒi[ (2011/7/14), ‹à‘ò

732080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‚ƒfƒŒ[ƒ^[) Šááىº‚Žèp‚É‚š‚¯‚é‹@”\‚Æ”ü—e‚Ì—Œ—§: Šá‰È‚Æ”ü—eŒ`¬ŠO‰È‚̐ړ_‚ð‚à‚Æ‚ß‚Ä. —é–؉ëM (Šá‰È): ‘æ16‰ñTokyo Ocular Surface Forum (2011/7/15), “Œ‹ž

732081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) ƒŠƒtƒ‰ƒNƒeƒBƒuƒT[ƒWƒFƒŠ[ up date -Phakic IOL-. _’J˜aF (Šá‰È): Refractive Surgery Update Seminar in Kyoto (2011/7/23), ‹ž“s

732082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) —Γàá‚Ì–ò•š—Ö@‚ƐV‚œ‚È—¬o˜HŽèp. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ8‰ñŽ©Ž¡ˆã‰È‘åŠw•‘®‚³‚¢‚œ‚܈ã—ÃZƒ“ƒ^[Šá‰ÈƒNƒŠƒjƒJƒ‹EƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/7/23), é‹Ê

732083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (uK‰ï) “ª’ɁEŠá’É. ŒŽ@’Œl1,2 (1_“ސ쎕‰È‘åŠw, 2Šá‰È): ‘æ27‰ñ^’߃Zƒ~ƒi[ (2011/7/24), ” ª

732084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[) _ŒoŠá‰È‹~‹}ŽŸŠ³|‚»‚Ì‚Æ‚«‚Ç‚€‚·‚é?|. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ10‰ñBay Ocular Club (2011/7/30), _“ސì

732085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[) ŒãŠá•”‚Ì‹Ù‹}Eèp|ŽèpŽº‚É“ü‚é‚܂Ł|. –ö“c’q•F (Šá‰È): ‘æ10‰ñBay Ocular Club (2011/7/30), _“ސì

732086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yƒI[ƒKƒiƒCƒU[z¯ŽiMs (ˆã—Éq¶Šw•”): ƒUƒ‰ƒJƒ€”­”„1Žü”N‹L”Ou‰‰‰ïin‰¡•l (2011/8/4), _“ސì

732087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (W’k‰ï) Ž‹_Œoâ‘–ŒŽî‚É—zŽqüŽ¡—Âðs‚Á‚œ1—á. ”–؍LÆ1,2, ’†F—fŽq3, “¡@@_4, ‘ºŽRds4, ‘º‹v[Žq5 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[”]_ŒoŠO‰È, 4Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[—zŽqüŽ¡—ÉÈ, 5‚³‚­‚çŠá‰È): ‘æ57‰ñÃ‰ªŒ§Šá‰Èˆã‰ïW’k‰ï (2011/8/27), Ã‰ª.

732088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) Ç—á‚©‚çŠw‚ÔŠy‚µ‚¢_ŒoŠá‰È. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ20‰ñƒTƒƒ“ƒhL“‡ (2011/8/27), L“‡.

732089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “œ”A•a‚̐_ŒoŠá‰È“I‡•¹Ç. Žs糋`Í (Šá‰È): ‘æ17‰ñ“œ”A•a«_ŒoáŠQ‚ðl‚Š‚é‰ï (2011/8/27), “Œ‹ž.

732090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) IT, 3DŽž‘ã‚̊ᐞ”æ˜J. Îì@‹Ï (ˆã—Éq¶Šw•”): Šá‰ÈƒAƒbƒvƒf[ƒgƒZƒ~ƒi[in‰ªŽR (2011/8/28), ‰ªŽR.

732091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) Ð‰î—á‚æ‚èŠw‚Ԑ_ŒoŠá‰È‹~‹}ŽŸŠ³. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ2‰ñ–ڍ•Šá‰ÈƒZƒ~ƒi[ (2011/9/7), “Œ‹ž.

732092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) _ŒoŠá‰ÈŽŸŠ³‚̐f•û. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ21‰ñŠá‰Èˆã—ÃtƒH[ƒ‰ƒ€ (2011/9/10), “¿“‡.

732093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰)yÀ’·zˆã—Ë@ŠÖ‚Å‚Ì–\—͑΍ô`ˆÀ‘S‚ňÀS‚Ȉã—Ë@ŠÖ‚ð‚ß‚Ž‚µ‚Ä. Ží“c–F˜Y (Šá‰È): ‘æ2‰ñ_“ސìŠá‰Èˆã—Ï]Ž–ŽÒ•×‹­‰ï (2011/9/10), _“ސì.

732094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šwpu‰‰) ƒXƒyƒNƒgƒ‰ƒ‹ƒhƒƒCƒ“OCT (SpectrailsÒ) ‚É‚æ‚é—ΓàáŠá‚Ì•]‰¿. X“c“N–ç (Šá‰È): ‘æ12‰ñ_“ސ쌧Šá‰ÈŠwpu‰‰‰ï (2011/9/17), _“ސì.

732095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zƒXƒyƒNƒgƒ‰ƒ‹ƒhƒƒCƒ“OCT (SpectrailsÒ) ‚É‚æ‚é—ΓàáŠá‚Ì•]‰¿. —é–؍‚‰“1,2 (1Šá‰È, 2_“ސ쌧Šá‰Èˆã‰ï): ‘æ12‰ñ_“ސ쌧Šá‰ÈŠwpu‰‰‰ï (2011/9/17), _“ސì.

732096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zOCTƒZƒ~ƒi[. Žs粋`Í (Šá‰È): ‘æ6‰ñ_“ސ쉩”ÁŒ€‹†‰ï‘æ1‰ñOCTƒZƒ~ƒi[ (2011/9/24), _“ސì.

732097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) –k—¢‘åŠwŠá‰È‚É‚š‚¯‚éŽÎŽ‹EŽãŽ‹Ž¡EÂ̎ÀÛ. ŒË’ˁ@Œå (Šá‰È): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

732098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰)yÀ’·zŽs粋`Í (Šá‰È): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

732099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰)yÀ’·z—Γàá‚É‚š‚¯‚é–ðŽÒ‚œ‚¿, ×–EƒŒƒxƒ‹‚̍lŽ@. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ2‰ñÃŒŠá‰ÈƒAƒJƒfƒ~[ (2011/10/5), ‘Š–ÍŒŽ.

732100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰)yÀ’·zbó‘BŠáÇ‚ÌŠO‰È“IŽ¡—Ã. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ2‰ñÃŒŠá‰ÈƒAƒJƒfƒ~[ (2011/10/5), ‘Š–ÍŒŽ.

732101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šwpu‰‰) OCT‚̐V‚µ‚¢“WŠJ. ’†Œ@Šî (Šá‰È): ÃŒŠá‰Èˆã‰ïŠwpu‰‰‰ïEƒXƒ^ƒbƒtuK‰ï (2011/10/15), Œú–Ø.

732102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) Ž‹–쌟ž‚Æ‚»‚ÌŠÇ—. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ13‰ñ‹³ˆçƒtƒH[ƒ‰ƒ€ (2011/10/15), •Ÿ‰ª.

732103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zu‰‰‰ï. Žs糋`Í (Šá‰È): ‘æ25‰ñ_“ސ샍[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒNŒ€C‰ï (2011/10/22), _“ސì.

732104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒZƒbƒVƒ‡ƒ“) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ð—p‚¢‚œV‚µ‚¢‹üÜ‹ž³Žèp: ReLEx. ŒÜ\—’ÍŽj (Šá‰È): ‘æ10‰ñBay Ophthalmic Surgical Seminar (2011/10/29), _“ސì.

732105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒZƒbƒVƒ‡ƒ“) ƒRƒ“ƒXƒeƒŒ[ƒVƒ‡ƒ“Ò‚ð—p‚¢‚œÉŽq‘ÌŽèp|ƒAƒLƒ…ƒ‰ƒX҂Ƃ̔äŠr|. –ö“c’q•F (Šá‰È): ‘æ10‰ñBay Ophthalmic Surgical Seminar (2011/10/29), _“ސì.

732106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œ€‹†”­•\) •œ¬22”N“xŠwZ•ÛŒ’‚Ì‘S‘’²ž•ñ. ‰F’ÃŒ©‹`ˆê1,2 (1_“ސ쌧ˆãŽt‰ï, 2Šá‰È): ‘æ42‰ñ ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï (2011/10/29), Ã‰ª.

732107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œ€‹†”­•\) Šá‰ÈŠwZˆã‚ÌŽæ‚è‘g‚Ý•û‚Ì“W–]. â–{‘¥•q1,2 (1_“ސ쌧ˆãŽt‰ï, 2Šá‰È): ‘æ42‰ñ ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï (2011/10/29), Ã‰ª.

732108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‚ƒfƒŒ[ƒ^[) ‹ßŽ‹ƒƒJƒjƒYƒ€‚Æ‚»‚Ì—\–hE‹ž³@¡Šî‘b•Ò. ‹›—¢@”Ž (ˆã—Éq¶Šw•”): 15th The IRSJ 2011 (2011/11/12), _“ސì.

732109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‚ƒfƒŒ[ƒ^[) ‹ßŽ‹ƒƒJƒjƒYƒ€‚Æ‚»‚Ì—\–hE‹ž³@¡—Տ°•Ò. —é–؉ëM1,2 (1–k—¢‘åŠw–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2Šá‰È): 15th The IRSJ 2011 (2011/11/12), _“ސì.

732110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‚ƒfƒŒ[ƒ^[) ‘OŠá•”O‚bT‚Ì–£—Í. X“c“N–ç (Šá‰È): ‘æ12‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2011/11/12), _“ސì.

732111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‚ƒfƒŒ[ƒ^[) ˆê”ʍu‰‰. “V–엝Œb (Šá‰È): ‘æ12‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2011/11/12), _“ސì.

732112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‚ƒfƒŒ[ƒ^[) V‚µ‚¢ÉŽq‘ÌŽèp‹@Ší@ƒRƒ“ƒXƒeƒŒ[ƒVƒ‡ƒ“. Žs粋`Í (Šá‰È): ‘æ12‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2011/11/12), _“ސì.

732113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) Å‹ß‚̃ŒƒZƒvƒg¿‹‚Å‚Ì’ˆÓ“_. Œ–{_”V (Šá‰È): _“ސ쌧Šá‰Èˆã‰ï@‰¡•lEÃ“썇“¯Œ’•Û§˜b‰ï (2011/11/12), _“ސì.

732114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) ƒJƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ðl‚Š‚é`–@‰ü³‚É‚æ‚ègƒJƒ‰ƒRƒ“h‚Í‚Ç‚€‚È‚é‚Ì‚©?`. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): _“ސ쌧Šá‰Èˆã‰ïŒã‰‡Šá‰ÈƒZƒ~ƒi[ (2011/12/10), _“ސì.

732115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zƒJƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ðˆ•û‚µ‚Ü‚·‚©? ‚µ‚Ü‚¹‚ñ‚©?. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): _“ސ쌧Šá‰Èˆã‰ïŒã‰‡Šá‰ÈƒZƒ~ƒi[ (2011/12/10), _“ސì.

732116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) –Ú‚ÅŒ©‚Ä—‰ðE”[“Ÿ‚·‚é_ŒoŠá‰ÈŽŸŠ³. Îì@‹Ï (ˆã—Éq¶Šw•”): é‹ÊŒ§Šá‰È‹³ˆçu‰‰‰ï (2012/1/15), é‹Ê.

732117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰)yÀ’·zŠááَèp‚ÌŒ»ó‚ɂ‚¢‚ā`_ŒoŠá‰È“I, ‘€–Ê‚©‚ç`. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ9‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2012/2/2), _“ސì.

732118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) Šááَèp‚ÌŒ»ó‚ɂ‚¢‚ā`_ŒoŠá‰È“I, ‘€–Ê‚©‚ç`. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ9‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2012/2/2), _“ސì.

732119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šwpu‰‰) “úíf—ÂɕK—v‚È‹üÜ‹ž³Žèp‚Ì’mŽ¯. _’J˜aF (Šá‰È): “Œ‹ž“sŠá‰Èˆã‰ïŠwpu‰‰‰ï (2012/2/4), “Œ‹ž.

732120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ) ”’“àá‚ÆIOL‚ÌŒõŠw“I“Á«. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/2/11), “Œ‹ž.

732121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ)yƒI[ƒKƒiƒCƒU[z”’“àá‚Ì‚·‚ׂÄ. Ž…Œö–ç (Šá‰È): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/2/11-12), “Œ‹ž.

732122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ) ”’“àáŽèp‚Ì•Ï‘J‚ƍ¡Œã. Ž…Œö–ç (Šá‰È): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/2/12), “Œ‹ž.

732123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰)yÀ’·zu‰‰‰ï. Žs糋`Í (Šá‰È): ‘æ26‰ñ_“ސ샍[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒNŒ€C‰ï (2012/2/18), _“ސì.

732124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) —ΓàáŽ¡—Ã: ’PÜ•¹—p‚©”z‡Ü‚©. ¯ŽiMs (ˆã—Éq¶Šw•”): Pfizer Glaucoma Symposium 2012 (2012/2/19), “Œ‹ž.

732125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z’²ß‹@”\‚ðl—¶‚µ‚œŠá‹Ÿˆ•û‚Ì•K—v«‚ɂ‚¢‚Ä. Ž…Œö–ç (Šá‰È): ‘æ38‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2012/3/1 _“ސì.

732126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ) ”’“àá‚ÆIOL‚ÌŒõŠw“I“Á«. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/3), •Ÿ‰ª.

732127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) ‰ßè¿‹—á‚ɂ‚¢‚Ä. Œ–{_”V1,2 (1‰¡{‰êŽs‚€‚í‚Ü‚¿•a‰@, 2Šá‰È): Œ’•Û§˜b‰ï (2012/3/3), _“ސì.

732128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ)yƒI[ƒKƒiƒCƒU[z”’“àá‚Ì‚·‚ׂÄ. Ž…Œö–ç (Šá‰È): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/3-4), •Ÿ‰ª.

732129. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ) ”’“àáŽèp‚Ì•Ï‘J‚ƍ¡Œã. Ž…Œö–ç (Šá‰È): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/4), •Ÿ‰ª.

732130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (uK‰ï) ƒhƒ‰ƒCƒAƒC‚ɐö‚ÞŠááÙáz¹. Žá‘q‰ë“o1,2 (1ˆäãŠá‰Èˆã‰@, 2Šá‰È): ƒhƒ‰ƒCƒAƒCŒ€‹†‰ïŽåÃuK‰ï@2012 (2012/3/4), “Œ‹ž.

732131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) ”’“àáŽèp:gŒ©‚Š•ûh‚ð‘I‚Ô”’“àáŽèp. Ž…Œö–ç (Šá‰È): Žs–¯ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€u¶Šˆ‚ÌŽ¿‚ð‚‚ß‚éˆã—Á|¢ŠE‚Ɍւé“ú–{‚ÌŽèp|v(2012/3/10), “Œ‹ž.

732132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) –Ú‚ÅŒ©‚ÄŠo‚Š‚é‚₳‚µ‚¢_ŒoŠá‰È. Îì@‹Ï (ˆã—Éq¶Šw•”): ŽD–yŠá‰ÈW’k‰ï (2012/3/10), –kŠC“¹.

732133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰)gŒ©‚éh‚±‚Æmonovision‚Æ‘œÅ“_ƒŒƒ“ƒY‚ðl‚Š‚é. Ž…Œö–ç (Šá‰È): ‘æ21‰ñ–¶“‡Šá‰ÈŒ€èr‰ï (2012/3/17), ‹{è.

732134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) —Ž‹‹ž³‚ÉŠÖ‚·‚éÅ‹ß‚̘b‘è. _’J˜aF (Šá‰È): ‘æ21‰ñ–¶“‡Šá‰ÈŒ€èr‰ï (2012/3/17), ‹{è.

732135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ) ”’“àá‚ÆIOL‚ÌŒõŠw“I“Á«. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/24), •ºŒÉ.

732136. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ)yƒI[ƒKƒiƒCƒU[z”’“àá‚Ì‚·‚ׂÄ. Ž…Œö–ç (Šá‰È): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/24-25), •ºŒÉ.

732137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ) ”’“àáŽèp‚Ì•Ï‘J‚ƍ¡Œã. Ž…Œö–ç (Šá‰È): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/25), •ºŒÉ.

732138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ) ”’“àá‚ÆIOL‚ÌŒõŠw“I“Á«. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/31), ˆ€’m.

732139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçuÀ)yƒI[ƒKƒiƒCƒU[z”’“àá‚Ì‚·‚ׂÄ. Ž…Œö–ç (Šá‰È): “ú–{Šá‰Èˆã‰ï‘æ63‰ñ¶ŠU‹³ˆçuÀ (2012/3/31-4/1), ˆ€’m.

733341. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’Œ—Ž‹, “|—Ž‹, ŽÎ—Ž‹‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿|—Ž‹Ž²‚ÆŽ‹‹@”\|. ¬‹Ž‰p’·1,2, _’J˜aF2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): ‘æ3‰ñ_“ސìŠá‰ÈŠw‰ï (2011/4/24), _“ސì.

733342. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —§‘ÌŠá’ê‰æ‘œ‚É‚æ‚鎋_Œo“û“ª‰ðÍ‚Ì—L—p«. ‰Á“¡¹–1, óì@Œ«2, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ3‰ñ_“ސìŠá‰ÈŠw‰ï (2011/4/24), _“ސì.

733343. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Femtosecond laser‚̐V‚œ‚ȉ”\«`ReLEx(Refractive Lenticule Extraction) ‚̏‰Šú—Տ°¬Ñ`. ŒÜ\—’ÍŽj1, _’J˜aF1, ²“¡M”V2, Ž…Œö–ç1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ3‰ñ_“ސìŠá‰ÈŠw‰ï (2011/4/24), _“ސì.

733344. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) Eã‰ºŽÎŽ‹ vertical one and a halfÇŒóŒQ‚ÌŽèpŒ‹‰Ê. E¬Ž™Ž‹—͒ቺ‚ÌŒŽˆö‚Æ‚µ‚Ă̕Γª’É. ŒŽ@’Œl (Šá‰È): ‘æ5‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2011/6/10), _“ސì.

733345. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) _ŒoŠá‰ÈŽŸŠ³‚ɑ΂·‚铪•”MRIŒŸž‚ÌŒ»ó. —é–Ø—T”ü (Šá‰È): ‘æ5‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2011/6/10), _“ސì.

733346. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ‘Š‡. Œü–ì˜a—Y (Šá‰È): ‘æ5‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2011/6/10), _“ސì.

733347. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆêEʍu‰‰) “àŽ‹‹Ÿ‚ð—p‚¢‚œ‹÷Šp–ü’…‰ð—£p. ‘O“cªG1, ‘åŠÑ˜a“¿1, ŒìŽu•ä2, “n•ÓŽOŒP2, Žsìˆê•v2,3 (1Šò•ŒÔ\Žš•a‰@, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 3Šá‰È): ‘æ423‰ñ“ŒŠCŠá‰ÈŠw‰ï (2011/6/26), Šò•Œ.

733348. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’ŽLŠp‘–žƒŒ[ƒU[ŒŸŠá‹ŸOptosÒ200Tx‚ÌŽg—pŒoŒ±. ¬Œû@—D1, ‰Á‰ê’BŽu1,2, ‹g“c‘¥•F1, ²“¡—T”V1, ’†‘º‰pŽ÷1, ‹gèŒ›Ž¡1, ’·£—zŽq1, ‰ªŒË•üŽq1, Žsìˆê•v1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È): ‘æ423‰ñ“ŒŠCŠá‰ÈŠw‰ï (2011/6/26), Šò•Œ.

733349. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒXƒeƒƒCƒh‚Ɉˑ¶«‚̍‚‚¢Ž‹_ŒoÇ‚Ì1—á. ÎŒŽ“ñ—t1, “c’†‚ ‚ä‚Ý1, Vˆä‰Ì“ލ]1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰Èˆã‰@, 2Šá‰È): ‘æ27‰ñ^’߃Zƒ~ƒi[ (2011/7/23), ” ª.

733350. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —zŽqüŽ¡—ÂðŽ{s‚µ‚œŽ‹_Œoâ‘–ŒŽî‚Ì2—á. ”–؍LÆ1,2, “¡@@_3, ‘ºŽRds3, Œ‹v[Žq4, –î“c_“ñ5 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[—zŽqüŽ¡—ÉÈ, 4‚³‚­‚çŠá‰È, 5–î“cŠá‰Èˆã‰@): ‘æ27‰ñ^’߃Zƒ~ƒi[ (2011/7/23), ” ª.

733351. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éƒ{ƒgƒbƒNƒXŽ¡—Â̌»ó. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, ’r“c“N–ç1, ŒèœA‰h1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ27‰ñ^’߃Zƒ~ƒi[ (2011/7/24), ” ª.

733352. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž‹_ŒoŽŸŠ³‚Ɖh—{. Î“c@‹Å1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‘æ27‰ñ^’߃Zƒ~ƒi[ (2011/7/24), ” ª.

733353. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹S«Ž‹–ì‹·ó‚ð‰”­Çó‚Æ‚µ‚œRƒAƒNƒAƒ|ƒŠƒ“4R‘Ì—z«Ž‹_Œo‰Š‚Ì1—á. “¡–{—²Žu1, Žá‘q‰ël1,2 (1ˆäãŠá‰Èˆã‰@, 2Šá‰È): ‘æ27‰ñ^’߃Zƒ~ƒi[ (2011/7/24), ” ª.

733354. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹•ŒŒ«Ž‹_ŒoÇ‚̗Տ°“I”wŒi. t–ؐ’G1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‘æ27‰ñ^’߃Zƒ~ƒi[ (2011/7/24), ” ª.

733355. ’n•ûŠw‰ïEŒ€‹†‰ï (Ç—ጟ“¢u‰‰) Šp–Œ‘OŒã–ÊŒ`ó‰ðÍ‚ð—p‚¢‚œ‰~Šp–ŒŠá‚Ìelevation•Ï‰»—ʂƏdÇ“x‚ÌŠÖ˜A. Îˆä—œŠG (‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Žñ“sŒ—Šp–ŒŒ€‹†‰ï`‘æ2‰ñ‚ß‚Ž‚¹! ƒRƒ‹ƒlƒA‚Ì“Sl` (2011/8/26), “Œ‹ž.

733356. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—ጟ“¢‰ï) ³íŽá”NŽÒ‚Ì–¬—–ŒŒú‚Ì“ú“à•Ï“®. Žs粋`Í (Šá‰È): ‘æ6‰ñ_“ސ쉩”ÁŒ€‹†‰ï‘æ1‰ñOCTƒZƒ~ƒi[ (2011/9/24), _“ސì.

733357. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚é‰~Šp–ŒEƒPƒ‰ƒgƒGƒNƒ^ƒWƒA‚ɑ΂·‚éŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO. Îˆä—œŠG1,2, ŒÜ\—’ÍŽj3, _’J˜aF3, Ž…Œö–ç3 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Šá‰È): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

733358. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá“àƒŒƒ“ƒY‚É‚æ‚éƒ}ƒCƒ‹ƒhƒ‚ƒmƒrƒWƒ‡ƒ“–@‚Ì–ž‘«“x‚ɉe‹¿‚·‚éˆöŽq‚ÌŒŸ“¢. ]•—Ft1, “V–엝Œb1, íœAr‘Ÿ˜Y1, ”Ñ“c‰Ã•F1, ˆÉ“¡”ü¹ŠG2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

733359. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰©”Á‰~E–Ô–Œ”—£‚ɑ΂·‚éÉŽq‘ÌŽèp¬Ñ. ”Ñ“‡@Œh1,2, –ö“c’q•F2, Ž…Œö–ç2 (1“ŒŽÅ—ÑŠÔ•a‰@, 2Šá‰È): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

733360. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) LASIKŒã‚Ɋሳ‘ª’荢“ï‚Æ‚È‚è, ’†SŽ‹–ì‚̏ÁŽž‚ð‚«‚œ‚µ‚œ—ΓàáŠ³ŽÒ‚Ì1—á. Î“c@‹Å1, ¯ŽiMs2, X“c“N–ç1, –Ø‘º“TŒh1, t–ؐ’G1, Š}ŒŽ³s1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

733361. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹•ŒŒ«Ž‹_ŒoÇ‚̗Տ°“I”wŒi. t–ؐ’G1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

733362. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʉ‰‘è. X“c“N–ç (Šá‰È): ‘æ47‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2011/9/29), ‘Š–ÍŒŽ.

733363. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá‹ŸƒŒƒ“ƒY‚̃vƒŠƒYƒ€Œø‰Ê‚ªŽpšˆÛŽ‚É‹y‚Ú‚·‰e‹¿. ‹ààV³Œp1, óì@Œ«2, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2 (1ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ53‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2011/10/29), “Œ‹ž.

733364. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹ßŽ‹ƒƒJƒjƒYƒ€‚Æ‚»‚Ì—\–hE‹ž³@¡—Տ°•Ò@ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ÆŠp–Œ‹üÜ‹ž³Žèp. _’J˜aF (Šá‰È): 15th The IRSJ 2011 (2011/11/12), _“ސì.

733365. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ÉŽq‘ÌŽèpE̕ϑJ. –ö“c’q•F (Šá‰È): ‘æ12‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2011/11/12), _“ސì.

733366. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z—Γàá‚ÆŠá’ê‚Ì‚©‚œ‚¿. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ37‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2011/12/1), _“ސì.

733367 [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z“œ”A•a–Ô–ŒÇ‚̗Տ°. Žs糋`Í (Šá‰È): ‘æ17‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï (2011/12/3), “Œ‹ž.

733368. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Microperimeter-1 (MP-1TM)‚ð—p‚¢‚œ‰©”Á‰~Ep‘OŒã‚ÌŽ‹‹@”\•]‰¿. —é–؃ŠƒŠŽq1,2, ‚–ì‰ë•F1, ”Ñ“c–ƒ—R‰À1, ‘å•œ@—º1, ‰–’J’ŒŽq1, Ž…Œö–ç2 (1‘Ûˆã—ÕŸŽƒ‘åŠw”MŠC•a‰@, 2Šá‰È): ‘æ44‰ñ_“ސ쌧Šá‰È—Տ°’k˜b‰ï (2012/1/9), _“ސì.

733369. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) TrabectomepŒã’ZŠú¬Ñ‚Ì•ñ‚ƏpŒã—\Œã•s—Ç—á‚Ì”wŒiˆöŽq‚ÌŒŸ“¢. ‚‹Ž³‰p1, Š}ŒŽ³s1,2, X“c“N–ç1, —Žˆä‰‘Žq1, Œ‘ºˆêO1, ¯ŽiMs2,3, Ž…Œö–ç1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ28‰ñ_“ސ쌧—Γàá’k˜b‰ï (2012/2/4), _“ސì.

733370. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ŠOŽÎŽ‹pŒã‚Ì“àŽÎŽ‹. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ21‰ñ¬Ž™Šá‰È (ŽÎŽ‹¥ŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2012/2/23), _“ސì.

733371. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ‰º’Œ‹Ø’f—ô‚Ì1—á. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ21‰ñ¬Ž™Šá‰È (ŽÎŽ‹¥ŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2012/2/23), _“ސì.

733372. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) •”•ª’²ß«“àŽÎŽ‹‚̃tƒŒƒlƒ‹–ŒŽ¡—Ã. ˆÀ“¡˜a‰ÌŽq (Šá‰È): ‘æ21‰ñ¬Ž™Šá‰È (ŽÎŽ‹¥ŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2012/2/23), _“ސì.

733373. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ƒ{ƒgƒbƒNƒXŽ¡—Â̌»ó‚Æ—LŒø«. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ4‰ñ_“ސìƒNƒƒXƒI[ƒo[ƒVƒ“ƒ|ƒWƒEƒ€ (2012/3/10), _“ސì.

733374. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z—Ž‹—pƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̏ˆ•û. ‰F’ÃŒ©‹`ˆê1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYƒZƒ~ƒi[Šî‘b•Ò (2012/3/17), _“ސì.

733375. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ÅŒã‚Í‚â‚Á‚Ï‚èƒCƒ“ƒvƒ‰ƒ“ƒg?. —Žˆä‰‘Žq1, ¯ŽiMs2, X“c“N–ç1, Œ‘ºˆêO1, Š}ŒŽ³s3, ‚‹Ž³‰p1 (1Šá‰È, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ23‰ñNG‰ï (2012/3/23), _“ސì.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-120003. [ŒŽ’˜] —ŒŠá‚Ì“µE‘ÎŒõ‰ž“š”gŒ`‚Æ‚»‚Ì“Á’¥•ªÍ‚ÉŠÖ‚·‚éˆêŒŸ“¢. ’†ŽR@ŽÀ, Nowak Wioletta, Îì@‹Ï1, óì@Œ«1, Žs粋`Í2 (1ˆã—Éq¶Šw•”, 2Šá‰È): MŠw‹Z–@ 2011/2; 110 (460): 1-6.


Žš•@ˆôA‰ÈŠw

[Šwp˜_•¶]

110244. [ŒŽ’˜] Diagnosis of the extent of advanced oropharyngeal and hypopharyngeal cancers by narrow band imaging with magnifying endoscopy. Matsuba H1, Katada C2, Masaki T1, Nakayama M1, Okamoto T1, Hanaoka N, Tanabe S2, Koizumi W2, Okamoto M1, Muto M: The Laryngosope 2011/4; 121 (4): 753-9. (Œ—tG‹N1, Œ˜“ce—˜2, ³˜Ò@—²1, ’†ŽR–Ÿm1, ‰ª–{—·l1, “c糁@‘2, ¬ò˜aŽO˜Y2, ‰ª–{–ql1: 1Žš•@, 2Á‰»Ší“à)

110245. [ŒŽ’˜] Clinical significance of intraoperative surgical margin study in supracricoid laryngectomy. Nakayama M1, Okamoto M1, Iwabuchi K2, Mikami T2, Seino Y1: Auris Nasus Larynx 2011/4; 38 (2): 261-5. (’†ŽR–Ÿm1, ‰ª–{–ql1, ŠâŸºŒ[ˆê2, ŽOã“N•v2, Ž–ì—R”y1: 1Žš•@, 2•a—)

110246. [ŒŽ’˜] Computer-based analysis with three-dimensional imaging constructed from fine-slice computed tomography scan of supracricoid laryngectomy with cricohyoidoepiglottopexy: report of two cases. Seino Y1, Nakayama M1 Okamoto M1, Hayashi S1: J Laryngol Otol 2011/5; 125 (5): 523-7. (Ž–ì—R”y1, ’†ŽR–Ÿm1, ‰ª–{–ql1, —с@­ˆê1: 1Žš•@)

110247. [ŒŽ’˜] Laminin-5 immunohistochemical mapping for analysis of local extension in hypopharyngeal cancer: A preliminary report. Nakayama M1, Sato Y, Iwabuchi K, Mikami T, Okamoto M1, Seino Y1, Okamoto T1, M iyamoto S1: Auris Nasus Larynx 2011/6; 39 (3): 301-4. (’†ŽR–Ÿm1, ‰ª–{–ql1, Ž–ì—R”y1, ‰ª–{—·l1, ‹{–{r•ã1: 1Žš•@)

110248. [ŒŽ’˜] A novel orthotopic mouse model of head and neck cancer with molecular imaging. Reddy NP, Miyamoto S1, Araki K, Liu T, Feldman M, O'Malley BW Jr, Li D: Laryngoscope 2011/6; 121 (6): 1202-7. (‹{–{r•ã1: 1Žš•@)

110249. [ŒŽ’˜] Clinical significance of positive Delphian node in supracricoid laryngectomy with cricohyoidoepiglottopexy. Nakayama M1, Seino Y1, Okamoto M1, Mikami T2, Okamoto T1, Miyamoto S1: Jpn J Clin Oncol 2011/8; 41 (8): 987-91. (’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{–ql1, ŽOã“N•v2, ‰ª–{—·l1, ‹{–{r•ã1: 1Žš•@, 2•a—)

110250. [ŒŽ’˜] 'Flaccid neoglottis' following supracricoid partial laryngectomy: laryngoscopic revision assisted by navigation system. Nakayama M1, Seino Y1, Okamoto M1, Matsuki T1: J Laryngol Otol 2011/12; 125 (12): 1315-9. (’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{–ql1, Œ–؁@’1: 1Žš•@)

110251. [ŒŽ’˜] Middle ear metastasis of thymoma. Yamaguchi T1, Sano H1, Suzuki T1, Makino H1, Ohashi K1, Okamoto M1: Auris Nasus Larynx 2012/2; 39 (1): 90-3. (ŽRŒû’mŽq1, ²–ì@”£1, —é–Ø—§r1, –q–슰”V1, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1: 1Žš•@)

110252. [ŒŽ’˜] Functional organ preservation for laryngeal cancer: past, present and future. Nakayama M1, Laccourreye O, Holsinger FC, Okamoto M1, Hayakawa K2: Jpn J Clin Oncol 2012/3; 42 (3): 155-60. (’†ŽR–Ÿm1, ‰ª–{–ql1, ‘ì˜ad2: 1Žš•@, 2•úŽËü (Žîá‡))

120080. [ŒŽ’˜] •â’®‚É‚æ‚é‰ï˜bƒŒƒxƒ‹‚̌ꉹ–Ÿ—Ä“x‚̉ü‘P. Œ•œ“oŽu³1, ŒŽ@—R‹I1, —é–ØŒbŽq, ã‘O@–q, ‘åÀKŒb, ˆäã—ŠG, ‘å‹ŽŒ’‘Ÿ˜Y2, “n•Ó—T”V2, ²–ì@”£2, ‰ª–{–ql2 (1ˆã—Éq¶, 2Žš•@): Aodiology Japan 2011/4; 54 (2): 162-8.

120081. [ŒŽ’˜] –k—¢‘åŠw‚É‚š‚¯‚é‰ß‹Ž16”NŠÔ‚Ì“Ë”­«“ï’®‚Ö‚ÌŽ¡—Õû–@‚Æ‚»‚ÌŒø‰Ê. ²–ì@”£1, “n•Ó—T”V1, ¬–ì—Yˆê, ’–@Œ’Žu, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1 (1Žš•@): Aodiology Japan 2011/4; 54 (2): 169-75.

120082. [ŒŽ’˜] ‹}«’†Žš‰ŠŽ¡—ÂɊւ·‚錻ó’²ž. —é–Ø—§r1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠŽõÇŒ€‹†‰ï‰ïŽ 2011/5; 29 (1): 19-22.

120083. [ŒŽ’˜] –k—¢‘åŠw•a‰@Žš•@ˆôA‰È‰fŠO—ˆŽ¡—Âɂš‚¯‚éˆã—Ô鏑“±“ü‚Ì—L—p«. ‰““¡‰p”ü, “Vì‹vŽq, ìã”ü’q‘ã, ŽR‰ª@—ç, —é–Ø—§r1, ’†ŽR–Ÿm1, ‰ª–{–ql1 (1Žš•@): –k—¢ˆãŠw 2011/6; 41 (1): 33-40.

120084. [ŒŽ’˜] ˆôA“ª•‚Žî‚ð‡•¹‚µ‚œƒ€ƒ“ƒvƒX4—á‚ÌŒŸ“¢. Œ–؁@’1, ‹{–{r•ã1, ‰iˆä_–€1, ‰ª–{–ql1 (1Žš•@): ˆôŽš•@ˆôA‰È—Տ° 2011/6; 104 (6): 441-6.

120085. [ŒŽE˜] OTOFˆâ“`Žq•ÏˆÙ‚ð”F‚ß‚éAuditory neuropathy spectrum disorder‚Ì“û—cŽ™—á‚É‚š‚¯‚élH“àŽš‘•—pŒø‰Ê. ‘匎‘ìÆ1, ‘×’nGM, Žç–{—ÏŽq, –{‘º•üŽq, Œ‰i’B—Y (1Žš•@): Aodiology Japan 2011/8; 54 (4): 289-94.

120086. [ŒŽ’˜] cŠuŒŒŽî‚ªŒŽˆö‚ƍl‚Š‚ç‚ê‚œ”œ‰ñ_Œo–ƒáƒ—á. –q–슰”V1, ‰ª–{–ql1, ’†ŽR–Ÿm1 (1Žš•@): Žš•@ˆôA‰È—Տ° 2011/10; 104 (10): 721-5.

120087. [ŒŽ’˜] •a—‘gDŠw“I‚ÉIgG4ŠÖ˜AŽŸŠ³‚Ɛf’f‚µ‚œ1—á. ŒIŒŽ—¢‰À, ”ª”ö˜a—Y, ‰Pˆä‘å—S1, ŒŽRkˆê˜Y, ²“¡Œ’‘Ÿ˜Y (1Žš•@): Žš•@ˆôA‰ÈE“ªèò•”ŠO‰È 2012/3; 84 (3): 227-31.

220024. [€ŒŽ’˜] ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@ (Hydration Therapy). ’·À‰p–Ÿ (Žš•@): “ú–{ˆãŽ–V•ñ 2011/4; 4537: 85-8.

522174. [uÀ]y“ÁW: Žš•@ˆôA‰ÈŠŽõÇ‚ÌŠ®‘Sƒ}ƒXƒ^[zIII. f’fEŽ¡—Âðƒ}ƒXƒ^[‚·‚é@5. 嗋_Œo‰ŠE‘O’ë_Œo‰Š. ²–ì@”£ (Žš•@): Žš•@ˆôA‰ÈE“ªèò•”ŠO‰È 2011/4; 83 (5): 240-4.

522175. [uÀ]yŽèpŽè‹ZzŽ„‚ªˆ€—p‚·‚éŽèpŠí‹ï89: ŽšŽŸŠ³‚ÌŽ¡—Âɗp‚¢‚éŠí‹ï. ²–ì@”£ (Žš•@): JOHNS 2011/5; 27 (5): 805-6.

522176. [uÀ]y“ÁW: Ž„‚̏ˆ•ûⳁzŽš‰ÈŠw—̈æ: ŠŽ‰¹“ï’®‹}«‘ˆ«. ²–ì@”£ (Žš•@): JOHNS 2011/9; 27 (9): 1350-51.

522177. [uÀ]yŒ€Cƒm[ƒgz•â’®ŠíƒtƒBƒbƒeƒBƒ“ƒO‚Æ‚»‚Ì•]‰¿. ²–ì@”£ (Žš•@): Žš•@—Տ° 2011/10; 104 (10): 756-7.

522178. [uÀ]y“ÁW: ŠÂ‹«E¶ŠˆKŠµ (•a)EƒXƒ|[ƒc‚ÆŽš•@ˆôA‰ÈzŠÂ‹«‚ÆŽš•@ˆôA‰ÈŽŸŠ³|‰·“x|. ²–ì@”£ (Žš•@): JOHNS 2011/12; 27 (12): 1843-5.

540055. [‚»‚Ì‘Œ (Ž˜^W)] —Šw—Ö@. ’·À‰p–Ÿ (Žš•@): ‘æ28‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ïˆãŽtuK‰ïŽ˜^W 2011/6; p.71-4.

540056. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†vz“Ë”­«“ï’®Ç—á‚ÌQOL‚ÉŠÖ‚·‚é‘œŽ{Ý‹€“¯Œ€‹†. ²–ì@”£1, ‘å‹ŽŒ’‘Ÿ˜Y1, ’–@Œ’Žu, –q@“ÖŽq1, ¬–ì—Yˆê, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.75-7.

540057. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†vz“Ë”­«“ï’®”­ÇŒã3‚©ŒŽˆÈã‚ÌŠ³ŽÒ‚ÌŽš–•]‰¿‚ƐS—•]‰¿‚ÉŠÖ‚·‚錀‹†. ’–@Œ’Žu, ²–ì@”£1, ¬–ì—Yˆê, –q@“ÖŽq1, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; 105-7.

540058. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†vz1. ƒƒjƒG[ƒ‹•a“®•šƒ‚ƒfƒ‹‚ÉŠÖ‚·‚éŠî‘bŒ€‹† (’·À), 2. ƒƒjƒG[ƒ‹•a, “«‘O’뎟Š³‚̐f’f‚ÆŽ¡—ÂɊւ·‚錀‹† (—é–Ø, ‚‹Ž, ‰F²”ü, ’·À, Â–Ø), 3DBPPV‚̐f’f‚ÆŽ¡—ÂɊւ·‚錀‹† (—é–Ø, ‚‹Ž), 4. –Œ–À˜HáŠQŠÖ‚·‚éŠî‘b“IŒ€‹† (—é–Ø), 6. ‰º‘D•a‚Ì•a‘Ô‚ÆŽ¡—ÂɊւ·‚錀‹† (‚‹Ž), 6D•œtƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŒ€‹† (’·À), 7. ƒƒjƒG[ƒ‹•a‚̈â“`Žqƒoƒ“ƒNƒvƒƒWƒFƒNƒg (‰F²”ü). —é–؁@‰q, ‚‹Ž³h, ‰F²”ü^ˆê, ’·À‰p–Ÿ1, Â–ØŒõL (1Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.25-31.

540059. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†vz2011”N“àƒŠƒ“ƒp…ŽîŽŸŠ³‰uŠw’²žŒ‹‰Ê. «Ï“úo•v1, “n•Ós—Y1, Â–ØŒõL2, ’r‰€“N˜Y3, ˆÉ“¡Žõˆê4, ‰F²”ü^ˆê5, Š`–؏͐L6, ”ì’ˁ@ò7, —é–؁@‰q8, ‚‹Ž³h9, ‚‹ŽŽ»10, H“c¹–ç11, •“cŒ›º12, “yˆäŸ”ü13, ’·À‰p–Ÿ14, ŽR‰º—TŽi15, ‚‹Ž@Žp16, ‘Ÿ“c‹vK17, ’Ø“c‰ëm18, ˆÀ‘º²“s‹I19, ‚‘q‘勧20, Ô”‹Ÿˆê20 (1•xŽR‘å, 2Šò•Œ‘å, 3“ú–{ˆã‘å, 4‹ž“s‘å, 5MB‘å, 6“Œ‹ž‘å, 7¹ƒ}ƒŠƒAƒ“ƒiˆã‘å, 8“Œ‹žˆã‘å, 9‚ß‚Ü‚¢ƒƒjƒG[ƒ‹•aƒZƒ“ƒ^[, 10ŒQ”n‘å, 11L“‡‘å, 12“¿“‡‘å, 13‹ß‹E‘å, 14Žš•@, 15ŽRŒû‘å, 16VŠƒ‘å, 17²“n‘‡•a‰@, 18ã‰z‘‡•a‰@, 19Ž…‹›ì‘‡•a‰@, 20•xŽRÔ\Žš•a‰@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ (‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†)u2011”N“àƒŠƒ“ƒp…ŽîŽŸŠ³‰uŠw’²žŒ‹‰Êv•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.83-6.

540060. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†vzŽÀŒ±“IArg-Vasopressin“Š—^ƒ‚ƒfƒ‹‚É‚š‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘ԕω»|Vasopressin V1a-receptorhR–ò‚̉e‹¿|. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ²“¡—º•œ2, —Ž‡@“Ö1, ‰Á”[Fˆê1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@, 2¶—): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²EžŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.115-8.

540061. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†vzŽ‘±‚·‚é•œtáŠQ‚É‚š‚¯‚é–k—¢‘åŠw•ûŽ®‚ß‚Ü‚¢ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Æ‚»‚Ì•]‰¿. —Ž‡@“Ö1, ’·À‰p–Ÿ1, “¿‘Œú“ñ, ‰Á”[Fˆê1, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.138-42.

540062. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†vzƒƒjƒG[ƒ‹•a‚Æ“Ë”­«“ï’®‚Æ‚ÌŒŒˆ³’l‚ÌŒŸ“¢. ‰Á”[Fˆê1, ’·À‰p–Ÿ1, —Ž‡@“Ö1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.178-9.

540063. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“x‰ÈŠwŒ€‹†”ï•â•‹à (Šî”ÕŒ€‹† (ý))zR—˜”Aƒzƒ‹ƒ‚ƒ““Š—^‚É‚æ‚錌ŠÇð‚ÌŒ`‘ԕω»‚É”º‚€’®—͏áŠQ‚ÉŠÖ‚·‚錀‹†. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ãã—ms3 (1Žš•@, 2¶—, 3‰ð–U): Œ€‹†ŽÀÑ•ñ‘ 2012/3.

[’˜@‘]

610016. [’˜‘] (•ª’SŽ·•M)yAn Atlas of Head and Neck Surgery, 4ezCommentary on Chapter 36 Supracricoid partial laryngectomy with cricohyoidopexy or Cricohyoidoepiglottopexy, p.346-58. Nakayama M1, Elsevier, USA, 2011”­s. (’†ŽR–Ÿm1: 1Žš•@)

620175. [’˜‘] (•ª’SŽ·•M)yƒCƒ“ƒ^[ƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹Eƒwƒ‹ƒXƒPƒA|ŽÀ‘H ƒ`[ƒ€ˆã—Ø_: ŽÀÛ‚Æ‹³ˆçƒvƒƒOƒ‰ƒ€|zI ƒ`[ƒ€ˆã—ÊT˜_@2. •ÛŒ’ˆã—ÕŸŽƒ‚̃VƒXƒeƒ€‚Æ‹@”\@2) Šeê–åE‚̐E”\‚ƈã—Ï]Ž–ŽÒ‚Ì‚Æ‚ç‚Š‚éƒ`[ƒ€ˆã—Á|ˆãŽt, p.14-5. ‰ª–{–ql1 (1Žš•@), •Ò’˜: …–{Ž‹v, ‰ª–{–ql1, Îˆä–M—Y, “y–{Š°“ñ, ˆãŽ•–òo”Å, “Œ‹ž, 2011/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712046. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Salvage supracricoid laryngectomy with Cricohyoidoepiglottopexy. Nakayama M1: 2011 Annual Meeting & International Conference of Taiwan Head and Neck Society (2011/7/9-10), TAIWAN Kaohsiung. (’†ŽR–Ÿm1: 1Žš•@)

712047. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) A“ªŠà‚ɑ΂·‚éA“ªˆŸ‘S“Eop. ’†ŽR–Ÿm (Žš•@): ‹g—Ñ‘åŠw–K–â’cµ‘ҍuE‰‰E(2011/10/10), ’†‘E’·t.

712048. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Supracricoid laryngectomy in laryngeal cancer. Nakayama M1: The 3rd World Chinese Otorhinolaryngology Head and Neck Surgery Conference (2011/11/12), TAIWAN Kaoshiung. (’†ŽR–Ÿm1: 1Žš•@)

713143. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Molecular imaging assisted surgery in an animal model with head and neck cancer. Miyamoto S1, Yamashita T, O'Malley BW Jr, Li D: AACR 102nd Annual Meeting (2011/4/2-6), Orlando, USA. (‹{–{r•ã1: 1Žš•@)

713144. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Urinary-LTE4 for Diagnosis of Eosinophilic Sinusitis. Yamaguchi T1, Ishii T1, Daimon H, Kazuhiro Y, Okamoto M1: 1st Congress of the Confederation of the European ORL-HNS (2011/7/5), ƒXƒyƒCƒ“. (ŽRŒû’mŽq1, Îˆä–L‘Ÿ1, ‰ª–{–ql1: 1Žš•@)

713145. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Salvage supracricoid laryngectomy with ricohyoidoepiglottopexy after radiation failure. Nakayama M1: 2011 Annual Meeting & International Conference of Taiwan Head and Neck Society (2011/7/9-10), TAIWAN Kaohsiung. (’†ŽR–Ÿm1: 1Žš•@)

713146. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Molecular imaging assisted surgery improves survival in a murine head and neck cancer model. Miyamoto S1, Nakayama M1, Seino Y1, Okamoto T1, Okamoto M1: 2011 Annual Meeting & International Conference of Taiwan Head and Neck Society (2011/7/9-10), TAIWAN Kaohsiung. (‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{—·l1, ‰ª–{–ql1: 1Žš•@)

713147. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Long-term evaluation of swallowing function after supracricoid laryngectomy with cricohyoidoepiglottopexy. Seino Y1, Nakayama M1, Okamoto M1, Okamoto T1: 2011 Annual Meeting & International Conference of Taiwan Head and Neck Society (2011/7/9-10), TAIWAN Kaohsiung. (Ž–ì—R”y1, ’†ŽR–Ÿm1, ‰ª–{–ql1, ‰ª–{—·l1: 1Žš•@)

713148. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Phase I study of TS-1 and Nedaplatin with concurrent adiotherapy in locally advanced mesopharyngeal and hypophary ngeal cancers. Okamoto T1, Nakayama M1, Miyamoto S1, Seino Y1, Okamoto M1: 2011 Annual Meeting & International Conference of Taiwan Head and Neck Society (2011/7/9-10), TAIWAN Kaohsiung. (‰ª–{—·l1, ’†ŽR–Ÿm1, ‹{–{r•ã1, Ž–ì—R”y1, ‰ª–{–ql1: 1Žš•@)

713149. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Is there still a role for salvage SCPL-CHEP. Nakayama M1, Seino Y1, Okamoto M1, Miyamoto S1, Okamoto T1: AAO-HNS Annual meeting, 2011 (2011/9/10-13), San Francisco, USA. (’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{–ql1, ‹{–{r•ã1, ‰ª–{—·l1: 1Žš•@)

713150. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Symptoms of the patients with idiopathic sudden sensorineural hearing loss in their acute phase. Sano H1, Ino T, Watanabe H1, Ohashi K1, Okamoto M1: 28th Politer Society Meeting Athens (2011/9/30), Athens, Greece. (²–ì@”£1, “n•Ó—T”V1, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1: 1Žš•@)

713151. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) An investigation of tinnitus distress, anxiety and depression in idiopathic sudden sensorineural hearing loss. Ino T, Sano H1, Ono Y, Watanabe H1, Watanabe A, Okamaoto M1: 28th Politer Society Meeting Athens (2011/9/30), Athens, Greece. (²–ì@”£1, “n•Ó—T”V1, “n•ÓˆŸŠóŽq1, ‰ª–{–ql1: 1Žš•@)

713152. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Intratympanic dexamethasone injection for idiopathic sudden sensorineural hearing loss. Watanabe H1, Ohashi K1, Ino T, Kamijo T, Ono Y, Sano H1, Okamaoto M1: 28th Politer Society Meeting Athens (2011/9/30), Athens, Greece. (“n•Ó—T”V1, ‘å‹ŽŒ’‘Ÿ˜Y1, ²–ì@”£1, ‰ª–{–ql1: 1Žš•@)

713153. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Middle ear metastasis of thymoma. Yamaguchi T1, Sano H1, Suzuki T1, Nakayama M1, Okamoto M1: The 3rd World Chinese Otorhinolaryngology Head and Neck Surgery Conference (2011/11/11), TAIWAN Kaoshiung. (ŽRŒû’mŽq1, ²–ì@”£1, —é–Ø—§r1, ’†ŽR–Ÿm1, ‰ª–{–ql1: 1Žš•@)

713154. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Open Laryngeal Surgery (Supracricoid laryngectomy ) in Laryngeal Cancer. Nakayama M1: The 3rd World Chinese Otorhinolaryngology Head and Neck Surgery Conference (2011/11/12), TAIWAN Kaoshiung. (’†ŽR–Ÿm1: 1Žš•@)

713155. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Molecular disruption of Rad50 sensitizes head and neck cancer to radiation therapy. Miyamoto S1, Nakayama M1, Seino Y1, Okamoto T1, Okamoto M1, Li D: 11th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery (2011/12/9), Kobe. (‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{—·l1, ‰ª–{–ql1: 1Žš•@)

713156. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Five cases of percutaneous endoscopic gastrostomy tube placement after supracricoid laryngectomy with cricohyoidoepiglottopexy. Seino Y1, Nakayama M1, Okamoto M1, Okamoto T1, Suzuki T1, Yokobori S: 11th Japan- Taiwan Conference on Otolaryngology-Head and Neck Surgery (2011/12/9), Kobe. (Ž–ì—R”y1, ’†ŽR–Ÿm1, ‰ª–{–ql1, ‰ª–{—·l1, —é–Ø—§r1: 1Žš•@)

722180. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) A“ªˆŸ‘S“Eop80—á‚©‚çŠw‚ñ‚Ÿ‚±‚Æ. ’†ŽR–Ÿm (Žš•@): ‘æ35‰ñ“ú–{“ªèò•”ŠàŠw‰ï (2011/6/9), ˆ€’m.

722181. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ‘€“ªœ‚̐¶— (Žå‚É’®ŠoE•œt‹@”\‚ÉŠÖ‚µ). ’·À‰p–Ÿ (Žš•@): ‘æ16‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2011/9/11), ‰¡•l.

722182. [Šw‰ï (‘S‘)] (ƒCƒ“ƒ^[ƒlƒbƒgƒZƒ~ƒi[) “Ë”­«“ï’®‚̐f’f‚ÆŽ¡—Ã. ‰ª–{–ql (Žš•@): ‚ß‚Ü‚¢EŽš–E“ï’®‚ÉŠÖ‚·‚éƒCƒ“ƒ^[ƒlƒbƒgƒZƒ~ƒi[u’®Šov (2012/1/28), “Œ‹ž.

723806. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹C“¹ŠÇ—‚ð•K—v‚Æ‚µ‚œ¬Ž™‹}«A“ªŠW‰Š‚Ì2—á. ×–ì_Žj1, ³˜Ò@—²1, Ž–ì—R”y1, Œ—tG‹N1, –xŒû—˜”V, ‰ª–{–ql1 (1Žš•@): ‘æ23‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/4/21), ˆ®ì.

723807. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚é‰ß‹Ž6”N‚̐º‘у|ƒŠ[ƒvŽèpÇ—á‚ÌŒŸ“¢. “n•Ó—T”V1, ³˜Ò@—²1, ×–ì_Žj1, –xŒû—˜”V, ‰ª–{–ql1 (1Žš•@): ‘æ23‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/4/21), ˆ®ì.

723808. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ°”÷‹Ÿ‰ºA“ª”÷×ŽèpŒã‚ɍA“ªŠW‚ÌŽî’¯‚ð2‰ñ‚«‚œ‚µ‚œ1—á. ³˜Ò@—²1, “n•Ó—T”V1, ×–ì_Žj1, –xŒû—˜”V, ‰ª–{–ql1 (1Žš•@): ‘æ23‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/4/21), ˆ®ì.

723809. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘æ1éҗñ—R—ˆ‚Ì‘€èòùN–E, ‘€èòᑂ̌Ÿ“¢. ‘匎‘ìÆ1, –Ø‘º•üŽq, Žç–{—ÏŽq, ‘×’nGM (1Žš•@): ‘æ112‰ñ“ú–{Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/5/19), ‹ž“s.

723810. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A“ªˆŸ‘S“EopŒãš‹‰º‹@”\‚Ì’†’·Šú“IŒŸ“¢|ƒrƒfƒIX‘B“§Ž‹ŒŸž‚𒆐S‚Ɂ|. Ž–ì—R”y1, ’†ŽR–Ÿm1, ‰¡–x@Šw, ‰ª–{—·l1, ‰ª–{–ql1 (1Žš•@): ‘æ112‰ñ“ú–{Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/5/19), ‹ž“s.

723811. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒVƒXƒvƒ‰ƒ`ƒ“‘ϐ«‹@\‚É‚š‚¯‚éMRE11/RAD50/NBS1•¡‡‘Ì‚ÌŠÖ—^‚ƕψٌ^NBS1ˆâ“`Žq“±“ü‚É‚æ‚鑝ŠŽŽ¡—Ã. ŽR‰º@‘ñ, ‹{–{r•ã1, r–؍Km, ‰–’J²_ (1Žš•@): ‘æ35‰ñ“ú–{“ªèò•”ŠàŠw‰ï (2011/6/9), –ŒŒÃ‰®, (“ªèò•”Šà 2011; 37 (2): 223.

723812. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹h‰¹Ž™‚Ì•]‰¿‚ÉŠÖ‚·‚é—\”õ“I’²ž. ‘åÀKŒb, ‹ù“cO”ü, ŒŽ@—R‹I1 (1ˆã—Éq¶Šw•”): ‘æ56‰ñ“ú–{‰¹ºŒŸŒêˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/6), “Œ‹ž.

723813. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éV¶Ž™’®ŠoƒXƒNƒŠ[ƒjƒ“ƒO|9”NŠÔ‚̂܂Ƃ߁|. “n•ÓˆŸŠóŽq1, ²–ì@”£1, ó–ì˜a], –F“c‚ЂƂÝ, ¬”Š@i, ‘ºŽR^‹|, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1 (1Žš•@): ‘æ56‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/27), •Ÿ‰ª.

723814. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) NICUŽ™‚Ì“ï’®f’f‚Æ•â’®Ší‘•—p. ˆäã—ŠG, ‘åÀKŒb, ŒŽ@—R‹I1, —é–ØŒbŽq1, ²–ì@”£2, ‰ª–{–ql2 (1ˆã—Éq¶Šw•”, 2Žš•@): ‘æ56‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/27), •Ÿ‰ª.

723815. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •â’®Ší‘•—p‚ɑ΂·‚é‘•—pó‹µ’²ž. ‘åÀKŒb, ˆäã—ŠG, ŒŽ@—R‹I1, —é–ØŒbŽq1, Œ•œ“oŽu³1, “n•ÓˆŸŠóŽq2, ‘å‹ŽŒ’‘Ÿ˜Y2, ²–ì@”£2, ‰ª–{–ql2 (1ˆã—Éq¶Šw•”, 2Žš•@): ‘æ56‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/27), •Ÿ‰ª.

723816. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÛ–ŒúEŽš‚É‚š‚¯‚éŽÀŽš—‡Žš—˜“Ÿ‚ÌŒŸ“¢. ²–ì@”£1, Œ•œ“oŽu³2, ˆäã—ŠG, ‘åÀKŒb, ‘å‹ŽŒ’‘Ÿ˜Y1, ŒŽ@—R‹I2, —é–ØŒbŽq2, ‰ª–{–ql1 (1Žš•@, 2ˆã—Éq¶Šw•”): ‘æ56‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/28), •Ÿ‰ª.

723817. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ï’®ŽÒ‚É‚š‚¯‚éƒRƒ~ƒ…ƒjƒP[EVƒ‡ƒ“ƒXƒgƒ‰ƒeƒW[|u‚«‚±‚Š‚ɂ‚¢‚Ä‚ÌŽ¿–⎆2002v‚̉ñ“š‚É•\‚ê‚œŒXŒü|. —é–ØŒbŽq1, ‰ª–{–ql2, —é–Ø–q•F3, ²–ì@”£2, ŒŽ@—R‹I1, ˆäã—ŠG, ‘åÀKŒb (1ˆã—Éq¶Šw•”, 2Žš•@, 3ˆê”Ê‹³ˆç•”): ‘æ56‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/28), •Ÿ‰ª.

723818. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O’됅ŠÇŠg‘åÇ‚̗Տ°‘œ. ‘å‹ŽŒ’‘Ÿ˜Y1, ²–ì@”£1, “n•ÓˆŸŠóŽq, ’–@Œ’Žu, ¬–ì—Yˆê, ‰ª–{–ql1 (1Žš•@): ‘æ56‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/28), •Ÿ‰ª.

723819. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 嗋ŠO‘€•Ç (ŒŒŠÇð) ‚ÌArg-Vasopressin“Š—^‚É‚æ‚é‘gDŽ_‘f•ªˆ³‚̕ω». ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, “¿‘Œú“ñ, —Ž‡@“Ö1, ‰ª–{–ql1 (1Žš•@, 2¶—): ‘æ56‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/10/28), •Ÿ‰ª, Audiology Japan 2011; 54 (5): 601-2.

723820. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) d«‹CŠÇŽx‹Ÿ‚Ì‘}“üŒã‚ɍA“ªŠW‚ÌŽî’¯‚ð‚«‚œ‚µ‚œA“ªƒŠƒ“ƒpŠÇŽî‚Ì1—á. ³˜Ò@—²1, –xŒû—˜”V, ‰ª–{–ql1 (1Žš•@): ‘æ63‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2011/11/10), –ŒŒÃ‰®.

723821. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xŠà‰»Šw—Ö@’†‚Éš‹‰ºáŠQ‚Ì‘žˆ«‚ðŒJ‚è•Ô‚µ‚œ1—á. —é–Ø—§r1, ‰ª•”‘•c, Ž–ì—R”y1, ‰ª–{–ql1 (1Žš•@): ‘æ63‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2011/11/10), –ŒŒÃ‰®.

723822. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒjƒG[ƒ‹•a‚Æ“Ë”­«“ï’®‚Æ‚ÌŒŒˆ³’l‚ÌŒŸ“¢. ‰Á”[Fˆê1, ’·À‰p–Ÿ1, —Ž‡@“Ö1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@): ‘æ70‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/17), ç—t.

723823. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽÀŒ±“IArg-Vasopressin“Š—^“®•šƒ‚ƒfƒ‹‚É‚š‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘ԕω»|Vasopressin V1-receptor|. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ²“¡—º•œ2, —Ž‡@“Ö1, ‰Á”[Fˆê1, ‘匎‘ìÆ1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@, 2¶—): ‘æ70‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/17), ç—t.

723824. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•ûŽ®‚ß‚Ü‚¢ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Æ‚»‚Ì•]‰¿. —Ž‡@“Ö1, ’·À‰p–Ÿ1, ‰Á”[Fˆê1, ‘匎‘ìÆ1, ‰ª–{–ql1 (1Žš•@): ‘æ70‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/17), ç—t.

723825. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•ûŽ®‚ß‚Ü‚¢ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŒø‰Ê. —Ž‡@“Ö1, ’·À‰p–Ÿ1, “¿‘Œú“ñ, ‰Á”[Fˆê1, ‘匎‘ìÆ1, ‰ª–{–ql1 (1Žš•@): ‘æ70‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/17), ç—t, Equilibrium Res 2011; 70 (5): 424.

723826. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —ǐ«”­ì«“ªˆÊ‚ß‚Ü‚¢Ç‚É‚š‚¯‚鏃‰¹’®—ÍŒŸžŒ‹‰Ê‚ÌŒŸ“¢. ‘匎‘ìÆ1, ’·À‰p–Ÿ1, —Ž‡@“Ö1, ‰Á”[Fˆê1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@): ‘æ70‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/17), ç—t, Equilibrium Res 2011; 70 (5): 406.

723827. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­“ï’®‚Å”­Ç‚µ‚œƒNƒŠƒvƒgƒRƒbƒJƒX‘–Œ‰Š‚Ì1—á. –Ø‘ºŽé—¢1, ²–ì@”£1, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1 (1Žš•@): ‘æ21‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/25), ‰«“ê.

723828. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àŽš“¹‚É‘¢‰eŒø‰Ê‚ð”F‚ß‚œ3Ç—á. –q–슰”V1, ²–ì@”£1, –Ø‘ºŽé—¢1, ‰ª–{–ql1 (1Žš•@): ‘æ21‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/25), ‰«“ê.

723829. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«“ï’®‚Ì”­Çó‹µ‚ÉŠÖ‚·‚é—\”õ“I’²ž. ²–ì@”£1, ‘å‹ŽŒ’‘Ÿ˜Y1, ’–@Œ’Žu, ‰ª–{–ql1 (1Žš•@): ‘æ21‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/11/26), ‰«“ê.

723830. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒM‘å—Ê”òŽUƒV[ƒYƒ“‚É‚š‚¯‚éƒXƒeƒƒCƒh“_•@–ò‚ÌŒø‰Ê. —é–Ø—§r1, —с@­ˆê1, –q–슰”V1, “n•Ó—T”V1, ’†ÀŽ‘ŽÀ1, ‰ª–{–ql1 (1Žš•@): ‘æ50‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/12/3), ‰ªŽR.

723831. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž¡—Âɓïa‚µ‚œƒAƒŒƒ‹ƒM[«^‹Û«•›•@o‰Š‚Ì1—á. ’†ÀŽ‘ŽÀ1, ‰ª–{–ql1, —é–Ø—§r1, —с@­ˆê1, ‰Á”[Fˆê1 (1Žš•@): ‘æ50‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/12/3), ‰ªŽR.

723832. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àŽ‹‹Ÿ‰ºˆôA“ªŽèp (ELPS) ‚ð—p‚¢‚Đ؏œ‚µ‚œ’†‰ºˆô“ªd•¡Šà‚Ì1—á. Ž–ì—R”y1, ’†ŽR–Ÿm1, Œ˜“ce—˜2, ‰ª–{–ql1 (1Žš•@, 2Á‰»Ší“à): ‘æ22‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2012/1/27), •Ÿ“‡.

723833. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€—œóŠ×‰š‚É“àŽ‹‹Ÿ‰ºˆô“ªŽèp (ELPS) ‚ðŽ{s‚µ‚œ‰ºˆô“ª•\ÝG•œã”çŠà‚Ì1—á. –Ø‘ºŽé—¢1, ’†ŽR–Ÿm1, Œ˜“ce—˜2, ‰ª–{–ql1 (1Žš•@, 2Á‰»Ší“à): ‘æ22‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2012/1/27), •Ÿ“‡

723834. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šg‘å‹@”\•t‚«‚ÌNarrow Band Imaging“‹Ú‚̏㕔Á‰»ŠÇ“àŽ‹‹Ÿ‚ňٌ^ŒŒŠÇ‚ðEώ@‚µ‚œA“ªG•œã”çŠà‚ÌŒŸ“¢. ³˜Ò@—²1, Œ˜“ce—˜2, ’†ŽR–Ÿm1, Ž–ì—R”y1, –xŒû—˜”V, ‰ª–{–ql1 (1Žš•@, 2Á‰»Ší“à): ‘æ24‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïE Šwpu‰‰‰ï (2012/3/8), ‹à‘ò.

731145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “ªèò•”Šàf—Á|“Á‚ɉºˆô“ªŠà‚ɂ‚¢‚ā|. ‰ª–{–ql (Žš•@): ‘æ63‰ñŒä’ƒƒm…Žš•@ˆôA‰ÈE“ªèò•”Ž¡—ÃŒ€‹†‰ï (2011/8/18), “Œ‹ž.

731146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) A“ªŠà‚ÌŽ¡—Ã: ‚¢‚Ü‚Ü‚Å‚Æ‚±‚ê‚©‚ç. ’†ŽR–Ÿm (Žš•@): ‘æ8‰ñ²‰êŒ§Žš•@ˆôA‰ÈW’k‰ï (2011/10/27), ²‰ê.

731147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@|Šî‘b‚ƗՏ°|. ’·À‰p–Ÿ (Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ïŠwpW‰ï (2012/1/21), ‰¡•l.

732140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@. ’·À‰p–Ÿ (Žš•@): ŽOdŒ§Žš•@ˆôA‰Èˆã‰ïŠwpu‰‰‰ï (2011/7/7), ŽOdŒ§.

732141. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) A“ªŠà‚ÌŽ¡—Ã: ‚¢‚Ü‚Ü‚Å‚Æ‚±‚ê‚©‚ç. ’†ŽR–Ÿm (Žš•@): ²‰êŒ§Žš•@ˆôA‰ÈW’k‰ï (2011/10/27), ²‰ê.

733376. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŠÇØŠJ‚ð•K—v‚Æ‚µ‚œ¬Ž™‹}«A“ªŠW‰Š‚Ì2—á. ×–ì_Žj (Žš•@): ‘æ5‰ñ‘Š–ÍŒŽDRIAOMSu‰‰‰ï (2011/6/2), ’¬“c.

733377. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –³Ž¡—ÂÅ2”NˆÈã‚ÌŒo‰ßŠÏŽ@‚ðs‚Á‚œ’†ˆô“ª•\ÝŠà‚Ì1—á. ³˜Ò@—²1, Œ˜“ce—˜2, ’†ŽR–Ÿm1, ‹{–{r•ã1, Ž–ì—R”y1, ’|“c¹•F1, –xŒû—˜”V, ‰ª–{–ql1 (1Žš•@, 2Á‰»Ší“à): ‘æ9‰ñ“ªèò•”•\ÝŠàŒ€‹†‰ï (2011/6/24), “Œ‹ž.

733378. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚鐅“—‘яóáv]ƒEƒCƒ‹ƒX‚É‚æ‚é_ŒoáŠQ. “n•ÓˆŸŠóŽq (Žš•@): ‘Š–ÍŒŽŽsŽš•@‰Èˆã‰ï (2011/6/30), ‘Š–ÍŒŽ.

733379. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€“àèòÃ–¬‚Ö‚Ì’†SÃ–¬ƒJƒe[ƒeƒ‹‘}“üŒã‚Ɉê‰ß«‚Ì—Œ‘€º‘Ñ–ƒáƒ‚𐶂¶‚œ1—á. ’†ì‹M”V1, ‰ª–{—·l1, Ž–ì—R”y1, ŽRŒû’mŽq1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ115‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2011/7/2), ‰¡•l.

733380. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚鎚‰º‘BŽîᇂ̎èp. ‰ª–{—·l (Žš•@): ‘æ24‰ñ_“ސ쌧Žš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŽèpŽè‹ZŒ€‹†‰ï (2011/7/14), ‰¡•l.

733381. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) BPPN‚ÌŠ³Žš‘€‚ɂ‚¢‚Ä. “¿‘Œú“ñ, ’·À‰p–Ÿ1, —Ž‡@“Ö1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ156‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2011/9/3), ‰¡•l.

733382. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŠÇØŠJp‚ðs‚Á‚œº‘у|ƒŠ[ƒv‚Ì1—á. –Ø‘ºŽé—¢1, ³˜Ò@—²1, ‘匎‘ìÆ1, ŽRŒû’mŽq1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ156‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2011/9/3), ‰¡•l.

733383. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚ß‚Ü‚¢‚̗Տ°. —Ž‡@“Ö (Žš•@): ‘Š–ÍŒŽŽs“à‰Èˆãu‰‰‰ï (2011/10/13), ‘Š–ÍŒŽ.

733384. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Še‰È‚Å‚Ý‚ç‚ê‚é‚ß‚Ü‚¢EŽš•@‰ÈŠO—ˆ‚Å‚Ý‚ç‚ê‚é‚ß‚Ü‚¢. —Ž‡@“Ö (Žš•@): ‘æ20‰ñ–k—¢Žš•@ˆôA‰È (2011/10/22), ‘Š–ÍŒŽ.

733385. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žš•@ˆôA‰ÈŠŽõÇ‚ɂ‚¢‚Ä. —é–Ø—§r (Žš•@): ‘æ20‰ñ–k—¢Žš•@ˆôA‰È (2011/10/22), ‘Š–ÍŒŽ.

733386. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‡–°Žž–³ŒÄ‹zÇŒóŒQ‚̐f’f‚ÆŽ¡—Á`“Á‚ɐ‡–°“±“ü–ò‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚ā`. ’|“c¹•F (Žš•@): ‡–°áŠQ‚É‚š‚¯‚鎡—Ð헪‚ÉŠÖ‚·‚éÀ’k‰ï (2011/11/17), ‰¡•l.

733387. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚é‘Á‰t‘BŠà‚̗Տ°“IŒŸ“¢.‹{–{r•ã (Žš•@): ‘æ11‰ñ_“ސ쓪èò•”ŠàƒtƒH[ƒ‰ƒ€ (2011/11/25), ‰¡•l.

733388. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹ÇŠis’†E‰ºˆô“ªŠà‚ɑ΂·‚éTS-1, Nedaplatin•¹—p‰»Šw•úŽËü—Ö@‚̗Տ°‘æE/E‘ŠŽŽŒ±‚ÌŒŸ“¢. ‰ª–{—·l (Žš•@): ‘Š–ÍŒŽŽsŽš•@‰Èˆã‰ï (2011/12/1), ‘Š–ÍŒŽ.

733389. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹CŠÇ“à‘}ŠÇŒã‚̍‡•¹Ç. ³˜Ò@—² (Žš•@): ‘Š–ÍŒŽŽsŽš•@‰Èˆã‰ï (2011/12/1), ‘Š–ÍŒŽ.

733390 [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŠÇØŠJ‚ð—v‚µ‚œ³’†èòùN–E‚Ì1—á. ’†ì‹Mm1, ‹{–{r•ã1, ‰ª–{—·l1, “n•ÓˆŸŠóŽq1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ157‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2011/12/3), ‰¡•l.

733391. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽÀŒ±“IArg-Vasopressin“Š—^“®•šƒ‚ƒfƒ‹‚É‚š‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘ԕω». ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ²“¡—º•œ2, —Ž‡@“Ö1, ‰ª–{–ql1 (1Žš•@, 2¶—): ‘æ22‰ñƒoƒ]ƒvƒŒƒVƒ“Œ€‹†‰ï (2012/1/7), “Œ‹ž.

733392. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽÀŒ±“IArg-Vasopressin“Š—^“®•šƒ‚ƒfƒ‹‚É‚š‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘ԕω»|Vasopressin V1-receptorhR–ò‚̉e‹¿| ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ²“¡—º•œ2, —Ž‡@“Ö1, ‰Á”[Fˆê1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@, 2¶—): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬23”N“x•ñ‰ï (2012/1/21), “Œ‹ž.

733393. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±‚·‚é•œtáŠQ‚É‚š‚¯‚é–k—¢‘åŠw•ûŽ®‚ß‚Ü‚¢ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Æ‚»‚Ì•]‰¿. —Ž‡@“Ö1, ’·À‰p–Ÿ1, “¿‘Œú“ñ, ‰Á”[Fˆê1, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬23”N“x•ñ‰ï (2012/1/21), “Œ‹ž.

733394. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒjƒG[ƒ‹•a‚Æ“Ë”­«“ï’®‚Æ‚ÌŒŒˆ³’l‚ÌŒŸ“¢. ‰Á”[Fˆê1, ’·À‰p–Ÿ1, —Ž‡@“Ö1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬23”N“x•ñ‰ï (2012/1/21), “Œ‹ž.

733395. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«“ï’®Ç—á‚ɑ΂·‚éÇó, ƒnƒ“ƒfƒBƒLƒƒƒbƒv, QOL’²ž‚̉ðÍ. ²–ì@”£1, ‘å‹ŽŒ’‘Ÿ˜Y1, –q@“ÖŽq1, ’–@Œ’Žu, ¬–ì—Yˆê, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†‚ÌŒ€‹†”ǁv•œ¬23”N“x•ñ‰ï (2012/1/21), “Œ‹ž.

733396. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«“ï’®”­ÇŒã3‚©ŒŽˆÈã‚ÌŠ³ŽÒ•]‰¿‚ƐS—•]‰¿. ’–@Œ’Žu, ²–ì@”£1, ¬–ì—Yˆê, –q@“ÖŽq1, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†‚ÌŒ€‹†”ǁv•œ¬23”N“x•ñ‰ï (2012/2/11), “Œ‹ž.

733397. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«“ï’®ŽÒ‚ɑ΂·‚éƒnƒ“ƒfƒBƒLƒƒƒbƒvƒAƒ“ƒP[ƒg’²ž|‘æˆê•ñ|. Šâè@‘, ²–ì@”£1, Œ”öMÆ, H@@÷, ‰ª–{–ql1, ‰F²”ü^ˆê (1Žš•@): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†‚ÌŒ€‹†”ǁv•œ¬23”N“x•ñ‰ï (2012/2/11), “Œ‹ž.

733398. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«“àŽšŽŸŠ³‚̈â“`Žqƒoƒ“ƒN\’z`“Ë”­«“ï’®‚̈â“`ŽqSNP‰ðÍ`. ‹S“ª—Ç•ã, Œ”öMÆ, ‰F²”ü^ˆê, ¬ì@ˆè, ‰ª–{–ql1, Šì‘œ‘ºŒ’, ‹Å@Ž•¶, ²“¡Gº, ’†“‡@–±, •Ÿ“‡–M”Ž, •Ÿ“c@—@, ŒŽ@@Í, ŽR‘Z’B–ç (1Žš•@): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†‚ÌŒ€‹†”ǁv•œ¬23”N“x•ñ‰ï (2012/2/11), “Œ‹ž.

733399. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šá‹…“ˏo‚ðŽå‘i‚Æ‚µ‚œ•›•@oŽîᇂ̈ê—á. ‰Á”[Fˆê1, –q–슰”V1, Îˆä–L‘Ÿ (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ158‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2012/3/24), ‰¡•l.

733400. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éNSTÛHEš‹‰ºƒ`[ƒ€‚Ì—§‚¿ã‚°. Ž–ì—R”y1, ‰ª•”‘•c, —é–Ø—§r1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ158‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2012/3/24), ‰¡•l.

H22”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H22-733014. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Narrow Band Imaging“àŽ‹‹Ÿ‚ōA“ª“û“ªŽî‚ðŠg‘åŠÏŽ@‚µ‚œ2—á. ³˜Ò@—²1, Œ˜“ce—˜2, ’†ŽR–Ÿm1, Ž–ì—R”y1, –xŒû—˜”V, ‰ª–{–ql1 (1Žš•@, 2Á‰»Ší“à): ‘æ7‰ñ“ªèò•”•\ÝŠàŒ€‹†‰ï (2010/6/12), “Œ‹ž, Žš•@ˆôA‰È“W 2011/6; 54 (3): 178-9.


ž_‰ÈŠw

[Šwp˜_•¶]

110253. [ŒŽ’˜] Subjective experiences of family caregivers of patients with dementia as predictive factors of quality of life. Takai M, Takahashi M1, Iwamitsu Y, Oishi S1, Miyaoka H1: Psychogeriatrics 2011/6; 11 (2): 98-104. (‚‹Ž@Œb1, ‘åÎ@’q1, ‹{‰ª@“™1: 1ž_)

110254. [ŒŽ’˜] Brief morning exposure to bright light improves subjective symptoms and performance in nurses with rapidly rotating shifts. Tanaka K, Takahashi M, Tanaka M, Takanao T, Nishinoue N, Kaku A, Kato N, Tagaya H, Miyaoka H1: J Occup Health 2011/7; 53 (4): 258-66. (‹{‰ª@“™1: 1ž_)

110255. [ŒŽ’˜] Changes in communication skills of clinical residents through psychiatric training. Yutani M, Takahashi M1, Miyaoka H1: Psychiatry Clin Neurosci 2011/10; 65 (6): 561-6. (‚‹Ž@Œb1, ‹{‰ª@“™1: 1ž_)

110256. [ŒŽ’˜] Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complains. Ando N, Iwamitsu Y, Kuranami M2, Okazaki S, Yamamoto K1, Watanabe M2, Miyaoka H1: Fam Cancer 2011/12; 10 (4): 681-9. (‘ •À@Ÿ2, ŽR–{Œ«Ži1, “n粏¹•F2, ‹{‰ª@“™1: 1ž_, 2ŠO‰È)

110257. [ŒŽ’˜] Relationship between autonomic nervous system activity during sleep and fasting glucose in Japanese workers. Kamata N1, Tanaka K, Morita S, Tagaya H, Kawashima M, Shichiri M2, Miyaoka H1: Ind Health 2011; 49 (4): 427-33. (Š™“c’ŒŽ÷1, Žµ—¢áÁ‹`2, ‹{‰ª@“™1: 1ž_, 2“à•ª”å‘ãŽÓ“à)

110258. [ŒŽ’˜] Relationship among white matter hyperintensity, arterial stiffness, associated diseases, and lifestyle in late-onset Alzheimer's disease patients. Arai H, Takahashi T1, Yutani M, Iked T, Oishi S1, Miyaoka H1: Kitasato Med J 2012/3; 42 (1): 83-90. (‚‹Ž@Œb1, ‘åÎ@’q1, ‹{‰ª@“™1: 1ž_)

120088. [ŒŽ’˜] t‘ŸˆÚA‘O‚ÌŠ³ŽÒ‚̐S—”œ‰ž‚Æ“Á«•sˆÀ‚Æ‚ÌŠÖŒW. —§Œ¹ˆê, Šâ–ž—D”ü, ŽR–{Œ«Ži1, ‹g“cˆê¬2, ‹{‰ª@“™1 (1ž_, 2”å”AŠí): ‘‡•a‰@ž_ˆãŠw 2011/10; 23 (4): 387-96.

210006. [ŒŽ’˜] Daily physical activity in patients with schizophrenia. Yamamoto H, Yamamoto K1, Miyaji S1, Yukawa-Inui M, Hori T, Tatematsu S, Yutani M, Tanaka K, Miyaoka H1: Kitasato Med J 2011/9; 41 (2): 145-53. (ŽR–{Œ«Ži1, ‹{’nLŒá1, ‹{‰ª@“™1: 1ž_)

220025. [€ŒŽ’˜] yŒ€‹†‚Æ•ñzS—ŒŸž‚ð—p‚¢‚œ“‡Žž’²Ç‚̏‰ŠúÇó‚ÉŠÖ‚·‚錀‹†|Œ’íŽÒ‚Æ‚Ì”äŠr‚©‚ç|. ”üŠ¹D, Šâ–ž—D”ü, ŽR–{Œ«Ži1, ‹{‰ª@“™1 (1ž_): ž_ˆãŠw 2011/12; 53 (12): 1157-65.

310028. [Ç—á•ñ] Metabolic syndrome in Japanese patients with mental retardation. Hoshino S, Yamamoto K1, Miyaji S, Sakai Y, Yamamoto H, Inui-Yukawa M, Miyaoka H1: Medical Case Studies 2011/6; 2 (4): 32-8. (ŽR–{Œ«Ži1, ‹{‰ª@“™1: 1ž_)

320050. [Ç—á•ñ] ‘‰tƒ~ƒGƒŠƒ“‰–Šî«’`”’‚̍ď㏞‚ð”F‚ß‚œˆêŽ_‰»’Y‘f’†“Å‚É‚æ‚é‘J‰„«ˆÓŽ¯áŠQ‚Ì1—á. ˆäo•¶Žq1, ˆäorŒõ2, ãžŠ‹gl2, ‘Š”nˆêˆå2 (1ž_, 2‹~–œ): “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ 2011; 32: 90-1.

520047. [‘à]yg‘ÌŽŸŠ³‚ÆŒüž_–ò|g‘ÌŽŸŠ³‚É”º‚€ž_áŠQŽ¡—Á|zI. ‘˜_@2. ƒvƒ‰ƒCE}ƒŠƒPƒA‚É‚š‚¯‚éŒüž_–ò‚Ì‘I‘ð. œA‰ªF—z, ‹{‰ª@“™1 (1ž_): “ú–{—Õଠ2012/1; 70 (1): 14-9.

521031. [‰ðà]y‘•]z“û—cŽ™ž_ˆãŠw“ü–å (–{éGŽŸ’˜). ˆäãŸ•v (ž_): Ž™“¶Â”Nž_ˆãŠw‚Æ‚»‚̋ߐڗ̈æ 2012/2; 53 (1): 70-1.

522179. [uÀ]yž_‰ÈƒNƒŠƒeƒBƒJƒ‹ƒpƒX˜_zž_‰È’nˆæ˜AŒgƒNƒŠƒeƒBƒJƒ‹ƒpƒX˜_. ‘åÎ@’q1, ˆÉ“¡Ol, ‰º‘º—TŒ©Žq, ‹{‰ª@“™1 (1ž_): ž_ˆã—à 2011/4; 62: 56-63.

522180. [uÀ]y“ÁW: “à‰ÈŠ³ŽÒ‚̐ž_‰È, S—Óà‰È“I‘Ήž|‚±‚±‚ë‚ÌŒ’N‚ð‚‚ß‚ézII. “à‰È“IŽŸŠ³‚É‚š‚¯‚鐞_Çó‚Æ‚»‚̑Ήž@ ŒÄ‹zŠíŽŸŠ³. ŽR–{Œ«Ži (ž_): f’f‚ÆŽ¡—à 2011/6; 99 (6): 1015-21.

522181. [uÀ]y“ÁWII. –ʐځE–Ê’k‚Ì‹Zpzˆã—Öʐڂ̊î‘b. ‚‹Ž@Œb (ž_): ž_‰È 2011/6; 18 (6): 634-9.

522182. [uÀ]y“ÁW: ’É‚Ý‚ðf‚éz2. Trend & Topics`’É‚Ý‚ðf‚é`@2. –«’ɂ̐S—ŽÐ‰ï“I“Á’¥. ‹{‰ª@“™1, ‹{’n‰p—Y1 (1ž_): Practice of Pain Management 2011/6; 2 (2): 26-8.

522183. [uÀ]y“ÁW: ‘ål‚É‚š‚¢‚čL”Đ«”­’BáŠQ‚ð‚Ç‚€f’f‚·‚é‚©z‘ål‚ÌPDDf’f‚Í‚Ç‚€‚ ‚é‚ׂ«‚©?: PDD‚Ì“Á«f’f‚Æprobable PDD. ˆäãŸ•v (ž_): ž__ŒoŠwŽGŽ 2011/11; 113 (11): 1130-6.

522184. [uÀ]y“ÁW: “®‚«Žn‚ß‚œ’nˆæ˜AŒgƒpƒXzž_‰Èˆã—Âɂš‚¯‚é’nˆæ˜AŒgƒpƒX‚ÌŽŽ‚Ý. ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_): “ú–{ž_‰È•a‰@‹Š‰ïŽGŽ 2011/12; 30 (12): 1151-9.

522185. [uÀ]yž_‰ÈE‚í‚œ‚µ‚̐f—Î菇zŽ‘±«g‘Ì•\Œ»áu’ɐ«áŠQ. ‹{’n‰p—Y (ž_): —Տ°ž_ˆãŠw 2011/12; 40 (12): 235-7.

522186. [uÀ]y“ÁW: ‘æ106‰ñ“ú–{ž__ŒoŠw‰ï‘‰ïƒVƒ“ƒ|ƒWƒEƒ€zŽáŽèˆãŽt‚É“`‚Š‚œ‚¢–ʐڋZp‚ðl‚Š‚é. ‚‹Ž@Œb (ž_): ž__ŒoŠwŽGŽ 2011; SS265-6.

522187. [uÀ]y“ÁW: ‘æ106‰ñ“ú–{ž__ŒoŠw‰ï‘‰ïƒVƒ“ƒ|ƒWƒEƒ€zƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‹Z”\K“Ÿ‚Ì‘€–Ê‚©‚ç@(1) Ï‹É“IŒX’®‚Æ‹€ŠŽ. ‚‹Ž@Œb (ž_): ž__ŒoŠwŽGŽ 2011; SS267-71.

522188. [uÀ]y“ÁW: ž_‰Èˆã‚Ì‘œÜ•¹—pE‘å—ʏˆ•û‚ðl‚Š‚é Iz“ÁWŠª“ªŒŸ: “ÁW‚É‚ ‚œ‚Á‚Ä. ‹{‰ª@“™ (ž_): ž_‰ÈŽ¡—Êw 2012/1; 27 (1): 1.

522189. [uÀ]y“ÁW: ‹~‹}‚É•K—v‚È ž_EȓI’mŽ¯‚ƑΉžz‹~‹}ŠO—ˆE•a“‚Å•K{‚ÈŒüž_–ò|‹~‹}ŠO—ˆE•a“‚Å•K{‚ÆŽv‚í‚ê‚é‹C•ªˆÀ’è–ò‚ð1`2‹³‚ŠEĂ­‚Ÿ‚³‚¢|. ŽR–{Œ«Ži (ž_): ‹~‹}EW’†Ž¡—à 2012/2; 24 (1): 22-9.

522190. [uÀ]y“ÁW: ‹~‹}‚É•K—v‚È ž_‰È“I’mŽ¯‚ƑΉžzŽ©ŽEŠé}‚Å“ü‰@‚µ‚œ‚€‚•aŠ³ŽÒ‚ւ̑Ήž. àVŽR@“§ (ž_): ‹~‹}EW’†Ž¡—à 2012/2; 24 (1): 105-12.

522191. [uÀ]y“ÁW: ’m‚Á‚Ä‚š‚«‚œ‚¢ž__Œo‰È‚Ì’mŽ¯|ê–åˆã‚̐f•ûEŽ¡‚µ•ûzž__Œo‰È“ü–å. À‘qF—˜, ‹{‰ª@“™1 (1ž_): Žš•@ˆôA‰ÈE“ªèò•”ŠO‰È 2012/3; 84 (3): 175-7.

530003. [‚»‚Ì‘Œ (’Z•ñ)] The short-term effect of the recent great earthquake on the general functioning status of psychiatric patients near Tokyo. Saito M1: Am J Psychiatry 2011/6; 168 (6): 649. (âV“¡³”Í1: 1ž_)

540064. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª–ì))u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†vz•a“IƒMƒƒƒ“ƒuƒŠƒ“ƒO (‚¢‚í‚ä‚éƒMƒƒƒ“ƒuƒ‹ˆË‘¶) ‚ÌŠT”O‚ÌŒŸ“¢‚ÆŠeŠÖ˜A‹@ŠÖ‚Ì“KØ‚ȘAŒg‚ÉŠÖ‚·‚錀‹†. ‹{‰ª@“™1, “c•Ó@“™, Îì@’B, Œ–{r•F, Œã“¡@Œb, ˆÉ”g^——Y, ”óŒû@i, ^‰h—¢m, _‘º‰hˆê, ‰ªè’Œl, Šâè³l, ˆî‘º@Œú, “c’†Ž—˜, ²“¡@‘ñ, ‘ºˆärÆ, ‰Í–{‘אM, XŽR¬•j, Ô–ØŒ’—˜, Œ‘º’Œ”V (1ž_): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª–ì))u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x•ª’SŒ€‹†•ñ‘•Êû 2012/3; p.7-68.

540065. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ)u(ž_áŠQ•ª–ìvz—lX‚Ȉˑ¶Ç‚É‚š‚¯‚éˆã—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†. ‹{‰ª@“™1, ”óŒû@i, Œ–{r•F, ¬ò“TÍ, ‘åÎ@’q1 (1ž_): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ)u(ž_áŠQ•ª–ìv•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.7-14, p.69-125.

540066. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŽ„—§‘åŠwí—ª“IŒ€‹†Šî”ÕŒ`¬Žx‰‡Ž–‹Æuw‚€‚•aŽÒ‚̎Љï“IŽx‰‡x‚š‚æ‚сwŽ©ŽE—\–hx‚ÉŠÖ‚·‚éƒ\[ƒVƒƒƒ‹ƒ‚ƒfƒ‹Œ€‹†EŠJ”­vzŽ¡—ÃŒø‰Ê‚ð‚‚ß‚é‰^“®ƒvƒƒOƒ‰ƒ€‚ÌŠJ”­`‰^“®¶—Šw‚ÌŠÏ“_‚©‚ç`. ˆÀŒŠ²“W, Œ”ö“N•v, “c’†G‹Å, ŽR–{Œ«Ži1 (1ž_): Ž„—§‘åŠwí—ª“IŒ€‹†Šî”ÕŒ`¬Žx‰‡Ž–‹Æuw‚€‚•aŽÒ‚̎Љï“IŽx‰‡x‚š‚æ‚сwŽ©ŽE—\–hx‚ÉŠÖ‚·‚éƒ\[ƒVƒƒƒ‹ƒ‚ƒfƒ‹Œ€‹†EŠJ”­v2010”N“x•ñ‘ 2012; p.27-30.

[’˜@‘]

620176. [Šwp‘] (•ª’SŽ·•M)yž_‰Èˆã‚Ì‚œ‚߂̃P[ƒXƒŒƒ|[ƒgEˆã—Õ¶‘‚̏‘‚«•û@ŽÀ—áWzA. “ú–{ž__ŒoŠw‰ï@ê–åˆãŽæ“Ÿ‚Ì‚œ‚߂̐\¿•¶‘@Ç—á•ñ‚̏‘‚«•û@3. _ŒoÇ«áŠQÇ—á@3) g‘̉»áŠQ, p. 36-7. ‹{‰ª@“™ (ž_), •Ò: ŽR“àr—Y, ŒŒŽŽO˜Y, ’†ŽR‘“X, “Œ‹ž, 2011/6”­s.

620177. [Šwp‘] (•ª’SŽ·•M)yž_‰ÈŒ€Cƒm[ƒgz‘æ2Í ž_‰ÈŒ€C‚Ń}ƒXƒ^[‚·‚ׂ«‚±‚Ɓ@C –ʐځE•]‰¿•û–@@1. –ʐڂ̋Z–@Eƒ}ƒi[, p.107-9. ‹{‰ª‰ÀŽq, ‹{‰ª@“™1 (1ž_), ƒVƒŠ[ƒY‘ŠÄC: ‰iˆä—ÇŽO, •Ò: Š}ˆäŽ“o, ‘ºˆärÆ, ŽO‘º@›’, ‰ª–{‘׏¹, ‘哇‹Il, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2011/6”­s.

620178. [Šwp‘] (•ª’SŽ·•M)yž_‰ÈŒ€Cƒm[ƒgz‘æ2Í ž_‰ÈŒ€C‚Ń}ƒXƒ^[‚·‚ׂ«‚±‚Ɓ@C –ʐځE•]‰¿•û–@@2. —\f‚ÌŽæ‚è•û, p.110-1. ‚‹Ž@Œb (ž_), ƒVƒŠ[ƒY‘ŠÄC: ‰iˆä—ÇŽO, •Ò: Š}ˆäŽ“o, ‘ºˆärÆ, ŽO‘º@›’, ‰ª–{‘׏¹, ‘哇‹Il, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2011/6”­s.

620179. [Šwp‘] (•ª’SŽ·•M)yž_ˆãŠwƒL[ƒ[ƒhŽ–“Tz281. ‚€‚•a, ‚€‚ó‘Ô‚ª•¹‘¶‚·‚ég‘ÌŽŸŠ³‚Ì—\Œã,p.447-56. ’––쑁•c, ‹{‰ª@“™1 (1ž_), ‘•ÒWFŒ‰º³–Ÿ, ’†ŽR‘“X, “Œ‹ž, 2011/7”­s.

620180. [Šwp‘] (•ª’SŽ·•M)yüˆÛ‹Ø’ɏǐf—ÃKƒCƒhƒ‰ƒCƒ“2011z4Í ŠÓ•Êf’f@4-5 .üˆÛ‹Ø’ɏǂƐž_ŽŸŠ³‚ÌŠÓ•Ê, p.70-5. ‹{‰ª@“™ (ž_), •Ò: “ú–{üˆÛ‹Ø’ɏNJw‰ï, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 2011/7”­s.

620181. [Šwp‘] (•ª’SŽ·•M)yž_‰È •K{–ò‚ð’T‚é [‰ü’ù2”Å]zE. Œ€Cˆã‚É’m‚Á‚Ä‚š‚¢‚Ä—~‚µ‚¢Œüž_–ò‚Ì’mŽ¯, p.229-39. ‹{‰ª@“™1, âV“¡³”Í1 (1ž_), •Ò: ‹{‰ª@“™1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/7”­s.

620182. [Šwp‘] (•ª’SŽ·•M)y‚±‚±‚ª’m‚è‚œ‚¢ Eê‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒXƒPƒA@ž_ˆãŠw‚Ì’mŽ¯•ž_ˆã—ÂƂ̘AŒg–@zchapter2. ž_‰Èˆã‚É‚æ‚鐞_ŽŸŠ³‚̐f‚©‚œ@A. ž_áŠQ‚̃AƒZƒXƒƒ“ƒg–@‚ð’m‚è‚œ‚¢, p.40-6. ‹{‰ª@“™1, Š™“c’ŒŽ÷ (1ž_), •Ò: “ú–{ŽY‹Æž_•ÛŒ’Šw‰ï, “ì]“°, “Œ‹ž, 2011/7”­s.

620183. [Šwp‘] (•ª’SŽ·•M)y‚±‚±‚ª’m‚è‚œ‚¢ Eê‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒXƒPƒA@ž_ˆãŠw‚Ì’mŽ¯•ž_ˆã—ÂƂ̘AŒg–@zchapter2. ž_‰Èˆã‚É‚æ‚鐞_ŽŸŠ³‚̐f‚©‚œ@B. ]—ˆ‚©‚ç‚̐ž_áŠQ‚̐f’f‚Æ‘€ìEIf’fŠî€‚̈Ⴂ‚ð’m‚è‚œ‚¢, p.46-9. ‹{‰ª@“™1, Š™“c’ŒŽ÷ (1ž_), •Ò: “ú–{ŽY‹Æž_•ÛŒ’Šw‰ï, “ì]“°, “Œ‹ž, 2011/7”­s.

620184. [Šwp‘] (•ª’SŽ·•M)yS——Տ°ŠwŽ–“Tz3. ˆã—Á@“‡Žž’²ÇŽü•Ó‚̐ž_áŠQ, p.250-1. ‹{‰ª@“™ (ž_), •Ò: “ú–{S——Տ°Šw‰ï, ŠÛ‘Po”Å, “Œ‹ž, 2011/8”­s.

620185. [Šwp‘] (•ª’SŽ·•M)y_ŒoÇ«áŠQ‚ÌŽ¡—ÃKƒCƒhƒ‰ƒCƒ“ (ž_‰ÈŽ¡—Êw ‘æ26Šª‘Š§†)z‘æ1Í ŽŸŠ³•Ê€–ځ@30. ‹@”\«g‘̏njóŒQ (FSS), p.261-3. ‹{‰ª@“™1, ‹{’n‰p—Y1 (1ž_), •Ò: už_‰ÈŽ¡—Êwv•ÒWˆÏˆõ‰ï, ¯˜a‘“X, “Œ‹ž, 2011/10”­s.

620186. [Šwp‘] (•ª’SŽ·•M)yŒ€Cˆã‚Ì‚œ‚߂̂ЂƂè‚Å‚Å‚«‚邱‚±‚ë‚Æ‚©‚ç‚Ÿ‚Ì‹~‹}Š³ŽÒ‘Ήž@‚±‚ê‚ÅŠyŸ! ž_‰¹’s‚ªŽ•ž‚Å‚«‚éƒp[ƒtƒFƒNƒgƒKƒCƒhz‘æ1Í ¡“ú‚©‚ç“Š‚°‚È‚¢! ž_‹~‹}@1. g‘ÌŽŸŠ³‚Ɛž_ŽŸŠ³‚𕹂¹‚à‚Š³ŽÒ‚ðŽ¡—Ã‚·‚é‚Ì‚Í’N‚©, p.8-12. ‹{‰ª@“™ (ž_), •Ò’˜: “ú–{‚±‚±‚ë‚Æ‚©‚ç‚Ÿ‚Ì‹~‹}Šw‰ï, ƒƒfƒBƒJo”Å, ‘åã, 2011/11”­s.

620187. [Šwp‘] (•ª’SŽ·•M)yŒ€Cˆã‚Ì‚œ‚߂̂ЂƂè‚Å‚Å‚«‚邱‚±‚ë‚Æ‚©‚ç‚Ÿ‚Ì‹~‹}Š³ŽÒ‘Ήž@‚±‚ê‚ÅŠyŸ! ž_‰¹’s‚ªŽ•ž‚Å‚«‚éƒp[ƒtƒFƒNƒgƒKƒCƒhz‘æ2Í ‚±‚±‚͉Ÿ‚³‚Š‚ë! ž_‹~‹}‚̃cƒ{@5. “]Š·«áŠQE‰ð—£«áŠQ, p.53-7. ‹{‰ª@“™ (ž_), •Ò’˜: “ú–{‚±‚±‚ë‚Æ‚©‚ç‚Ÿ‚Ì‹~‹}Šw‰ï, ƒƒfƒBƒJo”Å, ‘åã, 2011/11”­s.

620188. [Šwp‘] (•ª’SŽ·•M)yž_ˆãŠwƒeƒLƒXƒg@ž_áŠQ‚Ì—‰ð‚ÆŽ¡—Â̂œ‚߂Ɂ@‰ü’ù‘æ3”ŁzI. ž_ˆãŠw‚ÌŠî‘b’mŽ¯@F. ‚æ‚­‚Ý‚ç‚ê‚鐞_Çó‚Əó‘Ô‘œ@2. ’mŠoEŽvlEŠŽî‚ُ̈í, p.86-95. ‹{‰ª@“™ (ž_), •Ò: ã“‡‘—˜, —§ŽRäݗ¢, “ì]“°, “Œ‹ž, 2012/2”­s.

620189. [Šwp‘] (•ª’SŽ·•M)yž_ˆãŠwƒeƒLƒXƒg@ž_áŠQ‚Ì—‰ð‚ÆŽ¡—Â̂œ‚߂Ɂ@‰ü’ù‘æ3”ŁzI. ž_ˆãŠw‚ÌŠî‘b’mŽ¯@F. ‚æ‚­‚Ý‚ç‚ê‚鐞_Çó‚Əó‘Ô‘œ@3. ‹L‰¯EˆÓ—~Es“®EŽ©‰äˆÓŽ¯‚ُ̈í, p.95-8. ‹{‰ª@“™ (ž_), •Ò: ã“‡‘—˜, —§ŽRäݗ¢, “ì]“°, “Œ‹ž, 2012/2”­s.

620190. [Šwp‘] (•ª’SŽ·•M)yž_ˆãŠwƒeƒLƒXƒg@ž_áŠQ‚Ì—‰ð‚ÆŽ¡—Â̂œ‚߂Ɂ@‰ü’ù‘æ3”ŁzII. ž_áŠQ‚Ì—‰ð‚Ì‚œ‚ß‚Ì’mŽ¯@B. “àˆö«‚̐ž_áŠQ@2. “‡Žž’²Œ^áŠQ‚Æ–Ï‘z«áŠQ, p.166-71. âV“¡³”Í (ž_), •Ò: ã“‡‘—˜, —§ŽRäݗ¢, “ì]“°, “Œ‹ž, 2012/2”­s.

620191. [Šwp‘] (•ª’SŽ·•M)y•W€ž_ˆãŠw (‘æ5”Å)z‘æ4Í ž_ˆãŠw“IfE@‚Ɛf’f@I –ʐږ@, p.76-85. ‹{‰ª@“™ (ž_), •Ò: –쑺‘ˆê˜Y, ”óŒû‹P•F, ”öè‹I•v, ’©“c@—², ˆãŠw‘E@, “Œ‹ž, 2012/3”­s.

620192. [Šwp‘] (•ª’SŽ·•M)y•W€ž_ˆãŠw (‘æ5”Å)z‘æ6Í@ƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“EƒŠƒGƒ]ƒ“ž_ˆãŠw@I ŠT”O, II CLP‚ÌŽå‚ȑΏÛ, III CLP‚ÌŽü•Ó—̈æ, IV CLP‚̍¡Œã, p.165-74. ‹{‰ª@“™ (ž_), •Ò: –쑺‘ˆê˜Y, ”óŒû‹P•F, ”öè‹I•v, ’©“c@—², ˆãŠw‘‰@, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713157. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Association between Trait Anxiety and Psychological Reactions in Kidney Transplant Recipients before Transplantation. Tatematsu S, Iwamitsu Y, Yamamoto K1, Yoshida K2, Miyaoka H1: The 21st World Congress on Psychosomatic Medicine (2011/8/25), Seoul, Korea. (—§Œ¹ˆê, Šâ–ž—D”ü, ŽR–{Œ«Ži1, ‹g“cˆê¬2, ‹{‰ª@“™1: 1ž_, 2”å”AŠí)

713158. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Relationship of Somatic Symptoms with Depression. Inui-Yukawa M,Yamamoto K1, Miyachi H1, Miyaji S1, Yamamoto H, Yukawa H, Tatematsu S, Miyaoka H1: The 21st World Congress on Psychosomatic Medicine (2011/8/26), Seoul, Korea. (ŽR–{Œ«Ži1, ‹{’n‰p—Y1, ‹{’nLŒá1, ‹{‰ª@“™1: 1ž_)

713159. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘̐t‘ŸˆÚAƒŒƒVƒsƒGƒ“ƒg‚̏p‘OS—”œ‰ž‚Æ“Á«•sˆÀ‚ÌŠÖŒW. —§Œ¹ˆê, Šâ–ž—D”ü, ŽR–{Œ«Ži1, ‹{‰ª@“™1 (1ž_): “ú–{Œ’NS—Šw‰ï‘æ24‰ñ‘å‰ï (2011/9/12), “Œ‹ž.

722183. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€2-2züˆÛ‹Ø’ɏǂɂš‚¯‚鎡—ÃŽè’i‚̍l‚Š•û. ‹{‰ª@“™1, ‹{’n‰p—Y1 (1ž_): “ú–{üˆÛ‹Ø’ɏNJw‰ï‘æ3‰ñŠwpW‰ï (2011/9/11), ‰¡•l.

722184. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‚€‚•af—Â̍¬—. ‹{‰ª@“™ (ž_): ‘æ18‰ñ‘œ•¶‰»ŠÔž_ˆãŠw‰ïŠwp‘‰ï (2011/10/1), “Œ‹ž.

722185. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y¡“ú‚̐V‚œ‚È•a‹C‚Ɛž_ˆãŠw: disease-mongering‚ð’Ž‚Š‚āzdisease-mongering‚ƐüˆÛ‹Ø’ɏÇ. ‹{‰ª@“™1, ‹{’n‰p—Y1 (1ž_): ‘æ107‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2011/10/26), “Œ‹ž.

722186. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘ål‚É‚š‚¢‚čL”Đ«”­’BáŠQ‚ð‚Ç‚€f’f‚·‚é‚©: DSM‚ÆICD`ƒJƒeƒSƒŠ[‚ƃXƒyƒNƒgƒ‰ƒ€. ˆäãŸ•v (ž_): ‘æ107‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2011/10/26), “Œ‹ž.

722187. [Šw‰ï (‘S‘)] (Žs–¯ŒöŠJuÀ) ž_‰Èˆã‚Ì‘I‚Ñ•ûEƗ˜—p‚ÌŽd•û. ‹{‰ª@“™ (ž_): ‘æ107‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2011/10/27), “Œ‹ž.

722188. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) _ŒoÇ–³H—~Ç‚ÌŽ¡—Á|ž_‰Èˆã‚̉ۑè‚Æ–k—¢•ûŽ®Ž¡—Á|. ‚‹ŽŒb—1, ‹{‰ª@“™1 (1ž_): ‘æ107‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2011/10/27), “Œ‹ž.

722189. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ECT (Electroconvulsive Therapy) ‚É‚š‚¯‚é”­ì‘‹­. àVŽRŒb”g1, ‚‹Ž@Œb1, “c’†Žr, àVŽR@“§1, ‰œ•xr”V2, ‹{‰ª@“™1 (1ž_, 2–ƒŒ): ‘æ107‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2011/10/27), “Œ‹ž.

722190. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) —}‚€‚Â, •sˆÀ‚ɑ΂·‚é‘œÜ‘œ—ʏˆ•û‚ÌŒ»ó‚ƍ¡‚Å‚«‚é‘΍ô. ‹{‰ª@“™ (ž_): ‘æ21‰ñ“ú–{—Տ°ž__Œo–ò—Šw‰ïE‘æ41‰ñ“ú–{_Œož_–ò—Šw‰ï@‡“¯”N‰ï (2011/10/29), “Œ‹ž.

723835. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰îŒìEˆõ‚ɑ΂·‚éŽÀ‘HŽÒŒ€C‚Ì–ðŠ„|Œ€C‘OŒã‚̐E‹ÆƒXƒgƒŒƒX‚ƃR[ƒsƒ“ƒOƒXƒLƒ‹‚̕ω»|. ‘êàV‹B–î, ‚‹Ž@Œb1, ‚ˆä”ü’qŽq, –û’JŒ³‹K, Îˆä—Y‹g, ‘åÎ@’q1, ’r“c‘Ÿˆê˜Y, ‹{‰ª@“™1 (1ž_): ‘æ26‰ñ“ú–{˜V”Nž_ˆãŠw‰ï (2011/6/16), “Œ‹ž.

723836. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽèpŒã‚Ì“û‚ª‚ñŠ³ŽÒ‚É‚š‚¯‚éS—“I”œ‰ž‚ÆŠŽî—}§‚ɂ‚¢‚Ä. ’†’J—LŠó, Šâ–ž—D”ü, ‘ •À@Ÿ1, ‰ªè‰ê”ü, ˆÀ“c—TŒb, ŽR–{Œ«Ži2, “n粏¹•F1, ‹{‰ª@“™1 (1ŠO‰È, 2ž_): “ú–{S—Šw‰ï‘æ75‰ñ‘å‰ï (2011/9/15), “Œ‹ž.

723837. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šw¶‘Š’k—˜—pó‹µ‚©‚ç‚Ý‚œUPIÄl. ˆäãŸ•v1, ‹{‰ª@“™1 (1ž_): “ú–{S—Šw‰ï‘æ75‰ñ‘å‰ï (2011/9/17), “Œ‹ž.

723838. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]ŒŒŠÇáŠQ‚𔺂€‚€‚•a‚Ì–ò•š—Ö@. ‚‹Ž@Œb1, ’r“c‘Ÿˆê˜Y, “cÀ—Ž‘Ÿ˜Y1, ‹{‰ª@“™1 (1ž_): ‘æ107‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2011/10/27), “Œ‹ž.

723839. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)yÀ’·zƒŠƒGƒ]ƒ“1. ˆäãŸ•v (ž_): ‘æ52‰ñ“ú–{Ž™“¶Â”Nž_ˆãŠw‰ï‘‰ï (2011/11/10), “¿“‡.

723840. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž™“¶ž_‰ÈŠO—ˆ‚Å‚ÌWISC-III‚ÆK-ABC‚Ì—˜—p (‚»‚Ì1) WISC-III‚ÆK-ABC‚ÌŠÖ˜A. ˜a“c^—Žq, ˆäãŸ•v1, ‹{‰ª@“™1 (1ž_): ‘æ52‰ñ“ú–{Ž™“¶Â”Nž_ˆãŠw‰ï‘‰ï (2011/11/11), “¿“‡.

723841. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž™“¶ž_‰ÈŠO—ˆ‚Å‚ÌWISC-III‚ÆK-ABC‚Ì—˜—p (‚»‚Ì2) WISC-III‚ÆK-ABC‚Ì‘‡“I‚ÈŠˆ—p. ˆäãŸ•v1, ˜a“c^—Žq, ‹{‰ª@“™1 (1ž_): ‘æ52‰ñ“ú–{Ž™“¶Â”Nž_ˆãŠw‰ï‘‰ï (2011/11/11), “¿“‡.

723842. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇŠÓ•ÊŠO—ˆŽófŽÒ‚Ì“®–¬d‰»“x‚©‚ç‚Ý‚œ”]”gŠî‘bŠˆ“®‚ÌŒŸ“¢. —é–؏~Žq, •P“c‹v”ü, ‘ºŽR^‹|, ‰Ÿ“cD”ü, ‹g–{gŽq, âV“¡³”Í1, ‚‹Ž@Œb1 (1ž_): ‘æ41‰ñ“ú–{—Տ°_Œo¶—Šw‰ïEŠwp‘å‰ï (2011/11/11), Ã‰ª.

723843. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰»Šw—Ö@‘OŒã‚É‚š‚¯‚é“û‚ª‚ñŠ³ŽÒ‚̐S—“I”œ‰ž‚Æ“Á«•sˆÀ‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä. Šâ–ž—D”ü, ˆÀ“c—TŒb, ‰ªè‰ê”ü, ’†’J—LŠó, ŽR–{Œ«Ži1, ‹{‰ª@“™1 (1ž_): ‘æ27‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ïŠwp‘‰ï (2011/11/20), “Œ‹ž.

723844. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆŸ‹}«Šú‚̍ЊQˆã—ÃŽx‰‡ƒ`[ƒ€‚É‚š‚¯‚鐞_‰Èˆã‚Ì–ðŠ„‚É‚Â‚¢‚Ä. ‚‹ŽŒb—1, Š—¶—TŽi, ŽR–{Œ«Ži1, ‹{‰ª@“™1 (1ž_): ‘æ24‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2011/11/26), •Ÿ‰ª.

723845. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒ‰t“§Í‚ð‹‘”Û‚·‚鐞_áŠQŠ³ŽÒ‚ւ̑Ήž‚ɂ‚¢‚Ä. Vˆä‹v–«, ŽR–{Œ«Ži1, ˆäãŸ•v1, ŠÛ“ÞŒb, ’ËŒŽ“ÖŽq1, ‹{‰ª@“™1 (1ž_): ‘æ24‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2011/11/26), •Ÿ‰ª.

723846. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’nˆæŠˆ“®Žx‰‡ƒZƒ“ƒ^[‚É‚š‚¯‚éSST‚Ì“±“ü‚ƍH•v. –û’JŒ³‹K, ÔÎàVŸ, ŽR“c@—Ž, ‚‹Ž@Œb1, ‹{‰ª@“™1 (1ž_): SST•‹y‹Š‰ï‘æ16‰ñŠwpW‰ï (2011/12/3), ’·è.

723847. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—î‚ÌŽ©ŽEŠé}Š³ŽÒ‚ɂ‚¢‚Ă̍lŽ@|‘OŠú‚—îŽÒ, ŒãŠú‚—îŽÒ, ––Šú‚—îŽÒ3ŒQ‚Ì”äŠr‚©‚ç|. –x@’qŽq, ŽR–{Œ«Ži1, ‹{’nLŒá1, ŽR–{G–Ÿ, Š£@^”ü, —§Œ¹ˆê, ‚ˆä”ü’qŽq, ˆäo•¶Žq2, ãžŠ‹gl2, ‘Š”nˆêˆå2, ‹{‰ª@“™1 (1ž_, 2‹~–œ): ‘æ35‰ñ“ú–{Ž©ŽE—\–hŠw‰ï‘‰ï (2011/12/16), ‰«“ê.

723848. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬’†Šw¶‚ÌŽ©ŽEŠé}Š³ŽÒ‚ɂ‚¢‚Ä. ‹{’nLŒá1, ŽR–{Œ«Ži1, ŽR–{G–Ÿ, Š£@^”ü, —§Œ¹ˆê, –x@’qŽq, ˆäo•¶Žq2, Šâ–ž—D”ü, ãžŠ‹gl2, ‘Š”nˆêˆå2, ‹{‰ª@“™1 (1ž_, 2‹~–œ): ‘æ35‰ñ“ú–{Ž©ŽE—\–hŠw‰ï‘‰ï (2011/12/17), ‰«“ê.

732142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”]”g”»“ǂ̃|ƒCƒ“ƒg|•ñ‘‚̏‘‚«•û|. âV“¡³”Í (ž_): ŠÖ“Œ_Œo¶—ŒŸž‹ZpŒ€‹†‰ï‘æ45‰ñ“ú—juK‰ï (2012/1/22), “Œ‹ž.

733401. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “û‚ª‚ñŠ³ŽÒ‚É‚š‚¯‚鉻Šw—Ö@‘OŒã‚Ì”F’m‹@”\‚ÉŠÖ‚·‚錟“¢. “c•Ó‹LŽq, Šâ–ž—D”ü, ‘ •À@Ÿ1, ˆÀ“c—LŠó, ŽR–{Œ«Ži2, “n粏¹•F1, ‹{‰ª@“™2 (1ŠO‰È, 2ž_): ‘æ33‰ñ_“ސìSgˆãŠw‰ïŠwpW‰ï (2011/10/15), ‰¡•l.

733402. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t‘ŸˆÚA‘O‚ÌŠ³ŽÒ‚ª•ø‚­ŽèpŒã¶Šˆ‚̃Cƒ[ƒW‚ɂ‚¢‚Ä. —§Œ¹ˆê, Šâ–ž—D”ü, ŽR–{Œ«Ži1, ‹g“cˆê¬2, Îˆä‘å•ã2, –ìŒû•¶”T, ’r“c¬], ‹{‰ª@“™1 (1ž_, 2”å”AŠí): ‘æ22‰ñ“ú–{ƒTƒCƒRƒlƒtƒƒƒW[Œ€‹†‰ï (2011/5/28), ‘åã.

733403. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆ««ƒŠƒ“ƒpŽî‚É‚æ‚鐞_Çó‚ª‹^‚í‚ê‚œÇ—Ⴊ‘[’u“ü‰@‚É‚¢‚œ‚é‚Ü‚Å‚Ì–â‘è“_. —›@‰p_1, “cÀ—Ž‘Ÿ˜Y1, À‘qF—˜, ‘åÎ@’q1, ‚‹Ž@Œb1 (1ž_): ‘æ162‰ñ_“ސ쌧ž_ˆãŠw‰ï‘‰ï (2011/7/9), ‰¡•l.

733404. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž•‰È‚É‚š‚¯‚é™ù‡ˆá˜aŠŽ‚̗Տ°“IŒ€‹†|”­ÇŒŽˆö‚ÉŠÖ‚·‚錟“¢|. ¬—с@„, ‰v‰ª‘å•ã, ‘å’Ï®‹M, “‡“c@~, àF’J’q–Ÿ, ŽO‘º«•¶, ‹{’n‰p—Y1, ‹{‰ª@“™1, ˜a‹C—T”V, ‹Ê’uŸŽi (1ž_): ‘æ33‰ñ_“ސìSgˆãŠw‰ïŠwpW‰ï (2011/10/15), ‰¡•l.

733405. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™Šú‚©‚ç‚̐«“I‹s‘Ò‚ª‚ ‚è’·ŠúŠÔg‘Ì“I•s’èD‘i‚ªŽ‘±‚µ‚Ä‚¢‚éÇ—á‚ɂ‚¢‚Ä. Vˆä‹v–«, ŽR–{Œ«Ži1, ˆäãŸ•v1, ‹{‰ª@“™1 (1ž_): ‘æ33‰ñ_“ސìSgˆãŠw‰ïŠwpW‰ï (2011/10/15), ‰¡•l.

733406. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@3ŽŸ‹~–œ‹~‹}ƒZƒ“ƒ^[‚É”À‘—‚³‚ê‚œŽá”NŽ©ŽEŠ³ŽÒ‚Ì“®Œü‚ɂ‚¢‚Ä. Š£@^”ü, ŽR–{Œ«Ži1, ‹{’nLŒá1, —§Œ¹ˆê, –x@’qŽq, ˆäo•¶Žq2, ãžŠ‹gl2, Šâ–ž—D”ü, ‹{‰ª@“™1 (1ž_, 2‹~–œ): ‘æ34‰ñ_“ސìSgˆãŠw‰ïŠwpW‰ï (2012/3/31), ‰¡•l.

H22”N“xˆÈ‘O•ª

[’˜@‘]

H22-620005. [Šwp‘] (•ª’SŽ·•M)yˆã—Ë֊õƒ|ƒPƒbƒgƒ}ƒjƒ…ƒAƒ‹zž_E_ŒoES—ÉÈ. ŽR–{Œ«Ži (ž_), Ó”C•ÒW: •y–ìN“úŒÈ, ˆãŽ•–òo”Å, “Œ‹ž, 2011/3”­s.


•úŽËü‰ÈŠw (‰æ‘œf’fŠw)

[Šwp˜_•¶]

110259. [ŒŽ’˜] Lymph drainage from the mammary glands in mice: a magnetic resonance lymphographic study with gadofluorine M. Sheng F1,2, Inoue Y3, Kiryu S1, Watanabe M1, Ohtomo K4: Acad Radiol 2011/4; 18 (4): 512-7. (ˆäã—D‰î3: 1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š, 2’†‘–k‹žŒRŽ–ˆãŠw‰ÈŠw‰@•‘®ˆã‰@•úŽË‰È, 3•úŽËü (‰æ‘œ), 4“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È•úŽËü)

110260. [ŒŽ’˜] Distortion correction in whole-body imaging of live mice using a 1-Tesla compact magnetic resonance imaging system. Kiryu S1, Inoue Y2, Masutani Y1, Haishi T3, Yoshikawa K4, Watanabe M1, Ohtomo K1: Jpn J Radiol 2011/6; 29 (5): 353-60. (ˆäã—D‰î2: 1“Œ‹ž‘åŠw‰ÈŠwŒ€‹†Š, 2•úŽËü (‰æ‘œ), 3ƒGƒ€ƒA[ƒ‹ƒeƒNƒmƒƒW[, 4‹îàV‘åŠw)

110261. [ŒŽ’˜] Quantitative effect of reducing body thickness on visualizing murine deep abdominal lymph nodes by in vivo fluorescence reflectance imaging. Inoue Y1, Watanabe M2, Kiryu S2, Ohtomo K3: J Fluoresc 2011/7; 21 (4): 1325-9. (ˆäã—D‰î1: 1•úŽËü (‰æ‘œ), 2“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š, 3“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È•úŽËü)

110262. [ŒŽ’˜] Phase I clinical study of NMK36: a new PET tracer with the synthetic amino acid analogue anti-[18F]FACBC. Asano Y1, Inoue Y1, Ikeda Y2, Kikuchi K3, Hara T1, Taguchi C1, Tokushige T3, Maruo H3, Takeda T4, Nakamura T2, Fujita T2, Kumagai Y2, Hayakawa K5: Ann Nucl Med 2011/7; 25 (6): 414-8. (ó–ì—Y“ñ1, ˆäã—D‰î1, ’r“cN•F2, ‹e’r@Œh3, ŒŽ@•q«1, “cŒû’qŽq1, “¿d‘žé3, ŠÛ”öGŽ÷3, •“c@“O4, ’†‘º’q”ü2, “¡“c•üŒb2, ŒF’J—YŽ¡2, ‘ì˜ad5: 1•úŽËü (‰æ‘œ), 2“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 3•úŽËü•”, 4ˆã—Éq¶Šw•”, 5•úŽËü (Žîá‡))

110263. [ŒŽ’˜] Diffusion-weighted imaging of the breast: principles and clinical applications. Woodhams R1, Ramadan S2, Stanwell P3, Sakamoto S1, Hata H2, Ozaki M2, Kan S1, Inoue Y1: Radiographics 2011/7-8; 31 (4): 1059-85. ƒEƒbƒhƒnƒ€ƒX—æŽq1, â–{‘Žq1, ›@Mˆê1, ˆäã—D‰î1: 1•úŽËü (‰æ‘œ), 2Brigham and women's Hospital harvad Medical school, 3Facuity of Health University of Newcastle)

110264. [ŒŽ’˜] Effect of isoflurane anesthesia and hypothermia on the hepatic kinetics of Gd-EOB-DTPA: evaluation using MRI of conscious mice. Kiryu S1, Inoue Y2, Watanabe M1, Ohtomo K1: J Magn Reson Imaging 2011/8; 32 (2): 354-60. (ˆäã—D‰î2: 1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š, 2•úŽËü (‰æ‘œ))

110265. [ŒŽ’˜] Integrated lymphography using fluorescence imaging and magnetic resonance imaging in intact mice. Inoue Y1, Masutani Y2, Kiryu S3, Haishi T4, Yoshikawa K5, Watanabe M3, Shimada M5, Ohtomo K3: Mol Imaging 2011/10; 10 (5): 317-26. (ˆäã—D‰î1: 1•úŽËü (‰æ‘œ), 2“Œ‹ž‘åŠwˆãŠw•”•‘®•a‰@, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š, 4ƒGƒ€ƒA[ƒ‹ƒeƒNƒmƒƒW[, 5‹îàV‘åŠw)

110266. [ŒŽ’˜] Gaussia luciferase for bioluminescence tumor monitoring in comparison with firefly luciferase. Inoue Y1, Sheng F2, Kiryu S2, Watanabe M2, Ratanakanit H2, Izawa K2, Tojo A2, Ohtomo K2: Mol Imaging 2011/10; 10 (5): 377-85. (ˆäã—D‰î1: 1•úŽËü (‰æ‘œ), 2“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š)

110267. [ŒŽ’˜] Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy. Hara T1, Inoue Y1, Satoh T2, Ishiyama H3, Sakamoto S, Woodhams R1, Baba S2, Hayakawa K3: Magn Reson Imaging 2012/10; 30 (8): 1091-8. (ŒŽ@•q«1, ˆäã—D‰î1, ²“¡ˆÐ•¶2, ÎŽR”ŽžŠ3, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ”nêŽu˜Y2, ‘ì˜ad3: 1•úŽËü (‰æ‘œ), 2”å”AŠí, 3•úŽËü (Žîá‡))

110268. [ŒŽ’˜] Estimation of Tc-99m MAG3 clearance using camera-based methods without blood sampling. Inoue Y1, Ohtomo K2: Clin Nucl Med 2011/11; 36 (11): 1012-6. (ˆäã—D‰î1: 1•úŽËü (‰æ‘œ), 2“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š)

110269. [ŒŽ’˜] Motor and Nonmotor Components of Event-Brain Potential in Preparation of Motor Response. Kotani Y1, Ohgami Y1, Arai J2, Kiryu S3, Inoue Y4: Journal of Behavioral and Brain Science 2011/11; 1 (4): 234-41. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠwlŠÔƒVƒXƒeƒ€‰ÈŠw, 2ƒ_ƒCƒLƒ“H‹Æ‹ZpŠJ”­ƒZƒ“ƒ^[, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š, 4•úŽËü (‰æ‘œ))

110270. [ŒŽ’˜] Long-term assessment of contrast effects of gadofluorine M and gadofluorine P in magnetic resonance imaging of mice. Sheng F1,2, Inoue Y3, Kiryu S1, Watanabe M1, Ohtomo K4: Jpn J Radiol 2012/1; 30 (1): 86-91. (ˆäã—D‰î3: 1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š, 2–k‹žŒRŽ–ˆã‰ÈŠwŠw‰@, 3EúŽËü (‰æ‘œ), 4“Œ‹ž‘åŠw‘åŠw‰@•úŽËü‰È)

110271. [ŒŽ’˜] Use of an oral effervescent agent in the evaluation of gastric 67Ga uptake. Yamada T1, Inoue Y1, Asano Y1, Nippashi Y2, Woodhams R1, Matsunaga K1, Tago M2: Ann Nucl Med 2012/2; 26 (2): 192-6. (ŽR“cäŽm1, ˆäã—D‰î1, ó–ì—Y“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, Œ‰iŒh“ñ1: 1•úŽËü (‰æ‘œ), 2’é‹ž‘åŠwˆãŠw•”•‘®aŒû•a‰@•úŽËü‰È)

320051. [Ç—á•ñ] ’_ùNŠÇŠà‚Ì1—á. ‘åX’qŽq1, ‘ëì­˜a1, ¬Š}ŒŽ‹2, –x“cˆ»Žq3, âV“¡¶˜N3, ›–ì@‘4, ‹à“cŒå˜Y5, ²X–ؐ^‹|6 (1‘—§•a‰@‹@\‘Š–ÍŒŽ•a‰@•úŽËü‰È, 2•úŽËü (‰æ‘œ), 3‘—§•a‰@‹@\‘Š–ÍŒŽ•a‰@•a—, 4“¯Á‰»Ší‰È, 5“¯ŠO‰È, 6ŽŠœ‰ï‘æ“ñ•a‰@•úŽËü‰È): —Տ°•úŽËü 2011/9; 56 (9): 1138-42.

320052. [Ç—á•ñ] èò•”‚̉ߋü‹È‚ðŒ_‹@‚É”­Ç‚µ‚œÒ‘[Ç‚Ì1—á. ›@Mˆê1, ’†ŒŽ–M»2, Œ¢Ž”@‰~2 (1•úŽËü (‰æ‘œ), 2”]ŠO): Ò’ŐҐ‘ƒWƒƒ[ƒiƒ‹ 2011/9; 24 (9): 893-9.

320053. [Ç—á•ñ] ùN–E¬•ª‚𔺂Á‚œäX“à•›äB‚ª‹^‚í‚ê‚œ1—á. â–{‘Žq1, Œ‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, “¡ˆä@Š]1, “ü]‚‚®‚Ý1, ¬Š}ŒŽ‹1, –Ø“cŒõL2, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2Á‰»Ší“à): —Տ°•úŽËü 2011/10; 56 (10): 1274-5.

521032. [‰ðà]yPicked-up Knowledge from Foreign Journalsz_Œo•úŽËü. ›@Mˆê (•úŽËü (‰æ‘œ)): ‰æ‘œf’f 2011/6; 31 (7): 719-20.

521033. [‰ðà]yPicked-up Knowledge from Foreign Journalsz_Œo•úŽËü. ›@Mˆê (•úŽËü (‰æ‘œ)): ‰æ‘œf’f 2011/12; 31 (14): 1412-3.

521034. [‰ðà] •šŒê«‚Ì•œŒ . ›@Mˆê (•úŽËü (‰æ‘œ)): Ò’ŐҐ‘ƒWƒƒ[ƒiƒ‹ 2012/3; 25 (3): 155-6.

540067. [‚»‚Ì‘Œ]y˜AÚ: ‚·‚Æ‚ç‚Ñ‚·‚Þ‚·z”ü‚Ì’T‹. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‰æ‘œf’f 2011/5; 31 (6): 507.

540068. [‚»‚Ì‘Œ (’Z•ñ)]y’²ž•ñz‘æ8‰ñ“ú–{IVRŠw‰ï‰Ä‹GŠwpƒZƒ~ƒi[wB-RTO‚ÆNBCAÇðpxŽóu¶‚ÌŽóu‘OŒã‚̐f—Ís“®‚Ì’²ž. •Ä’Ž@“Ö1, ‘ëì­˜a2, Œ“c“TŽj3, ŽR–{@W3, ŒˆäL“o3, ‘O“cO²4, ¬—с@ŒO4, ŽR–{@‘4, ˆ¢’m”g¶çŽq4, –Ÿ_˜a‹I5, ‹Ž–{@‹B5, Œ‰iŒh“ñ6, ²X–ؐ^‹|7, ‚‹Ž@œ8, Žá‹{@œ9, •s”j‘ŠŒM10, ŒŽŒû‹MŽj10, ”ª_r–Ÿ11, åM“c@ŽÀ12, –쌩ŽROs13, ’JŠ|‰ël14, “n糌[‘Ÿ15, Œà_°15, ¡•ô—Ï•œ16, ’Ë“cŽÀ˜Y17, “c‘º@‘S17, ’†’ːœ”V17, HER’ŒŽq18, “àƒm‘º‘19, lŒ©ŽŸ˜Y20, •Û–{@‘ì, ’†‘ºƒŽõ, ’|Œû—²–ç, ²“¡_ŽO, _’JŽÀ‰À, X–ØŒ’¶, £”VŒû‹PŽõ, Îì—Sˆê, ’·’J‘ˆê˜Y, ŽR–勝ˆê˜Y (1ŠÖŒˆã‘å, 2‘Š–ÍŒŽ•a‰@, 3‘åãŽs‘å, 4•ºŒÉˆã‘å, 5“ŒŠC‘å, 6•úŽËü (‰æ‘œ), 7ŽŠœ‰ï‘æ“ñ•a‰@, 8ƒeƒ‹ƒ‚, 9Žs—§’·•l•a‰@, 10¹˜H‰Á‘Û•a‰@, 11Ï¶‰ï‰F“s‹{•a‰@, 12‘q•~’†‰›•a‰@, 13‹ãB˜JÐ•a‰@, 14‹ž“sŽs•a‰@, 15ŽY‹Æˆã‘å, 16“úÔ˜a‰ÌŽRˆã—ÃZ, 17Œcœä‘å, 18Œàˆã—ÃZ, 19ì‘å, 20{è‚­‚낵‚š•a‰@): IVR‰ïŽ 2012/2; 27 (1): 56-9.

[’˜@‘]

620193. [Šwp‘] (•ª’SŽ·•M)y‘Š’f‘ŠŒˆ!@‚Å‚«‚é‹~‹}IVR|Žè‹Z‚̃Rƒc‚ƃ|ƒCƒ“ƒgzVascular IVR@‘æ2Í ”ñŠO‚ÌIVR@E• •”@‚»‚Ì‘Œ@”ñ•ÂÇ«’°ŠÔ‹•ŒŒ , p.154-5. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠª@”Ž (1•úŽËü (‰æ‘œ)), •ÒW: “c“‡œA”V, ’†“‡N—Y, ŒŠª@”Ž, ‘å—FN—T, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2012/3”­s.

620194. [Šwp‘] (•ª’SŽ·•M)y‘Š’f‘ŠŒˆ!@‚Å‚«‚é‹~‹}IVR|Žè‹Z‚̃Rƒc‚ƃ|ƒCƒ“ƒgzVascular IVR@‘æ2Í ”ñŠO‚ÌIVR@E”å”AŠíE¶BŠí@Ž‘±«‰AŒs–u‹NÇ, p.160-1. ¬Š}ŒŽ‹1, ŒŠª@”Ž (1•úŽËü (‰æ‘œ)), •ÒW: “c“‡œA”V, ’†“‡N—Y, ŒŠª@”Ž, ‘å—FN—T, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712049. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Breast MRI; Review and Update. Woodhams R1: GEƒZƒ~ƒi[ (2011/5/7), ‘ä˜p. (ƒEƒbƒhƒnƒ€ƒX—æŽq1: 1•úŽËü (‰æ‘œ))

712050. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Imaging Prostate Cancer with F-18FACBC. Inoue Y1: High Country Nuclear Medicine Conference 2012 (2012/3/3-7), Steamboat Springs, ƒRƒƒ‰ƒhB, •Ä‘. (ˆäã—D‰î1: 1•úŽËü (‰æ‘œ))

713160. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Effect of Task Difficulty on Effective Connectivity of Right Anterior Insular Cortex. Kotani Y1, Ohgami Y1, Tsukamoto T2, Kiryu S3, Inoue Y4: 17th Annual Meeting of the Organization of Human Brain Mapping (2011/6/26-30), Qubec, Canada, Abstract Book 2011; p.85. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2GEƒwƒ‹ƒXƒPƒAƒWƒƒƒpƒ“, 3“Œ‹ž‘åŠw, 4•úŽËü (‰æ‘œ))

713161. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Right Anterior Insula Activations Irrespective of Stimulus Modality and Laterality. Ohgami Y1, Kotani Y1, Tsukamoto T2, Kiryu S3, Inoue Y4: 17th Annual Meeting of the Organization of Human Brain Mapping (2011/6/26-30), Qubec, Canada, Abstract Book 2011; p.85. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2GEƒwƒ‹ƒXƒPƒAƒWƒƒƒpƒ“, 3“Œ‹ž‘åŠw, 4•úŽËü (‰æ‘œ))

713162. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Interstitial Magnetic Resonance Lymphography in Mice: Comparative Study of Gadofluorine 8, Gadofluorine M, and Gadofluorine P. Kiryu S1, Inoue Y2, Sheng F3, Watanabe M1, Yoshikawa K4, Shimada M4, Ohtomo K5: World Molecular Imaging Congress 2011 (2011/9/7-11), San Diego, CA USA. (ˆäã—D‰î2: 1“Œ‹ž‘åŠw, 2•úŽËü (‰æ‘œ), 3–k‹žŒRŽ–‰ÈŠwƒAƒJƒfƒ~[, 4‹îàV‘åŠw, 5“Œ‹ž‘åŠw)

713163. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effect of task difficulty on neural systems of right anterior insular cortex. Kotani Y1, Ohgami Y1, Arai J2, Kiryu S3, Inoue Y4: 51th Annual Meeting of Society for Psychological Research (2011/9/14-18), Boston, USA, Psychophysiology 2011; 48 (Spuul): S78. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2ƒ_ƒCƒLƒ“H‹Æ, 3“Œ‹ž‘åŠw, 4•úŽËü (‰æ‘œ))

713164. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Stimulus-Preceding Negativity (SPN) prior to facial, verbal, and symbolic feedback stimuli. Ohgami Y1, Kotani Y1, Itagaki S2, Arai J3, Kiryu S2, Inoue Y4: 51th Annual Meeting of Society for Psychological Research (2011/9/14-18), Boston, USA, Psychophysiology 2011; 48 (Spuul): S78. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2“Œ‹ž‘åŠw, 3ƒ_ƒCƒLƒ“H‹Æ, 4•úŽËü (‰æ‘œ))

713165. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Dural sinus ectasia in fetus. Prenatal MRI diagnosis and follow-up. Kan S1, Hara T1, Inoue Y1: ESNR 2011 35th Annual meeting of European Society of Neuroradiology (2011/9/22-25), Antwerp, Belgium, Neuroradiology 2011; 53 (Suppl 1): S108. (›@Mˆê1, ŒŽ@•q«1, ˆäã—D‰î1: 1•úŽËü (‰æ‘œ))

713166. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Motion correction of diffusion-weighted imaging of the liver: utility of velocity-compensated diffusion gradients combined with hadamard encoding. Ozaki M, Inoue Y1, Miyati T2, Hata H, Matsunaga K1, Woodhams R1, Kan S1: ECR 2012 (‰¢B•úŽËüŠw‰ï2012) (2012/3/1-5), Vienna, Austria. (ˆäã—D‰î1, Œ‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ›@Mˆê1: 1•úŽËü (‰æ‘œ), 2Kanazawa/JP)

713167. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Usefulness of the Navigator-echo triggering Technique for Free-Breathing 3D MRCP. Matsunaga K1, Ogasawara G1, Fujii K1, Irie T1, Yamane T1, Ishida K1, Inoue Y1: ECR 2012 (‰¢B•úŽËüŠw‰ï2012) (2012/3/1-5), Vienna, Austria. (Œ‰iŒh“ñ1, ¬Š}ŒŽ‹1,@“¡ˆä@Š]1, “ü]‚‚®‚Ý1, ŽRª‘ñ˜Y1, Î“cŒ’ˆê˜Y1, ˆäã—D‰î1: 1•úŽËü (‰æ‘œ))

722191. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆÝÃ–¬áŽ‚ɑ΂·‚éfoam B-RTO‚É‚š‚¯‚éEOŽg—p—Ê‚ÌŒŸ“¢. ¬Š}ŒŽ‹1, ‘ëì­˜a1, Œ‰iŒh“ñ1, “¡ˆä@Š]1, ‘åX’qŽq1, –î“àŒŽ‹v1, ²X–ؐ^‹|1, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ)): ‘æ40‰ñ“ú–{IVRŠw‰ï‘‰ï (2011/5/19-21), ÂX, IVR 2011; 26 (suppl): 65.

722192. [Šw‰ï (‘S‘)] (˜A‘±ªŠ²ƒZƒ~ƒi[I) Šî–{‚Ì‚»‚€‚Ž‚ç‚¢@2. CT ŒŽ—‚©‚çÅæ’[‚Ü‚Å ‚»‚µ‚ÄŠî‘bŽŸŠ³‚̓lje “ª•”. ›@Mˆê (•úŽËü (‰æ‘œ)): ‘æ31‰ñ“ú–{‰æ‘œˆãŠw‰ï (2012/2/17), “Œ‹ž.

723849. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “û‘BŽîᇂÌADC’l‚ɑ΂·‚éGd-DTPA“Š—^‚̉e‹¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢. â–{‘Žq1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, “cŒû’qŽq1, ŒŽ@•q«1, “ü]‚‚®‚Ý1, ó–ì—Y“ñ1, ‘ •À@Ÿ2, åÎ‹I•F2, ŠâŸºŒ[ˆê3, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2ŠO‰È, 3•a—): ‘æ70‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2011/5/9-20 (WEBŠJÃ)), ‘æ70‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŽ˜^W 2011/2; S311.

723850. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰º•”Á‰»ŠÇoŒŒ‚ɑ΂·‚éƒ}ƒ‹ƒ`ƒXƒ‰ƒCƒXCT‚Ì—L—p«: “–‹~–œ‹~‹}ƒZƒ“ƒ^[‚É‚š‚¯‚錟“¢. ¬Š}ŒŽ‹1, ŒŠª@”Ž2, â–{‘Žq1, Š~Œ©•¶Ž}3, _œä’m“¹3, ‹e’nG•F4, ƒEƒbƒhƒnƒ€ƒX—æŽq1, Œ‰iŒh“ñ1, ˆäã—D‰î1, ‘Š”nˆêˆå3 (1•úŽËü (‰æ‘œ), 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw, 3‹~–œ, 4Á‰»Ší“à): ‘æ70‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2011/5/9-20 (WEBŠJÃ)), ‘æ70‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŽ˜^W 2011/2; S322.

723851. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”rŒŒ˜H‚Ƀoƒ‹[ƒ“‘}“ü‚ª¢“ï‚Å, ƒ}ƒCƒNƒƒJƒe[ƒeƒ‹‚݂̂ňݐ֬ᎂɑ΂µd‰»—Ö@‚ðŽ{s‚µ‚œ1—á. “¡ˆä@Š]1, ‘ëì­˜a2, Œ‰iŒh“ñ1, ‘åX’qŽq1, “cŒû’qŽq1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ¬Š}ŒŽ‹1, ²X–ؐ^‹|2, ˆé•”‹`Œ›2, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2‘Š–ÍŒŽ•a‰@•úŽËü‰È): ‘æ40‰ñ“ú–{IVRŠw‰ï‘‰ï (2011/5/19-21), ÂX, IVR 2011; 26 (suppl): 131.

723852. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ}ƒEƒX‚ÌŠÔŽ¿«MR ƒŠƒ“ƒpŠÇ‘¢‰e: Gadofl uorine 8, Gadofl uorine M, ‚š‚æ‚ÑGadofl uorine P‚Ì”äŠr. ‹Ë¶@–Î, ˆäã—D‰î1, Fugeng Sheng, “n•Ó@T, ‹gìG‹N, “ˆ“cŽç’j, ‘å—F@–M (1•úŽËü (‰æ‘œ)): ‘æ6‰ñ“ú–{•ªŽqƒCƒ[ƒWƒ“ƒOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/26-27), _ŒË, JSMI Report 2011; 4 (2): 86.

723853. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Mirror device ‚ðŽg—p‚µ‚œ”牺Žîᇃ‚ƒfƒ‹ƒ}ƒEƒX‚̐¶‘Ì”­Œõ‰æ‘œ. ‘“c“NŽj, ˆäã—D‰î1, ‹Ë¶@–Î, ŒŽ“c˜a³, ‹gìG‹N (1•úŽËü (‰æ‘œ)): ‘æ6‰ñ“ú–{•ªŽqƒCƒ[ƒWƒ“ƒOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/26-27), _ŒË, JSMI Report 2011; 4 (2): 152.

723854. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) • •”‘å“®–¬áŽ‚ɑ΂·‚éEVARŒã‚ÌType2endoleak‚ɑ΂·‚éTAE. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠª@”Ž2, “¡ˆä@Š]1, Š~Œ©•¶Ž}3, “c‘ºK•ä4, “à“c‘׎Š4, •œ“cŒõ”Ž4 (1•úŽËü (‰æ‘œ), 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw, 3‹~–œ, 4ŠO‰È): ‘æ17‰ñ“ú–{ŒŒŠÇ“àŽ¡—Êw‰ï‘‰ï (2011/6/10-11), ‰«“ê.

723855. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰º•”Á‰»ŠÇoŒŒ‚ɑ΂·‚éƒ}ƒ‹ƒ`ƒXƒ‰ƒCƒXCT‚Ì—L—p«. ¬Š}ŒŽ‹1, ŒŠª@”Ž2, Š~Œ©•¶Ž}3, _œä’m“¹3, •Ð‰ª—Sˆê3, ‹e’nG•F4, ‘Š”nˆêˆå3, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw, 3‹~–œ, 4Á‰»Ší“à): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/11-12), •Ÿ‰ª, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/2; 31 (2): 386.

723856. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘€“ªœ‚̉ð–U‚Ɖ摜f’f. ›@Mˆê (•úŽËü (‰æ‘œ)): ‘æ16‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2011/9/11), ‰¡•l.

723857. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) partial B-RTO‚ðŽŽ‚Ý‚é‚à–å–¬ŒŒð‚𐶂¶‚œŠÌ«”]Ç‚Ì1—á. ¬Š}ŒŽ‹1, ‘ëì­˜a2, Œ‰iŒh“ñ1, “¡ˆä@Š]1, ‘åX’qŽq2, –î“àŒŽ‹v3, ²X–ؐ^‹|4, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2‘Š–ÍŒŽ•a‰@, 3–k—¢Œ€‹†Š•a‰@, 4ŽŠœ‰ï‘æ“ñ•a‰@): ‘æ18‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2011/9/15-16), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 118.

723858. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) B-RTO‚É‚æ‚èFOLFOX“±“ü‚ª‰Â”\‚Æ‚È‚Á‚œŠÌd•Ï‡•¹is‘å’°Šà‚Ì1—á. •œìk‘å1, ‘ëì­˜a1, ‘åX’qŽq1, “cŒû’qŽq1, “¡ˆä@Š]2, ²X–ؐ^‹|3, ˆé•”‹`Œ›4 (1‘Š–ÍŒŽ•a‰@, 2•úŽËü (‰æ‘œ), 3ŽŠœ‰ï‘æ“ñ•a‰@, 4“Œ‹žˆã—ÃZƒ“ƒ^[): ‘æ18‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2011/9/15-16), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 128.

723859. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”rŒŒ˜H‚Ƀoƒ‹[ƒ“‘}“ü‚ª¢“ï‚Å, ƒ}ƒCƒNƒƒJƒe[ƒeƒ‹‚݂̂ňݐ֬ᎂɑ΂µd‰»—Ö@‚ðŽ{s‚µ‚œˆê—á. “¡ˆä@Š]1, ‘ëì­˜a2, Œ‰iŒh“ñ1, ‘åX’qŽq2, “cŒû’qŽq1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ¬Š}ŒŽ‹1, ²X–ؐ^‹|3, ˆé•”‹`Œ›4, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2‘Š–ÍŒŽ•a‰@, 3ŽŠœ‰ï‘æ“ñ•a‰@, 4“Œ‹žˆã—ÃZƒ“ƒ^[): ‘æ18‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2011/9/15-16), •Ÿ‰ª, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2011/8; 17 (3): 130.

723860. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •úŽËüŽ¡—ÃŒã‘O—§‘BŠàÄ”­f’f‚É‚š‚¯‚éMRIŠgŽU‹­’²‰æ‘œ‚Ì—L—p«‚ÌŒŸ“¢: Œo‰ï‰A“I22‚©Š¶ŒŸ‚Æ‚Ì”äŠr. ŒŽ@•q«1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, â–{‘Žq1, “ü]‚‚®‚Ý1, ¬Š}ŒŽ‹1, “¡ˆä@Š]1, Œ‰iŒh“ñ1, ˆäã—D‰î1, ²“¡ˆÐ•¶2, ”nêŽu˜Y2, ÎŽR”ŽžŠ3, ‘ì˜ad3 (1•úŽËü (‰æ‘œ), 2”å”AŠí, 3•úŽËü (Žîá‡)): ‘æ39‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2011/9/29-10/1), •Ÿ‰ª (¬‘q), “ú–{Ž¥‹C‹€–ˆãŠw‰ïŽGŽ 2011/9; 31S: 248.

723861. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) „ŽZGFR‚Æ99mTc-MAG3t“®‘ÔƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚æ‚éERPF‚ÌŠÖŒW. ŽRª‘ñ˜Y1, ó–ì—Y“ñ1, ‹e’r@Œh2, “¿d‘žé2, ‘åŠÖ—T‰î2, ƒEƒbƒhƒnƒ€ƒX—æŽq1, “ü]‚‚®‚Ý1, ¬Š}ŒŽ‹1, ŒŽ@•q«1, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2•úŽËü•”): ‘æ51‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ï (2011/10/27-29), ‚‚­‚Î, ŠjˆãŠw 2011/9; 48 (3): 293.

723862. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) FDG‚Ì‹¹œ“û“ˋ؏WÏ‚ɑ΂·‚éÃ’Œã‘Ò‹@’†‚̑̈ʂ̉e‹¿. ó–ì—Y“ñ1, ŽRª‘ñ˜Y1, ‹e’r@Œh2, “¿d‘žé2, ‘åŠÖ—T‰î2, ƒEƒbƒhƒnƒ€ƒX—æŽq1, “ü]‚‚®‚Ý1, ¬Š}ŒŽ‹1, ŒŽ@•q«1, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2•úŽËü•”): ‘æ51‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ï (2011/10/27-29), ‚‚­‚Î, ŠjˆãŠw 2011/9; 48 (3): 337.

723863. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’±Œ`œ“Ž‚É”­¶‚µ‚œ‘–ŒŽî‚̈ê—á. Îˆäm–ç1, ›@Mˆê1 (1•úŽËü (‰æ‘œ)): ‘æ41‰ñ“ú–{_Œo•úŽËüŠw‰ï (2012/2/2-3), Žu–€, ‘æ41‰ñ“ú–{_Œo•úŽËüŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012; p.129.

731148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yCT/MRIŽž‘ã‚̐S•s‘S‰æ‘œf’fz•ªŽqƒCƒ[ƒWƒ“ƒO‚ÌŒ»ó‚Æ“W–]. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ƒeƒ‹ƒ‚ƒƒfƒBƒJƒ‹ƒvƒ‰ƒlƒbƒNƒX (2012/3/29), _“ސ쌧‘«•¿ãŒS.

732143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) •ªŽqƒCƒ[ƒWƒ“ƒO: ŒõƒCƒ[ƒWƒ“ƒO‚ÆŠjˆãŠw. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ80‰ñ“ŒŠCŠjˆãŠwƒZƒ~ƒi[ (2011/5/21), –ŒŒÃ‰®.

732144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) S‘Ÿ‚̉摜f’f‚̐V“WŠJ: MRI‚𒆐S‚É. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ76‰ñ–k—¢zŠÂŠíƒZƒ~ƒi[ (2011/6/16), ‘Š–ÍŒŽ.

732145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰)y_Œo•úŽËü‚ÉŠÖ‚·‚éu‰‰‚Æ“¢˜_z¡‚͐Ì. ›@Mˆê (•úŽËü (‰æ‘œ)): ‘æ11‰ñ MR Retroscopy•×‹­‰ï (‹€Ã: ƒRƒ”ƒBƒfƒBƒGƒ“ƒWƒƒƒpƒ“ (Š”)) (2011/10/1), •Ÿ‰ª (¬‘q).

732146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) Beautiful evidence in Neuroradiology`Neuroimages‚ð’Ž‚Š‚ā`. ›@Mˆê (•úŽËü (‰æ‘œ)): ‘æ8‰ñŽRŒûŒ§—Տ°_ŒoƒtƒH[ƒ‰ƒ€ (‹€Ã: ƒtƒ@ƒCƒU[ (Š”)) (2011/10/5), ŽRŒû (‰F•”).

732147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) “úX‚ÌFDG-PETfŽ@|Ç—á‚𒆐S‚É‚µ‚ā|. ó–ì—Y“ñ (•úŽËü (‰æ‘œ)): ‘æ13‰ñ–k—¢_“ސì‰æ‘œŒ€‹†‰ï (ŽåÃF‘æˆêŽO‹€ (Š”) (2011/11/17), ‘Š–ÍŒŽ.

732148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) •ªŽqƒCƒ[ƒWƒ“ƒO‚ÌŒ»ó‚Æ“W–]. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ24‰ñ“ú–{‚ž“x•úŽËüŠO•”ÆŽËŒ€‹†‰ï (2012/2/4), ‰¡•l.

733407. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “Ý“IŠO«œœ‰ºEãüâ|“®–¬‘¹‚ɑ΂·‚éƒXƒeƒ“ƒgƒOƒ‰ƒtƒgŽ¡—Ã: 2Ç—á‚Ì•ñ. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠª@”Ž2, “c‘ºK•ä4, Š~Œ©•¶Ž}3, ˆäã—D‰î1, ‘Š”nˆêˆå3 (1•úŽËü (‰æ‘œ), 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw, 3‹~–œ, 4ŠO‰È): ‘æ29‰ñ“ú–{Metallic Stents & GraftsŒ€‹†‰ï (2011/5/20-21), ÂX.

733408. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •úŽËüŽ¡—ÃŒã‘O—§‘BŠàÄ”­f’f‚É‚š‚¯‚éMRIŠgŽU‹­’²‰æ‘œ‚Ì—L—p«‚ÌŒŸ“¢: ƒeƒ“ƒvƒŒ[ƒgƒKƒCƒh‰ºŒo‰ï‰A“I22‚©Š¶ŒŸ‚Æ‚Ì”äŠr. ŒŽ@•q«1, â–{‘Žq, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ˆäã—D‰î1, ²“¡ˆÐ•¶2, “c”šŒ’ˆê3, •âáÁ“ñ2, ’ѺGN2, “¡“c“N•v2, Œ–{˜a«2, ”nêŽu˜Y2, ÎŽR”ŽžŠ4, ‘ì˜ad4 (1•úŽËü (‰æ‘œ), 2”å”AŠí, 3—Տ°Œ€‹†EŠé‰æ, 4•úŽËü (Žîá‡)): ‘æ28‰ñ_“ސ쌧‘O—§‘BŽîᇌ€‹†‰ï (2011/7/2), ‰¡•l.

733409. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒKƒŠƒEƒ€ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚š‚¯‚éˆÝWÏ‚Ì•]‰¿‚Ì‚œ‚ß‚Ì”­–AÜ•‰‰×‚Ì—L—p«‚ÌŒŸ“¢. V‹Ž–õ^1, ’†”W—ǍN1, ‰Á“¡@‘1, ‚‘º•üG1, ‘œŒÎ³•v1, ˆäã—D‰î2 (1’é‹ž‘åŠwˆãŠw•”•‘®aŒû•a‰@, 2•úŽËü (‰æ‘œ)): ‘æ75‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•ûEE(2011/7/23), “Œ‹ž, ŠjˆãŠw 2011; 48 (4): 456.

733410. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CTAMRIŽž‘ã‚̐S•s‘S‰æ‘œf’f. ˆäã—D‰î (•úŽËü (‰æ‘œ)): Daiichi-sankyozŠÂŠíƒVƒ“ƒ|ƒWƒEƒ€ (ŽåÃ: ‘æˆêŽO‹€ (Š”)) (2011/10/20), ‰¡•l.

733411. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) V‹KPETƒAƒ~ƒmŽ_ƒgƒŒ[ƒT[FACBC‚É‚æ‚éŽîᇐf’f. ó–ì—Y“ñ (•úŽËü (‰æ‘œ)): ‘æ2‰ñ–k—¢‹@”\‰æ‘œƒZƒ~ƒi[ (ŽåÃ: “ú–{ƒƒWƒtƒBƒWƒbƒNƒX (Š”)) (2011/11/8), ‘Š–ÍŒŽ.

733412. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) MRI‚ÅEOB‚ÆSPIO‚Ì—Œ•û‚ÅŽæ‚荞‚Ý‚ðŽŠ‚µ‚œ‚œ‚ß‚ÉENH‚ÆŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚œ‘œŒŒ«ŠÌ×–EŠà‚̈ê—á. Î“cŒ’ˆê˜Y1, Œ‰iŒh“ñ1, ¬Š}ŒŽ‹1, “¡ˆä@Š]1, ‘å•”@œ2, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2ˆã—Éq¶Šw•”): ‘æ440‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠÖ“Œ’n•û‰ï’èŠú‘å‰ï (2011/12/10), é‹Ê, ‘å‹{ƒ\ƒjƒbƒNƒVƒeƒB¬ƒz[ƒ‹, ‘æ440‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠÖ“Œ’n•û‰ï’èŠú‘å‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.23.

733413. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) S‚̉摜‰ðÍ. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ3‰ñ–k—¢_Œo‰ÈŠwƒtƒH[ƒ‰ƒ€ (‹€Ã: ƒG[ƒUƒC (Š”)) (2011/12/19), ‘Š–ÍŒŽ.

733414. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á’ñŽŠ) ‹H‚ȐӔCŒŒŠÇ‚æ‚èoŒŒ‚µ‚Ä‚¢‚œˆÝ’×ᇂ̈ê—á. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ¬Š}ŒŽ‹1, “¡ˆä@Š]1, ŒŠª@”Ž2 (1•úŽËü (‰æ‘œ), 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw): “Œ‹žƒAƒ“ƒMƒIEIVR‰ï (‹€Ã: ‘æˆêŽO‹€ (Š”)) (2012/1/12), “Œ‹ž.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110004. [ŒŽ’˜] Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings. Woodhams R1, Kakita S, Hata H, Iwabuchi K2, Umeoka S, Mountford CE, Hatabu H.: AJR Am J Roentgenol 2009/7; 193 (1): 260-6. (ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŠâŸºŒ[ˆê2: 1•úŽËü (‰æ‘œ), 2•a—)

H21-110005. [ŒŽ’˜] Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings. Woodhams R1, Kakita S, Hata H, Iwabuchi K2, Kuranami M3, Gautam S, Hatabu H, Kan S1, Mountford C: Radiology 2010/2; 254 (2): 357-66. (ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŠâŸºŒ[ˆê2, ›@Mˆê1, ‘ •À@Ÿ3: 1•úŽËü (‰æ‘œ), 2•a—, 3ŠO‰È)

[’˜@‘]

H17-620002. [Šwp‘] (•ª’SŽ·•M)yV”Å ‚±‚ê‚Å‚í‚©‚éŠgŽUMRIz“û‘B, p.422-3. ƒEƒbƒhƒnƒ€ƒX—æŽq1, `@”Ž•¶ (1•úŽËü (‰æ‘œ)), •Ò: Â–Ø–ÎŽ÷, ˆ¢•”@C, ‘’J‰ÀF, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2005/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H22-713006. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Long-term assessment of contrast effects of gadofluorine M and gadofluorine P in magnetic resonance imaging of mice. Sheng F, Inoue Y1, Kiryu S, Watanabe M, Ohtomo K: European Congress of Radiology 2011 (2011/3/3-7), Vienna, Austria. (ˆäã—D‰î1: 1•úŽËü (‰æ‘œ))

H22-723013. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Ù“àf’f‚³‚ê‚œdural sinus ectasia‚̈ê—á. ŒŽ@•q«1, ›@Mˆê1, “cŒû’qŽq1, “ü]‚‚®‚Ý1, ¬Š}ŒŽ‹1, “¡ˆä@Š]1, â–{‘Žq1, “Œ“c®Ž÷1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ó–ì—Y“ñ1, Œ‰iŒh“ñ1, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ)): ‘æ40‰ñ“ú–{_Œo•úŽËüŠw‰ï (2011/2/24-26), •iì, ‘æ40‰ñ“ú–{_Œo•úŽËüŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.149.


•úŽËü‰ÈŠw (•úŽËüŽîᇊw)

[Šwp˜_•¶]

110272. [ŒŽ’˜] The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo. Gao Y, Ishiyama H1, Sun M, Brinkman KL, Wang X, Zhu J, Mai W, Huang Y, Floryk D, Ittmann M, Thompson TC, Butler EB, Xu B, Teh BS: Radiat Oncol 2011/4; 6: 39. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

110273. [ŒŽ’˜] MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway. Zhang C, Kang C, Wang P, Cao Y, Lv Z, Yu S, Wang G, Zhang A, Jia Z, Han L, Yang C, Ishiyama H1, Teh BS, Xu B, Pu P: Int J Radiat Oncol Biol Phys 2011/5; 80 (1): 240-8. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

110274. [ŒŽ’˜] Effects of ellipsoid prostate deformation on dose delivery during permanent interstitial brachytherapy. Nakamura R, Ishiyama H1, Tanji S, Satoh T2, Oikawa H, Inatsu W, Ehara S, Hayakawa K1: Brachytherapy 2011/5-6; 10 (3): 208-13. (ÎŽR”ŽžŠ1, ²“¡ˆÐ•¶2, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2”å”AŠí)

110275. [ŒŽ’˜] Stereotactic body radiation therapy for prostate cancer. Ishiyama H1, The BS, Lo SS, Mathews T, Blanco A, Amato R, Ellis RJ, Mayr NA, Xu B, Butler BE: Future Oncology 2011/7; 7 (9): 1077-86. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

110276. [ŒŽ’˜] Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer. Toita T, Kato S, Ishikura S, Tsujino K, Kodaira T, Uno T, Hatano K, Sakurai H, Niibe Y1, Kazumoto T, Nishimura T, Kitagawa R, Fukutani M, Oguchi M, Umayahara K, Hirashima Y, Aoki Y, Takizawa K (Disease Committee of Radiation Oncology, Japanese Gynecologic Oncology Group): Int J Clin Oncol 2011/8; 16 (4): 379-86. (V•”@÷1: 1•úŽËü (Žîá‡))

110277. [ŒŽ’˜] Stereotactic body radiotherapy (SBRT) for operable stgage I non-small-cell lung caner: Can SBRT be comparable to surgery ? Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K1, Niibe Y1, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T: Int J Radiat Oncol Biol Phys 2011/12; 81 (5): 1352-8. (‘ì˜ad1, V•”@÷1: 1•úŽËü (Žîá‡))

110278. [ŒŽ’˜] Prospecitve multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Toita T, Kato S, Niibe Y1, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N: International Journal of Radiation Oncology Biology Physics 2012/1; 82 (1): e49-56. (ŒË”F•¶, ‰Á“¡^Œá, V•”@÷1, ‘å–ì’B–ç, žž–{’qŽq, ŒÃ•œ@‹B, •Ð‰ª³–Ÿ, Ž­ŠÔ’Œl, Œ ä‰ë_, “¿ŠÛ’Œ˜Y, ŽR“à’qŽq, —é–؁@C, ŸNˆä‰pK, Àè•ä‚, Žè“‡ºŽ÷, ¬Œû³•F, ‰Á‰ê”ü–F˜a, ’†–ì—²Žj, •œ‰ª^Š°, ŽO‹Ž‹I•v: 1•úŽËü (Žîá‡))

110279. [ŒŽ’˜] The kinetochore protein Bub1 participates in the DNA damage response. Yang C, Wang H, Xu Y, Brinkman KL, Ishiyama H1, Wong ST, Xu B: DNA Repair (Amst) 2012/2; 11 (2): 185-91. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

110280. [ŒŽ’˜] Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303. Sanuki N, Ishikura S, Shinoda M, Ito Y, Hayakawa K1, Ando N: Int J Clin Oncol 2012/4; 17 (2): 105-11. (‘ì˜ad1: 1•úŽËü (Žîá‡))

110281. [ŒŽ’˜] Matched-pair analysis and dosimetric variations of two types of software for interstitial permanent brachytherapy for prostate cancer. Ishiyama H1, Nakamura R, Satoh T2, Tanji S, Teh BS, Uemae M3, Baba S2, Hayakawa K1: Medical Dosimetry 2012/Spring 37 (1): 84-6. (ÎŽR”ŽžŠ1, ²“¡ˆÐ•¶2, ã‘O•ôŽq3, ”nêŽu˜Y2, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2”å”AŠí, 3•úŽËü•”)

110282. [ŒŽ’˜] Serum testosterone level after intensity-modulated radiotherapy in low-risk prostate cancer patients: does testicular dose correlate with testosterone level? Ishiyama H1, The BS, Paulino AC, Yogeswaren S, Mai W, Bo BE. Butler B: J Radiat Oncol 2012/6; 1 (2): 173-7. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

210007. [€ŒŽ’˜] Hypofractionated radiotherapy for prostate cancer. Teh BS, Ishiyama H1: The Lancet Oncology 2012/1; 13 (1): 5-6. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

310029. [Ç—á•ñ] Spontaneous Regression of Thoracic Metastases While Progression of Brain Metastases After Stereotactic Radiosurgery and Stereotactic Body Radiotherapy for Metastatic Renal Cell Carcinoma: Abscopal Effect Prevented by the Blood-Brain Barrier? Ishiyama H1, Teh BS, Ren H, Chiang S, Tann A, Blanco AI, Paulino AC, Amato R: Clin Genitourin Cancer 2012/9; 10 (3): 196-8. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

520048. [‘à] ­”“]ˆÚE­”Ä”­ (oligometastases, oligo-recurrence)‚ɑ΂·‚é•úŽËüŽ¡—Ã. V•”@÷1, ¬’J³Žq1, ‘“c@Ši1, ‘ì˜ad1 (1•úŽËü (Žîá‡)): “ú“ƈã•ñ 2011/4; 55: 266-70.

520049. [‘à (Current Organ Topics)] “ú–{”xŠàŠw‰ï•Ò: ”xŠàf—ÃKƒCƒhƒ‰ƒCƒ“‚ɂ‚¢‚Ä. ‘ìEad1,2 (1“ú–{”xŠàŠw‰ïƒKƒCƒhƒ‰ƒCƒ“ŒŸ“¢ˆÏˆõ‰ïEƒ[ƒLƒ“ƒOƒOƒ‹[ƒv, 2•úŽËü (Žîá‡)): Šà‚Ɖ»Šw—Ö@ 2011/8; 38 (8): 1273-6.

522192. [uÀ]y“ÁW: ‚ª‚ñf—ÃTƒ|[ƒgƒKƒCƒhz‘å’°‚ª‚ñ|‚©‚©‚è‚‚¯ˆã‚©‚ç: •úŽËüŽ¡—Â̎í—ނƈӋ`‚ð‹³‚Š‚ĉº‚³‚¢. ‘ì˜ad (•úŽËü (Žîá‡)): Ž¡—à 2011/4; 93 (‘Š§): 831-3.

522193. [uÀ]y“ÁW: ”xŠàf—Â̐V‚µ‚¢Žž‘ãz”xŠà‚ÌŽ¡—Á@”xŠàŽ¡—Âɂš‚¯‚éV‚µ‚¢•úŽËü—Ö@. ‘ì˜ad (•úŽËü (Žîá‡)): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2012/1; 42 (1): 81-6.

[’˜@‘]

620195. [Šwp‘] (•ª’SŽ·•M)yEBMŒÄ‹zŠíŽŸŠ³‚ÌŽ¡—Ã2011-2012z˜22. Žîᇊ֌W@C. •úŽËüŽ¡—ÁEÇóŠÉ˜aŽ¡—ÂȂǁ@1. V‚µ‚¢•úŽËüŽ¡—Ö@‚̃Gƒrƒfƒ“ƒX (üŽ¿, ÆŽË–@‚È‚Ç), p.465-70. ‘ì˜ad (•úŽËü (Žîá‡)), •Ò: ‰iˆäŒúŽu, ‘å“c@Œ’, ‘å“c@Œ’, ]ŒûŒ€“ñ, ‹Ž–{@C, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

620196. [Šwp‘] (•ª’SŽ·•M)y•W€•úŽËüˆãŠw (‘æ7”Å)zIV •úŽËüŽ¡—Á@4. ‹¹•”Žîá‡, p.753-8. ‘ì˜ad (•úŽËü (Žîá‡)), •Ò: Œ’J@O, ‰““¡Œ[Œá, Œˆä@C, ˆÉ“Œ‹v•v, ˆãŠw‘‰@, “Œ‹ž, 2011/6”­s.

620197. [Šwp‘] (•ª’SŽ·•M)yV‚µ‚¢f’f‚ÆŽ¡—ÂÌABC 34u”xŠà (‰ü’ù‘æ2”Å)v(ÅVˆãŠw•Êû)z‘æ4Í ŠÇ—EŽ¡—Á@•úŽËü—Ö@, p.145-53. ‘ì˜ad (•úŽËü (Žîá‡)), •Ò: ˆ¢•”¯ì, ÅVˆãŠwŽÐ, ‘åã, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713168. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Impact of intensive local control with radiation therapy for bone-only oligo-recurrence on long-term results in breast cancer: a multi-institutional study in Japan. Shiraishi K, Niibe Y1, Nakagawa K, Takemoto M, Kaneyasu Y, Kanazawa S, Nagata Y, Hayakawa K1: 53rd Annual Meeting of American Society for Radiation Oncology (ASTRO 2011) (2011/10/2), Miami, USA. (”’ÎŒ›Žj˜Y, V•”@÷1, ’†ìŒbˆê, •–{[L, Œ“ˆÀ—SŽq, ‹ààV@‰E, ‰i“c@–õ, ‘ì˜ad1: 1•úŽËü (Žîá‡))

721006. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ”xŠàf—ÃKƒCƒhƒ‰ƒCƒ“‚ÌŠî–{“I‚ȍl‚Š•û. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ52‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2011/11/3), ‘åã.

722193. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”x‚ª‚ñ‚ɑ΂·‚鉻Šw•úŽËü—Ö@‚̐V“WŠJ. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ9‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2011/7/22), ‰¡•l.

722194. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”ñ¬×–E”xŠà‚ɑ΂·‚é’èˆÊ•úŽËüŽ¡—Ã. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ47‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2011/10/22), ‰ºŠÖ.

722195. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”x‚ª‚ñ•úŽËü—Ö@‚̐i•à‚Ɖۑè. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/29), –ŒŒÃ‰®.

723864. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ¬×–E”xŠà‚ɑ΂·‚éƒVƒXƒvƒ‰ƒ`ƒ“/ƒrƒmƒŒƒ‹ƒrƒ““¯Žž•¹—p‰»Šw•úŽËü—Ö@‚ÌŒŸ“¢. ‘“c@Ši1, ‘ì˜ad1, V•”@÷1, ÎŽR”ŽžŠ1, ¬’J³Žq1, ŠÖŒûˆ©ˆß1, ˆäì@‘2, ŽO“¡@‹v2, •Ð‹Ë^l3, ‰v“c“TK2 (1•úŽËü (Žîá‡), 2ŒÄ‹zŠí“à, 3ˆã—Éq¶Šw•”): “ú–{•úŽËüŽîᇊw‰ï‘æ24‰ñŠwp‘å‰ï (2011/11/18), _ŒË, “ú–{•úŽËüŽîᇊw‰ï‘æ24‰ñŠwp‘å‰ï•ñ•¶W 2011; p.247.

723865. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) èò•”•úŽËüÆŽËŒã‚Ìèò“®–¬‹·óÇ‚ɂ‚¢‚Ä‚Ì‘O•ûŽ‹“IŒŸ“¢. ¬’J³Žq1, ŽR“c@Ÿ2, ÎŽR”ŽžŠ1, ²“¡Œör2, ‘“c@Ši1, ŠÖŒûˆ©ˆß1, ‹{–{r•ã3, ’†ŽR–Ÿm3, ‰ª–{–ql3, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2”]ŠO, 3Žš•@): “ú–{•úŽËüŽîᇊw‰ï‘æ24‰ñŠwp‘å‰ï (2011/11/18), _ŒË, “ú–{•úŽËüŽîᇊw‰ï‘æ24‰ñŠwp‘å‰ï•ñ•¶W 2011; p.256.

723866. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒ‹ƒ`ƒmƒCƒhŽîᇂɑ΂·‚é•úŽËüŽ¡—Â̌Ÿ“¢. ŠÖŒûˆ©ˆß1, ‘ì˜ad1, ‘“c@Ši1, ¬’J³Žq1, ÎŽR”ŽžŠ1, V•”@÷1, ˆÉ˜¬“cº2, ²“¡”Vr2, ‰v“c“TK3, ’†ŽR–Ÿm4 (1•úŽËü (Žîá‡), 2ŒÄ‹zŠíŠO, 3ŒÄ‹zŠí“à, 4Žš•@): “ú–{•úŽËüŽîᇊw‰ï‘æ24‰ñŠwp‘å‰ï (2011/11/19), _ŒË, “ú–{•úŽËüŽîᇊw‰ï‘æ24‰ñŠwp‘å‰ï•ñ•¶W 2011; p.275.

731149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •úŽËüŽ¡—Â̕iŽ¿ŠÇ—|—Տ°“I‰Û‘è‚ƈã—Ðl‚Æ‚µ‚Ä‚ÌŽ‹ü|. ‘ì˜ad (•úŽËü (Žîá‡)): •œ¬23”N“x•úŽËü (f—Ã) ‹Æ–±]Ž–ŽÒ‚Ì‹³ˆçŒP—û (uK‰ï)w•úŽË«“¯ˆÊŒ³‘f‹y‚Ñ•úŽËü”­¶‘•’u“™‚̎戵‚¢IVx (2011/4/17), ‰¡•l.

732149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€)y¶–œ‰ÈŠwŠî”ÕŒ€‹†‚̐¬‰Ê‚ð—Տ°Œ€‹†‚Ö”­“W‚³‚¹‚éz•úŽËüŽ¡—Âɂš‚¯‚镪ŽqƒCƒ[ƒWƒ“ƒO‚Æ•ªŽq•W“I–ò‚̗Տ°“I–ðŠ„. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ6‰ñ–kŠC“¹‘åŠwˆãŠwŒ€‹†‰È˜AŒgŒ€‹†ƒZƒ“ƒ^[ƒVƒ“ƒ|ƒWƒEƒ€ (2011/11/4), –kŠC“¹.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110016. [ŒŽ’˜] Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. Teh BS, Ishiyama H1, Mathews T, Xu B, Butler EB, Mayr NA, Lo SS, Lu JJ, Blanco AI, Paulino AC, Timmerman RD: Discov Med 2010/9; 10 (52): 255-62. (ÎŽR”ŽžŠ1: 1•úŽËü (Žîá‡))

H22-310002. [Ç—á•ñ] Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report. Okuma K, Yamashita H, Niibe Y1, Hayakawa K1, Nakagawa K: J Med Case Rep 2011/3; 5: 111. (‘åŒF‰ÁŒb, ŽR‰º‰pb, V•”@÷1, ‘ì˜ad1, ’†ìŒbˆê: 1•úŽËü (Žîá‡))


–ƒŒ‰ÈŠw

[Šwp˜_•¶]

110283. [ŒŽ’˜] Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model. Fukushima S, Takenami T1, Yagishita S, Nara Y, Hoka S, Okamoto H1: Pain Med 2011/5; 12 (5): 717-25. (•Ÿ“‡¹–é”T, ’|˜Q–¯]1, –ö‰ºŽO˜Y, “ޗljÀ—m, ŠO{”ü•v, ‰ª–{_Žk1: 1–ƒŒ)

110284. [ŒŽ’˜] Upregulation of calbindin D28k in the late distal tubules in the potassium-loaded adrenalectomized mouse kidney. Kobayashi M1, Yasuoka Y2, Sato Y, Zhou M, Abe H, Kawahara K2, Okamoto H1: Clin Exp Nephrol 2011/6; 15 (3): 355-62. (¬—ѐ‰À1, ˆÀ‰ª—L‹IŽq2, ‰ÍŒŽŽ‰ë2, ‰ª–{_Žk1: 1–ƒŒ, 2¶—)

110285. [ŒŽ’˜] Sex difference in sensitivity to allopregnanolone neuroprotection in mice correlates with effect on spontaneous inhibitory post synaptic currents. Kelley MH, Kuroiwa M1, Taguchi N, Herson PS: Neuropharmacology 2011/9; 61 (4): 724-9. (•Šâ­”V1: 1–ƒŒ)

320054. [Ç—á•ñ] VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUA (H1N1) ‚É‚æ‚éS‹Ø‰Š‚ð‡•¹‚µdÇS•s‘S‚ð’悵‚œ‘å“®–¬“ñë•Ù‚Ì–ƒŒŒoŒ±. ŒË“c‰ë–ç1, ’†ŒŽŠG—¢1, ŽR“c—R—¢1, ¬”‹Žr”ü2, ’¹ˆäWŽO3, ‰ª–{_Žk1 (1–ƒŒ, 2zŠÂŠí“à, 3ˆã—ËZp‹³ˆç): Cardiovascular Anesthesia 2011/9; 15 (1): 209-14.

521035. [‰ðà]yŽ¿‹^‰ž“šz’鉀ØŠJŽž‚̍R‹Û–ò‚̃^ƒCƒ~ƒ“ƒO‚ð‹³‚Š‚­‚Ÿ‚³‚¢. ‰Á“¡—¢ŠG1, ‰œ•xr”V1 (1–ƒŒ): —Տ°–ƒŒ 2011/8; 35 (8): 1273-4.

521036. [‰ðà] Ð‰î: ‚킪‘‚Ì–³’É•ªEؑæ1—á–Ú‚Í—^ŽÓ–쏻Žq‚Ì•ª•Ø? ‰œ•xr”V (–ƒŒ): –ƒŒ 2011/10; 60 (10): 1214-20.

521037. [‰ðà] Eê‘ÌŽ€–S‰ñ”ð‚Ì‚œ‚߂Ɂ|ˆÙí‚Ì”­Œ©‚Ə‰Šú‘Ήž|. ’r“c’q–Ÿ, ‰Á“¡—¢ŠG1, ÆˆäŽ¶ (1–ƒŒ): “úŽY•wˆã‰ïŒ€Cƒjƒ…[ƒX 2011/12; p.16.

522194. [uÀ]y“ÁW: d–ŒŠO–ƒŒ•ª•Ø‚ɂ‚¢‚Ä’m‚ë‚€z‚킪‘‚É‚š‚¯‚éd–ŒŠO–³’É•ª•Ø‚Æ“ú–{–ƒŒ‰ÈŠw‰ï‚Å‚ÌŽæ‚è‘g‚Ý. ‰œ•xr”V (–ƒŒ): •ŽYŽGŽ 2011/5; 65 (5): 424-5.

522195. [uÀ]y“ÁW: p‘O•â…‚̈Ӌ`z”D•w‚É‚š‚¯‚ép‘O•â…. ‰œ•xr”V1, ‰Á“¡—¢ŠG1 (1–ƒŒ): –ƒŒ 2011/7; 60 (7): 799-806.

522196. [uÀ] ’鉀ØŠJp‚É‚š‚¯‚éÒ‘‚­‚à–Œ‰º–ƒŒ‚̃Xƒ^ƒ“ƒ_[ƒh. ‰Á“¡—¢ŠG (–ƒŒ): •ª•Ø‚Æ–ƒŒ 2011/12; 93: 8-15.

522197. [uÀ]y“ÁW: ‘å—ʏoŒŒ‚ւ̑ΉžzŽY‰È–ƒŒ—̈æ‚Ì‘å—ʏoŒŒ‚Æ‚»‚̑Ήž. ‰œ•xr”V (–ƒŒ): Anet 2011; 15 (2): 7-11.

522198. [uÀ]y˜AÚ: ŽY‰È–ƒŒ‚̍ŐV’mŽ¯zŽY‰È–ƒŒ‰Èˆã‚©‚ç‚̃ƒbƒZ[ƒW (1)@˜AÚ‚ðŽn‚ß‚é‚É‚ ‚œ‚Á‚Ä. ‰œ•xr”V1, ‰Á“¡—¢ŠG1 (1–ƒŒ): ŽüŽYŠúˆãŠw 2012/1/42 (1): 125-6.

522199. [uÀ]y˜AÚ: ŽY‰È–ƒŒ‚̍ŐV’mŽ¯zŽY‰È–ƒŒ‰Èˆã‚©‚ç‚̃ƒbƒZ[ƒW (2)@’鉀ØŠJp‚̐Ґ‘‚­‚à–Œ‰º–ƒŒ, –ƒŒ‚ðŽn‚ß‚é‘O‚É. ‰Á“¡—¢ŠG1, ‰œ•xr”V1 (1–ƒŒ): ŽüŽYŠúˆãŠw 2012/2; 42 (2): 163-5.

522200. [uÀ]y˜AÚ: ŽY‰È–ƒŒ‚̍ŐV’mŽ¯zŽY‰È–ƒŒ‰Èˆã‚©‚ç‚̃ƒbƒZ[ƒW (3)@ŽY‰È–ƒŒ‚̍ۂ̐Ґ‘‚­‚à–Œ‰º–ƒŒ‚̐j‚Ì‘Ÿ‚³‚ÆŽí—Þ‚Ì‘I‘ð‚ɂ‚¢‚Ä: ×‚¢ƒyƒ“ƒVƒ‹ƒ|ƒCƒ“ƒgj‚Æ‚Í? ‰œ•xr”V1, ‰Á“¡—¢ŠG1 (1–ƒŒ): ŽüŽYŠúˆãŠw 2012/3; 42 (3): 389-92.

522201. [uÀ]yŠª“ªŒŸzŠw‹†“I‚ÈŽY‰È–ƒŒ•”–å‚̐ݗ§‚ð–ÚŽw‚µ‚Ä. ‰œ•xr”V (–ƒŒ): —Տ°–ƒŒ 2012/3; 36 (3): 449.

522202. [uÀ]y˜AÚ: ŽY‰È–ƒŒ‚̍ŐV’mŽ¯zŽY‰È–ƒŒ‰Èˆã‚©‚ç‚̃ƒbƒZ[ƒW (4)@’鉀ØŠJp‚̐Ґ‘‚­‚à–Œ‰º–ƒŒ‚É—p‚¢‚é–òÜ. ‰Á“¡—¢ŠG1, ‰œ•xr”V1 (1–ƒŒ): ŽüŽYŠúˆãŠw 2012/4; 42 (4): 517-9.

522203. [uÀ]y˜AÚ: ŽY‰È–ƒŒ‚̍ŐV’mŽ¯zŽY‰È–ƒŒ‰Èˆã‚©‚ç‚̃ƒbƒZ[ƒW (5)@ŽY‰È–ƒŒ‚̍ۂ̐Ґ‘‚­‚à–Œ‰º–ƒŒ‚̏Á“Å‚ÆŠŽõÇ‚ɂ‚¢‚Ä: ƒAƒ‹ƒR[ƒ‹ŠÜ—L»Ü‚É‚æ‚é”畆Á“łƃ}ƒXƒN‚Ì’…—p‚̐„§. ‰œ•xr”V1, ‰Á“¡—¢ŠG1 (1–ƒŒ): ŽüŽYŠúˆãŠw 2012/5; 42 (5): 661-3.

[’˜@‘]

620198. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰ÈŠwƒŒƒrƒ…[2011@ÅVŽå—v•¶Œ£Wz26. ŽY‰È–ƒŒ, p.151-5. ‰Á“¡—¢ŠG (–ƒŒ), ŠÄC: “V‰HŒh—S, ‘‡ˆãŠwŽÐ, “Œ‹ž, 2011/5”­s.

620199. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰ÈˆãEW’†Ž¡—Èã‚É•K—v‚ÈŒŒ‰t‹ÃŒÅ, R‹ÃŒÅ, ü—nŒn‚ª•ª‚©‚é–{z—Տ°@4. ŽY‰ÈoŒŒ‚É‚š‚¯‚é‹ÃŒÅˆÙí‚Æ‚»‚̑΍ô, p.107-19. ‰Á“¡—¢ŠG1, ‰œ•xr”V1 (1–ƒŒ), •Ò: •“cƒŽO, “c’†Œ’ˆê, ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹ž, 2011/5”­s.

620200. [Šwp‘] (•ª’SŽ·•M)yS”x‘h¶zVI. –ƒŒ’†‚Ì“ÁŽê‚ȏ󋵂ł̑h¶@7. •p”, p.184-93. ‰ª–{_Žk (–ƒŒ), •Ò: ꠓc_Žj, Žœ“°o”Å, “Œ‹ž, 2011/12”­s.

620201. [Šwp‘] (•ª’SŽ·•M)yŽüŽYŠú–ƒŒzIII. –³’É•ª•Ø‚ðŒø‰Ê“I‚ɍs‚€@1. d–ŒŠO–³’É•ª•Ø‚ÌŠî‘b, .p211-20. 5. PDPH, p.250-60. ‰œ•xr”V (–ƒŒ), •Ò: ‰œ•xr”V1, ÆˆäŽ¶, Žœ“°o”Å, “Œ‹ž, 2012/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713169. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Comparative Neurotoxicity of Intrathecal Midazolam and Ketamine in Rats. Takenami T1, Nara Y, Yamada Y1, Kondo Y1, Matsuda H1, Okamoto H1: American Society of Anesthesiologists (ASA) 2011 Annual Meeting (2011/10/16), Chicago, USA. (’|˜Q–¯]1, ŽR“c—R—¢1, ‹ß“¡—S‰î1, Œ“cO”ü1, ‰ª–{_Žk1: 1–ƒŒ)

713170. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Outcomes of Intrathecal Bupivacaine Injection for Outpatients with Chronic Low Back and Leg Pain. Kanai A1, Okamoto T1, Niki Y, Suzuki A1, Wang G2, Okamoto H1: American Society of Anesthesiologists (ASA) 2011 Annual Meeting (2011/10/16), Chicago, USA. (‹àˆäº•¶1, ‰ª–{@‹M1, —é–Ø–ƒ—t1, ‰€@‘‹Õ2, ‰ª–{_Žk1: 1–ƒŒ, 2—Տ°Œ€‹†EŠé‰æ)

713171. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Safety of Intrathecally Administered High-Dose Fentanyl in Rats. Takenami T1, Fukushima S, Nara Y, Nagahara Y1, Okamoto H1: American Society of Anesthesiologists (ASA) 2011 Annual Meeting (2011/10/16), Chicago, USA. (’|˜Q–¯]1, ’·ŒŽ—R‹M1, ‰ª–{_Žk1: 1–ƒŒ)

713172. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Terminal Nerve Blok Attenuates Leg Ischemic Pain Refractory to Treatment. Hari J1, Kanai A1, Suzuki A1, Okamoto H1: American Society of Anesthesiologists (ASA) 2011 Annual Meeting (2011/10/16), Chicago, USA. (”g—¢ƒŽq1, ‹àˆäº•¶1, —é–Ø–ƒ—t1, ‰ª–{_Žk1: 1–ƒŒ)

713173. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Blockade of Leukotriene B4/BLT T1 Signaling Prevents Ischemia Reperfusion iljury of Kidney. Kosaka Y1, Okamoto H1, Nara Y, Yokomizo T, Matsuda H1, Majima M2: American Society of Anesthesiologists (ASA) 2011 Annual Meeting (2011/10/18), Chicago, USA. (¬âN°1, ‰ª–{_Žk1, Œ“cO”ü1, ”n“ˆ³—²2: 1–ƒŒ, 2–ò—)

713174. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effects of Intraarterial Prostaglandin E1 and Lidocaine on Pain and Skin Temperature in Patients with Peripheral Arterial Disease. Suzuki A1, Kanai A1, Okamoto H1: American Society of Anesthesiologists (ASA) 2011 Annual Meeting (2011/10/18), Chicago, USA. (—é–Ø–ƒ—t1, ‹àˆäº•¶1, ‰ª–{_Žk1: 1–ƒŒ)

713175. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Response to Intravenous Fentanyl Infusion Predicts Subsequent Response to Transdermal Fentanyl. Otuka T1, Kanai A1, Okamoto H1: American Society of Anesthesiologists (ASA) 2011 Annual Meeting (2011/10/18), Chicago, USA. (‘å’Ë’q‹v1, ‹àˆäº•¶1, ‰ª–{_Žk1: 1–ƒŒ)

721007. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‹•ŒŒ«ŽŸŠ³‚ÆŽOŽŸŒ³ŒoH“¹SƒGƒR[–@ (3DTEE)|–ƒŒ‰È‚Ì—§ê‚æ‚è|. ‰ª–{_Žk (–ƒŒ): ‘æ32‰ñ“ú–{zŠÂ§ŒäˆãŠw‰ï‘‰ï (2011/6/10), •xŽR.

722196. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)y–³’É•ª•Ø‚ðˆÀ‘S‚ɍs‚€‚œ‚ß‚ÌŒ»ê‚̐º‚Æ‹³ˆçz–³’É•ª•Ø‚ðs‚€‚œ‚ß, ]Ž–‚·‚éˆãŽt‚ªŠw‚Ԃׂ«ƒ|ƒCƒ“ƒg. ‰œ•xr”V (–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/3), ‰«“ê.

722197. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”D•w‚É‚š‚¯‚éS”x‘h¶–@‚ÌŒ[”­. ‰Á“¡—¢ŠG (–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/3), ‰«“ê.

722198. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ˆ««Žîᇎ¡—Ã’†‚ɏW’†Ž¡—Âð—v‚µ‚œÇ—á‚ÌŒŸ“¢. Vˆä³N1, •Šâ­”V2, ”g—¢ƒŽq1, Š‰Y’ŒŽq1, ¬âN°1, ŒË“c‰ë–ç1, ‰ª–{_Žk1, Š~Œ©•¶Ž}2, •Ð‰ª—Sˆê2, ‘Š”nˆêˆå2 (1–ƒŒ, 2‹~–œ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/28), –‹’£.

723867. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±Ò‘‚­‚à–Œ‰º–ƒŒ‚ÅŠÇ—‚µ‚œ18Ç—á‚ÌŒŸ“¢. —с@Œol1, ‹àˆäº•¶1, Š‰Y’ŒŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ58‰ñŠwpW‰ï (2011/5/19), _ŒË.

723868. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒgÒ‘‚­‚à–Œ‰º–ƒŒƒ‚ƒfƒ‹‚É‚š‚¯‚éƒtƒFƒ“ƒ^ƒjƒ‹‚ƃuƒsƒoƒJƒCƒ“‚̐_Œo“Ő«‚Ì”äŠr. •Ÿ“‡¹–é”T, ’|˜Q–¯]1, “ޗljÀ—m, ‹g–ì˜a‹v1, Š‰Y’ŒŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ58‰ñŠwpW‰ï (2011/5/20), _ŒË.

723869. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹C“¹Šë‹@ŠÇ—‚ÌŒoŒ±‚Əˆ’u‚ɂ‚¢‚ā]–ƒŒ‰Èˆã‚ւ̃Aƒ“ƒP[ƒg’²ž‚æ‚è. ç“cˆºŽq1, –؉º@L1, •Šâ­”V2, ‘º“‡_“ñ, ‰ª–{_Žk1 (1–ƒŒ, 2‹~–œ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ58‰ñŠwpW‰ï (2011/5/20), _ŒË.

723870. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O–ü’…‘ٔՂ̗Տ°“I•ª—Þ‚ð—p‚¢‚œdÇ‘O’u–ü’…‘Ù”Õ5Ç—á‚̒鉀ØŠJp‚Ì–ƒŒŠÇ—. âV“¡ŽõŒb1, ¬âN°1, ŒË“c‰ë–ç1, “V–ì@Š®2, ‰œ•xr”V1, ‰ª–{_Žk1 (1–ƒŒ, 2ŽY‰È): “ú–{–ƒŒ‰ÈŠw‰ï‘æ58‰ñŠwpW‰ï (2011/5/20), _ŒË.

723871. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V‚µ‚¢ã‹C“¹ƒGƒAƒEƒFƒCTulip‚Ì—LŒø«‚ɂ‚¢‚Ä. ‘º“‡_“ñ, ”öè«”V, –؉º@L1, ˆÉ“¡‘s•œ, •Šâ­”V2, ‰ª–{_Žk1 (1–ƒŒ, 2‹~–œ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ58‰ñŠwpW‰ï (2011/5/20), _ŒË.

723872. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”A’萫ŽŽŒ±Ž†‚É‚æ‚é”]Ò‘‰t’†‚Ì“œ‚Ì‘ª’è. Š‰Y’ŒŽq1, ‹àˆäº•¶1, —с@Œol1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ58‰ñŠwpW‰ï (2011/5/20), _ŒË.

723873. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«’ÉŠ³ŽÒ‚É‚š‚¯‚éƒtƒFƒ“ƒ^ƒjƒ‹‚Ì“_“H‚Æ“\•t‚Ì‘ŠŠÖ. —с@Œol1, ‹àˆäº•¶1, —é–Ø–ƒ—t1, m–Ø—L—Žq, ‰ª–{@‹M1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ45‰ñ‘å‰ï (2011/7/22), ŒŽR.

723874. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ‚ª‚ñ«–«’ÉŠ³ŽÒ205l‚ɑ΂·‚éƒvƒŒƒKƒoƒŠƒ“‚Ì•]‰¿. ’·ŒŽ—R‹M1, ‹àˆäº•¶1, m–Ø—L—Žq, ‰ª–{@‹M1, ‰ª–{_Žk1, —с@Œol1, —é–Ø–ƒ—t1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ45‰ñ‘å‰ï (2011/7/23), ŒŽR.

723875. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±‚­‚à–Œ‰ºƒ|[ƒg‚É‚æ‚è4ƒ–ŒŽˆÈã‚É‚í‚œ‚è—ǍD‚È’Á’É‚ª“Ÿ‚ç‚ê‚œ‚ª‚ñ«’É‚Ì2Ç—á. —с@Œol1, ‹àˆäº•¶1, ‘å’Ë’q‹v1, m–Ø—L—Žq, ‰ª–{@‹M1, —é–Ø–ƒ—t1, ‰ª–{_Žk1 (1–ƒŒ): ‘æ16‰ñ“ú–{ŠÉ˜aˆã—Êw‰ïŠwp‘å‰ï (2011/7/30), ŽD–y.

723876. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š¥“®–¬•Ùëˆí’E‚ð‡•¹‚µ‚œ¬Ž™SŽº’†ŠuŒ‡‘¹Ç‚É‚š‚¯‚éŒoH“¹SƒGƒR[‚Ì—L—p«. âV“¡ŽõŒb1, ç“cˆºŽq1, ŒË“c‰ë–ç1, ¬âN°1, Š‰Y’ŒŽq1, ”g—¢ƒŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ16‰ñŠwp‘å‰ï (2011/10/8), ˆ®ì.

723877. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œo‹¹•ÇSƒGƒR[, ŒoH“¹SƒGƒR[‚̘A‘±ƒ‚ƒjƒ^[‰º‚É–ƒŒŠÇ—‚ðs‚Á‚œdÇ•ÂÇ«”ì‘åŒ^S‹ØÇ‚ÌŒoŒ±. ç“cˆºŽq1, ŒË“c‰ë–ç1, ¬âN°1, âV“¡ŽõŒb1, Š‰Y’ŒŽq1, ”g—¢ƒŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ16‰ñŠwp‘å‰ï (2011/10/8), ˆ®ì.

723878. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶Žº—¬Žž‹·ó‚𐶂¶‚œ—Œ‘匌ŠÇ‰EŽº‹NŽnÇ‚̏Ǘá. Š‰Y’ŒŽq1, ŒË“c‰ë–ç1, ¬âN°1, âV“¡ŽõŒb1, ç“cˆºŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ16‰ñŠwp‘å‰ï (2011/10/9), ˆ®ì.

723879. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒã¶Žº—¬Žž˜H‚Ì‹@”\“I‹·ó‚𐶂¶‚œ‘m–X•ÙC•œ‚𔺂í‚È‚¢Œã“V«SŽŸŠ³S‘ŸŽèp‚Ì3Ç—á. ‰ª–{_Žk1, ŒË“c‰ë–ç1, ¬âN°1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ16‰ñŠwp‘å‰ï (2011/10/9), ˆ®ì.

723880. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RST‚©‚çRRT‚ւ̍L‚ª‚è`RSTƒŠ[ƒ_[‚Ì–ðŠ„`. Vˆä³N1, ¬’r•üF2, XˆÀŒbŽÀ, •ž•”@3, •Šâ­”V3, ¡ˆä@Š°4, ‰ª–{_Žk1, ‘Š”nˆêˆå3 (1–ƒŒ, 2ƒŠƒnƒrƒŠ•”, 3‹~–œ, 4ŽOd‘åŠwˆãŠw•”•‘®•a‰@‹~–œ‹~‹}ƒZƒ“ƒ^[): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/18), “Œ‹ž.

723881. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ª‚ñ‚ɑ΂·‚鉻Šw—Ö@,•úŽËüŽ¡—Âð‰Â”\‚É‚µ‚œŽ‘±_ŒoƒuƒƒbƒN‚Ì—L—p«. —é–Ø–ƒ—t1, ‘å’Ë’q‹v1, m–Ø—L—Žq, ‰ª–{@‹M1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/3), ‰«“ê.

723882. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹Ù‹}ã•”“àŽ‹‹ŸŒŸž‚Ì‘Sg–ƒŒŒã,”xoŒŒ‚ð‚«‚œ‚µ‚œ¬lTOFŠ³ŽÒ‚Ì1—á. ‹àŽq°1, ŒË“c‰ë–ç1, •Šâ­”V2, Vˆä³N1, ‰ª–{_Žk1 (1–ƒŒ, 2‹~–œ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/3), ‰«“ê.

723883. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’鉀ØŠJp’†‚̏žˆ³–ò‚ÌŽg—p—Ê‚ªä`‘ÑŒŒƒKƒX•ªÍ’l‚É‹y‚Ú‚·‰e‹¿: ŽY‰È–ƒŒ•”–å‚ÌŠÖ—^‚̈Ӌ`‚ɂ‚¢‚Ä. ¬—ѐ‰À1, ‰œ•xr”V1, ‰Á“¡—¢ŠG1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/3), ‰«“ê.

723884. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Intraaortic Balloon Pumping (IABP) ‘}“ü‰º‚É–ƒŒŠÇ—‚ðs‚Á‚œ‚“xS‹@”\’ቺ‚𔺂€”ñS‘ŸŽèp‚Ì2Ç—á. ‚‹Ž˜a¬1, ¬âN°1, ŽR“c—R—¢1, m–Ø—L—Žq, Vˆä³N1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723885. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ_ƒuƒ‹ƒ‹[ƒƒ“ƒ`ƒ…[ƒu‚̈ʒuŒˆ’荢“ï‚©‚ç‹CŠÇŽx•ªŠòˆÙí‚Ɛf’f‚³‚ê‚œˆê—á. ‹g–ì˜a‹v1, —é–Ø–ƒ—t1, Š‰Y’ŒŽq1, ¬âN°1, ŒË“c‰ë–ç1, ‹àˆäº•¶1, Vˆä³N1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723886. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹Ø–³—͏ǂɑ΂µ‹¹‘B“Eop‚ðŽ{s‚³‚ê‚œ12—á‚ÌŒŸ“¢. ŽR“c—R—¢1, ‚‹Ž˜a¬1, ”¢•ûhŽq1, –x]‘Ÿ˜N1, Œ–{ŽœŠ°1, ŒË“c‰ë–ç1, Vˆä³N1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723887. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒãŒÄ‹zŠÇ—‚ð—v‚µ‚œŽüpŠú”ñSŒŽ«”x…Žî6—á‚ÌŒŸ“¢. ˆÉ“¡—@Žq1, Vˆä³N1, ”g—¢ƒŽq1, Š‰Y’ŒŽq1, åUdçŠG, ˆÉ“¡‘s•œ1, •Šâ­”V2, ‰ª–{_Žk1 (1–ƒŒ, 2‹~–œ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723888. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Œ“ú–{‘åkÐŽž‚ÌŽñ“sŒ—‘åŠw•a‰@‚É‚š‚¯‚éŽèpŽºŠÇ—‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²ž. Vˆä³N1, ¬âN°1, ŽR“c—R—¢1, âV“¡ŽõŒb1, —é–Ø–ƒ—t1, ŒË“c‰ë–ç1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723889. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •Âœ_ŒoƒuƒƒbƒNŒã,pŒã5“ú–Ú‚Å“à“]‹ØŒQ‚ÉŒŒŽî‚𐶂¶‚œ1—á. ¶‰zŽq1, ˆÉ“¡‘s•œ1, “ˆ”ö~Žq1, ˆÉ“¡—@Žq1, –x]‘Ÿ˜N1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723890. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –{Ž{Ý‚É‚š‚¯‚閝«’ÉŠ³ŽÒ‚ɑ΂·‚éƒtƒFƒ“ƒ^ƒjƒ‹“\•tÜ‚Ì—L—p«. “ˆ”ö~Žq1, ‹àˆäº•¶1, —é–Ø–ƒ—t1, m–Ø—L—Žq, ‰ª–{@‹M1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723891. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) žôœ“®–¬˜HŠm•ÛŒã‰Œ«“®–¬áŽ‚ɃXƒeƒƒCƒh‚ª’˜Œø‚µ‚œ1Ç—á. –x]‘Ÿ˜N1, ‹àˆäº•¶1, —с@Œol1, ‘å’Ë’q‹v1, ‰ª–{@‹M1, m–Ø—L—Žq, —é–Ø–ƒ—t1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/4), ‰«“ê.

723892. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • •”‘å“®–¬áŽŽèp’†Š®‘S–[ŽºƒuƒƒbƒN‚𐶂¶,ŒoH“¹ƒGƒR[‰º‚ɂĈꎞƒy[ƒVƒ“ƒO‚ð‘}“ü‚µ‚œ1—á. Œ–{ŽœŠ°1, ¬âN°1, ŽR“c—R—¢1, âV“¡ŽõŒb1, åUdçŠG, Vˆä³N1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ31‰ñ‘å‰ï (2011/11/5), ‰«“ê.

731150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S‘ŸŒŒŠÇ–ƒŒ‚̐i•à. ‰ª–{_Žk (–ƒŒ): ‘æ15‰ñ‘啪–ƒŒŒ€‹†‰ï (2011/11/19), ‘啪.

731151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –³’É•ª•Ø‚̐³‚µ‚¢’mŽ¯. ‰Á“¡—¢ŠG1, ’rã@², RIKACO (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ïŽs–¯ŒöŠJuÀ (2011/6/25), “Œ‹ž.

731152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) oŽY‚ɂ‚¢‚čl‚Š‚é!!`’É‚­‚È‚¢•ª•Ø•û–@|d–ŒŠO–ƒŒ•ª•Ø‚Æ‚Í?`. ‰œ•xr”V (–ƒŒ): ‹ž“sƒ`ƒƒƒCƒ‹ƒhƒgƒ‰ƒXƒg@‘æ29‰ñ@Žqˆç‚ču‰‰‰ï (2012/2/11), ‹ž“s.

732150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (problem-based learning discussion) ‚æ‚­‚ ‚é’鉀ØŠJp‚Ì–ƒŒ. ‰Á“¡—¢ŠG1, ÆˆäŽ¶ (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï ŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ51‰ñ‡“¯ŠwpW‰ï (2011/9/10), ç—t.

733415. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒãŒÄ‹zŠÇ—‚ð—v‚µ‚œŽüpŠú”ñSŒŽ«”x…Žî5—á‚ÌŒŸ“¢. Vˆä³N1, Ž–쏃Žq, Š‰Y’ŒŽq1, åUdçŠG, —é–Ø–ƒ—t1, ˆÉ“¡‘s•œ2, •Šâ­”V3, ‰ª–{_Žk1, ‘Š”nˆêˆå3 (1–ƒŒ, 2“ŒŽÅ—ÑŠÔ•a‰@, 3‹~–œ): ‘æ20‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/7/30), “Œ‹ž.

733416. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éŒÄ‹z—Ö@ŠÖ˜AƒCƒ“ƒVƒfƒ“ƒg‚Ì•ªÍ. XˆÀŒbŽÀ, Vˆä³N1, ¬’r•üF, •ž•”@2, •Šâ­”V2, ¡ˆä@Š°3, ‰ª–{_Žk1, ‘Š”nˆêˆå2 (1–ƒŒ, 2‹~–œ, 3ŽOd‘åŠwˆãŠw•”•‘®•a‰@‹~–œ‹~‹}ƒZƒ“ƒ^[): ‘æ20‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/7/30), “Œ‹ž.

733417. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚“x”ì–ž‚𔺂€—Œ‰ºŽˆƒŠƒ“ƒpŠÇŽí“Eop‚ðŽ‘±Ò’Å‚­‚à–Œ‰º–ƒŒ‚ňӎ¯‰º‚ÉŠÇ—‚µ‚œ1Ç—á. Œ–{ŽœŠ°1, —с@Œol1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï ŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ51‰ñ‡“¯ŠwpW‰ï (2011/9/10), ç—t.

733418. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Œ“ú–{‘åkÐŽž‚ÌŽèpŽº‘Ήž‚Æ‚»‚Ì”œÈ. Vˆä³N1, ¬âN°1, ŽR“c—R—¢1, âV“¡ŽõŒb1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï ŠÖ“ŒEbM‰zE“Œ‹žŽx•”‘æ51‰ñ‡“¯ŠwpW‰ï (2011/9/10), ç—t.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-120004. [ŒŽ’˜] ƒuƒhƒE“œ‚͏ö—¯…‚æ‚èƒeƒgƒ‰ƒJƒCƒ“‚̐_Œo“Ő«‚ðŒyŒž‚·‚é. •Ÿ“‡¹–é”T, ’|˜Q–¯]1, –ö‰ºŽO˜Y, “ޗljÀ—m, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ 2011/2; 18 (2): 34-9.

H22-522011. [uÀ]y“ÁW: –¢—ˆ‚ÉŒü‚¯‚œzŠÂ§ŒäŒ€‹†‚Ö‚ÌŠú‘ҁz–¢—ˆ‚̏zŠÂ§Œä|ƒ‚ƒjƒ^[‚Æ‚µ‚Ä‚Ì3ŽŸŒ³S‘Ÿƒ‚ƒfƒ‹|. ‰ª–{_Žk (–ƒŒ): zŠÂ§Œä 2010/10; 31 (2): 97-102.

[’˜@‘]

H22-620006. [Šwp‘] (•ª’SŽ·•M)yŽüpŠúŒoH“¹SƒGƒR[ŽÀ‘H–@@‘æ2”ŁzIV —Տ°‰ž—p@15Í Š¥“®–¬ÄŒšp‚Ì‚œ‚ß‚ÌŒoH“¹SƒGƒR[, p.328-48. ‰ª–{_Žk (–ƒŒ), ŠÄC: •“cƒŽO, •Ò: –쑺@ŽÀ, ŽR“c’B–ç, ¬oNO, ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹ž, 2010/10”­s.

H22-620007. [Šwp‘] (•ª’SŽ·•M)yŽüpŠúŒoH“¹SƒGƒR[ŽÀ‘H–@@‘æ2”ŁzIV —Տ°‰ž—p@16Í ‹¹•”‘å“®–¬‚ÆŒoH“¹SƒGƒR[, p.351-75. ‰ª–{_Žk (–ƒŒ), ŠÄC: •“cƒŽO, •Ò: –쑺@ŽÀ, ŽR“c’B–ç, ¬oNO, ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹ž, 2010/10”­s.

H22-620008. [Šwp‘] (•ª’SŽ·•M)yŽüpŠúŒoH“¹SƒGƒR[ŽÀ‘H–@@‘æ2”ŁzIV —Տ°‰ž—p@17Í W’†Ž¡—ÃŽº‚É‚š‚¯‚éŒoH“¹SƒGƒR[–@ p.381-97. ‰ª–{_Žk (–ƒŒ), ŠÄC: •“cƒŽO, •Ò: –쑺@ŽÀ, ŽR“c’B–ç, ¬oNO, ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹ž, 2010/10”­s.

H22-620009. [Šwp‘] (•ª’SŽ·•M)yŽüpŠúŒoH“¹SƒGƒR[ŽÀ‘H–@@‘æ2”ŁzIV —Տ°‰ž—p@18Í ¬læ“V«SŽŸŠ³‚É‚š‚¯‚éŒoH“¹SƒGƒR[, p.400-33. ‰ª–{_Žk (–ƒŒ), ŠÄC: •“cƒŽO, •Ò: –쑺@ŽÀ, ŽR“c’B–ç, ¬oNO, ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹ž, 2010/10”­s.


—Տ°ŒŸžf’fŠw

[Šwp˜_•¶]

110286. [ŒŽ’˜] Cognate interaction plays a key role in the surveillance of autoreactive B cells in induced mixed bone marrow chimerism in BXSB lupus mice. Takeuchi E1, Shinohara N2, Takeuchi Y3: Autoimmunity 2011/8; 44 (5): 363-72. (’|“àŒb”üŽq1, ŽÂŒŽMŒ«2, ’|“àN—Y3: 1—ÕŒŸŠw, 2–Ɖu, 3t‘Ÿ“à)

110287. [ŒŽ’˜] Levels of acute inflammatory biomarkers in advanced prostate cancer patients with ƒ¿2-macroglobulin deficiency. Kanoh Y1, Ohtani H, Egawa S, Baba S2, Akahoshi T3: Int J Oncol 2011/12; 39 (6): 1553-8. (Žë–ì—Lì1, ”nêŽu˜Y2, Ô¯@“§3: 1—ÕŒŸŠw, 2”å”AŠí, 3‘‡f—Ã)

110288. [ŒŽ’˜] Changes of proteases and proteinase inhibitors in androgen-dependent advanced prostate cancer patients with alpha2-macroglobulin deficiency. Kanoh Y1, Ohtani H, Egawa S, Baba S2, Akahoshi T3: Clin Lab 2012/3; 58 (3-4): 217-25. (Žë–ì—Lì1, ”nêŽu˜Y2, Ô¯@“§3: 1—ÕŒŸŠw, 2”å”AŠí, 3‘‡f—Ã)

[’˜@‘]

610017. [Šwp‘] (•ª’SŽ·•M)yAn Update on Glomerulopathies - Clinical and Treatment AspectszChapter 16: Mixed Hematopoietic Chimerism Allows Cure of Autoimmune Glomerulonephritis: Its Potential and Risks, p.277-90. Takeuchi E1 (1Department of Laboratory Medicine, Kitasato University), Edited by Prabhakar SS, InTeck, Croatia, 2011/11”­s. (’|“àŒb”üŽq1: 1—ÕŒŸŠw)

[Šw‰ïEŒ€‹†‰ï“™]

723893. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RÔŒŒ‹…R‘Ì‚Ì‹qŠÏ“I‚ŠŽ“xŒŸo–@‚̍\’z. ”«‘º˜a’j, Žë–ì—Lì1, Ô¯@“§2 (1—ÕŒŸŠw, 2‘‡f—Ã): ‘æ58‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2011/11/17-20), ‰ªŽR.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110017. [ŒŽ’˜] Allogenic mixed chimerism prevented autoimmune thrombocytopenia in BXSB lupus mice receiving donor BMT with nonlymphoablative conditioning of low-dose TBI and anti CD40L mAb. Takeuchi E1 (1Department of Laboratry Medicine, Kitasato University): Kitasato Med J 2011/3; 41 (1): 50-6. (’|“àŒb”üŽq1: 1—ÕŒŸŠw)

[Šw‰ïEŒ€‹†‰ï“™]

H22-713007. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Dysfunction of selective suppression of auto-antibody production in SLE mouse and reconstruction of this mechanism by induction of bone-marrow chimerism. Takeuchi E1, Kobayashi K, Katagiri H, Eshima K2, Shinohara N, Takeuchi Y3: 7th International Congress on Autoimmunity (2010/8/7), Ljubjana, Slovenia. (’|“àŒb”üŽq1, ]“‡k“ñ2, ’|“àN—Y3: 1—ÕŒŸŠw, 2–Ɖu, 3t‘Ÿ“à)

H22-713008. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Dysfunction of selective suppression of auto-antibody production in SLE mice and reconstruction of this mechanism by induction of bone-marrow chimerism. Takeuchi E1: 1st Controversies in Rheumatorogy and Autoimmunity (2011/3/10-12), Firence, Italy. (’|“àŒb”üŽq1: 1—ÕŒŸŠw)

H22-723014. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MHCŠ®‘S•sˆê’vƒhƒi[‚©‚ç‚̍œ‘ˆÚA‚É‚æ‚鎩ŒÈ–Ɖu«ŒŒ¬”ÂŒž­Ç‚̉ü‘P‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’|“àŒb”üŽq1, Žë–ì—Lì1 (1—ÕŒŸŠw): ‘æ57‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2010/9/10), Vh.


—AŒŒE×–EˆÚAŠw

[Šwp˜_•¶]

110289. [ŒŽ’˜] Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL. Suzuki Y1, Yoshida T2, Wang G3, Togano T4, Miyamoto S5, Miyazaki K4, Iwabuchi K2, Nakayama M5, Horie R4, Niitsu N, Sato Y, Nakamura N: Ann Hematol 2012/7; 91 (7): 997-1005. (—é–Ø—TŽq1, ‹g“c@Œ÷2, ‰€@‘‹Õ3, ’Ì–ì•x‹P4, ‹{–{r•ã5, ‹{è_“ñ4, ŠâŸºŒ[ˆê2, ’†ŽR–Ÿm5, –x]—Ljê4: 1—AŒŒE×–EˆÚA, 2•a—, 3—Տ°Œ€‹†EŠé‰æ, 4ŒŒ‰t“à, 5Žš•@)

310030. [Ç—á•ñ] A patient with acute lymphoblastic leukemia presenting with an extremely high level (21.0%) of HbA1c. Suzuki S1, Shichishima T, Yamashiro Y, Kimura H2, Ishii R2, Miyazaki K2, Horie R2, Moriya T3, Hattori Y: Ann Clin Biochem 2011/9; 48 (Pt 5): 474-7. (Šp“c—TŽq1, –Ø‘º—T˜a2, Îˆä—²Ži2, ‹{è_“ñ2, –x]—Ljê2, Žç‰®’B”ü3: 1—AŒŒE×–EˆÚA, 2ŒŒ‰t“à, 3“à•ª”å‘ãŽÓ“à)

[’˜@‘]

620202. [Šwp‘] (•ª’SŽ·•M)yDMR—Տ°ŒŸž–òî•ñ’S“–ŽÒ Œ€CƒeƒLƒXƒgII 2012”N”ŁzII —Տ°ŒŸžŠw@8 —AŒŒŒŸž, p.182-92. ‘å’JTˆê (—AŒŒE×–EˆÚA), ŠÄC: XŽOŽ÷—Y, •Ò: “ú–{—Տ°ŒŸž–ò‹Š‰ï, –òŽ–“ú•ñŽÐ, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

723894. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚錌‰t»Ü‚Ì”pŠüó‹µ|10”NŠÔ‚Ì”pŠüŒŒíŒž‚ÌŽæ‚è‘g‚݁|. ¬–{”ü“Þ, •—ŠÔ‚ ‚«‚Ý, ‚–ì”g—¯”ü, ”ª–ؘa¢, •œ“c‘×—Ç, Šp“c—TŽq1, ‘å’JTˆê1 (1—AŒŒE×–EˆÚA): ‘æ59‰ñ“ú–{—AŒŒE×–EŽ¡—Êw‰ï‘‰ï (2011/4/14-16), “Œ‹ž (ŽãŠJÃ).

723895. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –k—¢‘åŠw•a‰@‚Å‚Ì, ^‹Û•ª—£ó‹µ‚Æ, —\–h“IR^‹ÛÜ‚ÌŽg—p‚È‚ÇŠ³ŽÒ—Տ°ˆöŽq‚Æ‚ÌŠÖ˜A‚ÌŒŸ“¢. Šp“c—TŽq1, ‹v•Ä@Œõ, ’Ì–ì•x‹P2, ‚–ؐç’ß, ŽRŒû“oŠóŽq, ‚ŽR—zEq3, ’hŒŽŠ²¶2, ‹{è_“ñ2, –x]—Ljê2, »ìŒc‰î4, “ŒŒŽ³–Ÿ2 (1—AŒŒE×–EˆÚA, 2ŒŒ‰t“à, 3‘‡f—Ã, 4ŠŽõŠÇ—Eº): ‘æ73‰ñ“ú–{ŒŒ‰tŠw‰ïŠwpW‰ï (2011/10/15), –ŒŒÃ‰®.

723896. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚錌‰tŽŸŠ³Š³ŽÒ‚ÌŒŸo^‹Û‚ÆŠ³ŽÒ”wŒi‚ÌŠÖ˜A‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Šp“c—TŽq (—AŒŒE×–EˆÚA): ‘æ55‰ñ“ú–{ˆã^‹ÛŠw‰ïŠwpW‰ï (2011/10/22), “Œ‹ž.

723897. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a—–UŒŸ—á‚É‚š‚¯‚é[Ý«^‹ÛÇ‚̉uŠw|“ú–{•a—–UŒŸS•ñ@‘æ52S (–UŒŸ—á2009”N“x)|. Šp“c—TŽq1, Žë–ì—Lì2, ’Ì–ì•x‹P3, “ŒŒŽ³–Ÿ3, ‹v•Ä@Œõ (1—AŒŒE×–EˆÚA, 2—ÕŒŸŠw, 3ŒŒ‰t“à): ^‹ÛÇƒtƒH[ƒ‰ƒ€‘æ13‰ñŠwpW‰ï (2012/2/18), “Œ‹ž.

733419. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŒŸo^‹Û‚ÆŒŒ‰tŽŸŠ³Š³ŽÒ—Տ°”wŒi‚ÌŠÖ˜A‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Šp“c—TŽq1, ’†‘º³‹P, ‚é—R”üŽq, •x‘ò@~, ²“¡çŒb, ‚–ؐç’ß, ¬”Š@i, ŽRŒû“oŠóŽq2, ’Ì–ì•x‹P3, ’†è¹•F, “ñ–{–öL2, “¡–Ø‚­‚ÉŽq4, ‹ß“¡—¯”üŽq, •œ“c‘×—Ç2, ‚ŽR—zŽq5, Žë–ì—Lì6, ‰Ô–؏G–Ÿ, »ìŒc‰î4, “ŒŒŽ³–Ÿ3, ‹v•Ä@Œõ (1—AŒŒE×–EˆÚA, 2—ÕŒŸ•”, 3ŒŒ‰t“à, 4ŠŽõŠÇ—Žº, 5‘‡f—Ã, 6—ÕŒŸŠw): ‘æ60‰ñ_“ސìˆã^‹ÛŒ€‹†‰ï (2011/6/25), ‰¡•l.

733420. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _ŒoÇó‚Å”­Ç‚µ‚œƒ}ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ‚̈ê—á. ‰Á“¡@–Œ, Šp“c—TŽq1, –x“àŒb”üŽq, ’·’JìˆêŽq, âV“¡¶˜N (1—AŒŒE×–EˆÚA): ‘æ17‰ñJapan International conference of Malignant Lymphoma (2011/9/17), “Œ‹ž.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-320003. [Ç—á•ñ] ‰E‘OŠz•”‚ɐ¶‚¶‚œPrimary Cutaneous Follicle Center Lymphoma‚Ì1—á. ‘哇@ž, ’·“ޏŽq, ìŒû^ŠìŽq, ”’ˆä@–Ÿ, ’©”ä“ޏº•F, âV“¡¶˜N, –k–ì‰ëŽj, Šp“c—TŽq1 (1—AŒŒE×–EˆÚA): ”畆‰È‚̗Տ° 2011/2; 53 (2): 316-20.


‹~–œ‹~‹}ˆãŠw

[Šwp˜_•¶]

110290. [ŒŽ’˜] A new technique for seeding chondrocytes onto solvent-preserved human meniscus using the chemokinetic effect of recombinant human bone morphogenetic protein-2. Minehara H1, Urabe K2, Naruse K2, Mehlhorn AT, Uchida K2, SŸdkamp NP, Itoman M2: Cell Tissue Bank 2011/8; 12 (3): 199-207. (•ôŒŽG¹1, è•”@Œ›2, ¬£NŽ¡2, “à“cŒ’‘Ÿ˜Y2, Ž…–ž·Œ›2: 1‹~–œ, 2®ŠO)

110291. [ŒŽ’˜] SK2 channels are neuroprotective for ischemia-induced neuronal cell death. Allen D, Nakayama S, Kuroiwa M1, Nakano T, Palmateer J, Kosaka Y2, Ballesteros C, Watanabe M, Bond CT, Luj‡n R, Maylie J, Adelman JP, Herson PS: J Cereb Blood Flow Metab 2011/12; 31 (12): 2302-12. (•Šâ­”V1, ¬âN°2: 1‹~–œ, 2–ƒŒ)

110292. [ŒŽ’˜] Elevated S100B level in verebrospinal fluid could predict poor outcome of carbon monoxide poisoning. Ide T1, Kamijo Y1, Ide A2, Yoshimura K, Nishikawa T, Soma K1, Mochizuki H3: Am J Emerg Med 2012/1; 30 (1): 222-5. (ˆäorŒõ1, ãžŠ‹gl1, ˆäo•¶Žq2, ‘Š”nˆêˆå1, –]ŒŽGŽ÷3: 1‹~–œ, 2ž_, 3_Œo“à)

120089. [ŒŽ’˜] ƒŠƒ‚ƒfƒŠƒ“ƒOŽx”z‘¥‚ð—p‚¢‚œƒ}ƒEƒX—pœÜŒÅ’èƒvƒŒ[ƒg‚É‚š‚¯‚éŒÅ’è–@‚ÌŒŸ“¢. Žðˆä—˜“Þ, Roland Steck, Gongfa Chen, Nichael Schuetz, ‰œ“c“Þ•ä, •ôŒŽG¹1, ã–쐳Šì2, “à“cŒ’‘Ÿ˜Y2, ‚‘Š»Žm2 (1‹~–œ, 2®ŠO): ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ïŽ 2011/5; 35 (2): 160-6.

120090. [ŒŽ’˜] —ˆ‰@ŽžŒŒ‰tƒ}[ƒJ[‚É‚æ‚édÇ‹~‹}Š³ŽÒ‚Ì—\Œã—\‘ª. ‹g“c@“O1, •ž•”@2, Š~Œ©•¶Ž}2, _œä’m“¹2, ²“¡çŒb2, ¡ˆä@Š°2, ‘Š”nˆêˆå2 (¹ƒ}ƒŠƒAƒ“ƒiˆã‘å1, 2‹~–œ): “ú–{‹~‹}ˆãŠw‰ïŽGŽ 2011/6; 22 (6): 245-54.

120091. [ŒŽ’˜] Respiratory Support Team (RST) ‚ÌŠˆ“®•ñ|–{–M‚É‚š‚¯‚éRapid Response System (RRS) \’z‚̈êlŽ@|. ¡ˆä@Š°1, ¬’r•üF, XˆÀŒbŽÀ, ‘Š”nˆêˆå1 (1‹~–œ): “ú–{—Տ°‹~‹}ˆãŠw‰ïŽGŽ 2011/6; 14 (3): 421-5.

120092. [ŒŽ’˜] —°Ž_ƒAƒ‹ƒxƒJƒVƒ“‚ÌŽŠ“KŒŒ’†ƒs[ƒN”Z“x‚ð’B¬‚·‚é‚œ‚ß‚Ì—p—ʐݒ莎Œ±. –Ø‘º—˜”ü, »ìŒc‰î1, ŒË’Ë‹±ˆê, Œ–{“N–ç, ‰Ô–؏G–Ÿ, ‘Š”nˆêˆå2, —é–؍K’j, ‹g“c@–«, ‘å’ËŠìl, ª–{@Šw, ‰¡“c—Ts, “ŒŒŽ³–Ÿ3, D“c¬l, HŽR@’š, ‹{”ö’ŒŽ÷, s‰ª“N’j, ‘剮•~ˆê”n, Vˆä—²’j, ’rãŒhˆê, ˆê˜a‘œr’j, ¬—я¹G4 (1ŠŽõŠÇ—Žº, 2‹~–œ, 3ŒŒ‰t“à, 4“Œ•a‰@–òÜ•”): “ú–{‰»Šw—Ö@Šw‰ïŽGŽ 2011/11; 59 (6): 597-604.

320055. [Ç—á•ñ] Streptococcus oralis‚É‚æ‚鐑–Œ‰Š‚Ì1—á. ˆäorŒõ1, ”~’ײ‘Ÿ, ˆîŠ_‘דl1, ŽR’J—§‘å1, ŽÄ“c^—RŽq, ¡ˆä@Š°, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ 2011; 32: 60-1.

320056. [Ç—á•ñ] ‚—îŽÒ‚É”­¶‚µ‚œ‰ñ’°Œ‹ŠjúE‚Ì1—á. ŽÄ“c^—RŽq, “‡“c@Œª1, ‰Ô“‡@Ž‘, ‰Í–”@Š°, •Ð‰ª—Sˆê1, ‘Š”nˆêˆå1 (1‹~–œ): “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2012/1; 32 (1): 125-8.

522204. [uÀ]y“ÁW: ŠÌ‘¹‚ɑ΂·‚éNon-operative managementz“Ý“IdÇŠÌ‘¹‚ɑ΂·‚éTAE‚Ì—L—p«. Š~Œ©•¶Ž}1, ŒŠª@”Ž2, •Ð‰ª—Sˆê1, ŽR’J—§‘å1, _œä’m“¹1, ƒEƒbƒhƒnƒ€ƒX—æŽq3, Œ‰iŒh“ñ3, ‘Š”nˆêˆå1 (1‹~–œ, 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwS‘ŸŒŒŠÇŠO‰È, 3•úŽËü (‰æ‘œ)): “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/4; 31 (4): 613-7.

522205. [uÀ]yƒXƒbƒLƒŠ‰ðŒˆ! Q&A@‘æ60‰ñz”]“àoŒŒŠ³ŽÒ‚Ì”­ŠŸ. ’†ŒŽ–M» (‹~–œ): ƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO 2011/5; 27 (5): 504.

522206. [uÀ]y˜AÚz‚æ‚­Žg‚€“úíŽ¡—Öò‚̐³‚µ‚¢Žg‚¢•û: ’†“łɑ΂·‚é–ò•š—Ö@`‰ð“Å–òEhR–ò‚𒆐S‚Ɂ`. ãžŠ‹gl (‹~–œ): ƒŒƒWƒfƒ“ƒgƒm[ƒg 2011/5; 13 (4): 743-6.

522207. [uÀ]y“ÁW: ŠÌ‘¹‚ɑ΂·‚éNon-operative managementz“Ý“IdÇŠÌ‘¹‚ɑ΂·‚éTEA‚Ì—L—p«. Š~Œ©•¶Ž}1, ŒŠª@”Ž2, •Ð‰ª—Sˆê1, ŽR’J—§‘å1, _œä’m“¹1, ƒEƒbƒhƒnƒ€ƒX—æŽq3, Œ‰iŒh“ñ3, ‘Š”nˆêˆå1 (1‹~–œ, 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwS‘ŸŒŒŠÇŠO‰È, 3•úŽËü (‰æ‘œ)): “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/5; 31 (4): 613-7.

522208. [uÀ] “–‰@‚ÅŒoŒ±‚µ‚œ”]Ž€‰º‘ŸŠí’ñ‹Ÿ‚̉ߒö‚Ő¶‚¶‚œ–â‘è“_. •Ð‰ª—Sˆê1, –kŒŽF—Y1, ¡–ìTŒá1, ’†ŒŽ–M»1, ’|“àˆê˜Y1, •Šâ­”V1, rì–@Žq, •œ@KŒb, ‘Š”nˆêˆå1 (1‹~–œ): “ú–{‹~‹}ˆãŠw‰ïŽGŽ 2011/8; 22 (8): 541.

522209. [uÀ]y“ÁW: ‹Ù‹}“xEdÇ“xŽw•W|ŒŸžŽ{sE“ü‰@”»’f‚Ì‚œ‚߂ɁzIII. —\Œã•]‰¿‚ÌŽw•W@6. ALI/ARDS. ‘Š”nˆêˆå (‹~–œ): ‹~‹}ˆãŠw 2011/10; 35 (11): 1610-2.

522210. [uÀ]y“ÁW: ŠO‰Èˆã‚ª’m‚Á‚Ä‚š‚­‚ׂ«’¥Œó‚ƏnjóŒQzIV. Á‰»ŠÇ@BoerhaaveÇŒóŒQ‚ÆMallory-WeissÇŒóŒQ. “‡“c@Œª1, ‘Š”nˆêˆå1 (1‹~–œ): ŠO‰È 2011/11; 73 (12): 1334-8.

522211. [uÀ]y“ÁW: NOMI (non-occlusive mesenteric ischemia) ‚ð‚¢‚©‚ɐf’f‚µ, Ž¡—·‚é‚©zNOMI (non-occluseive mesenteric ischemia) ‚̐f’f‚ƗÖ@‚ÉŠÖ‚·‚錟“¢|“Á‚É“®’—Ö@‚Ì—L—p«‚ɂ‚¢‚ā|. •Ð‰ª—Sˆê1, “‡“c@Œª1, Š~Œ©•¶Ž}1, _œä’m“¹1, ‰Ô“‡@Ž‘1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ‘Š”nˆêˆå1 (1‹~–œ, 2•úŽËü (‰æ‘œ)): “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/11; 31 (7): 1015-9.

522212. [uÀ]y“ÁW: NOMI (non-occlusive mesenteric ischemia)‚ð‚¢‚©‚ɐf’f‚µ, Ž¡—·‚é‚©zNOMI (non-occlusive mesenteric ischemia) ‚̐f’f‚ÆŽ¡—Ö@‚ÉŠÖ‚·‚錟“¢|“Á‚É“®’—Ö@‚Ì—L—p«‚ɂ‚¢‚ā|. •Ð‰ª—Sˆê1, “‡“c@Œª1, Š~Œ©•¶Ž}1, _œä’m“¹1, ‰Ô“‡@Ž‘1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ‘Š”nˆêˆå1 (1‹~–œ, 2•úŽËü (‰æ‘œ)): “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011; 31 (7): 1015-9.

522213. [uÀ]y”M’†Ç|“KØ‚ȑΏˆ‚Æ—\–hô|zI. ”M’†Ç‘˜_@1. ”M’†Ç‚Ì•ª—Þ. –kŒŽF—Y (‹~–œ): “ú–{—Õଠ2012/6; 70 (6): 929-33.

[’˜@‘]

620203. [Šwp‘] (•ª’SŽ·•M)yŠŽõÇê–åˆã‘æI•”‰ðà•ÒƒeƒLƒXƒgzŠe˜_I ‘ŸŠí•Ê‚É‚Ý‚œ•a‘Ô, f’f, Ž¡—Á@I. ŒÄ‹zŠíŠŽõÇ@5. lHŒÄ‹zŠíŠÖ˜A”x‰Š, p.653-4. ‘Š”nˆêˆå (‹~–œ), •ÒW: “ú–{ŠŽõÇŠw‰ï, “ì]“°, “Œ‹ž, 2011/4”­s.

620204. [Šwp‘] (•ª’SŽ·•M)y–òÜŽt‚Ì‚œ‚ß‚Ì‹~‹}EW’†Ž¡—×̈æ•W€ƒeƒLƒXƒgzIII ‹~‹}f—Á@7. ŠŽõÇ‚ÌŠÇ—, .p.168-74. ‘Š”nˆêˆå (‹~–œ), ŠÄC: “ú–{•a‰@–òÜŽt‰ï, “ú–{—Տ°‹~‹}ˆãŠw‰ï, •Ò: “ú–{—Տ°‹~‹}ˆãŠw‰ï, ‹~‹}”F’è–òÜŽt”F’èˆÏˆõ‰ï, ‚Ö‚é‚·o”Å, 2011/5”­s.

620205. [Šwp‘] (•ª’SŽ·•M)y”M’†Ç`“ú–{‚ðP‚€”M”g‚Ì‹°•|`z‘æ1•” ”M’†Ç‚̏펯@6. ”M’†Ç‚Ì•ª—Þ, p.40-6 –kŒŽF—Y (‹~–œ), •Ò: “ú–{‹~‹}ˆãŠw‰ï, ‚Ö‚é‚·o”Å, 2011/5”­s.

620206. [Šwp‘] (•ª’SŽ·•M)yf—ÃKƒCƒhƒ_ƒCƒWƒFƒXƒg2011 (Ž¡—à 2011”N5ŒŽ—ÕŽž‘Š§†)zzŠÂŠí@S•s‘S‚ÌŽ¡—Ã, p.40-5. ’|“àˆê˜Y (‹~–œ), •Ò: ‘O‘ò­ŽŸ, ”“Œ@_, “ì]“°, “Œ‹ž, 2011/5”­s.

620207. [Šwp‘] (•ª’SŽ·•M)yŠŽõÇê–åˆã‘æII•”ƒP[ƒXƒXƒ^ƒfƒB•ÒƒeƒLƒXƒgz‘æIIIÍ ƒGƒLƒXƒp[ƒg•Ò@6. ŽèpŒãlHŒÄ‹zŠÇ—’†‚É”­Ç‚µ‚œ‰@“à”x‰ŠÇ—á, p.277-84. ‘Š”nˆêˆå (‹~–œ), •Ò: “ú–{ŠŽõÇŠw‰ï, “ì]“°, “Œ‹ž, 2011/6”­s.

620208. [Šwp‘] (•ª’SŽ·•M)yƒKƒCƒhƒ‰ƒCƒ“ƒTƒ|[ƒgƒnƒ“ƒhƒuƒbƒN@ŒÄ‹zŠíŠŽõÇzŠe˜_@II ‰@“à”x‰Š (HAP) @2. Ž¡—Á@2) ’PÜ“Š—^‚Æ•¹—p“Š—^‚ÌŽg‚¢•ª‚¯‚Í‚Ç‚€‚·‚ê‚΂悢‚©? p.271-5. ‘Š”nˆêˆå (‹~–œ), •Ò: ‰Í–ì@–Î, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2011/6”­s.

620209. [Šwp‘] (•ª’SŽ·•M)yž_‰È •K{–ò‚ð’T‚é [‰ü’ù2”Å]zD. •a“, •a‰@•Ê‚É‚Ý‚œ•K{–ò@9 ‹~–œ‹~‹}ƒZƒ“ƒ^[, p.220-8. ãžŠ‹gl1 (1‹~–œ), •Ò: ‹{‰ª@“™2 (2ž_), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/7”­s.

620210. [Šwp‘] (•ª’SŽ·•M)yƒhƒLƒ…Eƒ“ƒg“Œ“ú–{‘åkÐ@‹~•‚̍őOü‚Łz‹‚ß‚ç‚ê‚Ä‚¢‚œ‚͈̂ã—Â̒·ŠúŽx‰‡‚Ÿ‚Á‚œ, p.291-301. ’|“àˆê˜Y (‹~–œ), ƒCEJƒƒXo”Å, “Œ‹ž, 2011/9”­s.

620211. [Šwp‘] (•ª’SŽ·•M)yƒAƒNƒ`ƒ…ƒA ƒ‹”]E_ŒoŽŸŠ³‚̗Տ°@Ž¯‚é f‚é Ž¡‚·@“ª’É‚Ì‚·‚ׂāzII. “ª’ɐf—Ẫ|ƒCƒ“ƒg@“ñŽŸ«“ª’É (ŠíŽ¿«ŽŸŠ³‚𔺂€“ª’É) ‚̐f—Ã|ƒCƒ“ƒg, p.51-62. ˆäorŒõ (‹~–œ), ê–å•ÒW: —é–Ø‘¥G, ‘•ÒW: ’ҁ@ÈŽŸ, ’†ŽR‘“X, “Œ‹ž, 2011/11”­s.

620212. [Šwp‘] (•ª’SŽ·•M)y–ƒŒEW’†Ž¡—Èã‚Ì‚œ‚߂̍R‹Û–òŽg—p‚ÆŠŽõ‘΍ôzCHAPTER2 W’†Ž¡—Èã•Ò@1. lHŒÄ‹zŠíŠÖ˜A”x‰Š (VAP) ‚ɑ΂·‚éR‹Û–òŽ¡—Ã, p.57-67. ‘Š”nˆêˆå (‹~–œ), •Ò: ’|–––F¶, ŽR“c–FŽk, Žœ“°o”Å, “Œ‹ž, 2012/1”­s.

620213. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚Ì‹~‹}Ž¡—ÃŽwj (‘æ2”Å)zII ŽŸŠ³E•a‘Ԃ̐f—Á@2. ŒÄ‹zŠíŒn, p.195-203. ‘Š”nˆêˆå (‹~–œ), ŠÄC: ‘Oì˜a•F, ‘Šì’ŒŽ÷, •Ò: ™–{@šæ, –x@iŒå, s‰ª“N’j, ŽR“cŽŠN, â–{“N–ç, ˆãŠw‘‰@, “Œ‹ž, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713176. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Soft tissue irritation and implant removal can be disastrous with locking compression plate fixasion. Minehara H1, Uhcino M2, Matsuura T2, Urabe K2, Takaso M2: 12th European Congress of Trauma Emergency Surgery (2011/4/28), Milano, Italy. (•ôŒŽG¹1, “à–쐳—²2, Œ‰YW³2, è•”@Œ›2, ‚‘Š»Žm2: 1‹~–œ, 2®ŠO)

713177. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Cytokine and Chemokine Profiles in Acute Carbon Monoxide Poisoning: Marked Elevation of Interleukin-6 in Cerebrospinal Fluid. Ide T1, Kamijo Y1, Yoshimura K, Ide A1, Nishikawa T, Soma K1, Mochizuki H2: European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) The 31st International Congress (2011/5/27), Dubrovnik, Croatia. (ˆäorŒõ1, ãžŠ‹gl1, ˆäo•¶Žq1, ‘Š”nˆêˆå1, –]ŒŽGŽ÷2: 1‹~–œ, 2_Œo“à)

713178. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Synbiotics reduce infectious complications by improving intestinal environment and enhancing immune function in critically ill trauma or emergency surgical patients. Kataoka Y1: International Surgical Week ISW2011 (2011/8/29), Yokohama. (•Ð‰ª—Sˆê1: 1‹~–œ)

713179. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Treatment strategy of damage control surgery for the patients with open long bone fractures and head injuries. Minehara H1, Konno S1, Soma K1, Suzuki T1 Matsuura, T2, Nakahara K3, Kitahara T1, Takaso M2: International Surgical Week ISW2011 (2011/8/29), Yokohama. (•ôŒŽG¹1, ¡–ìTŒá1, ‘Š”nˆêˆå1, —é–؁@‘ì1, Œ‰YW³2, ’†ŒŽ–M»3, –kŒŽF—Y1, ‚‘Š»Žm2: 1‹~–œ, 2®ŠO, 3”]ŠO)

722199. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰ºŽˆœÜŠO‚ð‡•¹‚µ‚œ“ª•”ŠO‚ÌŽ¡—Ã. ¡–ìTŒá1, •ôŒŽG¹1, ’†ŒŽ–M»2, ŽÄ“c^—RŽq, ‰““¡¹F, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ, 2”]ŠO): ‘æ25‰ñ“ú–{ŠOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/20), ‘åã.

722200. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ª•”ŠO‚ð‡•¹‚µ‚œŽlŽˆ‰ð•úœÜ‚ɑ΂·‚鎡—Ð헪‚Ì•]‰¿. •ôŒŽG¹1, ¡–ìTŒá1, —é–؁@‘ì1, ’†ŒŽ–M¹2, Œ‰YW³3, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ, 2”]ŠO, 3®ŠO): ‘æ25‰ñ“ú–{ŠOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/20), ‘åã.

722201. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ª•”ŠOŒãŠíŽ¿«ž_Çó‚ɑ΂·‚é—}ŠÌŽU‚Ì—LŒø«: ƒnƒCƒuƒŠƒbƒgŒ^W’†Ž¡—Âð–ÚŽw‚µ‚Ä. _œä’m“¹1, ’†ŒŽ–M»2, ¡–ìTŒá1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ, 2”]ŠO): ‘æ25‰ñ“ú–{ŠOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/20), ‘åã.

722202. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹~‹}ˆã—Âɂš‚¯‚é‘œEŽí˜AŒg‚ÉŠÖ‚·‚éŽæ‚è‘g‚Ý: ‹~–œ‹~‹}ƒZƒ“ƒ^[ƒXƒ^ƒbƒt‚É‚æ‚éƒf[ƒ^ƒx[ƒX\’z‚ÌŽæ‚è‘g‚Ý. _œä’m“¹1, ×“c_Ži, ‰““¡¹F, lŒ©ŸÆ, ‚—œ—˜–ž, ˆîŠ_‘דl1, •ž•”@1, ˆäo•¶Žq1, –kŒŽF—Y1, ‹à‘ò@—E, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/3), ŽD–y.

722203. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yS‘Ÿ“Ë‘RŽ€‚ÌŒ»ó‚Æ—\–hzS‘Ÿ“Ë‘RŽ€‚É‚š‚¯‚é—\Œã—\‘ªˆöŽq‚ÌŒŸ“¢. ¡–Ø—²‘Ÿ1, ’|“àˆê˜Y2 (1‹~–œ, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ47‰ñ“ú–{zŠÂŠí—\–hŠw‰ï‘‰ï (2011/6/3-4), •Ÿ‰ª.

722204. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‹~‹}ˆã—Âɂš‚¯‚éIVR‚̈ʒu•t‚¯ ŠOf—Âɂš‚¯‚éIVR‚̈ʒu•t‚¯. ŒŠª@”Ž, Š~Œ©•¶Ž}1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, Œ‰iŒh“ñ2, ‘Š”nˆêˆå1, –‹“à°˜Y (1‹~–œ, 2•úŽËü (‰æ‘œ)): ‘æ36‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï (2011/6/16), ‰YˆÀ, “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ 2011; 36 (3): 433.

722205. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y• o“à‘ŸŠí‘¹‚ÌŽ¡—Ð헪E|Operation or IVRz“Ý“IdÇŠÌ‘¹‚ɑ΂·‚éTAE‚Ì—L—p«. Š~Œ©•¶Ž}1, ŒŠª@”Ž, •Ð‰ª—Sˆê1, ¬Š}ŒŽ‹2, “¡ˆä@Š]2, •ž•”@1, _œä’m“¹1, “‡“c@Œª1, ‘Š”nˆêˆå1 (1‹~–œ, 2•úŽËü (‰æ‘œ)): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/11), •Ÿ‰ª, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/2; 31 (2): 300.

722206. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Žá‚³‚ÆProfessionalism@¡, ŽÐ‰ï‚É•K—v‚Æ‚³‚ê‚éŽáŽè‹~‹}ˆã|Acute Care Surgeon‚Æ‚µ‚Ä‚Ì‹~‹}ˆã‚Ì•K—v«|. •Ð‰ª—Sˆê1, “‡“c@Œª1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/12), •Ÿ‰ª.

722207. [Šw‰ï(‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y• •”‹~‹}—̈æ‚É‚š‚¯‚銿•û‚Ì–ðŠ„z• •”‹~‹}—̈æ‚É‚š‚¯‚é“Œ—mˆãŠw“IƒAƒvƒ[ƒ`‚Ì•¹—p|ƒnƒCƒuƒŠƒbƒhŒ^W’†Ž¡—Âð–ÚŽw‚µ‚ā|. _œä’m“¹1, •Ð‰ª—Sˆê1, “‡“c@Œª1, ’†’JŒ€“l1,2, ‘Š”nˆêˆå1 (1‹~–œ, 2Á‰»Ší“à): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/12), •Ÿ‰ª, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/2; 31 (2): 331.

722208. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) œ”՗֍œÜŒã‚Ì‹@”\•]‰¿. —é–؁@‘ì1, •ôŒŽG¹1, Œ‰YW³2, “àŽRŸ•¶2, ‚‘Š»Žm2 (1‹~–œ, 2®ŠO): ‘æ38‰ñ“ú–{ŒÒŠÖßŠw‰ï (2011/10/8), Ž­Ž™“‡.

722209. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) W’†Ž¡—ÃŽº‚ł̏dÇ‹~‹}Š³ŽÒŠÇ—|W’†Ž¡—Âɂš‚¯‚é‰h—{ŠÇ—‚̃Gƒrƒfƒ“ƒX‚ƃKƒCƒhƒ‰ƒCƒ“|. •Ð‰ª—Sˆê1, _œä’m“¹1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/18), “Œ‹ž.

722210. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) dÇ‹~‹}Š³ŽÒ‚ɑ΂·‚鐅—n«H•š‘@ˆÛEƒIƒŠƒS“œ‚ð—p‚¢‚œ”r•ÖƒRƒ“ƒgƒ[ƒ‹‚ÌŒŸ“¢. Œ“cŒb”ü, •Ð‰ª—Sˆê1, _œä’m“¹1 (1‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï‘‰ï (2012/2/23), _ŒË.

722211. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “–‰@‚É‚š‚¯‚éRRT‚ÌŒ»ó‚Æ“W–]. •ž•”@1, Vˆä³N2, ¬’r•üF3, XˆÀŒbŽÀ3, •Šâ­”V1, ‘Š”nˆêˆå1 (1‹~–œ, 2–ƒŒ, 3RST/RRT): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/28), –‹’£.

722212. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)ydÇŠŽõÇƒP[ƒXƒJƒ“ƒtƒ@ƒ‰ƒ“ƒXzNecrotizing soft tissue infection‚̐f’f‚ÆŽ¡—Á|“Á‚ÉŒ€ÇŒ^Ç—á‚ɂ‚¢‚ā|. •Ð‰ª—Sˆê1, _œä’m“¹1, ’©ŒG’õ—²1, •ž•”@1, —é–؁@‘ì1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), –‹’£.

722213. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒbƒVƒ‡ƒ“)y”x“®–¬ŒŒðÇðÇ‚Ì—\–hEf’fEŽ¡—ÁzŽüpŠú”xÇðÇ‚ÌŒ»ó‚Æ—\–h. •Šâ­”V (‹~–œ): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/18), •Ÿ‰ª.

723898. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}«ˆêŽ_‰»’Y‘f’†“Å‚É‚š‚¯‚éƒTƒCƒgƒJƒCƒ“EƒPƒ‚ƒJƒCƒ“ƒvƒƒtƒ@ƒCƒ‹. ˆäorŒõ1, ãžŠ‹gl1, ‹g‘º‹vmŽq, ˆäo•¶Žq1, Œì@—², ‘Š”nˆêˆå1, –]ŒŽGŽ÷2 (1‹~–œ, 2_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/20), –ŒŒÃ‰®.

723899. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 4‘ŸŠíˆÈã‚Ì‘œ‘ŸŠí•s‘S‚ÉŽŠ‚Á‚œdÇŠOÇ—á‚ÌŒŸ“¢. •Ð‰ª—Sˆê1, —é–؁@‘ì1, •ôŒŽG¹1, _œä’m“¹1, Š~Œ©•¶Ž}1, “‡“c@Œª1 (1‹~–œ): ‘æ25‰ñ“ú–{ŠOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/20), ‘åã.

723900. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t“®–¬ (–{Š²) ‘¹‚ɑ΂µƒXƒeƒ“ƒg—¯’u‚ðs‚Á‚œ4—á. Š~Œ©•¶Ž}1, ŒŠª@”Ž, ŽR’J—§‘å1, •ž•”@1, _œä’m“¹1, •Ð‰ª—Sˆê1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ25‰ñ“ú–{ŠOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/20), ‘åã.

723901. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Œ’BŒ¡ˆø‚ðs‚í‚È‚¢‘å‘ڍœœÜ‚ÌŽ¡—Ð헪. —é–؁@‘ì1, •ôŒŽG¹1, Œ‰YW³2, _œä’m“¹1, •Ð‰ª—Sˆê1, ‘Š”nˆêˆå1 (1‹~–œ, 2®ŠO): ‘æ25‰ñ“ú–{ŠOŠw‰ï‘‰ïEŠwpW‰ï (2011/5/20), ‘åã.

723902. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}Ž{ÝŠÔ‚Å‚Ì‹Ù‹}ŠJ“ªŽèp‘Ήž‚̈Ⴂ‚Æ–â‘è“_. ‰““¡¹F, aãNŽ¡, ŽáˆäT“ñ˜Y, “cŒûŠó, ‘Ÿ“cFŽu, “à“c—SŽi, –kŒŽ@_, ¡–ìTŒá1, –kŒŽF—Y1 (1‹~–œ): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/3), ŽD–y.

723903. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹”j—ôÇ—á‚ɑ΂·‚éCTƒKƒCƒh‰ºƒhƒŒƒi[ƒW‚Ì—L—p«. ŽR’J—§‘å1, •Ð‰ª—Sˆê1, Š~Œ©•¶Ž}1, _œä’m“¹1, ’©ŒG’õ—²1, “‡“c@Œª1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/3), ŽD–y.

723904. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Š–ÍŒŽŽs‚É‚š‚¯‚é‹~‹}ˆã—Ñ̐§. ‹Ë¶çŒ‰î1, –kŒŽF—Y2, •ž•”@2, ’|“àˆê˜Y2, •Ð‰ª—Sˆê2, “‡“c@Œª2, ‘Š”nˆêˆå2, ¡ˆä@Š°3 (1‘Š–ÍŒŽŽsˆãŽt‰ï, 2‹~–œ, 3ŽOd‘åŠwˆãŠw•”‹~‹}ˆãŠw): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/3), ŽD–y.

723905. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}ŠO‰ÈŽŸŠ³‚É‚š‚¯‚é4‘ŸŠíˆÈã‚Ì‘œ‘ŸŠí•s‘S‚ÌŽ¡—ЬÑ. •Ð‰ª—Sˆê1 “‡“c@Œª1, _œä’m“¹1, ‰Ô“‡@Ž‘1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1,‹~–œ): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/4), ŽD–y.

723906. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‹~–œ‹~‹}ƒZƒ“ƒ^[‚É”À‘—‚³‚ê‚œ”M’†ÇÇ—á‚ÌŒŸ“¢. •ž•”@1, –kŒŽF—Y1, ’–Žë—Y‘ 1, ’©ŒG’õ—²1, ŽR’J—§‘å1, ˆîŠ_‘דl1, ‰““¡¹F, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/4), ŽD–y.

723907. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) N-Acetylcysteine (NAC) ‚É‚æ‚églutathion (GSH) •â‹‹Œø‰Ê‚ÌŒŸØ. ‹g‘º‹vmŽq1, •Ÿ–{^—Žq2, ’†ŒŽ‘å‹M2, ŽRŒû–ƒ”ü3, Žs‘º@–G4, ãžŠ‹gl1, ‘Š”nˆêˆå1 (1‹~–œ, 2–òŠw•”’†“ÅŠw, 3“Œ‹ž“s‘œ–€‘‡ˆã—ÃZƒ“ƒ^[–òÜ•”, 4–ŒŒÃ‰®‘æ“ñÔ\Žš•a‰@–òÜ•”): ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ï (2011/7/30), Šò•Œ.

723908. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •Û‘¶“IŽ¡—Âɂæ‚èŒy‰õ‚µ‚œƒAƒ‹ƒJƒŠôòÜ‚É‚æ‚éH“¹úE‚̈ê—á. ’©ŒG’õ—²1, ãžŠ‹gl1, _œä’m“¹1, ²“¡çŒb1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ï (2011/7/30), Šò•Œ.

723909. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}Œƒ‚ÈŒûo“à‚Ì•ª”å•š‘‰Á‚̓RƒŠƒ“ì“®«ƒNƒŠ[ƒ[‚ð‹^‚€. _œä’m“¹1, ²“¡çŒb1, ˆäo•¶Žq1, ˆäorŒõ1, ‹g‘º‹vmŽq, ãžŠ‹gl1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ï (2011/7/31), Šò•Œ.

723910. [Šw‰ï (‘S‘)] (—v–]‰‰‘è) •…H«H“¹‰Š‚É‚æ‚éH“¹úE‚Ì1—á. ’©ŒG’õ—²1, •Ð‰ª—Sˆê1, “‡“c@Œª1, ŒŠª@”Ž, Š~Œ©•¶Ž}1, ’†’JŒ€“l1, ‹{àVŽu˜N2, ‘Š”nˆêˆå1 (1‹~–œ, 2Á‰»Ší“à): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/11), •Ÿ‰ª, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/2; 31 (2): 336.

723911. [Šw‰ï (‘S‘)] (—v–]‰‰‘è) ã•”Á‰»ŠÇoŒŒ‚É‚š‚¯‚é“àŽ‹‹Ÿ‘O‘¢‰eCTŒŸž‚Ì—L—p«. ’†’JŒ€“l1, ‹{àVŽu˜N2, •Ð‰ª—Sˆê1, Š~Œ©•¶Ž}1, ŽÄ“c^—RŽq, _œä’m“¹1, “‡“c@Œª1, ŒŠª@”Ž, ‘Š”nˆêˆå1 (1‹~–œ, 2Á‰»Ší“à): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/11), •Ÿ‰ª, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/2; 31 (2): 341.

723912. [Šw‰ï(‘S‘)] (—v–]‰‰‘è) dÇ‹}«äX‰Š‚ɑ΂·‚éBiapenem‚ð—p‚¢‚œäX‹ÇŠ“®’—Ö@‚ÌŽ¡—ЬÑ. ‹{àVŽu˜N1,2, ¡ò@O2, Š~Œ©•¶Ž}1, _œä’m“¹1, ’†’JŒ€“l1, •Ð‰ª—Sˆê1, ŒŠª@”Ž, –Ø“cŒõL2, ¬ò˜aŽO˜Y2, ‘Š”nˆêˆå1 (1‹~–œ, 2Á‰»Ší“à): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/11), •Ÿ‰ª, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/2; 31 (2): 344.

723913. [Šw‰ï (‘S‘)] (—v–]‰‰‘è) NOMI‚ɑ΂·‚é“®’—Ö@‚Ì—L—p«. •Ð‰ª—Sˆê1, “‡“c@Œª1, ŒŠª@”Ž, Š~Œ©•¶Ž}1, _œä’m“¹1, ’†’JŒ€“l1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/12), •Ÿ‰ª, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2011/2; 31 (2): 350.

723914. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • •”‹~‹}—̈æ‚É‚š‚¯‚é“Œ—mˆãŠw“IƒAƒvƒ[ƒ`‚Ì•¹—p|ƒnƒCƒuƒŠƒbƒhŒ^W’†Ž¡—Âð–ÚŽw‚µ‚ā|. _œä’m“¹1, •Ð‰ª—Sˆê1, “‡“c@Œª1, ’†’JŒ€“l1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ47‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2011/8/12), •Ÿ‰ª.

723915. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}ˆãŠw‹³Žº‚Ì‚±‚ê‚©‚ç‚ÉŒü‚¯‚ā|‹~‹}NST‚É‚æ‚éˆãŠw•”—Տ°ŽÀK‚ɑ΂·‚é‰h—{‹³ˆç|. _œä’m“¹1, •Ð‰ª—Sˆê1, ˆîŠ_‘דl1, ŽR’J—§‘å1, ’©ŒG’õ—²1, ’–Žë—Y‘ 1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/18), “Œ‹ž.

723916. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ƒJƒŠƒEƒ€ŒŒÇ‚É‚æ‚éS”x’âŽ~‚Å”À‘—‚³‚êŒo”ç“IS”x•â•–@‚š‚æ‚ÑŽ‘±ŒŒ‰t“§Í–@‚É‚Ä‹~–œ‚³‚ê‚œƒOƒŠƒzƒT[ƒgEŠE–ÊŠˆ«ÜŠÜ—Lœ‘Ü’†“ł̈ê—á. ãžŠ‹gl1, ’©ŒG’õ—²1, ˆîŠ_‘דl1, •ž•”@1, _œä’m“¹1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/18), “Œ‹ž.

723917. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘œÊ‚Å•¡ŽG‚ÈŒo‰ß‚ðŽŠ‚µWŠw“IŽ¡—Âŋ~–œ‚Å‚«‚œŒŒð«ŒŒ¬”ÂŒž­«Ž‡”Á•a‚Ì1—á. ŽR’J—§‘å1, _œä’m“¹1, ˆîŠ_‘דl1, Š~Œ©•¶Ž}1, •ž•”@1, ’†’JŒ€“l1, ’†ŒŽ–M»2, •Ð‰ª—Sˆê1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ, 2”]ŠO): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/18), “Œ‹ž, “ú–{‹~‹}ˆãŠw‰ïŽGŽ 2011/8; 22 (8): 623.

723918. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œ”]Ž€‰º‘ŸŠí’ñ‹Ÿ‚̉ߒö‚Ő¶‚¶‚œ–â‘è“_. •Ð‰ª—Sˆê1, –kŒŽF—Y1, ¡–ìTŒá1, ’†ŒŽ–M»2, ’|“àˆê˜Y1, •Šâ­”V1, rì–@Žq3, •œ@KŒb3, ‘Š”nˆêˆå1 (1‹~–œ, 2”]ŠO, 3ˆÚAˆã—ÃŽx‰‡Žº): ‘æ39‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/10/19), “Œ‹ž.

723919. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) EVARŒã‘Šú‚ɐt“®–¬‹·ó‚𗈂œ‚µ‚œ1—á. ¬ì•‹v, ŒŠª@”Ž, Š~Œ©•¶Ž}1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, Ec‘ºK•ä3, “à“c‘׎Š3, •œ“cŒõ”Ž3, ’†“‡N—Y, ˆÀ•”—T”V, –‹“à°˜N (1‹~–œ, 2•úŽËü (‰æ‘œ), 3ŠO‰È): ‘æ52‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (2011/10/20), Šò•Œ, –¬ŠÇŠw 2011; 51 (suppl): S178.

723920. [Šw‰ï(‘S‘)] (ƒ|ƒXƒ^[) ”ñÃ–¬áŽ«ã•”Á‰»ŠÇoŒŒ‚É‚š‚¯‚é“àŽ‹‹Ÿ‘O‘¢‰eCTŒŸž‚Ì—L—p«. ’†’JŒ€“l1,2, ‹{àVŽu˜N1,2, ‹à@–Ÿ“N2, “c糁@‘2, ¬ò˜aŽO˜Y2 (1‹~–œ, 2Á‰»Ší“à): JDDW2011 (2011/10/20), •Ÿ‰ª, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2011/9; 108 (—Õ‘): A793.

723921. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œüž_–ò‚̉ߗʕž—p‚É‚æ‚鎩ŽEŠé}‚ÌŽÀ‘Ô‚š‚æ‚ÑŠÖ˜A‚·‚é—vˆö‚ɂ‚¢‚Ä‚Ì’²ž: —\”õ“IŒ€‹†. ‚ˆä”ü’qŽq, ãžŠ‹gl1, ˆäo•¶Žq1, _œä’m“¹1, ²“¡çŒb1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ35‰ñ“ú–{Ž©ŽE—\–hŠw‰ï‘‰ï (2011/12/16), ‰«“ê.

723922. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹~‹}Š³ŽÒ‚É‚š‚¯‚éCONUT–@‚É‚æ‚é‰h—{•]‰¿‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ‰““¡¬Žq, •Ð‰ª—Sˆê1, _œä’m“¹1 (1‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï‘‰ï (2012/2/23), _ŒË.

723923. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ICU‰h—{ƒvƒƒgƒR[ƒ‹‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢|ˆãŽt‚ւ̃Aƒ“ƒP[ƒg’²ž‚æ‚è|. ’©ŒG’õ—²1, _œä’m“¹1, •Ð‰ª—Sˆê1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï‘‰ï (2012/2/24), _ŒË.

723924. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆãŠw•”—Տ°ŽÀK¶‚ɑ΂·‚é‰h—{‹³ˆç@‹~‹}NSTŠˆ“®ŽQ‰Á‚ÌŠŽ‘zƒdÇ‹~‹}Š³ŽÒ‚̉h—{ŠÇ—‚ÉŠÖ‚·‚錟“¢„. _œä’m“¹1, •Ð‰ª—Sˆê1, ˆîŠ_‘דl1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï‘‰ï (2012/2/24), _ŒË.

723925. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Necrotizing soft tissue infection ‚̐f’f‚ÆŽ¡—Ã: “Á‚ÉŒ€ÇŒ^Ç—á‚ɂ‚¢‚Ä. •Ð‰ª—Sˆê1, _œä’m“¹1, ’©ŒG’õ—²1, •ž•”@1, —é–؁@‘ì1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), –‹’£.

723926. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) W’†Ž¡—Â̎¿‚ÌŠm•Û‚ÆŒüã: NST‚©‚ç”­M‚·‚éƒ`[ƒ€ˆã—Ã. _œä’m“¹1, •Ð‰ª—Sˆê1, ˆîŠ_‘דl1, ŽR’J—§‘å1, Šâ‘º‹M”ü2, “y‰®Žu•Û2, ²“¡ÆŽq3, ’†‘º@—D4, ŽO‰Y–F“T5, à_èL–Ÿ6, ‘Š”nˆêˆå1 (1‹~–œ, 2ŠÅŒì•”, 3‰h—{•”, 4–òÜ•”, 5—ÕŒŸ•”, 6ƒŠƒnƒrƒŠ•”): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), –‹’£.

723927. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Ì“®‚̉e‹¿‚ðŽ©“®œ‹Ž‚·‚éE@”\‚ð—L‚·‚éŒg‘ÑŒ^EIT‘ª’è‘•’u‚ÌŠJ”­‚Æ‚»‚Ì—LŒø«•]‰¿. ª•’JŒá1, ¬’r•üF2, ¡ˆä@Š°3, ‘Š”nˆêˆå4 (1‘åŠw‰@ˆã—ÁEnŒ€‹†‰È, 2•a‰@RST/RRTŽº, 3ŽOd‘åŠwˆãŠw•”•‘®•a‰@‹~–œ‹~‹}ƒZƒ“ƒ^[, 4‹~–œ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/3/1), –‹’£.

723928. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Á”­«H“¹”j—ô‚ÌŽ¡—Ö@‚ÉŠÖ‚·‚錟“¢. •Ð‰ª—Sˆê1, “‡“c@Œª1, ‰Ô“‡@Ž‘1, ŽR’J—§‘å1, Š~Œ©•¶Ž}1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ48‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2012/3/14), ‹à‘ò.

723929. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “Ý“It‘¹ (tŒs•”ŒŒŠÇ‘¹‚ðŠÜ‚Þ) ‚ɑ΂·‚éIVR‚Ì—L—p«. Š~Œ©•¶Ž}1, ŒŠª@”Ž, ŽR’J—§‘å1, _œä’m“¹1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, •Ð‰ª—Sˆê1, Œ‰iŒh“ñ2, “‡“c@Œª1, ‘Š”nˆêˆå1 (1‹~–œ, 2•úŽËü (‰æ‘œ)): ‘æ48‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2012/3/14), ‹à‘ò, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2012; 32 (2): 412.

731153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) VAPŽ¡—ÂƗ\–h. ‘Š”nˆêˆå (‹~–œ): ‘æ282‰ñ“ŒŠCŠO‰ÈŠw‰ï (2011/10/16), ŽOd.

732151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹~‹}ˆã—Âɂš‚¯‚銎õÇ. ‘Š”nˆêˆå (‹~–œ): ‘æ70‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2011/9/24), ‰¡•l.

732152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) VAP‚ÌŽ¡—ÂƗ\–h. ‘Š”nˆêˆå (‹~–œ): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733421. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒOƒŠƒzƒT[ƒg‚É‚æ‚é’†“Ő«S‹ØáŠQ‚̈ê—á. ’–Žë—Y‘ 1, _œä’m“¹1, ãžŠ‹gl1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ26‰ñ“ú–{’†“ÅŠw‰ï“Œ“ú–{’n•û‰ï (2012/1/21), ·‰ª.

733422. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒoƒ‹ƒrƒc[ƒ‹‰ß—Ê•ž–ò‚É‚æ‚é—£’E‚¹‚ñ–ς̈ê—á. –ÁŠ¡”ü¢1, ãžŠ‹gl1, ‹g‘º‹vmŽq, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ26‰ñ“ú–{’†“ÅŠw‰ï“Œ“ú–{’n•û‰ï (2012/1/21), ·‰ª.

733423. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ ‚È‚œ‚Ì‹ß‚­‚ɐö‚ñ‚Å‚¢‚éu‹}•Ïv‚µ‚»‚€‚ÈŠ³ŽÒ‚Í‚¢‚Ü‚¹‚ñ‚©? XˆÀŒbŽÀ1, •ž•”@2, ¬’r•üF1, •Šâ­”V2,3, Vˆä³N1,3, ‘Š”nˆêˆå2 (1–k—¢‘åŠw•a‰@RST/RRTŽº, 2‹~–œ, 3–ƒŒ): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733424. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ ‚È‚œ‚Ì•a‰@‚É—\Šú‚¹‚ÊŽ€–S‚ð‰ñ”ð‚·‚éƒVƒXƒeƒ€‚Í‚ ‚è‚Ü‚·‚©? •ž•”@1, XˆÀEbŽÀ2, ¬’r•üF2, •Šâ­”V1,3, Vˆä³N2,3, ‘Š”nˆêˆå1 (1‹~–œ, 2–k—¢‘åŠw•a‰@RST/RRTŽº, 3–ƒŒ): ‘æ62‰ñ“ú–{‹~‹}ˆãEw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733425. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ_ƒ[ƒWƒRƒ“ƒgƒ[ƒ‹‚ƏWŠw“IŽ¡—ª‘tŒ÷‚µ‚œ‘œ”­ŠO‚Ì1—á. ’©ŒG’õ—²1, •Ð‰ª—Sˆê1, ’†ŒŽ–M»2, Š~Œ©•¶Ž}1, ²“¡çŒb1, ¡–ìTŒá1, “‡“c@Œª1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ, 2”]ŠO): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733426. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒ‹ƒ{ƒLƒTƒ~ƒ“‚Ì‘å—Ê•ž—p‚É‚æ‚è‹}«zŠÂ•s‘S, áz¹dÏ”­ì‚ª¶‚¶PCPS, ‹É—ʂ̃vƒƒ|ƒtƒH[ƒ‹Ž‘±Ã’‚É‚Ä‹~–œ‚³‚ê‚œ1Ç—á. –ÁŠ¡”ü¢1, ãžŠ‹gl1, ‹g‘º‹vmŽq, _œä’m“¹1, ²“¡çŒb1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733427. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠoÁÜ’ŽË•”‚Ì”^ᇂæ‚èClostridium tetani‚𕪗£‚µ‚œ”j•—‚̈ê—á. ŽR’J—§‘å1, •ž•”@1, ˆäorŒõ1, ˆîŠ_‘דl1, ˆäo•¶Žq1, •Ð‰ª—Sˆê1, ãžŠ‹gl1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733428. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹Ù‹}Žèp‚̏€”õ’†‚ɍĔj—ô‚µ‚œSƒ^ƒ“ƒ|ƒi[ƒf‚𔺂Á‚œ‘ŠúŒŒð•ÂÇŒ^‹}«‘å“®–¬‰ð—£‚Ì1—á. –ÁŠ¡”ü¢1, _œä’m“¹1, —F•Û‹M”Ž1, ŽR’J—§‘å1, ’©ŒG’õ—²1, ˆîŠ_‘דl1, •ž•”@1, Š~Œ©•¶Ž}1, •Ð‰ª—Sˆê1, ãžŠ‹gl1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733429. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •ÖŽž‹ÖŠÇ—ƒVƒXƒeƒ€Flexi-Seal‚É‚æ‚é‚ÆŽv‚í‚ê‚é’Œ’°úE‚Ì1—á. ‰Ô“‡@Ž‘1, “‡“c@Œª1, ’–Žë—Y‘ 1, ’©ŒG’õ—²1, ŽR’J—§‘å1, ˆîŠ_‘דl1, •Ð‰ª—Sˆê1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.


‘‡f—ÈãŠw

[Šwp˜_•¶]

120093. [ŒŽ’˜] ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (H1N1) 2009‚̈â“`Žqf’fƒLƒbƒg‚ÌŠŽ“xŽŽŒ±‚ÉŠÖ‚·‚錟“¢. “¡ŠÔºŸ1, ‰ª“cŽ”ü1, ‹›Z—˜Ž÷1, –ì“c“Ö–ç1, ˜aŽRs³1, ’|–{@‹B2, Ô¯@“§2, ‹v•Û@‹œ3, X“cŒöˆê3, •Ÿ“‡Šì‘ãN4 (1–k—¢‘å’˃oƒCƒIƒƒfƒBƒJƒ‹ƒAƒbƒZƒCŒ€‹†Š, 2‘‡f—Ã, 3’·è‘åŠw”M‘шãŠwŒ€‹†Š, 4“ú–{Ô\ŽšŽÐ’·èŒŽ”šæ|‘•a‰@): –k—¢ˆãŠw 2011/6; 41 (1): 1-7.

520050. [‘à]yCGM‚Ì‚·‚ׂā|Ž‘±ŒŒ“œƒ‚ƒjƒ^[‚ÌŠî–{‚Ɖž—p|zCGM‚̃pƒ^[ƒ“‚©‚çŠw‚Ô“KØ‚È–ò•š—Ö@: lH“§Í’†‚ÌŒŒ“œƒpƒ^[ƒ“‚ð‹³‚Š‚Ä‚­‚Ÿ‚³‚¢ (Q&A/“ÁW). —с@“N”Í1, ¬ìŒ°Žj2, Žç‰®’B”ü2 (1‘‡f—Ã, 2“à•ª”å‘ãŽÓ“à): “œ”A•aƒŒƒNƒ`ƒƒ[ 2011/10; 2 (3): 577-81.

520051. [‘à] ŠÖßƒŠƒEƒ}ƒ`‚É‚š‚¯‚éCXCL13”­Œ»‚Æ‚»‚̈Ӌ`. Ô¯@“§1, ’|–{@‹B1 (1‘‡f—Ã): ƒŠƒEƒ}ƒ`‰È 2011/11; 46 (5): 539-43.

522214. [uÀ]y“ÁW:gª‹’‚ÉŠî‚­h•a—𒮎æ‚Ɛg‘̐fŽ@z10. “ú–{‚É‚š‚¯‚éf’f„˜_‚Ì‘Ì“Ÿ‚Ɛf—ÃŒ»ê‚ւ̐Z“§. ’|–{@‹B (‘‡f—Ã): ŒŽŠ§ƒŒƒWƒfƒ“ƒg 2011/4; 4 (4): 82-8.

522215. [uÀ]y“ÁW: EBMƒAƒbƒvƒf[ƒgz‘˜_: —Տ°Œ€‹†ƒfƒUƒCƒ“‚̏d—v«. ’|–{@‹B (‘‡f—Ã): JIM (Journal of Integrated Medicine) 2011/7; 21 (7): 552-5.

522216. [uÀ]y“ÁW: “œ”A•a‚Æ”DPz8. ŒŒ“œŽ©ŒÈ‘ª’è (SMBG)|CGM‚Ì”D•w‚ւ̉ž—p|. —с@“N”Í1, Žç‰®’B”ü2 (1‘‡f—Ã, 2“à•ª”å‘ãŽÓ“à): ŒŽŠ§“œ”A•a 2011/10; 3 (10): 55-64.

522217. [uÀ]y“ÁW: ŠjŽ_‘ãŽÓ‚Æ‚»‚ُ̈íz’É•—”­ì‚Ì•ªŽq‹@\. Ô¯@“§ (‘‡f—Ã): “à•ª”åE“œ”A•aE‘ãŽÓ“à‰È 2011/11; 33 (5): 415-21.

522218. [uÀ]y‚±‚±‚Ü‚Å‚í‚©‚Á‚œŽ©ŒÈ–ƉuŽŸŠ³zŠe˜_: 4. ‚»‚Ì‚Ù‚©‚ÌŽ©ŒÈ–ƉuŽŸŠ³@6. –Ɖu—}§—Ö@‚Ì—˜“_‚ÆŒ‡“_. Ô¯@“§1, ’|–{@‹B1 (1‘‡f—Ã): —Տ°ŒŸž 2011/11; 55 (11): 1343-48.

522219. [uÀ]y“ÁW: —Տ°ˆã‚Ì‚œ‚߂̍‚”AŽ_ŒŒÇE’É•—‚ÌABCz’É•—”­ì@3. ’É•—”­ì‚ªŽ©‘R‚ÉŽ¡‚Ü‚é‚Ì‚Í‚Ç‚€‚µ‚Ä‚Å‚µ‚å‚€‚©? Ô¯@“§ (‘‡f—Ã): ‚”AŽ_ŒŒÇ‚Æ’É•— 2012/3; 20 (1): 19-21.

[’˜@‘]

620214. [Šwp‘] (•ª’SŽ·•M)y—Տ°f’fƒzƒbƒvEƒXƒeƒbƒvEƒWƒƒƒ“ƒv@53ÇŒó‚ւ̃Aƒvƒ[ƒ`z1. ‘SgŒ‘‘ÓŠŽ, p.10-21. ’|–{@‹B (‘‡f—Ã), •Ò: ‘å“c@Œ’, –¥—֗Ǎs, “A@“ŒF, “ì]“°, “Œ‹ž, 2011/9”­s.

620215. [Šwp‘] (•ª’SŽ·•M)y—Տ°f’fƒzƒbƒvEƒXƒeƒbƒvEƒWƒƒƒ“ƒv@53ÇŒó‚ւ̃Aƒvƒ[ƒ`z5. •nŒŒ—lÇó (ŠçF‚ªˆ«‚¢), p.53-64. ’|–{@‹B (‘‡f—Ã), •Ò: ‘å“c@Œ’, –¥—֗Ǎs, “A@“ŒF, “ì]“°, “Œ‹ž, 2011/9”­s.

620216. [Šwp‘] (•ª’SŽ·•M)y—Տ°f’fƒzƒbƒvEƒXƒeƒbƒvEƒWƒƒƒ“ƒv@53ÇŒó‚ւ̃Aƒvƒ[ƒ`z26. ŒŒ”A, p.232-41. ’|–{@‹B (‘‡f—Ã), •Ò: ‘å“c@Œ’, –¥—֗Ǎs, “A@EŒF, “ì]“°, “Œ‹ž, 2011/9”­s.

620217. [Šwp‘] (•ª’SŽ·•M)yƒGƒrƒfƒ“ƒX‚ÉŠî‚­zŠÂŠí•a—\–hˆãŠw|–«S•s‘S‚ð–h‚®—\–hí—ª‚Æ‚Í?|z‘æIIIÍzŠÂŠí•a—\–hˆãŠwŠe˜_@A ŽŸ•aŠÇ—‚Æ‚µ‚Ă̏zŠÂŠí•a—\–hˆãŠw@9. ‚”AŽ_ŒŒÇ¥’É•—, p.182-7. —с@“N”Í1, Žµ—¢áÁ‹`2 (1‘‡f—Ã, 2“à•ª”å‘ãŽÓ“à), ŠÄC: ˜aò@“O3
(3zŠÂŠí“à), •Ò: “ŒžŠ”ü“ÞŽq4, ’––”FŒ³3 (4ˆã—Éq¶Šw•”), “ìŽR“°, “Œ‹ž, 2012/1”­s.

622002. [Šwp‘] (–|–ó)yl‚Š‚é‹Zp —Տ°“IŽvl‚𕪐͂·‚é ‰ü’ù‘æ2”ŁzSYMPTOM TO DIAGNOSIS an evidence-based guide. cott DC Stern, Adam S Cifu, Diane Altkorn, –ó: ’|–{@‹B (‘‡f—Ã), “úŒoBPŽÐ, “Œ‹ž, 2011/6”­s.

622003. [Šwp‘] (–|–ó)yƒCƒ“EƒUEƒNƒŠƒjƒbƒN|f—ÃŒ»ê‚Å‚·‚®‚ɖ𗧂ƒGƒrƒfƒ“ƒX|z’|–{@‹B (‘‡f—Ã), •Ò: Laine C, Goldmann DR, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713180. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Improved Performance of the Modified Hodge Test Using the Mueller-Hinton Agar Supplemented with Cloxacillin for Screening Carbapenemase-Producing Clinical Isolates in Enterobacteriaceae. Takayama Y1, Adachi Y2, Nihonyanagi S2, Takagi Y3, Fujiki K3, Hirata Y3, Sunakawa K3, Okamoto R4: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (2011/9/17), Shicago, USA. (‚ŽR—zŽq1, ˆÀ’B@Œª2, “ñ–{–öL2, ‚é—R”üŽq3, “¡–Ø‚­‚ÉŽq3, •œ“c‘×—Ç3, »ìŒc‰î3, ‰ª–{—¹ˆê4: 1‘‡f—Ã, 2—ÕŒŸ•”, 3ŠŽõŠÇ—Žº, 4”÷¶•š)

723930. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚錌‰t”|—{—z«—á‚̗Տ°“IŒŸ“¢. ‚ŽR—zŽq1, •œ“c‘×—Ç2, “¡–Ø‚­‚ÉŽq2, »ìŒc‰î2 (1‘‡f—Ã, 2ŠŽõŠÇ—Žº): ‘æ85‰ñ“ú–{ŠŽõÇŠw‰ï‘‰ïEŠwpu‰‰‰ï (2011/4/21), “Œ‹ž, ŠŽõÇŠwŽGŽ 2011/3; 85: 277.

723931. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•atÇ‹³ŽºŽQ‰ÁŽÒ‚É‚š‚¯‚é‘«•a•Ï”­Ç‚̃ŠƒXƒNˆöŽq‚ÌŒŸ“¢. —с@“N”Í1, Žç‰®’B”ü2, ¬ìŒ°Žj2, ³–ØŽkl2, ŠÖªŠG—œŽq, ¬ì“Õ˜Y2, Žá‘q‰‘”ü2, •œ“ˆ—EŽm2, ‰«èiˆê˜Y3, Žsì—‹Žt2, Š™“c—T“ñ2, ‚“c“NG2, Žµ—¢áÁ‹`2 (1‘‡f—Ã, 2“à•ª”å‘ãŽÓ“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ3‰ñ“ú–{‰ºŽˆ‹~ÏE‘«•aŠw‰ïŠwpW‰ï (2011/5/13), ‰¡•l,“ú–{‰ºŽˆ‹~Ï¥‘«•aŠw‰ïŽ 2011/5; 3 (2): 109.

723932. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•a•a“‚©‚çŠO—ˆ‚ւ̃tƒbƒgƒPƒA˜AŒgŠˆ“®‚ƍ¡Œã‚̉ۑè. ’|“à—DŽq, —с@“N”Í1, ²”ŒŽu“s, ç–Ø—Ç“Þ‰›, “‡“cŽq, ‘åŠÑŒbŽq, ”‹ŒŽºŽq, â–{”~Žq, Žç‰®’B”ü2, Žµ—¢áÁ‹`2 (1‘‡f—Ã, 2“à•ª”å‘ãŽÓ“à): ‘æ3‰ñ“ú–{‰ºŽˆ‹~ÏE‘«•aŠw‰ïŠwpW‰ï (2011/5/13), ‰¡•l,“ú–{‰ºŽˆ‹~Ï¥‘«•aŠw‰ïŽ 2011/5; 3 (2): 110.

723933. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) 2Œ^“œ”A•aV‹KŒŒ‰t“§Í“±“üŠ³ŽÒ‚É‚š‚¯‚éCGM‚ð—p‚¢‚œÚ×‚ÈŒŒ“œ“®‘Ô‚Ì”cˆ¬. —с@“N”Í1, Žç‰®’B”ü2, ³–ØŽkl2, ŠÖªŠG—œŽq, Žá‘q‰‘”ü2, ¬ìŒ°Žj2, Žµ—¢áÁ‹`2 (1‘‡f—Ã, 2“à•ª”å‘ãŽÓ“à): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-327.

723934. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éƒJƒ‹ƒoƒyƒlƒ€Œn–òÜ‚ÉŠŽŽó«‚ðŽŠ‚·ƒJƒ‹ƒoƒyƒlƒ}[ƒ[ŽY¶‹Û‚Ì“®Œü. ‚ŽR—zŽq1, ˆÀ’B@Œª2, “ñ–{–öL2, ’†èM•F2, •œ“c‘×—Ç3, »ìŒc‰î3, ‰ª–{—¹ˆê4 (1‘‡f—Ã, 2—ÕŒŸ•”, 3ŠŽõŠÇ—Žº, 4”÷¶•š): ‘æ59‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2011/6/25), ŽD–y.

733430. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚錌‰t”|—{—z«—á‚̗Տ°“IŒŸ“¢. ‚ŽR—zŽq1, ‚é—R”üŽq2, •œ“c‘×—Ç2, “¡–Ø‚­‚ÉŽq2, »ìŒc‰î2 (1‘‡f—Ã, 2ŠŽõŠÇ—Žº): ‘æ14‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[ (2011/8/23-24), _“ސì.

733431. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒ‹ƒoƒyƒlƒ}[ƒ[ŽY¶‹Û‚ðŒŸo‚·‚éModified Hodge Test (MHT) ‚̉ü—ǂɂ‚¢‚Ä. ‚ŽR—zŽq1, •œ“c‘×—Ç2, “ñ–{–öL3, »ìŒc‰î2, ‰ª–{—¹ˆê4 (1‘‡f—Ã, 2ŠŽõŠÇ—Žº, 3—ÕŒŸ•”, 4”÷¶•š): ‘æ58‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï (2011/10/28), ŽRŒ`.

733432. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RHIV—Ö@“±“üŒã‚É”­Ç‚µ‚œŠÌŒŽ”­ˆ««ƒŠƒ“ƒpŽî‚̈ê–UŒŸ—á. ‚ŽR—zŽq (‘‡f—Ã): ‚³‚ª‚ÝŠŽõÇƒZƒ~ƒi[ (2011/11/18), _“ސì.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-110018. [ŒŽ’˜] Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution. Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y1, Yamamoto N, Kunishima H, Kaku M: J Antimicrob Chemother 2011/3; 66 (3): 494-8. (‚ŽR—zŽq1: 1‘‡f—Ã)


ˆãŠw•”•‘®ˆãŠw‹³ˆçŒ€‹†ŠJ”­ƒZƒ“ƒ^[

ˆãŠw‹³ˆçŒ€‹†•”–å


ŠwKŽx‰‡Œ€‹†•”–å


ˆãŠwŒŽ˜_Œ€‹†•”–å

[Šwp˜_•¶]

110293. [ŒŽ’˜] Building medical ethics education to improve Japanese medical students' attitudes toward respecting patients' rights. Saito Y1, Kudo Y2, Shibuya A2,3, Satoh T4, Higashihara M5, Aizawa Y6: The Tohoku Journal of Experimental Medicine 2011/8; 224 (4): 307-15. (âV“¡—L‹IŽq1, H“¡ˆÀŽj2, a’J–Ÿ—²2,3, ²“¡•q•F4, “ŒŒŽ³–Ÿ5, ‘ŠàVDŽ¡6: 1ˆãŠwŒŽ˜_, 2ˆã—ÃŒo‰c, 3ˆã—ÈÀ‘SEŠÇ—, 4—Տ°Œ€‹†EŠé‰æ, 5ŒŒ‰t“à, 6‰q¶)

120094. [ŒŽ’˜] Š³ŽÒ‚ÌŒ —˜‚𑞏d‚·‚éˆãŠw¶‚Ì‘Ô“x‚🌗{‚·‚éˆã—×ϗ‹³ˆç‚ÌŠm—§. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): –k—¢‘å‰@‰³‘æ1362†.

522220. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€3: ƒtƒ@[ƒ}ƒRƒQƒmƒ~ƒNƒX‰ðÍ‚ð‚ß‚®‚éÅ‹ß‚ÌŒ»ózu‰‰4: ¶–œ—Ï—‚Ì—§ê‚©‚ç|Rž‚̃|ƒCƒ“ƒg‚Æ•ª‚©‚è‚â‚·‚¢à–Ÿ‘|. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): –ò—‚ÆŽ¡—à 2012/3; 40 (3): 175°6.

[’˜@‘]

620218. [Šwp‘] (•ª’SŽ·•M)y–òŠw¶E–òÜŽt‚Ì‚œ‚߂̃qƒ…[ƒ}ƒjƒYƒ€z#2 ’a¶‚ÉŠÖ‚í‚é—Ï—“I–â‘è (¶B‹Zp, ƒNƒ[ƒ“‹Zp, o¶‘Of’f‚È‚Ç) ‚ÌŠT—ª‚Æ–â‘è“_‚ðà–Ÿ‚Å‚«‚é: —§ê‚É‚æ‚Á‚Ď󂯂Ƃߕû‚ªˆÙ‚È‚é‹Zp‚ÆŒü‚«‡‚€, p.24-32. âV“¡—L‹IŽq1, Œã“¡ŒbŽq, —L“c‰xŽq (1ˆãŠwŒŽ˜_), Ó”C•ÒW: Œã“¡ŒbŽq, —r“yŽÐ, “Œ‹ž, 2011/9”­s.

620219. [Šwp‘] (•ª’SŽ·•M)yƒCƒ“ƒ^[ƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹Eƒwƒ‹ƒXƒPƒA@ŽÀ‘H ƒ`[ƒ€ˆã—Ø_@ŽÀÛ‚Æ‹³ˆçƒvƒƒOƒ‰ƒ€zI ƒ`[ƒ€ˆã—ÊT˜_@3. ƒ`[ƒ€ˆã—Â̗ϗ@2) Œ€‹†‚É‚š‚¯‚éƒ`[ƒ€ˆã—Â̗ϗ, p.55-60. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_), •Ò: …–{Ž‹v, ‰ª–{–ql2, Îˆä–M—Y, “y–{Š°“ñ (2Žš•@), ˆãŽ•–òo”Å, “Œ‹ž, 2011/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713180. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Who can give consent to use/make one's gamates? Saito Y1: XXV. World Congress of Philosophy of Law and Social Philosophy (2011/8/18), Frankfult am mein, Germany. (âV“¡—L‹IŽq1: 1ˆãŠwŒŽ˜_)

722214. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠ³ŽÒ‹y‚щƑ°‚ÌŒ —˜—iŒì‚ƈӁEvŒˆ’èŽx‰‡zŠ³ŽÒ’†S‚̃NƒŠƒeƒBƒJƒ‹ƒPƒA‚ð‚³‚³‚Š‚éˆÓŽvŒˆ’èŽx‰‡‚Ì—Ï—. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): ‘æ7‰ñ“ú–{ƒNƒŠƒeƒBƒJE‹ƒPƒAŠÅŒìŠw‰ïŠwpW‰ï (2011/6/26), ‰¡•l.

722215. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –k—¢‘åŠw”_ˆã˜AŒg‹³ˆç: ˆãŠw•”‚ÌŽæ‚è‘g‚Ý. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): “ú–{’{ŽYŠw‰ï‘æ114‰ñ‘å‰ï (2011/8/26), ÂX.

722216. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒtƒ@[ƒ}ƒRƒQƒmƒ~ƒNƒX‰ðÍ‚ð‚ß‚®‚éÅ‹ß‚ÌŒ»ó: ¶–œ—Ï—‚Ì—§ê‚©‚ç|Rž‚̃|ƒCƒ“ƒg‚Æ•ª‚©‚è‚â‚·‚¢à–Ÿ‘|. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): ‘æ11‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2011 (2011/9/24), ‰ªŽR.

733433. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •ÛˆöŽÒî•ñ‚ðŠÜ‚Þˆâ“`Žq‰ðÍŒ€‹†‚̏î•ñŠJŽŠ‚Ì‚ ‚è•û‚ɂ‚¢‚Ä. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): ŽOÈŽwjŒ©’Œ‚µ‚ðl‚Š‚é•×‹­‰ï (2011/11/5), “Œ‹ž.

733434. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —×{¶Šˆ‚Æ—Ï—ElŒ -g‘̍S‘©EˆÝ‚ë‚€‚ð‚ß‚®‚é–â‘è. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): •œ¬23”N“x‘æ3‰ñ‚“™Œ€ƒvƒƒWƒFƒNƒguwƒPƒAx‚©‚ç‚Ý‚œŽÐ‰ï•Ûá‚̐V‚œ‚È“W–]vŒ€‹†‰ï (2012/2/25), ‹ž“s.

733435. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž–ŒÌŽ©“®’Ê•ñƒVƒXƒeƒ€ (ACN) ‚ª‹N“®‚·‚éƒhƒNƒ^[ƒwƒŠƒVƒXƒeƒ€‚É‚š‚¯‚é—Ï—“I‘€–Ê. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): Ž–ŒÌŽ©“®’Ê•ñƒVƒXƒeƒ€ (ACN) ‚ª‹N“®‚·‚éƒhƒNƒ^[ƒwƒŠƒVƒXƒeƒ€‚É‚æ‚éŒð’ÊŽ–ŒÌŽ€–SíŒžŒø‰Ê‚ÌŒ€‹†Œ€‹†”ljï‹c (2012/3/16), “Œ‹ž.


ˆã—ÈÀ‘SEŠÇ—ŠwŒ€‹†•”–å


ˆã—ËZp‹³ˆçŒ€‹†•”–å

[’˜@‘]

620220. [Šwp‘] (•ª’SŽ·•M)yICU/CCU‚Å‚Ì“d‰ðŽ¿ˆÙí (t‚Æ“§Í71 (4‘‘卆)z—A‰t, —AŒŒ, ŒŒ‰t»Ü, ‚»‚Ì‘Œ‚Ì–òÜ‚Ì“d‰ðŽ¿, …•ª‚Ì‘g¬|…“d‰ðŽ¿ˆÙí‚Ì—\–h‚ÆŽ¡—Â̂œ‚ß‚Ì—A‰t‚ÌŽg‚¢•û, p.627-38. â–{®“o1, ‘º–쏇–ç2, —Ñ‚Ý‚ä‚«2 (1ˆã—ËZp‹³ˆç, 2t‘Ÿ“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2011/10”­s.

620221. [Šwp‘] (•ª’SŽ·•M)y•a‹C‚ª‚Ý‚Š‚é vol.8 tE”å”AŠíz”A×ŠÇEŠÔŽ¿«ŽŸŠ³. â–{®“o1 (1ˆã—ËZp‹³ˆç), ŠÄC: ’rX (ãžŠ) “ÖŽq, ‰ÍŒŽŽ‰ë2, â–{®“o1, ‘Œ (2¶—), ƒƒfƒBƒbƒNƒƒfƒBƒA, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713182. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Eplerenone Effectively Diminish Renal Magnesium Wasting associated with Cisplatin Nephrotoxicity. Hayashi M1, Murano J1, Yokota K, Sakai T, Furuya M1, Kamata M1, Katada C2, Naito S1, Uchida M1, Sano T1, Kamata K1, Sakamoto H3: World Congress of Nephrology 2011 (2011/4/11), Vancouver, Canada, WCN 2011 Conference Program 2011/4; p.286. (—Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, ŒÃ‰®¹Žq1, Š™“c^—Žq1, Œ˜“ce—˜2, “à“¡³‹g1, “à“c–ž”üŽq1, ²–ì@—²1, Š™“cvšæ1, â–{®“o3: 1t‘Ÿ“à, 2Á‰»Ší“à, 3ˆã—ËZp‹³ˆç)

713183. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prevention of the cisplatin-induced renal magnesium wasting in response to eplerenone. Sakamoto H1, Murano J2, Hayashi M2: International Joint Meeting of Cellular and Molecular Physiology in Epithelia (2011/7/30), Shirokane Campus of Kitasato University, PROGRAM & ABSTRACTS 2011; p.6. (â–{®“o1, ‘º–쏇–ç2, —Ñ‚Ý‚ä‚«2: 1ˆã—ËZp‹³ˆç, 2t‘Ÿ“à)

731154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŒŸ”A‚ُ̈폊Œ©‚ɑ΂·‚éƒAƒvƒ[ƒ`. â–{®“o (ˆã—ËZp‹³ˆç): ‘Š–ÍŒŽfX˜AŒg‚̉ï (2011/4/21), ‘Š–ÍŒŽ.

731155. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) t‘ŸŽŸŠ³‚̃g[ƒ^ƒ‹ƒPƒA|•a‘Ԑ¶—‚©‚ç‚Ý‚œ–ò•š—Ö@|. â–{®“o (ˆã—ËZp‹³ˆç): ‘æ123‰ñ Pharmaceutical Care Œ€C‰ï (2011/7/17), ŠC˜V–Œ.

731156. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —A‰t—Ö@‚Ì—˜_‚ÆŽÀ‘H. â–{®“o (ˆã—ËZp‹³ˆç): •œ¬23”N“xŒ€Cˆã‹³ˆçƒZƒ~ƒi[ (2011/9/17), ‘Š–ÍŒŽ.

731157. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) V‚œ‚È•a‘Ԑ¶—‚ª‚à‚œ‚ç‚·t‹@”\•ÛŽ—Ö@‚ÌŽwj. â–{®“o (ˆã—ËZp‹³ˆç): ‘æ19‰ñ_“ސìˆãˆÓ‰ï-Šwpu‰‰‰ï (2011/10/15), “Œ‹ž.

731158. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŒŸ”AŠŒ©‚É–R‚µ‚¢–«tŽŸŠ³ (CKD) ‚ւ̃Aƒvƒ[ƒ`. â–{®“o (ˆã—ËZp‹³ˆç): ‘æ11‰ñŠwpu‰‰‰ï (–k—¢‘åŠwˆãŠw•”“¯‘‹‰ï_“ސ쌧Ã“ìEŒÃŽx•”) (2011/10/22), “¡‘ò.

731159. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Å‹ß‚Ì’mŒ©‚©‚ç‚Ý‚œ”AŽ_‚Ì•a“IˆÓ‹`‚ɂ‚¢‚Ä. â–{®“o (ˆã—ËZp‹³ˆç): ‘Š–ÍŒŽŽs“à‰Èˆã‰ïŠwpu‰‰‰ï (2012/3/6), “Œ‹ž (’¬“c).

H22”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H22-731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŒŸ”AŠŒ©‚É–R‚µ‚¢–«tŽŸŠ³ (CKD) ‚̐f’f‚ÆŽ¡—Âɂ‚¢‚Ä. â–{®“o (ˆã—ËZp‹³ˆç): ‘Š–ÍŒŽfX˜AŒg‚̉ï (2010/12/2), ‘Š–ÍŒŽ.


ˆãŠw•”•‘®—Տ°Œ€‹†ƒZƒ“ƒ^[

Šé‰æŠJ”­•”–å

[Šwp˜_•¶]

110294. [ŒŽ’˜] Simulation of deoxynivalenol intake from wheat consumption in Japan using the Monte Carlo method. Nakatani Y, Satoh T1, Saito S, Watanabe M, Yoshiike N, Kumagai S, Sugita-Konishi Y: Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2011/4; 28 (4): 471-6. (²“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

110295. [ŒŽ’˜] Systematic review: diagnostic accuracy of clinical decision rules for venous thromboembolism in elderly. Siccama RN, Janssen KJ, Verheijden NA, Oudega R, Bax L1, van Delden JJ, Moons KG: Ageing Res Rev 2011/4; 10 (2): 304-13. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)

110296. [ŒŽ’˜] Beyond publication bias. Bax L1, Moons KG: J Clin Epidemiol 2011/5; 64 (5): 459-62. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)

110297. [ŒŽ’˜] Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors. Kirigaya D, Nakayama T, Ishizaki T, Ikeda S, Satoh T1: Intern Med 2011/9; 50 (22): 2793-800. (²“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

110298. [ŒŽ’˜] What has made the population of Japan healthy? Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T1, Wada K2, Stickley A, Katanoda K, Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K: Lancet 2011/9; 378 (9796): 1094-105. (²“¡•q•F1, ˜a“ckŽ¡2: 1—Տ°Œ€‹†EŠé‰æ, 2ŒöO‰q¶)

110299. [ŒŽ’˜] Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model. Tabata K1, Kurosaka S2, Watanabe M, Edamura K, Satoh T2, Yang G, Abdelfattah E, Wang J, Goltsov A, Floryk D, Thompson TC: Gene Ther 2011/10; 18 (10 (969-78. (“c”šŒ’ˆê1, •âáÁ“ñ2, ²“¡ˆÐ•¶2: 1—Տ°Œ€‹†EŠé‰æ, 2”å”AŠí)

110300. [ŒŽ’˜] ST analysis of the fetal electrocardiogram in intrapartum fetal monitoring: a meta-analysis. Becker JH, Bax L1, Amer-WŒhlin I, Ojala K, Vayssire C, Westerhuis ME, Mol BW, Visser GH, MarsŽl K, Kwee A, Moons KG: Obstet Gynecol 2012 /1; 119 (1): 145-54. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)

110301. [ŒŽ’˜] Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. Ikeda N, Inoue M, Iso H, Ikeda S, Satoh T1, Noda M, Mizoue T, Imano H, Saito E, Katanoda K, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K: PLoS Med 2012/1; 9 (1): 1-17. (²“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

110302. [ŒŽ’˜] Disease burden estimates for lung cancer in Japan. Chimura H, Hirao T, Seki E, Araki K, Satoh T1: Kitasato Med J 2012/3; 42 (1): 76-82. (²“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

120095. [ŒŽ’˜] …“—ƒƒNƒ`ƒ“‚Ì’èŠúÚŽí‰»‚ÉŠÖ‚·‚éˆã—ÃŒoÏ•ªÍ. {‰ê–œ’q, Ô‘ò@Šw, ’r“cr–ç, ŒÜ\—’’†, ¬—Ñ”üˆŸ, ²“¡•q•F1, ”’Šâ@Œ’, ™X—TŽ÷, “c‘q’q”V, ŽíŽsÛŽq, •œ”ö’qL, ˜a“ckŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2ŒöO‰q¶): Œú¶‚ÌŽw•W 2011; 58 (8): 15-22.

220026. [€ŒŽ’˜] —Տ°Œ€‹†Žx‰‡•”–å‚É‚š‚¯‚éPromasys‚ð—p‚¢‚œƒf[ƒ^ƒ}ƒlƒWƒƒ“ƒg‹Æ–±‚ÌŒ»ó. ˆíŒ©@Ž¡1, ²“¡•q•F1, Arnold Frank, â–{‘×—1, ¯@‰À–F2, ‰€@‘‹Õ1, “V–ì‰pŽ÷3, “c”šŒ’ˆê1, ‘º“cWˆê˜Y4, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶, 3—Տ°Œ€‹†E‘n–òƒV[ƒY, 4•úŽËü (‰æ‘œ)): ‘æ31‰ñˆã—Ïî•ñŠw˜A‡‘å‰ï˜_•¶W 2011; 31: 418-9.

540069. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³E“œ”A•a“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–‹Æ)uŒ’N‚­‚èŽ{ô‚ÌŒø—Š«“™‚ÌŒoÏ•ªÍ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‰¡ŽR“OŽ¢)vz‚ŒŒ“œ–¢Ž¡—ÃŽÒ‚Ì“Á«: Œ’fƒŒƒZƒvƒg“ˍ‡î•ñ‚ð—p‚¢‚œŒŸ“¢. ²“¡•q•F1, ’Ò‘º—F, Îè’B˜Y, ’†ŽRŒ’•v (1—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³E“œ”A•a“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–‹Æ)uŒ’N‚­‚èŽ{ô‚ÌŒø—Š«“™‚ÌŒoÏ•ªÍ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.49-53.

540070. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vzIRBŠÖ˜A‹Æ–±‚ÌŒø—Š‰»‚ÉŠÖ‚·E錟“¢. ŽŒŽ@~, “n糒B–ç, ²“¡•q•F1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀEp‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.21-31.

540071. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vzŽ¡Œ±‚Ì—Ï—‚ÆŒ[”­‚ÉŠÖ‚·‚éƒVƒ“ƒ|ƒWƒEƒ€ŠJÃ (Ž¡Œ±‚ÌŒø—Š‰»‚ÆITŠˆ—p‚ðl‚Š‚é). ŽŒŽ@~, “n糒B–ç, ²“¡•q•F1, ŒF’J—YŽ¡2, ‘ŠàVDŽ¡3 (1—Տ°Œ€‹†EŠé‰æ, 2—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg, 3‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.33-9.

540072. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (H•i‚̈À‘SŠm•Û„iŒ€‹†Ž–‹Æ)uH•i‰˜õƒJƒr“Å‚ÌŽÀ‘Ô’²ž‚È‚ç‚тɐ¶‘̓Ő«‰e‹¿‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‹Ç@”Žˆê)vzƒJƒr“Å‚Ì–\˜I•]‰¿‚Ì–â‘è“_. ²“¡•q•F1, Ä“¡Žj˜N (1—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (H•i‚̈À‘SŠm•Û„iŒ€‹†Ž–‹Æ)uH•i‰˜õƒJƒr“Å‚ÌŽÀ‘Ô’²ž‚È‚ç‚тɐ¶‘̓Ő«‰e‹¿‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.47-51.

540073. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vzŽ¡Œ±‹y‚їՏ°Œ€‹†‚ðŽx‰‡‚·‚é‚œ‚߂̃f[ƒ^ƒ}ƒlƒWƒƒ“ƒg‹Æ–±‚ÉŠÖ‚·‚錀‹†. ²“¡•q•F1, â–{‘×—1, ¯@‰À–F2, ‰€@‘‹Õ1, “V–ì‰pŽ÷3, “c”šŒ’ˆê1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶, 3—Տ°Œ€‹†E‘n–òƒV[ƒY): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.51-9.

540074. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†Žx‰‡‚ÉŠÖ‚·‚錟“¢ (—Տ°Œ€‹†Žx‰‡‚ÌŽÀÑ‚ɂ‚¢‚Ä). ‰€@‘‹Õ1, ²“¡•q•F1, ¯@‰À–F2, â–{‘×—1, ˆíŒ©@Ž¡1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.63-7.

540075. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†‘Š’k‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²ž. ‰€@‘‹Õ1, ²“¡•q•F1, ¯@‰À–F2, â–{‘×—1, ˆíŒ©@Ž¡1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.69-88.

540076. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vzŒ€‹†—Ï—Žx‰‡‹Æ–±‚ÉŠÖ‚·‚錟“¢. â–{‘×—1, ‘ŠàVDŽ¡2, ²“¡•q•F1, ¯@‰À–F2, ‰€@‘‹Õ1, ˆíŒ©@Ž¡1 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.89-107.

540077. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†‘Š’k‚ÉŠÖ‚·‚鋳ˆçƒvƒƒOƒ‰ƒ€‚ðŠJ”­‚·‚é‚œ‚ß‚Ì’²ž (“Á•Êu‰‰: ƒIƒ~ƒNƒXŒ€‹†‚̃f[ƒ^‰ðÍ‚ÌŒ»ó‚Ə«—ˆ). ‰€@‘‹Õ1, ²“¡•q•F1, ¯@‰À–F2, â–{‘×—1, ˆíŒ©@Ž¡1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.179-88.

540078. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬23”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†Žx‰‡‚ÉŠÖ‚·‚錟“¢ (ƒCƒ“ƒ^[ƒlƒbƒg‚ð—p‚¢‚œ—Տ°Œ€‹†‚ÉŠÖ‚·‚鏉ŠwŽÒ‚Ì‚œ‚ß‚Ì‹³ˆçƒvƒƒOƒ‰ƒ€‚ÌŠJ”­). â–{‘×—1, ¯ ‰À–F2, ‰€@‘‹Õ1, ˆíŒ©@Ž¡1, ²“¡•q•F1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.189-203.

[’˜@‘]

620222. [Šwp‘] (•ª’SŽ·•M)y‘O—§‘BŠà (‘æ2”Å) (“ú–{—Õ଑Š§†)z•ªŽq•W“IŽ¡—Ã, p.165-9. “c”šŒ’ˆê (—Տ°Œ€‹†EŠé‰æ), “ú–{—Õ଎Ð, ‘åã, 2011/6”­s.

620223. [Šwp‘] (•ª’SŽ·•M)yƒƒNƒ`ƒ“‚ÌŽsê“®Œü‚ÆŠJ”­E»‘¢ŽÀ–±Wz‘æ10Í ƒƒNƒ`ƒ“ŠJ”­‚É‚š‚¯‚é‰uŠw’²ž‚̐i‚ß•û, p.295-307. ²“¡•q•F (—Տ°Œ€‹†EŠé‰æ), ‹Zpî•ñ‹Š‰ï, “Œ‹ž, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713184. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The learning curve for laparo-scopic radical prostatectomy: 200 cases of a single surgeon. Tabata K1, Iwamura M2, Satoh T2, Kurosaka S2, Sugita A2, Murakami Y2, Kohguchi D2, Hirano S2, Baba S2: 8th Annual Meeting of the East Asain Society of Endourology (2011/11/29), Kyoto. (“c”šŒ’ˆê1, Šâ‘º³Žk2, ²“¡ˆÐ•¶2, •âáÁ“ñ2, ™“c@“Ö2, ‘ºã‘אŽ2, ‚Œû@‘å2, •œ–ìC•œ2, ”nêŽu˜Y2: 1—Տ°Œ€‹†EŠé‰æ, 2”å”AŠí)

713185. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The learning curve for laparo-scopic radical prostatectomy: 200 cases of a single surgeon. Tabata K1, Iwamura M2, Satoh T2, Kurosaka S2, Sugita A2, Murakami Y2, Kohguchi D2, Hirano S2, Baba S2: 29th World Congress of Endourology and SWL (2011/11/30), Kyoto. (“c”šŒ’ˆê1, Šâ‘º³Žk2, ²“¡ˆÐ•¶2, •âáÁ“ñ2, ™“c@“Ö2, ‘ºã‘אŽ2, ‚Œû@‘å2, •œ–ìC•œ2, ”nêŽu˜Y2: 1—Տ°Œ€‹†EŠé‰æ, 2”å”AŠí)

722217. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ˆã—Ë@ŠÖ, ’nˆæ, ‘S‘ƒŒƒxƒ‹‚Å‚ÌIT‰»‚Æ“œ”A•af—ÁE—Տ°Œ€‹†‚̉”\«: ƒŒƒZƒvƒgƒf[ƒ^EŒ’fƒf[ƒ^‚̓ˍ‡‚É‚æ‚éƒf[ƒ^ƒx[ƒX‚̍\’z. ²“¡•q•F (—Տ°Œ€‹†EŠé‰æ): ‘æ54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/19), ŽD–y, “œ”A•a 2011; 54 (Suppl 1): S-19.

722218. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)gƒe[ƒ‰[ƒ[ƒh‚̐lŠÔƒhƒbƒNŒ’fh‚ÌŠm—§‚ð‚ß‚Ž‚µ‚Ä: lŠÔƒhƒbƒNŒ’f‚ÆŽŸ•a•‰’S. ²“¡•q•F (—Տ°Œ€‹†EŠé‰æ): ‘æ52‰ñ“ú–{lŠÔƒhƒbƒNŠw‰ïŠwp‘å‰ï (2011/8/26), ‘åã, “ú–{lŠÔƒhƒbƒNŠw‰ïŽ 2012; 26: 770-4.

723935. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ªŽ¡“I‘O—§‘B‘S“EœpŒãPSAÄ”­‚ɑ΂·‚ésalvage•úŽËü—Ö@‚Ì’·Šú¬Ñ. “c”šŒ’ˆê1, ²“¡ˆÐ•¶2, ‰oì@W, ’r“cŸb2, “y‹Ž³l2, Šâ‘º³Žk2, Eà“c–Lº, ‘å–x@—, ”nêŽu˜Y2 (1—Տ°Œ€‹†EŠé‰æ, 2”å”AŠí): ‘æ99‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2011/4/24), –ŒŒÃ‰®, “ú”å”A‰ïŽ 2011; 102 (2): 517.

723936. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰uŠwE—Տ°Œ€‹†‚ðs‚€‚œ‚ß‚ÌŽx‰‡‚Ì‚ ‚è•û‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‰€@‘‹Õ1, ¯@‰À–F2, â–{‘×—1, ˆíŒ©@Ž¡1, ²“¡•q•F1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): ‘æ70‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2011/10/20), H“c, “ú–{ŒöO‰q¶ŽGŽ 2011; 58 (10): 149.

723937. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰uŠwE—Տ°Œ€‹†‚ÉŠÖ‚·‚鋳ˆçƒvƒƒOƒ‰ƒ€ŠJ”­‚Ì‚œ‚ß‚Ì’²ž. â–{‘×—1, ¯@‰À–F2, ‰€@‘‹Õ1, ˆíŒ©@Ž¡1, ²“¡•q•F1, ‘ŠàV DŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): ‘æ70‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2011/10/20), H“c, “ú–{ŒöO‰q¶ŽGŽ 2011; 58 (10): 149.

723938. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷Šà‚É‚š‚¯‚éƒlƒXƒ`ƒ“‚̖Ɖu‘gDŠw“IŒŸ“¢. “c”šŒ’ˆê1, Œ–{˜a«2, ²“¡—Yˆê, ²“¡ˆÐ•¶2, ’r“cŸb2, “¡“c“N•v2, Îˆä‘å•ã2, Šâ‘º³Žk2, ”nêŽu˜Y2 (1—Տ°Œ€‹†EŠé‰æ, 2”å”AŠí): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/28), –ŒŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïŽ˜^† 2011; 46 (2): DVD.

723939. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{lŒ’NŽá”N’jŽq‚̈ÀÃŽžS“d}‚É‚š‚¯‚éQTŠî€’l. ˆíŒ©@Ž¡1, ‹{ŒŽ‰p•v, Œã“¡Š°Ži, ’r“cŒ›º, Žç“cŒ›’, ¬Œè“O–ç (1—Տ°Œ€‹†EŠé‰æ): ‘æ27‰ñS“dî•ñˆ—ƒ[ƒNƒVƒ‡ƒbƒv (2011/10/29), ŽR—œ.

723940. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‚Þ‚©‚Å‹£‘ˆ‚É‚š‚¯‚éŠO’²ž. “ŒŽR—玡, –Ø“‡ä”Ž, ‹{–{Žüˆê, “n•Ó‰pˆê˜Y, ‰€@‘‹Õ1, ¯@‰À–F2, ¬£NŽ¡3, ‘Šì@~3, Šâ£@‘å3, Œ©–Ú’q‹I3, ‚•œ®L4, ‚‘Š»Žm3 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶, 3®ŠO, 4ˆã—Éq¶Šw•”): ‘æ22‰ñ—Տ°ƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï(2011/11/6), ÂX, “ú–{—Տ°ƒXƒ|[ƒcˆãŠw‰ïŽ 2011; 19 (4): S201.

723941. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Տ°Œ€‹†Žx‰‡•”–å‚É‚š‚¯‚éPromasys‚ð—p‚¢‚œƒf[ƒ^ƒ}ƒlƒWƒƒ“ƒg‹Æ–±‚ÌŒ»ó. –k—¢‘åŠw—Տ°Œ€‹†ƒZƒ“ƒ^[‚É‚š‚¯‚éPromasys‚ð—p‚¢‚œƒ[ƒJƒ‹ƒf[ƒ^ƒ}ƒlƒWƒƒ“ƒg‹Æ–±‚ÌŒ»ó. ˆíŒ©@Ž¡1, ²“¡•q•F1, Frank Arnold, â–{‘×—1, ¯@‰À–F2, ‰€@‘‹Õ1, “V–ì‰pŽ÷3, “c”šŒ’ˆê1, ‘º“cWˆê˜Y4, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶, 3—Տ°Œ€EEE‘n–òƒV[ƒY, 4•úŽËü (‰æ‘œ)): ‘æ31‰ñˆã—Ïî•ñŠw˜A‡‘å‰ï (2011/11/21), Ž­Ž™“‡.

723942. [Šw‰ï (‘S‘)] (E|ƒXƒ^[) • o‹Ÿ‰ºªŽ¡“I‘O—§‘B“Eœp‚É‚š‚¯‚éLearning Curve; ’PˆêpŽÒ, 200—á‚Å‚ÌŒŸ“¢. “c”šŒ’ˆê1, Šâ‘º³Žk2, ²“¡ˆÐ•¶2, •âáÁ“ñ2, ™“c@“Ö2, ‘ºã‘אŽ2, ‚Œû@‘å2, •œ–ìC•œ2, ”nêŽu˜Y2 (1—Տ°Œ€‹†EŠé‰æ, 2”å”AŠí): ‘æ25‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2011/11/30), ‹ž“s, Japanese Journal of Endourology 2011; 24 (3): 133.

723943. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¶ŠˆKŠµ•adÇ‰»—\‘ªƒ‚ƒfƒ‹‚ÌŠJ”­ (‘æˆê•ñ). ‰€@ ‘‹Õ1, ˆÉ“¡’mŒb, ¯@‰À–F2, –Ø‘º^–ç, ²“¡•q•F1 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): ‘æ22‰ñ“ú–{‰uŠw‰ïŠwp‘‰ï (2012/1/28), “Œ‹ž.

723944. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A cross-sectional study on Chinese workers' occupational stress using Chinese version of the Brief Job Stress Questionnaire. ‰€@‘‹Õ1, Wu Dy, Aiba N, ²“¡•q•F1, Nakamura K (1—Տ°Œ€‹†EŠé‰æ): ‘æ82‰ñ“ú–{‰q¶Šw‰ïŠwp‘‰ï (2012/3/25), ‹ž“s, Japanese Journal of Hygiene 2012; 67 (2): 328.

731160. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ˆãŠw•”—Տ°Œ€‹†ŽÀŽ{ŽÒ‚Ì‚œ‚ß‚Ì‹³ˆçŽx‰‡ƒc[ƒ‹‚Æ‚µ‚Ä‚ÌMoodleŠˆ—p. â–{‘×—1, ‰€@‘‹Õ1, ¯@‰À–F2, ˆíŒ©@Ž¡1, ²“¡•q•F1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶): –k—¢‘åŠw‚“™‹³ˆçŠJ”­ƒZƒ“ƒ^[‹³ˆçŠJ”­•”–åE•œ¬23”N“xe-LearningƒvƒƒWƒFƒNƒgu‰‰‰ï(2011/7/11), ‘Š–ÍŒŽ.

731161. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)u‘œŽ{Ý‹€“¯—Տ°Œ€‹†‚𐄐i‚·‚é‚œ‚߂̐헪“I‘“àŠOƒlƒbƒgƒ[ƒN®”õv‚©‚çuŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õv‚Ö. ²“¡•q•F1, ŒF’J—YŽ¡2, ŽŒŽ@~, ˆÉ“¡Ÿ•F, ¯@‰À–F3, ‰€@‘‹Õ1, ˆíŒ©@Ž¡, “V–ì‰pŽ÷4, “c”šŒ’ˆê1, ˜eâ^”ü1, ’|“à³O, ”n“ˆ³—²5, ‘ŠàVDŽ¡3 (1—Տ°Œ€‹†EŠé‰æ, 2—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg, 3‰q¶, 4—Տ°Œ€‹†E‘n–òƒV[ƒY, 5–ò—): ‘æ8‰ñŽ¡Œ±’†Šj•a‰@E‹’“_ˆã—Ë@ŠÖ“™‹Š‹c‰ï(2012/2/16), “Œ‹ž

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]


H18-110001. [ŒŽ’˜] Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. Bax L1, Yu LM, Ikeda N, Tsuruta H, Moons KG: BMC Med Res Methodol 2006/10; 6: 50. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)

H18-110002. [ŒŽ’˜] Polychotomization of continuous variables in regression models based on the overall C index. Tsuruta H, Bax L1: BMC Med Inform Decis Mak 2006/12; 6: 41. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)

H19-110003. [ŒŽ’˜] A systematic comparison of software dedicated to meta-analysis of causal studies. Bax L1, Yu LM, Ikeda N, Moons KG: BMC Med Res Methodol 2007/9; 7: 40. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)

H19-110004. [ŒŽ’˜] Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death. Diamond GA, Bax L1, Kaul S: Ann Intern Med 2007/10; 147 (8): 578-81. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)


H22-110019. [ŒŽ’˜] Meta-analysis of thoracic epidural anesthesia versus general anesthesia for cardiac surgery. Svircevic V, van Dijk D, Nierich AP, Passier MP, Kalkman CJ, van der Heijden GJ, Bax L1: Anesthesiology 2011/2; 114 (2): 271-82. (ƒoƒbƒNƒXƒŒ[ƒ“ƒfƒ‹ƒgEƒˆ[ƒXƒg1: 1—Տ°Œ€‹†EŠé‰æ)

[Šw‰ïEŒ€‹†‰ï“™]

H19-713002. [Šw‰ï (‘Û)] Genetic variations of MRF-2/ARID5B confer risks to coronary artery disease and diabetes mellitus. Wang G1, Watanabe M, Imai Y, et ai: American Heart Association (AHA) 2007 Scientific Sessions (2007/11/3-7), Orlando, Florida, Abstract book 2007; p.2319. (‰€@‘‹Õ1: 1—Տ°Œ€‹†EŠé‰æ)


ƒoƒCƒIƒGƒVƒbƒNƒX•”–å


‘n–òƒV[ƒYŒ€‹†ŠJ”­•”–å


ƒvƒƒWƒFƒNƒg„i•”–å

[Šwp˜_•¶]

110303. [ŒŽ’˜] Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects. Kusuhara H, Ito S, Kumagai Y1, Jiang M, Shiroshita T, Moriyama Y, Inoue K, Yuasa H, Sugiyama Y: Clin Pharmacol Ther 2011/6; 89 (6): 837-44. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

110304. [ŒŽ’˜] Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in Japan. Uchimura N, Kuwahara H, Kumagai Y1, Mishima K, Inoue Y, Rayner CR, Toovey S, Davies BE, Hosaka Y, Abe M, Prinssen EP: Basic Clin Pharmacol Toxicol 2011/10; 109 (4): 309-14. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

110305. [ŒŽ’˜] A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women. Kumagai Y1, Hasunuma T, Padhi D: Bone 2011/11; 49 (5): 1101-7. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

220027. [€ŒŽ’˜]y“ÁW3: ƒtƒ@[ƒ}ƒRƒrƒWƒ‰ƒ“ƒXz”ñ—Տ°E—Տ°ƒWƒ‡ƒCƒ“ƒgƒfƒBƒXƒJƒbƒVƒ‡ƒ“‚É‚æ‚éƒqƒg‚ł̃ŠƒXƒNÅ¬‰»‚ւ̃`ƒƒƒŒƒ“ƒW|ƒVƒXƒeƒ€\’z‚ÖŒü‚¯‚ā|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ’J–{ŠwZ@“Ő«Ž¿–â”  2011/8; 13: 56-9.

522221. [uÀ]y‘æ7‰ñDIA“ú–{”N‰ï: ƒOƒ[ƒoƒ‹ŠJ”­‚É‚š‚¯‚é“ú–{‚Ì–ðŠ„E“ú–{‚̍vŒ£EŒ€‹†‹@ŠÖEŠé‹Æ‚ł̗Տ°ŽŽŒ±‚ÌŽÀÛzƒAƒJƒfƒ~ƒA‚É‚š‚¯‚é—Տ°ŽŽŒ±EŒ€‹†Žx‰‡‘̐§‚̍\’z. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): —Տ°ˆã–ò 2011/5; 27 (5): 323-30.

522222. [uÀ]y‘æ1‰ñDIAƒJ[ƒfƒBƒAƒbƒNEƒZƒCƒtƒeƒBEƒ[ƒNƒVƒ‡ƒbƒvTHOROUGH QT ŽŽŒ±: QT/QTc•]‰¿ŽŽŒ±‚ÌŒ»ó‚ƉۑèzQT/QTc•]‰¿ŽŽŒ±‚ð“ú–{‚ōs‚€‚œ‚߂Ɂ|Å‹ß‚ÌŒoŒ±‚©‚ç|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): —Տ°ˆã–ò 2011/11; 27 (11): 3-8.

[’˜@‘]

620224. [Šwp‘] (•ª’SŽ·•M)yž_‰È •K{–ò‚ð’T‚é [‰ü’ù2”Å]zA. •K{–ò‚̍l‚Š•û, p.1-10. ŒF’J—YŽ¡1 (1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg), •Ò: ‹{‰ª@“™2 (2ž_), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2011/7”­s.

620225. [Šwp‘] (•ª’SŽ·•M)y—Տ°–ò—Šw (‘æ3”Å)z‘æ2Í ˆã–ò•iŠJ”­‚É‚©‚©‚í‚é—Տ°ŽŽŒ±@A ˆã–ò•iŠJ”­‚ƗՏ°ŽŽŒ±@3 ”ñ—Տ°ŽŽŒ±‚©‚ç—Տ°ŽŽŒ±‚ւ̈ڍs, p.37-41. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg), •Ò: “ú–{—Տ°–ò—Šw‰ï, ˆãŠw‘‰@, “Œ‹ž, 2011/8”­s.

620226. [Šwp‘] (•ª’SŽ·•M)yƒ|ƒPƒbƒg”Ł@—Տ°ˆã–ò•iW2012z•ª’S€–Ú, p.229-39, p.278-94, p.676-88. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg), •ÒWÓ”C: ¯@ŒbŽq, –òŽ–“ú•ñŽÐ, “Œ‹ž, 2011/9”­s.

620227. [Šwp‘] (•ª’SŽ·•M)yƒNƒŠƒjƒJƒ‹ƒNƒGƒXƒ`ƒ‡ƒ“‚É‚±‚œ‚Š‚é! —Տ°ŽŽŒ±ƒx[ƒVƒbƒNƒiƒrz5. ‘æI‘ŠŽŽŒ± (’†S“I‚ÈŽŽŒ±F—ՁE°–ò—ŽŽŒ±), 6. ‘æII‘ŠŽŽŒ± (‘ã•\“I‚ÈŽŽŒ±F’Tõ“IŽŽŒ±), 7. ‘æIII‘ŠŽŽŒ± (‘ã•\“I‚ÈŽŽŒ±FŒŸØ“IŽŽŒ±), p.20-6. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg), •Ò: —Տ°ŽŽŒ±‚ð“K³‚ɍs‚Š‚éˆãŽt—{¬‚Ì‚œ‚ß‚Ì‹Š‹c‰ï, ˆãŠw‘‰@, “Œ‹ž, 2012/2”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713186. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A subject management system for safety and reliability in the early clinical trials in Japan by JACIC. Momma T, Iijima H, Sekine M, Arisawa N, Nakabayashi K, Higashihara F, Mabuchi Y, Kumagai Y1: 10th Congress of the European Association for Clinical Pharmacology and Therapetics (2011/6/27), Budapest, Hungary, Basic & Clinical Pharmacology & Toxicology 2011; 109 (Suppl 1): 86. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

713187. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Confirmation of QT prolongation by oral moxifloxacin in healthy Japanese subjects for thorough QT/QTc studies in Japan. Kumagai Y1, Ikeda Y, Fujita T2, Sasaki K, Saikawa T: 10th Congress of the European Association for Clinical Pharmacology and Therapetics (2011/6/27), Budapest, Hungary, Basic & Clinical Pharmacology & Toxicology 2011; 109 (Suppl 1): 102. (ŒF’J—YŽ¡1, “¡“c•üŒb2: 1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg, 2–ò—)

713188. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Favipiravir, A Novel Anti-Influenza Virus Compound Inhibits Viral RNA Polymerase. Murakawa Y, Kumagai Y1, Kobayashi O: Effects on QT Prolongation. American Society for Microbiology annual meeting (2011/9/20), New Orleans, USA. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

721008. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘Šú—Տ°ŽŽŒ±‚̍‘Û“WŠJ‚Ì’†‚Å“ú–{‚̐i‚ނׂ«•ûŒü«. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ2‰ñ‘Šú—Տ°ŽŽŒ±‘Û‰ï‹c (2012/2/18), •Ÿ‰ª.

722219. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yFirst In Man‚̗Տ°ŽŽŒ±‚Ì‘O‚ÉŠm”F‚·‚ׂ«‚±‚Ɓzƒqƒg‰‰ñ“Š—^‚ɍۂµ‚Ä’S“–ˆãŽt‚ª—¯ˆÓ‚·‚邱‚Æ. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ1‰ñƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒXŠw‰ïŠwp‘å‰ï (2011/9/3), “Œ‹ž.

722220. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‘Û‹€“¯Ž¡Œ±‚ÆŠJ”­í—ª|‰ß‹ŽEŒ»ÝE–¢—ˆ|z‘Û‹€“¯ŽŽŒ±‚É‚š‚¯‚é–¯‘°·|ŠO“I—vˆö‚́Ee‹¿|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ1‰ñƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒXŠw‰ïŠwp‘å‰ï (2011/9/3), “Œ‹ž.

722221. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) THOROUGH QTŽŽŒ±: QT/QTC•]‰¿ŽŽŒ±‚ÌŒ»ó‚Ɖۑè. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): 2nd DIA Cardiac Safety Workshop In Japan (2011/9/5), “Œ‹ž.

722222. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) —LŠQ”œ‰ž—\‘ª‚Ì‚œ‚߂̗Տ°ŽŽŒ±|QT/QTc•]‰¿ŽŽŒ±‚𒆐S‚Ɂ|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/2), •lŒ, “ú–{—Տ°–ò—Šw‰ïŽ 2011; 42 (suppl): 152.

722223. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –ò•šŠÔ‘ŠŒÝì—p‚ðŒŸ“¢‚·‚é—Տ°–ò—ŽŽŒ±‚ÌŽÀŽ{‘̐§‚Æ—¯ˆÓ“_. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/2), •lŒ, “ú–{—Տ°–ò—Šw‰ïŽ 2011; 42 (suppl): 158.

723945. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{l•ÂŒoŒã—«‚É‚š‚¯‚éƒfƒmƒXƒ}ƒu’P‰ñ”牺“Š—^‚̈À‘S«, ”E—e«, –ò•š“®‘Ô‹y‚Ñ–ò—ÍŠw‚Ì•]‰¿, •À‚Ñ‚ÉŠO‘l•ÂŒoŒã—«‚Æ‚Ì–ò•š“®‘Ô‹y‚Ñ–ò—ÍŠwƒvƒƒtƒ@ƒCƒ‹‚Ì”äŠr. ŒF’J—YŽ¡1, ˜@À’qŽq, Desmond Padhi (1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ13‰ñ“ú–{œ‘e頏NJw‰ï (2011/11/4), _ŒË.

723946. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ’N‚Ȑ¬l‹i‰ŒŽÒ‹y‚Ñ”ñ‹i‰Œ“ÁˆÙ«‚Ì‚ ‚éBiomarker‚Ì’TõI|”xã”çáŠQ, Ž_‰»ƒXƒgƒŒƒX|. ”ü“¡—²“ñ, âŒûŽüŽq, “ñ‘º‘׍s, ŒF’J—YŽ¡1, ‚‹Ž”Œ•v, ç—t@•×, ’ç@N‰›, áÁ‹|’‰”Í, ‹{“c‹vŽk, ŽRŒ³@O, ’†“‡ŒõD (1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/1), •lŒ, “ú–{—Տ°–ò—Šw‰ïŽ 2011; 42 (suppl): 276.

723947. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ’N‚Ȑ¬l‹i‰ŒŽÒ‹y‚Ñ”ñ‹i‰Œ“ÁˆÙ«‚Ì‚ ‚éBiomarker‚Ì’TõII|Ž‰Ž¿‘ãŽÓ, ‰ŠÇ, ‹ÃW/‹ÃŒÅEü—n, ŒŒŠÇ“à”ç‹@”\, “œ‘ãŽÓ|. âŒûŽüŽq, ”ü“¡—²“ñ, “ñ‘º‘׍s, ŒF’J—YŽ¡1, ‚‹Ž”Œ•v, ç—t@•×, ’ç@N‰›, áÁ‹|’‰”Í, ‹{“c‹vŽk, ŽRŒ³@O, ’†“‡ŒõD (1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/1), •lŒ, “ú–{—Տ°–ò—Šw‰ïŽ 2011; 42 (suppl): 276.

723948. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒŸ÷ƒsƒ‹ƒrƒ“Ž_”Z“x‚ƍ̌Œ•û–@‚š‚æ‚Ñ‘ª’èðŒ‚ÉŠÖ‚·‚錟“¢. ’†’J”ä˜CŽu, ˜@À’qŽq, –ƒ¶‰ëŽq, •Ÿ“ˆ–Mº, Œ˜e^ŽÀŽq, ‚•^Ž÷Žq, ŒK–”^—R”ü, ŒFEJ—YŽ¡1, ”Ñ“‡@”£ (1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/2), •lŒ, “ú–{—Տ°–ò—Šw‰ïŽ 2011; 42 (suppl): 314.

723949. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Open-label, Multicentre, Single Dose Study of Eldecalcitol Pharmacokinetics in Patients with Impaired Liver Function. ’r“cN•F, ŒF’J—YŽ¡1, —L‰iÆŽq, ²“c’Ê•v, œA–Ø’‰s, ‹{“c‹v”üŽq, ]–{—T”ü, ‘同–ŸO (1—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/3), •lŒ, “ú–{—Տ°–ò—Šw‰ïŽ 2011; 42 (suppl): 340.

723950. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) yPractical Implications of ICH E14 Guidelines for TQT Studies and Future ICH E14 ‚ÌŽO‹É‚É‚š‚¯‚é‰ðŽß‚Æ‚»‚̗Տ°ŽŽŒ±‚Ö‚Ì“K—p|TQT ŽŽŒ±‚Ə«—ˆ‚Ö‚Ì“W–]|z–{–M‚É‚š‚¯‚éE14ƒKƒCƒhƒ‰ƒCƒ“ŠÖ˜A—Տ°ŽŽŒ±‚ÌŒ»ó. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ƒoƒCƒIƒƒfƒBƒJƒ‹EƒVƒXƒeƒ€“ú–{ƒ[ƒNƒVƒ‡ƒbƒv (2011/5/26), “Œ‹ž.

732153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –k—¢‘åŠw‚É‚š‚¯‚éƒAƒJƒfƒ~ƒA CRO-KiTARO. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ƒoƒCƒIˆã–ò‚ÌŠJ”­í—ªƒtƒH[ƒ‰ƒ€ (2011/7/19), ‘åã.

732154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) —Տ°ŽŽŒ±‚É‚š‚¯‚éS“d}QT/QTc‚ð—p‚¢‚œS‘ŸˆÀ‘S«•]‰¿. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ4‰ñ“ú–{ƒtƒ@[ƒ}ƒRƒƒgƒŠƒNƒXŒ€‹†‰ï (2011/9/2), “Œ‹ž.

732155. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰ä‚ª‘‚É‚š‚¯‚鑁Šú—Տ°ŽŽŒ±‚Ì“WŠJ. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg) (2011”N“x–ò•š“®‘Ô’k˜b‰ï“Á•Ê—á‰ï (2011/11/11), •lŒ.

732156. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ú–{‚Ì‘ŠúE’Tõ“I—Տ°ŽÀŒ»‚ÉŒü‚¯‚ẴAƒJƒfƒ~ƒA‚Å‚ÌŽæ‚è‘g‚Ý. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg): ‘æ16‰ñˆã–ò•iŠJ”­Šî‘bŒ€‹†‰ï (2011/11/25), “Œ‹ž.

H22”N“xˆÈ‘O•ª

[’˜@‘]

H12-620001. [Šwp‘] (•ª’SŽ·•M)y–ò‚Æ‚Ì‚©‚©‚í‚è@—Տ°–ò—Šw (ƒVƒŠ[ƒYŠÅŒì‚ÌŠî‘b‰ÈŠw ‘æ7Šª)z‘æ11Í Á‰»E‹zŽûE‘ãŽÓ‚Æ–ò, ‘æ12Í ŒÄ‹z‚Æ–ò, p.219-45. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg), •Ò’˜: ’†’J°º, ‘å‹Ž‹žˆê, “ú–{ŠÅŒì‹Š‰ïo”ʼnï, “Œ‹ž, 2001/1”­s.

H22-620010. [Šwp‘] (•ª’SŽ·•M)yˆã–òƒWƒƒ[ƒiƒ‹@V–ò“W–]2011 (Vol.47 S-1)z‘æI•” V–ò‘no‚ð‚ß‚®‚éVŠÂ‹«@1. Ž¡Œ±‚̃Oƒ[ƒoƒ‹í—ª@1) ƒAƒJƒfƒ~ƒA‚Ì—§ê‚©‚ç, p.19-23. ŒF’J—YŽ¡ (—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg), Šé‰æ•ÒW‹Š—Í: ­“cŠ²•v, ²“¡@”Ž, ²X–Ø‹Ï, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2011/1”­s.


Œ’NŠÇ—ƒZƒ“ƒ^[

[Šwp˜_•¶]

522223. [uÀ]y“ÁW: “Œ“ú–{‘åkÐ‚Æ‘åŠwz”íÐ’n‹ß—ׂæ‚è‚Ì•ñ|–k—¢‘åŠw: ŒÇ—§‚µ‚œŽO—€ƒLƒƒƒ“ƒpƒX‚Ì‹~‰‡‚ƈړ]|. ‰ª“c@ƒ1, ’ѐA“¹Žq (1Œ’NŠÇ—ƒZ): CAMPUS HEALTH 2012; 49 (2): 102-6.

[’˜@‘]

620228. [Šwp‘] (•ª’SŽ·•M)y“ú–{—Õଁ@•Êû@V—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY@t‘ŸÇŒóŒQ (‘æ2”Å) ‰º|‚»‚Ì‘Œ‚̐t‘ŸŽŸŠ³‚ðŠÜ‚߂ā|zXII. ŠeŽí•a‘Ô‚É‚Ý‚ç‚ê‚étáŠQ@4. äPŒŽ•a, ŒŒŠÇ‰Š@6) SjoegrenÇŒóŒQ‚̐t•a•Ï, p.495-8. ‰ª“c@ƒ (Œ’NŠÇ—ƒZ), “ú–{—Õ଎Ð, ‘åã, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722224. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)@“®–¬d‰»‚̉摜f’f. ‰ª“c@ƒ1, ›@Mˆê2 (1Œ’NŠÇ—ƒZ, 2•úŽËü (‰æ‘œ)): “ú–{‘‡Œ’fˆãŠw‰ï‘æ40‰ñ‘å‰ï (2012/1/20-21), ‘ÛƒtƒH[ƒ‰ƒ€, 40th JHEP CONFERENCE 2012; p.91.

723951. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒhƒbƒNŽžŒŸž‚ðŒ_‹@‚É”­Œ©‚³‚ê‚œ‹‘åS–Œ”X–E‚Ì1—á. ‘“ãç»1,2, ¬—ѐŽ}1,2, â–{˜a‘ã1,2, ‰ª“c@ƒ1 (1Œ’NŠÇ—ƒZ, 2—ÕŒŸ•”): “ú–{‘‡Œ’fˆãŠw‰ï‘æ40‰ñ‘å‰ï (2012/1/20), “Œ‹ž, ‘‡Œ’f 2012/1; 39 (1): 159.

733436. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒhƒbƒNŽžS‘Ÿ’Ž‰¹”g‚É‚Ä‹‘åS–ŒùN–E‚ð‹^‚Á‚œ1—á. ‘“ãç»1, ¬—ѐŽ}1, â–{˜a‘ã1, ’ë–ì—TŒb2, ”šÎ—²Ž¡3, ‰¡ê³“T3, ‰ª“c@ƒ1 (1Œ’NŠÇ—ƒZ, 2zŠÂŠí“à, 3ŒÄ‹zŠí“à): JSSŠÖ“ŒbM‰z‘æ18‰ñ’n•û‰ï (2011/9/23), “Œ‹ž, “ú–{’Ž‰¹”gŒŸžŠw‰ï 2012/12; 36 (6): 659.


–k—¢‘åŠw•a‰@

ŠÅŒì•”

[Šwp˜_•¶]

120096. [ŒŽ’˜] ƒAƒNƒVƒ‡ƒ“ƒŠƒT[ƒ`–@‚ð—p‚¢‚œƒXƒg[ƒ}ŽüpŠúƒPƒA‰ü‘P‚̃vƒƒZƒX|ƒ`[ƒ€ˆã—Â̎æ‚è‘g‚݂ɏœ_‚𓖂Ăā|. ŒŒŽN”ü1, ˆî‹gŒõŽq2 (1ŠÅŒì•”, 2‘åŠw‰@ŠÅŒìŠwŒ€‹†‰È): “ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ïŽ 2011/4; 15 (1): 55-64.

520052. [‘à]yŠÅŒì‚̃XƒyƒVƒƒƒŠƒeƒBz¬lˆÚsŠúŽx‰‡ŠÅŒìŽt. Šp’JŽOŽ÷Žq, ‘å’ˁ@1, ²X–Ø”ü˜aŽq1 (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOEƒgƒDƒfƒB 2011/6; 26 (3): 56-8.

520053. [‘à]yÀ’k‰ïzŠO—ˆ‚ª‚ñ‰»Šw—Ö@‚É‚š‚¢‚ÄŠÅŒì‚Ì—Í‚ð”­Šö‚·‚é‚œ‚ß‚É. “c–nœšŽq1, ”ԏ ÍŽq2, Šâ›œ—DŽq3, ŽR“àÆ•v4 (1‘åã‘åŠwˆãŠw•”•‘®•a‰@ƒIƒ“ƒRƒƒW[ƒZƒ“ƒ^[, 2ŠÅŒì•”, 3Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[ŠÅŒì•”, 4¹˜H‰Á‘Û•a‰@ƒIƒ“ƒRƒƒW[ƒZƒ“ƒ^[): TŠ§ˆãŠwŠEV•· 2011/7; 2938†: 1-3.

520054. [‘à] ƒ`[ƒ€ˆã—Â̌»ê‚©‚ç|Šw¶Žž‘ã‚©‚ç“O’ꂵ‚œƒ`[ƒ€ˆã—˳ˆç‚ðs‚Á‚Ä‹Š“­‚́u‘gD•¶‰»v‚ðŽç‚é|. •Ê•{çŒb (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2011/8; 1 (4): 42-7.

520055. [‘à]y•¶•”‰ÈŠwÈ¢ŠÅŒìŽt‚̐lÞ—{¬ƒVƒXƒeƒ€‚ÌŠm—§£Ð‰î!E10 –k—¢‘åŠwz‹Š“­‚ðŠî”Õ‚Æ‚µ‚œ‚“xŽÀ‘HŽÒE‹³ˆçŽÒˆç¬|ŠÅŒìE‚̃Gƒ“ƒpƒ[‚ðˆç¬‚·‚éƒRƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“ƒVƒXƒeƒ€‚̍\’z|. •Ê•{çŒb (ŠÅŒì•”): ŠÅŒìŠÇ— 2011/12; 21 (13): 1180-3.

522224. [uÀ]yŒ©‚Ä‚í‚©‚é—Տ°ŠÅŒì‹ZpzŽèpŽºŠÅŒì: Žèp‚Ì—¬‚ê‚ÆŠÅŒìŽt‚Ì–ðŠ„‚ð—‰ð‚·‚é‚œ‚ß‚É. œA–ìŒbŽq1, ŠÄC: ’––”ŽŽq1, ‰Pˆä‚ä‚©‚è1 (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2011/4; 15 (3): 10-7.

522225. [uÀ]y“ÁW1: ŠÅŒìŽt’·‚ðˆç‚Ä‚é, Žx‚Š‚é|ƒ}ƒlƒWƒƒ“ƒgƒ‰ƒ_[\’z‚𒆐S‚Ɂ|z1Í ‘˜_uƒCƒ“ƒ^ƒrƒ…[v¡‹‚ß‚ç‚ê‚éˆç¬EƒTƒ|[ƒg‘̐§‚Ƃ́@ŠÅŒìŽt’·‚ÌŽ©—¥‚𑣂µ, ³”F‚·‚é. •Ê•{çŒb (ŠÅŒì•”): ŠÅŒì 2011/5; 63 (7): 6-10.

522226. [uÀ]y“ÁW: Š³ŽÒE‘ŒEŽí‚ªŠì‚Ôˆã–ò•iî•ñ‚Ì”­Mz3. •a‰@ŠÅŒìŽt‚ª—~‚µ‚¢ˆã–ò•iî•ñ|‰»Šw—Ö@‚ÉŒg‚í‚é•a‰@ŠÅŒìŽt‚Ì—§ê‚©‚ç|. ”ԏ ÍŽq (ŠÅŒì•”): ƒNƒŠƒjƒJƒ‹Eƒtƒ@[ƒ}ƒVƒXƒg 2011/5; 3 (3): 221-4.

522227. [uÀ]y“ÁW2: QOLŒüã‚ð–ÚŽw‚·!@ŽY•wl‰ÈŽèpŠÅŒì@pŒã‚ð•Ï‚Š‚é, p‘OEp’†î•ñ‚𐶂©‚µ‚œŒp‘±Žx‰‡z–¢ŽófE‹ì‚¯ž‚Ý‚ðŠÜ‚Þ‹Ù‹}Žèp‚É‚š‚¯‚郊ƒXƒN”cˆ¬‚ÆŠÅŒì. ‰ŽŠÚŽÀ1, ‰¡a@Žq1 (1ŠÅŒì•”): ŽÀ‘HˆÀ‘S ŽèpŠÅŒì 2011/5-6; 5 (1): 28-35.

522228. [uÀ]y¡‚³‚ç•·‚¯‚È‚¢ŠÅŒì‹Zpƒƒ“ƒ|ƒCƒ“ƒgEƒŒƒbƒXƒ“z˜R‚ê‚È‚¢‚š‚ނ‚̓–‚Ä•û. ²“¡—ÇŽq (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2011/8; 1 (4): 68-9.

522229. [uÀ]y¡‚³‚ç•·‚¯‚È‚¢ŠÅŒì‹Zpƒƒ“ƒ|ƒCƒ“ƒgEƒŒƒbƒXƒ“zƒlƒuƒ‰ƒCƒU[‚ÌTƒs[ƒX‚ÌŽ‚¿•û. ––‰i‰À‰h (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2011/9; 1 (5): 68-9.

522230. [uÀ]y¡‚³‚ç•·‚¯‚È‚¢ŠÅŒì‹Zpƒƒ“ƒ|ƒCƒ“ƒgEƒŒƒbƒXƒ“zŽž”s‚µ‚È‚¢¬Ž™‚ÌŒŒˆ³‘ª’è. ‘å’J®–ç (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2011/10; 1 (6): 68-9.

522231. [uÀ]y¡‚³‚ç•·‚¯‚È‚¢ŠÅŒì‹Zpƒƒ“ƒ|ƒCƒ“ƒgEƒŒƒbƒXƒ“zˆÀ‘S‚ȏ‰‰ñ—£°‚̃|ƒCƒ“ƒg. ‹àŒŽƒŽi (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2011/11; 1 (7): 76-7.

522232. [uÀ]y“ÁW: ‚—îŽÒ‚̃XƒLƒ“ƒgƒ‰ƒuƒ‹z—\–h“IƒPƒA‚ðdŽ‹‚µ‚œ—Տ°ŽÀ‘H. ŒŒŽN”ü (ŠÅŒì•”): ŠÅŒì‹Zp 2011/11; 57 (14): 6-45.

522233. [uÀ] Žå‚ȃXƒLƒ“ƒPƒA—p•iˆê——. ŒŒŽN”ü (ŠÅŒì•”): ŠÅŒì‹Zp2011/11; 57 (14): 44-5.

522234. [uÀ]y¡‚³‚ç•·‚¯‚È‚¢ŠÅŒì‹Zpƒƒ“ƒ|ƒCƒ“ƒgEƒŒƒbƒXƒ“z“_“HŽž‚̈À‘S•às‚̃|ƒCƒ“ƒg. ‹àŒŽƒŽi (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2011/12; 1 (8): 78-9.

522235. [uÀ] ƒXƒg[ƒ}‘¢Ýp‚̏p‘OƒPƒA. ŒŒŽN”ü (ŠÅŒì•”): ŒŽŠ§ƒi[ƒVƒ“ƒO 2011/12; 32 (1): 4-53.

522236. [uÀ] p‘O‚É‚š‚¯‚éƒXƒg[ƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚̈Ӌ`‚Əp‘OƒPƒA‚Ì–Ú•W. ŒŒŽN”ü (ŠÅŒì•”): ŒŽŠ§ƒi[ƒVƒ“ƒO 2011/12; 32 (1): 4-7.

522237. [uÀ] Š³ŽÒE‰Æ‘°‚Ö‚Ìà–Ÿ‚ɖ𗧂IƒXƒg[ƒ}‘•‹ï‚ƃAƒNƒZƒTƒŠ[50‘I. ŒŒŽN”ü (ŠÅŒì•”): ŒŽŠ§ƒi[ƒVƒ“ƒO 2011/12; 32 (1): 46-53.

522238. [uÀ]y•a‘Ô‚ª•ª‚©‚ézŠÂŠíŒn‚ÌŒŸžƒf[ƒ^‚Ì“Ç‚Ý•û‚Æ–òÜzS‹Ø‰Š. –x]çŒbŽq (ŠÅŒì•”): dÇW’†ƒPƒA 2011/12; 12E1ŒŽ†: 62-9.

522239. [uÀ]y¡‚³‚ç•·‚¯‚È‚¢ŠÅŒì‹Zpƒƒ“ƒ|ƒCƒ“ƒgEƒŒƒbƒXƒ“z’®fŠí‚̐³‚µ‚¢Žg‚¢•û. –x]çŒbŽq (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2012/1; 2 (1): 78-9.

522240. [uÀ]y¡‚³‚ç•·‚¯‚È‚¢ŠÅŒì‹Zpƒƒ“ƒ|ƒCƒ“ƒgEƒŒƒbƒXƒ“z• •”‚̃tƒBƒWƒJƒ‹ƒAƒZƒXƒƒ“ƒg. –x]çŒbŽq (ŠÅŒì•”): ŠÅŒìƒWƒƒ[ƒiƒ‹ 2012/2; 2 (2): 78-9.

522241. [uÀ]yŒoŠÇ‰h—{‚Ì’mŽ¯‚ƃgƒ‰ƒuƒ‹‘΍ôzˆÝᑎüˆÍ‚̃XƒLƒ“ƒPƒA. ŒŒŽN”ü (ŠÅŒì•”): —ÕଊŌì2012/3; 38 (4): 442-5.

540079. [‚»‚Ì‘Œ]yu‰‰‹LŽ–zŒ»ê‚É‚š‚¯‚錀‹†‚ÌŠˆ—p. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ37‰ñ“ú–{ŠÅŒìŒ€‹†Šw‰ïŠwpW‰ïu‰‰‹LŽ– 2012/8; 35 (1): 42-3.

[’˜@‘]

620229. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)zã•”Á‰»ŠÇ“àŽ‹‹ŸŒŸž, p.6-13. ”~ì’q‰ØŽq1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620230. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…EAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹Ÿ“I”S–ŒØœp (EMR), p.14-9. ”~ì’q‰ØŽq1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620231. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹Ÿ“I”S–Œ‰º‘w”—£p (ESD), p.20-1. ˜a’m‚³‚Æ‚Ý1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620232. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹Ÿ“IÃ–¬áŽŒ‹ãFp (EVL), p.22-6. ˜a’m‚³‚Æ‚Ý1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620233. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹Ÿ“Id‰»Ü’“ü—Ö@ (EIS), p.27-31. ”~ì’q‰ØŽq1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620234. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹Ÿ“IH“¹Šg’£p (H“¹ƒuƒW[), p.32-7. ŒŽ@—D‰Ô1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620235. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z’Ž‰¹”g“àŽ‹‹ŸŒŸž, p.38-41. ‘qÎ‚Ü‚ä‚Ý1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620236. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z‰º•”Á‰»ŠÇ“àŽ‹‹ŸŒŸž, p.42-7. ¬“‡”ŽŽq1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620237. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z‘å’°ƒ|ƒŠ[ƒv“Eœp, p.49-53. ¬“‡”ŽŽq1, ‘OàV”ü“ÞŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620238. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹Ÿ“I‹ts«äX’_ŠÇ‘¢‰eŒŸž (ERCP), p.54-61. ç•Ûˆ»”ü1, •zì–­Eq1, ‘ºŽR—F”ü1, “n•”—T”üŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620239. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹Ÿ“I‹ts«’_“¹ƒhƒŒƒi[ƒW (ERBD), “àŽ‹‹Ÿ“IŒo•@’_“¹ƒhƒŒƒi[ƒW (ENBD), p.62-6. ç•Ûˆ»”ü1, •zì–­Žq1, ‘ºŽR—F”ü1, “n•”—T”üŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620240. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)zŒo”ç“àŽ‹‹Ÿ“IˆÝᑑ¢Ýp (PEG), p.68-75. –¥—Ö˜aŽq1, “n•”—T”üŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620241. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z“àŽ‹‹ŸƒVƒXƒeƒ€‚Ì‹N“®‚š‚æ‚Ñ“_ŒŸ, p.76. ˜a’m‚³‚Æ‚Ý1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620242. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z• •”XüŒŸž, p.78-82. –ììŒhŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620243. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)zã•”Á‰»ŠÇ‘¢‰eŒŸž (UGI), p.84-9. —é–Ø’qŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620244. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z’’°‘¢‰eŒŸž, p.90-5. •Ÿ“‡—mŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620245. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z¬Ž™‚Ì‘¢‰eŒŸž, p.96-100. ÎŠÔ‚ ‚ä”ü1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620246. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)zŠjˆãŠwŒŸž, p.101-5‘å’ˁ@Œb1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620247. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z• •”CTŒŸž, p.106-10. ‚–Ø—R—¢1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620248. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)z• •”MRIŒŸž, p.112-7. ‚–Ø—R—¢1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620249. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)zŒo”çŒoŠÌ’_“¹ƒhƒŒƒi[ƒW (PTCD), Œo”çŒoŠÌ’_ùNƒhƒŒƒi[ƒW (PTGBD), p.122-30. ç•Ûˆ»”ü1, •zì–­Žq1, ‘ºŽR—F”ü1, ‚‹ŽˆŸ‹IŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620250. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)zƒCƒŒƒEƒXŠÇ‘}“ü (Œo•@), p.131-7. Ž…@–F1, X–{‰p”ü1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620251. [Šwp‘] (•ª’SŽ·•M)yƒPƒA‚ÉŠˆ‚©‚·ƒÁ‰»ŠíŒn„ŒŸžEˆ’uƒ}ƒjƒ…ƒAƒ‹ (ŒŽŠ§ƒi[ƒVƒ“ƒO4 ‘Š§†)zŒŸ‘ÌŒŸž‚ÆŠÅŒì, p.156-70. ’†“‡ßŽq1 (1ŠÅŒì•”), ŠÄC: ’––”ŽŽq1, ‘OàV”ü“ÞŽq1, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, 2011/4”­s.

620252. [Šwp‘] (•ª’SŽ·•M) Ž–—á“WŠJ‚Å‚í‚©‚éŠÅŒìf’f‚ðƒAƒZƒXƒƒ“ƒg, p.85-105. •“c—TŽq1 (1ŠÅŒìŠw•”), •ÒW: ŒÜ“¡—zŽq2, •“c—TŽq1 (2ŠÅŒì•”), ˆãŽ•–òo”ÅŠ”Ž®‰ïŽÐ, 2011/8”­s.

620253. [Šwp‘] (•ª’SŽ·•M) ƒzƒŠƒXƒeƒBƒbƒNƒPƒAuŒ’NŠÖ˜AQOL‚̍l‚Š•û‚ÆŽÀÛvŽ¡‚è‚É‚­‚¢‘n‚ÌŽ¡—ÂƃPƒA, p.194-6. ŒŒŽN”ü (ŠÅŒì•”), ŠÄC: Žs‰ª@Ž , {Š˜~Žq, Æ—ÑŽÐ, “Œ‹ž, 2011/9”­s.

620254. [Šwp‘] (•ª’SŽ·•M)ytˆÚAÇ—áW2011 (‘æ44‰ñ“ú–{tˆÚAŠw‰ï‹L˜^W)zRTC‚É‚æ‚éˆÚAŠÅŒìEŠ³ŽÒŽx‰‡‚Ì’nˆæ“à‹€’ʉ»‚ÌŽŽ‚Ý, p.394-7. –ìŒû•¶”T1, ’r“c¬]2, ‹g“cˆê¬2 (1ŠÅŒì•”, 2”å”AŠí), •ÒW: ‚‹ŽO‘Ÿ3, Žsì–õ“ñ4 (3VŠƒ‘åŠw‘åŠw‰@, 4•ºŒÉŒ§—§Œ‹{•a‰@), ŠÄC: “ú–{—Տ°ˆÚAŠw‰ï, “ú–{ˆãŠwŠÙ, 2011/10”­s.

620255. [Šwp‘] (•ª’SŽ·•M)yª‹’‚ª‚í‚©‚邪‚ñŠÅŒìƒxƒXƒgƒvƒ‰ƒNƒeƒBƒX (‚ª‚ñŠÅŒì2012”N1-2ŒŽ‘Š§†)z‘æIVÍ Še˜_: ‚ª‚ñŠ³ŽÒ‚ւ̃PƒA‚ƃGƒrƒfƒ“ƒX@Çóƒ}ƒlƒWƒƒ“ƒg‚ƃPƒA‚̃Gƒrƒfƒ“ƒX@ž_Çó (•sˆÀ), p.262-8. ‘ì–ž—˜Žq, ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”), “ì]“°, “Œ‹ž, 2012/2”­s.

620256. [ŠwEp‘] (•ª’SŽ·•M)y‚ª‚ñ‰»Šw—Ö@ƒPƒAƒKƒCƒh‰ü’ù”ŁzŒÄ‹z¢“ï, p.267-72. çø“”ü“oŽq1, ‘º“c—F‹IŽq1 (1ŠÅŒì•”), •ÒW: à_ŒûŒbŽq2, –{ŽRŽ”ü3 (2‚ª‚ñŒ€‹†‰ï—L–Ÿ•a‰@, 3Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[), ’†ŽR‘“X, 2012/2”­s.

621005. [‚»‚Ì‘Œ]yPDNƒŒƒNƒ`ƒƒ[@Chapter1 PEGE“úíŠÇ—zƒXƒLƒ“ƒPƒA(•’i‚ÌŽè“ü‚ê‚Æ“ü—‚È‚Ç), http://www.peg.or.jp/lecture/peg/05-02.html. ŒŒŽN”ü (ŠÅŒì•”), NPO–@lPEGƒhƒNƒ^[ƒYƒlƒbƒgƒ[ƒN, 2011/9/20.

[Šw‰ïEŒ€‹†‰ï“™]

713189. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Overview of research in decision-making by canser patients in Japan. Morooka K1, Minegishi H1 (1ŠÅŒì•”): Fifth Pan-Pacific Nursing Conference And Seventh Nurthing Symposium On Cancer Care (2011/9/22-24), `, Issues, Challenges, and Future Directions of Evidence-based Healthcare Conference Abstract Book 2011/9; p.80. Žt‰ªŒbŽq1, —äŠÝGŽq1 (1ŠÅŒì•”)

722225. [Šw‰ï (‘S‘)] (Œð—¬ƒZƒbƒVƒ‡ƒ“)yŠÅŒìŒ€‹†„iˆÏˆõ‰ïŽåÃz‰ïˆõ‚ÌŒ€‹†‚ðƒTƒ|[ƒg‚·‚é|Œ€‹†Œv‰æ‘‚Ì‚í‚©‚è‚â‚·‚¢ì‚è•û|. ŒÜ“¡—zŽq (ŠÅŒì•”): ‘æ17‰ñ“ú–{ŠÅŒìf’fŠw‰ïŠwpW‰ï (2011/6/19-20), _ŒË.

722226. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‘ŸŠí’ñ‹Ÿ‚ÉŠÖ‚·‚銳ŽÒ‚š‚æ‚щƑ°‚ÌŒ —˜—iŒì‚ƈӎvŒˆ’èŽx‰‡. žÒŒ‹v”üŽq (ŠÅŒì•”): ‘æ7‰ñ“ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ï (2011/6/26), ‰¡•l, “ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŽ 2011/5; 7 (2): 109.

722227. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) Œ€‹†‚ðŽÀ‘H‚É“±“ü‚·‚é. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ37‰ñ“ú–{ŠÅŒìŒ€‹†Šw‰ïŠwpW‰ï (2011/8/8), ‰¡•l, ‘æ37‰ñ“ú–{ŠÅŒìŒ€‹†Šw‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/8; p.123.

722228. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚ª‚ñƒTƒoƒCƒo[ƒVƒbƒv‚ÆŒü‚«‡‚€ƒPƒA‚ð. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ16‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2011/9/9), ‰¡•l, ‘æ16‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/9; p.113.

722229. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒtƒFƒ“ƒ^ƒjƒ‹ƒpƒbƒ`‚Ì“\•z•û–@‚ɂ‚¢‚Ä. ŒI“c‚©‚Ù‚é (ŠÅŒì•”): ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï (2011/9/24), ç—t, ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ïŽ˜^W 2011; p.101.

722230. [Šw‰ï (‘S‘)] (ƒVƒ“E|ƒWƒEƒ€) Š³ŽÒ‚â‰Æ‘°‚ªŽ©•ª‚É‚Æ‚Á‚Ä‘åØ‚ȏî•ñ‚ð“Ÿ‚Ä‚¢‚­‰ß’ö‚É‚š‚¯‚éŽx‰‡. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ24‰ñ“ú–{ƒTƒCƒRƒIƒ“ƒREƒW[Šw‰ï‘‰ï (2011/9/29), ‘å‹{, ‘æ24‰ñ“ú–{ƒTƒCƒRƒIƒ“ƒRƒƒW[Šw‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/9; p.44.

722231. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”x‚ª‚ñŠ³ŽÒ‚ðŠO—ˆEÝ‘î‚ÅŽx‚Š‚é. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ21‰ñ“ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2011/11/4), ’·–ì, “ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ 2011/11; 21 (Supll): 97.

722232. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒ`[ƒ€ˆã—Âɂæ‚éƒXƒg[ƒ}‚̏p‘O‹³ˆç‚ƃZƒ‹ƒtƒPƒAŠm—§“ú”‚š‚æ‚ÑQOL‚ÌŠÖŒW. ŒŒŽN”ü1, ˆî‹gŒõŽq2 (1ŠÅŒì•”, 2‘åŠw‰@ŠÅŒìŠwŒ€‹†‰È): ‘æ27‰ñ“ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï (2012/2/4), •Ÿ“‡, “ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï‘æ27‰ñ“ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ŠwpW‰ïŽ˜^W 2012/2; 28 (1): 81.

722233. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) R‚ª‚ñÜ‚̐E‹Æ“I–\˜I‚Ƒ΍ô‚ɂ‚¢‚Ä. ”ԏ ÍŽq (ŠÅŒì•”): ‘æ26‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2012/2/11), “‡ª.

722234. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) dÇ‹~‹}Š³ŽÒ‚ɑ΂·‚鐅—n«H•š‘@ˆÛEƒIƒŠƒS“œ‚ð—p‚¢‚œ”r•ÖƒRƒ“ƒgƒ[ƒ‹‚ÌŒŸ“¢. Œ“cŒb”ü1, “y‰®Žu•Û1, ‰ª“cŽ‡•ä1, HŽR—SŽq2, ‹ß“¡‰{Žq2, ²“¡ÆŽq2, ’†‘º@—D3, _œä’m“¹4, •Ð‰ª—Sˆê4 (1ŠÅŒì•”, 2‰h—{•”, 3–òÜ•”, 4‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2012/2/23), _ŒË, “ú–{Ã–¬Œo’°‰h—{Šw‰ï‹@ŠÖŽ 2012/1; 7 (1): 242.

722235. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ú–{Œê”Ńj[ƒ`ƒƒƒ€¬—ö—ó‘ÔƒXƒP[ƒ‹ (J-NCS) s“®ƒTƒuƒXƒP[ƒ‹‚ÌŒŸ“¢`Œ©“–Ž¯‚ª—ǍD‚ȏzŠÂŠíŽŸŠ³“ü‰@Š³ŽÒ‚ł̊댯s“®—\‘ª‚É—L—p‚©?`. ꎓ¡Œ\Žq1, ‘–숩‹IŽq1, ‘“c³˜a1, _’JŒ’‘Ÿ˜Y2, Œ–쎞Žq1, ’––”FŒ³3, ˜aò@“O3 (1ŠÅŒì•”, 2ƒŠƒnƒrƒŠ•”, 3zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/16), •Ÿ‰ª.

723952. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•a•a“‚©‚çŠO—ˆ‚ւ̃tƒbƒgƒPƒA˜AŒgŠˆ“®‚ƍ¡Œã‚̉ۑè. ’|“à—DŽq1, —с@“N”Í2, ²”ŒŽu“s1, ç–Ø—Ç“Þ‰›1, “‡“cŽq1, ‘åŠÑŒbŽq1, ”‹ŒŽºŽq1, â–{”~Žq1, Žç‰®’B”ü3, Žµ—¢áÁ‹`3 (1ŠÅŒì•”, 2‘‡f—Ã, 3“à•ª”å‘ãŽÓ“à): ‘æ3‰ñ“ú–{‰ºŽˆ‹~ÏE‘«•aŠw‰ïŠwpW‰ï (2011/5/13), ‰¡•l,“ú–{‰ºŽˆ‹~Ï¥‘«•aŠw‰ïŽ 2011/5; 3 (2): 110.

723953. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ÃŽ~Œ^ƒ}ƒbƒgƒŒƒX‚̐QS’n•]‰¿•û–@‚ÌŒŸ“¢. ŒŒŽN”ü (ŠÅŒì•”): ‘æ20‰ñ“ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ï (2011/5/21), ‹à‘ò, “ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ï‘æ20‰ñŠwpW‰ïŽ˜^W 2011/4; 15 (2): 176.

723954. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@“ú–{“œ”A•a—×{Žw“± (CDEJ) ŠO—ˆ‚̍¡Œã‚Ì“W–]|ƒAƒ“ƒP[ƒg‚ð—p‚¢‚œƒj[ƒY’²ž|. â–{”~Žq1, ‘åŠÑŒbŽq1, ”‹ŒŽºŽq1, “y•M’q»1, ŽO‰Y–F“T1, Žsì—‹Žt2, Žç‰®’B”ü2, Žµ—¢áÁ‹`2 (1ŠÅŒì•”, 2“à•ª”å‘ãŽÓ“à): 54‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2011/5/21), ŽD–y, “œ”A•a 2011/4; 54 (Suppl 1): S-113.

723955. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ÐŠQ‹’“_•a‰@‚É‚š‚¯‚é‹~‹}ŠÅŒìŽt‚Ì–ðŠ„`•a‰@‘SEˆõ‚̈ӎ¯‰üŠv‚ð–ÚŽw‚µ‚ā`. ŠŽR˜a”ü1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ï (2011/6/3), ŽD–y, “ú–{—Տ°‹~‹}ˆãŠw‰ïŽGŽ 2011/5; 14 (2): 247.

723956. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹~‹}—̈悚‚¯‚éƒWƒFƒlƒ‰ƒŠƒXƒg‚̈琬. “y‰®Žu•Û1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ï (2011/6/3), ŽD–y, “ú–{—Տ°‹~‹}ˆãŠw‰ïŽGŽ 2011/5; 14 (2): 247.

723957. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ú–{DMAT–òÜŽt‚͍¡‚±‚»’cŒ‹‚·‚é•K—v‚ª‚ ‚é. ŠŽR˜a”ü1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ï (2011/6/4), ŽD–y, “ú–{—Տ°‹~‹}ˆãŠw‰ïŽGŽ 2011/5; 14 (2): 317.

723958. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹~‹}Š³ŽÒ‚ɑ΂·‚鐅—n«H•š‘@ˆÛ, ƒIƒŠƒS“œ‰t‚ð—p‚¢‚œ”r•ÖƒRƒ“ƒgƒ[ƒ‹‚ÌŒŸ“¢. ˜a’m—ÉŽq1, óÀ@Œb1, —é–Ø–M•F1, “y‰®Žu•Û1, HŽR—SŽq2, _œä’m“¹3, ŽR–ì•Ó‚Ý‚¿Žq1, •Ð‰ª—Sˆê3, ‘Š”nˆêˆå3 (1ŠÅŒì•”, 2‰h—{•”, 3‹~–œ): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/4), ŽD–y.

723959. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘‡ŽüŽYŠú•êŽqˆã—ÃZƒ“ƒ^[‚ɋΖ±‚·‚é’†Œ˜•ŽYŽt‚̃LƒƒƒŠƒA”­’B. ’·“ì‹LŽuŽq1, ‚‹ŽáÁ—2, “‡‘܍Žq2 (1ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ13‰ñ“ú–{•ê«ŠÅŒìŠw‰ï (2011/6/11), “È–ØŒ§Ž©Ž¡ˆã‰È‘åŠwŠÅŒìŠw•”.

723960. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “§ÍŠÅŒì‚ƈڐAŠÅŒì‚̘AŒg‹­‰», ‚»‚ê‚Œ‚ꂪ‚Å‚«‚邱‚Æ. –ìŒû•¶”T1, ’r“c¬], rì–@Žq1, Îˆä‘å•ã2, ‹g“cˆê¬2 (1ŠÅŒì•”, 2”å”AŠí): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “§Í‰ïŽ 2011; 44 (Suppl): 483.

723961. [Šw‰ï (‘S‘)] (ˆêEʌû‰‰) Ž¡—Âɑ΂·‚éŽq‚Ç‚à‚̈ӎuŒˆ’è‚ðŽx‚Š‚é‚œ‚߂̉Ƒ°‚Ö‚ÌŽx‰‡. Œ“à‰ÀŽq1, ’†“‡ßŽq1 (1ŠÅŒì•”): ‘æ18‰ñ“ú–{‰Æ‘°ŠÅŒìŠwEEwpW‰ï (2011/6/25), ‹ž“s, ‘æ18‰ñ“ú–{‰Æ‘°ŠÅŒìŠw‰ïŠwpW‰ïŽ˜^W 2011/6; p.98.

723962. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Œûo•ÛŽŒÜ‚ð—p‚¢‚œŒûoƒPƒA‚Ì’è’…‚ÉŒü‚¯‚ā`“±“ü‘OŒã‚ÌŠÅŒìŽt‚̈ӎ¯‚ƍs“®‚̕ω»‚ɂ‚¢‚ā`. Î‘q@ˆ€1, –î•”hŽu1, XˆÀŒb”ü1, žÒŒ‹v”üŽq1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ7‰ñ“ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŠwpW‰ï (2011/6/26), ‰¡•l, “ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŽ 2011/5; 7 (2): 147.

723963. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹~‹}ŠÅŒìŽt‚ªŽÀŽ{‚µ‚Ä‚«‚œ3”NŠÔ‚Ì‘œ”•aŽÒ‚€‚¯“ü‚êŒP—û‚ɑ΂·‚éŽó‚¯Ž~‚߂ƍ¡Œã‚̉ۑè. ŠŽR˜a”ü1, Šâé_“ñ1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ7‰ñ“ú–{ƒNƒŠƒeƒBƒJƒ‹ŠÅŒìŠw‰ïŠwpW‰ï (2011/6/26), ‰¡•l, “ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŽ 2011/5; 7 (2): 159.

723964. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) I––Šú‚É‚š‚¯‚é‘ŸŠí’ñ‹ŸˆÓŽvŠm”F‚ÉŠÖ‚·‚éˆêlŽ@. žÒŒ‹v”üŽq1, ‚‹Ž@Œb1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ7‰ñ“ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŠwpW‰ï (2011/6/26), ‰¡•l, “ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŽ 2011/5; 7 (2): 171.

723965. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰)uŠm”F•s‘«v‚É”º‚€ƒŠƒXƒN–hŽ~‚Ö‚ÌŽæ‚è‘g‚݁|ˆã—ÃKYT‚ÌŒø‰ÊŒŸ“¢|. dM@—º1, žÒŒ‹v”üŽq1, ’·–ì—L‹IŽq1, “ŒŒb—œ‰Ø1, Šâé_“ñ1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ7‰ñ“ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŠwpW‰ï (2011/6/26), ‰¡•l, “ú–{ƒNƒŠƒeƒBƒJƒ‹ƒPƒAŠÅŒìŠw‰ïŽ 2011/5; 7 (2): 175.

723966. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “]“|“]—Ž–hŽ~—p‹ï‚Ì‘I‘ð–ÚˆÀ‚Ì–ŸŠm‰». –îŒûKŽq (ŠÅŒì•”): ‘æ14‰ñ“ú–{•a‰@”]_ŒoŠO‰ÈŠw‰ï (2011/7/16), ŒŽR, ‘æ14‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŽ˜^W 2011; p.193.

723967. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œüž_–ò‰ß—Ê•ž—pŠ³ŽÒ‚Ö‚ÌŠÅŒì‰î“ü‚ÉŠÖ‚·‚éˆêlŽ@. •œ–ì—L”ü1, —é–Ø–M•F1, žÒŒ‹v”üŽq1, ŽR–ì•Ó‚Ý‚¿Žq1, ãžŠ‹gl2, ‘Š”nˆêˆå2 (1ŠÅŒì•”, 2‹~–œ): ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ï (2011/7/31), Šò•Œ, ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ïEƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/7; p.68.

723968. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “û‚ª‚ñŠ³ŽÒƒTƒ|[ƒg‘̐§\’z‚É‚Þ‚¯‚Ä. Ž™‹Ê”ü—R‹I1, ‚‹Ž^—Žq1, ‹à‘ò‚µ‚ž‚Š1, ’r–{”üK1, ‰Á“¡–qŽq1, “ŒŠC—Ñ‚¿‚Š‚Ý1, åÎ‹I•F2, ¬â–ùŒ«2, —с@‹žŽq2, ‰|–{‘ñ–Î2, ‘ •À@Ÿ2, “n粏¹•F2 (1ŠÅŒì•”, 2ŠO‰È): ‘æ19‰ñ“ú–{“û‚ª‚ñŠw‰ïŠwpW‰ï (2011/9/3), å‘䍑ÛƒZƒ“ƒ^[, ‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/9; p.398.

723969. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “û‚ª‚ñŠ³ŽÒE‰Æ‘°‚ւ̃Tƒ|[ƒg‘̐§\’z‚ÉŒü‚¯‚ā|“û‚ª‚ñŠ³ŽÒƒTƒ|[ƒgƒvƒƒWƒFƒNƒg|. Ž™‹Ê”ü—R‹I (ŠÅŒì•” ): ‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwpW‰ï (2011/9/3), å‘䍑ÛƒZƒ“ƒ^[, ‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/9; p.398.

723970. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) PST“±“üŠ³ŽÒ‚É‚š‚¯‚éƒyƒvƒƒE‚̊Ō엝˜_‚ð—p‚¢‚œŠÅŒì‰î“ü. ¬“cŒŽ–Œ•à1, ‰iˆäD1, ‰Á“¡–qŽq1, Ž™‹Ê”ü—R‹I1, ‚“c’qŽq1 (1ŠÅŒì•”): ‘æ19‰ñ“ú–{“û‚ª‚ñŠw‰ïŠwpW‰ï (2011/9/3), å‘䍑ÛƒZƒ“ƒ^[, ‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/9; p.437.

723971. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Team Cordinator Nurseg‘åbh‚ª¬’·‚·‚邱‚Æ‚ÅŒ©‚Š‚œ•Ï‰». Œª®”ü1, ‰Á“¡–qŽq1, Ž™‹Ê”ü—R‹I1, “ŒŠC—Ñ‚¿‚Š‚Ý1, åÎ‹I•F2, ¬â–ùŒ«2, —с@‹žŽq2, ‰|–{‘ñ–Î2, ‘ •À@Ÿ2, “n粏¹•F2 (1ŠÅŒì•”, 2ŠO‰È): ‘æ19‰ñ“ú–{“û‚ª‚ñŠw‰ïŠwpW‰ï (2011/9/3), å‘䍑ÛƒZƒ“ƒ^[, ‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/9; p.468.

723972. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘åŠw•a‰@ŽY•wl‰È‚É‚š‚¯‚鐞Žq“€Œ‹•Û‘¶ŠOŠO—ˆ‚ł̌l–Ê’k‚ÌŽæ‚è‘g‚Ý. ŒI“c‚©‚Ù‚é1, —V²—TŽq1 (1ŠÅŒì•”): ‘æ9‰ñ“ú–{¶BŠÅŒìŠw‰ï (2011/9/11), “Œ‹ž, ‘æ9‰ñ“ú–{¶BŠÅŒìŠw‰ïŽ˜^W 2011; p.43.

723973. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘¢ŒŒŠíŽîᇊ³ŽÒ‚ÌŒûo“àƒtƒ[ƒV[ƒg‰ü’è‚ÉŒü‚¯‚ā`A•a‰@ŒŒ‰t“à‰È•a“ŠÅŒìŽt‚ÌŒûoƒPƒA‚ɑ΂·‚é”FŽ¯‚Ɖî“ü‚ÌŽÀ‘Ô’²ž`. ’©…”ü‰À1, —с@’m”ü1, ŽRì@Œb1, Žt‰ªŒbŽq1, ” “c”ü’mŒb1, ¬Šâ¹–ëŽq2 (1ŠÅŒì•”, 2–k—¢Œ€‹†Š•a‰@): ‘æ42‰ñ“ú–{ŠÅŒìŠw‰ï¬lŠÅŒìI¥II (2011/9/18), ‘åã.

723974. [Šw‰ï (‘S‘)] (Œû‰‰) ˆÚAŠÅŒìEŠ³ŽÒŽx‰‡‚Ì’nˆæ‹€’ʉ»‚ÌŽŽ‚Ý (Ž{Ý”äŠr•\‚©‚ç)`ˆÚAŒãƒyƒbƒg‚ƏãŽè‚É•t‚«‡‚€•û–@`. –ìŒû•¶”T1, “c’†”üŽ÷1, ¬âŽu•Û2, ¯–ì^Ÿ3, “¡–{‘×”Ž3, ŸNˆä—TŽq3, ’r“c¬]4, ‹g“cˆê¬4 (1ŠÅŒì•”, 2“Œ‹ž‘åŠw‘åŠw‰@, 3¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw•a‰@, 4”å”AŠí): ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/5), å‘ä, “ú–{ˆÚAŠw‰ïŽGŽ 2011/10; 46: 187.

723975. [Šw‰ï (‘S‘)] (Œû‰‰) ”]Ž€‰º‘ŸŠí’ñ‹Ÿ‚ðŒoŒ±‚µ‰@“à‘̐§‚̍ČŸ“¢. •œ@KŒb1, rì–@Eq1, ¬‰z–Ÿ”ü1, –kŒŽF—Y2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2‹~–œ, 3”å”AŠí): ‘æ47‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2011/10/5), å‘ä, “ú–{ˆÚAŠw‰ïEGŽ 2011/10; 46: 200.

723976. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹~‹}—̈æ‚É‚š‚¯‚éƒWƒFƒlƒ‰ƒŠƒXƒg‚̈琬. “y‰®Žu•Û1, dM@—º1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ13‰ñ“ú–{‹~‹}ŠÅŒìŠw‰ïŠwpW‰ï (2011/10/21), _ŒË, ‘æ13‰ñ“ú–{‹~‹}ŠÅŒìŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/10; 13 (3): 176.

723977. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘B‚ª‚ñŠÅŒìŠO—ˆ‚É‚š‚¯‚éî•ñ’ñ‹Ÿ‚ÆŽ¡—Ö@‚̈ӎuŒˆ’èŽx‰‡‚ÌŽæ‚è‘g‚Ý. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠw‰ï‘‰ï (2011/10/28), –ŒŒÃ‰®, ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/10; “dŽq”Å.

723978. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚邪‚ñƒTƒƒ“‚ÌŽæ‚è‘g‚Ý. ‘O“cŒiŽq1, ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”): ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠw‰ï‘‰ï (2011/10/28), –ŒŒÃ‰®, ‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2011/10; “dŽq”Å.

723979. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “Œ“ú–{‘åkÐ‚ɂČǗ§‚µ‚œŽO—€ƒLƒƒƒ“ƒpƒX‚Ì‹~‰‡Šˆ“®‚Æ‚»‚Ì–â‘è“_‚ÌŒŸ“¢. 傖Œ—Ï–€1, ŽÂŒŽ”ü–çŽq1, —é–Ø‘D1, ’ѐA“¹Žq2, ‰ª“c@ƒ2 (1ŠÅŒì•”, 2Œ’NŠÇ—ƒZ): ‘æ49‰ñ‘S‘‘åŠw•ÛŒ’ŠÇ—Œ€‹†W‰ï (2011/11/9), ŽRŒû, CAMPUS HEALTH 2012/2; 49 (1): 447.

723980. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒhƒi[ƒJ[ƒh‚ɑ΂·‚éŠw¶‚ÌŒ»óˆÓŽ¯’²ž. ’Ö”ü’q”Ž1, “ü]TŽ¡2, ¬Œ‚©‚š‚é2, Î“cçŠG2 (1ŠÅŒì•”, 2º˜a‘åŠw•ÛŒ¯ˆã—Êw•”ŠÅŒìŠw‰È): ‘æ31‰ñ“ú–{ŠÅŒì‰ÈŠwŠw‰ïŠwpW‰ï (2011/12/3), ‚’m, ‘æ31‰ñ“ú–{ŠÅŒì‰ÈŠwŠw‰ïŠwpW‰ïu‰‰W 2011/12; p.270.

723981. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Œ£tˆÚAŠó–]’·Šú‘Ò‹@Š³ŽÒ‚̍ĐfŠO—ˆŽóf‚Ö‚ÌRTC‚Ì–ðŠ„|‚»‚Ì2|. –ìŒû•¶”T1, ’r“c¬]2, rì–@Žq1, Îˆä‘å•ã2, ‹g“cˆê¬2, Žáˆä—zŠó2, ’|“àN’j3, ‰““¡’‰—Y2, ”nêŽu˜Y2 (1ŠÅŒì•”, 2”å”AŠí, 3t‘Ÿ“à): ‘æ45‰ñ—Տ°tˆÚAŠw‰ï (2012/2/2), Œyˆä‘ò, ‘æ45‰ñ—Տ°tˆÚAŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012/2; p.224.

723982. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘œEŽí‚©‚ç‚È‚é‰@“àƒhƒi[ƒR[ƒfƒBƒl[ƒ^[‚ÌŠˆ“®‚Ɖۑè. rì–@Žq1, •œ@KŒb1, ¬‰z–Ÿ”ü1, –kŒŽF—Y2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2‹~–œ, 3”å”AŠí): ‘æ45‰ñ—Տ°tˆÚAŠw‰ï (2012/2/2), Œyˆä‘ò, ‘æ45‰ñ—Տ°tˆÚAŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012/2; p.230.

723983. [Šw‰ï (‘S‘)] (ˆê”ʁEu‰‰) ¶‘̐tˆÚAƒhƒi[‚Ö‚Ì‘Þ‰@Žw“±‚ÌŽÀ‘Ô’²ž‚©‚ç‚Ý‚éƒNƒŠƒeƒBƒJƒ‹ƒpƒX‚ÌŒŸ“¢. “c’†”üŽ÷1, •B“c—LŠóŽq1, –ìŒû•¶”T1, žÒŒ‹v”üŽq1, ‰¡ŽR—˜1, –ؘeŒúŽq1, ‹g“cˆê¬2 (1ŠÅŒì•”, 2”å”AŠí): ‘æ45‰ñ—Տ°tˆÚAŠw‰ï (2012/2/3), Œyˆä‘ò, ‘æ45‰ñ—Տ°tˆÚAŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012/2; p.217.

723984. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “®‰æ‚ðŠˆ—p‚µ‚œŠŽõ—\–h‹³ˆç‚ÌŒŸ“¢. ŠÛŽR’ŒŽq1, ’†–ì—R‹IŽq1, X‰º’qˆÑ1, ‹{éÊ‰Á1, ‹Ë–{çŒb”ü1 (1ŠÅŒì•”): ‘æ27‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2012/2/4), •Ÿ‰ª, ‘æ27‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012/1; 27: 133.

723985. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚ªs‚€—Ï—’²®‚ÌŽ‹“_‚Æ•û—ª (‘æ2•ñ)|‹}Œƒ‚É•aó‚ªˆ«‰»‚µ‚œŠ³ŽÒ‚̈ӎvŒˆ’è‚ÉŠÖ‚·‚é—Ï—’²®3Ž–—á|. Žt‰ªŒbŽq1, ‹ß“¡‚Ü‚ä‚Ý1, çø“”ü“oŽq1, Ž™‹Ê”ü—R‹I1, –]ŒŽ”ü•ä1, ‹v•ÄŒb]1, ²“¡”ü‹I1, ŒK–ŒŽõ”ü1, Šâ–{ƒŽq1, ‰ª@‘œŒb2, —é–Ø‹M”ü2, ’·’Jì“ÞŽq2, ‘ì–ž—˜Žq3, Ž…—TŽq4, ‹vŽRKŒb5 (1ŠÅŒì•”, 2“Œ•a‰@ŠÅŒì•”, 3“ú–{Ž„—§ŠwZU‹»E‹€ÃŽ–‹Æ’c“Œ‹ž—ÕŠC•a‰@, 4Œö—§•x‰ª‘‡•a‰@, 5Ã‰ªŒ§—§‚ª‚ñƒZƒ“ƒ^[): ‘æ26‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2012/2/11), “‡ª, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2012/1; 26 (“Á•Ê†): 251.

723986. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚ªs‚€—Ï—’²®‚ÌŽ‹“_‚Æ•û—ª (‘æ3•ñ)|4Ž–—á‚Ì—Ï—’²®‰ß’ö‚É‚š‚¯‚é‹€’Ê“_‚Æ“Á’¥|. Žt‰ªŒbŽq1, ‹ß“¡‚Ü‚ä‚Ý1, çø“”ü“oŽq1, Ž™‹Ê”ü—R‹I1, –]ŒŽ”ü•ä1, ‹v•ÄŒb]1, ²“¡”ü‹I1, ŒK–ŒŽõ”ü1, Šâ–{ƒŽq1, ‰ª@‘œŒb2, —é–Ø‹M”ü2, ’·’Jì“ÞŽq2, ‘ì–ž—˜Žq3, Ž…—TŽq4, ‹vŽRKŒb5 (1ŠÅŒì•”, 2“Œ•a‰@ŠÅŒì•”, 3“ú–{Ž„—§ŠwZU‹»E‹€ÃŽ–‹Æ’c“Œ‹ž—ÕŠC•a‰@, 4Œö—§•x‰ª‘‡•a‰@, 5Ã‰ªŒ§—§‚ª‚ñƒZƒ“ƒ^[): ‘æ26‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2012/2/11), “‡ª, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2012/1; 26 (“Á•Ê†): 251.

723987. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘B‚ª‚ñŠÅŒìŠO—ˆ‚É‚š‚¯‚銳ŽÒ‚̃j[ƒY‚ÆŠÅŒìŽx‰‡. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ26‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2012/2/12), “‡ª, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2012/1; 26 (“Á•Ê†): 290.

723988. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰h—{ŠÇ—ƒvƒƒgƒR[ƒ‹“±“üŒã‚ÌŠÅŒìŽt‚Ì—‰ð‚â”FŽ¯‚ÉŠÖ‚·‚é’²ž. •œ–ì—L”ü1, ‰ª“cŽ‡•ä1, “y‰®Žu•Û1, _œä’m“¹2, •Ð‰ª—Sˆê2 (1ŠÅŒì•”, 2‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2012/2/23), _ŒË, “ú–{Ã–¬Œo’°‰h—{Šw‰ïŽ 2012/1; 27 (1): 328.

723989. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒoŒûÛŽæ‚ðŒ_‹@‚ɐS•s‘S‘ˆ«‚𗈂µ‚œŒ€ÇŒ^S‹Ø‰Š‚̈ê—á. •Ÿ–{@—•1, ¶‹î^—Žq2, •Ð‰ª—Sˆê3 (1ŠÅŒì•”, 2‰h—{•”, 3‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2012/2/24), _ŒË, “ú–{Ã–¬Œo’°‰h—{Šw‰ïŽ 2012/1; 27 (1): 543.

723990. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ICU‚É‚š‚¯‚éš‹‰º•]‰¿Eš‹‰ºŒP—û‚ɂ‚¢‚ā|‰h—{ŠÇ—ƒvƒƒgƒR[ƒ‹‚𓱓ü‚µ‚ā|. “y‰®Žu•Û1, ‰ª“cŽ‡•ä1, •œ–ì—L”ü1, ŽR–ì•Ó‚Ý‚¿Žq1, _œä’m“¹2, •Ð‰ª—Sˆê2 (1ŠÅŒì•”, 2‹~–œ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), ç—t, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ 2012/1; 19: 404.

723991. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) dÇ‹~‹}Š³ŽÒ‚ɑ΂·‚鐅—n«H•š‘@ˆÛEƒIƒŠƒS“œ‚ð—p‚¢‚œ”r•ÖƒRƒ“ƒgƒ[ƒ‹‚ÌŒŸ“¢. Œ“cŒb”ü1, “y‰®Žu•Û1, ‰ª“cŽ‡•ä1, _œä’m“¹2, •Ð‰ª—Sˆê2 (1ŠÅŒì•”, 2‹~–œ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), ç—t, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ 2012/1; 19: 404.

723992. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ICU‚É‚š‚¯‚éš‹‰º•]‰¿Eš‹‰ºŒP—û‚ɂ‚¢‚ā|‰h—{ŠÇ—ƒvƒƒgƒR[ƒ‹‚𓱓ü‚µ‚ā|. “y‰®Žu•Û1, •Ð‰ª—Sˆê2, _œä’m“¹2 (1ŠÅŒì•”, 2‹~–œ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), –‹’£.

723993. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹Ö‰ŒéŒŸ‚ÌŽó—e‚͐SŒŒŠÇ•aŠ³ŽÒ‚É‚š‚¯‚é‘Þ‰@Œã‚̍ċi‰Œ‰ñ”ð‚É—L—p‚Å‚ ‚é. ‰Í–ì^—1, _’JŒ’‘Ÿ˜Y1, 傖Œ—R‰Á—¢1, ‘q“‡^‹I1, Œ©ˆä“c˜a³1, ‘å–xŽ•F2, –ì“cçt2, ‘“c@‘ì3, ˜aò@“O2 (1S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Žº, 2zŠÂŠí“à, 3ˆã—Éq¶Šw•”): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/17), •Ÿ‰ª.

723994. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘Þ‰@Œã‚ɉîŒìƒT[ƒrƒX‚ª•K—v‚Æ‚È‚éSŒŒŠÇ•aŠ³ŽÒ‚ð“ü‰@‘Šú‚É—\‘ª‚·‚é‚œ‚߂̈öŽq‚ÌŒŸ“¢. 傖Œ—R‰Á—¢1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, ‰Í–ì^—1, ‘q“‡^‹I1, Œ©ˆä“c˜a³1, ˆ°àVŒ\Žq3, ‘å–xŽ•F4, –ì“cçt4, Œ–쎞Žq3, ˜aò@“O4 (1S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Žº, 2ˆã—Éq¶Šw•”, 3ŠÅŒì•”, 4zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/18), •Ÿ‰ª.

723995. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘œEŽí‰î“ü‚É‚æ‚éS‘Ÿ•a‹³Žº‚Í‹}«S‹Ø[ÇŠ³ŽÒ‚ÌŠO—ˆS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŽóf•p“x‚𑝉Á‚·‚é. ‘q“‡^‹I1, –ì“cçt2, ‰Í–ì^—1, 傖Œ—R‰Á—¢1, _’JŒ’‘Ÿ˜Y1, Œ©ˆä“c˜a³1, ‘å–xŽ•F2, ‘“c@‘ì3, ˜aò@“O2 (1S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Žº, 2zŠÂEú¯E 3ˆã—Éq¶Šw•”): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/18), •Ÿ‰ª.

732157. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ‘n‚ð‚à‚I––Šú‚ª‚ñŠ³ŽÒ‚Ö‚ÌŠÅŒìƒPƒA. ŒŒŽN”ü (ŠÅŒì•”): ‘æ3‰ñ“ú–{åñጊw‰ï‹ãB’n•û‰ïŠwpW‰ï (2011/5/14), ‹ãB.

732158. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘O—§‘B‚ª‚ñŠÅŒìŠO—ˆ‚É‚š‚¯‚éŽæ‚è‘g‚Ý. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‚ª‚ñˆã—Ã}ƒlƒWƒƒ“ƒgŒ€‹†‰ï (2011/6/18), “Œ‹ž.

732159. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚É‚æ‚é‘O—§‘B‚ª‚ñŠÅŒìŠO—ˆ‚ÌŽæ‚è‘g‚Ý. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ƒV[ƒhŒ€‹†‰ï (2011/7/17), “Œ‹ž.

732160. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) tˆÚA‚É‚š‚¯‚éRTC‚Ì–ðŠ„. –ìŒû•¶”T (ŠÅŒì•”): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733437. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) L”͈͐؊J‚ɂĉü‘P‚µ‚œDeep tissue injury‚Ì1—á. Ž‹{”ü‰r1, ì‘º”ü‹IŽq1, ¬—я»Žq1, ²“¡—ÇŽq1, ‚{@”Ž2, •“c@Œ[3 (1ŠÅŒì•”, 2”畆, 3Œ`¬E”üŠO): ‘æ8‰ñ“ú–{åñጊw‰ïŠÖ“ŒbM‰z’n•ûŠwpW‰ï (2011/6/4), ƒpƒVƒtƒBƒR‰¡•l, ‘æ8‰ñ“ú–{åñጊw‰ïŠÖ“ŒbM‰z’n•ûŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/6; p.100.

733438. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ”]_ŒoŠO‰È, ’Ž‹Ù‹}ŽèpŽž‚É‚š‚¯‚éŠíŠB“WŠJ‚̍H•v. “n粗S‰îE•º“®—SŽq1, ‰¡a@Žq1 (1ŠÅŒì•”): ‘æ22‰ñ“ú–{ŽèpŠÅŒìŠw‰ïŠÖ“ŒbM‰z’n‹æ (2011/6/11), ‰¡•l, ‘æ22‰ñ“ú–{ŽèpŠÅŒìŠw‰ïW˜^ (ŠÖ“ŒbM‰z’n‹æ) 2011/6; p.83-5.

733439. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’²ž•[‚É‚æ‚é‘ŸŠí’ñ‹Ÿ‚̈ӎv’ŠoŒ‹‰Ê‚Ì“®Œü‚Ɖ@“àƒhƒi[ƒR[ƒfƒBƒl[ƒ^[‚̍¡Œã‚̉ۑè. rì–@Žq1, •œ@KŒb1, ‚‹Ž@Œb1, žÒŒ‹v”üŽq1, ’[ŽR˜a”ü1, ¬‰z–Ÿ”ü1, –kŒŽF—Y2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2‹~–œ, 3”å”AŠí): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l.

733440. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œ£tˆÚAŒã‚ÌQOL ‚ðŒüã‚³‚¹‚é‚œ‚ß‚ÌŒŸ“¢`“ü‰@‚ª’·Šú‚Æ‚È‚Á‚œŠ³ŽÒ‚ÌŽ–—á‚ðŒoŒ±‚µ‚ā`. ‰H‰ê@»1, ‰¡ŽR—˜1, –ìŒû•¶”T1, –ؘeŒúŽq1, Îˆä‘å•ã2, ‹g“cˆê¬2 (1ŠÅŒì•”, 2”å”AŠí): ‘æ20‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2011/7/23), ‰¡•l, t‚Æ“§Í•Êûut•s‘SŠO‰È2012v2012/4; 72: 46-9.

733441. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ä”­ƒ^[ƒ~ƒiƒ‹Š³ŽÒ‚̈ӎvŒˆ’èŽx‰‡‚Æ‘Þ‰@’²®. ‰Á“¡–qŽq1, Ž™‹Ê”ü—R‹I1 (1ŠÅŒì•”): “ú–{“û‚ª‚ñŠÅŒìŒ€‹†‰ï (2011/10/16), ‘å‹{ƒ\ƒjƒbƒNƒVƒeƒB[.

733442. [Šw‰ï (’n•û‰ïEŒ€‹†EE] (ˆê”ʍu‰‰) –§••¬üŒ¹‰i‹v‘}“ü—Ö@‚ðŽó‚¯‚œŠ³ŽÒ‚É‚š‚¯‚é‘Þ‰@Žw“±‚Ì•]‰¿`‘Þ‰@Žw“±‚̉ü‘P“_‚â‰Û‘è‚ð”cˆ¬‚µ, Š³ŽÒƒj[ƒY‚É‘Š‚µ‚œ‘Þ‰@Žw“±‚ðl‚Š‚é`. •œ•û‹v”üŽq1, ¯–ì@Œ’1, ˆäŽèŒû—IŽq1, ŠC˜VŒŽ—‰hŽq1, V–ì’mŽq1, Ž‹{”ü‰r1, ç—tKŒb1 (1ŠÅŒì•”): ‘æ76‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2011/10/20-22), ‰¡•l.

733443. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒPƒAƒvƒ‰ƒ“ŠJŽŠ“±“üƒvƒƒWƒFƒNƒg‚É‚æ‚Á‚Ä“Ÿ‚œ’†Œ˜ŠÅŒìŽt‚Ì‘ÌŒ±. Îˆä—R”üŽq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733444. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰Æ‘°‚ƈꏏ‚ɃGƒ“ƒ[ƒ‹ƒPƒA‚ðs‚Á‚œŠÅŒìŽt‚̈ӎ¯‚̕ω»|M. ƒjƒ…[ƒ}ƒ“‚ÌŒ’N—˜_‚ÉŠî‚­–Ê’k‚ð’Ê‚µ‚ā|. ŽÄ“c‚â‚æ‚¢ (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733445. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘ÌŠOŽóžŽèp‚ðŽó‚¯‚銳ŽÒ‚̃IƒŠƒGƒ“ƒe[ƒVƒ‡ƒ“‚̉ü‘P`W’c‚©‚çŒÂ•ÊƒIƒŠƒGƒ“ƒe[ƒVƒ‡ƒ“‚̕ύX`. ŒˆäŠG—¢Žq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733446. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –§••¬üŒ¹‰i‹v‘}“ü—Ö@‚ðŽó‚¯‚œŠ³ŽÒ‚É‚š‚¯‚é‘Þ‰@Žw“±‚Ì•]‰¿`‘Þ‰@Žw“±‚̉ü‘P“_‚â‰Û‘è‚ð”cˆ¬‚µ, Š³ŽÒƒj[ƒY‚É‘Š‚µ‚œ‘Þ‰@Žw“±‚ðl‚Š‚é`. ¯–ì@Œš (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733447. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰h—{ŠÇ—ƒvƒƒgƒR[ƒ‹“±“üŒã‚ÌŠÅŒìŽt‚Ì—‰ð‚â”FŽ¯‚ÉŠÖ‚·‚é’²ž. •œ–ì—L”ü (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733448. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Š³ŽÒ‚̌•ʓI‚ȃPƒA‚𓥂܂Š‚œ–Ú•WÝ’è‚ÆŽ¡—ÃŽQ‰Á‚Ö‚ÌŽæ‚è‘g‚݁`ƒ`[ƒ€ƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚ÆŠÅŒìƒPƒAƒvƒ‰ƒ“ŠJŽŠ‚ðŠˆ—p‚µ‚ā`. ‹{“‡@Œd (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733449. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚¹‚ñ–ÏŠ³ŽÒ‚Ö‚ÌŠÅŒìŽt‚ÌŒ©•û‚̕ω»|Ž–—ጟ“¢‰ï‚ƕ׋­‰ï‚ð’Ê‚µ‚ā|. ‘ºãŠG–ƒ (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733450. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚ªs‚€—Ï—’²®‚ÌŽ‹“_‚Æ•û—ª (‘æ2•ñ)|‹}Œƒ‚É•aó‚ªE«‰»‚µ‚œŠ³ŽÒ‚̈ӎvŒˆ’è‚ÉŠÖ‚·‚é—Ï—’²®3Ž–—á|. Žt‰ªŒbŽq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733451. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚ªs‚€—Ï—’²®‚ÌŽ‹“_‚Æ•û—ª (‘æ3•ñ)|4Ž–—á‚Ì—Ï—’²®‰ß’ö‚É‚š‚¯‚é‹€’Ê“_‚Æ“Á’¥|. çø“”ü“oŽq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733452. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’ZŠúŠÔ‚ōA“ª‹@”\‰·‘¶Žèp‚̈ӎvŒˆ’è‚ð”—‚ç‚ê‚œŠO—ˆ“ªèò•”‚ª‚ñŠ³ŽÒ‚Ö‚ÌŽx‰‡. ìã”ü’q‘ã (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733453. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “à‰È‘‡ŠO—ˆ‚É‚š‚¯‚éŠÅŒìŽt–âf‚ÌŒ»ó‚ƍ¡Œã‚̉ۑè`ˆãŽt‚ւ̃Aƒ“ƒP[ƒg’²žŒ‹‰Ê‚©‚ç‚̍lŽ@`. Œ–{@ˆ² (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733454. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰Æ‘°‚Æ‹€‚ɍl‚Š‚œ“à•ž‰‡•‚ÌŒŸ“¢. ”ªŒË—”ü (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733455. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) èò‘‘¹Š³ŽÒ‚̌ċzƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. “ŒŒb—œ‰Ø (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733456. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Š³ŽÒ‚ÌŽ‚Ä‚é—Í‚ðˆø‚«o‚·ŠÅŒì`ƒyƒvƒƒE‚̑ΐl“IƒvƒƒZƒX‚𓥂܂Š‚ā`. ¬—Ñ—¢‰h (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733457. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒÂŽº•a“‚ŃŠ[ƒ_[–ðŠ„‚ð‘ÌŒ±‚·‚éŠÅŒìŽt‚̍¢“‚Ì—vˆö. ŠâŸº–¢—ˆ (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733458. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘Þ‰@‚·‚éŽq‚Ç‚à‚̉Ƒ°‚ɑ΂·‚é‹~‹}‘h¶–@Žw“±‚©‚獡Œã‚̉ۑè‚ðl‚Š‚é. ìã‘å•ã (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733459. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰Æ‘°ŠÔ‚Ì‹CŽ‚¿‚Ì‹€—L‚ÉŒü‚¯‚Ẳ‡•`“n•ÓŽ®‰Æ‘°ƒAƒZƒXƒƒ“ƒgƒ‚ƒfƒ‹‚ð—p‚¢‚ĉƑ°‚Ì‘S‘Ì‘œ‚ð‘š‚Š‚é`. ‘厺ˆŸ‹| (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733460. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) lHŒÒŠÖß‘S’uŠ·p‚ðŽó‚¯‚銳ŽÒ‚Ö‚Ì“ü‰@‘O‚©‚犈—p‚Å‚«‚éƒpƒ“ƒtƒŒƒbƒg‚Ì—LŒø«‚Ì•]‰¿`“ü‰@’†‚ÌŠ³ŽÒŽw“±‚Ƀpƒ“ƒtƒŒƒbƒgEðŽg—p‚µ‚œŠÅŒìŽt‚̈Ӑ}“I‚ÈŠÖ‚í‚è‚©‚ç`. –ŒŽq‰®ˆ€— (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733461. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ÛHEš‹‰ºƒ`[ƒ€Šˆ“®•ñ‚ƍ¡Œã‚̉ۑè. ‹{ø“—FŒb (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733462. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) öÝ“IŠë‹@‚ւ̉î“ü|Šë‹@“Ió‹µ‚̉ñ”ð‚ƏáŠQŽó—e‚ÉŒü‚¯‚Ä‚ÌŠÅŒìŽx‰‡|. Î‘q@ˆ€ (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733463. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘Þ‰@’²®‚É‚š‚¯‚é•a“ŠÅŒìŽt‚Ì–ðŠ„‚É‚Â‚¢‚Ä‚Ì”FŽ¯`‘Þ‰@’²®ŠÅŒìŽt‚Ƃ̘AŒg‚Ì‚œ‚ß‚É•K—v‚È‚±‚Ƃ͉œ‚©‚ðŒŸØ‚·‚é`. ²“¡‚©‚š‚è (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733464. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž©‘î‘Þ‰@‚ÉŒü‚¯‚Ä•sˆÀ‚ð•ø‚Š‚Ä‚¢‚銳ŽÒ‚Æ‚ÌŠÖŒW«‚̍\’z. ’†’JG”ü (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733465. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “Ë‘R‚Ì—\Šú‚¹‚ʎ󏝂©‚琶–œŠë‹@‚̏ó‘ԂɊׂÁ‚œ‰ä‚ªŽq‚ðŽv‚€•êe‚̐ž_“IŠë‹@‚ւ̉î“ü. ŠÛŽR’ŒŽq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733466. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠÅŒìŽt‚ÌŠŽî•\o‚ð–Ú“I‚É‚µ‚œƒfƒXƒP[ƒXƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚ÌŒø‰Ê‚Ɖ^‰c‚Ì•]‰¿. –p@‹I] (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733467. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘åŠw•a‰@ŽY•wl‰È‚É‚š‚¯‚鐞Žq“€Œ‹•Û‘¶ŠO—ˆ‚ł̌•ʖʐڂ̎æ‚è‘g‚Ý1`¶Bˆã—Ðê–åE‚ÌŠˆ—p`. ŒI“c‚©‚Ù‚é (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733468. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘åŠw•a‰@ŽY•wl‰È‚É‚š‚¯‚鐞Žq“€Œ‹•Û‘¶ŠO—ˆ‚ł̌•ʖʐڂ̎æ‚è‘g‚Ý2`“KØ‚ȏî•ñ’ñ‹Ÿ‚ð–ÚŽw‚µ‚ā`. —V²_Žq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733469. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹Æ–±‰ü‘P‚ÌŒø‰Ê‚ÆŠÅŒì‹Æ–±`“d˜b‘Š’k‹Æ–±‚ÌŒ©’Œ‚µ‚Å‚Å‚«‚œ‚±‚Ɓ@‘æ2•ñ`. ¶’J”ü•ä (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733470. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒŒ‰t“à‰ÈŽŸŠ³Š³ŽÒ‚Æ‚ÌŠÖ‚í‚è|ƒyƒvƒƒE‚̐lŠÔŠÖŒW—˜_‚ð—p‚¢‚ĐU‚è•Ô‚é|. ŽÂŒŽŠ°ŽÀ (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733471. [Šw‰ï (’n•û‰ïEE€‹†‰ï)] (ˆê”ʍu‰‰) ‘å“®–¬‰ð—£stanfordAŒ^Š³ŽÒ‚Ì“à‰È“IŽ¡—ÁEŽ©‘î‘Þ‰@‚ÉŒü‚¯‚Ä‚ÌQOL‚ðl—¶‚µ‚œƒTƒ|[ƒg|–{l‚̈ӎv‚𑞏d‚µ‚œŠÅŒì‰î“ü‚Ƃ́|. ‘–숩‹IŽq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733472. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠO—ˆ‘O—§‘B¶ŒŸ‚ÌŒŸž‘OƒIƒŠƒGƒ“ƒe[ƒVƒ‡ƒ“‚ÌŽÀ‘Ô”cˆ¬`ŒŸž‚Ì‚³‚ç‚È‚éˆÀ‘S«‚ð–ÚŽw‚µ‚ā`. ¬‹{çŒbŽq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733473. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œ€ÇŒ^S‹ØÇŠ³ŽÒE‰Æ‘°‚Ö‚ÌŽ©‘î‘Þ‰@Žx‰‡`‰Æ‘°ŠÅŒìƒGƒ“ƒpƒ[ƒƒ“ƒgƒ‚ƒfƒ‹‚ð—p‚¢‚ā`. ŒÃ“¡ŠG”ü (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733474. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™•a“‚É‚š‚¯‚éˆÀ‘S‚È‹CŠÇØŠJƒJƒjƒ…[ƒŒŠÇ—‚ÌŒŸ“¢E`¬Ž™‹CŠÇƒJƒjƒ…[ƒŒŽg—pŠ³ŽÒ@ŽwŽŠEƒ`ƒFƒbƒN•\‚̍쐬`. ŒIŒŽËŽq (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733475. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™•a“‚É‚š‚¯‚éˆÀ‘S‚È‹CŠÇØŠJƒJƒjƒ…[ƒŒŠÇ—‚ÌŒŸ“¢E`¬Ž™‹CŠÇƒJƒjƒ…[ƒŒŽg—pŠ³ŽÒŽwŽŠEƒ`ƒFƒbƒN•\Žg—p‘OŒã‚̃Cƒ“ƒVƒfƒ“ƒg•ªÍ`. ãŒŽŽáŽÑ (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733476. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “œ”A•aŠ³ŽÒ‚ɃJƒ‹ƒKƒŠ[‰Æ‘°ƒAƒZƒXƒƒ“ƒgƒ‚ƒfƒ‹‚ð—p‚¢‚œŠÖ‚í‚è‚ɂ‚¢‚ā|‰Æ‘°ƒCƒ“ƒ^ƒrƒ…[‚ª’fŽð‚𑣂µ‚œŽ–—á‚ɂ‚¢‚ā|. ˆÀ•”@—y (ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733477. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’ZŠú“ü‰@‚ʼn»Šw—Ö@‚ð‚€‚¯‚é•wl‰È‚ª‚ñŠ³ŽÒ‚Ì“úí¶Šˆ‚É‚š‚¯‚é‘ÌŒ±|2Ž–—á‚É‚š‚¯‚é1ƒR[ƒXI—¹Œã, ŽŸ‰ñ“ü‰@Ž¡—Â܂Ł|. ‰ª“cŒb1, “n•”‡Žq1, ²“¡”ü‹I1, ‚‹Ž@Œb1, H“c]—œŽq1, Ö“¡@–G1, ’r“cØ•ä1, çø“”ü“oŽq1 (1ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733478. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚»‚̐l‚炵‚³‚ɉˆ‚Á‚œŠÅŒì‚Ƃ́|1l‚̏I––ŠúŠ³ŽÒ‚Æ‚ÌŠÖ‚í‚è‚ð’Ê‚µ‚Ä‹C‚¢‚œ‚±‚Ɓ|. ‰Í‘º—zŽq1, “n•”‡Žq1, ²“¡”ü‹I1, Ñ—¬”ü1 (1ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733479. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”畆”rŸ•ƒPƒA”F’èŠÅŒìŽt‚Ì•a“”z’u‚É‚æ‚éåñ጑΍ô. ²“¡—ÇŽq1, ì‘º”ü‹IŽq1, Ž‹{”ü‰r1, ¬—я»Žq1 (1ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2012/12/17), _“ސ쌧–k—¢‘åŠw.

733480. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”]_ŒoŽŸŠ³Š³ŽÒ‚É‚š‚¯‚é‘Þ‰@’²®ƒnƒCƒŠƒXƒNEƒXƒNƒŠ[ƒjƒ“ƒO‚ÌŒŸ“¢. ŒIéŠG”ü1, Žl\—FŒb1, £ŒËtŒb1, ‰¡aˆç”ü1 (1ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733481. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠÅŒìŒv‰æŠJŽŠ‚ÌŠ³ŽÒ•·‚«Žæ‚è’²žŒ‹‰Ê‚ƍ¡Œã‚̉ۑè. ]“cˆêd1, ŒõŽR”ü’qŽq1, ‰¡aˆç”ü1 (1ŠÅŒì•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733482. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ÛHEš‹‰ºƒ`[ƒ€Šˆ“®•ñ‚ƍ¡Œã‚̉ۑè. ‹{ø“—FŒb1, Ž–ì—R”y2, ‰ª•”‘•c3, ’†“ˆ‚Æ‚µ‚Ý4 (1ŠÅŒì•”, 2Žš•@, 3ŒŸŒê’®ŠoŽm, 4‰h—{•”): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733483. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆÓŽ¯áŠQŠ³ŽÒ‚ɑ΂·‚é—¬…‚ð—p‚¢‚È‚¢ŒûoƒPƒA‚Ì—LŒø«‚ɂ‚¢‚Ä. ””nG‹I1, ‹{ø“—FŒb1, ‰¡“c‚³‚š‚è1, ‰F’Öؑ2, Œ¢Ž”@‰~2, “ñ–{–öL3, –Ø‘º—F”ü4 (1ŠÅŒì•”, 2”]ŠO, 3—ÕŒŸ•”, 4“Œ•a‰@Ž•‰È‰q¶Žm): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733484. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Š{œœØ‚èpŠ³ŽÒ‚Ì‹ê’ɂƑΏˆs“®|ŽÀ‘ԁEp‘OƒCƒ[ƒW‚Æ‚ÌŠÖ˜A|. _’J–FŠG1, ”’ˆä‹³Žq1, ×–ì@~2, ‘ºã”üŒb1, …ã‚¢‚ÂÝ1 (1ŠÅŒì•”, 2‚³‚ª‚ݗΕ—‰€): ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/17), _“ސ쌧–k—¢‘åŠw.

733485. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) ”]Ž€‰º‘ŸŠí’ñ‹Ÿ‚ðŒoŒ±‚µ‚ā|‰@“à‘̐§‚̍ČŸ“¢|. •œ@KŒb1, rì–@Žq1, ¬‰z–Ÿ”ü1, –kŒŽF—Y2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2‹~–œ, 3”å”AŠí): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž.

733486. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) öÝ“IŠë‹@ó‘Ԃւ̉î“ü`Šë‹@“Ió‹µ‚̉ñ”ð‚ƏáŠQŽó—e‚ÉŒü‚¯‚Ä‚ÌŠÅŒìŽx‰‡`. Î‘q@ˆ€1, žÒŒ‹v”üŽq1, ‚‹Ž@Œb1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž, ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012; p.174.

733487. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž©‘î‘Þ‰@‚ÉŒü‚¯‚Ä•sˆÀ‚ð•ø‚Š‚Ä‚¢‚銳ŽÒ‚Æ‚ÌŠÖŒW«‚̍\’z|ƒyƒvƒƒE‚Ì—˜_‚ð—p‚¢‚ā|. ’†’JG”ü1, žÒŒ‹v”üŽq1, ŠŽR˜a”ü1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012/2; p.175.

733488. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆÓŽ¯áŠQŠ³ŽÒ‚É‚š‚¯‚é‹CŠÇ‘}ŠÇŒã‚ÌŽ©‘R‹C“¹‚ð–ÚŽw‚µ‚ā`ˆÓŽ¯áŠQŠ³ŽÒ‚É‚š‚¯‚锲ŠÇ‚ÌŒ»ó’²ž`. ŒŽ“cˆŸŠó1, ‹àˆä‘Žq1, óÀ@Œb1, Œ“cGˆê1, ùŽR’q”ü1, “y‰®Žu•Û1, XˆÀŒbŽÀ1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2012/2/4), “Œ‹ž, ‘æ62‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2012/2; p.175.

733489. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ`[ƒ€ˆã—Á|MRIŒŸž‚̃{ƒfƒBƒ`ƒFƒbƒN‚ð’Ê‚¶‚ā|. ŒŽ@—D‰Ô1, —é–Ø’qŽq1, ŽÄø“’q”ü1, Â–Ø—”ü1 (1ŠÅŒì•”): “ú–{•úŽËü‹ZpŠw‰ï‘æ58‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ï (2012/2/5), ç—t.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H14-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ŒûOŒûŠW—ô‚ÉŠÖ‚·‚鍐’m‚ÌŽÀ‘Ô. —é–ØŒbŽq1, Ž‹{”ü‰r2, ”š–ì‰Ô“Þ2, £èWˆê˜Y3, ŽRèˆÀ°3, ’†–kMº3, ‹|í–ŸŽq2, ‰ª•”‘•c2 (1ˆã—Éq¶Šw•”, 2ŠÅŒì•”, 3Œ`¬E”üŠO): ŒûŠW—ôŠw‰ïŽ 2002/4; 27 (2): 267.

H16-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ŒûOŒûŠW—ôŽ™‚ðŽ‚Â‰Æ‘°‚Ö‚ÌŠO—ˆŠÅŒìŽt‚̉‡•. ŒÃ•œŒb”üŽq1, Ž‹{”ü‰r1, Œ–{çŽj1, ²“¡^‹IŽq1, —é–ØŒbŽq2, ‹|í–ŸŽq1, ŽRèˆÀ°3, £èWˆê˜Y3, “àÀ‰hŽ÷3 (1ŠÅŒì•”, 2ˆã—Éq¶Šw•”, 3Œ`¬E”üŠO): ŒûŠW—ôŠw‰ïŽ 2004/4; 29 (2): 227.

H16-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] –k—¢‘åŠw•a‰@‚É‚š‚¯‚é—ŒeŒü‚¯uÀ‚ÌŒ»ó‚Ɖۑè. ŒÃ•œŒb”üŽq1, Ž‹{”ü‰r1, Œ–{çŽj1, ²“¡^‹IŽq1, —é–ØŒbŽq2, ‹|í–ŸŽq1, ŽRèˆÀ°3, £èWˆê˜Y3, “àÀ‰hŽ÷3 (1ŠÅŒì•”, 2ˆã—Éq¶Šw•”, 3Œ`¬E”üŠO): ŒûŠW—ôŠw‰ïŽ 2004/4; 29 (2): 227.

[Šw‰ïEŒ€‹†‰ï“™]

H20-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]_ŒoŠO‰ÈŠO—ˆ‚É‚š‚¯‚é“d˜b‘Š’k‚ÌŽÀ‘Ô‚ÆŠÅŒìŽt‚Ì–ðŠ„. “c•Ó—Œb1, ²“¡^‹IŽq1, Ž‹{”ü‰r1 (1ŠÅŒì•”): ‘æ58‰ñ“ú–{•a‰@Šw‰ï (2008/7/3-4), ŽRŒ`.


—Տ°ŒŸž•”

[Šwp˜_•¶]

120097. [ŒŽ’˜] Ò‘¬”]•Ï«Ç‚É‚š‚¯‚édS“®—hŒŸž: “Á‚É3HzŽüŠú‚Ì“®—h‚ɂ‚¢‚Ä. ˆÉ•ÛŽŽq1, ó–ì˜a]1, ‘ºŽR^‹|1, ˆ¢‹v’Óñ•v2, ’·À‰p–Ÿ3, “¿‘Œú“ñ, ‰ª–{–ql3 (1—ÕŒŸ•”, 2_Œo“à, 3Žš•@): ‚ß‚Ü‚¢•œtˆãŠw 2011/4; 70 (2): 67-76.

120098. [ŒŽ’˜] ’Ž‰¹”gƒpƒ‹ƒXƒhƒvƒ‰–@‚ð—p‚¢‚œŠÌØœ‘OŒã‚ÌŠÌŒŒ—¬E®‘Ô‚ÌŒŸ“¢. –öŒŽ”ü’qŽq1, ŒFâ@L1, ‰““¡@—m1, “¡ˆä@Žœ1, ’†Œ‹vK1, “•ûLˆê1, Žë–ì—Lì2, ŒÃ“cˆê“¿3 (1—ÕŒŸ•”, 2—ÕŒŸŠw, 3ŠO‰È): ’Ž‰¹”gŒŸž‹Zp 2011/6; 36 (2): 133-41.

120099. [ŒŽ’˜] Ò‘¬”]•Ï«Ç‚ɑ΂·‚éTRH-T—Ö@Œø‰Ê‚̏dS“®—hŒŸž‚É‚æ‚é’ZŠúŠÔ•]‰¿. ‘ºŽR^‹|1, ˆÉ•ÛŽŽq1, ó–ì˜a]1, ˆ¢‹v’Óñ•v2, ’·À‰p–Ÿ3, “¿‘Œú“ñ, ‰ª–{–ql3 (1—ÕŒŸ•”, 2_Œo“à, 3Žš•@): Equilib Res 2012/2; 71 (1): 40-6.

120100. [ŒŽ’˜] –k—¢‘åŠw•a‰@‚É‚š‚¯‚éƒmƒƒEƒCƒ‹ƒXŒŸž‚ÌŽæ‚è‘g‚Ý‚š‚æ‚ÑŒŸoó‹µ‚ÉŠÖ‚·‚錟“¢. ÷ˆäŒc‘¢1, ’†èM•F1, ŽR•Ó°”ü1, ŽRŒû“o‹IŽq1, “•ûLˆê1,•œ“c‘×—Ç2, Žë–ì—Lì3 (1—ÕŒŸ•”, 2ŠŽõŠÇ—Žº, 3—ÕŒŸŠw): ˆãŠwŒŸž 2012/3; 61 (2): 400-6.

220028. [€ŒŽ’˜] –k—¢‘åŠw•a‰@‚É‚š‚¯‚éƒmƒƒEƒCƒ‹ƒXŒŸž‚ÌŽæ‚è‘g‚Ý‚š‚æ‚ÑŒŸoó‹µ‚ÉŠÖ‚·‚錟“¢. ŸNˆäŒc‘¢1, ’†èM•F1, ŽR•Ó°”ü1, ŽRŒû“oŠóŽq1, “•ûLˆê1, •œ“c‘×—Ç2, Žë–ì—Lì3 (1—ÕŒŸ•”, 2ŠŽõŠÇ—Žº, 3—ÕŒŸŠw): ˆãŠwŒŸž 2012/3; 61 (2): 400-6.

520056. [‘à]yLaboratory Practicez¶—: ”]”g‹L˜^Žž‚̐S“d}ƒA[ƒ`ƒtƒ@ƒNƒgœ‹Ž–@. ¬–ìàV—T–ç (—ÕŒŸ•”): ŒŸž‚Æ‹Zp 2011/9; 39 (9): 692-6.

522057. [uÀ]y“ÁW: W’c‹³Žº‚𒆐S‚Æ‚µ‚œCKD‚ÌŽ¡—ÂƉh—{ŠÇ—z—Տ°ŒŸž‹ZŽt‚Ì—§ê‚©‚ç. ”ª–؈ê•v (—ÕŒŸ•”): Current Issues in Nutrition (‰h—{EHŽ–ƒjƒ…[ƒX: –k—¢‘åŠw•a‰@‰h—{•””­s) 2012/3; 24†: 12-3.

[Šw‰ïEŒ€‹†‰ï“™]

723996. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) æ“V«ŠÌ—t‰ètŽî‚̈ê—á. Šâ|‹Ô‰›1, ‘ŽR–ƒ‹LŽq1, —é–ؐ­Žq1, •œ“cçL1, H“¡—ß—Ç1, ’†Œ‹vK1, ꠓcŠì”V1, ‰FŽ¡‹Ž‘PŸ1, Žë–ì—Lì2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ36‰ñ“ú–{’Ž‰¹”gŒŸžŠw‰ï (2011/6/25), ‚‚­‚Î, ’Ž‰¹”gŒŸž‹Zp 2011/6; 38: 110.

723997. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’†‰›ÌŒŒŽº‚ł̈À‘SŠÇ—‚É‚š‚¯‚銳ŽÒ‘Ήž‹L˜^•ë‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. •œˆä@œ1, ‰““¡¬Žq1, ‹{ŒEDº1, “à“cˆêO1, ‘å’JTˆê2, Žë–ì—Lì3 (1—ÕŒŸ•”, 2—AŒŒE×–EˆÚA, 3—ÕŒŸŠw): “ú–{—Տ°ŒŸžŽ©“®‰»Šw‰ï‘æ43‰ñ‘å‰ï (2011/10/7), ‰¡•l, “ú–{—Տ°ŒŸžŽ©“®‰»Šw‰ï‘æ43‰ñ‘å‰ïŽ˜^W 2011/9; 36 (4): 764.

723998. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚ð—p‚¢‚œMRSAv‘¬ŒŸž–@‚ÌŠî‘b“IŒŸ“¢. ŸNˆäŒc‘¢1, ’†èM•F1, “ñ–{–öL1, ŽRŒû“oŠóŽq1, “•ûLˆê1, ”“Œ—R‹I2, ‰ª“cŽ”ü3, ˜aŽRs³3, Žë–ì—Lì4, Ô¯@“§5 (1—ÕŒŸ•”, 2¬Ž™, 3KOBAL, 4—ÕŒŸŠw, 5‘‡f—Ã): ‘æ58‰ñ“ú–{ˆãŠwŒŸžŠw‰ïŠwpW‰ï (2011/11/17), ‰ªŽR, ‘æ58‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ïŽ˜^W 2011; 59 (•ßû): 148.

723999. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘Sg«”j•—Š³ŽÒ‚Ì‘n•”‚©‚番—£‚µ‚œClostridium tetani‚ÉŠÖ‚·‚錟“¢. ¬ŠÑ’q¢1, “ñ–{–öL1,2, ŸNˆäŒc‘¢1, “à“cˆêO1, “•ûLˆê1, ’†‘º³Ž÷4, •ž•”@5, ‘å’JTˆê6, Žë–ì—Lì1,3, ‘Š”nˆêˆå5 (1—ÕŒŸ•”, 2ŠŽõ‘΍ôƒ`[ƒ€, 3—ÕŒŸŠw, 4ˆã—Éq¶Šw•”, 5‹~–œ, 6—AŒŒE×–EˆÚA): ‘æ58‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2011/11/20), ‰ªŽR, ‘æ58‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ïŽ˜^W 2011; 59 (•ßû): 249.

7231000. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EŒû‰‰) d‹~‹}Š³ŽÒ‚É‚š‚¯‚éCONUT–@‚É‚æ‚é‰h—{•]‰¿‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ‰““¡¬Žq1, ŽO‰Y–F“T1, •œ–{—T”ü1, ˆÀ’B@÷1, X@D1, “•ûLˆê1, •Ð‰ª—Sˆê2, _œä’m“¹2 (1—ÕŒŸ•”, 2‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2012/2/24), _ŒË, Ã–¬Œo’°‰h—{ 2012; 27 (1): 537.

7231001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•aŠ³ŽÒ‚š‚æ‚Ñ”ñ“œ”A•aŽÒ‚É‚š‚¯‚éƒCƒ“ƒXƒŠƒ“’ïR«ƒ}[ƒJ[‚ÆŒŒ’†’Ž’á”ädƒŠƒ|ƒvƒƒeƒCƒ“’†ƒgƒŠƒOƒŠƒZƒ‰ƒCƒh’l‚ÌŠÖŒW. •èËŽj1, “y•M’q»2, ‰ª@Žüì1, K–쐳Œá1, ¬ì‘PŽ‘1 (1ˆã—Éq¶Šw•”, 2—ÕŒŸ•”): ‘æ22‰ñ¶•šŽŽ—¿•ªÍ‰ÈŠw‰ï”NŽŸŠwpW‰ï (2012/3/10), •Ÿ‰ª, ‘æ22‰ñ¶•šŽŽ—¿•ªÍ‰ÈŠw‰ï”NŽŸŠwpW‰ïŽ˜^W 2012/3; p.53.

731162. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –k—¢‘åŠw•a‰@E–k—¢‘åŠw“Œ•a‰@‚É‚š‚¯‚élÞˆç¬‚ÌŽæ‚è‘g‚݂ɂ‚¢‚Ä. “•ûLˆê1, Žë–ì—Lì2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ22‰ñ_“ސ쌧—Տ°ŒŸžˆãŠw‰ï‘å‰ï (2011/5/28), ‰¡•l, ‘æ22‰ñ_“ސ쌧—Տ°ŒŸžˆãŠw‰ï‘å‰ïŽ˜^W 2011/5; p.11.

731163. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰@“àŠŽõ‚ƗՏ°×‹ÛŒŸž|ŠŽõ§Œä”F’è—Տ°”÷¶•šŒŸž‹ZŽt (ICMT) ‚Ì–ðŠ„|. “ñ–{–öL (—ÕŒŸ•”): –k—¢‘åŠw‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È (2011/11/24), ‘Š–ÍŒŽ.

733490. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘ª’è–@‚̈Ⴂ‚É‚æ‚éLinezolid (LZD) MIC’l‚̘š—£‚ƍRMRSA–ò‚ÌMIC•ª•z. “ñ–{–öL (—ÕŒŸ•”): ‘æ26‰ñŒ§‰›EŒ§Œ’n‹æŠŽõÇƒtƒH[ƒ‰ƒ€ (2011/5/27), ‘Š–ÍŒŽ.

733491. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘Sg«”j•—Š³ŽÒ‚Ì‘n•”‚©‚番—£‚µ‚œClostridium tetani‚̈êÇ—á. E¬ŠÑ’q¢1, “ñ–{–öL1,2, ŸNˆäŒc‘¢1, “à“cˆêO1, “•ûLˆê1, ’†‘º³Ž÷3, Žë–ì—Lì4, ‘å’JTˆê5 (1—ÕŒŸ•”, 2–k—¢‘åŠw•a‰@ŠŽõ‘΍ôƒ`[ƒ€, 3ˆã—Éq¶Šw•”, 4—ÕŒŸŠw, 5—AŒŒE×–EˆÚA): ‘æ22‰ñ_“ސ쌧—Տ°ŒŸžˆãŠw‰ï‘å‰ï (2011/5/28), ‰¡•l, ‘æ22‰ñ_“ސ쌧—Տ°ŒŸžˆãŠw‰ï‘å‰ïŽ˜^W 2011/5; p.6.

733492. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CŒ^ŠÌ‰ŠƒEƒCƒ‹ƒX Genotype 1b ‚̈â“`Žq\‘¢‚ƃCƒ“ƒ^[ƒtƒFƒƒ“Ž¡—ÃŒø‰Ê‚ÉŠÖ‚·‚錀‹†. ‹vŒ’mŽq1, ’†èM•F1, ŽR•Ó°”ü1, ŸNˆäŒc‘¢1, “•ûLˆê1, Žë–ì—Lì1 (1—ÕŒŸ•”): ‘æ1‰ñ –k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2011/7/16), “Œ‹ž, ‘æ1‰ñ –k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ïƒvƒƒOƒ‰ƒ€ 2011/7; p.16.

733493. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) \ŠeŽ{Ý‚É‚æ‚éƒ`[ƒ€ˆã—Âւ̎Q‰æ‚ÌŒ»ó|“œ”A•a—×{Žw“±‚É‚š‚¯‚é—Տ°ŒŸž‹ZŽt‚ÌŠˆ“®‚ÆŠˆ–ô‚̏ê|. “y•M’q»1, ‘å–ì‹v”üŽq1, ¬—ѐŽ}1, ‰Í“‡]”ü1, ŽO‰Y–F“T1, “•ûLˆê1, Žë–ì—Lì2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ1‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2011/7/16), “Œ‹ž, ‘æ1‰ñ –k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ïƒvƒƒOƒ‰ƒ€ 2011/7; p.16.

733494. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰AŒû‰‰) KBMƒCƒ€ƒmƒNƒƒ}ƒgŒŸoƒLƒbƒg‚ð—p‚¢‚œMRSA“¯’è–@‚ÌŠî‘bŒŸ“¢‚ɂ‚¢‚Ä. ˆÀ’B@÷1, “c•”—S“ñ1, “ñ–{–öL1, ŸNˆäŒcŽO1, “•ûLˆê1, Žë–ì—Lì2, ‰Ô–؏G–Ÿ3, »ìŒc‰î4 (1—ÕŒŸ•”, 2—ÕŒŸŠw, 3–k—¢Œ€‹†ŠRŠŽõÇ–òŒ€‹†ƒZƒ“ƒ^[, 4–k—¢‘åŠw¶–œ‰ÈŠwŒ€‹†Š): ‘æ48‰ñŠÖ“ŒbM’n‹æˆãŠwŒŸžŠw‰ï (2011/10/29), ‘O‹Ž, ‘æ48‰ñŠÖ“ŒbM’n‹æˆãŠwŒŸžŠw‰ïŽ˜^W 2011/10; p.147.

H22”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H22-220001. [€ŒŽ’˜] –«t•s‘SŠ³ŽÒ‚Ì”]”g”»“Ç‚É‚š‚¯‚錌‰t¶‰»Šwƒf[ƒ^‚Ì—L—p«‚ɂ‚¢‚Ä. ¬–ìàV—T–ç1, –ìàV»Žq1, ‹g–{gŽq1, “•ûLˆê1 (1—ÕŒŸ•”): Ž„—§ˆã‰È‘åŠw—Տ°ŒŸž‹ZŽt‰ïŽ (Kameraden) 2011/3; 52: 26-8.


•úŽËü•”

[Šwp˜_•¶]

522242. [uÀ]y‹Ù‹}“ÁW: ƒhƒLƒ…ƒƒ“ƒg: “Œ“ú–{‘åkÐ••Ÿ“‡‘æˆêŒŽ”­Ž–ŒÌ@•úŽËüˆã—Ê֌WŽÒ‚̑Ήž‚Æ–ðŠ„|Šˆ“®‚Ì‹L˜^|zI ’nk‚Ì”íŠQ‚Æ‚»‚ÌŒã‚̑Ήž, •œ‹Œó‹µ‚ɂ‚¢‚ā|ƒ‚ƒ_ƒŠƒeƒB, ITƒCƒ“ƒtƒ‰, î•ñƒVƒXƒeƒ€Œn‚𒆐S‚Ɂ@2. Œv‰æ’â“d‚̉e‹¿‚ƑΉž, ‰ÛEè@–k—¢‘åŠw•a‰@|“–‰@‚É‚š‚¯‚éŒv‰æ’â“d‚ւ̑Ήž. —é–Ø’Œ“ñ1, ˆäã—D‰î2 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): INNERVISION 2011/5; 26 (6): 22-3.

522243. [uÀ] yŠjˆãŠw’è—ʐf’fƒZƒ~ƒi[186zS‹ØSPECT‚É‚š‚¯‚éÅ‹ß‚̉摜Ä\¬‚ɂ‚¢‚Ä. ‹e’r@Œh (•úŽËü•”): ‰f‘œî•ñƒƒfƒBƒJƒ‹ 2011/8; 43 (9): 732-3.

[Šw‰ïEŒ€‹†‰ï“™]

722236. [Šw‰ï (‘S‘)] (‹ZpƒVƒ“ƒ|ƒWƒEƒ€)y”ñ‘¢‰eMRAz‘ÌŠ²•”—̈æ‚Ì”ñ‘¢‰eMRA. `@”Ž•¶ (•úŽËü•”): ‘æ39‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2011/10/1), ¬‘q, ‘æ39‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ïu‰‰Ž˜^W 2011/9; p.130.

7231002. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Velocity-Compensated Tetrahedral Diffusion Gradients‚ð—p‚¢‚œŠgŽU‹­’²‰æ‘œƒV[ƒPƒ“ƒX‚ÌŠJ”­. ”öè³‘¥1,2, ‹{’n—˜–Ÿ2, `@”Ž•¶3, …ãT–ç3, ˆäã—D‰î4, ›@Mˆê4, Œ‰iŒh“ñ4, ƒEƒbƒhƒnƒ€ƒX—æŽq4 (1ˆã—Éq¶Šw•”, 2‹à‘ò‘åŠw, 3•úŽËü•”, 4•úŽËü (‰æ‘œ)): ‘æ39‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2011/9/29-10/1), •Ÿ‰ª (¬‘q), “ú–{Ž¥‹C‹€–ˆãŠw‰ïŽGŽ 2011/9; 31S: 406.

7231003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢t‹@”\‰ðÍƒ\ƒtƒgƒEƒFƒA‚Ì—L—p«‚ÌŒŸ“¢. ‘åŠÖ—T‰î1, ‹e’r@Œh1, “¿d‘žé1, “cã_ˆê1, ŠÛ”öGŽ÷1, ˆ¢•”@–L1, ‹{•”ä˜CŽ÷1, ó–ì—Y“ñ2, ˆäã—D‰î2 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ31‰ñ“ú–{ˆãŠw‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2011/10/27-29), ‚‚­‚Î, ŠjˆãŠw‹Zp 2011/9; 31 (—\eW): 320.

733495. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Test injection–@‚ð—p‚¢‚œS‹@”\„’è‚ÌŠî‘b“IŒŸ“¢. ²“¡@œ1, ”·@G“T1 (1•úŽËü•”): “ú–{•úŽËü‹ZpŠw‰ï‘æ58‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ï (2012/2/5), ç—t, “ú–{•úŽËü‹ZpŠw‰ï‘æ58‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ïŽ˜^W 2012/2; p.240.

733496. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) SPECT/CT‘•’u‚É‚š‚¯‚錞Žã•â³Œø‰Ê‚ÌŒŸ“¢. ‘åŽRÊŽq1, ˆ¢•”@–L1, ‹{•”ä˜CŽ÷1, ì–k–ƒ—œŽq2, ‹e’r@Œh1, âV“¡‹žŽq2 (1•úŽËü•”, 2ˆã—Éq¶Šw•”): “ú–{•úŽËü‹ZpŠw‰ï‘æ58‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ï (2012/2/5), ç—t, “ú–{•úŽËü‹ZpŠw‰ï‘æ58‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ïŽ˜^W 2012/2; p.258.


–òÜ•”

[Šwp˜_•¶]

120101. [ŒŽ’˜] ‚ª‚ñáu’ÉŽ¡—Âɂš‚¯‚é”ñƒIƒsƒIƒCƒh’Á’É–ò’·Šú“Š—^‚̈À‘S«‚ÉŠÖ‚·‚錟“¢. ŠC˜VÀŒcˆê1,2, ‘•ªG–ç3, ²X–ØŽõŽq3, –îŒã˜a•v3,4, ‚–ö—‘1, ŽR“cˆÀ•F1 (1“Œ‹ž–ò‰È‘åŠw–òŠw•”, 2Œ»Ž©Ž¡ˆã‰È‘åŠw•‘®•a‰@–òÜ•”, 3–òÜ•”, 4–òŠw•”): “ú–{ŠÉ˜aˆã—ÖòŠwŽGŽ 2011/6; 4 (2): 65-71.

120102. [ŒŽ’˜]yŠî‘bEf—Â̊î‘bzƒ}ƒOƒZƒ“ƒg’ƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒW»Ü40 mL‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ŒŒŽ@”£1, ”ö’¹Ÿ–ç2, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): V–ò‚Æ—Õଠ2011/8; 60 (8): 1554-9.

522244. [uÀ]y“ÁW: ’†“ňã—Âɋ‚ß‚ç‚ê‚é–òÜŽt‹Æ–±z–ò•š’†“ÅŽ¡—Âɂš‚¯‚錌‰tò‰»—Ö@. ‹ß“¡—¯”üŽq (–òÜ•”): ŒŽŠ§–òŽ– 2011/6; 53 (6): 57-60.

522245. [uÀ]y“ÁW: Äƒ`ƒFƒbƒN! ŽÀ–±ŽÀK Œ©ŠwŒ^‚©‚ç‘ÌŒ±Œ^ŽÀK‚Ö‚Ì•ÏŠvz‹³ˆçŒ»ê‚ƗՏ°Œ»ê‚̘AŒg|‘åŠw‹³ˆõ‚Æ•a‰@–òÜŽt‚ÌŽv‚€‚±‚Æ”Y‚Þ‚±‚Ɓ|. –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): Clinical Pharmacist 2011/7; 3 (4): 22-5.

522246. [uÀ]yˆ•ûÝŒv‚Ƀ`ƒƒƒŒƒ“ƒW ‚±‚ê‚Å‚í‚©‚éÃ–¬‰h—{–@zŠî–{•ÒE‘æ1ÍE—A‰t‚ðŽg‚¢‚±‚È‚·‚œ‚߂Ɂ@3. Ã–¬‰h—{Ü‚Ì“Á’¥@F. ‘‡ƒrƒ^ƒ~ƒ“»ÜE”÷—ÊŒ³‘f»Ü. ¬ìK—Y1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ŒŽŠ§–òŽ– 2011/9; 53 (10): 1439-43.

522247. [uÀ]yˆ•ûÝŒv‚Ƀ`ƒƒƒŒƒ“ƒW ‚±‚ê‚Å‚í‚©‚éÃ–¬‰h—{–@zŠî–{•ÒE‘æ2ÍE‰h—{‘f‚Ɖh—{áŠQ@4. ”÷—ÊŒ³‘fEƒrƒ^ƒ~ƒ“‚Ì•K—v—Ê. ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ŒŽŠ§–òŽ– 2011/9; 53 (10): 1467-72.

522248. [uÀ]y“ÁWE–ƒ–ò‚Ì“K³Žg—p‚Æ‚»‚ÌŠÇ—`ƒ`[ƒ€ˆã—Â̒†‚Å‚Ì–òÜŽt‚̐Ӗ±`z5. ƒIƒsƒIƒCƒh’Á’É–ò‚Ì–ò•š“®‘Ô. ‘•ªG–ç1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ˆã–òƒWƒƒ[ƒiƒ‹ 2011/12; 47 (12): 2938-43.

[’˜@‘]

620257. [Šwp‘] (•ª’SŽ·•M)y–òÜŽt‚Ì‚œ‚ß‚ÌŠŽõ§Œäƒ}ƒjƒ…ƒAƒ‹ ‘æ3”Łz‘æVÍ ŠŽõ‘΍ô‚ÌŽÀÛ@4. ôòE–Å‹Û‚ÌŽÀÛ, p.352-9. ŒŒŽ@”£1, –îŒã˜a•v1,2 1–òÜ•”, 2–òŠw•”), ŠÄC: ˆê”ÊŽÐ’c–@l “ú–{•a‰@–òÜŽt‰ï, •ÒW: “ú–{•a‰@–òÜŽt‰ï ŠŽõ§Œäê–å–òÜŽt•”–å, –òŽ–“ú•ñŽÐ, “Œ‹ž, 2011/12”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713190. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Pharmacokinetics of Oxycodone after intravenous and subcutaneous administration in Japanese cancer pain patients. Kokubun H1, Yoshimoto T2, Hojo M3, Fukumura K4, Matoba M5 (1Kitasato University Hospital, 2Chukyo Hospital, 3Nagasaki University school of Medicine, Anesthesiology, 4Shionogi & Co., Ltd., Clinical Research, 5National Cancer Center, Palliative Medicine & Psycho Oncology): 12th Congress of the European Association for Palliative Care (EAPC) (2011/5/18-5.21), Lisbon, 12th Congress of the European Association for Palliative Care (EAPC) —vŽ|W 2011/5; p.177. (‘•ªG–ç1: 1–òÜ•”)

722237. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™EƒVƒ“ƒ|ƒWƒEƒ€) R‹Û–ò‚ÌTDM•W€‰»‚ÉŒü‚¯‚œ’†ŠÔ•ñ. –Ø‘º—˜”ü1, ’JìŒŽ—S‰î2, ŒÜ\—’³”Ž3, ‰ª“cŒ«“ñ1, –Ø‘º‹§’j4, ¬—я¹G5, •l“cKG6, –]ŒŽŒh_7 (1“Œ‹ž—Žqˆã‰È‘åŠw•a‰@, 2Œc‰ž‹`m‘åŠw, 3ŒÕ‚Ì–å•a‰@, 4ˆ€’mˆã‰È‘åŠw•a‰@, 5–òÜ•”, 6“Œ•a‰@–òÜ•”, 7Ã‰ªŒ§—§‚ª‚ñƒZƒ“ƒ^[): ‘æ28‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï (2011/6/18), L“‡, TDMŒ€‹† 2011/6; 28 (3): S48-9.

7231004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹~‹}—̈æ‚Ö‚Ì–òÜŽt‚ÌŠÖ—^. •{ì”ü¹Žq1, ¬—я¹G1, ’†‘º@—D, Žç‰®‰Ä”ü1, ‹ß“¡—¯”üŽq1, ²“¡çŒb2, _œä’m“¹2, •Ð‰ª—Sˆê2, –îŒã˜a•v1,3, ‘Š”nˆêˆå2 (1–òÜ•”, 2‹~–œ, 3–òŠw•”): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/3-4), ŽD–y, ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï—vŽ|W 2011/6; 14 (2): 305.

7231005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) W’†Ž¡—ÃŽº‚É‚š‚¯‚é–òÜŽt‚̍R‹Û–ò‰»Šw—Ö@ˆ•ûŽx‰‡. ¬—я¹G1, •{ì”ü¹Žq1, ’†‘º@—D1, Žç‰®‰Ä”ü1, ‹ß“¡—¯”üŽq1, ²“¡çŒb2, •Ð‰ª—Sˆê2, »ìŒc‰î3, –îŒã˜a•v1,4, ‘Š”nˆêˆå2 (1–òÜ•”, 2‹~–œ, 3–k—¢¶–œ‰ÈŠwŒ€‹†ŠŠŽõÇŠwŒ€‹†Žº, 4–òŠw•”): ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2011/6/3-4), ŽD–y, ‘æ14‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï—vŽ|W 2011/6; 14 (2): 335.

7231006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒVƒXƒvƒ‰ƒ`ƒ““Š—^Š³ŽÒ‚É‚š‚¯‚é—\‘ªƒNƒŒƒAƒ`ƒjƒ“ƒNƒŠƒAƒ‰ƒ“ƒX‚̐M—Š«‚ÌŒŸ“¢. –ˆ€—1,2, A‘ò–FL1, –ìàV—æŽq1, ¬ìç»3, –î“c•”Œb3, ‹ß“¡’ŒŽ÷3, Ä“¡^ˆê˜Y3, —é–Ø‹`•F3, –Ñ—˜Œö‘¥1 (1–ŸŽ¡–ò‘å—Տ°–òÜŠw, 2–òÜ•”, 3“Œ‹žˆã—ÃZƒ“ƒ^[–òÜ‰È): ‘æ2‰ñ“ú–{ƒAƒvƒ‰ƒCƒhEƒZƒ‰ƒsƒ…[ƒeƒBƒNƒXŠw‰ïŠwp‘å‰ï (2011/6/11-12), Ž£, ‘æ“ñ‰ñŠwpƒvƒƒOƒ‰ƒ€ 2011/6; p.87.

7231007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) PCG‚ÌŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚æ‚è, ŠŽõ«S“à–Œ‰Š‚É‘tŒ÷‚µ‚œˆêÇ—á. ¬Œ•q²1, Šâ–{ŽO˜a2, ’––”FŒ³2, “c‘º˜aŒh1, ‘•ªG–ç1, ‹ß“¡—¯”üŽq1, ¬ìK—Y1, ŒŒŽ@”£1, ˜aò@“O2, –îŒã˜a•v1,3 (1–òÜ•”, 2zŠÂŠí“à, 3–òŠw•”): ‘æ28‰ñ“ú–{TMDŠw‰ïEŠwp‘å‰ï (2011/6/18-19), L“‡, “ú–{TDMŠw‰ï2011—vŽ|W 2011/6; 28 (3): 173.

7231008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •a‰@ŽÀ–±ŽÀK‚É‚š‚¯‚éŽÀKŽ{Ýí’“‹³ˆõ‚Ì•K—v« (‘æ2•ñ). –Ñ—˜‡ˆê1, ”ö’¹Ÿ–ç1, “cŒû—SŽq1, –Ø‘ºŒö”ü1, Î“c—L1, “n糐ç’ß1, ‹ß“¡—¯”üŽq2, ŒŒŽ@”£2, –îŒã˜a•v1,2 (1–òŠw•”, 2–òÜ•”): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011/‘æ19‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/9-10), ˆ®ì, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011u‰‰—vŽ|W 2011/7; p.210.

7231009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éŽÀ–±ŽÀK‚̑Ήž|‘åŠwE–òÜ•”‚̘AŒg‘̐§|. “cŒû—SŽq1, ”ö’¹Ÿ–ç1, –Ø‘ºŒö”ü1, –Ñ—˜‡ˆê1, Î“c—L1, “n糐ç’ß1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£2, –îŒã˜a•v1,2 (1–òŠw•”, 2–òÜ•”): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011/‘æ19‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/9-10), ˆ®ì, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011u‰‰—vŽ| 2011/7; 211.

7231010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) p‘OŠ³ŽÒ‚ɑ΂·‚é–òŠw“IŠÇ—‚ÌŽæ‚è‘g‚Ý. •yàV@~1, ¬Œ•q²1, Ä‹ž–ŸŽq1, •{ì”ü¹Žq1, ‹{“‡—¥Žq1, “¡–ؐŽ]1, Ÿ˜C”ü1, ¬—я¹G1, ŠLÀ@1, â‘q’qŽq1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011/‘æ19‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/9-10), ˆ®ì, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011u‰‰—vŽ| 2011/7; p.179.

7231011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚æ‚éˆã—Ã`[ƒ€‚Ì“Œ“ú–{‘åkÐˆã—ÃŽx‰‡Šˆ“®. ŠLÀ@1, ¬—я¹G1, ²X–ØŽõŽq1, Ô—䑏•F2, ‹ß“¡—¯”üŽq1, ¬ìK—Y1, ŒŒŽ@”£1, •ŽR­ˆê2,3, –îŒã˜a•v1,3 (1–òÜ•”, 2“Œ•a‰@–òÜ•”, 3–òŠw•”): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011/‘æ19‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/9-10), ˆ®ì, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011u‰‰—vŽ| 2011/7; p.262.

7231012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ú–{’†“ÅŠw‰ï”F’萧“xuƒNƒŠƒjƒJƒ‹EƒgƒLƒVƒRƒƒWƒXƒgv| §’è‚ÌŒoˆÜ‚ÆŒŸ“¢‚ðŽŠ‚µ‚ā|. {èaˆê˜Y1, •–Ø—R”üŽq1, ‹ß“¡—¯”üŽq1, ™“c@Šw1, “ޏ——Ǐº1, •œ“cŽ‹M1, –x@@”J1, ŽRŒû–F—T1, ‰¡“c—Ts1, ãð‹gl1, Ž“c˜a–ç1, Ä“¡@„1, L£•Û•v1, •õ‘ºƒŽq1 (1“ú–{’†“ÅŠw‰ï”F’萧“xŒŸ“¢ˆÏˆõ‰ïE“¯ƒ[ƒLƒ“ƒOƒOƒ‹[ƒv): ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ï (2011/7/30-31), ‘åŠ_, ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwp‘å‰ï—vŽ|W 2011/7; p.42.

7231013. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –{Šw‰ï”F’èuƒNƒŠƒjƒJƒ‹EƒgƒLƒVƒRƒƒWƒXƒgv‚Ì–ðŠ„|–òÜŽt‚Æ‚µ‚ā|. ‹ß“¡—¯”üŽq (–òÜ•”): ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ï (2011/7/30-31), ‘åŠ_, ‘æ33‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwp‘å‰ï—vŽ|W 2011/7; p.43.

7231014. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) NMDAŽó—e‘ÌŽÕ’f–ò‚Æ‚µ‚ẴfƒLƒXƒgƒƒƒgƒ‹ƒtƒ@ƒ“‚̃ƒ^‰ðÍ. ‹{â—Dl1, ¬Œ•q²1, “c‘º˜aŒh1, ‘•ªG–ç1, ¬ìK—Y1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï”N‰ï (2011/9/24-25), –‹’£, ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï—vŽ|W 2011/9; 5: 164.

7231015. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ªèò•”ŠàŠ³ŽÒ‚É‚š‚¯‚錌ŽƒAƒ‹ƒuƒ~ƒ“’l‚ð—˜—p‚µ‚œt‹@”\‚Ì“K³•]‰¿. –ˆ€—1,2, A‘ò–FL1, –ìàV—æŽq1, ¬ìç»3, –î“c•”Œb3, ‹ß“¡’ŒŽ÷3, Ä“¡^ˆê˜Y3, —é–Ø‹`•F3, –Ñ—˜Œö‘¥1 (1–ŸŽ¡–ò‘å—Տ°–òÜŠw, 2–òÜ•”, 3“Œ‹žˆã—ÃZƒ“ƒ^[–òÜ‰È): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/1-2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï—vŽ| 2011/10; p.203.

7231016. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) H•šƒAƒŒƒ‹ƒM[‚ÆŠÖ˜A‚µ‚Ä”­¶‚µ‚œˆã–ò•i‚Ì•›ì—pÇ—á‚Æ‚»‚̑΍ô. ŠÖ‚ß‚®‚Ý1, ²X–ØŽõŽq1, â‘q’qŽq1, ŠLÀ@1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/1-2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï—vŽ| 2011/10; p.295.

7231017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒuƒRƒ[ƒ‹•¹—p’†Ž~Žž‚̃ƒ‹ƒtƒ@ƒŠƒ“ƒJƒŠƒEƒ€‚ÌŽŠ“K“Š—^—Ê‚ÌŒŸ“¢. —F“c‹g‘¥1, “c‘º˜aŒh1, ‘•ªG–ç1, ¬ìK—Y1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/1-2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï—vŽ| 2011/10; p.344.

7231018. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘ÌŒ±Œ^’²ÜŽÀK‚ª—^‚Š‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg‚ɑ΂·‚éˆÓŽ¯‚̕ω». –Ø‘ºŒö”ü1, Î“c—L1, “n糐ç’ß1, “cŒû—SŽq1, –Ñ—˜‡ˆê1, ”ö’¹Ÿ–ç1, ”’‘ò˜aŽq2, “c‘º˜aŒh2, ‘•ªG–ç2, ¬ìK—Y2, ŒŒŽ@”£2, –îŒã˜a•v1,2 (1–òŠw•”, 2–òÜ•”): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/1-2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï—vŽ| 2011/10; p.385.

7231019. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒtƒFƒ“ƒ^ƒjƒ‹Œo”ç‹zŽûŒ^»Ü‚Ì”‚ª‚ê–ʐςɉe‹¿‚·‚é—vˆö. ‘•ªG–ç1, ‹g“c@ˆ©2, ŒI“c‚©‚Ù‚é3, ¬ìK—Y1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”, 3ŠÅŒì•”): ‘æ49‰ñ “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2011/10/27-29), –ŒŒÃ‰®, ‘æ49‰ñ “ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï—vŽ|W 2011/10; 46 (2): 1029.

7231020. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œo•@ˆÝŠÇƒ`ƒ…[ƒu‚̕ǖhŽ~‚ɍvŒ£‚µ‚œŠÈˆÕŒœ‘÷î•ñ‚Ì‹€—L|ƒ`[ƒ€‚Å–h‚®ƒ`ƒ…[ƒu•ÂÇ|. –Ø‘ºŒö”ü1, ¬ìK—Y2, “c‘º˜aŒh2, ‘•ªG–ç2, –îŒã˜a•v1,2, rˆä—L”ü3, Â–ö–ŸŽq3, ‘Š”nˆêˆå4 (1–òŠw•”, 2–òÜ•”, 3ˆã—ÈÀ‘SŠÇ—Žº, 4‹~–œ): ‘æ6‰ñˆã—Â̎¿EˆÀ‘SŠw‰ïŠwpW‰ï (2011/11/19-20), “Œ‹ž, ‘æ6‰ñˆã—Â̎¿EˆÀ‘SŠw‰ïŠwpW‰ï—vŽ|W 2011/11; p.220.


ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”

[’˜@‘]

620258. [Šwp‘]y•às‚ðf‚é|ŠÏŽ@‚©‚çŽn‚߂闝Šw—Ö@ŽÀ‘H|zŠe˜_|•às‚̐f‚©‚œ‚Æ—Šw—Ö@@20. SŽŸŠ³E––œ“®–¬ŽŸŠ³@SŽŸŠ³E––œ“®–¬ŽŸŠ³‚Ì•às‚̐f‚©‚œ‚Æ—Šw—Ö@, p.278-92. _’JŒ’‘Ÿ˜Y1, Œ‰i“Ä•F2 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”), ŠÄC: “ޗǁ@ŒM3 (3_ŒËŠw‰@‘åŠw), •Ò: Œ”ö‘P”ü4 (4•‘ ì—Žq‘åŠw), •¶Œõ“°, “Œ‹ž, 2011/4”­s.

620259. [Šwp‘]yƒGƒrƒfƒ“ƒX‚ÉŠî‚­zŠÂŠí•a—\–hˆãŠw|–«S•s‘S‚ð–h‚®—\–hí—ª‚Æ‚Í?|zC •ïŠ‡“IS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“@2. ƒoƒ‰ƒ“ƒX‹@”\ˆÛŽ‚Ì‚œ‚ß‚É. _’JŒ’‘Ÿ˜Y1, Œ‰i“Ä•F2 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”), ŠÄC: ˜aò@“O3 (3zŠÂŠí“à), •Ò: “ŒžŠ”ü“ÞŽq2, ’––”FŒ³3, “ìŽR“°, “Œ‹ž, 2012/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713191. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Quadriceps strength and balance function necessar to accomplish at least 300 meters in a six-minute walk distance in patients with ischemic heart disease. Kamiya K1, Masuda T2, Miida K1, Matsunaga A2, Ogura MN2, Kimura M2, Noda C3, Yamaoka-Tojo M2, Izumi T3: ESC Congress 2011 (2011/8/27-31), France. (_’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, Œ©ˆä“c˜a³1, Œ‰i“Ä•F2, ¬‘q@Ê2, –Ø‘º‰ë•F2, –ì“cçt3, “ŒžŠ”ü“ÞŽq2, ˜aò@“O3: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à)

713192. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) A case who recovered from range of supination-using modified T-J rotation splint-. Miyazaki M1, Jinbo T1, Tanabe R2, Naruse K3, Takaso M3, Hentona T1: The 5th Asia Pacific Occupational Therapy 2011 Congress (2011/11/19-24), Chiang Mai, Thailand. (‹{è“¹‹P1, _•Û•‘¥1, “c粗²ˆê2, ¬£NŽ¡3, ‚‘Š»Žm3, •Ó“y–Œ—²1: 1ƒŠƒnƒrƒŠ•”, 2–Ø‘º‹`ŽˆHìŒ€‹†Š, 3®ŠO)

713193. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Introduction the new type of static progressive forearm rotation splint to Occupational Therapy`challenge to the useful forearm splint; T-J rotation splint`. Jimbo T1, Tanabe R2, Fujita M3, Aikawa J4, Takaso M4, Naruse K4, Hentona T1: The 5th Asia Pacific Occupational Therapy 2011 Congress (2011/11/19-24), Chiang Mai, Thailand (_•Û•‘¥1, “c粗²ˆê2, “¡“c@Œì3, ‘Šì@~4, ‚‘Š¹Žm4, ¬£NŽ¡4, •Ó“y–Œ—²1: 1ƒŠƒnƒrƒŠ•”, 2–Ø‘º‹`ŽˆHìŒ€‹†Š, 3–L‹ŽŽs–¯•a‰@, 4®ŠO)

722238. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™)yƒP[ƒXƒXƒ^ƒfƒB`‚±‚̏Ǘá‚ð‚Ç‚€‚·‚é`zS‘ŸÄ“¯Šú—Ö@‚ªŽ{s‚³‚ê‚œƒJƒeƒRƒ‰ƒ~ƒ“ˆË‘¶«S•s‘SŠ³ŽÒ‚ɑ΂µœŠi‹ØˆÞk‚̉ü‘P‚Ì‚œ‚߂ɐ_Œo‹Ø“d‹CŽhŒƒ‚ÌŽg—p‚ªl—¶‚³‚ê‚œÇ—á. _’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, ²“¡@—z3, Œ©ˆä“c˜a³1, –ì“cçt3, •iì–íl3, “ŒžŠ”ü“ÞŽq2, ’––”FŒ³3, ’ë–ìTˆê3, Œ‰i“Ä•F2, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ17‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2011/7/16-17), ‘åã.

722239. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) SŽŸŠ³Š³ŽÒ‚Ì•às”\—Í‚ðˆÛŽ‚·‚é‚œ‚߂̐S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒAƒvƒ[ƒ`‚̏Љî. _’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, ‰Í–ì^—1, 傖Œ—R‰Á—¢1, ˜aòK‘ã1, –ì“cçt3, “ŒžŠ”ü“ÞŽq2, ’––”FŒ³3, Œ‰i“Ä•F2, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ15‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2011/10/13-15), Ž­Ž™“‡.

722240. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –k—¢‘åŠw•a‰@‚ÌRapid Response System (RRS) ‚ª‹@”\‚·‚éˆ×‚̉ۑè. ¬’r•üF1, Vˆä³N1, XˆÀŒbŽÀ1, •ž•”@2, •Šâ­”V2, ‰ª–{_Žk3, ¡ˆä@Š°4, ‘Š”nˆêˆå2 (1ƒŠƒnƒrƒŠ•”, 2‹~–œ, 3–ƒŒ, 4ŽOd‘åŠwˆãŠw•”•‘®•a‰@‹~–œ‹~‹}ƒZƒ“ƒ^[): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), –‹’£.

722241. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ‹@”\•Ê‚ÌŠÏ“_‚©‚çl‚Š‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“|—Šw—Ö@Žm‚ÌICUí’“‰»‚ªŒÄ‹z•s‘SŠ³ŽÒ‚É‚à‚œ‚ç‚·‰e‹¿|. à_èL–Ÿ1, ¬’r•üF2, ‰“ŒŽ‚Ü‚è‚Š1, XˆÀŒbŽÀ2, •ž•”@3, •Šâ­”V3, Vˆä³N4, ¡ˆä@Š°5, ‘Š”nˆêˆå3 (1ƒŠƒnƒrƒŠ•”, 2RST/RRTŽº, 3‹~–œ, 4–ƒŒ, 5ŽOd‘åŠwˆãŠw•”•‘®•a‰@‹~–œ‹~‹}ƒZƒ“ƒ^[): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/3/1), –‹’£.

7231021. [Šw‰ï (‘S‘)] (ˆê”ʍuE‰Eƒ|ƒXƒ^[) lHŒÒŠÖß‘S’uŠ·pŒã4“ú–Ú‚Ì‹Ø—Í‚©‚ç‘Þ‰@Ž‚Ì•às”\—Í‚ð—\‘ª‚Å‚«‚é‚©. ŒŠÛƒ‰À1, ‰“ŒŽ^ˆê1, _’JŒ’‘Ÿ˜Y1, Œ©ˆä“cEa³1, •Ó“y–Œ—²1, “à–쐳—²2, •Ÿ“‡Œ’‰î2, “àŽRŸ•¶2, ‚•œ®L3, Ž…–ž·Œ›4 (1ƒŠƒnƒrƒŠ•”, 2®ŠO, 3ˆã—Éq¶Šw•”, 4‹ãB˜JÐ•a‰@): ‘æ46‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2011/5/27-29), ‹{è, 2011; 38 (‘å‰ï“Á•Ê†2 [DVD-ROM]): ROMBUNNO.PI1-204.

7231022. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@”]Žîᇓü‰@Š³ŽÒ‚É‚š‚¯‚鎩‘î‘Þ‰@‚ɉe‹¿‚·‚éˆöŽq. •À–Ø—DŽq1, ²“¡ˆŸ—¢1, _’JŒ’‘Ÿ˜Y1, ŠâŒGŽ÷1, ²X–؏Gˆê1, ì’[—ÇŽ¡1 (1ƒŠƒnƒrƒŠ•”): ‘æ46‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2011/5/27-29), ‹{è.

7231023. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹ü“ü—͈ӎv“`’B‘•’u‚ÌŽg—p‚É‚š‚¯‚é”æ˜J“Á«. ’|“àŠ°l1, ‘Oê—m—C2, ‚‹Ž‘ãŽq2, •Ÿ“c—Ï–ç3, ‰¬–ì”üŒbŽq4 (1ƒŠƒnƒrƒŠ•”, 2“Œ•a‰@ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”, 3ˆã—Éq¶Šw•”, 4_Œo“à): ‘æ45‰ñ“ú–{ì‹Æ—Ö@Šw‰ï (2011/6/24-26), é‹Ê.

7231024. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¶ŽºŠg’£áŠQ‚É‚æ‚éS•s‘SŠ³ŽÒ‚̉^“®‹@”\‚͍¶ŽºŽûk”\‚̒ቺ‚É‚æ‚éS•s‘SŠ³ŽÒ‚Æ“¯“™‚ɒቺ‚·‚é. _’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, Œ©ˆä“c˜a³1, ‰Í–ì^—1, ‚‹Ž—R”ü1, ‘q“‡^‹I1, ¬‘q@Ê2, –Ø‘º‰ë•F2, –ì“cçt3, ’––”FŒ³3, Œ‰i“Ä•F2, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ17‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2011/7/16-17), ‘åã.

7231025. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 300 mˆÈã‚Ì6•ªŠÔ•às‹——£‚ð’B¬‚·‚éã‚Å•K—v‚ȉ^“®‹@”\…€. _’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, Œ©ˆä“c˜a³1, ‰Í–ì^—1, ‘q“‡^‹I1, ‚‹Ž—R”ü1, –Ø‘º‰ë•F2, ¬‘q@Ê2, –ì“cçt3, Œ‰i“Ä•F2, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ75‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2011/8/3-4), ‰¡•l.

7231026. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ñ•œŠú‹•ŒŒ«SŽŸŠ³Š³ŽÒ‚Ì“ñŽŸ—\–h‚Æ‚µ‚Ă̐g‘ÌŠˆ“®—ʈێ‚É‚Í6•ªŠÔ•às‹——£‚ª‹K’èˆöŽq‚Æ‚È‚é. Œ©ˆä“c˜a³1, _’JŒ’‘Ÿ˜Y1, ‘q“‡^‹I1, ‰Í–ì^—1, ‚‹Ž—R”ü1, ¬‘q@Ê2, –Ø‘º‰ë•F2, Œ‰i“Ä•F2, –ì“cçt3, ‘“c@‘ì2, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ75‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2011/8/3-4), ‰¡•l

7231027. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@¬Ž™ŒÄ‹z—Ö@ƒ`[ƒ€‚ÅŽæ‚è‘g‚Þ•a‘Ô‚ðl—¶‚µ‚œŒÄ‹z—Šw—Ö@‚Ì‘I‘ð. à_èL–Ÿ1, ã“cN‹v2, ¬’r•üF1, ‰¡ŽR”ü²Žq3, ‹àŽq’‰O2, “ì–쏉2, •Ÿ“‡’‹`2, ŒŽ@^l2, ”~ŒŽ@ŽÀ2 (1ƒŠƒnƒrƒŠ•”, 2¬Ž™, 3ˆã—Éq¶Šw•”): ‘æ44‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï (2011/10/15-16), “È–Ø.

7231028. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÀ’èŠúCOPDŠ³ŽÒ‚̌ċzƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚æ‚é‰^“®‘Ï—e”\‚ƌċz¢“ï‚̉ü‘P‚ÉŠÖŒW‚·‚éˆöŽq‚ÌŒŸ“¢. à_èL–Ÿ1, ‰“ŒŽ‚Ü‚è‚Š1, ¬’r•üF1, ˜a“c^—RŽq2, ‰¡ê³“T3 (1ƒŠƒnƒrƒŠ•”, 2ŒÄ‹zŠí“à, 3ˆã—Éq¶Šw•”): ‘æ21‰ñ“ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2011/11/3), ’·–ì, “ú–{ŒÄ‹zƒPƒA¥ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ 2011; 21 (‘Š§†): 128S.

7231029. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) lHŒÒŠÖß‘S’uŠ·pŒã1TˆÈ“à‚̉^“®‹@”\‹y‚Ñáu’É‚Ì‘O•ûƒAƒvƒ[ƒ`‚Æ‘€•ûƒAƒvƒ[ƒ`‚Ì”äŠr. ŒŠÛƒ‰À1, _’JŒ’‘Ÿ˜Y1, Œ©ˆä“c˜a³1, t“ú”ü•Û1, •Ó“y–Œ—²1, X’JŒõr2, •Ÿ“‡Œ’‰î2, “àŽRŸ•¶2, ¬£NŽ¡2, ‚•œ®L3, ‚‘Š»Žm2 (1ƒŠƒnƒrƒŠ•”, 2®ŠO, 3ˆã—Éq¶Šw•”): ‘æ42‰ñ“ú–{lHŠÖßŠw‰ï (2012/2/24), ‰«“ê, lHŠÖßŠw‰ïŽ 2012; 42: 781.

7231030. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yƒRƒƒfƒBƒJƒ‹—DGÜŽóÜz‰ñ•œŠúS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Í‘Þ‰@ŽžBNP‚’l‚Ì–«S•s‘SŠ³ŽÒ‚É‚š‚¢‚Ä‚àS•s‘S‚É‚æ‚éÄ“ü‰@‚ð–hŽ~‚·‚é. _’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, ‚‹Ž—R”ü1, Œ©ˆä“c˜a³1, ‰Í–ì^—1, ‘q“‡^‹I1, 傖Œ—R‰Á—¢1, Œ‰i“Ä•F2, ‘å–xŽ•F3, –ì“cçt3, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/16-18), •Ÿ‰ª.

7231031. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) SŽŸŠ³Š³ŽÒ‚É‚š‚¯‚é“œ”A•a«‘œ”­_ŒoáŠQ‚̍‡•¹‚͉^“®‹@”\‚Ɖ^“®‘Ï—e”\‚̒ቺ‚ÌŽå—v‚ÈŒŽˆö‚Æ‚È‚é. Œ©ˆä“c˜a³1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, ‘q“‡^‹I1, ‰Í–ì^—1, 傖Œ—R‰Á—¢1, ¬‘q@Ê2, Œ‰i“Ä•F2, ‘å–xŽ•F3, –ì“cçt3, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ76‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2012/3/16-18), •Ÿ‰ª.

733497. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@Respiratory Support Team (RST) ‚ÌŒ»ó‚©‚çlŽ@‚·‚éRapid Response Team (RRT) ‚Æ‚µ‚Ä‚Ì‹@”\‚ɂ‚¢‚Ä. ¬’r•üF1, Vˆä³N2 XˆÀŒbŽÀ2, •ž•”@3, •Šâ­”V3, ¡ˆä@Š°4, ‰ª–{_Žk2, ‘Š”nˆêˆå3 (1ƒŠƒnƒrƒŠ•”, 2–ƒŒ, 3‹~–œ, 4ŽOd‘åŠwˆãŠw•”•‘®•a‰@‹~–œ‹~‹}ƒZƒ“ƒ^[): ‘æ20‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/7/30), “Œ‹ž.

733498. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •ÏŒ`«ŒÒŠÖßÇŠ³ŽÒ‚Ì•GŠÖß’É‚Æ•às‘¬“x‚ÌŠÖŒW. ŒŠÛƒ‰À1, _’JŒ’‘Ÿ˜Y1, Œ©ˆä“c˜a³1, t“ú”ü•Û1, •Ó“y–Œ—²1, X’JŒõr2, •Ÿ“‡Œ’‰î2, “àŽRŸ•¶2, ¬£NŽ¡2, ‚•œ®L3, ‚‘Š»Žm2 (1ƒŠƒnƒrƒŠƒe•”, 2®ŠO, 3ˆã—Éq¶Šw•”): ‘æ60‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2011/9/16), ˆïé.


‰h—{•”

[Šwp˜_•¶]

120103. [ŒŽ’˜] ‰º•”Á‰»ŠÇpŒã‚Ì‘ŠúŒoŒûÛŽæ‚ÉŠÖ‚·‚錟“¢. [‘ò²ŒbŽq1, ’†‘º—²r2, ¬–ì—¢q2, “n粏¹•F2, ²“¡ÆŽq1, –ìŒû‹…Žq1 (1‰h—{•”, 2ŠO‰È): “ú–{•a‘Ô‰h—{Šw‰ïŽ 2011; 14 (4): 309-16.

522249. [uÀ]y“ÁW: §ŒÀ‚΂©‚è‚ð‰Ÿ‚µ‚‚¯‚È‚¢ “§ÍŠ³ŽÒ‚̉h—{ŠÇ—z“§ÍŠ³ŽÒ‚̉h—{ŠÇ—Q&A@(10) “§Í“±“ü‘OŒã‚ʼnœ‚ª•Ï‚í‚é‚Ì?|•Û‘¶Šúš“±“üŠúšˆÛŽŠú|. (11) “§Í—ð (’·Šú“§Í) ‚É‚æ‚Á‚Ä, ‚Ç‚Ì‚æ‚€‚ÉŽw“±“à—e‚ð•Ï‚Š‚ê‚΂¢‚¢‚Ì?. (12) H—~‚Ì‚È‚¢Š³ŽÒ‚ɏ\•ª‚ȉh—{‚ð‚Æ‚Á‚Ä‚à‚ç‚€‚É‚Í, ‚Ç‚€‚·‚ê‚΂¢‚¢‚Ì?. ‹g“c•üŽq (‰h—{•”): ƒjƒ…[ƒgƒŠƒVƒ‡ƒ“ƒPƒA 2012/1; 5 (1): 36-41.

522250. [uÀ]y“ÁW: –ÚŽw‚¹ƒXƒLƒ‹ƒAƒbƒv! —Տ°‚ÌŠÇ—‰h—{Žm‚Ì‚š‚µ‚²‚Æ24z1 —Տ°‰h—{ŠÇ—@(1) ‰h—{ŠÇ—Œv‰æ. (2) ‰h—{ŠÇ—Œv‰æ‘‚̍쐬. (3) ‰h—{ŠÇ—‚Ì•]‰¿. ‹ß“¡‰{Žq (‰h—{•”): ƒjƒ…[ƒgƒŠƒVƒ‡ƒ“ƒPƒA 2012/3; 5 (3): 10-5.

[Šw‰ïEŒ€‹†‰ï“™]

713194. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Do Overweight Pregnant Women with Glucose Intolerance Require Additional Energy Intake during Pregnancy?. Hitomi M1, Moriya T2, Ichikawa R2, Hayashi A3, Kawakami Y1, Nakashima T1, Sato T1: ‘æ71‰ñ•Ä‘“œ”A•aŠw‰ï (2011/6/26), •Ä‘ƒTƒ“ƒfƒBƒGƒS, Diabetes 2011/7; 60 (suppl 1): A55. (lŒ©–ƒ”üŽq1, Žç‰®’B”ü2, Žsì—‹Žt2, —с@“N”Í3, ìã—IŽq1, ’†“ˆ‚Æ‚µ‚Ý1, ²“¡ÆŽq1: 1‰h—{•”, 2“à•ª”å‘ãŽÓ“à, 3‘‡f—Ã)

722242. [Šw‰ï (‘S‘)] (ƒ~ƒjƒ[ƒNƒVƒ‡ƒbƒv) dŠOŠ³ŽÒ‚É‚š‚¯‚é‰h—{ŠÇ—`ŠÔÚ”M—Ê‘ª’è‚ÌŒ‹‰Ê‚©‚ç`. HŽR—SŽq1, •Ð‰ª—Sˆê2, _œä’m“¹2, ²“¡ÆŽq1, ‹ß“¡‰{Žq1, ŽR“à”ü1, ¶‹î^—Žq1, Šì‘œì—í1, “y‰®Žu•Û3, ’†‘º@—D4, ‰““¡¬Žq5 (1‰h—{•”, 2‹~–œ, 3ŠÅŒì•”, 4–òÜ•”, 5—ÕŒŸ•”): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2012/2/23-24), _ŒË, “ú–{Ã–¬Œo’°‰h—{Šw‰ïŽ 2012/1; 27 (1): 273.

7231032. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) dÇ“ª•”ŠOŠ³ŽÒ‚ɑ΂·‚é‰h—{ŠÇ—. ²“¡ÆŽq1, HŽR—SŽq1, ‹ß“¡‰{Žq1, ŽR“à”ü1, ¶‹î^—Žq1, Šì‘œì—í1, •Ð‰ª—Sˆê2, _œä’m“¹2 (1‰h—{•”, 2‹~–œ): ‘æ15‰ñ“ú–{•a‘Ô‰h—{Šw‰ïENŽŸŠwpW‰ï (2012/1/14-15), ‹ž“s, “ú–{•a‘Ô‰h—{Šw‰ïŽ 2012/1; 15: S-47.

7231033. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘åŠw•a‰@‚É‚š‚¯‚閝«t‘Ÿ•a (CKD) ƒXƒe[ƒW1`3‚̉h—{Žw“±‚ÌŒø‰Ê‚Æ–ðŠ„. ‹g“c•üŽq1, ŽÂèŒb—¢1, ‰ï“c—D”ü1, êm‘qm”ü1, ²“¡ÆŽq1, Š™“cvšæ2 (1‰h—{•”, 2t‘Ÿ“à): ‘æ15‰ñ“ú–{•a‘Ô‰h—{Šw‰ï”NŽŸŠwpW‰ï (2012/1/14-15), ‹ž“s, “ú–{•a‘Ô‰h—{Šw‰ïŽ 2012/1; 15: S-59.

7231034. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Metabolic analyser‚ðŽg—p‚µ‚œƒoƒZƒhƒE•a‚Ì–Ú•WƒGƒlƒ‹ƒM[—Ê‚ÌŒŸ“¢. ìã—IŽq1, lŒ©–ƒ”üŽq1, ²“¡ÆŽq1, —с@“N”Í2, Žsì—‹Žt3, Žç‰®’B”ü3 (1‰h—{•”, 2‘‡f—Ã, 3“à•ª”å‘ãŽÓ“à): ‘æ15‰ñ“ú–{•a‘Ô‰h—{Šw‰ï”NŽŸŠwpW‰ï (2012/1/14-15), ‹ž“s, “ú–{•a‘Ô‰h—{Šw‰ïŽ 2012/1; 15: S-150.

7231035. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇŠOŠ³ŽÒ‚̉h—{ŠÇ—|ŠÔÚ”M—Ê‘ª’è‚ÌŒ‹‰Ê‚©‚ç|. HŽR—SŽq1, •Ð‰ª—Sˆê2, _œä’m“¹2 (1‰h—{•”, 2‹~–œ): ‘æ27‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï‘‰ï (2012/2/24), _ŒË.

733499. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚é‰h—{ƒTƒ|[ƒgƒ`[ƒ€‰ÁŽZ‚Ɛf—ÕñVŽZ’èã‚Ì–â‘è. ‹ß“¡‰{Žq1, ²“¡ÆŽq1, ’†“ˆ‚Æ‚µ‚Ý1, ‰¡‘K—SŽq1, HŽR—SŽq1, —é–Ø–M•F2, V–xˆ»Žq2, “y‰®Žu•Û2, Šâ‘º‹M”ü2, •ÐŽRˆŸŽ÷2, ’†‘º@—D3, •{ì”ü¹Žq3, ‰““¡¬Žq4, ŽO‰Y–F“T4, _œä’m“¹5, •Ð‰ª—Sˆê5 (1‰h—{•”, 2ŠÅŒì•”, 3–òÜ•”, 4—ÕŒŸ•”, 5‹~–œ): ‘æ3‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŽñ“sŒ—Žx•”ŠwpW‰ï (2011/5/14), ‰¡•l, ‘æ3‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŽñ“sŒ—Žx•”ŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/5; p.51.

733500. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚éš‹‰º’²®H (š‹‰ºH) ‰ü‘P‚ÌŽæ‚è‘g‚Ý. Šì‘œì—í1, ‹ß“¡‰{Žq1, [’J—LŠó1, HŽR—SŽq1, ¶‹î^—Žq1, —é–Ø“TÄ1, ŽR“à”ü1, Ž‰Æ—R”üŽq1, ²“¡ÆŽq1, ’†“ˆ‚Æ‚µ‚Ý2, ‹{è—FŒb3, ‰ª•”‘•c4, Ž–ì—R”y4 (1‰h—{•”, 2“Œ•a‰@‰h—{•”, 3ŠÅŒì•”, 4Žš•@): ‘æ36‰ñ_“ސ쌧‰h—{‰ü‘PŠw‰ï (2012/3/22), ‰¡•l, ‘æ36‰ñ_“ސ쌧‰h—{‰ü‘PŠw‰ïŒû‰‰Ž˜^W 2012/3; p.3.

733501. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “ü‰@Š³ŽÒ‚É‚š‚¯‚ét‘Ÿ•aŽ¡—×p“ÁŽêH•i‚̐ێæ‚ÉŠÖ‚·‚éŽÀ‘Ô. ŽÂèŒb—¢1, êm‘qm”ü1, ‰ï“c—D”ü1, ‹g“c•üŽq1, ’†‘ºŠ€”ü1 (1‰h—{•”): ‘æ36‰ñ_“ސ쌧‰h—{‰ü‘PŠw‰ï (2012/3/22), ‰¡•l, ‘æ36‰ñ_“ސ쌧‰h—{‰ü‘PŠw‰ïŒû‰‰Ž˜^W 2012/3; p.4.


•a‰@•a—•”

[Šwp˜_•¶]

110306. [ŒŽ’˜] Immunohistochemical, molecular, and clinicopathological analyses of urothelial carcinoma,micropapillary variant. Ishii S1, Ohbu M2, Toomine Y1, Nishimura Y2, Hattori M2, Yokoyama M3, Toyonaga M3, Kakinuma H3, Matsumoto K4: Pathol Int 2011/12; 61 (12): 723-30. (ÎˆäC•œ1, ‘å•”@œ2, ‰“•ô—RŠóŒb1, Œ‘º—R—¢2, •ž•”@Šw2, ‰¡ŽR@‘å3, –L‰i^Ÿ3, Š`ÀœA–M3, Œ–{˜a«4: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3•a—•”, 4”å”AŠí)

521038. [‰ðà] PCR-SSCP/Direct-Sequencing–@‚Ì•a—f’f‚ւ̉ž—p|–òÜ‚Ì“K‰ž—\‘ª‚Æ‚µ‚ā|. ŽR‰º˜a–ç1, ‹vê@Ž÷1, ’¬“c‘å•ã1, ŽOã“N•v2, ‹g“c@Œ÷2, ŽOŽ}@M2 (1•a‰@•a—•”, 2•a—): ƒTƒNƒ‰ƒtƒ@ƒCƒ“ƒeƒbƒNwebî•ñŽ•W–{“¹ê (ƒxƒeƒ‰ƒ“•Ò )2011/8; 8ŒŽ†: 1-8.

522251. [uÀ]y‘gD•W–{ì»‚É‚š‚¯‚é‘ŸŠí•Ê•W€‰»‚Ɛž“xŠÇ—z×–EŒŸžŽm‚ªƒxƒbƒhƒTƒCƒh‚ōs‚€v‘¬ŒŸž‚ÌŒ»ó: L“‡‘åŠw•a‰@•a—f’f‰È‚É‚š‚¯‚éo’£×–Ef‚̉^—p. ¬ìŸ¬, ŽR‰º˜a–ç1, ˆÉ“¡@m, Œì@• (1•a‰@•a—•”): Histo-Logic Japan 2011/10; 39 (1): 2-5.

522252. [uÀ]y‘gD•W–{ì»‚É‚š‚¯‚é‘ŸŠí•Ê•W€‰»‚Ɛž“xŠÇ—zŽq‹{‹ØŽî‘gD•W–{ì»‚É‚š‚¯‚郁ƒ^ƒm[ƒ‹’E…‚ÌŒø‰Ê. ŽR‰º˜a–ç1, “¿‰i‰p”Ž, ¬ìŸ¬ (1•a‰@•a—•”): Histo-Logic Japan 2011/10; 39 (1): 5-8.

[’˜@‘]

620260. [Šwp‘] (•ª’SŽ·•M)yŠàf—ÃŽwj‚Ì‚œ‚ß‚Ì•a—f’fƒvƒ‰ƒNƒeƒBƒX ”xŠàz×–Ef’f. P.31-40. Š`ÀœA–M1, ²“¡”Vr2 (1•a‰@•a—•”, 2ŒÄ‹zŠíŠO), ê–å•ÒW: ŒŒŽ@C, ‘•ÒW: ÂùŽ”V, ’†ŽR‘“X, “Œ‹ž, 2011/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

7231036. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •a—•W–{‚ð—p‚¢‚œ–ƉuƒOƒƒuƒŠƒ“Hœˆâ“`ŽqÄ\¬‰ðÍ‚É‚š‚¯‚épitfall‚̑Ώˆ–@. ŽR‰º˜a–ç1, ‹vê@Ž÷1, ’¬“c‘å•ã1, ‹g“c@Œ÷2, ŽOã“N•v2, ŽOŽ}@M2 (1•a‰@•a—•”, 2•a—): ‘æ60‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2011/6/4), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€, ˆãŠwŒŸž 2011/4; 60 (4): 383.

7231037. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ûŠàƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß‚É‚š‚¯‚é×–E‘B”\‚ÌŒŸ“¢. âŒû@”E1, ŽR‰º˜a–ç1, ‘ •À@Ÿ2, ŽOã“N•v3, ŽOŽ}@M3 (1•a‰@•a—•”, 2ŠO‰È, 3•a—): ‘æ60‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2011/6/4), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€, ˆãŠwŒŸž 2011/4; 60 (4): 474.

7231038. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŽ”­«”x‘BŠà‚š‚æ‚ѝG•œã”çŠà‚̊ӕʐf’f‚É‚š‚¯‚é–Ɖu‘gD×–E‰»Šw–@‚Ì—L—p«. Ä“¡ƒ]1, Š`ÀœA–M1, ‰¡ŽR@‘å1, Œ‘º—R—¢2, •ž•”@Šw2, ŽR‰º˜a–ç1, ²“¡—Yˆê2, ²“¡”Vr3, ŽOã“N•v4, ŽOŽ}@M4 (1•a‰@•a—•”, 2ˆã—Éq¶Šw•”, 3ŒÄ‹zŠíŠO, 4•a—): ‘æ50‰ñ“ú–{—Տ°×–EŠw‰ïHŠú‘å‰ï (2011/10/22), ‹ž‰€ƒvƒ‰ƒUƒzƒeƒ‹.

733502. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)y•œ¬20”N“xEˆõŒ€‹† 2008-04zˆâ“`Žq‚ÆPCR‚ÌŠî‘b. ŽR‰º˜a–ç (•a‰@•a—•”): _“ސ쌧—Տ°‰q¶ŒŸž‹ZŽt‰ï •a—E×–EŒ€C”Ǎ‡“¯Œ€C‰ï (2011/6/25), ‰¡•l.


MEƒZƒ“ƒ^[

[Šwp˜_•¶]

120104. [ŒŽ’˜] —Տ°HŠw‹ZŽm‚É‚æ‚é‹~‹}ˆã—Âւ̎æ‚è‘g‚Ý. “ŒžŠŒ\ˆê (MEƒZ): _“ސ쌧•a‰@Šw‰ïŽ 2012/3; 30: 49-53.

220029. [€ŒŽ’˜] (Œ€‹†˜_•¶) ¬Ž™ŠJSp‚É‚š‚¯‚éD’†‹…ƒGƒ‰ƒXƒ^[ƒ[‘jŠQÜ‚Ì—\–h“I“Š—^‚ÉŠÖ‚·‚錟“¢. ŒÃ•œ@‘1, ˆäãMK2, “¡ˆä³ŽÀ1, •“cÍ”1, “ŒžŠŒ\ˆê1, ‹{’n@ŠÓ2 (1MEƒZ, 2S‘ŸŒŒŠÇŠO): ‘ÌŠOzŠÂ‹Zp 2012/6; 38 (2): 178-82.

522253. [uÀ]y“ÁWI: [ŽÀ‚µ‚œ—Տ°ŽÀK‚ð–ÚŽw‚µ‚āz—Տ°ŽÀK‚É—Õ‚ÞŠw¶‚ց|—Տ°Œ»ê‚̐æ”y‚©‚ç‚̃AƒhƒoƒCƒX|. ¬ŠÖMŒá, ’·‘º–ΑŸ1, ³–Ø—ÁŽq, –L“c‰pŽ¡ (1MEƒZ): Clinical Engineering 2011/6; 22 (7): 676-7.

522254. [uÀ]y“ÁW: ˆã—Ë@Ší‚̃Aƒ‰[ƒ€|–â‘è“_‚ƃgƒ‰ƒuƒ‹‚ð–h‚®Žæ‚è‘g‚݁|z¶‘̏î•ñƒ‚ƒjƒ^‚̃Aƒ‰[ƒ€‚Í‚±‚ñ‚Ȃɖ‚Á‚Ä‚¢‚é. ’†‘º‹±Žq1, œA£@–«2 (1MEƒZ, 2ˆã—Éq¶Šw•”): Clinical Engineering 2011/8; 22 (9): 859-61.

522255. [uÀ]y“ÁW: ˆã—Ë@Ší‚̃Aƒ‰[ƒ€|–â‘è“_‚ƃgƒ‰ƒuƒ‹‚ð–h‚®Žæ‚è‘g‚݁|zƒAƒ‰[ƒ€‚ÉŠÖ‚·‚éƒgƒ‰ƒuƒ‹‚ð–h‚®Žæ‚è‘g‚Ý: lHŒÄ‹zŠí|RST‚ð’Ê‚¶‚ẴAƒ‰[ƒ€‹³ˆç|. “ŒžŠŒ\ˆê1, ‘‘¬TŒá1 (1MEƒZ): Clinical Engineering 2011/8; 22 (9): 868-73.

522256. [uÀ]y“ÁW: ƒy[ƒXƒ[ƒJ‹Æ–±‚É‚š‚¯‚é—Տ°HŠw‹ZŽm‚Ì–ðŠ„|V‹Æ–±Žwj‚𓥂܂Š‚ā|z—Տ°HŠw‹ZŽm—{¬Ž{Ý‚É‚š‚¯‚éƒy[ƒXƒ[ƒJ‹³ˆç|–k—¢‘åŠwˆã—Éq¶Šw•”|. •“cÍ”1, œA£@–«2 (1MEƒZ, 2ˆã—Éq¶Šw•”): Clinical Engineering 2012/2; 23 (3): 859-61.

[Šw‰ïEŒ€‹†‰ï“™]

722243. [Šw‰ï (‘S‘)] (ƒ[ƒNEVƒ‡ƒbƒv) –³NP¬‡ŒŒŽ_‘f–O˜a“xŠÄŽ‹ƒVƒXƒeƒ€‚̗Տ°‰ž—p. “ŒžŠŒ\ˆê1, “¡ˆä³ŽÀ1, ŒÃ•œ@‘1 (1MEƒZ): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/29), –‹’£, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ 2012/1; 19 (Suppl): 428.

7231039. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Œõƒtƒ@ƒCƒo‚ð—p‚¢‚œ˜RŒŒŒx•ñ‘•’u‚̗Տ°Žg—p. ²“¡‰hŽ¡1, ¬ŽR@œ1, ’|“à–Ÿ”Ž2, ™•£—mK3, Žlƒc’J¹l3, “ŒžŠŒ\ˆê1, Š™“cvšæ4 (1MEƒZ, 2ˆã—Éq¶Šw•”, 3Š”Ž®‰ïŽÐHŽÐ, 4t‘Ÿ“à): ‘æ39‰ñ“ú–{ŒŒ‰tò‰»‹ZpŠw‰ïŠwp‘å‰ïE‘‰ï (2012/4/20), •Ÿ‰ª.

7231040. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–ƒZƒ“ƒ^[‚ÌŠŽõ‘΍ô‚ÌŽæ‚è‘g‚݁`ƒEƒHƒbƒVƒƒ[ƒfƒBƒXƒCƒ“ƒtƒFƒNƒ^[‚Ì“±“ü`. ”’ˆä“ÖŽj1, ‘‘¬TŒá1, “ŒžŠŒ\ˆê1, ˆî–с@”Ž1, ŒÃ•œ@‘1, š ³Œ©1, ²“¡Œb仓Þ1 (1MEƒZ): ‘æ21‰ñ“ú–{—Տ°HŠw‰ï (2011/5/22), •Ê•{, “ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽ 2011/4; 42: 181.

7231041. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒ[ƒe[ƒ^[‚ɑ΂·‚é“ž’B“x•]‰¿•\‚Ì“±“ü. “ŒžŠŒ\ˆê1, ˆî–с@”Ž1, –쑺’q”V1, ¬ŽR@œ1, ”’ˆä“ÖŽj1, ²“¡³Œ›1, ŒÃ•œ@‘1, “¡ˆä³ŽÀ1, –؉ºt“Þ1 (1MEƒZ): ‘æ21‰ñ“ú–{—Տ°HŠw‰ï (2011/5/22), •Ê•{, “ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽ 2011/4; 42: 190.

7231042. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –³|Ž_“§Í‰t‚ÌCRFŠ³ŽÒ‚̏zŠÂ“®‘Ô‚Ö‹y‚Ú‚·‰e‹¿. ŠOŠÔMl1, ¬ŽR@œ1, “¡ŒŽNì1, –ìì—²ˆê˜Y1, “Œ@Œ«ˆê1, “ŒžŠŒ\ˆê1, Š™“cvšæ2 (1MEƒZ, 2t‘Ÿ“à): ‘æ56‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2011/6/18), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2011/5; 44 (Suppl-1): 467.

7231043. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆã—Ë@ŠíŠÇ—‚É‚š‚¯‚銎õŠÇ—‚ÌŒŸ“¢. ‘‘¬TŒá1, “ŒžŠŒ\ˆê1, ”’ˆä“ÖŽj1, ˆî–с@”Ž1, ŒÃ•œ@‘1, š ³Œ©1, ²“¡Œb仓Þ1 (1MEƒZ): ‘æ86‰ñ“ú–{ˆã—Ë@ŠíŠw‰ï‘å‰ï (2011/6/3), ‰¡•l, ˆã—Ë@ŠíŠw 2011/4; 81 (4): 121.

7231044. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆã—Ë@Ší‚Ì”z’uˆÊ’u‚ÆŠeŽíƒR[ƒh—Þ‚ÉŠÖ‚·‚錟“¢. Œ‰ªNŽ¡1, “ŒžŠŒ\ˆê1, ”’ˆä“ÖŽj1, “¡ˆä³ŽÀ1, ‘‘¬TŒá1 (1MEƒZ): ‘æ86‰ñ“ú–{ˆã—Ë@ŠíŠw‰ï‘å‰ï (2011/6/3), ‰¡•l, ˆã—Ë@ŠíŠw 2011/4; 81 (4): 138.

7231045. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “K³Ÿó—¬—Ê‚ðÄl‚·‚é: ¬Ž™ŠJSp‚É‚š‚¯‚éƒVƒXƒeƒ€•ÏX‚É‚æ‚éŸó—¬ðŒ‚̕ω»‚Ɖe‹¿‚ÉŠÖ‚·‚錟“¢. ŒÃ•œ@‘1, “¡ˆä³ŽÀ1, •“cÍ”1, “ŒžŠŒ\ˆê1, ‹{’n@ŠÓ2 (1MEƒZ, 2S‘ŸŒŒŠÇŠO): ‘æ37‰ñ“ú–{‘ÌŠOzŠÂ‹ZpˆãŠw‰ï (2011/10/9), –ŒŒÃ‰®, ‘ÌŠOzŠÂ‹Zp 2011/9; 38 (3): 372.

7231046. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒGƒNƒZƒ‰ƒ“Kids’·ŠúŽg—pŽž‚É‚š‚¯‚鐫”\‚ÉŠÖ‚·‚錟“¢: ]—ˆŽg—p•i‚Æ‚Ì”äŠr. ‘哇O”V1, “ŒžŠŒ\ˆê1, “¡ˆä³ŽÀ1, •“cÍ”1, š ³Œ©1, ŒÃ•œ@‘1, ‹{’n@ŠÓ2 (1MEƒZ, 2S‘ŸŒŒŠÇŠO): ‘æ37‰ñ“ú–{‘ÌŠOzŠÂ‹ZpˆãŠw‰ï (2011/10/8), –ŒŒÃ‰®, ‘ÌŠOzŠÂ‹Zp 2011/9; 38 (3): 400.

7231047. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒCƒ“ƒVƒfƒ“ƒg”­¶‚©‚猎ˆö‹†–Ÿ, Ä”­–hŽ~‚É‚š‚¯‚é‘ŒEŽíŠÔ˜AŒg|ƒKƒXƒPƒbƒg‘¹Ž–—á‚ł̉@“à‘Ήž‚ɂ‚¢‚ā|. “ŒžŠŒ\ˆê1, •“cÍ”1, ‘‘¬TŒá1, rˆä—R”ü2, Â–ö–ŸŽq2, ‘Š”nˆêˆå3, ¬‰z–Ÿ”ü4, ‰ª“c@Œ’5, ã‘œOŽu5 (1MEƒZ, 2ˆã—ÈÀ‘SŠÇ—Žº, 3‹~–œ, 4ŠÅŒì•”, 5ƒeƒ‹ƒ‚Š”Ž®‰ïŽÐ): ‘æ6‰ñˆã—Â̎¿EˆÀ‘SŠw‰ïŠwpW‰ï (2011/11/19), “Œ‹ž, ˆã—Â̎¿EˆÀ‘SŠw‰ïŽ, 2011/10; 6 (suppl): 204.

7231048. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬Ž™W’†Ž¡—×̈æ‚É‚š‚¯‚éƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^[‚ð—p‚¢‚œSpCO, SpMet‚ÌŒŸ“¢. “¡ˆä³ŽÀ1, “ŒžŠŒ\ˆê1, –؉ºt“Þ1, ‘‘¬TŒá1, •“cÍ”1, ‹{’n@ŠÓ2 (1MEƒZ, 2S‘ŸŒŒŠÇŠO): ‘æ39‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2012/2/28-3/1), ç—t, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ 2012/2; 19 (Suppl): 435.

732161. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) —Տ°HŠw‹ZŽm‚É‚æ‚é‹~‹}ˆã—Âւ̎æ‚è‘g‚Ý. “ŒžŠŒ\ˆê (MEƒZ): ‘æ30‰ñ_“ސ쌧•a‰@Šw‰ï (2011/11/14), ‰¡•l, ‘æ30‰ñ_“ސ쌧•a‰@Šw‰ïŽ˜^W, 2011/11; p.7.

733503. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‰@“à‚ɐݒu‚³‚ê‚œœ×“®Ší‚ÌŽd—l‚ÉŠÖ‚·‚錟“¢. “c‘º”ü¹‹I1, “ŒžŠŒ\ˆê1, “¡ˆä³ŽÀ1, ¡•ª@—m2 (1MEƒZ, 2“ú–{Œõ“dH‹Æ): _“ސ쌧—Տ°HŠw‹ZŽm‰ï•œ¬23”N“xŠwp‘å‰ï (2011/5/29), ‰¡•l, •œ¬23”N“x_“ސ쌧—Տ°HŠw‹ZŽm‰ïŠwp‘å‰ïŽ˜^W 2011; p.5.


Ž¡Œ±ŠÇ—Žº


ˆã—ÈÀ‘SŠÇ—Žº


ŠŽõŠÇ—Žº


–k—¢‘åŠw“Œ•a‰@

“Œ•a‰@ŠÅŒì•”

[Šwp˜_•¶]


[’˜@‘]

620261. [Šwp‘] (•ª’SŽ·•M)yŽÀ‘H ž_‰ÈŠÅŒìƒeƒLƒXƒg (‰ü’ù”Å) ‘æ3Šª@ž_‹@”\^ž_‰Èf’fz‘æ2Í@ž_‰È—̈æ‚É‚š‚¯‚éf’f‚Æ•ª—ށ@ŠÅŒì•K—v“x‚ÆŠˆ—p‚ÌŽÀÛ, p.124-34. ’†‘º^Ži (“Œ•a‰@ŠÅŒì•”), ŠÄC “ú–{ž_‰ÈŠÅŒìŽžp‹Š‰ï, ž_ŠÅŒìo”Å, 2011.5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

7231049. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒWƒŒƒ“ƒ}‚ð•ø‚«‚È‚ª‚ç—Ï—’²®‚ðs‚Á‚œ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚ð–ÚŽw‚·C—¹¶‚̐¬’·|—Ï—’²®‚ÌŽ–—ጟ“¢‰ï‚ð’Ê‚µEā|. ‰ª@‘œŒb1, Ž™‹Ê”ü—R‹I2, ²“¡”ü‹I2 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒì•”): ‘æ26‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2012/2/11), “‡ª, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ2012/1; 26(“Á•Ê†): 180.

733504. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) —\Šú‚¹‚žƒ_ƒuƒ‹ƒXƒg[ƒ}‚Æ‚È‚Á‚œÂ”NŠú’j«‚ÌŽ–—á. “n•Ó¹D1, ŒŒŽN”ü2 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒì•”): ‘æ34‰ñ_“ސìƒXƒg[ƒ}Œ€‹†‰ï (2011/12/10), _“ސì.


“Œ•a‰@—Տ°ŒŸž•”

[Šwp˜_•¶]

120105. [ŒŽ’˜] ’Ž‰¹”gƒpƒ‹ƒXƒhƒvƒ‰–@‚ð—p‚¢‚œŠÌØœ‘OŒã‚ÌŠÌŒŒ—¬“®‘Ô‚ÌŒŸ“¢. –öŒŽ”ü’qŽq1, ŒFâ@L1, ‰““¡@—m1, “¡ˆä@Ž 1, ’†Œ‹vK2, “•ûLˆê2, Žë–ì—Lì3, ŒÃ“cˆê“¿4 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”, 3—ÕŒŸŠw, 4ŠO‰È): ’Ž‰¹”gŒŸž‹Zp 2011/4; 36 (2): 133-41.

120106. [ŒŽ’˜] ”F’mÇŠÓ•ÊŠO—ˆŽófŽÒ‚Ì“®–¬d‰»“x‚©‚ç‚Ý‚œ”]”gŠî‘bŠˆ“®‚ÌŒŸ“¢. —é–؏~Žq1, •P“c‹v”ü1, ‘ºŽR^‹|1, ‰Ÿ“cD”ü1, ‹g–{gŽq1, âV“¡³”Í2, ‚‹Ž@Œb2 (1“Œ•a‰@—ÕŒŸ•”, 2ž_): —Տ°_Œo¶—Šw 2011/10; 39 (5): 443.

120107. [ŒŽ’˜] Ò‘¬”]•Ï«Ç‚ɑ΂·‚éTRH-T—Ö@Œø‰Ê‚̏dS“®—hŒŸž‚É‚æ‚é’ZŠúŠÔ•]‰¿. ‘ºŽR^‹|1, ˆÉ•ÛŽŽq2, ó–ì˜a]2, ˆ¢‹v’Óñ•v3, ’·À‰p–Ÿ4, “¿‘Œú“ñ4, ‰ª–{–ql4 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”, 3_Œo“à, 4Žš•@): Equilib Res 2012/2; 7 (1): 40-6.

522257. [uÀ]y“ÁW (2): —Տ°Œ€‹†‚ÉŒg‚í‚é‚·‚ׂĂ̌€‹†ŽÒ‚Ì‚œ‚߂Ɂ|‰ž—p•Ò|z3. —Տ°¶—Šw“IŒŸž‚ÌŽÀÛ. ²‹Ž–M•F1,2, ’r“cN•F2, ŒF’J—YŽ¡2 (1“Œ‰@—ÕŒŸ•”, 2“Œ‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[): ˆã—ÂƌŸž‹@ŠíEŽŽ–ò 2011/6; 34 (3): 309-13.

522258. [uÀ]y‹Ù‹}•ñ‚·‚ׂ«ŒŸžŒ‹‰Ê‚Ì‚·‚ׂā|‚·‚®Žg‚Š‚éƒpƒjƒbƒN’lŽ–“TzE ¶—@S“d}. •xŒŽ@Œ’1, ‹g–{gŽq2, Ží‘º@³3, ¬’J“ÖŽu4, •ÄŽR¹Ži5, ŠÖª’q‹I6, ”’ÎŽüˆê7, –©ì–õ”V8 (1’é‹ž‘åŠwˆãŠw•”•‘®•a‰@’†‰›ŒŸž•”, 2“Œ•a‰@—ÕŒŸ•”, 3S‘ŸŒŒŠÇŒ€‹†Š—Տ°ŒŸž•”, 4‹ß‹E‘åŠwˆãŠw•”•‘®•a‰@’†‰›—Տ°ŒŸž•”, 5Ã‰ªŒ§Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[¶—ŒŸž‰È, 6‘•Ûˆ®’†‰›•a‰@’†‰›ŒŸž‰È, 7“ŒŠC‘åŠwˆãŠw•”•‘®•a‰@—Տ°ŒŸž‹Zp‰È, 8‘—§‘Ûˆã—ÃŒ€‹†ƒZƒ“ƒ^[’†‰›ŒŸž•”): ŒŸž‚Æ‹Zp 2011/9; 39 (10): 887-93.

[Šw‰ïEŒ€‹†‰ï“™]

722244. [Šw‰ï (‘S‘)] (ƒXƒeƒbƒvƒAƒbƒvƒŒƒNƒ`ƒƒ[) ”å”AŠí—̈æ. “¡ˆä@Ž  (“Œ•a‰@—ÕŒŸ•”): ‘æ36‰ñ“ú–{’Ž‰¹”gŒŸžŠw‰ï (2011/6/26), ’}”g‘Û‰ï‹cê.

7231050. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”F’mÇŠÓ•ÊŠO—ˆŽófŽÒ‚Ì“®–¬d‰»“x‚©‚ç‚Ý‚œ”]”gŠî‘bŠˆ“®‚ÌŒŸ“¢. —é–؏~Žq1, •P“c‹v”ü1, ‘ºŽR^‹|1, ‰Ÿ“cD”ü2, ‹g–{gŽq1, âV“¡³”Í3, ‚‹Ž@Œb3 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”, 3ž_): ‘æ41‰ñ“ú–{—Տ°_Œo¶—Šw‰ïEŠwp‘å‰ï (2011/11/11), Ã‰ª, —Տ°_Œo¶—Šw 2011/10; 39 (10): 443.

733505. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’Ž‰¹”gƒpƒ‹ƒXƒhƒvƒ‰–@‚ð—p‚¢‚œŠÌØœ‘OŒã‚ÌŠÌŒŒ—¬“®‘Ô‚ÌŒŸ“¢. –öŒŽ”ü’qŽq1, ŒFâ@L1, ‰““¡@—m1, “¡ˆä@Ž 1, “•ûLˆê2, Žë–ì—Lì3, ŒÃ“cˆê“¿4 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”, 3—ÕŒŸŠw, 4ŠO‰È): ‘æ1‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2011/7/16), “Œ‹ž.

733506. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰): “Œ•a‰@‚É‚š‚¯‚éƒ`[ƒ€ˆã—Âւ̎Q‰æ‚ÌŒ»ó|NSTŠˆ“®‚𒆐S‚Ɂ|. •P“c‹v”ü1, ‰Ÿ“cD”ü2, â–{’q”ü1, ‹g–{gŽq1 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”): ‘æ1‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2011/7/16), “Œ‹ž.


“Œ•a‰@–òÜ•”

[Šwp˜_•¶]

110307. [ŒŽ’˜] Antiproliferative and anti-invasive effects of inorganic and organic arsenic compounds on human and murine melanoma cells in vitro. Hiwatashi Y1,2, Tadokoro H1, Henmi K1, Arai M2, Kaise T3, Tanaka S1, Hirano T1 (1Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2Department of Pharmacy, Kitasato University East Hospital, 3Department of Environmental Chemodynamics, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences): J Pharm Pharmacol 2011/9; 63 (9): 1202-10. (”ó“n—zŽq1,2, Vˆä–œ—Žq2: 2“Œ•a‰@–òÜ•”)

110308. [ŒŽ’˜] Azithromycin suppresses proliferation, interleukin production and mitogen-activated protein kinases in human peripheral-blood mononuclear cells stimulated with bacterial superantigen. Hiwatashi Y1,2, Maeda M3, Fukushima H1, Onda K1, Tanaka S1, Utsumi H4, Hirano T1 (1Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2Department of Pharmacy, Kitasato University East Hospital, 3Bohsei Pharmacy, 4Third Department of Internal Medicine, Tokyo Medical University): J Pharm Pharmacol 2011/10; 63 (10): 1320-6. (”ó“n—zŽq1,2: 2“Œ•a‰@–òÜ•”)

110309. [ŒŽ’˜] Clinical efficacy of arbekacin for Gram-negative bacteria. Hamada Y1, Tamura K2, Koyama I2, Kuroyama M1,3, Yago K2,3, Sunagawa K4 (1Department of Pharmacy, Kitasato University East Hospital, 2Department of Pharmacy, Kitasato University Hospital, 3Kitasato University School of Pharmaceutical Science, 4Kitasato University of Kitasato Institute for Life Science): J Infect Chemother 2011/12; 17 (6): 876-9. (•l“cKG1, “c‘º˜aŒh2, ¬ŽRˆè”ü2, •ŽR­ˆê1,3, –îŒã˜a•v2,3, »ìŒc‰î4: 1“Œ•a‰@–òÜ•”, 2–òÜ•”, 3–òŠw•”, 4–k—¢¶–œ‰ÈŠwŒ€‹†Š)

110310. [ŒŽ’˜] Effects of inorganic and organic arsenic compounds on growth and apoptosis of human T-lymphoblastoid leukemia cells. Hikita E1, Arai M2, Tanaka S1, Onda K1, Utsumi H1, Yuan B1, Toyoda H1, Hirano T1 (1Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2Department of Pharmacy, Kitasato University East Hospital): Anticancer Res 2011/12; 31 (12): 4169-78. (Vˆä–œ—Žq2: 2“Œ•a‰@–òÜ•”)

110311. [ŒŽ’˜] Antiproliferative and apoptosis-inducing effects of lipophilic vitamins on human melanoma A375 cells in vitro. Ishibashi M1, Arai M2, Tanaka S1, Onda K1, Hirano T1 (1Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2Department of Pharmacy, Kitasato University East Hospital): Biol Pharm Bull 2012; 35 (1): 10-7. (Vˆä–œ—Žq2: 2“Œ•a‰@–òÜ•”)

110312. [ŒŽ’˜] Dose Conversion during Opioid Rotation from Continuous Intravenous Infusion of Morphine Hydrochloride to Oral Administration of Oxycodone Sustained-release Tablets. Kawano C1,2, Hirayama T1,2, Sasaki T3, Kuroyama M1,2 (1Pharmacy Practice and Science II, School of Pharmacy, Kitasato University, 2Department of Pharmacy, Kitasato University East Hospital, 3Department of Gastroenterology, Kitasato University East Hospital): Jpn J Pharm Health Care Sci 2012/3; 38 (3): 170-6. (ì–ìçq1,2, •œŽR•Ži1,2, ²X–Ø“O3, •ŽR­ˆê1,2: 1–òŠw•”, 2“Œ•a‰@–òÜ•”, 3Á‰»Ší“à)

120108. [ŒŽ’˜] ƒeƒŒƒrƒhƒ‰ƒ}‚É‚š‚¯‚é‹i‰ŒŠÖ˜A•`ŽÊ‚ÉŠÖ‚·‚é’²žŒ€‹†. •ŽR­ˆê1,2, ‘Š‘ò­–Ÿ1, —с@¹¢3, “cƒ–’J_–M3 (1“Œ•a‰@–òÜ•”, 2–òŠw•”, 3ˆã—Éq¶Šw•”): “ú–{‹Ö‰ŒŠw‰ïŽGŽ 2011/5; 6 (2): 16-20.

120109. [ŒŽ’˜] ¬Ž™MRSAŠŽõÇ‚ɑ΂·‚éLZD‚ÌŽg—pŒoŒ±. •l“cKG1, ŠÖ‚ß‚®‚Ý2, “c‘º˜aŒh2, ”ö’¹Ÿ–ç2,3, ŒŒŽ@”£2, ‰Ô–؏G–Ÿ4, •ŽR­ˆê1,3, –îŒã˜a•v2,3, »ìŒc‰î5 (1“Œ•a–òÜ•”, 2–òÜ•”, 3–òŠw•”, 4¶–œ‰ÈŠwŒ€‹†ŠRŠŽõ•a–òŒ€‹†ƒZƒ“ƒ^[, 5–k—¢‘åŠw¶–œ‰ÈŠwŒ€‹†ŠŠŽõ§ŒäŠw•{): ‰»Šw—Ö@‚̗̈æ 2011/9; 27 (9): 2103-12.

522259. [uÀ]y“ÁW: ‚—îŽÒ@“œ”A•az‚—îŽÒ“œ”A•a‚É‚š‚¯‚錌“œƒRƒ“ƒgƒ[ƒ‹‚ÌŠî–{@ƒVƒbƒNƒfƒC‚Ì‚Æ‚«‚ÌŒŒ“œ~‰º–ò‚Ì—p—ʐݒè‚Í? ‘Š‘ò­–Ÿ1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): –ò‹Ç 2011/12; 62 (13): 3850-4.

540080. [‚»‚Ì‘Œ (u‰‰‹L˜^)]y‘æ3‰ñICŒ€‹†‰ïŠwpW‰ïu‰‰‹L˜^zŽs”̖ŋۍς݃xƒ“ƒUƒ‹ƒRƒjƒEƒ€‰–‰»•šŽÀ—p”Z“x‰t‚̏¬•ª‚¯’²»Œã‚̊ܗʕω»‚È‚ç‚Ñ‚É”÷¶•š‰˜õ‚ÉŠÖ‚·‚錀‹†. ‘꓇˜aW1, •ŽR­ˆê1, •l“cKG1, ²X–Ø‘PM1 (1“Œ•a‰@–òÜ•”): ‘æ3‰ñICŒ€‹†‰ïŠwpW‰ïu‰‰‹L˜^ 2012; p.13-5.

[’˜@‘]

620262. [Šwp‘] (•ª’SŽ·•M)yÝ‘îˆã—ÃQ & A@•œ¬23”N”Ł@•ž–òŽx‰‡‚Æ‘œEŽí‹Š“­E˜AŒg‚̃|ƒCƒ“ƒgz‘æ7Í ŠÉ˜aƒPƒA‚Ì’mŽ¯@ŠÉ˜aƒPƒA, p.116-36. •œŽR•Ži1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”), ŠÄC: “ú–{–òÜŽt‰ï, ‚¶‚Ù‚€, “Œ‹ž, 2011/8”­s.

620263. [Šwp‘] (•ª’SŽ·•M)yÝ‘îˆã—ÃQ & A@•œ¬23”N”Ł@•ž–òŽx‰‡‚Æ‘œEŽí‹Š“­E˜AŒg‚̃|ƒCƒ“ƒgz‘æ7Í ŠÉ˜aƒPƒA‚Ì’mŽ¯@I––Šú, p.142-3. •œŽR•Ži1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”), ŠÄC: “ú–{–òÜŽt‰ï, ‚¶‚Ù‚€, “Œ‹ž, 2011/8”­s.

620264. [Šwp‘] (•ª’SŽ·•M)yƒCƒ“ƒ^[ƒvƒƒtƒFƒVƒ‡ƒiƒ‹Eƒwƒ‹ƒXƒPƒA@ŽÀ‘H ƒ`[ƒ€ˆã—Ø_zI ƒ`[ƒ€ˆã—ÊT˜_@2. •ÛŒ’ˆã—ÕŸŽƒ‚̃VƒXƒeƒ€‚ƐE”\@2) Šeˆã—ÐE‚̐E”\‚ƈã—Ï]Ž–ŽÒ‚Ì‚Æ‚ç‚Š‚éƒ`[ƒ€ˆã—Ã, p.15-6. •ŽR­ˆê1,2 (1“Œ•a‰@–òÜ•”, 2–òŠw•”), •ÒW: …–{Ž‹v, ‰ª–{–ql3, Îˆä–M—Y, “y–{Š°“ñ (3Žš•@), ˆãŽ•–òo”Å, “Œ‹ž, 2011/10”­s.

620265. [Šwp‘] (•ª’SŽ·•M)y–òÜŽt‚Ì‚œ‚ß‚ÌŠŽõ‘΍ôE§Œäƒ}ƒjƒ…ƒAƒ‹ ‘æ3”Łz‘æVÍ ŠŽõ‘΍ô‚ÌŽÀÛ@7. ’ŽË–ò‚Ì–³‹Û’²»|—A‰t’²»‚̃|ƒCƒ“ƒg|, p.370-6. •ŽR­ˆê1, •œŽR•Ži1, î@Ž}1 (1“Œ•a‰@–òÜ•”), ŠÄC: “ú–{•a‰@–òÜŽt‰ï, •ÒW: “ú–{•a‰@–òÜŽt‰ïŠŽõ§Œäê–å–òÜŽt•”–å, –òŽ–“ú•ñŽÐ, “Œ‹ž, 2011/12”­s.

620266. [Šwp‘] (•ª’SŽ·•M)yŽ¡—Öòƒnƒ“ƒhƒuƒbƒN2012@–òÜ‘I‘ð‚Əˆ•û‚̃|ƒCƒ“ƒgz“¯Œø–ò”äŠr•\, Šª“ª7-Šª“ª37. •ŽR­ˆê1, ‚‹Ž”ü—R‹I1 (1“Œ•a‰@–òÜ•”), ŠÄC: ‚‹vŽj–›2 (2Ž©Ž¡ˆã‰È‘åŠw), •ÒW: –x@³“ñ3, ›–쌒‘Ÿ˜Y2, –å˜e@F4, Š£@Œ«ˆê5, —с@¹—m6 (3‘åã•{—§¬l•aƒZƒ“ƒ^[, 4“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È, 5‹ž“s–ò‰È‘åŠw, 6ŒÕƒm–å•a‰@), ‚¶‚Ù‚€, “Œ‹ž, 2012/1”­s.

620267. [Šwp‘] (•ª’SŽ·•M)yŽ¡—Öòƒnƒ“ƒhƒuƒbƒN2012@–òÜ‘I‘ð‚Əˆ•û‚̃|ƒCƒ“ƒgz–òÜƒŠƒXƒg. •ŽR­ˆê1, ‚‹Ž”ü—R‹I1, ‘Œ31–Œ (1“Œ•a‰@–òÜ•”), ŠÄC: ‚‹vŽj–›2 (2Ž©Ž¡ˆã‰È‘åŠw), •ÒW: –x@³“ñ3, ›–쌒‘Ÿ˜Y2, –å˜e@F4, Š£@Œ«ˆê5, —с@¹—m6 (3‘åã•{—§¬l•aƒZƒ“ƒ^[, 4“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È, 5‹ž“s–ò‰È‘åŠw, 6ŒÕƒm–å•a‰@), ‚¶‚Ù‚€, “Œ‹ž, 2012/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722245. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€10: ŠÉ˜a–ò•š—Ö@”F’è–òÜŽt‚Ì”F’èŽæ“Ÿ‚ÉŒü‚¯‚Ä (”F’èˆÏˆõ‰ï)zƒVƒ“ƒ|ƒWƒEƒ€‚ÌŽåŽ|‚Ɛ\¿Ž‘Ši. •œŽR•Ži (“Œ•a‰@–òÜ•”): ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï (2011/9/24), –‹’£, ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ïƒvƒƒOƒ‰ƒ€E—vŽ|W 2011/9; p.104.

7231051. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Tazobactam/Piperacillin (1:8»Ü) ‚ÌPK-PD‰ðÍ. •l“cKG1, ‚‹Ž¹Ž÷2, »ìŒc‰î3, •ŽR­ˆê1,2 (1“Œ•a‰@–òÜ•”, 2‘åŠw‰@–òŠwŒ€‹†‰È, 3¶–œ‰ÈŠwŒ€‹†ŠŠŽõÇŠw): ‘æ59‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2011/6/24), ŽD–y, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ 2011/6; 59 (S-A): 239.

7231052. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’·è‘åŠw•a‰@‚É‚š‚¯‚éƒ{ƒŠƒRƒiƒ][ƒ‹ŒŒ’†”Z“x‘ª’è—á‚ÌŒŸ“¢. ‚‰€‹MO1,2, òìŒöˆê1, •l“cKG3, ˆäŽèž‘Ÿ˜Y1, •œ–쏟Ž¡1, “c‘㏫l1, ŽOŒŽ@’q1, X‰i–F’q4, ’†‘º–ÎŽ÷1, ¡‘ºŒ\•¶1, ‹{è‘׉Â1, ŠÖ@‰ë•¶1, Š|‰®@O1, ŽR–{‘P—T1, –öŒŽŽ‹I4, {ŽR®Žj2, “c‘ã—²—Ç5, ‰Í–ì@–Î1 (1’·è‘åŠw‘åŠw‰@ˆãŽ•–ò‘‡Œ€‹†‰ÈŠŽõ–ƉuŠwuÀ, 2’·èŽs—§Žs–¯•a‰@“à‰È, 3“Œ•a‰@–òÜ•”, 4’·è‘åŠw•a‰@ŒŸž•”, 5’·è‘åŠwˆãŠw•”•ÛŒ’Šw‰È): ‘æ59‰ñ“ú–{‰»Šw—Ö@Šw‰ïE‰E(2011/6/24), ŽD–y, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ 2011/6; 59 (S-A): 259.

7231053. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw“Œ•a‰@–òÜ•”‚Å‚ÌŽ¡Œ±‹Æ–±‚ÉŠÖ‚·‚éŠw¶ŽÀK‚Ö‚ÌŽæ‚è‘g‚݁|iPad‚ðŠˆ—p‚µ‚œŽÀK•û–@‚ÌŒŸ“¢|. âV“¡—R”üŽq1,2, ¬ò—º•ã1,2, ‚‹ŽŒ«¬1,2, ‘O“cŽÀ‰Ô1,2, î@Ž}1,2, í“cˆ€Žq1,2, ’†‘º’q”ü1, —F•”’qŽ}1,2, Vˆä–œ—Žq1,2, •ŽR­ˆê1,3 (1“Œ•a‰@–òÜ•”, 2“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 3–òŠw•”): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€‘æ19‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/8), ˆ®ì, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011u‰‰—vŽ|W 2011/7; p.213.

7231054. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –ò‹ÇŽÀ–±ŽÀK—šC‚Ì—L–³“™‚É‚æ‚é•a‰@ŽÀ–±ŽÀK‚ւ̉e‹¿‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²ž. ”ò“c—[‹I1, •œŽR•Ži1, ì–ìçq1, •ŽR­ˆê1, –îŒã˜a•v2 (1“Œ•a‰@–òÜ•”, 2–òÜ•”): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€‘æ19‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/9), ˆ®ì ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011u‰‰—vŽ|W 2011/7; p.215.

7231055. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ª‚ñáu’ÉŠ³ŽÒ‚ð‘ΏۂƂµ‚œƒIƒLƒVƒRƒhƒ“™•úù‚©‚çƒtƒFƒ“ƒ^ƒjƒ‹“\•tÜ‚Ö‚Ì“Š—^—ÊŠ·ŽZ”ä‚ÉŠÖ‚·‚錀‹†. •œŽR•Ži1, ì–ìçq1, ”ò“c—[‹I1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï (2011/9/24), –‹’£, ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ïƒvƒƒOƒ‰ƒ€E—vŽ|W 2011; p.198.

7231056. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Á‰»Ší‚ª‚ñáu’ÉŠ³ŽÒ‚ð‘ΏۂƂµ‚œƒ‚ƒ‹ƒqƒl’ŽËÜŽ‘±Ã–¬“à“Š—^‚©‚çƒIƒLƒVƒRƒhƒ“™•úù‚Ö‚Ì“Š—^—ÊŠ·ŽZ”ä‚ÉŠÖ‚·‚錀‹†. ì–ìçq1, •œŽR•Ži1, ”ò“c—[‹I1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï (2011/9/24), –‹’£, ‘æ5‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ïƒvƒƒOƒ‰ƒ€E—vŽ|W 2011; p.199.

7231057. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) isEÄ”­ˆÝŠàŠ³ŽÒ‘ΏہERˆ««Žîᇖò‘æIII‘Š—Տ°ŽŽŒ±‚̏Ǘá“o˜^Žž‚Ì‹Æ–±‚ÌŒø—Š‰». í“cˆ€Žq1,2, î@Ž}1,2, âV“¡—R”üŽq1,2, —F•”’qŽ}1,2, ¬ò—º•ã1,2, ‘O“cŽÀ‰Ô1,2, Vˆä–œ—Žq1,2, •ŽR­ˆê1, ŒF’J—YŽ¡2, ¬ò˜aŽO˜Y3 (1“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 2“Œ•a‰@–òÜ•”, 3Á‰»Ší“à): ‘æ11‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c (2011/9/25), ‰ªŽR, ‘æ11‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2011 in ‰ªŽRƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.150.

7231058. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž¡Œ±–òŠÇ—‘̐§‚ÌŒø—Š‰»‚ÉŠÖ‚·‚錟“¢`Ž¡Œ±–òŠÇ—•\‚Ì•W€—lŽ®‚̍쐬`. —F•”’qŽ}1,2, âV“¡—R”üŽq1,2, ‘O“cŽÀ‰Ô1,2, î@Ž}1,2, í“cˆ€Žq1,2, ¬ò—º•ã1,2, ‰¡ER_Žq1,2, Vˆä–œ—Žq1,2, •ŽR­ˆê2, ŒF’J—YŽ¡1 (1“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 2“Œ•a‰@–òÜ•”): ‘æ11‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c (2011/9/25), ‰ªŽR, ‘æ11‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2011 in ‰ªŽRƒvƒƒOƒ‰ƒ€EŽ˜^W 2011; p.226.

7231059. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Œ“ú–{‘åkÐŒã‚̍ЊQˆã—ɇ•ƒ`[ƒ€‚É‚š‚¯‚é–òÜŽt‚Ì–ðŠ„. Ô—䑏•F1, ²X–ØŽõŽq2, ¬—я¹G2, ŠLÀ@2, ‚‹Ž”ü—R‹I1, Vˆä–œ—Žq1, ¡–ìTŒá3, –îŒã˜a•v2,4, •ŽR­ˆê1,4 (1“Œ•a‰@–òÜ•”, 2–òÜ•”, 3‹~–œ, 4–òŠw•”): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2011/9; p.185.

7231060. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a‰@–òÜŽt‚Ì‚ª‚ñˆã—ÂɊւí‚錀‹†‚ÌŒ»ó|“ú–{•a‰@–òÜŽt‰ïŽGŽ‚š‚æ‚шã—ÖòŠw‚Ö‚Ì“Še˜_•¶‚©‚猩‚œlŽ@|. ‰ª–{Œb”üŽq1, •ŽR­ˆê1,2 (1“Œ•a‰@–òÜ•”, 2–òŠw•”): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2011/9; p.234.

7231061. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žs”̖ŋۍς݃xƒ“ƒUƒ‹ƒRƒjƒEƒ€‰–‰»•šŽÀ—p”Z“x‰t‚̏¬•ª‚¯’²»Œã‚̊ܗʕω»‚È‚ç‚Ñ‚É”÷¶•š‰˜õ‚ÉŠÖ‚·‚錟“¢. ‘꓇˜aW1, •l“cKG1, ²X–Ø‘PM1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2011/9; p.252.

7231062. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –òÜŽt‚Ì‹Ö‰ŒŽx‰‡‚ÉŠÖ‚·‚é’mŽ¯‚Æ‹Ö‰Œu‹`‚ÌŒø‰Ê. ‘Š‘ò­–Ÿ1, ˜hŒ©³G2, ²X–Ø‘PM1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”, 2‰¡•l–ò‰È‘åŠw—Տ°–òŠw): ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2011/10/2), _ŒË, ‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2011/9; p.284.

7231063. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚éƒ{ƒŠƒRƒiƒ][ƒ‹“Š—^Ç—á‚Ì•›ì—p‚ÌŒŸ“¢. •œ–쏟Ž¡1, òìŒöˆê1, •l“cKG2, ‚‰€‹MO3, ˆäŽèž‘Ÿ˜Y1, “c‘㏫l1, ŽOŒŽ@’q1, X‰i–F’q4, ’†‘º–ÎŽ÷1, ¡‘ºŒ\•¶1, ‹{è‘׉Â1, Š|‰®@O1, ŽR–{‘P—T1, –öŒŽŽ‹I4, {ŽR®Žj3, “c‘ã—²—Ç5, ‰Í–ì@–Î1 (1’·è‘åŠw‘åŠw‰@ˆãŽ•–ò‘‡Œ€‹†‰ÈŠŽõ–ƉuŠwuÀ, 2“Œ•a‰@–òÜ•”, 3’·èŽs—§Žs–¯•a‰@“à‰È, 4’·è‘åŠw•a‰@ŒŸž•”, 5’·è‘åŠwˆãŠw•”•ÛŒ’Šw‰È): ‘æ55 ‰ñ“ú–{ˆã^‹ÛŠwEEwpW‰ï (2011/10/22), “Œ‹ž, Medical Mycology Journal 2011; 52 (Supple 1): 101.

7231064. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EE|ƒXƒ^[) —Տ°–ò—ŽŽŒ±ŽQ‰ÁŠó–]ŽÒ‚ÌŒŸžƒf[ƒ^‚Ì”NŽŸ’²ž2|ŒŒˆ³, –¬””|. ’†‘º’q”ü1,2, Îè¹D3, ‘O“cŽÀ‰Ô1,2, Vˆä–œ—Žq1,2, •ŽR­ˆê1, “cƒ–’J_–M3, ’r“cN•F2, “¡“c•üŒb2, ŒF’J—YŽ¡2 (1“Œ•a‰@–òÜ•”, 2“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 3ˆã—Éq¶Šw•”): ‘æ32‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2011/12/2), •lŒ, —Տ°–ò— 2011/10; 42 (Suppl): S315.

7231065. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒsƒyƒ‰ƒVƒŠƒ“ƒiƒgƒŠƒEƒ€’PÜ‚É‹Nˆö‹ÛŒŸo•”ˆÊEMIC‚ðl—¶‚µ‚œ—LŒø«‚ÉŠÖ‚·‚錀‹†. •œŽR•Ži1, •l“cKG1, ¬ŒŽ”ü]1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ27‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2012/2/3), •Ÿ‰ª, ŠÂ‹«ŠŽõŽ 2012/1; 27 (Supple 1): 211.

7231066. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žs”̖ŋۍς݃xƒ“ƒUƒ‹ƒRƒjƒEƒ€‰–‰»•šŽÀ—p”Z“x‰t‚̏¬•ª‚¯’²»Œã‚̊ܗʕω»‚È‚ç‚Ñ‚É”÷¶•š‰˜õ‚ÉŠÖ‚·‚錟“¢. ‘꓇˜aW1, •l“cKG1, ²X–Ø‘PM1, Š‰Y@H2, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”, 2‹g“c»–òŠ”Ž®‰ïŽÐ): ‘æ27‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2012/2/4), •Ÿ‰ª, ŠÂ‹«ŠŽõŽ 2012/1; 27 (Supple 1): 321.

7231067. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ®Œ`ŠO‰È—̈æ‚É‚š‚¯‚鉺ŽˆŠO‰ÈŽèpŒã‚̐Ö¬ŒŒðÇðÇ—\–h–ò‚Ì—LŒø«‹y‚шÀ‘S«‚ÉŠÖ‚·‚鏉Šú‰ðÍ. Ô—䑏•F1, Šâ²Œ³‹P2, •l“cKG1, •œŽR•Ži1,2, Vˆä–œ—Žq1, ‚•œ®L3, •ŽR­ˆê1,2 (1“Œ•a‰@–òÜ•”, 2–òŠw•”, 3ˆã—Éq¶Šw•”): “ú–{–òŠw‰ï‘æ132”N‰ï (2012/3/31), ŽD–y, “ú–{–òŠw‰ï‘æ132”N‰ïDVD—vŽ|W 2012; 132 (4): 280.

732162. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ¶ŠˆKŠµ•aŠO—ˆ‚É‚š‚¯‚郊ƒAƒ‹ƒ^ƒCƒ€ƒ`[ƒ€ˆã—Â̗L—p«. ‘Š‘ò­–Ÿ1, ‘êìˆŸ–í1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ104‰ñŠÖ“ŒŽ„—§ˆã‘å•a‰@–òÜ•”Œ€‹†‰ï (2012/11/12), “Œ‹ž.

733507. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Žs”̖ŋۍς݃xƒ“ƒUƒ‹ƒRƒjƒEƒ€‰–‰»•šŽÀ—p”Z“x‰t‚̏¬•ª‚¯’²»Œã‚̊ܗʕω»‚È‚ç‚Ñ‚É”÷¶•š‰˜õ‚ÉŠÖ‚·‚錀‹†. ‘꓇˜aW1, •ŽR­ˆê1, •l“cKG1, ²X–Ø‘PM1 (1“Œ•a‰@–òÜ•”): ICŒ€‹†‰ï|ƒtƒ[ƒŒƒ“ƒXƒNƒ‰ƒu‘æ3‰ñŠwpW‰ï (2011/6/11), “Œ‹ž, ICŒ€‹†‰ï|ƒtƒ[ƒŒƒ“ƒXƒNƒ‰ƒu\‘æ3‰ñŠwpW‰ïŽ˜^W 2011; p.13.

733508. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Žs”̖ŋۍς݃xƒ“ƒUƒ‹ƒRƒjƒEƒ€‰–‰»•šŽÀ—p”Z“x‰t‚̏¬•ª‚¯’²»Œã‚̊ܗʕω»‚È‚ç‚Ñ‚É”÷¶•š‰˜õ‚ÉŠÖ‚·‚錀‹†. ‘꓇˜aW1, •ŽR­ˆê1, •l“cKG1, ²X–Ø‘PM1 (1“Œ•a‰@–òÜ•”): –k—¢‘åŠw“Œ•a‰@EˆõŒ€‹†”­•\‰ï (2011/6/27), ‘Š–ÍŒŽ, •œ¬22”N“x–k—¢‘åŠw“Œ•a‰@EˆõŒ€‹†Ž˜^W 2011; 25†: 1-4.

733509. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’ŽË—pƒLƒbƒg»Ü‚Ì—L—p«; —Տ°‚Ì—§ê‚©‚ç‚Ì•]‰¿. •ŽR­ˆê (“Œ•a‰@–òÜ•”): Pharmatec Japan 2012 (2012/3/22), “Œ‹ž, Pharmatec Japan 2012ƒZƒ~ƒi[ƒvƒƒOƒ‰ƒ€ 2012.

“Œ•a‰@ˆã—Ïî•ñŠÇ—•”f—Ïî•ñŠÇ—‰Û